PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Curk, T; Marenduzzo, D; Dobnikar, J				Curk, Tine; Marenduzzo, Davide; Dobnikar, Jure			Chemotactic Sensing towards Ambient and Secreted Attractant Drives Collective Behaviour of E. coli	PLOS ONE			English	Article							PATTERNS	We simulate the dynamics of a suspension of bacterial swimmers, which chemotactically sense gradients in either ambient or self-secreted attractants (e.g. nutrient or aspartate respectively), or in both. Unlike previous mean field models based on a set of continuum partial differential equations, our model resolves single swimmers and therefore incorporates stochasticity and effects due to fluctuations in the bacterial density field. The algorithm we use is simple enough that we can follow the evolution of colonies of up to over a million bacteria for timescales relevant to pattern formation for E. coli growing in semisolid medium such as agar, or in confined geometries. Our results confirm previous mean field results that the patterns observed experimentally can be reproduced with a model incorporating chemoattractant secretion, chemotaxis (towards gradients in the chemoattractant field), and bacterial reproduction. They also suggest that further experiments with bacterial strains chemotactically moving up both nutrient and secreted attractant field may yield yet more dynamical patterns.	[Curk, Tine; Dobnikar, Jure] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Marenduzzo, Davide] Univ Edinburgh, Dept Phys, Edinburgh, Midlothian, Scotland; [Dobnikar, Jure] Jozef Stefan Inst, Dept Theoret Phys, Ljubljana, Slovenia	University of Cambridge; University of Edinburgh; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Dobnikar, J (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	jd489@cam.ac.uk	Dobnikar, Jure/C-8765-2011	Dobnikar, Jure/0000-0002-1169-6619; Curk, Tine/0000-0002-2167-5336; Marenduzzo, Davide/0000-0003-3974-4915	European Union [G-ERC COLSTRUCTION 227758, ITN-COMPLOIDS 234810]; Pan-European Research Infrastructure for High Performance Computing HPC-Europa2; Slovenian Research Agency [P1-0055]; EPSRC [EP/J007404/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J007404/1] Funding Source: researchfish	European Union(European Commission); Pan-European Research Infrastructure for High Performance Computing HPC-Europa2; Slovenian Research Agency(Slovenian Research Agency - Slovenia); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the 7th Framework Program of European Union through grants ARG-ERC COLSTRUCTION 227758 and ITN-COMPLOIDS 234810, by the Pan-European Research Infrastructure for High Performance Computing HPC-Europa2 (http://www.hpc-europa.org/), and by the Slovenian Research Agency through grant P1-0055 (J.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Baskaran A, 2009, P NATL ACAD SCI USA, V106, P15567, DOI 10.1073/pnas.0906586106; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; Berg H C, 2003, E COLI MOTION; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Cates ME, 2010, P NATL ACAD SCI USA, V107, P11715, DOI 10.1073/pnas.1001994107; Curk T, 2012, ADV EXP MED BIOL, V736, P381, DOI 10.1007/978-1-4419-7210-1_22; Elgeti J, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/38002; Esipov SE, 1998, J MATH BIOL, V36, P249, DOI 10.1007/s002850050100; Flores M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.148101; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Kalinin YV, 2009, BIOPHYS J, V96, P2439, DOI 10.1016/j.bpj.2008.10.027; Kawasaki K, 1997, J THEOR BIOL, V188, P177, DOI 10.1006/jtbi.1997.0462; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Li GL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.078101; Matthaus F, 2009, BIOPHYS J, V97, P946, DOI 10.1016/j.bpj.2009.04.065; Matthaus F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018623; Murray J. D., 2001, MATH BIOL, V18; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; SHAPIRO JA, 1995, BIOESSAYS, V17, P597, DOI 10.1002/bies.950170706; Tailleur J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218103; Tyson R, 1999, P ROY SOC B-BIOL SCI, V266, P299, DOI 10.1098/rspb.1999.0637; WOODWARD DE, 1995, BIOPHYS J, V68, P2181; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	28	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74878	10.1371/journal.pone.0074878	http://dx.doi.org/10.1371/journal.pone.0074878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098352	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600010
J	Punjabi, GA; Chellam, R; Vanak, AT				Punjabi, Girish Arjun; Chellam, Ravi; Vanak, Abi Tamim			Importance of Native Grassland Habitat for Den-Site Selection of Indian Foxes in a Fragmented Landscape	PLOS ONE			English	Article							CLASSIFICATION-BASED ANALYSES; VULPES-BENGALENSIS; RESOURCE SELECTION; RED FOXES; COMPETITION; SURVIVAL; COYOTES; DOGS; HOME	Fragmentation of native habitats is now a ubiquitous phenomenon affecting wildlife at various scales. We examined selection of den-sites (n = 26) by Indian foxes (Vulpes bengalensis) in a highly modified short-grassland landscape in central India (Jan-May, 2010). At the scale of the home-range, defined by an 800 m circular buffer around den sites, we examined the effect of land-cover edges and roads on selection of sites for denning using a distance-based approach. At the smaller den-area scale, defined by a 25 m x 25 m plot around den and paired available sites, the effect of microhabitat characteristics was examined using discrete-choice models. Indian foxes selected den-sites closer to native grasslands (t = -9.57, P < 0.001) and roads (t = -2.04, P = 0.05) than random at the home-range scale. At the smaller scale, abundance of rodents and higher visibility increased the odds of selection of a site by eight and four times respectively, indicating resource availability and predator avoidance to be important considerations for foxes. Indian foxes largely chose to den in human-made structures, indicated by the proportion of dens found in earthen bunds (0.69) and boulder piles (0.27) in the study area. With agricultural expansion and human modification threatening native short-grassland habitats, their conservation and effective management in human-dominated landscapes will benefit the Indian fox. The presence of some human-made structures within native grasslands would also be beneficial for this den-dependent species. We suggest future studies examine the impact of fragmentation and connectivity of grasslands on survival and reproductive success of the Indian fox.	[Punjabi, Girish Arjun] Tata Inst Fundamental Res, Post Grad Programme Wildlife Biol & Conservat, Wildlife Conservat Soc, India Program,Natl Ctr Biol Sci, Bengaluru, India; [Chellam, Ravi] Ctr Herpetol, Madras Crocodile Bank Trust, Mamallapuram, Tamil Nadu, India; [Vanak, Abi Tamim] Ashoka Trust Res Ecol & Environm, Ctr Biodivers & Conservat, Bengaluru, India; [Vanak, Abi Tamim] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Kwazulu Natal	Punjabi, GA (corresponding author), Tata Inst Fundamental Res, Post Grad Programme Wildlife Biol & Conservat, Wildlife Conservat Soc, India Program,Natl Ctr Biol Sci, Bengaluru, India.	girisharjunpunjabi@gmail.com	Vanak, Abi/F-8519-2010	Vanak, Abi/0000-0003-2435-4260	Department of Science & Technology, Government of India	Department of Science & Technology, Government of India(Department of Science & Technology (India))	The study was funded by the Department of Science & Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, R VERS 2 15 2; Bhaskaran A, 2006, MODELLING HABITAT SE; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Conner LM, 2005, ECOLOGY, V86, P3125, DOI 10.1890/05-0760; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Di Bitetti MS, 2009, J MAMMAL, V90, P479, DOI 10.1644/08-MAMM-A-113.1; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; EBERHARDT LE, 1983, J MAMMAL, V64, P97, DOI 10.2307/1380754; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fitz-Gibbon Carol T., 1987, HOW TO ANAL DATA; Gompper Matthew E., 2006, Mammalian Species, P1, DOI 10.1644/795.1; Google Inc, 2011, GOOGL EARTH VERS 5 1; Gosselink TE, 2003, J WILDLIFE MANAGE, V67, P90, DOI 10.2307/3803065; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Habib B, 2007, J ZOOL, V272, P259, DOI 10.1111/j.1469-7998.2006.00265.x; Home Chandrima, 2010, Canid News, V13, P1; Home C, 2009, MAMM BIOL, V74, P403, DOI 10.1016/j.mambio.2009.05.011; Johnsingh AJT, 2008, IUCN 2010 IUCN RED L; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kamler JF, 2012, J WILDLIFE MANAGE, V76, P1241, DOI 10.1002/jwmg.354; Kamler JF, 2003, J MAMMAL, V84, P989, DOI 10.1644/BJK-033; Koopman ME, 1998, J WILDLIFE MANAGE, V62, P373, DOI 10.2307/3802301; Lesmeister DB, 2008, J MAMMAL, V89, P1512, DOI 10.1644/07-MAMM-A-361.1; Manakadan Ranjit, 2000, Journal of the Bombay Natural History Society, V97, P3; Mazerolle M. J., 2012, MODEL SELECTION MULT; Nelson JL, 2007, J WILDLIFE MANAGE, V71, P1467, DOI 10.2193/2006-234; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; QGIS, 2020, QGIS GEOGR INF SYST; Ramesh D, 2013, POPUL ECOL, V55, P241, DOI 10.1007/s10144-012-0340-7; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; SARGEANT AB, 1987, J WILDLIFE MANAGE, V51, P285, DOI 10.2307/3801004; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Singh P., 2006, REPORT TASK FORCE GR; Snow NP, 2012, J WILDLIFE MANAGE, V76, P243, DOI 10.1002/jwmg.247; Szor G, 2008, POLAR BIOL, V31, P351, DOI 10.1007/s00300-007-0364-1; Tannerfeldt M., 2003, ECOLOGY CONSERVATION, P167; Vanak AT, 2010, J ZOOL, V281, P140, DOI 10.1111/j.1469-7998.2010.00690.x; Vanak A.T., 2008, INTRAGUILD INTERACTI; Vanak AT, 2007, WILDLIFE BIOL, V13, P219, DOI 10.2981/0909-6396(2007)13[219:EONTFS]2.0.CO;2; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak Abi Tamim, 2005, Canid News, V8, P1; Vanak AT, 2009, J MAMMAL, V90, P1058, DOI 10.1644/09-MAMM-A-107.1; Vieira EM, 2007, J ZOOL, V272, P57, DOI 10.1111/j.1469-7998.2006.00237.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	47	11	13	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76410	10.1371/journal.pone.0076410	http://dx.doi.org/10.1371/journal.pone.0076410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098494	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600046
J	Siegl, C; Hamminger, P; Jank, H; Ahting, U; Bader, B; Danek, A; Gregory, A; Hartig, M; Hayflick, S; Hermann, A; Prokisch, H; Sammler, EM; Yapici, Z; Prohaska, R; Salzer, U				Siegl, Claudia; Hamminger, Patricia; Jank, Herbert; Ahting, Uwe; Bader, Benedikt; Danek, Adrian; Gregory, Allison; Hartig, Monika; Hayflick, Susan; Hermann, Andreas; Prokisch, Holger; Sammler, Esther M.; Yapici, Zuhal; Prohaska, Rainer; Salzer, Ulrich			Alterations of Red Cell Membrane Properties in Nneuroacanthocytosis	PLOS ONE			English	Article							PHOSPHATIDYLSERINE EXPOSURE; LYSOPHOSPHATIDIC ACID; ERYTHROCYTE-MEMBRANE; CHOREA-ACANTHOCYTOSIS; MOLECULAR-MECHANISM; MCLEOD-SYNDROME; PROTEIN; BLOOD; CYTOSKELETON; BRAIN	Neuroacanthocytosis (NA) refers to a group of heterogenous, rare genetic disorders, namely chorea acanthocytosis (ChAc), McLeod syndrome (MLS), Huntington's disease-like 2 (HDL2) and pantothenate kinase associated neurodegeneration (PKAN), that mainly affect the basal ganglia and are associated with similar neurological symptoms. PKAN is also assigned to a group of rare neurodegenerative diseases, known as NBIA (neurodegeneration with brain iron accumulation), associated with iron accumulation in the basal ganglia and progressive movement disorder. Acanthocytosis, the occurrence of misshaped erythrocytes with thorny protrusions, is frequently observed in ChAc and MLS patients but less prevalent in PKAN (about 10%) and HDL2 patients. The pathological factors that lead to the formation of the acanthocytic red blood cell shape are currently unknown. The aim of this study was to determine whether NA/NBIA acanthocytes differ in their functionality from normal erythrocytes. Several flow-cytometry-based assays were applied to test the physiological responses of the plasma membrane, namely drug-induced endocytosis, phosphatidylserine exposure and calcium uptake upon treatment with lysophosphatidic acid. ChAc red cell samples clearly showed a reduced response in drug-induced endovesiculation, lysophosphatidic acid-induced phosphatidylserine exposure, and calcium uptake. Impaired responses were also observed in acanthocyte-positive NBIA (PKAN) red cells but not in patient cells without shape abnormalities. These data suggest an "acanthocytic state" of the red cell where alterations in functional and interdependent membrane properties arise together with an acanthocytic cell shape. Further elucidation of the aberrant molecular mechanisms that cause this acanthocytic state may possibly help to evaluate the pathological pathways leading to neurodegeneration.	[Siegl, Claudia; Hamminger, Patricia; Jank, Herbert; Prohaska, Rainer; Salzer, Ulrich] Med Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Ahting, Uwe; Hartig, Monika; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Bader, Benedikt; Danek, Adrian] Univ Munich, Neurol Klin & Poliklin, Munich, Germany; [Gregory, Allison; Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Hermann, Andreas] Tech Univ Dresden, Div Neurodegenerat Dis, Dept Neurol, Dresden, Germany; [Hermann, Andreas] German Ctr Neurodegenerat Dis DZNE, Dresden, Germany; [Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Sammler, Esther M.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Neurol, Dundee DD1 9SY, Scotland; [Yapici, Zuhal] Istanbul Univ, Div Child Neurol, Dept Neurol, Istanbul Fac Med, Istanbul, Turkey; [Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Oregon Health & Science University; Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Dundee; Istanbul University; Oregon Health & Science University; Oregon Health & Science University	Salzer, U (corresponding author), Med Univ Vienna, Max F Perutz Labs, Vienna, Austria.	ulrich.salzer@meduniwien.ac.at	Prokisch, Holger/N-8964-2013; Hermann, Andreas/D-4213-2017; Danek, Adrian/G-7339-2011	Hermann, Andreas/0000-0002-7364-7791; Danek, Adrian/0000-0001-8857-5383; Prokisch, Holger/0000-0003-2379-6286; Salzer, Ulrich/0000-0002-3721-7225; Sammler, Esther/0000-0003-3218-7116	Advocacy for Neuroacanthocytosis Patients; NBIA Disorders Association; Herzfelder'sche Familienstiftung; Austrian Science Fund (FWF) [I 438-B13]; ERA-Net/E-Rare project "EMINA" (European Multidisciplinary Initiative on Neuroacanthocytosis); European Commission [277984]; Austrian Science Fund (FWF) [I 438] Funding Source: researchfish	Advocacy for Neuroacanthocytosis Patients; NBIA Disorders Association; Herzfelder'sche Familienstiftung; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ERA-Net/E-Rare project "EMINA" (European Multidisciplinary Initiative on Neuroacanthocytosis); European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded in part by the Advocacy for Neuroacanthocytosis Patients (www.naadvocacy.org), the NBIA Disorders Association, the Herzfelder'sche Familienstiftung, the Austrian Science Fund (FWF), grant I 438-B13, the ERA-Net/E-Rare project "EMINA" (European Multidisciplinary Initiative on Neuroacanthocytosis (www.e-rare.eu/financed-projects/emina), the European Commission Seventh Framework Programme (FP7/2007-2013, HEALTH-F2-2011, No. 277984, TIRCON) and Tenovus Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; An XL, 2004, BIOCHEMISTRY-US, V43, P310, DOI 10.1021/bi035653h; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Bader B, 2010, MOVEMENT DISORD, V25, P127, DOI 10.1002/mds.22863; Chung SM, 2007, ARTERIOSCL THROM VAS, V27, P414, DOI 10.1161/01.ATV.0000252898.48084.6a; De Franceschi L, 2011, BLOOD, V118, P5652, DOI 10.1182/blood-2011-05-355339; de Jong K, 2002, BIOCHEMISTRY-US, V41, P12562, DOI 10.1021/bi025882o; Dobson-Stone C, 2004, ANN NEUROL, V56, P299, DOI 10.1002/ana.20200; Nguyen DB, 2011, CELL PHYSIOL BIOCHEM, V28, P847, DOI 10.1159/000335798; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; FEINBERG TE, 1991, NEUROLOGY, V41, P1000, DOI 10.1212/WNL.41.7.1000; Foller M, 2012, FASEB J, V26, P1526, DOI 10.1096/fj.11-198317; Gimsa J, 1998, BIOPHYS J, V75, P568, DOI 10.1016/S0006-3495(98)77546-0; GIMSA J, 1995, MOL MEMBR BIOL, V12, P247, DOI 10.3109/09687689509072424; Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; HO MF, 1994, CELL, V77, P869, DOI 10.1016/0092-8674(94)90136-8; Hogarth P, 2013, NEUROLOGY, V80, P268, DOI 10.1212/WNL.0b013e31827e07be; Hosokawa T, 1992, No To Shinkei, V44, P739; Jeremy KP, 2009, HAEMATOL-HEMATOL J, V94, P1354, DOI 10.3324/haematol.2009.006585; KHODADAD JK, 1989, J MEMBRANE BIOL, V107, P213, DOI 10.1007/BF01871936; Khodadad JK, 1996, BIOPHYS J, V70, P1036, DOI 10.1016/S0006-3495(96)79649-2; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; LANGE Y, 1984, J MEMBRANE BIOL, V77, P153; MARIANI M, 1993, J BIOL CHEM, V268, P12996; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Olivieri O, 1997, HAEMATOLOGICA, V82, P648; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Prohaska R, 2012, NEUROBIOL DIS, V46, P607, DOI 10.1016/j.nbd.2012.03.006; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Salzer U, 2002, BLOOD, V99, P2569, DOI 10.1182/blood.V99.7.2569; Salzer U, 2008, ADV PLANAR LIP BILAY, V6, P49, DOI 10.1016/S1554-4516(07)06003-6; Sayas CL, 2002, BBA-MOL CELL BIOL L, V1582, P144, DOI 10.1016/S1388-1981(02)00149-X; Scheid R, 2009, NEUROLOGY, V73, P1419, DOI 10.1212/WNL.0b013e3181bd80d4; SCHRIER SL, 1983, J CLIN INVEST, V72, P1698, DOI 10.1172/JCI111129; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Terada N, 1999, ACTA HAEMATOL-BASEL, V101, P25, DOI 10.1159/000040917; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Walker RH, 2007, NEUROLOGY, V68, P92, DOI 10.1212/01.wnl.0000250356.78092.cc; Walker RH, 2003, NEUROLOGY, V61, P1002, DOI 10.1212/01.WNL.0000085866.68470.6D; Wieschhaus A, 2012, BIOCHEM J, V448, P141, DOI 10.1042/BJ20121008; Wong P, 1999, J THEOR BIOL, V196, P343, DOI 10.1006/jtbi.1998.0845; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	45	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76715	10.1371/journal.pone.0076715	http://dx.doi.org/10.1371/journal.pone.0076715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098554	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600073
J	Yamanaka-Tatematsu, M; Nakashima, A; Fujita, N; Shima, T; Yoshimori, T; Saito, S				Yamanaka-Tatematsu, Mikiko; Nakashima, Akitoshi; Fujita, Naonobu; Shima, Tomoko; Yoshimori, Tamotsu; Saito, Shigeru			Autophagy Induced by HIF1 alpha Overexpression Supports Trophoblast Invasion by Supplying Cellular Energy	PLOS ONE			English	Article							HUMAN PLACENTAL DEVELOPMENT; INDUCIBLE FACTOR-I; 1ST TRIMESTER; HYPOXIA; CELLS; OXYGEN; PREECLAMPSIA; ESTABLISHMENT; RECEPTORS; PREGNANCY	Extravillous trophoblasts (EVTs) characterize the invasion of the maternal decidua under low oxygen and poor nutrition at the early feto-maternal interface to establish a successful pregnancy. We previously reported that autophagy in EVTs was activated under 2% O-2 in vitro, and autophagy activation was also observed in EVTs at the early feto-maternal interface in vivo. Here, we show that autophagy is an energy source for the invasion of EVTs. Cobalt chloride (CoCl2), which induces hypoxia inducible factor 1 alpha (HIF1 alpha) overexpression, activated autophagy in HTR8/SVneo cells, an EVT cell line. The number of invading HTR8-ATG4B(C74A) cells, an autophagy-deficient EVT cell line, was markedly reduced by 81 percent with the CoCl2 treatment through the suppression of MMP9 level, although CoCl2 did not affect the cellular invasion of HTR8-mStrawberry cells, a control cell line. HTR8-ATG4B(C74A) cells treated with CoCl2 showed a decrease in cellular adenosine triphosphate (ATP) levels and a compensatory increase in the expression of purinergic receptor P2X ligand-gated ion channel 7 (P2RX7), which is stimulated with ATP, whereas HTR8- mStrawberry cells maintained cellular ATP levels and did not affect P2RX7 expression. Furthermore, the decreased invasiveness of HTR8-ATG4B(C74A) cells treated with CoCl2 was neutralized by ATP supplementation to the level of HTR8-ATG4B(C74A) cells treated without CoCl2. These results suggest that autophagy plays a role in maintaining homeostasis by countervailing HIF1 alpha-mediated cellular energy consumption in EVTs.	[Yamanaka-Tatematsu, Mikiko; Nakashima, Akitoshi; Shima, Tomoko; Saito, Shigeru] Toyama Univ, Fac Med, Dept Obstet & Gynecol, Toyama 930, Japan; [Fujita, Naonobu; Yoshimori, Tamotsu] Osaka Univ, Dept Genet, Grad Sch Med, Suita, Osaka, Japan	University of Toyama; Osaka University	Saito, S (corresponding author), Toyama Univ, Fac Med, Dept Obstet & Gynecol, Toyama 930, Japan.	s30saito@med.u-toyama.ac.jp	Fujita, Naonobu/A-1218-2010	Fujita, Naonobu/0000-0003-1914-8438	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390386, 22659297, 23791817]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [a Grant-in-Aid for Scientific Research, (B)-23390386, a Grant-in-Aid for Challenging Exploratory Research, (C)-22659297, and a Grant-in-Aid for young scientists, (B)-23791817]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chen G, 2013, CARDIOVASC RES, V98, P437, DOI 10.1093/cvr/cvt035; Choi Jong-Ho, 2012, Clin Exp Reprod Med, V39, P73, DOI 10.5653/cerm.2012.39.2.73; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Ietta F, 2006, BIOL REPROD, V75, P112, DOI 10.1095/biolreprod.106.051557; Jauniaux E, 2005, J CLIN ENDOCR METAB, V90, P1171, DOI 10.1210/jc.2004-1513; Jauniaux E, 2001, AM J OBSTET GYNECOL, V184, P998, DOI 10.1067/mob.2001.111935; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Lai ZB, 2011, HYPERTENSION, V57, P505, DOI 10.1161/HYPERTENSIONAHA.110.163329; Lu HF, 2007, BIOCHEM BIOPH RES CO, V362, P946, DOI 10.1016/j.bbrc.2007.08.095; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Nakashima A, 2013, AUTOPHAGY, V9, P303, DOI 10.4161/auto.22927; Nakashima A, 2010, AM J REPROD IMMUNOL, V63, P104, DOI 10.1111/j.1600-0897.2009.00771.x; Omi H, 2009, INT J MOL MED, V23, P229, DOI 10.3892/ijmm_00000121; Poellinger L, 2004, CURR OPIN GENET DEV, V14, P81, DOI 10.1016/j.gde.2003.12.006; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Redman CWG, 1997, NAT MED, V3, P610, DOI 10.1038/nm0697-610; Rolfo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013288; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Starzyk KA, 1997, HUM PATHOL, V28, P353, DOI 10.1016/S0046-8177(97)90135-0; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Trabanelli S, 2012, J IMMUNOL, V189, P1303, DOI 10.4049/jimmunol.1103800; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	32	57	59	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76605	10.1371/journal.pone.0076605	http://dx.doi.org/10.1371/journal.pone.0076605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098539	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600067
J	Larsen, BB; Chen, LN; Maust, BS; Kim, M; Zhao, H; Deng, WJ; Westfall, D; Beck, I; Frenkel, LM; Mullins, JI				Larsen, Brendan B.; Chen, Lennie; Maust, Brandon S.; Kim, Moon; Zhao, Hong; Deng, Wenjie; Westfall, Dylan; Beck, Ingrid; Frenkel, Lisa M.; Mullins, James I.			Improved Detection of Rare HIV-1 Variants using 454 Pyrosequencing	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; LIMITING DILUTION ASSAYS; VIRUS TYPE-1 RNA; ANTIRETROVIRAL THERAPY; TREATMENT-NAIVE; REVERSE-TRANSCRIPTASE; RESISTANT VARIANTS; DRUG-RESISTANCE; VIRAL VARIANTS; PCR ASSAY	454 pyrosequencing, a massively parallel sequencing (MPS) technology, is often used to study HIV genetic variation. However, the substantial mismatch error rate of the PCR required to prepare HIV-containing samples for pyrosequencing has limited the detection of rare variants within viral populations to those present above similar to 1%. To improve detection of rare variants, we varied PCR enzymes and conditions to identify those that combined high sensitivity with a low error rate. Substitution errors were found to vary up to 3-fold between the different enzymes tested. The sensitivity of each enzyme, which impacts the number of templates amplified for pyrosequencing, was shown to vary, although not consistently across genes and different samples. We also describe an amplicon-based method to improve the consistency of read coverage over stretches of the HIV-1 genome. Twenty-two primers were designed to amplify 11 overlapping amplicons in the HIV-1 clade B gag-pol and env gp120 coding regions to encompass 4.7 kb of the viral genome per sample at sensitivities as low as 0.01-0.2%.	[Larsen, Brendan B.; Chen, Lennie; Maust, Brandon S.; Kim, Moon; Zhao, Hong; Deng, Wenjie; Westfall, Dylan; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Beck, Ingrid; Frenkel, Lisa M.] Childrens Hosp Res Inst, Seattle, WA USA; [Beck, Ingrid; Frenkel, Lisa M.; Mullins, James I.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Frenkel, Lisa M.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu		Frenkel, Lisa M/0000-0001-9566-8959	National Institute of Allergy and Infectious Diseases [PO1AI057005, UM1AI068618, R37AI47734]; University of Washington Centers for AIDS Research Computational Biology Core [P30AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R37AI047734, P01AI057005, UM1AI068618] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Centers for AIDS Research Computational Biology Core; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from National Institute of Allergy and Infectious Diseases to J.I.M. (PO1AI057005, UM1AI068618 and R37AI47734) and the University of Washington Centers for AIDS Research Computational Biology Core (P30AI027757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1; Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; Becker EA, 2012, GENOME BIOL EVOL, V4, P457, DOI 10.1093/gbe/evs029; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buzon MJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002314; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Geretti AM, 2009, JAIDS-J ACQ IMM DEF, V52, P569, DOI 10.1097/QAI.0b013e3181ba11e8; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Iyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073015; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Lataillade M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030118; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Love TMT, 2010, J VIROL, V84, P5802, DOI 10.1128/JVI.00117-10; Luo LX, 2013, BIOINFORMATICS: CONCEPTS, METHODOLOGIES, TOOLS, AND APPLICATIONS, P798, DOI 10.4018/978-1-4666-3604-0.ch042; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Mallona I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-404; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Redd AD, 2011, J CLIN MICROBIOL, V49, P2859, DOI 10.1128/JCM.00804-11; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schmitt MW, 2012, P NATL ACAD SCI US; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; TASWELL C, 1981, J IMMUNOL, V126, P1614; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119	47	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76502	10.1371/journal.pone.0076502	http://dx.doi.org/10.1371/journal.pone.0076502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098517	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500069
J	Moquin, DM; McQuade, T; Chan, FKM				Moquin, David M.; McQuade, Thomas; Chan, Francis Ka-Ming			CYLD Deubiquitinates RIP1 in the TNF alpha-Induced Necrosome to Facilitate Kinase Activation and Programmed Necrosis	PLOS ONE			English	Article							NF-KAPPA-B; RECEPTOR-INTERACTING PROTEIN; MIXED LINEAGE KINASE; CELL-DEATH; INDUCED APOPTOSIS; DEPENDENT APOPTOSIS; SIGNALING COMPLEX; ENZYME CYLD; DOMAIN-LIKE; UBIQUITINATION	Background: Necroptosis/programmed necrosis is initiated by a macro-molecular protein complex termed the necrosome. Receptor interacting protein kinase 1 (RIPK1/RIP1) and RIP3 are key components of the necrosome. TNF alpha is a prototypic inducer of necrosome activation, and it is widely believed that deubiquitination of RIP1 at the TNFR-1 signaling complex precedes transition of RIP1 into the cytosol where it forms the RIP1-RIP3 necrosome. Cylindromatosis (CYLD) is believed to promote programmed necrosis by facilitating RIP1 deubiquitination at this membrane receptor complex. Methodology/Principal Findings: We demonstrate that RIP1 is indeed the primary target of CYLD in TNF alpha-induced programmed necrosis. We observed that CYLD does not regulate RIP1 ubiquitination at the TNF receptor. TNF and zVAD-induced programmed necrosis was highly attenuated in CYLD-/- cells. However, in the presence of cycloheximide or SMAC mimetics, programmed necrosis was only moderately reduced in CYLD-/- cells. Under the latter conditions, RIP1-RIP3 necrosome formation is only delayed, but not abolished in CYLD-/- cells. We further demonstrate that RIP1 within the NP-40 insoluble necrosome is ubiquitinated and that CYLD regulates RIP1 ubiquitination in this compartment. Hence, RIP1 ubiquitination in this late-forming complex is greatly increased in CYLD-/- cells. Increased RIP1 ubiquitination impairs RIP1 and RIP3 phosphorylation, a signature of kinase activation. Conclusions/Significance: Our results show that CYLD regulates RIP1 ubiquitination in the TNFa-induced necrosome, but not in the TNFR-1 signaling complex. In cells sensitized to programmed necrosis with SMAC mimetics, CYLD is not essential for necrosome assembly. Since SMAC mimetics induces the loss of the E3 ligases cIAP1 and cIAP2, reduced RIP1 ubiquitination could lead to reduced requirement for CYLD to remove ubiquitin chains from RIP1 in the TNFR-1 complex. As increased RIP1 ubiquitination in the necrosome correlates with impaired RIP1 and RIP3 phosphorylation and function, these results suggest that CYLD controls RIP1 kinase activity during necrosome assembly.	[Moquin, David M.; McQuade, Thomas; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Chan, FKM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	francis.chan@umassmed.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; 	NIH [AI083497, AI088502]; NIH T32 training grant [T32 AI07349]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007349, R21AI088502, R01AI083497] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI083497 and AI088502 (to FKMC). DMM is supported by NIH T32 training grant (T32 AI07349). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Ch'en IL, 2011, J EXP MED; Challa S, 2010, J VIROL, V84, P10467, DOI 10.1128/JVI.00983-10; Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8; Chan FK, 2012, COLD SPRING HARB PER, V4; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Cho Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023209; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Fujikura D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.3; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lu JV, 2012, IMMUNOL REV, V249, P205, DOI 10.1111/j.1600-065X.2012.01147.x; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; O'Donnell MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041238; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; O'Donnell MA, 2011, FEBS J, V278, P877, DOI 10.1111/j.1742-4658.2011.08016.x; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	48	208	219	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76841	10.1371/journal.pone.0076841	http://dx.doi.org/10.1371/journal.pone.0076841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098568	Green Published, gold			2022-12-27	WOS:000325434500089
J	Beckham, TH; Cheng, JC; Lu, P; Marrison, ST; Norris, JS; Liu, X				Beckham, Thomas H.; Cheng, Joseph C.; Lu, Ping; Marrison, S. Tucker; Norris, James S.; Liu, Xiang			Acid Ceramidase Promotes Nuclear Export of PTEN through Sphingosine 1-Phosphate Mediated Akt Signaling	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; PROSTATE-CANCER; THYROID-TUMORS; UP-REGULATION; CELL-CYCLE; EXPRESSION; PHOSPHATASE; APOPTOSIS; CHROMOSOME-10; PROGRESSION	The tumor suppressor PTEN is now understood to regulate cellular processes at the cytoplasmic membrane, where it classically regulates PI3K signaling, as well as in the nucleus where multiple roles in controlling cell cycle and genome stability have been elucidated. Mechanisms that dictate nuclear import and, less extensively, nuclear export of PTEN have been described, however the relevance of these processes in disease states, particularly cancer, remain largely unknown. We investigated the impact of acid ceramidase on the nuclear-cytoplasmic trafficking of PTEN. Immunohistochemical analysis of a human prostate tissue microarray revealed that nuclear PTEN was lost in patients whose tumors had elevated acid ceramidase. We found that acid ceramidase promotes a reduction in nuclear PTEN that is dependent upon sphingosine 1-phosphate-mediated activation of Akt. We were further able to show that sphingosine 1-phosphate promotes formation of a complex between Crm1 and PTEN, and that leptomycin B prevents acid ceramidase and sphingosine 1-phosphate mediated loss of nuclear PTEN, suggesting an active exportin-mediated event. To investigate whether the tumor promoting aspects of acid ceramidase in prostate cancer depend upon its ability to export PTEN from the nucleus, we used enforced nuclear expression of PTEN to study docetaxel-induced apoptosis and cell killing, proliferation, and xenoengraftment. Interestingly, while acid ceramidase was able to protect cells expressing wild type PTEN from docetaxel, promote proliferation and xenoengraftment, acid ceramidase had no impact in cells expressing PTEN-NLS. These findings suggest that acid ceramidase, through sphingosine 1-phosphate, promotes nuclear export of PTEN as a means of promoting tumor formation, cell proliferation, and resistance to therapy.	[Beckham, Thomas H.; Cheng, Joseph C.; Lu, Ping; Marrison, S. Tucker; Norris, James S.; Liu, Xiang] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina	Beckham, TH (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	beckham@musc.edu		Beckham, Thomas/0000-0001-6189-6996	Department of Defense PCTA [W81XWH-11-1-0334, NCI 5P01CA097132]; National Center For Research Resources [UL1RR029882]; Cancer Center [P30 CA138313]; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE [P20 RR017677]; NATIONAL CANCER INSTITUTE [P01CA097132, P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	Department of Defense PCTA; National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cancer Center; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Department of Defense PCTA W81XWH-11-1-0334, NCI 5P01CA097132, and National Center For Research Resources UL1RR029882. All core facilities were supported, in part, by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina. This work was also supported by Lipidomics Core in the SC Lipidomics and Pathobiology COBRE (P20 RR017677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckham TH, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.14; Beckham TH, 2012, INT J CANCER, V131, P2034, DOI 10.1002/ijc.27480; BROTHMAN AR, 1991, J UROLOGY, V145, P1088, DOI 10.1016/S0022-5347(17)38540-3; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Dahia PLM, 1997, CANCER RES, V57, P4710; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Ginn-Pease ME, 2003, CANCER RES, V63, P282; Jang KS, 2010, HISTOPATHOLOGY, V56, P229, DOI 10.1111/j.1365-2559.2009.03468.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Mosessian S, 2009, J BIOL CHEM, V284, P30159, DOI 10.1074/jbc.M109.027995; Norris JS, 2006, CANCER GENE THER, V13, P1045, DOI 10.1038/sj.cgt.7700965; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Saad AF, 2007, CANCER BIOL THER, V6, P1455; Seelan RS, 2000, GENE CHROMOSOME CANC, V29, P137, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	32	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76593	10.1371/journal.pone.0076593	http://dx.doi.org/10.1371/journal.pone.0076593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098536	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100078
J	Fitzpatrick, CJ; Gopalakrishnan, S; Cogan, ES; Yager, LM; Meyer, PJ; Lovic, V; Saunders, BT; Parker, CC; Gonzales, NM; Aryee, E; Flagel, SB; Palmer, AA; Robinson, TE; Morrow, JD				Fitzpatrick, Christopher J.; Gopalakrishnan, Shyam; Cogan, Elizabeth S.; Yager, Lindsay M.; Meyer, Paul J.; Lovic, Vedran; Saunders, Benjamin T.; Parker, Clarissa C.; Gonzales, Natalia M.; Aryee, Emmanuel; Flagel, Shelly B.; Palmer, Abraham A.; Robinson, Terry E.; Morrow, Jonathan D.			Variation in the Form of Pavlovian Conditioned Approach Behavior among Outbred Male Sprague-Dawley Rats from Different Vendors and Colonies: Sign-Tracking vs. Goal-Tracking	PLOS ONE			English	Article							INCENTIVE SALIENCE; LABORATORY ENVIRONMENT; GENETIC DRIFT; WISTAR RATS; MICE; INHIBITION; STIMULUS; STOCKS; ATTRIBUTION; EXPRESSION	Even when trained under exactly the same conditions outbred male Sprague-Dawley (SD) rats vary in the form of the Pavlovian conditioned approach response (CR) they acquire. The form of the CR (i.e. sign-tracking vs. goal-tracking) predicts to what degree individuals attribute incentive salience to cues associated with food or drugs. However, we have noticed variation in the incidence of these two phenotypes in rats obtained from different vendors. In this study, we quantified sign- and goal-tracking behavior in a reasonably large sample of SD rats obtained from two vendors (Harlan or Charles River), as well as from individual colonies operated by both vendors. Our sample of rats acquired from Harlan had, on average, more sign-trackers than goal-trackers, and vice versa for our sample of rats acquired from Charles River. Furthermore, there were significant differences among colonies of the same vendor. Although it is impossible to rule out environmental variables, SD rats at different vendors and barriers may have reduced phenotypic heterogeneity as a result of genetic variables, such as random genetic drift or population bottlenecks. Consistent with this hypothesis, we identified marked population structure among colonies from Harlan. Therefore, despite sharing the same name, investigators should be aware that important genetic and phenotypic differences exist among SD rats from different vendors or even from different colonies of the same vendor. If used judiciously this can be an asset to experimental design, but it can also be a pitfall for those unaware of the issue.	[Fitzpatrick, Christopher J.; Flagel, Shelly B.; Robinson, Terry E.; Morrow, Jonathan D.] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Gopalakrishnan, Shyam; Parker, Clarissa C.; Gonzales, Natalia M.; Aryee, Emmanuel; Palmer, Abraham A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Cogan, Elizabeth S.; Yager, Lindsay M.; Saunders, Benjamin T.; Robinson, Terry E.] Univ Michigan, Biopsychol Grad Program, Ann Arbor, MI 48109 USA; [Meyer, Paul J.; Lovic, Vedran; Flagel, Shelly B.; Robinson, Terry E.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Flagel, Shelly B.; Morrow, Jonathan D.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA	University of Michigan System; University of Michigan; University of Chicago; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Chicago	Morrow, JD (corresponding author), Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA.	jonmorro@umich.edu	Meyer, Paul/GQJ-8502-2022; Palmer, Abraham/L-2158-2014; Morrow, Jonathan D/M-9790-2016; Gopalakrishnan, Shyam/J-1546-2019; Flagel, Shelly B/G-5561-2012	Palmer, Abraham/0000-0003-3634-0747; Morrow, Jonathan D/0000-0002-3530-4544; Gopalakrishnan, Shyam/0000-0002-2004-6810; Flagel, Shelly B/0000-0002-7309-9908; Saunders, Benjamin/0000-0002-4733-1101; Lovic, Vedran/0000-0002-7622-2430; Cogan, Elizabeth/0000-0003-2075-4494	National Institute on Drug Abuse [PO1 DA031656, 5T32DA007281, F31 DA030801, T31 DA007281, T32 DA007268]; National Institute of Health [R01GM097737, R01DA021336, R01MH079103, T32GM07197]; University of Michigan Department of Psychiatry [U032826]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197, R01GM097737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021336, F31DA030801, T32DA007268, T32DA007281, P01DA031656] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Department of Psychiatry; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institute on Drug Abuse (PO1 DA031656 [TER]; 5T32DA007281 [CJF]; F31 DA030801 [BTS]; T31 DA007281 [LMY]; T32 DA007268 [PJM]), the National Institute of Health (R01GM097737, R01DA021336, and R01MH079103 [AAP]; T32GM07197 [NMG]), the University of Michigan Department of Psychiatry (U032826 [JDM]), the Chicago Biomedical Consortium (AAP), the Searle Funds at The Chicago Community Trust (AAP), and the Natural Sciences and Engineering Research Council of Canada (VL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinger KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004729; Beckmann JS, 2012, BEHAV BRAIN RES, V226, P331, DOI 10.1016/j.bbr.2011.09.021; Bert B, 2001, PHARMACOL BIOCHEM BE, V70, P411, DOI 10.1016/S0091-3057(01)00629-3; Bueno A, 2003, EXP TOXICOL PATHOL, V55, P287, DOI 10.1078/0940-2993-00327; Buhimschi IA, 2001, AM J OBSTET GYNECOL, V184, P686, DOI 10.1067/mob.2001.110448; Charles River Laboratories International Inc, 2011, INT GEN STAND IGS PR; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Festing MFW, 2010, TOXICOL PATHOL, V38, P681, DOI 10.1177/0192623310373776; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; Fuller DD, 2001, PHYSIOL GENOMICS, V4, P175, DOI 10.1152/physiolgenomics.2001.4.3.175; GLICK SD, 1986, PHYSIOL BEHAV, V38, P67, DOI 10.1016/0031-9384(86)90133-2; HOGER H, 1992, EXP ANIM TOKYO, V41, P215, DOI 10.1538/expanim1978.41.2_215; Honndorf S, 2011, EPILEPSY RES, V94, P26, DOI 10.1016/j.eplepsyres.2010.12.012; Kearns DN, 2006, BEHAV BRAIN RES, V169, P193, DOI 10.1016/j.bbr.2006.01.005; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lovic V, 2011, BEHAV NEUROSCI, V125, P481, DOI 10.1037/a0024367; Marosi M, 2006, J NEUROSCI METH, V156, P231, DOI 10.1016/j.jneumeth.2006.03.010; Meyer PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038987; MILLER FP, 1968, SCIENCE, V162, P463, DOI 10.1126/science.162.3852.463; Oliff HS, 1997, J CEREBR BLOOD F MET, V17, P571, DOI 10.1097/00004647-199705000-00012; PAPAIOANNOU VE, 1980, LAB ANIM, V14, P11, DOI 10.1258/002367780780943015; Pare WP, 1997, PHYSIOL BEHAV, V62, P643, DOI 10.1016/S0031-9384(97)00191-1; Pecoraro N, 2006, PHYSIOL BEHAV, V89, P598, DOI 10.1016/j.physbeh.2006.07.019; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pollock DM, 1998, AM J PHYSIOL-REG I, V275, pR1719, DOI 10.1152/ajpregu.1998.275.5.R1719; Pritchard JK, 2000, GENETICS, V155, P945; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Saunders BT, 2011, NEUROPSYCHOPHARMACOL, V36, P1668, DOI 10.1038/npp.2011.48; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; Shim S, 2009, EXP ANIM TOKYO, V58, P11, DOI 10.1538/expanim.58.11; Silver L.M., 1995, MOUSE GENETICS CONCE; Swerdlow NR, 2001, PHARMACOL BIOCHEM BE, V70, P219, DOI 10.1016/S0091-3057(01)00598-6; Tomie A, 2012, BEHAV BRAIN RES, V226, P571, DOI 10.1016/j.bbr.2011.10.021; Turnbull AV, 1999, NEUROENDOCRINOLOGY, V70, P186, DOI 10.1159/000054475; Yager LM, 2010, BEHAV BRAIN RES, V214, P30, DOI 10.1016/j.bbr.2010.04.021	41	86	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75042	10.1371/journal.pone.0075042	http://dx.doi.org/10.1371/journal.pone.0075042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098363	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100014
J	Salinas, JL; Alave, JL; Westfall, AO; Paz, J; Moran, F; Carbajal-Gonzalez, D; Callacondo, D; Avalos, O; Rodriguez, M; Gotuzzo, E; Echevarria, J; Willig, JH				Salinas, Jorge L.; Alave, Jorge L.; Westfall, Andrew O.; Paz, Jorge; Moran, Fiorella; Carbajal-Gonzalez, Danny; Callacondo, David; Avalos, Odalie; Rodriguez, Martin; Gotuzzo, Eduardo; Echevarria, Juan; Willig, James H.			Medication Possession Ratio Predicts Antiretroviral Regimens Persistence in Peru	PLOS ONE			English	Article							HIV-INFECTED ADULTS; EARLY VIROLOGICAL FAILURE; OF-THE-LITERATURE; MEASURING RETENTION; THERAPY; CARE; ADHERENCE; ENGAGEMENT; SURVIVAL	Objectives: In developing nations, the use of operational parameters (OPs) in the prediction of clinical care represents a missed opportunity to enhance the care process. We modeled the impact of multiple measurements of antiretroviral treatment (ART) adherence on antiretroviral treatment outcomes in Peru. Design And Methods: Retrospective cohort study including ART naive, non-pregnant, adults initiating therapy at Hospital Nacional Cayetano Heredia, Lima-Peru (2006-2010). Three OPs were defined: 1) Medication possession ratio (MPR): days with antiretrovirals dispensed/days on first-line therapy; 2) Laboratory monitory constancy (LMC): proportion of 6 months intervals with >= 1 viral load or CD4 reported; 3) Clinic visit constancy (CVC): proportion of 6 months intervals with >= 1 clinic visit. Three multi-variable Cox proportional hazard (PH) models (one per OP) were fit for (1) time of first-line ART persistence and (2) time to second-line virologic failure. All models were adjusted for socio-demographic, clinical and laboratory variables. Results: 856 patients were included in first-line persistence analyses, median age was 35.6 years [29.4-42.9] and most were male (624; 73%). In multivariable PH models, MPR (per 10% increase HR=0.66; 95% CI=0.61-0.71) and LMC (per 10% increase 0.83; 0.71-0.96) were associated with prolonged time on first-line therapies. Among 79 individuals included in time to second-line virologic failure analyses, MPR was the only OP independently associated with prolonged time to second-line virologic failure (per 10% increase 0.88; 0.77-0.99). Conclusions: The capture and utilization of program level parameters such as MPR can provide valuable insight into patient-level treatment outcomes.	[Salinas, Jorge L.; Rodriguez, Martin; Willig, James H.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Alave, Jorge L.; Avalos, Odalie; Gotuzzo, Eduardo; Echevarria, Juan] Hosp Nacl Cayetano Heredia, Minist Salud, Lima, Peru; [Westfall, Andrew O.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Alave, Jorge L.; Paz, Jorge; Gotuzzo, Eduardo; Echevarria, Juan] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Moran, Fiorella; Carbajal-Gonzalez, Danny] Minist Salud, Serv Rural & Urbano Marginal Salud, Lima, Peru; [Callacondo, David] Univ Peruana Cayetano Heredia, Dept Microbiol, Labs Invest & Desarrollo, Lima, Peru	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Salinas, JL (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	jlsalinas@emory.edu; jwillig@uab.edu	Alave, Jorge/GSN-3726-2022; Salinas, Jorge/ABC-7735-2021	Alave, Jorge/0000-0002-1178-2445; Salinas, Jorge/0000-0002-9193-820X; Westfall, Andrew/0000-0002-0468-4695	Mary Fisher CARE fund; Fogarty International Center at the U.S. National Institutes of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award (Peru ICOHRTA network for AIDS/TB research) [1U2RTW007368-01A1]	Mary Fisher CARE fund; Fogarty International Center at the U.S. National Institutes of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award (Peru ICOHRTA network for AIDS/TB research)	This study was partially financed by the Mary Fisher CARE fund and the Fogarty International Center at the U.S. National Institutes of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award (Peru ICOHRTA network for AIDS/TB research) [grant number 1U2RTW007368-01A1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JW, 2011, AIDS, V25, P279, DOI 10.1097/QAD.0b013e328340feb0; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Chen RY, 2003, CLIN INFECT DIS, V37, P714, DOI 10.1086/377271; Danel C, 2009, AIDS RES HUM RETROV, V25, P783, DOI 10.1089/aid.2009.0018; Davila JA, 2013, AIDS CARE, V25, P202, DOI 10.1080/09540121.2012.689811; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hong SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056307; Kavasery R, 2009, JAIDS-J ACQ IMM DEF, V50, P360, DOI 10.1097/QAI.0b013e318198a800; Leon A, 2005, AIDS, V19, P213, DOI 10.1097/00002030-200501280-00017; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; Lodwick RK, 2008, AIDS, V22, P1039, DOI 10.1097/QAD.0b013e3282fec415; Maitland D, 2005, AIDS, V19, P1183, DOI 10.1097/01.aids.0000176218.40861.14; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; *MIN SAL PER, 2006, NAC AT GUIA INT PERS, P99152; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P100, DOI 10.1097/QAI.0b013e31818d5c37; *NAC EST I INF, 2008, PER COMP EST, P99152; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Olatosi BA, 2009, AIDS, V23, P725, DOI 10.1097/QAD.0b013e328326f546; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; UNAIDS, 2010, GLOB REP UNAIDS REP; WHO, 2010, ANT THER HIV INF AD; Willig JH, 2010, JAIDS-J ACQ IMM DEF, V53, P215, DOI 10.1097/QAI.0b013e3181bc0f10; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	27	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76323	10.1371/journal.pone.0076323	http://dx.doi.org/10.1371/journal.pone.0076323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098475	gold, Green Submitted, Green Published			2022-12-27	WOS:000325427100058
J	Webb, IC; Coolen, LM; Lehman, MN				Webb, Ian C.; Coolen, Lique M.; Lehman, Michael N.			NMDA and PACAP Receptor Signaling Interact to Mediate Retinal-Induced SCN Cellular Rhythmicity in the Absence of Light	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; CYCLASE-ACTIVATING POLYPEPTIDE; RAT SUPRACHIASMATIC NUCLEUS; CLOCK GENE-EXPRESSION; INDUCED PHASE-SHIFT; PROTEIN-KINASE-C; CIRCADIAN-RHYTHMS; GANGLION-CELLS; NEURONAL-ACTIVITY; SYRIAN-HAMSTER	The "core" region of the suprachiasmatic nucleus (SCN), a central clock responsible for coordinating circadian rhythms, shows a daily rhythm in phosphorylation of extracellular regulated kinase (pERK). This cellular rhythm persists under constant darkness and, despite the absence of light, is dependent upon inputs from the eye. The neural signals driving this rhythmicity remain unknown and here the roles of glutamate and PACAP are examined. First, rhythmic phosphorylation of the NR1 NMDA receptor subunit (pNR1, a marker for receptor activation) was shown to coincide with SCN core pERK, with a peak at circadian time (CT) 16. Enucleation and intraocular TTX administration attenuated the peak in the pERK and pNR1 rhythms, demonstrating that activation of the NMDA receptor and ERK in the SCN core at CT16 are dependent on retinal inputs. In contrast, ERK and NR1 phosphorylation in the SCN shell region were unaffected by these treatments. Intraventricular administration of the NMDA receptor antagonist MK-801 also attenuated the peak in SCN core pERK, indicating that ERK phosphorylation in this region requires NMDA receptor activation. As PACAP is implicated in photic entrainment and is known to modulate glutamate signaling, the effects of a PAC(1) receptor antagonist (PACAP (6-38)) on SCN core pERK and pNR1 also were examined. PACAP (6-38) administration attenuated SCN core pERK and pNR1, suggesting that PACAP induces pERK directly, and indirectly via a modulation of NMDA receptor signaling. Together, these data indicate that, in the absence of light, retinal-mediated NMDA and PAC(1) receptor activation interact to induce cellular rhythms in the SCN core. These results highlight a novel function for glutamate and PACAP release in the hamster SCN apart from their well-known roles in the induction of photic circadian clock resetting.	[Webb, Ian C.; Coolen, Lique M.; Lehman, Michael N.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA; [Coolen, Lique M.; Lehman, Michael N.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Coolen, Lique M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Western University (University of Western Ontario)	Lehman, MN (corresponding author), Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA.	mlehman@umc.edu	Lehman, Michael/ABC-9076-2020	Lehman, Michael/0000-0002-9076-5108; Coolen, Lique/0000-0003-2920-1116	NSERC Discovery grant; CIHR Fellowship	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by a NSERC Discovery grant to MNL and a CIHR Fellowship to ICW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; Aioun J, 1998, CELL TISSUE RES, V291, P239, DOI 10.1007/s004410050994; Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Arima H, 2002, ENDOCRINOLOGY, V143, P4165, DOI 10.1210/en.2002-220393; Bergstrom AL, 2003, EUR J NEUROSCI, V18, P2552, DOI 10.1046/j.1460-9568.2003.03000.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bryant DN, 2000, J BIOL RHYTHM, V15, P103, DOI 10.1177/074873040001500204; Butcher GQ, 2005, J NEUROSCI, V25, P5305, DOI 10.1523/JNEUROSCI.4361-04.2005; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; CARD JP, 1984, NEUROSCIENCE, V13, P415, DOI 10.1016/0306-4522(84)90240-9; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; Coogan AN, 2003, J NEUROSCI, V23, P3085; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; DEVRIES MJ, 1994, BRAIN RES, V642, P206, DOI 10.1016/0006-8993(94)90923-7; Dominguez JM, 2007, BEHAV NEUROSCI, V121, P1023, DOI 10.1037/0735-7044.121.5.1023; Doyle SE, 2002, VISUAL NEUROSCI, V19, P593, DOI 10.1017/S0952523802195058; Dziema H, 2002, J NEUROPHYSIOL, V88, P1374, DOI 10.1152/jn.2002.88.3.1374; EARNEST DJ, 1993, BRAIN RES, V627, P205, DOI 10.1016/0006-8993(93)90322-E; Engelund A, 2010, CELL TISSUE RES, V340, P243, DOI 10.1007/s00441-010-0950-3; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; Gamble KL, 2011, J BIOL RHYTHM, V26, P99, DOI 10.1177/0748730410396678; GILLETTE MU, 1987, BRAIN RES BULL, V19, P135, DOI 10.1016/0361-9230(87)90176-6; GLASS JD, 1993, J BIOL RHYTHM, V8, pS47; Glickman G, 2012, J BIOL RHYTHM, V27, P308, DOI 10.1177/0748730412450826; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guillaumond F, 2007, J NEUROCHEM, V101, P1224, DOI 10.1111/j.1471-4159.2006.04416.x; Hannibal J, 2000, J COMP NEUROL, V418, P147; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Hannibal J, 2006, INT REV CYTOL, V251, P1, DOI 10.1016/S0074-7696(06)51001-0; Harlow E., 1988, ANTIBODIES LAB MANUA; Harrington ME, 1999, J NEUROSCI, V19, P6637; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Honma S, 1996, AM J PHYSIOL-REG I, V271, pR579, DOI 10.1152/ajpregu.1996.271.3.R579; Kopp MDA, 2001, J NEUROCHEM, V79, P161, DOI 10.1046/j.1471-4159.2001.00553.x; Lee HS, 2003, NAT NEUROSCI, V6, P111, DOI 10.1038/nn1006; Lee HS, 2003, J BIOL RHYTHM, V18, P435, DOI 10.1177/0748730403259106; LeSauter J, 2011, J NEUROPHYSIOL, V106, P576, DOI 10.1152/jn.00060.2011; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050602; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; Maywood ES, 2011, P NATL ACAD SCI US; Maywood ES, 2011, EXP NEUROL; McArthur AJ, 2000, J NEUROSCI, V20, P5496, DOI 10.1523/JNEUROSCI.20-14-05496.2000; Michel S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-15; Minami Y, 2002, NEUROSCIENCE, V113, P37, DOI 10.1016/S0306-4522(02)00148-3; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; NEWMAN GC, 1986, BRAIN RES, V381, P345, DOI 10.1016/0006-8993(86)90086-7; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; Piggins HD, 2001, NEUROSCI LETT, V305, P25, DOI 10.1016/S0304-3940(01)01796-7; REA MA, 1993, AM J PHYSIOL, V265, pR1191, DOI 10.1152/ajpregu.1993.265.5.R1191; Romijn HJ, 1996, J COMP NEUROL, V372, P1; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shinohara K, 1998, NEUROREPORT, V9, P137, DOI 10.1097/00001756-199801050-00027; Staudt MD, 2011, J SEX MED, V8, P1015, DOI 10.1111/j.1743-6109.2010.02168.x; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tanaka M, 1997, NEUROREPORT, V8, P2187, DOI 10.1097/00001756-199707070-00020; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2007, BRAIN RES, V1148, P76, DOI 10.1016/j.brainres.2007.02.055; Tosini G, 2007, BRAIN RES, V1159, P134, DOI 10.1016/j.brainres.2007.05.023; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; Zhou CJ, 2001, PEPTIDES, V22, P1111, DOI 10.1016/S0196-9781(01)00437-5	87	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76365	10.1371/journal.pone.0076365	http://dx.doi.org/10.1371/journal.pone.0076365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098484	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100064
J	Byrareddy, SN; Ayash-Rashkovsky, M; Kramer, VG; Lee, SJ; Correll, M; Novembre, FJ; Villinger, F; Johnson, WE; von Gegerfelt, A; Felber, BK; Ruprecht, RM				Byrareddy, Siddappa N.; Ayash-Rashkovsky, Mila; Kramer, Victor G.; Lee, Sandra J.; Correll, Mick; Novembre, Francis J.; Villinger, Francois; Johnson, Welkin E.; von Gegerfelt, Agneta; Felber, Barbara K.; Ruprecht, Ruth M.			Live Attenuated Rev-Independent Nef(-)SIV Enhances Acquisition of Heterologous SIVsmE660 in Acutely Vaccinated Rhesus Macaques	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CONTROL REPLICATION; MUCOSAL INFECTION; MICROARRAY DATA; SURVIVAL-TIME; HIV-1 VACCINE; VIRAL LOAD; SIV; PROTECTION; CHALLENGE	Background: Rhesus macaques (RMs) inoculated with live-attenuated Rev-Independent Nef(-) simian immunodeficiency virus (Rev-Ind Nef(-)SIV) as adults or neonates controlled viremia to undetectable levels and showed no signs of immunodeficiency over 6-8 years of follow-up. We tested the capacity of this live-attenuated virus to protect RMs against pathogenic, heterologous SIVsmE660 challenges. Methodology/Principal Findings: Three groups of four RM were inoculated with Rev-Ind Nef(-)SIV and compared. Group 1 was inoculated 8 years prior and again 15 months before low dose intrarectal challenges with SIVsmE660. Group 2 animals were inoculated with Rev-Ind Nef(-)SIV at 15 months and Group 3 at 2 weeks prior to the SIVsmE660 challenges, respectively. Group 4 served as unvaccinated controls. All RMs underwent repeated weekly low-dose intrarectal challenges with SIVsmE660. Surprisingly, all RMs with acute live-attenuated virus infection (Group 3) became superinfected with the challenge virus, in contrast to the two other vaccine groups (Groups 1 and 2) (P=0.006 for each) and controls (Group 4) (P=0.022). Gene expression analysis showed significant upregulation of innate immune response-related chemokines and their receptors, most notably CCR5 in Group 3 animals during acute infection with Rev-Ind Nef(-)SIV. Conclusions/Significance: We conclude that although Rev-Ind Nef(-)SIV remained apathogenic, acute replication of the vaccine strain was not protective but associated with increased acquisition of heterologous mucosal SIVsmE660 challenges.	[Byrareddy, Siddappa N.; Ayash-Rashkovsky, Mila; Kramer, Victor G.; Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Byrareddy, Siddappa N.; Ayash-Rashkovsky, Mila; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Lee, Sandra J.; Correll, Mick] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Correll, Mick] Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA; [Novembre, Francis J.; Villinger, Francois] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Novembre, Francis J.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Villinger, Francois] Emory Univ, Dept Pathol & Lab Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Johnson, Welkin E.] Boston Coll, Dept Biol, Boston, MA USA; [von Gegerfelt, Agneta; Felber, Barbara K.] Ctr Canc Res, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Frederick, MD USA; [von Gegerfelt, Agneta; Felber, Barbara K.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Emory University; Emory University; Emory University; Boston College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University	Byrareddy, SN (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	siddappa.n.byrareddy@emory.edu		Byrareddy, Siddappa/0000-0002-7423-1763	National Institutes of Health [R01 RR014180, P01 AI048240]; NIH [R01 AI083118]; Intramural Research Program of the National Cancer Institute, NIH; National Center for Research Resources [P51RR169]; Office of Research Infrastructure Programs/OD [P51OD11107]; NATIONAL CANCER INSTITUTE [ZIABC010350, ZIABC010334] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083118, P01AI048240] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107, P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Cancer Institute, NIH; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health grants R01 RR014180, P01 AI048240 to RMR, NIH R01 AI083118 to WEJ, and the Intramural Research Program of the National Cancer Institute, NIH to BKF. This project was also funded by the National Center for Research Resources grant P51RR169 and is currently supported by the Office of Research Infrastructure Programs/OD P51OD11107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander L, 2003, J VIROL, V77, P6823, DOI 10.1128/JVI.77.12.6823-6835.2003; ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Barnabas RV, 2011, JAIDS-J ACQ IMM DEF, V57, P238, DOI 10.1097/QAI.0b013e31821acb5; Barnabas RV, 2011, J ACQUIR IMMUNE DEFI; Berry N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023092; Birch MR, 2001, J CLIN VIROL, V22, P263, DOI 10.1016/S1386-6532(01)00198-6; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buckley KA, 2003, VIROLOGY, V312, P470, DOI 10.1016/S0042-6822(03)00262-9; Carey VJ, 2005, BIOINFORMATICS, V21, P135, DOI 10.1093/bioinformatics/bth458; Chenine AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000265; Clevert DA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr197; Cline AN, 2005, J MED PRIMATOL, V34, P303; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P607, DOI 10.1089/aid.1994.10.607; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1997, J VIROL, V71, P7711, DOI 10.1128/JVI.71.10.7711-7718.1997; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Kulkarni V, 2011, VACCINE, V29, P6742, DOI 10.1016/j.vaccine.2010.12.056; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Lakhashe SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022010; Lallemant M, 1998, NEW ENGL J MED, V338, P839; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Nilsson C, 1998, AIDS, V12, P2261, DOI 10.1097/00002030-199817000-00006; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Ruprecht RM, 1996, SCIENCE, V271, P1790; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Siddappa NB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001270; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Stauber RH, 1998, BIOTECHNIQUES, V24, P462, DOI 10.2144/98243rr01; Sugimoto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011678; Vlasak J, 2006, AIDS, V20, P2135, DOI 10.1097/QAD.0b013e328010beb5; von Gegerfelt AS, 2006, AIDS RES HUM RETROV, V22, P516, DOI 10.1089/aid.2006.22.516; von Gegerfelt AS, 1999, J VIROL, V73, P6159, DOI 10.1128/JVI.73.7.6159-6165.1999; von Gegerfelt AS, 2002, J VIROL, V76, P96, DOI 10.1128/JVI.76.1.96-104.2002; vonGegerfelt A, 1997, VIROLOGY, V232, P291, DOI 10.1006/viro.1997.8567; Whitney JB, 2004, CURR OPIN INFECT DIS, V17, P17, DOI 10.1097/00001432-200402000-00004; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996	65	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75556	10.1371/journal.pone.0075556	http://dx.doi.org/10.1371/journal.pone.0075556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098702	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500073
J	Chaalali, A; Beaugrand, G; Raybaud, V; Goberville, E; David, V; Boet, P; Sautour, B				Chaalali, Aurelie; Beaugrand, Gregory; Raybaud, Virginie; Goberville, Eric; David, Valerie; Boet, Philippe; Sautour, Benoit			Climatic Facilitation of the Colonization of an Estuary by Acartia tonsa	PLOS ONE			English	Article							LONG-TERM CHANGES; GIRONDE ESTUARY; EGG-PRODUCTION; SPATIAL-DISTRIBUTION; CALANOID COPEPODS; HATCHING SUCCESS; ZOOPLANKTON; SALINITY; FISH; TEMPERATURE	Global change has become a major driving force of both terrestrial and marine systems. Located at the interface between these two realms, estuarine ecosystems are probably the place where both direct and indirect effects of human activities conspire together to affect biodiversity from phytoplankton to top predators. Among European estuarine systems, the Gironde is the largest estuary of Western Europe and many studies have provided evidence that it has been affected by a variety of anthropogenic stressors such as thermal and chemical pollution, physical alterations and exploitation, especially for maritime traffic. In such a context, species introduction is also a current major issue with the establishment of strong competitive species that could lead to ecosystem reorganization with potential decrease or even disappearance of native species. In the Gironde estuary, this hypothesis was proposed for the invasive shrimp species Palaemon macrodactylus as a decrease in the native species abundance was observed at the same time. Although species introduction often takes place via ballast water, the influence of climate-driven changes on the establishment of new species remains a key issue. The calanoid copepod Acartia tonsa, observed in the Gironde estuary for the first time in 1983, have since colonized most part of the estuary, reaching a level of abundance comparable to the dominant native species Eurytemora affinis. In this study, using both the concept of the ecological niche sensu Hutchinson (fundamental and realized niches) and statistical models, we reveal that the dynamics of the colonization of A. tonsa was facilitated by environmental conditions that have become closer to its environmental optimum with respect to temperature and salinity.	[Chaalali, Aurelie; David, Valerie; Sautour, Benoit] Univ Bordeaux 1, UMR EPOC 5805, Stn Marine Arcachon, Arcachon, France; [Chaalali, Aurelie; David, Valerie; Sautour, Benoit] CNRS, UMR EPOC 5805, Arcachon, France; [Beaugrand, Gregory; Raybaud, Virginie; Goberville, Eric] Univ Lille 1, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France; [Beaugrand, Gregory; Raybaud, Virginie; Goberville, Eric] CNRS, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France; [Beaugrand, Gregory] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [Goberville, Eric] Univ Lille 1, UMR GEPV 8198, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France; [Boet, Philippe] Irstea, Unite Ecosyst Estuariens & Poissons Migrateurs Am, Cestas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; INRAE	Chaalali, A (corresponding author), Univ Bordeaux 1, UMR EPOC 5805, Stn Marine Arcachon, Arcachon, France.	a.chaalali@epoc.u-bordeaux1.fr	David, Valerie/A-8770-2017; Goberville, Eric/A-2621-2017	David, Valerie/0000-0001-6950-9604; Goberville, Eric/0000-0002-1843-7855; BEAUGRAND, GREGORY/0000-0002-0712-5223; Boet, Philippe/0000-0002-9387-9071; Raybaud, Virginie/0000-0001-6426-3326	Electricite de France (EDF); Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER); Centre National de la Recherche Scientifique (CNRS); Conseil Regional d'Aquitaine; IFREMER	Electricite de France (EDF)(Electricite de France (EDF)); Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); IFREMER	The data the authors used for their research article come from monitoring programs supported by Electricite de France (EDF), the Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER), and the Centre National de la Recherche Scientifique (CNRS). This study was funded by the Conseil Regional d'Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 1999, LIMNOL OCEANOGR, V44, P1304, DOI 10.4319/lo.1999.44.5.1304; ALLEN GP, 1972, CR ACAD SCI D NAT, V275, P181; Allen JI, 2007, J MARINE SYST, V64, P3, DOI 10.1016/j.jmarsys.2006.02.010; Aravena G, 2009, ESTUAR COAST SHELF S, V83, P621, DOI 10.1016/j.ecss.2009.05.013; Arrehenius A S, 1889, PHYS CHEM, V4, P226; BAKKER C, 1975, Netherlands Journal of Sea Research, V9, P145, DOI 10.1016/0077-7579(75)90013-7; BARETTA JW, 1988, NETH J SEA RES, V22, P69, DOI 10.1016/0077-7579(88)90053-1; Beaugrand G, 2007, PROG OCEANOGR, V72, P259, DOI 10.1016/j.pocean.2007.01.002; Beaugrand G, 2011, MAR ECOL PROG SER, V424, P175, DOI 10.3354/meps08939; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaugrand G, 2010, CLIM RES, V41, P15, DOI 10.3354/cr00838; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beguer M, 2011, AQUAT INVASIONS, V6, P301, DOI 10.3391/ai.2011.6.3.07; BLABER SJM, 1980, J FISH BIOL, V17, P143, DOI 10.1111/j.1095-8649.1980.tb02749.x; BRYLINSKI J M, 1981, Journal of Plankton Research, V3, P255, DOI 10.1093/plankt/3.2.255; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Cervetto G, 1999, J EXP MAR BIOL ECOL, V239, P33, DOI 10.1016/S0022-0981(99)00023-4; Chaalali A, ESTUARINE C IN PRESS; Chaalali A, ESTUARIES C IN PRESS; Coupry B, 2008, EVALUATION IMPACTS C; David V, 2005, ESTUAR COAST SHELF S, V64, P171, DOI 10.1016/j.ecss.2005.01.014; David V, 2007, ESTUAR COAST SHELF S, V71, P429, DOI 10.1016/j.ecss.2006.08.018; Diekmann ABS, 2012, MAR BIOL, V159, P2399, DOI 10.1007/s00227-012-1955-0; Dzialowski AR, 2010, HYDROBIOLOGIA, V652, P139, DOI 10.1007/s10750-010-0326-4; Edwards M, 2001, J MAR BIOL ASSOC UK, V81, P207, DOI 10.1017/S0025315401003654; Fort J., 2012, PLOS ONE, V7; Gasparini S, 1997, J PLANKTON RES, V19, P877, DOI 10.1093/plankt/19.7.877; Gaudy R, 2000, J EXP MAR BIOL ECOL, V247, P51, DOI 10.1016/S0022-0981(00)00139-8; Goberville E, 2010, MAR ECOL PROG SER, V408, P129, DOI 10.3354/meps08564; GONZALEZ JG, 1974, MAR BIOL, V27, P219, DOI 10.1007/BF00391947; Gucu AC, 2002, ESTUAR COAST SHELF S, V54, P439, DOI 10.1006/ecss.2000.0657; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haedrich R.L., 1983, P183; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Helaouet P, 2009, ECOSYSTEMS, V12, P1235, DOI 10.1007/s10021-009-9261-5; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hojgaard JK, 2008, AQUAC RES, V39, P828, DOI 10.1111/j.1365-2109.2008.01936.x; Holste L, 2006, MAR BIOL, V148, P1061, DOI 10.1007/s00227-005-0132-0; Hutchinson G.E., 1978, INTRO POPULATION ECO; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jousson O, 2000, NATURE, V408, P157, DOI 10.1038/35041623; Lenoir S, 2011, GLOBAL CHANGE BIOL, V17, P115, DOI 10.1111/j.1365-2486.2010.02229.x; Lobry J, 2008, MAR ECOL PROG SER, V358, P13, DOI 10.3354/meps07294; Loots C, 2010, ICES J MAR SCI, V67, P244, DOI 10.1093/icesjms/fsp238; MacDonald Ian A. W., 1994, P199; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Mauchline J, 1998, BIOL CALANOID COPEPO; Nicolas D, 2011, REG ENVIRON CHANGE, V11, P639, DOI 10.1007/s10113-010-0196-3; Norse E.A., 1993, GLOBAL MARINE BIOL D; OMORI M, 1994, PROG OCEANOGR, V34, P211, DOI 10.1016/0079-6611(94)90009-4; Omori M, 1998, ANTHROPOGENIC SHORT, P279; Parkes SM, 2012, DIVERS DISTRIB, V18, P1199, DOI 10.1111/j.1472-4642.2012.00913.x; Pasquaud S, 2008, ESTUAR COAST SHELF S, V78, P267, DOI 10.1016/j.ecss.2007.12.014; Pasquaud S, 2008, ESTUARINE COASTAL SH, V86, P237; Pasquaud S, 2012, ESTUAR COAST SHELF S, V104, P46, DOI 10.1016/j.ecss.2012.03.021; Pastorinho R, 2003, ACTA OECOL, V24, pS259, DOI 10.1016/S1146-609X(03)00018-3; Pauly D, 2003, GLOBAL CHANGE NEWSLE, V55, P21; Peck MA, 2006, AQUACULTURE, V255, P341, DOI 10.1016/j.aquaculture.2005.11.055; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Raick C, 2006, PROG OCEANOGR, V70, P27, DOI 10.1016/j.pocean.2006.03.001; Raitsos DE, 2010, LIMNOL OCEANOGR, V55, P1478, DOI 10.4319/lo.2010.55.4.1478; Raybaud V, 2011, J MARINE SYST, V84, P1, DOI 10.1016/j.jmarsys.2010.08.001; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Rombouts I, 2012, ESTUAR COAST SHELF S, V99, P153, DOI 10.1016/j.ecss.2011.12.026; SAUTOUR B, 1995, HYDROBIOLOGIA, V311, P139, DOI 10.1007/BF00008577; Savoye N, 2012, ESTUAR COAST SHELF S, V108, P16, DOI 10.1016/j.ecss.2011.12.005; Selleslagh J, 2012, ESTUAR COAST SHELF S, V112, P243, DOI 10.1016/j.ecss.2012.07.030; SORBE JC, 1981, OCEANIS, V6, P579; Sottolichio A, 1999, CR ACAD SCI II-MEC P, V329, P895; Staneck RS, 1998, TRENDS ECOL EVOL, V13, P429, DOI 10.1016/S0169-5347(98)01494-3; Svetlichny L, 2010, MAR ECOL PROG SER, V419, P109, DOI 10.3354/meps08837; Taylor CM, 2012, BIOL INVASIONS, V14, P307, DOI 10.1007/s10530-011-0063-2; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Tester P.A., 1991, P 4 INT C COPEPODA K, P603; Vilas C, 2009, J EXP MAR BIOL ECOL, V369, P165, DOI 10.1016/j.jembe.2008.11.010; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WHITE JR, 1992, MAR ECOL PROG SER, V86, P239, DOI 10.3354/meps086239; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Zillioux EJ, 1972, EGG DORMANCY NERITIC, P217	79	29	30	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74531	10.1371/journal.pone.0074531	http://dx.doi.org/10.1371/journal.pone.0074531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098656	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500027
J	Chen, YY; Wu, JF; Tu, LL; Xiong, XK; Hu, XD; Huang, J; Xu, ZG; Zhang, XS; Hu, CM; Hu, XY; Guo, AZ; Wang, YL; Chen, HC				Chen, Yingyu; Wu, Junfang; Tu, Lingling; Xiong, Xuekai; Hu, Xidan; Huang, Jiong; Xu, Zhiguang; Zhang, Xiansong; Hu, Changmin; Hu, Xueying; Guo, Aizhen; Wang, Yulan; Chen, Huanchun			H-1-NMR Spectroscopy Revealed Mycobacterium tuberculosis Caused Abnormal Serum Metabolic Profile of Cattle	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; INFECTION; BOVIS; HOST; H-1; TRANSMISSION; MARKER	To re-evaluate virulence of Mycobacterium tuberculosis (M. tb) in cattle, we experimentally infected calves with M. tb and Mycobacterium bovisvia intratracheal injection at a dose of 2.0x10(7) CFU and observed the animals for 33 weeks. The intradermal tuberculin test and IFN-gamma in vitro release assay showed that both M. tb and M. bovis induced similar responses. Immunohistochemical staining of pulmonary lymph nodes indicated that the antigen MPB83 of both M. tb and M. bovis were similarly distributed in the tissue samples. Histological examinations showed all of the infected groups exhibited neutrophil infiltration to similar extents. Although the infected cattle did not develop granulomatous inflammation, the metabolic profiles changed significantly, which were characterized by a change in energy production pathways and increased concentrations of N-acetyl glycoproteins. Glycolysis was induced in the infected cattle by decreased glucose and increased lactate content, and enhanced fatty acid beta-oxidation was induced by decreased TG content, and decreased gluconeogenesis indicated by the decreased concentration of glucogenic and ketogenic amino acids promoted utilization of substances other than glucose as energy sources. In addition, an increase in acute phase reactive serum glycoproteins, together with neutrophil infiltration and increased of IL-1 beta production indicated an early inflammatory response before granuloma formation. In conclusion, this study indicated that both M. tb and M. bovis were virulent to cattle. Therefore, it is likely that cattle with M. tb infections would be critical to tuberculosis transmission from cattle to humans. Nuclear magnetic resonance was demonstrated to be an efficient method to systematically evaluate M. tb and M. bovi sinfection in cattle.	[Chen, Yingyu; Tu, Lingling; Xiong, Xuekai; Zhang, Xiansong; Guo, Aizhen; Chen, Huanchun] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Chen, Yingyu] Huazhong Agr Univ, Coll Anim Sci, Wuhan, Hubei, Peoples R China; [Xiong, Xuekai; Zhang, Xiansong; Hu, Changmin; Hu, Xueying; Guo, Aizhen; Chen, Huanchun] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Wu, Junfang; Wang, Yulan] Chinese Acad Sci, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan, Hubei, Peoples R China; [Tu, Lingling] Wuhan Keqian Anim Biol Prod Co Ltd, Wuhan, Hubei, Peoples R China; [Hu, Xidan; Huang, Jiong; Xu, Zhiguang] Xinjiang Acad Anim Husb & Vet Inst, Urumqi, Xinjiang, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Guo, AZ (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	aizhen@mail.hzau.edu.cn; yulan.wang@wipm.ac.cn	chen, ying/HHS-8254-2022; Wang, Yulan/A-8864-2012; Wu, Junfang/AAN-9409-2020	Wang, Yulan/0000-0002-2831-8737; 	China National Basic Research (973) Program [2012CB518801, 2009CB118804, 2012CB934004]; Key Special Science and Technology Program for Important Infectious Diseases such as AIDS and viral hepatitis [2012ZX10003002-016, 2012ZX10004214-004]; National Natural Science Foundation of China (NSFC) [31101843, 20825520, 20921004, 21105115, 20221064]; NSFC Science Fund for Creative Research Groups [31121004]; Fok Ying Tung Education Foundation [132026]	China National Basic Research (973) Program(National Basic Research Program of China); Key Special Science and Technology Program for Important Infectious Diseases such as AIDS and viral hepatitis; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Science Fund for Creative Research Groups; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by the China National Basic Research (973) Program (2012CB518801, 2009CB118804, 2012CB934004), the Key Special Science and Technology Program for Important Infectious Diseases such as AIDS and viral hepatitis (2012ZX10003002-016; 2012ZX10004214-004), and National Natural Science Foundation of China (NSFC) (31101843, 20825520, 20921004, 21105115, 20221064), the NSFC Science Fund for Creative Research Groups (31121004) and Supported by Fok Ying Tung Education Foundation (132026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2011, MALAYS J MED SCI, V18, P5; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; BELL JD, 1987, FEBS LETT, V215, P311, DOI 10.1016/0014-5793(87)80168-0; BIRD TA, 1990, J BIOL CHEM, V265, P13578; Chen YingYu, 2012, African Journal of Biotechnology, V11, P15733; Chen YY, 2009, TUBERCULOSIS, V89, P95, DOI 10.1016/j.tube.2008.07.003; de Kantor IN, 2010, INT J TUBERC LUNG D, V14, P1369; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; Dong FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051060; du Preez I, 2013, TUBERCULOSIS, V93, P330, DOI 10.1016/j.tube.2013.02.008; Du YF, 2011, RES VET SCI, V90, P385, DOI 10.1016/j.rvsc.2010.07.020; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Hewinson RG, 1996, SCAND J IMMUNOL, V43, P490, DOI 10.1046/j.1365-3083.1996.d01-78.x; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Koch R, 1901, BOSTON MED SURG J, V145, P2; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Kurtis JD, 2011, INFECT IMMUN, V79, P1254, DOI 10.1128/IAI.01072-10; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; NODA C, 1976, J BIOCHEM, V80, P1159, DOI 10.1093/oxfordjournals.jbchem.a131371; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; OIE website, OIE TERR MAN MAN DIA; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Phong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056037; Qi J, 2012, PLOS ONE, V7, DOI [10.1371/journal. pone.0038239, DOI 10.1371/J0URNAL.P0NE.0038239, 10.1371/journal.pone.0038239]; Saric J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000254; Saule P, 2005, J PARASITOL, V91, P737, DOI 10.1645/GE-3402.1; Schluger NW, 1998, AM J RESP CRIT CARE, V157, P679, DOI 10.1164/ajrccm.157.3.9708002; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x; Sun LY, 2012, J PROTEOME RES, V11, P2937, DOI 10.1021/pr3000317; Sunder S, 2009, J CLIN MICROBIOL, V47, P1249, DOI 10.1128/JCM.02042-08; Tao L, 2010, THESIS HUAZHONG AGR, P38; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Venkatesh SK, 2001, J MAGN RESON IMAGING, V14, P8, DOI 10.1002/jmri.1144; Vordermeier M, 2012, COMP IMMUNOL MICROB, V35, P227, DOI 10.1016/j.cimid.2012.01.003; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Whelan AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008527; Winters A., 2005, Morbidity and Mortality Weekly Report, V54, P605; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; World Health Organization, 2011, GLOB TUB CONTR WHO R; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wu J, 2010, PLOS NEGLECT TROP D, P4; Zhang X, 2012, MICROBIOLOGY; Zinsstag JSE, 2006, EC BOVINE TUBERCULOS, P68	54	10	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74507	10.1371/journal.pone.0074507	http://dx.doi.org/10.1371/journal.pone.0074507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098654	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500025
J	Corso, A; Mangiacavalli, S; Cocito, F; Pascutto, C; Ferretti, VV; Pompa, A; Ciampichini, R; Pochintesta, L; Mantovani, LG				Corso, Alessandro; Mangiacavalli, Silvia; Cocito, Federica; Pascutto, Cristiana; Ferretti, Virginia Valeria; Pompa, Alessandra; Ciampichini, Roberta; Pochintesta, Lara; Mantovani, Lorenzo G.			Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							CHEMOTHERAPY; MELPHALAN; PREDNISONE; SURVIVAL; YOUNGER; LIFE	Background: High-dose therapy with autologous peripheral stem cell transplantation represents today the standard approach for younger multiple myeloma patients. This study aimed to evaluate the long term economic impact of autologous transplantation with respect to conventional therapy. Methods: We retrospectively reviewed the charts of multiple myeloma patients diagnosed at our department between 1986 and 2003 and treated according to the therapy considered standard at the time of diagnosis. Analysis of costs was done by assessing resource utilization and direct costs were measured and monetized before proceeding with the analysis, based on public health service tariffs. Results: Group A including 78 patients treated with Melphalan and Prednisone was compared with Group B including 74 patients who received an autologous transplant. The median overall survival was 3.2 and 5.4 years respectively (p = 0.0002). Mean cost per patient was significantly higher in group B with respect to group A (102373(sic) vs 23825(sic); p < 0.001). The final quality-adjusted-life-year gain in group B patients as compared to group A was 1.73 QALY, with an incremental costeffectiveness ratio of 45460(sic). With a threshold of 75000(sic) per QALY gained, the cost effectiveness acceptability curve indicated that the probability that autologous transplantation in multiple myeloma is a cost-effective intervention is 90%. Conclusions: The cost of autologous transplantation remains high. The calculated incremental cost-effectiveness ratio, however, given the significant prolongation of overall survival obtained with autologous transplantation, is within an acceptable threshold. Notwithstanding, its high cost should be taken into account when considering the whole cost of multiple myeloma.	[Corso, Alessandro; Mangiacavalli, Silvia; Cocito, Federica; Pascutto, Cristiana; Ferretti, Virginia Valeria; Pompa, Alessandra; Pochintesta, Lara] Univ Pavia, Div Hematol, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy; [Ciampichini, Roberta] Fdn Charta, Milan, Italy; [Mantovani, Lorenzo G.] Univ Naples Federico II, Fac Pharm, Ctr Pharmacoecon, I-80138 Naples, Italy	IRCCS Fondazione San Matteo; University of Pavia; University of Naples Federico II	Corso, A (corresponding author), Univ Pavia, Div Hematol, Fdn IRCCS Policlin San Matteo, Via Palestro 3, I-27100 Pavia, Italy.	a.corso@smatteo.pv.it	Ferretti, Virginia/ABA-6196-2021; Mantovani, Lorenzo Giovanni/AAC-4263-2021	Ferretti, Virginia/0000-0003-0130-915X; Mantovani, Lorenzo Giovanni/0000-0003-3866-8199; Pompa, Alessandra/0000-0001-8583-4976				Alexander DD, 2007, INT J CANCER, P40, DOI 10.1002/ijc.22718; De Portu S, 2011, ITALIAN J PUBLIC HLT, V9, P245; GREGORY WM, 1992, J CLIN ONCOL, V10, P334, DOI 10.1200/JCO.1992.10.2.334; Gulbrandsen N, 2001, EUR J HAEMATOL, V66, P328, DOI 10.1034/j.1600-0609.2001.066005328.x; HENON P, 1995, BONE MARROW TRANSPL, V16, P19; Kouroukis CT, 2003, LEUKEMIA LYMPHOMA, V44, P29, DOI 10.3109/10428190309178811; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Messori A, 2003, PHARMACOECON ITAL RE, V5, P53, DOI [10.1007/ BF03320605, DOI 10.1007/BF03320605]; Mishra V, 2005, BONE MARROW TRANSPL, V35, P1149, DOI 10.1038/sj.bmt.1704988; Mishra V, 2003, CLIN LAB HAEMATOL, V25, P179, DOI 10.1046/j.1365-2257.2003.00512.x; Moeremans K, 2006, EUR J CANCER, V42, P1684, DOI 10.1016/j.ejca.2005.11.036; NORD E, 1992, SOC SCI MED, V34, P559, DOI 10.1016/0277-9536(92)90211-8; O'Brien BJ, 2002, STAT METHODS MED RES, V11, P455, DOI 10.1191/0962280202sm304ra; Sampson FC, 2001, BRIT J HAEMATOL, V113, P1015, DOI 10.1046/j.1365-2141.2001.02854.x; Staquet MJ, 1998, OX MED PUBL, P337; Thiede C, 1998, J CLIN ONCOL, V16, P3822, DOI 10.1200/JCO.1998.16.12.3822; Trippoli S, 1998, ONCOL REP, V5, P1475	17	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75047	10.1371/journal.pone.0075047	http://dx.doi.org/10.1371/journal.pone.0075047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098678	Green Published			2022-12-27	WOS:000325423500049
J	Cyran, CC; Kazmierczak, PM; Hirner, H; Moser, M; Ingrisch, M; Havla, L; Michels, A; Eschbach, R; Schwarz, B; Reiser, MF; Bruns, CJ; Nikolaou, K				Cyran, Clemens C.; Kazmierczak, Philipp M.; Hirner, Heidrun; Moser, Matthias; Ingrisch, Michael; Havla, Lukas; Michels, Alexandra; Eschbach, Ralf; Schwarz, Bettina; Reiser, Maximilian F.; Bruns, Christiane J.; Nikolaou, Konstantin			Regorafenib Effects on Human Colon Carcinoma Xenografts Monitored by Dynamic Contrast-Enhanced Computed Tomography with Immunohistochemical Validation	PLOS ONE			English	Article							CELL LUNG-CANCER; ANTIANGIOGENIC THERAPY; CT; ANGIOGENESIS; BEVACIZUMAB; SORAFENIB; MRI; GEMCITABINE; ANTIBODY; GROWTH	Objective: To investigate dynamic contrast-enhanced computed tomography for monitoring the effects of regorafenib on experimental colon carcinomas in rats by quantitative assessments of tumor microcirculation parameters with immunohistochemical validation. Materials and Methods: Colon carcinoma xenografts (HT-29) implanted subcutaneously in female athymic rats (n = 15) were imaged at baseline and after a one-week treatment with regorafenib by dynamic contrast-enhanced computed tomography (128-slice dual-source computed tomography). The therapy group (n = 7) received regorafenib daily (10 mg/kg bodyweight). Quantitative parameters of tumor microcirculation (plasma flow, mL/100 mL/min), endothelial permeability (PS, mL/100 mL/min), and tumor vascularity (plasma volume, %) were calculated using a 2-compartment uptake model. Dynamic contrast-enhanced computed tomography parameters were validated with immunohistochemical assessments of tumor microvascular density (CD-31), tumor cell apoptosis (TUNEL), and proliferation (Ki-67). Results: Regorafenib suppressed tumor vascularity (15.7 +/- 5.3 to 5.5 +/- 3.5%; p<0.05) and tumor perfusion (12.8 +/- 2.3 to 8.8 +/- 2.9 mL/100 mL/min; p = 0.063). Significantly lower microvascular density was observed in the therapy group (CD-31; 48 +/- 10 vs. 113 +/- 25, p<0.05). In regorafenib-treated tumors, significantly more apoptotic cells (TUNEL; 11844 +/- 2927 vs. 5097 +/- 3463, p<0.05) were observed. Dynamic contrast-enhanced computed tomography tumor perfusion and tumor vascularity correlated significantly (p<0.05) with microvascular density (CD-31; r = 0.84 and 0.66) and inversely with apoptosis (TUNEL; r = -0.66 and -0.71). Conclusions: Regorafenib significantly suppressed tumor vascularity (plasma volume) quantified by dynamic contrast-enhanced computed tomography in experimental colon carcinomas in rats with good-to-moderate correlations to an immunohistochemical gold standard. Tumor response biomarkers assessed by dynamic contrast-enhanced computed tomography may be a promising future approach to a more personalized and targeted cancer therapy.	[Cyran, Clemens C.; Kazmierczak, Philipp M.; Hirner, Heidrun; Moser, Matthias; Michels, Alexandra; Eschbach, Ralf; Reiser, Maximilian F.; Nikolaou, Konstantin] Univ Hosp Munich, Expt Radiol Lab, Dept Clin Radiol, Munich, Germany; [Ingrisch, Michael; Havla, Lukas] Univ Hosp Munich, Josef Lissner Lab Biomed Imaging, Dept Clin Radiol, Munich, Germany; [Schwarz, Bettina; Bruns, Christiane J.] Univ Hosp Munich, Dept Surg, Munich, Germany	University of Munich; University of Munich; University of Munich	Cyran, CC (corresponding author), Univ Hosp Munich, Expt Radiol Lab, Dept Clin Radiol, Grosshadern Campus, Munich, Germany.	clemens.cyran@med.lmu.de	Ingrisch, Michael/T-3408-2017	Ingrisch, Michael/0000-0003-0268-9078; Nikolaou, Konstantin/0000-0003-2668-7325	German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4 [01EX1021X]; Bayer HealthCare	German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4(Federal Ministry of Education & Research (BMBF)); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	This study was supported by the German Federal Ministry of Education and Research (BMBF, www.bmbf.de) Excellence Cluster M4 (01EX1021X) (www.m4.de) and a research grant from Bayer HealthCare (healthcare.bayer.de). Funding solely concerned the animals and materials used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; Bruns CJ, 2000, CLIN CANCER RES, V6, P1936; Chang YC, 2012, J MAGN RESON IMAGING, V36, P387, DOI 10.1002/jmri.23660; Cyran CC, 2012, AM J ROENTGENOL, V198, P384, DOI 10.2214/AJR.11.6951; Cyran CC, 2012, INVEST RADIOL, V47, P49, DOI 10.1097/RLI.0b013e3182300fe4; Diederich S, 2012, CANCER IMAGING, V12, P347, DOI 10.1102/1470-7330.2012.9013; Faria SC, 2007, AM J ROENTGENOL, V189, P378, DOI 10.2214/AJR.07.2164; Figlin R, 2012, J UROLOGY, V188, P707, DOI 10.1016/j.juro.2012.04.108; Fournier LS, 2010, RADIOLOGY, V256, P511, DOI 10.1148/radiol.10091362; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Holubec L, 2012, ANTICANCER RES, V32, P4007; Huellner MW, 2012, CANCER IMAGING, V12, P212, DOI 10.1102/1470-7330.2012.0021; Jitawatanarat P, 2013, J GASTROINTEST ONCOL, V4, P231, DOI 10.3978/j.issn.2078-6891.2013.008; Jost G, 2013, INVEST RADIOL, V48, P715, DOI 10.1097/RLI.0b013e318290cafb; Kalia M, 2013, METABOLISM, V62, pS11, DOI 10.1016/j.metabol.2012.08.016; Kopetz S, 2013, AM SOC CLIN ONCOL ED, V2013, P115; Koukourakis MI, 2007, AM J CLIN ONCOL-CANC, V30, P315, DOI 10.1097/01.coc.0000258119.90805.ca; Lind JSW, 2010, EUR RADIOL, V20, P2890, DOI 10.1007/s00330-010-1869-5; Miles KA, 2012, EUR RADIOL, V22, P1430, DOI 10.1007/s00330-012-2379-4; Raatschen HJ, 2009, INVEST RADIOL, V44, P265, DOI 10.1097/RLI.0b013e31819f1b60; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Shastry M, 2012, MOL IMAGING, V11, P353, DOI 10.2310/7290.2011.00052; Sohaib A, 2012, CANCER IMAGING, V12, P345, DOI 10.1102/1470-7330.2012.9011; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Tai JH, 2010, NEOPLASIA, V12, P697, DOI 10.1593/neo.10292; Uller W, 2011, CLIN HEMORHEOL MICRO, V49, P55, DOI 10.3233/CH-2011-1457; van der Meel R, 2010, DRUG DISCOV TODAY, V15, P102, DOI 10.1016/j.drudis.2009.12.003; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Zagouri F, 2012, GYNECOL ONCOL, V127, P662, DOI 10.1016/j.ygyno.2012.08.040	31	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76009	10.1371/journal.pone.0076009	http://dx.doi.org/10.1371/journal.pone.0076009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098755	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500125
J	Hou, CC; Yang, WX				Hou, Cong-Cong; Yang, Wan-Xi			Acroframosome-Dependent KIFC1 Facilitates Acrosome Formation during Spermatogenesis in the Caridean Shrimp Exopalaemon modestus	PLOS ONE			English	Article							VESICLE TRANSPORT; NUCLEAR-ENVELOPE; MOTOR PROTEINS; MACROBRACHIUM-NIPPONENSE; MANCHETTE MICROTUBULES; EXPRESSION PATTERN; CYTOPLASMIC DYNEIN; CANDIDATE MOTORS; KINESIN GENE; SPERMIOGENESIS	Background: Acrosome formation and nuclear shaping are the main events in spermatogenesis. During spermiogenesis in Exopalaemon modestus, a unique microtubular structure called the acroframosome (AFS) forms in spermatids. The AFS links to a temporary organelle called the lamellar complex (LCx) leading to the formation of an everted umbrella-shaped acrosome and a dish-shaped nucleus in the mature sperm. These morphological changes require complex cell motility in which the C-terminal kinesin motor protein called KIFC1 is involved. In this study, we demonstrate that KIFC1 moves along the AFS and plays an important role in acrosome formation and nuclear shaping during spermatogenesis in E. modestus. Methodology/Principal Findings: We cloned a 3125 bp complete cDNA of kifc1 from the testis of E. modestus by PCR. The predicted secondary and tertiary structures of E. modestus KIFC1 contain three domains: a) the C-terminus, b) the stalk region, and the c) N-terminusl. Semi-quantitative RT-PCR detected the expression of kifc1 mRNA in different tissues of E. modestus. In situ hybridization demonstrated the temporal and spatial expression profile of kifc1 during spermiogenesis. Western blot identified the expression of KIFC1 in different tissues of E. modestus, including the testis. Immunofluorescence localized KIFC1, tubulin, GM130, and mitochondria in order to elucidate their role during spermiogenesis in E. modestus. Conclusion/Significance: Our results indicate that KIFC1 transports the Golgi complex, mitochondria, and other cellular components that results in acrosome formation and nuclear shaping in E. modestus. The KIFC1 transport function depends upon the microtubular structure called the acroframosome (AFS). This study describes some of the molecular mechanisms involved in the acrosome formation and nuclear shaping in E. modestus. In addition, this study may provide a model for studying the molecular mechanisms involved in spermatogenesis in other crustacean species and lead to a better understanding of the fertilization process in crustaceans.	[Hou, Cong-Cong; Yang, Wan-Xi] Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yang, WX (corresponding author), Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China.	wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	Yang, Wan-Xi/0000-0001-5695-0150; Yang, Wan-Xi/0000-0001-9304-195X	National Natural Science Foundation of China [41276151, 31072198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 41276151 and 31072198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge AC, 2007, FLY, V1, P38, DOI 10.4161/fly.3913; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; BRADKE DL, 1963, ANAT REC, V145, P210; COLE A, 1988, BIOL REPROD, V38, P385, DOI 10.1095/biolreprod38.2.385; COURTENS JL, 1981, REPROD NUTR DEV, V21, P467, DOI 10.1051/rnd:19810312; Dorner C, 1998, J BIOL CHEM, V273, P20267, DOI 10.1074/jbc.273.32.20267; Du Nanshan, 1988, Oceanologia et Limnologia Sinica, V19, P71; Du Nanshan, 1987, Oceanologia et Limnologia Sinica, V18, P119; Erickson RP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002032; HALL ES, 1992, BIOL REPROD, V46, P817, DOI 10.1095/biolreprod46.5.817; Hayasaka S, 2008, ASIAN J ANDROL, V10, P561, DOI 10.1111/j.1745-7262.2008.00392.x; Henthorn KS, 2011, MOL BIOL CELL, V22, P4038, DOI 10.1091/mbc.E10-07-0572; Hou CC, 2013, MOL BIOL REP, V40, P1043, DOI 10.1007/s11033-012-2145-3; Hu JR, 2012, MOL BIOL REP, V39, P4207, DOI 10.1007/s11033-011-1206-3; Jiang YQ, 2002, DONGHAI MARINE SCI, V20, P45; KALLIO M, 1995, ENVIRON MOL MUTAGEN, V25, P106, DOI 10.1002/em.2850250204; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li Z, 2010, INVERTEBR REPROD DEV, V54, P121, DOI 10.1080/07924259.2010.9652324; MACKINNON EA, 1972, Z ZELLFORSCH MIK ANA, V124, P1; MEISTRICH ML, 1990, AM J ANAT, V188, P74, DOI 10.1002/aja.1001880109; Miller MG, 1999, BIOL REPROD, V60, P1047, DOI 10.1095/biolreprod60.4.1047; Mochizuki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019632; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Navolanic PM, 2000, BIOL REPROD, V62, P1360, DOI 10.1095/biolreprod62.5.1360; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sperry AO, 1996, MOL BIOL CELL, V7, P289, DOI 10.1091/mbc.7.2.289; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Terada S, 2000, CELL, V103, P141, DOI 10.1016/S0092-8674(00)00094-5; Wang DH, 2010, COMP BIOCHEM PHYS A, V157, P123, DOI 10.1016/j.cbpa.2010.05.015; Wang W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015616; Wang W, 2010, COMP BIOCHEM PHYS A, V157, P237, DOI 10.1016/j.cbpa.2010.07.004; Wang YT, 2012, MOL BIOL REP, V39, P7591, DOI 10.1007/s11033-012-1593-0; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Yang W. Y., 1998, CHIN J APPL ENV BIOL, V4, P49; Yang Wan-Xi, 1998, Acta Zoologica Sinica, V44, P377; Yang WX, 2006, BIOL REPROD, V74, P684, DOI 10.1095/biolreprod.105.049312; Yang WX, 2003, BIOL REPROD, V69, P1719, DOI 10.1095/biolreprod.102.014878; YOSHIDA T, 1994, J CELL SCI, V107, P625; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang YG, 2004, CELL MOTIL CYTOSKEL, V58, P213, DOI 10.1002/cm.20008; Zhang Y, 2012, DEV BIOL, V366, P101, DOI 10.1016/j.ydbio.2012.04.026; Zhou J, 2009, DEVELOPMENT, V136, P373, DOI 10.1242/dev.030858; Zou Y, 2002, BIOL REPROD, V66, P843, DOI 10.1095/biolreprod66.3.843	51	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76065	10.1371/journal.pone.0076065	http://dx.doi.org/10.1371/journal.pone.0076065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098763	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500133
J	Lernout, T; Cardinale, E; Jego, M; Despres, P; Collet, L; Zumbo, B; Tillard, E; Girard, S; Filleul, L				Lernout, Tinne; Cardinale, Eric; Jego, Mael; Despres, Philippe; Collet, Louis; Zumbo, Betty; Tillard, Emmanuel; Girard, Sebastien; Filleul, Laurent			Rift Valley Fever in Humans and Animals in Mayotte, an Endemic Situation?	PLOS ONE			English	Article							NORTHEASTERN KENYA; VIRUS; OUTBREAK; SEROPREVALENCE; RUMINANTS; SENEGAL; SHEEP	Retrospective studies and surveillance on humans and animals revealed that Rift Valley Fever virus (RVFV) has been circulating on Mayotte for at least several years. A study was conducted in 2011 to estimate the seroprevalence of RVF in humans and in animals and to identify associated risk factors. Using a multistage cluster sampling method, 1420 individuals were enrolled in the human study, including 337 children aged 5 to 14 years. For the animal study, 198 seronegative ruminants from 33 randomly selected sentinel ruminant herds were followed up for more than one year. In both studies, information on environment and risk factors was collected through a standardized questionnaire. The overall weighted seroprevalence of RVFV antibodies in the general population aged >= 5 years was 3.5% (95% CI 2.6-4.8). The overall seroprevalence of RVFV antibodies in the ruminant population was 25.3% (95% CI 19.8-32.2). Age (>= 15), gender (men), place of birth on the Comoros, living in Mayotte since less than 5 years, low educational level, farming and living close to a water source were significantly associated with RVFV seropositivity in humans. Major risk factors for RFV infection in animals were the proximity of the farm to a water point, previous two-month rainfall and absence of abortions disposal. Although resulting in few clinical cases in humans and in animals, RVFV has been circulating actively on the island of Mayotte, in a context of regular import of the virus from nearby countries through illegal animal movements, the presence of susceptible animals and a favorable environment for mosquito vectors to maintain virus transmission locally. Humans and animals share the same ways of RVFV transmission, with mosquitoes playing an important role. The studies emphasize the need for a one health approach in which humans and animals within their ecosystems are included.	[Lernout, Tinne; Filleul, Laurent] French Inst Publ Hlth Surveillance, Inst Veille Sanitaire, Reg Off Cire, Mamoudzou, Mayotte, France; [Cardinale, Eric; Jego, Mael; Girard, Sebastien] French Agr Res Ctr Int Dev CIRAD, Emerging & Exot Anim Dis Control Joint Res Unit U, Montpellier, France; [Cardinale, Eric] Cyclotron Reunion Indian Ocean Platform Cyroi, Ctr Res & Surveillance Emerging Dis Indian Ocean, St Denis, Reunion, France; [Despres, Philippe] Inst Pasteur, Interact Mol Flavivirus Hotes Unit, Paris, France; [Despres, Philippe] Inst Pasteur, WHO Collaborating Ctr Reference & Res Arboviruses, Paris, France; [Collet, Louis] Lab Hosp Ctr Mayotte CHM, Mamoudzou, Mayotte, France; [Zumbo, Betty] Agence Sante Ocean Indien, Publ Hlth Author, Vector Control Unit, Mamoudzou, Mayotte, France; [Tillard, Emmanuel] French Agr Res Ctr Int Dev CIRAD, Trop & Mediterranean Anim Prod Syst Joint Res Uni, Montpellier, France	Institute of Public Health Surveillance; AgroParisTech; CIRAD; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; AgroParisTech; CIRAD	Lernout, T (corresponding author), French Inst Publ Hlth Surveillance, Inst Veille Sanitaire, Reg Off Cire, Mamoudzou, Mayotte, France.	tinne.lernout@gmail.com; eric.cardinale@cirad.fr			Agence de sante ocean Indien (ARS); Prefecture of Mayotte with CIRAD	Agence de sante ocean Indien (ARS); Prefecture of Mayotte with CIRAD	The study in humans was financed by the Agence de sante ocean Indien (ARS), representing the Public Health Authority in Mayotte and for the animal part by the Prefecture of Mayotte with CIRAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P157; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P169; Beaty B.J., 1996, BIOL DIS VECTORS; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P969, DOI 10.3201/eid1806.110994; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P972, DOI 10.3201/eid1806.111165; Chevalier W, 2005, EMERG INFECT DIS, V11, P1693, DOI 10.3201/eid1111.050193; CRAIG DE, 1967, APPL MICROBIOL, V15, P446, DOI 10.1128/AEM.15.2.446-447.1967; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Elfadil AA, 2006, REV SCI TECH OIE, V25, P1137, DOI 10.20506/rst.25.3.1722; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; Hosmer D. W., APPL LOGISTIC REGRES; Institut national de la statistique et des etudes economiques (Insee), 2007, REP POP AG REC; Jeanmaire EM, 2011, VECTOR-BORNE ZOONOT, V11, P395, DOI 10.1089/vbz.2009.0249; LaBeaud AD, 2008, EMERG INFECT DIS, V14, P1240, DOI 10.3201/eid1408.080082; Le Goff G, 2011, C MULT APPR IMPR PES; LeBreton M, 2006, EMERG INFECT DIS, V12, P702, DOI 10.3201/eid1204.051428; Lernout T, 2009, B VEILLE SANITAIRE, V02; Lernout T, 2011, B VEILLE SANITAIRE, V12; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Nabeth P, 2001, EMERG INFECT DIS, V7, P1052, DOI 10.3201/eid0706.010627; Pepin M, 2011, MED MALADIES INFECT, V41, P322, DOI 10.1016/j.medmal.2010.12.010; Pourrut X, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000763; Roger M, 2011, EMERG INFECT DIS, V17, P1319, DOI 10.3201/eid1707.102031; Sissoko D, 2009, EMERGENCE CHEZ HOMME; SWANEPOEL R, 1986, J HYG-CAMBRIDGE, V97, P331, DOI 10.1017/S0022172400065426; THEILER M, 1957, P SOC EXP BIOL MED, V96, P380, DOI 10.3181/00379727-96-23483; Turell MJ, 2008, J MED ENTOMOL, V45, P102, DOI 10.1603/0022-2585(2008)45[102:VCOSAM]2.0.CO;2; WILSON ML, 1994, AM J TROP MED HYG, V50, P663, DOI 10.4269/ajtmh.1994.50.663; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023	31	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74192	10.1371/journal.pone.0074192	http://dx.doi.org/10.1371/journal.pone.0074192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098637	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500008
J	Sadjadi, A; Yazdanbod, A; Lee, YY; Boreiri, M; Samadi, F; Alizadeh, BZ; Islami, F; Fyfe, V; Babaei, M; Namazi, MJ; Going, JJ; Sotoudeh, M; de Bock, GH; Malekzadeh, R; Derakhshan, MH				Sadjadi, Alireza; Yazdanbod, Abbas; Lee, Yeong Yeh; Boreiri, Majid; Samadi, Fatemeh; Alizadeh, Behrooz Z.; Islami, Farhad; Fyfe, Valerie; Babaei, Masoud; Namazi, Mohammad J.; Going, James J.; Sotoudeh, Masoud; de Bock, Geertruida H.; Malekzadeh, Reza; Derakhshan, Mohammad H.			Serum Ghrelin; A New Surrogate Marker of Gastric Mucosal Alterations in Upper Gastrointestinal Carcinogenesis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HELICOBACTER-PYLORI INFECTION; 2 DISTINCT ETIOLOGIES; INCREASED RISK-FACTOR; SEROLOGICAL MARKERS; ESOPHAGEAL CANCER; CARDIA CANCER; ATROPHY; ADENOCARCINOMA; JAPAN	Background: A few studies have indicated inverse relationships between serum ghrelin and gastric and esophageal cancers but those associations have been restricted to specific populations, including smokers and overweight individuals. We examined the association between ghrelin and gastroesophageal cancers and atrophic gastritis in a population-based setting. Methods: In total 220 gastroesophageal cancers, comprising non-cardia and cardia gastric cancer, esophageal adenocarcinoma, esophageal squamous cell carcinoma (SCC) and age and gender-matched controls were recruited. Serum ghrelin, pepsinogen I/II ratio (PGI/II) and anti-H. pylori IgG antibodies were measured. Relationships between ghrelin and gastroesophageal cancers, after adjustment for PGI/II ratio, H. pylori status and smoking, were tested using logistic regression. Furthermore, in 125 endoscopically normal volunteers, with and without histological atrophic gastritis, the relationship with ghrelin was compared. Results: Serum ghrelin (lowest vs. highest quintile) was inversely associated with gastric cancer: OR (95% CI) 8.71 (1.70-44.59) for cardia and 6.58 (1.26-34.46) for non-cardia cancer. Lower serum ghrelin was also associated with esophageal SCC: OR (95% CI) 5.69 (1.36-23.78), but not with esophageal adenocarcinoma. A similar association was observed between gastric cancer (cardia and non-cardia) and esophageal SCC when serum ghrelin was analysed as a continuous scaled variable. In endoscopically-normal volunteers, extensive atrophic gastritis was associated with low serum ghrelin [OR (95% CI) 0.25 (0.10-0.64)]. Conclusion: Inverse associations between ghrelin and some gastroesophageal cancers suggest a potential role for serum ghrelin as a biomarker of upper gastrointestinal cancers and atrophic gastritis. In areas with a high incidence of gastric and/or esophageal cancer, screening might be more effectively targeted to individuals with low serum ghrelin in addition to the PGI/II ratio.	[Sadjadi, Alireza; Boreiri, Majid; Alizadeh, Behrooz Z.; Sotoudeh, Masoud; Malekzadeh, Reza; Derakhshan, Mohammad H.] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Sadjadi, Alireza; Alizadeh, Behrooz Z.; de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Yazdanbod, Abbas; Samadi, Fatemeh; Babaei, Masoud] Ardabil Univ Med Sci, Gastrointestinal Canc Res Ctr, Ardebil, Iran; [Lee, Yeong Yeh; Fyfe, Valerie; Namazi, Mohammad J.; Derakhshan, Mohammad H.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Lee, Yeong Yeh] Univ Sains Malaysia, Sch Med Sci, Kubang Kerian, Kelantan, Malaysia; [Islami, Farhad] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA; [Namazi, Mohammad J.] Sabzevar Univ Med Sci, Sabzevar, Iran; [Going, James J.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	Tehran University of Medical Sciences; University of Groningen; Ardabil University of Medical Sciences; University of Glasgow; Universiti Sains Malaysia; Icahn School of Medicine at Mount Sinai; University of Glasgow	Derakhshan, MH (corresponding author), Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran.	mohammad.derakhshan@glasgow.ac.uk	Malekzadeh, Reza/U-1382-2017; Alizadeh, Behrooz Z Ziad/J-2921-2017; Yazdanbod, Abbas/S-2266-2017; de Bock, Geertruida Hendrika/F-6529-2014; Lee, Yeong Yeh/H-2777-2019; , Alireza/AAE-4134-2022; Derakhshan, Mohammad H/K-8694-2016; Lee, Yeong Yeh/G-2470-2010	Malekzadeh, Reza/0000-0002-9820-6335; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; de Bock, Geertruida Hendrika/0000-0003-3104-4471; Lee, Yeong Yeh/0000-0002-6486-7717; , Alireza/0000-0003-0788-2491; Derakhshan, Mohammad H/0000-0002-2549-7100; Lee, Yeong Yeh/0000-0002-6486-7717; Namazi, Mohammad Javad/0000-0001-5680-3919; Malekzadeh, Reza/0000-0003-1043-3814; Islami, Farhad/0000-0002-7357-5994; Going, James/0000-0001-9120-919X; Yazdanbod, Abbas/0000-0002-1381-6717	Digestive Disease Research Centre (DDRC) of Tehran University of Medical Sciences [301/438]; Iran's National Elites Foundation (INEF); Nano Engineering Company, Tehran, Iran	Digestive Disease Research Centre (DDRC) of Tehran University of Medical Sciences; Iran's National Elites Foundation (INEF); Nano Engineering Company, Tehran, Iran	This work was supported by a research grant (301/438) from the Digestive Disease Research Centre (DDRC) of Tehran University of Medical Sciences, a postdoctoral fund from Iran's National Elites Foundation (INEF) and a research grant from Nano Engineering Company, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-34; Atalayer D, 2013, PROG NEURO-PSYCHOPH, V40, P70, DOI 10.1016/j.pnpbp.2012.08.011; Carrasco F, 2012, NUTRITION, V28, P757, DOI 10.1016/j.nut.2011.11.004; Chopin L, 2011, MOL CELL ENDOCRINOL, V340, P65, DOI 10.1016/j.mce.2011.04.013; Cook MB, 2010, CANCER EPIDEM BIOMAR, V19, P1966, DOI 10.1158/1055-9965.EPI-10-0270; CORREA P, 1992, CANCER RES, V52, P6735; de Martel C, 2007, AM J GASTROENTEROL, V102, P1166, DOI 10.1111/j.1572-0241.2007.01116.x; de Vries AC, 2009, INT J CANCER, V124, P2135, DOI 10.1002/ijc.23955; Derakhshan MH, 2008, GUT, V57, DOI 10.1136/gut.2007.137364; Derakhshan MH, 2007, GUT, V56, pA68; Derakhshan MH, 2006, J CLIN PATHOL, V59, P1293, DOI 10.1136/jcp.2005.036111; Derakhshan MH, 2004, GUT, V53, P1262, DOI 10.1136/gut.2003.035857; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hansen S, 2007, GUT, V56, P918, DOI 10.1136/gut.2006.114504; Hosoda H, 2004, CLIN CHEM, V50, P1077, DOI 10.1373/clinchem.2003.025841; Iijima K, 2007, AM J GASTROENTEROL, V102, P1603, DOI 10.1111/j.1572-0241.2007.01257.x; Islami F, 2011, ANN ONCOL, V22, P754, DOI 10.1093/annonc/mdq411; Isomoto H, 2005, AM J GASTROENTEROL, V100, P1711, DOI 10.1111/j.1572-0241.2005.41492.x; Kamangar F, 2009, INT J CANCER, V124, P456, DOI 10.1002/ijc.23918; Kawashima J, 2009, J GASTROENTEROL, V44, P1046, DOI 10.1007/s00535-009-0120-0; Kerem M, 2008, WORLD J GASTROENTERO, V14, P3633, DOI 10.3748/wjg.14.3633; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Komarowska H, 2012, NEUROENDOCRINOL LETT, V33, P749; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; McColl KEL, 2008, GUT, V57, P721, DOI 10.1136/gut.2007.144774; McColl Kenneth E L, 2002, Keio J Med, V51 Suppl 2, P53; Murphy G, 2012, GUT, V61, P1533, DOI 10.1136/gutjnl-2011-300653; Murphy G, 2011, J NATL CANCER I, V103, P1123, DOI 10.1093/jnci/djr194; Ohata H, 2005, CANCER SCI, V96, P713, DOI 10.1111/j.1349-7006.2005.00098.x; Percy C, 2000, INT CLASSIFICATION D; Rindi G, 2002, HISTOCHEM CELL BIOL, V117, P511, DOI 10.1007/s00418-002-0415-1; Sadeghi-Bazargani H, 2011, VASC HEALTH RISK MAN, V7, P417, DOI 10.2147/VHRM.S22727; Sadjadi A, 2003, INT J CANCER, V107, P113, DOI 10.1002/ijc.11359; Sadjadi A, 2014, INT J CANCER, V134, P181, DOI 10.1002/ijc.28344; Strickertsson JAB, 2011, WORLD J GASTROENTERO, V17, P3117, DOI 10.3748/wjg.v17.i26.3117; Taniaka-Shintani M, 2005, J GASTROENTEROL, V40, P345, DOI 10.1007/s00535-004-155-03; WU Y, 1993, INT J CANCER, V54, P713, DOI 10.1002/ijc.2910540502; Ye WM, 2004, JNCI-J NATL CANCER I, V96, P388, DOI 10.1093/jnci/djh057; Zub-Pokrowiecka A, 2010, MED SCI MONITOR, V16, pCR493; Zub-Pokrowiecka A, 2011, WORLD J GASTROENTERO, V17, P449, DOI 10.3748/wjg.v17.i4.449	41	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74440	10.1371/journal.pone.0074440	http://dx.doi.org/10.1371/journal.pone.0074440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098650	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000325423500021
J	Schwarzkopf, A; Rosenberger, D; Niebergall, M; Gershenzon, J; Kunert, G				Schwarzkopf, Alexander; Rosenberger, Daniel; Niebergall, Martin; Gershenzon, Jonathan; Kunert, Grit			To Feed or Not to Feed: Plant Factors Located in the Epidermis, Mesophyll, and Sieve Elements Influence Pea Aphid's Ability to Feed on Legume Species	PLOS ONE			English	Article							SYMPATRIC HOST RACES; AMINO-ACID-COMPOSITION; ACYRTHOSIPHON-PISUM; MEDICAGO-TRUNCATULA; TISSUE LOCALIZATION; GENETIC-DIVERGENCE; PHLOEM SAP; RESISTANCE; BEHAVIOR; POTATO	The pea aphid (Acyrthosiphon pisum HARRIS), a legume specialist, encompasses at least 11 genetically distinct sympatric host races. Each host race shows a preference for a certain legume species. Six pea aphid clones from three host races were used to localize plant factors influencing aphid probing and feeding behavior on four legume species. Aphid performance was tested by measuring survival and growth. The location of plant factors influencing aphid probing and feeding was determined using the electrical penetration graph (EPG) technique. Every aphid clone performed best on the plant species from which it was originally collected, as well as on Vicia faba. On other plant species, clones showed intermediate or poor performance. The most important plant factors influencing aphid probing and feeding behavior were localized in the epidermis and sieve elements. Repetitive puncturing of sieve elements might be relevant for establishing phloem feeding, since feeding periods appear nearly exclusively after these repetitive sieve element punctures. A combination of plant factors influences the behavior of pea aphid host races on different legume species and likely contributes to the maintenance of these races.	[Schwarzkopf, Alexander; Rosenberger, Daniel; Niebergall, Martin; Gershenzon, Jonathan; Kunert, Grit] Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany	Max Planck Society	Kunert, G (corresponding author), Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany.	gkunert@ice.mpg.de	Kunert, Grit/H-4271-2014; Gershenzon, Jonathan/K-1331-2013	Kunert, Grit/0000-0002-9969-8044; Gershenzon, Jonathan/0000-0002-1812-1551	Max Planck Society	Max Planck Society(Max Planck Society)	The work was funded by the Max Planck Society (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AE, 2006, ENTOMOL EXP APPL, V121, P145, DOI 10.1111/j.1570-8703.2006.00464.x; BACKUS EA, 1985, ENTOMOL EXP APPL, V37, P219, DOI 10.1111/j.1570-7458.1985.tb03478.x; Bos JIB, 2010, PLOS GENET, V6; Caillaud MC, 1999, ENTOMOL EXP APPL, V91, P227, DOI 10.1023/A:1003623915679; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Del Campo ML, 2003, ECOL ENTOMOL, V28, P405, DOI 10.1046/j.1365-2311.2003.00524.x; DREYER DL, 1987, J CHEM ECOL, V13, P925, DOI 10.1007/BF01020171; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Gabrys B, 1997, J CHEM ECOL, V23, P1661, DOI 10.1023/B:JOEC.0000006442.56544.1a; Gao LL, 2008, PLANT PHYSIOL, V146, P996, DOI 10.1104/pp.107.111971; GIBSON RW, 1983, NATURE, V302, P608, DOI 10.1038/302608a0; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Golawska S, 2006, J INSECT PHYSIOL, V52, P737, DOI 10.1016/j.jinsphys.2006.04.001; Golawska S, 2009, BIOLOGIA, V64, P377, DOI 10.2478/s11756-009-0051-5; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Hewer A, 2011, J EXP BIOL, V214, P3868, DOI 10.1242/jeb.060913; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Kaloshian I, 2000, ENVIRON ENTOMOL, V29, P690, DOI 10.1603/0046-225X-29.4.690; Karley AJ, 2002, J EXP BIOL, V205, P3009; Klingler J, 1998, ENTOMOL EXP APPL, V86, P79, DOI 10.1023/A:1003153410049; Klingler J, 2005, PLANT PHYSIOL, V137, P1445, DOI 10.1104/pp.104.051243; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; MCLEAN DL, 1968, ANN ENTOMOL SOC AM, V61, P927, DOI 10.1093/aesa/61.4.927; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INS SCI, V6; Pallipparambil GR, 2010, ENTOMOL EXP APPL, V135, P295, DOI 10.1111/j.1570-7458.2010.00995.x; Peccoud J, 2010, ECOL ENTOMOL, V35, P119, DOI 10.1111/j.1365-2311.2009.01147.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Pitino M, 2013, MOL PLANT MICROBE IN, V26, P130, DOI 10.1094/MPMI-07-12-0172-FI; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Powell G, 1999, ENTOMOL EXP APPL, V91, P115, DOI 10.1023/A:1003639225674; Powell G, 2000, PHYSIOL ENTOMOL, V25, P54, DOI 10.1046/j.1365-3032.2000.00164.x; R Core Team, 2011, R LANG ENV STAT COMP; SANDSTROM J, 1994, J INSECT PHYSIOL, V40, P947, DOI 10.1016/0022-1910(94)90133-3; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Tjallingii WF, 1999, ENTOMOL EXP APPL, V91, P97, DOI 10.1023/A:1003655902224; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; TJALLINGII WF, 1986, ENTOMOL EXP APPL, V40, P89, DOI 10.1007/BF00187027; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Van Hoof HA, 1958, INVESTIGATION BIOL T, P81; VANHELDEN M, 1993, ENTOMOL EXP APPL, V68, P269, DOI 10.1007/BF02380780; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; WENSLER RJ, 1969, J MORPHOL, V129, P473, DOI 10.1002/jmor.1051290406; Wilkinson TL, 1998, ENTOMOL EXP APPL, V87, P43, DOI 10.1023/A:1003255713767; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Will T, 2009, J EXP BIOL, V212, P3305, DOI 10.1242/jeb.028514; YAMAMOTO RT, 1974, J INSECT PHYSIOL, V20, P641, DOI 10.1016/0022-1910(74)90185-1	53	47	48	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75298	10.1371/journal.pone.0075298	http://dx.doi.org/10.1371/journal.pone.0075298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098691	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500062
J	Smit, M; Smit, C; Geerlings, S; Gras, L; Brinkman, K; Hallett, TB; de Wolf, F				Smit, Mikaela; Smit, Colette; Geerlings, Suzanne; Gras, Luuk; Brinkman, Kees; Hallett, Timothy B.; de Wolf, Frank		Athena Observational Cohort	Changes in First-Line cART Regimens and Short-Term Clinical Outcome between 1996 and 2010 in The Netherlands	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TENOFOVIR DISOPROXIL FUMARATE; NAIVE PATIENTS; HIV-1-INFECTED PATIENTS; COMBINATION THERAPY; GENDER-DIFFERENCES; EFAVIRENZ; MORTALITY; EMTRICITABINE; PROGRESSION	Objectives: Document progress in HIV-treatment in the Netherlands since 1996 by reviewing changing patterns of cART use and relating those to trends in patients' short-term clinical outcomes between 1996 and 2010. Design and Methods: 1996-2010 data from 10,278 patients in the Dutch ATHENA national observational cohort were analysed. The annual number of patients starting a type of regimen was quantified. Trends in the following outcomes were described: i) recovery of 150 CD4 cells/mm(3) within 12 months of starting cART; ii) achieving viral load (VL) suppression <= 1,000 copies/ml within 12 months of starting cART; iii) switching from first-line to second-line regimen within three years of starting treatment; and iv) all-cause mortality rate per 100 person-years within three years of starting treatment. Results: Between 1996 and 2010, first-line regimens changed from lamivudine/zidovudine-based or lamivudine/stavudine-based regimens with unboosted-PIs to tenofovir with either emtricitabine or lamivudine with NNRTIs. Mortality rates did not change significantly over time. VL suppression and CD4 recovery improved over time, and the incidence of switching due to virological failure and toxicity more than halved between 1996 and 2010. These effects appear to be related to the use of new regimens rather than improvements in clinical care. Conclusion: The use of first-line cART in the Netherlands closely follows changes in guidelines, to the benefit of patients. While there was no significant improvement in mortality, newer drugs with better tolerability and simpler dosing resulted in improved immunological and virological recovery and reduced incidences of switching due to toxicity and virological failure.	[Smit, Mikaela; Hallett, Timothy B.; de Wolf, Frank] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Fac Med, London, England; [Smit, Colette; Gras, Luuk; de Wolf, Frank] HIV Monitoring Fdn, Amsterdam, Netherlands; [Geerlings, Suzanne] Dis Amsterdam Med Ctr, Div Infect, Amsterdam, Netherlands; [Brinkman, Kees] Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands	Imperial College London; Onze Lieve Vrouwe Gasthuis Hospital	Smit, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Fac Med, London, England.	mikaela.smit@imperial.ac.uk	van der Ven, A.J.A.M./H-8102-2014	van der Ven, A.J.A.M./0000-0003-1833-3391; Smit, Mikaela/0000-0001-8530-748X; Hallett, Timothy/0000-0002-9681-0424; Warris, Adilia/0000-0001-6586-3358; Rijnders, Bart/0000-0003-3343-9610	Medical Research Council; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MS's PhD is funded by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bogner JR, 2001, J ACQ IMMUN DEF SYND, V27, P237, DOI 10.1097/00126334-200107010-00004; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Dube MP, 2002, ANTIVIR THER, V7, pL18; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; European AIDS Clinical Society, 2011, GUIDELINES; Falco V, 2003, EXPERT OPIN PHARMACO, V4, P1321, DOI 10.1517/14656566.4.8.1321; FDA, 2012, ANT DRUGS US TREATM; Floridia M, 2008, PHARMACOL RES, V58, P173, DOI 10.1016/j.phrs.2008.07.007; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gilead Sciences, 2009, TRUV; Gilead Sciences and Bristol-Myers Squibb, 2010, ATR; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hill A, 2007, EXPERT OPIN PHARMACO, V8, P679, DOI 10.1517/14656566.8.5.679; Kirk O, 1999, AIDS, V13, pF9, DOI 10.1097/00002030-199901140-00002; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Madruga JVR, 2007, HIV CLIN TRIALS, V8, P381, DOI 10.1310/hct0806-381; Martin A, 2004, AIDS, V18, P1029, DOI 10.1097/00002030-200404300-00011; Marzolini C, 2011, J ANTIMICROB CHEMOTH, V66, P2107, DOI 10.1093/jac/dkr248; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2005, REASONS STOPPING ANT; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Nederlandse Verening van HIV-Behandelaren, 2012, RICHTL HIV; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Ofotokun I, 2007, GENDER MED, V4, P106, DOI 10.1016/S1550-8579(07)80025-8; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Portsmouth Simon D, 2007, Ther Clin Risk Manag, V3, P579; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Prosperi MCF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-296; Rhone SA, 1998, AIDS, V12, P619, DOI 10.1097/00002030-199806000-00011; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Robison LS, 2008, AIDS RES HUM RETROV, V24, P1347, DOI 10.1089/aid.2008.0083; Smit M, 2012, AIDS, V26, P1953, DOI 10.1097/QAD.0b013e32835722bd; van Griensven J, 2011, T ROY SOC TROP MED H, V105, P694, DOI 10.1016/j.trstmh.2011.08.007; van Sighem AI, 2003, AIDS, V17, P2227, DOI 10.1097/00002030-200310170-00011; Wandeler G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027903; Willig JH, 2008, AIDS, V22, P1951, DOI 10.1097/QAD.0b013e32830efd79; Yuan Y, 2006, HIV MED, V7, P156, DOI 10.1111/j.1468-1293.2006.00355.x	42	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76071	10.1371/journal.pone.0076071	http://dx.doi.org/10.1371/journal.pone.0076071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098764	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500134
J	Yamamoto, K; Tsuzuki, S; Minami, Y; Yamamoto, Y; Abe, A; Ohshima, K; Seto, M; Naoe, T				Yamamoto, Kiyoko; Tsuzuki, Shinobu; Minami, Yosuke; Yamamoto, Yukiya; Abe, Akihiro; Ohshima, Koichi; Seto, Masao; Naoe, Tomoki			Functionally Deregulated AML1/RUNX1 Cooperates with BCR-ABL to Induce a Blastic Phase-Like Phenotype of Chronic Myelogenous Leukemia in Mice	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; MYELODYSPLASTIC SYNDROME; GENE-EXPRESSION; RUNX GENES; AML1 GENE; PHILADELPHIA-CHROMOSOME; SOMATIC MUTATIONS; RAPID INDUCTION; POINT MUTATIONS	Patients in the chronic phase (CP) of chronic myelogenous leukemia (CML) have been treated successfully following the advent of ABL kinase inhibitors, but once they progress to the blast crisis (BC) phase the prognosis becomes dismal. Although mechanisms underlying the progression are largely unknown, recent studies revealed the presence of alterations of key molecules for hematopoiesis, such as AML1/RUNX1. Our analysis of 13 BC cases revealed that three cases had AML1 mutations and the transcript levels of wild-type (wt.) AML1 were elevated in BC compared with CP. Functional analysis of representative AML1 mutants using mouse hematopoietic cells revealed the possible contribution of some, but not all, mutants for the BC-phenotype. Specifically, K83Q and R139G, but neither R80C nor D171N mutants, conferred upon BCR-ABL-expressing cells a growth advantage over BCR-ABL-alone control cells in cytokine-free culture, and the cells thus grown killed mice upon intravenous transfer. Unexpectedly, wt. AML1 behaved similarly to K83Q and R139G mutants. In a bone marrow transplantation assay, K83Q and wt. AML1s induced the emergence of blast-like cells. The overall findings suggest the roles of altered functions of AML1 imposed by some, but not all, mutants, and the elevated expression of wt. AML1 for the disease progression of CML.	[Yamamoto, Kiyoko; Tsuzuki, Shinobu; Seto, Masao] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan; [Yamamoto, Kiyoko; Minami, Yosuke; Naoe, Tomoki] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Yamamoto, Yukiya; Abe, Akihiro] Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi 47011, Japan; [Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan	Aichi Cancer Center; Nagoya University; Fujita Health University; Kurume University	Tsuzuki, S (corresponding author), Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan.	stsuzuki@aichi-cc.jp	Yamamoto, Yukiya/E-9529-2010; Naoe, Tomoki/I-1888-2012; Yamamoto, Yukiya/M-5713-2019	Yamamoto, Yukiya/0000-0002-7439-4925; Yamamoto, Yukiya/0000-0002-7439-4925; Tsuzuki, Shinobu/0000-0002-3209-3550	Health and Labor Scientific Research Grant for Clinical Cancer Research [H23-Gan Rinsho-Ippan-004]; Ministry of Health, Labor and Welfare [23-A-23]; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Princess Takamatsu Cancer Research Fund [11-24307]	Health and Labor Scientific Research Grant for Clinical Cancer Research; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Princess Takamatsu Cancer Research Fund	This work was supported by the Health and Labor Scientific Research Grant for Clinical Cancer Research (H23-Gan Rinsho-Ippan-004), Grant-in-Aid for Reseach from the Ministry of Health, Labor and Welfare (23-A-23), grant-in-aid for scientific research from The Ministry of Education, Culture, Sports, Science and Technology (M. S.), a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (S. T.), and a research grant from the Princess Takamatsu Cancer Research Fund (11-24307) (S. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE A, 1995, LEUKEMIA, V9, P341; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Boyapati A, 2011, BIOCHEM BIOPH RES CO, V411, P115, DOI 10.1016/j.bbrc.2011.06.107; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Cuenco GM, 2000, P NATL ACAD SCI USA, V97, P1760, DOI 10.1073/pnas.030421197; Cuenco GM, 2001, ONCOGENE, V20, P8236, DOI 10.1038/sj.onc.1205095; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; De Keersmaecker K, 2012, NAT MED, V16, P1321; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Grossmann V, 2011, LEUKEMIA, V25, P557, DOI 10.1038/leu.2010.298; Hamelin V, 2006, BLOOD, V107, P3106, DOI 10.1182/blood-2005-07-2953; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Imai Y, 2000, BLOOD, V96, P3154, DOI 10.1182/blood.V96.9.3154.h8003154_3154_3160; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Makishima H, 2011, BLOOD, V117, pE198, DOI 10.1182/blood-2010-06-292433; Matsuura S, 2012, BLOOD, V120, P4028, DOI 10.1182/blood-2012-01-404533; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Miething C, 2007, P NATL ACAD SCI USA, V104, P4594, DOI 10.1073/pnas.0604716104; MITANI K, 1994, EMBO J, V13, P504, DOI 10.1002/j.1460-2075.1994.tb06288.x; MIYOSHI H, 1995, NUCLEIC ACIDS RES, V23, P2762, DOI 10.1093/nar/23.14.2762; Nakagawa M, 2011, HAEMATOL-HEMATOL J, V96, P1318, DOI 10.3324/haematol.2011.041053; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; NUCIFORA G, 1994, P NATL ACAD SCI USA, V91, P4004, DOI 10.1073/pnas.91.9.4004; OGURA M, 1985, BLOOD, V66, P1384; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Roche-Lestienne C, 2008, BLOOD, V111, P3735, DOI 10.1182/blood-2007-07-102533; RUBIN CM, 1990, BLOOD, V76, P2594; Shen Q, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-42; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Sood R, 1999, LEUKEMIA, V13, P348, DOI 10.1038/sj.leu.2401360; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; TANAKA T, 1995, MOL CELL BIOL, V15, P2383; Tsuzuki S, 2007, PLOS MED, V4, P880, DOI 10.1371/journal.pmed.0040172; Tsuzuki S, 2012, BLOOD, V119, P727, DOI 10.1182/blood-2011-06-362277; Tsuzuki S, 2011, BLOOD, V117, P3858, DOI 10.1182/blood-2010-11-320515; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Wotton S, 2002, CANCER RES, V62, P7181; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Yanagida M, 2005, ONCOGENE, V24, P4477, DOI 10.1038/sj.onc.1208675; Zhao LJ, 2012, BLOOD, V119, P2873, DOI 10.1182/blood-2011-08-370981	57	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74864	10.1371/journal.pone.0074864	http://dx.doi.org/10.1371/journal.pone.0074864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098673	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500044
J	Chen, J; Lin, MY; Foxe, JJ; Pedrosa, E; Hrabovsky, A; Carroll, R; Zheng, DY; Lachman, HM				Chen, Jian; Lin, Mingyan; Foxe, John J.; Pedrosa, Erika; Hrabovsky, Anastasia; Carroll, Reed; Zheng, Deyou; Lachman, Herbert M.			Transcriptome Comparison of Human Neurons Generated Using Induced Pluripotent Stem Cells Derived from Dental Pulp and Skin Fibroblasts	PLOS ONE			English	Article							SCHIZOPHRENIA; AUTISM; ASSOCIATION; EXPRESSION; INDUCTION; DISORDER; GENES; MODEL; BDNF	Induced pluripotent stem cell (iPSC) technology is providing an opportunity to study neuropsychiatric disorders through the capacity to grow patient-specific neurons in vitro. Skin fibroblasts obtained by biopsy have been the most reliable source of cells for reprogramming. However, using other somatic cells obtained by less invasive means would be ideal, especially in children with autism spectrum disorders (ASD) and other neurodevelopmental conditions. In addition to fibroblasts, iPSCs have been developed from cord blood, lymphocytes, hair keratinocytes, and dental pulp from deciduous teeth. Of these, dental pulp would be a good source for neurodevelopmental disorders in children because obtaining material is non-invasive. We investigated its suitability for disease modeling by carrying out gene expression profiling, using RNA-seq, on differentiated neurons derived from iPSCs made from dental pulp extracted from deciduous teeth (T-iPSCs) and fibroblasts (F-iPSCs). This is the first RNA-seq analysis comparing gene expression profiles in neurons derived from iPSCs made from different somatic cells. For the most part, gene expression profiles were quite similar with only 329 genes showing differential expression at a nominally significant p-value (p<0.05), of which 63 remained significant after correcting for genome-wide analysis (FDR <0.05). The most striking difference was the lower level of expression detected for numerous members of the all four HOX gene families in neurons derived from T-iPSCs. In addition, an increased level of expression was seen for several transcription factors expressed in the developing forebrain (FOXP2, OTX1, and LHX2, for example). Overall, pathway analysis revealed that differentially expressed genes that showed higher levels of expression in neurons derived from T-iPSCs were enriched for genes implicated in schizophrenia (SZ). The findings suggest that neurons derived from T-iPSCs are suitable for disease-modeling neuropsychiatric disorder and may have some advantages over those derived from F-iPSCs.	[Chen, Jian; Pedrosa, Erika; Hrabovsky, Anastasia; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lin, Mingyan; Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Foxe, John J.; Carroll, Reed; Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dominick Purpura Dept Neurosci, Bronx, NY 10467 USA; [Foxe, John J.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Lachman, HM (corresponding author), Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA.	Herb.Lachman@einstein.yu.edu	lin, mingyan/HDL-9420-2022	Foxe, John/0000-0002-4300-3098; Zheng, Deyou/0000-0003-4354-5337	National Institutes of Health [MH087840, MH073164]; CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1RR025750, KL2RR025749, TL1RR025748]; NIH roadmap for Medical Research; Eunice Kennedy Shriver National Institute of Child Health AMP; Human Development (NICHD) at the NIH [1P30HD071593-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025748, KL2RR025749, UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073164, R33MH087840, R21MH087840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health AMP; Human Development (NICHD) at the NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (MH087840 and MH073164 to HML). This publication was also supported in part by the CTSA Grant UL1RR025750, KL2RR025749 and TL1RR025748 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research, and a grant to The Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK-IDDRC) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) at the NIH (1P30HD071593-01). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Casey JP, 2012, HUM GENET, V131, P565, DOI 10.1007/s00439-011-1094-6; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; DeRosa BA, 2012, NEUROSCI LETT, V516, P9, DOI 10.1016/j.neulet.2012.02.086; Di Lieto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032869; Farra N, 2012, MOL PSYCHIATR, V17, P1261, DOI 10.1038/mp.2011.180; Grande I, 2010, PSYCHIAT INVEST, V7, P243, DOI 10.4306/pi.2010.7.4.243; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Juhasz G, 2011, BIOL PSYCHIAT, V69, P762, DOI 10.1016/j.biopsych.2010.11.019; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; KIM KY, 2012, TRENDS MOL MED, P45237, DOI DOI 10.1016/J.M0LMED.2012.06.002; Larimore J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065069; Lei JX, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-9; LI W, 2013, NEUROPHARMACOLOGY, P45237, DOI DOI 10.1016/J.NEUR0PHARM.2013.03.024; Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Miletich I, 2003, HUM MOL GENET, V12, pR69, DOI 10.1093/hmg/ddg085; Muenthaisong S, 2012, EXP CELL RES, V318, P2482, DOI 10.1016/j.yexcr.2012.07.014; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pal R, 2013, J BIOSCI BIOENG, V115, P200, DOI 10.1016/j.jbiosc.2012.08.018; Patthey C, 2011, EUR J NEUROSCI, V34, P1516, DOI 10.1111/j.1460-9568.2011.07871.x; Pedrosa E, 2011, J NEUROGENET, V25, P88, DOI 10.3109/01677063.2011.597908; Petit I, 2012, STEM CELL RES, V8, P134, DOI 10.1016/j.scr.2011.09.003; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Thompson M, 2011, J PSYCHIATR NEUROSCI, V36, P195, DOI 10.1503/jpn.100048; Toma C, 2013, PSYCHIAT GENET, V23, P82, DOI 10.1097/YPG.0b013e32835d6fc6; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xavier GM, 2011, J MOL HISTOL, V42, P383, DOI 10.1007/s10735-011-9341-7; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314	43	30	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75682	10.1371/journal.pone.0075682	http://dx.doi.org/10.1371/journal.pone.0075682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098394	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600021
J	Dutton, JL; Li, B; Woo, WP; Marshak, JO; Xu, Y; Huang, ML; Dong, LC; Frazer, IH; Koelle, DM				Dutton, Julie L.; Li, Bo; Woo, Wai-Ping; Marshak, Joshua O.; Xu, Yan; Huang, Meei-li; Dong, Lichun; Frazer, Ian H.; Koelle, David M.			A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in Mice	PLOS ONE			English	Article							T-CELL EPITOPES; VIRUS TYPE-2; DENDRITIC CELLS; GLYCOPROTEIN-B; GENITAL HERPES; WILD-TYPE; IMMUNITY; UBIQUITIN; EFFICACY; INFECTION	While there are a number of licensed veterinary DNA vaccines, to date, none have been licensed for use in humans. Here, we demonstrate that a novel technology designed to enhance the immunogenicity of DNA vaccines protects against lethal herpes simplex virus 2 (HSV-2) challenge in a murine model. Polynucleotides were modified by use of a codon optimization algorithm designed to enhance immune responses, and the addition of an ubiquitin-encoding sequence to target the antigen to the proteasome for processing and to enhance cytotoxic T cell responses. We show that a mixture of these codon-optimized ubiquitinated and non-ubiquitinated constructs encoding the same viral envelope protein, glycoprotein D, induced both B and T cell responses, and could protect against lethal viral challenge and reduce ganglionic latency. The optimized vaccines, subcloned into a vector suitable for use in humans, also provided a high level of protection against the establishment of ganglionic latency, an important correlate of HSV reactivation and candidate endpoint for vaccines to proceed to clinical trials.	[Dutton, Julie L.; Li, Bo; Woo, Wai-Ping; Xu, Yan; Frazer, Ian H.] Coridon Pty Ltd, Brisbane, Qld, Australia; [Marshak, Joshua O.; Dong, Lichun; Koelle, David M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Huang, Meei-li; Koelle, David M.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Huang, Meei-li; Koelle, David M.] Fred Hutchinson Canc Res Inst, Vaccine & Infect Dis Div, Seattle, WA USA; [Frazer, Ian H.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Koelle, David M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Koelle, David M.] Benaroya Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Queensland; University of Washington; University of Washington Seattle; Benaroya Research Institute	Koelle, DM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	viralimm@u.washington.edu	Koelle, David/Q-6529-2016; Frazer, Ian/A-1137-2007	Koelle, David/0000-0003-1255-9023; Woo, Yvonne/0000-0002-1293-5124; Dutton, Julie/0000-0002-9798-1284; Frazer, Ian/0000-0002-8002-4680	Australian Government; Jagen Pty Ltd.; Coridon Pty Ltd.; National Institutes of Health [AI030731]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER	Australian Government(Australian GovernmentCGIAR); Jagen Pty Ltd.; Coridon Pty Ltd.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in-part funded by an R & D Start Grant from the Australian Government, by Jagen Pty Ltd. and by Coridon Pty Ltd. National Institutes of Health grant AI030731, Lab Core, supported development of the HSV-2 PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bergman PJ, 2006, VACCINE, V24, P4582, DOI 10.1016/j.vaccine.2005.08.027; Chou B, 2010, BIOCHEM BIOPH RES CO, V392, P277, DOI 10.1016/j.bbrc.2009.12.166; Davidson AH, 2005, JAVMA-J AM VET MED A, V226, P240, DOI 10.2460/javma.2005.226.240; Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Domingo C, 2003, VACCINE, V21, P3565, DOI 10.1016/S0264-410X(03)00423-7; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; Frazer IH, 2011, St Lucia US, Patent No. [2011/0287039 A1, 20110287039]; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Garver KA, 2005, DIS AQUAT ORGAN, V64, P13, DOI 10.3354/dao064013; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Hou YH, 2008, VACCINE, V26, P1438, DOI 10.1016/j.vaccine.2007.12.057; Hu K, 2011, IMMUNOL INVEST, V40, P265, DOI 10.3109/08820139.2010.534219; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Ilyinskii PO, 2008, VACCINE, V26, P2177, DOI 10.1016/j.vaccine.2008.02.050; Johnson JE, 1998, CURR BIOL, V8, pR914, DOI 10.1016/S0960-9822(98)00008-6; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Kask AS, 2010, VACCINE, V28, P7483, DOI 10.1016/j.vaccine.2010.09.014; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Lee AJ, 2012, CURR OPIN INFECT DIS, V25, P92, DOI 10.1097/QCO.0b013e32834e9a56; Liu K, 2012, VACCINE, V30, P3034, DOI 10.1016/j.vaccine.2011.10.010; Liu WJ, 2001, VACCINE, V20, P862, DOI 10.1016/S0264-410X(01)00406-6; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; McCormack PL, 2010, DRUGS, V70, P2449, DOI 10.2165/11204920-000000000-00000; Milligan GN, 1998, J IMMUNOL, V160, P6093; Mo A, 2011, VACCINE, V29, P8530, DOI 10.1016/j.vaccine.2011.07.011; Mueller SN, 2006, J IMMUNOL, V176, P7379, DOI 10.4049/jimmunol.176.12.7379; Muller WJ, 2009, J GEN VIROL, V90, P1153, DOI 10.1099/vir.0.008771-0; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; PARR MB, 1994, LAB INVEST, V70, P369; Shao Wen-ai, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P286; Shen HG, 2009, VIROLOGY, V393, P104, DOI 10.1016/j.virol.2009.07.035; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shlapobersky M, 2012, J GEN VIROLOGY; Sin JI, 2001, HUM GENE THER, V12, P1091, DOI 10.1089/104303401750214302; SLOBEDMAN B, 1994, J GEN VIROL, V75, P2469, DOI 10.1099/0022-1317-75-9-2469; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; Veselenak RL, 2012, VACCINE, V30, P7046, DOI 10.1016/j.vaccine.2012.09.057; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Wang KN, 2012, J VIROL, V86, P12891, DOI 10.1128/JVI.01055-12; Zhang M, 2005, GENE THER, V12, P1049, DOI 10.1038/sj.gt.3302490	46	33	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76407	10.1371/journal.pone.0076407	http://dx.doi.org/10.1371/journal.pone.0076407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098493	gold, Green Submitted, Green Published			2022-12-27	WOS:000325483600045
J	Wang, Q; Wright, CJ; Huang, DM; Uriarte, SM; Lamont, RJ				Wang, Qian; Wright, Christopher J.; Huang Dingming; Uriarte, Silvia M.; Lamont, Richard J.			Oral Community Interactions of Filifactor alocis In Vitro	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; STREPTOCOCCUS-GORDONII; AGGRESSIVE PERIODONTITIS; MICROBIAL COMMUNITIES; BIOFILM FORMATION; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; SUBGINGIVAL PLAQUE; EPITHELIAL-CELLS; RED COMPLEX; HEALTH	Filifactor alocis is a gram positive anaerobe that is emerging as an important periodontal pathogen. In the oral cavity F. alocis colonizes polymicrobial biofilm communities; however, little is known regarding the nature of the interactions between F. alocis and other oral biofilm bacteria. Here we investigate the community interactions of two strains of F. alocis with Streptococcus gordonii, Fusobacterium nucleatum, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, organisms with differing pathogenic potential in the oral cavity. In an in vitro community development model, S. gordonii was antagonistic to the accumulation of F. alocis into a dual species community. In contrast, F. nucleatum and the type strain of F. alocis formed a synergistic partnership. Accumulation of a low passage isolate of F. alocis was also enhanced by F. nucleatum. In three species communities of S. gordonii, F. nucleatum and F. alocis, the antagonistic effects of S. gordonii superseded the synergistic effects of F. nucleatum toward F. alocis. The interaction between A. actinomycetemcomitans and F. alocis was strain specific and A. actinomycetemcomitans could either stimulate F. alocis accumulation or have no effect depending on the strain. P. gingivalis and F. alocis formed heterotypic communities with the amount of P. gingivalis greater than in the absence of F. alocis. However, while P. gingivalis benefited from the relationship, levels of F. alocis in the dual species community were lower compared to F. alocis alone. The inhibitory effect of P. gingivalis toward F. alocis was dependent, at least partially, on the presence of the Mfa1 fimbrial subunit. In addition, Al-2 production by P. gingivalis helped maintain levels of F. alocis. Collectively, these results show that the pattern of F. alocis colonization will be dictated by the spatial composition of microbial microenvironments, and that the organism may preferentially accumulate at sites rich in F. nucleatum.	[Wang, Qian; Wright, Christopher J.; Lamont, Richard J.] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA; [Uriarte, Silvia M.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Wang, Qian; Huang Dingming] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Peoples R China	University of Louisville; University of Louisville; Sichuan University	Lamont, RJ (corresponding author), Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA.	rich.lamont@louisville.edu	Wang, Qian/C-5155-2016; Wang, Qian/H-1111-2015	Wang, Qian/0000-0001-8516-4482; Wang, Qian/0000-0002-1355-1616	National Institutes of Health [DE22867, DE12505]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022867, R01DE012505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding provided by National Institutes of Health DE22867, DE12505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Aruni AW, 2012, PROTEOMICS, V12, P3343, DOI 10.1002/pmic.201200211; Aruni AW, 2011, INFECT IMMUN, V79, P3872, DOI 10.1128/IAI.05631-11; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Chung WO, 2000, INFECT IMMUN, V68, P6758, DOI 10.1128/IAI.68.12.6758-6762.2000; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Cuadra-Saenz G, 2012, MICROBIOL-SGM, V158, P1783, DOI 10.1099/mic.0.057182-0; Daep CA, 2011, INFECT IMMUN, V79, P67, DOI 10.1128/IAI.00361-10; Dahlen G, 2006, ORAL MICROBIOL IMMUN, V21, P6, DOI 10.1111/j.1399-302X.2005.00243.x; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Fine DH, 2013, J CLIN MICROBIOL, V51, P2850, DOI 10.1128/JCM.00729-13; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Haubek D, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2010.02665.x; Herce HD, 2013, J MICROSC-OXFORD, V249, P184, DOI 10.1111/jmi.12008; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Kolenbrander PE, 2011, INT J ORAL SCI, V3, P49, DOI 10.4248/IJOS11025; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Kuboniwa M, 2010, PERIODONTOL 2000, V52, P38, DOI 10.1111/j.1600-0757.2009.00311.x; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Mans JJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-380; Mansfield JM, 2012, J ORAL MAXIL SURG, V70, P1507, DOI 10.1016/j.joms.2011.09.049; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; Moffatt CE, 2011, MOL ORAL MICROBIOL, V26, P365, DOI 10.1111/j.2041-1014.2011.00624.x; Montagner F, 2012, J ENDODONT, V38, P158, DOI 10.1016/j.joen.2011.09.029; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Rylev M, 2011, MOL ORAL MICROBIOL, V26, P35, DOI 10.1111/j.2041-1014.2010.00593.x; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; Shaddox LM, 2012, J DENT RES, V91, P927, DOI 10.1177/0022034512456039; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Wang BY, 2009, J CLIN MICROBIOL, V47, P3902, DOI 10.1128/JCM.00072-09; WESTERGAARD J, 1978, SCAND J DENT RES, V86, P421; Whitmore SE, 2011, MOL MICROBIOL, V81, P305, DOI 10.1111/j.1365-2958.2011.07707.x; Wright CJ, 2013, MOL ORAL MICROBIOL, V28, P83, DOI 10.1111/omi.12012; Xie H, 2007, MICROBIOL-SGM, V153, P3228, DOI 10.1099/mic.0.2007/009050-0; Zeituni AE, 2010, J BACTERIOL, V192, P4103, DOI 10.1128/JB.00275-10	45	37	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76271	10.1371/journal.pone.0076271	http://dx.doi.org/10.1371/journal.pone.0076271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098460	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600034
J	Machnes, ZM; Huang, TCT; Chang, PKY; Gill, R; Reist, N; Dezsi, G; Ozturk, E; Charron, F; O'Brien, TJ; Jones, NC; McKinney, RA; Szyf, M				Machnes, Ziv M.; Huang, Tony C. T.; Chang, Philip K. Y.; Gill, Raminder; Reist, Nicholas; Dezsi, Gabriella; Ozturk, Ezgi; Charron, Francois; O'Brien, Terence J.; Jones, Nigel C.; McKinney, R. Anne; Szyf, Moshe			DNA Methylation Mediates Persistent Epileptiform Activity In Vitro and In Vivo	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GENE-EXPRESSION; CPG METHYLATION; MESSENGER-RNA; RAT MODEL; GLUR2; TWINS; ACID; NEUROTRANSMISSION; DEMETHYLATION	Epilepsy is a chronic brain disorder involving recurring seizures often precipitated by an earlier neuronal insult. The mechanisms that link the transient neuronal insult to the lasting state of epilepsy are unknown. Here we tested the possible role of DNA methylation in mediating long-term induction of epileptiform activity by transient kainic acid exposure using in vitro and in vivo rodent models. We analyzed changes in the gria2 gene, which encodes for the GluA2 subunit of the ionotropic glutamate, alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid receptor and is well documented to play a role in epilepsy. We show that kainic acid exposure for two hours to mouse hippocampal slices triggers methylation of a 5' regulatory region of the gria2 gene. Increase in methylation persists one week after removal of the drug, with concurrent suppression of gria2 mRNA expression levels. The degree of kainic acid-induced hypermethylation of gria2 5' region varies between individual slices and correlates with the changes in excitability induced by kainic acid. In a rat in vivo model of post kainic acid-induced epilepsy, we show similar hypermethylation of the 5' region of gria2. Inter-individual variations in gria2 methylation, correlate with the frequency and intensity of seizures among epileptic rats. Luciferase reporter assays support a regulatory role for methylation of gria2 5' region. Inhibition of DNA methylation by RG108 blocked kainic acid-induced hypermethylation of gria2 5' region in hippocampal slice cultures and bursting activity. Our results suggest that DNA methylation of such genes as gria2 mediates persistent epileptiform activity and inter-individual differences in the epileptic response to neuronal insult and that pharmacological agents that block DNA methylation inhibit epileptiform activity raising the prospect of DNA methylation inhibitors in epilepsy therapeutics.	[Machnes, Ziv M.; Huang, Tony C. T.; Chang, Philip K. Y.; Gill, Raminder; Reist, Nicholas; Charron, Francois; McKinney, R. Anne; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Dezsi, Gabriella; Ozturk, Ezgi; O'Brien, Terence J.; Jones, Nigel C.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3052, Australia	McGill University; Royal Melbourne Hospital; University of Melbourne	McKinney, RA (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	anne.mckinney@mcgill.ca; moshe.szyf@mcgill.ca	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621; Jones, Nigel/0000-0002-1080-8439; Chang, Philip Keng-Yu/0000-0002-4732-1536	Canadian Institute Health Research [MOP-42411, MOP 86724]; NHMRC [566544, 1006077]; Sackler program in epigenetics and psychobiology at McGill University; GSK/CIHR professorship in pharmacology	Canadian Institute Health Research(Canadian Institutes of Health Research (CIHR)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sackler program in epigenetics and psychobiology at McGill University; GSK/CIHR professorship in pharmacology	This work was supported by Canadian Institute Health Research grants MS (MOP-42411), RAM (MOP 86724) and by NHMRC project grants to NJ and TO (566544 & 1006077). This work was also supported by the Sackler program in epigenetics and psychobiology at McGill University (MS). MS is a fellow of the Canadian Institute for Advanced research and is supported by a GSK/CIHR professorship in pharmacology. NR held an NSERC USRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Bao GS, 2011, CHINESE MED J-PEKING, V124, P2622, DOI 10.3760/cma.j.issn.0366-6999.2011.17.011; Bell JT, 2012, INT J EPIDEMIOL, V41, P140, DOI 10.1093/ije/dyr179; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Dong E, 2007, P NATL ACAD SCI USA, V104, P4676, DOI 10.1073/pnas.0700529104; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Friedman LK, 1999, J NEUROSCI, V19, P9412; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Holopainen IE, 2004, NEUROCHEM INT, V45, P1, DOI 10.1016/j.neuint.2004.01.005; Huang YF, 2002, J NEUROSCI, V22, P8422; Jamali S, 2006, BRAIN, V129, P625, DOI 10.1093/brain/awl001; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Jupp B, 2012, EPILEPSIA, V53, P1233, DOI 10.1111/j.1528-1167.2012.03525.x; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031; Kobow K, 2011, EPILEPSIA, V52, P15, DOI 10.1111/j.1528-1167.2011.03145.x; Kobow K, 2009, J NEUROPATH EXP NEUR, V68, P356, DOI 10.1097/NEN.0b013e31819ba737; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; MATEVOSSIAN A, 2008, JOVE-J VIS EXP, P78943; Miller-Delaney SFC, 2012, J NEUROSCI, V32, P1577, DOI 10.1523/JNEUROSCI.5180-11.2012; Milutinovic S, 2007, CARCINOGENESIS, V28, P560, DOI 10.1093/carcin/bgl167; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Myers SJ, 1998, J NEUROSCI, V18, P6723; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Patel A, 2003, HIPPOCAMPUS, V13, P59, DOI 10.1002/hipo.10045; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Petronis A, 2006, TRENDS GENET, V22, P347, DOI 10.1016/j.tig.2006.04.010; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; PORTELA A, 2013, ONCOGENE, P86312; Qureshi IA, 2010, NEUROBIOL DIS, V39, P53, DOI 10.1016/j.nbd.2010.02.005; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Routbort MJ, 1999, NEUROSCIENCE, V94, P755, DOI 10.1016/S0306-4522(99)00358-9; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Singh S, 2002, CLIN GENET, V62, P97, DOI 10.1034/j.1399-0004.2002.620201.x; Suzuki F, 2000, NEUROSCIENCE, V101, P41, DOI 10.1016/S0306-4522(00)00359-6; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wierschke S, 2010, BIOCHEM BIOPH RES CO, V403, P385, DOI 10.1016/j.bbrc.2010.10.138; Xi ZQ, 2009, SYNAPSE, V63, P1017, DOI 10.1002/syn.20681; Zachariah RM, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/415825	57	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76299	10.1371/journal.pone.0076299	http://dx.doi.org/10.1371/journal.pone.0076299			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098468	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500060
J	Ren, ZG; Cui, GY; Lu, HF; Chen, XH; Jiang, JW; Liu, H; He, Y; Ding, SM; Hu, ZH; Wang, WL; Zheng, SS				Ren, Zhigang; Cui, Guangying; Lu, Haifeng; Chen, Xinhua; Jiang, Jianwen; Liu, Hui; He, Yong; Ding, Songming; Hu, Zhenhua; Wang, Weilin; Zheng, Shusen			Liver Ischemic Preconditioning (IPC) Improves Intestinal Microbiota Following Liver Transplantation in Rats through 16s rDNA-Based Analysis of Microbial Structure Shift	PLOS ONE			English	Article							REPERFUSION INJURY; PREVENTION; PROTECTION; TRIAL; MICE	Background: Ischemia-reperfusion (I/R) injury is associated with intestinal microbial dysbiosis. The "gut-liver axis" closely links gut function and liver function in health and disease. Ischemic preconditioning (IPC) has been proven to reduce I/R injury in the surgery. This study aims to explore the effect of IPC on intestinal microbiota and to analyze characteristics of microbial structure shift following liver transplantation (LT). Methods: The LT animal models of liver and gut IPC were established. Hepatic graft function was assessed by histology and serum ALT/AST. Intestinal barrier function was evaluated by mucosal ultrastructure, serum endotoxin, bacterial translocation, fecal sIgA content and serum TNF-alpha. Intestinal bacterial populations were determined by quantitative PCR. Microbial composition was characterized by DGGE and specific bacterial species were determined by sequence analysis. Principal Findings: Liver IPC improved hepatic graft function expressed as ameliorated graft structure and reduced ALT/AST levels. After administration of liver IPC, intestinal mucosal ultrastructure improved, serum endotoxin and bacterial translocation mildly decreased, fecal sIgA content increased, and serum TNF-alpha decreased. Moreover, liver IPC promoted microbial restorations mainly through restoring Bifidobacterium spp., Clostridium clusters XI and Clostridium cluster XIVab on bacterial genus level. DGGE profiles indicated that liver IPC increased microbial diversity and species richness, and cluster analysis demonstrated that microbial structures were similar and clustered together between the NC group and Liver-IPC group. Furthermore, the phylogenetic tree of band sequences showed key bacteria corresponding to 10 key band classes of microbial structure shift induced by liver IPC, most of which were assigned to Bacteroidetes phylum. Conclusion: Liver IPC cannot only improve hepatic graft function and intestinal barrier function, but also promote restorations of intestinal microbiota following LT, which may further benefit hepatic graft by positive feedback of the "gut-liver axis".	[Ren, Zhigang; Chen, Xinhua; Jiang, Jianwen; He, Yong; Ding, Songming; Hu, Zhenhua; Wang, Weilin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China; [Ren, Zhigang; Chen, Xinhua; Jiang, Jianwen; He, Yong; Ding, Songming; Hu, Zhenhua; Wang, Weilin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Cui, Guangying; Lu, Haifeng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Hui] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn	Ren, Zhigang/AAO-8576-2020		National Basic Research Program (973 Program) in China [2013CB531403, 2009CB522403]; National S & T Major Project of China [2012ZX10002-004]; NSFC for Innovative Research Group of China [81121002]; National Natural Science Foundation of China [81200331]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); National S & T Major Project of China; NSFC for Innovative Research Group of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (973 Program) in China (2013CB531403, 2009CB522403), National S & T Major Project of China (2012ZX10002-004), NSFC for Innovative Research Group of China (81121002) and National Natural Science Foundation of China (81200331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg F, 2011, SCAND J SURG, V100, P14, DOI 10.1177/145749691110000104; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Cai ZQP, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0277-1; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; CHASSAING B, 2013, HEPATOLOGY; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Deschenes M, 1998, TRANSPLANTATION, V66, P302, DOI 10.1097/00007890-199808150-00005; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Er F, 2012, CIRCULATION, V126, P296, DOI 10.1161/CIRCULATIONAHA.112.096370; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glanemann M, 2001, ACTA ANAESTH SCAND, V45, P333, DOI 10.1034/j.1399-6576.2001.045003333.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hubscher SG, 2011, J HEPATOL, V55, P702, DOI 10.1016/j.jhep.2011.03.005; Jaeschke H, 1996, J HEPATOL, V25, P774, DOI 10.1016/S0168-8278(96)80253-4; KAMADA N, 1983, SURGERY, V93, P64; KELSEY R, 2012, NAT REV NEPHROL; Kim YW, 2012, NEUROSURGERY, V71, pE553, DOI 10.1227/01.neu.0000417720.26333.46; Li QR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020460; LLORISCARSI JM, 1993, TRANSPLANT P, V25, P3303; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Oh PL, 2012, AM J TRANSPLANT, V12, P753, DOI 10.1111/j.1600-6143.2011.03860.x; Peralta C, 1997, HEPATOLOGY, V25, P934, DOI 10.1002/hep.510250424; Petrowsky H, 2006, ANN SURG, V244, P921, DOI 10.1097/01.sla.0000246834.07130.5d; Ren ZG, 2011, HEPATOB PANCREAT DIS, V10, P489, DOI 10.1016/S1499-3872(11)60083-0; Shen XD, 2003, HEPATOLOGY, V37, P296, DOI 10.1053/jhep.2003.50066; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042027; Wiesner RH, 2001, LIVER TRANSPLANT, V7, pS60, DOI 10.1053/jlts.2001.29094; Xing HC, 2006, J GASTROEN HEPATOL, V21, P647, DOI 10.1111/j.1440-1746.2006.04306.x; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	35	40	45	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75950	10.1371/journal.pone.0075950	http://dx.doi.org/10.1371/journal.pone.0075950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098410	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500040
J	Ding, JX; Jin, X; Pan, Y; Liu, S; Li, YM				Ding, Jiexia; Jin, Xi; Pan, Yue; Liu, Shan; Li, Youming			Glyceryl Trinitrate for Prevention of Post-ERCP Pancreatitis and Improve the Rate of Cannulation: A Meta-Analysis of Prospective, Randomized, Controlled Trials	PLOS ONE			English	Article							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; RISK-FACTORS; SPHINCTER; ODDI; NITROGLYCERIN; MULTICENTER; SUCCESS; STENT	Background: Acute pancreatitis is the most common complication of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP). Several clinical trials used glyceryl trinitrate (GTN) to prevent the incidence of post-ERCP pancreatitis (PEP). However, the results were still controversial. Objective: To conduct a meta-analysis of published, full-length, randomized controlled trials evaluating the effect of prophylactic GTN on the prevention of PEP, improve the rate of cannulation and the prevention of hyperamylasemia. Methods: Literature searches were conducted using PubMed, EMBASE, The Cochrane Library and Web of Knowledge databases, using keywords "post-ERCP" and "pancreatitis" and limited in randomized controlled trials. Results: Twelve RCTs involving 2649 patients were included. Eleven RCTs compared GTN with placebo for PEP prevention. Meta-analysis showed the overall incidence of PEP was significantly reduced by GTN treatment (RR 0.67; 95% CI, 0.52-0.87). Nevertheless, GTN administration did not decrease the incidence of moderate to severe PEP (RR 0.70; 95% CI, 0.42-1.15). Subgroup analyses revealed that GTN administered by sublingual was more effective than transdermal and topical in reducing the incidence of PEP. Besides, the prophylactic effect of GTN was far more obvious in the group of high PEP incidence than in the group of low PEP incidence. Additionally, the incidence of hyperamylasemia was significantly reduced by GTN treatment (RR 0.69; 95% CI, 0.54-0.90). No differences of the successful cannulation rate of bile ducts (RR 1.03; 95% CI, 0.99-1.06) attributable to GTN were observed. Conclusion: Prophylactic use of GTN reduced the overall incidence of PEP and hyperamylasemia. However, GTN was not helpful for the severity of PEP and the rate of cannulation.	[Ding, Jiexia; Jin, Xi; Pan, Yue; Liu, Shan; Li, Youming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	Li_youming1956@163.com		Ma, Han/0000-0001-9985-3035	Natural Science Funds of China [81230012]; National Science and Technology Support Program of China [2012BAI06B04]	Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China	Research grants supported by the Natural Science Funds of China (No. 81230012) and the National Science and Technology Support Program of China (No. 2012BAI06B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arata S, 2010, J HEPATO-BIL-PAN SCI, V17, P70, DOI 10.1007/s00534-009-0220-5; Aziz AMA, 2007, WORLD J GASTROENTERO, V13, P2655, DOI 10.3748/wjg.v13.i19.2655; Bai Y, 2009, ENDOSCOPY, V41, P690, DOI 10.1055/s-0029-1214951; Bang UC, 2009, ALIMENT PHARM THER, V29, P1078, DOI 10.1111/j.1365-2036.2009.03978.x; Beauchant M, 2008, ENDOSCOPY, V40, P631, DOI 10.1055/s-2008-1077362; Bhatia V, 2011, J CLIN GASTROENTEROL, V45, P170, DOI 10.1097/MCG.0b013e3181eb600e; Chen B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-85; Chen X., 2012, CHIN J DIG ENDOSC, V29, P181; Cheung J, 2009, GASTROINTEST ENDOSC, V70, P1211, DOI 10.1016/j.gie.2009.08.007; Cooper ST, 2007, GASTROENTEROL CLIN N, V36, P259, DOI 10.1016/j.gtc.2007.03.006; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Ding XW, 2012, GASTROINTEST ENDOSC, V76, P1152, DOI 10.1016/j.gie.2012.08.021; Donnellan F, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/796751; Dumonceau JM, 2010, GASTROINTEST ENDOSC, V71, P934, DOI 10.1016/j.gie.2009.10.055; Freeman ML, 2007, CLIN GASTROENTEROL H, V5, P1354, DOI 10.1016/j.cgh.2007.09.007; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P8, DOI 10.1016/S0016-5107(03)02530-6; Freeman ML, 2002, GASTROINTEST ENDOSC, V56, pS273, DOI 10.1067/mge.2002.129028; Ghori A, 2002, J ROY COLL SURG EDIN, V47, P634; Gottlieb K, 1998, Gastrointest Endosc Clin N Am, V8, P87; HANM Nashaat E, 2010, NAT SCI, V8, P27; Hao JY, 2009, WORLD J GASTROENTERO, V15, P366, DOI 10.3748/wjg.15.366; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kaffes AJ, 2006, GASTROINTEST ENDOSC, V64, P351, DOI 10.1016/j.gie.2005.11.060; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Luman W, 1997, GUT, V40, P541, DOI 10.1136/gut.40.4.541; Moreto M, 2003, GASTROINTEST ENDOSC, V57, P1, DOI 10.1067/mge.2003.29; Nojgaard Camilla, 2009, Gastrointest Endosc, V69, pe31, DOI 10.1016/j.gie.2008.11.042; Shao LM, 2010, DIGEST DIS SCI, V55, P1, DOI 10.1007/s10620-008-0709-9; Sofuni A, 2007, CLIN GASTROENTEROL H, V5, P1339, DOI 10.1016/j.cgh.2007.07.008; STARITZ M, 1985, GUT, V26, P194, DOI 10.1136/gut.26.2.194; Sudhindran S, 2001, BRIT J SURG, V88, P1178, DOI 10.1046/j.0007-1323.2001.01842.x; Talwar A, 2005, SURG ENDOSC, V19, P902, DOI 10.1007/s00464-004-9166-5; Testoni PA, 2010, AM J GASTROENTEROL, V105, P1753, DOI 10.1038/ajg.2010.136; Wehrmann T, 2001, ENDOSCOPY, V33, P323, DOI 10.1055/s-2001-13687	36	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75645	10.1371/journal.pone.0075645	http://dx.doi.org/10.1371/journal.pone.0075645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098392	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100020
J	Sharvit, E; Abramovitch, S; Reif, S; Bruck, R				Sharvit, Efrat; Abramovitch, Shirley; Reif, Shimon; Bruck, Rafael			Amplified Inhibition of Stellate Cell Activation Pathways by PPAR-gamma, RAR and RXR Agonists	PLOS ONE			English	Article							PANCREATIC-CANCER CELLS; RECEPTOR-GAMMA; MOLECULAR-MECHANISMS; GROWTH-INHIBITION; HEPATIC-FIBROSIS; GENE-EXPRESSION; ALL-TRANS; LIGANDS; PTEN; APOPTOSIS	Peroxisome proliferator activator receptors (PPAR) ligands such as 15-Delta 12,13-prostaglandin L(2) [PJ] and all trans retinoic acid (ATRA) have been shown to inhibit the development of liver fibrosis. The role of ligands of retinoic X receptor (RXR) and its ligand, 9-cis, is less clear. The purpose of this study was to investigate the effects of combined treatment of the three ligends, PJ, ATRA and 9-cis, on key events during liver fibrosis in rat primary hepatic stellate cells (HSCs). We found that the anti-proliferative effect of the combined treatment of PJ, ATRA and 9-cis on HSCs was additive. Further experiments revealed that this inhibition was due to cell cycle arrest at the G(0)/G(1) phase as demonstrated by FACS analysis. In addition, the combined treatment reduced cyclin D1 expression and increased p21 and p27 protein levels. Furthermore, we found that the three ligands down regulated the phosphorylation of mTOR and p70(S6K). The activation of HSCs was also inhibited by the three ligands as shown by inhibition of vitamin A lipid droplets depletion from HSCs. Studies using real time PCR and western blot analysis showed marked inhibition of collagen I alpha 1 and alpha SMA by the combination of the three ligands. These findings suggest that the combined use of PJ, ATRA and 9-cis causes inhibition of cell proliferation by cell cycle arrest and down-regulation of fibrotic markers to a greater extent compared to each of the ligands alone.	[Sharvit, Efrat; Reif, Shimon; Bruck, Rafael] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel; [Sharvit, Efrat; Reif, Shimon; Bruck, Rafael] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Sharvit, Efrat; Abramovitch, Shirley; Reif, Shimon] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dana Childrens Hosp, Pediat Gastroenterol Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Bruck, R (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel.	rafib@tlvmc.gov.il						Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Bruck R, 2009, DIGEST DIS SCI, V54, P292, DOI 10.1007/s10620-008-0336-5; Chang Q, 2007, J NEURO-ONCOL, V84, P263, DOI 10.1007/s11060-007-9380-9; FRIEDMAN SL, 1993, AM J PHYSIOL, V264, pG947, DOI 10.1152/ajpgi.1993.264.5.G947; Fujiyoshi M, 2011, J HEPATO-BIL-PAN SCI, V18, P13, DOI 10.1007/s00534-010-0304-2; Gabele E, 2005, J BIOL CHEM, V280, P13374, DOI 10.1074/jbc.M409444200; Galli A, 2002, GASTROENTEROLOGY, V122, P1924, DOI 10.1053/gast.2002.33666; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Glass CK, 2000, GENE DEV, V14, P121; Hao LS, 2009, APMIS, V117, P681, DOI 10.1111/j.1600-0463.2009.02515.x; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Hellemans K, 1999, GUT, V45, P134, DOI 10.1136/gut.45.1.134; Hisamori S, 2008, LIVER INT, V28, P1217, DOI 10.1111/j.1478-3231.2008.01745.x; Imai K, 2000, ANAT RECORD, V258, P338, DOI 10.1002/(SICI)1097-0185(20000401)258:4<338::AID-AR2>3.0.CO;2-G; Karpen SJ, 2002, J HEPATOL, V36, P832, DOI 10.1016/S0168-8278(02)00129-0; Lee SJ, 2006, MOL PHARMACOL, V70, P415, DOI 10.1124/mol.106.022954; Lee YR, 2007, INT J HEMATOL, V85, P231, DOI 10.1532/IJH97.A30615; Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Morais AD, 2007, INT J MOL MED, V19, P105; Pratt MAC, 2003, J CELL BIOCHEM, V90, P692, DOI 10.1002/jcb.10682; RAVID A, 1990, J CLIN ENDOCR METAB, V70, P1687, DOI 10.1210/jcem-70-6-1687; Sun K, 2006, ACTA PHARMACOL SIN, V27, P715, DOI 10.1111/j.1745-7254.2006.00299.x; Toyota M, 2002, LIFE SCI, V70, P1565, DOI 10.1016/S0024-3205(01)01524-7; Tsujie M, 2003, INT J ONCOL, V23, P325; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zang CB, 2003, J NEURO-ONCOL, V65, P107, DOI 10.1023/B:NEON.0000003728.80052.a8; Zhou YJ, 2007, LAB INVEST, V87, P488, DOI 10.1038/labinvest.3700532	31	33	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76541	10.1371/journal.pone.0076541	http://dx.doi.org/10.1371/journal.pone.0076541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098526	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100075
J	Zhang, XJ; Huang, YJ; Harvey, PR; Li, HM; Ren, Y; Li, JS; Wang, JN; Yang, HT				Zhang, Xinjian; Huang, Yujie; Harvey, Paul R.; Li, Hongmei; Ren, Yan; Li, Jishun; Wang, Jianing; Yang, Hetong			Isolation and Characterization of Carbendazim-degrading Rhodococcus erythropolis djl-11	PLOS ONE			English	Article							FUNGICIDE CARBENDAZIM; BIODEGRADATION; TOXICITY	Carbendazim (methyl 1H-benzimidazol-2-yl carbamate) is one of the most widely used fungicides in agriculture worldwide, but has been reported to have adverse effects on animal health and ecosystem function. A highly efficient carbendazim-degrading bacterium (strain dj1-11) was isolated from carbendazim-contaminated soil samples via enrichment culture. Strain dj1-11 was identified as Rhodococcus erythropolis based on morphological, physiological and biochemical characters, including sequence analysis of the 16S rRNA gene. In vitro degradation of carbendazim (1000 mg.L-1) by dj1-11 in minimal salts medium (MSM) was highly efficient, and with an average degradation rate of 333.33 mg.L-1.d(-1) at 28 degrees C. The optimal temperature range for carbendazim degradation by dj1-11 in MSM was 25-30 degrees C. Whilst strain dj1-11 was capable of metabolizing cabendazim as the sole source of carbon and nitrogen, degradation was significantly (P<0.05) increased by addition of 12.5 mM NH4NO3. Changes in MSM pH (4-9), substitution of NH4NO3 with organic substrates as N and C sources or replacing Mg2+ with Mn2+, Zn2+ or Fe2+ did not significantly affect carbendazim degradation by dj1-11. During the degradation process, liquid chromatography-mass spectrometry (LC-MS) detected the metabolites 2-aminobenzimidazole and 2-hydroxybenzimidazole. A putative carbendazim-hydrolyzing esterase gene was cloned from chromosomal DNA of djl-11 and showed 99% sequence homology to the mheI carbendazim-hydrolyzing esterase gene from Nocardioides sp. SG-4G.	[Zhang, Xinjian; Huang, Yujie; Harvey, Paul R.; Li, Hongmei; Ren, Yan; Li, Jishun; Wang, Jianing; Yang, Hetong] Shandong Acad Sci, Ctr Biotechnol, Shandong Prov Key Lab Appl Microbiol, Jinan, Shandong, Peoples R China; [Harvey, Paul R.] CSIRO Sustainable Agr Natl Res Flagship, Glen Osmond, SA, Australia; [Harvey, Paul R.] CSIRO Ecosyst Sci, Glen Osmond, SA, Australia	Qilu University of Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Yang, HT (corresponding author), Shandong Acad Sci, Ctr Biotechnol, Shandong Prov Key Lab Appl Microbiol, Jinan, Shandong, Peoples R China.	yanght@sdas.org	Harvey, Paul/C-7013-2008	Zhang, Xinjian/0000-0002-5839-6197; Li, Jishun/0000-0001-7615-7483	Ministry of Science and Technology of China [2010DFA32330]; Department of Science and Technology of Shandong province [2012GNC11004]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Department of Science and Technology of Shandong province	This work was supported by the grant 2010DFA32330 from the Ministry of Science and Technology of China (http://www.most.gov.cn), the grant 2012GNC11004 and Taishan Research Fellowship from Department of Science and Technology of Shandong province (http://www.sdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Boudina A, 2003, CHEMOSPHERE, V50, P649, DOI 10.1016/S0045-6535(02)00620-3; Chen Y, 2009, PHYTOPATHOLOGY, V99, P441, DOI 10.1094/PHYTO-99-4-0441; Fang H, 2010, BIODEGRADATION, V21, P939, DOI 10.1007/s10532-010-9353-0; Farag A, 2011, BIRTH DEFECTS RES B, V92, P122, DOI 10.1002/bdrb.20290; Goodfellow M, 1989, BERGEYS MANUAL SYSTE, V4, P2362; Holtman MA, 1997, APPL MICROBIOL BIOT, V47, P578, DOI 10.1007/s002530050976; Kiss A, 2009, J ENVIRON QUAL, V38, P157, DOI 10.2134/jeq2007.0504; Pandey G, 2010, APPL ENVIRON MICROB, V76, P2940, DOI 10.1128/AEM.02990-09; Sandahl M, 2000, J CHROMATOGR A, V893, P123, DOI 10.1016/S0021-9673(00)00697-X; Selmanoglu G, 2001, HUM EXP TOXICOL, V20, P625, DOI 10.1191/096032701718890603; STRINGER A, 1976, PESTIC SCI, V7, P459, DOI 10.1002/ps.2780070507; Wang YS, 2009, J HAZARD MATER, V172, P84, DOI 10.1016/j.jhazmat.2009.06.142; Wang ZC, 2010, CHEMOSPHERE, V81, P639, DOI 10.1016/j.chemosphere.2010.08.040; Xu JL, 2007, INT J SYST EVOL MICR, V57, P2754, DOI 10.1099/ijs.0.65095-0; Xu JL, 2006, CURR MICROBIOL, V53, P72, DOI 10.1007/s00284-005-0474-3; YARDEN O, 1990, CAN J MICROBIOL, V36, P15, DOI 10.1139/m90-004; Zhang LZ, 2009, INT J ENVIRON POLLUT, V38, P309, DOI 10.1504/IJEP.2009.027231	18	30	34	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74810	10.1371/journal.pone.0074810	http://dx.doi.org/10.1371/journal.pone.0074810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098350	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100010
J	Bergan, J; Skotland, T; Sylvanne, T; Simolin, H; Ekroos, K; Sandvig, K				Bergan, Jonas; Skotland, Tore; Sylvanne, Tuulia; Simolin, Helena; Ekroos, Kim; Sandvig, Kirsten			The Ether Lipid Precursor Hexadecylglycerol Causes Major Changes in the Lipidome of HEp-2 Cells	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT; ELECTROSPRAY-IONIZATION; MOLECULAR LIPIDOMICS; BIOSYNTHESIS; PLASMALOGENS; CANCER; ACID; QUANTIFICATION; FRAGMENTATION	The ether-lipid precursor sn-1-O-hexadecylglycerol (HG) can be used to compensate for early metabolic defects in ether-lipid biosynthesis. To investigate a possible metabolic link between ether-linked phospholipids and the rest of the cellular lipidome, we incubated HEp-2 cells with HG. Mass spectrometry analysis revealed major changes in the lipidome of HG-treated cells compared to that of untreated cells or cells treated with palmitin, a control substance for HG containing an acyl group instead of the ether group. We present quantitative data for a total of 154 species from 17 lipid classes. These species are those constituting more than 2% of their lipid class for most lipid classes, but more than 1% for the ether lipids and glycosphingolipids. In addition to the expected ability of HG to increase the levels of ether-linked glycerophospholipids with 16 carbon atoms in the sn-1 position, this precursor also decreased the amounts of glycosphingolipids and increased the amounts of ceramide, phosphatidylinositol and lysophosphatidylinositol. However, incubation with palmitin, the fatty acyl analogue of HG, also increased the amounts of ceramide and phosphatidylinositols. Thus, changes in these lipid classes were not ether lipid-dependent. No major effects were observed for the other lipid classes, and cellular functions such as growth and endocytosis were unaffected. The data presented clearly demonstrate the importance of performing detailed quantitative lipidomic studies to reveal how the metabolism of ether-linked glycerophospholipids is coupled to that of glycosphingolipids and ester-linked glycerophospholipids, especially phosphatidylinositols.	[Bergan, Jonas; Skotland, Tore; Sandvig, Kirsten] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Bergan, Jonas; Skotland, Tore; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Bergan, Jonas; Sandvig, Kirsten] Univ Oslo, Dept Biosci, Oslo, Norway; [Sylvanne, Tuulia; Simolin, Helena; Ekroos, Kim] Zora Biosci, Espoo, Finland	University of Oslo; University of Oslo; University of Oslo	Sandvig, K (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway.	kirsten.sandvig@ibv.uio.no		Bergan, Jonas/0000-0003-4267-8904	The Norwegian Council for Science and Humanities, The Norwegian Cancer Society; Southern and Eastern Norway Regional Authority	The Norwegian Council for Science and Humanities, The Norwegian Cancer Society; Southern and Eastern Norway Regional Authority	The work performed by the Oslo group has been supported by The Norwegian Council for Science and Humanities, The Norwegian Cancer Society, and Southern and Eastern Norway Regional Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; da Silva TF, 2012, BBA-MOL BASIS DIS, V1822, P1501, DOI 10.1016/j.bbadis.2012.05.014; DAS AK, 1992, LIPIDS, V27, P401, DOI 10.1007/BF02536379; Deniau AL, 2011, BIOCHIMIE, V93, P1, DOI 10.1016/j.biochi.2009.12.010; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; FELLMANN P, 1993, CHEM PHYS LIPIDS, V66, P225, DOI 10.1016/0009-3084(93)90010-Z; FORD DA, 1994, BIOCHEMISTRY-US, V33, P1216, DOI 10.1021/bi00171a022; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Iannitti T, 2010, MAR DRUGS, V8, P2267, DOI 10.3390/md8082267; Ivanova PT, 2010, J LIPID RES, V51, P1581, DOI 10.1194/jlr.D003715; Jung HR, 2011, BBA-MOL CELL BIOL L, V1811, P925, DOI 10.1016/j.bbalip.2011.06.025; Kanzawa N, 2009, P NATL ACAD SCI USA, V106, P17711, DOI 10.1073/pnas.0904762106; Lessig J, 2009, CURR MED CHEM, V16, P2021; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; Mayinger P, 2012, BBA-MOL CELL BIOL L, V1821, P1104, DOI 10.1016/j.bbalip.2012.01.002; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Murphy RA, 2012, CURR OPIN CLIN NUTR, V15, P246, DOI 10.1097/MCO.0b013e328351c32f; Ong WY, 2010, CURR MED CHEM, V17, P2746, DOI 10.2174/092986710791859289; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Pineiro R, 2012, BBA-MOL CELL BIOL L, V1821, P694, DOI 10.1016/j.bbalip.2012.01.009; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; SCHRAKAMP G, 1988, J LIPID RES, V29, P325; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith RE, 2008, LIPIDS, V43, P79, DOI 10.1007/s11745-007-3133-6; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Styger R, 2002, BBA-MOL CELL BIOL L, V1585, P39, DOI 10.1016/S1388-1981(02)00320-7; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-182	42	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75904	10.1371/journal.pone.0075904	http://dx.doi.org/10.1371/journal.pone.0075904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098742	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500113
J	Cai, SX; Zhong, Y; Li, YH; Huang, JN; Zhang, J; Luo, GA; Liu, ZH				Cai, Shuxian; Zhong, Yuan; Li, Yinhua; Huang, Jianan; Zhang, Jing; Luo, Guoan; Liu, Zhonghua			Blockade of the Formation of Insoluble Ubiquitinated Protein Aggregates by EGCG3 '' Me in the Alloxan-Induced Diabetic Kidney	PLOS ONE			English	Article							END-PRODUCTS; EGCG; P62; ACTIVATION; MECHANISMS; FIBRILS; SYSTEM; MICE	Background: Renal accumulation of reactive carbonyl compounds (RCCs) has been linked to the progression of diabetic nephropathy. We previously demonstrated that carbonyl stress induces the formation of amino-carbonyl cross-links and sharply increases the content of beta-sheet-rich structures, which is the seed of insoluble aggregates formation, and tea catechin (-)-epigallocatechin 3-gallate (EGCG) can reverse this process in vitro and in vivo. In this study, methylated derivative (-)-epigallocatechin-3-O-(3-O-methyl)-gallate (EGCG3 '' Me) was hypothesized to neutralize carbonyl stress mediating the formation of insoluble ubiquitinated protein (IUP) aggregates, and reduce the early development of diabetic nephropathy. Methods and results: Diabetes was induced in mice by intraperitoneally injecting alloxan monohydrate (200 mg/kg/d) twice and administering EGCG3 '' Me by gavage for 15 d. Reagent case and western blot results showed that, in diabetic kidneys, the carbonyl proteins in the serum increased; and in insoluble protein fraction, 4-hydroxynonenal-modified proteins, IUP aggregates and p62 accumulated; FT-IR study demonstrated that the lipid content, anti-parallel beta-sheet structure and aggregates increased. EGCG3 '' Me treatment could effectively reverse this process, even better than the negative control treatment. Conclusions: EGCG3 '' Me exhibiting anti-beta-sheet-rich IUP aggregate properties, maybe represents a new strategy to impede the progression of diabetic nephropathy and other diabetic complications.	[Cai, Shuxian; Zhong, Yuan; Huang, Jianan; Liu, Zhonghua] Hunan Agr Univ, Key Lab, Minist Educ Tea Sci, Changsha, Hunan, Peoples R China; [Cai, Shuxian] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Zhong, Yuan; Li, Yinhua; Zhang, Jing; Liu, Zhonghua] Natl Res Ctr Engn Technol Utilizat Bot Funct Ingr, Changsha, Hunan, Peoples R China; [Luo, Guoan; Liu, Zhonghua] Tsinghua Univ, Dept Chem Tsinghua, Beijing 100084, Peoples R China; [Luo, Guoan; Liu, Zhonghua] Tsinghua Univ, Key Lab Biol Organ Phosphorus & Chem Biol, Minist Educ, Beijing 100084, Peoples R China	Hunan Agricultural University; Peking University; Tsinghua University; Tsinghua University	Liu, ZH (corresponding author), Hunan Agr Univ, Key Lab, Minist Educ Tea Sci, Changsha, Hunan, Peoples R China.	larkin-liu@163.com			National Natural Science Foundation of China [31100501]; China Postdoctoral Science Foundation [2012M520128]; National Science and Technology Support Program [2011BAD01B01]; Ministry of Education Innovation Team Program [201042]; National Tea Industry Technology System Projects [CARS-23-C]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science and Technology Support Program; Ministry of Education Innovation Team Program; National Tea Industry Technology System Projects	This study was supported by the National Natural Science Foundation of China (No. 31100501), the China Postdoctoral Science Foundation (No. 2012M520128), National Science and Technology Support Program (NO. 2011BAD01B01), Ministry of Education Innovation Team Program (NO. 201042), and National Tea Industry Technology System Projects (CARS-23-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Bansode SB, 2013, MOL CELL PROTEOMICS, V12, P228, DOI 10.1074/mcp.M112.020651; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Cai SX, 2011, J MED PLANTS RES, V5, P5470; Cai ShuXian, 2010, Journal of Tea Science, V30, P1; Caine S, 2012, NEUROIMAGE, V59, P3624, DOI 10.1016/j.neuroimage.2011.11.033; Chandrashekaran IR, 2011, ARCH BIOCHEM BIOPHYS, V513, P153, DOI 10.1016/j.abb.2011.07.008; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Di Scala C, 2014, J NEUROCHEM, V128, P186, DOI 10.1111/jnc.12390; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Finley KD, 2003, J NEUROSCI, V23, P1254, DOI 10.1523/JNEUROSCI.23-04-01254.2003; Forbes JM, 2003, FASEB J, V17, P1762, DOI 10.1096/fj.02-1102fje; Goh BC, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12027-8; Inagaki H, 2009, J JPN SOC FOOD SCI, V56, P403, DOI 10.3136/nskkk.56.403; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Maeda-Yamamoto M, 2004, J IMMUNOL, V172, P4486, DOI 10.4049/jimmunol.172.7.4486; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Rak M, 2007, BIOPOLYMERS, V87, P207, DOI 10.1002/bip.20820; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Ren WK, 2012, AMINO ACIDS, V42, P2089, DOI 10.1007/s00726-011-0942-y; Seidel K, 2012, NEUROPATH APPL NEURO, V38, P548, DOI 10.1111/j.1365-2990.2011.01220.x; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Waschuk S, 2002, NEUROBIOL AGING, V23, pS393; Yano S, 2007, J AGR FOOD CHEM, V55, P7144, DOI 10.1021/jf071176o; Yao K, 2012, AMINO ACIDS, V42, P2491, DOI 10.1007/s00726-011-1060-6; Yin DZ, 1995, GERONTOLOGY, V41, P159; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao J, 2012, BBA-BIOMEMBRANES, V1818, P3121, DOI 10.1016/j.bbamem.2012.08.012	36	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75687	10.1371/journal.pone.0075687	http://dx.doi.org/10.1371/journal.pone.0075687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098713	gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500084
J	Chen, SH; Lin, QS; Xiao, Y; Deng, YY; Chang, CQ; Zhong, GH; Hu, MY; Zhang, LH				Chen, Shaohua; Lin, Qingsheng; Xiao, Ying; Deng, Yinyue; Chang, Changqing; Zhong, Guohua; Hu, Meiying; Zhang, Lian-Hui			Monooxygenase, a Novel Beta-Cypermethrin Degrading Enzyme from Streptomyces sp	PLOS ONE			English	Article							HYDROLYZING CARBOXYLESTERASE GENE; PYRETHROID INSECTICIDES; MOLECULAR-CLONING; BIOCHEMICAL-CHARACTERIZATION; STRAIN; BIODEGRADATION; EXPOSURE; PURIFICATION; URBAN; DEGRADATION	The widely used insecticide beta-cypermethrin has become a public concern because of its environmental contamination and toxic effects on mammals. In this study, a novel beta-cypermethrin degrading enzyme designated as CMO was purified to apparent homogeneity from a Streptomyces sp. isolate capable of utilizing beta-cypermethrin as a growth substrate. The native enzyme showed a monomeric structure with a molecular mass of 41 kDa and pI of 5.4. The enzyme exhibited the maximal activity at pH 7.5 and 30 degrees C. It was fairly stable in the pH range from 6.5-8.5 and at temperatures below 10 degrees C. The enzyme activity was significantly stimulated by Fe2+, but strongly inhibited by Ag+, Al3+, and Cu2+. The enzyme catalyzed the degradation of beta-cypermethrin to form five products via hydroxylation and diaryl cleavage. A novel beta-cypermethrin detoxification pathway was proposed based on analysis of these products. The purified enzyme was identified as a monooxygenase by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry analysis (MALDI-TOF-MS) and N-terminal protein sequencing. Given that all the characterized pyrethroid-degrading enzymes are the members of hydrolase family, CMO represents the first pyrethroid-degrading monooxygenase identified from environmental microorganisms. Taken together, our findings depict a novel pyrethroid degradation mechanism and indicate that the purified enzyme may be a promising candidate for detoxification of beta-cypermethrin and environmental protection.	[Chen, Shaohua; Lin, Qingsheng; Xiao, Ying; Zhong, Guohua; Hu, Meiying; Zhang, Lian-Hui] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Deng, Yinyue; Chang, Changqing; Zhang, Lian-Hui] Inst Mol & Cell Biol, Singapore, Singapore	South China Agricultural University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hu, MY (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn; lianhui@imcb.a-star.edu.sg	Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626	National Natural Science Foundation of China [30871660]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful to the National Natural Science Foundation (No.30871660) of China for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari RA, 2011, ECOTOX ENVIRON SAFE, V74, P150, DOI 10.1016/j.ecoenv.2010.08.036; Arora PK, 2012, APPL MICROBIOL BIOT, V93, P2265, DOI 10.1007/s00253-012-3927-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao ZY, 2011, ENVIRON HEALTH PERSP, V119, P1239, DOI 10.1289/ehp.1003394; Chen S, 2012, PLOS ONE, V6; Chen SH, 2013, BIORESOURCE TECHNOL, V132, P16, DOI 10.1016/j.biortech.2013.01.002; Chen SH, 2012, BIORESOURCE TECHNOL, V110, P97, DOI 10.1016/j.biortech.2012.01.106; Chen SH, 2011, BIORESOURCE TECHNOL, V102, P8110, DOI 10.1016/j.biortech.2011.06.055; Chen SH, 2011, J HAZARD MATER, V187, P433, DOI 10.1016/j.jhazmat.2011.01.049; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Corcellas C, 2012, ENVIRON INT, V47, P17, DOI 10.1016/j.envint.2012.05.007; Cycon M, 2013, J ENVIRON MANAGE, V117, P7, DOI 10.1016/j.jenvman.2012.12.031; Cycon M, 2011, BIODEGRADATION, V22, P573, DOI 10.1007/s10532-010-9430-4; Delgado-Moreno L, 2011, J AGR FOOD CHEM, V59, P9448, DOI 10.1021/jf202049s; Fan XJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-33; Farag AT, 2007, REPROD TOXICOL, V23, P560, DOI 10.1016/j.reprotox.2007.01.002; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038137; George J, 2011, PROTEOMICS, V11, P4411, DOI 10.1002/pmic.201100233; Guo P, 2009, INT BIODETER BIODEGR, V63, P1107, DOI 10.1016/j.ibiod.2009.09.008; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Jin YX, 2011, CHEMOSPHERE, V84, P124, DOI 10.1016/j.chemosphere.2011.02.034; Jin YX, 2011, FISH SHELLFISH IMMUN, V30, P1049, DOI 10.1016/j.fsi.2011.02.001; Jin YX, 2011, CHEMOSPHERE, V82, P398, DOI 10.1016/j.chemosphere.2010.09.072; Kuivila KM, 2012, ENVIRON SCI TECHNOL, V46, P4297, DOI 10.1021/es2044882; Kumar A, 2012, CELL MOL BIOL, V58, P153, DOI 10.1170/T935; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li G, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-38; Liang WQ, 2005, J AGR FOOD CHEM, V53, P7415, DOI 10.1021/jf051460k; Lin QS, 2011, INT J ENVIRON SCI TE, V8, P45, DOI 10.1007/BF03326194; Lu CS, 2013, ENVIRON SCI TECHNOL, V47, P2018, DOI 10.1021/es303912n; Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P8622, DOI 10.1021/es802697m; MALONEY SE, 1993, APPL ENVIRON MICROB, V59, P2007, DOI 10.1128/AEM.59.7.2007-2013.1993; Meeker JD, 2009, REPROD TOXICOL, V27, P155, DOI 10.1016/j.reprotox.2008.12.012; Morgan MK, 2012, INT J ENV RES PUB HE, V9, P2964, DOI 10.3390/ijerph9082964; Peng Y, 2009, APPL MICROBIOL BIOT, V85, P85, DOI 10.1007/s00253-009-2061-1; Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254; Tallur PN, 2008, BIODEGRADATION, V19, P77, DOI 10.1007/s10532-007-9116-8; Wang BZ, 2009, APPL ENVIRON MICROB, V75, P5496, DOI 10.1128/AEM.01298-09; Wang H, 2011, ENVIRON TOXICOL, V26, P382, DOI 10.1002/tox.20566; Wang XZ, 2009, THERIOGENOLOGY, V72, P599, DOI 10.1016/j.theriogenology.2009.04.016; Weston DP, 2009, ENVIRON POLLUT, V157, P287, DOI 10.1016/j.envpol.2008.06.037; Weston DP, 2010, ENVIRON SCI TECHNOL, V44, P1833, DOI 10.1021/es9035573; Wolansky MJ, 2008, NEUROTOXICOL TERATOL, V30, P55, DOI 10.1016/j.ntt.2007.10.005; Wu PC, 2006, J AGR FOOD CHEM, V54, P836, DOI 10.1021/jf052691u; Yang L, 2011, BIOL FERT SOILS, V47, P917, DOI 10.1007/s00374-011-0602-0; Zhai Y, 2012, J HAZARD MATER, V221, P206, DOI 10.1016/j.jhazmat.2012.04.031; Zhang C, 2011, BIORESOURCE TECHNOL, V102, P7139, DOI 10.1016/j.biortech.2011.03.086; Zhang C, 2010, BIORESOURCE TECHNOL, V101, P3423, DOI 10.1016/j.biortech.2009.12.083; Zhuang RS, 2011, J HAZARD MATER, V189, P323, DOI 10.1016/j.jhazmat.2011.02.034	49	23	28	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75450	10.1371/journal.pone.0075450	http://dx.doi.org/10.1371/journal.pone.0075450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098697	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500068
J	Dong, ZY; Yang, YS; Li, YW; Zhang, KP; Lou, HJ; An, XL; Dong, LL; Gu, YQ; Anderson, OD; Liu, X; Qin, HJ; Wang, DW				Dong, Zhenying; Yang, Yushuang; Li, Yiwen; Zhang, Kunpu; Lou, Haijuan; An, Xueli; Dong, Lingli; Gu, Yong Qiang; Anderson, Olin D.; Liu, Xin; Qin, Huanju; Wang, Daowen			Haplotype Variation of Glu-D1 Locus and the Origin of Glu-D1d Allele Conferring Superior End-Use Qualities in Common Wheat	PLOS ONE			English	Article							SEED STORAGE PROTEINS; GLUTENIN SUBUNIT COMPOSITION; MARKER-ASSISTED SELECTION; BREAD-MAKING QUALITY; TRITICUM-SPELTA L.; AEGILOPS-TAUSCHII; HEAT-STRESS; MOLECULAR ANALYSIS; HEXAPLOID WHEAT; D-GENOME	In higher plants, seed storage proteins (SSPs) are frequently expressed from complex gene families, and allelic variation of SSP genes often affects the quality traits of crops. In common wheat, the Glu-D1 locus, encoding 1Dx and 1Dy SSPs, has multiple alleles. The Glu-D1d allele frequently confers superior end-use qualities to commercial wheat varieties. Here, we studied the haplotype structure of Glu-D1 genomic region and the origin of Glu-D1d. Using seven diagnostic DNA markers, 12 Glu-D1 haplotypes were detected among common wheat, European spelt wheat (T. spelta, a primitive hexaploid relative of common wheat), and Aegilops tauschii (the D genome donor of hexaploid wheat). By comparatively analyzing Glu-D1 haplotypes and their associated 1Dx and 1Dy genes, we deduce that the haplotype carrying Glu-D1d was likely differentiated in the ancestral hexaploid wheat around 10,000 years ago, and was subsequently transmitted to domesticated common wheat and T. spelta. A group of relatively ancient Glu-D1 haplotypes was discovered in Ae. tauschii, which may serve for the evolution of other haplotypes. Moreover, a number of new Glu-D1d variants were found in T. spelta. The main steps in Glu-D1d differentiation are proposed. The implications of our work for enhancing the utility of Glu-D1d in wheat quality improvement and studying the SSP alleles in other crop species are discussed.	[Dong, Zhenying; Yang, Yushuang; Li, Yiwen; Zhang, Kunpu; Lou, Haijuan; An, Xueli; Dong, Lingli; Liu, Xin; Qin, Huanju; Wang, Daowen] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosomal Engn, Beijing, Peoples R China; [Yang, Yushuang; Lou, Haijuan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gu, Yong Qiang; Anderson, Olin D.] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of Agriculture (USDA)	Wang, DW (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosomal Engn, Beijing, Peoples R China.	dwwang@genetics.ac.cn		wang, dao wen/0000-0002-6230-8735	Ministry of Science and Technology of China [2009CB118300, 2011BAD07B02-2]; Ministry of Agriculture of China [2011ZX08002-004, 2011ZX08009-003-004]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This project was supported by grants from Ministry of Science and Technology of China (2009CB118300, 2011BAD07B02-2) and Ministry of Agriculture of China (2011ZX08002-004, 2011ZX08009-003-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeret O, 2005, VEG HIST ARCHAEOBOT, V14, P279, DOI 10.1007/s00334-005-0071-1; Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Anderson O. D., 2003, Functional & Integrative Genomics, V3, P56; ANDERSON OD, 1989, NUCLEIC ACIDS RES, V17, P461, DOI 10.1093/nar/17.1.461; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blatter RHE, 2004, THEOR APPL GENET, V108, P360, DOI 10.1007/s00122-003-1441-7; BLUMENTHAL C, 1995, CEREAL CHEM, V72, P539; Caldwell KS, 2004, GENETICS, V167, P941, DOI 10.1534/genetics.103.016303; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Don C, 2005, J CEREAL SCI, V42, P69, DOI 10.1016/j.jcs.2005.01.005; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Garg M, 2009, BREEDING SCI, V59, P519, DOI 10.1270/jsbbs.59.519; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gibbon BC, 2005, TRENDS GENET, V21, P227, DOI 10.1016/j.tig.2005.02.009; Giles RJ, 2006, THEOR APPL GENET, V112, P1563, DOI 10.1007/s00122-006-0259-5; Groos C, 2007, THEOR APPL GENET, V115, P313, DOI 10.1007/s00122-007-0563-8; Gu YQ, 2006, GENETICS, V174, P1493, DOI 10.1534/genetics.106.060756; Gu YQ, 2010, FUNCT INTEGR GENOMIC, V10, P111, DOI 10.1007/s10142-009-0135-x; Gustafson P., 2009, WHEAT SCI TRADE, P3, DOI DOI 10.1002/9780813818832.CH1; Holding DR, 2008, ADV PL BIOCH MOL BIO, V1, P107, DOI 10.1016/S1755-0408(07)01005-3; Irmak S, 2008, J CEREAL SCI, V48, P513, DOI 10.1016/j.jcs.2007.12.002; Jegadeesan S, 2012, THEOR APPL GENET, V124, P365, DOI 10.1007/s00122-011-1711-8; Kawakatsu T, 2008, J EXP BOT, V59, P4233, DOI 10.1093/jxb/ern265; Kim WS, 2008, J AGR FOOD CHEM, V56, P11320, DOI 10.1021/jf801831w; Krattinger SG, 2013, THEOR APPL GENET, V126, P663, DOI 10.1007/s00122-012-2009-1; Krattinger SG, 2011, PLANT J, V65, P392, DOI 10.1111/j.1365-313X.2010.04430.x; LAFIANDRA D, 1993, J CEREAL SCI, V18, P197, DOI 10.1006/jcrs.1993.1046; Li W. H, 1997, MOL EVOLUTION; Liu SX, 2008, THEOR APPL GENET, V118, P177, DOI 10.1007/s00122-008-0886-0; Liu YN, 2012, THEOR APPL GENET, V125, P1, DOI 10.1007/s00122-012-1829-3; Liu Z, 2003, THEOR APPL GENET, V106, P1368, DOI 10.1007/s00122-002-1175-y; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Miclaus M, 2011, GENETICS, V189, P1271, DOI 10.1534/genetics.111.133918; Miclaus M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002131; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Payne P. I., 1983, Cereal Research Communications, V11, P29; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Stadler T, 2002, P NATL ACAD SCI USA, V99, P11730, DOI 10.1073/pnas.182267799; Surjani Uthayakumaran, 2012, Journal of Agricultural Science (Toronto), V4, P41; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terasawa Y, 2011, GENET RESOUR CROP EV, V58, P283, DOI 10.1007/s10722-010-9573-5; Wang G, 2011, GENETICS, V189, P1281, DOI 10.1534/genetics.111.133967; Wang YH, 2005, CELL RES, V15, P622, DOI 10.1038/sj.cr.7290332; Wani, 2009, J PLANT BREED CROP S, V1, P244, DOI DOI 10.5897/JPBCS.9000113; Wanjugi H, 2009, GENOME, V52, P576, DOI [10.1139/G09-033, 10.1139/g09-033]; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2009, PLANT PHYSIOL, V149, P258, DOI 10.1104/pp.108.129734; Wrigley C., 2009, WHEAT SCI TRADE, P495, DOI DOI 10.1002/9780813818832.CH21; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yan Y, 2003, THEOR APPL GENET, V107, P1321, DOI 10.1007/s00122-003-1315-z; Yan ZH, 2008, CEREAL RES COMMUN, V36, P477, DOI 10.1556/CRC.36.2008.3.12; [张平平 ZHANG Ping-Ping], 2009, [作物学报, Acta Agronomica Sinica], V35, P1606; Zhang Y, 2008, GENETICS, V178, P23, DOI 10.1534/genetics.107.077412	65	6	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74859	10.1371/journal.pone.0074859	http://dx.doi.org/10.1371/journal.pone.0074859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098671	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500042
J	Higo, K; Ikura, T; Oda, M; Morii, H; Takahashi, J; Abe, R; Ito, N				Higo, Kunitake; Ikura, Teikichi; Oda, Masayuki; Morii, Hisayuki; Takahashi, Jun; Abe, Ryo; Ito, Nobutoshi			High Resolution Crystal Structure of the Grb2 SH2 Domain with a Phosphopeptide Derived from CD28	PLOS ONE			English	Article							HIGH-AFFINITY; BINDING; PATHWAY	Src homology 2 (SH2) domains play a critical role in cellular signal transduction. They bind to peptides containing phosphotyrosine (pY) with various specificities that depend on the flanking amino-acid residues. The SH2 domain of growth-factor receptor-bound protein 2 (Grb2) specifically recognizes pY-X-N-X, whereas the SH2 domains in phosphatidylinositol 3-kinase (PI3K) recognize pY-X-X-M. Binding of the pY site in CD28 (pY-M-N-M) by PI3K and Grb2 through their SH2 domains is a key step that triggers the CD28 signal transduction for T cell activation and differentiation. In this study, we determined the crystal structure of the Grb2 SH2 domain in complex with a pY-containing peptide derived from CD28 at 1.35 angstrom resolution. The peptide was found to adopt a twisted U-type conformation, similar to, but distinct from type-I beta-turn. In all previously reported crystal structures, the peptide bound to the Grb2 SH2 domains adopts a type-I beta-turn conformation, except those with a proline residue at the pY+3 position. Molecular modeling also suggests that the same peptide bound to PI3K might adopt a very different conformation.	[Higo, Kunitake; Takahashi, Jun; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan; [Ikura, Teikichi; Ito, Nobutoshi] Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Tokyo, Japan; [Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 606, Japan; [Morii, Hisayuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan	Tokyo University of Science; Tokyo Medical & Dental University (TMDU); Kyoto Prefectural University; National Institute of Advanced Industrial Science & Technology (AIST)	Ito, N (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Tokyo, Japan.	ito.str@tmd.ac.jp	Ikura, Teikichi/N-1490-2015; Ikura, Teikichi/T-5912-2019	Ikura, Teikichi/0000-0003-2377-5434; Oda, Masayuki/0000-0002-8568-4223	JSPS KAKENHI [20159453]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by JSPS KAKENHI Grant Number 20159453 (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENFIELD AP, 2006, ANGEW CHEM INT ED EN, V0118; Das S, 2011, J MOL BIOL, V414, P217, DOI 10.1016/j.jmb.2011.09.046; DeLorbe JE, 2010, ACS MED CHEM LETT, V1, P448, DOI 10.1021/ml100142y; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ettmayer P, 1999, J MED CHEM, V42, P971, DOI 10.1021/jm9811007; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNemar C, 1997, BIOCHEMISTRY-US, V36, P10006, DOI 10.1021/bi9704360; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nioche P, 2002, J MOL BIOL, V315, P1167, DOI 10.1006/jmbi.2001.5299; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Ogura K, 1999, J MOL BIOL, V289, P439, DOI 10.1006/jmbi.1999.2792; Rahuel J, 1998, J MOL BIOL, V279, P1013, DOI 10.1006/jmbi.1998.1790; Rahuel J, 1996, NAT STRUCT BIOL, V3, P586, DOI 10.1038/nsb0796-586; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Suga T, 1998, ACTA CRYSTALLOGR C, V54, P83, DOI 10.1107/S0108270197009827; Thornton KH, 1996, BIOCHEMISTRY-US, V35, P11852, DOI 10.1021/bi952615s; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	23	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74482	10.1371/journal.pone.0074482	http://dx.doi.org/10.1371/journal.pone.0074482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098653	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500024
J	Huebner, L; Engeli, S; Wrann, CD; Goudeva, L; Laue, T; Kielstein, H				Huebner, Lena; Engeli, Stefan; Wrann, Christiane D.; Goudeva, Lilia; Laue, Tobias; Kielstein, Heike			Human NK Cell Subset Functions Are Differentially Affected by Adipokines	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ADIPOSE-TISSUE; IFN-GAMMA; OBESITY; LEPTIN; INFLAMMATION; ADIPONECTIN; DYSFUNCTION; CYTOKINES; IDENTIFICATION	Background: Obesity is a risk factor for various types of infectious diseases and cancer. The increase in adipose tissue causes alterations in both adipogenesis and the production of adipocyte-secreted proteins (adipokines). Since natural killer (NK) cells are the host's primary defense against virus-infected and tumor cells, we investigated how adipocyte-conditioned medium (ACM) affects functions of two distinct human NK cell subsets. Methods: Isolated human peripheral blood mononuclear cells (PBMCs) were cultured with various concentrations of human and murine ACM harvested on two different days during adipogenesis and analyzed by fluorescent-activated cell sorting (FACS). Results: FACS analyses showed that the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), granzyme A (GzmA) and interferon (IFN)-gamma in NK cells was regulated in a subset-specific manner. ACM treatment altered IFN-gamma expression in CD56(dim) NK cells. The production of GzmA in CD56(bright) NK cells was differentially affected by the distinct adipokine compositions harvested at different states of adipogenesis. Comparison of the treatment with either human or murine ACM revealed that adipokine-induced effects on NK cell expression of the leptin receptor (Ob-R), TRAIL and IFN-gamma were species-specific. Conclusion: Considering the growing prevalence of obesity and the various disorders related to it, the present study provides further insights into the roles human NK cell subsets play in the obesity-associated state of chronic low-grade inflammation.	[Huebner, Lena; Laue, Tobias] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Huebner, Lena] Univ Med Berlin, Charite, Dept Gen Visceral Vasc & Thorac Surg, Berlin, Germany; [Engeli, Stefan] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany; [Wrann, Christiane D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA; [Goudeva, Lilia] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Kielstein, Heike] Univ Halle Wittenberg, Dept Anat & Cell Biol, Fac Med, D-06108 Halle, Saale, Germany	Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hannover Medical School; Martin Luther University Halle Wittenberg	Kielstein, H (corresponding author), Univ Halle Wittenberg, Dept Anat & Cell Biol, Fac Med, D-06108 Halle, Saale, Germany.	heike.kielstein@medizin.uni-halle.de	Kielstein, Heike/GNW-4839-2022; Kielstein, Jan T./I-2956-2019	Kielstein, Jan T./0000-0001-8110-9064; Seidemann, Lena/0000-0002-1531-7735	Institute for Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany	Institute for Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany	The study was an investigator initiated study that was mainly supported by an institutional grant from the Institute for Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Corazza N, 2009, ANN NY ACAD SCI, V1171, P50, DOI 10.1111/j.1749-6632.2009.04905.x; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Housa D, 2006, PHYSIOL RES, V55, P233, DOI 10.33549/physiolres.930848; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim KY, 2006, J IMMUNOL, V176, P5958, DOI 10.4049/jimmunol.176.10.5958; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lago F, 2007, CYTOKINE GROWTH F R, V18, P313, DOI 10.1016/j.cytogfr.2007.04.007; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lautenbach A, 2009, OBESITY, V17, P1848, DOI 10.1038/oby.2009.140; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; McLaughlin T, 2010, DIABETOLOGIA, V53, P369, DOI 10.1007/s00125-009-1496-3; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Nave H, 2008, ENDOCRINOLOGY, V149, P3370, DOI 10.1210/en.2007-1516; O'Shea D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008660; Ogden Cynthia L, 2007, NCHS Data Brief, P1; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Rosenow A, 2010, J PROTEOME RES, V9, P5389, DOI 10.1021/pr100621g; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Takeda K, 2001, CELL IMMUNOL, V214, P194, DOI 10.1006/cimm.2001.1896; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Trayhurn P, 2005, ENDOCRINOLOGY, V146, P1003, DOI 10.1210/en.2004-1597; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wrann CD, 2012, AM J PHYSIOL-ENDOC M, V302, pE108, DOI 10.1152/ajpendo.00057.2011; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Zhao YR, 2003, BIOCHEM BIOPH RES CO, V300, P247, DOI 10.1016/S0006-291X(02)02838-3; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c	44	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75703	10.1371/journal.pone.0075703	http://dx.doi.org/10.1371/journal.pone.0075703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098717	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500088
J	Maciel, IS; Silva, RBM; Morrone, FB; Calixto, JB; Campos, MM				Maciel, Izaque S.; Silva, Rodrigo B. M.; Morrone, Fernanda B.; Calixto, Joao B.; Campos, Maria M.			Synergistic Effects of Celecoxib and Bupropion in a Model of Chronic Inflammation-Related Depression in Mice	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; NECROSIS-FACTOR-ALPHA; INDOLEAMINE 2,3-DIOXYGENASE; MECHANICAL ALLODYNIA; INTERFERON-GAMMA; UP-REGULATION; DOUBLE-BLIND; MOUSE MODEL; BEHAVIOR; PAIN	This study was aimed to characterize the depression-like behaviour in the classical model of chronic inflammation induced by Complete Freund's Adjuvant (CFA). Male Swiss mice received an intraplantar (i.pl.) injection of CFA (50 mu l/paw) or vehicle. Behavioural and inflammatory responses were measured at different time-points (1 to 4 weeks), and different pharmacological tools were tested. The brain levels of IL-1 beta and BDNF, or COX-2 expression were also determined. CFA elicited a time-dependent edema formation and mechanical allodynia, which was accompanied by a significant increase in the immobility time in the tail suspension (TST) or forced-swimming (FST) depression tests. Repeated administration of the antidepressants imipramine (10 mg/kg), fluoxetine (20 mg/kg) and bupropion (30 mg/kg) significantly reversed depression-like behaviour induced by CFA. Predictably, the anti-inflammatory drugs dexamethasone (0.5 mg/kg), indomethacin (10 mg/kg) and celecoxib (30 mg/kg) markedly reduced CFA-induced edema. The oral treatment with the analgesic drugs dipyrone (30 and 300 mg/kg) or pregabalin (30 mg/kg) significantly reversed the mechanical allodyinia induced by CFA. Otherwise, either dipyrone or pregabalin (both 30 mg/kg) did not significantly affect the paw edema or the depressive-like behaviour induced by CFA, whereas the oral treatment with dipyrone (300 mg/kg) was able to reduce the immobility time in TST. Noteworthy, CFA-induced edema was reduced by bupropion (30 mg/kg), and depression behaviour was prevented by celecoxib (30 mg/kg). The co-treatment with bupropion and celecoxib (3 mg/kg each) significantly inhibited both inflammation and depression elicited by CFA. The same combined treatment reduced the brain levels of IL-1 beta, as well as COX-2 immunopositivity, whilst it failed to affect the reduction of BDNF levels. We provide novel evidence on the relationship between chronic inflammation and depression, suggesting that combination of antidepressant and anti-inflammatory agents bupropion and celecoxib might represent an attractive therapeutic strategy for depression.	[Maciel, Izaque S.; Silva, Rodrigo B. M.; Morrone, Fernanda B.; Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil; [Morrone, Fernanda B.] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Cellular & Mol Biol, Porto Alegre, RS, Brazil; [Morrone, Fernanda B.; Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Inst Pharmacol & Toxicol, Porto Alegre, RS, Brazil; [Calixto, Joao B.] Univ Fed Santa Catarina, Dept Pharmacol, Florianopolis, SC, Brazil; [Morrone, Fernanda B.] Pontificia Univ Catolica Rio Grande do Sul, Fac Pharm, Porto Alegre, RS, Brazil; [Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Fac Dent, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal de Santa Catarina (UFSC); Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Campos, MM (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil.	camposmmartha@yahoo.com	de Sousa Maciel, Izaque/AAD-9693-2020; Campos, Maria Martha M/J-8829-2015; Morrone, Fernanda B/K-7703-2015; Maciel, Izaque/I-1038-2014; Morrone, Fernanda/AAH-6044-2020; Silva, Rodrigo BM/O-7441-2017	de Sousa Maciel, Izaque/0000-0001-6597-5288; Campos, Maria Martha M/0000-0002-1153-3633; Morrone, Fernanda B/0000-0002-2709-2801; Morrone, Fernanda/0000-0002-2709-2801; Silva, Rodrigo BM/0000-0001-6284-7387; Campos, Maria/0000-0001-7738-9892; calixto, joao Batista/0000-0003-4041-7153	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [63]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao do Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) [01.11.0014-00]; PUCRS (PROBOLSAS Program)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao do Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA); PUCRS (PROBOLSAS Program)	This work was supported by grants from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Fundacao do Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) # 01.11.0014-00. ISM and RBMS are a MSc. students in Medicine and Health Sciences, supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Edital no 63 Toxinologia and PUCRS (PROBOLSAS Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi SH, 2012, J AFFECT DISORDERS, V141, P308, DOI 10.1016/j.jad.2012.03.033; Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Akhondzadeh S, 2009, DEPRESS ANXIETY, V26, P607, DOI 10.1002/da.20589; Barichello T, 2012, J NEURAL TRANSM, V119, P653, DOI 10.1007/s00702-011-0749-8; Bay-Richter C, 2011, BEHAV BRAIN RES, V222, P193, DOI 10.1016/j.bbr.2011.03.060; Bernardi A, 2009, BRIT J PHARMACOL, V158, P1104, DOI 10.1111/j.1476-5381.2009.00244.x; Blatteau JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049069; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Caldarone BJ, 2003, PSYCHOPHARMACOLOGY, V170, P94, DOI 10.1007/s00213-003-1518-7; Capuron L, 2004, BIOL PSYCHIAT, V56, P819, DOI 10.1016/j.biopsych.2004.02.009; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Cassano P, 2006, PHARMACOGENOMICS J, V6, P381, DOI 10.1038/sj.tpj.6500385; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHEN CY, 2010, GEN HOSP PSYCHIAT, V32, pE647; Crown WH, 2002, J CLIN PSYCHIAT, V63, P963, DOI 10.4088/JCP.v63n1102; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; dos Santos DA, 2010, J ETHNOPHARMACOL, V127, P543, DOI 10.1016/j.jep.2009.09.061; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Farooq RK, 2012, BEHAV BRAIN RES, V231, P130, DOI 10.1016/j.bbr.2012.03.020; Fekadu A, 2009, J AFFECT DISORDERS, V116, P4, DOI 10.1016/j.jad.2008.10.014; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Fu X, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-43; Galecki P, 2012, J AFFECT DISORDERS, V138, P360, DOI 10.1016/j.jad.2012.01.016; Guo JY, 2009, EUR J PHARMACOL, V612, P54, DOI 10.1016/j.ejphar.2009.03.076; Inoue N, 2009, J PHARMACOL SCI, V109, P600, DOI 10.1254/jphs.08287FP; Jesse CR, 2010, PSYCHOPHARMACOLOGY, V212, P513, DOI 10.1007/s00213-010-1977-6; Johansson D, 2012, PROG NEURO-PSYCHOPH, V39, P143, DOI 10.1016/j.pnpbp.2012.06.003; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim EJ, 2001, BRAIN RES, V908, P1, DOI 10.1016/S0006-8993(01)02432-5; Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884; Liu DX, 2011, NEUROPHARMACOLOGY, V61, P592, DOI 10.1016/j.neuropharm.2011.04.033; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; MAES M, 1995, PSYCHONEUROENDOCRINO, V20, P111, DOI 10.1016/0306-4530(94)00066-J; Matsuzawa-Yanagida K, 2008, NEUROPSYCHOPHARMACOL, V33, P1952, DOI 10.1038/sj.npp.1301590; Moreau M, 2008, BRAIN BEHAV IMMUN, V22, P1087, DOI 10.1016/j.bbi.2008.04.001; Muller N, 2011, NEUROTOX RES, V19, P308, DOI 10.1007/s12640-010-9210-2; Murphy LB, 2012, ARTHRIT CARE RES, V64, P968, DOI 10.1002/acr.21685; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Narita M, 2006, NEUROPSYCHOPHARMACOL, V31, P739, DOI 10.1038/sj.npp.1300858; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; Ohgi Y, 2013, PHARMACOL BIOCHEM BE, V103, P853, DOI 10.1016/j.pbb.2012.12.003; Park HJ, 2010, CAN J ANAESTH, V57, P664, DOI 10.1007/s12630-010-9318-0; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Recla Jill M, 2010, J Pain Res, V3, P89; Schmidt HD, 2011, NEUROPSYCHOPHARMACOL, V36, P2375, DOI 10.1038/npp.2011.151; Schmidt LS, 2010, PSYCHOPHARMACOLOGY, V207, P547, DOI 10.1007/s00213-009-1685-2; Pereira PJS, 2011, PAIN, V152, P2861, DOI 10.1016/j.pain.2011.09.016; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Soncini R, 2012, NEUROSCI LETT, V516, P114, DOI 10.1016/j.neulet.2012.03.070; Souza AH, 2008, PAIN, V140, P115, DOI 10.1016/j.pain.2008.07.014; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tanti A, 2010, BRIT J PHARMACOL, V159, P1187, DOI 10.1111/j.1476-5381.2009.00585.x; Thase ME, 1998, J CLIN PSYCHIAT, V59, P5; Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011; Vartanian MG, 2006, EPILEPSY RES, V68, P189, DOI 10.1016/j.eplepsyres.2005.11.001; Viana AF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-98; Wichers M, 2009, BRIT J PSYCHIAT, V195, P498, DOI 10.1192/bjp.bp.108.056853; WITTCHEN HU, 1994, BRIT J PSYCHIAT, V165, P16, DOI 10.1192/S0007125000293240; Yamamoto H, 2009, NEUROPHARMACOLOGY, V57, P403, DOI 10.1016/j.neuropharm.2009.06.037; Yokoyama T, 2007, J PAIN, V8, P422, DOI 10.1016/j.jpain.2006.11.007; Yu H, 2011, ACTA PHARMACOL SIN, V32, P3, DOI 10.1038/aps.2010.184; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	70	57	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77227	10.1371/journal.pone.0077227	http://dx.doi.org/10.1371/journal.pone.0077227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086771	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900114
J	Emadi, N; Esteky, H				Emadi, Nazli; Esteky, Hossein			Neural Representation of Ambiguous Visual Objects in the Inferior Temporal Cortex	PLOS ONE			English	Article							ANTERIOR INFEROTEMPORAL CORTEX; PERCEPTUAL DECISION-MAKING; MACAQUE CEREBRAL-CORTEX; RESPONSE PROPERTIES; SINGLE NEURONS; RHESUS-MONKEYS; RECOGNITION; CATEGORIZATION; ATTENTION; COMPLEX	Inferior temporal (IT) cortex as the final stage of the ventral visual pathway is involved in visual object recognition. In our everyday life we need to recognize visual objects that are degraded by noise. Psychophysical studies have shown that the accuracy and speed of the object recognition decreases as the amount of visual noise increases. However, the neural representation of ambiguous visual objects and the underlying neural mechanisms of such changes in the behavior are not known. Here, by recording the neuronal spiking activity of macaque monkeys' IT we explored the relationship between stimulus ambiguity and the IT neural activity. We found smaller amplitude, later onset, earlier offset and shorter duration of the response as visual ambiguity increased. All of these modulations were gradual and correlated with the level of stimulus ambiguity. We found that while category selectivity of IT neurons decreased with noise, it was preserved for a large extent of visual ambiguity. This noise tolerance for category selectivity in IT was lost at 60% noise level. Interestingly, while the response of the IT neurons to visual stimuli at 60% noise level was significantly larger than their baseline activity and full (100%) noise, it was not category selective anymore. The latter finding shows a neural representation that signals the presence of visual stimulus without signaling what it is. In general these findings, in the context of a drift diffusion model, explain the neural mechanisms of perceptual accuracy and speed changes in the process of recognizing ambiguous objects.	[Emadi, Nazli; Esteky, Hossein] Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran; [Emadi, Nazli; Esteky, Hossein] Shahid Beheshti Univ, Sch Med, Res Ctr Brain & Cognit, Tehran, Iran; [Emadi, Nazli] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Emadi, Nazli] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Shahid Beheshti University; Howard Hughes Medical Institute; Stanford University; Stanford University	Emadi, N (corresponding author), Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran.	nazlie@stanford.edu; esteky@ipm.ir						Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Bell AH, 2009, J NEUROPHYSIOL, V101, P688, DOI 10.1152/jn.90657.2008; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BUCHWALD JS, 1970, J NEUROPHYSIOL, V33, P148, DOI 10.1152/jn.1970.33.1.148; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Gazzaniga M. S., 2009, COGNITIVE NEUROSCIEN; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiani R, 2005, J NEUROPHYSIOL, V94, P1587, DOI 10.1152/jn.00540.2004; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOVACS G, 1995, J NEUROSCI, V15, P1984, DOI 10.1523/JNEUROSCI.15-03-01984.1995; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Larsson J, 1999, EUR J NEUROSCI, V11, P4024, DOI 10.1046/j.1460-9568.1999.00805.x; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Lerner Y, 2002, CEREB CORTEX, V12, P163, DOI 10.1093/cercor/12.2.163; Li N, 2009, J NEUROPHYSIOL, V102, P360, DOI 10.1152/jn.90745.2008; Liu Y, 2008, J NEUROPHYSIOL, V100, P966, DOI 10.1152/jn.01354.2007; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Mack ML, 2008, PSYCHON B REV, V15, P28, DOI 10.3758/PBR.15.1.28; Mack ML, 2010, J EXP PSYCHOL HUMAN, V36, P1067, DOI 10.1037/a0020254; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCARTHY RA, 1986, J NEUROL NEUROSUR PS, V49, P1233, DOI 10.1136/jnnp.49.11.1233; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Mruczek REB, 2007, J NEUROSCI, V27, P2825, DOI 10.1523/JNEUROSCI.4102-06.2007; Oram MW, 2010, J PHYSIOL-PARIS, V104, P167, DOI 10.1016/j.jphysparis.2009.11.021; Oram MW, 2002, PHILOS T ROY SOC B, V357, P987, DOI 10.1098/rstb.2002.1113; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Rainer G, 2002, NEUROIMAGE, V16, P607, DOI 10.1006/nimg.2002.1086; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Sachdev RNS, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00043; Saleem KS, 1996, J NEUROSCI, V16, P4757; Saleem KS, 2000, J NEUROSCI, V20, P5083; Salimpour Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021256; Sary G, 2008, EUR J NEUROSCI, V28, P2137, DOI 10.1111/j.1460-9568.2008.06499.x; Sary G, 2007, EUR J NEUROSCI, V25, P2558, DOI 10.1111/j.1460-9568.2007.05494.x; Sato T, 2009, CEREB CORTEX, V19, P1870, DOI 10.1093/cercor/bhn218; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Shidara M, 2005, EXP BRAIN RES, V163, P239, DOI 10.1007/s00221-005-2230-0; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Super H, 2005, PROG BRAIN RES, V147, P263, DOI 10.1016/S0079-6123(04)47020-4; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Tanaka K, 1992, Curr Opin Neurobiol, V2, P502, DOI 10.1016/0959-4388(92)90187-P; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tompa T, 2010, BRAIN RES REV, V62, P165, DOI 10.1016/j.brainresrev.2009.10.001; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; Zipser K, 1996, J NEUROSCI, V16, P7376	73	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76856	10.1371/journal.pone.0076856	http://dx.doi.org/10.1371/journal.pone.0076856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098569	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600079
J	Eom, YH; Shepelyansky, DL				Eom, Young-Ho; Shepelyansky, Dima L.			Highlighting Entanglement of Cultures via Ranking of Multilingual Wikipedia Articles	PLOS ONE			English	Article							GOOGLE MATRIX	How different cultures evaluate a person? Is an important person in one culture is also important in the other culture? We address these questions via ranking of multilingual Wikipedia articles. With three ranking algorithms based on network structure of Wikipedia, we assign ranking to all articles in 9 multilingual editions of Wikipedia and investigate general ranking structure of PageRank, CheiRank and 2DRank. In particular, we focus on articles related to persons, identify top 30 persons for each rank among different editions and analyze distinctions of their distributions over activity fields such as politics, art, science, religion, sport for each edition. We find that local heroes are dominant but also global heroes exist and create an effective network representing entanglement of cultures. The Google matrix analysis of network of cultures shows signs of the Zipf law distribution. This approach allows to examine diversity and shared characteristics of knowledge organization between cultures. The developed computational, data driven approach highlights cultural interconnections in a new perspective. Dated: June 26, 2013	[Eom, Young-Ho; Shepelyansky, Dima L.] Univ Toulouse, UPS, IRSAMC, Lab Phys Theor,CNRS, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Shepelyansky, DL (corresponding author), Univ Toulouse, UPS, IRSAMC, Lab Phys Theor,CNRS, Toulouse, France.	dima@irsamc.ups-tlse.fr	Shepelyansky, Dima L/G-6050-2016	Shepelyansky, Dima L/0000-0002-2752-0765; Eom, Young-Ho/0000-0002-4828-7333	EC FET [288956]	EC FET	This research is supported in part by the EC FET Open project "New tools and algorithms for directed network analysis'' (NADINE number 288956). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges JL, 1962, THE LIBRARY OF BABEL; Brandes U., 2009, P 18 INT C WORLD WID, P731, DOI DOI 10.1145/1526709.1526808; Brin M, 2002, INTRODUCTION TO DYNA; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Callahan ES, 2011, J AM SOC INF SCI TEC, V62, P1899, DOI 10.1002/asi.21577; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Chepelianskii AD, 2010, ARXIV 1003 5455 CS S; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Darren Gergle, 2009, P 4 INT C COMM TECHN, P11, DOI DOI 10.1145/1556460.1556463; Eom YH, 2013, ARXIV 1304 6601 PHYS; Ermann L, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/27/275101; Ermann L, 2011, ACTA PHYS POL A, V120, pA158; Ermann L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-31090-8; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Kaltenbrunner A, 2012, PROC OF THE 8TH INTL; Kaltenbrunner A, 2012, PROCEEDINGS OF THE E; Kandiah V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061519; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Meyer CD, 2006, GOOGLE S PAGERANK AN; Nemoto K, 2011, PROCD SOC BEHV, V26, DOI 10.1016/j.sbspro.2011.10.574; Norenzayan A, 2011, SCIENCE, V332, P1041, DOI 10.1126/science.1207050; Torok J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.088701; Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048386; Zhirov AO, 2010, EUR PHYS J B, V77, P523, DOI 10.1140/epjb/e2010-10500-7; ZIPF G. K., 1949, HUMAN BEHAVIOR AND T	25	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74554	10.1371/journal.pone.0074554	http://dx.doi.org/10.1371/journal.pone.0074554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098338	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000325483600005
J	Walmer, DK; Eder, PS; Bell, L; Salim, H; Kobayashi, L; Ndirangu, J; Tinfo, N; Castle, PE				Walmer, David K.; Eder, Paul S.; Bell, Laura; Salim, Hiam; Kobayashi, Lori; Ndirangu, Jackie; Tinfo, Nicole; Castle, Philip E.			Human Papillomavirus Prevalence in a Population of Women Living in Port-au-Prince and Leogane, Haiti	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; CANCER; INFECTION; HPV; DISEASE; BIOPSY; TRENDS; RISK; AGE; DNA	Background: There have been no published studies of carcinogenic human papillomavirus (HPV)-the necessary cause of cervical cancer-in Haiti, a nation that has one of the greatest burdens of cervical cancer globally. Objective: Characterize prevalence of carcinogenic HPV and the prevalence of individual carcinogenic HPV genotypes in women with cervical precancer or cancer, cervical intraepithelial neoplasia grade 2 (CIN2) or more severe (CIN2+). Methods: Women (n=9,769; aged 25-60 years) were screened for carcinogenic HPV by Hybrid Capture 2 (HC2; Qiagen, Gaithersburg, MD). Carcinogenic HPV positives underwent colposcopy and visible lesions were biopsied. A subset of carcinogenic HPV positives was tested for individual HPV genotypes using a GP5+/6+ assay. Results: The prevalence of carcinogenic HPV was 19.0% (95% confidence interval: 18.4%-19.9%) and decreased with increasing age (p(trend) < 0.001). Women with 3 or more sexual partners and who started sex before the age of 18 years had twice the age-adjusted prevalence of carcinogenic HPV of women with one partner and who started sex after the age of 21 (24.3% vs. 12.9%, respectively). HPV16 and HPV35 were the most common HPV genotypes detected in CIN2+ and more common in women with CIN2+ than those without CIN2+. HPV16 and/or HPV18 were detected in 21.0% of CIN2 (n = 42), 46.2% of CIN3 (n = 52), and 80% of cancers (n = 5). Conclusions: The prevalence of carcinogenic HPV in Haiti was much greater than the prevalence in other Latin American countries. High carcinogenic HPV prevalence and a lack of cervical cancer screening may explain the high burden of cervical cancer in Haiti.	[Walmer, David K.; Ndirangu, Jackie; Tinfo, Nicole] Family Hlth Minist, Durham, NC USA; [Walmer, David K.] Duke Global Hlth Inst, Durham, NC USA; [Eder, Paul S.; Bell, Laura; Salim, Hiam; Kobayashi, Lori] Qiagen Sci Inc, Gaithersburg, MD USA; [Castle, Philip E.] Global Canc Initiat, Chestertown, MD USA	Duke University	Walmer, DK (corresponding author), Family Hlth Minist, Durham, NC USA.	dkwalmer@atlanticreproductive.com	Castle, Philip/AAP-6395-2020	Castle, Philip/0000-0003-1082-6554; Ndirangu, Jackie/0000-0001-8346-7359	Family Health Ministries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	Family Health Ministries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was supplied by Family Health Ministries, no grants were used to perform these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke O, 2012, J WOMENS HEALTH, V21, P1031, DOI 10.1089/jwh.2011.3385; Almonte M, 2011, INT J GYNECOL CANCER, V21, P1654, DOI 10.1097/IGC.0b013e3182288104; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Arrossi S, 2003, SALUD PUBLICA MEXICO, V45, pS306; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Carozzi FM, 2010, CANCER EPIDEM BIOMAR, V19, P2389, DOI 10.1158/1055-9965.EPI-10-0131; Castle PE, 2010, CANCER EPIDEM BIOMAR, V19, P1675, DOI 10.1158/1055-9965.EPI-10-0251; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; FARLEY J, 2010, GLOBOCAN 2008 CANC I, P45237; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; GISSMANN L, 1977, VIROLOGY, V76, P569, DOI 10.1016/0042-6822(77)90239-2; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kobetz E, 2012, J ONCOL, V2012, DOI 10.1155/2012/728397; Lazcano-Ponce E, 2010, CANCER CAUSE CONTROL, V21, P1693, DOI 10.1007/s10552-010-9598-2; MITACEK EJ, 1986, INT J CANCER, V38, P9, DOI 10.1002/ijc.2910380103; Nazarenko I, 2008, J VIROL METHODS, V154, P76, DOI 10.1016/j.jviromet.2008.09.002; Porras C, 2009, CANCER EPIDEM BIOMAR, V18, P863, DOI 10.1158/1055-9965.EPI-08-0951; Pretorius RG, 2004, AM J OBSTET GYNECOL, V191, P430, DOI 10.1016/j.ajog.2004.02.065; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Simonella LM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-114; Valles X, 2009, INT J CANCER, V125, P1161, DOI 10.1002/ijc.24444; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Zandberg DP, 2013, CA-CANCER J CLIN, V63, P57, DOI 10.3322/caac.21167	29	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76110	10.1371/journal.pone.0076110	http://dx.doi.org/10.1371/journal.pone.0076110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098429	gold, Green Submitted, Green Published			2022-12-27	WOS:000325483600027
J	Cunha, MR; Matos, FL; Genio, L; Hilario, A; Moura, CJ; Ravara, A; Rodrigues, CF				Cunha, Marina R.; Matos, Fabio L.; Genio, Luciana; Hilario, Ana; Moura, Carlos J.; Ravara, Ascensao; Rodrigues, Clara F.			Are Organic Falls Bridging Reduced Environments in the Deep Sea? - Results from Colonization Experiments in the Gulf of Cadiz	PLOS ONE			English	Article							WOOD-BORING BIVALVES; WHALE-FALL; SPECIES-DIVERSITY; BACTERIAL ENDOSYMBIONTS; MARINE-ENVIRONMENT; NORTHEAST ATLANTIC; SEEP COMMUNITIES; PLANT REMAINS; MUD VOLCANOS; DWARF MALES	Organic falls create localised patches of organic enrichment and disturbance where enhanced degradation is mediated by diversified microbial assemblages and specialized fauna. The view of organic falls as "stepping stones" for the colonization of deep-sea reducing environments has been often loosely used, but much remains to be proven concerning their capability to bridge dispersal among such environments. Aiming the clarification of this issue, we used an experimental approach to answer the following questions: Are relatively small organic falls in the deep sea capable of sustaining taxonomically and trophically diverse assemblages over demographically relevant temporal scales? Are there important depth- or site-related sources of variability for the composition and structure of these assemblages? Is the proximity of other reducing environments influential for their colonization? We analysed the taxonomical and trophic diversity patterns and partitioning (alpha- and beta-diversity) of the macrofaunal assemblages recruited in small colonization devices with organic and inorganic substrata after 1-2 years of deployment on mud volcanoes of the Gulf of Cadiz. Our results show that small organic falls can sustain highly diverse and trophically coherent assemblages for time periods allowing growth to reproductive maturity, and successive generations of dominant species. The composition and structure of the assemblages showed variability consistent with their biogeographic and bathymetric contexts. However, the proximity of cold seeps had limited influence on the similarity between the assemblages of these two habitats and organic falls sustained a distinctive fauna with dominant substrate-specific taxa. We conclude that it is unlikely that small organic falls may regularly ensure population connectivity among cold seeps and vents. They may be a recurrent source of evolutionary candidates for the colonization of such ecosystems. However, there may be a critical size of organic fall to create the necessary intense and persistent reducing conditions for sustaining typical chemosymbiotic vent and seep organisms.	[Cunha, Marina R.; Matos, Fabio L.; Genio, Luciana; Hilario, Ana; Moura, Carlos J.; Ravara, Ascensao; Rodrigues, Clara F.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Cunha, Marina R.; Matos, Fabio L.; Genio, Luciana; Hilario, Ana; Moura, Carlos J.; Ravara, Ascensao; Rodrigues, Clara F.] Univ Aveiro, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Moura, Carlos J.] Univ Acores, Dept Oceanog & Pescas, Horta, Acores, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade dos Acores	Cunha, MR (corresponding author), Univ Aveiro, Dept Biol, Campus Santiago, P-3800 Aveiro, Portugal.	marina.cunha@ua.pt	Ravara, Ascensão/C-6613-2018; Hilário, Ana/C-1260-2008; Matos, Fábio L./K-3556-2012; Cunha, Marina R/B-7644-2008; Rodrigues, Clara F./A-4536-2009; Gènio, Luciana/M-4325-2013; Moura, Carlos J./F-1822-2011	Ravara, Ascensão/0000-0002-1689-2985; Hilário, Ana/0000-0001-8287-1528; Matos, Fábio L./0000-0002-5447-4055; Cunha, Marina R/0000-0001-8833-6980; Rodrigues, Clara F./0000-0002-3426-8342; Gènio, Luciana/0000-0003-3120-7875; Moura, Carlos J./0000-0002-6243-5988	CHEMECO ESF EURODEEP project (FCT) [EURODEEP/0001/2007]; HERMES project (EC) under European Commission [GOCE-CT-511234]; HERMIONE project European Commission [ENV/2008/1/226354]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/22383/2005, SFRH/BD/31155/2006, SFRH/BD/16563/2004, SFRH/BPD/64154/2009]; Fundação para a Ciência e a Tecnologia [2021.04780.BD, EURODEEP/0001/2007] Funding Source: FCT	CHEMECO ESF EURODEEP project (FCT); HERMES project (EC) under European Commission; HERMIONE project European Commission; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was funded by the CHEMECO ESF EURODEEP project (FCT; EURODEEP/0001/2007) as well as by the HERMES project (EC contract number GOCE-CT-511234) under the European Commission's Framework Sixth Programme and by the HERMIONE project (contract ENV/2008/1/226354) under the European Commission's Framework Seventh Programme. A Hilario, CJ Moura, A Ravara and CF Rodrigues were supported by Fundacao para a Ciencia e Tecnologia, grants SFRH/BPD/22383/2005, SFRH/BD/31155/2006, SFRH/BD/16563/2004, and SFRH/BPD/64154/2009, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Bernardino AF, 2010, DEEP-SEA RES PT I, V57, P708, DOI 10.1016/j.dsr.2010.03.004; Bienhold C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053590; Blair NE, 2012, ANNU REV MAR SCI, V4, P401, DOI 10.1146/annurev-marine-120709-142717; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; CAYRE P, 2002, RECHERCHE, V355, P59; Cordes EE, 2010, DEEP-SEA RES PT II, V57, P1870, DOI 10.1016/j.dsr2.2010.05.010; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Cunha MR, 2013, BIOGEOSCIENCES, V10, P2553, DOI 10.5194/bg-10-2553-2013; DANDO PR, 1992, NATURE, V356, P667, DOI 10.1038/356667a0; De Robertis A, 2001, MAR ECOL PROG SER, V219, P221, DOI 10.3354/meps219221; Dial R, 1998, ECOLOGY, V79, P1412, DOI 10.2307/176752; Distel DL, 2003, ACS SYM SER, V845, P253; Distel DL, 1997, BIOL BULL, V192, P253, DOI 10.2307/1542719; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Duperron S, 2008, FEMS MICROBIOL ECOL, V63, P338, DOI 10.1111/j.1574-6941.2008.00438.x; Fagervold SK, 2012, FEMS MICROBIOL ECOL, V82, P616, DOI 10.1111/j.1574-6941.2012.01432.x; Feldman RA, 1998, BIOL BULL, V194, P116, DOI 10.2307/1543041; Foggo A, 2007, J ANIM ECOL, V76, P695, DOI 10.1111/j.1365-2656.2007.01245.x; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Gaudron SM, 2012, BIOL BULL-US, V222, P6, DOI 10.1086/BBLv222n1p6; Genio L, 2013, BIOGEOSCIENCES, V10, P5159, DOI 10.5194/bg-10-5159-2013; Genio L, 2012, DEEP-SEA RES PT I, V64, P86, DOI 10.1016/j.dsr.2012.02.002; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; Gorley C.K., 2006, GETTING STARTED PRIM; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Haga T, 2013, J MOLLUS STUD, V79, P90, DOI 10.1093/mollus/eys037; HECKER B, 1985, BIOL SOC WASH B, V6, P465; Hilario A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016309; Hoyoux C, 2009, MAR BIOL, V156, P2421, DOI 10.1007/s00227-009-1266-2; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; JUMARS PA, 1989, LIFE SCI R, V44, P235; Khelaifia S, 2011, INT J SYST EVOL MICR, V61, P2706, DOI 10.1099/ijs.0.028670-0; Kiel S, 2006, P ROY SOC B-BIOL SCI, V273, P2625, DOI 10.1098/rspb.2006.3620; LAMBSHEAD PJD, 1983, J NAT HIST, V17, P859, DOI 10.1080/00222938300770671; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2013, DEEP-SEA RES PT II, V92, P214, DOI 10.1016/j.dsr2.2013.02.006; Levin LA, 2012, P ROY SOC B-BIOL SCI, V279, P2580, DOI 10.1098/rspb.2012.0205; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; Macdonald T, 2010, CAN TECH REP FISH AQ, V2874, P63; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MARTILL DM, 1995, PALAIOS, V10, P96, DOI 10.2307/3515011; Nishimoto A, 2009, DEEP-SEA RES PT II, V56, P1683, DOI 10.1016/j.dsr2.2009.05.032; Palacios C, 2009, MICROB ECOL, V58, P737, DOI 10.1007/s00248-009-9538-4; PIELOU E C, 1969, P286; Pradillon F, 2001, NATURE, V413, P698, DOI 10.1038/35099674; Prevedelli D, 2005, MAR ECOL-EVOL PERSP, V26, P286, DOI 10.1111/j.1439-0485.2005.00067.x; Ritt B, 2012, MAR ECOL PROG SER, V466, P93, DOI 10.3354/meps09896; Rodrigues CF, 2013, NATURWISSENSCHAFTEN, V100, P21, DOI 10.1007/s00114-012-0985-2; SAINTE-MARIE B, 1990, CAN J ZOOL, V68, P1639, DOI 10.1139/z90-243; Samadi S, 2010, CAH BIOL MAR, V51, P459; SHILLING FM, 1994, BIOL BULL, V187, P398, DOI 10.2307/1542296; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SMITH CR, 1985, DEEP-SEA RES, V32, P417, DOI 10.1016/0198-0149(85)90089-5; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; STOCKTON WL, 1982, DEEP-SEA RES, V29, P157, DOI 10.1016/0198-0149(82)90106-6; Swearer SE, 2002, B MAR SCI, V70, P251; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thornhill DJ, 2012, ECOL EVOL, V2, P1958, DOI 10.1002/ece3.314; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; TURNER RD, 1973, SCIENCE, V180, P1377, DOI 10.1126/science.180.4093.1377; Turner RD, 1977, B AM MALACOLOGICAL U, V213, P13; Turner Ruth D., 2002, Bulletin of the Museum of Comparative Zoology, V157, P223; Tyler PA, 2007, MAR ECOL PROG SER, V343, P151, DOI 10.3354/meps06832; Vetter EW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002617; VETTER EW, 1994, NATURE, V372, P47, DOI 10.1038/372047a0; Vetter EW, 1999, MAR ECOL PROG SER, V186, P137, DOI 10.3354/meps186137; Vetter EW, 1998, DEEP-SEA RES PT II, V45, P25, DOI 10.1016/S0967-0645(97)00048-9; Voight JR, 2007, J MOLLUS STUD, V73, P377, DOI 10.1093/mollus/eym034; Voight JR, 2009, J MOLLUS STUD, V75, P167, DOI 10.1093/mollus/eyp012; Vrijenhoek RC, 2008, MOL ECOL, V17, P4535, DOI 10.1111/j.1365-294X.2008.03937.x; Vrijenhoek RC, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-74; Wagner HH, 2000, LANDSCAPE ECOL, V15, P219, DOI 10.1023/A:1008114117913; West AJ, 2011, LIMNOL OCEANOGR, V56, P77, DOI 10.4319/lo.2011.56.1.0077; Wiklund H, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2228.1.3; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Young CM, 2003, ECOSY WORLD, V28, P381; YOUNG CM, 1999, AQUATIC LIFE CYCLE S, P1; Young CM, 2013, DEEP-SEA RES PT II, V92, P36, DOI 10.1016/j.dsr2.2013.01.027; Yucel M, 2013, CHEMOSPHERE, V90, P403, DOI 10.1016/j.chemosphere.2012.07.036; Zbinden M, 2010, FEMS MICROBIOL ECOL, V74, P450, DOI 10.1111/j.1574-6941.2010.00959.x	85	34	35	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76688	10.1371/journal.pone.0076688	http://dx.doi.org/10.1371/journal.pone.0076688			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098550	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500082
J	Elgamal, OA; Park, JK; Gusev, Y; Azevedo-Pouly, ACP; Jiang, JM; Roopra, A; Schmittgen, TD				Elgamal, Ola A.; Park, Jong-Kook; Gusev, Yuriy; Azevedo-Pouly, Ana Clara P.; Jiang, Jinmai; Roopra, Avtar; Schmittgen, Thomas D.			Tumor Suppressive Function of mir-205 in Breast Cancer Is Linked to HMGB3 Regulation	PLOS ONE			English	Article							EXPRESSION ANALYSIS; LUNG-CANCER; MICRORNA-205; MELANOMA; CARCINOMAS; PROGNOSIS; PROFILES; PROSTATE; PROTEIN; FAMILY	Identifying targets of dysregulated microRNAs (miRNAs) will enhance our understanding of how altered miRNA expression contributes to the malignant phenotype of breast cancer. The expression of miR-205 was reduced in four breast cancer cell lines compared to the normal-like epithelial cell line MCF10A and in tumor and metastatic tissues compared to adjacent benign breast tissue. Two predicted binding sites for miR-205 were identified in the 3' untranslated region of the high mobility group box 3 gene, HMGB3. Both dual-luciferase reporter assay and Western blotting confirmed that miR-205 binds to and regulates HMGB3. To further explore miR-205 targeting of HMGB3, WST-1 proliferation and in vitro invasion assays were performed in MDA-MB-231 and BT549 cells transiently transfected with precursor miR-205 oligonucleotide or HMGB3 small interfering RNA (siRNA). Both treatments reduced the proliferation and invasion of the cancer cells. The mRNA and protein levels of HMGB3 were higher in the tumor compared to adjacent benign specimens and there was an indirect correlation between the expression of HMGB3 mRNA and patient survival. Treatment of breast cancer cells with 5-Aza/TSA derepressed miR-205 and reduced HMGB3 mRNA while knockdown of the transcriptional repressor NRSF/REST, reduced miR-205 and increased HMGB3. In conclusion, regulation of HMGB3 by miR-205 reduced both proliferation and invasion of breast cancer cells. Our findings suggest that modulating miR-205 and/or targeting HMGB3 are potential therapies for advanced breast cancer.	[Elgamal, Ola A.; Park, Jong-Kook; Azevedo-Pouly, Ana Clara P.; Jiang, Jinmai; Schmittgen, Thomas D.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Gusev, Yuriy] Georgetown Univ, Ctr Canc, Washington, DC USA; [Roopra, Avtar] Univ Wisconsin, Dept Neurosci, Madison, WI USA	University System of Ohio; Ohio State University; Georgetown University; University of Wisconsin System; University of Wisconsin Madison	Schmittgen, TD (corresponding author), Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA.	Schmittgen.2@osu.edu		Azevedo-Pouly, Ana Clara/0000-0001-8308-9271; Elgamal, Ola/0000-0001-5011-3909; Park, Jong Kook/0000-0002-3946-5687; Gusev, Yuriy/0000-0001-7371-4715	Ohio State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065067] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a Provost's Targeted Investment in Excellence (TIE) Award from The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CS, 2001, GENOMICS, V77, P135, DOI 10.1006/geno.2001.6631; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Greene SB, 2010, RNA BIOL, V7, P300, DOI 10.4161/rna.7.3.11837; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Hulf T, 2013, ONCOGENE, V32, P2891, DOI 10.1038/onc.2012.300; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maciotta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043464; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Savad S, 2012, ASIAN PAC J CANCER P, V13, P873, DOI 10.7314/APJCP.2012.13.3.873; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Wu HL, 2009, EXPERT OPIN THER TAR, V13, P1439, DOI 10.1517/14728220903338777; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	30	87	90	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76402	10.1371/journal.pone.0076402	http://dx.doi.org/10.1371/journal.pone.0076402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098490	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500066
J	Lewandowsky, S; Gignac, GE; Oberauer, K				Lewandowsky, Stephan; Gignac, Gilles E.; Oberauer, Klaus			The Role of Conspiracist Ideation and Worldviews in Predicting Rejection of Science	PLOS ONE			English	Article							GENETICALLY-MODIFIED FOODS; CLIMATE-CHANGE; CULTURAL COGNITION; UNITED-STATES; EUROPEAN-UNION; HPV VACCINE; ATTITUDES; BELIEF; CONSERVATISM; RELIABILITY	Background: Among American Conservatives, but not Liberals, trust in science has been declining since the 1970's. Climate science has become particularly polarized, with Conservatives being more likely than Liberals to reject the notion that greenhouse gas emissions are warming the globe. Conversely, opposition to genetically-modified (GM) foods and vaccinations is often ascribed to the political Left although reliable data are lacking. There are also growing indications that rejection of science is suffused by conspiracist ideation, that is the general tendency to endorse conspiracy theories including the specific beliefs that inconvenient scientific findings constitute a "hoax." Methodology/Principal findings: We conducted a propensity weighted internet-panel survey of the U. S. population and show that conservatism and free-market worldview strongly predict rejection of climate science, in contrast to their weaker and opposing effects on acceptance of vaccinations. The two worldview variables do not predict opposition to GM. Conspiracist ideation, by contrast, predicts rejection of all three scientific propositions, albeit to greatly varying extents. Greater endorsement of a diverse set of conspiracy theories predicts opposition to GM foods, vaccinations, and climate science. Conclusions: Free-market worldviews are an important predictor of the rejection of scientific findings that have potential regulatory implications, such as climate science, but not necessarily of other scientific issues. Conspiracist ideation, by contrast, is associated with the rejection of all scientific propositions tested. We highlight the manifold cognitive reasons why conspiracist ideation would stand in opposition to the scientific method. The involvement of conspiracist ideation in the rejection of science has implications for science communicators.	[Lewandowsky, Stephan; Gignac, Gilles E.; Oberauer, Klaus] Univ Western Australia, Sch Psychol, Crawley, WA, Australia; [Lewandowsky, Stephan] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England; [Oberauer, Klaus] Univ Zurich, Dept Psychol, Zurich, Switzerland	University of Western Australia; University of Bristol; University of Zurich	Lewandowsky, S (corresponding author), Univ Western Australia, Sch Psychol, Crawley, WA, Australia.	stephan.lewandowsky@bristol.ac.uk	Lewandowsky, Stephan/L-4272-2019	Lewandowsky, Stephan/0000-0003-1655-2013; Gignac, Gilles/0000-0002-4900-6855	School of Psychology at the University of Western Australia	School of Psychology at the University of Western Australia	This project was supported by funds from the School of Psychology at the University of Western Australia under the auspices of the Adjunct Professor scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Bogart LM, 2005, JAIDS-J ACQ IMM DEF, V38, P213, DOI 10.1097/00126334-200502010-00014; Briones R, 2012, HEALTH COMMUN, V27, P478, DOI 10.1080/10410236.2011.610258; C. f.R.E. Modeling, 2009, EPA100K09003 OFF SCI; Cassell JA, 2006, PUBLIC HEALTH, V120, P783, DOI 10.1016/j.puhe.2006.03.011; Ceccoli S, 2012, INT POLIT SCI REV, V33, P301, DOI 10.1177/0192512111418788; Cheung GW, 2008, ORGAN RES METHODS, V11, P296, DOI 10.1177/1094428107300343; Coffman DL, 2005, MULTIVAR BEHAV RES, V40, P235, DOI 10.1207/s15327906mbr4002_4; Darwin H, 2011, PERS INDIV DIFFER, V50, P1289, DOI 10.1016/j.paid.2011.02.027; Diethelm P, 2009, EUR J PUBLIC HEALTH, V19, P2, DOI 10.1093/eurpub/ckn139; Douglas KM, 2011, BRIT J SOC PSYCHOL, V50, P544, DOI 10.1111/j.2044-8309.2010.02018.x; Dunlap RE, 2008, ENVIRONMENT, V50, P26, DOI 10.3200/ENVT.50.5.26-35; Feinberg M, 2012, PSYCHOL SCI; Feygina I, 2010, PERS SOC PSYCHOL B, V36, P326, DOI 10.1177/0146167209351435; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; GOERTZEL T, 1994, POLIT PSYCHOL, V15, P731, DOI 10.2307/3791630; Goertzel T, 2010, EMBO REP, V11, P493, DOI 10.1038/embor.2010.84; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Hayduk L.A., 1996, LISREL ISSUES DEBATE; Heath Y, 2006, ENVIRON BEHAV, V38, P48, DOI 10.1177/0013916505277998; Hennes EP, 2012, SOC COGNITION, V30, P669, DOI 10.1521/soco.2012.30.6.669; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Inhofe JM, 2012, GREATEST HOAX GLOBAL; Iyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042366; Jacobson RA, 2007, VACCINE, V25, P3146, DOI 10.1016/j.vaccine.2007.01.046; Jensen A.R., 1998, G FACTOR SCI MENTAL; JORESKOG KG, 1982, J MARKETING RES, V19, P404, DOI 10.2307/3151714; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kahan DM, 2010, LAW HUMAN BEHAV, V34, P501, DOI 10.1007/s10979-009-9201-0; Kahan DM, 2009, NAT NANOTECHNOL, V4, P87, DOI [10.1038/nnano.2008.341, 10.1038/NNANO.2008.341]; Kalichman S. C., 2009, DENYING AIDS CONSPIR; Keeley BL, 1999, J PHILOS, V96, P109, DOI 10.2307/2564659; Kim SY, 2010, POLIT BEHAV, V32, P1, DOI 10.1007/s11109-009-9099-8; Kloor K, 2012, GMO OPPONENTS ARE CL; Komaroff E, 1997, APPL PSYCH MEAS, V21, P337, DOI 10.1177/01466216970214004; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Legge JS, 2010, REV POLICY RES, V27, P59, DOI 10.1111/j.1541-1338.2009.00427.x; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Lord F. M., 1968, STAT THEORIES MENTAL; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; McDonald RP., 1985, FACTOR ANAL RELATED; McKewon E, 2012, RURAL SOC, V21, P99, DOI 10.5172/rsj.2012.21.2.99; Mehrabian A, 1996, BASIC APPL SOC PSYCH, V18, P469, DOI 10.1207/s15324834basp1804_7; Mooney C., 2011, SCI WHY WE DONT BELI; Nattrass N, 2010, AIDS BEHAV, V14, P248, DOI 10.1007/s10461-009-9641-z; Nyhan B, 2010, FORUM, V8; Oreskes N, 2010, MERCHANTS DOUBT; Osborne J. W., 2002, PRACTICAL ASSESSMENT, V8, P2, DOI [10.7275/R222-HV23, DOI 10.7275/R222-HV23]; Paulhus DL, 2004, MULTIVAR BEHAV RES, V39, P303, DOI 10.1207/s15327906mbr3902_7; Penev S, 2006, MULTIVAR BEHAV RES, V41, P105, DOI 10.1207/s15327906mbr4102_1; Raykov T, 1997, APPL PSYCH MEAS, V21, P173, DOI 10.1177/01466216970212006; Redlawsk DP, 2002, J POLITICS, V64; Rolfe-Redding J, 2012, TECHNICAL REPORT; Roll Carrie A, 2007, J HLTH CARE LAW POLI, V10, P421; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Shermer M., 2013, LIBERALS WAR SCI; Smith N, 2012, RISK ANAL, V32, P1021, DOI 10.1111/j.1539-6924.2012.01801.x; Sunstein CR, 2009, J POLIT PHILOS, V17, P202, DOI 10.1111/j.1467-9760.2008.00325.x; Swami V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00280; Swami V, 2010, APPL COGNITIVE PSYCH, V24, P749, DOI 10.1002/acp.1583; Wood MJ, 2012, SOC PSYCHOL PERS SCI, V3, P767, DOI 10.1177/1948550611434786	70	314	316	12	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75637	10.1371/journal.pone.0075637	http://dx.doi.org/10.1371/journal.pone.0075637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098391	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500035
J	Maruyama, Y; Okuda, K; Ogata, T; Yasunaga, M; Ishikawa, H; Hirakawa, Y; Fukuyo, K; Horiuchi, H; Nakashima, O; Kinoshita, H				Maruyama, Yuichiro; Okuda, Koji; Ogata, Toshiro; Yasunaga, Masafumi; Ishikawa, Hiroto; Hirakawa, Yusuke; Fukuyo, Kenjiro; Horiuchi, Hiroyuki; Nakashima, Osamu; Kinoshita, Hisafumi			Perioperative Challenges and Surgical Treatment of Large Simple, and Infectious Liver Cyst - A 12-Year Experience	PLOS ONE			English	Article							HEPATIC CYSTS; MANAGEMENT; LESIONS	Background: Cystic lesions of the liver consist of a heterogeneous group of disorders that can present diagnostic and therapeutic challenges. Methods: A retrospective review of all medical records of adult patients diagnosed with large (> 7 cm) cystic lesions of the liver between January 2000 and December 2011, at Kurume University Hospital. Cases with polycystic disease were excluded. Results: Twenty three patients were identified. The mean size was 13.9 cm (range, 7-22cm). The majority of simple cysts were found in women (females: males, 2: 21). In 19 patients, the cyst was removed surgically by wide deroofing (laparoscopically in 16 cases, combined with ethanol sclerotherapy in 13 cases). Infection of the liver cyst occurred in one patient, who later underwent central bi-segmentectomy. Conclusion: Simple large cysts of the liver can be successfully treated by laparoscopic deroofing and alcohol sclerotherapy. Large hepatic cyst considered to need drainage should be removed surgically to avoid possible infection.	[Maruyama, Yuichiro; Okuda, Koji; Ogata, Toshiro; Yasunaga, Masafumi; Ishikawa, Hiroto; Hirakawa, Yusuke; Fukuyo, Kenjiro; Horiuchi, Hiroyuki; Kinoshita, Hisafumi] Univ Sch Med, Dept Surg, Kurume, Fukuoka, Japan; [Nakashima, Osamu] Univ Sch Med, Dept Pathol, Kurume, Fukuoka, Japan		Maruyama, Y (corresponding author), Univ Sch Med, Dept Surg, Kurume, Fukuoka, Japan.	yumaruyama@med.kurume-u.ac.jp						Blonski WC, 2006, WORLD J GASTROENTERO, V12, P2949, DOI 10.3748/wjg.v12.i18.2949; ChouillFangio P, 2010, MINERVA CHIR, V65, P495; Cowles RA, 2000, J AM COLL SURGEONS, V191, P311, DOI 10.1016/S1072-7515(00)00345-8; Diez J, 1998, BRIT J SURG, V85, P25, DOI 10.1046/j.1365-2168.1998.02870.x; Katkhouda N, 1999, ANN SURG, V229, P460, DOI 10.1097/00000658-199904000-00003; Martin IJ, 1998, ANN SURG, V228, P167, DOI 10.1097/00000658-199808000-00004; Mazza OM, 2009, J AM COLL SURGEONS, V209, P733, DOI 10.1016/j.jamcollsurg.2009.09.006; Moorthy K, 2001, ANN ROY COLL SURG, V83, P409; Mortele KJ, 2001, RADIOGRAPHICS, V21, P895, DOI 10.1148/radiographics.21.4.g01jl16895; Regev A, 2001, J AM COLL SURGEONS, V193, P36, DOI 10.1016/S1072-7515(01)00865-1; SANCHEZ H, 1991, AM J SURG, V161, P113, DOI 10.1016/0002-9610(91)90370-S; Yamaguchi K, 2000, EUR J SURG, V166, P141, DOI 10.1080/110241500750009492; Zacherl J, 2000, SURG ENDOSC-ULTRAS, V14, P59, DOI 10.1007/s004649900012	13	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76537	10.1371/journal.pone.0076537	http://dx.doi.org/10.1371/journal.pone.0076537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098524	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500071
J	Xu, LR; Liu, XL; Chen, J; Liang, Y				Xu, Li-Rong; Liu, Xiao-Ling; Chen, Jie; Liang, Yi			Protein Disulfide Isomerase Interacts with Tau Protein and Inhibits Its Fibrillization	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; THIOREDOXIN-LIKE DOMAINS; BINDING SITE; AGGREGATION; DISEASE; NEURODEGENERATION; DIMERIZATION; INCLUSIONS; PLASTICITY; SUBSTRATE	Background: Tau protein is implicated in the pathogenesis of neurodegenerative disorders such as tauopathies including Alzheimer disease, and Tau fibrillization is thought to be related to neuronal toxicity. Physiological inhibitors of Tau fibrillization hold promise for developing new strategies for treatment of Alzheimer disease. Because protein disulfide isomerase (PDI) is both an enzyme and a chaperone, and implicated in neuroprotection against Alzheimer disease, we want to know whether PDI can prevent Tau fibrillization. In this study, we have investigated the interaction between PDI and Tau protein and the effect of PDI on Tau fibrillization. Methodology/Principal Findings: As evidenced by co-immunoprecipitation and confocal laser scanning microscopy, human PDI interacts and co-locates with some endogenous human Tau on the endoplasmic reticulum of undifferentiated SH-SY5Y neuroblastoma cells. The results from isothermal titration calorimetry show that one full-length human PDI binds to one full-length human Tau (or human Tau fragment Tau(244-372)) monomer with moderate, micromolar affinity at physiological pH and near physiological ionic strength. As revealed by thioflavin T binding assays, Sarkosyl-insoluble SDS-PAGE, and transmission electron microscopy, full-length human PDI remarkably inhibits both steps of nucleation and elongation of Tau(244-372) fibrillization in a concentration-dependent manner. Furthermore, we find that two molecules of the a-domain of human PDI interact with one Tau(244-372) molecule with sub-micromolar affinity, and inhibit both steps of nucleation and elongation of Tau(244-372) fibrillization more strongly than full-length human PDI. Conclusions/Significance: We demonstrate for the first time that human PDI binds to Tau protein mainly through its thioredoxin-like catalytic domain a, forming a 1:1 complex and preventing Tau misfolding. Our findings suggest that PDI could act as a physiological inhibitor of Tau fibrillization, and have applications for developing novel strategies for treatment and early diagnosis of Alzheimer disease.	[Xu, Li-Rong; Liu, Xiao-Ling; Chen, Jie; Liang, Yi] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Liang, Y (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; Liu, Xiaoling/HGD-3566-2022	Liang, Yi/0000-0002-7349-8300; 	National Key Basic Research Foundation of China [2013CB910702, 2012CB911003]; National Natural Science Foundation of China [31170744, 31370774]; Fundamental Research Funds for the Central Universities of China [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant nos. 2013CB910702 and 2012CB911003, YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant nos. 31170744 and 31370774, YL), and Fundamental Research Funds for the Central Universities of China (http://www.moe.edu.cn/, Grant no. 1104006, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Andreu CI, 2012, FEBS LETT, V586, P2826, DOI 10.1016/j.febslet.2012.07.023; Arrasate M, 2000, NEUROCHEM RES, V25, P43, DOI 10.1023/A:1007583214722; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cheng H, 2010, CELL STRESS CHAPERON, V15, P415, DOI 10.1007/s12192-009-0157-2; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; Farg MA, 2012, NEUROBIOL AGING, V33, P2855, DOI 10.1016/j.neurobiolaging.2012.02.009; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Freedman RB, 1998, BIOL CHEM, V379, P321, DOI 10.1515/bchm.1998.379.3.321; Friedhoff P, 2000, BBA-MOL BASIS DIS, V1502, P122, DOI 10.1016/S0925-4439(00)00038-7; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Honjo Y, 2012, NEUROREPORT, V23, P611, DOI 10.1097/WNR.0b013e3283552a75; Honjo Y, 2010, BRAIN RES, V1349, P90, DOI 10.1016/j.brainres.2010.06.016; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Meng SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038903; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; NOIVA R, 1992, J BIOL CHEM, V267, P3553; Patterson KR, 2011, BIOCHEMISTRY-US, V50, P10300, DOI 10.1021/bi2009147; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Uberti D, 1997, NEUROSCI LETT, V235, P149, DOI 10.1016/S0304-3940(97)00715-5; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Voss K, 2012, BIOCHEMISTRY-US, V51, P888, DOI 10.1021/bi2018078; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; WANG CC, 1993, FASEB J, V7, P1515, DOI 10.1096/fasebj.7.15.7903263; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	68	75	77	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76657	10.1371/journal.pone.0076657	http://dx.doi.org/10.1371/journal.pone.0076657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098548	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500081
J	Yang, TW; Rao, ZM; Zhang, X; Xu, MJ; Xu, ZH; Yang, ST				Yang, Taowei; Rao, Zhiming; Zhang, Xian; Xu, Meijuan; Xu, Zhenghong; Yang, Shang-Tian			Improved Production of 2,3-Butanediol in Bacillus amyloliquefaciens by Over-Expression of Glyceraldehyde-3-Phosphate Dehydrogenase and 2,3-butanediol Dehydrogenase	PLOS ONE			English	Article							METABOLIC FLUX REDISTRIBUTION; KLEBSIELLA-PNEUMONIAE; ACETOIN; REDUCTION; SUBTILIS; ETHANOL	Background: Previously, a safe strain, Bacillus amyloliquefaciens B10-127 was identified as an excellent candidate for industrial-scale microbial fermentation of 2,3-butanediol (2,3-BD). However, B. amyloliquefaciens fermentation yields large quantities of acetoin, lactate and succinate as by-products, and the 2,3-BD yield remains prohibitively low for commercial production. Methodology/Principal Findings: In the 2,3-butanediol metabolic pathway, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyzes the conversion of 3-phosphate glyceraldehyde to 1,3-bisphosphoglycerate, with concomitant reduction of NAD(+) to NADH. In the same pathway, 2,3-BD dehydrogenase (BDH) catalyzes the conversion of acetoin to 2,3-BD with concomitant oxidation of NADH to NAD(+). In this study, to improve 2,3-BD production, we first over-produced NAD(+)-dependent GAPDH and NADH-dependent BDH in B. amyloliquefaciens. Excess GAPDH reduced the fermentation time, increased the 2,3-BD yield by 12.7%, and decreased the acetoin titer by 44.3%. However, the process also enhanced lactate and succinate production. Excess BDH increased the 2,3-BD yield by 16.6% while decreasing acetoin, lactate and succinate production, but prolonged the fermentation time. When BDH and GAPDH were co-overproduced in B. amyloliquefaciens, the fermentation time was reduced. Furthermore, in the NADH-dependent pathways, the molar yield of 2,3-BD was increased by 22.7%, while those of acetoin, lactate and succinate were reduced by 80.8%, 33.3% and 39.5%, relative to the parent strain. In fed-batch fermentations, the 2,3-BD concentration was maximized at 132.9 g/l after 45 h, with a productivity of 2.95 g/l.h. Conclusions/Significance: Co-overexpression of bdh and gapA genes proved an effective method for enhancing 2,3-BD production and inhibiting the accumulation of unwanted by-products (acetoin, lactate and succinate). To our knowledge, we have attained the highest 2,3-BD fermentation yield thus far reported for safe microorganisms.	[Yang, Taowei; Rao, Zhiming; Zhang, Xian; Xu, Meijuan; Xu, Zhenghong] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu Provinc, Peoples R China; [Xu, Zhenghong] Jiangnan Univ, Sch Med & Pharmaceut, Lab Pharmaceut Engn, Wuxi, Jiangsu Provinc, Peoples R China; [Yang, Shang-Tian] Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA	Jiangnan University; Jiangnan University; University System of Ohio; Ohio State University	Rao, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu Provinc, Peoples R China.	raozhm@jiangnan.edu.cn; zhenghxu@163.com	Xu, Meijuan/C-1790-2012; Yang, Shang-Tian/A-7892-2009		Program for New Century Excellent Talents in University [NCET-10-0459]; National Basic Research Program of China (973 Program) [2012CB725202]; High-tech Research and Development Programs of China [2011AA02A211]; National Natural Science Foundation of China [21276110]; Fundamental Research Funds for the Central Universities [JUSRP51306A, JUSRP1009]; Research Fund for the Doctoral Program of Higher Education of China [20110093120001]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); High-tech Research and Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Program for New Century Excellent Talents in University (NCET-10-0459), the National Basic Research Program of China (973 Program) (2012CB725202), the High-tech Research and Development Programs of China (2011AA02A211), the National Natural Science Foundation of China (21276110), the Fundamental Research Funds for the Central Universities (JUSRP51306A, JUSRP1009), the Research Fund for the Doctoral Program of Higher Education of China (20110093120001) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas R, 2012, APPL MICROBIOL BIOT, V94, P651, DOI 10.1007/s00253-011-3774-5; Celinska E, 2009, BIOTECHNOL ADV, V27, P715, DOI 10.1016/j.biotechadv.2009.05.002; DEBOER AS, 1991, APPL MICROBIOL BIOT, V36, P1; Ehsani M, 2009, APPL ENVIRON MICROB, V75, P3196, DOI 10.1128/AEM.02157-08; Ezeji TC, 2004, APPL MICROBIOL BIOT, V63, P653, DOI 10.1007/s00253-003-1400-x; FERDINAND W, 1964, BIOCHEM J, V92, P578, DOI 10.1042/bj0920578; FLICKINGER MC, 1980, BIOTECHNOL BIOENG, V22, P27; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; Han SH, 2013, NEW BIOTECHNOL, V30, P166, DOI 10.1016/j.nbt.2012.09.004; Hespell RB, 1996, CURR MICROBIOL, V32, P291, DOI 10.1007/s002849900052; Ji XJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-7; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; Jung MY, 2012, APPL MICROBIOL BIOT, V95, P461, DOI 10.1007/s00253-012-3883-9; JUNI E, 1952, J BIOL CHEM, V195, P715; LARSEN SH, 1973, EUR J BIOCHEM, V34, P100, DOI 10.1111/j.1432-1033.1973.tb02734.x; Li ZJ, 2010, APPL MICROBIOL BIOT, V87, P2001, DOI 10.1007/s00253-010-2676-2; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; Ma Z, 2013, J BASIC MICROB, V53, P348, DOI 10.1002/jobm.201100580; Menzel K, 1998, BIOTECHNOL BIOENG, V60, P617, DOI 10.1002/(SICI)1097-0290(19981205)60:5<617::AID-BIT12>3.3.CO;2-C; Metsoviti M, 2012, PROCESS BIOCHEM, V47, P1872, DOI 10.1016/j.procbio.2012.06.011; NELSON K, 1991, P NATL ACAD SCI USA, V88, P6667, DOI 10.1073/pnas.88.15.6667; Nicholson WL, 2008, APPL ENVIRON MICROB, V74, P6832, DOI 10.1128/AEM.00881-08; Sambrook J., 2001, MOL CLONING LAB MANU; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Shen X, 2012, J IND MICROBIOL BIOT; Siemerink MAJ, 2011, APPL ENVIRON MICROB, V77, P2582, DOI 10.1128/AEM.01616-10; van Haveren J, 2008, BIOFUEL BIOPROD BIOR, V2, P41, DOI 10.1002/bbb.43; Vojcic L, 2012, APPL MICROBIOL BIOT, V94, P487, DOI 10.1007/s00253-012-3987-2; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Yang TW, 2012, WORLD J MICROB BIOT, V28, P1563, DOI 10.1007/s11274-011-0960-7; Yang TW, 2011, J BASIC MICROB, V51, P650, DOI 10.1002/jobm.201100033; Zhang LY, 2010, J IND MICROBIOL BIOT, V37, P857, DOI 10.1007/s10295-010-0733-6; Zhang WG, 2012, GREEN CHEM, V14, P3441, DOI 10.1039/c2gc36324k; Zhang YP, 2009, METAB ENG, V11, P101, DOI 10.1016/j.ymben.2008.11.001	34	47	51	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76149	10.1371/journal.pone.0076149	http://dx.doi.org/10.1371/journal.pone.0076149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098433	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500045
J	Coleman, RG; Carchia, M; Sterling, T; Irwin, JJ; Shoichet, BK				Coleman, Ryan G.; Carchia, Michael; Sterling, Teague; Irwin, John J.; Shoichet, Brian K.			Ligand Pose and Orientational Sampling in Molecular Docking	PLOS ONE			English	Article							VIRTUAL SCREENING APPROACH; STRUCTURE-BASED DISCOVERY; PROTEIN-COUPLED RECEPTOR; HIGH-THROUGHPUT; CRYSTAL-STRUCTURES; KINASE INHIBITORS; AUTOMATED DOCKING; SCORING FUNCTIONS; BINDING-AFFINITY; 3D CONFORMATION	Molecular docking remains an important tool for structure-based screening to find new ligands and chemical probes. As docking ambitions grow to include new scoring function terms, and to address ever more targets, the reliability and extendability of the orientation sampling, and the throughput of the method, become pressing. Here we explore sampling techniques that eliminate stochastic behavior in DOCK3.6, allowing us to optimize the method for regularly variable sampling of orientations. This also enabled a focused effort to optimize the code for efficiency, with a three-fold increase in the speed of the program. This, in turn, facilitated extensive testing of the method on the 102 targets, 22,805 ligands and 1,411,214 decoys of the Directory of Useful Decoys - Enhanced (DUD-E) benchmarking set, at multiple levels of sampling. Encouragingly, we observe that as sampling increases from 50 to 500 to 2000 to 5000 to 20000 molecular orientations in the binding site (and so from about 1x10(10) to 4x10(10) to 1x10(11) to 2x10(11) to 5x10(11) mean atoms scored per target, since multiple conformations are sampled per orientation), the enrichment of ligands over decoys monotonically increases for most DUD-E targets. Meanwhile, including internal electrostatics in the evaluation ligand conformational energies, and restricting aromatic hydroxyls to low energy rotamers, further improved enrichment values. Several of the strategies used here to improve the efficiency of the code are broadly applicable in the field.	[Coleman, Ryan G.; Carchia, Michael; Sterling, Teague; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Irwin, John J.; Shoichet, Brian K.] Univ Toronto, Fac Pharm, Toronto, ON, Canada	University of California System; University of California San Francisco; University of Toronto	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	bshoichet@gmail.com		Irwin, John/0000-0002-1195-6417	US NIH [R01s GM59957, GM71896]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096544, R01GM059957, R01GM071896] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the US NIH, R01s GM59957 and GM71896. www.nigms.nih.gov. NIH Kirschtein-NRSA Postdoctoral Fellow F32GM096544 (to RGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula N, 2011, BIOORG MED CHEM LETT, V21, P4183, DOI 10.1016/j.bmcl.2011.05.086; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Allen KN, 1996, J PHYS CHEM-US, V100, P2605, DOI 10.1021/jp952516o; [Anonymous], 2009, PGI WORKSTATION 9 0; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; Balius TE, 2013, J COMPUT CHEM, V34, P1226, DOI 10.1002/jcc.23245; Barelier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069153; Benod C., 2013, J BIOL CHEM; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOURGEOIS F, 1971, COMMUN ACM, V14, P802, DOI 10.1145/362919.362945; Boyce SE, 2009, J MOL BIOL, V394, P747, DOI 10.1016/j.jmb.2009.09.049; Brenk R, 2006, J MOL BIOL, V357, P1449, DOI 10.1016/j.jmb.2006.01.034; Brozell SR, 2012, J COMPUT AID MOL DES, V26, P749, DOI 10.1007/s10822-012-9565-y; Carchia M, 2010, J CHEM INFORM MODELL; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; Carr RAE, 2005, DRUG DISCOV TODAY, V10, P987, DOI 10.1016/S1359-6446(05)03511-7; Cavasotto CN, 2008, J MED CHEM, V51, P581, DOI 10.1021/jm070759m; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Cheng JF, 2008, J MED CHEM, V51, P2057, DOI 10.1021/jm7011326; Cheng TJ, 2012, AAPS J, V14, P133, DOI 10.1208/s12248-012-9322-0; Daidone F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031610; de Graaf C, 2008, J MED CHEM, V51, P4978, DOI 10.1021/jm800710x; de Graaf C, 2011, J MED CHEM, V54, P8195, DOI 10.1021/jm2011589; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diao YY, 2012, J MED CHEM, V55, P8341, DOI 10.1021/jm300630p; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; El Turk F, 2010, BIOORGAN MED CHEM, V18, P5425, DOI 10.1016/j.bmc.2010.05.010; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Engel S, 2008, J AM CHEM SOC, V130, P5115, DOI 10.1021/ja077620l; Ewing TJA, 1997, J COMPUT CHEM, V18, P1175, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1175::AID-JCC6>3.0.CO;2-O; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; Ferrari S, 2011, J MED CHEM, V54, P211, DOI 10.1021/jm1010572; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gallagher K, 1998, BIOPHYS J, V75, P769, DOI 10.1016/S0006-3495(98)77566-6; Gaulton A, 2011, NUCL ACIDS RES; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Guasch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044972; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hamza A, 2011, BIOORGAN MED CHEM, V19, P6077, DOI 10.1016/j.bmc.2011.08.040; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Hawkins GD, 2004, AMSOL 7 1; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hawkins PCD, 2012, J CHEM INFORM MODELI; Homan KT, 2010, BIOORGAN MED CHEM, V18, P5449, DOI 10.1016/j.bmc.2010.04.050; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Irwin John J, 2012, J CHEM INFORM MODELI, V4, P7; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; KEARSLEY SK, 1994, J COMPUT AID MOL DES, V8, P565, DOI 10.1007/BF00123666; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031004; Kirchmair J, 2006, J CHEM INF MODEL, V46, P1848, DOI 10.1021/ci060084g; Kiss R, 2008, J MED CHEM, V51, P3145, DOI 10.1021/jm7014777; Knehans T, 2011, J COMPUT AID MOL DES, V25, P263, DOI 10.1007/s10822-011-9418-0; Kolb P, 2008, PROTEINS, V73, P11, DOI 10.1002/prot.22028; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lagorce David, 2009, BMC Chemical Biology, V9, P6, DOI 10.1186/1472-6769-9-6; Langmead CJ, 2012, J MED CHEM, V55, P1904, DOI 10.1021/jm201455y; Lee K, 2009, BIOORGAN MED CHEM, V17, P3152, DOI 10.1016/j.bmc.2009.02.054; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010126; Li Y, 2011, J CHEM INF MODEL, V51, P2904, DOI 10.1021/ci200257b; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu XF, 2011, J COMPUT AID MOL DES, V25, P977, DOI 10.1007/s10822-011-9476-3; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Lorber DM, 1998, PROTEIN SCI, V7, P938; Mahasenan KV, 2012, J CHEM INF MODEL, V52, P1345, DOI 10.1021/ci300040c; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Miteva MA, 2010, NUCLEIC ACIDS RES, V38, pW622, DOI 10.1093/nar/gkq325; Montes M, 2008, J CHEM INF MODEL, V48, P157, DOI 10.1021/ci700313e; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mortier J, 2010, BIOORG MED CHEM LETT, V20, P4515, DOI 10.1016/j.bmcl.2010.06.027; Mpamhanga CP, 2009, J MED CHEM, V52, P4454, DOI 10.1021/jm900414x; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Mysinger MM, 2012, P NATL ACAD SCI USA, V109, P5517, DOI 10.1073/pnas.1120431109; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Park H, 2008, BIOORGAN MED CHEM, V16, P284, DOI 10.1016/j.bmc.2007.09.036; Park H, 2012, BIOORG MED CHEM LETT, V22, P1271, DOI 10.1016/j.bmcl.2011.10.083; Park H, 2009, BIOORG MED CHEM LETT, V19, P4372, DOI 10.1016/j.bmcl.2009.05.078; PEARLMAN DA, 1991, AMBER 4 0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce AC, 2008, J MED CHEM, V51, P1972, DOI 10.1021/jm701248t; Podvinec M, 2010, J MED CHEM, V53, P1483, DOI 10.1021/jm900776m; Ravindranathan KP, 2010, J MED CHEM, V53, P1662, DOI 10.1021/jm901386e; Ren JX, 2011, J CHEM INF MODEL, V51, P1364, DOI 10.1021/ci100464b; Rocklin GJ, 2013, J MOL BIOL; Salam NK, 2008, CHEM BIOL DRUG DES, V71, P57, DOI 10.1111/j.1747-0285.2007.00606.x; Schlessinger A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388157; Schlessinger A, 2011, P NATL ACAD SCI USA, V108, P15810, DOI 10.1073/pnas.1106030108; Shah F, 2011, J CHEM INF MODEL, V51, P852, DOI 10.1021/ci200029y; SHARP KA, 1995, BIOPOLYMERS, V36, P227, DOI 10.1002/bip.360360210; SHOICHET BK, 1992, J COMPUT CHEM, V13, P380, DOI 10.1002/jcc.540130311; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Song CH, 2012, J BIOL CHEM, V287, P30769, DOI 10.1074/jbc.M112.379107; Song YW, 2013, BIOORG MED CHEM LETT, V23, P2078, DOI 10.1016/j.bmcl.2013.01.128; Stengl B, 2007, J MOL BIOL, V370, P492, DOI 10.1016/j.jmb.2007.04.008; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Teotico DG, 2009, P NATL ACAD SCI USA, V106, P7455, DOI 10.1073/pnas.0813029106; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Nguyen TTH, 2011, BIOORG MED CHEM LETT, V21, P3088, DOI 10.1016/j.bmcl.2011.03.034; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tirado-Rives J, 2006, J MED CHEM, V49, P5880, DOI 10.1021/jm060763i; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Villoutreix BO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021117; von Grotthuss M, 2003, BIOINFORMATICS, V19, P1041, DOI 10.1093/bioinformatics/btg117; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; Weiss DR, 2013, ACS CHEM BIOL; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xu WJ, 2010, BIOORG MED CHEM LETT, V20, P5763, DOI 10.1016/j.bmcl.2010.07.140; Xu WJ, 2009, BIOORG MED CHEM LETT, V19, P3188, DOI 10.1016/j.bmcl.2009.04.113; Yang QY, 2006, J CHEM THEORY COMPUT, V2, P1152, DOI 10.1021/ct060009c; Yuriev E, 2011, J MOL RECOGNIT, V24, P149, DOI 10.1002/jmr.1077	126	87	89	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75992	10.1371/journal.pone.0075992	http://dx.doi.org/10.1371/journal.pone.0075992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098414	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100032
J	He, QF; Fan, CH; Yu, M; Wallar, G; Zhang, ZF; Wang, LX; Zhang, XW; Hu, RY				He, Qingfang; Fan, Chunhong; Yu, Min; Wallar, Gina; Zhang, Zuo-Feng; Wang, Lixin; Zhang, Xinwei; Hu, Ruying			Associations of ACE Gene Insertion/Deletion Polymorphism, ACE Activity, and ACE mRNA Expression with Hypertension in a Chinese Population	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; BLOOD-PRESSURE; I/D POLYMORPHISM; DELETION; LINKAGE; SYSTEM; RISK; PCR	Background: The present study was designed to explore the association of angiotensin converting enzyme (ACE) gene insertion/deletion (I/D, rs4646994) polymorphism, plasma ACE activity, and circulating ACE mRNA expression with essential hypertension (EH) in a Chinese population. In addition, a new detection method for circulating ACE mRNA expression was explored. Methods: The research was approved by the ethics committee of Zhejiang Provincial Center for Disease Prevention and Control. Written informed consent was obtained prior to the investigation. 221 hypertensives (cases) and 221 normotensives (controls) were interviewed, subjected to a physical examination, and provided blood for biochemical and genetic tests. The ACE mRNA expression was analyzed by real time fluorescent quantitative Reverse Transcription PCR (FQ-RT-PCR). We performed logistic regression to assess associations of ACE I/D genotypes, ACE activity, and ACE mRNA expression levels with hypertension. Results: The results of the multivariate logistic regression analysis showed that the additive model (ID, DD versus II) of the ACE genotype revealed an association with hypertension with adjusted OR of 1.43(95% CI: 1.04-1.97), and ACE ID genotype with adjusted OR of 1.72(95% CI: 1.01-2.92), DD genotype with adjusted OR of 1.94(95% CI: 1.01-3.73), respectively. In addition, our data also indicate that plasma ACE activity (adjusted OR was 1.13(95% CI: 1.08-1.18)) was significantly related to hypertension. However, the plasma ACE mRNA expressions were not different between the cases and controls. Conclusion: ACE I/D polymorphism and ACE activity revealed significant influence on hypertension, while circulating ACE mRNA expression was not important factors associated with hypertension in this Chinese population. The detection of circulating ACE mRNA expression by FQ-RT-PCR might be a useful method for early screening and monitoring of EH.	[He, Qingfang; Yu, Min; Wang, Lixin; Zhang, Xinwei; Hu, Ruying] Zhejiang Prov Ctr Dis Prevent & Control, Hangzhou, Zhejiang, Peoples R China; [Fan, Chunhong] Zhejiang Med Coll, Hangzhou, Zhejiang, Peoples R China; [Wallar, Gina; Zhang, Zuo-Feng] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles	Yu, M (corresponding author), Zhejiang Prov Ctr Dis Prevent & Control, Hangzhou, Zhejiang, Peoples R China.	minyuzj@gmail.com		Zhang, Zuo-Feng/0000-0002-4669-3995	Grand Science and Technology Projects of Zhejiang Province [2011C12032-1]; Medical and Health Science Research Fund of Zhejiang Province [2006A 019, 2007A 035, 2008 A034]; NATIONAL CANCER INSTITUTE [T32CA009142] Funding Source: NIH RePORTER	Grand Science and Technology Projects of Zhejiang Province; Medical and Health Science Research Fund of Zhejiang Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This paper was supported by Grand Science and Technology Projects of Zhejiang Province (project number 2011C12032-1) (http://www.zjkjt.gov.cn/), and by Medical and Health Science Research Fund of Zhejiang Province (project number 2006A 019, 2007A 035, and 2008 A034) (http://www.zjwst.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajala AR, 2012, AM J HYPERTENS, V25, P827, DOI 10.1038/ajh.2012.50; Ali A, 2012, J RENIN-ANGIO-ALDO S; Bernstein KE, 2006, HYPERTENSION, V47, P509, DOI 10.1161/01.HYP.0000196266.23639.c6; BONITHONKOPP C, 1994, CIRCULATION, V89, P952, DOI 10.1161/01.CIR.89.3.952; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Camos S, 2012, CLIN CHEM LAB MED, V50, P1749, DOI 10.1515/cclm-2012-0042; Cole JM, 2003, HYPERTENSION, V41, P313, DOI 10.1161/01.HYP.0000050650.52007.83; Danser AHJ, 2007, PHARMACOL THERAPEUT, V113, P607, DOI 10.1016/j.pharmthera.2006.12.001; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Ji LD, 2010, J HYPERTENS, V28, P419, DOI 10.1097/HJH.0b013e32833456b9; Jiang X, 2009, J HUM HYPERTENS, V23, P176, DOI 10.1038/jhh.2008.123; Kabadou IA, 2013, CLIN LAB, V59, P85, DOI 10.7754/Clin.Lab.2013.111105; Lely AT, 2007, CURR DIABETES REV, V3, P41, DOI 10.2174/157339907779802049; Ljungberg L, 2011, J RENIN-ANGIO-ALDO S, V12, P281, DOI 10.1177/1470320310391326; McKenzie CA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-23; Mizuiri S, 2001, KIDNEY INT, V60, P1124, DOI 10.1046/j.1523-1755.2001.0600031124.x; Nassar I, 2008, AM J HYPERTENS, V21, P200, DOI 10.1038/ajh.2007.38; Nawaz SK, 2009, BIOCHEM MEDICA, V19, P36; Oosterga M, 1997, CIRCULATION, V95, P2607, DOI 10.1161/01.CIR.95.12.2607; OVERLACK A, 1983, KLIN WOCHENSCHR, V61, P377, DOI 10.1007/BF01485031; Persu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059537; Rasyid Haerani, 2012, Acta Med Indones, V44, P280; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; Smithies O, 2000, KIDNEY INT, V58, P2265, DOI 10.1046/j.1523-1755.2000.00411.x; Suehiro T, 2004, HUM GENET, V115, P91, DOI 10.1007/s00439-004-1136-4; Tascilar N, 2009, J NEUROL SCI, V285, P137, DOI 10.1016/j.jns.2009.06.016; TIRET L, 1992, AM J HUM GENET, V51, P197; Tsantes A.E., 2013, MINERVA ANESTESIOL; Zarouk WA, 2012, BRATISL MED J, V113, P14, DOI 10.4149/BLL_2012_003; Zhang CY, 2005, PROG BIOCHEM BIOPHYS, V32, P883; Zhu XF, 2000, AM J HUM GENET, V67, P1144; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	33	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75870	10.1371/journal.pone.0075870	http://dx.doi.org/10.1371/journal.pone.0075870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098401	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100023
J	Howard, BE; Hu, QW; Babaoglu, AC; Chandra, M; Borghi, M; Tan, XP; He, LY; Winter-Sederoff, H; Gassmann, W; Veronese, P; Heber, S				Howard, Brian E.; Hu, Qiwen; Babaoglu, Ahmet Can; Chandra, Manan; Borghi, Monica; Tan, Xiaoping; He, Luyan; Winter-Sederoff, Heike; Gassmann, Walter; Veronese, Paola; Heber, Steffen			High-Throughput RNA Sequencing of Pseudomonas-Infected Arabidopsis Reveals Hidden Transcriptome Complexity and Novel Splice Variants	PLOS ONE			English	Article							DEFENSE RESPONSES; IMMUNE-RESPONSE; GENE; RESISTANCE; PROTEINS; RPS4	We report the results of a genome-wide analysis of transcription in Arabidopsis thaliana after treatment with Pseudomonas syringae pathovar tomato. Our time course RNA-Seq experiment uses over 500 million read pairs to provide a detailed characterization of the response to infection in both susceptible and resistant hosts. The set of observed differentially expressed genes is consistent with previous studies, confirming and extending existing findings about genes likely to play an important role in the defense response to Pseudomonas syringae. The high coverage of the Arabidopsis transcriptome resulted in the discovery of a surprisingly large number of alternative splicing (AS) events - more than 44% of multi-exon genes showed evidence for novel AS in at least one of the probed conditions. This demonstrates that the Arabidopsis transcriptome annotation is still highly incomplete, and that AS events are more abundant than expected. To further refine our predictions, we identified genes with statistically significant changes in the ratios of alternative isoforms between treatments. This set includes several genes previously known to be alternatively spliced or expressed during the defense response, and it may serve as a pool of candidate genes for regulated alternative splicing with possible biological relevance for the defense response against invasive pathogens.	[Howard, Brian E.; Hu, Qiwen; Babaoglu, Ahmet Can; Heber, Steffen] N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA; [Chandra, Manan; Borghi, Monica; Tan, Xiaoping; Veronese, Paola] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [He, Luyan; Winter-Sederoff, Heike] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Gassmann, Walter] Univ Missouri, Div Plant Sci, Columbia, MO USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia	Howard, BE (corresponding author), N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA.	itsbehoward@hotmail.com	Hu, Qiwen/A-8309-2019	Heber, Steffen/0000-0002-1050-3635; Gassmann, Walter/0000-0002-7527-0385; Borghi, Monica/0000-0003-1359-7611; Sederoff, Heike/0000-0002-0960-9678	National Science Foundation [IOS-0951512]; National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health [2T32ES007329-10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007329] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the National Science Foundation IOS-0951512 and by grant number 2T32ES007329-10 from the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belhaj K, 2009, PLANT J, V58, P287, DOI 10.1111/j.1365-313X.2008.03779.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bove J, 2008, PLANT MOL BIOL, V67, P71, DOI 10.1007/s11103-008-9302-z; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Cui XF, 2007, PLANT CELL, V19, P1388, DOI 10.1105/tpc.107.051375; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; English AC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-102; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gassmann W, 2008, CURR TOP MICROBIOL, V326, P219; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; Howard BE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S6; Jeong HJ, 2011, PLANT CELL PHYSIOL, V52, P2147, DOI 10.1093/pcp/pcr144; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawamura Y, 2009, PLANT CELL PHYSIOL, V50, P924, DOI 10.1093/pcp/pcp044; Kim SS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-6; Knoth C, 2008, PLANT J, V55, P53, DOI 10.1111/j.1365-313X.2008.03486.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Nomura H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1926; Quirino BF, 2003, MOL PLANT PATHOL, V4, P517, DOI 10.1046/J.1364-3703.2003.00198.X; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rozen S, 2000, Methods Mol Biol, V132, P365; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Schenk PM, 2011, PLANT PHYSL BIOCH PP, V43, P997; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xu SH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002159; Zhang XC, 2007, PLANT PHYSIOL, V145, P1577, DOI 10.1104/pp.107.108720	45	56	61	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74183	10.1371/journal.pone.0074183	http://dx.doi.org/10.1371/journal.pone.0074183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098335	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100004
J	Lan, KC; Chen, YT; Chang, CS; Chang, YC; Lin, HJ; Huang, KE; Kang, HY				Lan, Kuo-Chung; Chen, Yen-Ta; Chang, Chawnshang; Chang, Yung-Chiao; Lin, Hsin-Jung; Huang, Ko-En; Kang, Hong-Yo			Up-Regulation of SOX9 in Sertoli Cells from Testiculopathic Patients Accounts for Increasing Anti-Mullerian Hormone Expression via Impaired Androgen Receptor Signaling	PLOS ONE			English	Article							FUNCTIONAL MATURATION; CAMPOMELIC DYSPLASIA; MICE LACKING; HUMAN TESTIS; GERM-CELLS; GENE; SEX; PROTEIN; SPERMATOGENESIS; AZOOSPERMIA	Background: Testosterone provokes Sertoli cell maturation and represses AMH production. In adult patients with Sertoli-cells-only syndrome (SCOS) and androgen insensitivity syndrome (AIS), high level of AMH expression is detected in Sertoli cells due to defect of androgen/AR signaling. Objective: We postulated that up-regulation of SOX9 due to impairment of androgen/AR signaling in Sertoli cells might explain why high level of anti-Mullerian hormone (AMH) expression occur in these testiculopathic patients. Methods: Biological research of testicular specimens from men with azoospermia or mouse. The serum hormone levels were studied in 23 men with obstructive azoospermia, 33 men with SCOS azoospermia and 21 volunteers with normal seminograms during a period of 4 years. Immunohistochemical staining and reverse-transcription PCR were used to examine the relationships among AR, SOX9 and AMH expression in adult human and mouse testes. The ability of AR to repress the expression of SOX9 and AMH was evaluated in vitro in TM4 Sertoli cells and C3H10T1/2 cells. Results: SCOS specimens showed up-regulation of SOX9 and AMH proteins but down-regulation of AR proteins in Sertoli cells. The mRNA levels of AR were significantly lower and the SOX9, AMH mRNA levels higher in all SCOS patients compared to controls (P<0.05). The testosterone levels in the SCOS patients were within the normal range, but most were below the median of the controls. Furthermore, our in vitro cell line experiments demonstrated that androgen/AR signaling suppressed the gene and protein levels of AMH via repression of SOX9. Conclusions: Our data show that the functional androgen/AR signaling to repress SOX9 and AMH expression is essential for Sertoli cell maturation. Impairment of androgen/AR signaling promotes SOX9-mediated AMH production, accounts for impairments of Sertoli cells in SCOS azoospermic patients.	[Lan, Kuo-Chung; Huang, Ko-En] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Lan, Kuo-Chung; Chen, Yen-Ta; Chang, Yung-Chiao; Lin, Hsin-Jung; Huang, Ko-En; Kang, Hong-Yo] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lan, Kuo-Chung; Kang, Hong-Yo] Chang Gung Univ, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Lan, Kuo-Chung; Chang, Yung-Chiao; Lin, Hsin-Jung; Huang, Ko-En; Kang, Hong-Yo] Kaohsiung Chang Gung Mem Hosp, Hormone Res Ctr, Kaohsiung, Taiwan; [Chen, Yen-Ta] Kaohsiung Chang Gung Mem Hosp, Dept Urol, Kaohsiung, Taiwan; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Kang, HY (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Kaohsiung, Taiwan.	hkang3@mail.cgu.edu.tw	Kang, Hong-Yo/W-9031-2019	Kang, Hong-Yo/0000-0003-0626-5037; Chang, Chawnshang/0000-0001-8510-3516	Chang Gung Memorial Hospital [CMRPG890541-2]; National Science Council of Taiwan [NMRPG896041-3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants CMRPG890541-2 from the Chang Gung Memorial Hospital and NMRPG896041-3 from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlAttar L, 1997, J CLIN INVEST, V100, P1335, DOI 10.1172/JCI119653; Anniballo R, 2000, HUM REPROD, V15, P2269, DOI 10.1093/humrep/15.11.2269; Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P1995, DOI 10.1210/jc.2007-0634; Boukari K, 2009, J CLIN ENDOCR METAB, V94, P1818, DOI 10.1210/jc.2008-1909; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Chemes HE, 2008, J CLIN ENDOCR METAB, V93, P4408, DOI 10.1210/jc.2008-0915; Clarkson MJ, 2002, TRENDS ENDOCRIN MET, V13, P106, DOI 10.1016/S1043-2760(01)00541-0; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Sanctis Vincenzo, 2010, Pediatr Endocrinol Rev, V8 Suppl 1, P178; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Frojdman K, 2000, HISTOCHEM CELL BIOL, V113, P31, DOI 10.1007/s004180050004; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Hiort O, 2003, INT J ANDROL, V26, P16, DOI 10.1046/j.1365-2605.2003.00369.x; Jorgensen JS, 2001, MOL ENDOCRINOL, V15, P1505, DOI 10.1210/me.15.9.1505; Josso N, 2001, MOL CELL ENDOCRINOL, V179, P25, DOI 10.1016/S0303-7207(01)00467-1; Kang HY, 2008, MOL CELL BIOL, V28, P7354, DOI 10.1128/MCB.00582-08; Kato T, 2012, REPRODUCTION, V143, P663, DOI 10.1530/REP-11-0365; Klein Claudia, 2011, BMC Res Notes, V4, P120, DOI 10.1186/1756-0500-4-120; Kobayashi A, 2005, ANN NY ACAD SCI, V1061, P9, DOI 10.1196/annals.1336.003; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lan KC, 2008, FERTIL STERIL, V89, P1397, DOI 10.1016/j.fertnstert.2007.03.092; Lasala C, 2011, AM J PHYSIOL-ENDOC M, V301, pE539, DOI 10.1152/ajpendo.00187.2011; Laurich VM, 2002, ENDOCRINOLOGY, V143, P3351, DOI 10.1210/en.2001-211352; Mackay S, 2000, INT REV CYTOL, V200, P47, DOI 10.1016/S0074-7696(00)00002-4; Majumdar SS, 2012, HUM REPROD, V27, P2515, DOI 10.1093/humrep/des184; Maymon BBS, 2002, FERTIL STERIL, V77, P904, DOI 10.1016/S0015-0282(02)03060-1; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Papanastasopoulos P, 2009, FERTIL STERIL, V92, DOI 10.1016/j.fertnstert.2009.05.030; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Racine C, 1998, P NATL ACAD SCI USA, V95, P594, DOI 10.1073/pnas.95.2.594; Regadera J, 2001, J CLIN ENDOCR METAB, V86, P413, DOI 10.1210/jc.86.1.413; REY R, 1993, J CLIN ENDOCR METAB, V77, P1220, DOI 10.1210/jc.77.5.1220; Rey R, 2003, MOL CELL ENDOCRINOL, V211, P21, DOI 10.1016/j.mce.2003.09.007; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Steger K, 1999, HUM REPROD, V14, P136, DOI 10.1093/humrep/14.1.136; Suarez-Quian CA, 1999, J CLIN ENDOCR METAB, V84, P350, DOI 10.1210/jc.84.1.350; Toulis KA, 2010, HUM REPROD UPDATE, V16, P713, DOI 10.1093/humupd/dmq024; TRAN D, 1987, J HISTOCHEM CYTOCHEM, V35, P733, DOI 10.1177/35.7.3295030; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; Wikstrom AM, 2007, J CLIN ENDOCR METAB, V92, P714, DOI 10.1210/jc.2006-1892; Willems A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014168	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76303	10.1371/journal.pone.0076303	http://dx.doi.org/10.1371/journal.pone.0076303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098470	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100056
J	Li, HY; Chen, X; Guan, LZ; Qi, Q; Shu, G; Jiang, QY; Yuan, L; Xi, QY; Zhang, YL				Li, Hongyi; Chen, Xiao; Guan, Lizeng; Qi, Qien; Shu, Gang; Jiang, Qingyan; Yuan, Li; Xi, Qianyun; Zhang, Yongliang			MiRNA-181a Regulates Adipogenesis by Targeting Tumor Necrosis Factor-alpha (TNF-alpha) in the Porcine Model	PLOS ONE			English	Article							ADIPOCYTE GENE-EXPRESSION; STIMULATES LIPOLYSIS; NEGATIVE REGULATOR; ADIPOSE-TISSUE; PPAR-GAMMA; DIFFERENTIATION; MICRORNAS; TRANSCRIPTION; ACTIVATION; REPRESSION	Adipogenesis is tightly regulated by altering gene expression, and TNF-alpha is a multifunctional cytokine that plays an important role in regulating lipogenesis. MicroRNAs are strong post-transcriptional regulators of cell differentiation. In our previous work, we found high expression of miR-181a in a fat-rich pig breed. Using bioinformatic analysis, miR-181a was identified as a potential regulator of TNF-alpha. Here, we validated TNF-alpha as the target of miR-181a by a dual luciferase assay. In response to adipogenesis, a mimic or inhibitor was used to overexpress or reduce miR-181a expression in porcine pre-adipocytes, which were then induced into mature adipocytes. Overexpression of miR-181a accelerated accumulation of lipid droplets, increased the amount of triglycerides, and repressed TNF-alpha protein expression, while the inhibitor had the opposite effect. At the same time, TNF-alpha rescued the increased lipogenesis by miR181a mimics. Additionally, miR-181a suppression decreased the expression of fatty synthesis associated genes PDE3B (phosphodiesterase 3B), LPL (lipoprotein lipase), PPAR gamma (proliferator-activated receptor-gamma), GLUT1(glucose transporter), GLUT4, adiponectin and FASN (fatty acid synthase), as well as key lipolytic genes HSL (hormone-sensitive lipase) and ATGL (adipose triglyceride lipase) as revealed by quantitative real-time PCR. Our study provides the first evidence of the role of miR-181a in adipocyte differentiation by regulation of TNF-alpha, which may became a new therapeutic target for anti-obesity drugs.	[Li, Hongyi; Chen, Xiao; Guan, Lizeng; Qi, Qien; Shu, Gang; Jiang, Qingyan; Yuan, Li; Xi, Qianyun; Zhang, Yongliang] South China Agr Univ, ALLTECH SCAU Anim Nutr Control Res Alliance, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Li, Hongyi] Longyan Univ, Coll Life Sci, Fujian Prov Key Lab Prevent Vet Med & Biotechnol, Fuzhou, Fujian, Peoples R China; [Yuan, Li] Xiamen Univ, Coll Life Sci, Xiamen, Peoples R China	South China Agricultural University; Longyan University; Xiamen University	Xi, QY (corresponding author), South China Agr Univ, ALLTECH SCAU Anim Nutr Control Res Alliance, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China.	xqy0228@scau.edu.cn; zhangyl@scau.edu.cn			Chinese Key Basic Plan [2009CB941600]; Chinese 973 Plan [2011CB944202]; Chinese Transgenic breeding Key Project [2014ZX08009-048B]; National Natural Science Foundation of China [31072105]	Chinese Key Basic Plan; Chinese 973 Plan(National Basic Research Program of China); Chinese Transgenic breeding Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Key Basic Plan (No. 2009CB941600), Chinese 973 Plan (2011CB944202); the Chinese Transgenic breeding Key Project, (2014ZX08009-048B); and the National Natural Science Foundation of China (31072105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2010, EXP CELL RES, V316, P1681, DOI 10.1016/j.yexcr.2010.04.002; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coenen KR, 2007, DIABETES, V56, P564, DOI 10.2337/db06-1375; Dodson MV, 2010, J FOOD SCI, V75, pR1, DOI 10.1111/j.1750-3841.2009.01396.x; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; German AJ, 2010, VET J, V185, P4, DOI 10.1016/j.tvjl.2010.04.004; Jain RG, 1999, J CELL PHYSIOL, V179, P58, DOI 10.1002/(SICI)1097-4652(199904)179:1<58::AID-JCP8>3.0.CO;2-1; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; KAWAKAMI M, 1987, J BIOCHEM-TOKYO, V101, P331, DOI 10.1093/oxfordjournals.jbchem.a121917; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lee EK, 2010, MOL CELL BIOL, V31, P626; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu M, 2011, INT J ONCOL, V38, P1013, DOI 10.3892/ijo.2011.924; Loftus TM, 1997, CURR OPIN GENET DEV, V7, P603, DOI 10.1016/S0959-437X(97)80006-8; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Ouyang YB, 2012, NEUROBIOL DIS, V45, P555, DOI 10.1016/j.nbd.2011.09.012; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; Qadir AS, 2011, BIOCHEM BIOPH RES CO, V408, P399, DOI 10.1016/j.bbrc.2011.04.029; RIO P, 2012, BLOOD; Romao JM, 2011, EXP BIOL MED, V236, P997, DOI 10.1258/ebm.2011.011101; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Takada I, 2009, EXPERT OPIN THER TAR, V13, P593, DOI [10.1517/14728220902915310 , 10.1517/14728220902915310]; TORTI FM, 1985, SCIENCE, V229, P867, DOI 10.1126/science.3839597; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; WANG Z, 2009, MICRORNA INTERFERENC, P127, DOI DOI 10.1007/978-3-642-00489-6_7; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xie YF, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-20; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao J, 2012, J IMMUNOL, V188, P1266, DOI 10.4049/jimmunol.1101976; Zhou GX, 2010, MEAT SCI, V86, P440, DOI 10.1016/j.meatsci.2010.05.031	53	88	101	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e71568	10.1371/journal.pone.0071568	http://dx.doi.org/10.1371/journal.pone.0071568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098322	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100002
J	Wiegering, A; Pfann, C; Uthe, FW; Otto, C; Rycak, L; Mader, U; Gasser, M; Waaga-Gasser, AM; Eilers, M; Germer, CT				Wiegering, Armin; Pfann, Christina; Uthe, Friedrich Wilhelm; Otto, Christoph; Rycak, Lukas; Maeder, Uwe; Gasser, Martin; Waaga-Gasser, Anna-Maria; Eilers, Martin; Germer, Christoph-Thomas			CIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression	PLOS ONE			English	Article							INDUCED APOPTOSIS; UP-REGULATION; TRANSFORMATION; INHIBITOR; MIR-34A; PP2A	The cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncogenic factor that stabilises the c-Myc protein. CIP2A is overexpressed in several tumours, and expression levels are an independent marker for long-term outcome. To determine whether CIP2A expression is elevated in colon cancer and whether it might serve as a prognostic marker for survival, we analysed CIP2A mRNA expression by real-time PCR in 104 colon cancer samples. CIP2A mRNA was overexpressed in colon cancer samples and CIP2A expression levels correlated significantly with tumour stage. We found that CIP2A serves as an independent prognostic marker for disease-free and overall survival. Further, we investigated CIP2A-dependent effects on levels of c-Myc, Akt and on cell proliferation in three colon cancer cell lines by silencing CIP2A using small interfering (si) and short hairpin (sh) RNAs. Depletion of CIP2A substantially inhibited growth of colon cell lines and reduced c-Myc levels without affecting expression or function of the upstream regulatory kinase, Akt. Expression of CIP2A was found to be dependent on MAPK activity, linking elevated c-Myc expression to deregulated signal transduction in colon cancer.	[Wiegering, Armin; Otto, Christoph; Gasser, Martin; Waaga-Gasser, Anna-Maria; Germer, Christoph-Thomas] Univ Hosp Wuerzburg, Dept Gen Visceral Vasc & Paediat Surg, Dept Surg 1, Wurzburg, Germany; [Wiegering, Armin; Pfann, Christina; Uthe, Friedrich Wilhelm; Eilers, Martin] Univ Wurzburg, Dept Biochem & Mol Biol, D-97070 Wurzburg, Germany; [Rycak, Lukas] Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany; [Maeder, Uwe; Eilers, Martin; Germer, Christoph-Thomas] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; Philipps University Marburg; University of Wurzburg	Wiegering, A (corresponding author), Univ Hosp Wuerzburg, Dept Gen Visceral Vasc & Paediat Surg, Dept Surg 1, Wurzburg, Germany.	wiegering_a@chirurgie.uni-wuerzburg.de	; Wiegering, Armin/X-7541-2018	Eilers, Martin/0000-0002-0376-6533; Wiegering, Armin/0000-0001-7777-0909	university of Wurburg [IZKF B-186]; German Research Foundation (DFG); University of Wuerzburg	university of Wurburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	AW has funding from the university of Wurburg for a screen in comparison with APC the funding number is: IZKF B-186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript for this study. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. No current external other funding sources for this study.	Bockelman C, 2011, BRIT J CANCER, V105, P989, DOI 10.1038/bjc.2011.346; Bockelman C, 2012, CANC BIOL THER; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Chen KF, 2011, MOL CANCER THER, V10, P892, DOI 10.1158/1535-7163.MCT-10-0794; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Fukazawa H, 2000, CANCER RES, V60, P2104; Huang CY, 2012, CANCER LETT, V317, P9, DOI 10.1016/j.canlet.2011.11.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Lin YC, 2012, ORAL ONCOL, V48, P585, DOI 10.1016/j.oraloncology.2012.01.012; Liu J, 2011, GYNECOL ONCOL, V122, P430, DOI 10.1016/j.ygyno.2011.04.031; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lucas CM, 2011, BLOOD, V117, P6660, DOI 10.1182/blood-2010-08-304477; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Teng HW, 2012, J GASTROINTEST SURG; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhao DP, 2010, J MED MICROBIOL, V59, P259, DOI 10.1099/jmm.0.014704-0	22	34	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75292	10.1371/journal.pone.0075292	http://dx.doi.org/10.1371/journal.pone.0075292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098375	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100018
J	Chang, YJ; Ho, TY; Wu, ML; Hwang, SM; Chiou, TW; Tsai, MS				Chang, Yu-Jen; Ho, Tsung-Yen; Wu, Mei-Ling; Hwang, Shiaw-Min; Chiou, Tzyy-Wen; Tsai, Ming-Song			Amniotic Fluid Stem Cells with Low gamma-Interferon Response Showed Behavioral Improvement in Parkinsonism Rat Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CLASS-II EXPRESSION; HUMAN BONE-MARROW; DOPAMINERGIC-NEURONS; STROMAL CELLS; IFN-GAMMA; IN-VIVO; HLA-G; DISEASE; TRANSPLANTATION	Amniotic fluid stem cells (AFSCs) are multipotent stem cells that may be used in transplantation medicine. In this study, AFSCs established from amniocentesis were characterized on the basis of surface marker expression and differentiation potential. To further investigate the properties of AFSCs for translational applications, we examined the cell surface expression of human leukocyte antigens (HLA) of these cells and estimated the therapeutic effect of AFSCs in parkinsonian rats. The expression profiles of HLA-II and transcription factors were compared between AFSCs and bone marrow-derived mesenchymal stem cells (BMMSCs) following treatment with gamma-IFN. We found that stimulation of AFSCs with gamma-IFN prompted only a slight increase in the expression of HLA-Ia and HLA-E, and the rare HLA-II expression could also be observed in most AFSCs samples. Consequently, the expression of CIITA and RFX5 was weakly induced by gamma-IFN stimulation of AFSCs compared to that of BMMSCs. In the transplantation test, Sprague Dawley rats with 6-hydroxydopamine lesioning of the substantia nigra were used as a parkinsonian-animal model. Following the negative gamma-IFN response AFSCs injection, apomorphine-induced rotation was reduced by 75% in AFSCs engrafted parkinsonian rats but was increased by 53% in the control group after 12-weeks post-transplantation. The implanted AFSCs were viable, and were able to migrate into the brain's circuitry and express specific proteins of dopamine neurons, such as tyrosine hydroxylase and dopamine transporter. In conclusion, the relative insensitivity AFSCs to gamma-IFN implies that AFSCs might have immune-tolerance in gamma-IFN inflammatory conditions. Furthermore, the effective improvement of AFSCs transplantation for apomorphine-induced rotation paves the way for the clinical application in parkinsonian therapy.	[Chang, Yu-Jen; Wu, Mei-Ling; Hwang, Shiaw-Min] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan; [Ho, Tsung-Yen; Chiou, Tzyy-Wen] Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan; [Ho, Tsung-Yen; Chiou, Tzyy-Wen] Natl Dong Hwa Univ, Inst Biotechnol, Hualien, Taiwan; [Tsai, Ming-Song] Cathay Gen Hosp, Prenatal Diag Ctr, Taipei, Taiwan; [Tsai, Ming-Song] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Tsai, Ming-Song] Taipei Med Univ, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan	National Dong Hwa University; National Dong Hwa University; Cathay General Hospital; Fu Jen Catholic University; Taipei Medical University	Chiou, TW (corresponding author), Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan.	twchiou@mail.ndhu.edu.tw; mstsai@cgh.org.tw			Ministry of Economic Affairs, Taiwan [101-EC-17-A-01-04-0525]; National Science Council, Taiwan [NSC 99-2311-B-080-001-MY2, NSC97-2314-B-281-002-MY3]	Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant 101-EC-17-A-01-04-0525 from the Ministry of Economic Affairs, Taiwan (http://www.moea.gov.tw), and Grant NSC 99-2311-B-080-001-MY2 and NSC97-2314-B-281-002-MY3 from the National Science Council, Taiwan (http://www.sinica.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Antonucci I, 2011, CELL TRANSPLANT, V20, P789, DOI 10.3727/096368910X539074; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chang YJ, 2006, STEM CELLS, V24, P679, DOI 10.1634/stemcells.2004-0308; Chiavegato A, 2007, J MOL CELL CARDIOL, V42, P746, DOI 10.1016/j.yjmcc.2006.12.008; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Donaldson AE, 2009, STEM CELLS DEV, V18, P1003, DOI 10.1089/scd.2008.0300; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Fondaneche MC, 1998, HUM MOL GENET, V7, P879, DOI 10.1093/hmg/7.5.879; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gobin SJP, 2000, HUM IMMUNOL, V61, P1102, DOI 10.1016/S0198-8859(00)00198-1; Hellmann MA, 2006, NEUROSCI LETT, V395, P124, DOI 10.1016/j.neulet.2005.10.097; Isacson O, 2003, ANN NEUROL, V53, pS135, DOI 10.1002/ana.10482; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945; Klemmt PAB, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt20; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; McLaughlin D, 2006, J NEUROSCI RES, V83, P1190, DOI 10.1002/jnr.20828; Mendez I, 2002, J NEUROSURG, V96, P589, DOI 10.3171/jns.2002.96.3.0589; Moretta L, 2001, TRANSPLANT P, V33, P60, DOI 10.1016/S0041-1345(00)02790-1; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008; Peng H, 2007, J NEUROIMMUNE PHARM, V2, P251, DOI 10.1007/s11481-007-9081-3; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Rousseau P, 2004, IMMUNOLOGY, V111, P53, DOI 10.1111/j.1365-2567.2004.01783.x; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; Shaw SWS, 2011, CELL TRANSPLANT, V20, P1015, DOI 10.3727/096368910X543402; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Toulouse A, 2008, PROG NEUROBIOL, V85, P376, DOI 10.1016/j.pneurobio.2008.05.003; Trounson A, 2007, NAT BIOTECHNOL, V25, P62, DOI 10.1038/nbt0107-62; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Wang Y, 2007, J NEUROIMMUNE PHARM, V2, P243, DOI 10.1007/s11481-007-9074-2; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76118	10.1371/journal.pone.0076118	http://dx.doi.org/10.1371/journal.pone.0076118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098771	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500141
J	Saltaji, H; Cummings, GG; Armijo-Olivo, S; Major, MP; Amin, M; Major, PW; Hartling, L; Flores-Mir, C				Saltaji, Humam; Cummings, Greta G.; Armijo-Olivo, Susan; Major, Michael P.; Amin, Maryam; Major, Paul W.; Hartling, Lisa; Flores-Mir, Carlos			A Descriptive Analysis of Oral Health Systematic Reviews Published 1991-2012: Cross Sectional Study	PLOS ONE			English	Review							PUBLICATION; QUALITY; MEDLINE; TRIALS; BIAS	Objectives: To identify all systematic reviews (SRs) published in the domain of oral health research and describe them in terms of their epidemiological and descriptive characteristics. Design: Cross sectional, descriptive study. Methods: An electronic search of seven databases was performed from inception through May 2012; bibliographies of relevant publications were also reviewed. Studies were considered for inclusion if they were oral health SRs defined as therapeutic or non-therapeutic investigations that studied a topic or an intervention related to dental, oral or craniofacial diseases/disorders. Data were extracted from all the SRs based on a number of epidemiological and descriptive characteristics. Data were analysed descriptively for all the SRs, within each of the nine dental specialities, and for Cochrane and non-Cochrane SRs separately. Results: 1,188 oral health (126 Cochrane and 1062 non-Cochrane) SRs published from 1991 through May 2012 were identified, encompassing the nine dental specialties. Over half (n = 676; 56.9%) of the SRs were published in specialty oral health journals, with almost all (n = 1,178; 99.2%) of the SRs published in English and almost none of the non-Cochrane SRs (n = 11; 0.9%) consisting of updates of previously published SRs. 75.3% of the SRs were categorized as therapeutic, with 64.5% examining non-drug interventions, while approximately half (n = 150/294; 51%) of the non-therapeutic SRs were classified as epidemiological SRs. The SRs included a median of 15 studies, with a meta-analysis conducted in 43.6%, in which a median of 9 studies/1 randomized trial were included in the largest meta-analysis conducted. Funding was received for 25.1% of the SRs, including nearly three-quarters (n = 96; 76.2%) of the Cochrane SRs. Conclusion: Epidemiological and descriptive characteristics of the 1,188 oral health SRs varied across the nine dental specialties and by SR category (Cochrane vs. non-Cochrane). There is a clear need for more updates of SRs in all the dental specialties.	[Saltaji, Humam; Major, Michael P.; Major, Paul W.; Flores-Mir, Carlos] Univ Alberta, Sch Dent, Orthodont Grad Program, Edmonton, AB, Canada; [Cummings, Greta G.; Armijo-Olivo, Susan] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Armijo-Olivo, Susan] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada; [Amin, Maryam] Univ Alberta, Sch Dent, Div Pediat Dent, Edmonton, AB, Canada; [Hartling, Lisa] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Hartling, Lisa] Univ Alberta, Dept Pediat, Cochrane Child Hlth Field, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Saltaji, H (corresponding author), Univ Alberta, Sch Dent, Orthodont Grad Program, Edmonton, AB, Canada.	saltaji@ualberta.ca	Cummings, Greta G/B-4121-2009; Flores-Mir, Carlos/Q-5763-2016; Saltaji, Humam/N-6539-2014	Cummings, Greta G/0000-0002-0668-6176; Flores-Mir, Carlos/0000-0002-0887-9385; Saltaji, Humam/0000-0002-8978-458X	Dentistry Summer Research Program at the University of Alberta; Clinician Fellowship Award by Alberta Innovates - Health Solutions (AIHS); Honorary Izaak Walton Killam Memorial Scholarship by the University of Alberta; Honorary WCHRI Award by the Women and Children's Health Research Institute (WCHRI); Alberta Innovates [201300026] Funding Source: researchfish	Dentistry Summer Research Program at the University of Alberta; Clinician Fellowship Award by Alberta Innovates - Health Solutions (AIHS); Honorary Izaak Walton Killam Memorial Scholarship by the University of Alberta; Honorary WCHRI Award by the Women and Children's Health Research Institute (WCHRI); Alberta Innovates	This study was funded in part by the Dentistry Summer Research Program at the University of Alberta. No additional external funding was received for this study. HS is supported through a Clinician Fellowship Award by Alberta Innovates - Health Solutions (AIHS), the Honorary Izaak Walton Killam Memorial Scholarship by the University of Alberta, and the Honorary WCHRI Award by the Women and Children's Health Research Institute (WCHRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz T, 2013, J ORAL REHABIL; Bader J, 2004, J AM DENT ASSOC, V135, P464, DOI 10.14219/jada.archive.2004.0212; Bow Simon, 2010, BMC Pediatr, V10, P34, DOI 10.1186/1471-2431-10-34; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Edwards P, 2002, STAT MED, V21, P1635, DOI 10.1002/sim.1190; Egger M, 2003, Health Technol Assess, V7, P1; Epstein JB, 2010, SUPPORT CARE CANCER, V18, P1023, DOI 10.1007/s00520-010-0897-7; Fleming PS, 2012, EUR J ORTHOD, P2012; Glenny AM, 2003, EUR J ORAL SCI, V111, P85, DOI 10.1034/j.1600-0722.2003.00013.x; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hopewell S, 2002, STAT MED, V21, P1625, DOI 10.1002/sim.1191; Koletsi D, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.02.024; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Major MP, 2006, J AM DENT ASSOC, V137, P1252, DOI 10.14219/jada.archive.2006.0382; Major Michael P, 2007, Evid Based Dent, V8, P66, DOI 10.1038/sj.ebd.6400504; Millett D, 2011, J ORTHOD, V38, P158, DOI 10.1179/14653121141407; Moher D, 2006, LANCET, V367, P881, DOI 10.1016/S0140-6736(06)68358-X; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Needleman I, 2005, PERIODONTOL 2000, V37, P12, DOI 10.1111/j.1600-0757.2004.37100.x; Papageorgiou SN, 2011, ORTHOD CRANIOFAC RES, V14, P116, DOI 10.1111/j.1601-6343.2011.01522.x; Richards Derek, 2010, Evid Based Dent, V11, P27, DOI 10.1038/sj.ebd.6400710; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Suarez-Almazor ME, 2000, CONTROL CLIN TRIALS, V21, P476, DOI 10.1016/S0197-2456(00)00067-2; Tubert-Jeannin S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007592.pub2; Turner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053536	26	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74545	10.1371/journal.pone.0074545	http://dx.doi.org/10.1371/journal.pone.0074545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098657	Green Published, gold			2022-12-27	WOS:000325423500028
J	Zhou, ZS; Rasmann, S; Li, M; Guo, JY; Chen, HS; Wan, FH				Zhou, Zhong-Shi; Rasmann, Sergio; Li, Min; Guo, Jian-Ying; Chen, Hong-Song; Wan, Fang-Hao			Cold Temperatures Increase Cold Hardiness in the Next Generation Ophraella communa Beetles	PLOS ONE			English	Article							RICE STEM BORER; ARMIGERA HUBNER LEPIDOPTERA; CHILO-SUPPRESSALIS WALKER; DROSOPHILA-MELANOGASTER; LIFE-TABLE; SEASONAL-CHANGES; COLEOPTERA-CHRYSOMELIDAE; LESAGE COLEOPTERA; GLYCEROL CONTENT; SHONAI ECOTYPE	The leaf beetle, Ophraella communa, has been introduced to control the spread of the common ragweed, Ambrosia artemisiifolia, in China. We hypothesized that the beetle, to be able to track host-range expansion into colder climates, can phenotypically adapt to cold temperatures across generations. Therefore, we questioned whether parental experience of colder temperatures increases cold tolerance of the progeny. Specifically, we studied the demography, including development, fecundity, and survival, as well as physiological traits, including supercooling point (SCP), water content, and glycerol content of O. communa progeny whose parents were maintained at different temperature regimes. Overall, the entire immature stage decreased survival of about 0.2%-4.2% when parents experienced cold temperatures compared to control individuals obtained from parents raised at room temperature. However, intrinsic capacity for increase (r), net reproductive rate (R-0) and finite rate of increase (lambda) of progeny O. communa were maximum when parents experienced cold temperatures. Glycerol contents of both female and male in progeny was significantly higher when maternal and paternal adults were cold acclimated as compared to other treatments. This resulted in the supercooling point of the progeny adults being significantly lower compared to beetles emerging from parents that experienced room temperatures. These results suggest that cold hardiness of O. communa can be promoted by cold acclimation in previous generation, and it might counter-balance reduced survival in the next generation, especially when insects are tracking their host-plants into colder climates.	[Zhou, Zhong-Shi; Guo, Jian-Ying; Chen, Hong-Song; Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Rasmann, Sergio] Univ Calif Irvine, Irvine, CA USA; [Li, Min] Fujian Entry Exit Inspect & Quarantine Bur, Fuzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of California System; University of California Irvine	Wan, FH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	wanfanghao@caas.cn	Rasmann, Sergio/T-5376-2017	Rasmann, Sergio/0000-0002-3120-6226	National Natural Science Foundation of China [31171908, 31170392]; National Basic Research and Development Program of China [2009CB119200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China)	This work was funded by the National Natural Science Foundation of China (No. 31171908; 31170392), and the National Basic Research and Development Program of China (No. 2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, AM NAT, V157, P555, DOI 10.1086/319932; Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; ASAHINA E, 1969, Advances in Insect Physiology, V(6), P1; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; Bernardo J, 1996, AM ZOOL, V36, P83; BLOCK W, 1990, PHILOS T ROY SOC B, V326, P613, DOI 10.1098/rstb.1990.0035; Block W, 2001, POLAR BIOL, V24, P764; BRADSHAW AD, 1991, ANN BOT-LONDON, V67, P5, DOI 10.1093/oxfordjournals.aob.a088209; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Chantarasa-ard S., 1984, Esakia, V22, P145; Chen WL, 2008, BIOL CONTROL, V46, P122, DOI 10.1016/j.biocontrol.2008.04.007; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., 2005, TWOSEX MSCHART COMPU; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Costanzo JP, 1998, J INSECT PHYSIOL, V44, P1173, DOI 10.1016/S0022-1910(98)00082-1; COULSON SC, 1992, J INSECT PHYSIOL, V38, P421, DOI 10.1016/0022-1910(92)90118-W; Daane KM, 2004, BIOL CONTROL, V31, P123, DOI 10.1016/j.biocontrol.2004.04.010; Danks HV, 1996, EUR J ENTOMOL, V93, P383; Diss AL, 1996, OECOLOGIA, V106, P470, DOI 10.1007/BF00329704; Farhadi R, 2011, BIOL CONTROL, V59, P83, DOI 10.1016/j.biocontrol.2011.07.013; Gibbs M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-345; Gilchrist GW, 2001, EVOLUTION, V55, P209, DOI 10.1111/j.0014-3820.2001.tb01287.x; GOEDEN RD, 1985, PAN-PAC ENTOMOL, V61, P32; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Goto M, 2001, APPL ENTOMOL ZOOL, V36, P323, DOI 10.1303/aez.2001.323; Guo JY, 2012, BIOL INVASIONS, V14, P1597, DOI 10.1007/s10530-010-9932-3; Holmstrup M, 1999, J COMP PHYSIOL B, V169, P207, DOI 10.1007/s003600050213; Huang Yu-Bing, 2012, Insect Science, V19, P263, DOI 10.1111/j.1744-7917.2011.01424.x; Huang Z, 2008, BIOL CONTROL, V46, P209, DOI 10.1016/j.biocontrol.2008.04.004; Huffaker Carl, 1999, P269; Ines SM, 2009, CHEMOSPHERE, V76, P1451; Irwin JT, 2000, J INSECT PHYSIOL, V46, P655, DOI 10.1016/S0022-1910(99)00153-5; Ishiguro S, 2007, J INSECT PHYSIOL, V53, P392, DOI 10.1016/j.jinsphys.2006.12.014; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; Jervis MA, 2007, EVOL ECOL, V21, P307, DOI 10.1007/s10682-006-9102-3; Jha RK, 2012, ENVIRON ENTOMOL, V41, P30, DOI 10.1603/EN11206; Kavousi A, 2009, J ECON ENTOMOL, V102, P595, DOI 10.1603/029.102.0217; Lee R.E. Jr, 1991, P17; LeSage L, 1986, MEMOIRS ENTOMOLOGICA, V133, P1, DOI [10.4039/entm118133fv, DOI 10.4039/ENTM118133FV]; Li YP, 2002, ARCH INSECT BIOCHEM, V50, P53, DOI 10.1002/arch.10024; Liu ZD, 2007, J INSECT PHYSIOL, V53, P1016, DOI 10.1016/j.jinsphys.2007.05.005; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Luo Min, 2011, Acta Entomologica Sinica, V54, P76; MacAlpine JLP, 2011, J INSECT PHYSIOL, V57, P35, DOI 10.1016/j.jinsphys.2010.09.003; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; Marshall DJ, 2003, MAR ECOL PROG SER, V259, P139, DOI 10.3354/meps259139; Marshall DJ, 2006, INTEGR COMP BIOL, V46, P643, DOI 10.1093/icb/icl013; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; Montiel PO, 1998, POLAR BIOL, V19, P250, DOI 10.1007/s003000050242; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Muise AM, 1999, CRYO-LETT, V20, P223; Nedved O, 1998, FUNCT ECOL, V12, P816, DOI 10.1046/j.1365-2435.1998.00250.x; Neven LG, 1999, CRYOBIOLOGY, V38, P43, DOI 10.1006/cryo.1998.2140; PALMER WA, 1991, COLEOPTS BULL, V45, P115; Papaj DR, 2000, ANNU REV ENTOMOL, V45, P423, DOI 10.1146/annurev.ento.45.1.423; Rako L, 2006, J INSECT PHYSIOL, V52, P94, DOI 10.1016/j.jinsphys.2005.09.007; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Rivers DB, 2000, J INSECT PHYSIOL, V46, P99, DOI 10.1016/S0022-1910(99)00106-7; Roff DA, 2004, J EVOLUTION BIOL, V17, P663, DOI 10.1046/j.1420-9101.2003.00673.x; Roff Derek, 2002, pi; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; SAS Institute, 2004, SAS US GUID STAT; Sharaf N., 1996, Dirasat Agricultural Sciences, V23, P214; Sinclair BJ, 1999, EUR J ENTOMOL, V96, P157; Stelgenga MJ, 2007, J THERM BIOL, V32, P396, DOI 10.1016/j.jtherbio.2007.06.001; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; TANIGOSHI LK, 1977, HILGARDIA, V45, P237, DOI 10.3733/hilg.v45n08p237; Terblanche JS, 2005, J INSECT PHYSIOL, V51, P1013, DOI 10.1016/j.jinsphys.2005.04.016; Teshler M. P., 2002, BIOL CONTROL PROGRAM, P290, DOI DOI 10.1079/9780851995274.0290; Teshler M.P., 2000, WEED SCI SOC AM ABST, V40, P29; Tsumuki H., 1990, Advances in Invertebrate Reproduction, V5, P273; Tsumuki H, 1978, BER OHARA I LANDWIRT, V17, P98; Uckan Fevzi, 2001, Turkish Journal of Zoology, V25, P187; van Lenteren JC, 2006, ANNU REV ENTOMOL, V51, P609, DOI 10.1146/annurev.ento.51.110104.151129; Wan F.H., 2005, BIOL MANAGEMENT INVA, P662; Wang HS, 2006, CRYOBIOLOGY, V53, P206, DOI 10.1016/j.cryobiol.2006.06.003; Wang HS, 2005, CRYOBIOLOGY, V51, P220, DOI 10.1016/j.cryobiol.2005.07.003; Worland MR, 2008, J INSECT PHYSIOL, V54, P1281, DOI 10.1016/j.jinsphys.2008.06.009; Yoder JA, 2006, J INSECT PHYSIOL, V52, P202, DOI 10.1016/j.jinsphys.2005.10.005; Zhou ZS, 2011, ENTOMOL EXP APPL, V140, P85, DOI 10.1111/j.1570-7458.2011.01128.x; Zhou Zhong-shi, 2008, Chinese Journal of Biological Control, V24, P376; Zhou ZS, 2010, ENVIRON ENTOMOL, V39, P1021, DOI 10.1603/EN09176	87	21	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74760	10.1371/journal.pone.0074760	http://dx.doi.org/10.1371/journal.pone.0074760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098666	Green Published, gold			2022-12-27	WOS:000325423500037
J	Cao, KJ; Ryvkin, P; Hwang, YC; Johnson, FB; Wang, LS				Cao, Kajia; Ryvkin, Paul; Hwang, Yih-Chii; Johnson, F. Brad; Wang, Li-San			Analysis of Nonlinear Gene Expression Progression Reveals Extensive Pathway and Age-Specific Transitions in Aging Human Brains	PLOS ONE			English	Article							TRANSCRIPTIONAL PROFILES; ALZHEIMERS-DISEASE; OXIDATIVE DAMAGE; AMYLOID-BETA; FATTY-ACIDS; DNA-DAMAGE; BIOLOGY; STRESS; KEGG; RNA	Several recent gene expression studies identified hundreds of genes that are correlated with age in brain and other tissues in human. However, these studies used linear models of age correlation, which are not well equipped to model abrupt changes associated with particular ages. We developed a computational algorithm for age estimation in which the expression of each gene is treated as a dichotomized biomarker for whether the subject is older or younger than a particular age. In addition, for each age-informative gene our algorithm identifies the age threshold with the most drastic change in expression level, which allows us to associate genes with particular age periods. Analysis of human aging brain expression datasets from three frontal cortex regions showed that different pathways undergo transitions at different ages, and the distribution of pathways and age thresholds varies across brain regions. Our study reveals age-correlated expression changes at particular age points and allows one to estimate the age of an individual with better accuracy than previously published methods.	[Cao, Kajia; Johnson, F. Brad; Wang, Li-San] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Ryvkin, Paul; Hwang, Yih-Chii] Univ Penn, Genom & Computat Biol Grad Grp, Philadelphia, PA 19104 USA; [Cao, Kajia; Wang, Li-San] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Johnson, F. Brad; Wang, Li-San] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Wang, LS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA.	lswang@mail.med.upenn.edu			University of Pennsylvania Research Foundation; National Institute on Aging [U01-AG032984, P30-AG010124]; National Institute of Neurological Disorders and Stroke [P50-NS053488]; National Human Genome Research Institute [T32-HG000046]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG032984, P30AG010124] Funding Source: NIH RePORTER	University of Pennsylvania Research Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is funded by a University of Pennsylvania Research Foundation Pilot Grant (to KC and LSW); the National Institute on Aging (U01-AG032984 and P30-AG010124 to LSW), National Institute of Neurological Disorders and Stroke (P50-NS053488 to LSW), and National Human Genome Research Institute (T32-HG000046 to PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7; Bergman A, 2007, PLOS COMPUT BIOL, V3, P1648, DOI 10.1371/journal.pcbi.0030170; BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bourre J M, 2004, J Nutr Health Aging, V8, P163; Cao K, 2010, PLOS ONE, V5, P5; Cook PE, 2007, NAT PROTOC, V2, P2796, DOI 10.1038/nprot.2007.396; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; David-Eden H, 2008, NUCLEIC ACIDS RES, V36, P4641, DOI 10.1093/nar/gkn433; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Forester BP, 2010, NMR BIOMED, V23, P242, DOI 10.1002/nbm.1444; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Fry RC, 2003, MECH AGEING DEV, V124, P839, DOI 10.1016/S0047-6374(03)00144-1; Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69; Golden TR, 2006, EXP GERONTOL, V41, P1040, DOI 10.1016/j.exger.2006.06.034; Golden TR, 2008, AGING CELL, V7, P850, DOI 10.1111/j.1474-9726.2008.00433.x; Hall M, 2007, KNOWL-BASED SYST, V20, P120, DOI 10.1016/j.knosys.2006.11.008; Hawse JR, 2004, EXP EYE RES, V79, P935, DOI 10.1016/j.exer.2004.04.007; Ho JWK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S16; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kooperberg C, 1997, J AM STAT ASSOC, V92, P117, DOI 10.2307/2291455; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Langley P., 1992, ANAL BAYESIAN CLASSI; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Manke Thomas, 2005, Genome Inform, V16, P159; Masoro E, 2006, HDB BIOL AGING; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Nakamura E, 2003, J GERONTOL A-BIOL, V58, P196; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Simpson JE, 2011, NEUROBIOL AGING; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tsugita A, 2000, ELECTROPHORESIS, V21, P1853, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1853::AID-ELPS1853>3.3.CO;2-P; Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33; Ueno Linda Massako, 2003, Journal of Physiological Anthropology and Applied Human Science, V22, P37, DOI 10.2114/jpa.22.37; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wu JZ, 2007, GERMA BACKGROUND ADJ; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yehuda S, 2002, NEUROBIOL AGING, V23, P843, DOI 10.1016/S0197-4580(02)00074-X; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607	60	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74578	10.1371/journal.pone.0074578	http://dx.doi.org/10.1371/journal.pone.0074578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098339	Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600006
J	Polfus, LM; Smith, JA; Shimmin, LC; Bielak, LF; Morrison, AC; Kardia, SLR; Peyser, PA; Hixson, JE				Polfus, Linda M.; Smith, Jennifer A.; Shimmin, Lawrence C.; Bielak, Lawrence F.; Morrison, Alanna C.; Kardia, Sharon L. R.; Peyser, Patricia A.; Hixson, James E.			Genome-Wide Association Study of Gene by Smoking Interactions in Coronary Artery Calcification	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; DISEASE RISK-FACTORS; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; PROINSULIN LEVELS; PROGNOSTIC VALUE; HEART-DISEASE; CALCIUM; EVENTS; METAANALYSIS	Many GWAS have identified novel loci associated with common diseases, but have focused only on main effects of individual genetic variants rather than interactions with environmental factors (GxE). Identification of GxE interactions is particularly important for coronary heart disease (CHD), a major preventable source of morbidity and mortality with strong non-genetic risk factors. Atherosclerosis is the major cause of CHD, and coronary artery calcification (CAC) is directly correlated with quantity of coronary atherosclerotic plaque. In the current study, we tested for genetic variants influencing extent of CAC via interaction with smoking (GxS), by conducting a GxS discovery GWAS in Genetic Epidemiology Network of Arteriopathy (GENOA) sibships (N = 915 European Americans) followed by replication in Framingham Heart Study (FHS) sibships (N = 1025 European Americans). Generalized estimating equations accounted for the correlation within sibships in strata-specific groups of smokers and nonsmokers, as well as GxS interaction. Primary analysis found SNPs that showed suggestive associations (p <= 10(-5)) in GENOA GWAS, but these index SNPs did not replicate in FHS. However, secondary analysis was able to replicate candidate gene regions in FHS using other SNPs (+/-250 kb of GENOA index SNP). In smoker and nonsmoker groups, replicated genes included TCF7L2 (p = 6.0610(-5)) and WWOX (p = 4.5610(-6)); and TNFRSF8 (p = 7.8610(-5)), respectively. For GxS interactions, replicated genes included TBC1D4 (p = 6.9610(-5)) and ADAMTS9 (P = 7.1610(-5)). Interestingly, these genes are involved in inflammatory pathways mediated by the NF-kappa B axis. Since smoking is known to induce chronic and systemic inflammation, association of these genes likely reflects roles in CAC development via inflammatory pathways. Furthermore, the NF-kappa B axis regulates bone remodeling, a key physiological process in CAC development. In conclusion, GxS GWAS has yielded evidence for novel loci that are associated with CAC via interaction with smoking, providing promising new targets for future population-based and functional studies of CAC development.	[Polfus, Linda M.; Shimmin, Lawrence C.; Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Smith, Jennifer A.; Bielak, Lawrence F.; Kardia, Sharon L. R.; Peyser, Patricia A.; Hixson, James E.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Hixson, JE (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	James.E.Hixson@uth.tmc.edu		Smith, Jennifer Ann/0000-0002-3575-5468; Hixson, James/0000-0002-0849-9315; Morrison, Alanna/0000-0001-6381-4296	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL091988, R01HL87660]; Burroughs Wellcome Fund; Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the Brown Foundation Institute of Molecular Medicine of UTHealth Medical School (BWF) [1008200]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091988, R01HL087660] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the Brown Foundation Institute of Molecular Medicine of UTHealth Medical School (BWF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HL091988 to J.E.H., R01HL87660 to S. L. R. K.), and in part by a training fellowship from the Burroughs Wellcome Fund - The Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the Brown Foundation Institute of Molecular Medicine of UTHealth Medical School (BWF Grant No. 1008200 to L. M. P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Baud'huin M, 2007, CELL MOL LIFE SCI, V64, P2334, DOI 10.1007/s00018-007-7104-0; Bielinski SJ, 2008, DIABETOLOGIA, V51, P968, DOI 10.1007/s00125-008-1004-1; Botman SL, 2000, VITAL HLTH STAT, V130, P1; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Del Mare S, 2011, AM J CANCER RES, V1, P585; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gokulakrisnan A, 2011, MOL CELL BIOCHEM, V354, P1, DOI 10.1007/s11010-011-0785-6; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hoff JA, 2003, ANN EPIDEMIOL, V13, P163, DOI 10.1016/S1047-2797(02)00277-6; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Levinger I, 2011, ARTHRITIS RHEUM-US, V63, P1343, DOI 10.1002/art.30287; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Loos RJF, 2007, DIABETES, V56, P1943, DOI 10.2337/db07-0055; Muendlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017978; North KE, 2007, ATHEROSCLEROSIS, V193, P11, DOI 10.1016/j.atherosclerosis.2006.08.015; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; Peyser PA, 2002, CIRCULATION, V106, P304, DOI 10.1161/01.CIR.0000022664.21832.5D; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Rumberger JA, 2010, VASC HEALTH RISK MAN, V6, P579; Saez ME, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-148; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Turner ST, 2006, ATHEROSCLEROSIS, V185, P340, DOI 10.1016/j.atherosclerosis.2005.06.010; Ueno H, 2006, CARDIOVASC TOXICOL, V6, P39, DOI 10.1385/CT:6:1:39; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	40	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74642	10.1371/journal.pone.0074642	http://dx.doi.org/10.1371/journal.pone.0074642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098343	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600008
J	Edwards, TG; Vidmar, TJ; Koeller, K; Bashkin, JK; Fisher, C				Edwards, Terri G.; Vidmar, Thomas J.; Koeller, Kevin; Bashkin, James K.; Fisher, Chris			DNA Damage Repair Genes Controlling Human Papillomavirus (HPV) Episome Levels under Conditions of Stability and Extreme Instability	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; MRN COMPLEX; REPLICATION; IMIDAZOLE; INFECTION; PATHWAY; PHOSPHODIESTERASE; DIFFERENTIATION; RAD9-HUS1-RAD1; POLYAMIDES	DNA damage response (DDR) genes and pathways controlling the stability of HPV episomal DNA are reported here. We set out to understand the mechanism by which a DNA-binding, N-methylpyrrole-imidazole hairpin polyamide (PA25) acts to cause the dramatic loss of HPV DNA from cells. Southern blots revealed that PA25 alters HPV episomes within 5 hours of treatment. Gene expression arrays identified numerous DDR genes that were specifically altered in HPV16 episome-containing cells (W12E) by PA25, but not in HPV-negative (C33A) cells or in cells with integrated HPV16 (SiHa). A siRNA screen of 240 DDR genes was then conducted to identify enhancers and repressors of PA25 activity. Serendipitously, the screen also identified many novel genes, such as TDP1 and TDP2, regulating normal HPV episome stability. MRN and 9-1-1 complexes emerged as important for PA25-mediated episome destruction and were selected for follow-up studies. Mre11, along with other homologous recombination and dsDNA break repair genes, was among the highly significant PA25 repressors. The Mre11 inhibitor Mirin was found to sensitize HPV episomes to PA25 resulting in a similar to 5-fold reduction of the PA25 IC50. A novel assay that couples end-labeling of DNA to Q-PCR showed that PA25 causes strand breaks within HPV DNA, and that Mirin greatly enhances this activity. The 9-1-1 complex member Rad9, a representative PA25 enhancer, was transiently phosphorylated in response to PA25 treatment suggesting that it has a role in detecting and signaling episome damage by PA25 to the cell. These results establish that DNA-targeted compounds enter cells and specifically target the HPV episome. This action leads to the activation of numerous DDR pathways and the massive elimination of episomal DNA from cells. Our findings demonstrate that viral episomes can be targeted for elimination from cells by minor groove binding agents, and implicate DDR pathways as important mediators of this process.	[Edwards, Terri G.; Bashkin, James K.; Fisher, Chris] NanoVir, Kalamazoo, MI USA; [Vidmar, Thomas J.] BioStat Consultants, Portage, MI USA; [Koeller, Kevin; Bashkin, James K.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Fisher, C (corresponding author), NanoVir, Kalamazoo, MI USA.	chris.fisher@nanovirpharm.com	Bashkin, James K./F-5327-2010; Edwards, Terri G/L-4710-2018	Bashkin, James K./0000-0001-6735-4733; 	NIH [AI062182, AI068159, AI083803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI062182, R41AI068159, R01AI083803, R42AI062182, R42AI068159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI062182, AI068159, and AI083803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird EE, 1996, J AM CHEM SOC, V118, P6141, DOI 10.1021/ja960720z; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Chen HC, 2011, JNCI-J NATL CANCER I, V103, P1387, DOI 10.1093/jnci/djr283; Chenoweth DM, 2010, J AM CHEM SOC, V132, P14521, DOI 10.1021/ja105068b; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Dickinson LA, 2004, CHEM BIOL, V11, P1583, DOI 10.1016/j.chembiol.2004.09.004; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Edwards TG, 2011, ANTIVIR RES, V91, P177, DOI 10.1016/j.antiviral.2011.05.014; Edwards TG, 2013, J VIROL, V87, P11; Fradet-Turcotte A, 2011, J VIROLOGY; Garner-Hamrick PA, 2002, VIROLOGY, V301, P334, DOI 10.1006/viro.2002.1558; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Gillespie KA, 2012, J VIROL, V86, P9520, DOI 10.1128/JVI.00247-12; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hoffmann R, 2006, J VIROL, V80, P4431, DOI 10.1128/JVI.80.9.4431-4439.2006; Hong SY, 2011, J VIROL, V85, P9486, DOI 10.1128/JVI.05007-11; Hoskins EE, 2009, ONCOGENE, V28, P674, DOI 10.1038/onc.2008.416; Hoskins EE, 2012, J VIROL, V86, P8131, DOI 10.1128/JVI.00408-12; Howley PM, 2007, FIELDS VIROLOGY, V2, P2299; Hunt RA, 2011, NUCLEIC ACIDS RES, V39, P4265, DOI 10.1093/nar/gkq1362; Kastan MB, 2008, MOL CANCER RES, V6, P517, DOI 10.1158/1541-7786.MCR-08-0020; Kravchenko J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030736; Kutler DI, 2003, J NATL CANCER I, V95, P1718, DOI 10.1093/jnci/djg091; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lu ZM, 2004, J BIOL CHEM, V279, P35664, DOI 10.1074/jbc.M403385200; McBride AA, 2012, BBA-GENE REGUL MECH, V1819, P820, DOI 10.1016/j.bbagrm.2012.01.011; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Molho-Pessach Vered, 2007, Curr Probl Dermatol, V35, P39, DOI 10.1159/000106409; Moody CA, 2007, P NATL ACAD SCI USA, V104, P19541, DOI 10.1073/pnas.0707947104; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; Nickols NG, 2013, MOL CANCER THER, V12, P675, DOI 10.1158/1535-7163.MCT-12-1040; Nikitin PA, 2011, FUTURE VIROL, V6, P813, DOI 10.2217/FVL.11.55; Nitiss JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003370; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Querol-Audi J, 2012, P NATL ACAD SCI USA, V109, P8528, DOI 10.1073/pnas.1121116109; Sakakibara N, 2011, J VIROL, V85, P8981, DOI 10.1128/JVI.00541-11; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Synold TW, 2012, CANCER CHEMOTH PHARM, V70, P617, DOI 10.1007/s00280-012-1954-3; Turnell AS, 2012, J GEN VIROL, V93, P2076, DOI 10.1099/vir.0.044412-0; van Zeeburg HJT, 2008, J NATL CANCER I, V100, P1649, DOI 10.1093/jnci/djn366; Walker WL, 1997, P NATL ACAD SCI USA, V94, P5634, DOI 10.1073/pnas.94.11.5634; Wang S, 2012, BIOCHEMISTRY-US, V51, P9796, DOI 10.1021/bi301327v; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035159; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	56	38	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75406	10.1371/journal.pone.0075406	http://dx.doi.org/10.1371/journal.pone.0075406			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098381	Green Published, gold			2022-12-27	WOS:000325434500029
J	Geng, LY; Sun, CH; Bai, JF				Geng, Liangyuan; Sun, Changhua; Bai, Jianfeng			Single Incision versus Conventional Laparoscopic Cholecystectomy Outcomes: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CLINICAL-TRIAL; PORT; SURGERY; PAIN; SITE; SCORES	Background: Previous meta-analyses that compared the outcome of SILC and CLC have not presented consistent conclusions. This meta-analysis was performed after adding many recent RCTs, to clarify this issue. Methods: Relevant articles published in English were identified by searching PubMed, Embase, Web of Knowledge, and the Cochrane Controlled Trial Register from January 1997 to February 2013. Reference lists of the retrieved articles were reviewed to identify additional articles. Primary outcomes (postoperative pain scores, cosmetic score, and length of incision) and secondary outcomes (operating time, blood loss, conversion rates, postoperative complications, postoperative hospital stay, time to initial oral intake, and time to resume work) were pooled. Quantitative variables were calculated using the weighted mean difference (WMD), and qualitative variables were pooled using odds ratios (OR). Results: 25 appropriate RCTs were identified from 2128 published articles. 1841 patients were treated, 944 with SILC and 897 with CLC. SILC was superior to CLC in cosmetic score (WMD = 1.155, P<0.001), shorter length of incision (WMD = -3.285, P = 0.029), and postoperative pain within 12 h (VAS in 3-4 h, WMD = -0.704, P = 0.026; VAS in 6-8 h, WMD = -0.613, P = 0.010). CLC was superior to SILC in operating time (OT) (WMD = 13.613, P<0.001) and need of additional instruments (OR = 7.448, P<0.001). Other secondary outcomes were similar. Conclusions: SILC offered a better cosmetic result and less postoperative pain for patients with uncomplicated cholelithiasis or polypoid lesions of the gallbladder. However, SILC was associated with a longer OT and required additional instruments.	[Geng, Liangyuan; Sun, Changhua; Bai, Jianfeng] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Bai, JF (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	jianfeng_bai@qq.com						Aprea G, 2011, J SURG RES, V166, pE109, DOI 10.1016/j.jss.2010.11.885; Arezzo A, 2013, SURG ENDOSC, V27, P2293, DOI 10.1007/s00464-012-2763-9; Bresadola F, 1999, EUR J SURG, V165, P29, DOI 10.1080/110241599750007478; Bucher P, 2011, BRIT J SURG, V98, P1695, DOI 10.1002/bjs.7689; Canes D, 2008, EUR UROL, V54, P1020, DOI 10.1016/j.eururo.2008.07.009; Cantore F, 2008, Int J Surg, V6 Suppl 1, pS89, DOI 10.1016/j.ijsu.2008.12.033; Cao ZG, 2011, SURG LAPARO ENDO PER, V21, P311, DOI 10.1097/SLE.0b013e31822cfacd; Chang SKY, 2013, ASIAN J ENDOSC SURG, V6, P14, DOI 10.1111/j.1758-5910.2012.00154.x; Garg P, 2012, J GASTROINTEST SURG, V16, P1618, DOI 10.1007/s11605-012-1906-6; Garg P, 2012, J LAPAROENDOSC ADV S, V22, P127, DOI 10.1089/lap.2011.0391; Gurusamy KS, 2008, COCHRANE DB SYST REV, V16; Hall TC, 2012, ARCH SURG-CHICAGO, V147, P657, DOI 10.1001/archsurg.2012.814; Han HJ, 2012, AM SURGEON, V78, P485; Hao LX, 2012, SURG LAPARO ENDO PER, V22, P487, DOI 10.1097/SLE.0b013e3182685d0a; Hauters P, 2013, SURG ENDOSC, V27, P1689, DOI 10.1007/s00464-012-2657-x; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Joseph S, 2011, SURG ENDOSC, V25, P3008, DOI 10.1007/s00464-011-1661-x; Kapischke M, 2006, SURG ENDOSC, V20, P1060, DOI 10.1007/s00464-005-0016-x; Kilian M, 2011, LANGENBECK ARCH SURG, V396, P709, DOI 10.1007/s00423-011-0769-8; Lai ECH, 2011, AM J SURG, V202, P254, DOI 10.1016/j.amjsurg.2010.12.009; Lee PC, 2010, BRIT J SURG, V97, P1007, DOI 10.1002/bjs.7087; Leung D, 2012, J AM COLL SURGEONS, V215, P702, DOI 10.1016/j.jamcollsurg.2012.05.038; Lirici MM, 2011, AM J SURG, V202, P45, DOI 10.1016/j.amjsurg.2010.06.019; Luna RA, 2013, SURG ENDOSC, V27, P1254, DOI 10.1007/s00464-012-2589-5; Ma J, 2011, ANN SURG, V254, P22, DOI 10.1097/SLA.0b013e3182192f89; Markar SR, 2012, SURG ENDOSC, V26, P1205, DOI 10.1007/s00464-011-2051-0; Marks J, 2011, AM J SURG, V201, P369, DOI 10.1016/j.amjsurg.2010.09.012; Mehmood Z, 2010, J SURG PAK INT, V15, P122; Mehmood Z, 2011, PAK J MED SCI, V27, P38; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Muhe E, 1991, Langenbecks Arch Chir Suppl Kongressbd, P416; Navarra G, 1997, BRIT J SURG, V84, P695, DOI 10.1002/bjs.1800840536; Noguera JF, 2012, SURG ENDOSC, V26, P3435, DOI 10.1007/s00464-012-2359-4; Ostlie DJ, 2013, J PEDIATR SURG, V48, P209, DOI 10.1016/j.jpedsurg.2012.10.039; Pan MX, 2013, WORLD J GASTROENTERO, V19, P394, DOI 10.3748/wjg.v19.i3.394; Phillips MS, 2012, SURG ENDOSC, V26, P1296, DOI 10.1007/s00464-011-2028-z; Pisanu A, 2012, J GASTROINTEST SURG, V16, P1790, DOI 10.1007/s11605-012-1956-9; Rasic Z, 2010, COLLEGIUM ANTROPOL, V34, P595; Saad S, 2013, BRIT J SURG, V100, P339, DOI 10.1002/bjs.9003; Sajid MS, 2012, WORLD J SURG, V36, P2644, DOI 10.1007/s00268-012-1719-5; Sasaki A, 2012, SURG LAPARO ENDO PER, V22, P396, DOI 10.1097/SLE.0b013e3182631a9a; Sinan H, 2012, SURG LAPARO ENDO PER, V22, P12, DOI 10.1097/SLE.0b013e3182402448; Solomon D, 2012, SURG ENDOSC, V26, P2823, DOI 10.1007/s00464-012-2253-0; Steinemann DC, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-24; Tacchino R, 2011, SURG ENDOSC, V25, pS35; Trastulli S, 2013, BRIT J SURG, V100, P191, DOI 10.1002/bjs.8937; Tsimoyiannis EC, 2010, SURG ENDOSC, V24, P1842, DOI 10.1007/s00464-010-0887-3; Madureira FAV, 2013, SURG ENDOSC, V27, P1009, DOI 10.1007/s00464-012-2556-1; Vilallonga R, 2012, J MINIM ACCESS SURG, V8, P74, DOI 10.4103/0972-9941.97586; Wang ZH, 2012, ANZ J SURG, V82, P885, DOI 10.1111/j.1445-2197.2012.06284.x; Zheng MW, 2012, MINIM INVASIV THER, V21, P113, DOI 10.3109/13645706.2011.577787; Zhong X, 2012, J LAPAROENDOSC ADV S, V22, P449, DOI 10.1089/lap.2011.0521	53	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76530	10.1371/journal.pone.0076530	http://dx.doi.org/10.1371/journal.pone.0076530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098522	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500070
J	Hellmuth, C; Demmelmair, H; Schmitt, I; Peissner, W; Bluher, M; Koletzko, B				Hellmuth, Christian; Demmelmair, Hans; Schmitt, Isabel; Peissner, Wolfgang; Blueher, Matthias; Koletzko, Berthold			Association between Plasma Nonesterified Fatty Acids Species and Adipose Tissue Fatty Acid Composition	PLOS ONE			English	Article							METABOLISM; BIOSYNTHESIS; MOBILIZATION; BIOMARKERS; LIPIDOMICS; RELEASE; INSULIN; OBESITY; STORAGE; HUMANS	Fatty acid composition of adipose tissue (AT) is an established long-term biomarker for fatty acid (FA) intake and status, but AT samples are not easily available. Nonesterified FA composition in plasma (pNEFA) may be a good indicator of AT FA composition, because pNEFA are mainly generated by AT lipolysis. We investigated the correlation of 42 pNEFA and subcutaneous as well as visceral AT FA in 27 non-diabetic women with a median BMI of 36 kg/m(2) (Q(0.25): 25 kg/m(2); Q(0.75): 49 kg/m(2)). Close correlations of pNEFA and AT FA were found for odd-chain FA (15:0 r = 0.838 and 0.862 for subcutaneous and visceral AT, respectively) and omega-3 FA (22:6 r = 0.719/0.535), while no significant or low correlations were found for other FA including 18:1 (r = 0.384/0.325) and 20:4 (r = 0.386/0.266). Close correlations of pNEFA and AT FA were found for essential fatty acids, like 18:2 (r = 0.541/0.610) and 20:5 (r = 0.561/0.543). The lower correlation for some pNEFA species with AT FA indicates that the variation of most pNEFA is significantly affected by other FA sources and flux of FA to tissue, in addition to release from AT. A relevant influence of BMI on the level of correlation was shown for saturated FA. NEFA analysis in fasted plasma can serve as a virtual AT biopsy for some FA, and as a biomarker for intake of dairy products and sea fish.	[Hellmuth, Christian; Demmelmair, Hans; Schmitt, Isabel; Peissner, Wolfgang; Koletzko, Berthold] Univ Munich, Med Ctr, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Munich, Germany; [Blueher, Matthias] Univ Hosp Leipzig, Clin Endocrinol & Nephrol, Dept Internal Med, Leipzig, Germany	University of Munich; Leipzig University	Koletzko, B (corresponding author), Univ Munich, Med Ctr, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Munich, Germany.	office.koletzko@med.lmu.de	Hellmuth, Christian/C-2575-2017	Hellmuth, Christian/0000-0001-9778-497X	"Kompetenznetz Adipositas" ("Competence Network for Adiposity"); German Federal Ministry of Education and Research [01GI0826, 01GI1128]; Commission of the European Communities [FP7-212652]; Munich Center of Health Sciences (McHealth); Deutsche Forschungsgemeinschaft (DFG) for the Clinical Research group "Atherobesity" [KFO 152]	"Kompetenznetz Adipositas" ("Competence Network for Adiposity"); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Commission of the European Communities(European Commission); Munich Center of Health Sciences (McHealth); Deutsche Forschungsgemeinschaft (DFG) for the Clinical Research group "Atherobesity"(German Research Foundation (DFG))	This work was supported financially by the "Kompetenznetz Adipositas" ("Competence Network for Adiposity") funded by the German Federal Ministry of Education and Research (FKZ, grant 01GI0826 and FKZ, grant 01GI1128). Further support by the Commission of the European Communities, within the seventh Framework Programme, NUTRIMENTHE, grant FP7-212652, and by the Munich Center of Health Sciences (McHealth) is gratefully acknowledged. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. This work was additionally supported by a grant from Deutsche Forschungsgemeinschaft (DFG) for the Clinical Research group "Atherobesity" KFO 152 (project BL 833/1-1) (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AH, 2011, DIABETES, V60, P2300, DOI 10.2337/db11-0219; Baylin A, 2002, AM J CLIN NUTR, V76, P750, DOI 10.1093/ajcn/76.4.750; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Caron-Jobin M, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2011.19; Connor WE, 1996, J LIPID RES, V37, P290; Decsi T, 1998, EUR J CLIN NUTR, V52, P541, DOI 10.1038/sj.ejcn.1600607; Frayn KN, 2012, AM J PHYSIOL-ENDOC M, V302, pE468, DOI 10.1152/ajpendo.00527.2011; Garaulet M, 2001, AM J CLIN NUTR, V74, P585; Garaulet M, 2011, NUTRITION, V27, P170, DOI 10.1016/j.nut.2010.01.004; Garland M, 1998, AM J CLIN NUTR, V67, P25, DOI 10.1093/ajcn/67.1.25; Halliwell KJ, 1996, J LIPID RES, V37, P1842; Hellmuth C, 2012, ANAL CHEM, V84, P1483, DOI 10.1021/ac202602u; HIRSCH J, 1960, AM J CLIN NUTR, V8, P499, DOI 10.1093/ajcn/8.4.499; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jensen MD, 2002, J ROY SOC MED, V95, P3; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Klingler M, 2011, LIPIDS, V46, P981, DOI 10.1007/s11745-011-3576-7; Koenker R., 2013, QUANTREG QUANTILE RE; Koutsari C, 2012, DIABETES, V61, P329, DOI 10.2337/db11-0748; Kremmyda LS, 2011, BIOMED PAP, V155, P195, DOI 10.5507/bp.2011.052; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; LEAF DA, 1995, AM J CLIN NUTR, V62, P68, DOI 10.1093/ajcn/62.1.68; MALCOM GT, 1989, AM J CLIN NUTR, V50, P288, DOI 10.1093/ajcn/50.2.288; Mansson Helena Lindmark, 2008, Food Nutr Res, V52, DOI 10.3402/fnr.v52i0.1821; Mittendorfer B, 2003, DIABETES, V52, P1641, DOI 10.2337/diabetes.52.7.1641; Ozogul Y, 2009, INT J FOOD SCI NUTR, V60, P464, DOI [10.1080/09637480701838175, 10.1080/09637480701425650]; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Pettinella C, 2007, J CHROMATOGR B, V850, P168, DOI 10.1016/j.jchromb.2006.11.023; Raclot T, 1997, BIOCHEM J, V324, P911, DOI 10.1042/bj3240911; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sprecher H, 1999, PROSTAG LEUKOTR ESS, V60, P317, DOI 10.1016/S0952-3278(99)80006-4; Sprecher H, 1999, LIPIDS, V34, pS153, DOI 10.1007/BF02562271; Summers LKM, 2000, AM J CLIN NUTR, V71, P1470; Sun Q, 2007, AM J CLIN NUTR, V86, P929, DOI 10.1093/ajcn/86.4.929; Teegala SM, 2009, J AOAC INT, V92, P1250; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; Votruba SB, 2007, DIABETES, V56, P2589, DOI 10.2337/db07-0439; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291; Wolk A, 2001, J NUTR, V131, P828, DOI 10.1093/jn/131.3.828; Xie BG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/805683; Yli-Jama P, 2001, Eur J Intern Med, V12, P107, DOI 10.1016/S0953-6205(01)00119-4	44	43	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74927	10.1371/journal.pone.0074927	http://dx.doi.org/10.1371/journal.pone.0074927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098359	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500017
J	Kowalkowski, MA; Mims, MP; Amiran, ES; Lulla, P; Chiao, EY				Kowalkowski, Marc A.; Mims, Martha P.; Amiran, E. Susan; Lulla, Premal; Chiao, Elizabeth Y.			Effect of Immune Reconstitution on the Incidence of HIV-Related Hodgkin Lymphoma	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; EPSTEIN-BARR-VIRUS; AIDS-DEFINING MALIGNANCIES; UNITED-STATES; CANCER-RISK; IMMUNODEFICIENCY; ERA; EPIDEMIOLOGY; POPULATION; PEOPLE	Background: The incidence of Hodgkin lymphoma (HL) has increased since introduction of combined antiretroviral therapy (cART). While HIV-related HL is highly associated with EBV, the causes underlying the rising incidence remain unclear. The aim of this study was to evaluate the effect of immune reconstitution on HL incidence among a cohort of HIV-infected male veterans ever receiving cART. Methods: We performed a retrospective cohort study utilizing data from the Veterans Affairs HIV Clinical Case Registry from 1985-2010. HL cases were identified using ICD-9 codes (201.4-9). Poisson regression was conducted to evaluate relationships between cART-related immunologic measures (e.g., nadir CD4 before cART, time-updated CD4, % time undetectable HIV RNA) and HL incidence. Additionally, we examined CD4 change after cART initiation. Results: 31,056 cART users contributed 287,256 person-years and 196 HL cases (IR=6.8/10,000 person-years). Rate of CD4 increase after cART was worse among HL cases than non-cases (p<0.05). In multivariate regression, HL risk was elevated among veterans with recent CD4 200-350 cells/mu L (IRR=1.67, 95% CI=1.16-2.40) and <200 cells/mu L (IRR=1.61, 95% CI=1.09-2.39), compared to >350 cells/mu L. HL risk was lower among veterans with >80% time undetectable HIV RNA (IRR=0.57, 95% CI=0.35-0.92) and 40-80% undetectable (IRR=0.68, 95% CI=0.47-0.99), compared to <40% undetectable. HL risk was higher in the first 12 months (IRR=2.02, 95% CI=1.32-3.10) and 12-24 months (IRR=1.75, 95% CI=1.16-2.64) after cART initiation, compared to >36 months. Conclusion: These data highlight immunosuppression and poor viral control may increase HL risk, specifically during immune reconstitution in the interval post cART initiation. Findings suggest an immune reconstitution type mechanism in HIV-related HL development.	[Kowalkowski, Marc A.; Mims, Martha P.; Lulla, Premal; Chiao, Elizabeth Y.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kowalkowski, Marc A.; Chiao, Elizabeth Y.] Michael E DeBakey VA Med Ctr, Houston Hlth Serv Res & Dev Ctr Excellence, Houston, TX USA; [Amiran, E. Susan] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Amiran, E. Susan] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kowalkowski, MA (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	kowalkow@bcm.edu		Chiao, Elizabeth/0000-0001-5752-2916; Kowalkowski, Marc/0000-0003-2624-4209	Houston Health Services Research and Development Center of Excellence [HFP90-020]; Michael E. DeBakey Veterans Affairs Medical Center; Baylor College of Medicine Dan L. Duncan Cancer Center [P30CA125123-04S1]; Baylor-UTHouston Center for AIDS Research (CFAR), NIH [AI036211]; National Cancer Institute [P50CA126752, R01CA163103]; NATIONAL CANCER INSTITUTE [P50CA126752, R01CA163103, P30CA125123] Funding Source: NIH RePORTER	Houston Health Services Research and Development Center of Excellence; Michael E. DeBakey Veterans Affairs Medical Center; Baylor College of Medicine Dan L. Duncan Cancer Center; Baylor-UTHouston Center for AIDS Research (CFAR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by resources and the use of facilities at the Houston Health Services Research and Development Center of Excellence (HFP90-020), Michael E. DeBakey Veterans Affairs Medical Center and the Baylor College of Medicine Dan L. Duncan Cancer Center (P30CA125123-04S1). This research was also supported by the Baylor-UTHouston Center for AIDS Research (CFAR), an NIH-funded program (AI036211). Martha Mims (P50CA126752) and Elizabeth Chiao (R01CA163103) also received support from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus L, 2001, J CLIN EPIDEMIOL, V54, pS12, DOI 10.1016/S0895-4356(01)00442-5; Backus LI, 2009, J AM MED INFORM ASSN, V16, P775, DOI 10.1197/jamia.M3203; Bedimo RJ, 2009, JAIDS-J ACQ IMM DEF, V52, P203, DOI 10.1097/QAI.0b013e3181b033ab; Biggar RJ, 2006, BLOOD, V108, P3786, DOI 10.1182/blood-2006-05-024109; Bohlius J, 2011, BLOOD, V117, P6100, DOI 10.1182/blood-2010-08-301531; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Carbone A, 2009, CURR OPIN HIV AIDS, V4, P3, DOI 10.1097/COH.0b013e32831a722b; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiao EY, 2008, J CLIN ONCOL, V26, P474, DOI 10.1200/JCO.2007.14.2810; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dolcetti R, 2001, EUR J CANCER, V37, P1276, DOI 10.1016/S0959-8049(01)00105-8; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Engels EA, 2009, AIDS, V23, P875, DOI 10.1097/QAD.0b013e328329216a; Friis AMC, 2010, VIRUSES-BASEL, V2, P867, DOI 10.3390/v2040867; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gloghini A, 2007, INT J CANCER, V120, P2753, DOI 10.1002/ijc.22650; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Herida M, 2003, J CLIN ONCOL, V21, P3447, DOI 10.1200/JCO.2003.01.096; Hessol NA, 2007, AM J EPIDEMIOL, V165, P1143, DOI 10.1093/aje/kwm017; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kramer JR, 2005, AM J GASTROENTEROL, V100, P56, DOI 10.1111/j.1572-0241.2005.40670.x; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lanoy E, 2011, BLOOD, V118, P44, DOI 10.1182/blood-2011-02-339275; Levine AM, 2006, BLOOD, V108, P3630, DOI 10.1182/blood-2006-09-047498; Mahnke YD, 2012, BLOOD, V119, P3105, DOI 10.1182/blood-2011-09-380840; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Powles T, 2009, J CLIN ONCOL, V27, P884, DOI 10.1200/JCO.2008.19.6626; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; Righetti E, 2002, AIDS, V16, P63, DOI 10.1097/00002030-200201040-00009; Sereti I, 2010, CURR OPIN HIV AIDS, V5, P504, DOI 10.1097/COH.0b013e32833ed774; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca	36	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77409	10.1371/journal.pone.0077409	http://dx.doi.org/10.1371/journal.pone.0077409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098586	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500100
J	Dominguez, LG; Stieben, J; Velazquez, JLP; Shanker, S				Dominguez, Luis Garcia; Stieben, Jim; Velazquez, Jose Luis Perez; Shanker, Stuart			The Imaginary Part of Coherency in Autism: Differences in Cortical Functional Connectivity in Preschool Children	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; EEG; INDIVIDUALS; COMPLEXITY; POWER	Cognition arises from the transient integration and segregation of activity across functionally distinct brain areas. Autism Spectrum Disorders (ASD), which encompass a wide range of developmental disabilities, have been presumed to be associated with a problem in cortical and sub-cortical dynamics of coordinated activity, often involving enhanced local but decreased long range coordination over areas of integration. In this paper we challenge this idea by presenting results from a relatively large population of ASD children and age-matched controls during a face-processing task. Over most of the explored domain, children with ASD exhibited enhanced synchronization, although finer detail reveals specific enhancement/reduction of synchrony depending on time, frequency and brain site. Our results are derived from the use of the imaginary part of coherency, a measure which is not susceptible to volume conduction artifacts and therefore presents a credible picture of coordinated brain activity. We also present evidence that this measure is a good candidate to provide features in building a classifier to be used as a potential biomarker for autism.	[Dominguez, Luis Garcia] Univ Toronto, Temerty Ctr Therapeut Brain Intervent, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Dominguez, Luis Garcia; Stieben, Jim; Shanker, Stuart] York Univ, Milton & Ethel Harris Res Initiat, Toronto, ON M3J 2R7, Canada; [Velazquez, Jose Luis Perez] Hosp Sick Children, Neurosci & Mental Hlth Programme, Brain & Behaviour Ctr, Div Neurol, Toronto, ON M5G 1X8, Canada; [Velazquez, Jose Luis Perez] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Velazquez, Jose Luis Perez] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; York University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Dominguez, LG (corresponding author), Univ Toronto, Temerty Ctr Therapeut Brain Intervent, Ctr Addict & Mental Hlth, Toronto, ON, Canada.	l.garcia.d@gmail.com; jstieben@sympatico.ca			Harris Steel Foundation; Harris family; Unicorn Foundation; Cure Autism Now; Public Health Agency of Canada; Templeton Foundation; York University; facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET); Compute/Calcul Canada	Harris Steel Foundation; Harris family; Unicorn Foundation; Cure Autism Now; Public Health Agency of Canada; Templeton Foundation; York University; facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET); Compute/Calcul Canada	This research was made possible by the generous support of the Harris Steel Foundation and the Harris family, which made it possible to create the Milton and Ethel Harris Research Initiative (www.mehri.ca). The authors have also received support from the Unicorn Foundation, Cure Autism Now, the Public Health Agency of Canada, the Templeton Foundation, York University, and the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET: www.sharcnet.ca) and Compute/Calcul Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amjad AM, 1997, J NEUROSCI METH, V73, P69, DOI 10.1016/S0165-0270(96)02214-5; Avarvand FS, 2010, FRONT NEUROSCI; Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004; Balconi M, 2009, PHYSIOL BEHAV, V97, P455, DOI 10.1016/j.physbeh.2009.03.023; Bosl W, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-18; Brock J, 2002, DEV PSYCHOPATHOL, V14, P209, DOI 10.1017/S0954579402002018; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Coben R, 2008, CLIN NEUROPHYSIOL, V119, P1002, DOI 10.1016/j.clinph.2008.01.013; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Dominguez LG, 2007, INT J PHYS SCI, V2, P305; Dominguez LG, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/058001; Duffy FH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-64; FEIN G, 1988, ELECTROEN CLIN NEURO, V69, P581, DOI 10.1016/0013-4694(88)90171-X; Fingelkurts AA, 2004, INT J NEUROSCI, V114, P843, DOI 10.1080/00207450490450046; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kayser J., 2009, CURRENT SOURCE DENSI; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Lord C., 1999, AUTISM DIAGNOSTIC OB; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez P.L, 1981, ELECT FIELDS BRAIN N; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Perez Velazquez JL, 2011, BRAIN BEHAV CONTINUU; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Quian Quiroga R, 2002, PHYS REV E, V65, P32; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Velazquez JLP, 2009, INT J PSYCHOPHYSIOL, V73, P341, DOI 10.1016/j.ijpsycho.2009.05.009	38	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75941	10.1371/journal.pone.0075941	http://dx.doi.org/10.1371/journal.pone.0075941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098409	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100028
J	Dai, H; Zhao, Y; Qian, C; Cai, M; Zhang, RY; Chu, MJ; Dai, JC; Hu, ZB; Shen, HB; Chen, F				Dai, Hui; Zhao, Yang; Qian, Cheng; Cai, Min; Zhang, Ruyang; Chu, Minjie; Dai, Juncheng; Hu, Zhibin; Shen, Hongbing; Chen, Feng			Weighted SNP Set Analysis in Genome-Wide Association Study	PLOS ONE			English	Article							MULTIPLE SNPS; SUSCEPTIBILITY; DISEASE; GENE; TESTS; LOCI	Genome-wide association studies (GWAS) are popular for identifying genetic variants which are associated with disease risk. Many approaches have been proposed to test multiple single nucleotide polymorphisms (SNPs) in a region simultaneously which considering disadvantages of methods in single locus association analysis. Kernel machine based SNP set analysis is more powerful than single locus analysis, which borrows information from SNPs correlated with causal or tag SNPs. Four types of kernel machine functions and principal component based approach (PCA) were also compared. However, given the loss of power caused by low minor allele frequencies (MAF), we conducted an extension work on PCA and used a new method called weighted PCA (wPCA). Comparative analysis was performed for weighted principal component analysis (wPCA), logistic kernel machine based test (LKM) and principal component analysis (PCA) based on SNP set in the case of different minor allele frequencies (MAF) and linkage disequilibrium (LD) structures. We also applied the three methods to analyze two SNP sets extracted from a real GWAS dataset of non-small cell lung cancer in Han Chinese population. Simulation results show that when the MAF of the causal SNP is low, weighted principal component and weighted IBS are more powerful than PCA and other kernel machine functions at different LD structures and different numbers of causal SNPs. Application of the three methods to a real GWAS dataset indicates that wPCA and wIBS have better performance than the linear kernel, IBS kernel and PCA.	[Dai, Hui; Zhao, Yang; Qian, Cheng; Cai, Min; Zhang, Ruyang; Chu, Minjie; Dai, Juncheng; Hu, Zhibin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn		Chen, Feng/0000-0002-2699-7190	National Natural Science Foundation of China [NSFC81072389, NSFC30901232]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [11KJA330001, 10KJA33034]; Research Fund for the Doctoral Program of Higher Education of China [2011323411002]; Research and the Innovation Project for College Graduates of Jiangsu Province [CXZZ11_0733]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research and the Innovation Project for College Graduates of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (NSFC81072389 to FC, NSFC30901232 to YZ), Key Grant of Natural Science Foundation of the Jiangsu Higher Education Institutions of China (11KJA330001 and 10KJA33034), the Research Fund for the Doctoral Program of Higher Education of China (2011323411002), the Research and the Innovation Project for College Graduates of Jiangsu Province (CXZZ11_0733) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or prepararion of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Gao QS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-75; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li Ang, 2005, Zhonghua Yi Xue Za Zhi, V85, P2623; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; McKeen HD, 2011, BIOCHEM SOC T, V39, P663, DOI 10.1042/BST0390663; Montana G, 2005, BIOINFORMATICS, V21, P4309, DOI 10.1093/bioinformatics/bti689; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Witte JS, 2010, ANNU REV PUBL HEALTH, V31, P9, DOI 10.1146/annurev.publhealth.012809.103723; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044978; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	25	3	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75897	10.1371/journal.pone.0075897	http://dx.doi.org/10.1371/journal.pone.0075897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098741	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500112
J	Ning, CY; Jiang, JJ; Ye, L; Yang, XB; Wei, B; Deng, W; Wei, SS; Huang, JG; Qin, B; Upur, H; Zhong, CH; Wang, QQ; Wang, Q; Ruan, YH; Wei, FM; Xu, N; Xie, PY; Hsi, JH; Shao, YM; Liang, H				Ning, Chuanyi; Jiang, Junjun; Ye, Li; Yang, Xiaobo; Wei, Bo; Deng, Wei; Wei, Suosu; Huang, Jiegang; Qin, Bo; Upur, Halmurat; Zhong, Chaohui; Wang, Qianqiu; Wang, Qian; Ruan, Yuhua; Wei, Fumei; Xu, Na; Xie, Peiyan; Hsi, Jenny H.; Shao, Yiming; Liang, Hao			Comparison of Three Intervention Models for Promoting Circumcision among Migrant Workers in Western China to Reduce Local Sexual Transmission of HIV	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; POTENTIAL IMPACT; RISK; PREVENTION; TRIAL; METAANALYSIS; INFECTION; PROGRAMS; MEN	Objective: Three models for promoting male circumcision (MC) as a preventative intervention against HIV infection were compared among migrant worker populations in western China. Methods: A cohort study was performed after an initial cross-sectional survey among migrant workers in three provincial level districts with high HIV prevalence in western China. A total of 1,670 HIV seronegative male migrants were cluster-randomized into three intervention models, in which the dissemination of promotional materials and expert-and volunteer-led discussions are conducted in one, two, and three stage interventions. Changes in knowledge of MC, acceptability of MC, MC surgery uptake, and the costs of implementation were analyzed at 6-month and 9-month follow-up visits. Results: All three models significantly increased the participants' knowledge about MC. The three-stage model significantly increased the acceptability of MC among participants and led to greatest increase in MC uptake. At the end of follow-up, 9.2% (153/1,670) of participants underwent MC surgery; uptake among the one-, two-, and three-stage models were 4.9%, 9.3%, and 14.6%, respectively. Multivariable Cox regression analysis showed that three-stage model was the most effective method to scale up MC, with RR = 2.0 (95% CI, 1.3-3.1, P=0.002) compared to the on-site session model. The two-stage intervention model showed no significant difference with either the on-site session model (RR=1.5, 95% CI, 0.92-2.4, P=0.12) or three-stage model (P=0.10). Conclusions: A three-stage intervention with gradual introduction of knowledge led to the significantly increase in MC uptake among migrant workers in western China, and was also the most cost-effective method among the three models.	[Ning, Chuanyi; Jiang, Junjun; Ye, Li; Yang, Xiaobo; Wei, Bo; Deng, Wei; Wei, Suosu; Huang, Jiegang; Wei, Fumei; Xu, Na; Xie, Peiyan; Shao, Yiming; Liang, Hao] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Ning, Chuanyi; Jiang, Junjun; Ye, Li; Yang, Xiaobo; Huang, Jiegang; Wei, Fumei; Xu, Na; Xie, Peiyan; Liang, Hao] Guangxi Med Univ, Guangxi Key Lab AIDS Prevent & Treatment, Nanning, Guangxi, Peoples R China; [Qin, Bo] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Upur, Halmurat; Wang, Qian] Xinjiang Med Univ, Sch Publ Hlth, Urumqi, Xinjiang, Peoples R China; [Zhong, Chaohui] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China; [Wang, Qianqiu] Chinese Ctr Dis Control & Prevent, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China; [Ruan, Yuhua; Hsi, Jenny H.; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Ruan, Yuhua; Hsi, Jenny H.; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China	Guangxi Medical University; Guangxi Medical University; Chongqing Medical University; Xinjiang Medical University; Chongqing Medical University; Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Shao, YM (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China.	yshao08@gmail.com; haolphd@163.com	Ning, Chuanyi/AAF-5601-2020; Ning, Chuanyi/B-4120-2016; Jiang, Junjun/AAH-9095-2020; Yang, Xiaobo/G-3854-2016	Ning, Chuanyi/0000-0002-8748-2780; Ning, Chuanyi/0000-0002-8748-2780; 	National Key Science and Technology Project [2008ZX10001-016]; Guangxi Natural Science Foundation [2010GXNSFD013045]; Program for Innovative Research Team of Intellectual Highland in Guangxi Universities [Guijiaoren [2010] 38]	National Key Science and Technology Project; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Program for Innovative Research Team of Intellectual Highland in Guangxi Universities	The study was supported by National Key Science and Technology Project (Grant Number 2008ZX10001-016), Guangxi Natural Science Foundation (2010GXNSFD013045,http://gxnsf.gxsti.net), Program for Innovative Research Team of Intellectual Highland in Guangxi Universities (Guijiaoren [2010] 38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KM, 2011, AIDS BEHAV, V15, P938, DOI 10.1007/s10461-010-9784-y; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Ben Kun-Long, 2009, Zhonghua Nan Ke Xue, V15, P395; Ben Kun-Long, 2008, Zhonghua Nan Ke Xue, V14, P291; Council of State, 2006, NOT DISTR CHIN ACT P; Division of Policy Research and Information NCAIDS China CDC, 2011, END AN DAT HIV EP RE; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Meng XJ, 2011, BIOMED ENVIRON SCI, V24, P343, DOI 10.3967/0895-3988.2011.04.004; Ministry of Health of China UNAIDS WHO, 2010, EST HIV AIDS CHIN 20; Mshana G, 2011, AIDS CARE, V23, P1111, DOI 10.1080/09540121.2011.554518; National Bureau of Statistics of China, 2012, ON REP MIGR WORK CHI; Rou KM, 2010, INT J EPIDEMIOL, V39, pII38, DOI 10.1093/ije/dyq211; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198; Zang CP, 2011, CHINESE MED J-PEKING, V124, P1890, DOI 10.3760/cma.j.issn.0366-6999.2011.12.022; Zhuang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031986	25	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76107	10.1371/journal.pone.0076107	http://dx.doi.org/10.1371/journal.pone.0076107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098770	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500140
J	Ruff, SE; Arnds, J; Knittel, K; Amann, R; Wegener, G; Ramette, A; Boetius, A				Ruff, S. Emil; Arnds, Julia; Knittel, Katrin; Amann, Rudolf; Wegener, Gunter; Ramette, Alban; Boetius, Antje			Microbial Communities of Deep-Sea Methane Seeps at Hikurangi Continental Margin (New Zealand)	PLOS ONE			English	Article							MOSBY MUD VOLCANO; IN-SITU HYBRIDIZATION; COLD SEEP; ANAEROBIC METHANOTROPHS; BACTERIAL DIVERSITY; SULFATE REDUCTION; IDENTIFICATION; OXIDATION; HABITATS; BIOGEOCHEMISTRY	The methane-emitting cold seeps of Hikurangi margin (New Zealand) are among the few deep-sea chemosynthetic ecosystems of the Southern Hemisphere known to date. Here we compared the biogeochemistry and microbial communities of a variety of Hikurangi cold seep ecosystems. These included highly reduced seep habitats dominated by bacterial mats, partially oxidized habitats populated by heterotrophic ampharetid polychaetes and deeply oxidized habitats dominated by chemosynthetic frenulate tubeworms. The ampharetid habitats were characterized by a thick oxic sediment layer that hosted a diverse and biomass-rich community of aerobic methanotrophic Gammaproteobacteria. These bacteria consumed up to 25% of the emanating methane and clustered within three deep-branching groups named Marine Methylotrophic Group (MMG) 1-3. MMG1 and MMG2 methylotrophs belong to the order Methylococcales, whereas MMG3 methylotrophs are related to the Methylophaga. Organisms of the groups MMG1 and MMG3 are close relatives of chemosynthetic endosymbionts of marine invertebrates. The anoxic sediment layers of all investigated seeps were dominated by anaerobic methanotrophic archaea (ANME) of the ANME-2 clade and sulfate-reducing Deltaproteobacteria. Microbial community analysis using Automated Ribosomal Intergenic Spacer Analysis (ARISA) showed that the different seep habitats hosted distinct microbial communities, which were strongly influenced by the seep-associated fauna and the geographic location. Despite outstanding features of Hikurangi seep communities, the organisms responsible for key ecosystem functions were similar to those found at seeps worldwide. This suggests that similar types of biogeochemical settings select for similar community composition regardless of geographic distance. Because ampharetid polychaetes are widespread at cold seeps the role of aerobic methanotrophy may have been underestimated in seafloor methane budgets.	[Ruff, S. Emil; Wegener, Gunter; Ramette, Alban; Boetius, Antje] Max Planck Inst Marine Mikrobiol, HGF MPG Grp Deep Sea Ecol & Technol, D-28359 Bremen, Germany; [Ruff, S. Emil; Arnds, Julia; Knittel, Katrin; Amann, Rudolf] Max Planck Inst Marine Mikrobiol, Dept Mol Ecol, D-28359 Bremen, Germany; [Wegener, Gunter; Boetius, Antje] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Boetius, Antje] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany	Max Planck Society; Max Planck Society; University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Ruff, SE (corresponding author), Max Planck Inst Marine Mikrobiol, HGF MPG Grp Deep Sea Ecol & Technol, D-28359 Bremen, Germany.	eruff@mpi-bremen.de	Boetius, Antje/D-5459-2013; Ramette, Alban/E-9197-2016; Ruff, Emil/H-4249-2019; Amann, Rudolf I/C-6534-2014	Boetius, Antje/0000-0003-2117-4176; Ramette, Alban/0000-0002-3437-4639; Ruff, Emil/0000-0002-6872-6188; Amann, Rudolf I/0000-0002-0846-7372; Wegener, Gunter/0000-0002-6819-373X	German Ministry of Education and Research [03G0608A]; Max Planck Society; DFG Leibniz program	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG Leibniz program(German Research Foundation (DFG))	Cruise SO191 was part of the COMET/MUMM II project within the program GEOTECHNOLOGIEN funded by the German Ministry of Education and Research (Grant No: 03G0608A). Further support was provided by the Max Planck Society, and by the DFG Leibniz program to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNDS J, 2009, MOL CHARACTERIZATION, P158; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; BIALAS J, 2007, SO LEIBN I MAR SCI F, P190; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Carlier A, 2010, MAR BIOL, V157, P2545, DOI 10.1007/s00227-010-1518-1; CHAO A, 1984, SCAND J STAT, V11, P265; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Degelmann DM, 2010, APPL ENVIRON MICROB, V76, P3228, DOI 10.1128/AEM.02730-09; Felden J, 2010, LIMNOL OCEANOGR, V55, P2366, DOI 10.4319/lo.2010.55.6.2366; FELDEN J, 2013, BIOGEOSCIENCES DISCU, V10, P335, DOI DOI 10.5194/BGD-10-335-2013; Fischer D., 2011, BIOGEOSCIENCES DISCU, V8, P9763, DOI DOI 10.5194/BGD-8-9763-2011; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Greinert J, 2010, MAR GEOL, V272, P6, DOI 10.1016/j.margeo.2010.01.017; Grunke S, 2012, BIOGEOSCIENCES, V9, P2947, DOI 10.5194/bg-9-2947-2012; Hamdan LJ, 2011, FEMS MICROBIOL ECOL, V77, P518, DOI 10.1111/j.1574-6941.2011.01133.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hankeln W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024797; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HAYASHI T, 2007, RES J ENV SCI, V1, P275, DOI DOI 10.3923/RJES.2007.275.284; Hewson I, 2006, MICROB ECOL, V51, P147, DOI 10.1007/s00248-005-0144-9; Hewson I, 2007, ENVIRON MICROBIOL, V9, P923, DOI 10.1111/j.1462-2920.2006.01214.x; Inagaki F, 2004, APPL ENVIRON MICROB, V70, P7445, DOI 10.1128/AEM.70.12.7445-7455.2004; Ishii K, 2004, FEMS MICROBIOL ECOL, V50, P203, DOI 10.1016/j.femsec.2004.06.015; Jones AT, 2010, MAR GEOL, V272, P154, DOI 10.1016/j.margeo.2009.03.008; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P657, DOI 10.4319/lo.1977.22.4.0657; Jorgensen BB, 2001, DEEP-SEA RES PT I, V48, P2097, DOI 10.1016/S0967-0637(01)00007-3; JUKES TH, 1969, EVOLUTION PROTEIN MO, P566; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; KIMURA M, 1983, NEUTRAL THEORY MOL E, P369; Klaucke I, 2010, MAR GEOL, V272, P49, DOI 10.1016/j.margeo.2009.02.009; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Krabbenhoeft A, 2010, MAR GEOL, V272, P71, DOI 10.1016/j.margeo.2009.08.001; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Levin LA, 2007, MAR ECOL-EVOL PERSP, V28, P131, DOI 10.1111/j.1439-0485.2006.00131.x; Lewis KB, 1996, NEW ZEAL J GEOL GEOP, V39, P181, DOI 10.1080/00288306.1996.9514704; Lichtschlag A, 2010, LIMNOL OCEANOGR, V55, P931, DOI 10.4319/lo.2009.55.2.0931; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Naudts L, 2010, MAR GEOL, V272, P233, DOI 10.1016/j.margeo.2009.08.002; Thang NM, 2013, ESTUAR COAST, V36, P98, DOI 10.1007/s12237-012-9557-0; Niemann H, 2009, BIOGEOSCIENCES, V6, P2383, DOI 10.5194/bg-6-2383-2009; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pruesse E, 2012, BIOINFORMATICS; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; RIDGWAY N M, 1969, New Zealand Journal of Marine and Freshwater Research, V3, P57; Ristova PP, 2012, BIOGEOSCIENCES, V9, P5031, DOI 10.5194/bg-9-5031-2012; Roalkvam I, 2011, FEMS MICROBIOL ECOL, V78, P233, DOI 10.1111/j.1574-6941.2011.01153.x; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Sellanes J, 2008, ICES J MAR SCI, V65, P1102, DOI 10.1093/icesjms/fsn099; Sommer S, 2010, MAR GEOL, V272, P223, DOI 10.1016/j.margeo.2009.06.003; Tavormina PL, 2008, APPL ENVIRON MICROB, V74, P3985, DOI 10.1128/AEM.00069-08; Thurber AR, 2010, MAR GEOL, V272, P260, DOI 10.1016/j.margeo.2009.06.001; Urakawa H, 2000, ENVIRON MICROBIOL, V2, P542, DOI 10.1046/j.1462-2920.2000.00137.x; Villeneuve C, 2012, J BACTERIOL, V194, P4126, DOI 10.1128/JB.00726-12; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Wegener G, 2008, BIOGEOSCIENCES, V5, P1127, DOI 10.5194/bg-5-1127-2008; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	73	57	60	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e72627	10.1371/journal.pone.0072627	http://dx.doi.org/10.1371/journal.pone.0072627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098632	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500004
J	Schaumberg, DA; Uchino, M; Christen, WG; Semba, RD; Buring, JE; Li, JZ				Schaumberg, Debra A.; Uchino, Miki; Christen, William G.; Semba, Richard D.; Buring, Julie E.; Li, Jim Z.			Patient Reported Differences in Dry Eye Disease between Men and Women: Impact, Management, and Patient Satisfaction	PLOS ONE			English	Article							WORKSHOP 2007; CARDIOVASCULAR-DISEASE; PHYSICIANS HEALTH; BETA-CAROTENE; HIGH-ALTITUDE; PREVALENCE; SUBCOMMITTEE; POPULATION; VALIDATION; THERAPY	Purpose: Dry eye disease affects women twice as often as men, but there is little information on whether dry eye treatments, treatment satisfaction, or the impact of dry eye disease on patients' lives and vision might differ by sex. Design: Questionnaire survey of 4000 participants in the Women's Health Study and the Physicians' Health Studies I and II with a prior report of a diagnosis of DED. Methods: Among participants who re-confirmed a diagnosis of dry eye disease, we assessed symptoms, treatments, patient satisfaction and impact of dry eye disease, and analyzed differences between men and women using regression models. Results: The final study population consisted of 1,518 women (mean age 70.7 years) and 581 men (mean age 76.7 years), with a mean reported duration of dry eye disease of 10.5 years and 10.1 years, respectively. The frequency and severity of dry eye disease symptoms were higher among women (each P<0.0001), and women reported a greater impact on everyday activities (P<0.0001). Women were more likely to use artificial tears (P<0.0001) use them more often (P<0.0001), and to use Restasis (R) (P<0.0001), omega-3 fatty acids (P=0.0006), and have punctal occlusion (P=0.005). Women spent more money per month on dry eye treatments (P<0.0001), but reported greater dissatisfaction with treatment side effects (P=0.001), and the amount of time before treatments started working (P=0.03). Conclusions: These data show that dry eye disease is generally experienced as being more severe among women, having a greater impact on their self-assessed well-being.	[Schaumberg, Debra A.; Christen, William G.; Semba, Richard D.; Buring, Julie E.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA; [Schaumberg, Debra A.] Univ Utah, Dept Ophthalmol & Visual Sci, Ctr Translat Med, John A Moran Eye Ctr,Sch Med, Salt Lake City, UT USA; [Schaumberg, Debra A.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA USA; [Schaumberg, Debra A.; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Uchino, Miki] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Semba, Richard D.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Li, Jim Z.] Pfizer Inc, Global Outcomes Res, San Diego, CA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Keio University; Johns Hopkins University; Johns Hopkins Medicine; Pfizer	Schaumberg, DA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA.	debra.schaumberg@utah.edu	Uchino, Miki/T-9102-2019		Pfizer, Inc.; National Institutes of Health (NIH) [CA40360, CA47988, HL43851]; NATIONAL CANCER INSTITUTE [R01CA047988, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	Pfizer, Inc.(Pfizer); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was sponsored by Pfizer, Inc. Follow-up of the Physicians' Health Study cohort is supported by National Institutes of Health (NIH) grant CA40360, and the Women's Health Study by NIH grants CA47988 and HL43851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Gulati A, 2006, AM J OPHTHALMOL, V142, P125, DOI 10.1016/j.ajo.2006.02.038; Guo B, 2010, OPHTHAL EPIDEMIOL, V17, P234, DOI 10.3109/09286586.2010.498659; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Lee AJ, 2002, BRIT J OPHTHALMOL, V86, P1347, DOI 10.1136/bjo.86.12.1347; Lemp MA, 2007, OCUL SURF, V5, P75; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Lu P, 2008, CORNEA, V27, P545, DOI 10.1097/ICO.0b013e318165b1b7; Miljanovic B, 2005, AM J CLIN NUTR, V82, P887, DOI 10.1093/ajcn/82.4.887; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Pflugfelder SC, 2007, OCUL SURF, V5, P163; Popescu A, 2010, PAIN, V150, P309, DOI 10.1016/j.pain.2010.05.013; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2001, JAMA-J AM MED ASSOC, V286, P2114, DOI 10.1001/jama.286.17.2114; Schaumberg DA, 2007, OCUL SURF, V5, P50, DOI 10.1016/S1542-0124(12)70053-8; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Smith JA, 2007, OCUL SURF, V5, P93; Uchino M, 2008, AM J OPHTHALMOL, V146, P925, DOI 10.1016/j.ajo.2008.06.030; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022	23	80	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76121	10.1371/journal.pone.0076121	http://dx.doi.org/10.1371/journal.pone.0076121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098772	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500142
J	Schuetz, JM; Daley, D; Leach, S; Conde, L; Berry, BR; Gallagher, RP; Connors, JM; Gascoyne, RD; Bracci, PM; Skibola, CF; Spinelli, JJ; Brooks-Wilson, AR				Schuetz, Johanna M.; Daley, Denise; Leach, Stephen; Conde, Lucia; Berry, Brian R.; Gallagher, Richard P.; Connors, Joseph M.; Gascoyne, Randy D.; Bracci, Paige M.; Skibola, Christine F.; Spinelli, John J.; Brooks-Wilson, Angela R.			Non-Hodgkin Lymphoma Risk and Variants in Genes Controlling Lymphocyte Development	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GERMLINE VARIATION; MISMATCH REPAIR; EARLY-ONSET; NEUROFIBROMATOSIS; SUSCEPTIBILITY; POLYMORPHISMS; INSTABILITY; EXPRESSION; APOPTOSIS	Non-Hodgkin lymphomas (NHL) are a heterogeneous group of solid tumours of lymphoid cell origin. Three important aspects of lymphocyte development include immunity and inflammation, DNA repair, and programmed cell death. We have used a previously established case-control study of NHL to ask whether genetic variation in genes involved in these three important processes influences risk of this cancer. 118 genes in these three categories were tagged with single nucleotide polymorphisms (SNPs), which were tested for association with NHL and its subtypes. The main analysis used logistic regression (additive model) to estimate odds ratios in European-ancestry cases and controls. 599 SNPs and 1116 samples (569 cases and 547 controls) passed quality control measures and were included in analyses. Following multiple-testing correction, one SNP in MSH3, a mismatch repair gene, showed an association with diffuse large B-cell lymphoma (OR: 1.91; 95% CI: 1.41-2.59; uncorrected p = 0.00003; corrected p = 0.010). This association was not replicated in an independent European-ancestry sample set of 251 diffuse large B-cell lymphoma cases and 737 controls, indicating this result was likely a false positive. It is likely that moderate sample size, inter-subtype and other genetic heterogeneity, and small true effect sizes account for the lack of replicable findings.	[Schuetz, Johanna M.; Leach, Stephen; Brooks-Wilson, Angela R.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Daley, Denise] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Conde, Lucia; Skibola, Christine F.] Univ Alabama Birmingham, Ctr Comprehens Canc, Dept Epidemiol, Birmingham, AL 35294 USA; [Berry, Brian R.] Royal Jubilee Hosp, Dept Pathol, Victoria, BC, Canada; [Gallagher, Richard P.; Spinelli, John J.] BC Canc Agcy, Vancouver, BC, Canada; [Connors, Joseph M.] BC Canc Agcy, Div Med Oncol, Vancouver, BC, Canada; [Connors, Joseph M.; Gascoyne, Randy D.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Gascoyne, Randy D.] BC Canc Agcy, Dept Pathol, Vancouver, BC, Canada; [Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of British Columbia; University of Alabama System; University of Alabama Birmingham; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of California System; University of California San Francisco; University of British Columbia; Simon Fraser University	Brooks-Wilson, AR (corresponding author), BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	abrooks-wilson@bcgsc.ca	Brooks-Wilson, Angela/E-9399-2012; Gascoyne, Randy D/A-6009-2013; Conde, Lucia/D-9295-2011; Spinelli, John J./B-6210-2013; Connors, Joseph/AAF-5284-2019	Brooks-Wilson, Angela/0000-0003-1009-6408; Gascoyne, Randy D/0000-0002-2610-5690; Spinelli, John J./0000-0002-9119-3287; Connors, Joseph/0000-0002-1361-7531; Conde, Lucia/0000-0001-5180-543X	Canadian Institutes for Health Research (CIHR); Canadian Cancer Society; National Institutes of Health, National Cancer Institute [R01CA87014, R03CA143947, R03CA150037, R01CA104682, RO1CA122663, RO1CA154643]; NATIONAL CANCER INSTITUTE [R03CA150037, R01CA104682, R03CA143947, R01CA087014, R01CA154643, R01CA122663] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) and the Canadian Cancer Society. DD holds a Tier II Canada Research Chair (Genetic Epidemiology of Common Complex Diseases). AB-W is a Senior Scholar, and DD and JG are Scholars of the Michael Smith Foundation for Health Research. For the UCSF study, CFS and PMB have support from the National Institutes of Health, National Cancer Institute (R01CA87014, R03CA143947, R03CA150037, R01CA104682, RO1CA122663, RO1CA154643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bajdik CD, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-17; Bandipalliam P, 2005, FAM CANCER, V4, P323, DOI 10.1007/s10689-005-8351-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; CALVERT R, 1995, LANCET, V345, P26, DOI 10.1016/S0140-6736(95)91154-5; Campbell MR, 2005, CANCER RES, V65, P2626, DOI 10.1158/0008-5472.CAN-04-3158; Cerhan JR, 2008, CANCER EPIDEM BIOMAR, V17, P3161, DOI 10.1158/1055-9965.EPI-08-0536; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; INOKUCHI K, 1995, BIOCHEM BIOPH RES CO, V214, P171, DOI 10.1006/bbrc.1995.2271; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Kelly JL, 2010, CANCER EPIDEM BIOMAR, V19, P2847, DOI 10.1158/1055-9965.EPI-10-0581; Morton LM, 2009, CANCER EPIDEM BIOMAR, V18, P1259, DOI 10.1158/1055-9965.EPI-08-1037; Nagy M, 2000, LEUKEMIA, V14, P2142, DOI 10.1038/sj.leu.2401978; Ostergaard JR, 2005, AM J MED GENET A, V139A, P96, DOI 10.1002/ajmg.a.30998; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Schuetz JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031560; Schuetz JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-117; Skibola CF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002816; Spinelli JJ, 2007, INT J CANCER, V121, P2767, DOI 10.1002/ijc.23005; Tan A, 2011, BIOINFORMATICS, V27, P2422, DOI 10.1093/bioinformatics/btr389; Trimbath J D, 2001, Fam Cancer, V1, P101; Volpe G, 1996, ANN HEMATOL, V72, P67, DOI 10.1007/BF00641310; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75170	10.1371/journal.pone.0075170	http://dx.doi.org/10.1371/journal.pone.0075170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098683	gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500054
J	Tan, K; Hu, ZW; Chen, WW; Wang, ZW; Wang, YC; Nieh, JC				Tan, Ken; Hu, Zongwen; Chen, Weiwen; Wang, Zhengwei; Wang, Yuchong; Nieh, James C.			Fearful Foragers: Honey Bees Tune Colony and Individual Foraging to Multi-Predator Presence and Food Quality	PLOS ONE			English	Article							CRAB SPIDERS; TOP-DOWN; TROPHIC CASCADES; ECOLOGY; CHOICE; RISK; ANTIPREDATOR; POLLINATORS; HYMENOPTERA; BEHAVIOR	Fear can have strong ecosystem effects by giving predators a role disproportionate to their actual kill rates. In bees, fear is shown through foragers avoiding dangerous food sites, thereby reducing the fitness of pollinated plants. However, it remains unclear how fear affects pollinators in a complex natural scenario involving multiple predator species and different patch qualities. We studied hornets, Vespa velutina (smaller) and V. tropica (bigger) preying upon the Asian honey bee, Apis cerana in China. Hornets hunted bees on flowers and were attacked by bee colonies. Bees treated the bigger hornet species (which is 4 fold more massive) as more dangerous. It received 4.5 fold more attackers than the smaller hornet species. We tested bee responses to a three-feeder array with different hornet species and varying resource qualities. When all feeders offered 30% sucrose solution (w/w), colony foraging allocation, individual visits, and individual patch residence times were reduced according to the degree of danger. Predator presence reduced foraging visits by 55-79% and residence times by 17-33%. When feeders offered different reward levels (15%, 30%, or 45% sucrose), colony and individual foraging favored higher sugar concentrations. However, when balancing food quality against multiple threats (sweeter food corresponding to higher danger), colonies exhibited greater fear than individuals. Colonies decreased foraging at low and high danger patches. Individuals exhibited less fear and only decreased visits to the high danger patch. Contrasting individual with emergent colony-level effects of fear can thus illuminate how predators shape pollination by social bees.	[Tan, Ken] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Tan, Ken; Hu, Zongwen; Chen, Weiwen; Wang, Zhengwei; Wang, Yuchong] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Peoples R China; [Nieh, James C.] Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Agricultural University; University of California System; University of California San Diego	Tan, K (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	kentan@xtbg.ac.cn	Nieh, James C/H-8705-2014	Nieh, James C/0000-0001-6237-0726	Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden; Chinese Academy of Science [XTBG-T01]; China National Research Fund [31260585]	Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden; Chinese Academy of Science(Chinese Academy of Sciences); China National Research Fund	This work was supported by the Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, and the CAS 135 program (XTBG-T01) of Chinese Academy of Science, China National Research Fund (31260585) to Ken Tan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; Abrol Dharam Pal, 2006, Journal of Apicultural Science, V50, P39; Anderson C, 1999, BEHAV ECOL SOCIOBIOL, V46, P73, DOI 10.1007/s002650050595; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Borrell BJ, 2006, J EXP BIOL, V209, P4901, DOI 10.1242/jeb.02593; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Buchmann S.L., 1997, FORGOTTEN POLLINATOR; Burgett M., 1982, Psyche (Cambridge), V89, P347, DOI 10.1155/1982/37970; COLINVAUX P, 1978, WHY BIG FIERCE ANIMA; Corlett RT, 2001, J TROP ECOL, V17, P155, DOI 10.1017/S0266467401001109; Dukas R, 2005, ECOLOGY, V86, P1401, DOI 10.1890/04-1663; Dukas R, 2005, ECOSCIENCE, V12, P244, DOI 10.2980/i1195-6860-12-2-244.1; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Guan Huang Y, 2005, ACTA ENTOMOLOGICA SI, V3; Hanna C, 2013, J APPL ECOL, V50, P147, DOI 10.1111/1365-2664.12027; Higginson AD, 2010, OECOLOGIA, V164, P411, DOI 10.1007/s00442-010-1681-6; Hilton GM, 1999, OIKOS, V87, P295, DOI 10.2307/3546744; IVES AR, 1987, AM NAT, V130, P431, DOI 10.1086/284719; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Jones EI, 2011, BEHAV ECOL SOCIOBIOL, V65, P1505, DOI 10.1007/s00265-011-1160-z; Kim W, 2011, P NATL ACAD SCI USA, V108, P16618, DOI 10.1073/pnas.1108642108; Kingsolver J.G., 1995, P32; Knight TM, 2006, ECOL LETT, V9, P1173, DOI 10.1111/j.1461-0248.2006.00967.x; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Lehman A., 2005, JMP BASIC UNIVARIATE; LIMA SL, 1992, ANN ZOOL FENN, V29, P217; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Matsuura M., 1990, BIOL VESPINE WASPS; MORSE DH, 1986, AM MIDL NAT, V116, P341, DOI 10.2307/2425742; MORSE DH, 1979, OECOLOGIA, V39, P309, DOI 10.1007/BF00345442; MORSE DH, 1986, OIKOS, V46, P223, DOI 10.2307/3565470; MORSE DH, 1982, ECOLOGY, V63, P172, DOI 10.2307/1937042; Nieh JC, 2004, APIDOLOGIE, V35, P159, DOI 10.1051/apido:2004007; NONACS P, 1990, ECOLOGY, V71, P1886, DOI 10.2307/1937596; Partap U, 2011, HONEYBEES OF ASIA, P227, DOI 10.1007/978-3-642-16422-4_11; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Ranabhat N. B., 2009, J NATURAL HIST MUSEU, V23, P125, DOI DOI 10.3126/JNHM.V23I0.1849; Reader T, 2006, BEHAV ECOL, V17, P933, DOI 10.1093/beheco/arl027; Riginos C, 2008, ECOLOGY, V89, P2228, DOI 10.1890/07-1250.1; Robertson IC, 2005, OIKOS, V109, P577, DOI 10.1111/j.0030-1299.2005.13903.x; Romero GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020689; ROUBIK DW, 1984, OECOLOGIA, V61, P1, DOI 10.1007/BF00379082; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; Shurin JB, 2012, PHILOS T R SOC B, V367, P3008, DOI 10.1098/rstb.2012.0243; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Suttle KB, 2003, ECOL LETT, V6, P688, DOI 10.1046/j.1461-0248.2003.00490.x; Tan K, 2008, NATURWISSENSCHAFTEN, V95, P1165, DOI 10.1007/s00114-008-0437-1; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Tan K, 2012, APIDOLOGIE, V43, P195, DOI 10.1007/s13592-011-0098-5; Tepedino VJ, 1980, GREAT BASIN NAT, V3, P139; THOMSON JD, 1989, CAN J ZOOL, V67, P2588, DOI 10.1139/z89-364; WADDINGTON KD, 1990, J INSECT BEHAV, V3, P429, DOI 10.1007/BF01052010; WELLS P H, 1968, Journal of Apicultural Research, V7, P77; Wendorf CA, 2012, STAT APA STYLE STA 4, P1; Wilby A, 2010, APPL MICROBIOL BIOT, V87, P87, DOI [10.1007/s00253-010-2573-8, DOI 10.1007/S00253-010-2573-8]; Wilson EE, 2010, ECOLOGY, V91, P3294, DOI 10.1890/09-1187.1; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	70	28	30	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75841	10.1371/journal.pone.0075841	http://dx.doi.org/10.1371/journal.pone.0075841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098734	gold, Green Published			2022-12-27	WOS:000325423500105
J	Wright-Williams, S; Flecknell, PA; Roughan, JV				Wright-Williams, Sian; Flecknell, Paul A.; Roughan, Johnny V.			Comparative Effects of Vasectomy Surgery and Buprenorphine Treatment on Faecal Corticosterone Concentrations and Behaviour Assessed by Manual and Automated Analysis Methods in C57 and C3H Mice	PLOS ONE			English	Article							POSTOPERATIVE PAIN; LABORATORY MOUSE; 2 STRAINS; RATS; LAPAROTOMY; CARPROFEN; NOCICEPTION; ANALGESIA; MELOXICAM; RECOVERY	Establishing effective cage-side pain assessment methods is essential if post-surgical pain is to be controlled effectively in laboratory animals. Changes to overall activity levels are the most common methods of assessment, but may not be the most appropriate for establishing the analgesic properties of drugs, especially in mice, due their high activity levels. Use of drugs that can affect activity (e.g. opioids) is also a problem. The relative merits of both manual and automated behaviour data collection methods was determined in two inbred mouse strains undergoing vasectomy following treatment with one of 2 buprenorphine dose rates. Body weights and the effects of surgery and buprenorphine on faecal corticosterone were also measured. Surgery caused abnormal behaviour and reduced activity levels, but high dose buprenorphine caused such large-scale increases in activity in controls that we could not establish analgesic effects in surgery groups. Only pain-specific behaviour scoring using the manual approach was effective in showing 0.05 mg/kg buprenorphine alleviated post-vasectomy pain. The C57 mice also responded better to buprenorphine than C3H mice, indicating they were either less painful, or more responsive to its analgesic effects. C3H mice were more susceptible to the confounding effects of buprenorphine irrespective of whether data were collected manually or via the automated approach. Faecal corticosterone levels, although variable, were higher in untreated surgery mice than in control groups, also indicating the presence of pain or distress. Pain-specific scoring was superior to activity monitoring for assessing the analgesic properties of buprenorphine in vasectomised mice. Buprenorphine (0.01 mg/kg), in these strains of male mice, for this procedure, provided inadequate analgesia and although 0.05 mg/kg was more effective, not completely so. The findings support the recommendation that analgesic dose rates should be adjusted in relation to the potential severity of the surgical procedure, the mouse strain, and the individual animals' response.	[Wright-Williams, Sian; Flecknell, Paul A.; Roughan, Johnny V.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Roughan, JV (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	j.v.roughan@ncl.ac.uk	Roughan, John Vincent/AAF-3586-2021	Roughan, John Vincent/0000-0002-0031-3918; Flecknell, Paul/0000-0002-1075-1129	Pfizer; BBSRC; UK NC3Rs	Pfizer(Pfizer); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))	The work was supported by Pfizer and BBSRC via an Industrial CASE award. Johnny Roughan was sponsored by the UK NC3Rs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson TW, 2010, J AM ASSOC LAB ANIM, V49, P610; Arras Margarete, 2007, BMC Vet Res, V3, P16, DOI 10.1186/1746-6148-3-16; Chappell MG, 2011, J AM ASSOC LAB ANIM, V50, P227; Christoph T, 2005, EUR J PHARMACOL, V507, P87, DOI 10.1016/j.ejphar.2004.11.052; Clark MD, 2004, COMPARATIVE MED, V54, P558; COWAN A, 1977, BRIT J PHARMACOL, V60, P547, DOI 10.1111/j.1476-5381.1977.tb07533.x; Dickinson AL, 2009, LAB ANIM-UK, V43, P357, DOI 10.1258/la.2009.009005; Elmer GI, 1998, PAIN, V75, P129, DOI 10.1016/S0304-3959(97)00215-7; Goldkuhl R, 2010, LAB ANIM-UK, V44, P337, DOI 10.1258/la.2010.009115; Hayes KE, 2000, CONTEMP TOP LAB ANIM, V39, P18; Jirkof P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00165; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Matsumiya LC, 2012, J AM ASSOC LAB ANIM, V51, P42; Miller AL, 2012, LAB ANIM-UK, V46, P304, DOI 10.1258/la.2012.012078; Miller AL, 2011, APPL ANIM BEHAV SCI, V131, P138, DOI 10.1016/j.applanim.2011.02.007; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Roughan JV, 2009, LAB ANIM-UK, V43, P17, DOI 10.1258/la.2008.007156; Roughan JV, 2006, APPL ANIM BEHAV SCI, V96, P327, DOI 10.1016/j.applanim.2005.06.012; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2000, RES VET SCI, V69, P283, DOI 10.1053/rvsc.2000.0430; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Siswanto H, 2008, IN VIVO, V22, P435; Tubbs JT, 2011, J AM ASSOC LAB ANIM, V50, P185; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003	26	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75948	10.1371/journal.pone.0075948	http://dx.doi.org/10.1371/journal.pone.0075948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098748	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500118
J	Scheuplein, F; Thariath, A; Macdonald, S; Truneh, A; Mashal, R; Schaub, R				Scheuplein, Felix; Thariath, Abraham; Macdonald, Susan; Truneh, Alemseged; Mashal, Robert; Schaub, Robert			A Humanized Monoclonal Antibody Specific for Invariant Natural Killer T (iNKT) Cells for In Vivo Depletion	PLOS ONE			English	Article							NKT CELLS; PULMONARY INFLAMMATION; ACTIVATION; DISEASE; RECOVERY; INJURY	Invariant Natural Killer T (iNKT) cells are a subset of T cells recognizing glycolipid antigens presented by CD1d. Human iNKT cells express a conserved T cell receptor (TCR)-alpha chain (V alpha 24-J alpha 18) paired with a specific beta chain, V beta 11. The cells are both innate-like, with rapid cytokine release, and adaptive-like, including thymic positive selection. Over activation of iNKT cells can mediate tissue injury and inflammation in multiple organ systems and play a role in mediating the pathology associated with clinically important inflammatory diseases. At the same time, iNKT cell activation can play a role in protecting against infectious disease and cancer or modulate certain autoimmune diseases through its impact on both the innate and adaptive immune system. This suggests that approaches to cause iNKT cell reduction and/or depletion could treat inflammatory diseases while approaches to promote activation may have therapeutic potential in certain infections, cancer or autoimmune disease. This report summarizes the characterization of a humanized monoclonal depleting antibody (NKTT120) in the cynomolgus macaque. NKTT120 is being developed to treat iNKT mediated inflammation that is associated with chronic inflammatory conditions like sickle cell disease and asthma. NKTT120 binds to human iTCRs and to FC gamma RI and FC gamma RIII and has been shown to kill target cells in an ADCC assay at low concentrations consistent with the FC gamma R binding. iNKT cells were depleted within 24 hours in cynomolgus macaques, but T cell, B cell, and NK cell frequencies were unchanged. iNKT cell recovery was dose and time dependent. T cell dependent antigen responses were not impaired by NKTT120 mediated iNKT depletion as measured by response to KLH challenge. NKTT120 administration did not induce an inflammatory cytokine release at doses up to 10 mg/kg. These data support the use of NKTT120 as an intervention in inflammatory diseases where iNKT reduction or depletion could be beneficial.	[Scheuplein, Felix; Thariath, Abraham; Macdonald, Susan; Truneh, Alemseged; Mashal, Robert; Schaub, Robert] NKT Therapeut Inc, Waltham, MA 02451 USA		Scheuplein, F (corresponding author), NKT Therapeut Inc, Waltham, MA 02451 USA.	FScheuplein@NKTRX.com	Truneh, Alem/ABB-7891-2020		NKT Therapeutics	NKT Therapeutics	This work was done as part of development of NKTT120. The work was self-funded by NKT Therapeutics (www.nktrx.com). There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Beziat V, 2010, CLIN IMMUNOL, V135, P364, DOI 10.1016/j.clim.2010.01.010; Bienemann K, 2011, SCAND J IMMUNOL, V74, P406, DOI 10.1111/j.1365-3083.2011.02591.x; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Field JJ, 2013, BLOOD, V121, P3329, DOI 10.1182/blood-2012-11-465963; Field JJ, 2011, CLIN IMMUNOL, V140, P177, DOI 10.1016/j.clim.2011.03.002; Haraguchi K, 2004, BONE MARROW TRANSPL, V34, P595, DOI 10.1038/sj.bmt.1704582; JENDRO MC, 1995, ARTHRITIS RHEUM, V38, P1242, DOI 10.1002/art.1780380912; Leveque D, 2005, ANTICANCER RES, V25, P2327; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3; Rubio MT, 2012, BLOOD, V120, P2144, DOI 10.1182/blood-2012-01-404673; Stewart R, 2011, PROTEIN ENG DES SEL, V24, P671, DOI 10.1093/protein/gzr015; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Van Kaer L, 2011, CELL TISSUE RES, V343, P43, DOI 10.1007/s00441-010-1023-3; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Wu L, 2009, CURR MOL MED, V9, P4, DOI 10.2174/156652409787314534	20	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76692	10.1371/journal.pone.0076692	http://dx.doi.org/10.1371/journal.pone.0076692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086759	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900108
J	Courtial, N; Mucke, C; Herkt, S; Kolodziej, S; Hussong, H; Lausen, J				Courtial, Nadine; Muecke, Christian; Herkt, Stefanie; Kolodziej, Stephan; Hussong, Helge; Lausen, Joern			The T-Cell Oncogene Tal2 Is a Target of PU.1 and Upregulated during Osteoclastogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; STEM-CELLS; CHROMOSOMAL TRANSLOCATION; DIFFERENTIATION; LEUKEMIA; BROWSER; NFATC1; SCL; LYL-1	Transcription factors play a crucial role in regulating differentiation processes during human life and are important in disease. The basic helix-loop-helix transcription factors Tal1 and Lyl1 play a major role in the regulation of gene expression in the hematopoietic system and are involved in human leukemia. Tal2, which belongs to the same family of transcription factors as Tal1 and Lyl1, is also involved in human leukaemia. However, little is known regarding the expression and regulation of Tal2 in hematopoietic cells. Here we show that Tal2 is expressed in hematopoietic cells of the myeloid lineage. Interestingly, we found that usage of the Tal2 promoter is different in human and mouse cells. Two promoters, hP1 and hP2 drive Tal2 expression in human erythroleukemia K562 cells, however in mouse RAW cells only the mP1 promoter is used. Furthermore, we found that Tal2 expression is upregulated during oesteoclastogenesis. We show that Tal2 is a direct target gene of the myeloid transcription factor PU.1, which is a key transcription factor for osteoclast gene expression. Strikingly, PU.1 binding to the P1 promoter is conserved between mouse and human, but PU.1 binding to P2 was only detected in human K562 cells. Additionally, we provide evidence that Tal2 influences the expression of the osteoclastic differentiation gene TRACP. These findings provide novel insight into the expression control of Tal2 in hematopoietic cells and reveal a function of Tal2 as a regulator of gene expression during osteoclast differentiation.	[Courtial, Nadine; Muecke, Christian; Herkt, Stefanie; Kolodziej, Stephan; Hussong, Helge; Lausen, Joern] Inst Biomed Res, Frankfurt, Germany		Lausen, J (corresponding author), Inst Biomed Res, Frankfurt, Germany.	lausen@em.uni-frankfurt.de			LOEWE initiative Onkogene Signaltransduktion Frankfurt; LOEWE Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/55.004, III L 4-518/17004]; Deutsche Forschungsgemeinschaft [SPP-1463, LA 1389/5-1]; Georg-Speyer-Haus; German Federal Ministry of Health; Ministry of Higher Education, Research and the Arts of the state of Hessen	LOEWE initiative Onkogene Signaltransduktion Frankfurt; LOEWE Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-Speyer-Haus; German Federal Ministry of Health; Ministry of Higher Education, Research and the Arts of the state of Hessen	This work was supported in part by the LOEWE initiative Onkogene Signaltransduktion Frankfurt, the LOEWE Center for Cell and Gene Therapy Frankfurt, Hessisches Ministerium fur Wissenschaft und Kunst, III L 4-518/55.004 and III L 4-518/17004, the Deutsche Forschungsgemeinschaft (SPP-1463, LA 1389/5-1) and institutional funds of the Georg-Speyer-Haus. The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health and the Ministry of Higher Education, Research and the Arts of the state of Hessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BAER R, 1993, SEMIN CANCER BIOL, V4, P341; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P2031, DOI 10.1073/pnas.86.6.2031; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bucher K, 2000, DEV BIOL, V227, P533, DOI 10.1006/dbio.2000.9920; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Courtial N, 2012, FASEB J, V26, P523, DOI 10.1096/fj.11-190850; Curtis DJ, 2012, STEM CELLS, V30, P1053, DOI 10.1002/stem.1093; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Guo Y, 2012, ONCOL REP, V27, P286, DOI 10.3892/or.2011.1483; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; Herglotz J, 2012, ONCOGENE; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; Mori S, 1999, MOL BRAIN RES, V64, P199, DOI 10.1016/S0169-328X(98)00323-4; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pinheiro P, 2004, GENE EXPR PATTERNS, V4, P85, DOI 10.1016/S1567-133X(03)00145-5; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Tsuneto M, 2005, STEM CELLS, V23, P134, DOI 10.1634/stemcells.2004-0154; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; XIA Y, 1994, ONCOGENE, V9, P1437; XIA Y, 1991, P NATL ACAD SCI USA, V88, P11416, DOI 10.1073/pnas.88.24.11416; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76637	10.1371/journal.pone.0076637	http://dx.doi.org/10.1371/journal.pone.0076637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086757	Green Submitted, Green Published, gold			2022-12-27	WOS:000325220000071
J	Chaimani, A; Higgins, JPT; Mavridis, D; Spyridonos, P; Salanti, G				Chaimani, Anna; Higgins, Julian P. T.; Mavridis, Dimitris; Spyridonos, Panagiota; Salanti, Georgia			Graphical Tools for Network Meta-Analysis in STATA	PLOS ONE			English	Article							PUBLICATION BIAS; INCONSISTENCY; CONSISTENCY; INTERVENTIONS; INFERENCE; MODEL	Network meta-analysis synthesizes direct and indirect evidence in a network of trials that compare multiple interventions and has the potential to rank the competing treatments according to the studied outcome. Despite its usefulness network meta-analysis is often criticized for its complexity and for being accessible only to researchers with strong statistical and computational skills. The evaluation of the underlying model assumptions, the statistical technicalities and presentation of the results in a concise and understandable way are all challenging aspects in the network meta-analysis methodology. In this paper we aim to make the methodology accessible to non-statisticians by presenting and explaining a series of graphical tools via worked examples. To this end, we provide a set of STATA routines that can be easily employed to present the evidence base, evaluate the assumptions, fit the network meta-analysis model and interpret its results.	[Chaimani, Anna; Mavridis, Dimitris; Salanti, Georgia] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Higgins, Julian P. T.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Higgins, Julian P. T.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Mavridis, Dimitris] Univ Ioannina, Dept Primary Educ, GR-45110 Ioannina, Greece; [Spyridonos, Panagiota] Univ Ioannina, Sch Med, Dept Med Phys, GR-45110 Ioannina, Greece	University of Ioannina; University of Bristol; University of York - UK; University of Ioannina; University of Ioannina	Salanti, G (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	gsalanti@cc.uoi.gr	Spyridonos, Panagiota/AAN-8293-2021; Mavrids, Dimitris/H-5452-2019; Higgins, Julian PT/H-4008-2011; Chaimani, Anna/AAA-3048-2020	Mavrids, Dimitris/0000-0003-1041-4592; Higgins, Julian PT/0000-0002-8323-2514; Chaimani, Anna/0000-0003-2828-6832; Salanti, Georgia/0000-0002-3830-8508	European Research Council [IMMA 260559]; MRC [MC_U105285807] Funding Source: UKRI; Medical Research Council [MC_U105285807] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AC, DM and GS received funding from the European Research Council (IMMA 260559 project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, STAT STAT SOFTW REL; ANSCOMBE FJ, 1973, AM STAT, V27, P17, DOI 10.2307/2682899; Anzures-Cabrera J, 2010, RES SYNTH METHODS, V1, P66, DOI 10.1002/jrsm.6; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; Chung HJ, 2008, CLIN TRIALS, V5, P301, DOI 10.1177/1740774508093614; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Cooper H, 2009, HDB RES SYNTHESIS ME; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S., 2011, NICE DSU TECHNICAL S; Donegan S, 2013, RES SYN MET IN PRESS; Donegan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011054; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Everitt B., 1997, ANAL PROXIMITY DATA; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Jackson D, 2011, STAT MED, V30, P2481, DOI 10.1002/sim.4172; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Krahn U, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-35; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2006, J AM STAT ASS, V101; Lu GB, 2011, RES SYNTH METHODS, V2, P43, DOI 10.1002/jrsm.34; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Mavridis D, 2013, STAT METHODS MED RES, V22, P133, DOI 10.1177/0962280211432219; Mavridis D, 2013, STAT MED, V32, P51, DOI 10.1002/sim.5494; MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098; Peters JL, 2010, J R STAT SOC A STAT, V173, P575, DOI 10.1111/j.1467-985X.2009.00629.x; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Romesburg, 1985, CLUSTER ANAL RES; Rucker G, 2013, NETMETA R PACKAGE NE; Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Singh JA, 2009, CAN MED ASSOC J, V181, P787, DOI 10.1503/cmaj.091391; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; White IR, 2011, STATA J, V11, P255, DOI 10.1177/1536867X1101100206	48	1232	1249	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76654	10.1371/journal.pone.0076654	http://dx.doi.org/10.1371/journal.pone.0076654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098547	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600069
J	Kaushik, M; Wang, CY; Barnett, MH; Garrick, R; Parratt, J; Graham, SL; Sriram, P; Yiannikas, C; Klistorner, A				Kaushik, Megha; Wang, Chen Yu; Barnett, Michael H.; Garrick, Raymond; Parratt, John; Graham, Stuart L.; Sriram, Prema; Yiannikas, Con; Klistorner, Alexandr			Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis	PLOS ONE			English	Article							MICROCYSTIC MACULAR EDEMA; MULTIPLE-SCLEROSIS; COHERENCE TOMOGRAPHY; DEGENERATION; PATHOLOGY; ABNORMALITIES; THICKNESS	Aim: To examine the relationship between retinal ganglion cell loss and changes in the inner nuclear layer (INL) in optic neuritis (ON). Methods: 36 multiple sclerosis (MS) patients with a history of ON and 36 age and sex-matched controls underwent Optical Coherence Tomography. The paramacular retinal nerve fiber layer (RNFL), combined ganglion cell and inner plexiform layers (GCL/IPL) and inner nuclear layer (INL) thickness were measured at 36 points around the fovea. To remove inter-subject variability, the difference in thickness of each layer between the ON and fellow eye of each patient was calculated. A topographic analysis was conducted. Results: The INL of the ON patients was thicker than the controls (42.9 mu m versus 39.6 mu m, p=0.002). ON patients also had a thinner RNFL (27.8 mu m versus 32.2 mu m, p<0.001) and GCL/IPL (69.3 mu m versus 98.1 mu m, p<0.001). Among the controls, there was no correlation between RNFL and GCL/IPL as well as RNFL and INL, but a positive correlation was seen between GCL/IPL and INL (r=0.65, p<0.001). In the ON group, there was a positive correlation between RNFL and GCL/IPL (r=0.80, p<0.001) but a negative correlation between RNFL and INL (r=-0.61, p<0.001) as well as GCL/IPL and INL (r=-0.44, p=0.007). The negative correlation between GCL/IPL and INL strengthened in the ON group when inter-subject variability was removed (r=-0.75, p<0.001). Microcysts within the INL were present in 5 ON patients, mainly in the superior and infero-nasal paramacular regions. While patients with microcysts lay at the far end of the correlation curve between GCL/IPL and INL (i.e. larger INL and smaller GCL/IPL compared to other patients), their exclusion did not affect the correlation (r=-0.76, p<0.001). Conclusions: INL enlargement in MS-related ON is associated with the severity of GCL loss. This is a continuous relationship and patients with INL microcysts may represent the extreme end of the scale.	[Kaushik, Megha; Sriram, Prema; Klistorner, Alexandr] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [Wang, Chen Yu; Barnett, Michael H.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Garrick, Raymond] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Parratt, John] Royal N Shore Hosp, Dept Neurol, Sydney, NSW, Australia; [Graham, Stuart L.; Sriram, Prema; Klistorner, Alexandr] Macquarie Univ, Sydney, NSW 2109, Australia; [Yiannikas, Con] Concord Hosp, Dept Neurol, Sydney, NSW, Australia	University of Sydney; University of Sydney; St Vincents Hospital Sydney; Royal North Shore Hospital; University of Sydney; Macquarie University; Concord Repatriation General Hospital	Klistorner, A (corresponding author), Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia.	sasha.klistorner@sydney.edu.au		Sriram, P.S/0000-0002-6103-3573; Klistorner, Alexander/0000-0003-0361-6399; Graham, Stuart/0000-0001-7519-969X	National Health and Medical Research Council [1056517]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by National Health and Medical Research Council (number: 1056517). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg M, 2012, BRAIN, V135, DOI 10.1093/brain/aws215; Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Arnold AC, 2005, AM J OPHTHALMOL, V139, P1101, DOI 10.1016/j.ajo.2005.01.031; Balk LJ, 2012, BRAIN, V135, DOI 10.1093/brain/aws216; Barboni P, 2013, BRAIN; Chen Ling, 2005, Curr Opin Ophthalmol, V16, P315, DOI 10.1097/01.icu.0000179804.49842.e2; Davies EC, 2011, J NEURO-OPHTHALMOL, V31, P260, DOI 10.1097/WNO.0b013e318221b434; Forooghian F, 2006, DOC OPHTHALMOL, V113, P123, DOI 10.1007/s10633-006-9022-0; Garas A, 2011, EUR J OPHTHALMOL, V21, P473, DOI 10.5301/EJO.2010.5844; Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Green AJ, 2013, BRAIN, V136, DOI 10.1093/brain/awt155; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gundogan FC, 2007, INVEST OPHTH VIS SCI, V48, P5773, DOI 10.1167/iovs.07-0834; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Petzold A, 2012, LANCET NEUROL, V11, P933, DOI 10.1016/S1474-4422(12)70231-4; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Seigo MA, 2012, J NEUROL, V259, P2119, DOI 10.1007/s00415-012-6466-x; Sigler EJ, 2013, GRAEF ARCH CLIN EXP, V251, P1679, DOI 10.1007/s00417-012-2253-8; Sotirchos ES, 2013, NEUROLOGY, V80, P1406, DOI 10.1212/WNL.0b013e31828c2f7a; Sriram P, 2012, INVEST OPHTH VIS SCI, V53, P1271, DOI 10.1167/iovs.11-8732; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032; Wolff B, 2013, RETINAL INNER NUCL L	28	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e78341	10.1371/journal.pone.0078341	http://dx.doi.org/10.1371/journal.pone.0078341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098599	Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600092
J	Park, EJ; Jang, HJ; Tsoyi, K; Kim, YM; Park, SW; Kim, HJ; Lee, JH; Chang, KC				Park, Eun Jung; Jang, Hwa Jin; Tsoyi, Konstantin; Kim, Young Min; Park, Sang Won; Kim, Hye Jung; Lee, Jae Heun; Chang, Ki Churl			The Heme Oxygenase-1 Inducer THI-56 Negatively Regulates iNOS Expression and HMGB1 Release in LPS-Activated RAW 264.7 Cells and CLP-Induced Septic Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VASCULAR SMOOTH-MUSCLE; MOBILITY GROUP BOX-1; EXPERIMENTAL ENDOTOXEMIA; SIGNALING PATHWAY; CECAL LIGATION; YS 49; MONOXIDE; LIPOPOLYSACCHARIDE; MACROPHAGES	The nuclear DNA binding protein high mobility group box 1 (HMGB1) has recently been suggested to act as a late mediator of septic shock. The effect of ((S)-6,7-dihydroxy-1-(4-hydroxynaphthylmethyl)-1,2,3,4-tetrahydroisoquinoline alkaloid, also known as THI-56, in an experimental model of sepsis was investigated. THI-56 exhibited potent anti-inflammatory properties in response to LPS in RAW 264.7 cells. In particular, THI-56 significantly inhibited the expression of inducible nitric oxide synthase (iNOS) and the release of HMGB1 in activated macrophages. THI-56 activated NE-F2-regulated factor 2 (Nrf-2)/heme oxygenase 1 (HO-1). The specific knockdown of the HO-1 gene by HO-1 siRNA significantly reversed the inhibitory effects of THI-56 on iNOS expression and HMGB1 release in LPS-stimulated macrophages. Importantly, THI-56 administration protected animals from death induced by either a lethal dose of LPS or cecal ligation and puncture (CLP). Furthermore, the ALT, AST, BUN, creatinine, and HMGB1 levels in the blood were significantly increased in CLP-induced septic mice, and the administration of THI-56 reduced these levels in a concentration-dependent and zinc protoporphyrin IX (ZnPPIX)-sensitive manner. In addition, the administration of THI-56 significantly ameliorated not only lung damage but also macrophage infiltration in the livers of CLP-induced septic mice, and these effects were also abrogated in the presence of ZnPPIX. Thus, we conclude that THI-56 significantly attenuates the proinflammatory response induced by LPS and reduces organ damage in a CLP-induced sepsis model through the upregulation of Nrf-2/HO-1.	[Chang, Ki Churl] Gyeongsang Natl Univ, Dept Pharmacol, Sch Med, Jinju, South Korea; Inst Hlth Sci, Jinju, South Korea	Gyeongsang National University	Chang, KC (corresponding author), Gyeongsang Natl Univ, Dept Pharmacol, Sch Med, Jinju, South Korea.	kcchang@gnu.kr			Ministry of Health and Welfare [A111425]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633] Funding Source: NIH RePORTER	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Ministry of Health and Welfare (A111425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bani-Hani Mohamed G, 2006, Pharmacol Rep, V58 Suppl, P132; Beutler B, 2008, J IMMUNOL, V181, P7; DiNapoli MR, 1996, J EXP MED, V183, P1323, DOI 10.1084/jem.183.4.1323; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; HEINZEL FP, 1990, J IMMUNOL, V145, P2920; Heo JM, 2007, BIOCHEM PHARMACOL, V74, P1361, DOI 10.1016/j.bcp.2007.07.023; Horvath I., 2001, European Respiratory Journal, V18, P420, DOI 10.1183/09031936.01.00231201; Jiang WW, 2006, J IMMUNOL, V177, P3337, DOI 10.4049/jimmunol.177.5.3337; Kang YJ, 2002, J PHARMACOL EXP THER, V301, P561, DOI 10.1124/jpet.301.2.561; Kang YJ, 1999, BRIT J PHARMACOL, V128, P357, DOI 10.1038/sj.bjp.0702787; Kim HJ, 2007, J PHARMACOL EXP THER, V320, P782, DOI 10.1124/jpet.106.112052; Kim JH, 2009, J IMMUNOL, V182, P2458, DOI 10.4049/jimmunol.0801364; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Park EJ, 2013, FOOD CHEM TOXICOL, V55, P386, DOI 10.1016/j.fct.2012.12.027; Park JE, 2006, INT IMMUNOPHARMACOL, V6, P226, DOI 10.1016/j.intimp.2005.08.007; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Remy S, 2009, J IMMUNOL, V182, P1877, DOI 10.4049/jimmunol.0802436; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Su X, 2004, INTENS CARE MED, V30, P133, DOI 10.1007/s00134-003-2001-y; Sun JJ, 2008, LIFE SCI, V82, P600, DOI 10.1016/j.lfs.2007.12.015; Takamiya R, 2009, AM J RESP CELL MOL, V41, P129, DOI 10.1165/rcmb.2008-0331OC; Tsoyi K, 2008, CELL SIGNAL, V20, P1839, DOI 10.1016/j.cellsig.2008.06.012; Tsoyi K, 2009, ATHEROSCLEROSIS, V207, P412, DOI 10.1016/j.atherosclerosis.2009.05.012; Tsoyi K, 2009, INFLAMMATION, V32, P364, DOI 10.1007/s10753-009-9144-0; Tsoyi K, 2009, MOL PHARMACOL, V76, P173, DOI 10.1124/mol.109.055137; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015	35	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76293	10.1371/journal.pone.0076293	http://dx.doi.org/10.1371/journal.pone.0076293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098466	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600036
J	Lu, GR; Wu, YN; Jiang, YY; Wang, S; Hou, YN; Guan, XQ; Brunzelle, J; Sirinupong, N; Sheng, SJ; Li, CY; Yang, Z				Lu, Guorong; Wu, Yanning; Jiang, Yuanyuan; Wang, Shuo; Hou, Yuning; Guan, Xiaoqing; Brunzelle, Joseph; Sirinupong, Nualpun; Sheng, Shijie; Li, Chunying; Yang, Zhe			Structural Insights into Neutrophilic Migration Revealed by the Crystal Structure of the Chemokine Receptor CXCR2 in Complex with the First PDZ Domain of NHERF1	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BINDING; SPECIFICITY; PROTEINS; CFTR; INFLAMMATION; INHIBITION; REFINEMENT; MECHANISM; PARTNERS	Neutrophil plays an essential role in host defense against infection, but uncontrolled neutrophilic infiltration can cause inflammation and severe epithelial damage. We recently showed that CXCR2 formed a signaling complex with NHERF1 and PLC-2, and that the formation of this complex was required for intracellular calcium mobilization and neutrophilic transepithelial migration. To uncover the structural basis of the complex formation, we report here the crystal structure of the NHERF1 PDZ1 domain in complex with the C-terminal sequence of CXCR2 at 1.16 angstrom resolution. The structure reveals that the CXCR2 peptide binds to PDZ1 in an extended conformation with the last four residues making specific side chain interactions. Remarkably, comparison of the structure to previously studied PDZ1 domains has allowed the identification of PDZ1 ligand-specific interactions and the mechanisms that govern PDZ1 target selection diversities. In addition, we show that CXCR2 can bind both NHERF1 PDZ1 and PDZ2 in pulldown experiments, consistent with the observation that the peptide binding pockets of these two PDZ domains are highly structurally conserved. The results of this study therefore provide structural basis for the CXCR2-mediated neutrophilic migration and could have important clinical applications in the prevention and treatment of numerous neutrophil-dependent inflammatory disorders.	[Lu, Guorong; Wu, Yanning; Jiang, Yuanyuan; Wang, Shuo; Hou, Yuning; Guan, Xiaoqing; Li, Chunying; Yang, Zhe] Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48202 USA; [Brunzelle, Joseph] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Sirinupong, Nualpun] Prince Songkla Univ, Nutraceut & Funct Food Res & Dev Ctr, Hat Yai, Songkhla, Thailand; [Sheng, Shijie] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Wayne State University; United States Department of Energy (DOE); Argonne National Laboratory; Prince of Songkla University; Wayne State University	Li, CY (corresponding author), Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48202 USA.	cl@med.wayne.edu; zyang@med.wayne.edu	jiang, anyi/GPT-0379-2022; Sirinupong, Nualpun/AAX-4886-2020	Sirinupong, Nualpun/0000-0002-9986-3011; Hou, Yuning/0000-0001-9894-3821	Leukemia Research Foundation; Aplastic Anemia & MDS International Foundation; Elsa U. Pardee Foundation; American Heart Association	Leukemia Research Foundation; Aplastic Anemia & MDS International Foundation; Elsa U. Pardee Foundation; American Heart Association(American Heart Association)	This study was supported by the Leukemia Research Foundation (to ZY) and the Aplastic Anemia & MDS International Foundation (to ZY), as well as the Elsa U. Pardee Foundation (to CL) and American Heart Association (to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Cardone RA, 2012, MOL BIOL CELL, V23, P2028, DOI 10.1091/mbc.E11-11-0911; Chapman RW, 2009, PHARMACOL THERAPEUT, V121, P55, DOI 10.1016/j.pharmthera.2008.10.005; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geng JG, 2001, CELL RES, V11, P85, DOI 10.1038/sj.cr.7290071; Glynn PC, 2002, PULM PHARMACOL THER, V15, P103, DOI 10.1006/pupt.2001.0323; Harris BZ, 2001, J CELL SCI, V114, P3219; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Munz M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002749; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Velthuis AJWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016047; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weinman EJ, 2000, AM J PHYSIOL-RENAL, V279, pF393, DOI 10.1152/ajprenal.2000.279.3.F393; Wu YN, 2012, J BIOL CHEM, V287, P5744, DOI 10.1074/jbc.M111.315762; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	45	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76219	10.1371/journal.pone.0076219	http://dx.doi.org/10.1371/journal.pone.0076219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098448	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500053
J	Parikh, SM; Obuku, EA; Walker, SA; Semeere, AS; Auerbach, BJ; Hakim, JG; Mayanja-Kizza, H; Mugyenyi, PN; Salata, RA; Kityo, CM				Parikh, Sujal M.; Obuku, Ekwaro A.; Walker, Sarah A.; Semeere, Aggrey S.; Auerbach, Brandon J.; Hakim, James G.; Mayanja-Kizza, Harriet; Mugyenyi, Peter N.; Salata, Robert A.; Kityo, Cissy M.		DART Trial Team	Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial	PLOS ONE			English	Article							VAGINAL SYMPTOMS; HIV-INFECTION; PREVALENCE; COHORT; AIDS; BEHAVIOR; WOMEN; AGE	Objective: Clinical and immunological data about HIV in older adults from low and middle income countries is scarce. We aimed to describe differences between younger and older adults with HIV starting antiretroviral therapy in two low-income African countries. Methods: Setting: HIV clinics in Uganda and Zimbabwe. Design: Secondary exploratory cross-sectional analysis of the DART randomized controlled trial. Outcome Measures: Clinical and laboratory characteristics were compared between adults aged 18-49 years (younger) and >= 50 years (older), using two exploratory multivariable logistic regression models, one with HIV viral load (measured in a subset pre-ART) and one without. Results: A total of 3316 eligible participants enrolled in DART were available for analysis; 219 (7%) were >= 50 years and 1160 (35%) were male. Across the two adjusted regression models, older adults had significantly higher systolic blood pressure, lower creatinine clearance and were consistently less likely to be females compared to younger adults with HIV. Paradoxically, the models separately suggested that older adults had statistically significant (but not clinically important) higher CD4+ cell counts and higher plasma HIV-1 viral copies at initiation. Crude associations between older age and higher baseline hemoglobin, body mass index, diastolic blood pressure and lower WHO clinical stage were not sustained in the adjusted analysis. Conclusions: Our study found clinical and immunological differences between younger and older adults, in a cohort of Africans starting antiretroviral therapy. Further investigations should explore how these differences could be used to ensure equity in service delivery and affect outcomes of antiretroviral therapy.	[Parikh, Sujal M.; Obuku, Ekwaro A.; Mugyenyi, Peter N.; Kityo, Cissy M.] Joint Clin Res, Kampala, Uganda; [Walker, Sarah A.] Med Res Council Clin Trials Unit, London, England; [Parikh, Sujal M.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Salata, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Semeere, Aggrey S.; Auerbach, Brandon J.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Auerbach, Brandon J.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Hakim, James G.] Univ Zimbabwe, Clin Res Ctr, Coll Hlth Sci, Harare, Zimbabwe	Medical Research Council Clinical Trials Unit; University of Michigan System; University of Michigan; Case Western Reserve University; Makerere University; Makerere University; Harvard University; Harvard Medical School; University of Zimbabwe	Obuku, EA (corresponding author), Joint Clin Res, Kampala, Uganda.	eobuku@jcrc.org.ug	Mayanja-Kizza, Harriet/AAM-5372-2020; Obuku, Ekwaro A./H-4988-2011	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Grosskurth, Heiner/0000-0001-9960-7280; Semeere, Aggrey/0000-0003-1826-2239	Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; American Relief and Recovery Act, Fogarty International Centre, National Institutes of Health, USA; United Kingdom Medical Research Council [G0600344]; United Kingdom Department for International Development; Rockefeller Foundation; MRC [G0600344] Funding Source: UKRI; Medical Research Council [G0600344] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; American Relief and Recovery Act, Fogarty International Centre, National Institutes of Health, USA; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Kingdom Department for International Development; Rockefeller Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act, Fogarty International Centre, National Institutes of Health, USA. DART was funded by the United Kingdom Medical Research Council (grant number G0600344), the United Kingdom Department for International Development, and the Rockefeller Foundation. Viiv Healthcare/GlaxoSmithKline, Gilead and Boehringer-Ingelheim donated first-line drugs for DART, and Abbott provided Kaletra/Aluvia as part of the second-line regimen for DART. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agate LL, 2003, JAIDS-J ACQ IMM DEF, V33, pS238, DOI 10.1097/00126334-200306012-00024; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Balestre E, 2012, AIDS, V26, P951, DOI 10.1097/QAD.0b013e3283528ad4; Biraro S, 2009, SEX TRANSM INFECT, V85, pI3, DOI 10.1136/sti.2008.033928; Buchacz K, 2008, AIDS, V22, P1345, DOI 10.1097/QAD.0b013e328304b38b; Centers for Disease Control and Prevention, 2010, CAS HIV AIDS US DEP; Centers for Disease Control and Prevention, 2005, CAS HIV AIDS US DEP; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Conde DM, 2009, MENOPAUSE, V16, P199, DOI 10.1097/gme.0b013e318177352c; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Eylar E H, 2001, BMC Immunol, V2, P10, DOI 10.1186/1471-2172-2-10; Feruglio F S, 1966, G Gerontol, V14, P229; Freeman E, 2012, INT J STD AIDS, V23, P490, DOI 10.1258/ijsa.2011.011340; Geneau Robert, 2012, AIDS, V26 Suppl 1, pS7; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Huang AJ, 2010, MENOPAUSE, V17, P121, DOI 10.1097/gme.0b013e3181acb9ed; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS3, DOI 10.1016/S0895-4356(01)00440-1; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Marcus Mary Brophy, 2002, US News World Rep, V133, P40; McGrath N, 2009, SEX TRANSM INFECT, V85, pI49, DOI 10.1136/sti.2008.033324; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Murrow E, 1996, S C NURSE, V3, P20; Mutevedzi PC, 2011, FUTURE VIROL, V6, P755, DOI 10.2217/FVL.11.43; Negin Joel, 2012, AIDS, V26 Suppl 1, pS1; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Palella FJ, 2010, AIDS, V24, P1657, DOI 10.1097/QAD.0b013e3283389dfa; Ress B, 2003, CRIT CARE NURSE, V23, P34; Santoro N, 2009, J SEX MED, V6, P2133, DOI 10.1111/j.1743-6109.2009.01335.x; SCHIMMLE.W, 1965, ARCH KREISLAUFFORSCH, V47, P189, DOI 10.1007/BF02119983; SCHIMMLER W, 1965, Z KREISLAUFFORSCH, V54, P802; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; Ssali F, 2006, ANTIVIR THER, V11, P741; Stoff DM, 2004, AIDS, V18, pS1, DOI 10.1097/00002030-200401001-00001; Tsai AC, 2009, AIDS CARE, V21, P59, DOI 10.1080/09540120802068811; United Nations, 2009, WORLD POP AG 2009 NE; Waysdorf Susan L, 2002, Elder Law J, V10, P47; Zingmond DS, 2003, JAIDS-J ACQ IMM DEF, V33, pS84, DOI 10.1097/00126334-200306012-00005	40	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76158	10.1371/journal.pone.0076158	http://dx.doi.org/10.1371/journal.pone.0076158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098434	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000325434500046
J	Schmidt, SA; Akrofi, K; Carpenter-Thompson, JR; Husain, FT				Schmidt, Sara A.; Akrofi, Kwaku; Carpenter-Thompson, Jake R.; Husain, Fatima T.			Default Mode, Dorsal Attention and Auditory Resting State Networks Exhibit Differential Functional Connectivity in Tinnitus and Hearing Loss	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BRAIN; FMRI; PLASTICITY	We investigated auditory, dorsal attention, and default mode networks in adults with tinnitus and hearing loss in a resting state functional connectivity study. Data were obtained using continuous functional magnetic resonance imaging (fMRI) while the participants were at "rest" and were not performing any task. Participants belonged to one of three groups: middle-aged adults with tinnitus and mild-to-moderate high frequency hearing loss (TIN), age-matched controls with normal hearing and no tinnitus (NH), and a second control group with mild-to-moderate high frequency hearing loss without tinnitus (HL). After standard preprocessing, (a) a group independent component analysis (ICA) using 30 components and (b) a seeding-based connectivity analysis were conducted. In the group ICA, the default mode network was the only network to display visual differences between subject groups. In the seeding analysis, we found increased connectivity between the left parahippocampus and the auditory resting state network in the TIN group when compared to NH controls. Similarly, there was also an increased correlation between the right parahippocampus and the dorsal attention network when compared to HL controls. Other group differences in this attention network included decreased correlations between the seed regions and the right supramarginal gyrus in TIN patients when compared to HL controls. In the default mode network, there was a strong decrease in correlation between the seed regions and the precuneus when compared to both control groups. The findings of this study identify specific alterations in the connectivity of the default mode, dorsal attention, and auditory resting state networks due to tinnitus. The results suggest that therapies for tinnitus that mitigate the increased connectivity of limbic regions with auditory and attention resting state networks and the decreased coherence of the default mode network could be effective at reducing tinnitus-related distress.	[Schmidt, Sara A.; Akrofi, Kwaku; Carpenter-Thompson, Jake R.; Husain, Fatima T.] Univ Illinois, Neurosci Program, Champaign, IL USA; [Akrofi, Kwaku; Husain, Fatima T.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL USA; [Husain, Fatima T.] Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Schmidt, SA (corresponding author), Univ Illinois, Neurosci Program, Champaign, IL USA.	schmsr@gmail.com		Schmidt, Sara/0000-0002-0161-8350	Tinnitus Research Consortium; NeuroEngineering NSF IGERT; NSF [0903622]	Tinnitus Research Consortium; NeuroEngineering NSF IGERT; NSF(National Science Foundation (NSF))	Funding was provided by the Tinnitus Research Consortium (through http://www.aro.org/index.html). Funding for graduate students (Sara Schmidt, Jake Carpenter-Thompson) was provided via the NeuroEngineering NSF IGERT (Integrative Graduate Education and Research Traineeship), NSF Grant No. 0903622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Tinnitus Association website ATA's top 10 most frequently asked questions, ATAS TOP 10 MOST FRE; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; Filippi M, 2011, J ALZHEIMERS DIS, V24, P455, DOI 10.3233/JAD-2011-101854; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Golm D, 2013, HEARING RES, V295, P87, DOI 10.1016/j.heares.2012.03.003; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Himberg J, 2003, 2003 IEEE XIII WORKSHOP ON NEURAL NETWORKS FOR SIGNAL PROCESSING - NNSP'03, P259, DOI 10.1109/NNSP.2003.1318025; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Kim JY, 2012, INT J AUDIOL, V51, P413, DOI 10.3109/14992027.2011.652677; Lockwood AH, 2002, NEW ENGL J MED, V347, P904, DOI 10.1056/NEJMra013395; Lorenz I, 2009, NEUROSCI LETT, V453, P225, DOI 10.1016/j.neulet.2009.02.028; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Maudoux A, 2012, BRAIN RES, V1485, P10, DOI 10.1016/j.brainres.2012.05.006; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Ooms E, 2012, EUR ARCH OTO-RHINO-L; Perrachione TK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00055; Pihlajamaki M, 2009, BEHAV NEUROL, V21, P77, DOI 10.3233/BEN-2009-0231; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Repovs G, 2011, BIOL PSYCHIAT, V69, P967, DOI 10.1016/j.biopsych.2010.11.009; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Shore SE, 2011, HEARING RES, V281, P38, DOI 10.1016/j.heares.2011.05.001; Swanson N, 2011, HUM BRAIN MAPP, V32, P654, DOI 10.1002/hbm.21055; the Gabrieli Lab McGovern Institute for Brain Research Massachusetts Institute of Technology, 2013, REX REG INT EXTR TOO; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vernon JA, 1997, TINNITUS TREATMENT R; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wineland AM, 2012, OTOLARYNG HEAD NECK, V147, P900, DOI 10.1177/0194599812451414; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701	54	139	139	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76488	10.1371/journal.pone.0076488	http://dx.doi.org/10.1371/journal.pone.0076488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098513	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500067
J	Wang, WJ; Yao, Y; Jiang, LL; Hu, TH; Ma, JQ; Liao, ZJ; Yao, JT; Li, DF; Wang, SH; Nan, KJ				Wang, Wen-Juan; Yao, Yu; Jiang, Li-Li; Hu, Ting-Hua; Ma, Jie-Qun; Liao, Zi-Jun; Yao, Jun-Tao; Li, Dong-Fan; Wang, Shu-Hong; Nan, Ke-Jun			Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo	PLOS ONE			English	Article							COLORECTAL-CANCER; BREAST-CANCER; NOTCH; LEF-1; GROWTH; EXPRESSION; PROTEIN; TARGET; GENE; PROLIFERATION	Expression of lymphoid enhancer factor 1 (LEF1) is frequently altered in different human cancers. This study aimed to assess LEF1 expression in colon cancer tissues and to explore changed phenotypes, gene expressions, and the possible mechanism after knocked down LEF1 expression in colon cancer cell lines. A total of 106 colon cancer and matched paratumorous normal tissues were used to assess LEF1 expression using immunohistochemistry and qRT-PCR. LEF1 lentivirus was used to knockdown LEF1 expression for the assessment of cell viability, cell cycle distribution, apoptosis, and gene expressions. The nude mouse xenograft assay was performed to detect the effects of LEF1 knockdown in vivo. The data showed that the levels of LEF1 mRNA and protein were significantly increased in human colon cancer tissues compared to the matched paratumorous normal tissues and were associated with infiltration depth, lymph node and distant metastases, advanced TNM (tumor-node-metastasis) stages, and shorter overall survival. Furthermore, LEF1 knockdown reduced tumor cell viability, invasion capacity, MMP2 and MMP-9 expression, but induced apoptosis. Nude mouse xenograft assay showed that LEF1 knockdown suppressed tumor formation and growth in vivo. In addition, the expression of Notch pathway-related proteins RBP-jk and Hes1 was reduced in LEF1 knockdown cells. Taken together, LEF1 protein was overexpressed in colon cancer tissues and knockdown of LEF1 expression inhibited colon cancer growth in vitro and in vivo. These data suggest that targeting of LEF1 expression should be further evaluated for colon cancer prevention and therapy.	[Wang, Wen-Juan; Yao, Yu; Jiang, Li-Li; Hu, Ting-Hua; Ma, Jie-Qun; Wang, Shu-Hong; Nan, Ke-Jun] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China; [Liao, Zi-Jun; Yao, Jun-Tao] Xi An Jiao Tong Univ, Affiliated Shaanxi Prov Canc Hosp, Coll Med, Xian 710049, Peoples R China; [Li, Dong-Fan] Xian Cent Hosp, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, SH (corresponding author), Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China.	wsh2003@126.com; nankejun@126.com			National Natural Science Foundation of China [81001090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81001090) (http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bucan V, 2012, GENES CELLS, V17, P559, DOI 10.1111/j.1365-2443.2012.01613.x; Chen DL, 2013, CARCINOGENESIS, V34, P803, DOI 10.1093/carcin/bgs400; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gansler T, 2010, CA-CANCER J CLIN, V60, P345, DOI 10.3322/caac.20088; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Guo H, 2011, CARCINOGENESIS, V32, P1897, DOI 10.1093/carcin/bgr220; Hoeppner LH, 2011, J BIOL CHEM, V286, P10950, DOI 10.1074/jbc.M110.165100; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Huang FI, 2012, CARCINOGENESIS, V33, P1142, DOI 10.1093/carcin/bgs131; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kriegl L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-123; Lei Tao, 2009, Zhonghua Zhongliu Zazhi, V31, P428, DOI 10.3760/cma.j.issn.0253-3766.2009.06.007; Li YR, 2009, CANCER RES, V69, P3332, DOI 10.1158/0008-5472.CAN-08-3380; Lin AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016636; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pannequin J, 2009, CANCER RES, V69, P6065, DOI 10.1158/0008-5472.CAN-08-2409; Ross DA, 2001, MOL CELL BIOL, V21, P7537, DOI 10.1128/MCB.21.22.7537-7544.2001; Shelton DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040312; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Somiari SB, 2006, INT J CANCER, V119, P1403, DOI 10.1002/ijc.21989; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Ungerback J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017957; Wang SH, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-53; Waterman ML, 2004, CANCER METAST REV, V23, P41, DOI 10.1023/A:1025858928620; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492	33	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76596	10.1371/journal.pone.0076596	http://dx.doi.org/10.1371/journal.pone.0076596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098538	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500076
J	Biddle, AS; Black, SJ; Blanchard, JL				Biddle, Amy S.; Black, Samuel J.; Blanchard, Jeffrey L.			An In Vitro Model of the Horse Gut Microbiome Enables Identification of Lactate-Utilizing Bacteria That Differentially Respond to Starch Induction	PLOS ONE			English	Article							EQUINE LARGE-INTESTINE; OLIGOFRUCTOSE-INDUCED LAMINITIS; GASTROINTESTINAL-TRACT; MEGASPHAERA-ELSDENII; ACID PRODUCTION; RNA; RUMEN; COMMUNITY; HINDGUT; DIET	Laminitis is a chronic, crippling disease triggered by the sudden influx of dietary starch. Starch reaches the hindgut resulting in enrichment of lactic acid bacteria, lactate accumulation, and acidification of the gut contents. Bacterial products enter the bloodstream and precipitate systemic inflammation. Hindgut lactate levels are normally low because specific bacterial groups convert lactate to short chain fatty acids. Why this mechanism fails when lactate levels rapidly rise, and why some hindgut communities can recover is unknown. Fecal samples from three adult horses eating identical diets provided bacterial communities for this in vitro study. Triplicate microcosms of fecal slurries were enriched with lactate and/or starch. Metabolic products (short chain fatty acids, headspace gases, and hydrogen sulfide) were measured and microbial community compositions determined using Illumina 16S rRNA sequencing over 12-hour intervals. We report that patterns of change in short chain fatty acid levels and pH in our in vitro system are similar to those seen in in vivo laminitis induction models. Community differences between microcosms with disparate abilities to clear excess lactate suggest profiles conferring resistance of starch-induction conditions. Where lactate levels recover following starch induction conditions, propionate and acetate levels rise correspondingly and taxa related to Megasphaera elsdenii reach levels exceeding 70% relative abundance. In lactate and control cultures, taxa related to Veillonella montpellierensis are enriched as lactate levels fall. Understanding these community differences and factors promoting the growth of specific lactate utilizing taxa may be useful to prevent acidosis under starch-induction conditions.	[Biddle, Amy S.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Black, Samuel J.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Black, Samuel J.; Blanchard, Jeffrey L.] Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Grad Program Organismal & Evolutionary Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Biddle, AS (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	abiddle@microbio.umass.edu	Black, Samuel/L-8429-2016; Blanchard, Jeffrey/AAA-5173-2020	Blanchard, Jeffrey/0000-0002-7310-9678; Biddle, Amy/0000-0001-8261-1128	National Science Foundation Graduate Research Fellowship; Div Of Industrial Innovation & Partnersh [1342640] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Div Of Industrial Innovation & Partnersh(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Support of research supplies and services provided by: Pilot Study: Morris Animal Foundation: D-12EQ-814: Identifying bacteria associated with starch induced laminitis and colic with the potential to attenuate lactate in the equine gut http://www.morrisanimalfoundation.org. For salary support: National Science Foundation Graduate Research Fellowship: http://www.nsfgrfp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikman PC, 2011, J DAIRY SCI, V94, P2840, DOI 10.3168/jds.2010-3783; Al Jassim R. A. M., 2005, RECENT ADV ANIMAL NU, V15, P155; Al Jassim RAM, 2009, VET CLIN N AM-EQUINE, V25, P199, DOI 10.1016/j.cveq.2009.04.005; Al Jassim RAM, 2005, FEMS MICROBIOL LETT, V248, P75, DOI 10.1016/j.femsle.2005.05.023; Andrews S., 2012, FASTQC; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; ARGENZIO RA, 1972, J NUTR, V102, P879, DOI 10.1093/jn/102.7.879; ARGENZIO RA, 1975, CORNELL VET, V65, P303; Bailey SR, 2009, VET IMMUNOL IMMUNOP, V129, P167, DOI 10.1016/j.vetimm.2008.11.009; Bailey SR, 2003, APPL ENVIRON MICROB, V69, P2087, DOI 10.1128/AEM.69.4.2087-2093.2003; BRYANT MP, 1953, J DAIRY SCI, V36, P205, DOI 10.3168/jds.S0022-0302(53)91482-9; Caporaso J.G., 2012, ISME J; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; de Carvalho IPC, 2011, REV BRAS ZOOTECN, V40, P1260, DOI 10.1590/S1516-35982011000600014; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Crawford C, 2007, J ANIM SCI, V85, P2949, DOI 10.2527/jas.2006-600; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; Daly K, 2012, BRIT J NUTR, V107, P989, DOI 10.1017/S0007114511003825; de Fombelle A, 2003, ANIM SCI, V77, P293; de Fombelle A, 2001, J EQUINE VET SCI, V21, P439, DOI 10.1016/S0737-0806(01)70018-4; DeAngelis KM, 2010, ENVIRON MICROBIOL, V12, P3137, DOI 10.1111/j.1462-2920.2010.02286.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; GARNER HE, 1975, AM J VET RES, V36, P441; GARNER HE, 1978, EQUINE VET J, V10, P249, DOI 10.1111/j.2042-3306.1978.tb02273.x; Goncalves S, 2002, VET RES, V33, P641, DOI 10.1051/vetres:2002044; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Haikara A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P965, DOI 10.1007/0-387-30744-3_32; JANIS C, 1976, EVOLUTION, V30, P757, DOI 10.1111/j.1558-5646.1976.tb00957.x; KERN DL, 1974, J ANIM SCI, V38, P559, DOI 10.2527/jas1974.383559x; Kolenbrander P, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1022, DOI 10.1007/0-387-30744-3_36; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; KUNG LM, 1995, J ANIM SCI, V73, P250; Lameness and Laminitis in U. S. Horses, 2005, USDAAPHISVS CEAH, V4, P250; MACKIE RI, 1988, APPL ENVIRON MICROB, V54, P2155, DOI 10.1128/AEM.54.9.2155-2160.1988; MACKIE RI, 1979, APPL ENVIRON MICROB, V38, P416, DOI 10.1128/AEM.38.3.416-421.1979; MACKIE RI, 1984, J AGR SCI, V103, P37, DOI 10.1017/S0021859600043306; MAROUNEK M, 1987, J APPL BACTERIOL, V63, P233, DOI 10.1111/j.1365-2672.1987.tb04941.x; Milinovich GJ, 2008, ISME J, V2, P1089, DOI 10.1038/ismej.2008.67; Milinovich GJ, 2007, ENVIRON MICROBIOL, V9, P2090, DOI 10.1111/j.1462-2920.2007.01327.x; Milinovich GJ, 2006, ENVIRON MICROBIOL, V8, P885, DOI 10.1111/j.1462-2920.2005.00975.x; Poyart C, 2002, INT J SYST EVOL MICR, V52, P1247, DOI 10.1099/00207713-52-4-1247; Respondek F, 2008, J ANIM SCI, V86, P316, DOI 10.2527/jas.2006-782; ROBINSON J A, 1992, Journal of Animal Science, V70, P310; Schlegel L, 2003, INT J SYST EVOL MICR, V53, P631, DOI 10.1099/ijs.0.02361-0; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; van Eps AW, 2006, EQUINE VET J, V38, P203, DOI 10.2746/042516406776866327; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806	51	59	60	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e77599	10.1371/journal.pone.0077599	http://dx.doi.org/10.1371/journal.pone.0077599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098591	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100087
J	DeKrey, GK; Teagarden, RE; Lenberg, JL; Titus, RG				DeKrey, Gregory K.; Teagarden, Riane E.; Lenberg, Jerica L.; Titus, Richard G.			2,3,7,8-Tetrachlorodibenzo-p-dioxin Slows the Progression of Experimental Cutaneous Leishmaniasis in Susceptible BALB/c and SCID Mice	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; STREPTOCOCCUS-PNEUMONIAE; COSTIMULATORY MOLECULES; INFLAMMATORY RESPONSE; NITRIC-OXIDE; IFN-GAMMA; IN-VITRO; TCDD; CELLS; ACTIVATION	In a model of experimental cutaneous leishmaniasis, pre-exposure of Leishmania major-resistant mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), an aryl hydrocarbon receptor agonist, causes suppression of the protective anti-parasite T helper 1 response while paradoxically also reducing parasite burdens in those animals. In this study, we examined if TCDD exposure could also reduce parasite burdens in L. major-susceptible BALB/c mice. In the highest dose group (160 mu g/Kg), TCDD treatment caused a significant reduction of parasite burdens by 10-fold after three weeks while also causing a significant lymphoid atrophy indicating suppression of the non-protective T helper 2 response. A dose-dependent delay of foot lesion progression was also observed such that lesion size in the highest dose group was less than half that of controls after 35 days of infection. Importantly, although TCDD exposure initially reduced disease severity and prolonged the course of disease by as much as three fold in some animals, this effect was transitory and TCDD did not induce resistance to L. major infection. Because TCDD exposure reduced L. major burdens in both resistant and susceptible mice, we hypothesized that TCDD reduces L. major burdens in mice by a mechanism that does not involve adaptive immunity. To test this, severe combined immunodeficient (SCID) mice were used. In mice infected with a moderate number of L. major (10,000), TCDD treatment caused a time-and dose-dependent decrease of parasite burdens by nearly 100-fold after six weeks in the highest dose group (200 mu g/Kg). A significant and dose-dependent delay of foot lesion progression was also observed in these animals. These results indicate that TCDD exposure can reduce the severity of leishmanial disease in mice independent of adaptive immunity.	[DeKrey, Gregory K.; Teagarden, Riane E.; Lenberg, Jerica L.] Univ No Colorado, Sch Biol Sci, Coll Nat & Hlth Sci, Greeley, CO 80639 USA; [Titus, Richard G.] Colorado State Univ, Coll Vet & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of Northern Colorado; Colorado State University	DeKrey, GK (corresponding author), Univ No Colorado, Sch Biol Sci, Coll Nat & Hlth Sci, Greeley, CO 80639 USA.	gregory.dekrey@unco.edu			Colorado State University; University of Northern Colorado; Public Health Service grant from the National Institute of Allergy and Infectious Disease [29955]	Colorado State University; University of Northern Colorado; Public Health Service grant from the National Institute of Allergy and Infectious Disease	Supported by Colorado State University: http://www.colostate.edu; University of Northern Colorado: http://www.unco.edu; and Public Health Service grant 29955 from the National Institute of Allergy and Infectious Disease: http://www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Antoine JC, 1998, TRENDS MICROBIOL, V6, P392, DOI 10.1016/S0966-842X(98)01324-9; Benson JM, 2011, TOXICOL SCI, V120, P68, DOI 10.1093/toxsci/kfq360; Birnbaum LS, 2000, FOOD ADDIT CONTAM A, V17, P275, DOI 10.1080/026520300283351; Bogdan C, 1996, CURR OPIN IMMUNOL, V8, P517, DOI 10.1016/S0952-7915(96)80040-9; Bowers OJ, 2006, AM J TROP MED HYG, V75, P749, DOI 10.4269/ajtmh.2006.75.749; Brodskyn CI, 2001, INFECT IMMUN, V69, P665, DOI 10.1128/IAI.69.2.665-672.2001; CLARK GC, 1994, EXP CLIN IMMUNOGENET, V11, P136; CORRADIN SB, 1991, J IMMUNOL, V146, P279; Corsini E, 2011, J IMMUNOTOXICOL, V8, P251, DOI 10.3109/1547691X.2011.598885; DEKREY GK, 1995, TOXICOLOGY, V97, P105, DOI 10.1016/0300-483X(94)02929-O; DeKrey GK, 1999, J IMMUNOL METHODS, V228, P1, DOI 10.1016/S0022-1759(99)00085-X; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dong B, 2008, MOL PHARMACOL, V74, P255, DOI 10.1124/mol.107.044669; Elizondo G, 2011, INT J BIOL SCI, V7, P1220, DOI 10.7150/ijbs.7.1220; EVANS TG, 1993, J IMMUNOL, V151, P907; Frericks M, 2007, TOXICOL APPL PHARM, V220, P320, DOI 10.1016/j.taap.2007.01.014; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Goto Y, 2007, PARASITOL INT, V56, P231, DOI 10.1016/j.parint.2007.02.007; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; GREEN SJ, 1990, J IMMUNOL, V145, P4290; GREIG JB, 1984, TOXICOL APPL PHARM, V74, P17, DOI 10.1016/0041-008X(84)90265-5; GUY RA, 1995, CLIN EXP IMMUNOL, V100, P440; Haarmann-Stemmann T, 2009, BIOCHEM PHARMACOL, V77, P508, DOI 10.1016/j.bcp.2008.09.013; Hezarjaribi HZ, 2013, EXP PARASITOL, V134, P341, DOI 10.1016/j.exppara.2013.03.012; HINSDILL RD, 1980, J ENVIRON PATHOL TOX, V4, P401; HOLSAPPLE MP, 1991, ANNU REV PHARMACOL, V31, P73; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Laberton J, 1979, Am Ind Hyg Assoc J, V40, P816; LATCHNEY SE, 2012, J NEUROCHEM; Launois P, 1998, Int Rev Immunol, V17, P157, DOI 10.3109/08830189809084491; LIEW FY, 1990, IMMUNOLOGY, V71, P556; LIEW FY, 1989, CLIN EXP IMMUNOL, V75, P438; Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2; Lohoff M, 1998, INT ARCH ALLERGY IMM, V115, P191, DOI 10.1159/000023900; LOUIS J, 1979, EUR J IMMUNOL, V9, P841, DOI 10.1002/eji.1830091103; LUSTER MI, 1980, INT J IMMUNOPHARMACO, V2, P301, DOI 10.1016/0192-0561(80)90030-2; Mbow ML, 2001, EUR J IMMUNOL, V31, P1400, DOI 10.1002/1521-4141(200105)31:5&lt;1400::AID-IMMU1400&gt;3.0.CO;2-J; Moos AB, 1997, TOXICOL LETT, V90, P145, DOI 10.1016/S0378-4274(96)03838-6; MOOS AB, 1994, TOXICOL APPL PHARM, V127, P331, DOI 10.1006/taap.1994.1169; MULLER RL, 1990, MED PARASITOLOGY; Myler PJ, 2008, LEISHMANIA GENOME; National Toxicology Program, 1982, Natl Toxicol Program Tech Rep Ser, V209, P1; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Okwor I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00128; POLAND A, 1994, MOL PHARMACOL, V46, P915; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Shi LZ, 2007, J IMMUNOL, V179, P6952, DOI 10.4049/jimmunol.179.10.6952; Solbach W, 2000, Adv Immunol, V74, P275, DOI 10.1016/S0065-2776(08)60912-8; Steinbrink K, 2000, IMMUNOBIOLOGY, V202, P442, DOI 10.1016/S0171-2985(00)80103-5; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Sugita-Konishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P89, DOI 10.1271/bbb.67.89; Sun YV, 2004, NUCLEIC ACIDS RES, V32, P4512, DOI 10.1093/nar/gkh782; SUNDERKOTTER C, 1993, J IMMUNOL, V151, P4891; TAYLOR MJ, 1992, TOXICOL APPL PHARM, V117, P126, DOI 10.1016/0041-008X(92)90227-J; Temchura VV, 2005, EUR J IMMUNOL, V35, P2738, DOI 10.1002/eji.200425641; TITUS RG, 1989, J EXP MED, V170, P2097, DOI 10.1084/jem.170.6.2097; Titus RG, 2001, INFECT IMMUN, V69, P5189, DOI 10.1128/IAI.69.8.5189-5192.2001; VANDENBERG M, 1994, CRIT REV TOXICOL, V24, P1; VARKILA K, 1993, EUR J IMMUNOL, V23, P262, DOI 10.1002/eji.1830230141; Veiga-Parga T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002427; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel Christoph F A, 2004, Cardiovasc Toxicol, V4, P363, DOI 10.1385/CT:4:4:363; Vogel CFA, 2007, ARCH BIOCHEM BIOPHYS, V461, P169, DOI 10.1016/j.abb.2007.01.015; Vorderstrasse BA, 2006, INFECT IMMUN, V74, P5679, DOI 10.1128/IAI.00837-06; VOS JG, 1974, TOXICOL APPL PHARM, V29, P229, DOI 10.1016/0041-008X(74)90060-X; Wang T, 2012, INT IMMUNOPHARMACOL, V13, P490, DOI 10.1016/j.intimp.2012.05.008	69	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76259	10.1371/journal.pone.0076259	http://dx.doi.org/10.1371/journal.pone.0076259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098456	gold, Green Published			2022-12-27	WOS:000325427100051
J	Raida, Z; Hundahl, CA; Nyengaard, JR; Hay-Schmidt, A				Raida, Zindy; Hundahl, Christian Ansgar; Nyengaard, Jens R.; Hay-Schmidt, Anders			Neuroglobin Over Expressing Mice: Expression Pattern and Effect on Brain Ischemic Infarct Size	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CYTOGLOBIN EXPRESSION; PROTECTS NEURONS; MESSENGER-RNA; IN-VIVO; MOUSE; STROKE; OXYGEN; OVEREXPRESSION; OCCLUSION	Background: Stroke is a major cause of death and severe disability, but effective treatments are limited. Neuroglobin, a neuronal heme-globin, has been advocated as a novel pharmacological target in combating stroke and neurodegenerative disorders based on cytoprotective properties. Using thoroughly validated antibodies and oligos, we give a detailed brain anatomical characterization of transgenic mice over expressing Neuroglobin. Moreover, using permanent middle artery occlusion the effect of elevated levels of Neuroglobin on ischemic damage was studied. Lastly, the impact of mouse strain genetic background on ischemic damage was investigated. Principal Findings: A four to five fold increase in Neuroglobin mRNA and protein expression was seen in the brain of transgenic mice. A beta-actin promoter was used to drive Neuroglobin over expression, but immunohistochemistry and in situ hybridization showed over expression to be confined to primarily the cortex, hippocampus, cerebellum, and only in neurons. The level and expression pattern of endogenous Neuroglobin was unaffected by insertion of the over expressing Ngb transgene. Neuroglobin over expression resulted in a significant reduction in infarct volume 24 hours after ischemia. Immunohistochemistry showed no selective sparing of Neuroglobin expressing cells in the ischemic core or penumbra. A significant difference in infarct volume was found between mice of the same strain, but from different colonies. Significance: In contrast to some previous reports, Neuroglobin over expression is not global but confined to a few welldefined brain regions, and only in neurons. This study confirms previous reports showing a correlation between reduced infarct volume and elevated Neuroglobin levels, but underlines the need to study the likely contribution from compensatory mechanisms to the phenotype following a genetic perturbation. We also stress, that care should be taken when comparing results where different mouse strains and colonies have been used due to large genetic background contribution to the observed phenotype.	[Raida, Zindy; Hay-Schmidt, Anders] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Hundahl, Christian Ansgar] Univ Tartu, Ctr Excellence Translat Med, EE-50090 Tartu, Estonia; [Nyengaard, Jens R.] Aarhus Univ, Ctr Stochast Geometry & Adv Bioimaging, Stereol & Elect Microscopy Lab, Aarhus, Denmark	University of Copenhagen; University of Tartu; Aarhus University	Raida, Z (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	zindy@sund.ku.dk; c.hundahl@gmail.com; ahay@sund.ku.dk	Hundahl, Christian Ansgar/H-3938-2015		Lundbeck Foundation; NOVO-Nordisk Foundation; Foundation for Providing Medical Research; Hartmann Foundation, the Estonian Ministry of Science and Education [GARFS0120P]; European Regional Development Fund; Villum Foundation; Lundbeck Foundation [R77-2010-7108] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); NOVO-Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Foundation for Providing Medical Research; Hartmann Foundation, the Estonian Ministry of Science and Education; European Regional Development Fund(European Commission); Villum Foundation(Villum Fonden); Lundbeck Foundation(Lundbeckfonden)	Financial support was given by Lundbeck Foundation, the NOVO-Nordisk Foundation, the Foundation for Providing Medical Research, the Hartmann Foundation, the Estonian Ministry of Science and Education (GARFS0120P) and the European Regional Development Fund. Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brittain Thomas, 2012, Cells, V1, P1133, DOI 10.3390/cells1041133; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dietz GPH, 2011, EXP NEUROL, V231, P1, DOI 10.1016/j.expneurol.2011.05.010; Eberspacher E, 2009, ACTA ANAESTH SCAND, V53, P774, DOI 10.1111/j.1399-6576.2009.01954.x; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Fordel E, 2007, FEBS J, V274, P1312, DOI 10.1111/j.1742-4658.2007.05679.x; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Heuschmann PU, 2009, STROKE, V40, P1557, DOI 10.1161/STROKEAHA.108.535088; Hundahl CA, 2012, BIOCHEM BIOPH RES CO, V425, P100, DOI 10.1016/j.bbrc.2012.07.061; Hundahl C, 2006, BRAIN RES, V1085, P19, DOI 10.1016/j.brainres.2006.02.040; Hundahl CA, 2013, BRAIN STRUCT FUNCT, V218, P603, DOI 10.1007/s00429-012-0480-8; Hundahl CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028160; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; Khan AA, 2007, GENE, V398, P172, DOI 10.1016/j.gene.2007.02.044; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Lee HM, 2011, FREE RADICAL BIO MED, V51, P2281, DOI 10.1016/j.freeradbiomed.2011.09.026; Li RC, 2010, J CEREBR BLOOD F MET, V30, P1874, DOI 10.1038/jcbfm.2010.90; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majid A, 2000, STROKE, V31, P2707, DOI 10.1161/01.STR.31.11.2707; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Raida Z, 2012, BIOCHEM BIOPH RES CO, V424, P274, DOI 10.1016/j.bbrc.2012.06.105; Schellinger PD, 2001, CRIT CARE MED, V29, P1812, DOI 10.1097/00003246-200109000-00027; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Schmidt-Kastner R, 2006, BRAIN RES, V1103, P173, DOI 10.1016/j.brainres.2006.05.047; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Truelsen T, 2005, EUR J NEUROL, V12, P78, DOI 10.1111/j.1468-1331.2005.01199.x; Wang SL, 2010, CIRC RES, V107, P558, DOI 10.1161/CIRCRESAHA.110.224634; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; WARD R, 1985, BEHAV GENET, V15, P537, DOI 10.1007/BF01065449; WARD R, 1990, J ANAT, V173, P87; Williams RS, 2000, J APPL PHYSIOL, V88, P1119, DOI 10.1152/jappl.2000.88.3.1119; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10	48	32	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76565	10.1371/journal.pone.0076565	http://dx.doi.org/10.1371/journal.pone.0076565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098534	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100077
J	Docampo, E; Collado, A; Escaramis, G; Carbonell, J; Rivera, J; Vidal, J; Alegre, J; Rabionet, R; Estivill, X				Docampo, Elisa; Collado, Antonio; Escaramis, Georgia; Carbonell, Jordi; Rivera, Javier; Vidal, Javier; Alegre, Jose; Rabionet, Raquel; Estivill, Xavier			Cluster Analysis of Clinical Data Identifies Fibromyalgia Subgroups	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; SYMPTOM CLUSTERS; HEALTH SURVEY; FATIGUE; SEVERITY; IMPACT; SCALE; PAIN; DEFINITION; VALIDATION	Introduction: Fibromyalgia (FM) is mainly characterized by widespread pain and multiple accompanying symptoms, which hinder FM assessment and management. In order to reduce FM heterogeneity we classified clinical data into simplified dimensions that were used to define FM subgroups. Material and Methods: 48 variables were evaluated in 1,446 Spanish FM cases fulfilling 1990 ACR FM criteria. A partitioning analysis was performed to find groups of variables similar to each other. Similarities between variables were identified and the variables were grouped into dimensions. This was performed in a subset of 559 patients, and cross-validated in the remaining 887 patients. For each sample and dimension, a composite index was obtained based on the weights of the variables included in the dimension. Finally, a clustering procedure was applied to the indexes, resulting in FM subgroups. Results: Variables clustered into three independent dimensions: "symptomatology", "comorbidities" and "clinical scales". Only the two first dimensions were considered for the construction of FM subgroups. Resulting scores classified FM samples into three subgroups: low symptomatology and comorbidities (Cluster 1), high symptomatology and comorbidities (Cluster 2), and high symptomatology but low comorbidities (Cluster 3), showing differences in measures of disease severity. Conclusions: We have identified three subgroups of FM samples in a large cohort of FM by clustering clinical data. Our analysis stresses the importance of family and personal history of FM comorbidities. Also, the resulting patient clusters could indicate different forms of the disease, relevant to future research, and might have an impact on clinical assessment.	[Docampo, Elisa; Escaramis, Georgia; Rabionet, Raquel; Estivill, Xavier] CRG, Genom & Dis Grp, Barcelona, Spain; [Docampo, Elisa; Escaramis, Georgia; Rabionet, Raquel; Estivill, Xavier] Univ Pompeu Fabra, Barcelona, Spain; [Docampo, Elisa; Escaramis, Georgia; Rabionet, Raquel; Estivill, Xavier] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [Collado, Antonio] Hosp Clin Barcelona, Rheumatol Serv, Fibromyalgia Unit, Barcelona, Spain; [Carbonell, Jordi] Parc Salut Mar, Rheumatol Serv, Fibromyalgia Unit, Barcelona, Spain; [Carbonell, Jordi] Hosp del Mar, Res Inst, Barcelona, Spain; [Rivera, Javier] Hosp Univ Gregorio Maranon, Inst Prov Rehabil, Rheumatol Unit, Madrid, Spain; [Vidal, Javier] Hosp Gen Guadalajara, Rheumatol Unit, Guadalajara, Spain; [Alegre, Jose] Hosp Valle De Hebron, Chron Fatigue Syndrome Unit, Barcelona, Spain; [Collado, Antonio; Carbonell, Jordi; Rivera, Javier; Vidal, Javier; Alegre, Jose] Fdn Fibromyalgia & Fatigue, Fibromyalgia & Chron Fatigue Syndrome Spanish Gen, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; General University Gregorio Maranon Hospital; Hospital Universitari Vall d'Hebron	Collado, A (corresponding author), Hosp Clin Barcelona, Rheumatol Serv, Fibromyalgia Unit, Barcelona, Spain.	ACOLLADO@clinic.ub.es	Escaramis, Georgia/B-2997-2015; Estivill, Xavier/A-3125-2013; Alegre, Jose/M-7218-2014; Rabionet, Raquel/C-8379-2009; Escaramis, Georgia/AAR-5586-2020; rabionet, raquel/A-7407-2009	Escaramis, Georgia/0000-0002-5416-3177; Estivill, Xavier/0000-0002-0723-2256; Alegre, Jose/0000-0002-7582-7585; Rabionet, Raquel/0000-0001-5006-8140; rabionet, raquel/0000-0001-5006-8140	Foundation FF of affected people with Fibromyalgia and/or Chronic Fatigue Syndrome; Lilly Foundation; Spanish Ministry of Health (FIS-PFIS)	Foundation FF of affected people with Fibromyalgia and/or Chronic Fatigue Syndrome; Lilly Foundation; Spanish Ministry of Health (FIS-PFIS)	This study was supported by an unrestricted grant provided by the Foundation FF of affected people with Fibromyalgia and/or Chronic Fatigue Syndrome, and by the Lilly Foundation to Xavier Estivill. Elisa Docampo is supported by the Spanish Ministry of Health (FIS-PFIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas A, 2010, PALLIATIVE MED, V24, P373, DOI 10.1177/0269216310367842; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Benito-Leon J, 2007, MULT SCLER J, V13, P645, DOI 10.1177/1352458506073528; Bennett RM, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-134; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Collado AG-MA, 2011, PAIN EUR 7 7 C EUR F; Cuesta-Vargas A, 2012, QUAL LIFE RES; de Souza JB, 2009, RHEUMATOL INT, V29, P509, DOI 10.1007/s00296-008-0722-5; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gaston-Johansson F, 1999, CANCER PRACT, V7, P240, DOI 10.1046/j.1523-5394.1999.75008.x; Giesecke T, 2003, ARTHRITIS RHEUM, V48, P2916, DOI 10.1002/art.11272; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Hurtig IM, 2001, CLIN J PAIN, V17, P316, DOI 10.1097/00002508-200112000-00005; Kashikar-Zuck S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1392, DOI 10.1002/art.24099; Kindler LL, 2010, J PAIN, V11, P1320, DOI 10.1016/j.jpain.2010.03.007; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Loevinger BL, 2012, CLIN RHEUMATOL; Okifuji A, 1997, J RHEUMATOL, V24, P377; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Rutledge DN, 2009, NURS RES, V58, P359, DOI 10.1097/NNR.0b013e3181b499d2; Silverman S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-66; Turk DC, 1998, ARTHRIT CARE RES, V11, P397, DOI 10.1002/art.1790110511; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson HD, 2009, ARTHRIT RHEUM-ARTHR, V61, P527, DOI 10.1002/art.24163; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zigmond AS, 1983, PSYCHIAT SCAND, V76, P361, DOI [DOI 10.1111/J.1600-0447.1983.TB09716.X, DOI 10.1111/J.1600-0447.1983.TB09716.X.PUBMED:6880820]	32	44	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74873	10.1371/journal.pone.0074873	http://dx.doi.org/10.1371/journal.pone.0074873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098674	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500045
J	Flores, F; Collier, CJ; Mercurio, P; Negri, AP				Flores, Florita; Collier, Catherine J.; Mercurio, Philip; Negri, Andrew P.			Phytotoxicity of Four Photosystem II Herbicides to Tropical Seagrasses	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ECOSYSTEM SERVICES; PSII HERBICIDES; HERVEY BAY; ATRAZINE; TOXICITY; DIURON; EXPOSURE; IMPACT; PESTICIDE	Coastal waters of the Great Barrier Reef (GBR) are contaminated with agricultural pesticides, including the photosystem II (PSII) herbicides which are the most frequently detected at the highest concentrations. Designed to control weeds, these herbicides are equally potent towards non-target marine species, and the close proximity of seagrass meadows to flood plumes has raised concerns that seagrasses may be the species most threatened by herbicides from runoff. While previous work has identified effects of PSII herbicides on the photophysiology, growth and mortality in seagrass, there is little comparative quantitative toxicity data for seagrass. Here we applied standard ecotoxicology protocols to quantify the concentrations of four priority PSII herbicides that inhibit photochemistry by 10, 20 and 50% (IC10, IC20 and IC50) over 72 h in two common seagrass species from the GBR lagoon. The photosystems of seagrasses Zostera muelleri and Halodule uninervis were shown to be generally more sensitive to the PSII herbicides Diuron, Atrazine, Hexazinone and Tebuthiuron than corals and tropical microalgae. The herbicides caused rapid inhibition of effective quantum yield (Delta F/F-m'), indicating reduced photosynthesis and maximum effective yields (F-v/F-m) corresponding to chronic damage to PSII. The PSII herbicide concentrations which affected photosynthesis have been exceeded in the GBR lagoon and all of the herbicides inhibited photosynthesis at concentrations lower than current marine park guidelines. There is a strong likelihood that the impacts of light limitation from flood plumes and reduced photosynthesis from PSII herbicides exported in the same waters would combine to affect seagrass productivity. Given that PSII herbicides have been demonstrated to affect seagrass at environmental concentrations, we suggest that revision of environmental guidelines and further efforts to reduce PSII herbicide concentrations in floodwaters may both help protect seagrass meadows of the GBR from further decline.	[Flores, Florita; Mercurio, Philip; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Collier, Catherine J.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Mercurio, Philip] Univ Queensland, Sch Med, Coopers Plains, Qld, Australia; [Mercurio, Philip] Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia	Australian Institute of Marine Science; James Cook University; University of Queensland	Negri, AP (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	a.negri@aims.gov.au	Collier, Catherine/M-6308-2014; Negri, Andrew P/G-9909-2017; Flores, Florita/I-3033-2017	Collier, Catherine/0000-0001-9494-6582; Negri, Andrew P/0000-0003-1388-7395; Flores, Florita/0000-0003-4637-1379	Australian Government [4.2]	Australian Government(Australian GovernmentCGIAR)	This research was conducted with the support of funding from the Australian Government's National Environmental Research Program (http://www.environment.gov.au/index.html) NERP Tropical Ecosystems Hub Project 4.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan S, 2012, GEOCHEM J, V46, P169, DOI 10.2343/geochemj.1.0163; Barrett K, 2012, INT J ENVIRON HEAL R, V22, P481, DOI 10.1080/09603123.2012.667794; BAYLEY S, 1978, ESTUARIES, V1, P73; Chesworth JC, 2004, AQUAT TOXICOL, V66, P293, DOI 10.1016/j.aquatox.2003.10.002; Collier CJ, 2012, ECOL INDIC, V23, P211, DOI 10.1016/j.ecolind.2012.04.005; Collier CJ, 2012, MAR POLLUT BULL, V65, P342, DOI 10.1016/j.marpolbul.2011.06.017; Collier CJ, 2011, LIMNOL OCEANOGR, V56, P2200, DOI 10.4319/lo.2011.56.6.2200; CORRELL DL, 1982, AQUAT BOT, V14, P151, DOI 10.1016/0304-3770(82)90094-8; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cullen-Unsworth L, 2013, ENVIRONMENT, V55, P14, DOI 10.1080/00139157.2013.785864; Davis AM, 2012, MAR POLLUT BULL, V65, P182, DOI 10.1016/j.marpolbul.2011.08.025; DELISTRATY DA, 1984, AQUAT BOT, V18, P353, DOI 10.1016/0304-3770(84)90056-1; den Hartog C., 1975, AQUAT BOT, V1, P141, DOI DOI 10.1016/0304-3770(75)90019-4; Devault AD, 2013, SCIENCE, V340, P353; Escher BI, 2008, J ENVIRON MONITOR, V10, P612, DOI 10.1039/b800949j; Fabricius KE, 2013, ESTUAR COAST SHELF S, V116, P57, DOI 10.1016/j.ecss.2012.03.010; Gao YP, 2011, MAR POLLUT BULL, V62, P1628, DOI 10.1016/j.marpolbul.2011.06.014; GBRMPA, 2010, WAT QUAL GUID GREAT; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Haynes D, 2000, MAR POLLUT BULL, V41, P288, DOI 10.1016/S0025-326X(00)00127-2; Haynes D, 2000, MAR POLLUT BULL, V41, P279, DOI 10.1016/S0025-326X(00)00097-7; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; JOHNSON JR, 1995, BOT MAR, V38, P307, DOI 10.1515/botm.1995.38.1-6.307; Jones R, 2005, MAR POLLUT BULL, V51, P495, DOI 10.1016/j.marpolbul.2005.06.027; Jones RJ, 2004, MAR ECOL PROG SER, V284, P133, DOI 10.3354/meps284133; Jones RJ, 2003, MAR ECOL PROG SER, V261, P149, DOI 10.3354/meps261149; Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153; JONES TW, 1984, J ENVIRON QUAL, V13, P243, DOI 10.2134/jeq1984.00472425001300020014x; Kennedy K, 2012, MAR POLLUT BULL, V65, P292, DOI 10.1016/j.marpolbul.2011.10.029; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Lewis SE, 2011, 19TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2011), P2051; Lewis SE, 2012, MAR POLLUT BULL, V65, P280, DOI 10.1016/j.marpolbul.2011.11.009; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Limpus CJ, 2012, MARINE WILDLIFE STRA, V3, P1; Longstaff BJ, 1999, AQUAT BOT, V65, P105, DOI 10.1016/S0304-3770(99)00035-2; Lough J., 2007, CLIMATE CHANGE GREAT, P15; Macinnis-Ng CMO, 2004, AQUAT TOXICOL, V67, P227, DOI 10.1016/j.aquatox.2004.01.012; Magnusson M, 2013, WATER RES, V47, P5211, DOI 10.1016/j.watres.2013.06.003; Magnusson M, 2010, MAR POLLUT BULL, V60, P1978, DOI 10.1016/j.marpolbul.2010.07.031; Marsh H., 2012, ECOLOGY CONSERVATION, DOI [10.1017/CBO9781139013277, DOI 10.1017/CBO9781139013277]; McMahon K, 2005, MAR POLLUT BULL, V51, P325, DOI 10.1016/j.marpolbul.2004.10.045; Muller R, 2008, SCI TOTAL ENVIRON, V401, P51, DOI 10.1016/j.scitotenv.2008.02.062; Nash SMB, 2005, MAR POLLUT BULL, V51, P351, DOI 10.1016/j.marpolbul.2004.10.017; Nasha SMB, 2005, BIOSENS BIOELECTRON, V20, P1443, DOI 10.1016/j.bios.2004.09.019; Negri AP, 2011, LIMNOL OCEANOGR, V56, P471, DOI 10.4319/lo.2011.56.2.0471; Oettmeier W., 1992, PHOTOSYSTEMS STRUCTU, V11, P349; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Osmond CB, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P1; Packett R, 2009, MAR POLLUT BULL, V58, P976, DOI 10.1016/j.marpolbul.2009.02.017; Ralph P. J., 2007, Toxicological and Environmental Chemistry, V89, P589, DOI 10.1080/02772240701561593; Ralph PJ, 2000, AQUAT BOT, V66, P141, DOI 10.1016/S0304-3770(99)00024-8; Scarlett A, 1999, AQUAT TOXICOL, V45, P159, DOI 10.1016/S0166-445X(98)00098-8; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Schreiber U, 2007, BIOSENS BIOELECTRON, V22, P2554, DOI 10.1016/j.bios.2006.10.018; SCHWARZSCHILD AC, 1994, J EXP MAR BIOL ECOL, V183, P77, DOI 10.1016/0022-0981(94)90158-9; Shaw CM, 2008, MAR POLLUT BULL, V57, P473, DOI 10.1016/j.marpolbul.2008.04.002; Shaw M, 2005, MAR POLLUT BULL, V51, P876, DOI 10.1016/j.marpolbul.2005.04.015; Shaw M, 2010, MAR POLLUT BULL, V60, P113, DOI 10.1016/j.marpolbul.2009.08.026; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P155; Smith R, 2012, MAR POLLUT BULL, V65, P117, DOI 10.1016/j.marpolbul.2011.08.010; Tomlin C., 2000, PESTICIDE MANUAL WOR; van Dam JW, 2012, MAR POLLUT BULL, V65, P373, DOI 10.1016/j.marpolbul.2011.08.008; Wahedally S.F., 2012, TANZ J NAT APPL SCI, V3, P458; WALSH GE, 1982, MAR ENVIRON RES, V7, P1, DOI 10.1016/0141-1136(82)90047-2; Warne Michael St J., 2008, Australasian Journal of Ecotoxicology, V14, P1; Waters DK, 2013, TECHNICAL REPORT; Waycott M., 2004, GUIDE TROPICAL SEAGR, P72; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481	69	48	50	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75798	10.1371/journal.pone.0075798	http://dx.doi.org/10.1371/journal.pone.0075798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098726	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325423500097
J	Lomate, PR; Jadhav, BR; Giri, AP; Hivrale, VK				Lomate, Purushottam R.; Jadhav, Bhakti R.; Giri, Ashok P.; Hivrale, Vandana K.			Alterations in the Helicoverpa armigera Midgut Digestive Physiology after Ingestion of Pigeon Pea Inducible Leucine Aminopeptidase	PLOS ONE			English	Article							POLYPHENOL OXIDASE; PLANT DEFENSE; JASMONATE; MECHANISM; ELECTROPHORESIS; OVEREXPRESSION; PURIFICATION; HERBIVORES; RESISTANCE; INHIBITORS	Jasmonate inducible plant leucine aminopeptidase (LAP) is proposed to serve as direct defense in the insect midgut. However, exact functions of inducible plant LAPs in the insect midgut remain to be estimated. In the present investigation, we report the direct defensive role of pigeon pea inducible LAP in the midgut of Helicoverpa armigera (Lepidoptera: Noctuidae) and responses of midgut soluble aminopeptidases and serine proteinases upon LAP ingestion. Larval growth and survival was significantly reduced on the diets supplemented with pigeon pea LAP. Aminopeptidase activities in larvae remain unaltered in presence or absence of inducible LAP in the diet. On the contrary, serine proteinase activities were significantly decreased in the larvae reared on pigeon pea LAP containing diet as compared to larvae fed on diet without LAP. Our data suggest that pigeon pea inducible LAP is responsible for the degradation of midgut serine proteinases upon ingestion. Reduction in the aminopeptidase activity with LpNA in the H. armigera larvae was compensated with an induction of aminopeptidase activity with ApNA. Our findings could be helpful to further dissect the roles of plant inducible LAPs in the direct plant defense against herbivory.	[Lomate, Purushottam R.; Jadhav, Bhakti R.; Hivrale, Vandana K.] Dr Babasaheb Ambedkar Marathwada Univ, Dept Biochem, Aurangabad, Maharashtra, India; [Lomate, Purushottam R.; Giri, Ashok P.] CSIR, Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Unit, Pune, Maharashtra, India	Dr. Babasaheb Ambedkar Marathwada University (BAMU); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Hivrale, VK (corresponding author), Dr Babasaheb Ambedkar Marathwada Univ, Dept Biochem, Aurangabad, Maharashtra, India.	vkhbiochem@gmail.com		Lomate, Purushottam/0000-0003-4765-3597	Department of Biotechnology (DBT), Government of India, New Delhi	Department of Biotechnology (DBT), Government of India, New Delhi(Department of Biotechnology (DBT) India)	PRL acknowledges support from Department of Biotechnology (DBT), Government of India, New Delhi for Research Associateship.	Bozic N, 2003, COMP BIOCHEM PHYS B, V134, P231, DOI 10.1016/S1096-4959(02)00257-9; Bozic NA, 2005, ELECTROPHORESIS, V26, P2476, DOI 10.1002/elps.200500047; BROADWAY RM, 1988, J INSECT PHYSIOL, V34, P1111, DOI 10.1016/0022-1910(88)90213-2; BROADWAY RM, 1995, J INSECT PHYSIOL, V41, P107, DOI 10.1016/0022-1910(94)00101-L; BROADWAY RM, 1986, J INSECT PHYSIOL, V32, P827, DOI 10.1016/0022-1910(86)90097-1; Chao WS, 1999, PLANT PHYSIOL, V120, P979, DOI 10.1104/pp.120.4.979; Chao WS, 2000, PLANTA, V210, P563, DOI 10.1007/s004250050045; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Duffey SS, 1996, ARCH INSECT BIOCHEM, V32, P3, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;3::AID-ARCH2&gt;3.0.CO;2-1; Felicioli R, 1997, ANAL BIOCHEM, V244, P176, DOI 10.1006/abio.1996.9917; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Hartl M, 2008, NEW PHYTOL, V179, P356, DOI 10.1111/j.1469-8137.2008.02479.x; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Lomate PR, 2011, PLANT PHYSIOL BIOCH, V49, P609, DOI 10.1016/j.plaphy.2011.02.023; Lomate PR, 2010, COMP BIOCHEM PHYS B, V155, P164, DOI 10.1016/j.cbpb.2009.10.018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahanil S, 2008, PLANT SCI, V174, P456, DOI 10.1016/j.plantsci.2008.01.006; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; MCDONALD JK, 1986, MAMMALIAN PROTEASES, V2; Nagarkatti S., 1974, TECHNICAL B COMMONWE, V17; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Pechan T, 2002, P NATL ACAD SCI USA, V99, P13319, DOI 10.1073/pnas.202224899; RENDUELES PS, 1988, FEMS MICROBIOL LETT, V54, P17; Walling LL, 2006, CURR OPIN PLANT BIOL, V9, P227, DOI 10.1016/j.pbi.2006.03.009; WALLING LL, 1996, AMINOPEPTIDASES, P174	32	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74889	10.1371/journal.pone.0074889	http://dx.doi.org/10.1371/journal.pone.0074889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098675	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500046
J	Mezzaroba, N; Zorzet, S; Secco, E; Biffi, S; Tripodo, C; Calvaruso, M; Mendoza-Maldonado, R; Capolla, S; Granzotto, M; Spretz, R; Larsen, G; Noriega, S; Lucafo, M; Mansilla, E; Garrovo, C; Marin, GH; Baj, G; Gattei, V; Pozzato, G; Nunez, L; Macor, P				Mezzaroba, Nelly; Zorzet, Sonia; Secco, Erika; Biffi, Stefania; Tripodo, Claudio; Calvaruso, Marco; Mendoza-Maldonado, Ramiro; Capolla, Sara; Granzotto, Marilena; Spretz, Ruben; Larsen, Gustavo; Noriega, Sandra; Lucafo, Marianna; Mansilla, Eduardo; Garrovo, Chiara; Marin, Gustavo H.; Baj, Gabriele; Gattei, Valter; Pozzato, Gabriele; Nunez, Luis; Macor, Paolo			New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine- Loaded Anti-CD20 Nanoparticles	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MONOCLONAL-ANTIBODY; IN-VIVO; BIODEGRADABLE NANOPARTICLES; LYMPHOMA-CELLS; CANCER; RITUXIMAB; COMPLEMENT; HYDROXYCHLOROQUINE; CD55	Current B-cell disorder treatments take advantage of dose-intensive chemotherapy regimens and immunotherapy via use of monoclonal antibodies. Unfortunately, they may lead to insufficient tumor distribution of therapeutic agents, and often cause adverse effects on patients. In this contribution, we propose a novel therapeutic approach in which relatively high doses of Hydroxychloroquine and Chlorambucil were loaded into biodegradable nanoparticles coated with an anti-CD20 antibody. We demonstrate their ability to effectively target and internalize in tumor B-cells. Moreover, these nanoparticles were able to kill not only p53 mutated/deleted lymphoma cell lines expressing a low amount of CD20, but also circulating primary cells purified from chronic lymphocitic leukemia patients. Their safety was demonstrated in healthy mice, and their therapeutic effects in a new model of Burkitt's lymphoma. The latter serves as a prototype of an aggressive lymphoproliferative disease. In vitro and in vivo data showed the ability of anti-CD20 nanoparticles loaded with Hydroxychloroquine and Chlorambucil to increase tumor cell killing in comparison to free cytotoxic agents or Rituximab. These results shed light on the potential of anti-CD20 nanoparticles carrying Hydroxychloroquine and Chlorambucil for controlling a disseminated model of aggressive lymphoma, and lend credence to the idea of adopting this therapeutic approach for the treatment of B-cell disorders.	[Mezzaroba, Nelly; Zorzet, Sonia; Secco, Erika; Capolla, Sara; Lucafo, Marianna; Baj, Gabriele; Macor, Paolo] Univ Trieste, Dept Life Sci, Trieste, Italy; [Biffi, Stefania; Granzotto, Marilena] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Tripodo, Claudio; Calvaruso, Marco] Univ Palermo, Dept Human Pathol, Palermo, Italy; [Mendoza-Maldonado, Ramiro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34012 Trieste, Italy; [Spretz, Ruben; Larsen, Gustavo; Noriega, Sandra] LNK Chemsolut LLC, Lincoln, NE USA; [Larsen, Gustavo; Nunez, Luis] Biotarget, Chicago, IL USA; [Mansilla, Eduardo; Marin, Gustavo H.] Minist Hlth, Ctr Unico Coordinador Ablac & Implante Prov Bueno, La Plata, Buenos Aires, Argentina; [Garrovo, Chiara] Opt Imaging Lab, Cluster BioMed, Trieste, Italy; [Gattei, Valter] Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, I-33081 Aviano, Italy; [Pozzato, Gabriele] Univ Trieste, Dipartimento Univ Clin Sci Med Chirurg & Salute, Trieste, Italy; [Nunez, Luis] Univ Chicago, Chicago, IL 60637 USA	University of Trieste; IRCCS Burlo Garofolo; University of Palermo; International Center for Genetic Engineering & Biotechnology (ICGEB); IRCCS Aviano (CRO); University of Trieste; University of Chicago	Macor, P (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	pmacor@units.it	Tripodo, Claudio/O-4536-2016; Biffi, Stefania/C-6652-2015; Lucafo, Marianna/K-2312-2018; Tripodo, Claudio/AAB-6004-2022; Gattei, Valter/AAB-5048-2020; Baj, Gabriele/H-4228-2012	Tripodo, Claudio/0000-0002-0821-6231; Biffi, Stefania/0000-0003-2257-2053; Lucafo, Marianna/0000-0003-1355-3782; Tripodo, Claudio/0000-0002-0821-6231; Gattei, Valter/0000-0001-5933-9680; Macor, Paolo/0000-0003-3079-4019; Marin, Gustavo/0000-0002-6380-6453; Baj, Gabriele/0000-0002-2625-9454; Sonia, Zorzet/0000-0001-5161-3542; Garrovo, Chiara/0000-0003-1432-0147; CALVARUSO, MARCO/0000-0003-2387-8273	Italian Association for Cancer Research (AIRC) [12965/2012]; Fondazione Casali - Trieste; National Institutes of Health, USA [2R44CA135906-02]; NATIONAL CANCER INSTITUTE [R44CA135906] Funding Source: NIH RePORTER	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Casali - Trieste; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study has been made possible by research grants from Italian Association for Cancer Research (AIRC. Project nu 12965/2012) and Fondazione Casali - Trieste. Nanoparticles fabrication at LNK Chemsolutions, USA, was possible in part by Grant 2R44CA135906-02 (SBIR Phase II) from the National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008; Agemy L, 2010, BLOOD, V116, P2847, DOI 10.1182/blood-2010-03-274258; Aldoss IT, 2008, ONCOLOGY-NY, V22, P1508; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bae KH, 2011, MOL CELLS, V31, P295, DOI 10.1007/s10059-011-0051-5; Bellosillo B, 2001, BLOOD, V98, P2771, DOI 10.1182/blood.V98.9.2771; Bicho A, 2010, INT J PHARMACEUT, V399, P80, DOI 10.1016/j.ijpharm.2010.08.005; Biffi S, 2008, MOL IMAGING, V7, P272, DOI 10.2310/7290.2008.00028; Bloehdorn J, 2010, J NUCL ACIDS INVESTI, V2, pe8; Cheson BD, 2006, CANCER IMMUNOL IMMUN, V55, P188, DOI 10.1007/s00262-005-0010-0; Chiellini F, 2008, NANOMEDICINE-UK, V3, P367, DOI 10.2217/17435889.3.3.367; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; de Jong D, 2011, J PATHOL, V223, P274, DOI 10.1002/path.2807; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Fayad L, 2007, CLIN LYMPHOMA MYELOM, V8, pS57, DOI 10.3816/CLM.2007.s.034; Feng SS, 2008, BIOMATERIALS, V29, P4146; Feng SS, 2006, NANOMEDICINE-UK, V1, P297, DOI 10.2217/17435889.1.3.297; Golay J, 2000, BLOOD, V95, P3900; Golay J, 2006, HAEMATOL-HEMATOL J, V91, P176; Golay J, 2003, HAEMATOLOGICA, V88, P1002; Jaffe E. S., 2008, WHO CLASSIFICATION T; Johnson NA, 2009, BLOOD, V113, P3773, DOI 10.1182/blood-2008-09-177469; Kalil N, 2000, DRUG AGING, V16, P9, DOI 10.2165/00002512-200016010-00002; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; Lagneaux L, 2002, LEUKEMIA LYMPHOMA, V43, P1087, DOI 10.1080/10428190290021506; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Macor P, 2007, CANCER RES, V67, P10556, DOI 10.1158/0008-5472.CAN-07-1811; Macor P, 2007, IMMUNOL LETT, V111, P6, DOI 10.1016/j.imlet.2007.04.014; Mahoney E, 2012, BLOOD, V120, P1262, DOI 10.1182/blood-2011-12-400184; Malavasi F, 2011, BLOOD, V118, P3470, DOI 10.1182/blood-2011-06-275610; Mansilla E, 2010, CANCER BIOTHER RADIO, V25, P97, DOI 10.1089/cbr.2009.0655; Marin GH, 2010, CURR CLIN PHARMACOL, V5, P246, DOI 10.2174/157488410793352058; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McLaughlin P, 1998, ONCOLOGY-NY, V12, P1763; Mead GM, 2008, BLOOD, V112, P2248, DOI 10.1182/blood-2008-03-145128; Mendoza-Maldonado R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013720; Molyneux EM, 2012, LANCET, V379, P1234, DOI 10.1016/S0140-6736(11)61177-X; Parveen S, 2008, J DRUG TARGET, V16, P108, DOI [10.1080/10611860701794353, 10.1080/10611860701794353 ]; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pridgen EM, 2007, NANOMEDICINE-UK, V2, P669, DOI 10.2217/17435889.2.5.669; Rahim R, 2009, ANTI-CANCER DRUG, V20, P736, DOI 10.1097/CAD.0b013e32832f4e50; Rao DA, 2010, J PHARM SCI-US, V99, P2018, DOI 10.1002/jps.21970; REFF ME, 1994, BLOOD, V83, P435; Rima W, 2013, BIOMATERIALS, V34, P181, DOI 10.1016/j.biomaterials.2012.09.029; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Stein M, 2000, J RHEUMATOL, V27, P2927; Tehrani Rodney, 2008, Semin Ophthalmol, V23, P201, DOI 10.1080/08820530802049962; Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; ZABUCCHI G, 1986, AM J PATHOL, V124, P510; Zauli G, 2011, CLIN CANCER RES, V17, P762, DOI 10.1158/1078-0432.CCR-10-2572; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512; Ziller F, 2005, EUR J IMMUNOL, V35, P2175, DOI 10.1002/eji.200425920	55	26	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74216	10.1371/journal.pone.0074216	http://dx.doi.org/10.1371/journal.pone.0074216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098639	Green Published, gold			2022-12-27	WOS:000325423500010
J	Mirkin, EV; Chang, FS; Kleckner, N				Mirkin, Ekaterina V.; Chang, Frederick S.; Kleckner, Nancy			Dynamic Trans Interactions in Yeast Chromosomes	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; ODORANT RECEPTOR GENES; BUDDING YEAST; EXPRESSION; MEIOSIS; LOCALIZATION; LOCI; TRANSCRIPTION; ORGANIZATION; PROTEINS	Three-dimensional organization of the genome is important for regulation of gene expression and maintenance of genomic stability. It also defines, and is defined by, contacts between different chromosomal loci. Interactions between loci positioned on different chromosomes, i.e. "trans'' interactions are one type of such contacts. Here, we describe a case of inducible trans interaction in chromosomes of the budding yeast S. cerevisiae. Special DNA sequences, inserted in two ectopic chromosomal loci positioned in trans, pair with one another in an inducible manner. The spatial proximity diagnostic of pairing is observable by both chromosome capture analysis (3C) and epifluorescence microscopy in whole cells. Protein synthesis de novo appears to be required for this process. The three-dimensional organization of the yeast nucleus imposes a constraint on such pairing, presumably by dictating the probability with which the two sequences collide with one another.	[Mirkin, Ekaterina V.; Chang, Frederick S.; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu			National Institutes of Health [RO1GM044794, F32GM083427]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794, F32GM083427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant to N.K. from the National Institutes of Health RO1GM044794 and a postdoctoral fellowship to E.M. from the National Institutes of Health F32GM083427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Bateman JR, 2008, GENETICS, V180, P1329, DOI 10.1534/genetics.108.094862; Bateman JR, 2012, G3-GENES GENOM GENET, V2, P731, DOI 10.1534/g3.112.002840; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; Brar GA, 2009, MOL BIOL CELL, V20, P1030, DOI 10.1091/mbc.E08-06-0637; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Burgess SM, 1999, GENE DEV, V13, P1627, DOI 10.1101/gad.13.12.1627; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Gartenberg MR, 2009, GENE DEV, V23, P1027, DOI 10.1101/gad.1805309; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hediger F, 2004, METHOD ENZYMOL, V375, P345; HIRAOKA Y, 1993, J CELL BIOL, V120, P591, DOI 10.1083/jcb.120.3.591; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Hunter N, 2007, MOL GENETICS RECOMBI, P381; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joyce EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002667; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Koeman JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000176; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kundu S, 2007, GENE DEV, V21, P997, DOI 10.1101/gad.1506607; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; LOIDL J, 1990, GENOME, V33, P759, DOI 10.1139/g90-115; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; McIsaac RS, 2011, MOL BIOL CELL, V22, P4447, DOI 10.1091/mbc.E11-05-0466; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Meldi L, 2011, TRENDS CELL BIOL, V21, P701, DOI 10.1016/j.tcb.2011.08.001; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Molnar M, 2008, GENETICS, V178, P99, DOI 10.1534/genetics.107.082826; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Picard D, 1999, NUCL RECEPTORS PRACT, P261; Rog O, 2013, CURR OPIN CELL BIOL; Sadoni N, 2008, CHROMOSOMA, V117, P381, DOI 10.1007/s00412-008-0157-5; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Teller K, 2007, P NATL ACAD SCI USA, V104, P14970, DOI 10.1073/pnas.0704285104; Therizols P, 2010, P NATL ACAD SCI USA, V107, P2025, DOI 10.1073/pnas.0914187107; Thomas SE, 2005, CELL, V123, P555, DOI 10.1016/j.cell.2005.08.043; Tsai JH, 2011, J CELL SCI, V124, P1955, DOI 10.1242/jcs.006387; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Xu M, 2008, BBA-MOL CELL RES, V1783, P2155, DOI 10.1016/j.bbamcr.2008.07.013; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	75	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75895	10.1371/journal.pone.0075895	http://dx.doi.org/10.1371/journal.pone.0075895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098740	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500111
J	Wu, MJ; Zhang, H; Hu, JH; Weng, ZY; Li, CY; Li, H; Zhao, Y; Mei, XF; Ren, F; Li, LH				Wu, Minjun; Zhang, Hua; Hu, Jiehua; Weng, Zhiyong; Li, Chenyuan; Li, Hong; Zhao, Yan; Mei, Xifan; Ren, Fu; Li, Lihua			Isoalantolactone Inhibits UM-SCC-10A Cell Growth via Cell Cycle Arrest and Apoptosis Induction	PLOS ONE			English	Article							S-PHASE ARREST; LEUKEMIA HL-60 CELLS; SESQUITERPENE LACTONES; INULA-HELENIUM; SMALL-MOLECULE; CANCER CELLS; DNA-DAMAGE; DEATH; MITOCHONDRIA; PROGRESSION	Isoalantolactone is a sesquiterpene lactone compound isolated from the roots of Inula helenium L. Previous studies have demonstrated that isoalantolactone possesses antifungal, anti-bacterial, anti-helminthic and anti-proliferative properties in a variety of cells, but there are no studies concerning its effects on head and neck squamous cell carcinoma (HNSCC). In the present study, an MTT assay demonstrated that isoalantolactone has anti-proliferative activity against the HNSCC cell line (UM-SCC-10A). Immunostaining identified that this compound induced UM-SCC-10A cell apoptosis but not necrosis. To explain the molecular mechanisms underlying its effects, flow cytometry and western blot analysis showed that the apoptosis was associated with cell cycle arrest during the G1 phase, up-regulation of p53 and p21, and down-regulation of cyclin D. Furthermore, our results revealed that induction of apoptosis through a mitochondrial pathway led to upregulation of pro-apoptotic protein expression (Bax), down-regulation of anti-apoptotic protein expression (Bcl-2), mitochondrial release of cytochrome c (Cyto c), reduction of mitochondrial membrane potential (MMP) and activation of caspase-3 (Casp-3). Involvement of the caspase apoptosis pathway was confirmed using caspase inhibitor Z-VAD-FMK pretreatment. Together, our findings suggest that isoalantolactone induced caspase-dependent apoptosis via a mitochondrial pathway and was associated with cell cycle arrest in the G1 phase in UM-SCC-10A cells. Therefore, isoalantolactone may become a potential drug for treating HNSCC.	[Wu, Minjun; Zhang, Hua; Weng, Zhiyong; Li, Chenyuan; Li, Hong; Zhao, Yan; Mei, Xifan; Ren, Fu; Li, Lihua] Liaoning Med Univ, Dept Cell Biol & Anat, Jinzhou, Peoples R China; [Hu, Jiehua] Naval Univ, Educ Technol & Simulat Training Ctr, Tianjin, Peoples R China	Jinzhou Medical University; Wuhan Naval University of Engineering	Ren, F (corresponding author), Liaoning Med Univ, Dept Cell Biol & Anat, Jinzhou, Peoples R China.	renpu1970@hotmail.com; lilihua1018@sina.com		REN, Fu/0000-0003-4432-6320	National Natural Science Foundation of China [81200262]; Projects of Science and Technology of Liaoning [20121092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Science and Technology of Liaoning	This work was supported by National Natural Science Foundation of China (No. 81200262), Projects of Science and Technology of Liaoning (No. 20121092). The funder of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Fujimoto K, 1999, INT J CANCER, V81, P637, DOI 10.1002/(SICI)1097-0215(19990517)81:4<637::AID-IJC21>3.0.CO;2-4; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ghantous A, 2010, DRUG DISCOV TODAY, V15, P668, DOI 10.1016/j.drudis.2010.06.002; Hail N, 2005, APOPTOSIS, V10, P687, DOI 10.1007/s10495-005-0792-8; Hall B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-45; Ji YB, 2011, EXP TOXICOL PATHOL, V63, P69, DOI 10.1016/j.etp.2009.09.010; Khan M, 2012, INT J BIOL SCI, V8, P533, DOI 10.7150/ijbs.3753; Konishi T, 2002, BIOL PHARM BULL, V25, P1370, DOI 10.1248/bpb.25.1370; Lawrence NJ, 2001, BIOORG MED CHEM LETT, V11, P429, DOI 10.1016/S0960-894X(00)00686-7; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li Y, 2012, Z NATURFORSCH C, V67, P375; Lu YJ, 2007, TOXICOL IN VITRO, V21, P90, DOI 10.1016/j.tiv.2006.09.008; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Pal HC, 2010, TOXICOL IN VITRO, V24, P1599, DOI 10.1016/j.tiv.2010.06.007; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Tang HJ, 2006, GYNECOL ONCOL, V100, P308, DOI 10.1016/j.ygyno.2005.08.044; Toogood PL, 2002, CURR OPIN CHEM BIOL, V6, P472, DOI 10.1016/S1367-5931(02)00342-3; Torres K, 1998, CANCER RES, V58, P3620; Xie SQ, 2009, TOXICOLOGY, V263, P127, DOI 10.1016/j.tox.2009.07.001; Zhang Siyuan, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P239, DOI 10.2174/1568011053765976; Zhang YX, 2000, CANCER RES, V60, P2025; Zhang Z, 2002, CHEM RES TOXICOL, V15, P950, DOI 10.1021/tx0255018; Zhu HB, 2004, ONCOGENE, V23, P4984, DOI 10.1038/sj.onc.1207645; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	33	73	77	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76000	10.1371/journal.pone.0076000	http://dx.doi.org/10.1371/journal.pone.0076000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098753	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500123
J	Pham, DM; Byrkit, M; Pham, HV; Pham, T; Nguyen, CT				Duc Minh Pham; Mona Byrkit; Hoang Van Pham; Trung Pham; Chien Thang Nguyen			Improving Pharmacy Staff Knowledge and Practice on Childhood Diarrhea Management in Vietnam: Are Educational Interventions Effective?	PLOS ONE			English	Article							PRIVATE PHARMACIES; DISPENSING PRACTICES; PRESCRIPTION	Background: In many developing countries, private pharmacies play an important role in providing health information and services to local communities for common health issues. The aim of this study was to ascertain medium-term impact of educational interventions on knowledge and practice of pharmacy staff regarding management of childhood diarrhea in Vietnam. Methods: This was a pre- and post-intervention study with 32 and 44 months difference from the time of the baseline survey to the conclusion of trainings and the time of the end-line survey, respectively. Interventions included in-class training for pharmacy staff, printed materials at the pharmacy, and supportive supervision. Knowledge/reported practice and actual practice of pharmacy staff were measured before and after interventions. Results: After interventions, significant improvements (p<0.01) were observed for all indexes related to pharmacy staff's knowledge about childhood diarrhea; for instance, 31% and 60% of surveyed staff asked about weight of the child and accompanying symptoms of childhood diarrhea, respectively, an increase from 11% and 45% at the baseline. Oral rehydration solution (ORS) was the most frequently reported product recommended (97% to 99%), but probiotics and antidiarrheals were the products most frequently prescribed at pharmacies. Public health facilities remained the preferred choice for referrals from pharmacies, but the use of private clinics was increasing. Consultations and advice provided to caregivers also improved, but considerable gaps between knowledge and actual practice of staff in real pharmacy settings remained. Conclusions: Educational interventions were effective in improving pharmacy staff knowledge and practice regarding management of childhood diarrhea. Knowledge and actual practice of staff in real pharmacy settings did not always correlate; there is need for a stronger regulatory and law enforcement system. Interventions to improve pharmacy practice in developing countries should be focused, comprehensive, and evidence-based.	[Duc Minh Pham; Mona Byrkit; Trung Pham; Chien Thang Nguyen] PATH, Hanoi, Vietnam; [Hoang Van Pham] Inst Social & Med Studies, Hanoi, Vietnam; [Duc Minh Pham] Management Sci Hlth, Hanoi, Vietnam		Pham, DM (corresponding author), PATH, Hanoi, Vietnam.	minhp1974@gmail.com		Pham, Minh D./0000-0002-5932-3491	Atlantic philanthropies [15336]	Atlantic philanthropies	This study was supported by the Atlantic philanthropies, grant application number 15336 (http://www.atlanticphilanthropies.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktekin M, 1998, PUBLIC HEALTH, V112, P323, DOI 10.1016/S0033-3506(98)00263-7; Association VS, 2011, STAT DAT SOC POS 63; BARRON PM, 1989, S AFR MED J, V76, P487; BERIH AA, 1989, PUBLIC HEALTH, V103, P455, DOI 10.1016/S0033-3506(89)80056-3; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; Chuc NTK, 2002, J CLIN EPIDEMIOL, V55, P1148, DOI 10.1016/S0895-4356(02)00458-4; Chuc NTK, 2001, ANN PHARMACOTHER, V35, P1283, DOI 10.1345/aph.10313; Das B. P., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1562; Driesen Annelies, 2009, Int J Pharm Pract, V17, P215; Garcia PJ, 2012, PLOS ONE, V7; GOODBURN E, 1991, BMJ-BRIT MED J, V302, P440, DOI 10.1136/bmj.302.6774.440; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Hoa NB, 2011, TROP MED INT HEALTH, V16, P1260, DOI 10.1111/j.1365-3156.2011.02823.x; Hussain A., 2012, Eastern Mediterranean Health Journal, V18, P635; IGUN UA, 1987, SOC SCI MED, V24, P689, DOI 10.1016/0277-9536(87)90312-1; IGUN UA, 1994, SOC SCI MED, V39, P797, DOI 10.1016/0277-9536(94)90041-8; IGUN UA, 1994, J DIARRHOEAL DIS RES, V12, P65; Isenbarger DW, 2001, EPIDEMIOLOGY INFECT, P127; Karim R, 2004, INT J CLIN PRACT, V58, P264, DOI 10.1111/j.1368-5031.2004.0095.x; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lonnroth K, 2003, INT J TUBERC LUNG D, V7, P1147; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Nsimba SED, 2007, TROP DOCT, V37, P197, DOI 10.1258/004947507782333099; Nsimba Stephen E D, 2007, East Afr J Public Health, V4, P5; Nyazema N, 2007, J ANTIMICROB CHEMOTH, V59, P718, DOI 10.1093/jac/dkm013; Minh PD, 2013, TROP MED INT HEALTH, V18, P426, DOI 10.1111/tmi.12062; Qidwai Waris, 2006, J Coll Physicians Surg Pak, V16, P743; RossDegnan D, 1996, HEALTH POLICY PLANN, V11, P308, DOI 10.1093/heapol/11.3.308; Saengcharoen Woranuch, 2010, Int J Pharm Pract, V18, P323, DOI 10.1111/j.2042-7174.2010.00066.x; Smith F, 2009, PHARM WORLD SCI, V31, P351, DOI 10.1007/s11096-009-9294-z; Sokar-Todd BH, 2003, J SOCIAL ADM PHARM, P20; TOMSON G, 1986, LANCET, V2, P620; Van Duong D, 1997, INT J PHARM PRACTICE, V5, P97; Vietnam CPAHCSCo, 2010, 2009 VIETN POP HOUS; Wachter DA, 1999, TROP MED INT HEALTH, V4, P782, DOI 10.1046/j.1365-3156.1999.00476.x; WATSON MC, 2006, INT J PHARM PRACT, V14, P83; WHO, 1993, DIARRH DIS CONTR PRO; [WHO (World Health Organization of the United Nations) WHO Department of Health Statistics and Information Systems of the Innovation Information Evidence and Research Cluster], 2012, WORLD HLTH STAT 2012, P180; Zamora Gutierrez A D, 1995, Bull Pan Am Health Organ, V29, P322	39	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74882	10.1371/journal.pone.0074882	http://dx.doi.org/10.1371/journal.pone.0074882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232HM	24098355	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600011
J	Guan, AL; Gong, H; Ye, Y; Jia, JG; Zhang, GP; Li, BY; Yang, CJ; Qian, SL; Sun, AJ; Chen, RZ; Ge, JB; Zou, YZ				Guan, Aili; Gong, Hui; Ye, Yong; Jia, Jianguo; Zhang, Guoping; Li, Bingyu; Yang, Chunjie; Qian, Sanli; Sun, Aijun; Chen, Ruizhen; Ge, Junbo; Zou, Yunzeng			Regulation of p53 by Jagged1 Contributes to Angiotensin II-Induced Impairment of Myocardial Angiogenesis	PLOS ONE			English	Article							PRESSURE-OVERLOAD; ENDOTHELIAL-CELLS; CARDIAC-HYPERTROPHY; NOTCH; ACTIVATION; HEART; EXPRESSION; PROTECTS; TUMOR; INHIBITOR	Angiotensin II (AngII) is a major contributor to the development of heart failure, however, the molecular and cellular mechanisms still remain elucidative. Inadequate angiogenesis in myocardium leads to transition from cardiac hypertrophy to dysfunction, this study was therefore conducted to examine the effects of AngII on myocardial angiogenesis and the underlying mechanisms. AngII treatment significantly impaired angiogenetic responses, which were determined by counting the capillaries either in matrigel formed by cultured cardiac microvascular endothelial cells (CMVECs) or in myocardium of mice and by measuring the in vitro and in vivo production of VEGF proteins, and stimulated accumulation and phosphorylation of cytosolic p53 which led to increases in phosphorylated p53 and decreases of hypoxia inducible factor (Hif-1) in nucleus. All of these cellular and molecular events induced by AngII in CEMCs and hearts of mice were largely reduced by a p53 inhibitor, pifithrin-alpha (PFT-alpha). Interestingly, AngII stimulated the upregulation of Jagged1, a ligand of Notch, but it didn't affect the expression of Delta-like 4 (Dll-4), another ligand of Notch. Inhibition of p53 by PFT-alpha partly abolished this effect of AngII. Further experiments showed that knockdown of Jagged1 by addition of siRNA to cultured CMVECs dramatically declined AngII-stimulated accumulation and phosphorylation of p53 in cytosol, upregulation of phosphorylated p53 and downregulation of Hif-1 expression in nucleus, decrease of VEGF production and impairment of capillary-like tube formation by the cells. Our data collectively suggest that AngII impairs myocardial angiogenetic responses through p53-dependent downregulation of Hif-1 which is regulated by Jagged1/Notch1 signaling.	[Guan, Aili; Gong, Hui; Ye, Yong; Jia, Jianguo; Zhang, Guoping; Li, Bingyu; Yang, Chunjie; Qian, Sanli; Sun, Aijun; Chen, Ruizhen; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Guan, Aili; Gong, Hui; Ye, Yong; Jia, Jianguo; Zhang, Guoping; Li, Bingyu; Yang, Chunjie; Qian, Sanli; Sun, Aijun; Chen, Ruizhen; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Guan, Aili] Qingdao Municipal Hosp, Dept Cardiol, Qingdao, Peoples R China	Fudan University; Fudan University; Qingdao Municipal Hospital	Zou, YZ (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China.	zou.yunzeng@zs-hospital.sh.cn			National Natural Science Foundation of China [30930043, 81000041]; Doctoral Fund of Ministry of Education of China [20110071110051]; Science and Technology Commission of Shanghai Municipality [11JC1402400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China (30930043, 81000041), Doctoral Fund of Ministry of Education of China (20110071110051), and Science and Technology Commission of Shanghai Municipality (11JC1402400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscough JFX, 2009, CARDIOVASC RES, V81, P592, DOI 10.1093/cvr/cvn230; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Belabbas H, 2008, AM J PHYSIOL-REG I, V295, pR1512, DOI 10.1152/ajpregu.00014.2008; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gottifredi V, 2001, SCIENCE, V292, P1851, DOI 10.1126/science.1062238; Guan AL, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/737134; He ZH, 2005, J BIOL CHEM, V280, P15719, DOI 10.1074/jbc.M413493200; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Le TT, 2012, DEV DYNAM, V241, P493, DOI 10.1002/dvdy.23739; Li L, 2010, HYPERTENS RES, V33, P1289, DOI 10.1038/hr.2010.182; Liang SH, 2001, EUR J BIOCHEM, V268, P2779, DOI 10.1046/j.1432-1327.2001.02227.x; Lin L, 2011, BIOCHEM BIOPH RES CO, V404, P28, DOI 10.1016/j.bbrc.2010.11.037; Liu PT, 2006, SHOCK, V26, P608, DOI 10.1097/01.shk.0000232273.11225.af; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Masuda T, 2012, AM J PHYSIOL-HEART C, V302, pH1871, DOI 10.1152/ajpheart.00663.2011; Prives C, 1999, J PATHOL, V187, P112; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Rehman AO, 2006, TRENDS CELL BIOL, V16, P293, DOI 10.1016/j.tcb.2006.04.003; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; SCHUNKERT H, 1990, J CLIN INVEST, V86, P1913, DOI 10.1172/JCI114924; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sohn D, 2009, CELL DEATH DIFFER, V16, P869, DOI 10.1038/cdd.2009.17; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Wang XH, 2009, LIFE SCI, V84, P240, DOI 10.1016/j.lfs.2008.12.010; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zou YZ, 2011, J MOL CELL CARDIOL, V51, P821, DOI 10.1016/j.yjmcc.2011.07.030	33	17	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76529	10.1371/journal.pone.0076529	http://dx.doi.org/10.1371/journal.pone.0076529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098521	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600061
J	Tarantal, AF; Lee, CCI; Kukis, DL; Cherry, SR				Tarantal, Alice F.; Lee, C. Chang I.; Kukis, David L.; Cherry, Simon R.			Radiolabeling Human Peripheral Blood Stem Cells for Positron Emission Tomography (PET) Imaging in Young Rhesus Monkeys	PLOS ONE			English	Article							MACACA-MULATTA; FETAL; MICROPET; EXPRESSION	These studies focused on a new radiolabeling technique with copper (Cu-64) and zirconium (Zr-89) for positron emission tomography (PET) imaging using a CD45 antibody. Synthesis of Cu-64-CD45 and Zr-89-CD45 immunoconjugates was performed and the evaluation of the potential toxicity of radiolabeling human peripheral blood stem cells (hPBSC) was assessed in vitro (viability, population doubling times, colony forming units). hPBSC viability was maintained as the dose of Cu-64-TETA-CD45 increased from 0 (92%) to 160 mu Ci/mL (76%, p>0.05). Radiolabeling efficiency was not significantly increased with concentrations of Cu-64-TETA-CD45 >20 mu Ci/mL (p>0.50). Toxicity affecting both growth and colony formation was observed with hPBSC radiolabeled with >= 40 mu Ci/mL (p<0.05). For Zr-89, there were no significant differences in viability (p>0.05), and a trend towards increased radiolabeling efficiency was noted as the dose of Zr-89-Df-CD45 increased, with a greater level of radiolabeling with 160 mCi/mL compared to 0-40 mu Ci/mL (p<0.05). A greater than 2,000 fold-increase in the level of Zr-89-Df-CD45 labeling efficiency was observed when compared to Cu-64-TETA-CD45. Similar to Cu-64-TETA-CD45, toxicity was noted when hPBSC were radiolabeled with >= 40 mu Ci/mL (p<0.05) (growth, colony formation). Taken together, 20 mu Ci/mL resulted in the highest level of radiolabeling efficiency without altering cell function. Young rhesus monkeys that had been transplanted prenatally with 25x10(6) hPBSC expressing firefly luciferase were assessed with bioluminescence imaging (BLI), then 0.3 mCi of Zr-89-Df-CD45, which showed the best radiolabeling efficiency, was injected intravenously for PET imaging. Results suggest that Zr-89-Df-CD45 was able to identify engrafted hPBSC in the same locations identified by BLI, although the background was high.	[Tarantal, Alice F.] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Tarantal, Alice F.; Lee, C. Chang I.; Cherry, Simon R.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Cherry, Simon R.] Univ Calif Davis, Dept Radiol, Davis, CA 95616 USA; [Kukis, David L.; Cherry, Simon R.] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA; [Cherry, Simon R.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tarantal, AF (corresponding author), Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA.	afterantal@primate.ucdavis.edu	Cherry, Simon/AAH-1000-2019	Cherry, Simon/0000-0002-0155-5644	California Institute for Regenerative Medicine (CIRM) Tools and Technologies grant [RT1-01019]; Primate Center base operating grant [OD011107]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) Tools and Technologies grant; Primate Center base operating grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by the California Institute for Regenerative Medicine (CIRM) Tools and Technologies grant #RT1-01019 and the Primate Center base operating grant #OD011107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Freedenberg M, 2013, PHYS MED; Huang J, 2008, MOL IMAGING, V7, P1, DOI 10.2310/7290.2008.00001; MEIJS WE, 1992, APPL RADIAT ISOTOPES, V43, P1443, DOI 10.1016/0883-2889(92)90170-J; Pecking AP, 2012, CLIN EXP METASTAS, V29, P847, DOI 10.1007/s10585-012-9501-5; Rizvi SNF, 2012, EUR J NUCL MED MOL I, V39, P512, DOI 10.1007/s00259-011-2008-5; Tai YC, 2001, PHYS MED BIOL, V46, P1845, DOI 10.1088/0031-9155/46/7/308; Tarantal AF, 2000, TRANSPLANTATION, V69, P1818, DOI 10.1097/00007890-200005150-00015; Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9; Tarantal AF, 2006, HUM GENE THER, V17, P1254, DOI 10.1089/hum.2006.17.1254; Tarantal AF, 2012, MOL IMAGING BIOL, V14, P197, DOI 10.1007/s11307-011-0487-1; Tarantal AF, 2010, HUM GENE THER, V21, P143, DOI 10.1089/hum.2009.126; Wallhaus TR, 2001, J NUCL CARDIOL, V8, P67, DOI 10.1067/mnc.2001.109929; Zhang Y, 2011, CURR RADIOPHARM, V4, P131, DOI 10.2174/1874471011104020131	13	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77148	10.1371/journal.pone.0077148	http://dx.doi.org/10.1371/journal.pone.0077148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098579	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600084
J	Umegaki-Arao, N; Tamai, K; Nimura, K; Serada, S; Naka, T; Nakano, H; Katayama, I				Umegaki-Arao, Noriko; Tamai, Katsuto; Nimura, Keisuke; Serada, Satoshi; Naka, Tetsuji; Nakano, Hajime; Katayama, Ichiro			Karyopherin Alpha2 Is Essential for rRNA Transcription and Protein Synthesis in Proliferative Keratinocytes	PLOS ONE			English	Article							IMPORTIN-ALPHA; GENE-EXPRESSION; NUCLEAR-IMPORT; CANCER; SURVIVAL; BINDING; GROWTH; CELLS; KPNA2; CYCLE	Karyopherin proteins mediate nucleocytoplasmic trafficking and are critical for protein and RNA subcellular localization. Recent studies suggest KPNA2 expression is induced in tumor cells and is strongly associated with prognosis, although the precise roles and mechanisms of KPNA2 overexpression in proliferative disorders have not been defined. We found that KPNA2 expression is induced in various proliferative disorders of the skin such as psoriasis, Bowen's disease, actinic keratosis, squamous cell carcinoma, Paget's disease, Merkel cell carcinoma, and mycosis fungoides. siRNA-mediated KPNA suppression revealed that KPNA2 is essential for significant suppression of HaCaT proliferation under starvation conditions. Ribosomal RNA transcription and protein synthesis were suppressed by starvation combined with knockdown of KPNA (including KPNA2) expression. KPNA2 localized to the nucleolus and interacted with proteins associated with mRNA processing, ribonucleoprotein complex biogenesis, chromatin modification, and transcription, as demonstrated by tandem affinity purification and mass spectrometry. KPNA2 may be an important promoter of ribosomal RNA and protein synthesis in tumor cells.	[Umegaki-Arao, Noriko; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Tamai, Katsuto] Osaka Univ, Dept Stem Cell Therapy Sci, Grad Sch Med, Osaka, Japan; [Nimura, Keisuke] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Osaka, Japan; [Serada, Satoshi; Naka, Tetsuji] Natl Inst Biomed Innovat Lab Immune Signal, Osaka, Japan; [Nakano, Hajime] Hirosaki Univ, Sch Med, Dept Dermatol, Hirosaki, Aomori 036, Japan	Osaka University; Osaka University; Osaka University; Hirosaki University	Tamai, K (corresponding author), Osaka Univ, Dept Stem Cell Therapy Sci, Grad Sch Med, Osaka, Japan.	tamai@gts.med.osaka-u.ac.jp	Nimura, Keisuke/AAE-9925-2020	yi lang, pian shan/0000-0002-3270-1085; Serada, Satoshi/0000-0001-6948-9009; Naka, Tetsuji/0000-0002-1269-3997	Ministry of Education, Culture, Science and Technology of Japan; Health and Labour Science Research Grant from the Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Science Research Grant from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid of Scientific Research from the Ministry of Education, Culture, Science and Technology of Japan, and a Health and Labour Science Research Grant from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Freire J, 2001, BIOCHEM CELL BIOL, V79, P123, DOI 10.1139/bcb-79-2-123; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hall MN, 2011, DEV BIOL, V357, P248, DOI 10.1016/j.ydbio.2011.06.032; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Teng SC, 2006, J MOL HISTOL, V37, P293, DOI 10.1007/s10735-006-9032-y; Umegaki N, 2007, J INVEST DERMATOL, V127, P1456, DOI 10.1038/sj.jid.5700716; van der Watt PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027723; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Wang CI, 2011, INT J CANCER, V128, P2364, DOI 10.1002/ijc.25568; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yasuda Y, 2012, EMBO J, V31, P83, DOI 10.1038/emboj.2011.360; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003	29	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76416	10.1371/journal.pone.0076416	http://dx.doi.org/10.1371/journal.pone.0076416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098495	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600047
J	Barton, KL; Misuraca, K; Cordero, F; Dobrikova, E; Min, HD; Gromeier, M; Kirsch, DG; Becher, OJ				Barton, Kelly L.; Misuraca, Katherine; Cordero, Francisco; Dobrikova, Elena; Min, Hooney D.; Gromeier, Matthias; Kirsch, David G.; Becher, Oren J.			PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma	PLOS ONE			English	Article							INTRINSIC PONTINE GLIOMAS; DEPENDENT KINASE 4/6; PD 0332991; GLIOBLASTOMA; MUTATION; GROWTH; CELLS; PHOSPHORYLATION; INACTIVATION; SENSITIVITY	Diffuse intrinsic pontine glioma (DIPG) is an incurable tumor that arises in the brainstem of children. To date there is not a single approved drug to effectively treat these tumors and thus novel therapies are desperately needed. Recent studies suggest that a significant fraction of these tumors contain alterations in cell cycle regulatory genes including amplification of the D-type cyclins and CDK4/6, and less commonly, loss of Ink4a-ARF leading to aberrant cell proliferation. In this study, we evaluated the therapeutic approach of targeting the cyclin-CDK-Retinoblastoma (Rb) pathway in a genetically engineered PDGF-B-driven brainstem glioma (BSG) mouse model. We found that PD-0332991 (PD), a CDK4/6 inhibitor, induces cell-cycle arrest in our PDGF-B; Ink4a-ARF deficient model both in vitro and in vivo. By contrast, the PDGF-B; p53 deficient model was mostly resistant to treatment with PD. We noted that a 7-day treatment course with PD significantly prolonged survival by 12% in the PDGF-B; Ink4a-ARF deficient BSG model. Furthermore, a single dose of 10 Gy radiation therapy (RT) followed by 7 days of treatment with PD increased the survival by 19% in comparison to RT alone. These findings provide the rationale for evaluating PD in children with Ink4a-ARF deficient gliomas.	[Barton, Kelly L.; Cordero, Francisco; Becher, Oren J.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Cordero, Francisco; Becher, Oren J.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Barton, Kelly L.; Cordero, Francisco; Becher, Oren J.] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27706 USA; [Misuraca, Katherine] Duke Univ, Grad Program Mol Canc Biol, Durham, NC 27706 USA; [Dobrikova, Elena; Gromeier, Matthias] Duke Univ, Dept Surg, Durham, NC 27706 USA; [Min, Hooney D.; Kirsch, David G.] Duke Univ, Dept Radiat Oncol, Durham, NC 27706 USA; [Kirsch, David G.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Becher, OJ (corresponding author), Duke Univ, Dept Pediat, Durham, NC 27706 USA.	oren.becher@duke.edu	Becher, Oren/AAI-7495-2020	Becher, Oren/0000-0003-4016-8492	Duke Cancer Institute; Rory David Deutsch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA124756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER	Duke Cancer Institute; Rory David Deutsch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Duke Cancer Institute seed grant to OJB and DGK. OJB is also supported by the Rory David Deutsch Foundation. http://www.roryd.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Aoki Y, 2012, J NEURO-ONCOL, V108, P29, DOI 10.1007/s11060-011-0796-x; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509; Fry DW, 2004, MOL CANCER THER, V3, P1427; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Huillard E, 2012, P NATL ACAD SCI USA, V109, P8710, DOI 10.1073/pnas.1117255109; Katsumi Y, 2011, BIOCHEM BIOPH RES CO, V413, P62, DOI 10.1016/j.bbrc.2011.08.047; Leonard JP, 2012, BLOOD, V119, P4597, DOI 10.1182/blood-2011-10-388298; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Newton J, 2011, MED PHYS, V38, P6754, DOI 10.1118/1.3663675; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Warren KE, 2012, NEURO-ONCOLOGY, V14, P326, DOI 10.1093/neuonc/nor190; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463	24	107	109	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77639	10.1371/journal.pone.0077639	http://dx.doi.org/10.1371/journal.pone.0077639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098593	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500103
J	Lu, X; Liu, JF; Fu, WX; Zhou, JP; Luo, YR; Ding, XD; Liu, Y; Zhang, Q				Lu, Xin; Liu, JianFeng; Fu, WeiXuan; Zhou, JiaPeng; Luo, YanRu; Ding, XiangDong; Liu, Yang; Zhang, Qin			Genome-Wide Association Study for Cytokines and Immunoglobulin G in Swine	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INTERLEUKIN-10; BLOOD; PIGS; EXPRESSION; GAMMA	Increased disease resistance through improved immune capacity would be beneficial for the welfare and productivity of farm animals. To identify genomic regions responsible for immune capacity traits in swine, a genome-wide association study was conducted. In total, 675 pigs were included. At 21 days of age, all piglets were vaccinated with modified live classical swine fever vaccine. Blood samples were sampled when the piglets were 20 and 35 days of age, respectively. Four traits, including Interferon-gamma (IFN-gamma) and Interleukin 10 (IL-10) levels, the ratio of IFN-gamma to IL-10 and Immunoglobulin G (IgG) blocking percentage to CSFV in serum were measured. All the samples were genotyped for 62,163 single nucleotide polymorphisms (SNP) using the Illumina porcineSNP60k BeadChip. After quality control, 46,079 SNPs were selected for association tests based on a single-locus regression model. To tackle the issue of multiple testing, 10,000 permutations were performed to determine the chromosome-wise and genome-wise significance level. In total, 32 SNPs with chromosome-wise significance level (including 4 SNPs with genome-wise significance level) were identified. These SNPs account for 3.23% to 13.81% of the total phenotypic variance individually. For the four traits, the numbers of significant SNPs range from 5 to 15, which jointly account for 37.52%, 82.94%, 26.74% and 24.16% of the total phenotypic variance of IFN-gamma, IL-10, IFN-gamma/IL-10, and IgG, respectively. Several significant SNPs are located within the QTL regions reported in previous studies. Furthermore, several significant SNPs fall into the regions which harbour a number of known immunity-related genes. Results herein lay a preliminary foundation for further identifying the causal mutations affecting swine immune capacity in follow-up studies.	[Lu, Xin; Liu, JianFeng; Fu, WeiXuan; Zhou, JiaPeng; Luo, YanRu; Ding, XiangDong; Liu, Yang; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Beijing 100094, Peoples R China; [Lu, Xin] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Fu, WeiXuan] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of Delaware	Zhang, Q (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Beijing 100094, Peoples R China.	qzhang@cau.edu.cn		Liu, Jian-Feng/0000-0002-5766-7864	National Natural Science Foundations of China [30972092]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2009ZX08009-146B]; Natural Science Foundations of Beijing [6102016]; New-Century Training Programme Foundation for the Talents by the State Education Commission of China [NETC-10-0783]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms; Natural Science Foundations of Beijing; New-Century Training Programme Foundation for the Talents by the State Education Commission of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The authors appreciate the financial support provided by the National Natural Science Foundations of China (30972092), the National High Technology Research and Development Program of China (863 Program 2011AA100302), the National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (2009ZX08009-146B), the Natural Science Foundations of Beijing (6102016), New-Century Training Programme Foundation for the Talents by the State Education Commission of China (NETC-10-0783), and Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chung HK, 2003, J COMP PATHOL, V129, P205, DOI 10.1016/S0021-9975(03)00036-7; Conley ME, 2003, J CLIN INVEST, V112, P1636, DOI 10.1172/JCI20408; de Groot J, 2005, IMMUNOLOGY, V115, P495, DOI 10.1111/j.1365-2567.2005.02184.x; Diaz MA, 2003, VET IMMUNOL IMMUNOP, V93, P81, DOI 10.1016/S0165-2427(03)00071-0; Doster AR, 2010, J VET SCI, V11, P177, DOI 10.4142/jvs.2010.11.3.177; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Flori Laurence, 2011, BMC Proc, V5 Suppl 4, pS32, DOI 10.1186/1753-6561-5-S4-S32; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gomez-Laguna J, 2010, J COMP PATHOL, V142, P51, DOI 10.1016/j.jcpa.2009.07.004; Hamilton GR, 2001, HUMAN IGG SUBCLASSES; Jensen J, 1994, P 5 WORLD C GEN APPL; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Jonasson R, 2006, J MED MICROBIOL, V55, P845, DOI 10.1099/jmm.0.46538-0; Kruse R, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-32; Kyriakis SC, 2002, J COMP PATHOL, V126, P38, DOI 10.1053/jcpa.2001.0520; Laman JD, 1998, IMMUNOL TODAY, V19, P489, DOI 10.1016/S0167-5699(98)01320-6; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Lu X, 2011, ANIM GENET, V42, P1, DOI 10.1111/j.1365-2052.2010.02071.x; Lu X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-488; Lu X, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-79; Maes M, 1999, ADV EXP MED BIOL, V461, P25; MALLARD BA, 1989, VET IMMUNOL IMMUNOP, V21, P139, DOI 10.1016/0165-2427(89)90062-7; Meulenbroek AJ, 1996, HUMAN IGG SUBCLASSES, P125; MOSMANN TR, 1991, IMMUNOPARASITOL TOD, pA49; Muller A, 2002, IMMUNOBIOLOGY, V205, P35, DOI 10.1078/0171-2985-00109; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Reiner G, 2008, ANIM GENET, V39, P163, DOI 10.1111/j.1365-2052.2008.01700.x; Rentzos M, 2009, ACTA NEUROL SCAND, V119, P332, DOI 10.1111/j.1600-0404.2008.01103.x; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Segundo FDS, 2010, J VIROL, V84, P2063, DOI 10.1128/JVI.01874-09; Shahabi S, 2006, MED HYPOTHESES, V67, P900, DOI 10.1016/j.mehy.2006.03.039; Sigal LH, 1997, ANNU REV IMMUNOL, V15, P63, DOI 10.1146/annurev.immunol.15.1.63; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Tribout T, 2010, J ANIM SCI, V88, P2856, DOI 10.2527/jas.2009-2356; Vandenbroeck K, 2003, TRENDS PHARMACOL SCI, V24, P284, DOI 10.1016/S0165-6147(03)00131-7; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang J, 2012, ANIM GENET, DOI [10.1111/j.1365-2052.2012.02366.x, DOI 10.1111/J.1365-2052.2012.02366.X.[]; Yazawa S, 2004, VET MICROBIOL, V98, P221, DOI 10.1016/j.vetmic.2003.11.005	46	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74846	10.1371/journal.pone.0074846	http://dx.doi.org/10.1371/journal.pone.0074846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098351	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500015
J	Peacey, M; Hall, RJ; Wang, J; Todd, AK; Yen, S; Chan-Hyams, J; Rand, CJ; Stanton, JA; Huang, QS				Peacey, Matthew; Hall, Richard J.; Wang, Jing; Todd, Angela K.; Yen, Seiha; Chan-Hyams, Jasmine; Rand, Christy J.; Stanton, Jo-Ann; Huang, Q. Sue			Enterovirus 74 Infection in Children	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; FREQUENT RECOMBINATION; EVOLUTION; VP1; SEROTYPES; REGIONS; GENOME; CHINA	Enterovirus 74 (EV74) is a rarely detected viral infection of children. In 2010, EV74 was identified in New Zealand in a 2 year old child with acute flaccid paralysis (AFP) through routine polio AFP surveillance. A further three cases of EV74 were identified in children within six months. These cases are the first report of EV74 in New Zealand. In this study we describe the near complete genome sequence of four EV74 isolates from New Zealand, which shows only limited sequence identity in the non-structural proteins when compared to the other two known EV74 sequences. As is typical of enteroviruses multiple recombination events were evident, particularly in the P2 region and P3 regions. This is the first complete EV74 genome sequenced from a patient with acute flaccid paralysis.	[Peacey, Matthew; Hall, Richard J.; Wang, Jing; Todd, Angela K.; Yen, Seiha; Chan-Hyams, Jasmine; Huang, Q. Sue] Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Wellington, New Zealand; [Rand, Christy J.; Stanton, Jo-Ann] Univ Otago, Dept Anat, Dunedin, New Zealand	Institute of Environmental Science & Research (ESR) - New Zealand; University of Otago	Peacey, M (corresponding author), Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Wellington, New Zealand.	matthew.peacey@esr.cri.nz	Stanton, Jo-Ann L/C-6621-2009; Yen, Seiha/L-7678-2015	Stanton, Jo-Ann L/0000-0001-8139-4694; Yen, Seiha/0000-0001-6208-3313; Huang, Q. Sue/0000-0002-3923-5195; Hall, Richard/0000-0002-9879-9476; Peacey, Matthew/0000-0002-4312-8085; Rand, Christy/0000-0003-1617-6089	Ministry for Business, Innovation and Employment; Ministry of Health	Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Ministry of Health	This study was funded by the Ministry for Business, Innovation and Employment and the Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bessaud M, 2012, J CLIN MICROBIOL, V50, P1650, DOI 10.1128/JCM.06657-11; Blomqvist S, 2008, J CLIN MICROBIOL, V46, P2410, DOI 10.1128/JCM.00313-08; Han JF, 2012, EMERG INFECT DIS, V18, P351, DOI 10.3201/eid1802.111524; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Norder H, 2003, J GEN VIROL, V84, P827, DOI 10.1099/vir.0.18647-0; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Oberste MS, 2004, J GEN VIROL, V85, P3205, DOI 10.1099/vir.0.80148-0; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Phan TG, 2005, J MED VIROL, V77, P257, DOI 10.1002/jmv.20445; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Smura T, 2011, FUTURE VIROL, V6, P109, DOI 10.2217/FVL.10.62; Tan CYQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018022; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Wang JT, 2012, ARCH VIROL, V157, P1593, DOI 10.1007/s00705-012-1332-9; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76492	10.1371/journal.pone.0076492	http://dx.doi.org/10.1371/journal.pone.0076492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098514	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500068
J	Pedro, MP; Vilcaes, AA; Tomatis, VM; Oliveira, RG; Gomez, GA; Daniotti, JL				Pedro, Maria P.; Vilcaes, Aldo A.; Tomatis, Vanesa M.; Oliveira, Rafael G.; Gomez, Guillermo A.; Daniotti, Jose L.			2-Bromopalmitate Reduces Protein Deacylation by Inhibition of Acyl-Protein Thioesterase Enzymatic Activities	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN-43; H-RAS; PLASMA-MEMBRANE; DISTINCT ROLES; IN-VIVO; PALMITOYLATION; TRAFFICKING; LOCALIZATION; LYSOPHOSPHOLIPASE; EXPRESSION	S-acylation, the covalent attachment of palmitate and other fatty acids on cysteine residues, is a reversible post-translational modification that exerts diverse effects on protein functions. S-acylation is catalyzed by protein acyltransferases (PAT), while deacylation requires acyl-protein thioesterases (APT), with numerous inhibitors for these enzymes having already been developed and characterized. Among these inhibitors, the palmitate analog 2-brompalmitate (2-BP) is the most commonly used to inhibit palmitoylation in cells. Nevertheless, previous results from our laboratory have suggested that 2-BP could affect protein deacylation. Here, we further investigated in vivo and in vitro the effect of 2-BP on the acylation/deacylation protein machinery, with it being observed that 2-BP, in addition to inhibiting PAT activity in vivo, also perturbed the acylation cycle of GAP-43 at the level of depalmitoylation and consequently affected its kinetics of membrane association. Furthermore, 2-BP was able to inhibit in vitro the enzymatic activities of human APT1 and APT2, the only two thioesterases shown to mediate protein deacylation, through an uncompetitive mechanism of action. In fact, APT1 and APT2 hydrolyzed both the monomeric form as well as the micellar state of the substrate palmitoyl-CoA. On the basis of the obtained results, as APTs can mediate deacylation on membrane bound and unbound substrates, this suggests that the access of APTs to the membrane interface is not a necessary requisite for deacylation. Moreover, as the enzymatic activity of APTs was inhibited by 2-BP treatment, then the kinetics analysis of protein acylation using 2-BP should be carefully interpreted, as this drug also inhibits protein deacylation.	[Pedro, Maria P.; Vilcaes, Aldo A.; Oliveira, Rafael G.; Daniotti, Jose L.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba, RA-5000 Cordoba, Argentina; [Tomatis, Vanesa M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Gomez, Guillermo A.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld, Australia	National University of Cordoba; University of Queensland; University of Queensland	Daniotti, JL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba, RA-5000 Cordoba, Argentina.	daniotti@dqb.fcq.unc.edu.ar	Tomatis, Vanesa/D-5367-2017; Gomez, Guillermo/J-2993-2014	Tomatis, Vanesa/0000-0003-4379-8502; Gomez, Guillermo/0000-0002-0494-2404; Oliveira, Rafael Gustavo/0000-0001-5948-5338	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); CONICET (Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by Grants from Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC) (www.secyt.unc.edu.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (www.conicet.gov.ar) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (www.agencia.gov.ar). M.P.P. is a recipient of CONICET (Argentina) fellowship. R.G.O. and J.L.D. are career investigators of CONICET (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Chamberlain LH, 2013, BIOCHEM SOC T, V41, P62, DOI 10.1042/BST20120243; Chenette EJ, 2005, J BIOL CHEM, V280, P13784, DOI 10.1074/jbc.M411300200; COLEMAN RA, 1992, BIOCHIM BIOPHYS ACTA, V1125, P203, DOI 10.1016/0005-2760(92)90046-X; De Moliner KL, 2005, J NEUROSCI RES, V79, P652, DOI 10.1002/jnr.20388; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Denny JB, 2004, EUR J BIOCHEM, V271, P2480, DOI 10.1111/j.1432-1033.2004.04179.x; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Draper JM, 2007, J LIPID RES, V48, P1873, DOI 10.1194/jlr.M700179-JLR200; Draper JM, 2009, MOL MEMBR BIOL, V26, P5, DOI 10.1080/09687680802683839; Ducker CE, 2006, MOL CANCER THER, V5, P1647, DOI 10.1158/1535-7163.MCT-06-0114; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Eisenberg S, 2013, BIOCHEM SOC T, V41, P79, DOI 10.1042/BST20120268; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gomez GA, 2007, FEBS J, V274, P2210, DOI 10.1111/j.1742-4658.2007.05758.x; Montoro AG, 2009, BIOCHEM J, V419, P301, DOI 10.1042/BJ20080921; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Kong E, 2013, J BIOL CHEM, V288, P9112, DOI 10.1074/jbc.M112.421073; Liang XQ, 2002, J BIOL CHEM, V277, P33032, DOI 10.1074/jbc.M204607200; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; MAGGIO B, 1994, BBA-BIOMEMBRANES, V1190, P137, DOI 10.1016/0005-2736(94)90043-4; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; RANSAC S, 1991, METHOD ENZYMOL, V197, P49; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sugimoto H, 1996, J BIOL CHEM, V271, P7705, DOI 10.1074/jbc.271.13.7705; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Toyoda T, 1999, BBA-MOL CELL BIOL L, V1437, P182, DOI 10.1016/S1388-1981(99)00007-4; Trenchi A, 2009, BIOCHEM J, V421, P357, DOI 10.1042/BJ20090484; Wang AJ, 1997, J BIOL CHEM, V272, P22030, DOI 10.1074/jbc.272.35.22030; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329; Zimmermann TJ, 2013, CHEMBIOCHEM, V14, P115, DOI 10.1002/cbic.201200571	54	39	39	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75232	10.1371/journal.pone.0075232	http://dx.doi.org/10.1371/journal.pone.0075232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098372	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500025
J	Tsou, YL; Lin, YW; Chang, HW; Lin, HY; Shao, HY; Yu, SL; Liu, CC; Chitra, E; Sia, C; Chow, YH				Tsou, Yueh-Liang; Lin, Yi-Wen; Chang, Hsuen-Wen; Lin, Hsiang-Yin; Shao, Hsiao-Yun; Yu, Shu-Ling; Liu, Chia-Chyi; Chitra, Ebenezer; Sia, Charles; Chow, Yen-Hung			Heat Shock protein 90: Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy	PLOS ONE			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; CENTRAL-NERVOUS-SYSTEM; MOLECULAR CHAPERONE; CYNOMOLGUS MONKEYS; CELLULAR RECEPTOR; CAPSID PROTEIN; MOUTH-DISEASE; INFECTION; HSP90; GELDANAMYCIN	Although several factors participating in enterovirus 71 (EV71) entry and replication had been reported, the precise mechanisms associated with these events are far from clear. In the present study, we showed that heat shock protein 90 (HSP90) is a key element associated with EV71 entry and replication in a human rhabdomyosarcoma of RD cells. Inhibition of HSP90 by pretreating host cells with HSP90 beta siRNA or blocking HSP90 with a HSP90-specific antibody or geldanamycin (GA), a specific inhibitor of HSP90, as well as recombinant HSP90 beta resulted in inhibiting viral entry and subsequent viral replication. Co-immunprecipitation of EV71 with recombinant HSP90 beta and colocalization of EV71-HSP90 in the cells demonstrated that HSP90 was physically associated with EV71 particles. HSP90 seems to mediate EV71 replication by preventing proteosomal degradation of the newly synthesized capsid proteins, but does not facilitate viral gene expression at transcriptional level. This was evident by post-treatment of host cells with GA, which did not affect the expression of viral transcripts but accelerated the degradation of viral capsid proteins and interfered with the formation of assembled virions. In vivo studies were carried out using human SCARB2-transgenic mice to evaluate the protection conferred by HSP90 inhibitor, 17-allyamino-17-demethoxygeldanamycin (17-AAG), an analog of geldanamycin, that elicited similar activity but with less toxicity. The results showed that the administration of 17-AAG twice conferred the resistance to hSCARB2 mice challenged with C2, C4, and B4 genotypes of EV71. Our data supports HSP90 plays an important role in EV71 infection. Targeting of HSP90 with clinically available drugs might provide a feasible therapeutic approach to treat EV71 infection.	[Tsou, Yueh-Liang; Lin, Yi-Wen; Chang, Hsuen-Wen; Lin, Hsiang-Yin; Shao, Hsiao-Yun; Yu, Shu-Ling; Liu, Chia-Chyi; Chitra, Ebenezer; Sia, Charles; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan; [Tsou, Yueh-Liang; Lin, Yi-Wen] Natl Tsing Hua Univ, Grad Program Biotechnol Med, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Sia, Charles] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Sia, C (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan.	siady@nhri.org.tw; choeyenh@nhri.org.tw	Sia, Dwo-Yuan/E-3860-2010; Liu, Chia-Chyi/A-8215-2012; Chow, Yen-Hung/E-3863-2010; Chitra, Ebenezer/F-5984-2019	Liu, Chia-Chyi/0000-0002-6257-0389; Chitra, Ebenezer/0000-0002-5818-6587	National Science Council [100-2311-B-400-003-, 101-2311-B-400-002-]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council's funding (http://web1.nsc.gov.tw/), 100-2311-B-400-003- and 101-2311-B-400-002-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Glaze ER, 2005, CANCER CHEMOTH PHARM, V56, P637, DOI 10.1007/s00280-005-1000-9; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; HASHIMOTO I, 1978, ARCH VIROL, V56, P257, DOI 10.1007/BF01317855; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Hung CY, 2011, J GEN VIROL, V92, P2803, DOI 10.1099/vir.0.033993-0; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kawashima D, 2013, J VIROL, V87, P6482, DOI 10.1128/JVI.03428-12; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin TW, 2007, J VIROL, V81, P8730, DOI 10.1128/JVI.00332-07; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057591; Lin YW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030507, 10.1371/journal.pone.0052490]; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu JN, 2012, ARCH VIROL, V157, P539, DOI 10.1007/s00705-011-1198-2; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; MELNICK JL, 1979, INTERVIROLOGY, V12, P297, DOI 10.1159/000149088; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Neckers L, 1999, INVEST NEW DRUG, V17, P361, DOI 10.1023/A:1006382320697; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Stuart Kirsty, 2006, Aust Fam Physician, V35, P219; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Wang RYL, 2013, VIROLOGY, V443, P236, DOI 10.1016/j.virol.2013.05.001; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141; Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11	64	40	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77133	10.1371/journal.pone.0077133	http://dx.doi.org/10.1371/journal.pone.0077133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098578	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500095
J	Domingues, PH; Teodosio, C; Otero, A; Sousa, P; Ortiz, J; Macias, MDG; Goncalves, JM; Nieto, AB; Lopes, MC; de Oliveira, C; Orfao, A; Tabernero, MD				Henriques Domingues, Patricia; Teodosio, Cristina; Otero, Alvaro; Sousa, Pablo; Ortiz, Javier; Garcia Macias, Maria del Carmen; Maria Goncalves, Jesus; Belen Nieto, Ana; Celeste Lopes, Maria; de Oliveira, Catarina; Orfao, Alberto; Dolores Tabernero, Maria			Association between Inflammatory Infiltrates and Isolated Monosomy 22/del(22q) in Meningiomas	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; GENE-EXPRESSION PROFILES; CELL-CYCLE DISTRIBUTION; CANCER-THERAPY; IMMUNE CELLS; TUMOR-CELLS; NK CELLS; MACROPHAGE; PROGNOSIS; ACTIVATION	Meningiomas contain highly variable levels of infiltrating tissue macrophages (TiMa) and other immune cells. In this study we investigated the potential association between the number and immunophenotype of inflammatory and other immune cells infiltrating the tumor as evaluated by multiparameter flow cytometry, and the clinico-biological, cytogenetic and gene expression profile (GEP) of 75 meningioma patients. Overall, our results showed a close association between the amount and cellular composition of the inflammatory and other immune cell infiltrates and the cytogenetic profile of the tumors. Notably, tumors with isolated monosomy 22/del(22q) showed greater numbers of TiMa, NK cells and (recently)-activated CD69(+) lymphocytes versus meningiomas with diploid and complex karyotypes. In addition, in the former cytogenetic subgroup of meningiomas, tumor-infiltrating TiMa also showed a more activated and functionally mature phenotype, as reflected by a greater fraction of CD69(+), CD63(+), CD16(+) and CD33(+) cells. GEP at the mRNA level showed a unique GEP among meningiomas with an isolated monosomy 22/del(22q) versus all other cases, which consisted of increased expression of genes involved in inflammatory/immune response, associated with an M1 TiMa phenotype. Altogether, these results suggest that loss of expression of specific genes coded in chromosome 22 (e. g. MIF) is closely associated with an increased homing and potentially also anti-tumoral effect of TiMa, which could contribute to explain the better outcome of this specific good-prognosis cytogenetic subgroup of meningiomas.	[Henriques Domingues, Patricia; Celeste Lopes, Maria; de Oliveira, Catarina] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Henriques Domingues, Patricia; Celeste Lopes, Maria; de Oliveira, Catarina] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Henriques Domingues, Patricia; Teodosio, Cristina; Belen Nieto, Ana; Orfao, Alberto; Dolores Tabernero, Maria] Univ Salamanca, Ctr Canc Res CIC IBMCC, CSIC USAL, IBSAL, E-37008 Salamanca, Spain; [Henriques Domingues, Patricia; Teodosio, Cristina; Belen Nieto, Ana; Orfao, Alberto; Dolores Tabernero, Maria] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Otero, Alvaro; Sousa, Pablo; Maria Goncalves, Jesus] Univ Hosp Salamanca, Neurosurg Serv, Salamanca, Spain; [Ortiz, Javier] Univ Hosp Salamanca, Pathol Serv, Salamanca, Spain; [Garcia Macias, Maria del Carmen] CSIC USAL, Ctr Canc Res CIC IBMCC, Mol Pathol Serv, Salamanca, Spain; [Dolores Tabernero, Maria] Univ Hosp Salamanca, Inst Estudios Ciencias Salud Castilla & Leon IECS, Salamanca, Spain; [Dolores Tabernero, Maria] Univ Hosp Salamanca, Res Unit, Salamanca, Spain	Universidade de Coimbra; Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Tabernero, MD (corresponding author), Univ Salamanca, Ctr Canc Res CIC IBMCC, CSIC USAL, IBSAL, E-37008 Salamanca, Spain.	taberner@usal.es	Lopes, Maria/GXF-7507-2022; Orfao, Alberto/B-5801-2017; Estella, Jesús María Gonçalves/AAB-4324-2021	Estella, Jesús María Gonçalves/0000-0002-7433-3137; Nieto-Librero, Ana B./0000-0001-6643-247X; Lopes, Maria/0000-0002-6469-0894; Teodosio, Cristina/0000-0002-2097-7199; Oliveira, Catarina/0000-0001-6942-4328	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [PIC/IC/83108/2007]; Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid, Spain) [FIS/FEDER 06/0312, RETICC RD06/0020/0035]; Caja Burgos (Spain); Fundacion MMA (Madrid, Spain) [exp 75312010, 87692011]; FCT [SFRH/BD/64799/2009]; IECSCYL (Soria, Spain)	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid, Spain); Caja Burgos (Spain); Fundacion MMA (Madrid, Spain); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); IECSCYL (Soria, Spain)	This work was partially supported by grants from the Fundacao para a Ciencia e Tecnologia (PIC/IC/83108/2007, FCT, Portugal), Fondo de Investigaciones Sanitarias (FIS/FEDER 06/0312 and RETICC RD06/0020/0035, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid, Spain), Caja Burgos (Spain), and Fundacion MMA (exp 75312010 and 87692011, Madrid, Spain). Patricia Domingues is supported by grant (SFRH/BD/64799/2009) from FCT. Maria Dolores Tabernero is supported by IECSCYL (Soria, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490, DOI 10.1002/jlb.47.6.490; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bowdridge S, 2010, NAT IMMUNOL, V11, P879, DOI 10.1038/ni1010-879; Braga Montelli Terezinha de Cresci, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P8; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Cruz I, 2005, AM J CLIN PATHOL, V123, P66, DOI 10.1309/WP3QWKVJFYDHHXQD; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; Tabernero MD, 2009, BRAIN PATHOL, V19, P409, DOI 10.1111/j.1750-3639.2008.00191.x; Domingues PH, 2012, AM J PATHOL, V181, P1749, DOI 10.1016/j.ajpath.2012.07.033; Duff MD, 2007, J SURG RES, V142, P119, DOI 10.1016/j.jss.2006.12.542; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; Espinosa AB, 2006, CLIN CANCER RES, V12, P772, DOI 10.1158/1078-0432.CCR-05-1480; Fersching DMI, 2012, ANTICANCER RES, V32, P2047; Frankenberger M, 2000, AM J RESP CELL MOL, V23, P419, DOI 10.1165/ajrcmb.23.3.4182; Garcia Garcia J, 1992, CIR ESPAN, V51, P16; Geldhof AB, 2002, BLOOD, V100, P4049, DOI 10.1182/blood-2001-11-0106; Grund S, 2009, NEUROPATH APPL NEURO, V35, P82, DOI 10.1111/j.1365-2990.2008.00960.x; Ishizaki S, 2012, LIFE SCI, V90, P657, DOI 10.1016/j.lfs.2012.03.018; Jochems C, 2011, EXP BIOL MED, V236, P567, DOI 10.1258/ebm.2011.011007; Kaji K, 2001, J IMMUNOL, V166, P3256, DOI 10.4049/jimmunol.166.5.3256; Kalala JP, 2004, IN VIVO, V18, P411; Kamimura A, 2000, CANCER, V89, P334, DOI 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Louis DN, 2007, MENINGIAS WHO CLASSI, P163; Maillo A, 2007, NEURO-ONCOLOGY, V9, P438, DOI 10.1215/15228517-2007-026; Matarraz S, 2011, CYTOM PART B-CLIN CY, V80B, P354, DOI 10.1002/cyto.b.20605; Mitchell RA, 2004, CELL SIGNAL, V16, P13, DOI 10.1016/j.cellsig.2003.07.002; Muramaki M, 2006, ONCOL REP, V15, P253; PAZBOUZA JI, 1994, PATHOL RES PRACT, V190, P682, DOI 10.1016/S0344-0338(11)80747-8; Pfistershammer K, 2004, J IMMUNOL, V173, P6000, DOI 10.4049/jimmunol.173.10.6000; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Rendon BE, 2009, EXP MOL PATHOL, V86, P180, DOI 10.1016/j.yexmp.2009.01.001; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; ROSSI ML, 1988, J CLIN PATHOL, V41, P314, DOI 10.1136/jcp.41.3.314; Sayagues JM, 2004, J MOL DIAGN, V6, P316, DOI 10.1016/S1525-1578(10)60527-2; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Tabernero MD, 2007, ONCOLOGIST, V12, P1225, DOI 10.1634/theoncologist.12-10-1225; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wang XB, 2012, J NEURO-ONCOL, V106, P43, DOI 10.1007/s11060-011-0640-3; Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x; Zheng YX, 2012, WORLD J GASTROENTERO, V18, P2253, DOI 10.3748/wjg.v18.i18.2253	43	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74798	10.1371/journal.pone.0074798	http://dx.doi.org/10.1371/journal.pone.0074798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098347	gold, Green Published			2022-12-27	WOS:000325427100008
J	Wang, LG; Liu, X; Zhang, LC; Yan, H; Luo, WZ; Liang, J; Cheng, DX; Chen, SK; Ma, XJ; Song, X; Zhao, KB; Wang, LX				Wang, Ligang; Liu, Xin; Zhang, Longchao; Yan, Hua; Luo, Weizhen; Liang, Jing; Cheng, Duxue; Chen, Shaokang; Ma, Xiaojun; Song, Xin; Zhao, Kebin; Wang, Lixian			Genome-Wide Copy Number Variations Inferred from SNP Genotyping Arrays Using a Large White and Minzhu Intercross Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; HIDDEN-MARKOV MODEL; METABOLIC-RATE; QTL ANALYSIS; ASSOCIATION; GENES; SUSCEPTIBILITY; REPRESENTATION; SYSTEM; IMPACT	Copy number variations (CNVs) are one of the main contributors to genetic diversity in animals and are broadly distributed in the genomes of swine. Investigating the performance and evolutionary impacts of pig CNVs requires comprehensive knowledge of their structure and function within and between breeds. In the current study, 4 different programs (i.e., GADA, PennCNV, QuantiSNP, and cnvPartition) were used to analyze Porcine SNP60 genotyping data of 585 pigs from one Large White x Minzhu intercross population to detect copy number variant regions (CNVRs). Overlapping CNVRs recalled by at least 2 programs were used to construct a powerful and comprehensive CNVR map, which contained249 CNVRs (i.e., 70 gains, 43 losses, and 136 gains/losses) and covered 26.22% of the regions in the swine genome. Ten CNVRs, representing different predicted statuses, were selected for validation via quantitative real-time PCR (QPCR); 9/10 CNVRs (i.e., 90%) were validated. When being traced back to the F0 generation, 58 events were identified in only Minzhu F0 parents and 2 events were identified in only Large White F0 parents. A series of CNVR function analyses were performed. Some of the CNVRs functions were predicted, and several interesting CNVRs for meat quality traits and hematological parameters were obtained. A comprehensive and lower false rate genome-wide CNV map was constructed for Large White and Minzhu pig genomes in this study. Our results may provide an important basis for determining the relationship between CNVRs and important qualitative and quantitative traits. In addition, it can help to further understand genetic processes in pigs.	[Wang, Ligang; Liu, Xin; Zhang, Longchao; Yan, Hua; Luo, Weizhen; Liang, Jing; Cheng, Duxue; Ma, Xiaojun; Zhao, Kebin; Wang, Lixian] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China; [Chen, Shaokang] China Agr Univ, State Key Lab Agrobiotechnol, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Song, Xin] Sichuan Agr Univ, Coll Vet Med, Yaan, Sichuan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; China Agricultural University; Sichuan Agricultural University	Zhang, LC (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China.	zhlchias@163.com; iaswlx@263.net			National Key Technology R&D Program of China [2011BAD28B01]; earmarked fund for Modern Agro-industry Technology Research System; National Technology Program of China [2011ZX08006-003]; Chinese Academy of Agricultural Sciences Foundation [2011cj-5, 2012ZL069]	National Key Technology R&D Program of China(National Key Technology R&D Program); earmarked fund for Modern Agro-industry Technology Research System; National Technology Program of China; Chinese Academy of Agricultural Sciences Foundation(Chinese Academy of Sciences)	This research was supported by the National Key Technology R&D Program of China (No.2011BAD28B01), earmarked fund for Modern Agro-industry Technology Research System, National Technology Program of China (No.2011ZX08006-003) and Chinese Academy of Agricultural Sciences Foundation (No.2011cj-5 and No.2012ZL069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Castle JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-244; Cho IC, 2011, ANIM GENET, V42, P621, DOI 10.1111/j.1365-2052.2011.02204.x; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Durovcova V, 2010, PHYSIOL RES, V59, P415, DOI 10.33549/physiolres.931801; Duthie CA, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-27; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu GS, 2008, MAMM GENOME, V19, P429, DOI 10.1007/s00335-008-9132-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo WZ, 2012, INT J BIOL SCI, V8, P870, DOI 10.7150/ijbs.4027; Luo WZ, 2012, INT J BIOL SCI, V8, P580, DOI 10.7150/ijbs.3614; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Mizoguchi Y, 2010, ANIM GENET, V41, P436, DOI 10.1111/j.1365-2052.2010.02022.x; Munoz Maria, 2012, Frontiers in Genetics, V2, P101, DOI 10.3389/fgene.2011.00101; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Nii M, 2006, ANIM GENET, V37, P342, DOI 10.1111/j.1365-2052.2006.01485.x; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Quintanilla R, 2011, J ANIM SCI, V89, P2963, DOI 10.2527/jas.2011-3974; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	53	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74879	10.1371/journal.pone.0074879	http://dx.doi.org/10.1371/journal.pone.0074879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098353	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100011
J	Ji, GZ; Ruan, WM; Liu, K; Wang, F; Sakellariou, D; Chen, JJ; Yang, Y; Okuka, M; Han, JY; Liu, ZH; Lai, LX; Gagos, S; Xiao, L; Deng, HK; Li, N; Liu, L				Ji, Guangzhen; Ruan, Weimin; Liu, Kai; Wang, Fang; Sakellariou, Despoina; Chen, Jijun; Yang, Yang; Okuka, Maja; Han, Jianyong; Liu, Zhonghua; Lai, Liangxue; Gagos, Sarantis; Xiao, Lei; Deng, Hongkui; Li, Ning; Liu, Lin			Telomere Reprogramming and Maintenance in Porcine iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENOMIC STABILITY; LENGTH; GENERATION; DNA; CIRCLES; PIG; INDUCTION; RECOMBINATION; ASSOCIATION	Telomere reprogramming and silencing of exogenous genes have been demonstrated in mouse and human induced pluripotent stem cells (iPS cells). Pigs have the potential to provide xenotransplant for humans, and to model and test human diseases. We investigated the telomere length and maintenance in porcine iPS cells generated and cultured under various conditions. Telomere lengths vary among different porcine iPS cell lines, some with telomere elongation and maintenance, and others telomere shortening. Porcine iPS cells with sufficient telomere length maintenance show the ability to differentiate in vivo by teratoma formation test. IPS cells with short or dysfunctional telomeres exhibit reduced ability to form teratomas. Moreover, insufficient telomerase and incomplete telomere reprogramming and/or maintenance link to sustained activation of exogenous genes in porcine iPS cells. In contrast, porcine iPS cells with reduced expression of exogenous genes or partial exogene silencing exhibit insufficient activation of endogenous pluripotent genes and telomerase genes, accompanied by telomere shortening with increasing passages. Moreover, telomere doublets, telomere sister chromatid exchanges and t-circles that presumably are involved in telomere lengthening by recombination also are found in porcine iPS cells. These data suggest that both telomerase-dependent and telomerase-independent mechanisms are involved in telomere reprogramming during induction and passages of porcine iPS cells, but these are insufficient, resulting in increased telomere damage and shortening, and chromosomal instability. Active exogenes might compensate for insufficient activation of endogenous genes and incomplete telomere reprogramming and maintenance of porcine iPS cells. Further understanding of telomere reprogramming and maintenance may help improve the quality of porcine iPS cells.	[Ji, Guangzhen; Liu, Kai; Wang, Fang; Liu, Lin] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Ruan, Weimin; Han, Jianyong; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Sakellariou, Despoina; Gagos, Sarantis] Acad Athens Greece BRFAA, Biomed Res Fdn, Ctr Basic Res 2, Genet Lab, Athens, Greece; [Chen, Jijun; Xiao, Lei] Zhejiang Univ, Coll Anim Sci, Stem Cell & Dev Biol Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Yang; Deng, Hongkui] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Okuka, Maja] Univ S Florida, Coll Med, Dept Obstet & Gynecol, Tampa, FL USA; [Liu, Zhonghua] North East Agr Univ, Life Sci Coll, Harbin, Heilongjiang, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China	Nankai University; China Agricultural University; Academy of Athens; Zhejiang University; Peking University; State University System of Florida; University of South Florida; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Liu, L (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	liulin@nankai.edu.cn	chen, JJ/HGB-6029-2022; Liu, Zhunghua/F-2485-2010	Liu, Zhunghua/0000-0002-9199-6493; Sakellariou, Despoina/0000-0001-5894-7879; GAGOS, SARANTIS/0000-0003-4907-7706	MOST National Major Basic Research Program [2009CB941000, 2011CBA01002]; National Natural Science Foundation of China [31271587]	MOST National Major Basic Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by MOST National Major Basic Research Program (2009CB941000 and 2011CBA01002) and National Natural Science Foundation of China (31271587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SJ, 2008, METHOD ENZYMOL, V439, P39, DOI 10.1016/S0076-6879(07)00404-1; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Cohen S, 1996, MOL CELL BIOL, V16, P2002; Cozzi E, 2009, ORGANOGENESIS, V5, P288; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; GREIDER CW, 1990, BIOESSAYS, V12, P363, DOI 10.1002/bies.950120803; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Ji GZ, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-36; Ji GZ, 2012, SCI CHINA LIFE SCI, V55, P1029, DOI 10.1007/s11427-012-4420-x; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lu WS, 2013, EXP CELL RES, V319, P133, DOI 10.1016/j.yexcr.2012.09.005; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Marion RM, 2010, CURR OPIN GENET DEV, V20, P190, DOI 10.1016/j.gde.2010.01.005; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Mathew R, 2010, FASEB J, V24, P2702, DOI 10.1096/fj.09-148973; Mitchell TRH, 2009, MOL CELL BIOL, V29, P4918, DOI 10.1128/MCB.00009-09; Montanaro L, 2008, CELL ONCOL, V30, P483, DOI 10.3233/CLO-2008-0436; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Oganesian L, 2011, MOL CELL, V42, P224, DOI 10.1016/j.molcel.2011.03.015; Okada M, 2011, BBA-GEN SUBJECTS, V1810, P226, DOI 10.1016/j.bbagen.2010.10.004; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pickett HA, 2011, HUM MOL GENET, V20, P4684, DOI 10.1093/hmg/ddr402; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Samstein B, 2001, J AM SOC NEPHROL, V12, P182, DOI 10.1681/ASN.V121182; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Vaziri H, 2010, REGEN MED, V5, P345, DOI 10.2217/RME.10.21; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Wang F, 2012, CELL RES, V22, P757, DOI 10.1038/cr.2011.201; West F, 2011, ANN NY ACAD SCI, V1245, P21, DOI 10.1111/j.1749-6632.2011.06337.x; West FD, 2011, STEM CELLS, V29, P1640, DOI 10.1002/stem.713; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	72	23	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74202	10.1371/journal.pone.0074202	http://dx.doi.org/10.1371/journal.pone.0074202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098638	gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500009
J	Kregting, LT; Bass, AL; Guadayol, O; Yund, PO; Thomas, FIM				Kregting, Louise T.; Bass, Anna L.; Guadayol, Oscar; Yund, Philip O.; Thomas, Florence I. M.			Effects of Oscillatory Flow on Fertilization in the Green Sea Urchin Strongylocentrotus droebachiensis	PLOS ONE			English	Article							SUCCESSFUL EXTERNAL FERTILIZATION; FREE-SPAWNING INVERTEBRATE; DOPPLER-VELOCIMETER DATA; ACANTHASTER-PLANCI; REPRODUCTIVE SUCCESS; LARGE POPULATIONS; FLUID SHEAR; SPERM; DENSITY; CONSEQUENCES	Broadcast spawning invertebrates that live in shallow, high-energy coastal habitats are subjected to oscillatory water motion that creates unsteady flow fields above the surface of animals. The frequency of the oscillatory fluctuations is driven by the wave period, which will influence the stability of local flow structures and may affect fertilization processes. Using an oscillatory water tunnel, we quantified the percentage of eggs fertilized on or near spawning green sea urchins, Strongylocentrotus droebachiensis. Eggs were sampled in the water column, wake eddy, substratum and aboral surface under a range of different periods (T = 4.5 - 12.7 s) and velocities of oscillatory flow. The root-mean-square wave velocity (rms(u(w))) was a good predictor of fertilization in oscillatory flow, although the root-mean-square of total velocity (rms(u)), which incorporates all the components of flow (current, wave and turbulence), also provided significant predictions. The percentage of eggs fertilized varied between 50 - 85% at low flows (rms(u(w)) < 0.02 m s(-1)), depending on the location sampled, but declined to below 10% for most locations at higher rms(u(w)). The water column was an important location for fertilization with a relative contribution greater than that of the aboral surface, especially at medium and high rms(u(w)) categories. We conclude that gametes can be successfully fertilized on or near the parent under a range of oscillatory flow conditions.	[Kregting, Louise T.; Bass, Anna L.; Yund, Philip O.] Univ New England, Ctr Marine Sci, Biddeford, ME USA; [Kregting, Louise T.; Guadayol, Oscar; Thomas, Florence I. M.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA	University of New England - Maine; University of Hawaii System	Kregting, LT (corresponding author), Queens Univ Belfast, Sch Planning Architecture & Civil Engn, Belfast BT7 1NN, Antrim, North Ireland.	l.kregting@qub.ac.uk	Guadayol, Òscar/N-2940-2013	Guadayol, Òscar/0000-0001-9552-1041; Yund, Philip/0000-0003-0474-5205; Thomas, Florence/0000-0003-4347-6474	National Science Foundation, Ocean Science Division [OCE-04-25088, OCE-12-33868, OCE-04-24978]	National Science Foundation, Ocean Science Division	Funding was provided by the National Science Foundation, Ocean Science Division, OCE-04-25088 and OCE-12-33868 to POY and OCE-04-24978 to FIMT. This is contribution number 1563 from the Hawaii Institute of Marine Biology and 8858 from University of Hawaii, School of Ocean and Earth Science and Technology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABCOCK RC, 1992, AUST J MAR FRESH RES, V43, P525; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; BENZIE JAH, 1994, BIOL BULL, V186, P153, DOI 10.2307/1542049; Chen CC, 2009, INT J NUMER METH FL, V60, P79, DOI 10.1002/fld.1881; Crimaldi JP, 2004, J MARINE SYST, V49, P3, DOI 10.1016/j.jmarsys.2003.06.005; DENNY M, 1992, BIOL BULL, V183, P220, DOI 10.2307/1542209; Gaudette J, 2006, LIMNOL OCEANOGR, V51, P1485, DOI 10.4319/lo.2006.51.3.1485; Goring DG, 2002, J HYDRAUL ENG-ASCE, V128, P117, DOI 10.1061/(ASCE)0733-9429(2002)128:1(117); Guichard F, 1998, MAR ECOL PROG SER, V171, P59, DOI 10.3354/meps171059; Himmelman JH, 2008, MAR ECOL PROG SER, V361, P161, DOI 10.3354/meps07415; IPCC, 2007, CONTRIBUTION WORKING; Keesing JK, 2011, MAR BIOL, V158, P1163, DOI 10.1007/s00227-011-1638-2; KEULEGAN GH, 1958, J RES NAT BUR STAND, V60, P423, DOI 10.6028/jres.060.043; Lam KM, 2010, J FLUID STRUCT, V26, P703, DOI 10.1016/j.jfluidstructs.2010.03.007; Lamare MD, 1998, MAR BIOL, V132, P135, DOI 10.1007/s002270050379; Levitan D.R., 1988, P181; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; Levitan DR, 2002, ECOLOGY, V83, P464, DOI 10.2307/2680028; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; LEVITAN DR, 1995, J EXP MAR BIOL ECOL, V190, P221, DOI 10.1016/0022-0981(95)00039-T; Marshall DJ, 2002, MAR ECOL PROG SER, V236, P113, DOI 10.3354/meps236113; McLelland SJ, 2000, HYDROL PROCESS, V14, P351, DOI 10.1002/(SICI)1099-1085(20000215)14:2<351::AID-HYP963>3.0.CO;2-K; MEAD KS, 1995, BIOL BULL-US, V188, P46, DOI 10.2307/1542066; Meidel SK, 2001, BIOL BULL, V201, P84, DOI 10.2307/1543529; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Pearson GA, 1996, MAR ECOL PROG SER, V143, P211, DOI 10.3354/meps143211; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; Reuter KE, 2010, BIOL BULL-US, V219, P198, DOI 10.1086/BBLv219n3p198; Riffell JA, 2007, J EXP BIOL, V210, P3644, DOI 10.1242/jeb.008516; Serrao EA, 1996, P NATL ACAD SCI USA, V93, P5286, DOI 10.1073/pnas.93.11.5286; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Simon TN, 2011, BIOL BULL-US, V220, P32, DOI 10.1086/BBLv220n1p32; Stiansen JE, 2001, SCI MAR, V65, P151, DOI 10.3989/scimar.2001.65n2151; THOMAS FIM, 1994, J EXP BIOL, V194, P263; Voulgaris G, 1998, J ATMOS OCEAN TECH, V15, P272, DOI 10.1175/1520-0426(1998)015<0272:EOTADV>2.0.CO;2; Wahl TL, 2003, J HYDRAUL ENG-ASCE, V129, P484, DOI 10.1061/(ASCE)0733-9429(2003)129:6(484); Wahle RA, 1999, MAR BIOL, V134, P127, DOI 10.1007/s002270050531; Weitzman JS, 2013, MAR ECOL PROG SER, V475, P65, DOI 10.3354/meps09965; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; YUND PO, 1994, ECOLOGY, V75, P2151, DOI 10.2307/1940874; Yund PO, 2003, LIMNOL OCEANOGR, V48, P795, DOI 10.4319/lo.2003.48.2.0795; Zimmer RK, 2011, P NATL ACAD SCI USA, V108, P13200, DOI 10.1073/pnas.1018666108	43	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76082	10.1371/journal.pone.0076082	http://dx.doi.org/10.1371/journal.pone.0076082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098766	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000325423500136
J	Li, X; Liu, YY; Hou, XL; Peng, HJ; Zhang, L; Jiang, QB; Shi, M; Ji, Y; Wang, YY; Shi, WF				Li, Xiang; Liu, Yuanyuan; Hou, Xueling; Peng, Hongjun; Zhang, Li; Jiang, Qingbo; Shi, Mei; Ji, Yun; Wang, Yuyue; Shi, Weifeng			Chlorogenic Acid Inhibits the Replication and Viability of Enterovirus 71 In Vitro	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; APOPTOTIC CELL-DEATH; PROINFLAMMATORY CYTOKINES; ANTIVIRAL ACTIVITY; DRUG DISCOVERY; CAFFEIC ACID; MACROPHAGES; INFECTION; PROTEASE; POLYMERASE	Enterovirus 71 (EV71) is an etiology for a number of diseases in humans. Traditional Chinese herbs have been reported to be effective for treating EV71 infection. However, there is no report about the antiviral effects of CHA against EV71. In this study, plaque reduction assay demonstrated that the inhibitory concentration 50% (IC50) of CHA on EV71 replication is 6.3 mu g/ml. When both CHA (20 mu g/ml) and EV71 were added, or added post-infection at different time points, CHA was able to effectively inhibit EV71 replication between 0 and 10 h. In addition, CHA inhibited EV71 2A transcription and translation in EV71-infected RD cells, but did not affect VP1, 3C, and 3D expression. Furthermore, CHA inhibited secretions of IL-6, TNF-alpha, IFN-gamma and MCP-1 in EV71-infected RD cells. Altogether, these results revealed that CHA may have antiviral properties for treating EV71 infection.	[Li, Xiang; Hou, Xueling; Peng, Hongjun; Zhang, Li; Jiang, Qingbo; Shi, Mei; Ji, Yun; Wang, Yuyue; Shi, Weifeng] Suzhou Univ, Affiliated Hosp 3, Dept Clin Lab, Changzhou, Jiangsu, Peoples R China; [Liu, Yuanyuan] Nanjing Med Univ, Huai An Affliated Hosp 1, Dept Endocrinol, Huaian, Jiangsu, Peoples R China	Nanjing Medical University	Shi, WF (corresponding author), Suzhou Univ, Affiliated Hosp 3, Dept Clin Lab, Changzhou, Jiangsu, Peoples R China.	shiweifeng67@163.com	liu, yuanyuan/GWZ-5838-2022		Health Department of Jiangsu province, China [ky 0904]	Health Department of Jiangsu province, China	This work was supported by Health Department of Jiangsu province, China(grant ky 0904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chen XM, 2010, VIROLOGY, V398, P251, DOI 10.1016/j.virol.2009.12.007; Chiang LC, 2002, ANTIVIR RES, V55, P53, DOI 10.1016/S0166-3542(02)00007-4; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; Goldstaub D, 2000, MOL CELL BIOL, V20, P1271, DOI 10.1128/MCB.20.4.1271-1277.2000; Gong X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-224; Hsu BM, 2007, VIRUS RES, V126, P69, DOI 10.1016/j.virusres.2007.01.018; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; Ikeda K, 2011, INT J MOL MED, V28, P595, DOI 10.3892/ijmm.2011.739; Irani DN, 2008, NEUROL CLIN, V26, P635, DOI 10.1016/j.ncl.2008.03.003; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Khan MTH, 2005, ANTIVIR RES, V67, P107, DOI 10.1016/j.antiviral.2005.05.002; Kleymann G, 2003, EXPERT OPIN INV DRUG, V12, P165, DOI 10.1517/13543784.12.2.165; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Lin CW, 2008, INT J ANTIMICROB AG, V32, P355, DOI 10.1016/j.ijantimicag.2008.04.018; Lin TY, 2009, AM J CHINESE MED, V37, P143, DOI 10.1142/S0192415X09006734; Luckemeyer DD, 2012, PHYTOTHER RES, V26, P535, DOI 10.1002/ptr.3590; McDougall B, 1998, ANTIMICROB AGENTS CH, V42, P140, DOI 10.1128/AAC.42.1.140; Morrison JM, 2009, J VIROL, V83, P4412, DOI 10.1128/JVI.02177-08; Olivier AK, 2011, EXP LUNG RES, V37, P131, DOI 10.3109/01902148.2010.484518; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Qi W, 2011, J PHARM ANAL, V1, P270, DOI 10.1016/j.jpha.2011.09.006; Rivas-Aravena A, 2011, J VIROL, V85, P8037, DOI 10.1128/JVI.00533-11; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Shang LQ, 2013, ANTIVIR RES, V97, P183, DOI 10.1016/j.antiviral.2012.12.005; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Superti F, 2008, CURR MED CHEM, V15, P900, DOI 10.2174/092986708783955419; Tamura H, 2006, MOL NUTR FOOD RES, V50, P396, DOI 10.1002/mnfr.200500216; Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wu BW, 2007, AM J CHINESE MED, V35, P153, DOI 10.1142/S0192415X07004709; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008	37	42	49	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76007	10.1371/journal.pone.0076007	http://dx.doi.org/10.1371/journal.pone.0076007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098754	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500124
J	Moller, M; Nielsen, SS; Ramachandran, S; Li, YX; Tria, G; Streicher, W; Petoukhov, MV; Cerione, RA; Gillilan, RE; Vestergaard, B				Moller, Magda; Nielsen, Soren S.; Ramachandran, Sekar; Li, Yuxing; Tria, Giancarlo; Streicher, Werner; Petoukhov, Maxim V.; Cerione, Richard A.; Gillilan, Richard E.; Vestergaard, Bente			Small Angle X-Ray Scattering Studies of Mitochondrial Glutaminase C Reveal Extended Flexible Regions, and Link Oligomeric State with Enzyme Activity	PLOS ONE			English	Article							KIDNEY-TYPE GLUTAMINASE; BIOLOGICAL MACROMOLECULES; PROTEINS; CANCER; MECHANISM; PROGRAM; INHIBITION; ACTIVATION; EXPRESSION; SYSTEM	Glutaminase C is a key metabolic enzyme, which is unregulated in many cancer systems and believed to play a central role in the Warburg effect, whereby cancer cells undergo changes to an altered metabolic profile. A long-standing hypothesis links enzymatic activity to the protein oligomeric state, hence the study of the solution behavior in general and the oligomer state in particular of glutaminase C is important for the understanding of the mechanism of protein activation and inhibition. In this report, this is extensively investigated in correlation to enzyme concentration or phosphate level, using a high-throughput microfluidic-mixing chip for the SAXS data collection, and we confirm that the oligomeric state correlates with activity. The in-depth solution behavior analysis further reveals the structural behavior of flexible regions of the protein in the dimeric, tetrameric and octameric state and investigates the C-terminal influence on the enzyme solution behavior. Our data enable SAXS-based rigid body modeling of the full-length tetramer states, thereby presenting the first ever experimentally derived structural model of mitochondrial glutaminase C including the N- and C-termini of the enzyme.	[Moller, Magda; Vestergaard, Bente] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Nielsen, Soren S.] Univ Copenhagen, Dept Struct Biophys, Copenhagen, Denmark; [Nielsen, Soren S.; Gillilan, Richard E.] Cornell Univ, CHESS, Ithaca, NY USA; [Nielsen, Soren S.; Gillilan, Richard E.] Cornell Univ, CHESS MacCHESS, Macromol Diffract Facil, Ithaca, NY USA; [Ramachandran, Sekar; Li, Yuxing; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Tria, Giancarlo; Petoukhov, Maxim V.] DESY, European Mol Biol Lab, Hamburg Outstn, Hamburg, Germany; [Tria, Giancarlo] Univ Hamburg, Ctr Bioinformat, Hamburg, Germany; [Streicher, Werner] Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY USA	University of Copenhagen; University of Copenhagen; Cornell University; Cornell University; Cornell University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Cornell University	Vestergaard, B (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	bente.vestergaard@sund.ku.dk	Petoukhov, Maxim V/R-7371-2016; Ramachandran, Sekar/AAP-2287-2020	Petoukhov, Maxim V/0000-0001-6760-4595; Ramachandran, Sekar/0000-0002-2243-1368; Streicher, Werner/0000-0002-2425-5839; TRIA, Giancarlo/0000-0003-4736-471X; Vestergaard, Bente/0000-0001-8011-6414	Faculty of Health and Medical Sciences, University of Copenhagen; Bioxtas project group; NABITT program of the Danish Ministry of Science, Technology and Development [2106-050047]; National Science Foundation (NSF); National Institutes of Health/National Institute of General Medical Sciences under NSF [DMR-0936384]; National Institutes of Health through its National Center for Research Resources [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER	Faculty of Health and Medical Sciences, University of Copenhagen; Bioxtas project group; NABITT program of the Danish Ministry of Science, Technology and Development; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health through its National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded in part by The Faculty of Health and Medical Sciences, University of Copenhagen and the Bioxtas project group with funding from the NABITT program of the Danish Ministry of Science, Technology and Development (grant number 2106-050047). This work is based in part upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation (NSF) and the National Institutes of Health/National Institute of General Medical Sciences under NSF award DMR-0936384, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by award RR-01646 from the National Institutes of Health through its National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamenko II, 2006, J MOL LIQ, V127, P90, DOI 10.1016/j.molliq.2006.03.023; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Boulay A-C, 2012, BIOCHIMIE; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Erickson JW, 2010, GLUTAMINASE HOT SPOT; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GODFREY S, 1977, J BIOL CHEM, V252, P1927; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; Kenny J, 2003, PROTEIN EXPRES PURIF, V31, P140, DOI 10.1016/S1046-5928(03)00161-X; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konarev PV, 2001, J APPL CRYSTALLOGR, V34, P527, DOI 10.1107/S0021889801006100; Lafleur JP, 2011, J APPL CRYSTALLOGR, V44, P1090, DOI 10.1107/S0021889811030068; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; MOREHOUSE RF, 1981, BIOCHEM J, V193, P709, DOI 10.1042/bj1930709; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; OLSEN BR, 1973, J MOL BIOL, V74, P239, DOI 10.1016/0022-2836(73)90109-5; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Toft KN, 2008, ANAL CHEM, V80, P3648, DOI 10.1021/ac800011y; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yoshimune K, 2010, FEBS J, V277, P738, DOI 10.1111/j.1742-4658.2009.07523.x	35	19	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74783	10.1371/journal.pone.0074783	http://dx.doi.org/10.1371/journal.pone.0074783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098668	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500039
J	Nicholas, C; Yang, J; Peters, SB; Bill, MA; Baiocchi, RA; Yan, FT; Sif, S; Tae, S; Gaudio, E; Wu, X; Grever, MR; Young, GS; Lesinski, GB				Nicholas, Courtney; Yang, Jennifer; Peters, Sara B.; Bill, Matthew A.; Baiocchi, Robert A.; Yan, Fengting; Sif, Said; Tae, Sookil; Gaudio, Eugenio; Wu, Xin; Grever, Michael R.; Young, Gregory S.; Lesinski, Gregory B.			PRMT5 Is Upregulated in Malignant and Metastatic Melanoma and Regulates Expression of MITF and p27(Kip1)	PLOS ONE			English	Article							ARGININE METHYLTRANSFERASE 5; FIBROBLAST-GROWTH-FACTOR; IFN-ALPHA; BINDING PROTEIN; TARGETING P27; METHYLATION; PROLIFERATION; CELLS; GENE; BRAF	Protein arginine methyltransferase-5 (PRMT5) is a Type II arginine methyltransferase that regulates various cellular functions. We hypothesized that PRMT5 plays a role in regulating the growth of human melanoma cells. Immunohistochemical analysis indicated significant upregulation of PRMT5 in human melanocytic nevi, malignant melanomas and metastatic melanomas as compared to normal epidermis. Furthermore, nuclear PRMT5 was significantly decreased in metastatic melanomas as compared to primary cutaneous melanomas. In human metastatic melanoma cell lines, PRMT5 was predominantly cytoplasmic, and associated with its enzymatic cofactor Mep50, but not STAT3 or cyclin D1. However, histologic examination of tumor xenografts from athymic mice revealed heterogeneous nuclear and cytoplasmic PRMT5 expression. Depletion of PRMT5 via siRNA inhibited proliferation in a subset of melanoma cell lines, while it accelerated growth of others. Loss of PRMT5 also led to reduced expression of MITF (microphthalmia-associated transcription factor), a melanocyte-lineage specific oncogene, and increased expression of the cell cycle regulator p27(Kip1). These results are the first to report elevated PRMT5 expression in human melanoma specimens and indicate this protein may regulate MITF and p27(Kip1) expression in human melanoma cells.	[Nicholas, Courtney; Yang, Jennifer; Bill, Matthew A.; Lesinski, Gregory B.] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA; [Peters, Sara B.] Ohio State Univ, Ctr Comprehens Canc, Dept Pathol, Div Dermatopathol, Columbus, OH 43210 USA; [Baiocchi, Robert A.; Yan, Fengting; Grever, Michael R.] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Sif, Said; Tae, Sookil] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Gaudio, Eugenio] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Wu, Xin] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Young, Gregory S.] Ohio State Univ, Arthur G James Canc Hosp, Ctr Biostat, Columbus, OH 43210 USA; [Young, Gregory S.] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lesinski, GB (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA.	Gregory.Lesinski@osumc.edu	Lesinski, Gregory B/E-3496-2011; nicholas, courtney/AAU-3887-2021; Sif, Said/AAE-5554-2019	Sif, Said/0000-0001-6268-1145; Nicholas, Courtney/0000-0001-8596-0200	Valvano Foundation for Cancer Research; NIH [P30CA016058-36];  [NIH1K22CA134551];  [NIHU01CA076576]; NATIONAL CANCER INSTITUTE [U01CA076576, K22CA134551, P30CA016058] Funding Source: NIH RePORTER	Valvano Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by The Valvano Foundation for Cancer Research (Lesinski), NIH1K22CA134551 (Lesinski), NIHU01CA076576 (Grever), and NIH P30CA016058-36 (Caligiuri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Andreu-Perez P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001936; Bao XX, 2013, J HISTOCHEM CYTOCHEM, V61, P206, DOI 10.1369/0022155413475452; Bill MA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-165; Bruns AF, 2009, BIOL CHEM, V390, P59, DOI 10.1515/BC.2009.001; Budden T, 2013, INT J MOL SCI, V14, P1132, DOI 10.3390/ijms14011132; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chuang TW, 2011, J BIOL CHEM, V286, P8722, DOI 10.1074/jbc.M110.190587; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Durant ST, 2009, CELL CYCLE, V8, P801, DOI 10.4161/cc.8.6.7850; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gu Z, 2012, BIOCH J; Gu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044033; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; Haflidadottir BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011574; Handoko HY, 2013, J INVEST DERMATOL, V133, P1803, DOI 10.1038/jid.2013.9; Hartmann A, 1999, CANCER RES, V59, P1578; He W, 2011, NUCLEIC ACIDS RES, V39, P4719, DOI 10.1093/nar/gkq1264; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jung GA, 2011, EXP MOL MED, V43, P550, DOI 10.3858/emm.2011.43.10.061; Kanade SR, 2012, J BIOL CHEM, V287, P7313, DOI 10.1074/jbc.M111.331660; Kirkwood JM, 1999, MOL MED, V5, P11, DOI 10.1007/BF03402135; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Loewe R, 2004, J INVEST DERMATOL, V123, P733, DOI 10.1111/j.0022-202X.2004.23402.x; Majumder S, 2010, J CELL BIOCHEM, V109, P553, DOI 10.1002/jcb.22432; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Powers MA, 2011, CANCER RES, V71, P5579, DOI 10.1158/0008-5472.CAN-11-0458; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; TERRIS DJ, 1994, ARCH OTOLARYNGOL, V120, P283; Wang BC, 2012, BIOCHEM BIOPH RES CO, V421, P4, DOI 10.1016/j.bbrc.2012.03.025; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang W, 2008, J INVEST DERMATOL, V128, P1997, DOI 10.1038/jid.2008.26; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Yan F, 2011, ASH ANN M, P118; Yan F., 2010, AM ASS CANC RES 2010	60	58	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74710	10.1371/journal.pone.0074710	http://dx.doi.org/10.1371/journal.pone.0074710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098663	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500034
J	Uchiyama, T; Miyazaki, K				Uchiyama, Taku; Miyazaki, Kentaro			Metagenomic Screening for Aromatic Compound-Responsive Transcriptional Regulators	PLOS ONE			English	Article							DIOXYGENASE GENES; DEGRADATION; PSEUDOMONAS; EXPRESSION; DIVERSITY; EVOLUTION; ENZYMES; METABOLISM; RESISTANCE; PATHWAYS	We applied a metagenomics approach to screen for transcriptional regulators that sense aromatic compounds. The library was constructed by cloning environmental DNA fragments into a promoter-less vector containing green fluorescence protein. Fluorescence-based screening was then performed in the presence of various aromatic compounds. A total of 12 clones were isolated that fluoresced in response to salicylate, 3-methyl catechol, 4-chlorocatechol and chlorohydroquinone. Sequence analysis revealed at least 1 putative transcriptional regulator, excluding 1 clone (CHLO8F). Deletion analysis identified compound-specific transcriptional regulators; namely, 8 LysR-types, 2 two-component-types and 1 AraC-type. Of these, 9 representative clones were selected and their reaction specificities to 18 aromatic compounds were investigated. Overall, our transcriptional regulators were functionally diverse in terms of both specificity and induction rates. LysR- and AraC- type regulators had relatively narrow specificities with high induction rates (5-50 fold), whereas two-component-types had wide specificities with low induction rates (3 fold). Numerous transcriptional regulators have been deposited in sequence databases, but their functions remain largely unknown. Thus, our results add valuable information regarding the sequence-function relationship of transcriptional regulators.	[Uchiyama, Taku] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Miyazaki, Kentaro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Miyazaki, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan.	miyazaki-kentaro@aist.go.jp	Miyazaki, Kentaro/F-7022-2010	Miyazaki, Kentaro/0000-0002-4349-566X	Japan Society for Promotion of Science [19880040]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for Promotion of Science (No. 19880040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2000, MICROBIOL-UK, V146, P1707, DOI 10.1099/00221287-146-7-1707; Bosch R, 1999, J BACTERIOL, V181, P2315, DOI 10.1128/JB.181.8.2315-2322.1999; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Chen SH, 1999, ENVIRON SCI TECHNOL, V33, P435, DOI 10.1021/es9805730; Duffner FM, 2000, GENE, V256, P215, DOI 10.1016/S0378-1119(00)00352-8; Esteve-Nunez A, 2001, MICROBIOL MOL BIOL R, V65, P335, DOI 10.1128/MMBR.65.3.335-352.2001; EVANS WC, 1971, BIOCHEM J, V122, P509, DOI 10.1042/bj1220509; Furukawa K, 2004, J BACTERIOL, V186, P5189, DOI 10.1128/JB.186.16.5189-5196.2004; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Galvao TC, 2005, TRENDS BIOTECHNOL, V23, P497, DOI 10.1016/j.tibtech.2005.08.002; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Lessner DJ, 2003, J BACTERIOL, V185, P3895, DOI 10.1128/JB.185.13.3895-3904.2003; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Meyer S, 1999, MICROBIOL-SGM, V145, P1731, DOI 10.1099/13500872-145-7-1731; MILLS SD, 1993, J BACTERIOL, V175, P1656, DOI 10.1128/JB.175.6.1656-1664.1993; Silva CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061811; Suenaga H, 2007, ENVIRON MICROBIOL, V9, P2289, DOI 10.1111/j.1462-2920.2007.01342.x; Suenaga H, 2009, ISME J, V3, P1335, DOI 10.1038/ismej.2009.76; Suenaga H, 2009, FEMS MICROBIOL ECOL, V69, P472, DOI 10.1111/j.1574-6941.2009.00719.x; Sul WJ, 2009, APPL ENVIRON MICROB, V75, P5501, DOI 10.1128/AEM.00121-09; Uchiyama T, 2005, NAT BIOTECHNOL, V23, P88, DOI 10.1038/nbt1048; van Hellemond EW, 2007, APPL ENVIRON MICROB, V73, P5832, DOI 10.1128/AEM.02708-06; WILLIAMS PA, 1976, J BACTERIOL, V125, P818, DOI 10.1128/JB.125.3.818-828.1976; Williams Peter A., 1994, Biodegradation, V5, P195, DOI 10.1007/BF00696460; Wittich RM, 1998, APPL MICROBIOL BIOT, V49, P489, DOI 10.1007/s002530051203; YOU IS, 1988, J BACTERIOL, V170, P5409, DOI 10.1128/jb.170.12.5409-5415.1988; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001; ZYLSTRA GJ, 1988, APPL ENVIRON MICROB, V54, P1498, DOI 10.1128/AEM.54.6.1498-1503.1988	29	16	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75795	10.1371/journal.pone.0075795	http://dx.doi.org/10.1371/journal.pone.0075795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098725	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500096
J	Yan, ZQ; Wang, J				Yan, Zhiqiang; Wang, Jin			Optimizing Scoring Function of Protein-Nucleic Acid Interactions with Both Affinity and Specificity	PLOS ONE			English	Article							KNOWLEDGE-BASED POTENTIALS; COMPUTATIONAL REDESIGN; MEAN FORCE; BINDING-AFFINITY; ENERGY FUNCTION; DATA-BANK; DOCKING; DESIGN; LIGAND; RECOGNITION	Protein-nucleic acid (protein-DNA and protein-RNA) recognition is fundamental to the regulation of gene expression. Determination of the structures of the protein-nucleic acid recognition and insight into their interactions at molecular level are vital to understanding the regulation function. Recently, quantitative computational approach has been becoming an alternative of experimental technique for predicting the structures and interactions of biomolecular recognition. However, the progress of protein-nucleic acid structure prediction, especially protein-RNA, is far behind that of the protein-ligand and protein-protein structure predictions due to the lack of reliable and accurate scoring function for quantifying the protein-nucleic acid interactions. In this work, we developed an accurate scoring function (named as SPA-PN, SPecificity and Affinity of the Protein-Nucleic acid interactions) for protein-nucleic acid interactions by incorporating both the specificity and affinity into the optimization strategy. Specificity and affinity are two requirements of highly efficient and specific biomolecular recognition. Previous quantitative descriptions of the biomolecular interactions considered the affinity, but often ignored the specificity owing to the challenge of specificity quantification. We applied our concept of intrinsic specificity to connect the conventional specificity, which circumvents the challenge of specificity quantification. In addition to the affinity optimization, we incorporated the quantified intrinsic specificity into the optimization strategy of SPA-PN. The testing results and comparisons with other scoring functions validated that SPA-PN performs well on both the prediction of binding affinity and identification of native conformation. In terms of its performance, SPA-PN can be widely used to predict the protein-nucleic acid structures and quantify their interactions.	[Yan, Zhiqiang; Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA; [Yan, Zhiqiang; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Wang, J (corresponding author), SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA.	jin.wang.1@stonybrook.edu	Yan, Zhiqiang/AAI-2187-2019	Yan, Zhiqiang/0000-0003-3865-3229	National Science Foundation [0947767, 0926287]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (grant numbers 0947767,0926287). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bahadur RP, 2008, NUCLEIC ACIDS RES, V36, P2705, DOI 10.1093/nar/gkn102; Barik A, 2012, PROTEINS, V80, P1866, DOI 10.1002/prot.24083; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chiu W, 2006, TRENDS CELL BIOL, V16, P144, DOI 10.1016/j.tcb.2006.01.002; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Dominy BN, 2004, J MED CHEM, V47, P4538, DOI 10.1021/jm0498046; Donald JE, 2007, NUCLEIC ACIDS RES, V35, P1039, DOI 10.1093/nar/gkl1103; Dutta S, 2005, STRUCTURE, V13, P381, DOI 10.1016/j.str.2005.01.008; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; GOLDSTEIN RA, 1992, P NATL ACAD SCI USA, V89, P4918, DOI 10.1073/pnas.89.11.4918; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Huang SY, 2008, PROTEINS, V72, P557, DOI 10.1002/prot.21949; Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a; Janin J, 1996, PROTEINS, V25, P438, DOI 10.1002/(SICI)1097-0134(199608)25:4<438::AID-PROT4>3.3.CO;2-1; Janin J, 2002, PROTEINS, V47, P257, DOI 10.1002/prot.10111; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Janin J, 2010, PROTEINS, V78, P3067, DOI 10.1002/prot.22774; Jiang L, 2002, PROTEINS, V46, P190, DOI 10.1002/prot.10031; Kirsanov DD, 2013, NUCLEIC ACIDS RES, V41, pD517, DOI 10.1093/nar/gks1199; Koppensteiner WA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P247; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Liu ZJ, 2005, NUCLEIC ACIDS RES, V33, P546, DOI 10.1093/nar/gki204; Liu ZJ, 2004, J AM CHEM SOC, V126, P8515, DOI 10.1021/ja032018q; Lu Q, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128105; Luscombe NM, 2000, GENOME BIOL, V1; Miller DW, 1997, PROTEIN SCI, V6, P2166; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Norambuena T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-262; Perez-Cano L, 2012, PROTEINS, V80, P1872, DOI 10.1002/prot.24075; Pommier Yves, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P421; Rejto PA, 1996, P NATL ACAD SCI USA, V93, P8945, DOI 10.1073/pnas.93.17.8945; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Saven JG, 2011, CURR OPIN CHEM BIOL, V15, P452, DOI 10.1016/j.cbpa.2011.03.014; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Spirin S, 2007, BIOINFORMATICS, V23, P3247, DOI 10.1093/bioinformatics/btm519; Steven AC, 2008, J STRUCT BIOL, V163, P186, DOI 10.1016/j.jsb.2008.06.002; Su Y, 2009, PROTEIN SCI, V18, P2550, DOI 10.1002/pro.257; Thomas PD, 1996, J MOL BIOL, V257, P457, DOI 10.1006/jmbi.1996.0175; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Uil TG, 2003, NUCLEIC ACIDS RES, V31, P6064, DOI 10.1093/nar/gkg815; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van Dijk M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn386; Wall M. E., 2012, QUANTITATIVE BIOL MO; Wang J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188101; Wang J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.198101; Wang W, 2001, ANNU REV BIOPH BIOM, V30, P211, DOI 10.1146/annurev.biophys.30.1.211; Xu BS, 2009, PROTEINS, V76, P718, DOI 10.1002/prot.22384; Yan ZQ, 2013, CHEM SCI, V4, P2387, DOI 10.1039/c3sc50478f; Yan ZQ, 2013, BIOINFORMATICS, V29, P1127, DOI 10.1093/bioinformatics/btt121; Yan ZQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00309; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d	64	16	16	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74443	10.1371/journal.pone.0074443	http://dx.doi.org/10.1371/journal.pone.0074443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098651	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500022
J	Zhu, Y; Li, YG; Zhu, SS; Tang, RK; Liu, YZ; Li, JB				Zhu, Ying; Li, Yongguo; Zhu, Shisheng; Tang, Renkuan; Liu, Yunzhi; Li, Jianbo			Association of Survivin Polymorphisms with Tumor Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							PROMOTER POLYMORPHISM; COLORECTAL-CANCER; LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; GENE POLYMORPHISMS; BLADDER-CANCER; APOPTOSIS; RISK; EXPRESSION	Background: The survivin polymorphisms have been shown to confer genetic susceptibility to various tumors, but the results are inconsistent. In order to accomplish a more precise estimation of the relationship, a meta-analysis was performed. Results: For rs9904341, a significantly increased tumor risk was found in overall meta-analysis under C/C vs. G/G (OR = 1.40, 95% CI = 1.13-1.74, p = 0.002), dominant (OR = 1.18, 95% CI = 1.01-1.38, p = 0.039) and recessive (OR = 1.34, 95% CI = 1.13-1.58, p = 0.001) genetic models and Asians group. In subgroup analyses of tumor types, we found a significant association between this SNP and an increased risk of gastric, colorectal, bladder and other tumors as well as a decreased risk of hepatocellular cancer. For rs17878467, a significantly decreased tumor risk was identified in overall meta-analysis for allele contrast (T vs. C: OR = 0.69, 95% CI = 0.51-0.92, p = 0.012), C/T vs. C/C (OR = 0.61, 95% CI = 0.42-0.88, p = 0.009) and dominant (OR = 0.62, 95% CI = 0.43-0.88, p = 0.007) genetic models and Asians group. For rs2071214, we found a significant association between this SNP and an increased tumor risk in overall meta-analysis under G/G vs. A/A (OR = 1.51, 95% CI = 1.04-2.18, p = 0.029) and recessive (OR = 1.54, 95% CI = 1.07-2.22, p = 0.020) genetic models and Asians group. Besides, there was a significant association of rs8073069 with an increased tumor risk under recessive genetic model (OR = 1.37, 95% CI = 1.01-1.84, p = 0.040), while no significant association between rs1042489 and tumor risk was detected. Conclusions: The survivin rs9904341 most likely contributed to increased susceptibility to tumor in Asians as well as to gastric, colorectal and bladder cancers. As for rs17878467, the T allele might be a protective factor for tumor, especially in Asians. Moreover, the survivin rs8073069 and rs2071214 seemed to be associated with an increased tumor risk in Asians, while there was no association between the survivin rs1042489 and tumor risk.	[Zhu, Ying; Li, Yongguo; Zhu, Shisheng; Tang, Renkuan; Liu, Yunzhi; Li, Jianbo] Chongqing Med Univ, Fac Basic Med Sci, Dept Forens Med, Chongqing, Peoples R China	Chongqing Medical University	Li, JB (corresponding author), Chongqing Med Univ, Fac Basic Med Sci, Dept Forens Med, Chongqing, Peoples R China.	lijianbo136@163.com						Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 1999, LAB INVEST, V79, P1327; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177; Andric M, 2012, EUR J ORAL SCI, V120, P9, DOI 10.1111/j.1600-0722.2011.00919.x; Antonacopoulou AG, 2011, CELL ONCOL, V34, P381, DOI 10.1007/s13402-011-0038-4; Atlasi Y, 2009, CANCER DETECT PREV, V32, P308, DOI 10.1016/j.cdp.2008.12.001; Bayram S, 2011, CANCER EPIDEMIOL, V35, P555, DOI 10.1016/j.canep.2011.01.004; Borbely AA, 2007, J CLIN PATHOL, V60, P303, DOI 10.1136/jcp.2006.037804; Borges BD, 2011, CLIN EXP MED, V11, P189, DOI 10.1007/s10238-010-0122-5; Chen SG, 2010, BIOCHEM BIOPH RES CO, V391, P552, DOI 10.1016/j.bbrc.2009.11.096; Cheng Zheng-Jiang, 2008, Ai Zheng, V27, P258; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Duffy MJ, 2007, CANCER LETT, V249, P49, DOI 10.1016/j.canlet.2006.12.020; Gazouli M, 2009, INT J COLORECTAL DIS, V24, P145, DOI 10.1007/s00384-008-0601-2; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsieh YS, 2012, ANN SURG ONCOL, V19, pS625, DOI 10.1245/s10434-011-2123-3; [黄俊 HUANG Jun], 2010, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V31, P59; [黄俊 HUANG Jun], 2009, [中国病理生理杂志, Chinese Journal of Pathophysiology], V25, P2344; Jaiswal PK, 2012, MOL BIOL REP, V39, P5615, DOI 10.1007/s11033-011-1366-1; Jang JS, 2008, LUNG CANCER, V60, P31, DOI 10.1016/j.lungcan.2007.09.008; Jin LJ, 2012, HEBEI MED J, V34, P2253; Karam JA, 2007, UROLOGY, V70, P482, DOI 10.1016/j.urology.2007.05.009; Kawasaki H, 1998, CANCER RES, V58, P5071; Kawata N, 2011, INT J CANCER, V129, P1872, DOI 10.1002/ijc.25850; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li Y, 2012, MOL CARCINOG, DOI 10.1002/mc.21966; Li YH, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-1; Liarmakopoulos E, 2012, MOL MED REPORT; Ma FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016748; Melet A, 2008, ADV EXP MED BIOL, V615, P47, DOI 10.1007/978-1-4020-6554-5_4; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Qin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028829; Radojevic-Skodric S, 2012, J PEDIAT HEMATOL ONC, V34, pE310, DOI 10.1097/MPH.0b013e31825d3076; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Shi H, 2012, BREAST CANCER RES TR, V131, P1039, DOI 10.1007/s10549-011-1826-2; Shivapurkar N, 2003, J CELL BIOCHEM, V88, P885, DOI 10.1002/jcb.10440; Srivastava K, 2012, MOL BIOL REP, V39, P1509, DOI 10.1007/s11033-011-0889-9; Theodoropoulos GE, 2010, PANCREAS, V39, P976, DOI 10.1097/MPA.0b013e3181d705d4; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Ulukus EC, 2007, APPL IMMUNOHISTO M M, V15, P31, DOI 10.1097/01.pai.0000201808.35931.78; Ulybina YM, 2011, TUMORI, V97, P248, DOI 10.1700/667.7794; Upadhyay R, 2011, ANN SURG ONCOL, V18, P880, DOI 10.1245/s10434-010-1371-y; Wang XF, 2012, EUR J HUM GENET, V20, P790, DOI 10.1038/ejhg.2011.276; Wang YH, 2009, UROLOGY, V73, P670, DOI 10.1016/j.urology.2008.09.048; Weng CJ, 2012, J DENT RES, V91, P358, DOI 10.1177/0022034512438402; Xu Y, 2004, DNA CELL BIOL, V23, P527, DOI 10.1089/dna.2004.23.527; Yamamoto Tetsuhisa, 2001, Medical Electron Microscopy, V34, P207, DOI 10.1007/s007950100017; Yang L, 2009, DIGEST DIS SCI, V54, P1021, DOI 10.1007/s10620-008-0441-5; Yang XY, 2009, J CANCER RES CLIN, V135, P1341, DOI 10.1007/s00432-009-0575-7; Yazdani N, 2012, PATHOL RES PRACT, V208, P100, DOI 10.1016/j.prp.2011.12.009; Zahedi P, 2012, INT J GYNECOL CANCER, V22, P35, DOI 10.1097/IGC.0b013e318229902c; Zhu HJ, 2009, PHARMACERTICAL CLIN, V17, P9; Zu YK, 2013, BIOCHEM BIOPH RES CO, V430, P529, DOI 10.1016/j.bbrc.2012.12.001	55	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74778	10.1371/journal.pone.0074778	http://dx.doi.org/10.1371/journal.pone.0074778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098667	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500038
J	McCusker, CD; Gardiner, DM				McCusker, Catherine D.; Gardiner, David M.			Positional Information Is Reprogrammed in Blastema Cells of the Regenerating Limb of the Axolotl (Ambystoma mexicanum)	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; INTERCALARY REGENERATION; PATTERN REGULATION; WOUND EPITHELIUM; AMPHIBIAN LIMB; APICAL CAP; DISTAL; ORGANIZATION; FORELIMBS; DEDIFFERENTIATION	The regenerating region of an amputated salamander limb, known as the blastema, has the amazing capacity to replace exactly the missing structures. By grafting cells from different stages and regions of blastemas induced to form on donor animals expressing Green Fluorescent Protein (GFP), to non-GFP host animals, we have determined that the cells from early stage blastemas, as well as cells at the tip of late stage blastemas are developmentally labile such that their positional identity is reprogrammed by interactions with more proximal cells with stable positional information. In contrast, cells from the adjacent, more proximal stump tissues as well as the basal region of late bud blastemas are positionally stable, and thus form ectopic limb structures when grafted. Finally, we have found that a nerve is required to maintain the blastema cells in a positionally labile state, thus indicating a role for reprogramming cues in the blastema microenvironment.	[McCusker, Catherine D.; Gardiner, David M.] Univ Calif Irvine, Dept Dev & Cellular Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Gardiner, DM (corresponding author), Univ Calif Irvine, Dept Dev & Cellular Biol, Irvine, CA 92697 USA.	dmgardin@uci.edu			American Cancer Society [PF-12-145-01-DDC]; US Army Research Office Multidisciplinary University Research Initiative (MURI) [TUL 589-09/10]; National Science Foundation through Ambystoma Genetic Stock Center at the University of Kentucky, Lexington	American Cancer Society(American Cancer Society); US Army Research Office Multidisciplinary University Research Initiative (MURI)(MURI); National Science Foundation through Ambystoma Genetic Stock Center at the University of Kentucky, Lexington	Catherine McCusker was supported by a Postdoctoral Fellowship, PF-12-145-01-DDC from the American Cancer Society. Additional support was provided by the US Army Research Office Multidisciplinary University Research Initiative (MURI) (TUL 589-09/10) and the National Science Foundation through its support of the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando T, 2009, DEVELOPMENT, V136, P2235, DOI 10.1242/dev.035204; BRYANT SV, 1987, AM ZOOL, V27, P675; BRYANT SV, 1976, DEV BIOL, V50, P212, DOI 10.1016/0012-1606(76)90079-8; BRYANT SV, 1981, SCIENCE, V212, P993, DOI 10.1126/science.212.4498.993; Christensen RN, 2001, J EXP ZOOL, V290, P529, DOI 10.1002/jez.1097; DUNIS DA, 1977, DEV BIOL, V56, P97, DOI 10.1016/0012-1606(77)90157-9; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Ferris DR, 2010, DEV GROWTH DIFFER, V52, P715, DOI 10.1111/j.1440-169X.2010.01208.x; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; FRENCH V, 1978, J EMBRYOL EXP MORPH, V47, P53; GARDINER DM, 1989, J EXP ZOOL, V251, P47, DOI 10.1002/jez.1402510107; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; HORTON C, 1995, DEV DYNAM, V202, P312, DOI 10.1002/aja.1002020310; ITEN LE, 1975, DEV BIOL, V44, P119, DOI 10.1016/0012-1606(75)90381-4; Khan P, 2002, DEV BIOL, V250, P383, DOI 10.1006/dbio.2002.0801; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; MADEN M, 1980, J EMBRYOL EXP MORPH, V56, P201; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Mariani FV, 2010, REGEN MED, V5, P451, DOI 10.2217/RME.10.27; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; Mescher AL, 2000, WOUND REPAIR REGEN, V8, P110, DOI 10.1046/j.1524-475x.2000.00110.x; MICHAEL M. I., 1961, ARCH BIOL, V72, P301; MILOJEVIC BD, 1924, W ROUX ARCH, V103, P80; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; MORGAN TH, 1901, REGENERATION, P62; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Mullen LM, 1996, DEVELOPMENT, V122, P3487; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; Nacu E, 2011, ANNU REV CELL DEV BI, V27, P409, DOI 10.1146/annurev-cellbio-092910-154115; Naiche LA, 2011, DEV DYNAM, V240, P2290, DOI 10.1002/dvdy.22731; Neufeld DA, 1996, ANAT RECORD, V246, P155; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; NIAZI IA, 1985, ROUX ARCH DEV BIOL, V194, P355, DOI 10.1007/BF00877373; Ohgo S, 2010, DEV BIOL, V338, P148, DOI 10.1016/j.ydbio.2009.11.026; PESCITELLI MJ, 1980, DEV BIOL, V79, P255, DOI 10.1016/0012-1606(80)90115-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rageh MAE, 2002, J EXP ZOOL, V292, P255, DOI 10.1002/jez.10015; ROLLMANDINSMORE C, 1982, J EXP ZOOL, V223, P51, DOI 10.1002/jez.1402230109; ROSE M, 1962, TISSUE ARC CONTROL R; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Satoh A, 2008, DEV GROWTH DIFFER, V50, P743, DOI 10.1111/j.1440-169X.2008.01072.x; Schilling TF, 2001, DEV BIOL, V231, P201, DOI 10.1006/dbio.2000.9997; Schwidefsky G, 1934, ROUX ARCH DEV BIOL, V132, P57; Shimokawa Takashi, 2012, Okajimas Folia Anatomica Japonica, V89, P75; SINGER M, 1964, J EXP ZOOL, V155, P105, DOI 10.1002/jez.1401550108; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697; STINSON BD, 1963, J EXP ZOOL, V153, P37, DOI 10.1002/jez.1401530105; STOCUM DL, 1968, DEV BIOL, V18, P457, DOI 10.1016/0012-1606(68)90052-3; STOCUM DL, 1977, J EXP ZOOL, V201, P451, DOI 10.1002/jez.1402010312; STOCUM DL, 1980, J EXP ZOOL, V212, P361, DOI 10.1002/jez.1402120308; STOCUM DL, 1984, DIFFERENTIATION, V27, P13, DOI 10.1111/j.1432-0436.1984.tb01403.x; STOCUM DL, 1975, DEV BIOL, V45, P112, DOI 10.1016/0012-1606(75)90246-8; STOCUM DL, 1982, J EMBRYOL EXP MORPH, V71, P193; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; THORNTON CS, 1957, J EXP ZOOL, V134, P357, DOI 10.1002/jez.1401340209; WALLACE H, 1981, ERTEBR LIMBS REGENER; Weiss P, 1925, W ROUX ARCH ENTWICKL, V104, P359; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171	63	56	56	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77064	10.1371/journal.pone.0077064	http://dx.doi.org/10.1371/journal.pone.0077064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086768	Green Published, gold			2022-12-27	WOS:000325223900112
J	Le, VL; Courtney, CL; Steel, J; Compans, RW				Le, Vy L.; Courtney, Cynthia L.; Steel, John; Compans, Richard W.			Closely Related Influenza Viruses Induce Contrasting Respiratory Tract Immunopathology	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; PANDEMIC INFLUENZA; A H5N1; H1N1 INFLUENZA; INFECTION; MACROPHAGES; PNEUMONIA; DEATH; HUMANS; INNATE	The swine-origin H1N1 virus which emerged in 2009 resulted in the first influenza pandemic of the 21st century. Although the majority of infections were moderate, a significant proportion of infections were severe and characterized by acute respiratory distress syndrome and pulmonary edema. We compared two isolates from the 2009 H1N1 pandemic; A/California/07/09 (CA/07) and A/Netherlands/602/09 (NL/602) viruses that share greater than 99% sequence identity. Though genetically similar, these viruses exhibit contrasting pathological effects. Mice that were infected with 800 plaque forming unit (PFU) of CA/07 virus rapidly lost weight, which was concurrent with detection of high pulmonary concentrations of MCP-1, MIG, IP-10 and TIMP-1. Initially, severe bronchiolar epithelial necrosis and acute respiratory distress was observed, followed by marked bronchiolar epithelial hyperplasia. Mononuclear cell infiltration was initially localized to perivascular and peribronchiolar interstitium and then spread to adjacent alveoli. Infiltrating cells were phenotypically CD11b(hi), F4/80(lo). In contrast, when mice were infected with 800 PFU of NL/602 virus, minimal weight loss was observed, and concentrations of cytokines in the lung were significantly lower. Inflammation was primarily restricted to the bronchioles and perivascular interstitium with minimal spread to alveoli. Infiltrating cells include foamy macrophages and surface markers were characterized as CD11b(lo/-), F4/80(hi). These two genetically similar viruses can be useful strains with which to investigate immune-regulatory determinants of pathogenesis of influenza virus.	[Le, Vy L.; Steel, John; Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Courtney, Cynthia L.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University	Le, VL (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	vlle@emory.edu; rcompan@emory.edu	Compans, Richard W/I-4087-2013	Compans, Richard W/0000-0003-2360-335X	National Institutes of Health (NIH) [A1074579, P51OD11132, T32-A1074492]; Queensland Institute of Medical Research-Australian Center for Vaccine Development and Emory Vaccine Center (ACVD-EVC) Pilot projects; Centers for Excellence in Influenza Research and Surveillance (CEIRS) [HHSN266200700006C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074492, U01AI074579] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Queensland Institute of Medical Research-Australian Center for Vaccine Development and Emory Vaccine Center (ACVD-EVC) Pilot projects; Centers for Excellence in Influenza Research and Surveillance (CEIRS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health (NIH) grants A1074579, P51OD11132 and a Queensland Institute of Medical Research-Australian Center for Vaccine Development and Emory Vaccine Center (ACVD-EVC) Pilot projects. V. L. Le is supported by NIH grant T32-A1074492 and J. Steel is supported through a pilot project from the Centers for Excellence in Influenza Research and Surveillance (CEIRS) contract number HHSN266200700006C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2002, CELL IMMUNOL, V219, P48, DOI 10.1016/S0008-8749(02)00584-1; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Cao WP, 2012, J IMMUNOL, V189, P2257, DOI 10.4049/jimmunol.1200168; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Le TVL, 2008, J IMMUNOL, V181, P6027, DOI 10.4049/jimmunol.181.9.6027; Le TVL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018780; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; Lycett SJ, 2009, J VIROL, V83, P9901, DOI 10.1128/JVI.00608-09; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morens DM, 2010, CRIT CARE MED, V38, pE10, DOI 10.1097/CCM.0b013e3181ceb25b; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; PEPER RL, 1995, MICROB PATHOGENESIS, V19, P175, DOI 10.1006/mpat.1995.0056; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Pica N, 2011, J VIROL, V85, P12825, DOI 10.1128/JVI.05930-11; Reading PC, 2010, IMMUNOL CELL BIOL, V88, P641, DOI 10.1038/icb.2010.11; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Takiyama A, 2010, JPN J INFECT DIS, V63, P72; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10	48	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76708	10.1371/journal.pone.0076708	http://dx.doi.org/10.1371/journal.pone.0076708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086762	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000073
J	Wouters, J; Stas, M; Gremeaux, L; Govaere, O; Van den Broeck, A; Maes, H; Agostinis, P; Roskams, T; van den Oord, JJ; Vankelecom, H				Wouters, Jasper; Stas, Marguerite; Gremeaux, Lies; Govaere, Olivier; Van den Broeck, Anke; Maes, Hannelore; Agostinis, Patrizia; Roskams, Tania; van den Oord, Joost J.; Vankelecom, Hugo			The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis	PLOS ONE			English	Article							P-GLYCOPROTEIN; STEM-CELLS; CANCER-CELLS; DNA METHYLTRANSFERASE; INITIATING CELLS; EXPRESSION; GROWTH; ESTABLISHMENT; CHEMOTHERAPY; METHYLATION	Melanoma remains the most lethal skin cancer, mainly because of high resistance to therapy. Side population (SP) cells are found in many types of cancer and are usually enriched in therapy-resistant as well as tumorigenic cells. Here, we identified a Hoechst dye-effluxing SP in a large series of human melanoma samples representing different progression phases. The SP size did not change with disease stage but was correlated with the prognostic "Breslow's depth" in the primary (cutaneous) tumors. When injected into immunodeficient mice, the SP generated larger tumors than the bulk "main population" (MP) melanoma cells in two consecutive generations, and showed tumorigenic capacity at lower cell numbers than the MP. In addition, the SP reconstituted the heterogeneous composition of the human A375 melanoma cell line, and its clonogenic activity was 2.5-fold higher than that of the MP. Gene-expression analysis revealed upregulated expression in the melanoma SP (versus the MP) of genes associated with chemoresistance and anti-apoptosis. Consistent with these molecular characteristics, the SP increased in proportion when A375 cells were exposed to the melanoma standard chemotherapeutic agent dacarbazine, and to the aggravating condition of hypoxia. In addition, the SP showed enhanced expression of genes related to cell invasion and migration, as well as to putative (melanoma) cancer stem cells (CSC) including ABCB1 and JARID1B. ABCB1 immunoreactivity was detected in a number of tumor cells in human melanomas, and in particular in clusters at the invasive front of the primary tumors. Together, our findings support that the human melanoma SP is enriched in tumorigenic and chemoresistant capacity, considered key characteristics of CSC. The melanoma SP may therefore represent an interesting therapeutic target.	[Wouters, Jasper; Govaere, Olivier; Roskams, Tania; van den Oord, Joost J.] Univ Leuven KU Leuven, Dept Imaging & Pathol, Leuven, Belgium; [Wouters, Jasper; Gremeaux, Lies; Van den Broeck, Anke; Vankelecom, Hugo] Univ Leuven KU Leuven, Dept Dev & Regenerat, Cluster Stem Cell Biol & Embryol, Res Unit Stem Cell Res,Lab Tissue Plast, Leuven, Belgium; [Stas, Marguerite; Van den Broeck, Anke] Univ Leuven KU Leuven, Dept Oncol, Leuven, Belgium; [Maes, Hannelore; Agostinis, Patrizia] Univ Leuven KU Leuven, Dept Cellular & Mol Med, Lab Cell Death Res & Therapy, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Vankelecom, H (corresponding author), Univ Leuven KU Leuven, Dept Dev & Regenerat, Cluster Stem Cell Biol & Embryol, Res Unit Stem Cell Res,Lab Tissue Plast, Leuven, Belgium.	hugo.vankelecom@med.kuleuven.be	Govaere, Olivier/R-9372-2019; Wouters, Jasper/AAK-8597-2020; Agostinis, Patrizia/AAO-2468-2020; Agostinis, Patrizia/ABI-1177-2020	Govaere, Olivier/0000-0002-4426-6930; Wouters, Jasper/0000-0002-7129-2990; Agostinis, Patrizia/0000-0003-1314-2115; Roskams, Tania/0000-0002-2816-1530; Vankelecom, Hugo/0000-0002-2251-7284	Fund for Scientific Research-Flanders (Belgium) (FWO-Vlaanderen); Research Fund (Onderzoeksfonds) of the KU Leuven; Cycle For Life Award from the Leuven Cancer Institute (Leuven, Belgium); Flemish Association against Cancer (Belgium)	Fund for Scientific Research-Flanders (Belgium) (FWO-Vlaanderen)(FWO); Research Fund (Onderzoeksfonds) of the KU Leuven; Cycle For Life Award from the Leuven Cancer Institute (Leuven, Belgium); Flemish Association against Cancer (Belgium)	Research was made possible by financial support from the Fund for Scientific Research-Flanders (Belgium) (FWO-Vlaanderen), the Research Fund (Onderzoeksfonds) of the KU Leuven, and the Cycle For Life Award from the Leuven Cancer Institute (Leuven, Belgium). JW is currently funded as Emmanuel Vanderschueren Fellow of the Flemish Association against Cancer (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2012, CANC FACTS FIG 2012; Arancia G, 2001, MARC MALPIG SYMP SER, V7, P59; Bangoura G, 2007, WORLD J GASTROENTERO, V13, P3176, DOI 10.3748/wjg.v13.i23.3176; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Beck S, 2011, MOL CELLS, V31, P9, DOI 10.1007/s10059-011-0008-8; Biroccio A, 2002, ONCOGENE, V21, P3011, DOI 10.1038/sj.onc.1205415; Blokzijl H, 2007, INFLAMM BOWEL DIS, V13, P710, DOI 10.1002/ibd.20088; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Borght SV, 2008, LIVER INT, V28, P1370, DOI 10.1111/j.1478-3231.2008.01889.x; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Chen MF, 2012, CANCER-AM CANCER SOC, V118, P4074, DOI 10.1002/cncr.26736; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Colone M, 2008, J INVEST DERMATOL, V128, P957, DOI 10.1038/sj.jid.5701082; Depeille P, 2005, BRIT J CANCER, V93, P216, DOI 10.1038/sj.bjc.6602681; Dou J, 2009, CELL BIOL INT, V33, P807, DOI 10.1016/j.cellbi.2009.05.003; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fukunaga-Kalabis M, 2010, ONCOGENE, V29, P6115, DOI 10.1038/onc.2010.350; Fukunaga-Kalabis M, 2012, J INVEST DERMATOL, V132, P2317, DOI 10.1038/jid.2012.220; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Giatromanolaki A, 2003, MELANOMA RES, V13, P493, DOI 10.1097/00008390-200310000-00008; Girouard SD, 2011, LAB INVEST, V91, P647, DOI 10.1038/labinvest.2011.50; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Keshet GI, 2008, BIOCHEM BIOPH RES CO, V368, P930, DOI 10.1016/j.bbrc.2008.02.022; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Klinger P, 2011, TRANSCR-AUSTIN, V2, P269, DOI 10.4161/trns.2.6.18619; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lindgren D, 2006, ONCOGENE, V25, P2685, DOI 10.1038/sj.onc.1209249; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Luo YC, 2012, J INVEST DERMATOL, V132, P2440, DOI 10.1038/jid.2012.161; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; METELMANN H-R, 1983, International Journal of Cell Cloning, V1, P24; Milde-Langosch K, 2005, BRIT J CANCER, V92, P2206, DOI 10.1038/sj.bjc.6602655; Molinari A., 2005, Italian Journal of Anatomy and Embryology, V110, P135; Molinari A, 2002, MELANOMA RES, V12, P109, DOI 10.1097/00008390-200204000-00002; Molinari A, 1998, INT J CANCER, V75, P885, DOI 10.1002/(SICI)1097-0215(19980316)75:6<885::AID-IJC11>3.0.CO;2-2; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Paranjape AN, 2012, ONCOGENE, V31, P1896, DOI 10.1038/onc.2011.378; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Rausch V, 2012, J PATHOL, V227, P325, DOI 10.1002/path.3994; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SCHEPER RJ, 1988, INT J CANCER, V42, P389, DOI 10.1002/ijc.2910420314; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seong I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031477; Shen GM, 2010, FEBS LETT, V584, P4366, DOI 10.1016/j.febslet.2010.09.040; Shibuya H, 2003, MELANOMA RES, V13, P457, DOI 10.1097/00008390-200310000-00004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vander Borght S, 2005, J PATHOL, V207, P471, DOI 10.1002/path.1852; Vasquez-Moctezuma I, 2010, ACTAS DERMO-SIFILOGR, V101, P341, DOI 10.1016/S1578-2190(10)70645-4; VIRAG L, 1995, J IMMUNOL METHODS, V185, P199, DOI 10.1016/0022-1759(95)00115-Q; Walsh N, 2010, BRIT J CANCER, V102, P1157, DOI 10.1038/sj.bjc.6605590; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wouters J, 2009, EXPERT REV DERMATOL, V4, P225, DOI DOI 10.1586/EDM.09.17; Wouters J, 2012, PIGM CELL MELANOMA R, V25, P454, DOI 10.1111/j.1755-148X.2012.01004.x; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Zabierowski SE, 2008, CANCER CELL, V13, P185, DOI 10.1016/j.ccr.2008.02.015	79	42	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76550	10.1371/journal.pone.0076550	http://dx.doi.org/10.1371/journal.pone.0076550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098529	gold, Green Submitted, Green Published			2022-12-27	WOS:000325483600064
J	El-Sayed, MA; Shabaka, AA; El-Shabrawy, OA; Yassin, NA; Mahmoud, SS; El-Shenawy, SM; Al-Ashqar, E; Eisa, WH; Farag, NM; El-Shaer, MA; Salah, N; Al-Abd, AM				El-Sayed, Mostafa A.; Shabaka, Ali A.; El-Shabrawy, Osama A.; Yassin, Nemat A.; Mahmoud, Sawsan S.; El-Shenawy, Siham M.; Al-Ashqar, Emad; Eisa, Wael H.; Farag, Niveen M.; El-Shaer, Marwa A.; Salah, Nabila; Al-Abd, Ahmed M.			Tissue Distribution and Efficacy of Gold Nanorods Coupled with Laser Induced Photoplasmonic Therapy in Ehrlich Carcinoma Solid Tumor Model	PLOS ONE			English	Article							PLASMONIC PHOTOTHERMAL THERAPY; PENETRATION; RESISTANCE; NANOPARTICLES; MECHANISM; PROSPECTS; PPTT	Gold nanorods (GNR) within tumor microregions are characterized by their ability to absorb near IR light and emit heat in what is called photoplasmonic effect. Yet, the efficacy of nanoparticles is limited due to intratumoral tissue distribution reasons. In addition, distribution of GNRs to normal tissue might result in non specific toxicity. In the current study, we are assessing the intratumoral and tissue distribution of PEGylated GNRs on the top of its antitumor characteristics when given intravenously or intratumoral to solid tumor bearing mice and coupled with laser photoplasmonic sessions. PEGylated GNRs with a longitudinal size of less than 100 nm were prepared with aspect ratio of 4.6 showing strong surface plasmon absorption at wavelength 800 nm. Pharmacokinetics of GNR after single I. V. administration (0.1 mg/kg) showed very short systemic circulating time (less than 3 h). On the other hand, tissue distribution of I. V. GNR (0.1 mg/kg) to normal animals showed preferential deposition in spleen tissue. Repeated administration of I. V. GNR resulted in preferential accumulation in both liver and spleen tissues. In addition, I. V. administration of GNR to Ehrlich carcinoma tumor bearing mice resulted in similar tissue distribution; tumor accumulation and anti-tumor effect compared to intratumoral administration. In conclusion, the concentration of GNR achieved within tumors microregions after I. V. administration was comparable to I. T. administration and sufficient to elicit tumoral growth arrest when coupled with laser-aided photoplasmonic treatment.	[El-Sayed, Mostafa A.] Georgia Inst Technol, Sch Chem & Biochem, Laser Dynam Lab, Atlanta, GA 30332 USA; [Shabaka, Ali A.; Al-Ashqar, Emad; Eisa, Wael H.; Farag, Niveen M.] Natl Res Ctr, Dept Laser Phys, Giza, Egypt; [El-Shabrawy, Osama A.; Yassin, Nemat A.; Mahmoud, Sawsan S.; El-Shenawy, Siham M.; Al-Abd, Ahmed M.] Natl Res Ctr, Dept Pharmacol, Giza, Egypt; [El-Shaer, Marwa A.; Salah, Nabila] Natl Res Ctr, Dept Pathol, Giza, Egypt; [Al-Abd, Ahmed M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol, Jeddah 21413, Saudi Arabia	University System of Georgia; Georgia Institute of Technology; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Abdulaziz University	Al-Abd, AM (corresponding author), Natl Res Ctr, Dept Pharmacol, Giza, Egypt.	amalabd@kau.edu.sa	Al-Abd, Ahmed/J-2826-2012	Al-Abd, Ahmed/0000-0001-7872-4867; Mahmoud, Sawasn/0000-0003-2172-0763; , Siham/0000-0002-8057-0331; Al Ashkar, Emad/0000-0003-3160-6833; El-Shaer, Marwa/0000-0003-0562-3680; El-Shabrawy, Osama/0000-0003-4320-9499; Eisa, Wael/0000-0001-5570-4994; Yassin, Nemat/0000-0001-8895-7533	Misr El-Kheir Foundation, Cairo, Egypt; National Research Center, Dokki, Giza, Egypt	Misr El-Kheir Foundation, Cairo, Egypt(Misr El Kheir Foundation (MEK)); National Research Center, Dokki, Giza, Egypt(National Research Centre (NRC))	This work was supported by a grant from the Misr El-Kheir Foundation, Cairo, Egypt. The project was partly supported by the internal project fund of the National Research Center, Dokki, Giza, Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, ACS NANO, V5, P4919, DOI 10.1021/nn201010q; Akiyama Y, 2009, J CONTROL RELEASE, V139, P81, DOI 10.1016/j.jconrel.2009.06.006; Al-Abd AM, 2009, J CONTROL RELEASE, V137, P130, DOI 10.1016/j.jconrel.2009.03.009; Arnida, 2011, EUR J PHARM BIOPHARM, V77, P417, DOI 10.1016/j.ejpb.2010.11.010; Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486; Boca SC, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/23/235601; Bogliotti N, 2011, J COLLOID INTERF SCI, V357, P75, DOI 10.1016/j.jcis.2011.01.053; Chen T, 2011, NANOSCALE, V3, P546, DOI 10.1039/c0nr00646g; Choi WI, 2012, ANN BIOMED ENG, V40, P534, DOI 10.1007/s10439-011-0388-0; Dickerson EB, 2008, CANCER LETT, V269, P57, DOI 10.1016/j.canlet.2008.04.026; Dua P, 2011, METHODS, V54, P215, DOI 10.1016/j.ymeth.2011.02.002; Goodrich GP, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290817; Gormley AJ, 2011, J DRUG TARGET, V19, P915, DOI 10.3109/1061186X.2011.623701; Gormley AJ, 2011, INT J PHARMACEUT, V415, P315, DOI 10.1016/j.ijpharm.2011.05.068; Gu M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3502566; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; Hicks KO, 2003, CANCER RES, V63, P5970; Huang HC, 2011, J CONTROL RELEASE, V155, P344, DOI 10.1016/j.jconrel.2011.06.004; Huang P, 2011, BIOMATERIALS, V32, P9796, DOI 10.1016/j.biomaterials.2011.08.086; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Huang YF, 2008, LANGMUIR, V24, P11860, DOI 10.1021/la801969c; Huff TB, 2007, NANOMEDICINE-UK, V2, P125, DOI 10.2217/17435889.2.1.125; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kopwitthaya A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/31/315101; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; Lassen U, 2012, BRIT J CANCER, V106, P678, DOI 10.1038/bjc.2011.609; Li PC, 2008, OPT EXPRESS, V16, P18605, DOI 10.1364/OE.16.018605; Li ZM, 2010, MOL PHARMACEUT, V7, P94, DOI 10.1021/mp9001415; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Niidome T, 2010, BIOORGAN MED CHEM, V18, P4453, DOI 10.1016/j.bmc.2010.04.070; Niidome T, 2009, J BIOMAT SCI-POLYM E, V20, P1203, DOI 10.1163/156856209X452953; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Pissuwan D, 2008, BIOTECHNOL GENET ENG, V25, P93, DOI 10.5661/bger-25-93; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Shan L, 2004, POLYETHYLENE GLYCOL; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Tunggal JK, 1999, CLIN CANCER RES, V5, P1583; Wang X, 2011, MINI-REV MED CHEM, V11, P114, DOI 10.2174/138955711794519528; Yamashita S, 2011, BIOORGAN MED CHEM, V19, P2130, DOI 10.1016/j.bmc.2011.02.042; Yang DP, 2008, CHEM-ASIAN J, V3, P2010, DOI 10.1002/asia.200800195	40	38	39	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76207	10.1371/journal.pone.0076207	http://dx.doi.org/10.1371/journal.pone.0076207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098446	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500052
J	Kazantseva, J; Kivil, A; Tints, K; Kazantseva, A; Neuman, T; Palm, K				Kazantseva, Jekaterina; Kivil, Anri; Tints, Kairit; Kazantseva, Anna; Neuman, Toomas; Palm, Kaia			Alternative Splicing Targeting the hTAF4-TAFH Domain of TAF4 Represses Proliferation and Accelerates Chondrogenic Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							TATA-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVATION; TFIID COMPLEX; PROMOTES OSTEOGENESIS; P53 PLAYS; COACTIVATOR; SUBUNIT; IDENTIFICATION; PROGRESSION; REGULATORS	Transcription factor IID (TFIID) activity can be regulated by cellular signals to specifically alter transcription of particular subsets of genes. Alternative splicing of TFIID subunits is often the result of external stimulation of upstream signaling pathways. We studied tissue distribution and cellular expression of different splice variants of TFIID subunit TAF4 mRNA and biochemical properties of its isoforms in human mesenchymal stem cells (hMSCs) to reveal the role of different isoforms of TAF4 in the regulation of proliferation and differentiation. Expression of TAF4 transcripts with exons VI or VII deleted, which results in a structurally modified hTAF4-TAFH domain, increases during early differentiation of hMSCs into osteoblasts, adipocytes and chondrocytes. Functional analysis data reveals that TAF4 isoforms with the deleted hTAF4-TAFH domain repress proliferation of hMSCs and preferentially promote chondrogenic differentiation at the expense of other developmental pathways. This study also provides initial data showing possible cross-talks between TAF4 and TP53 activity and switching between canonical and non-canonical WNT signaling in the processes of proliferation and differentiation of hMSCs. We propose that TAF4 isoforms generated by the alternative splicing participate in the conversion of the cellular transcriptional programs from the maintenance of stem cell state to differentiation, particularly differentiation along the chondrogenic pathway.	[Kazantseva, Jekaterina; Kivil, Anri; Tints, Kairit; Kazantseva, Anna; Neuman, Toomas; Palm, Kaia] Protobios LLC, Tallinn, Estonia; [Kivil, Anri; Kazantseva, Anna; Palm, Kaia] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	Protobios LLC; Tallinn University of Technology	Palm, K (corresponding author), Protobios LLC, Tallinn, Estonia.	kaia@protobios.com	Kazantseva, Jekaterina/M-1037-2016; Kazantseva, Jekaterina/AAA-2882-2021; Palm, Kaia/AGF-0479-2022	Kazantseva, Jekaterina/0000-0001-6108-5499; 	Enterprise of Estonia; Estonian Ministry of Education and Research	Enterprise of Estonia; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This study was supported by Protobios's grants from the Enterprise of Estonia and baseline financing from Estonian Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; Armesilla-Diaz A, 2009, EXP CELL RES, V315, P3598, DOI 10.1016/j.yexcr.2009.08.004; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bereczki O, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-57; Bieniossek C., 2013, NATURE; Boyer-Guittaut M, 2005, J BIOL CHEM, V280, P9937, DOI 10.1074/jbc.M414149200; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Brunkhorst A, 2004, BIOCHEM BIOPH RES CO, V325, P574, DOI 10.1016/j.bbrc.2004.10.078; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Buschmann T, 2001, J BIOL CHEM, V276, P13852, DOI 10.1074/jbc.M007955200; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; D'Alessio JA, 2011, P NATL ACAD SCI USA, V108, P3906, DOI 10.1073/pnas.1100640108; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Deato MDE, 2008, COLD SH Q B, V73, P217, DOI 10.1101/sqb.2008.73.028; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eizenberg O, 1996, MOL CELL BIOL, V16, P5178; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; Freiman RN, 2009, BBA-GENE REGUL MECH, V1789, P161, DOI 10.1016/j.bbagrm.2009.01.005; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gegonne A, 2012, MOL CELL BIOL, V32, P1984, DOI 10.1128/MCB.06305-11; Geles KG, 2006, P NATL ACAD SCI USA, V103, P2594, DOI 10.1073/pnas.0510764103; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Guermah M, 2003, MOL CELL, V12, P991, DOI 10.1016/S1097-2765(03)00396-4; Guven-Ozkan T, 2008, CELL, V135, P149, DOI 10.1016/j.cell.2008.07.040; Im GI, 2010, TISSUE ENG PT A, V16, P2405, DOI 10.1089/ten.TEA.2009.0359; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kauts ML, 2013, STEM CELL RES, V10, P166, DOI 10.1016/j.scr.2012.11.004; Kazantseva A, 2009, J NEUROCHEM, V109, P807, DOI 10.1111/j.1471-4159.2009.06005.x; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Lin TM, 2007, BIOCHEM BIOPH RES CO, V361, P883, DOI 10.1016/j.bbrc.2007.07.116; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Ma G, 2012, J MOL CELL BIOL, V4, P118, DOI 10.1093/jmcb/mjs006; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; Marr MT, 2009, P NATL ACAD SCI USA, V106, P1295, DOI 10.1073/pnas.0812990106; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; Metzger D, 1999, EMBO J, V18, P4823, DOI 10.1093/emboj/18.17.4823; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Perletti L, 2001, BMC Mol Biol, V2, P4, DOI 10.1186/1471-2199-2-4; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Pointud JC, 2003, J CELL SCI, V116, P1847, DOI 10.1242/jcs.00391; Sadra A, 2000, ANAL BIOCHEM, V278, P235, DOI 10.1006/abio.1999.4453; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Stuyver LJ, 2003, ANTIMICROB AGENTS CH, V47, P244, DOI 10.1128/AAC.47.1.244-254.2003; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Tatarakis A, 2008, MOL CELL, V31, P531, DOI 10.1016/j.molcel.2008.07.013; Tataria M, 2006, J PEDIATR SURG, V41, P624, DOI 10.1016/j.jpedsurg.2005.12.001; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Voronina E, 2007, DEV BIOL, V303, P715, DOI 10.1016/j.ydbio.2006.12.011; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Wei YF, 2007, NAT STRUCT MOL BIOL, V14, P653, DOI 10.1038/nsmb1258; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wright KJ, 2009, P NATL ACAD SCI USA, V106, P55, DOI 10.1073/pnas.0811914106	72	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74799	10.1371/journal.pone.0074799	http://dx.doi.org/10.1371/journal.pone.0074799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098348	Green Submitted, gold, Green Published			2022-12-27	WOS:000325434500014
J	Tsai, SW; Liaw, JW; Kao, YC; Huang, MY; Lee, CY; Rau, LR; Huang, CY; Wei, KC; Ye, TC				Tsai, Shiao-Wen; Liaw, Jiunn-Woei; Kao, Ya-Chen; Huang, Meng-Yu; Lee, Chia-Ying; Rau, Lih-Rou; Huang, Chiung-Yin; Wei, Kuo-Chen; Ye, Tzu-Chen			Internalized Gold Nanoparticles Do Not Affect the Osteogenesis and Apoptosis of MG63 Osteoblast-Like Cells: A Quantitative, In Vitro Study	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CELLULAR UPTAKE; QUANTUM DOTS; CYTOTOXICITY; TOXICITY; SURFACE; DIFFERENTIATION; NANORODS; THERAPY; CANCER	The long-term toxicity effects of gold nanoparticles (GNPs) on the proliferation and differentiation of a progenitor cell line, MG63 osteoblast-like cells, was investigated. These cells were treated for 20 hours with two media that contained 10 nm GNPs at concentrations of 1 ppm and 10 ppm. The mitosis of the GNP-treated MG63 was observed after at least 21 hours using dark-field and fluorescence microscopy. The TEM, LSCM and dark-field hyperspectral images indicated that the late endosomes in cells that contained aggregated GNPs were caused by vesicle fusion. Subsequently, after 21 days of being cultured in fresh medium, the specific nodule-like phenotypes and bone-associated gene expression of the treated MG63 cells exhibited the same behaviors as those of the control group. Statistically, after 21 days, the viability of the treated cells was identical to that of the untreated ones. During the cell death program analysis, the apoptosis and necrosis percentages of cells treated for 8 or fewer days were also observed to exhibit no significant difference with those of the untreated cells. In summary, our experiments show that the long-term toxicity of GNPs on the osteogenetic differentiation of MG63 is low. In addition, because of their low toxicity and non-biodegradability, GNPs can potentially be used as biomarkers for the long-term optical observation of the differentiation of progenitor or stem cells based on their plasmonic light-scattering properties.	[Tsai, Shiao-Wen; Kao, Ya-Chen; Lee, Chia-Ying; Rau, Lih-Rou] Chang Gung Univ, Grad Inst Biochem & Biomed Engn, Tao Yuan, Taiwan; [Tsai, Shiao-Wen; Liaw, Jiunn-Woei] Chang Gung Univ, Ctr Biomed Engn, Tao Yuan, Taiwan; [Liaw, Jiunn-Woei; Huang, Meng-Yu] Chang Gung Univ, Dept Mech Engn, Tao Yuan, Taiwan; [Huang, Chiung-Yin; Wei, Kuo-Chen] Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan; [Wei, Kuo-Chen] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Ye, Tzu-Chen] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Ye, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Linkou, Taiwan; [Ye, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Linkou, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tsai, SW (corresponding author), Chang Gung Univ, Grad Inst Biochem & Biomed Engn, Tao Yuan, Taiwan.	swtsai@mail.cgu.edu.tw		Tsai, Shiao-Wen/0000-0002-6225-6613; Wei, Kuochen/0000-0003-3505-2196	National Science Council, Taiwan, R.O.C. [NSC 99-2221-E-182-010-MY3]; Chang Gung Memorial Hospital [CMRPD290041, CMRPD2A0051]	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The authors are grateful to the Molecular Imaging Center, Chang Gung Memorial Hospital for providing the hyperspectral microscopy. This research was supported by the National Science Council, Taiwan, R.O.C. (NSC 99-2221-E-182-010-MY3) and by Chang Gung Memorial Hospital (CMRPD290041 and CMRPD2A0051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron J, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2737351; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486; Balasubramanian SK, 2010, BIOMATERIALS, V31, P2034, DOI 10.1016/j.biomaterials.2009.11.079; Busson MP, 2011, NANO LETT, V11, P5060, DOI 10.1021/nl2032052; Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6; Chen YS, 2010, OPT EXPRESS, V18, P8867, DOI 10.1364/OE.18.008867; Cho EC, 2009, NANO LETT, V9, P1080, DOI 10.1021/nl803487r; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Cloyd KL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone 0047562, DOI 10.1371/J0URNAL.P0NE.0047562.PUBMED:23082177]; Comenge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047562; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; Helary G, 2009, ACTA BIOMATER, V5, P124, DOI 10.1016/j.actbio.2008.07.037; HEREMANS H, 1978, ONCOLOGY, V35, P246, DOI 10.1159/000225298; Hsieh SC, 2006, J BIOMED MATER RES B, V79B, P95, DOI 10.1002/jbm.b.30517; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Ji XH, 2007, J AM CHEM SOC, V129, P13939, DOI 10.1021/ja074447k; Klein S, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3461170; Kumar S, 2007, NANO LETT, V7, P1338, DOI 10.1021/nl070365i; Lee H, 2008, BIOMATERIALS, V29, P4709, DOI 10.1016/j.biomaterials.2008.08.038; Li HX, 2004, P NATL ACAD SCI USA, V101, P14036, DOI 10.1073/pnas.0406115101; Liaw JW, 2012, J QUANT SPECTROSC RA, V113, P2234, DOI 10.1016/j.jqsrt.2012.08.002; Liaw JW, 2010, J NANOSCI NANOTECHNO, V10, P467, DOI 10.1166/jnn.2010.2021; Liu KK, 2009, BIOMATERIALS, V30, P4249, DOI 10.1016/j.biomaterials.2009.04.056; Male KB, 2008, ANAL CHEM, V80, P5487, DOI 10.1021/ac8004555; Paino IMM, 2012, TOXICOL LETT, V215, P119, DOI 10.1016/j.toxlet.2012.09.025; Mironava T, 2010, NANOTOXICOLOGY, V4, P120, DOI 10.3109/17435390903471463; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nam J, 2009, J AM CHEM SOC, V131, P13639, DOI 10.1021/ja902062j; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pepper C, 1998, LEUKEMIA RES, V22, P439, DOI 10.1016/S0145-2126(98)00013-7; Pernodet N, 2006, SMALL, V2, P766, DOI 10.1002/smll.200500492; Raji V, 2011, EXP CELL RES, V317, P2052, DOI 10.1016/j.yexcr.2011.04.010; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Soenen SJ, 2012, ACS NANO, V6, P5767, DOI 10.1021/nn301714n; Tarantola M, 2011, NANOTOXICOLOGY, V5, P254, DOI 10.3109/17435390.2010.528847; Tarantola M, 2009, ACS NANO, V3, P213, DOI 10.1021/nn800721j; Taylor U, 2010, CYTOM PART A, V77A, P439, DOI 10.1002/cyto.a.20846; Thakor AS, 2011, SMALL, V7, P126, DOI 10.1002/smll.201001466; Tsai SW, 2008, SENSORS-BASEL, V8, P2306, DOI 10.3390/s8042306; Tsai SW, 2008, SENSORS-BASEL, V8, P6660, DOI 10.3390/s8106660; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r; Yu CX, 2007, LANGMUIR, V23, P9114, DOI 10.1021/la701111e; Zhang XX, 2009, J BIOL CHEM, V284, P18174, DOI 10.1074/jbc.M109.001354	48	44	46	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76545	10.1371/journal.pone.0076545	http://dx.doi.org/10.1371/journal.pone.0076545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098527	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500073
J	Umhau, JC; Zhou, WY; Thada, S; Demar, J; Hussein, N; Bhattacharjee, AK; Ma, KZ; Majchrzak-Hong, S; Herscovitch, P; Salem, N; Urish, A; Hibbeln, JR; Cunnane, SC; Rapoport, SI; Hirvonen, J				Umhau, John C.; Zhou, Weiyin; Thada, Shantalaxmi; Demar, James; Hussein, Nahed; Bhattacharjee, Abesh K.; Ma, Kaizong; Majchrzak-Hong, Sharon; Herscovitch, Peter; Salem, Norman, Jr.; Urish, Abigail; Hibbeln, Joseph R.; Cunnane, Stephen C.; Rapoport, Stanley I.; Hirvonen, Jussi			Brain Docosahexaenoic Acid [DHA] Incorporation and Blood Flow Are Increased in Chronic Alcoholics: A Positron Emission Tomography Study Corrected for Cerebral Atrophy	PLOS ONE			English	Article							ALPHA-LINOLENIC ACID; FATTY-ACIDS; DOCOSAPENTAENOIC ACID; METABOLISM; CONSUMPTION; TURNOVER; DEPRIVATION; PLASMA; RATS; NEUROINFLAMMATION	Objective: Chronic alcohol dependence has been associated with disturbed behavior, cerebral atrophy and a low plasma concentration of docosahexaenoic acid (DHA, 22:6n-3), particularly if liver disease is present. In animal models, excessive alcohol consumption is reported to reduce brain DHA concentration, suggesting disturbed brain DHA metabolism. We hypothesized that brain DHA metabolism also is abnormal in chronic alcoholics. Methods: We compared 15 non-smoking chronic alcoholics, studied within 7 days of their last drink, with 22 non-smoking healthy controls. Using published neuroimaging methods with positron emission tomography (PET), we measured regional coefficients (K*) and rates (J(in)) of DHA incorporation from plasma into the brain of each group using [1-C-11]DHA, and regional cerebral blood flow (rCBF) using [O-15]water. Data were partial volume error corrected for brain atrophy. Plasma unesterified DHA concentration also was quantified. Results: Mean K* for DHA was significantly and widely elevated by 10-20%, and rCBF was elevated by 7%-34%, in alcoholics compared with controls. Unesterified plasma DHA did not differ significantly between groups nor did whole brain J(in), the product of K* and unesterified plasma DHA concentration. Discussion: Significantly higher values of K* for DHA in alcoholics indicate increased brain avidity for DHA, thus a brain DHA metabolic deficit vis-a-vis plasma DHA availability. Higher rCBF in alcoholics suggests increased energy consumption. These changes may reflect a hypermetabolic state related to early alcohol withdrawal, or a general brain metabolic change in chronic alcoholics.	[Umhau, John C.; Zhou, Weiyin; Urish, Abigail] NIAAA, Lab Clin & Translat Studies, NIH, Bethesda, MD USA; [Thada, Shantalaxmi; Herscovitch, Peter] NIH, PET Dept, Bethesda, MD 20892 USA; [Demar, James; Bhattacharjee, Abesh K.; Ma, Kaizong; Rapoport, Stanley I.] NIA, Brain Physiol & Metab Sect, Neurosci Lab, NIH, Bethesda, MD 20892 USA; [Demar, James; Hussein, Nahed; Majchrzak-Hong, Sharon; Salem, Norman, Jr.; Hibbeln, Joseph R.] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA; [Cunnane, Stephen C.] Univ Sherbrooke, Dept Med, Sherbrook, PQ, Canada; [Hirvonen, Jussi] Univ Turku, Dept Radiol, Turku, Finland; [Hirvonen, Jussi] Univ Turku, Turku PET Ctr, Turku, Finland	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Sherbrooke; University of Turku; University of Turku	Umhau, JC (corresponding author), NIAAA, Lab Clin & Translat Studies, NIH, Bethesda, MD USA.	Umhau@nih.gov	Majchrzak, Sharon/F-1830-2013; Hussein, Nahed/AAL-1240-2020; Hirvonen, Jussi/H-2521-2012; Hirvonen, Jussi/AAC-1864-2020	Majchrzak, Sharon/0000-0001-8934-7294; Hussein, Nahed/0000-0001-5113-105X	National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000115, ZIAAA000262] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Intramural Research Programs of the National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA), and NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN JJ, 1992, J LIPID RES, V33, P1871; ALLING C, 1984, SCAND J CLIN LAB INV, V44, P283, DOI 10.3109/00365518409083809; AVELDANO MI, 1983, J LIPID RES, V24, P83; Basselin M, 2011, J CEREBR BLOOD F MET, V31, P486, DOI 10.1038/jcbfm.2010.111; Basselin M, 2010, J LIPID RES, V51, P3166, DOI 10.1194/jlr.M008334; Bazan NG, 2013, PROSTAG LEUKOTR ESS, V88, P127, DOI 10.1016/j.plefa.2012.08.008; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Brown J, 2009, NEUROCHEM RES, V34, P260, DOI 10.1007/s11064-008-9765-y; Buydens-Branchey L, 2009, AM J ADDICTION, V18, P73, DOI 10.1080/10550490802544003; Chang MCJ, 1997, BRAIN RES, V755, P74, DOI 10.1016/S0006-8993(97)00088-7; Chen CH, 2012, ALCOHOL CLIN EXP RES, V36, P625, DOI 10.1111/j.1530-0277.2011.01662.x; Christie IC, 2008, ALCOHOL, V42, P269, DOI 10.1016/j.alcohol.2008.03.132; Contreras MA, 2000, J NEUROCHEM, V75, P2392, DOI 10.1046/j.1471-4159.2000.0752392.x; DEGEORGE JJ, 1991, J NEUROCHEM, V56, P352, DOI 10.1111/j.1471-4159.1991.tb02603.x; DeMar JC, 2005, J NEUROCHEM, V94, P1063, DOI 10.1111/j.1471-4159.2005.03258.x; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DEVONSHIRE RE, 1976, PFLUG ARCH EUR J PHY, V364, P161, DOI 10.1007/BF00585185; ECKARDT MJ, 1978, BIOL PSYCHIAT, V13, P551; Eintrei C, 1999, BRIT J ANAESTH, V82, P596, DOI 10.1093/bja/82.4.596; Gazdzinski S, 2010, ALCOHOL CLIN EXP RES, V34, P2089, DOI 10.1111/j.1530-0277.2010.01305.x; Giovacchini G, 2004, J NUCL MED, V45, P1471; Giovacchini G, 2002, J CEREBR BLOOD F MET, V22, P1453, DOI 10.1097/01.WCB.0000033209.60867.7A; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Igarashi M, 2007, J LIPID RES, V48, P152, DOI 10.1194/jlr.M600396-JLR200; Igarashi M, 2012, BBA-MOL CELL BIOL L, V1821, P1235, DOI 10.1016/j.bbalip.2011.11.002; Igarashi M, 2012, J NEUROCHEM, V120, P985, DOI 10.1111/j.1471-4159.2011.07597.x; Ilbanez V, 2004, BRAIN RES BULL, V63, P147, DOI 10.1016/j.brainresbull.2004.02.003; Lands W., 1976, ENZYMES BIOL MEMBRAN, V2, P3; Manzo-Avalos S, 2010, INT J ENV RES PUB HE, V7, P4281, DOI 10.3390/ijerph7124281; MELGAARD B, 1990, ACTA NEUROL SCAND, V82, P87; NICOLAS JM, 1993, J NUCL MED, V34, P1452; Pawlosky RJ, 2004, ALCOHOL, V34, P27, DOI 10.1016/j.alcohol.2004.07.009; Pawlosky RJ, 2001, ALCOHOL CLIN EXP RES, V25, P1758, DOI 10.1097/00000374-200112000-00011; PAWLOSKY RJ, 1995, AM J CLIN NUTR, V61, P1284, DOI 10.1093/ajcn/61.6.1284; Pires PW, 2013, AM J PHYSIOL-HEART C, V304, pH1598, DOI 10.1152/ajpheart.00490.2012; Pita ML, 1997, THROMB HAEMOSTASIS, V78, P808; Purdon A.D., 2007, HDB NEUROCHEMISTRY M, P401; Purdon AD, 1998, BIOCHEM J, V335, P313, DOI 10.1042/bj3350313; Rapoport SI, 2001, J LIPID RES, V42, P678; Rapoport Stanley I., 1995, P1401; Reivich M, 1974, Res Publ Assoc Res Nerv Ment Dis, V53, P125; ROBINSON PJ, 1986, AM J PHYSIOL, V251, pR1212, DOI 10.1152/ajpregu.1986.251.6.R1212; ROBINSON PJ, 1992, BRAIN RES REV, V17, P187, DOI 10.1016/0165-0173(92)90016-F; ROGERS RL, 1983, J AM GERIATR SOC, V31, P540, DOI 10.1111/j.1532-5415.1983.tb02198.x; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rousset OG, 1998, J NUCL MED, V39, P904; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SALEM N, 1993, ALCOHOL, CELL MEMBRANES, AND SIGNAL TRANSDUCTION IN BRAIN, P33; Siennicki-Lantz A, 2002, AGING CLIN EXP RES, V14, P108; Smith QR, 2001, J MOL NEUROSCI, V16, P167, DOI 10.1385/JMN:16:2-3:167; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Suzuki Y, 2002, ALCOHOL CLIN EXP RES, V26, p95S, DOI 10.1097/01.ALC.0000026984.37262.82; Tan EK, 2010, ANN NEUROL, V67, P148, DOI 10.1002/ana.21663; Umhau JC, 2009, J LIPID RES, V50, P1259, DOI 10.1194/jlr.M800530-JLR200; VICTOR M, 1973, ANN NY ACAD SCI, V215, P210, DOI 10.1111/j.1749-6632.1973.tb28273.x; VOLKOW ND, 1992, AM J PSYCHIAT, V149, P1016; WAKU K, 1992, BIOCHIM BIOPHYS ACTA, V1124, P101, DOI 10.1016/0005-2760(92)90085-A; Wong DF, 2003, ALCOHOL RES HEALTH, V27, P161; Zheng JS, 2012, LIPIDS, V47, P549, DOI 10.1007/s11745-012-3671-4; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567	63	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75333	10.1371/journal.pone.0075333	http://dx.doi.org/10.1371/journal.pone.0075333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098376	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500026
J	Mori, T; Maeda, N; Inoue, K; Sekimoto, R; Tsushima, Y; Matsuda, K; Yamaoka, M; Suganami, T; Nishizawa, H; Ogawa, Y; Funahashi, T; Shimomura, I				Mori, Takuya; Maeda, Norikazu; Inoue, Kana; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Yamaoka, Masaya; Suganami, Takayoshi; Nishizawa, Hitoshi; Ogawa, Yoshihiro; Funahashi, Tohru; Shimomura, Iichiro			A Novel Role for Adipose Ephrin-B1 in Inflammatory Response	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; TYROSINE KINASE; EXPRESSION; OBESITY; EPH; IMPACT; TISSUE	Aims: Ephrin-B1 (EfnB1) was selected among genes of unknown function in adipocytes or adipose tissue and subjected to thorough analysis to understand its role in the development of obesity. Methods and Results: EfnB1 mRNA and protein levels were significantly decreased in adipose tissues of obese mice and such reduction was mainly observed in mature adipocytes. Exposure of 3T3-L1 adipocytes to tumor necrosis factor-alpha (TNF-alpha) and their culture with RAW264.7 cells reduced EFNB1 levels. Knockdown of adipose EFNB1 increased monocyte chemoattractant protein-1 (Mcp-1) mRNA level and augmented the TNF-alpha-mediated THP-1 monocyte adhesion to adipocytes. Adenovirus-mediated adipose EFNB1-overexpression significantly reduced the increase in Mcp-1 mRNA level induced by coculture of 3T3-L1 adipocytes with RAW264.7 cells. Monocyte adherent assay showed that adipose EfnB1-overexpression significantly decreased the increase of monocyte adhesion by coculture with RAW264.7 cells. TNF-alpha-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) was reduced by EFNB1-overexpression. Conclusions: EFNB1 contributes to the suppression of adipose inflammatory response. In obesity, reduction of adipose EFNB1 may accelerate the vicious cycle involved in adipose tissue inflammation.	[Mori, Takuya; Maeda, Norikazu; Inoue, Kana; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Yamaoka, Masaya; Nishizawa, Hitoshi; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan; [Suganami, Takayoshi] Tokyo Med & Dent Univ, Dept Organ Network, Grad Sch Med & Dent Sci, Tokyo, Japan; [Suganami, Takayoshi; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Metab, Grad Sch Med & Dent Sci, Tokyo, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Endocrinol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Funahashi, Tohru] Osaka Univ, Dept Metab, Grad Sch Med, Suita, Osaka, Japan; [Funahashi, Tohru] Osaka Univ, Dept Atherosclerosis, Grad Sch Med, Suita, Osaka, Japan	Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Osaka University; Osaka University	Maeda, N (corresponding author), Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp	SUGANAMI, Takayoshi/A-9475-2016	Ogawa, Yoshihiro/0000-0002-0834-2836	Takeda Science Foundation;  [22590979];  [24390238];  [22126008]	Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; 	This work was supported in part by a Grants-in-Aid for Scientific Research (C) no. 22590979 (to NM), a Grants-in-Aid for Scientific Research (B) no. 24390238 (to IS), a Grants-in-Aid for Scientific Research on Innovative Areas no. 22126008 (to TF), and Takeda Science Foundation (to NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamizu S, 2009, J ENDOCRINOL, V202, P199, DOI 10.1677/JOE-08-0363; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Funahashi T, 2007, ANN MED, V39, P482, DOI 10.1080/07853890701491026; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; Hiuge-Shimizu A, 2011, ARTERIOSCL THROM VAS, V31, P792, DOI 10.1161/ATVBAHA.110.221747; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hosono T, 2005, GENE, V348, P157, DOI 10.1016/j.gene.2005.01.005; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Maeda K, 1997, GENE, V190, P227, DOI 10.1016/S0378-1119(96)00730-5; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Maeda N, 2013, ENDOCR J, V60, P251, DOI 10.1507/endocrj.EJ13-0016; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Sakamoto A, 2008, CLIN SCI, V114, P643, DOI 10.1042/CS20070339; Sakamoto A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/127149; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; Yamaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047377; Yoshimura H, 2006, INFLAMM RES, V55, P543, DOI 10.1007/s00011-006-5144-9	37	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76199	10.1371/journal.pone.0076199	http://dx.doi.org/10.1371/journal.pone.0076199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098442	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100047
J	Roy, A; Lahiry, L; Banerjee, D; Ghosh, M; Banerjee, S				Roy, Anita; Lahiry, Lakshmishri; Banerjee, Debasis; Ghosh, Malay; Banerjee, Subrata			Increased Cytoplasmic Localization of p27(kip1) and Its Modulation of RhoA Activity during Progression of Chronic Myeloid Leukemia	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; CELL-CYCLE; C-JUN; HEMATOPOIETIC-CELLS; SIGNALING PATHWAYS; KINASE; APOPTOSIS; EXPRESSION; INHIBITION	The role of p27(kip1) in Chronic Myeloid Leukemia (CML) has been well studied in relation to its function as a cell cycle inhibitor. However, its cytoplasmic function especially in CML remains to be seen. We studied the localization of p27(kip1) and its function during the progression of CML from chronic to blast phase. Our investigations revealed an increased localization of p27(kip1) in the cytoplasm of CD34(+) cells in the blast phase compared to chronic phase. Cytoplasmic p27(kip1) was found to modulate RhoA activity in CD34(+) stem and progenitor cells. Further, RhoA activity was shown to be dependent on cytoplasmic p27(kip1) which in turn was dependent on p210(Bcr-Abl) kinase activity. Interestingly, RhoA activity was observed to affect cell survival in the presence of imatinib through the SAPK/JNK pathway. Accordingly, inhibition of SAPK/JNK pathway using SP600125 increased apoptosis of K562 cells in presence of imatinib. Our results, for the first time, thus reveal a crucial link between cytoplasmic p27(kip1), RhoA activity and SAPK/JNK signalling. To this effect we observed a correlation between increased cytoplasmic p27(kip1), increased RhoA protein levels, decreased RhoA-GTP levels and increased SAPK/JNK phosphorylation in blast phase CD34(+) cells compared to chronic phase CD34(+) cells.	[Roy, Anita; Lahiry, Lakshmishri; Banerjee, Subrata] Saha Inst Nucl Phys, Struct Genom Div, Kolkata, W Bengal, India; [Banerjee, Debasis] Ramkrishna Mission Seva Pratisthan, Dept Haematol, Kolkata, W Bengal, India; [Ghosh, Malay] NRS Med Coll & Hosp, Dept Haematol, Kolkata, W Bengal, India	Saha Institute of Nuclear Physics	Banerjee, S (corresponding author), Saha Inst Nucl Phys, Struct Genom Div, Kolkata, W Bengal, India.	subrata.banerjee@saha.ac.in		Roy, Anita/0000-0002-7297-2920	IBOP project of DAE, Govt. of India	IBOP project of DAE, Govt. of India	The study was funded by the IBOP project of DAE, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; BEDI A, 1994, BLOOD, V83, P2038; Bellucci R, 2004, BLOOD, V103, P656, DOI 10.1182/blood-2003-07-2559; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; Borriello A, 2011, CARCINOGENESIS, V32, P10, DOI 10.1093/carcin/bgq211; Burgess GS, 1998, BLOOD, V92, P2450, DOI 10.1182/blood.V92.7.2450.2450_2450_2460; Chu S, 2010, LEUKEMIA, V24, P779, DOI 10.1038/leu.2010.24; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Cortez D, 1997, ONCOGENE, V15, P2333, DOI 10.1038/sj.onc.1201400; CORTEZ D, 1995, MOL CELL BIOL, V15, P5531; Daubon T, 2008, ONCOGENE, V27, P2673, DOI 10.1038/sj.onc.1210933; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fromigue O, 2008, J BIOL CHEM, V283, P30549, DOI 10.1074/jbc.M801436200; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; HIRATA K, 1992, J BIOL CHEM, V267, P8719; Jena N, 2002, CANCER RES, V62, P535; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Minambres R, 2006, J CELL SCI, V119, P271, DOI 10.1242/jcs.02723; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Ohmine K, 2003, STEM CELLS, V21, P315, DOI 10.1634/stemcells.21-3-315; Parada Y, 2001, J BIOL CHEM, V276, P23572, DOI 10.1074/jbc.M101885200; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Roy A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.119; Sahay S, 2008, ONCOGENE, V27, P2064, DOI 10.1038/sj.onc.1210841; Sengupta A, 2007, LEUKEMIA, V21, P2559, DOI 10.1038/sj.leu.2404842; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Sengupta A, 2006, J GENE MED, V8, P1251, DOI 10.1002/jgm.959; Street CA, 2011, ANTICANCER RES, V31, P3645; TAKAISHI K, 1993, MOL CELL BIOL, V13, P72, DOI 10.1128/MCB.13.1.72; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Unwin RD, 2005, J BIOL CHEM, V280, P6316, DOI 10.1074/jbc.M410598200; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Yoshioka K, 1999, CANCER RES, V59, P2004; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248; Zhao RC, 2001, BLOOD, V97, P2406, DOI 10.1182/blood.V97.8.2406; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790	54	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76527	10.1371/journal.pone.0076527	http://dx.doi.org/10.1371/journal.pone.0076527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098519	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100074
J	Bosutti, A; Qi, J; Pennucci, R; Bolton, D; Matou, S; Ali, K; Tsai, LH; Krupinski, J; Petcu, EB; Montaner, J; Al Baradie, R; Caccuri, F; Caruso, A; Alessandri, G; Kumar, S; Rodriguez, C; Martinez-Gonzalez, J; Slevin, M				Bosutti, Alessandra; Qi, Jie; Pennucci, Roberta; Bolton, David; Matou, Sabine; Ali, Kamela; Tsai, Li-Huei; Krupinski, Jerzy; Petcu, Eugene B.; Montaner, Joan; Al Baradie, Raid; Caccuri, Francesca; Caruso, Arnaldo; Alessandri, Giulio; Kumar, Shant; Rodriguez, Cristina; Martinez-Gonzalez, Jose; Slevin, Mark			Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; MYOCYTE ENHANCER FACTOR-2; ACUTE ISCHEMIC-STROKE; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; ACTIVATOR P35; IN-VITRO; BRAIN; CDK5; EXPRESSION	Cyclin-dependent kinase-5 (Cdk5) is over-expressed in both neurons and microvessels in hypoxic regions of stroke tissue and has a significant pathological role following hyper-phosphorylation leading to calpain-induced cell death. Here, we have identified a critical role of Cdk5 in cytoskeleton/focal dynamics, wherein its activator, p35, redistributes along actin microfilaments of spreading cells co-localising with p((Tyr15))Cdk5, talin/integrin beta-1 at the lamellipodia in polarising cells. Cdk5 inhibition (roscovitine) resulted in actin-cytoskeleton disorganisation, prevention of protein co-localization and inhibition of movement. Cells expressing Cdk5 (D144N) kinase mutant, were unable to spread, migrate and form tube-like structures or sprouts, while Cdk5 wild-type over-expression showed enhanced motility and angiogenesis in vitro, which was maintained during hypoxia. Gene microarray studies demonstrated myocyte enhancer factor (MEF2C) as a substrate for Cdk5-mediated angiogenesis in vitro. MEF2C showed nuclear co-immunoprecipitation with Cdk5 and almost complete inhibition of differentiation and sprout formation following siRNA knock-down. In hypoxia, insertion of Cdk5/p25-inhibitory peptide (CIP) vector preserved and enhanced in vitro angiogenesis. These results demonstrate the existence of critical and complementary signalling pathways through Cdk5 and p35, and through which coordination is a required factor for successful angiogenesis in sustained hypoxic condition.	[Bosutti, Alessandra; Qi, Jie; Matou, Sabine; Ali, Kamela; Krupinski, Jerzy; Kumar, Shant; Slevin, Mark] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England; [Pennucci, Roberta] Dibit Ist Sci San Raffaele, Dept Neurosci Dibit, Cell Adhes Unit, Milan, Italy; [Bolton, David] Chip Man Technol Ltd, Tampere, Finland; [Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Cambridge, MA USA; [Tsai, Li-Huei] MIT, Stanley Ctr Psychiat Res, Broad Inst, Cambridge, MA 02139 USA; [Krupinski, Jerzy] Hosp Univ Mutua Terrassa, Dept Neurol, Barcelona, Spain; [Petcu, Eugene B.; Slevin, Mark] Griffith Univ, Sch Med, Southport, Qld 4215, Australia; [Montaner, Joan] Vall DeHebron Univ Hosp, Neurovasc Res Lab, Barcelona, Spain; [Al Baradie, Raid] Almajmaah Univ, Coll Appl Med Sci, Almajmaah, Saudi Arabia; [Caccuri, Francesca; Caruso, Arnaldo] Univ Brescia, Microbiol Sect, Dept Expt & Appl Med, Sch Med, Brescia, Italy; [Alessandri, Giulio] Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Cellular Neurobiol Lab, Dept Cerebrovasc Dis, Milan, Italy; [Kumar, Shant] Univ Manchester, Dept Pathol Sci, Manchester, Lancs, England; [Kumar, Shant] Christie Hosp, Manchester, Lancs, England; [Rodriguez, Cristina; Martinez-Gonzalez, Jose] Hosp Santa Creu & St, Ctr Invest Cardiovasc, Barcelona, Spain	Manchester Metropolitan University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Hospital Universitario Mutua Terrassa; Griffith University; Majmaah University; University of Brescia; University of Manchester; Christie NHS Foundation Trust; Christie Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Slevin, M (corresponding author), Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England.	m.a.slevin@mmu.ac.uk	Rodriguez, Cristina/D-3099-2011; Slevin, Mark/AFT-1420-2022; slevin, mark a/A-1593-2008; Montaner, Joan/D-3063-2015; Caccuri, Francesca/AAC-1281-2022; Petcu, Eugen B/C-3824-2011; Caruso, Arnaldo/H-7818-2014	Rodriguez, Cristina/0000-0002-6472-5647; Montaner, Joan/0000-0003-4845-2279; Caccuri, Francesca/0000-0002-1923-9033; Petcu, Eugen B/0000-0001-5726-729X; Martinez-Gonzalez, Jose/0000-0002-3894-7166; CARUSO, Arnaldo/0000-0001-5178-566X; alessandri, giulio/0000-0002-1861-8461; slevin, mark/0000-0003-3767-4861	Wellcome Trust [082496/Z/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (Project number: 082496/Z/07/Z)URL: http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; Antoniou X, 2011, BRAIN RES, V1381, P1, DOI 10.1016/j.brainres.2010.10.071; Avraham HK, 2003, J BIOL CHEM, V278, P36661, DOI 10.1074/jbc.M301253200; Barros-Minones L, 2013, BBA-MOL BASIS DIS, V1832, P705, DOI 10.1016/j.bbadis.2013.02.002; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Futatsugi A, 2012, CELL CYCLE, V11, P1603, DOI 10.4161/cc.20009; Haarmann A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013568; Hayashi T, 1999, NEUROSCI LETT, V265, P37, DOI 10.1016/S0304-3940(99)00201-3; He LS, 2011, CELL MOL LIFE SCI, V68, P1633, DOI 10.1007/s00018-010-0562-9; Hsieh WS, 2009, CLIN CANCER RES, V15, P1435, DOI 10.1158/1078-0432.CCR-08-1748; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Jin G, 2011, SURGERY, V150, P429, DOI 10.1016/j.surg.2011.07.001; Kanungo J, 2009, CELL MOL NEUROBIOL, V29, P1073, DOI 10.1007/s10571-009-9410-6; Kesavapany Sashi, 2007, Biotechnology Journal, V2, P978, DOI 10.1002/biot.200700057; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Le Goff MM, 2012, J BIOL CHEM, V287, P28027, DOI 10.1074/jbc.M111.331157; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Lin Q, 1998, DEVELOPMENT, V125, P4565; Love CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012812; Love S, 2003, NEUROSCI LETT, V353, P29, DOI 10.1016/j.neulet.2003.09.004; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maiti D, 2008, INVEST OPHTH VIS SCI, V49, P3640, DOI 10.1167/iovs.08-1760; Metzger W, 2011, CYTOTHERAPY, V13, P1000, DOI 10.3109/14653249.2011.583233; Mitsios N, 2007, BRAIN PATHOL, V17, P11, DOI 10.1111/j.1750-3639.2006.00031.x; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Qiao F, 2008, EXP CELL RES, V314, P3542, DOI 10.1016/j.yexcr.2008.08.023; Rashidian J, 2009, J NEUROSCI, V29, P12497, DOI 10.1523/JNEUROSCI.3892-09.2009; Shi LL, 2012, NEUROCHEM INT, V61, P227, DOI 10.1016/j.neuint.2012.04.019; Slevin M, 2006, CLIN SCI, V111, P171, DOI 10.1042/CS20060049; Slevin M, 2009, CURR OPIN PHARMACOL, V9, P119, DOI 10.1016/j.coph.2008.10.003; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Stec J, 2005, J MOL DIAGN, V7, P357, DOI 10.1016/S1525-1578(10)60565-X; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Timsit S, 2012, CLIN PHARMACOL THER, V91, P327, DOI 10.1038/clpt.2011.312; Vath A, 2002, ACT NEUR S, V81, P307; Wesierska-Gadek J, 2008, J CELL BIOCHEM, V105, P1161, DOI 10.1002/jcb.21903; Zahler S, 2010, ANGIOGENESIS, V13, P239, DOI 10.1007/s10456-010-9181-1	40	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75538	10.1371/journal.pone.0075538	http://dx.doi.org/10.1371/journal.pone.0075538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098701	gold, Green Published, Green Accepted			2022-12-27	WOS:000325423500072
J	Latronico, N; Filosto, M; Fagoni, N; Gheza, L; Guarneri, B; Todeschini, A; Lombardi, R; Padovani, A; Lauria, G				Latronico, Nicola; Filosto, Massimiliano; Fagoni, Nazzareno; Gheza, Laura; Guarneri, Bruno; Todeschini, Alice; Lombardi, Raffaella; Padovani, Alessandro; Lauria, Giuseppe			Small Nerve Fiber Pathology in Critical Illness	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; SKIN BIOPSY; CUTANEOUS INNERVATION; PERIPHERAL-NERVE; CHRONIC PAIN; ILL PATIENTS; CARE; NEUROPATHY; WEAKNESS; POLYNEUROPATHY	Background: Degeneration of intraepidermal nerve fibers (IENF) is a hallmark of small fiber neuropathy of different etiology, whose clinical picture is dominated by neuropathic pain. It is unknown if critical illness can affect IENF. Methods: We enrolled 14 adult neurocritical care patients with prolonged intensive care unit (ICU) stay and artificial ventilation (>= 3 days), and no previous history or risk factors for neuromuscular disease. All patients underwent neurological examination including evaluation of consciousness, sensory functions, muscle strength, nerve conduction study and needle electromyography, autonomic dysfunction using the finger wrinkling test, and skin biopsy for quantification of IENF and sweat gland innervation density during ICU stay and at follow-up visit. Development of infection, sepsis and multiple organ failure was recorded throughout the ICU stay. Results: Of the 14 patients recruited, 13 (93%) had infections, sepsis or multiple organ failure. All had severe and non-length dependent loss of IENF. Sweat gland innervation was reduced in all except one patient. Of the 7 patients available for follow-up visit, three complained of diffuse sensory loss and burning pain, and another three showed clinical dysautonomia. Conclusions: Small fiber pathology can develop in the acute phase of critical illness and may explain chronic sensory impairment and pain in neurocritical care survivors. Its impact on long term disability warrants further studies involving also non-neurologic critical care patients.	[Latronico, Nicola; Fagoni, Nazzareno; Gheza, Laura] Univ Brescia, Spedali Civili, Sect Neuroanesthesia & Neurocrit Care, Dept Anesthesia & Crit Care Med, Brescia, Italy; [Filosto, Massimiliano; Todeschini, Alice; Padovani, Alessandro] Univ Brescia, Spedali Civili, Dept Clin Neurol, Sect Neuromuscular Dis & Neuropathies, Brescia, Italy; [Guarneri, Bruno] Univ Brescia, Spedali Civili, Dept Clin Neurophysiol, Brescia, Italy; [Lombardi, Raffaella; Lauria, Giuseppe] IRCCS Fdn, Carlo Besta Neurol Inst, Neuromuscular Dis Unit, Milan, Italy	Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta	Latronico, N (corresponding author), Univ Brescia, Spedali Civili, Sect Neuroanesthesia & Neurocrit Care, Dept Anesthesia & Crit Care Med, Brescia, Italy.	nicola.latronico@med.unibs.it	Fagoni, Nazzareno/I-1156-2016; lauria, giuseppe/AAN-5371-2020; Padovani, Alessandro/ABI-7312-2020; Lombardi, Raffaella/K-7951-2016; Filosto, Massimiliano/S-9446-2019; Lauria, Giuseppe/T-1378-2017; LATRONICO, Nicola/F-1557-2010	Fagoni, Nazzareno/0000-0002-7312-8174; lauria, giuseppe/0000-0001-9773-020X; Padovani, Alessandro/0000-0002-0119-3639; Lombardi, Raffaella/0000-0003-0080-6699; Filosto, Massimiliano/0000-0002-2852-7512; Lauria, Giuseppe/0000-0001-9773-020X; LATRONICO, Nicola/0000-0002-2521-5871	University of Brescia; "Carlo Besta" Neurological Institute	University of Brescia; "Carlo Besta" Neurological Institute	The study was funded with internal funds of the University of Brescia and of the "Carlo Besta" Neurological Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel MJ, 2007, CAN J NEUROL SCI, V34, P427, DOI 10.1017/S0317167100007307; Batt J, 2013, AM J RESP CRIT CARE, V187, P238, DOI 10.1164/rccm.201205-0954SO; Battle CE, 2013, CRIT CARE, V17, DOI 10.1186/cc12746; Bolton C, 2007, CAN J NEUROL SCI, V34, P313, DOI 10.1017/S0317167100006739; Chiang MC, 2002, NEUROLOGY, V59, P1094, DOI 10.1212/WNL.59.7.1094; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fenzi F, 2003, ACTA NEUROPATHOL, V106, P75, DOI 10.1007/s00401-003-0704-3; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Guarneri B, 2008, J NEUROL NEUROSUR PS, V79, P838, DOI 10.1136/jnnp.2007.142430; Iwashyna TJ, 2010, ANN INTERN MED, V153, P204, DOI 10.7326/0003-4819-153-3-201008030-00013; Kramer HH, 2004, DIABETES CARE, V27, P2386, DOI 10.2337/diacare.27.10.2386; Kyranou M, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-36; Latronico N, 2005, CURR OPIN CRIT CARE, V11, P381, DOI 10.1097/01.ccx.0000168530.30702.3e; Latronico N, 2007, CRIT CARE, V11, DOI 10.1186/cc5671; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Lauria G, 2004, MUSCLE NERVE, V30, P310, DOI 10.1002/mus.20098; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Lauria G, 2007, BRIT MED J, V334, P1159, DOI 10.1136/bmj.39192.488125.BE; Lauria G, 2010, J PERIPHER NERV SYST, V15, P202, DOI 10.1111/j.1529-8027.2010.00271.x; Martinez V, 2010, PAIN, V151, P53, DOI 10.1016/j.pain.2010.05.017; Misak CJ, 2011, AM J RESP CRIT CARE, V183, P845, DOI 10.1164/rccm.201007-1110OE; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Pan CL, 2003, BRAIN, V126, P386, DOI 10.1093/brain/awg039; Ruts L, 2012, PAIN, V153, P399, DOI 10.1016/j.pain.2011.10.037; Seneviratne U, 2002, J NEUROL NEUROSUR PS, V72, P540; Sghirlanzoni A, 2005, LANCET NEUROL, V4, P349, DOI 10.1016/S1474-4422(05)70096-X; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Sommer C, 2007, LANCET NEUROL, V6, P632, DOI 10.1016/S1474-4422(07)70172-2; Sorensen L, 2006, DIABETES CARE, V29, P883, DOI 10.2337/diacare.29.04.06.dc05-2180; Teoh HL, 2008, J NEUROL NEUROSUR PS, V79, P835, DOI 10.1136/jnnp.2007.140947; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Wilder-Smith EP, 2009, CLIN NEUROPHYSIOL, V120, P953, DOI 10.1016/j.clinph.2009.03.011; Zamperetti N, 2008, INTENS CARE MED, V34, P1330, DOI 10.1007/s00134-008-1096-6	37	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75696	10.1371/journal.pone.0075696	http://dx.doi.org/10.1371/journal.pone.0075696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098716	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500087
J	Zhong, XW; Zou, Y; Liu, SP; Yi, QY; Hu, CM; Wang, C; Xia, QY; Zhao, P				Zhong, Xiao-wu; Zou, Yong; Liu, Shi-ping; Yi, Qi-ying; Hu, Cui-mei; Wang, Chen; Xia, Qing-you; Zhao, Ping			Proteomic-Based Insight into Malpighian Tubules of Silkworm Bombyx mori	PLOS ONE			English	Article							DOMESTICATED SILKWORM; RENAL TUBULE; H+-ATPASE; DROSOPHILA; ELECTROPHORESIS; SUBUNIT; GENOME; TOOL; L.	Malpighian tubules (MTs) are highly specific organs of arthropods (Insecta, Myriapoda and Arachnida) for excretion and osmoregulation. In order to highlight the important genes and pathways involved in multi-functions of MTs, we performed a systematic proteomic analysis of silkworm MTs in the present work. Totally, 1,367 proteins were identified by one-dimensional gel electrophoresis coupled with liquid chromatography-tandem mass spectrometry, and as well as by Trans Proteomic Pipeline (TPP) and Absolute protein expression (APEX) analyses. Forty-one proteins were further identified by two-dimensional gel electrophoresis. Some proteins were revealed to be significantly associated with various metabolic processes, organic solute transport, detoxification and innate immunity. Our results might lay a good foundation for future functional studies of MTs in silkworm and other lepidoptera.	[Zhong, Xiao-wu; Zou, Yong; Liu, Shi-ping; Yi, Qi-ying; Hu, Cui-mei; Wang, Chen; Xia, Qing-you; Zhao, Ping] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Zhao, P (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	zhaop@swu.edu.cn	Liu, Shiping/W-2577-2019	Liu, Shiping/0000-0002-2917-0172	National Basic Research Program of China [2012CB114604]; National Hi-Tech Research and Development Program of China [2011AA100306]; National Natural Science Foundation [31172157]	National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (Grant No. 2012CB114604), http://www.973.gov.cn/Default_3.aspx, the National Hi-Tech Research and Development Program of China (Grant No. 2011AA100306), http://www.863.gov.cn/, the National Natural Science Foundation (Grant No. 31172157), http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; Dow JAT, 2003, PHYSIOL REV, V83, P687, DOI 10.1152/physrev.00035.2002; Dow JAT, 2001, ADV INSECT PHYSIOL, V28, P1, DOI 10.1016/S0065-2806(01)28008-4; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Fu Q, 2011, PROTEOMICS, V11, P3761, DOI 10.1002/pmic.201000506; Fuster DG, 2008, KIDNEY INT, V73, P1151, DOI 10.1038/ki.2008.96; Hou Y, 2007, INSECT BIOCHEM MOLEC, V37, P486, DOI 10.1016/j.ibmb.2007.02.011; Hou Y, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-45; Igarashi P, 2005, J AM SOC NEPHROL, V16, P296, DOI 10.1681/ASN.2004110951; Jung AC, 2005, J AM SOC NEPHROL, V16, P322, DOI 10.1681/ASN.2004090729; Kajiwara H, 2009, J ELECTROPHORESIS, V53, P33; KENCHINGTON W, 1983, J INSECT PHYSIOL, V29, P355, DOI 10.1016/0022-1910(83)90037-9; Kuntumalla S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-22; LEE SHC, 1986, BIOCHEM J, V233, P621, DOI 10.1042/bj2330621; Li JY, 2010, INSECT BIOCHEM MOLEC, V40, P293, DOI 10.1016/j.ibmb.2010.01.008; Li JY, 2009, J PROTEOME RES, V8, P2620, DOI 10.1021/pr8006123; Li JY, 2010, AMINO ACIDS, V39, P751, DOI 10.1007/s00726-010-0517-3; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Millares P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033590; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Nappi AJ, 2000, NITRIC OXIDE-BIOL CH, V4, P423, DOI 10.1006/niox.2000.0294; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Reidegeld KA, 2008, PROTEOMICS, V8, P1129, DOI 10.1002/pmic.200701073; TEIGLER DJ, 1972, TISSUE CELL, V4, P173, DOI 10.1016/S0040-8166(72)80014-4; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Weng XH, 2003, J EXP BIOL, V206, P2211, DOI 10.1242/jeb.00385; WESSING A, 1993, J COMP PHYSIOL B, V163, P452; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yang HJ, 2010, AMINO ACIDS, V38, P1333, DOI 10.1007/s00726-009-0342-8; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yao HP, 2009, BIOSCIENCE REP, V29, P363, DOI 10.1042/BSR20080144; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhong XW, 2012, INSECT SCI, V19, P559, DOI 10.1111/j.1744-7917.2011.01479.x; Zhong XW, 2012, BMB REP, V45, P665, DOI 10.5483/BMBRep.2012.45.11.261	46	13	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75731	10.1371/journal.pone.0075731	http://dx.doi.org/10.1371/journal.pone.0075731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098719	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500090
J	Hess, A; Yu, LC; Klein, I; De Mazancourt, M; Jebrak, G; Mal, H; Brugiere, O; Fournier, M; Courbage, M; Dauriat, G; Schouman-Clayes, E; Clerici, C; Mangin, L				Hess, Agathe; Yu, Lianchun; Klein, Isabelle; De Mazancourt, Marine; Jebrak, Gilles; Mal, Herve; Brugiere, Olivier; Fournier, Michel; Courbage, Maurice; Dauriat, Gaelle; Schouman-Clayes, Elisabeth; Clerici, Christine; Mangin, Laurence			Neural Mechanisms Underlying Breathing Complexity	PLOS ONE			English	Article							PRE-BOTZINGER COMPLEX; RESPIRATORY RHYTHM GENERATION; DEFAULT-MODE; CHAOTIC DYNAMICS; BRAIN; FLUCTUATIONS; NETWORK; NEURONS; ROBUST; FMRI	Breathing is maintained and controlled by a network of automatic neurons in the brainstem that generate respiratory rhythm and receive regulatory inputs. Breathing complexity therefore arises from respiratory central pattern generators modulated by peripheral and supra-spinal inputs. Very little is known on the brainstem neural substrates underlying breathing complexity in humans. We used both experimental and theoretical approaches to decipher these mechanisms in healthy humans and patients with chronic obstructive pulmonary disease (COPD). COPD is the most frequent chronic lung disease in the general population mainly due to tobacco smoke. In patients, airflow obstruction associated with hyperinflation and respiratory muscles weakness are key factors contributing to load-capacity imbalance and hence increased respiratory drive. Unexpectedly, we found that the patients breathed with a higher level of complexity during inspiration and expiration than controls. Using functional magnetic resonance imaging (fMRI), we scanned the brain of the participants to analyze the activity of two small regions involved in respiratory rhythmogenesis, the rostral ventro-lateral (VL) medulla (pre-Botzinger complex) and the caudal VL pons (parafacial group). fMRI revealed in controls higher activity of the VL medulla suggesting active inspiration, while in patients higher activity of the VL pons suggesting active expiration. COPD patients reactivate the parafacial to sustain ventilation. These findings may be involved in the onset of respiratory failure when the neural network becomes overwhelmed by respiratory overload We show that central neural activity correlates with airflow complexity in healthy subjects and COPD patients, at rest and during inspiratory loading. We finally used a theoretical approach of respiratory rhythmogenesis that reproduces the kernel activity of neurons involved in the automatic breathing. The model reveals how a chaotic activity in neurons can contribute to chaos in airflow and reproduces key experimental fMRI findings.	[Hess, Agathe; Yu, Lianchun; De Mazancourt, Marine; Courbage, Maurice; Mangin, Laurence] Univ Paris 07, CNRS, Lab Mat & Syst Complexes, UMR 7057, Paris, France; [Hess, Agathe; Klein, Isabelle; Schouman-Clayes, Elisabeth] Hop Bichat Claude Bernard, AP HP, Serv Radiol, F-75877 Paris 18, France; [Yu, Lianchun] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China; [Klein, Isabelle] Univ Paris 07, INSERM, U698, Paris, France; [De Mazancourt, Marine] Ecole Normale Super, F-75231 Paris, France; [Jebrak, Gilles; Mal, Herve; Brugiere, Olivier; Fournier, Michel; Dauriat, Gaelle] Hop Bichat Claude Bernard, AP HP, Serv Pneumol, F-75877 Paris 18, France; [Clerici, Christine; Mangin, Laurence] Hop Bichat Claude Bernard, AP HP, Dept Physiol Explorat Fonct, F-75877 Paris 18, France; [Clerici, Christine] Univ Paris 07, INSERM, U700, Paris, France; [Mangin, Laurence] Hop Bichat Claude Bernard, AP HP, Ctr Invest Clin, F-75877 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Lanzhou University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mangin, L (corresponding author), Univ Paris 07, CNRS, Lab Mat & Syst Complexes, UMR 7057, Paris, France.	laurence.mangin@bch.aphp.fr		Courbage, Maurice/0000-0001-6615-9039	PHRC [P100136]; BQR Paris 7 University; Fond de Dotation Recherche Respiratoire; National Natural Science Foundation of China [11105062]	PHRC; BQR Paris 7 University; Fond de Dotation Recherche Respiratoire; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by PHRC P100136 AP-HP; BQR Paris 7 University; Fond de Dotation Recherche Respiratoire; Dr Lianchun Yu was partially supported by National Natural Science Foundation of China (Grants 11105062) No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KA, 2002, J PHYSIOL-LONDON, V541, P653, DOI 10.1113/jphysiol.2001.013462; Barahona M, 1996, NATURE, V381, P215, DOI 10.1038/381215a0; Barnes PJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000220; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; Caubit X, 2010, J NEUROSCI, V30, P9465, DOI 10.1523/JNEUROSCI.1765-10.2010; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Courbage M, 2007, CHAOS, V17, DOI 10.1063/1.2795435; Courbage M, 2004, CHAOS, V14, P1148, DOI 10.1063/1.1821691; Courbage M, 2010, INT J BIFURCAT CHAOS, V20, P1631, DOI 10.1142/S0218127410026733; DANGELO E, 1991, J APPL PHYSIOL, V70, P2602, DOI 10.1152/jappl.1991.70.6.2602; Del Negro CA, 2002, BIOPHYS J, V82, P206, DOI 10.1016/S0006-3495(02)75387-3; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Evans KC, 2009, NEUROIMAGE, V47, P961, DOI 10.1016/j.neuroimage.2009.05.025; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fiamma MN, 2006, AM J PHYSIOL, V292, pR1985; Fortuna MG, 2008, J NEUROSCI, V28, P2506, DOI 10.1523/JNEUROSCI.5595-07.2008; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOZAL D, 1995, P NATL ACAD SCI USA, V92, P6607, DOI 10.1073/pnas.92.14.6607; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Gray P, 2011, NATURE NEUROSC, V4, P927; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hopkinson NS, 2011, RESP PHYSIOL NEUROBI, V141, P1; Jacono PJ, 2010, RESP PHYSIOL NEUROBI, V178, P429; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Jolley CJ, 2009, EUR RESPIR J, V33, P289, DOI 10.1183/09031936.00093408; Kantz H., 2004, NONLINEAR TIME SERIE; Lavezzi AM, 2008, NEUROPATHOLOGY, V28, P10, DOI 10.1111/j.1440-1789.2007.00824.x; LIEBERT W, 1991, EUROPHYS LETT, V14, P521, DOI 10.1209/0295-5075/14/6/004; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mangin L, 2008, RESP PHYSIOL NEUROBI, V161, P189, DOI 10.1016/j.resp.2008.02.006; Mangin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016297; Mangin L, 2009, AM J PHYSIOL-REG I, V296, pR1088, DOI 10.1152/ajpregu.90862.2008; McKay LC, 2003, J APPL PHYSIOL, V95, P1170, DOI 10.1152/japplphysiol.00641.2002; Milsom WK, 2010, AM J PHYSIOL-REG I, V299, pR1, DOI 10.1152/ajpregu.00069.2010; Murphy PB, 2011, THORAX, V66, P602, DOI 10.1136/thx.2010.151332; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2006, J APPL PHYSIOL, V100, P2094, DOI 10.1152/japplphysiol.00119.2006; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; Pattinson KTS, 2009, NEUROIMAGE, V44, P295, DOI 10.1016/j.neuroimage.2008.09.007; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Peng T, 2013, MAGN RES IM IN PRESS; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; Poon CS, 2001, P NATL ACAD SCI USA, V98, P7107, DOI 10.1073/pnas.131173198; Que CL, 2001, J APPL PHYSIOL, V91, P1131, DOI 10.1152/jappl.2001.91.3.1131; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Samara Z, 2009, RESP PHYSIOL NEUROBI, V165, P82, DOI 10.1016/j.resp.2008.10.015; Schmidt M, 2010, ANESTHESIOLOGY, V112, P670, DOI 10.1097/ALN.0b013e3181cea375; Schwarzacher SW, 2011, BRAIN, V134, P24, DOI 10.1093/brain/awq327; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Smith GD, 2000, J NEUROPHYSIOL, V83, P588, DOI 10.1152/jn.2000.83.1.588; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Wittmeier S, 2008, P NATL ACAD SCI USA, V105, P18000, DOI 10.1073/pnas.0809377105; Yan S, 2000, EUR RESPIR J, V16, P684, DOI 10.1034/j.1399-3003.2000.16d20.x; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982	67	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75740	10.1371/journal.pone.0075740	http://dx.doi.org/10.1371/journal.pone.0075740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098396	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600022
J	Kausar, S; Asif, M; Bibi, N; Rashid, S				Kausar, Samina; Asif, Muhammad; Bibi, Nousheen; Rashid, Sajid			Comparative Molecular Docking Analysis of Cytoplasmic Dynein Light Chain DYNLL1 with Pilin to Explore the Molecular Mechanism of Pathogenesis Caused by Pseudomonas aeruginosa PAO	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; SWINE-FEVER VIRUS; SPLICED EXON-B; NF-KAPPA-B; PROTEIN-DOCKING; STRUCTURAL BASIS; MOTOR COMPLEX; MYOSIN VA; INFECTION; BINDING	Cytoplasmic dynein light chain 1 (DYNLL1) is a component of large protein complex, which is implicated in cargo transport processes, and is known to interact with many cellular and viral proteins through its short consensus motif (K/R) XTQT. Still, it remains to be explored that bacterial proteins also exhibit similar recognition sequences to make them vulnerable to host defense mechanism. We employed multiple docking protocols including AUTODOCK, PatchDock, ZDOCK, DOCK/PIERR and CLUSPRO to explore the DYNLL1 and Pilin interaction followed by molecular dynamics simulation assays. Subsequent structural comparison of the predicted binding site for DYNLL1-Pilin complex against the experimentally verified DYNLL1 binding partners was performed to cross check the residual contributions and to determine the binding mode. On the basis of in silico analysis, here we describe a novel interaction of DYNLL1 and receptor binding domain of Pilin (the main protein constituent of bacterial type IV Pili) of gram negative bacteria Pseudomonas aeruginosa (PAO), which is the third most common nosocomial pathogen associated with the life-threatening infections. Evidently, our results underscore that Pilin specific motif (KSTQD) exhibits a close structural similarity to that of Vaccinia virus polymerase, P protein Rabies and P protein Mokola viruses. We speculate that binding of DYNLL1 to Pilin may trigger an uncontrolled inflammatory response of the host immune system during P. aeruginosa chronic infections thereby opening a new pioneering area to investigate the role of DYNLL1 in gram negative bacterial infections other than viral infections. Moreover, by manifesting a strict correspondence between sequence and function, our study anticipates a novel drug target site to control the complications caused by P. aeruginosa infections.	[Kausar, Samina; Asif, Muhammad; Bibi, Nousheen; Rashid, Sajid] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan	Quaid I Azam University	Rashid, S (corresponding author), Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan.	sajidrwp@yahoo.co.uk	Rashid, Sajid/K-8640-2019; Kausar, Samina/U-5555-2017	Kausar, Samina/0000-0002-5207-7136				Almagro P, 2012, RESPIRATION, V84, P36, DOI 10.1159/000331224; Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Arlehamn CSL, 2011, CELL MICROBIOL, V13, P388, DOI 10.1111/j.1462-5822.2010.01541.x; Asikyan ML, 2008, J BACTERIOL, V190, P7022, DOI 10.1128/JB.00938-08; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Bergen JM, 2007, MOL PHARMACEUT, V4, P119, DOI 10.1021/mp060086o; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bucior I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002616; Campbell AP, 1995, BIOCHEMISTRY-US, V34, P16255, DOI 10.1021/bi00050a005; CECCALDI PE, 1989, J NEUROPATH EXP NEUR, V48, P620, DOI 10.1097/00005072-198911000-00004; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dohner K, 2005, CURR TOP MICROBIOL, V285, P67; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Garcia-Mayoral MF, 2011, FEBS LETT, V585, P53, DOI 10.1016/j.febslet.2010.11.027; Funk A, 2004, J VIROL, V78, P8289, DOI 10.1128/jvi.78.15.8289-8300.2004; Garcia-Mayoral MF, 2010, FEBS J, V277, P2340, DOI 10.1111/j.1742-4658.2010.07649.x; Giantsou E, 2011, MINERVA ANESTESIOL, V77, P964; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Hanson RM, 2010, J APPL CRYSTALLOGR, V43, P1250, DOI 10.1107/S0021889810030256; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; Jouvenet N, 2004, J VIROL, V78, P7990, DOI 10.1128/JVI.78.15.7990-8001.2004; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Kozakov D, 2005, BIOPHYS J, V89, P867, DOI 10.1529/biophysj.104.058768; Kube DM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-69; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mabit H, 2002, J VIROL, V76, P9962, DOI 10.1128/JVI.76.19.9962-9971.2002; Martinez-Moreno M, 2003, FEBS LETT, V544, P262, DOI 10.1016/S0014-5793(03)00516-7; Mashiach E, 2010, PROTEINS, V78, P1503, DOI 10.1002/prot.22668; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Merino-Gracia J, 2011, FEBS J, V278, P2997, DOI 10.1111/j.1742-4658.2011.08252.x; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PFISTER KK, 1982, CELL MOTIL CYTOSKEL, V2, P525, DOI 10.1002/cm.970020604; Ramanathan K, 2009, INTERDISCIP SCI, V1, P290, DOI 10.1007/s12539-009-0035-8; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Ravikant DVS, 2010, PROTEINS, V78, P400, DOI 10.1002/prot.22550; Schneider MA, 2011, CELL MICROBIOL, V13, P32, DOI 10.1111/j.1462-5822.2010.01515.x; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Smith KD, 2002, CURR TOP MICROBIOL, V270, P93; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Suikkanen S, 2003, J VIROL, V77, P10270, DOI 10.1128/JVI.77.19.10270-10279.2003; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Tramper-Stranders GA, 2012, CLIN MICROBIOL INFEC, V18, P567, DOI 10.1111/j.1469-0691.2011.03627.x; Viswanath S, 2013, PROTEINS, V81, P592, DOI 10.1002/prot.24214; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Williams JC, 2005, J BIOL CHEM, V280, P21981, DOI 10.1074/jbc.M414643200; Zlenko D. V., 2012, Biofizika, V57, P197	68	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76730	10.1371/journal.pone.0076730	http://dx.doi.org/10.1371/journal.pone.0076730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098557	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600074
J	Kirkby, HM; Calvert, M; McManus, RJ; Draper, H				Kirkby, Helen M.; Calvert, Melanie; McManus, Richard J.; Draper, Heather			Informing Potential Participants about Research: Observational Study with an Embedded Randomized Controlled Trial	PLOS ONE			English	Article							CLINICAL-TRIALS; CONSENT; INFORMATION; COMPREHENSION	Objectives: To assess: 1) the feasibility of electronic information provision; 2) gather evidence on the topics and level of detail of information potential research participant's accessed; 3) to assess satisfaction and understanding. Design: Observational study with an embedded randomised controlled trial. Setting: Low risk intervention study based in primary care. Participants: White British & Irish, South Asian and African-Caribbean subjects aged between 40-74 years eligible for a blood pressure monitoring study. Interventions: PDF copy of the standard paper participant information sheet (PDF-PIS) and an electronic Interactive Information Sheet (IIS) where participants could choose both the type and level of detail accessed. Main Outcome Measures: 1) Proportion of participants providing an email address and accessing electronic information 2) Willingness to participate in a recruitment clinic. 3) Type and depth of information accessed on the IIS. 4) Participant satisfaction and understanding. Results: 1160 participants were eligible for the study. Of these, 276 (24%) provided an active email address, of whom 84 did not respond to the email. 106 responded to the email but chose not to access any electronic information and were therefore ineligible for randomisation. 42 were randomised to receive the PDF-PIS and 44 to receive the IIS (with consent rates of 48% and 36%, respectively; odds ratio 0.6, 95% confidence interval 0.25 to 1.4). Electronic observation of information accessed by potential participants showed 41% chose to access no information and only 9% accessed the detail presented on the Research Ethics Committee approved participant information sheet before booking to attend a recruitment clinic for the intervention study. 63 of the 106 participants (59%) who chose not to access any electronic information also booked an appointment. Conclusions: Current written information about research may not be read, emphasising the importance of the consent interview and consideration of new ways of presenting complex information.	[Kirkby, Helen M.; Calvert, Melanie; Draper, Heather] Univ Birmingham, Med Res Council Midland Hub Trials Methodol Res, Birmingham, W Midlands, England; [Calvert, Melanie] Univ Birmingham, Natl Inst Hlth Res Sch Primary Care Res, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [McManus, Richard J.] Univ Oxford, Natl Inst Hlth Res Sch Primary Care Res, Dept Primary Care Hlth Sci, Oxford, England; [Draper, Heather] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Kirkby, Helen M.] Univ Birmingham, Canc Res UK Clin Trials Unit, Sch Canc Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Oxford; University of Birmingham; Cancer Research UK; University of Birmingham	Calvert, M (corresponding author), Univ Birmingham, Med Res Council Midland Hub Trials Methodol Res, Birmingham, W Midlands, England.	M.Calvert@bham.ac.uk	Calvert, Melanie/F-7055-2011	Calvert, Melanie/0000-0002-1856-837X; Draper, Heather/0000-0002-0020-4252	MRC Midlands Hub for Trials Methodology Research [G0800808]; NIHR Research for Patient Benefit [PB-PG-1207-15042]; NIHR Career Development Fellowship; MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-015, CDF/01/017] Funding Source: researchfish	MRC Midlands Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Research for Patient Benefit; NIHR Career Development Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the MRC Midlands Hub for Trials Methodology Research (Grant ID G0800808) and NIHR Research for Patient Benefit (PB-PG-1207-15042). Richard McManus was supported by an NIHR Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed are those of the authors and do not necessarily reflect those of the MRC, NHS, NIHR, or the Department of Health.	Antoniou EE, 2011, J MED ETHICS, V37, P557, DOI 10.1136/jme.2010.041871; Behrendt C, 2011, J MED ETHICS, V37, P74, DOI 10.1136/jme.2010.035485; Blazeby JM, 2011, BRIT J SURG, V98, P1132, DOI 10.1002/bjs.7585; Blencowe N, WHICH OUTCOMES IMPOR; Carver R. P., 1990, READING RATE REV RES; Cohn E, 2007, J NURS SCHOLARSHIP, V39, P273, DOI 10.1111/j.1547-5069.2007.00180.x; Communities and Local Government, 2010, MUK L ENGL IND DEPR; Davis TC, 1998, JNCI-J NATL CANCER I, V90, P668, DOI 10.1093/jnci/90.9.668; Dawson A, 2004, BIOM HLTH R, V58, P41; *EUR MED AG, 2002, CPMPICH13595 EUR MED; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Hargittai E, 2008, COMMUN RES, V35, P602, DOI 10.1177/0093650208321782; HAWKINS MJ, 1993, J NATL CANCER I, V85, P1618, DOI 10.1093/jnci/85.20.1618; ICH Expert Working Group, 1996, PRACTITIONER E, VE6, P10; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; Kirkby HM, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-89; Kirkby HM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000509; Kruse AY, 2000, CONTROL CLIN TRIALS, V21, P223, DOI 10.1016/S0197-2456(00)00048-9; Lantos J, 1993, CANCER S, V72; Madsen S M, 2000, Bull Med Ethics, P13; National Cancer Institute, 2009, USNIOH GUID UND INF; National Patient Safety Agency, 2009, INF SHEETS CONS FORM; Ormond KE, 2009, PATIENT EDUC COUNS, V75, P244, DOI 10.1016/j.pec.2008.09.020; Stead M, 2005, J MED ETHICS, V31, P664, DOI 10.1136/jme.2004.011064; Sugarman J, 1999, Hastings Cent Rep, V29, pS1, DOI 10.2307/3528546; Tully C, 2003, B SCI TECHNOL SOC, V23, P456; WHITE DR, 1984, AM J CLIN ONCOL-CANC, V7, P183, DOI 10.1097/00000421-198404000-00012; Wood S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001598; World Health Organization, 1995, GUID GOOD CLIN PRACT, P850; Ziefle M, 1998, HUM FACTORS, V40, P554, DOI 10.1518/001872098779649355	30	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76435	10.1371/journal.pone.0076435	http://dx.doi.org/10.1371/journal.pone.0076435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232HM	24098499	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600050
J	Li, SJ; Li, XF; Guo, HP; Liu, ST; Huang, HB; Liu, NN; Yang, CS; Tang, P; Liu, JB				Li, Shujue; Li, Xiaofen; Guo, Haiping; Liu, Shouting; Huang, Hongbiao; Liu, Ningning; Yang, Changshan; Tang, Ping; Liu, Jinbao			Intracellular ATP Concentration Contributes to the Cytotoxic and Cytoprotective Effects of Adenosine	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; EXTRACELLULAR ADENOSINE; COMPARTMENTALIZED ATP; RECEPTOR ACTIVATION; A(3) RECEPTORS; MUSCLE-CELLS; IN-VITRO; APOPTOSIS; RAT; ISCHEMIA	Extracellular adenosine (Ade) interacts with cells by two pathways: by activating cell surface receptors at nanomolar/micromolar concentrations; and by interfering with the homeostasis of the intracellular nucleotide pool at millimolar concentrations. Ade shows both cytotoxic and cytoprotective effects; however, the underlying mechanisms remain unclear. In the present study, the effects of adenosine-mediated ATP on cell viability were investigated. Adenosine treatment was found to be cytoprotective in the low intracellular ATP state, but cytotoxic under the normal ATP state. Adenosine-mediated cytotoxicity and cytoprotection rely on adenosine-derived ATP formation, but not via the adenosine receptor pathway. Ade enhanced proteasome inhibition-induced cell death mediated by ATP generation. These data provide a new pathway by which adenosine exerts dual biological effects on cell viability, suggesting an important role for adenosine as an ATP precursor besides the adenosine receptor pathway.	[Li, Shujue; Li, Xiaofen; Guo, Haiping; Liu, Shouting; Huang, Hongbiao; Liu, Ningning; Yang, Changshan; Tang, Ping; Liu, Jinbao] Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China; [Li, Shujue] Guangzhou Med Univ, Dept Urol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Liu, Ningning] Guangzhou Med Univ, Guangzhou Res Inst Cardiovasc Dis, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Liu, JB (corresponding author), Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China.	jliu@gzhmc.edu.cn			National High Technology Research and Development Program of China [2006AA02Z4B5]; National Natural Science Foundation of China [81070033/H0108, 30770835, 81072091]; Guangdong Province Natural Science Foundation [9251018201002, 94510018201003604]; Guangzhou Municipal Education Commission [10A057S, 08A108]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangzhou Municipal Education Commission	Supported by the National High Technology Research and Development Program of China (Project 2006AA02Z4B5), National Natural Science Foundation of China (Project 81070033/H0108, 30770835, 81072091), Key Projects (9251018201002, 94510018201003604) from Guangdong Province Natural Science Foundation, and Key Projects from Guangzhou Municipal Education Commission (10A057S, 08A108) (to JL and PT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 1995, MOL PHARMACOL, V48, P1038; Apasov S, 2000, BLOOD, V95, P3859; Baharav E, 2005, J RHEUMATOL, V32, P469; Barankiewicz J, 1997, J PHARMACOL EXP THER, V283, P1230; Bes S, 2002, EUR J PHARMACOL, V452, P145, DOI 10.1016/S0014-2999(02)02295-1; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Eguchi Y, 1997, CANCER RES, V57, P1835; ETHIER MF, 1993, AM J PHYSIOL, V265, pH131, DOI 10.1152/ajpheart.1993.265.1.H131; Ethier MF, 1997, AM J PHYSIOL-HEART C, V272, pH1470, DOI 10.1152/ajpheart.1997.272.3.H1470; Fishman P, 1998, CANCER RES, V58, P3181; Fishman P, 2001, EXP CELL RES, V269, P230, DOI 10.1006/excr.2001.5327; FOZARD JR, 1993, BRIT J PHARMACOL, V109, P3, DOI 10.1111/j.1476-5381.1993.tb13522.x; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gao ZH, 2001, MOL PHARMACOL, V59, P76, DOI 10.1124/mol.59.1.76; Gu JG, 1996, J NEUROCHEM, V67, P972; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049062; Huang HB, 2010, CELL RES, V20, P1372, DOI 10.1038/cr.2010.123; Imura T, 2000, J NEUROSCI RES, V62, P539; Jacobson KA, 1998, TRENDS PHARMACOL SCI, V19, P184, DOI 10.1016/S0165-6147(98)01203-6; Kohno Y, 1996, BIOCHEM BIOPH RES CO, V219, P904, DOI 10.1006/bbrc.1996.0331; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li XF, 2013, CELL REP, V3, P211, DOI 10.1016/j.celrep.2012.11.023; Livingston M, 2004, INFLAMM RES, V53, P171, DOI 10.1007/s00011-004-1248-2; Merighi S, 2002, J INVEST DERMATOL, V119, P923, DOI 10.1046/j.1523-1747.2002.00111.x; Montesinos MC, 1997, J EXP MED, V186, P1615, DOI 10.1084/jem.186.9.1615; Okusa MD, 2000, AM J PHYSIOL-RENAL, V279, pF809, DOI 10.1152/ajprenal.2000.279.5.F809; Ongini E, 1998, DRUG DEVELOP RES, V45, P387, DOI 10.1002/(SICI)1098-2299(199811/12)45:3/4<387::AID-DDR39>3.0.CO;2-U; PEARSON JD, 1978, BIOCHEM J, V170, P265, DOI 10.1042/bj1700265; Ramkumar V, 2001, JPN J PHARMACOL, V86, P265, DOI 10.1254/jjp.86.265; RAPAPORT E, 1980, J CELL PHYSIOL, V105, P267, DOI 10.1002/jcp.1041050210; RAPAPORT E, 1976, P NATL ACAD SCI USA, V73, P3122, DOI 10.1073/pnas.73.9.3122; Schrier SM, 2001, BIOCHEM PHARMACOL, V61, P417, DOI 10.1016/S0006-2952(00)00573-6; Shneyvays V, 2000, EXP CELL RES, V257, P111, DOI 10.1006/excr.2000.4882; Xu RH, 2005, CANCER RES, V65, P613	35	16	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76731	10.1371/journal.pone.0076731	http://dx.doi.org/10.1371/journal.pone.0076731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098558	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600075
J	Mathioni, SM; Patel, N; Riddick, B; Sweigard, JA; Czymmek, KJ; Caplan, JL; Kunjeti, SG; Kunjeti, S; Raman, V; Hillman, BI; Kobayashi, DY; Donofrio, NM				Mathioni, Sandra M.; Patel, Nrupali; Riddick, Bianca; Sweigard, James A.; Czymmek, Kirk J.; Caplan, Jeffrey L.; Kunjeti, Sridhara G.; Kunjeti, Saritha; Raman, Vidhyavathi; Hillman, Bradley I.; Kobayashi, Donald Y.; Donofrio, Nicole M.			Transcriptomics of the Rice Blast Fungus Magnaporthe oryzae in Response to the Bacterial Antagonist Lysobacter enzymogenes Reveals Candidate Fungal Defense Response Genes	PLOS ONE			English	Article							BIOLOGICAL-CONTROL ACTIVITY; SACCHAROMYCES-CEREVISIAE; STRAIN C3; PROTEIN; PREDICTION; LOCALIZATION; GRISEA; COEXPRESSION; BIOCONTROL; EXPRESSION	Plants and animals have evolved a first line of defense response to pathogens called innate or basal immunity. While basal defenses in these organisms are well studied, there is almost a complete lack of understanding of such systems in fungal species, and more specifically, how they are able to detect and mount a defense response upon pathogen attack. Hence, the goal of the present study was to understand how fungi respond to biotic stress by assessing the transcriptional profile of the rice blast pathogen, Magnaporthe oryzae, when challenged with the bacterial antagonist Lysobacter enzymogenes. Based on microscopic observations of interactions between M. oryzae and wild-type L. enzymogenes strain C3, we selected early and intermediate stages represented by time-points of 3 and 9 hours post-inoculation, respectively, to evaluate the fungal transcriptome using RNA-seq. For comparative purposes, we also challenged the fungus with L. enzymogenes mutant strain DCA, previously demonstrated to be devoid of antifungal activity. A comparison of transcriptional data from fungal interactions with the wild-type bacterial strain C3 and the mutant strain DCA revealed 463 fungal genes that were down-regulated during attack by C3; of these genes, 100 were also found to be up-regulated during the interaction with DCA. Functional categorization of genes in this suite included those with roles in carbohydrate metabolism, cellular transport and stress response. One gene in this suite belongs to the CFEM-domain class of fungal proteins. Another CFEM class protein called PTH11 has been previously characterized, and we found that a deletion in this gene caused advanced lesion development by C3 compared to its growth on the wild-type fungus. We discuss the characterization of this suite of 100 genes with respect to their role in the fungal defense response.	[Mathioni, Sandra M.; Riddick, Bianca; Kunjeti, Sridhara G.; Kunjeti, Saritha; Raman, Vidhyavathi; Donofrio, Nicole M.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Patel, Nrupali; Hillman, Bradley I.; Kobayashi, Donald Y.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Sweigard, James A.] DuPont Stine Haskell Res Ctr, Newark, DE USA; [Czymmek, Kirk J.; Caplan, Jeffrey L.] Univ Delaware, Delaware Biotechnol Inst BioImaging Ctr, Newark, DE USA; [Czymmek, Kirk J.] Univ Delaware, Dept Biol Sci, Newark, DE USA	University of Delaware; Rutgers State University New Brunswick; DuPont; University of Delaware; University of Delaware	Kobayashi, DY (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	kobayashi@aesop.rutgers.edu; ndonof@udel.edu	Kunjeti, Sridhara/AFU-0653-2022	Caplan, Jeffrey/0000-0002-3991-0912; Kunjeti, Sridhara/0000-0002-6326-2644; Czymmek, Kirk/0000-0002-5471-7395; Hillman, Bradley/0000-0002-2552-5087	USDA/NRI [2008-35319-04474]; EPSCoR [0814251] Funding Source: National Science Foundation	USDA/NRI(United States Department of Agriculture (USDA)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by a joint grant between Kobayashi and Donofrio from USDA/NRI grant number 2008-35319-04474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bourett TM, 2002, FUNGAL GENET BIOL, V37, P211, DOI 10.1016/S1087-1845(02)00524-8; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Chen X, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P51, DOI 10.1007/978-1-4020-9500-9_6; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Crowe JD, 2001, APPL ENVIRON MICROB, V67, P2088, DOI 10.1128/AEM.67.5.2088-2094.2001; Dawson K, 2008, EUKARYOT CELL, V7, P926, DOI 10.1128/EC.00037-08; de Boer M, 2000, NUCLEIC ACIDS RES, V28, P974; Dean R., 2012, MOL PLANT PATHOL, V13, P1; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; GARCIAESTRADA C, 2010, CURRENT RES TECHNOLO, V1, P577; Giallourakis C, 2006, GENOME RES, V16, P1056, DOI 10.1101/gr.5285206; Giesler LJ, 1998, CROP PROT, V17, P509, DOI 10.1016/S0261-2194(98)00049-0; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Holcombe LJ, 2011, FUTURE MICROBIOL, V6, P799, DOI [10.2217/FMB.11.60, 10.2217/fmb.11.60]; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kim S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000909; Kobayashi D.Y., 2007, CAB REV PERSPECT AGR, V2, DOI DOI 10.1079/PAVSNNR20072007; Kobayashi D. Y, 2005, FUNGAL COMMUNITY ITS, P399; Kobayashi DY, 2005, CAN J MICROBIOL, V51, P719, DOI 10.1139/W05-056; Kobayashi DY, 2005, APPL ENVIRON MICROB, V71, P261, DOI 10.1128/AEM.71.1.261-269.2005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li QL, 2011, BIOL CONTROL, V58, P139, DOI 10.1016/j.biocontrol.2011.04.013; Li SJ, 2009, J EUKARYOT MICROBIOL, V56, P182, DOI 10.1111/j.1550-7408.2008.00384.x; Lindow SE, 2002, CURR OPIN BIOTECH, V13, P238, DOI 10.1016/S0958-1669(02)00313-0; Lou LL, 2011, J AM CHEM SOC, V133, P643, DOI 10.1021/ja105732c; Marco A, 2009, BIOINFORMATICS, V25, P2473, DOI 10.1093/bioinformatics/btp462; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; Meier S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-24; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; Missall TA, 2004, EUKARYOT CELL, V3, P835, DOI 10.1128/EC.3.4.835-846.2004; Mulligan CN, 2005, ENVIRON POLLUT, V133, P183, DOI 10.1016/j.envpol.2004.06.009; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Newcomb LL, 2002, MOL CELL BIOL, V22, P1607, DOI 10.1128/MCB.22.5.1607-1614.2002; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Palumbo JD, 2005, PHYTOPATHOLOGY, V95, P701, DOI 10.1094/PHYTO-95-0701; PATEL N, 2013, ANTON LEEUW INT J G, V103, P1; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Saikia R, 2011, MICROBIOL RES, V166, P216, DOI 10.1016/j.micres.2010.03.002; Schouten A, 2008, ENVIRON MICROBIOL, V10, P1145, DOI 10.1111/j.1462-2920.2007.01531.x; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; SINGH RS, 1971, MYCOPATH MYCOL APPL, V44, P373, DOI 10.1007/BF02052711; Soanes DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012725; Sweeney MJ, 1999, FEMS MICROBIOL LETT, V175, P149, DOI 10.1111/j.1574-6968.1999.tb13614.x; THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Yoshida S, 2000, MOL GEN GENET, V263, P877, DOI 10.1007/s004380000255; Yuan Z, 2002, BIOINFORMATICS, V18, P1109, DOI 10.1093/bioinformatics/18.8.1109; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204; Zhang Z, 2010, BIOINFORMATICS, V26, P1918, DOI 10.1093/bioinformatics/btq303	68	25	25	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76487	10.1371/journal.pone.0076487	http://dx.doi.org/10.1371/journal.pone.0076487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098512	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600058
J	Lafontaine, ER; Zimmerman, SM; Shaffer, TL; Michel, F; Gao, XD; Hogan, RJ				Lafontaine, Eric R.; Zimmerman, Shawn M.; Shaffer, Teresa L.; Michel, Frank; Gao, Xiudan; Hogan, Robert J.			Use of a Safe, Reproducible, and Rapid Aerosol Delivery Method to Study Infection by Burkholderia pseudomallei and Burkholderia mallei in Mice	PLOS ONE			English	Article							POLYSACCHARIDE MICROARRAY TECHNOLOGY; CAPSULAR POLYSACCHARIDE; MOLECULAR CHARACTERIZATION; SUBTRACTIVE HYBRIDIZATION; IN-VITRO; MELIOIDOSIS; GLANDERS; VIRULENCE; IDENTIFICATION; BALB/C	Burkholderia pseudomallei, the etiologic agent of melioidosis, is a saprophytic bacterium readily isolated from wet soils of countries bordering the equator. Burkholderia mallei is a host-adapted clone of B. pseudomallei that does not persist outside of its equine reservoir and causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by these organisms typically occurs via percutaneous inoculation or inhalation of aerosols, and the most common manifestation is severe pneumonia leading to fatal bacteremia. Glanders and melioidosis are difficult to diagnose and require prolonged antibiotic therapy with low success rates. There are no vaccines available to protect against either Burkholderia species, and there is concern regarding their use as biological warfare agents given that B. mallei has previously been utilized in this manner. Hence, experiments were performed to establish a mouse model of aerosol infection to study the organisms and develop countermeasures. Using a hand-held aerosolizer, BALB/c mice were inoculated intratracheally with strains B. pseudomallei 1026b and B. mallei ATCC23344 and growth of the agents in the lungs, as well as dissemination to the spleen, were examined. Mice infected with 10(2), 10(3) and 10(4) organisms were unable to control growth of B. mallei in the lungs and bacteria rapidly disseminated to the spleen. Though similar results were observed in mice inoculated with 10(3) and 10(4) B. pseudomallei cells, animals infected with 10(2) organisms controlled bacterial replication in the lungs, dissemination to the spleen, and the extent of bacteremia. Analysis of sera from mice surviving acute infection revealed that animals produced antibodies against antigens known to be targets of the immune response in humans. Taken together, these data show that small volume aerosol inoculation of mice results in acute disease, dose-dependent chronic infection, and immune responses that correlate with those seen in human infections.	[Lafontaine, Eric R.; Zimmerman, Shawn M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Shaffer, Teresa L.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Michel, Frank; Gao, Xiudan; Hogan, Robert J.] Univ Georgia, Dept Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hogan, RJ (corresponding author), Univ Georgia, Dept Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA.	jhogan@uga.edu			DTRA [HDTRA1-09-1-0003]	DTRA(United States Department of DefenseDefense Threat Reduction Agency)	This study was supported by DTRA contract HDTRA1-09-1-0003. The funders had input in the study design and decision to publish (DTRA PA-13-325). The funders had no role in data collection and analysis or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Alibek K, 1999, BIOHAZARD CHILLING T; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Anuntagool N, 2002, MICROBIOL IMMUNOL, V46, P143, DOI 10.1111/j.1348-0421.2002.tb02679.x; Arun S, 1999, VET REC, V144, P255, DOI 10.1136/vr.144.10.255; ATOYNATAN T, 1969, AM J EPIDEMIOL, V89, P472, DOI 10.1093/oxfordjournals.aje.a120959; Balder R, 2007, INFECT IMMUN, V75, P2765, DOI 10.1128/IAI.00079-07; Balder R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-250; Barnes KB, 2013, INT J ANTIMICROB AG, V41, P552, DOI 10.1016/j.ijantimicag.2013.02.007; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Bryan L E, 1994, Can J Infect Dis, V5, P170; Burtnick MN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00108; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Carr-Gregory B, 2007, MED ASPECTS BIOL WAR, P121; Chandenier J, 2009, MYCOSES, V52, P239, DOI 10.1111/j.1439-0507.2009.01695.x; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cowell R, 2008, DIAGNOSTIC CYTOLOGY, P238; Cowell R, 2002, DIAGNOSTIC CYTOLOGY, P70; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; DeShazer D, 2001, MICROB PATHOGENESIS, V30, P253, DOI 10.1006/mpat.2000.0430; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Funk CJ, 2009, J GEN VIROL, V90, P2956, DOI 10.1099/vir.0.014282-0; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Goff AJ, 2011, J VIROL, V85, P4898, DOI 10.1128/JVI.02525-10; Goodyear A, 2012, INFECT IMMUN, V80, P110, DOI 10.1128/IAI.05819-11; Goodyear A, 2010, J IMMUNOL, V184, P1445, DOI 10.4049/jimmunol.0900411; Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Ho M, 1997, INFECT IMMUN, V65, P3648, DOI 10.1128/IAI.65.9.3648-3653.1997; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Howe C., 1950, OXFORD MED, P185; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Judy BM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-88; KNIREL YA, 1992, CARBOHYD RES, V233, P185, DOI 10.1016/S0008-6215(00)90930-3; Kortepeter M, 2001, USAMRIIDS MED MANAGE, P44; Lehavi O, 2002, HAREFUAH, V141, P88; Lever MS, 2009, INT J EXP PATHOL, V90, P16, DOI 10.1111/j.1365-2613.2008.00619.x; Lever MS, 2003, J MED MICROBIOL, V52, P1109, DOI 10.1099/jmm.0.05180-0; Lipsitz R., 2012, EMERG INFECT DIS, V18, pe2; Lipski SL, 2007, INFECT IMMUN, V75, P314, DOI 10.1128/IAI.01330-06; Majerczyk C, 2013, INFECT IMMUN, V81, P1471, DOI 10.1128/IAI.00048-13; Massey S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00174; Munder A, 2002, EXP TOXICOL PATHOL, V54, P127, DOI 10.1078/0940-2993-00240; Neubauer H., 1997, Revue Internationale des Services de Sante des Forces Armees, V70, P258; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Owen SJ, 2009, J INFECT DIS, V199, P1761, DOI 10.1086/599210; Parthasarathy N, 2008, CARBOHYD RES, V343, P2783, DOI 10.1016/j.carres.2008.05.021; Parthasarathy N, 2008, J CARBOHYD CHEM, V27, P32, DOI 10.1080/07328300802030761; Parthasarathy N, 2006, DIAGN MICR INFEC DIS, V56, P329, DOI 10.1016/j.diagmicrobio.2006.04.018; PERRY MB, 1995, INFECT IMMUN, V63, P3348, DOI 10.1128/IAI.63.9.3348-3352.1995; Peyron P, 2001, J BIOL CHEM, V276, P35512, DOI 10.1074/jbc.M104399200; Prakash H, 2010, J BIOL CHEM, V285, P20291, DOI 10.1074/jbc.M109.096297; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Reed L.J., 1938, AM J HYG, V27, P793; Regis E, 1999, BIOL DOOM; Revelli DA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00164; Rolim DB, 2005, EMERG INFECT DIS, V11, P1458, DOI 10.3201/eid1109.050493; Sambrook J., 2001, MOL CLONING LAB MANU; SHOHAM D, 1998, NONPROLIFERATION REV, V5, P48, DOI DOI 10.1080/10736709808436720; Sim BMQ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r89; Smart JK, 1997, TXB MILITARY MED, P16; Song H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000922; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Su X, 2004, EXP LUNG RES, V30, P479, DOI 10.1080/01902140490476382; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Ulrich RL, 2005, VACCINE, V23, P1986, DOI 10.1016/j.vaccine.2004.10.017; Vietri N. J., 2007, MED ASPECTS BIOL WAR, P147; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7; Waag DM, 2004, BIOL WEAPONS DEFENSE; Warawa JM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00133; Warawa JM, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00141; Weiss D, 2010, SCHALMS VET HEMATOLO, P270; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; Wheelis M., 1999, BIOLOGICAL TOXIN WEA, P35; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; Whitlock GC, 2009, J MED MICROBIOL, V58, P554, DOI 10.1099/jmm.0.007724-0; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2009, CURR OPIN INFECT DIS, V22, P102, DOI 10.1097/QCO.0b013e328322e727; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Zou NX, 2008, HYBRIDOMA, V27, P231, DOI 10.1089/hyb.2008.0012	89	23	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76804	10.1371/journal.pone.0076804	http://dx.doi.org/10.1371/journal.pone.0076804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098563	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500085
J	Wang, WW; Diacovo, TG; Chen, JC; Freund, JB; King, MR				Wang, Weiwei; Diacovo, Thomas G.; Chen, Jianchun; Freund, Jonathan B.; King, Michael R.			Simulation of Platelet, Thrombus and Erythrocyte Hydrodynamic Interactions in a 3D Arteriole with In Vivo Comparison	PLOS ONE			English	Article							RED-BLOOD-CELLS; VON-WILLEBRAND-FACTOR; ADHESIVE DYNAMICS; FLOW; VELOCITY; AGGREGATION; DOPPLER; MARGINATION; STENOSIS; GROWTH	Cylindrical blood vessels, ellipsoid platelets and biconcave-shaped deformable erythrocytes (RBCs) are important participants in hemostasis and thrombosis. However, due to the challenge of combining these components in simulation tools, few simulation studies have included all of them in realistic three-dimensional models. In the present study, we apply a recently developed simulation model to incorporate these components and analyze the flow in a thrombotic tubular arteriole, particularly the detailed hydrodynamic interactions between the thrombus shape, RBCs and platelets. It was found that at certain azimuth positions, the velocity drops in the proximity of both the upstream and downstream edge of the thrombus, which is accompanied by a rapid velocity increase in the narrowed region. The RBCs alter the flow profiles significantly from the typical low Reynolds (Re) number flow, and also enhance the deposition of free flowing platelets onto the thrombus. By evaluating the platelet-thrombus interaction and platelet-RBC interaction together, several mechanisms of platelet deposition augmentation are identified. With in vivo data comparison, our model illustrates the potential of future thrombosis studies that incorporate detailed receptor-ligand adhesion modules.	[Wang, Weiwei; King, Michael R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Diacovo, Thomas G.; Chen, Jianchun] Columbia Univ, Med Ctr, Dept Pediat & Pathol & Cell Biol, New York, NY USA; [Freund, Jonathan B.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL USA; [Freund, Jonathan B.] Univ Illinois, Dept Aerosp Engn, Urbana, IL USA	Cornell University; Columbia University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	King, MR (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	mike.king@cornell.edu	Freund, Jonathan B/A-6409-2014		National Institutes of Health [HL097971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was funded by National Institutes of Health Grant No. HL097971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett ES, 2006, AM J NEURORADIOL, V27, P638; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; Chen JC, 2008, NAT BIOTECHNOL, V26, P114, DOI 10.1038/nbt1373; Colman RW, 2006, HEMOSTASIS THROMBOSI; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8; Fahraeus R, 1929, PHYSIOL REV, V9, P241, DOI 10.1152/physrev.1929.9.2.241; Fogelson AL, 2004, MATH MED BIOL, V21, P293, DOI 10.1093/imammb21.4.293; Freund JB, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4718752; Freund JB, 2011, J FLUID MECH, V671, P466, DOI 10.1017/S0022112010005835; GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; HASIMOTO H, 1959, J FLUID MECH, V5, P317, DOI 10.1017/S0022112059000222; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Jordan A, 2004, BIORHEOLOGY, V41, P641; Kim S, 1991, MICROHYDRODYNAMICS P, Vxxiii; Kumar P, KUMAR CLARKS CLIN ME; Magallon J, 2011, TRENDS CARDIOVAS MED, V21, P33, DOI 10.1016/j.tcm.2012.02.001; Mody NA, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2126937; Mody NA, 2005, BIOPHYS J, V88, P1432, DOI 10.1529/biophysj.104.047001; Mody NA, 2008, BIOPHYS J, V95, P2556, DOI [10.1529/biophysj.107.128520, 10.1529/biophysj.107.12X520]; Mody NA, 2008, BIOPHYS J, V95, P2539, DOI 10.1529/biophysj.107.127670; Mori D, 2008, THROMB HAEMOSTASIS, V99, P108, DOI 10.1160/TH07-08-0490; Murciano Juan-Carlos, 2003, Discov Med, V3, P28; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; OVERBECK JR, 1992, ULTRASOUND MED BIOL, V18, P19, DOI 10.1016/0301-5629(92)90004-T; PHILLIPS DJ, 1989, ULTRASOUND MED BIOL, V15, P205, DOI 10.1016/0301-5629(89)90065-3; Pivkin IV, 2006, P NATL ACAD SCI USA, V103, P17164, DOI 10.1073/pnas.0608546103; Pozrikidis C, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1830484; Pozrikidis C, 2003, ANN BIOMED ENG, V31, P1194, DOI 10.1114/1.1617985; Pozrikidis C, 1992, BOUNDARY INTEGRAL SI, Vxi; RIVA CE, 1985, INVEST OPHTH VIS SCI, V26, P1124; Saintillan D, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1862262; SCHRANK E, 1990, ULTRASOUND MED BIOL, V16, P499, DOI 10.1016/0301-5629(90)90172-9; SKALAK R, 1973, BIOPHYS J, V13, P245, DOI 10.1016/S0006-3495(73)85983-1; SUTERA S P, 1970, Microvascular Research, V2, P420, DOI 10.1016/0026-2862(70)90035-X; Tokarev AA, 2011, BIOPHYS J, V101, P1835, DOI 10.1016/j.bpj.2011.08.031; Tomaiuolo G, 2011, MICROVASC RES, V82, P35, DOI 10.1016/j.mvr.2011.03.004; Wang WW, 2013, J COMPUT PHYS, V244, P223, DOI 10.1016/j.jcp.2012.08.014; Wang WW, 2012, ANN BIOMED ENG, V40, P2345, DOI 10.1007/s10439-012-0558-8; Xu ZL, 2011, ARTERIOSCL THROM VAS, V31, P500, DOI 10.1161/ATVBAHA.110.213397; Zhao H, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061924; Zhao H, 2010, J COMPUT PHYS, V229, P3726, DOI 10.1016/j.jcp.2010.01.024	44	29	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76949	10.1371/journal.pone.0076949	http://dx.doi.org/10.1371/journal.pone.0076949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098571	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500090
J	Gijsbers, EF; van Sighem, A; Harskamp, AM; Welkers, MRA; de Wolf, F; Brinkman, K; Prins, JM; Schuitemaker, H; van 't Wout, AB; Kootstra, NA				Gijsbers, Esther F.; van Sighem, Ard; Harskamp, Agnes M.; Welkers, Matthijs R. A.; de Wolf, Frank; Brinkman, Kees; Prins, Jan M.; Schuitemaker, Hanneke; van 't Wout, Angelique B.; Kootstra, Neeltje A.			The Presence of CXCR4-Using HIV-1 Prior to Start of Antiretroviral Therapy Is an Independent Predictor of Delayed Viral Suppression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; CD4 CELL COUNT; DISEASE PROGRESSION; BIOLOGICAL PHENOTYPE; TYPE-1 INFECTION; CORECEPTOR TROPISM; PROGNOSTIC VALUE; CLINICAL-COURSE; IMPACT	The emergence of CXCR4-using HIV variants (X4-HIV) is associated with accelerated disease progression in the absence of antiretroviral therapy. However, the effect of X4-HIV variants on the treatment response remains unclear. Here we determined whether the presence of X4-HIV variants influenced the time to undetectable viral load and CD4+ T cell reconstitution after initiation of cART in 732 patients. The presence of X4-HIV variants was determined by MT-2 assay prior to cART initiation and viral load and CD4+ T cell counts were analyzed every 3 to 6 months during a three year follow-up period. Kaplan-Meier and Cox proportional hazard analyses were performed to compare time to viral suppression and the absolute CD4+ T cell counts and increases in CD4+ T cell counts during follow-up were compared for patients with and without X4-HIV at start of cART. Patients harboring X4-HIV variants at baseline showed a delay in time to achieve viral suppression below the viral load detection limit. This delay in viral suppression was independently associated with high viral load and the presence of X4-HIV variants. Furthermore, the absolute CD4+ T cell counts were significantly lower in patients harboring X4-HIV variants at all time points during follow-up. However, no differences were observed in the increase in absolute CD4+ T cell numbers after treatment initiation, indicating that the reconstitution of CD4+ T cells is independent of the presence of X4-HIV variants. The emergence of X4-HIV has been associated with an accelerated CD4+ T cell decline during the natural course of infection and therefore, patients who develop X4-HIV variants may benefit from earlier treatment initiation in order to obtain faster reconstitution of the CD4+ T cell population to normal levels.	[Gijsbers, Esther F.; Harskamp, Agnes M.; Welkers, Matthijs R. A.; Schuitemaker, Hanneke; van 't Wout, Angelique B.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Sanquin Res,Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Gijsbers, Esther F.; Harskamp, Agnes M.; Welkers, Matthijs R. A.; Schuitemaker, Hanneke; van 't Wout, Angelique B.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van Sighem, Ard; de Wolf, Frank] Stichting HIV Monitoring, Amsterdam, Netherlands; [de Wolf, Frank] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England; [Brinkman, Kees] Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands; [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Onze Lieve Vrouwe Gasthuis Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Kootstra, NA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Sanquin Res,Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	N.A.Kootstra@amc.uva.nl	Prins, Jan M./AAF-4945-2020	Prins, Jan/0000-0002-5415-8933; Kootstra, Neeltje A./0000-0001-9429-7754; van 't Wout, Angelique/0000-0003-3705-2392; Welkers, Matthijs/0000-0002-2982-0278	Aids Fonds Netherlands [2008023]	Aids Fonds Netherlands	This work was supported by the Aids Fonds Netherlands [grant 2008023]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650; Goetz MB, 2009, JAIDS-J ACQ IMM DEF, V50, P259, DOI 10.1097/QAI.0b013e3181989a8b; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; KARLSSON A, 1994, J CLIN MICROBIOL, V32, P364, DOI 10.1128/JCM.32.2.364-370.1994; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KOOT M, 1992, AIDS, V6, P49, DOI 10.1097/00002030-199201000-00006; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Koot M, 1999, J INFECT DIS, V179, P254, DOI 10.1086/314539; KOOT M, 1993, J INFECT DIS, V168, P733, DOI 10.1093/infdis/168.3.733; Lanca AM, 2012, MEM I OSWALDO CRUZ, V107, P96, DOI 10.1590/S0074-02762012000100014; Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Seclen E, 2011, J INFECT DIS, V204, P139, DOI 10.1093/infdis/jir218; van Rij RP, 1998, J INFECT DIS, V178, P1806, DOI 10.1086/314522; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11	28	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76255	10.1371/journal.pone.0076255	http://dx.doi.org/10.1371/journal.pone.0076255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098454	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100050
J	Hou, LJ; Han, X; Sheng, P; Tong, WS; Li, ZQ; Xu, DY; Yu, MK; Huang, LQ; Zhao, ZX; Lu, YC; Dong, Y				Hou, Lijun; Han, Xi; Sheng, Ping; Tong, Wusong; Li, Zhiqiang; Xu, Dayuan; Yu, Mingkun; Huang, Liuqing; Zhao, Zhongxin; Lu, Yicheng; Dong, Yan			Risk Factors Associated with Sleep Disturbance following Traumatic Brain Injury: Clinical Findings and Questionnaire Based Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EXCESSIVE DAYTIME SLEEPINESS; INSOMNIA; COMPLAINTS; PREVALENCE	Background: Sleep disturbance is very common following traumatic brain injury (TBI), which may initiate or exacerbate a variety of co-morbidities and negatively impact rehabilitative treatments. To date, there are paradoxical reports regarding the associations between inherent characteristics of TBI and sleep disturbance in TBI population. The current study was designed to explore the relationship between the presence of sleep disturbance and characteristics of TBI and identify the factors which are closely related to the presence of sleep disturbance in TBI population. Methods: 98 TBI patients (72 males, mean age +/- SD, 47 +/- 13 years, range 18-70) were recruited. Severity of TBI was evaluated based on Glasgow Coma Scale (GCS). All participants performed cranial computed tomography and were examined on self-reported sleep quality, anxiety, and depression. Results: TBI was mild in 69 (70%), moderate in 15 (15%) and severe in 14 (15%) patients. 37 of 98 patients (38%) reported sleep disturbance following TBI. Insomnia was diagnosed in 28 patients (29%) and post-traumatic hypersomnia in 9 patients (9%). In TBI with insomnia group, 5 patients (18%) complained of difficulty falling asleep only, 8 patients (29%) had difficulty maintaining sleep without difficulty in initial sleep and 15 patients (53%) presented both difficulty falling asleep and difficulty maintaining sleep. Risk factors associated with insomnia were headache and/or dizziness and more symptoms of anxiety and depression rather than GCS. In contrast, GCS was independently associated with the presence of hypersomnia following TBI. Furthermore, there was no evidence of an association between locations of brain injury and the presence of sleep disturbance after TBI. Conclusion: Our data support and contribute to a growing body of evidence which indicates that TBI patients with insomnia are prone to suffer from concomitant headache and/or dizziness, report more symptoms of anxiety and depression and severe TBI patients are likely to experience hypersomnia.	[Hou, Lijun; Sheng, Ping; Yu, Mingkun; Lu, Yicheng; Dong, Yan] Second Mil Med Univ, Dept Neurosurg, Shanghai Inst Neurosurg, PLA Inst Neurosurg,Changzhang Hosp, Shanghai, Peoples R China; [Han, Xi] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China; [Tong, Wusong] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Li, Zhiqiang; Xu, Dayuan] Fengxian Cent Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Huang, Liuqing; Zhao, Zhongxin] Second Mil Med Univ, Dept Neurol, Changzhang Hosp, Shanghai, Peoples R China	Naval Medical University; Fudan University; Naval Medical University	Hou, LJ (corresponding author), Second Mil Med Univ, Dept Neurosurg, Shanghai Inst Neurosurg, PLA Inst Neurosurg,Changzhang Hosp, Shanghai, Peoples R China.	lj_hou@hotmail.com; dongyan2006@yahoo.com			Natural Science Foundation from Science and Technology Commission of Shanghai Municipality [11ZR1448700]; Research Foundation for Returned Scholars from Ministry of Education of China	Natural Science Foundation from Science and Technology Commission of Shanghai Municipality; Research Foundation for Returned Scholars from Ministry of Education of China	Dr. Yan Dong is supported by Natural Science Foundation from Science and Technology Commission of Shanghai Municipality (11ZR1448700) and Research Foundation for Returned Scholars from Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, P298; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Flesher MR, 2001, BRAIN INJURY, V15, P879, DOI 10.1080/02699050110065682; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Hossain Jamil L, 2002, Sleep Breath, V6, P85, DOI 10.1055/s-2002-32322; Johnson VE, 2012, EXP NEUROL; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Liang Siyu, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P370, DOI 10.3969/j.issn.1672-7347.2013.04.006; Liu Y, 2013, CHINA MED HERALD, V10, P60; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mayers AG, 2006, INT J PSYCHIAT CLIN, V10, P2, DOI 10.1080/13651500500328087; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Plante DT, 2009, SLEEP MED CLIN, V4, P407, DOI 10.1016/j.jsmc.2009.04.008; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Tobe EH, 1999, J NEUROPSYCH CLIN N, V11, P504, DOI 10.1176/jnp.11.4.504; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wu SQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-849	40	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76087	10.1371/journal.pone.0076087	http://dx.doi.org/10.1371/journal.pone.0076087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231OR	24098425	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100040
J	Moore, AR; Boyce, M; Steele, IA; Campbell, F; Varro, A; Pritchard, DM				Moore, Andrew R.; Boyce, Malcolm; Steele, Islay A.; Campbell, Fiona; Varro, Andrea; Pritchard, D. Mark			Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis	PLOS ONE			English	Article							OCTREOTIDE SUPPRESSION TEST; CHROMOGRANIN-A; CELL HYPERPLASIA; CARCINOID-TUMORS; YF476; ANTRECTOMY; EXPRESSION; GUIDELINES; MANAGEMENT; POTENT	Introduction: Autoimmune chronic atrophic gastritis (CAG) causes hypochlorhydria and hypergastrinaemia, which can lead to enterochromaffin-like (ECL) cell hyperplasia and gastric neuroendocrine tumours (type 1 gastric NETs). Most behave indolently, but some larger tumours metastasise. Antrectomy, which removes the source of the hypergastrinaemia, usually causes tumour regression. Non-clinical and healthy-subject studies have shown that netazepide (YF476) is a potent, highly selective and orally-active gastrin/CCK-2 receptor antagonist. Also, it is effective in animal models of ECL-cell tumours induced by hypergastrinaemia. Aim: To assess the effect of netazepide on tumour biomarkers, number and size in patients with type I gastric NETs. Methods: We studied 8 patients with multiple tumours and raised circulating gastrin and chromogranin A (CgA) concentrations in an open trial of oral netazepide for 12 weeks, with follow-up 12 weeks later. At 0, 6, 12 and 24 weeks, we carried out gastroscopy, counted and measured tumours, and took biopsies to assess abundances of several ECL-cell constituents. At 0, 3, 6, 9, 12 and 24 weeks, we measured circulating gastrin and CgA and assessed safety and tolerability. Results: Netazepide was safe and well tolerated. Abundances of CgA (p<0.05), histidine decarboxylase (p<0.05) and matrix metalloproteinase-7(p<0.10) were reduced at 6 and 12 weeks, but were raised again at follow-up. Likewise, plasma CgA was reduced at 3 weeks (p<0.01), remained so until 12 weeks, but was raised again at follow-up. Tumours were fewer and the size of the largest one was smaller (p<0.05) at 12 weeks, and remained so at follow-up. Serum gastrin was unaffected. Conclusion: The reduction in abundances, plasma CgA, and tumour number and size by netazepide show that type 1 NETs are gastrin-dependent tumours. Failure of netazepide to increase serum gastrin further is consistent with achlorhydria. Netazepide is a potential new treatment for type 1 NETs. Longer, controlled trials are justified.	[Moore, Andrew R.; Pritchard, D. Mark] Univ Liverpool, Dept Gastroenterol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Moore, Andrew R.; Steele, Islay A.; Varro, Andrea] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Boyce, Malcolm] Hammersmith Med Res, London, England; [Campbell, Fiona] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Dept Pathol, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Pritchard, DM (corresponding author), Univ Liverpool, Dept Gastroenterol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	mark.pritchard@liverpool.ac.uk	Varro, Andras/M-2647-2016	Boyce, Malcolm/0000-0001-8807-612X; Pritchard, David Mark/0000-0001-7971-3561	Trio Medicines Ltd; National Institute of Health Research (NIHR)	Trio Medicines Ltd; National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR))	Trio Medicines Ltd funded the study. This report is independent research arising in part from a Biomedical Research Fellowship to ARM funded by the National Institute of Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, NIHR or the Department of Health. The funders (Trio Medicines Ltd.) participated in study design, data monitoring and manuscript preparation.	Berna MJ, 2007, CURR TOP MED CHEM, V7, P1211; Black JW, 2002, PHARMACOL TOXICOL, V91, P275, DOI 10.1034/j.1600-0773.2002.910602.x; Borch K, 2005, ANN SURG, V242, P64, DOI 10.1097/01.sla.0000167862.52309.7d; Boyce M, 2012, ALIMENT PHARM THER, V36, P181, DOI 10.1111/j.1365-2036.2012.05143.x; BOYCE M, 2013, BR J CLIN PHARM, P32415; Burkitt MD, 2006, ALIMENT PHARM THER, V24, P1305, DOI 10.1111/j.1365-2036.2006.03130.x; Campana D, 2008, ENDOCR-RELAT CANCER, V15, P337, DOI 10.1677/ERC-07-0251; Campana D, 2007, J CLIN ONCOL, V25, P1967, DOI 10.1200/JCO.2006.10.1535; Cui GL, 2006, LAB INVEST, V86, P1037, DOI 10.1038/labinvest.3700462; Dakin GF, 2006, J SURG ONCOL, V93, P368, DOI 10.1002/jso.20468; Derendorf H, 2005, J CLIN PHARMACOL, V45, P845, DOI 10.1177/0091270005276738; DOCKRAY GJ, 1980, REGUL PEPTIDES, V1, P169, DOI 10.1016/0167-0115(80)90270-0; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; ECKHAUSER FE, 1988, SURGERY, V104, P1046; Ellis L, 2010, AM J GASTROENTEROL, V105, P2563, DOI 10.1038/ajg.2010.341; Fossmark R, 2012, ALIMENT PHARM THER, V36, P1067, DOI 10.1111/apt.12090; Fykse V, 2004, SCAND J GASTROENTERO, V39, P621, DOI 10.1080/00365520410005225; Grozinsky-Glasberg S, 2008, EUR J ENDOCRINOL, V159, P475, DOI 10.1530/EJE-08-0420; Herranz R, 2003, MED RES REV, V23, P559, DOI 10.1002/med.10042; Higashino K, 2004, HEPATO-GASTROENTEROL, V51, P269; Higham AD, 1998, GASTROENTEROLOGY, V114, P817, DOI 10.1016/S0016-5085(98)70596-7; HIRSCHOWITZ BI, 1992, GASTROENTEROLOGY, V102, P1409; Hodgson N, 2005, SURG ENDOSC, V19, P1610, DOI 10.1007/s00464-005-0232-4; Hopper AD, 2009, J GASTROEN HEPATOL, V24, P1516, DOI 10.1111/j.1440-1746.2009.05909.x; Hoshino M, 2010, HEPATO-GASTROENTEROL, V57, P379; Jianu CS, 2010, TUMOR BIOL, V31, P373, DOI 10.1007/s13277-010-0045-5; Kenny S, 2008, AM J PHYSIOL-GASTR L, V295, pG431, DOI 10.1152/ajpgi.90283.2008; Khuroo MS, 2010, J GASTROEN HEPATOL, V25, P548, DOI 10.1111/j.1440-1746.2009.06131.x; Kidd M, 2010, REGUL PEPTIDES, V162, P52, DOI 10.1016/j.regpep.2010.01.009; Kitano M, 2000, BRIT J PHARMACOL, V130, P699, DOI 10.1038/sj.bjp.0703342; Kulke MH, 2010, PANCREAS, V39, P735, DOI 10.1097/MPA.0b013e3181ebb168; LIM SG, 1993, ALIMENT PHARM THERAP, V7, P317, DOI 10.1111/j.1365-2036.1993.tb00103.x; Martinsen TC, 2003, CARCINOGENESIS, V24, P1887, DOI 10.1093/carcin/bgg156; Merola E, 2012, NEUROENDOCRINOLOGY, V95, P207, DOI 10.1159/000329043; Modlin IM, 2004, AM J GASTROENTEROL, V99, P23, DOI 10.1046/j.1572-0241.2003.04027.x; Murugesan SV, 2013, EUR J GASTROEN HEPAT, V25, P474, DOI 10.1097/MEG.0b013e32835cec52; Norsett KG, 2011, AM J PHYSIOL-GASTR L, V301, pG446, DOI 10.1152/ajpgi.00527.2010; Ozao-Choy J, 2010, J SURG RES, V162, P22, DOI 10.1016/j.jss.2010.01.005; Peracchi M, 2005, EUR J ENDOCRINOL, V152, P443, DOI 10.1530/eje.1.01862; Plockinger U, 2004, NEUROENDOCRINOLOGY, V80, P394, DOI 10.1159/000085237; PLOCKINGER U, 1990, J CLIN ENDOCR METAB, V71, P1658; Redrup MJ, 2002, J CHROMATOGR B, V772, P317, DOI 10.1016/S1570-0232(02)00118-6; Rehfeld JF, 2012, CLIN CHEM, V58, P831, DOI 10.1373/clinchem.2011.179929; Rehfeld JF, 2011, GASTROENTEROLOGY, V140, P1444, DOI 10.1053/j.gastro.2011.01.051; Salazar R, 2012, NEUROENDOCRINOLOGY, V95, P71, DOI 10.1159/000335600; Sanduleanu S, 2001, EUR J CLIN INVEST, V31, P802, DOI 10.1046/j.1365-2362.2001.00890.x; Scherubl H, 2010, ENDOSCOPY, V42, P664, DOI 10.1055/s-0030-1255564; Semple G, 1997, J MED CHEM, V40, P331, DOI 10.1021/jm960669+; SOLCIA E, 1988, DIGESTION, V41, P185, DOI 10.1159/000199786; Takaishi S, 2005, GASTROENTEROLOGY, V128, P1965, DOI 10.1053/j.gastro.2005.03.027; Takemoto Y, 1998, ARZNEIMITTELFORSCH, V48, P403; Takinami Y, 1997, ALIMENT PHARM THERAP, V11, P113, DOI 10.1046/j.1365-2036.1997.110281000.x; *TRIO MED, 2011, INV BROCH NET, P99152; Varro A, 2003, ANN CLIN BIOCHEM, V40, P472, DOI 10.1258/000456303322326380; Varro A, 2002, GASTROENTEROLOGY, V123, P271, DOI 10.1053/gast.2002.34162; Varro A, 2007, AM J PHYSIOL-GASTR L, V292, pG1133, DOI 10.1152/ajpgi.00526.2006	56	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76462	10.1371/journal.pone.0076462	http://dx.doi.org/10.1371/journal.pone.0076462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098507	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100068
J	Lin, KJ; Weng, YH; Hsieh, CJ; Lin, WY; Wey, SP; Kung, MP; Yen, TC; Lu, CS; Hsiao, IT				Lin, Kun-Ju; Weng, Yi-Hsin; Hsieh, Chia-Ju; Lin, Wey-Yil; Wey, Shiaw-Pyng; Kung, Mei-Ping; Yen, Tzu-Chen; Lu, Chin-Song; Hsiao, Ing-Tsung			Brain Imaging of Vesicular Monoamine Transporter Type 2 in Healthy Aging Subjects by F-18-FP-(+)-DTBZ PET	PLOS ONE			English	Article							IDIOPATHIC PARKINSONS-DISEASE; POSITRON-EMISSION-TOMOGRAPHY; DOPAMINE; DENSITY; BINDING; MARKERS; AGE	F-18-FP-(+)-DTBZ is a novel PET radiotracer targeting vesicular monoamine transporter type 2 (VMAT2). The goal was to explore the image features in normal human brains with F-18-FP-(+)-DTBZ as a reference of molecular landmark for clinical diagnosis in Parkinson's disease (PD) and related disorders. Materials and Methods: A total of 22 healthy subjects (59.3 +/- 6.0 years old) including 7 men and 15 women were recruited for MRI and F-18-FP-(+)-DTBZ PET scans. A total number of 55 brain VOIs were selected for quantitation analysis. The regional specific uptake ratio (SUR) was calculated with occipital as reference from MRI-based spatially normalized F-18-FP-(+)-DTBZ images. Regional percentage SUR to that of anterior putamen was calculated. Average SUR images were displayed in 2D and 3D space to illustrate the image patterns. The correlation between age and regional VMAT2 uptake was also examined. Results: Visual assessment showed symmetric uptake of F-18-FP-(+)-DTBZ and obviously highest in striatum, followed by nucleus accumbens, hypothalamus, substantia nigra, and raphe nuclei. Quantification analysis revealed striatal VMAT2 density of anterior putamen > posterior putamen > caudate nucleus. Other subcortical regions were with moderate VMAT2 distribution (6 similar to 51% SUR of anterior putamen), while slightly lower VMAT2 was observed in cerebellum (10.60% SUR) and much lower in neocortex (<5% SUR). No significant correlation of SUR to age was found in subcortical regions. Conclusion: Using F-18-FP-(+)-DTBZ PET, we showed the 2D and 3D imaging features of the VMAT2 distribution in vivo in healthy aging brains. The in vivo imaging characteristics of VMAT2 is consistent with the expression of VMAT2 in a recent autopsy study. Therefore, 3D visualization and higher image quality of F-18-FP-(+)-DTBZ PET imaging might potentially be a powerful biomarker in detecting VMAT2 distribution of subcortical regions, and for Parkinson's disease and related neuropsychiatric disorders involving related monoaminergic systems.	[Lin, Kun-Ju; Hsieh, Chia-Ju; Wey, Shiaw-Pyng; Kung, Mei-Ping; Hsiao, Ing-Tsung] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Lin, Kun-Ju; Weng, Yi-Hsin; Hsieh, Chia-Ju; Wey, Shiaw-Pyng; Kung, Mei-Ping; Lu, Chin-Song; Hsiao, Ing-Tsung] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Lin, Kun-Ju; Yen, Tzu-Chen; Hsiao, Ing-Tsung] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan; [Lin, Kun-Ju; Yen, Tzu-Chen; Hsiao, Ing-Tsung] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan, Taiwan; [Weng, Yi-Hsin; Lin, Wey-Yil; Lu, Chin-Song] Chang Gung Mem Hosp, Dept Neurol, Div Movement Disorders, Tao Yuan, Taiwan; [Weng, Yi-Hsin; Lin, Wey-Yil; Lu, Chin-Song] Chang Gung Mem Hosp, Neurosci Res Ctr, Tao Yuan, Taiwan; [Weng, Yi-Hsin; Lu, Chin-Song] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan; [Kung, Mei-Ping] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; University of Pennsylvania	Lu, CS (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan.	bob.cslu@gmail.com; ihsiao@mail.cgu.edu.tw	Lin, Wey-Yil/AAE-5068-2020; Lin, Kun-Ju/H-3120-2015	Lin, Kun-Ju/0000-0003-1933-4564; Hsiao, Ing-Tsung/0000-0002-5255-7498; Hsieh, Chia-Ju/0000-0002-2833-7727	National Science Council, Taiwan [NSC-98-2314-B-182-034-MY2, 99-2314-B-182A-067-MY2, 100-2314-B-182-038, 100-2314-B-182A-092-MY3, 101-2314-B-182-061-MY2]; Research Fund of Chang Gung Memorial Hospital [CMRPD1A0312, CMRPD1C0381, CMRPG390912, CMRPG390913]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Research Fund of Chang Gung Memorial Hospital	This study was carried out with financial support from the National Science Council, Taiwan (Grant NSC-98-2314-B-182-034-MY2 and 99-2314-B-182A-067-MY2, 100-2314-B-182-038, 100-2314-B-182A-092-MY3, 101-2314-B-182-061-MY2), and grants from the Research Fund of Chang Gung Memorial Hospital (CMRPD1A0312, CMRPD1C0381, CMRPG390912, CMRPG390913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Brooks DJ, 2006, BIOL PSYCHIAT, V59, P908, DOI 10.1016/j.biopsych.2005.12.017; Chan GLY, 1999, J NUCL MED, V40, P283; FAHN S, 1971, J NEUROL SCI, V14, P427, DOI 10.1016/0022-510X(71)90178-X; Frey KA, 1996, ANN NEUROL, V40, P873, DOI 10.1002/ana.410400609; Gilman S, 1998, ANN NEUROL, V44, P326, DOI 10.1002/ana.410440307; Goswami R, 2006, NUCL MED BIOL, V33, P685, DOI 10.1016/j.nucmedbio.2006.05.006; Haycock JW, 2003, J NEUROCHEM, V87, P574, DOI 10.1046/j.1471-4159.2003.02017.x; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; Hirano S, 2012, J NEUROL NEUROSUR PS, V83, P963, DOI 10.1136/jnnp-2011-301818; KILBOURN MR, 1993, J NEUROCHEM, V60, P2315, DOI 10.1111/j.1471-4159.1993.tb03521.x; Kim J, 2007, IEEE T INF TECHNOL B, V11, P161, DOI 10.1109/TITB.2006.875669; Kim JK, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790763; Koeppe RA, 1999, J CEREBR BLOOD F MET, V19, P1376, DOI 10.1097/00004647-199912000-00011; Koeppe RA, 1996, J CEREBR BLOOD F MET, V16, P1288, DOI 10.1097/00004647-199611000-00025; Lin KJ, 2011, NUCL MED BIOL; Lin KJ, 2010, J NUCL MED, V51, P1480, DOI 10.2967/jnumed.110.078196; Litvan I, 1998, ARCH NEUROL-CHICAGO, V55, P1313, DOI 10.1001/archneur.55.10.1313; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McNamee RL, 2009, J NUCL MED, V50, P348, DOI 10.2967/jnumed.108.057612; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Okamura N, 2010, J NUCL MED, V51, P223, DOI 10.2967/jnumed.109.070094; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; SCHERMAN D, 1988, J NEUROCHEM, V50, P1131, DOI 10.1111/j.1471-4159.1988.tb10583.x; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; Sun JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049483; Tong J, 2007, J NEUROCHEM, V102, P1691, DOI 10.1111/j.1471-4159.2007.04636.x; Tong JC, 2011, J CEREBR BLOOD F MET, V31, P2065, DOI 10.1038/jcbfm.2011.63; Troiano AR, 2010, SYNAPSE, V64, P146, DOI 10.1002/syn.20708; Tsao HH, 2010, NUCL MED BIOL, V37, P413, DOI 10.1016/j.nucmedbio.2010.01.002; Tzen KY, 2001, J NUCL MED, V42, P408; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Dyck CH, 2002, AM J GERIAT PSYCHIAT, V10, P36, DOI 10.1176/appi.ajgp.10.1.36; Villablanca JP, 2002, AM J NEURORADIOL, V23, P1187; VOLKOW ND, 1994, ANN NEUROL, V36, P237, DOI 10.1002/ana.410360218; Weng YH, 2004, J NUCL MED, V45, P393	38	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75952	10.1371/journal.pone.0075952	http://dx.doi.org/10.1371/journal.pone.0075952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098749	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500119
J	Ratnik, K; Viru, L; Merits, A				Ratnik, Kaspar; Viru, Liane; Merits, Andres			Control of the Rescue and Replication of Semliki Forest Virus Recombinants by the Insertion of miRNA Target Sequences	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; SINDBIS VIRAL VECTORS; IN-VIVO; PLASMA-MEMBRANE; MOSQUITO CELLS; MESSENGER-RNA; HUMAN CANCERS; DNA VACCINES; MICRORNA; PROTEIN	Due to their broad cell- and tissue-tropism, alphavirus-based replication-competent vectors are of particular interest for anti-cancer therapy. These properties may, however, be potentially hazardous unless the virus infection is controlled. While the RNA genome of alphaviruses precludes the standard control techniques, host miRNAs can be used to down-regulate viral replication. In this study, target sites from ubiquitous miRNAs and those of miRNAs under-represented in cervical cancer cells were inserted into replication-competent DNA/RNA layered vectors of Semliki Forest virus. It was found that in order to achieve the most efficient suppression of recombinant virus rescue, the introduced target sequences must be fully complementary to those of the corresponding miRNAs. Target sites of ubiquitous miRNAs, introduced into the 39 untranslated region of the viral vector, profoundly reduced the rescue of recombinant viruses. Insertion of the same miRNA targets into coding region of the viral vector was approximately 300-fold less effective. Viruses carrying these miRNAs were genetically unstable and rapidly lost the target sequences. This process was delayed, but not completely prevented, by miRNA inhibitors. Target sites of miRNA under-represented in cervical cancer cells had much smaller but still significant effects on recombinant virus rescue in cervical cancer-derived HeLa cells. Over-expression of miR-214, one of these miRNAs, reduced replication of the targeted virus. Though the majority of rescued viruses maintained the introduced miRNA target sequences, genomes with deletions of these sequences were also detected. Thus, the low-level repression of rescue and replication of targeted virus in HeLa cells was still sufficient to cause genetic instability.	[Ratnik, Kaspar; Viru, Liane; Merits, Andres] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu	Merits, A (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	andres.merits@ut.ee	Merits, Andres/H-3125-2015	Merits, Andres/0000-0001-8193-0071	Estonian Science Foundation [7501, 9400, SF0180087s08]; European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology	Estonian Science Foundation; European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology	The work was supported by Estonian Science Foundation grants 7501 and 9400, target financing project SF0180087s08, and by the European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; Atasheva S, 2008, J VIROL, V82, P4028, DOI 10.1128/JVI.02330-07; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; FROLOV I, 1994, J VIROL, V68, P1721, DOI 10.1128/JVI.68.3.1721-1727.1994; Frolova EI, 2010, J VIROL, V84, P11679, DOI 10.1128/JVI.01441-10; Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Heiss BL, 2011, J VIROL, V85, P1464, DOI 10.1128/JVI.02091-10; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kamrud KI, 2010, J VIROL, V84, P7713, DOI 10.1128/JVI.00310-10; Karlsson Gunilla B, 2004, Methods Mol Biol, V246, P543; Kelly EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000820; Kelly EJ, 2010, J VIROL, V84, P1550, DOI 10.1128/JVI.01788-09; Kelvin AA, 2011, J INFECT DEV COUNTR, V5, P441, DOI 10.3855/jidc.2171; Kim DY, 2013, J VIROL, V87, P4202, DOI 10.1128/JVI.03142-12; Lee CYF, 2009, CLIN CANCER RES, V15, P5126, DOI 10.1158/1078-0432.CCR-09-0051; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leitner WW, 2004, VACCINE, V22, P1537, DOI 10.1016/j.vaccine.2003.10.013; Li N, 2013, NUCLEIC ACIDS RES, V41, P3619, DOI 10.1093/nar/gkt072; Li N, 2008, NUCLEIC ACIDS RES, V36, P4277, DOI 10.1093/nar/gkn388; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Lulla A, 2012, J VIROL, V86, P553, DOI 10.1128/JVI.05195-11; Lundstrom Kenneth, 2003, Expert Rev Vaccines, V2, P447; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Merits A, 2001, J GEN VIROL, V82, P765, DOI 10.1099/0022-1317-82-4-765; Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142; Quetglas JI, 2010, VIRUS RES, V153, P179, DOI 10.1016/j.virusres.2010.07.027; RAJU R, 1991, J VIROL, V65, P2501, DOI 10.1128/JVI.65.5.2501-2510.1991; Rausalu K, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-33; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Simion A, 2010, BIOCHEM BIOPH RES CO, V391, P293, DOI 10.1016/j.bbrc.2009.11.052; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; Stelter L, 2013, MOL IMAGING BIOL, V15, P166, DOI 10.1007/s11307-012-0585-8; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tamberg N, 2007, J GEN VIROL, V88, P1225, DOI 10.1099/vir.0.82436-0; Thomas JM, 2003, J VIROL, V77, P5598, DOI 10.1128/JVI.77.10.5598-5606.2003; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tseng JC, 2009, GENE THER, V16, P291, DOI 10.1038/gt.2008.153; Tseng JC, 2010, CANCER GENE THER, V17, P244, DOI 10.1038/cgt.2009.70; Tseng JC, 2004, NAT BIOTECHNOL, V22, P70, DOI 10.1038/nbt917; Ulper L, 2008, J VIROL METHODS, V148, P265, DOI 10.1016/j.jviromet.2007.10.007; Varjak M, 2013, J VIROL; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Viru L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-243; Volkova E, 2008, VIROLOGY, V377, P160, DOI 10.1016/j.virol.2008.04.020; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Ylosmaki E, 2013, J VIROL, V87, P335, DOI 10.1128/JVI.01940-12; Zheng Z, 2013, J VIROL; Zhigou W, 2009, MICRORNA INTERFERENC; Zusinaite E, 2007, J GEN VIROL, V88, P1977, DOI 10.1099/vir.0.82865-0	60	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75802	10.1371/journal.pone.0075802	http://dx.doi.org/10.1371/journal.pone.0075802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098728	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500099
J	Soumya, RS; Vineetha, VP; Reshma, PL; Raghu, KG				Soumya, Rema Sreenivasan; Vineetha, Vadavanath Prabhakaran; Reshma, Premachandran Latha; Raghu, Kozhiparambil Gopalan			Preparation and Characterization of Selenium Incorporated Guar Gum Nanoparticle and Its Interaction with H9c2 Cells	PLOS ONE			English	Article							DRUG-DELIVERY; SURFACE DECORATION; CELLULAR UPTAKE; POLYSACCHARIDES; CANCER; TOXICITY	This study deals with the preparation and characterization of selenium incorporated guar gum nanoparticle (SGG), and its effect on H9c2 cardiomyoblast. Herein, nanoprecipitation techniques had been employed for the preparation of SGG nanoparticle. The prepared nanoparticle had been subjected to various types of analytical techniques like transmission electron microscopy (TEM), X-ray diffraction (XRD) and particle size analysis to confirm the characteristics of nanoparticle as well as for selenium incorporation. Physical characterization of nanoparticle showed that the size of nanoparticles increase upto similar to 69-173 nm upon selenium incorporation from similar to 41-132 nm. Then the prepared nanoparticles were evaluated for its effect on H9c2 cells. In this regard, the effect of nanoparticle on various vital parameters of H9c2 cells was studied. Parameters like cell viability, uptake of selenium incorporated guar gum nanoparticle by the cells, effect of SGG on DNA integrity, apoptosis, reactive oxygen species generation, alteration in transmembrane potential of mitochondria and cytoskeletal integrity had been investigated. Viability results showed that up to 25 nM of SGG was safe (10.31%) but beyond that it induces cytotoxicity. Cellular uptake of selenium showed that cell permeability for SGG is significantly high compared to normal selenium (7.2 nM of selenium for 25 nM SGG compared with 5.2 nM selenium for 25 nM sodium selenite). There was no apoptosis with SGG and also it protects DNA from hydroxyl radical induced breakage. Likewise no adverse effect on mitochondria and cytoskeleton was observed for 25 nM of SGG. Overall results reveal that SGG is highly suitable for biomedical research application.	[Soumya, Rema Sreenivasan; Vineetha, Vadavanath Prabhakaran; Reshma, Premachandran Latha; Raghu, Kozhiparambil Gopalan] NIIST, CSIR, Agroproc & Nat Prod Div, Thiruvananthapuram, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Raghu, KG (corresponding author), NIIST, CSIR, Agroproc & Nat Prod Div, Thiruvananthapuram, Kerala, India.	raghukgopal2009@gmail.com	Raghu, K G/AAT-8042-2021		Indian Council of Medical Research, Govt. of India [45/32/2010-PHA/BMS]	Indian Council of Medical Research, Govt. of India(Indian Council of Medical Research (ICMR))	Funder - Indian Council of Medical Research, Govt. of India, for Senior Research Fellowship (45/32/2010-PHA/BMS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Halim ES, 2011, CARBOHYD POLYM, V85, P692, DOI 10.1016/j.carbpol.2011.03.039; Bayliss C. E., 1986, APPL ENVIRON MICROB, V48, P626; Bilati U, 2005, EUR J PHARM SCI, V24, P67, DOI 10.1016/j.ejps.2004.09.011; Bjorkhem-Bergman L, 2002, BIOCHEM PHARMACOL, V63, P1875, DOI 10.1016/S0006-2952(02)00981-4; Chakravarthi SS, 2007, NANOPARTICULATE DRUG, P51; Cheng WH, 2009, ENVIRON MOL MUTAGEN, V50, P349, DOI 10.1002/em.20489; Couvreur P, 2006, PROG SOLID STATE CH, V34, P231, DOI 10.1016/j.progsolidstchem.2005.11.009; El-Ansary A, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/754810; Goldstein AM, 1993, IND GUMS POLYSACCHAR; Guhagarkar SA, 2009, AAPS PHARMSCITECH, V10, P935, DOI 10.1208/s12249-009-9284-4; Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1; Lee JW, 2000, J PHARM SCI-US, V89, P850, DOI 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G; Lemarchand C, 2004, EUR J PHARM BIOPHARM, V58, P327, DOI 10.1016/j.ejpb.2004.02.016; Li YH, 2011, BIOMATERIALS, V32, P9068, DOI 10.1016/j.biomaterials.2011.08.001; Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001; Mahapatro A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-55; Moak MA, 2001, BIOL TRACE ELEM RES, V79, P257, DOI 10.1385/BTER:79:3:257; Navas-Acien A, 2008, CURR OPIN LIPIDOL, V19, P43, DOI 10.1097/MOL.0b013e3282f2b261; Pandey S, 2012, INT J BIOL MACROMOL, V51, P583, DOI 10.1016/j.ijbiomac.2012.06.033; Pandya VM, 2011, PHARM LETT, V3, P129; Prabaharan M, 2011, INT J BIOL MACROMOL, V49, P117, DOI 10.1016/j.ijbiomac.2011.04.022; Ramoutar RR, 2007, J INORG BIOCHEM, V101, P1028, DOI 10.1016/j.jinorgbio.2007.03.016; Ray AL, 2006, J NUTR, V136, P172, DOI 10.1093/jn/136.1.172; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Rubinstein A, 2000, DRUG DEVELOP RES, V50, P435, DOI 10.1002/1098-2299(200007/08)50:3/4<435::AID-DDR26>3.0.CO;2-5; Ruiz-Meana M, 2010, CARDIOVASC RES, V88, P30, DOI 10.1093/cvr/cvq225; Sanmartin C, 2012, INT J MOL SCI, V13, P9649, DOI 10.3390/ijms13089649; Shimizu R, 2009, J HEALTH SCI, V55, P271, DOI 10.1248/jhs.55.271; Soenen SJ, 2011, NANO TODAY, V6, P446, DOI 10.1016/j.nantod.2011.08.001; Sohaebuddin S, 2010, FIBRE TOXICOL, V7, P1; Soumya RS, 2010, INT J BIOL MACROMOL, V46, P267, DOI 10.1016/j.ijbiomac.2009.11.003; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Vandamme TF, 2002, CARBOHYD POLYM, V48, P219, DOI 10.1016/S0144-8617(01)00263-6; Vineetha VP, 2013, CARDIOVASC TOXICOL, V13, P123, DOI 10.1007/s12012-012-9191-x; Wu HL, 2012, J MATER CHEM, V22, P9602, DOI 10.1039/c2jm16828f; Xiang N, 2009, CANCER CHEMOTH PHARM, V63, P351, DOI 10.1007/s00280-008-0745-3; Yang F, 2012, INT J NANOMED, V7, P835, DOI 10.2147/IJN.S28278; Zhang S, 2011, J NUTR BIOCHEM, V22, P1137, DOI 10.1016/j.jnutbio.2010.09.014; Zhang YB, 2013, NANOMED-NANOTECHNOL, V9, P74, DOI 10.1016/j.nano.2012.04.002; Zhang YF, 2010, LANGMUIR, V26, P17617, DOI 10.1021/la1033959	41	35	36	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74411	10.1371/journal.pone.0074411	http://dx.doi.org/10.1371/journal.pone.0074411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098647	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500018
J	Starr, KF; Porsch, EA; Heiss, C; Black, I; Azadi, P; St Geme, JW				Starr, Kimberly F.; Porsch, Eric A.; Heiss, Christian; Black, Ian; Azadi, Parastoo; St Geme, Joseph W., III			Characterization of the Kingella kingae Polysaccharide Capsule and Exopolysaccharide	PLOS ONE			English	Article							K-ANTIGENS; CHILDREN; INFECTIONS; GENETICS; LIPOPOLYSACCHARIDES; ASSOCIATION; C-13	Recent evidence indicates that Kingella kingae produces a polysaccharide capsule. In an effort to determine the composition and structure of this polysaccharide capsule, in the current study we purified capsular material from the surface of K. kingae strain 269-492 variant KK01 using acidic conditions to release the capsule and a series of steps to remove DNA, RNA, and protein. Analysis of the resulting material by gas chromatography and mass spectrometry revealed N-acetyl galactosamine (GalNAc), 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo), and galactose (Gal). Further analysis by NMR demonstrated two distinct polysaccharides, one consisting of GalNAc and Kdo with the structure -> 3)-beta-GalpNAc-(1 -> 5)-beta-Kdop-(2 -> and the other containing galactose alone with the structure -> 5)-beta-Galf-(1 ->. Disruption of the ctrA gene required for surface localization of the K. kingae polysaccharide capsule resulted in elimination of GalNAc and Kdo but had no effect on the presence of Gal in bacterial surface extracts. In contrast, deletion of the pamABCDE locus involved in production of a reported galactan exopolysaccharide eliminated Gal but had no effect on the presence of GalNAc and Kdo in surface extracts. Disruption of ctrA and deletion of pamABCDE resulted in a loss of all carbohydrates in surface extracts. These results establish that K. kingae strain KK01 produces a polysaccharide capsule with the structure -> 3)-beta-GalpNAc-(1 -> 5)-beta-Kdop-(2 -> and a separate exopolysaccharide with the structure -> 5)-beta-Galf-(1 ->. The polysaccharide capsule and the exopolysaccharide require distinct genetic loci for surface localization.	[Starr, Kimberly F.; Porsch, Eric A.; St Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Starr, Kimberly F.; Porsch, Eric A.; St Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Heiss, Christian; Black, Ian; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Duke University; Duke University; University System of Georgia; University of Georgia	St Geme, JW (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.	j.stgeme@duke.edu	Heiss, Christian/GPX-7678-2022	Heiss, Christian/0000-0003-1118-8953	Ubited States Department of Energy [DE-FG02-93ER-20097]	Ubited States Department of Energy(United States Department of Energy (DOE))	This study was supported by the Ubited States Department of Energy, DE-FG02-93ER-20097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit U, 2012, CLIN INFECT DIS, V55, P1074, DOI 10.1093/cid/cis622; Bendaoud M, 2011, J BACTERIOL, V193, P3879, DOI 10.1128/JB.00311-11; BHATTACHARJEE AK, 1978, BIOCHEMISTRY-US, V17, P645, DOI 10.1021/bi00597a013; Bidet P, 2013, PEDIATR INFECT DIS J, V32, P558, DOI 10.1097/INF.0b013e3182867f5e; Corbett D, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P111, DOI 10.1007/978-3-642-05062-6_3; Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740; Donot F, 2012, CARBOHYD POLYM, V87, P951, DOI 10.1016/j.carbpol.2011.08.083; Dubnov-Raz G, 2008, PEDIATRICS, V122, P1305, DOI 10.1542/peds.2007-3070; Fraysse N, 2005, GLYCOBIOLOGY, V15, P101, DOI 10.1093/glycob/cwh142; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; JANN B, 1983, CARBOHYD RES, V120, P131, DOI 10.1016/0008-6215(83)88012-4; JANN K, 1983, PROG ALLERGY, V33, P53; Kalin M, 1998, THORAX, V53, P159, DOI 10.1136/thx.53.3.159; Kehl-Fie TE, 2008, J BACTERIOL, V190, P7157, DOI 10.1128/JB.00884-08; Kehl-Fie TE, 2010, INFECT IMMUN, V78, P1692, DOI 10.1128/IAI.00908-09; Kim JS, 1996, GLYCOBIOLOGY, V6, P433, DOI 10.1093/glycob/6.4.433; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; PERRY MB, 1990, SERODIAG IMMUN INF D, V4, P299, DOI 10.1016/0888-0786(90)90018-J; Porsch EA, 2012, MBIO, V3, DOI 10.1128/mBio.00372-12; REISTAD R, 1993, CARBOHYD RES, V245, P129, DOI 10.1016/0008-6215(93)80065-M; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Sambrock J, 1989, MOL CLONING LAB MANU, V1; TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Weiss-Salz I, 2011, ADV EXP MED BIOL, V719, P67, DOI 10.1007/978-1-4614-0204-6_7; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; YAGUPSKY P, 1995, PEDIATR INFECT DIS J, V14, P673, DOI 10.1097/00006454-199508000-00005; YAGUPSKY P, 1992, J CLIN MICROBIOL, V30, P1278, DOI 10.1128/JCM.30.5.1278-1281.1992; Yagupsky P, 2011, PEDIATRICS, V127, P557, DOI 10.1542/peds.2010-1867; Yagupsky P, 2009, PEDIATR INFECT DIS J, V28, P155, DOI 10.1097/INF.0b013e318184dbb8	32	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75409	10.1371/journal.pone.0075409	http://dx.doi.org/10.1371/journal.pone.0075409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098695	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500066
J	Nolle, A; van Haastert, ES; Zwart, R; Hoozemans, JJM; Scheper, W				Nolle, Anna; van Haastert, Elise S.; Zwart, Rob; Hoozemans, Jeroen J. M.; Scheper, Wiep			Ubiquilin 2 Is Not Associated with Tau Pathology	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ALZHEIMERS-DISEASE; ACCUMULATION; DEGENERATION; HIPPOCAMPUS; AUTOPHAGY; CHAPERONE; NEURONS	Accumulation of aberrant proteins in inclusion bodies is a hallmark of many neurodegenerative diseases. Impairment of proteolytic systems is a common event in these protein misfolding diseases. Recently, mutations in the UBQLN 2 gene encoding ubiquilin 2 have been identified in X-linked amyotrophic lateral sclerosis (ALS). Furthermore, ubiquilin 2 is associated with inclusions in familial and sporadic ALS/dementia, synucleinopathies and polyglutamine diseases. Ubiquilin 2 exerts a regulatory role in proteostasis and thus it has been suggested that ubiquilin 2 pathology may be a common event in neurodegenerative diseases. Tauopathies, a heterogenous group of neurodegenerative diseases accompanied with dementia, are characterized by inclusions of the microtubule-binding protein tau. In the present study, we investigate whether ubiquilin 2 is connected with tau pathology in Alzheimer's disease (AD), supranuclear palsy (PSP) and Pick's disease (PiD) and familial cases with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). We show that ubiquilin 2 positive inclusions are absent in these tauopathies. Furthermore, we find decreased ubiquilin 2 protein levels in AD patients, but our results do not indicate a correlation with tau pathology. Our data show no evidence for involvement of ubiquilin 2 and indicate that other mechanisms underly the proteostatic disturbances in tauopathies.	[Nolle, Anna; Zwart, Rob; Scheper, Wiep] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [van Haastert, Elise S.; Hoozemans, Jeroen J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Scheper, Wiep] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Scheper, W (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.scheper@amc.uva.nl	Scheper, Wiep/AAI-7323-2020	Hoozemans, Jeroen/0000-0002-2888-8967; Scheper, Wiep/0000-0002-1431-4559	Internationale Stichting Alzheimer Onderzoek (ISAO) [10502]	Internationale Stichting Alzheimer Onderzoek (ISAO)	This study was financially supported by Internationale Stichting Alzheimer Onderzoek (ISAO #10502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P825, DOI 10.1007/s00401-012-0970-z; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Fecto F, 2012, MUSCLE NERVE, V45, P157, DOI 10.1002/mus.23278; Ford DL, 2006, BIOCHEM J, V399, P397, DOI 10.1042/BJ20060441; Goedert M, 2011, J MOL NEUROSCI, V45, P425, DOI 10.1007/s12031-011-9593-4; Haapasalo Annakaisa, 2011, Commun Integr Biol, V4, P428, DOI 10.4161/cib.4.4.15283; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Kamboh MI, 2006, MOL PSYCHIATR, V11, P273, DOI 10.1038/sj.mp.4001775; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Mori F, 2012, ACTA NEUROPATHOL, V124, P149, DOI 10.1007/s00401-012-0999-z; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Nijholt DAT, 2011, CURR MED CHEM, V18, P2459; Nijholt DAT, 2012, J PATHOL, V226, P693, DOI 10.1002/path.3969; Probst A, 2001, ACTA NEUROPATHOL, V102, P636, DOI 10.1007/s004010100420; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Satoh J, 2013, NEUROPATHOL APPL NEU; Stieren ES, 2011, J BIOL CHEM, V286, P35689, DOI 10.1074/jbc.M111.243147; Viswanathan J, 2011, TRAFFIC, V12, P330, DOI 10.1111/j.1600-0854.2010.01149.x; Wu SL, 2002, BBA-MOL CELL RES, V1542, P41, DOI 10.1016/S0167-4889(01)00164-1; Zhang Can, 2009, Discov Med, V8, P18; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76598	10.1371/journal.pone.0076598	http://dx.doi.org/10.1371/journal.pone.0076598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086754	gold, Green Published, Green Submitted			2022-12-27	WOS:000325220000070
J	Groth, AC; Liu, MD; Wang, H; Lovelett, E; Emery, DW				Groth, Amy C.; Liu, Mingdong; Wang, Hao; Lovelett, Emilie; Emery, David W.			Identification and Characterization of Enhancer-Blocking Insulators to Reduce Retroviral Vector Genotoxicity	PLOS ONE			English	Article							BETA-GLOBIN INSULATOR; CHROMATIN INSULATOR; GENE-THERAPY; CTCF; CELLS; THALASSEMIA; ACTIVATION; MECHANISMS; EXPRESSION; PROTECTS	The chromatin insulator cHS4 can reduce silencing chromosomal position effects and genotoxicity associated with integrating viral vectors. However, the fully active version of this element can also reduce vector titers and is only partially effective. In order to identify alternatives to cHS4, we developed a functional lentiviral vector-based reporter screen for enhancer-blocking insulators. Using this system, we screened candidate sequences that were initially identified by chromatin profiling for binding by CTCF and for DNase hypersensitivity. All 12 analyzed candidates blocked enhancer-promoter activity. The enhancer-blocking activity of the top two candidates was confirmed in two complementary plasmid-based assays. Studies in a gammaretroviral reporter vector indicated these two candidates have little to no effect on vector titers, and do not diminish vector expression in primary mouse bone marrow cultures. Subsequent assessment in a mouse in vivo tumor formation model demonstrated that both candidates reduced the rate of gammaretroviral vector-mediated genotoxicity as effectively as the cHS4 insulator. In summary, we have developed a novel lentiviral vector-based method of screening candidate elements for insulator activity, and have used this method to identify two new insulator elements capable of improving the safety of retroviral vectors without diminishing vector titers or expression. These findings expand the limited arsenal of insulators functionally validated to reduce the rate of retroviral vector-mediated genotoxicity.	[Groth, Amy C.; Liu, Mingdong; Lovelett, Emilie; Emery, David W.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Wang, Hao] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Emery, David W.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Emery, DW (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	demery@uw.edu			National Institutes of Health [PO1 HL53750, RO1 HL75713]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750, R01HL075713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants PO1 HL53750 and RO1 HL75713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Aker M, 2010, J BIOL CHEM, V285, P37589, DOI 10.1074/jbc.M110.174532; Arumugam PI, 2009, MOL THER, V17, P1929, DOI 10.1038/mt.2009.183; Arumugam PI, 2009, PLOS ONE, V4, pe6995, DOI [10.1371/journal.pone.0006995, DOI 10.1371/J0URNAL.P0NE.0006995.PUBMED:19746166]; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bos TJ, 2010, J BIOTECHNOL, V150, P37, DOI 10.1016/j.jbiotec.2010.07.010; Bowers SR, 2009, MOL CELL BIOL, V29, P1682, DOI 10.1128/MCB.01411-08; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gaussin A, 2012, GENE THER, V19, P15, DOI 10.1038/gt.2011.70; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519; HAWLEY RG, 1994, GENE THER, V1, P136; Horn PA, 2004, BLOOD, V103, P3710, DOI 10.1182/blood-2003-07-2414; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6024, DOI 10.1073/pnas.87.16.6024; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ramezani A, 2008, STEM CELLS, V26, P3257, DOI 10.1634/stemcells.2008-0258; Riviere I, 2012, BLOOD, V119, P1107, DOI 10.1182/blood-2011-09-349993; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tubb J, 2005, BIOTECHNIQUES, V39, P553, DOI 10.2144/000112030; Urbinati F, 2009, MOL THER, V17, P1527, DOI 10.1038/mt.2009.89; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582; Yannaki E, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001626; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; ZHANG JW, 1990, DEV GENET, V11, P168, DOI 10.1002/dvg.1020110207; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	36	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76528	10.1371/journal.pone.0076528	http://dx.doi.org/10.1371/journal.pone.0076528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098520	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600060
J	Liu, XD; Tian, YY; Lu, N; Gin, T; Cheng, CHK; Chan, MTV				Liu, Xiaodong; Tian, Yuanyuan; Lu, Na; Gin, Tony; Cheng, Christopher H. K.; Chan, Matthew T. V.			Stat3 Inhibition Attenuates Mechanical Allodynia through Transcriptional Regulation of Chemokine Expression in Spinal Astrocytes	PLOS ONE			English	Article							NEUROPATHIC PAIN; CORD; INFLAMMATION; FRACTALKINE; MICROGLIA; CANCER; INJURY; RATS; MICE; GLIA	Background: Signal transducer and activator of transcription 3 (Stat3) is known to induce cell proliferation and inflammation by regulating gene transcription. Recent studies showed that Stat3 modulates nociceptive transmission by reducing spinal astrocyte proliferation. However, it is unclear whether Stat3 also contributes to the modulation of nociceptive transmission by regulating inflammatory response in spinal astrocytes. This study aimed at investigating the role of Stat3 on neuroinflammation during development of pain in rats after intrathecal injection of lipopolysaccharide (LPS). Methods: Stat3 specific siRNA oligo and synthetic selective inhibitor (Stattic) were applied to block the activity of Stat3 in primary astrocytes or rat spinal cord, respectively. LPS was used to induce the expression of proinflammatory genes in all studies. Immunofluorescence staining of cells and slices of spinal cord was performed to monitor Stat3 activation. The impact of Stat3 inhibition on proinflammatory genes expression was determined by cytokine antibody array, enzyme-linked immunosorbent assay and real-time polymerase chain reaction. Mechanical allodynia, as determined by the threshold pressure that could induce hind paw withdrawal after application of standardized von Frey filaments, was used to detect the effects of Stat3 inhibition after pain development with intrathecal LPS injection. Results: Intrathecal injection of LPS activated Stat3 in reactive spinal astrocytes. Blockade of Stat3 activity attenuated mechanical allodynia significantly and was correlated with a lower number of reactive astrocytes in the spinal dorsal horn. In vitro study demonstrated that Stat3 modulated inflammatory response in primary astrocytes by transcriptional regulation of chemokine expression including Cx3cl1, Cxcl5, Cxcl10 and Ccl20. Similarly, inhibition of Stat3 reversed the expression of these chemokines in the spinal dorsal horn. Conclusions: Stat3 acted as a transcriptional regulator of reactive astrocytes by modulating chemokine expression. Stat3 regulated inflammatory response in astrocytes and contributed to pain modulation. Blockade of Stat3 represents a new target for pain control.	[Liu, Xiaodong; Tian, Yuanyuan; Lu, Na; Gin, Tony; Chan, Matthew T. V.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Shatin, Hong Kong, Peoples R China; [Cheng, Christopher H. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Cheng, CHK (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	chkcheng@cuhk.edu.hk; mtvchan@cuhk.edu.hk	LAU, Greg/AAA-2538-2019; Liu, Xiaodong/J-9827-2019; GIN, Tony/J-2521-2013; CHENG, Ki Christopher/R-9641-2018; Chan, Matthew/J-2884-2013	Liu, Xiaodong/0000-0002-5915-4499; GIN, Tony/0000-0001-7283-6761; CHENG, Ki Christopher/0000-0001-8970-9048; Chan, Matthew/0000-0002-3574-7855	Direct Grant for Research [2041564]; Chinese University of Hong Kong; Australian and New Zealand College of Anaesthetists [AEG13/001]	Direct Grant for Research; Chinese University of Hong Kong(Chinese University of Hong Kong); Australian and New Zealand College of Anaesthetists	This work was supported by a Direct Grant for Research (2041564), The Chinese University of Hong Kong and an Academic Enhancement Grant of the Australian and New Zealand College of Anaesthetists (AEG13/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Fu ES, 2010, PAIN, V148, P509, DOI 10.1016/j.pain.2010.01.001; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Lindia JA, 2005, J PAIN, V6, P434, DOI 10.1016/j.jpain.2005.02.001; Meares GP, 2012, GLIA, V60, P771, DOI 10.1002/glia.22307; Milligan E, 2005, EUR J NEUROSCI, V22, P2775, DOI 10.1111/j.1460-9568.2005.04470.x; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Park SJ, 2012, J IMMUNOL, V188, P5132, DOI 10.4049/jimmunol.1101600; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Tang J, 2012, J EVID BASED COMPLEM, V2012, P13; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong JX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009593	27	38	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75804	10.1371/journal.pone.0075804	http://dx.doi.org/10.1371/journal.pone.0075804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098399	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600024
J	Olaiya, MT; Chiou, HY; Jeng, JS; Lien, LM; Hsieh, FI				Olaiya, Muideen Tunbosun; Chiou, Hung-Yi; Jeng, Jiann-Shing; Lien, Li-Ming; Hsieh, Fang-I			Significantly Increased Risk of Cardiovascular Disease among Patients with Gallstone Disease: A Population-Based Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GROWTH-FACTOR-I; GALLBLADDER-DISEASE; TOTAL HOMOCYSTEINE; OXIDATIVE STRESS; ARTERY-DISEASE; GLOBAL BURDEN; CHOLELITHIASIS; EPIDEMIOLOGY; ASSOCIATION	Objective: To investigate whether gallstone disease (GD) increases the risk of developing cardiovascular disease (CVD) in a large population-based cohort. Methods: A study population including 6,981 patients with GD was identified from The Taiwan National Health Insurance Research Database between 2004 and 2005. GD patients were defined as patients with principal discharge diagnoses of cholelithiasis using the ICD-9-CM code 574. 27,924 patients without GD were randomly selected and matched for age and gender. All patients were followed for 6 years or until diagnosis for CVD. Cox proportional hazards regression model was used to assess the risk of developing CVD with adjustment for age, gender and co-morbid conditions. Results: During the six years follow-up period, 935 patients with GD and 2,758 patients without GD developed CVD. Patients with GD had an elevated risk of CVD (HR, 1.32; 95% CI, 1.22-1.43) when compared with those without GD. Similar relationship was observed when CVD was categorized i.e. stroke (HR, 1.15; 95% CI, 1.01-1.32), coronary heart disease (HR, 1.42; 95% CI, 1.28-1.58) and heart failure (HR, 1.31; 95% CI, 1.00-1.73). When GD was classified according to the level of severity, using patients without GD as reference, the risks of CVD were elevated in patients with non-severe GD (HR, 1.34; 95% CI, 1.24-1.46) as well as those with severe GD (HR, 1.20, 95% CI, 1.02-1.40), after adjusting for age, gender and comorbidities. In age-stratified analysis, patients aged 18-40 years with GD were at higher risk of developing CVD (HR, 1.42; 95% CI, 1.09-1.84) than older GD patients. Conclusion: This study found an increased risk of CVD in patients diagnosed with GD. The excess risk was particularly high in younger GD patients. Prevention of GD could help reduce the risk of developing CVD, and the better effect could be achieved for the younger age groups.	[Olaiya, Muideen Tunbosun; Chiou, Hung-Yi; Hsieh, Fang-I] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lien, Li-Ming] Shin Kong WHS Mem Hosp, Dept Neurol, Taipei, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Shin Kong Wu Ho Su Memorial Hospital	Hsieh, FI (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.	hsiehfangi@tmu.edu.tw		Chiou, Hung Yi/0000-0002-4545-9697; JENG, JIANN-SHING/0000-0002-1456-3686	National Science Council of Taiwan [NSC99-2314-B-038-022-MY3, NSC00-2314-B-038-030-My3, NSC100-2314-B-038-031-My3]; Taipei Medical University [TMU99-AE1-B07]; Department of Health Center of Excellence for Clinical Trial and Research in Neuroscience [DOH101-TD-B-111-003, DOH102-TD-B-111-003]; Dr. Chi-Chin Huang Stroke Research Center	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University; Department of Health Center of Excellence for Clinical Trial and Research in Neuroscience; Dr. Chi-Chin Huang Stroke Research Center	This study was supported by grants from the National Science Council of Taiwan (NSC99-2314-B-038-022-MY3, NSC00-2314-B-038-030-My3, NSC100-2314-B-038-031-My3), Taipei Medical University (TMU99-AE1-B07), the Department of Health Center of Excellence for Clinical Trial and Research in Neuroscience (DOH101-TD-B-111-003, DOH102-TD-B-111-003), and Dr. Chi-Chin Huang Stroke Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ata N, 2011, CAN J GASTROENTEROL, V25, P274, DOI 10.1155/2011/356761; BORTNICHAK EA, 1985, AM J EPIDEMIOL, V121, P19, DOI 10.1093/oxfordjournals.aje.a113978; Browning Jeffrey D, 2003, Semin Gastrointest Dis, V14, P165; Cavalca V, 2001, CLIN CHEM, V47, P887; Chavez-Tapia NC, 2012, ANN HEPATOL, V11, P85, DOI 10.1016/S1665-2681(19)31490-5; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chilton Robert J, 2004, J Am Osteopath Assoc, V104, pS5; Cho JY, 2010, ARCH SURG-CHICAGO, V145, P329, DOI 10.1001/archsurg.2010.35; Conti E, 2011, CLIN SCI, V120, P377, DOI 10.1042/CS20100400; Deaton C, 2011, J CARDIOVASC NURS, V26, pS5, DOI 10.1097/JCN.0b013e318213efcf; Eaton CB, 2005, PRIMARY CARE, V32, P963, DOI 10.1016/j.pop.2005.09.009; Geetha A, 2002, J Biochem Mol Biol Biophys, V6, P427, DOI 10.1080/1025814021000036179; Huang J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-63; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kozak LJ, 2002, VITAL HLTH STAT, V13, P1; LamonFava S, 1996, ARTERIOSCL THROM VAS, V16, P1509, DOI 10.1161/01.ATV.16.12.1509; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Marschall HU, 2007, J INTERN MED, V261, P529, DOI 10.1111/j.1365-2796.2007.01783.x; Mendez-Sanchez N, 2005, AM J GASTROENTEROL, V100, P827, DOI 10.1111/j.1572-0241.2005.41214.x; Mendez-Sanchez N, 2008, LIVER INT, V28, P402, DOI 10.1111/j.1478-3231.2007.01632.x; Moschetta A, 2004, DIGEST DIS SCI, V49, P529, DOI 10.1023/B:DDAS.0000020515.75879.2f; Nieto FJ, 1999, AM J PUBLIC HEALTH, V89, P292, DOI 10.2105/AJPH.89.3.292; Otani H, 2011, ANTIOXID REDOX SIGN, V15, P1911, DOI 10.1089/ars.2010.3739; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Ren J, 1999, J MOL CELL CARDIOL, V31, P2049, DOI 10.1006/jmcc.1999.1036; Ruhl CE, 2011, GASTROENTEROLOGY, V140, P508, DOI 10.1053/j.gastro.2010.10.060; Sakuta H, 2005, J GASTROENTEROL, V40, P1061, DOI 10.1007/s00535-005-1691-z; Schroecksnadel K, 2010, THROMB HAEMOSTASIS, V103, P926, DOI 10.1160/TH09-07-0422; Scott J, 2004, CURR OPIN GENET DEV, V14, P271, DOI 10.1016/j.gde.2004.04.012; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Sin DD, 2005, CAN J PHYSIOL PHARM, V83, P8, DOI 10.1139/Y04-116; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; STOLK MFJ, 1995, GASTROENTEROLOGY, V108, P1882, DOI 10.1016/0016-5085(95)90153-1; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257; Twickler MTB, 2005, AM J GASTROENTEROL, V100, P2363, DOI 10.1111/j.1572-0241.2005.50650_3.x; Vogt DP, 2002, CLEV CLIN J MED, V69, P977, DOI 10.3949/ccjm.69.12.977; WHO, 2013, CARD DIS ATL HEART D; World Health Organization, 2012, CARD DIS; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zaliekas J, 2008, SURG CLIN N AM, V88, P1345, DOI 10.1016/j.suc.2008.07.011	40	27	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76448	10.1371/journal.pone.0076448	http://dx.doi.org/10.1371/journal.pone.0076448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098504	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600054
J	Bazile, C; Siegler, IA; Benguigui, N				Bazile, Christophe; Siegler, Isabelle A.; Benguigui, Nicolas			Major Changes in a Rhythmic Ball-Bouncing Task Occur at Age 7 Years	PLOS ONE			English	Article							TEMPORAL ELEMENTS; COORDINATION; CHILDREN; INFORMATION; PERCEPTION; PATTERNS; ADAPTATION; STABILITY; SYNCHRONIZATION; PREDICTION	The aim of the study was to investigate the development of a rhythmical skill of children aged from 5 to 12 years old. Five age groups (5-6, 7-8, 9-10, 11-12, and young adults) performed a virtual ball bouncing task (16 forty-second long test trials). Task performances, racket oscillation, ball-racket impacts as well as the ball-racket coupling were analysed. The results showed a change in both performance and behaviour at the age of 7 years old. Before this age, children exhibited restricted perceptual-motor coordination with a high frequency of racket oscillation and a poor level of performance. After the age of 7, cycle-to-cycle adaptive coordination based on visual information was progressively acquired leading to increasing performance levels with age. Overall these results revealed a rapid change in capability to perform the ball bouncing task across age with a late emergence of the required coordination and significant change in the coordination at the age of 7.	[Bazile, Christophe; Siegler, Isabelle A.] Univ Paris 11, Lab CIAMS Complex Innovat Act Motrices & Sport, Orsay, France; [Benguigui, Nicolas] Normandie Univ, Caen, France; [Benguigui, Nicolas] UNICAEN, Lab CESAMS Ctr Etud Sport & Act MotriceS, Caen, France	UDICE-French Research Universities; Universite Paris Saclay; Universite de Caen Normandie	Siegler, IA (corresponding author), Univ Paris 11, Lab CIAMS Complex Innovat Act Motrices & Sport, Orsay, France.	isabelle.siegler@u-psud.fr	Benguigui, Nicolas/A-5611-2008	Siegler, Isabelle/0000-0002-5140-7682	ministere de l'enseignement superieur et de la recherche	ministere de l'enseignement superieur et de la recherche(Estonian Research CouncilEuropean Commission)	The research has been supported by a grant "contrat doctoral" from ministere de l'enseignement superieur et de la recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON GJ, 1974, J MOTOR BEHAV, V6, P217, DOI 10.1080/00222895.1974.10734998; BARD C, 1983, CAN J PSYCHOL, V37, P390, DOI 10.1037/h0080742; Benguigui N, 2008, BRIT J DEV PSYCHOL, V26, P389, DOI 10.1348/026151008X295146; Broderick MP, 1999, J MOTOR BEHAV, V31, P165, DOI 10.1080/00222899909600986; Butterfield SA, 2012, PERCEPT MOTOR SKILL, V114, P261, DOI 10.2466/10.11.25.PMS.114.1.261-274; Clizbe D, 2010, MOTOR CONTROL, V14, P59, DOI 10.1123/mcj.14.1.59; Cohen J.E., 1988, STAT POWER ANAL BEHA; Debrabant J, 2012, HUM MOVEMENT SCI, V31, P801, DOI 10.1016/j.humov.2011.09.006; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Ferrel-Chapus C, 2002, EXP BRAIN RES, V144, P506, DOI 10.1007/s00221-002-1064-2; FISCHMAN MG, 1992, RES Q EXERCISE SPORT, V63, P349, DOI 10.1080/02701367.1992.10608755; Fitzpatrick P, 1996, CHILD DEV, V67, P2691, DOI 10.2307/1131747; Getchell N, 2003, J EXP CHILD PSYCHOL, V85, P120, DOI 10.1016/S0022-0965(03)00059-6; Getchell N, 2007, MOTOR CONTROL, V11, P1; Getchell N, 2006, DEV PSYCHOBIOL, V48, P675, DOI 10.1002/dev.20186; HAY L, 1991, ACTA PSYCHOL, V77, P203, DOI 10.1016/0001-6918(91)90035-X; Hove MJ, 2013, PSYCHOL RES-PSYCH FO, V77, P388, DOI 10.1007/s00426-012-0441-0; Konczak J, 2003, J MOTOR BEHAV, V35, P41, DOI 10.1080/00222890309602120; Konczak J, 2009, J MOTOR BEHAV, V41, P243, DOI 10.3200/JMBR.41.3.243-252; Kugler P.N., 1987, INFORM NATURAL LAW S; Lambert J, 2005, NEUROSCI LETT, V377, P1, DOI 10.1016/j.neulet.2004.11.058; Lantero DA, 2007, J MOTOR BEHAV, V39, P139, DOI 10.3200/JMBR.39.2.139-157; Lefebvre C, 1998, ADAPT PHYS ACT Q, V15, P299, DOI 10.1123/apaq.15.4.299; MANYAM VJ, 1986, PERCEPTION, V15, P313, DOI 10.1068/p150313; Morice AHP, 2008, J NEUROSCI METH, V169, P255, DOI 10.1016/j.jneumeth.2007.11.020; Morice AHP, 2007, EXP BRAIN RES, V181, P249, DOI 10.1007/s00221-007-0924-1; Olivier I, 1997, PERCEPT MOTOR SKILL, V85, P123; REDON C, 1994, HUM MOVEMENT SCI, V13, P95, DOI 10.1016/0167-9457(94)90030-2; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Ringenbach SDR, 2005, ECOL PSYCHOL, V17, P1, DOI 10.1207/s15326969eco1701_1; Robertson SD, 2001, J MOTOR BEHAV, V33, P114, DOI 10.1080/00222890109603144; Rosengren K.S., 2003, DEV MOVEMENT COORDIN, V1st, P56; Savelsbergh GJP, 2000, INT J SPORT PSYCHOL, V31, P467; Schaal S, 1996, J MOTOR BEHAV, V28, P165, DOI 10.1080/00222895.1996.9941743; Schneiberg S, 2002, EXP BRAIN RES, V146, P142, DOI 10.1007/s00221-002-1156-z; Siegler IA, 2013, EXP BRAIN RES, V226, P603, DOI 10.1007/s00221-013-3475-7; Siegler IA, 2010, J EXP PSYCHOL HUMAN, V36, P729, DOI 10.1037/a0016462; SMOLL FL, 1975, PERCEPT MOTOR SKILL, V40, P140, DOI 10.2466/pms.1975.40.1.140; SMOLL FL, 1974, J MOTOR BEHAV, V6, P53, DOI 10.1080/00222895.1974.10734979; SMOLL FL, 1974, PERCEPT MOTOR SKILL, V39, P767, DOI 10.2466/pms.1974.39.2.767; Sternad D, 2001, J EXP PSYCHOL HUMAN, V27, P1163, DOI 10.1037//0096-1523.27.5.1163; THELEN E, 1982, DEV PSYCHOL, V18, P760, DOI 10.1037/0012-1649.18.5.760; THELEN E, 1981, DEV PSYCHOL, V17, P237, DOI 10.1037/0012-1649.17.3.237; THELEN E, 1979, ANIM BEHAV, V27, P699, DOI 10.1016/0003-3472(79)90006-X; Volman MJM, 2000, PSYCHOL RES-PSYCH FO, V63, P62, DOI 10.1007/PL00008168; VONHOFSTEN C, 1984, J EXP CHILD PSYCHOL, V38, P208, DOI 10.1016/0022-0965(84)90122-X; VONHOFSTEN C, 1982, DEV PSYCHOL, V18, P450, DOI 10.1037/0012-1649.18.3.450; VONHOFSTEN C, 1980, J EXP CHILD PSYCHOL, V30, P369, DOI 10.1016/0022-0965(80)90043-0; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; WILKENING F, 1981, COGNITIVE PSYCHOL, V13, P231, DOI 10.1016/0010-0285(81)90009-8	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74127	10.1371/journal.pone.0074127	http://dx.doi.org/10.1371/journal.pone.0074127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098332	Green Published, gold			2022-12-27	WOS:000325434500010
J	Mezlini, AM; Wang, B; Deshwar, A; Morris, Q; Goldenberg, A				Mezlini, Aziz M.; Wang, Bo; Deshwar, Amit; Morris, Quaid; Goldenberg, Anna			Identifying Cancer Specific Functionally Relevant miRNAs from Gene Expression and miRNA-to-Gene Networks Using Regularized Regression	PLOS ONE			English	Article							PROGNOSTIC-FACTOR; MICRORNA; HYPOXIA; HSA-MIR-210; MIR-210; MARKER	Identifying microRNA signatures for the different types and subtypes of cancer can result in improved detection, characterization and understanding of cancer and move us towards more personalized treatment strategies. However, using microRNA's differential expression (tumour versus normal) to determine these signatures may lead to inaccurate predictions and low interpretability because of the noisy nature of miRNA expression data. We present a method for the selection of biologically active microRNAs using gene expression data and microRNA-to-gene interaction network. Our method is based on a linear regression with an elastic net regularization. Our simulations show that, with our method, the active miRNAs can be detected with high accuracy and our approach is robust to high levels of noise and missing information. Furthermore, our results on real datasets for glioblastoma and prostate cancer are confirmed by microRNA expression measurements. Our method leads to the selection of potentially functionally important microRNAs. The associations of some of our identified miRNAs with cancer mechanisms are already confirmed in other studies (hypoxia related hsa-mir-210 and apoptosis-related hsa-mir-296-5p). We have also identified additional miRNAs that were not previously studied in the context of cancer but are coherently predicted as active by our method and may warrant further investigation. The code is available in Matlab and R and can be downloaded on http://www.cs.toronto.edu/goldenberg/Anna_Goldenberg/Current_Research.html.	[Mezlini, Aziz M.; Wang, Bo; Goldenberg, Anna] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Mezlini, Aziz M.; Wang, Bo; Goldenberg, Anna] SickKids Res Inst, Toronto, ON, Canada; [Deshwar, Amit] Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Goldenberg, A (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.	anna.goldenberg@utoronto.ca	Wang, Bo/HDO-6738-2022; Morris, Quaid/ABE-8343-2020	Wang, Bo/0000-0002-9620-3413; Morris, Quaid/0000-0002-2760-6999				Alshalalfa M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-112; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cheng P., 2009, J REPROD CONTRACEP, V20, pl; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Quon G, 2012, COMPUTATIONAL PURIFI; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	19	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e73168	10.1371/journal.pone.0073168	http://dx.doi.org/10.1371/journal.pone.0073168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098326	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500004
J	Nau, F; Yu, BN; Martin, D; Nichols, CD				Nau, Felix, Jr.; Yu, Bangning; Martin, David; Nichols, Charles D.			Serotonin 5-HT2A Receptor Activation Blocks TNF-alpha Mediated Inflammation In Vivo	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DISEASE; ATHEROSCLEROSIS; MECHANISMS; EXPRESSION; PROTEINS; SYSTEM; RNA	Tumor necrosis factor alpha (TNF-alpha) plays a key role in inflammation, and its production and signaling contribute to many inflammatory related diseases. Recently, we discovered that selective activation of serotonin 5-HT2A receptors with the agonist (R)-DOI produces a super-potent blockade of proinflammatory markers in primary rat aortic smooth muscle cells. Here, we demonstrate that systemic administration of (R)-DOI can block the systemic effects of TNF-alpha in whole animal, with potent anti-inflammatory effects in the aortic arch and small intestine. This includes blockade of TNF-alpha-induced expression of pro-inflammatory cell adhesion (Icam-1, Vcam-1), cytokine (Il-6, IL-1b), and chemokine (Mcp-1, Cx3cl1) genes, and expression of VCAM-1 protein in the intestine. Further, systemic (R)-DOI also prevents the TNF-alpha-induced increase of circulating IL-6. Importantly, utilizing receptor selective antagonists, we have demonstrated that the mechanism underlying the systemic anti-inflammatory effects of (R)-DOI is activation of serotonin 5-HT2A receptors. Our results highlight a powerful new role for the serotonin 5-HT2A receptor in inflammatory processes, and indicate that agonism of serotonin receptors may represent an effective and novel approach to develop powerful small molecule therapeutics for inflammatory diseases and conditions such as atherosclerosis and inflammatory bowel disease.	[Nau, Felix, Jr.; Yu, Bangning; Martin, David; Nichols, Charles D.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Nichols, CD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA.	cnich1@lsuhsc.edu	Nichols, Charles D/F-7153-2012	Nichols, Charles D/0000-0002-0615-0646	NHLBI [R21HL095961]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095961] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CDN was supported by a NHLBI grant R21HL095961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Canal CE, 2012, DRUG TEST ANAL, V4, P556, DOI 10.1002/dta.1333; Comet MA, 2007, EUR J NEUROSCI, V26, P345, DOI 10.1111/j.1460-9568.2007.05673.x; Crowell MD, 2004, BRIT J PHARMACOL, V141, P1285, DOI 10.1038/sj.bjp.0705762; Fox MA, 2010, PSYCHOPHARMACOLOGY, V212, P13, DOI 10.1007/s00213-009-1694-1; Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108; Garvin Brian, 2008, Curr Gastroenterol Rep, V10, P363, DOI 10.1007/s11894-008-0070-3; GERSHON MD, 2001, ALIMENT PHARM THER, V13, P15, DOI DOI 10.1046/J.1365-2036.1999.00002.X-I2; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hummon AB, 2007, BIOTECHNIQUES, V42, P467, DOI 10.2144/000112401; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kubera M, 2005, PSYCHIAT RES, V134, P251, DOI 10.1016/j.psychres.2004.01.014; Lee TW, 2010, GASTROENTEROL CLIN N, V39, P543, DOI 10.1016/j.gtc.2010.08.018; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Markoutsaki T, 2011, J CLIN GASTROENTEROL, V45, P514, DOI 10.1097/MCG.0b013e318205e13b; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Neal KB, 2009, J PHYSIOL-LONDON, V587, P567, DOI 10.1113/jphysiol.2008.160416; Ngo Benjamin, 2010, Curr Mol Pharmacol, V3, P145; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nishiyama T, 2009, EUR J PHARMACOL, V614, P122, DOI 10.1016/j.ejphar.2009.03.041; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sanger GJ, 2008, TRENDS PHARMACOL SCI, V29, P465, DOI 10.1016/j.tips.2008.06.008; Schmid CL, 2008, P NATL ACAD SCI USA, V105, P1079, DOI 10.1073/pnas.0708862105; Smith RL, 2003, PSYCHOPHARMACOLOGY, V166, P61, DOI 10.1007/s00213-002-1252-6; Spiller R, 2007, NEUROGASTROENT MOTIL, V19, P25, DOI 10.1111/j.1365-2982.2007.00965.x; Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016; Stefulj J, 2000, BRAIN BEHAV IMMUN, V14, P219, DOI 10.1006/brbi.1999.0579; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Villalon CM, 2007, N-S ARCH PHARMACOL, V376, P45, DOI 10.1007/s00210-007-0179-1; Watts SW, 2011, CARDIOVASC THER, V29, P54, DOI 10.1111/j.1755-5922.2010.00173.x; Yu BN, 2008, J PHARMACOL EXP THER, V327, P316, DOI 10.1124/jpet.108.143461	37	91	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75426	10.1371/journal.pone.0075426	http://dx.doi.org/10.1371/journal.pone.0075426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098382	Green Submitted, gold, Green Published			2022-12-27	WOS:000325434500030
J	Schussek, S; Groves, PL; Apte, SH; Doolan, DL				Schussek, Sophie; Groves, Penny L.; Apte, Simon H.; Doolan, Denise L.			Highly Sensitive Quantitative Real-Time PCR for the Detection of Plasmodium Liver-Stage Parasite Burden following Low-Dose Sporozoite Challenge	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MALARIA PARASITES; YOELII SPOROZOITES; MIQE GUIDELINES; BALB/C MICE; BERGHEI; HOST; INFECTIONS; IMMUNITY; VACCINE	The pre-erythrocytic stages of Plasmodium spp. are increasingly recognised as ideal targets for prophylactic vaccines and drug treatments. Intense research efforts in the last decade have been focused on in vitro culture and in vivo detection and quantification of liver stage parasites to assess the effects of candidate vaccines or drugs. Typically, the onset of blood stage parasitaemia is used as a surrogate endpoint to estimate the efficacy of vaccines and drugs targeting pre-erythrocytic parasite stages in animal models. However, this provides no information on the parasite burden in the liver after vaccination or treatment and therefore does not detect partial efficacy of any vaccine or drug candidates. Herein, we describe a quantitative RT-PCR method adapted to detect and quantitate Plasmodium yoelii liver stages in mice with increased sensitivity even after challenge with as few as 50 cryopreserved sporozoites (corresponding to approximately 5-10 freshly isolated sporozoites). We have validated our quantitative RT-PCR assay according to the MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) guidelines and established high reproducibility and accuracy. Our assay provides a rapid and reproducible assessment of liver stage parasite burden in rodent malaria models, thereby facilitating the evaluation of the efficacy of anti-malarial drugs or prophylactic vaccines with high precision and efficacy.	[Schussek, Sophie; Groves, Penny L.; Apte, Simon H.; Doolan, Denise L.] Queensland Inst Med Res, Infect Dis Programme, Herston, Qld 4006, Australia; [Schussek, Sophie; Doolan, Denise L.] Univ Queensland, Sch Med, St Lucia, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Doolan, DL (corresponding author), Queensland Inst Med Res, Infect Dis Programme, Bramston Terrace, Herston, Qld 4006, Australia.	Denise.Doolan@qimrberghofer.edu.au	Doolan, Denise L/F-1969-2015; Apte, Simon/R-8794-2019; Apte, Simon/H-2798-2016	Apte, Simon/0000-0003-3105-0820; Apte, Simon/0000-0003-3105-0820; Doolan, Denise/0000-0001-7354-8817; Schussek, Sophie/0000-0001-8893-7276	National Health and Medical Research Council (NHMRC) Australia [496600]	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Program Grant (#496600) awarded by the National Health and Medical Research Council (NHMRC) Australia (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; Annoura Takeshi, 2013, Methods Mol Biol, V923, P429; Bell AS, 2004, INT J PARASITOL, V34, P795, DOI 10.1016/j.ijpara.2004.03.008; Bell AS, 2002, TRENDS PARASITOL, V18, P337, DOI 10.1016/S1471-4922(02)02331-0; Briones MRS, 1996, MOL BIOCHEM PARASIT, V77, P7, DOI 10.1016/0166-6851(96)02574-1; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Conteh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008947; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; HOFFMAN SL, 1994, IMMUNOL LETT, V41, P89, DOI 10.1016/0165-2478(94)90113-9; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Hulier E, 1996, MOL BIOCHEM PARASIT, V77, P127, DOI 10.1016/0166-6851(96)02584-4; KHAN ZM, 1991, INFECT IMMUN, V59, P2529, DOI 10.1128/IAI.59.8.2529-2534.1991; KHAN ZM, 1992, INFECT IMMUN, V60, P264, DOI 10.1128/IAI.60.1.264-270.1992; Lau AOT, 2001, J PARASITOL, V87, P19, DOI 10.1645/0022-3395(2001)087[0019:DOPYSM]2.0.CO;2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCUTCHAN TF, 1995, PARASITOL TODAY, V11, P134, DOI 10.1016/0169-4758(95)80132-4; McKenna KC, 2000, INFECT IMMUN, V68, P2224, DOI 10.1128/IAI.68.4.2224-2230.2000; Mota MM, 2001, MOL BIOCHEM PARASIT, V113, P271, DOI 10.1016/S0166-6851(01)00228-6; Mwakingwe A, 2009, J INFECT DIS, V200, P1470, DOI 10.1086/606115; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ploemen I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-350; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Roestenbeng M, 2013, AM J TROP MED HYG, V88, P5, DOI 10.4269/ajtmh.2012.12-0613; SINDEN RE, 1985, T ROY SOC TROP MED H, V79, P598, DOI 10.1016/0035-9203(85)90165-8; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Witney AA, 2001, MOL BIOCHEM PARASIT, V118, P233, DOI 10.1016/S0166-6851(01)00372-3; YOELI M, 1965, NATURE, V208, P903, DOI 10.1038/208903a0	34	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77811	10.1371/journal.pone.0077811	http://dx.doi.org/10.1371/journal.pone.0077811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098596	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500104
J	Gupta, A; Rohlfsen, C; Leppo, MK; Chacko, VP; Wang, YB; Steenbergen, C; Weiss, RG				Gupta, Ashish; Rohlfsen, Cory; Leppo, Michelle K.; Chacko, Vadappuram P.; Wang, Yibin; Steenbergen, Charles; Weiss, Robert G.			Creatine Kinase-Overexpression Improves Myocardial Energetics, Contractile Dysfunction and Survival in Murine Doxorubicin Cardiotoxicity	PLOS ONE			English	Article							ANTHRACYCLINE-INDUCED CARDIOTOXICITY; ADRIAMYCIN-INDUCED CARDIOTOXICITY; ENERGY PHOSPHATE-METABOLISM; PERFUSED RAT-HEART; MAGNETIC-RESONANCE; INDUCED APOPTOSIS; ATP DEPLETION; MOUSE HEART; INACTIVATION; CARDIOMYOPATHY	Doxorubicin (DOX) is a commonly used life-saving antineoplastic agent that also causes dose-dependent cardiotoxicity. Because ATP is absolutely required to sustain normal cardiac contractile function and because impaired ATP synthesis through creatine kinase (CK), the primary myocardial energy reserve reaction, may contribute to contractile dysfunction in heart failure, we hypothesized that impaired CK energy metabolism contributes to DOX-induced cardiotoxicity. We therefore overexpressed the myofibrillar isoform of CK (CK-M) in the heart and determined the energetic, contractile and survival effects of CK-M following weekly DOX (5mg/kg) administration using in vivo(31)P MRS and H-1 MRI. In control animals, in vivo cardiac energetics were reduced at 7 weeks of DOX protocol and this was followed by a mild but significant reduction in left ventricular ejection fraction (EF) at 8 weeks of DOX, as compared to baseline. At baseline, CK-M overexpression (CK-M-OE) increased rates of ATP synthesis through cardiac CK (CK flux) but did not affect contractile function. Following DOX however, CK-M-OE hearts had better preservation of creatine phosphate and higher CK flux and higher EF as compared to control DOX hearts. Survival after DOX administration was significantly better in CK-M-OE than in control animals (p<0.02). Thus CK-M-OE attenuates the early decline in myocardial high-energy phosphates and contractile function caused by chronic DOX administration and increases survival. These findings suggest that CK impairment plays an energetic and functional role in this DOX-cardiotoxicity model and suggests that metabolic strategies, particularly those targeting CK, offer an appealing new strategy for limiting DOX-associated cardiotoxicity.	[Gupta, Ashish; Rohlfsen, Cory; Leppo, Michelle K.; Weiss, Robert G.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Gupta, Ashish; Chacko, Vadappuram P.; Weiss, Robert G.] Johns Hopkins Univ, Sch Med, Dept Radiol, Div Magnet Resonance Res, Baltimore, MD 21205 USA; [Wang, Yibin] Univ Calif Los Angeles, Los Angeles, CA USA; [Steenbergen, Charles] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; Johns Hopkins University	Weiss, RG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	rweiss@jhmi.edu		Wang, Yibin/0000-0003-0852-0767	National Institutes of Health [HL-63030, HL61912, HL-39752]; Clarence Doodeman Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039752, R29HL039752, R01HL063030, R01HL061912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clarence Doodeman Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL-63030 and HL61912 (to RGW), HL-39752 (to CS) and funds from the Clarence Doodeman Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akki A, 2013, AM J PHYSIOL-HEART C, V304, pH633, DOI 10.1152/ajpheart.00771.2011; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; BIANCHI C, 1987, EXP MOL PATHOL, V46, P123, DOI 10.1016/0014-4800(87)90036-0; BUJA LM, 1973, CANCER-AM CANCER SOC, V32, P771, DOI 10.1002/1097-0142(197310)32:4<771::AID-CNCR2820320407>3.0.CO;2-A; DeAtley SM, 1999, TOXICOLOGY, V134, P51, DOI 10.1016/S0300-483X(99)00039-6; Diotte NM, 2009, BBA-MOL CELL RES, V1793, P427, DOI 10.1016/j.bbamcr.2008.10.014; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; E MY, 2008, CARDIOLOGY, V111, P119, DOI 10.1159/000119699; Eidenschink AB, 2000, CARDIOL YOUNG, V10, P610; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Gupta A, 2012, J CLIN INVEST, V122, P291, DOI 10.1172/JCI57426; Gupta A, 2011, CIRC-CARDIOVASC IMAG, V4, P42, DOI 10.1161/CIRCIMAGING.110.959320; Gupta A, 2009, AM J PHYSIOL-HEART C, V297, pH59, DOI 10.1152/ajpheart.00178.2009; Horenstein MS, 2000, MOL GENET METAB, V71, P436, DOI 10.1006/mgme.2000.3043; Jeyaseelan R, 1997, J BIOL CHEM, V272, P5828, DOI 10.1074/jbc.272.9.5828; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Maslov MY, 2007, AM J PHYSIOL-HEART C, V292, pH387, DOI 10.1152/ajpheart.00737.2006; Maslov MY, 2010, AM J PHYSIOL-HEART C, V299, pH332, DOI 10.1152/ajpheart.00727.2009; Mihm MJ, 2002, BRIT J PHARMACOL, V135, P581, DOI 10.1038/sj.bjp.0704495; Mihm MJ, 2001, CARDIOVASC RES, V49, P798, DOI 10.1016/S0008-6363(00)00307-2; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MIURA T, 1994, BIOL PHARM BULL, V17, P1220; Miura T, 2000, BIOCHEM PHARMACOL, V60, P95, DOI 10.1016/S0006-2952(00)00303-8; Muraoka S, 2004, FREE RADICAL RES, V38, P963, DOI 10.1080/10715760400000919; Naumova AV, 2003, AM J PHYSIOL-HEART C, V285, pH1976, DOI 10.1152/ajpheart.00474.2003; NERI GC, 1991, ONCOLOGY, V48, P327; NICOLAY K, 1987, BIOCHIM BIOPHYS ACTA, V929, P5, DOI 10.1016/0167-4889(87)90234-5; OHHARA H, 1981, J MOL CELL CARDIOL, V13, P741, DOI 10.1016/0022-2828(81)90256-X; OLSON RD, 1990, FASEB J, V4, P3076, DOI 10.1096/fasebj.4.13.2210154; PELIKAN PCD, 1986, J CARDIOVASC PHARM, V8, P1058, DOI 10.1097/00005344-198609000-00026; PRAGA C, 1979, CANCER TREAT REP, V63, P827; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; SERAYDARIAN MW, 1977, J MOL CELL CARDIOL, V9, P375, DOI 10.1016/S0022-2828(77)80004-7; Simunek T, 2009, PHARMACOL REP, V61, P154; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; STEINBERG JS, 1987, CANCER, V60, P1213, DOI 10.1002/1097-0142(19870915)60:6<1213::AID-CNCR2820600609>3.0.CO;2-V; STEINHERZ LJ, 1991, JAMA-J AM MED ASSOC, V266, P1672, DOI 10.1001/jama.266.12.1672; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; THOMAS C, 1994, FREE RADICAL RES, V21, P387, DOI 10.3109/10715769409056591; Tokarska-Schlattner M, 2005, AM J PHYSIOL-HEART C, V289, pH37, DOI 10.1152/ajpheart.01057.2004; Tokarska-Schlattner M, 2002, MOL PHARMACOL, V61, P516, DOI 10.1124/mol.61.3.516; Tokarska-Schlattner M, 2006, J MOL CELL CARDIOL, V41, P389, DOI 10.1016/j.yjmcc.2006.06.009; Tokarska-Schlattner M, 2006, CR BIOL, V329, P657, DOI 10.1016/j.crvi.2005.08.007; TOLEIKIS A I, 1988, Biokhimiya, V53, P649; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; WALLIMANN T, 1994, CURR BIOL, V4, P42, DOI 10.1016/S0960-9822(00)00008-7; Xu MF, 2001, LIFE SCI, V68, P889, DOI 10.1016/S0024-3205(00)00990-5; Zhou SY, 2001, CANCER RES, V61, P771	52	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74675	10.1371/journal.pone.0074675	http://dx.doi.org/10.1371/journal.pone.0074675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098344	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100006
J	Bah, E; Carrieri, MP; Hainaut, P; Bah, Y; Nyan, O; Taal, M				Bah, Ebrima; Carrieri, Maria Patrizia; Hainaut, Pierre; Bah, Yusupha; Nyan, Ousman; Taal, Makie			20-Years of Population-Based Cancer Registration in Hepatitis B and Liver Cancer Prevention in The Gambia, West Africa	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; INFECTION; ZIMBABWE; AIDS; UGANDA; TRENDS; HARARE; EPIDEMIOLOGY; WOMEN	Background: The Gambia Hepatitis Intervention Study (GHIS) was designed as a randomised control trial of infant hepatitis B vaccination applied to public health policy, with the main goal of preventing primary liver cancer later in adult life in The Gambia. To that effect, the National Cancer Registry of The Gambia (NCR), a population-based cancer registry (PBCR), was established in 1986 to actively collect data on all cancer diagnosis nation-wide. We extracted 20-years (1990-2009) of data to assess for the first time, the evolution of the most common cancers, also describe and demonstrate the role of the PBCR in a hepatitis B and liver cancer prevention programme in this population. Methods and Findings: We estimated Age-Standardised Incidence Rates (ASR (W)) of the most common cancers registered during the period by gender. The registration period was divided into four 5-year intervals and incidence rates were estimated for each interval. The most common cancers in males were liver, prostate, lung plus bronchus, non-Hodgkin lymphoma (NHL) and stomach, accounting for 60%, 5%, 4%, 5% and 3%, respectively. Similarly, cancers of the cervix uteri, liver, breast and NHL, were the most common in females, accounting for 33%, 24%, 11% and 4% of the female cancers, respectively. Conclusions: Cancer incidence has remained relatively stable over time, but as shown elsewhere in sub-Saharan Africa the disease is a threat in The Gambia. The infection related cancers which are mostly preventable (HBV in men and HPV/HIV in women) were the most common. At the moment the data is not enough to detect an effect of hepatitis B vaccination on liver cancer incidence in The Gambia. However, we observed that monitoring case occurrence through PBCR is a key public health pre-requisite for rational planning and implementation of targeted interventions for improving the health of the population.	[Bah, Ebrima; Taal, Makie] Minist Hlth & Social Welf, Banjul, Gambia; [Carrieri, Maria Patrizia] INSERM, U379, F-13258 Marseille, France; [Hainaut, Pierre] IPRI, Lyon, France; [Bah, Ebrima; Bah, Yusupha] Natl Canc Registry, Fajara, Gambia; [Nyan, Ousman] Univ Gambia, Brikama, Senegal; [Bah, Ebrima] Univ Tampere, FIN-33101 Tampere, Finland; [Bah, Ebrima; Bah, Yusupha] Gambia Hepatitis Intervent Study GHIS Project, Fajara, Gambia	Institut National de la Sante et de la Recherche Medicale (Inserm); University of the Gambia	Bah, E (corresponding author), Minist Hlth & Social Welf, Banjul, Gambia.	eb71608@yahoo.co.uk	Hainaut, Pierre/B-6018-2012	Hainaut, Pierre/0000-0002-1303-1610; Carrieri, Patrizia/0000-0002-6794-4837	Gambian Government (GG); International Agency for Research on Cancer (IARC); Medical Research Council of the United Kingdom; Gambia Unit (MRC) via The Gambia Hepatitis Intervention Study (GHIS) project; Direzione Generale per la Cooperazione allo Sviluppo of the Ministry of Foreign Affairs of Italy; Regione Autonoma Valle d'Aosta, Italy; Swedish Medical Research Council	Gambian Government (GG); International Agency for Research on Cancer (IARC)(World Health Organization); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gambia Unit (MRC) via The Gambia Hepatitis Intervention Study (GHIS) project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Direzione Generale per la Cooperazione allo Sviluppo of the Ministry of Foreign Affairs of Italy; Regione Autonoma Valle d'Aosta, Italy; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	The work was supported through a collaborative initiative between the Gambian Government (GG), International Agency for Research on Cancer (IARC) and the Medical Research Council of the United Kingdom, The Gambia Unit (MRC) via The Gambia Hepatitis Intervention Study (GHIS) project. The GHIS project was a joint venture between the above three institutions with financial support from the Direzione Generale per la Cooperazione allo Sviluppo of the Ministry of Foreign Affairs of Italy, the Regione Autonoma Valle d'Aosta, Italy and the Swedish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG BK, 1992, CANCER CAUSE CONTROL, V3, P569, DOI 10.1007/BF00052754; Bah E, 2001, BRIT J CANCER, V84, P1207, DOI 10.1054/bjoc.2001.1730; BAH E, 1990, BRIT J CANCER, V62, P647, DOI 10.1038/bjc.1990.347; BASSETT MT, 1995, INT J CANCER, V63, P29, DOI 10.1002/ijc.2910630107; BASSETT MT, 1995, INT J CANCER, V63, P24, DOI 10.1002/ijc.2910630106; BAYO S, 1990, INT J CANCER, V45, P679, DOI 10.1002/ijc.2910450418; Bowen RL, 2008, BRIT J CANCER, V98, P277, DOI 10.1038/sj.bjc.6604174; Boyle P, 1991, CANC REGISTRATION PR, V95; Brawley OW, 2012, WORLD J UROL, V30, P195, DOI 10.1007/s00345-012-0824-2; Central Statistics Department, 1996, NAT MIGR AN, P1; Chokunonga E, 1999, AIDS, V13, P2583, DOI 10.1097/00002030-199912240-00012; Chokunonga E, 2000, INT J CANCER, V85, P54, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;54::AID-IJC10&gt;3.0.CO;2-D; Cooke A, 1998, 9803 IARC; Echimane AK, 2000, CANCER, V89, P653, DOI 10.1002/1097-0142(20000801)89:3&lt;653::AID-CNCR22&gt;3.0.CO;2-Z; Esteve J, 1994, IARC SCI PUBL, VIV, P1; Fritz A, 2000, INT CLASSIFICATION D; HALL A J, 1987, Cancer Research, V47, P5782; Hennis AJ, 2009, INT J CANCER, V124, P429, DOI 10.1002/ijc.23889; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Koulibaly M, 1997, INT J CANCER, V70, P39, DOI 10.1002/(SICI)1097-0215(19970106)70:1&lt;39::AID-IJC6&gt;3.0.CO;2-7; Muir C S, 1977, Natl Cancer Inst Monogr, V47, P3; Muir C S, 1985, IARC Sci Publ, P13; MUIR CS, 1984, ARCH GESCHWULSTFORSC, V54, P491; Ogunbiyi JO, 1999, J NATL MED ASSOC, V91, P159; Parkin D M, 1992, IARC Sci Publ, P45; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010; Parkin DM, 2003, CANC AFRICA EPIDEMIO; Parkin DM, 2006, NAT REV CANCER, V6, P603, DOI 10.1038/nrc1948; Plesko I, 1993, Cent Eur J Public Health, V1, P19; RYDER RW, 1992, AM J EPIDEMIOL, V136, P1122, DOI 10.1093/oxfordjournals.aje.a116578; Serraino D, 1999, AIDS, V13, P2589, DOI 10.1097/00002030-199912240-00013; Shimakawa Y, 2013, INT J CANCER, V132, P658, DOI 10.1002/ijc.27646; Sighoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018415; Sighoko D, 2010, INT J CANCER, V127, P2248, DOI 10.1002/ijc.25244; Szymanska K, 2003, ACTA BIOCHIM POL, V50, P231; TORTEY E, 1985, LANCET, V1, P514; Valsecchi MG, 2008, LANCET ONCOL, V9, P159, DOI 10.1016/S1470-2045(08)70028-7; van der Loeff MFS, 2003, AIDS, V17, P1841, DOI [10.1097/00002030-200308150-00014, 10.1097/01.aids.0000076303.76477.49]; Viviani S, 2008, CANCER EPIDEM BIOMAR, V17, P3216, DOI 10.1158/1055-9965.EPI-08-0303; WABINGA HR, 1993, INT J CANCER, V54, P26, DOI 10.1002/ijc.2910540106; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Wall SR, 2005, BRIT J CANCER, V93, P1068, DOI 10.1038/sj.bjc.6602736; Waterhouse J, 1982, CANC INCIDENCE 5 CON, VIV, P1; WILKINS A, 1991, AIDS, V5, P1127, DOI 10.1097/00002030-199109000-00012	45	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75775	10.1371/journal.pone.0075775	http://dx.doi.org/10.1371/journal.pone.0075775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098724	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500095
J	Cheng, C; Singh, V; Krishnan, A; Kan, M; Martinez, JA; Zochodne, DW				Cheng, Chu; Singh, Vandana; Krishnan, Anand; Kan, Michelle; Martinez, Jose A.; Zochodne, Douglas W.			Loss of Innervation and Axon Plasticity Accompanies Impaired Diabetic Wound Healing	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; HAIR FOLLICLE INNERVATION; PERIPHERAL-NERVE; SKIN; FACILITATION; NEUROPATHY; INSULIN; CELLS; PTEN	Loss of cutaneous innervation from sensory neuropathy is included among mechanisms for impaired healing of diabetic skin wounds. The relationships between cutaneous axons and their local microenvironment during wound healing are challenged in diabetes. Here, we show that secondary wound closure of the hairy dorsal skin of mice is delayed by diabetes and is associated with not only a pre-existing loss of cutaneous axons but substantial retraction of axons around the wound. At 7d following a 3mm punch wound, a critical period of healing and reinnervation, both intact skin nearby the wound and skin directly at the wound margins had over 30-50% fewer axons and a larger deficit of ingrowing axons in diabetics. These findings contrasted with a pre-existing 10-15% deficit in axons. Moreover, new diabetic ingrowing axons had less evidence of plasticity. Unexpectedly, hair follicles adjacent to the wounds had a 70% reduction in their innervation associated with depleted expression of hair follicular stem cell markers. These impairments were associated with the local upregulation of two established axon regenerative 'roadblocks': PTEN and RHOA, potential but thus far unexplored mediators of these changes. The overall findings identify striking and unexpected superimposed cutaneous axon loss or retraction beyond that expected of diabetic neuropathy alone, associated with experimental diabetic skin wounding, a finding that prompts new considerations in diabetic wounds.	[Zochodne, Douglas W.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Zochodne, DW (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	dzochodn@ucalgary.ca	Krishnan, Anand/AAJ-6043-2020	Krishnan, Anand/0000-0002-0064-942X	Canadian Diabetes Association; Alberta Innovates-Health Solutions	Canadian Diabetes Association; Alberta Innovates-Health Solutions	This study was funded by an operating grant of the Canadian Diabetes Association. Anand Krishnan is a PDF supported by Alberta Innovates-Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiswenger KK, 2008, NEUROSCI LETT, V442, P267, DOI 10.1016/j.neulet.2008.06.079; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Blakytny R, 2009, INT J LOW EXTR WOUND, V8, P95, DOI 10.1177/1534734609337151; Botchkarev VA, 1997, J COMP NEUROL, V386, P379, DOI 10.1002/(SICI)1096-9861(19970929)386:3<379::AID-CNE4>3.0.CO;2-Z; Brussee V, 2008, DIABETES, V57, P1664, DOI 10.2337/db07-1737; Cao L, 2011, INVEST OPHTH VIS SCI, V52, P2272, DOI 10.1167/iovs.10-5972; Cheng C, 2008, EXP NEUROL, V212, P358, DOI 10.1016/j.expneurol.2008.04.023; Cheng C, 2010, J NEUROSCI, V30, P14735, DOI 10.1523/JNEUROSCI.2919-10.2010; CHENG L, 1995, J CELL BIOL, V129, P789, DOI 10.1083/jcb.129.3.789; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Galkowska H, 2006, J SURG RES, V134, P252, DOI 10.1016/j.jss.2006.02.006; Gibran NS, 2002, J SURG RES, V108, P122, DOI 10.1006/jsre.2002.6525; Guo GF, 2011, NEUROBIOL DIS, V43, P414, DOI 10.1016/j.nbd.2011.04.012; Hendrix S, 2008, EXP DERMATOL, V17, P214, DOI 10.1111/j.1600-0625.2007.00653.x; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kan M, 2012, J NEUROPATH EXP NEUR, V71, P494, DOI 10.1097/NEN.0b013e3182580673; Kennedy JM, 2000, BRAIN, V123, P2118, DOI 10.1093/brain/123.10.2118; Kennedy JM, 2005, J PERIPHER NERV SYST, V10, P144, DOI 10.1111/j.1085-9489.2005.0010205.x; Kennedy JM, 2005, DIABETES, V54, P830, DOI 10.2337/diabetes.54.3.830; Kennedy JM, 2002, DIABETES, V51, P2233, DOI 10.2337/diabetes.51.7.2233; Krishnan STM, 2007, DIABETES CARE, V30, P3058, DOI 10.2337/dc07-1421; Lambrecht BN, 1999, EUR J IMMUNOL, V29, P3815, DOI 10.1002/(SICI)1521-4141(199912)29:12<3815::AID-IMMU3815>3.0.CO;2-#; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; McDonald DS, 2007, NEUROREPORT, V18, P1635, DOI 10.1097/WNR.0b013e3282f03fff; MOST RS, 1983, DIABETES CARE, V6, P87, DOI 10.2337/diacare.6.1.87; Peppa M, 2009, WOUND REPAIR REGEN, V17, P461, DOI 10.1111/j.1524-475X.2009.00518.x; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Rathur HM, 2007, CLIN DERMATOL, V25, P109, DOI 10.1016/j.clindermatol.2006.09.015; Rathur HM, 2007, NAT CLIN PRACT ENDOC, V3, P14, DOI 10.1038/ncpendmet0347; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Toda M, 2008, P NATL ACAD SCI USA, V105, P13550, DOI 10.1073/pnas.0800767105; Toda M, 2008, BIOMED PHARMACOTHER, V62, P352, DOI 10.1016/j.biopha.2008.02.003; Toth CC, 2009, J NEUROPATH EXP NEUR, V68, P326, DOI 10.1097/NEN.0b013e31819ac71b; Zochodne DW, 2007, DIABETES-METAB RES, V23, P490, DOI 10.1002/dmrr.716	36	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75877	10.1371/journal.pone.0075877	http://dx.doi.org/10.1371/journal.pone.0075877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098736	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500107
J	Kaplan, WA; Wirtz, VJ; Stephens, P				Kaplan, Warren A.; Wirtz, Veronika J.; Stephens, Peter			The Market Dynamics of Generic Medicines in the Private Sector of 19 Low and Middle Income Countries between 2001 and 2011: A Descriptive Time Series Analysis	PLOS ONE			English	Article							PRICE	This observational study investigates the private sector, retail pharmaceutical market of 19 low and middle income countries (LMICs) in Latin America, Asia and the Middle East/South Africa analyzing the relationships between volume market share of generic and originator medicines over a time series from 2001 to 2011. Over 5000 individual pharmaceutical substances were divided into generic (unbranded generic, branded generic medicines) and originator categories for each country, including the United States as a comparator. In 9 selected LMICs, the market share of those originator substances with the largest decrease over time was compared to the market share of their counterpart generic versions. Generic medicines (branded generic plus unbranded generic) represent between 70 and 80% of market share in the private sector of these LMICs which exceeds that of most European countries. Branded generic medicine market share is higher than that of unbranded generics in all three regions and this is in contrast to the U. S. Although switching from an originator to its generic counterpart can save money, this narrative in reality is complex at the level of individual medicines. In some countries, the market behavior of some originator medicines that showed the most temporal decrease, showed switching to their generic counterpart. In other countries such as in the Middle East/South Africa and Asia, the loss of these originators was not accompanied by any change at all in market share of the equivalent generic version. For those countries with a significant increase in generic medicines market share and/or with evidence of comprehensive "switching" to generic versions, notably in Latin America, it would be worthwhile to establish cause-effect relationships between pharmaceutical policies and uptake of generic medicines. The absence of change in the generic medicines market share in other countries suggests that, at a minimum, generic medicines have not been strongly promoted.	[Kaplan, Warren A.; Wirtz, Veronika J.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA; [Kaplan, Warren A.; Wirtz, Veronika J.] Boston Univ, World Hlth Org Collaborating Ctr Pharmaceut Polic, Boston, MA 02215 USA; [Stephens, Peter] IMS Hlth, London, England; [Stephens, Peter] UIPS, World Hlth Org Collaborating Ctr Pharmacoepidemio, Utrecht, Netherlands	Boston University; Boston University; World Health Organization; Utrecht University; World Health Organization	Wirtz, VJ (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA.	vwirtz@bu.edu	Wirtz, Veornika/AAG-9712-2019	Kaplan, Warren/0000-0001-6127-4820; Wirtz, Veronika J./0000-0002-0863-8768				Cameron A, 2012, VALUE HEALTH, V15, P664, DOI 10.1016/j.jval.2012.04.004; Dylst P, 2011, PHARMACOECONOMICS, V29, P875, DOI 10.2165/11585970-000000000-00000; Dylst P, 2010, PHARMACEUTICALS, V3, P471, DOI 10.3390/ph3030471; Generic Pharmaceutical Association, 2012, SAV 1 TRILL 10 YEARS; Gomes Barra AC, 2011, J GENERIC MED, V2, P72, DOI DOI 10.1177/1741134311411266; Gonzalez Pier E, 2011, WORKING HLTH POPULAT; Hamburg M, 2012, GPHA ANN M; IMS Health, IMS HLTH GLOB HLTH R; Kanavos P, 2008, EUROPEAN OBSERVATORY; Kaplan WA, 2012, HEALTH POLICY, V106, P211, DOI 10.1016/j.healthpol.2012.04.015; King DR, 2002, CROAT MED J, V43, P462; Madden JM, 2010, REV PANAM SALUD PUBL, V27, P291, DOI 10.1590/S1020-49892010000400008; Pan American Health Organization (Organizacion Panamericana de Salud), 2010, GUID IMPL GEN MED ST; Sheppard A., 2011, GENERIC MED ESSENTIA; Singal GL, 2011, INDIAN J PHARMACOL, V43, P131, DOI 10.4103/0253-7613.77344; Sooksriwong C., 2009, Southern Med Review, V2, P10; The Global Use of Medicines, 2012, OUTLOOK 2016 REPORT; Tobar F, 2008, REV PANAM SALUD PUBL, V23, P59, DOI 10.1590/S1020-49892008000100008; US Department of Health and Human Services, 2010, ASPE ISS BRIEF EXP U; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Waning B, 2010, GLOB HLTH, V6; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; Waning B, 2009, B WORLD HEALTH ORGAN, V87, P520, DOI 10.2471/BLT.08.058925	23	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74399	10.1371/journal.pone.0074399	http://dx.doi.org/10.1371/journal.pone.0074399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098644	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500015
J	Pang, LH; Wei, ZL; Li, O; Huang, RD; Qin, JZ; Chen, HY; Fan, XJ; Chen, ZJ				Pang, Lihong; Wei, Zhouling; Li, Ouyang; Huang, Rudian; Qin, Junzhen; Chen, Hongyan; Fan, Xiaojing; Chen, Zi-Jiang			An Increase in Vascular Endothelial Growth Factor (VEGF) and VEGF Soluble Receptor-1 (sFlt-1) Are Associated with Early Recurrent Spontaneous Abortion	PLOS ONE			English	Article							PREECLAMPSIA; HYPERTENSION; PREGNANCY	Recurrent spontaneous abortion (RSA) is a health problem that affects approximately 1% to 5% reproductive age woman. Yet, in around half of these patients, the mechanism for RSA is unexplained. Recent studies have indicated that placental ischemia/hypoxia and endothelial dysfunction are important factors in miscarriage. Other studies have indicated that the level and expression of soluble FMS-like tyrosine kinase-1 (sFlt1) is increased under a hypoxic environment. However, decreased sFlt-1 in the maternal circulation during the first trimester has recently been proposed as a potential marker for identifying risk of pregnancy loss. In this prospective study clinical samples were obtained within a short time after the fetal death, protein expression and maternal serum levels of sFlt1 were assessed and compared to samples taken from those with normal pregnancies. Our results indicate that levels of VEGF and sFlt-1 are both increased in women during early pregnancy compared women that are not pregnant (p<0.05) indicating that VEGF and sFlt-1 are both associated with pregnancy. More importantly, we detected a significant (p<0.05) increase in sFlt1 and VEGF levels and expression in the RSA patients who suffered subsequent miscarriages compare to controls. These results demonstrate that there is likely a relationship between VEGF, sFlt-1 and RSA suggesting that the high levels and over expression of sFlt-1 and VEGF might be associated with the pathogenesis of RSA.	[Pang, Lihong] Shandong Univ, Jinan 250100, Peoples R China; [Wei, Zhouling; Li, Ouyang; Huang, Rudian; Qin, Junzhen; Chen, Hongyan; Fan, Xiaojing] GuangXi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China; [Chen, Zi-Jiang] Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China; [Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Chen, Zi-Jiang] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China	Shandong University; Guangxi Medical University; Shandong University	Chen, ZJ (corresponding author), Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China.	chenzijiang@hotmail.com	Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022	Chen, Zi-Jiang/0000-0001-6637-6631	National Natural Science Foundation of China [81060053]; National Basic Research Program of China (973 Program) [2012CB944700]; National Key Technology Research and Development Program [2011BAI17B00]; Scientific Research and Technological Development Fund of Guangxi, China [11217004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Technology Research and Development Program(National Key Technology R&D Program); Scientific Research and Technological Development Fund of Guangxi, China	This study was supported by a grant from the National Natural Science Foundation of China (81060053), National Basic Research Program of China (973 Program) (2012CB944700) and the National Key Technology Research and Development Program square 2011BAI17B00), and The Scientific Research and Technological Development Fund of Guangxi, China (11217004). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; Daponte A, 2011, J CLIN ENDOCR METAB, V96, pE1444, DOI 10.1210/jc.2011-0037; Dib C, 2012, TEX HEART I J, V39, P249; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Kaitu'u-Lino TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032509; Lin QD, 1993, CHIN J OBSTET GYNECO, V28, P674; Lin Qi-de, 2003, Zhonghua Fu Chan Ke Za Zhi, V38, P481; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McKeeman GC, 2004, AM J OBSTET GYNECOL, V191, P1240, DOI 10.1016/j.ajog.2004.03.004; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Muttukrishna S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002302; Pang LH, 2011, J INT MED RES, V39, P830, DOI 10.1177/147323001103900316; SCOTT JR, 1987, OBSTET GYNECOL, V70, P645; Stephenson MD, 1996, FERTIL STERIL, V66, P24; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; Weimar CHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041424; Yu CC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056667, 10.1371/journal.pone.0054627]; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	22	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75759	10.1371/journal.pone.0075759	http://dx.doi.org/10.1371/journal.pone.0075759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098721	gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500092
J	Zhu, Y; Hollis, JH				Zhu, Yong; Hollis, James H.			Soup Consumption Is Associated with a Reduced Risk of Overweight and Obesity but Not Metabolic Syndrome in US Adults: NHANES 2003-2006	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; UNITED-STATES; WEIGHT-LOSS; PREVALENCE; PREVENTION; MORTALITY; SATIETY	A limited number of studies have found that soup consumption is related to a lower risk of overweight and obesity in Asian and European populations, however, these studies do not provide a consistent picture regarding the association between soup consumption and markers of metabolic syndrome. To date, no study examining the relationship between soup and body weight or metabolic syndrome have been conducted in the US population. The present study used a sample of 4158 adults aged 19-64 who participated in the National Health and Nutrition Examination Survey between 2003 and 2006. The frequency of soup consumption was determined using a food frequency questionnaire. The weighted prevalence of soup consumption was 94%, with a seasonal variation in the frequency of soup consumption being found. Non-consumers of soup were at a higher risk of being overweight or obese (adjusted odds ratio = 1.381, P = 0.013), with a higher adjusted prevalence of reduced HDL cholesterol (adjusted odds ratio = 1.280, P = 0.045), but there was no association between soup consumption and metabolic syndrome (P = 0.520). The frequency of soup consumption was inversely associated with covariate-adjusted body mass index and waist circumference (P<0.05), but not with biomarkers of metabolic syndrome, except for a lower fasting insulin level in frequent soup consumers (P = 0.022). Results from the present study suggest soup consumption is not associated with metabolic syndrome. However, there is an inverse relationship between soup consumption and body weight status in US adults, which support laboratory studies showing a potential benefit of soup consumption for body weight management.	[Zhu, Yong] Univ Iowa, Dept Epidemiol, Iowa City, IA 52240 USA; [Hollis, James H.] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA	University of Iowa; Iowa State University	Hollis, JH (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.	jhollis@iastate.edu						Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Bertrais S, 2001, J HUM NUTR DIET, V14, P121, DOI 10.1046/j.1365-277X.2001.00275.x; Bessa M, 2008, ACTA MEDICA PORT, V21, P161; Brauchla M, 2012, J NUTR METAB, V2012; Centers for Disease Control and Prevenion, NHANES 2003 2004; Centers for Disease Control and Prevention, NHANES 2005 2006; Centers for Disease Control and Prevention, BMI AD; Clegg ME, 2013, EUR J CLIN NUTR, V67, P8, DOI 10.1038/ejcn.2012.152; Cugnet-Anceau C, 2010, BRIT J NUTR, V103, P422, DOI 10.1017/S0007114509991875; Ervin R.B., 2009, NATL HLTH STAT REPOR, V5, P1; Feldeisen SE, 2007, APPL PHYSIOL NUTR ME, V32, P46, DOI [10.1139/H06-101, 10.1139/h06-101]; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flood JE, 2007, APPETITE, V49, P626, DOI 10.1016/j.appet.2007.04.002; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; FOREYT JP, 1986, J AM DIET ASSOC, V86, P524; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Galan P, 2003, INT J VITAM NUTR RES, V73, P315, DOI 10.1024/0300-9831.73.5.315; Giacosa A, 1997, MED DOCTOR, V8, P40; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Himaya A, 1998, APPETITE, V30, P199, DOI 10.1006/appe.1997.0138; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; JORDAN HA, 1981, J AM DIET ASSOC, V79, P24; Kuroda M, 2011, J AM DIET ASSOC, V111, P137, DOI 10.1016/j.jada.2010.10.004; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Martinez-Tomas R, 2012, EUR J NUTR, V51, P231, DOI 10.1007/s00394-011-0211-6; Mattes R, 2005, PHYSIOL BEHAV, V83, P739, DOI 10.1016/j.physbeh.2004.09.021; Moreira Pedro, 2006, Eat Behav, V7, P220, DOI 10.1016/j.eatbeh.2005.08.008; O'Neil CE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-107; O'Neil CE, 2011, J AM COLL NUTR, V30, P502, DOI 10.1080/07315724.2011.10719996; Poppitt SD, 1996, APPETITE, V26, P153, DOI 10.1006/appe.1996.0013; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9; Wang Y, 2009, INT J OBESITY, V33, P621, DOI 10.1038/ijo.2009.45; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067482; Zhu Y, 2013, BRIT J NUTR, V110, P384, DOI 10.1017/S0007114512005053; Zhu Y, 2013, INT J FOOD SCI NUTR, V64, P385, DOI 10.3109/09637486.2012.759183	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75630	10.1371/journal.pone.0075630	http://dx.doi.org/10.1371/journal.pone.0075630			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098709	gold, Green Published			2022-12-27	WOS:000325423500080
J	Jang, YH; Byun, YH; Lee, KH; Park, ES; Lee, YH; Lee, YJ; Lee, J; Kim, KH; Seong, BL				Jang, Yo Han; Byun, Young Ho; Lee, Kwang-Hee; Park, Eun-Sook; Lee, Yun Ha; Lee, Yoon-Jae; Lee, Jinhee; Kim, Kyun-Hwan; Seong, Baik Lin			Host Defense Mechanism-Based Rational Design of Live Vaccine	PLOS ONE			English	Article							INFLUENZA-A VIRUS; FACTOR-INDUCED APOPTOSIS; CELL-DEATH APOPTOSIS; CASPASE FAMILY; CLEAVAGE SITE; NS1 PROTEIN; B VIRUSES; IN-VIVO; NUCLEOPROTEIN; INFECTION	Live attenuated vaccine (LAV), mimicking natural infection, provides an excellent protection against microbial infection. The development of LAV, however, still remains highly empirical and the rational design of clinically useful LAV is scarcely available. Apoptosis and caspase activation are general host antiviral responses in virus-infected cells. Utilizing these tightly regulated host defense mechanisms, we present a novel apoptosis-triggered attenuation of viral virulence as a rational design of live attenuated vaccine with desired levels of safety, efficacy, and productivity. Mutant influenza viruses carrying caspase recognition motifs in viral NP and the interferon-antagonist NS1 proteins were highly attenuated both in vitro and in vivo by caspase-mediated cleavage of those proteins in infected cells. Both viral replication and interferon-resistance were substantially reduced, resulting in a marked attenuation of virulence of the virus. Despite pronounced attenuation, the viruses demonstrated high growth phenotype in embryonated eggs at lower temperature, ensuring its productivity. A single dose vaccination with the mutant virus elicited high levels of systemic and mucosal antibody responses and provided complete protection against both homologous and heterologous lethal challenges in mouse model. While providing a practical means to generate seasonal or pandemic influenza live vaccines, the sensitization of viral proteins to pathogen-triggered apoptotic signals presents a potentially universal, mechanism-based rational design of live vaccines against many viral infections.	[Jang, Yo Han; Byun, Young Ho; Lee, Kwang-Hee; Lee, Yun Ha; Lee, Yoon-Jae; Lee, Jinhee; Seong, Baik Lin] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea; [Park, Eun-Sook; Kim, Kyun-Hwan] Konkuk Univ, Sch Med, IBST, Dept Pharmacol, Seoul, South Korea; [Seong, Baik Lin] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea	Yonsei University; Konkuk University; Konkuk University Medical Center; Yonsei University	Seong, BL (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea.	blseong@yonsei.ac.kr	Lee, Yoon Jae/HGE-5712-2022	Park, Eun-Sook/0000-0002-6652-9404; Kim, Kyun-Hwan/0000-0001-5266-072X	Ministry for Health, Welfare and Family Affairs of Republic of Korea [A085105]	Ministry for Health, Welfare and Family Affairs of Republic of Korea	This work was supported by a grant from the Korea Healthcare Technology R&D project of Ministry for Health, Welfare and Family Affairs of Republic of Korea [grant number A085105]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada GL, 1990, NEW GENERATION VACCI, P19; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; CHANOCK RM, 1988, VACCINE, V6, P129, DOI 10.1016/S0264-410X(88)80014-8; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; FESQ H, 1994, IMMUNOBIOLOGY, V190, P175, DOI 10.1016/S0171-2985(11)80292-5; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Jang YH, 2012, CLIN EXP VACCINE RES, V1, P35, DOI 10.7774/cevr.2012.1.1.35; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le TVL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018780; Lee KH, 2006, VACCINE, V24, P1966, DOI 10.1016/j.vaccine.2005.10.051; Lipatov AS, 2008, ARCH VIROL, V153, P427, DOI 10.1007/s00705-007-0003-8; Maassab HF, 1999, REV MED VIROL, V9, P237, DOI 10.1002/(SICI)1099-1654(199910/12)9:4&lt;237::AID-RMV252&gt;3.0.CO;2-G; MAASSAB HF, 1985, VACCINE, V3, P355, DOI 10.1016/0264-410X(85)90124-0; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NEUMANN G, 1994, VIROLOGY, V202, P477, DOI 10.1006/viro.1994.1365; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Robert BB, 2004, VIRUS RES, V103, P177; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schultz-Cherry S, 2001, J VIROL, V75, P7875, DOI 10.1128/JVI.75.17.7875-7881.2001; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Silverman RB, 1992, ENZYME INHIBITION IN, P146; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; Stech J, 2005, NAT MED, V11, P683, DOI 10.1038/nm1256; Steegenga WT, 1998, ONCOGENE, V16, P349, DOI 10.1038/sj.onc.1201540; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Watanabe S, 2009, J VIROL, V83, P5947, DOI 10.1128/JVI.00450-09; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zhirnov Oleg P, 2009, J Mol Genet Med, V3, P124; Zhirnov OP, 2009, VIROLOGY, V394, P57, DOI 10.1016/j.virol.2009.08.013	53	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75043	10.1371/journal.pone.0075043	http://dx.doi.org/10.1371/journal.pone.0075043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098364	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500019
J	Ollivier, M; Tresset, A; Hitte, C; Petit, C; Hughes, S; Gillet, B; Duffraisse, M; Pionnier-Capitan, M; Lagoutte, L; Arbogast, RM; Balasescu, A; Boroneant, A; Mashkour, M; Vigne, JD; Hanni, C				Ollivier, Morgane; Tresset, Anne; Hitte, Christophe; Petit, Coraline; Hughes, Sandrine; Gillet, Benjamin; Duffraisse, Marilyne; Pionnier-Capitan, Maud; Lagoutte, Laetitia; Arbogast, Rose-Marie; Balasescu, Adrian; Boroneant, Adina; Mashkour, Marjan; Vigne, Jean-Denis; Haenni, Catherine			Evidence of Coat Color Variation Sheds New Light on Ancient Canids	PLOS ONE			English	Article							DOG DOMESTICATION; URSUS-ARCTOS; BROWN BEAR; POPULATIONS; MULTIPLE; GENETICS; SEQUENCE; HISTORY; REVEAL; ORIGIN	We have used a paleogenetics approach to investigate the genetic landscape of coat color variation in ancient Eurasian dog and wolf populations. We amplified DNA fragments of two genes controlling coat color, Mc1r (Melanocortin 1 Receptor) and CBD103 (canine-beta-defensin), in respectively 15 and 19 ancient canids (dogs and wolf morphotypes) from 14 different archeological sites, throughout Asia and Europe spanning from ca. 12 000 B.P. (end of Upper Palaeolithic) to ca. 4000 B.P. (Bronze Age). We provide evidence of a new variant (R301C) of the Melanocortin 1 receptor (Mc1r) and highlight the presence of the beta-defensin melanistic mutation (CDB103-K locus) on ancient DNA from dog-and wolf-morphotype specimens. We show that the dominant K-B allele (CBD103), which causes melanism, and R301C (Mc1r), the variant that may cause light hair color, are present as early as the beginning of the Holocene, over 10 000 years ago. These results underline the genetic diversity of prehistoric dogs. This diversity may have partly stemmed not only from the wolf gene pool captured by domestication but also from mutations very likely linked to the relaxation of natural selection pressure occurring in-line with this process.	[Ollivier, Morgane; Petit, Coraline; Hughes, Sandrine; Gillet, Benjamin; Duffraisse, Marilyne; Pionnier-Capitan, Maud; Haenni, Catherine] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR5242, F-69365 Lyon 07, France; [Tresset, Anne; Pionnier-Capitan, Maud; Mashkour, Marjan; Vigne, Jean-Denis] MNHN, CNRS, UMR Archeozool Archeobot Soc Prat & Environm 7209, Dept Ecol & Gest Biodiversite, Paris, France; [Hitte, Christophe; Lagoutte, Laetitia] Univ Rennes 1, Inst Genet & Dev Rennes, CNRS, UMR6290, Rennes, France; [Gillet, Benjamin; Haenni, Catherine] Ecole Normale Super Lyon, CNRS, French Natl Platform Paleogenet, PALGENE, F-69364 Lyon 07, France; [Arbogast, Rose-Marie] CNRS, UMR Maison Interuniv Sci Homme Alsace 7044, Strasbourg, France; [Balasescu, Adrian] Natl Museum Romanian Hist, Ctr Natl Rech Pluridisciplinaires, Bucharest, Romania; [Boroneant, Adina] Romanian Acad, Inst Archaeol Vasile Parvan, Bucharest, Romania	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Romanian Academy of Sciences	Hanni, C (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR5242, F-69365 Lyon 07, France.	catherine.hanni@ens-lyon.fr	Gillet, Benjamin/ABD-6704-2020; Balasescu, Adrian/L-6149-2013; Boroneanț, Adina/N-5002-2015; Ollivier, Morgane/AAA-6059-2019; Mashkour, Marjan/B-5724-2018	Balasescu, Adrian/0000-0001-7834-5111; Ollivier, Morgane/0000-0002-8361-4221; Hitte, Christophe/0000-0003-1714-437X; Mashkour, Marjan/0000-0003-3630-9459	CNRS; ENS de Lyon; Romanian National Authority for Scientific Research, CNS - UEFISCDI [PN-II-ID-PCE-2011-3-0982]	CNRS(Centre National de la Recherche Scientifique (CNRS)); ENS de Lyon; Romanian National Authority for Scientific Research, CNS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	The following organizations supported this work: CNRS (http://www.cnrs.fr/), ENS de Lyon (http://www.ens-lyon.eu/) and the Romanian National Authority for Scientific Research, CNS - UEFISCDI for the grant it provided (project number PN-II-ID-PCE-2011-3-0982, http://www.seera-ei.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Benecke N, 1996, ACTA PRAEHISTORICA A, V28, P213; Blankenberg D, 2010, CURRENT PROTOCOLS MO, V19; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Calvignac S, 2009, DIVERS DISTRIB, V15, P742, DOI 10.1111/j.1472-4642.2009.00586.x; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Everts RE, 2000, ANIM GENET, V31, P194, DOI 10.1046/j.1365-2052.2000.00639.x; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Germonpre M, 2012, J ARCHAEOL SCI, V39, P184, DOI 10.1016/j.jas.2011.09.022; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pionnier-Capitan M, 2010, THESIS ENS LYON; Pionnier-Capitan M, 2011, J ARCHAEOL SCI, V38, P2123, DOI 10.1016/j.jas.2011.02.028; Randi E, 2002, CONSERV GENET, V3, P31; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Turnbull PF, 1974, FIELDIANA ANTHR, V63; Vigne JD, 2005, MUNIBE, V51, P279; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013	39	22	22	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75110	10.1371/journal.pone.0075110	http://dx.doi.org/10.1371/journal.pone.0075110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098367	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500021
J	Segard, BD; Delort, F; Bailleux, V; Simon, S; Leccia, E; Gausseres, B; Briki, F; Vicart, P; Batonnet-Pichon, S				Segard, Bertrand-David; Delort, Florence; Bailleux, Virginie; Simon, Stephanie; Leccia, Emilie; Gausseres, Blandine; Briki, Fatma; Vicart, Patrick; Batonnet-Pichon, Sabrina			N-Acetyl-L-Cysteine Prevents Stress-Induced Desmin Aggregation in Cellular Models of Desminopathy	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK-PROTEIN; OXIDATIVE STRESS; SKELETAL MYOPATHY; MOUSE MODEL; MUTATIONS; MUSCLE; EXPRESSION; MICE; CADMIUM	Mutations within the human desmin gene are responsible for a subcategory of myofibrillar myopathies called desminopathies. However, a single inherited mutation can produce different phenotypes within a family, suggesting that environmental factors influence disease states. Although several mouse models have been used to investigate organ-specific desminopathies, a more general mechanistic perspective is required to advance our knowledge toward patient treatment. To improve our understanding of disease pathology, we have developed cellular models to observe desmin behaviour in early stages of disease pathology, e. g., upon formation of cytoplasmic desmin aggregates, within an isogenic background. We cloned the wildtype and three mutant desmin cDNAs using a Tet-On Advanced (R) expression system in C2C12 cells. Mutations were selected based on positioning within desmin and capacity to form aggregates in transient experiments, as follows: DesS46Y (head domain; low aggregation), DesD399Y (central rod domain; high aggregation), and DesS460I (tail domain; moderate aggregation). Introduction of these proteins into a C2C12 background permitted us to compare between desmin variants as well as to determine the role of external stress on aggregation. Three different types of stress, likely encountered during muscle activity, were introduced to the cell models-thermal (heat shock), redox-associated (H2O2 and cadmium chloride), and mechanical (stretching) stresses-after which aggregation was measured. Cells containing variant DesD399Y were more sensitive to stress, leading to marked cytoplasmic perinuclear aggregations. We then evaluated the capacity of biochemical compounds to prevent this aggregation, applying dexamethasone (an inducer of heat shock proteins), fisetin or N-acetyl-L-cysteine (antioxidants) before stress induction. Interestingly, N-acetyl-L-cysteine pretreatment prevented DesD399Y aggregation during most stress. N-acetyl-L-cysteine has recently been described as a promising antioxidant in myopathies linked to selenoprotein N or ryanodin receptor defects. Our findings indicate that this drug warrants further study in animal models to speed its potential development as a therapy for DesD399Y-linked desminopathies.	[Segard, Bertrand-David; Delort, Florence; Simon, Stephanie; Gausseres, Blandine; Vicart, Patrick; Batonnet-Pichon, Sabrina] Univ Paris Diderot, Unite Biol Fonct & Adaptat, CNRS, Sorbonne Paris Cite,EAC4413, Paris, France; [Bailleux, Virginie; Leccia, Emilie; Briki, Fatma] Univ Paris 11, Phys Solides Lab, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Vicart, P (corresponding author), Univ Paris Diderot, Unite Biol Fonct & Adaptat, CNRS, Sorbonne Paris Cite,EAC4413, Paris, France.	patrick.vicart@univ-paris-diderot.fr	Stephanie, Simon/A-3845-2013; Ségard, Bertrand-David/B-8251-2015	Ségard, Bertrand-David/0000-0001-8972-9786	Universite Paris Diderot; "Centre National de la Recherche Scientifique" (CNRS); Association Francaise contre les Myopathies (AFM) [15454]; National Research Agency (ANR); ministere de la recherche et de l'enseignement superieur; AFM	Universite Paris Diderot; "Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); National Research Agency (ANR)(French National Research Agency (ANR)); ministere de la recherche et de l'enseignement superieur; AFM(Association Francaise contre les Myopathies)	This work was supported by "Universite Paris Diderot" (http://www.univ-paris-diderot.fr), the "Centre National de la Recherche Scientifique" (CNRS, http://www.cnrs.fr), and grants from the "Association Francaise contre les Myopathies" (AFM No15454; http://www.afm-telethon.fr). The authors are also grateful for financial support from the "rare diseases program" of the National Research Agency (ANR, http://www.agence-nationale-recherche.fr). BDS was supported by a fellowship from the "ministere de la recherche et de l'enseignement superieur" and AFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbulut O, 1996, BIOL CELL, V88, P131, DOI 10.1016/S0248-4900(97)83528-9; Arbogast S, 2009, ANN NEUROL, V65, P677, DOI 10.1002/ana.21644; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Bar H, 2007, HUM MUTAT, V28, P374, DOI 10.1002/humu.20459; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Biol AJ, 2007, J NEUROPATH EXP NEUR, V66, P711, DOI 10.1097/nen.0b013e3181256b4c; Blunt BC, 2007, AM J PHYSIOL-HEART C, V293, pH1518, DOI 10.1152/ajpheart.00269.2006; Bonakdar N, 2012, BIOCHEM BIOPH RES CO, V419, P703, DOI 10.1016/j.bbrc.2012.02.083; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; Chourbagi O, 2011, EXP CELL RES, V317, P886, DOI 10.1016/j.yexcr.2011.01.013; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; Clemen CS, 2005, FEBS LETT, V579, P3777, DOI 10.1016/j.febslet.2005.05.051; Croute F, 2005, J TOXICOL ENV HEAL A, V68, P703, DOI 10.1080/15287390590925447; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Dowling JJ, 2012, BRAIN, V135, P1115, DOI 10.1093/brain/aws036; Duband-Goulet I, 2011, EXP CELL RES, V317, P2800, DOI 10.1016/j.yexcr.2011.09.012; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; Goudeau B, 2006, HUM MUTAT, V27, P906, DOI 10.1002/humu.20351; Hoffman EP, 2003, MUSCLE NERVE, V27, P643, DOI 10.1002/mus.10400; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Janue A, 2007, BRAIN PATHOL, V17, P377, DOI 10.1111/j.1750-3639.2007.00087.x; Joanne P, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-4; KHAN N, 2012, ANTIOXID REDOX SIGNA, P99152; Kostareva A, 2008, J MUSCLE RES CELL M, V29, P25, DOI 10.1007/s10974-008-9139-8; Kreplak L, 2009, J MOL BIOL, V385, P1043, DOI 10.1016/j.jmb.2008.10.095; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; Lapouge K, 2006, J CELL SCI, V119, P4974, DOI 10.1242/jcs.03255; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; Leccia E, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/1/016001; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129; Mavroidis M, 2008, FASEB J, V22, P3318, DOI 10.1096/fj.07-088724; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Muntoni F, 2006, BRAIN, V129, P1260, DOI 10.1093/brain/awl062; Nedellec P, 2002, NEUROMUSCULAR DISORD, V12, P457, DOI 10.1016/S0960-8966(01)00306-6; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Selcen D, 2011, NEUROMUSCULAR DISORD, V21, P161, DOI 10.1016/j.nmd.2010.12.007; Sharma S, 2009, J MOL MED, V87, P1207, DOI 10.1007/s00109-009-0521-9; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; Vigouroux C, 2001, J CELL SCI, V114, P4459; Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402; Wu W, 1996, TOXICOL APPL PHARM, V141, P330; Zheng HQ, 2010, J AM COLL CARDIOL, V56, P1418, DOI 10.1016/j.jacc.2010.01.075; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	50	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76361	10.1371/journal.pone.0076361	http://dx.doi.org/10.1371/journal.pone.0076361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098483	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100063
J	Wood, TJ; Thistlethwaite, A; Harris, MR; Lovell, SC; Millar, CB				Wood, Thomas J.; Thistlethwaite, Angela; Harris, Michael R.; Lovell, Simon C.; Millar, Catherine B.			Mutations in Non-Acid Patch Residues Disrupt H2A.Z's Association with Chromatin through Multiple Mechanisms	PLOS ONE			English	Article							HISTONE VARIANT H2A.Z; N-TERMINUS; CHAPERONE; TRANSCRIPTION; ACETYLATION; RECRUITMENT; HTZ1; ACTIVATION; DEPOSITION; VERSATILE	The incorporation of histone variants into nucleosomes is a critical mechanism for regulating essential DNA-templated processes and for establishing distinct chromatin architectures with specialised functions. H2A.Z is an evolutionarily conserved H2A variant that has diverse roles in transcriptional regulation, heterochromatin boundary definition, chromosome stability and DNA repair. The H2A.Z C-terminus diverges in sequence from canonical H2A and imparts unique functions to H2A.Z in the yeast S. cerevisiae. Although mediated in part through the acid patch-containing M6 region, many molecular determinants of this divergent structure-function relationship remain unclear. Here, by using an unbiased random mutagenesis screen of H2A.Z alleles, we identify point mutations in the C-terminus outside of the M6 region that disrupt the normal function of H2A.Z in response to cytotoxic stress. These functional defects correlate with reduced chromatin association, which we attribute to reduced physical stability within chromatin, but also to altered interactions with the SWR and INO80 chromatin remodeling complexes. Together with experimental data, computational modelling of these residue changes in the context of protein structure suggests the importance of C-terminal domain integrity and configuration for maintaining the level of H2A.Z in nucleosomes.	[Wood, Thomas J.; Thistlethwaite, Angela; Harris, Michael R.; Lovell, Simon C.; Millar, Catherine B.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Millar, CB (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	catherine.millar@manchester.ac.uk	Wood, Thomas/GWZ-2481-2022	Wood, Thomas/0000-0001-8962-8571; Millar, Catherine/0000-0002-8649-5408; Lovell, Simon/0000-0002-4092-8458	Wellcome Trust through a Career Development Fellowship [WT082335MA]; Wellcome Trust PhD studentship; Biotechnology and Biological Sciences Research Council [BB/I020489/1] Funding Source: researchfish; BBSRC [BB/I020489/1] Funding Source: UKRI	Wellcome Trust through a Career Development Fellowship(Wellcome Trust); Wellcome Trust PhD studentship(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust through a Career Development Fellowship to CBM (WT082335MA) and a Wellcome Trust PhD studentship to TJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Gardner JM, 2011, J CELL BIOL, V193, P489, DOI 10.1083/jcb.201011017; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Jackson JD, 1996, TRENDS BIOCHEM SCI, V21, P466, DOI 10.1016/S0968-0004(96)20028-3; Jensen K, 2011, MOL GENET GENOMICS, V285, P287, DOI 10.1007/s00438-011-0604-5; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kawano A, 2011, GENES CELLS, V16, P590, DOI 10.1111/j.1365-2443.2011.01512.x; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Larochelle M, 2003, EMBO J, V22, P4512, DOI 10.1093/emboj/cdg427; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Mehta M, 2010, J BIOL CHEM, V285, P39855, DOI 10.1074/jbc.M110.185967; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; MIZUGUCHI G, 2004, ATP DRIVEN EXCHANGE, P45854; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; SHARP JA, 2001, YEAST HISTONE DEPOSI, P1; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Wan YK, 2009, MOL CELL BIOL, V29, P2346, DOI 10.1128/MCB.01233-08; Wang AY, 2011, MOL CELL BIOL, V31, P3871, DOI 10.1128/MCB.05182-11; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Wratting D, 2012, J BIOL CHEM, V287, P19148, DOI 10.1074/jbc.M111.317990; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	42	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76394	10.1371/journal.pone.0076394	http://dx.doi.org/10.1371/journal.pone.0076394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098487	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100065
J	Boettcher, J; Leek, L; Matson, L; Holmes, EA; Browning, M; MacLeod, C; Andersson, G; Carlbring, P				Boettcher, Johanna; Leek, Linda; Matson, Lisa; Holmes, Emily A.; Browning, Michael; MacLeod, Colin; Andersson, Gerhard; Carlbring, Per			Internet-Based Attention Bias Modification for Social Anxiety: A Randomised Controlled Comparison of Training towards Negative and Training Towards Positive Cues	PLOS ONE			English	Article							SELECTIVE ATTENTION; SELF-REPORT; PSYCHOMETRIC PROPERTIES; MODIFICATION PROGRAM; FACIAL EXPRESSIONS; AVOIDANCE PATTERN; PHOBIA; THREAT; VULNERABILITY; VALIDATION	Biases in attention processes are thought to play a crucial role in the aetiology and maintenance of Social Anxiety Disorder (SAD). The goal of the present study was to examine the efficacy of a programme intended to train attention towards positive cues and a programme intended to train attention towards negative cues. In a randomised, controlled, double-blind design, the impact of these two training conditions on both selective attention and social anxiety were compared to that of a control training condition. A modified dot probe task was used, and delivered via the internet. A total of 129 individuals, diagnosed with SAD, were randomly assigned to one of these three conditions and took part in a 14-day programme with daily training/control sessions. Participants in all three groups did not on average display an attentional bias prior to the training. Critically, results on change in attention bias implied that significantly differential change in selective attention to threat was not detected in the three conditions. However, symptoms of social anxiety reduced significantly from pre- to follow-up-assessment in all three conditions (d(within) = 0.63-1.24), with the procedure intended to train attention towards threat cues producing, relative to the control condition, a significantly greater reduction of social fears. There were no significant differences in social anxiety outcome between the training condition intended to induce attentional bias towards positive cues and the control condition. To our knowledge, this is the first RCT where a condition intended to induce attention bias to negative cues yielded greater emotional benefits than a control condition. Intriguingly, changes in symptoms are unlikely to be by the mechanism of change in attention processes since there was no change detected in bias per se. Implications of this finding for future research on attention bias modification in social anxiety are discussed. Trial Registration: ClinicalTrials.gov NCT01463137	[Boettcher, Johanna; Carlbring, Per] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Boettcher, Johanna] Free Univ Berlin, Berlin, Germany; [Leek, Linda; Matson, Lisa] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Holmes, Emily A.] MRC Cognit & Brain Sci Unit, Cambridge, England; [Browning, Michael] Univ Oxford, Funct MRI Brain Ctr, Oxford, England; [MacLeod, Colin] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Dept Clin Neurosci, Psychiat Sect, Stockholm, Sweden	Stockholm University; Free University of Berlin; Umea University; University of Oxford; University of Western Australia; Linkoping University; Karolinska Institutet	Boettcher, J (corresponding author), Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden.	johanna.boettcher@fu-berlin.de	Andersson, Gerhard/J-8529-2012; Carlbring, Per/R-1220-2019; browning, michael/M-7338-2017; Carlbring, Per/D-3628-2009; Holmes, Emily/ABD-4367-2020	Andersson, Gerhard/0000-0003-4753-6745; Carlbring, Per/0000-0002-2172-8813; browning, michael/0000-0001-9108-3144; Carlbring, Per/0000-0002-2172-8813; Holmes, Emily/0000-0001-7319-3112; MacLeod, Colin/0000-0003-2407-7339; Boettcher, Johanna/0000-0002-8220-9291	Swedish Council for Working Life and Social Research [FAS 2009-0222]; MRC [MC_UP_0901/1] Funding Source: UKRI; Medical Research Council [MC_UP_0901/1] Funding Source: researchfish	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was made possible by a grant from the Swedish Council for Working Life and Social Research (www.fas.se; Grant number: FAS 2009-0222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir N, 2003, BEHAV RES THER, V41, P1325, DOI 10.1016/S0005-7967(03)00039-1; Amir N, 2008, J ABNORM PSYCHOL, V117, P860, DOI 10.1037/a0013445; Amir N, 2011, J CONSULT CLIN PSYCH, V79, P533, DOI 10.1037/a0023808; Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; Andersson Gerhard, 2006, Cognitive Behaviour Therapy, V35, P55, DOI 10.1080/16506070500372469; [Anonymous], 2010, R LANG ENV STAT COMP; ASMUNDSON GJG, 1994, J ANXIETY DISORD, V8, P107, DOI 10.1016/0887-6185(94)90009-4; Baker SL, 2002, BEHAV RES THER, V40, P701, DOI 10.1016/S0005-7967(01)00060-2; Beard C, 2012, BEHAV THER, V43, P724, DOI 10.1016/j.beth.2012.01.002; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berry AC, 2009, DEPRESS ANXIETY, V26, P22, DOI 10.1002/da.20511; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Boettcher J, 2012, COGNITIVE THER RES, V36, P522, DOI 10.1007/s10608-011-9374-y; Bradley BP, 1997, BEHAV RES THER, V35, P911, DOI 10.1016/S0005-7967(97)00053-3; Browning M, 2010, COGN AFFECT BEHAV NE, V10, P8, DOI 10.3758/CABN.10.1.8; Calamaras MR, 2012, J CLIN PSYCHOL, V68, P745, DOI 10.1002/jclp.21875; Carlbring P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-66; Chen YP, 2002, BEHAV RES THER, V40, P677, DOI 10.1016/S0005-7967(01)00086-9; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Clark DM, 2006, J CONSULT CLIN PSYCH, V74, P568, DOI 10.1037/0022-006X.74.3.568; Dear BF, 2011, J PAIN, V12, P1247, DOI 10.1016/j.jpain.2011.07.003; Eldar S, 2012, AM J PSYCHIAT, V169, P213, DOI 10.1176/appi.ajp.2011.11060886; Field A., 2012, DISCOVERING STAT USI; First M.B., 2004, STRUCTURED CLIN INTE, DOI DOI 10.1002/9780471726753; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Frisch M.B., 1992, PSYCHOL ASSESS, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Furmark T, 1999, SOC PSYCH PSYCH EPID, V34, P416, DOI 10.1007/s001270050163; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Heeren A, 2012, BEHAV RES THER, V50, P30, DOI 10.1016/j.brat.2011.10.005; Helfinstein SM, 2008, BEHAV RES THER, V46, P799, DOI 10.1016/j.brat.2008.03.011; HOPE DA, 1990, COGNITIVE THER RES, V14, P177, DOI 10.1007/BF01176208; Houck PR, 2004, PSYCHIAT RES, V129, P209, DOI 10.1016/j.psychres.2004.08.001; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jose P., 2012, NLME LINEAR NONLINEA; Julian K, 2012, BEHAV RES THER, V50, P350, DOI 10.1016/j.brat.2012.02.015; Klumpp H, 2010, COGNITIVE THER RES, V34, P263, DOI 10.1007/s10608-009-9251-0; Klumpp H, 2009, ANXIETY STRESS COPIN, V22, P283, DOI 10.1080/10615800802449602; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; LeMoult J, 2012, COGNITIVE THER RES, V36, P47, DOI 10.1007/s10608-010-9322-2; Li SW, 2008, BEHAV RES THER, V46, P905, DOI 10.1016/j.brat.2008.04.005; Lindner P, COGNITIVE B IN PRESS; Lundh LG, 1996, PERS INDIV DIFFER, V20, P725, DOI 10.1016/0191-8869(96)00008-6; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Macleod C, 2012, AM J PSYCHIAT, V169, P118, DOI 10.1176/appi.ajp.2011.11111682; Maidenberg E, 1996, J ANXIETY DISORD, V10, P529, DOI 10.1016/S0887-6185(96)00028-X; MATTIA JI, 1993, BEHAV RES THER, V31, P305, DOI 10.1016/0005-7967(93)90029-T; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Mogg K, 2004, J ABNORM PSYCHOL, V113, P160, DOI 10.1037/0021-843X.113.1.160; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Muhlberger A, 2008, CYBERPSYCHOL BEHAV, V11, P425, DOI 10.1089/cpb.2007.0084; Mueller EM, 2009, PSYCHOL MED, V39, P1141, DOI 10.1017/S0033291708004820; Musa C, 2003, BEHAV RES THER, V41, P1043, DOI 10.1016/S0005-7967(02)00212-7; Neubauer K, 2013, BEHAV RES THER, V51, P87, DOI 10.1016/j.brat.2012.10.006; Nielsen T, 2007, NORD PSYCHOL, V59, P231, DOI 10.1027/1901-2276.59.3.231; Ononaiye MSP, 2007, COGNITIVE THER RES, V31, P727, DOI 10.1007/s10608-006-9096-8; PATTERSON WM, 1983, PSYCHOSOMATICS, V24, P343, DOI 10.1016/S0033-3182(83)73213-5; Pflugshaupt T, 2005, J ANXIETY DISORD, V19, P105, DOI 10.1016/j.janxdis.2003.12.002; Pineles SL, 2005, J ABNORM PSYCHOL, V114, P314, DOI 10.1037/0021-843X.114.2.314; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Roberts KE, 2010, COGNITIVE THER RES, V34, P388, DOI 10.1007/s10608-009-9245-y; ROSNOW RL, 1991, PSYCHOL BULL, V110, P574, DOI 10.1037/0033-2909.110.3.574; Samuelsson H, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2196; Schmidt NB, 2009, J ABNORM PSYCHOL, V118, P5, DOI 10.1037/a0013643; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Schofield CA, 2012, COGNITION EMOTION, V26, P300, DOI 10.1080/02699931.2011.602050; See J, 2009, J ABNORM PSYCHOL, V118, P65, DOI 10.1037/a0014377; Staugaard SR., 2009, PSYCHOL SCI Q, V51, P339, DOI [DOI 10.1080/02699930903205698, 10.4081/mi.2011.e5, DOI 10.4081/MI.2011.E5]; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Thorndike FP, 2009, COMPUT HUM BEHAV, V25, P393, DOI 10.1016/j.chb.2008.05.006; Vassilopoulos SP, 2005, BEHAV COGN PSYCHOTH, V33, P13, DOI 10.1017/S1352465804001730; Wieser MJ, 2009, J NEURAL TRANSM, V116, P717, DOI 10.1007/s00702-008-0101-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	78	70	71	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e71760	10.1371/journal.pone.0071760	http://dx.doi.org/10.1371/journal.pone.0071760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098630	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500002
J	Chung, RY; Leung, JCS; Chan, DCC; Woo, J; Wong, CKM; Wong, SYS				Chung, Roger Y.; Leung, Jason C. S.; Chan, Dicken C. C.; Woo, Jean; Wong, Carmen K. M.; Wong, Samuel Y. S.			Lower Urinary Tract Symptoms (LUTS) as a Risk Factor for Depressive Symptoms in Elderly Men: Results from a Large Prospective Study in Southern Chinese Men	PLOS ONE			English	Article							QUALITY-OF-LIFE; BENIGN PROSTATIC HYPERPLASIA; HONG-KONG CHINESE; ERECTILE DYSFUNCTION; OVERACTIVE BLADDER; PREVALENCE; DISEASE; IMPACT; ASSOCIATION; HOSPITALIZATION	A cross-sectional relationship between lower urinary tract symptoms (LUTS) and depressive symptoms was previously reported among Southern Chinese men; however, the temporal relationship was unclear. Our objective is to evaluate the temporal relationship between moderate to severe lower urinary tract symptoms and clinically significant depressive symptoms in elderly Chinese men aged 65 in a prospective manner. In a prospective cohort of 2,000 Chinese men aged 65 to 92 years in Hong Kong, we studied the association of having moderate to severe LUTS at baseline and having clinically relevant depressive symptoms at year 2 follow-up. After excluding men with prostate or bladder cancer or surgery (n = 20) and lost to follow-up (n = 254), data on 1,726 subjects were analyzed. LUTS were measured by the International Prostate Symptom score; and clinically relevant depressive symptoms were measured by the Geriatric Depression Scale. The multiple logistic regressions showed that the presence of moderate-to-severe LUTS at baseline were significantly associated with increased risk for being depressed at two-year follow-up, with adjustments for demographic, lifestyle, medical factors, weight status and stressful life events (OR = 2.97; CI: 1.70-5.20). Association remained significant with additional adjustments for baseline GDS score (OR = 1.88; CI: 1.03-3.41). LUTS are important risk factors in predicting the presence of clinically relevant depressive symptoms. In elderly men, increased awareness and possible screening are needed to detect the increased risk of clinically relevant depressive symptoms.	[Chung, Roger Y.; Chan, Dicken C. C.; Wong, Carmen K. M.; Wong, Samuel Y. S.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason C. S.] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China; [Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, SYS (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	yeungshanwong@cuhk.edu.hk	Woo, Jean/K-2625-2014; Chung, Roger Y. N./B-7288-2016; WONG, Samuel Yeung Shan/D-7311-2013	Woo, Jean/0000-0001-7593-3081; WONG, Samuel Yeung Shan/0000-0003-0934-6385	Food and Health Bureau, the Hong Kong Special Administrative Region [02030661]	Food and Health Bureau, the Hong Kong Special Administrative Region	This work was supported by the Health and Health Services Research Fund (Grant no. 02030661), Food and Health Bureau, the Hong Kong Special Administrative Region. URL of funder's website: http://www.fhb.gov.hk/grants/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AB, 2000, AM J EPIDEMIOL, V152, P533, DOI 10.1093/aje/152.6.533; Bertaccini A, 2001, EUR UROL, V40, P13, DOI 10.1159/000049872; Bula CJ, 2001, ARCH INTERN MED, V161, P2609, DOI 10.1001/archinte.161.21.2609; Chan HC, 2004, THESIS HONG KONG U H; Chi I, 2005, AM J GERIAT PSYCHIAT, V13, P409, DOI 10.1176/appi.ajgp.13.5.409; Chou KL, 2005, INT J GERIATR PSYCH, V20, P41, DOI 10.1002/gps.1246; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Eckhardt MD, 2001, J UROLOGY, V166, P563, DOI 10.1016/S0022-5347(05)65985-X; Engstrom G, 2005, BJU INT, V95, P810, DOI 10.1111/j.1464-410X.2005.05406.x; Fitzgerald MP, 2007, EUR UROL, V52, P407, DOI 10.1016/j.eururo.2007.03.014; Gannon K, 2005, BJU INT, V96, P823, DOI 10.1111/j.1464-410X.2005.05720.x; Glover L, 2004, BJU INT, V94, P563, DOI 10.1111/j.1464-410X.2004.05001.x; Irwin DE, 2006, BJU INT, V97, P96, DOI 10.1111/j.1464-410X.2005.05889.x; Kirby RS, 2000, UROLOGY, V56, P3, DOI 10.1016/S0090-4295(00)00747-0; Lau EMC, 1996, J BONE MINER RES, V11, P1364; Laumann EO, 2008, J UROLOGY, V180, P233, DOI 10.1016/j.juro.2008.03.055; Lee H.-c.B., 1993, CLIN GERONTOLOGIST, V14, P37; Marc LG, 2008, AM J GERIAT PSYCHIAT, V16, P914, DOI 10.1097/JGP.0b013e318186bd67; Mariappan P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004742.pub2; Marschall-Kehrel D, 2004, UROLOGY, V64, P21, DOI 10.1016/j.urology.2004.10.072; Ng TP, 2007, ARCH INTERN MED, V167, P60, DOI 10.1001/archinte.167.1.60; Platz EA, 2002, UROLOGY, V59, P877, DOI 10.1016/S0090-4295(01)01673-9; Quek KF, 2004, INT J UROL, V11, P848, DOI 10.1111/j.1442-2042.2004.00903.x; Roehrborn Claus G, 2004, Rev Urol, V6, P121; Rosen RC, 2004, BJU INT, V93, P689, DOI 10.1111/j.1464-410X.2003.04767.x; Sherwood A, 2007, ARCH INTERN MED, V167, P367, DOI 10.1001/archinte.167.4.367; Sundquist J, 2005, AM J PREV MED, V29, P428, DOI 10.1016/j.amepre.2005.08.002; Takao T, 2011, AGING MALE, V14, P110, DOI 10.3109/13685538.2010.512374; Trueman P, 1999, BJU INT, V83, P410; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Welch G, 2002, UROLOGY, V59, P245, DOI 10.1016/S0090-4295(01)01506-0; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Wong SY, 2010, AGING MALE, V13, P113, DOI 10.3109/13685530903440432; Wong SYS, 2007, BRIT J NUTR, V98, P1237, DOI 10.1017/S0007114507787433; Wong SYS, 2006, J AFFECT DISORDERS, V96, P83, DOI 10.1016/j.jad.2006.05.013; Wong SYS, 2006, INT J UROL, V13, P1304, DOI 10.1111/j.1442-2042.2006.01560.x; Wong SYS, 2005, OSTEOPOROSIS INT, V16, P1933, DOI 10.1007/s00198-005-1968-3	37	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76017	10.1371/journal.pone.0076017	http://dx.doi.org/10.1371/journal.pone.0076017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098757	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500127
J	Rutherford, A; Cebrian, M; Rahwan, I; Dsouza, S; McInerney, J; Naroditskiy, V; Venanzi, M; Jennings, NR; deLara, JR; Wahlstedt, E; Miller, SU				Rutherford, Alex; Cebrian, Manuel; Rahwan, Iyad; Dsouza, Sohan; McInerney, James; Naroditskiy, Victor; Venanzi, Matteo; Jennings, Nicholas R.; deLara, J. R.; Wahlstedt, Eero; Miller, Steven U.			Targeted Social Mobilization in a Global Manhunt	PLOS ONE			English	Article							SEARCH; WORLD; NETWORKS	Social mobilization, the ability to mobilize large numbers of people via social networks to achieve highly distributed tasks, has received significant attention in recent times. This growing capability, facilitated by modern communication technology, is highly relevant to endeavors which require the search for individuals that possess rare information or skills, such as finding medical doctors during disasters, or searching for missing people. An open question remains, as to whether in time-critical situations, people are able to recruit in a targeted manner, or whether they resort to so-called blind search, recruiting as many acquaintances as possible via broadcast communication. To explore this question, we examine data from our recent success in the U. S. State Department's Tag Challenge, which required locating and photographing 5 target persons in 5 different cities in the United States and Europe - in under 12 hours - based only on a single mug-shot. We find that people are able to consistently route information in a targeted fashion even under increasing time pressure. We derive an analytical model for social-media fueled global mobilization and use it to quantify the extent to which people were targeting their peers during recruitment. Our model estimates that approximately 1 in 3 messages were of targeted fashion during the most time-sensitive period of the challenge. This is a novel observation at such short temporal scales, and calls for opportunities for devising viral incentive schemes that provide distance or time-sensitive rewards to approach the target geography more rapidly. This observation of '12 hours of separation' between individuals has applications in multiple areas from emergency preparedness, to political mobilization.	[Rutherford, Alex; Rahwan, Iyad; Dsouza, Sohan] Masdar Inst Sci & Technol, Abu Dhabi, U Arab Emirates; [Rahwan, Iyad] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland; [Cebrian, Manuel] Natl Informat & Commun Technol Australia, Melbourne, Vic, Australia; [Cebrian, Manuel] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [McInerney, James; Naroditskiy, Victor; Venanzi, Matteo; Jennings, Nicholas R.] Univ Southampton, Sch Elect & Comp Sci, Southampton, Hants, England; [deLara, J. R.] George Washington Univ, Washington, DC USA; [Wahlstedt, Eero] Univ Oxford, Oxford, England; [Miller, Steven U.] Champlain Coll, Burlington, VT USA	Khalifa University of Science & Technology; University of Edinburgh; University of California System; University of California San Diego; University of Southampton; George Washington University; University of Oxford	Rahwan, I (corresponding author), Masdar Inst Sci & Technol, Abu Dhabi, U Arab Emirates.	irahwan@acm.org	Mcinerney, James/AAF-7234-2020; Jennings, Nick/HGU-8308-2022; Rahwan, Iyad/ABB-2422-2020	Jennings, Nick/0000-0003-0166-248X; Rahwan, Iyad/0000-0002-1796-4303; /0000-0002-9433-7661	Masdar Institute of Science Technology [11CAAA1]; EPSRC [EP/I011587/1]; National Science Foundation [0905645]; DARPA/Lockheed Martin Guard Dog Program under PO [4100149822]; Army Research Office [W911NF-11-1-0363]; Australian Government; Engineering and Physical Sciences Research Council [EP/I011587/1] Funding Source: researchfish	Masdar Institute of Science Technology; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); DARPA/Lockheed Martin Guard Dog Program under PO; Army Research Office; Australian Government(Australian GovernmentCGIAR); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	I. Rahwan acknowledges support by Masdar Institute of Science & Technology under grant 11CAAA1. N. R. Jennings acknowledges support of EPSRC-funded ORCHID project (EP/I011587/1). M. Cebrian acknowledges support from the National Science Foundation under grant 0905645, from DARPA/Lockheed Martin Guard Dog Program under PO #4100149822, from the Army Research Office under Grant W911NF-11-1-0363, and the Australian Government as represented by DBCDE and ARC through the ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamic L, 2005, SOC NETWORKS, V27, P187, DOI 10.1016/j.socnet.2005.01.007; [Anonymous], PHYS REV LETT, V103; Backstrom L, 2011, ARXIV1114570; Backstrom L, 2011, INT C WEBL SOC MED I; Beaverstock JV, 1999, CITIES, V16, P445, DOI 10.1016/S0264-2751(99)00042-6; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Cebrian M, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P775; Choi JH, 2006, GLOBAL NETW, V6, P81, DOI 10.1111/j.1471-0374.2006.00134.x; Chomsky Noam, 2012, OCCUPY; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064679; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055957; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; Firth N, 2012, NEW SCI; Gao H, 2011, IEEE INTELL SYST, V26, P10, DOI 10.1109/MIS.2011.52; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Hellerstein JM, 2011, COMMUN ACM, V54, P77, DOI 10.1145/1965724.1965744; Hodas NO, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P249, DOI 10.1109/SocialCom-PASSAT.2012.129; Iribarren JL, 2011, ABS11053316 CORR; Kleinberg J, 2005, ANN IEEE SYMP FOUND, P132, DOI 10.1109/SFCS.2005.63; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Iribarren JL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038702; Marlow C, 2011, ABS11114503 CORR; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Miritello G, 2013, SOCIAL NETWORKS; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Ozel F, 2001, SAFETY SCI, V38, P95, DOI 10.1016/S0925-7535(00)00061-8; Pickard G, 2011, SCIENCE, V334, P509, DOI 10.1126/science.1205869; Rahwan I, 2013, COMPUTER, V46, P68, DOI 10.1109/MC.2012.295; Rutherford Alex, 2013, Proc Natl Acad Sci U S A, V110, P6281, DOI 10.1073/pnas.1216338110; State B., 2013, ARXIV13030045; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; Tang JC, 2011, COMMUN ACM, V54, P78, DOI 10.1145/1924421.1924441; Watts D, 2013, PUBLIC RESPONSE ALER; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104	39	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74628	10.1371/journal.pone.0074628	http://dx.doi.org/10.1371/journal.pone.0074628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098660	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500031
J	Singh, N; Bhattacharya, A; Bhattacharya, S				Singh, Nishant; Bhattacharya, Alok; Bhattacharya, Sudha			Homologous Recombination Occurs in Entamoeba and Is Enhanced during Growth Stress and Stage Conversion	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; CONTINUOUS EXPRESSION; AXENIC CULTIVATION; HETEROLOGOUS GENES; PROVIDES EVIDENCE; MEIOTIC GENES; CELL-CYCLE; HISTOLYTICA; GIARDIA; MEIOSIS	Homologous recombination (HR) has not been demonstrated in the parasitic protists Entamoeba histolytica or Entamoeba invadens, as no convenient method is available to measure it. However, HR must exist to ensure genome integrity, and possible genetic exchange, especially during stage conversion from trophozoite to cyst. Here we show the up regulation of mitotic and meiotic HR genes in Entamoeba during serum starvation, and encystation. To directly demonstrate HR we use a simple PCR-based method involving inverted repeats, which gives a reliable read out, as the recombination junctions can be determined by sequencing the amplicons. Using this read out, we demonstrate enhanced HR under growth stress in E. histolytica, and during encystation in E. invadens. We also demonstrate recombination between chromosomal inverted repeats. This is the first experimental demonstration of HR in Entamoeba and will help future investigations into this process, and to explore the possibility of meiosis in Entamoeba.	[Singh, Nishant; Bhattacharya, Sudha] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; [Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Bhattacharya, S (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India.	sbjnu110@gmail.com	Singh, Nishant/T-9054-2019	Singh, Nishant/0000-0002-8466-8862	Department of Biotechnology; Council of Scientific and Industrial Research India	Department of Biotechnology; Council of Scientific and Industrial Research India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by Department of Biotechnology and Council of Scientific and Industrial Research India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipova I, 2000, P NATL ACAD SCI USA, V97, P14473, DOI 10.1073/pnas.97.26.14473; AVRON B, 1986, J PROTOZOOL, V33, P522, DOI 10.1111/j.1550-7408.1986.tb05655.x; BaezCamargo M, 1997, INVAS METAST, V16, P269; Bagchi A, 1999, INT J PARASITOL, V29, P1775, DOI 10.1016/S0020-7519(99)00125-3; Bakre AA, 2005, EXP PARASITOL, V110, P207, DOI 10.1016/j.exppara.2005.02.009; Bhattacharya A, 2000, INT J PARASITOL, V30, P401, DOI 10.1016/S0020-7519(99)00189-7; Birky CW, 2010, TRENDS PARASITOL, V26, P70, DOI 10.1016/j.pt.2009.11.007; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Carpenter ML, 2012, J CELL SCI, V125, P2523, DOI 10.1242/jcs.103879; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; Conway C, 2002, MOL MICROBIOL, V45, P1687, DOI 10.1046/j.1365-2958.2002.03122.x; Cooper MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/j.cub.2007.10.020; Das S, 2002, CELL MICROBIOL, V4, P55, DOI 10.1046/j.1462-5822.2002.00165.x; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DIAMOND LS, 1995, J EUKARYOT MICROBIOL, V42, P277, DOI 10.1111/j.1550-7408.1995.tb01579.x; DiRuggiero J, 1999, J MOL EVOL, V49, P474, DOI 10.1007/PL00006570; DVORAK JA, 1995, J EUKARYOT MICROBIOL, V42, P610, DOI 10.1111/j.1550-7408.1995.tb05915.x; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Ganguly A, 2001, MOL BIOCHEM PARASIT, V112, P277, DOI 10.1016/S0166-6851(00)00376-5; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gerton JL, 2002, P NATL ACAD SCI USA, V99, P6895, DOI 10.1073/pnas.102167899; GLAZER PM, 1989, P NATL ACAD SCI USA, V86, P1163, DOI 10.1073/pnas.86.4.1163; Groth P, 2012, NUCLEIC ACIDS RES, V40, P6585, DOI 10.1093/nar/gks315; Gupta AK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00303; HAMANN L, 1995, P NATL ACAD SCI USA, V92, P8975, DOI 10.1073/pnas.92.19.8975; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Huntley DM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-321; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Krogstad D, 1988, AMEBIASIS HUMAN INFE; Lopez-Camarillo C, 2009, INFECT GENET EVOL, V9, P1051, DOI 10.1016/j.meegid.2009.06.024; Lopez-Casamichana M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-35; Lorenzi Hernan, 2008, BMC Genomics, V9, P595, DOI 10.1186/1471-2164-9-595; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Moreau S, 1999, MOL CELL BIOL, V19, P556; Mukherjee C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000281; Papadopoulou B, 1997, NUCLEIC ACIDS RES, V25, P4278, DOI 10.1093/nar/25.21.4278; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANCHEZ L, 1994, MOL BIOCHEM PARASIT, V67, P125, DOI 10.1016/0166-6851(94)90102-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shrimal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000929; Singh N, 2010, EXP PARASITOL, V127, P329; Singh N, 2012, MOL BIOCHEM PARASIT, V184, P9, DOI 10.1016/j.molbiopara.2012.02.012; Singh N, 2012, MOL BIOCHEM PARASIT, V183, P90, DOI 10.1016/j.molbiopara.2012.01.003; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Teodorovic S, 2007, EUKARYOT CELL, V6, P1421, DOI 10.1128/EC.00138-07; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Weber C, 2009, MOL BIOCHEM PARASIT, V164, P165, DOI 10.1016/j.molbiopara.2008.12.005; Weedall GD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001209; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Willers H, 2001, CARCINOGENESIS, V22, P1757, DOI 10.1093/carcin/22.11.1757; Willhoeft U, 1999, MOL BIOCHEM PARASIT, V99, P41, DOI 10.1016/S0166-6851(98)00178-9; Yadav VP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1855; Yamamoto K, 1996, GENETICS, V143, P27	63	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74465	10.1371/journal.pone.0074465	http://dx.doi.org/10.1371/journal.pone.0074465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098652	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500023
J	Tzika, AA; Constantinou, C; Bandyopadhaya, A; Psychogios, N; Lee, S; Mindrinos, M; Martyn, JAJ; Tompkins, RG; Rahme, LG				Tzika, A. Aria; Constantinou, Caterina; Bandyopadhaya, Arunava; Psychogios, Nikolaos; Lee, Sangseok; Mindrinos, Michael; Martyn, J. A. Jeevendra; Tompkins, Ronald G.; Rahme, Laurence G.			A Small Volatile Bacterial Molecule Triggers Mitochondrial Dysfunction in Murine Skeletal Muscle	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MUCOID PSEUDOMONAS-AERUGINOSA; LIPOPROTEIN-LIPASE ACTIVITY; ACTIVATED-RECEPTOR-GAMMA; FREE FATTY-ACIDS; INSULIN-RESISTANCE; CYSTIC-FIBROSIS; PPAR-GAMMA; IN-VIVO; LIPID-CONTENT	Mitochondria integrate distinct signals that reflect specific threats to the host, including infection, tissue damage, and metabolic dysfunction; and play a key role in insulin resistance. We have found that the Pseudomonas aeruginosa quorum sensing infochemical, 2-amino acetophenone (2-AA), produced during acute and chronic infection in human tissues, including in the lungs of cystic fibrosis (CF) patients, acts as an interkingdom immunomodulatory signal that facilitates pathogen persistence, and host tolerance to infection. Transcriptome results have led to the hypothesis that 2-AA causes further harm to the host by triggering mitochondrial dysfunction in skeletal muscle. As normal skeletal muscle function is essential to survival, and is compromised in many chronic illnesses, including infections and CF-associated muscle wasting, we here determine the global effects of 2-AA on skeletal muscle using high-resolution magic-angle-spinning (HRMAS), proton (1 H) nuclear magnetic resonance (NMR) metabolomics, in vivo P-31 NMR, whole-genome expression analysis and functional studies. Our results show that 2-AA when injected into mice, induced a biological signature of insulin resistance as determined by 1 H NMR analysis-, and dramatically altered insulin signaling, glucose transport, and mitochondrial function. Genes including Glut4, IRS1, PPAR-c, PGC1 and Sirt1 were downregulated, whereas uncoupling protein UCP3 was up-regulated, in accordance with mitochondrial dysfunction. Although 2-AA did not alter high-energy phosphates or pH by in vivo P-31 NMR analysis, it significantly reduced the rate of ATP synthesis. This affect was corroborated by results demonstrating down-regulation of the expression of genes involved in energy production and muscle function, and was further validated by muscle function studies. Together, these results further demonstrate that 2-AA, acts as a mediator of interkingdom modulation, and likely effects insulin resistance associated with a molecular signature of mitochondrial dysfunction in skeletal muscle. Reduced energy production and mitochondrial dysfunctional may further favor infection, and be an important step in the establishment of chronic and persistent infections.	[Tzika, A. Aria; Constantinou, Caterina; Bandyopadhaya, Arunava; Psychogios, Nikolaos; Tompkins, Ronald G.; Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Tzika, A. Aria; Constantinou, Caterina; Bandyopadhaya, Arunava; Psychogios, Nikolaos; Lee, Sangseok; Martyn, J. A. Jeevendra; Tompkins, Ronald G.; Rahme, Laurence G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tzika, A. Aria; Psychogios, Nikolaos] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Mindrinos, Michael] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Lee, Sangseok; Martyn, J. A. Jeevendra] Harvard Univ, Sch Med, Dept Anesthesiol & Crit Care, Boston, MA USA; [Tzika, A. Aria; Constantinou, Caterina; Bandyopadhaya, Arunava; Psychogios, Nikolaos; Lee, Sangseok; Martyn, J. A. Jeevendra; Rahme, Laurence G.] Shriners Hosp Children Boston, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Stanford University; Harvard University; Harvard Medical School	Tzika, AA (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	atzika@hms.harvard.edu; rahme@molbio.mgh.harvard.edu	Lee, Sangseok/AAF-5091-2021; Constantinou, Caterina/D-3844-2018	Lee, Sangseok/0000-0001-7023-3668; Constantinou, Caterina/0000-0003-3589-0739; Psychogios, Nikolaos/0000-0002-2747-6012	Shriner's Hospital for Children [87100]; Center grant of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI105902, R21AI105902] Funding Source: NIH RePORTER	Shriner's Hospital for Children; Center grant of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Shriner's Hospital for Children research grant no. 87100 to Laurence G. Rahme, and by a Center grant of the National Institutes of Health to the Stanford Genome Technology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, INT MICROBIOL, V7, P181; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Astrakas LG, 2005, FASEB J, V19, P1431, DOI 10.1096/fj.04-2005com; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Bandyopadhaya A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003024; Befroy DE, 2009, METHOD ENZYMOL, V457, P373, DOI 10.1016/S0076-6879(09)05021-6; BEISEL WR, 1967, ANN INTERN MED, V67, P744, DOI 10.7326/0003-4819-67-4-744; BEISEL WR, 1975, ANNU REV MED, V26, P9, DOI 10.1146/annurev.me.26.020175.000301; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Boesch C, 1997, MAGN RESON MED, V37, P484, DOI 10.1002/mrm.1910370403; BRINDLE KM, 1989, BIOCHEMISTRY-US, V28, P4887, DOI 10.1021/bi00437a054; Cobas JC, 2006, J MAGN RESON, V183, P145, DOI 10.1016/j.jmr.2006.07.013; CHANDRA RK, 1983, LANCET, V1, P688; Chang HR, 1998, JPEN-PARENTER ENTER, V22, P156, DOI 10.1177/0148607198022003156; Chiang MC, 2012, NEUROBIOL DIS, V45, P322, DOI 10.1016/j.nbd.2011.08.016; COX CD, 1979, J CLIN MICROBIOL, V9, P479; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Debril MB, 2001, J MOL MED, V79, P30, DOI 10.1007/s001090000145; Dekkers JF, 2012, TRENDS MOL MED, V18, P283, DOI 10.1016/j.molmed.2012.03.004; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Frick CG, 2008, INTENS CARE MED, V34, P561, DOI 10.1007/s00134-007-0852-3; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Hardin DS, 2001, AM J PHYSIOL-ENDOC M, V281, pE1022, DOI 10.1152/ajpendo.2001.281.5.E1022; HAVEL RJ, 1964, J APPL PHYSIOL, V19, P613, DOI 10.1152/jappl.1964.19.4.613; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hussey J, 2002, J Cyst Fibros, V1, P116, DOI 10.1016/S1569-1993(02)00074-7; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ilyinskii PO, 2007, CELL CYCLE, V6, P2043, DOI 10.4161/cc.6.16.4564; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Jiang JH, 2012, IUBMB LIFE, V64, P397, DOI 10.1002/iub.1021; Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997; KAYAR SR, 1986, EUR J APPL PHYSIOL O, V54, P578, DOI 10.1007/BF00943344; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192; KIENS B, 1989, J CLIN INVEST, V84, P1124, DOI 10.1172/JCI114275; KINGSLEYHICKMAN PB, 1990, J BIOL CHEM, V265, P1545; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Kulhmann J, 2005, MAGN RESON MED, V53, P1275, DOI 10.1002/mrm.20501; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Macallan DC, 1998, CLIN SCI, V94, P321, DOI 10.1042/cs0940321; MACALLAN DC, 1995, AM J CLIN NUTR, V61, P818, DOI 10.1093/ajcn/61.4.818; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Majai G, 2007, EUR J IMMUNOL, V37, P1343, DOI 10.1002/eji.200636398; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MORTON RE, 1988, AM J CLIN NUTR, V47, P214, DOI 10.1093/ajcn/47.2.214; Morvan D, 2003, MAGN RESON MED, V49, P241, DOI 10.1002/mrm.10368; Navon-Venezia S, 2005, CURR OPIN INFECT DIS, V18, P306, DOI 10.1097/01.qco.0000171920.44809.f0; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; O'Riordan SMP, 2008, PEDIATR DIABETES, V9, P338, DOI 10.1111/j.1399-5448.2008.00437.x; Padfield KE, 2005, P NATL ACAD SCI USA, V102, P5368, DOI 10.1073/pnas.0501211102; Paton NI, 2001, CLIN SCI, V100, P101, DOI 10.1042/CS20000037; Perez A, 2008, AM J PHYSIOL-LUNG C, V295, pL303, DOI 10.1152/ajplung.90276.2008; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI [10.1056/NEJMoa031314, DOI 10.1056/NEJMOA031314]; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; POLLARE T, 1991, ARTERIOSCLER THROMB, V11, P1192, DOI 10.1161/01.ATV.11.5.1192; REES D, 1989, MAGNET RESON MED, V9, P39, DOI 10.1002/mrm.1910090107; REYNOLDS HY, 1976, JAMA-J AM MED ASSOC, V236, P2190, DOI 10.1001/jama.236.19.2190; Rietschel E, 2008, INT J REHABIL RES, V31, P253, DOI 10.1097/MRR.0b013e3282fb783d; Righi V, 2010, INT J MOL MED, V26, P175, DOI 10.3892/ijmm_00000450; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rumbaugh KP, 2011, CURR OPIN MICROBIOL; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; SAKO EY, 1988, J BIOL CHEM, V263, P10600; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Savage David B., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008793; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Scott-Thomas A, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046002; Scott-Thomas AJ, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-56; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Tzika AA, 2008, INT J MOL MED, V21, P825; van Heeckeren AM, 2000, AM J RESP CRIT CARE, V161, P271, DOI 10.1164/ajrccm.161.1.9903019; VANARK G, 1977, BIOCHIM BIOPHYS ACTA, V459, P119, DOI 10.1016/0005-2728(77)90014-7; Vermathen P, 2004, MAGNET RESON MED, V51, P253, DOI 10.1002/mrm.10721; Yasuhara S, 2000, AM J PHYSIOL-ENDOC M, V279, pE1114, DOI 10.1152/ajpendo.2000.279.5.E1114; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	93	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74528	10.1371/journal.pone.0074528	http://dx.doi.org/10.1371/journal.pone.0074528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098655	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500026
J	Huang, CC; Tu, SH; Lien, HH; Jeng, JY; Huang, CS; Huang, CJ; Lai, LC; Chuang, EY				Huang, Chi-Cheng; Tu, Shih-Hsin; Lien, Heng-Hui; Jeng, Jaan-Yeh; Huang, Ching-Shui; Huang, Chi-Jung; Lai, Liang-Chuan; Chuang, Eric Y.			Concurrent Gene Signatures for Han Chinese Breast Cancers	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER ALTERATIONS; CIRCULAR BINARY SEGMENTATION; ARRAY-CGH; EXPRESSION PATTERNS; MOLECULAR PORTRAITS; WIDE ANALYSIS; SUBTYPES; GROWTH; TRANSCRIPTION	The interplay between copy number variation (CNV) and differential gene expression may be able to shed light on molecular process underlying breast cancer and lead to the discovery of cancer-related genes. In the current study, genes concurrently identified in array comparative genomic hybridization (CGH) and gene expression microarrays were used to derive gene signatures for Han Chinese breast cancers. We performed 23 array CGHs and 81 gene expression microarrays in breast cancer samples from Taiwanese women. Genes with coherent patterns of both CNV and differential gene expression were identified from the 21 samples assayed using both platforms. We used these genes to derive signatures associated with clinical ER and HER2 status and disease-free survival. Distributions of signature genes were strongly associated with chromosomal location: chromosome 16 for ER and 17 for HER2. A breast cancer risk predictive model was built based on the first supervised principal component from 16 genes (RCAN3, MCOLN2, DENND2D, RWDD3, ZMYM6, CAPZA1, GPR18, WARS2, TRIM45, SCRN1, CSNK1E, HBXIP, CSDE1, MRPL20, IKZF1, and COL20A1), and distinct survival patterns were observed between the high- and low-risk groups from the combined dataset of 408 microarrays. The risk score was significantly higher in breast cancer patients with recurrence, metastasis, or mortality than in relapse-free individuals (0.241 versus 0, P<0.001). The concurrent gene risk predictive model remained discriminative across distinct clinical ER and HER2 statuses in subgroup analysis. Prognostic comparisons with published gene expression signatures showed a better discerning ability of concurrent genes, many of which were rarely identifiable if expression data were pre-selected by phenotype correlations or variability of individual genes. We conclude that parallel analysis of CGH and microarray data, in conjunction with known gene expression patterns, can be used to identify biomarkers with prognostic values in breast cancer.	[Huang, Chi-Cheng; Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Huang, Chi-Cheng; Jeng, Jaan-Yeh] Cathay Gen Hosp SiJhih, Taipei, Taiwan; [Huang, Chi-Cheng; Lien, Heng-Hui; Jeng, Jaan-Yeh; Huang, Chi-Jung] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Huang, Chi-Cheng; Tu, Shih-Hsin; Huang, Ching-Shui] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Tu, Shih-Hsin; Lien, Heng-Hui; Huang, Ching-Shui] Cathay Gen Hosp, Dept Surg, Taipei, Taiwan; [Huang, Chi-Jung] Cathay Med Res Inst, New Taipei City, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan	National Taiwan University; Cathay General Hospital; Fu Jen Catholic University; Taipei Medical University; Cathay General Hospital; Cathay General Hospital; National Taiwan University	Chuang, EY (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	chuangey@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338; Tu, Shih-Hsin/0000-0002-4106-8146	Cathay Medical Research Institute [CGH-P-101057]; National Science Council [100-2314-B-281-005-MY2]	Cathay Medical Research Institute; National Science Council(Ministry of Science and Technology, Taiwan)	The work was supported in part by Cathay Medical Research Institute grant CGH-P-101057 and National Science Council grant 100-2314-B-281-005-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Ciucci A, 2006, MOL PHARMACOL, V70, P1812, DOI 10.1124/mol.106.025759; Cui WJ, 2012, FEBS LETT, V586, P766, DOI 10.1016/j.febslet.2012.01.039; Elston C W, 2002, Histopathology, V41, P154; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fazeny-Dorner B, 2003, CANCER GENET CYTOGEN, V146, P161, DOI 10.1016/S0165-4608(03)00144-4; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang CC, IJDMB IN PRESS; Huang CC, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S10; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Hyman E, 2002, CANCER RES, V62, P6240; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamalakaran S, 2005, J BIOL CHEM, V280, P21491, DOI 10.1074/jbc.M409176200; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Karn T, 2010, BREAST CANCER RES TR, V120, P567, DOI 10.1007/s10549-009-0416-z; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Ling B, 2013, LUNG CANCER, V79, P104, DOI 10.1016/j.lungcan.2012.10.012; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Miyoshi N, 2010, J SURG ONCOL, V101, P156, DOI 10.1002/jso.21459; Nessling M, 2005, CANCER RES, V65, P439; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oostlander AE, 2004, CLIN GENET, V66, P488, DOI 10.1111/j.1399-0004.2004.00322.x; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reis JS, 2005, PATHOL RES PRACT, V201, P713, DOI 10.1016/j.prp.2005.05.013; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; Simon R, 2007, CANCER INFORM, V3, P11; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Beers EH, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1510; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang XS, 2008, CANCER EPIDEM BIOMAR, V17, P2101, DOI 10.1158/1055-9965.EPI-08-0134; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Zudaire I, 2002, HISTOPATHOLOGY, V40, P547, DOI 10.1046/j.1365-2559.2002.01413.x	55	47	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76421	10.1371/journal.pone.0076421	http://dx.doi.org/10.1371/journal.pone.0076421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098497	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600049
J	Krais, JJ; De Crescenzo, O; Harrison, RG				Krais, John J.; De Crescenzo, Olivier; Harrison, Roger G.			Purine Nucleoside Phosphorylase Targeted by Annexin V to Breast Cancer Vasculature for Enzyme Prodrug Therapy	PLOS ONE			English	Article							FLUDARABINE PHOSPHATE; ANIONIC PHOSPHOLIPIDS; TUMOR-CELLS; IN-VIVO; GENE-THERAPY; GROWTH; PHOSPHATIDYLSERINE; MALIGNANCIES; SUPPRESSES; METABOLISM	Background and Purpose: The targeting of therapeutics is a promising approach for the development of new cancer treatments that seek to reduce the devastating side effects caused by the systemic administration of current drugs. This study evaluates a fusion protein developed as an enzyme prodrug therapy targeted to the tumor vasculature. Cytotoxicity would be localized to the site of the tumor using a protein fusion of purine nucleoside phosphorylase (PNP) and annexin V. Annexin V acts as the tumor-targeting component of the fusion protein as it has been shown to bind to phosphatidylserine expressed externally on cancer cells and the endothelial cells of the tumor vasculature, but not normal vascular endothelial cells. The enzymatic component of the fusion, PNP, converts the FDA-approved cancer therapeutic, fludarabine, into a more cytotoxic form. The purpose of this study is to determine if this system has a good potential as a targeted therapy for breast cancer. Methods: A fusion of E. coli purine nucleoside phosphorylase and human annexin V was produced in E. coli and purified. Using human breast cancer cell lines MCF-7 and MDA-MB-231 and non-confluent human endothelial cells grown in vitro, the binding strength of the fusion protein and the cytotoxicity of the enzyme prodrug system were determined. Endothelial cells that are not confluent expose phosphatidylserine and therefore mimic the tumor vasculature. Results: The purified recombinant fusion protein had good enzymatic activity and strong binding to the three cell lines. There was significant cell killing (p < 0.001) by the enzyme prodrug treatment for all three cell lines, with greater than 80% cytotoxicity obtained after 6 days of treatment. Conclusion: These results suggest that this treatment could be useful as a targeted therapy for breast cancer.	[Krais, John J.; De Crescenzo, Olivier; Harrison, Roger G.] Univ Oklahoma, Ctr Bioengn, Norman, OK 73019 USA; [Krais, John J.; De Crescenzo, Olivier; Harrison, Roger G.] Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA; [Harrison, Roger G.] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center	Harrison, RG (corresponding author), Univ Oklahoma, Ctr Bioengn, Norman, OK 73019 USA.	rharrison@ou.edu		Krais, John/0000-0002-3916-3435	Oklahoma Center for the Advancement of Science and Technology Health Research Program [HR11-210]; School of Chemical, Biological and Materials Engineering at the University of Oklahoma	Oklahoma Center for the Advancement of Science and Technology Health Research Program; School of Chemical, Biological and Materials Engineering at the University of Oklahoma	This study was supported by a grant from the Oklahoma Center for the Advancement of Science and Technology Health Research Program (grant number HR11-210; www.ok.gov/ocast) and by funding from the School of Chemical, Biological and Materials Engineering at the University of Oklahoma (www.cbme.ou.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar S, 2009, MOL CANCER THER, V8, P185, DOI 10.1158/1535-7163.MCT-08-0652; Boogaerts MA, 2004, HEMATOL J, V5, pS31, DOI 10.1038/sj.thj.6200389; CASPER ES, 1985, CANCER CHEMOTH PHARM, V15, P233; Chan N, 2011, BLOOD BRAIN BARRIER, V686; DANHAUSER L, 1986, CANCER CHEMOTH PHARM, V18, P145; Ding XY, 2008, EXPERT REV OPHTHALMO, V3, P97, DOI 10.1586/17469899.3.1.97; HERSHFIELD MS, 1991, P NATL ACAD SCI USA, V88, P7185, DOI 10.1073/pnas.88.16.7185; Hong JS, 2004, CANCER RES, V64, P6610, DOI 10.1158/0008-5472.CAN-04-0012; Kikuchi E, 2007, CANCER GENE THER, V14, P279, DOI 10.1038/sj.cgt.7701013; Koellner G, 2002, J MOL BIOL, V315, P351, DOI 10.1006/jmbi.2001.5211; Kremmidiotis G, 2010, MOL CANCER THER, V9, P1562, DOI 10.1158/1535-7163.MCT-09-0815; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2001, PROTEIN EXPRES PURIF, V22, P180, DOI 10.1006/prep.2001.1437; LEVELT CN, 1994, CYTOMETRY, V15, P84, DOI 10.1002/cyto.990150114; Mao C, 1997, STRUCTURE, V5, P1373, DOI 10.1016/S0969-2126(97)00287-6; Martiniello-Wilks R, 2004, J GENE MED, V6, P1343, DOI 10.1002/jgm.629; Mikleusevic G, 2011, BIOCHIMIE, V93, P1610, DOI 10.1016/j.biochi.2011.05.030; MITTELMAN A, 1988, CANCER CHEMOTH PHARM, V22, P63; Modrak-Wojcik A, 2006, PROTEIN SCI, V15, P1794, DOI 10.1110/ps.062183206; Mohr L, 2000, HEPATOLOGY, V31, P606, DOI 10.1002/hep.510310310; MONTGOMERY JA, 1969, J MED CHEM, V12, P498, DOI 10.1021/jm00303a605; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Parker WB, 1998, BIOCHEM PHARMACOL, V55, P1673, DOI 10.1016/S0006-2952(98)00034-3; Parker WB, 1997, HUM GENE THER, V8, P1637, DOI 10.1089/hum.1997.8.14-1637; Pierige F, 2010, INT J ONCOL, V37, P133, DOI 10.3892/ijo_00000661; Ran S, 2005, CLIN CANCER RES, V11, P1551, DOI 10.1158/1078-0432.CCR-04-1645; Ran S, 2002, CANCER RES, V62, P6132; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; Sigma, 1994, ENZ ASS NUCL PHOSPH; SUGIMURA M, 1994, BLOOD COAGUL FIBRIN, V5, P365; UTSUGI T, 1991, CANCER RES, V51, P3062; Van Den Neste E, 2005, INT J ONCOL, V27, P1113; Van Rite BD, 2011, CANCER LETT, V307, P53, DOI 10.1016/j.canlet.2011.03.016; Van Rite BD, 2011, CANCER LETT, V301, P177, DOI 10.1016/j.canlet.2010.11.013; VONHOFF DD, 1990, SEMIN ONCOL, V17, P33; Xie X, 2011, J GENE MED; Zang XP, 2006, ANTICANCER RES, V26, P1745	37	14	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76403	10.1371/journal.pone.0076403	http://dx.doi.org/10.1371/journal.pone.0076403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098491	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600043
J	Li, L; Sun, GQ; Liang, SJ; Li, JJ; Li, TY; Wang, Z; Liu, W; Yang, SM; Liu, YJ; Wang, XL; Li, JY				Li, Lin; Sun, Guoqing; Liang, Shujia; Li, Jianjian; Li, Tianyi; Wang, Zhe; Liu, Wei; Yang, Shaomin; Liu, Yongjian; Wang, Xiaolin; Li, Jingyun			Different Distribution of HIV-1 Subtype and Drug Resistance Were Found among Treatment Naive Individuals in Henan, Guangxi, and Yunnan Province of China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; GENETIC DIVERSITY; BLOOD-DONORS; MUTATIONS; TYPE-1; SEX; MEN; PREVALENCE; MANAGEMENT	Yunnan, Guangxi and Henan are the provinces with the most severe HIV epidemic in China, which were also among the first group of areas providing free ART in 2004. However, little comprehensive data are available on prevalence of HIV subtype and baseline drug resistance in drug-naive populations. In this study, 1746 treatment-naive HIV-positive individuals were randomly selected from new-reported cases in Henan, Guangxi and Yunnan. Among of them, subtypes and drug resistance of 1159 strains were determined by amplifying and sequencing full-length pol genes. Significantly different distributions of HIV subtypes prevalent in three provinces were identified (P<0.01). CRF08_BC was found dominant in Yunnan (59.8%), while CRF01_AE was dominant in Guangxi (77.3%) and subtype B was dominant in Henan province (93.9%). The total prevalence of drug resistance was 7.1%. The highest prevalence of HIV drug resistance was found in Henan (12.2%), followed by Yunnan (5.6%) and Guangxi (3.3%). The results of this study suggest that genetic drug-resistance should be tested before initiation of ART in China, especially in Henan province. Furthermore, the prevalence of HIV drug resistant strains should be considered separately in different areas in China before the change of different free ART regimens.	[Li, Lin; Li, Tianyi; Liu, Yongjian; Wang, Xiaolin; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China; [Sun, Guoqing; Wang, Zhe] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Liang, Shujia; Liu, Wei] Guangxi Ctr Dis Prevent & Control, Nanning, Peoples R China; [Li, Jianjian; Yang, Shaomin] Yunnan Prov Hosp Infect Dis, AIDS Care Ctr YNACC, Kunming, Yunnan, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China.	lijy@nic.bmi.ac.cn	Liu, Yong/GWQ-6163-2022		National Key S&T Special Projects on Major Infectious Diseases [2012ZX10001-002]; National Natural Science Foundation of China [81072348, 81273137]	National Key S&T Special Projects on Major Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key S&T Special Projects on Major Infectious Diseases (Grant No. 2012ZX10001-002) and the National Natural Science Foundation of China (No. 81072348, 81273137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Chen M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-382; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Li Han-ping, 2011, Zhonghua Yi Xue Za Zhi, V91, P1443; Li J, 2009, CHINESE MED J-PEKING, V122, P1081, DOI 10.3760/cma.j.issn.0366-6999.2009.09.013; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046777; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li L, 2010, AIDS RES HUM RETROV, V26, P699, DOI 10.1089/aid.2010.0026; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Ma LY, 2010, AIDS RES HUM RETROV, V26, P1007, DOI 10.1089/aid.2009.0252; Paredes R, 2010, ANTIVIR RES, V85, P245, DOI 10.1016/j.antiviral.2009.09.015; Pingen M, 2012, ANTIVIR THER, V17, P1621, DOI 10.3851/IMP2267; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; SHAO Y, 2004, REPORT 2 NATL HIV MO; Smith DM, 2005, AIDS, V19, P1251, DOI 10.1097/01.aids.0000180095.12276.ac; State Council AIDS Working Committee Office and Un Theme Group on HIV/AIDS in China, 2008, JOINT ASS HIV AIDS P; Su QJ, 2012, AIDS RES HUM RETROV, V28, P725, DOI [10.1089/AID.2011.0246, 10.1089/aid.2011.0246]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsibris AMN, 2010, J VIROL, V84, P5458, DOI 10.1128/JVI.02524-09; Turner D, 2006, AIDS REV, V8, P17; VERCAUTEREN JAM, 2006, 15 INT HIV DRUG RES, pS111; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; Wainberg Mark A, 2012, Mol Biol Int, V2012, P256982, DOI 10.1155/2012/256982; Wainberg MA, 2010, VIRUSES-BASEL, V2, P2493, DOI 10.3390/v2112493; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; Wang X, 2012, AIDS RES HUM RETROV, V28, P1637, DOI [10.1089/aid.2012.0164, 10.1089/AID.2012.0164]; Yao X, 2012, JAIDS-J ACQ IMM DEF, V60, P328, DOI 10.1097/QAI.0b013e31824f19f5; YONG W, 2013, S CHINA J PREV MED, V39, P6; Yuan Yuan, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P619; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]	36	30	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75777	10.1371/journal.pone.0075777	http://dx.doi.org/10.1371/journal.pone.0075777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098398	Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600023
J	Alves, CRR; Merege, CAA; Benatti, FB; Brucki, S; Pereira, RMR; Pinto, ALD; Lima, FR; Roschel, H; Gualano, B				Rodrigues Alves, Christiano Robles; Abujabra Merege Filho, Carlos Alberto; Benatti, Fabiana Braga; Brucki, Sonia; Pereira, Rosa Maria R.; de Sa Pinto, Ana Lucia; Lima, Fernanda Rodrigues; Roschel, Hamilton; Gualano, Bruno			Creatine Supplementation Associated or Not with Strength Training upon Emotional and Cognitive Measures in Older Women: A Randomized Double-Blind Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; PHYSICAL-ACTIVITY; ORAL SUPPLEMENTATION; HUMAN BRAIN; EXERCISE; PERFORMANCE; MONOHYDRATE; DEPRESSION; STRESS; MOOD	Purpose: To assess the effects of creatine supplementation, associated or not with strength training, upon emotional and cognitive measures in older woman. Methods: This is a 24-week, parallel-group, double-blind, randomized, placebo-controlled trial. The individuals were randomly allocated into one of the following groups (n=14 each): 1) placebo, 2) creatine supplementation, 3) placebo associated with strength training or 4) creatine supplementation associated with strength training. According to their allocation, the participants were given creatine (4 x 5 g/d for 5 days followed by 5 g/d) or placebo (dextrose at the same dosage) and were strength trained or not. Cognitive function, assessed by a comprehensive battery of tests involving memory, selective attention, and inhibitory control, and emotional measures, assessed by the Geriatric Depression Scale, were evaluated at baseline, after 12 and 24 weeks of the intervention. Muscle strength and food intake were evaluated at baseline and after 24 weeks. Results: After the 24-week intervention, both training groups (ingesting creatine supplementation and placebo) had significant reductions on the Geriatric Depression Scale scores when compared with the non-trained placebo group (p = 0.001 and p = 0.01, respectively) and the non-trained creatine group (p < 0.001 for both comparison). However, no significant differences were observed between the non-trained placebo and creatine (p = 0.60) groups, or between the trained placebo and creatine groups (p = 0.83). Both trained groups, irrespective of creatine supplementation, had better muscle strength performance than the non-trained groups. Neither strength training nor creatine supplementation altered any parameter of cognitive performance. Food intake remained unchanged. Conclusion: Creatine supplementation did not promote any significant change in cognitive function and emotional parameters in apparently healthy older individuals. In addition, strength training per se improved emotional state and muscle strength, but not cognition, with no additive effects of creatine supplementation.	[Rodrigues Alves, Christiano Robles; Roschel, Hamilton; Gualano, Bruno] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Abujabra Merege Filho, Carlos Alberto; Benatti, Fabiana Braga; Brucki, Sonia; Pereira, Rosa Maria R.; de Sa Pinto, Ana Lucia; Lima, Fernanda Rodrigues; Roschel, Hamilton; Gualano, Bruno] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Gualano, B (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	gualano@usp.br	Gualano, Bruno/C-7190-2012; Alves, Christiano RR/C-5912-2013; Pereira, Rosa M R/C-5192-2012; Gualano, Bruno/ABA-9571-2020; Brucki, Sonia/L-4201-2019; Brucki, Sonia MD/B-5736-2014; Roschel, Hamilton/D-4353-2012; Benatti, Fabiana/H-7167-2016	Gualano, Bruno/0000-0001-7100-8681; Alves, Christiano RR/0000-0002-2646-9689; Pereira, Rosa M R/0000-0002-3723-5028; Gualano, Bruno/0000-0001-7100-8681; Brucki, Sonia/0000-0002-8303-6732; Brucki, Sonia MD/0000-0002-8303-6732; Roschel, Hamilton/0000-0002-9513-6132; Benatti, Fabiana/0000-0002-8320-7044	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN H, 1988, J NEURAL TRANSM, V74, P55, DOI 10.1007/BF01243575; ALMEIDA OP, 2003, ARQ NEURO-PSIQUIAT, V57, P421; Amital D, 2006, J CLIN PSYCHIAT, V67, P836, DOI 10.4088/JCP.v67n0521c; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; BENTON D, 2010, BJ NUTR, V105, P1; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Burroughs S., 2007, CURRENT ANAESTHESIA, V18, P4, DOI [10.1016/j.cacc.2007.01.007, DOI 10.1016/J.CACC.2007.01.007]; Cassilhas RC, 2007, MED SCI SPORT EXER, V39, P1401, DOI 10.1249/mss.0b013e318060111f; Cassilhas RC, 2010, PERCEPT MOTOR SKILL, V110, P265, DOI 10.2466/PMS.110.1.265-276; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; CRONHOLM B, 1956, Nord Med, V56, P1612; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Dechent P, 1999, AM J PHYSIOL-REG I, V277, pR698, DOI 10.1152/ajpregu.1999.277.3.R698; Dechent P, 1999, BIOL PSYCHIAT, V46, P406, DOI 10.1016/S0006-3223(98)00346-1; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gabbay V, 2007, AM J PSYCHIAT, V164, P1881, DOI 10.1176/appi.ajp.2007.06122032; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Iosifescu DV, 2008, BIOL PSYCHIAT, V63, P1127, DOI 10.1016/j.biopsych.2007.11.020; Kaldis P, 1996, DEV NEUROSCI-BASEL, V18, P542, DOI 10.1159/000111452; Kalia M, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2005.01.009; KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Lyoo IK, 2003, PSYCHIAT RES-NEUROIM, V123, P87, DOI 10.1016/S0925-4927(03)00046-5; Manji HK, 2000, MOL PSYCHIATR, V5, P578, DOI 10.1038/sj.mp.4000811; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; McMorris T, 2007, PHYSIOL BEHAV, V90, P21, DOI 10.1016/j.physbeh.2006.08.024; McMorris T, 2007, AGING NEUROPSYCHOL C, V14, P517, DOI 10.1080/13825580600788100; Moore CM, 1997, AM J PSYCHIAT, V154, P116; Moretti A, 2003, MOL PSYCHIATR, V8, P773, DOI 10.1038/sj.mp.4001353; Nitrini R, 2004, J INT NEUROPSYCH SOC, V10, P634, DOI 10.1017/S1355617704104062; Parkin AJ, 1999, NEUROPSYCHOLOGY, V13, P539, DOI 10.1037/0894-4105.13.4.539; Perrig-Chiello P, 1998, AGE AGEING, V27, P469, DOI 10.1093/ageing/27.4.469; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Rawson ES, 2011, AMINO ACIDS, V40, P1349, DOI 10.1007/s00726-011-0855-9; Roitman S, 2007, BIPOLAR DISORD, V9, P754, DOI 10.1111/j.1399-5618.2007.00532.x; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; SPIRDUSO WW, 1975, J GERONTOL, V30, P435, DOI 10.1093/geronj/30.4.435; Spreen O, 1998, COMPENDIUM NEUROPSYC; Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5; van Gool CH, 2007, AM J PUBLIC HEALTH, V97, P2121, DOI [10.2105/AJPH.2004.053199, 10.2105/AJPH.2004.053199e]; van Gool CH, 2003, AGE AGEING, V32, P81, DOI 10.1093/ageing/32.1.81; Watanabe A, 2002, NEUROSCI RES, V42, P279, DOI 10.1016/S0168-0102(02)00007-X; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	51	36	38	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76301	10.1371/journal.pone.0076301	http://dx.doi.org/10.1371/journal.pone.0076301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098469	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600037
J	Gomes, T; Vinhas, SA; Reis-Santos, B; Palaci, M; Peres, RL; Aguiar, PP; Ribeiro, FKC; Marques, HS; Dettoni, VD; Johnson, JL; Riley, LW; Maciel, EL				Gomes, Teresa; Vinhas, Solange Alves; Reis-Santos, Barbara; Palaci, Moises; Peres, Renata Lyrio; Aguiar, Paola P.; Correa Ribeiro, Fabiola Karla; Marques, Hebert Silva; Dettoni, Valderio do Valle; Johnson, John L.; Riley, Lee W.; Maciel, Ethel Leonor			Extrapulmonary Tuberculosis: Mycobacterium tuberculosis Strains and Host Risk Factors in a Large Urban Setting in Brazil	PLOS ONE			English	Article							IDENTIFICATION; EPIDEMIOLOGY; PULMONARY; LINEAGE	Background: Factors related to the development of extrapulmonary forms of tuberculosis (EPTB) are still poorly understood, particularly in high-endemic countries like Brazil. The objective of the paper is to determine host and Mycobacterium tuberculosis (MTB) strain-related factors associated with the development of EPTB in Espirito Santo state, Brazil. Methods and Findings: We conducted a retrospective laboratory-based surveillance study of new tuberculosis (TB) cases diagnosed in Espirito Santo state, Brazil between 1998 and 2007. We genotyped 612 isolates of MTB from 606 TB patients using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) typing and compared sociodemographic and clinical characteristics of patients with pulmonary TB (PTB) and EPTB. Among 606 patients, 464 (77%) had PTB, 79 (13%) had EPTB, 51 (8%) had both, and 12 (2%) had miliary TB. The IS6110 RFLP analysis demonstrated that 250 (41%) isolates belonged to clustered RFLP patterns, 27 (11%) of which were from EPTB. We identified 73 clusters including 35 (48%) composed of 2 isolates each. By spoligotyping, 506 (83%) MTB isolates fell into known patterns and 106 (17%) fell into patterns with no family assignment; 297 (48%) isolates belonged to the Latin-American Mediterranean family. Higher school level (4-7 years OR: 0.16 95% CI 0.34-0.73 and > 8 years of education, OR 0.06 95% CI 0.009-0.50) white ethnicity (OR: 2.54 95% CI 1.03-6.25) and HIV infection (OR: 16.83 95% CI 5.23-54.18) were associated with EPTB. No specific strain lineage or percentage of clustering was associated with EPTB. Conclusions: These results demonstrate that risk factors for EPTB are related more to host than to MTB strain lineage characteristics.	[Gomes, Teresa; Vinhas, Solange Alves; Reis-Santos, Barbara; Palaci, Moises; Peres, Renata Lyrio; Aguiar, Paola P.; Correa Ribeiro, Fabiola Karla; Marques, Hebert Silva; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Grad Program Infect Dis, Vitoria, Brazil; [Dettoni, Valderio do Valle] Univ Fed Espirito Santo, TB Control Program, Vitoria, Brazil; [Johnson, John L.] Case Western Reserve Univ, Dept Med, Div Infect Dis, TB Res Unit, Cleveland, OH 44106 USA; [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Maciel, Ethel Leonor] Univ Fed Espirito Santo, Grad Program Publ Hlth, Vitoria, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Case Western Reserve University; University of California System; University of California Berkeley; Universidade Federal do Espirito Santo	Maciel, EL (corresponding author), Univ Fed Espirito Santo, Grad Program Infect Dis, Vitoria, Brazil.	ethel.maciel@gmail.com	Maciel, Ethel Leonor LN/G-1027-2012; Tuberculose, Inct/K-2302-2013; Reis-Santos, Barbara/A-3149-2014	Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos, Barbara/0000-0001-6952-0352	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Fundacao de Amparo a Pesquisa do Espirito Santo (Fapes); Tuberculosis Research Unit at Case Western Reserve University; United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health and Human Services [NO1-AI95383, HHSN266200700022C/NO1-AI-70022, ICOHRTA 5 U2R TW006883-02]; FOGARTY INTERNATIONAL CENTER [U2RTW006883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Espirito Santo (Fapes); Tuberculosis Research Unit at Case Western Reserve University; United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Human Genome Research Institute (NHGRI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil and Fundacao de Amparo a Pesquisa do Espirito Santo (Fapes). The laboratory work for this study was supported, in part, by the Tuberculosis Research Unit at Case Western Reserve University, established with funds from the United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health and Human Services, under contract NO1-AI95383 and HHSN266200700022C/NO1-AI-70022 and ICOHRTA 5 U2R TW006883-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti A, 2010, AM J EPIDEMIOL, V172, P318, DOI 10.1093/aje/kwq124; Borgdorff MW, 2011, AM J EPIDEMIOL, V174, P243, DOI 10.1093/aje/kwr061; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CDC, 2011, REP TUB US; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; da Roza DL, 2012, REV SOC BRAS MED TRO, V45, P607, DOI 10.1590/S0037-86822012000500013; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; *EP MDSSDVESDDV, 2008, MAN NAC VIG LAB TUB; Fiske CT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-16; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Garcia de Viedma D, 2005, J INFECT DIS, V192, P2059, DOI [10.1086/498245, DOI 10.1086/498245.PUBMED:16288368]; Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P1126, DOI 10.1016/j.ympev.2010.05.005; GOMES T, 2013, THESIS U FEDERAL ESP; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kingkaew N, 2009, INT J INFECT DIS, V13, P722, DOI 10.1016/j.ijid.2008.11.013; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Maciel E, 2012, PROMOCAO SAUDE DIVER; Mazza-Stalder J, 2012, REV MAL RESPIR, V29, P566, DOI 10.1016/j.rmr.2011.05.021; *MIN PLAN, 2012, CONT POP; *MIN SAUD, 2011, MAN REC CONTR TUB BR, P32; *MIN SAUD, 2012, B EP ESP TUB, P43; *MIN SAUD, 2012, SER HIST TAX MORT TU; Nicol MP, 2005, J CLIN MICROBIOL, V43, P5779, DOI 10.1128/JCM.43.11.5779-5781.2005; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Razanamparany VR, 2002, J CLIN MICROBIOL, V40, P3964, DOI 10.1128/JCM.40.11.3964-3969.2002; RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347; Sankar MM, 2013, TUBERCULOSIS, V93, P75, DOI 10.1016/j.tube.2012.10.005; Seiscento M, 2009, J BRAS PNEUMOL, V35, P548, DOI 10.1590/S1806-37132009000600008; Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VINHAS SP, 2012, TUBERCULOSI IN PRESS; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; *WHO, 2011, GLOB TB CONTR; *WHO, 2012, TUB COUNTR PROF; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; 2011, SISTEMA NACL VIGILAN, P5	44	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74517	10.1371/journal.pone.0074517	http://dx.doi.org/10.1371/journal.pone.0074517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098337	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500012
J	Gong, XH; Wu, X; Ma, XJ; Wu, DD; Zhang, T; He, L; Qin, SY; Li, XT				Gong, Xiaohui; Wu, Xi; Ma, Xiaojing; Wu, Dandan; Zhang, Ting; He, Li; Qin, Shengying; Li, Xiaotian			Microdeletion and Microduplication Analysis of Chinese Conotruncal Defects Patients with Targeted Array Comparative Genomic Hybridization	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; CHROMOSOME 22Q11.2 DELETION; CLINICAL-FEATURES; GENE DELETIONS; CGH; SINGLE; ACGH; EXPERIENCE; DIAGNOSIS; SPECTRUM	Objective: The current study aimed to develop a reliable targeted array comparative genomic hybridization (aCGH) to detect microdeletions and microduplications in congenital conotruncal defects (CTDs), especially on 22q11.2 region, and for some other chromosomal aberrations, such as 5p15-5p, 7q11.23 and 4p16.3. Methods: Twenty-seven patients with CTDs, including 12 pulmonary atresia (PA), 10 double-outlet right ventricle (DORV), 3 transposition of great arteries (TGA), 1 tetralogy of Fallot (TOF) and one ventricular septal defect (VSD), were enrolled in this study and screened for pathogenic copy number variations (CNVs), using Agilent 8 x 15K targeted aCGH. Real-time quantitative polymerase chain reaction (qPCR) was performed to test the molecular results of targeted aCGH. Results: Four of 27 patients (14.8%) had 22q11.2 CNVs, 1 microdeletion and 3 microduplications. qPCR test confirmed the microdeletion and microduplication detected by the targeted aCGH. Conclusion: Chromosomal abnormalities were a well-known cause of multiple congenital anomalies (MCA). This aCGH using arrays with high-density coverage in the targeted regions can detect genomic imbalances including 22q11.2 and other 10 kinds CNVs effectively and quickly. This approach has the potential to be applied to detect aneuploidy and common microdeletion/microduplication syndromes on a single microarray.	[Gong, Xiaohui; Li, Xiaotian] Shanghai Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China; [Wu, Xi; He, Li; Qin, Shengying] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Ma, Xiaojing] Shanghai Fudan Univ, Pediat Hosp, Shanghai, Peoples R China; [Wu, Dandan] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Zhang, Ting] Capital Inst Pediat, Beijing, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University; Capital Institute of Pediatrics (CIP)	Qin, SY (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	chinsir@sjtu.edu.cn; xiaotianli555@163.com	Li, Xiaotian/ABI-3309-2020	Li, Xiaotian/0000-0002-2051-4581	Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China [201002013]; National Science Fund of China [81270712]; Program of Shanghai Subject Chief Scientist [12XD1401300]; Program of Shanghai Leading Talent; Shanghai Municipal Health Bureau [12GWZX0301]; National Key Basic Research Plan of China (973 Plan) [2010CB529500]; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Key Specialty Project of the Ministry of Health, People's Republic of China; 863 Program [2012AA02A515]; 973 Program [2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Nature Science Foundation of China [81121001, 81273596, J1210047, 30900799, 30972823]; Shanghai Municipal Commission of Science and Technology Program [11DZ1950300, 09DJ1400601]; Public Health Key Disciplines in Shanghai-Health Microbiology [square12GWZX0801square]; Public Science and Technology Research Funds [201210056]; Shanghai Jiaotong University Interdisciplinary Research fund; Shanghai Leading Academic Discipline Project [B205]	Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China; National Science Fund of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Program of Shanghai Leading Talent; Shanghai Municipal Health Bureau; National Key Basic Research Plan of China (973 Plan)(National Basic Research Program of China); Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Key Specialty Project of the Ministry of Health, People's Republic of China; 863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Public Health Key Disciplines in Shanghai-Health Microbiology; Public Science and Technology Research Funds; Shanghai Jiaotong University Interdisciplinary Research fund; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was partly supported by the grants from Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China (201002013), the National Science Fund of China (81270712), Program of Shanghai Subject Chief Scientist (12XD1401300), Program of Shanghai Leading Talent (2012), Shanghai Municipal Health Bureau (12GWZX0301), National Key Basic Research Plan of China (973 Plan) (2010CB529500), the Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, and the Key Specialty Project of the Ministry of Health, People's Republic of China, and 863 Program (2012AA02A515), the 973 Program (2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Nature Science Foundation of China (81121001, 81273596, J1210047, 30900799, 30972823), the Shanghai Municipal Commission of Science and Technology Program (11DZ1950300, 09DJ1400601), the Public Health Key Disciplines in Shanghai-Health Microbiology square 12GWZX0801 square, Public Science and Technology Research Funds (201210056), the Shanghai Jiaotong University Interdisciplinary Research fund, and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales AM, 2010, GENET MED, V12, P135, DOI 10.1097/GIM.0b013e3181cdeb9a; Bittel DC, 2009, CYTOGENET GENOME RES, V124, P113, DOI 10.1159/000207515; Borozdin W, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9396; Brunet A, 2006, AM J MED GENET A, V140A, P2426, DOI 10.1002/ajmg.a.31499; Butler MG, 2008, AM J MED GENET A, V146A, P854, DOI 10.1002/ajmg.a.32249; Chew C, 2007, ULTRASOUND OBST GYN, V29, P619, DOI 10.1002/uog.4023; Derbent M, 2003, AM J MED GENET A, V116A, P129, DOI 10.1002/ajmg.a.10832; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Gagnon A, 2009, J OBSTET GYNAECOL CA, V31, P875, DOI 10.1016/S1701-2163(16)34307-9; Halder A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-101; Harris Susan E, 2011, J Registry Manag, V38, P24; Harvard C, 2005, CLIN GENET, V67, P341, DOI 10.1111/j.1399-0004.2005.00406.x; Helen Dolk ML, 2010, AM J MED GENET A, V158A, P509; Hu YL, 2009, CARDIOL YOUNG, V19, P179, DOI 10.1017/S1047951109003667; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Marino B, 1999, AM J CARDIOL, V84, P360, DOI 10.1016/S0002-9149(99)00297-0; Matsumoto A, 2012, PEDIATR INT, V54, P634, DOI 10.1111/j.1442-200X.2012.03639.x; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; Oster ME, 2013, PEDIATRICS, V131, pE1502, DOI 10.1542/peds.2012-3435; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Scott TE, 2013, J ULTRAS MED, V32, P973, DOI 10.7863/ultra.32.6.973; Shen YP, 2007, CLIN CHEM, V53, P2051, DOI 10.1373/clinchem.2007.090290; Staaf J, 2008, HUM MUTAT, V29, P555, DOI 10.1002/humu.20678; Syrmou A, 2013, PEDIATR RES, V73, P772, DOI 10.1038/pr.2013.41; Tanner K, 2005, PEDIATRICS, V116, pE833, DOI 10.1542/peds.2005-0397; Tayeh MK, 2009, GENET MED, V11, P232, DOI 10.1097/GIM.0b013e318195e191; Vasson A, 2013, EUR J HUM GENET; Vissers LELM, 2005, HUM MOL GENET, V14, pR215, DOI 10.1093/hmg/ddi268; Wang J, 2012, MOL GENET METAB, V106, P221, DOI 10.1016/j.ymgme.2012.03.005; Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721; Wu DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054404; Xu YJ, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-169	33	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76314	10.1371/journal.pone.0076314	http://dx.doi.org/10.1371/journal.pone.0076314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098474	Green Submitted, gold, Green Published			2022-12-27	WOS:000325434500061
J	Kang, K; Zhong, JS; Jiang, L; Liu, G; Gou, CY; Wu, Q; Wang, Y; Luo, J; Gou, DM				Kang, Kang; Zhong, Jiasheng; Jiang, Liang; Liu, Gang; Gou, Christine Yuan; Wu, Qiong; Wang, You; Luo, Jun; Gou, Deming			Identification of microRNA-Like RNAs in the Filamentous Fungus Trichoderma reesei by Solexa Sequencing	PLOS ONE			English	Article							GENE; EXPRESSION; CRE1	microRNAs (miRNAs) are non-coding small RNAs (sRNAs) capable of negatively regulating gene expression. Recently, microRNA-like small RNAs (milRNAs) were discovered in several filamentous fungi but not yet in Trichoderma reesei, an industrial filamentous fungus that can secrete abundant hydrolases. To explore the presence of milRNA in T. reesei and evaluate their expression under induction of cellulose, two T. reesei sRNA libraries of cellulose induction (IN) and non-induction (CON) were generated and sequenced using Solexa sequencing technology. A total of 726 and 631 sRNAs were obtained from the IN and CON samples, respectively. Global expression analysis showed an extensively differential expression of sRNAs in T. reesei under the two conditions. Thirteen predicted milRNAs were identified in T. reesei based on the short hairpin structure analysis. The milRNA profiles obtained in deep sequencing were further validated by RT-qPCR assay. Computational analysis predicted a number of potential targets relating to many processes including regulation of enzyme expression. The presence and differential expression of T. reesei milRNAs imply that milRNA might play a role in T. reesei growth and cellulase induction. This work lays foundation for further functional study of fungal milRNAs and their industrial application.	[Kang, Kang; Jiang, Liang; Liu, Gang; Wang, You; Gou, Deming] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Peoples R China; [Zhong, Jiasheng; Wu, Qiong] Shenzhen Univ, Dept Marine Biol, Shenzhen Key Lab Marine Biotechnol & Ecol, Shenzhen, Peoples R China; [Kang, Kang; Luo, Jun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Gou, Christine Yuan] Northwestern Univ, Evanston, IL USA	Shenzhen University; Shenzhen University; Northwest A&F University - China; Northwestern University	Luo, J (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	luojun1@yahoo.com; dmgou@hotmail.com		zhong, jiasheng/0000-0001-6864-2294	National Basic Research Program of China (973 Program) [2012CB124701]; National Natural Science Foundation of China [81170047, 81370151]; Shenzhen overseas high-level talents innovation program [YFZZ20111009]; Shenzhen Municipal Basic Research Program [JC201006010725A, JCYJ20130329120507746]; Postdoctoral Science Foundation of China [2013M542203]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen overseas high-level talents innovation program; Shenzhen Municipal Basic Research Program; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This study was supported in part by National Basic Research Program of China (973 Program, 2012CB124701); National Natural Science Foundation of China No. 81170047, 81370151 (to D. G.); Shenzhen overseas high-level talents innovation program No. YFZZ20111009 (to D. G.); Shenzhen Municipal Basic Research Program No. JC201006010725A (to D. G.); Shenzhen Municipal Basic Research Program No. JCYJ20130329120507746 (to K. K.); and Postdoctoral Science Foundation of China No. 2013M542203 (to K. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brody HM, 2009, IND BIOTECHNOL, V5, P53, DOI [10.1089/ind.2009.5.53, DOI 10.1089/IND.2009.5.53]; Cziferszky A, 2002, J BIOL CHEM, V277, P14688, DOI 10.1074/jbc.M200744200; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Fulci V, 2007, CURR OPIN MICROBIOL, V10, P199, DOI 10.1016/j.mib.2007.03.016; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Hancock MH, 2012, VIROLOGY, V425, P133, DOI 10.1016/j.virol.2012.01.009; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/j.1574-6968.2011.02441.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Lin WC, 2009, GENOMICS, V93, P487, DOI 10.1016/j.ygeno.2009.01.004; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Portnoy T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-269; Qin LN, 2012, BIORESOURCE TECHNOL, V109, P116, DOI 10.1016/j.biortech.2012.01.013; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang YQ, 2009, COMPUT BIOL CHEM, V33, P391, DOI 10.1016/j.compbiolchem.2009.07.013; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zhou Q, 2012, FUNGAL BIOL-UK, V116, P1156, DOI 10.1016/j.funbio.2012.09.001; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	29	46	49	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76288	10.1371/journal.pone.0076288	http://dx.doi.org/10.1371/journal.pone.0076288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098464	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500059
J	Koffman, J; Gao, W; Goddard, C; Burman, R; Jackson, D; Shaw, P; Barnes, F; Silber, E; Higginson, IJ				Koffman, Jonathan; Gao, Wei; Goddard, Cassie; Burman, Rachel; Jackson, Diana; Shaw, Pauline; Barnes, Fiona; Silber, Eli; Higginson, Irene J.			Progression, Symptoms and Psychosocial Concerns among Those Severely Affected by Multiple Sclerosis: A Mixed-Methods Cross-Sectional Study of Black Caribbean and White British People	PLOS ONE			English	Article							AFRICAN-AMERICANS; PALLIATIVE CARE; VULNERABLE POPULATIONS; DIAGNOSTIC-CRITERIA; ETHNIC-GROUPS; SEVERITY; PREVALENCE; DISABILITY; CANCER; EXPERIENCES	Objective: Multiple sclerosis is now more common among minority ethnic groups in the UK but little is known about their experiences, especially in advanced stages. We examine disease progression, symptoms and psychosocial concerns among Black Caribbean (BC) and White British (WB) people severely affected by MS. Design: Mixed methods study of 43 BC and 43 WB people with MS (PwMS) with an Expanded Disability Status Scale (EDSS) >= 6 involving data from in clinical records, face-to-face structured interviews and a nested-qualitative component. Progression Index (PI) and Multiple Sclerosis Severity Score (MSSS) were calculated. To control for selection bias, propensity scores were derived for each patient and adjusted for in the comparative statistical analysis; qualitative data were analysed using the framework approach. Results: Median EDSS for both groups was (6.5; range: 6.0-9.0). Progression Index (PI) and Multiple Sclerosis Severity Score (MSSS) based on neurological assessment of current EDSS scores identified BC PwMS were more likely to have aggressive disease (PI F = 4.04, p = 0.048, MSSS F = 10.30, p < 0.001). Patients' reports of the time required to reach levels of functional decline equivalent to different EDSS levels varied by group; EDSS 4: BC 2.7 years v/s WB 10.2 years (U = 258.50, p = 0.013), EDSS 6: 6.1 years BC v/s WB 12.7 years (U = 535.500, p = 0.011), EDSS 8: BC 8.7 years v/s WB 10.2 years. Both groups reported high symptom burden. BC PwMS were more cognitively impaired than WB PwMS (F = 9.65, p = 0.003). Thematic analysis of qualitative interviews provides correspondence with quantitative findings; more BC than WB PwMS referred to feelings of extreme frustration and unresolved loss/confusion associated with their rapidly advancing disease. The interviews also reveal the centrality, meanings and impact of common MS-related symptoms. Conclusions: Delays in diagnosis should be avoided and more frequent reviews may be justified by healthcare services. Culturally acceptable interventions to better support people who perceive MS as an assault on identity should be developed to help them achieve normalisation and enhance self-identity.	[Koffman, Jonathan; Gao, Wei; Goddard, Cassie; Burman, Rachel; Jackson, Diana; Higginson, Irene J.] Kings Coll London, Sch Med, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England; [Shaw, Pauline; Barnes, Fiona; Silber, Eli] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust	Koffman, J (corresponding author), Kings Coll London, Sch Med, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England.	jonathan.koffman@kcl.ac.uk	Gao, Wei/G-8653-2011; Harding, Richard/G-9729-2012; Higginson, Irene Julie/C-7309-2012	Gao, Wei/0000-0001-8298-3415; Higginson, Irene Julie/0000-0002-3687-1313; Koffman, Jonathan/0000-0001-8513-5681	MS Society, United Kingdom [922/09]; National Institute for Health Research [NF-SI-0611-10209] Funding Source: researchfish	MS Society, United Kingdom; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by a grant (922/09) from the MS Society, United Kingdom. www.mssociety.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshami E, 1998, NEUROLOGY, V50, pA210; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Buchanan RJ, 2004, MULT SCLER J, V10, P660, DOI 10.1191/1352458504ms1086oa; Buchanan RJ, 2010, ETHNIC DIS, V20, P451; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; Cree B, 2010, NEUROLOGY, V74, P532, DOI 10.1212/WNL.0b013e3181d0374f; DEAN G, 1976, BMJ-BRIT MED J, V1, P861, DOI 10.1136/bmj.1.6014.861; Department of Health, 2008, END LIF CAR STRAT PR; Department of Health, 2012, 4 DEP HLTH; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Edmonds P, 2007, PALLIATIVE MED, V21, P101, DOI 10.1177/0269216307076333; ELIAN M, 1990, J NEUROL NEUROSUR PS, V53, P906, DOI 10.1136/jnnp.53.10.906; Evans N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-141; Vasconcelos CCF, 2010, MULT SCLER J, V16, P597, DOI 10.1177/1352458509360987; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117; GREWAL I, 2006, HLTH SOCIAL RES MULT; Gruenewald DA, 2004, MULT SCLER J, V10, P690, DOI 10.1191/1352458504ms1116rr; Gunaratnam Y., 2003, RES RACEETHNICITY; Hearn J, 1999, QUAL HEALTH CARE, V8, P219, DOI 10.1136/qshc.8.4.219; Higginson IJ, 2013, BMC MED, V11, P2013; Higginson Irene J, 2004, Health Qual Life Outcomes, V2, P68, DOI 10.1186/1477-7525-2-68; Higginson IJ, 2006, J PALLIATIVE CARE, V22, P158, DOI 10.1177/082585970602200306; Higginson IJ, 2009, J PAIN SYMPTOM MANAG, V38, P816, DOI 10.1016/j.jpainsymman.2009.07.002; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Howard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043061; Hubbard G, 2010, HEALTH-LONDON, V14, P131, DOI 10.1177/1363459309353294; International Organization for Migration, 2009, FACTS FIG; Jeannin S, 2007, REV NEUROL-FRANCE, V163, P440, DOI 10.1016/S0035-3787(07)90419-1; Johnson SK, 2007, STRESS HEALTH, V23, P207, DOI 10.1002/smi.1138; Kaufman MD, 2003, AM J PHYS MED REHAB, V82, P582, DOI 10.1097/01.phm.0000078199.99484.E2; Kister I, 2010, NEUROLOGY, V75, P217, DOI 10.1212/WNL.0b013e3181e8e72a; Koffman J, 2008, PALLIATIVE MED, V22, P350, DOI 10.1177/0269216308090168; Koffman J, 2003, J ROY SOC MED, V96, P10, DOI 10.1258/jrsm.96.1.10; Koffman J, 2009, J MED ETHICS, V35, P440, DOI 10.1136/jme.2008.027839; Koffman J, 2008, SOC SCI MED, V67, P780, DOI 10.1016/j.socscimed.2008.05.004; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Loftis JM, 2004, J AFFECT DISORDERS, V82, P175, DOI 10.1016/j.jad.2004.04.002; Macklin R, 1998, KENNEDY INST ETHIC J, V8, P1, DOI 10.1353/ken.1998.0005; Marrie RA, 2006, NEUROLOGY, V66, P1235, DOI 10.1212/01.wnl.0000208505.81912.82; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Moran-Ellis J, 2006, QUAL RES, V6, P45, DOI [10.1177/1468794106058870, DOI 10.1177/1468794106058870]; Moss-Morris R, 2012, J CONSULTING CLIN PS; Nickel PJ, 2006, THEOR MED BIOETH, V27, P245, DOI 10.1007/s11017-006-9000-2; Office for National Statistics, 2004, ETHN ID; Patten SB, 2005, MULT SCLER J, V11, P175, DOI 10.1191/1352458505ms1144oa; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER S, 1982, ACTA NEUROL SCAND, V66, P355; Quest T, 2003, ACAD EMERG MED, V10, P1294, DOI 10.1197/S1069-6563(03)00502-5; Richie J., 1994, ANAL QUALITATIVE DAT; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ross KA, 2010, NEUROLOGY, V75, P2097, DOI 10.1212/WNL.0b013e318200d7b9; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sheikh A, 2004, BMJ-BRIT MED J, V329, P87, DOI 10.1136/bmj.38061.593935.F7; Taylor BV, 2010, MULT SCLER J, V16, P1422, DOI 10.1177/1352458510379614; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75431	10.1371/journal.pone.0075431	http://dx.doi.org/10.1371/journal.pone.0075431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098384	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500032
J	Li, Y; Li, J; Li, Y; Wang, XX; Cao, AC				Li, Yan; Li, Jun; Li, Yuan; Wang, Xia-xia; Cao, Ao-cheng			Antimicrobial Constituents of the Leaves of Mikania micrantha H. B. K.	PLOS ONE			English	Article							OCCURRING TERPENE DERIVATIVES; SESQUITERPENE LACTONES; PHENOLIC CONSTITUENTS; SCANDENOLIDE	Background: To isolate plant-derived compounds with antimicrobial activity from the leaves of Mikania micrantha, to determine the compounds configuration, and to evaluate their antimicrobial activity against eight plant pathogenic fungi (Exserohilum turcicum, Colletotrichum lagenarium, Pseudoperonispora cubensis, Botrytis cirerea, Rhizoctonia solani, Phytophthora parasitica, Fusarium solani, and Pythium aphanidermatum,) and four plant pathogenic bacteria (gram negative bacteria: Ralstonia dolaanacearum, Xanthomonas oryzae pv. Oryzae, Xanthomonas Campestris pv. Vesicatoria, and Xanthomonas campestris pv. Citri), and four bacteria (gram positive bacteria: Staphyloccocus aureus, Bacillus subtilis, Micrococcus luteus, and Bacillus cereus). Methods and Results: Antimicrobial constituents of the leaves of M. micrantha were isolated using bioactivity-guided fractionation. The antifungal activity of the isolated compounds was evaluated by the inhibit hypha growth method and inhibit spore germination method. Characterization of antibacterial activity was carried out using the minimum inhibitory concentrations (MICs) and the minimum bactericidal concentrations (MBCs). MIC and MBC were determined by the broth microdilution method. Six compounds - deoxymikanolide, scandenolide, dihydroscandenolide, mikanolide, dihydromikanolide, and m - methoxy benzoic acid - have been isolated from leaves of Mikania micrantha H. B. K. Deoxymikanolide, scandenolide, and dihydroscandenolide were new compounds. The result of bioassay showed that all of isolated compounds were effective against tested strains and deoxymikanolide showed the strongest activity. Conclusions and Significance: The leaves of M. micrantha may be a promising source in the search for new antimicrobial drugs due to its efficacy and the broadest range. Meanwhile, adverse impact of M. micrantha will be eliminated.	[Li, Yan; Li, Jun; Li, Yuan; Cao, Ao-cheng] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China; [Li, Jun] South China Agr Univ, Coll Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Wang, Xia-xia] Anhui Acad Agr Sci, Inst Anim Sci, Hefei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; South China Agricultural University; Anhui Academy of Agricultural Sciences	Cao, AC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China.	caoac@vip.sina.com			Study of Invasive Plants Comprehensive Prevention [201103027]; Research of Chemistry Prevention and Control Technology [1610142012012]	Study of Invasive Plants Comprehensive Prevention; Research of Chemistry Prevention and Control Technology	Thanks are due to the Study of Invasive Plants Comprehensive Prevention (201103027) and the Research of Chemistry Prevention and Control Technology about Mikania micrantha (1610142012012) for its financial support to the present research. The funders had no role in study design, data collection and analysis, decision to publishi, or preparation of the manuscript.	Ahmed M, 2001, FITOTERAPIA, V72, P919, DOI 10.1016/S0367-326X(01)00318-5; [Anonymous], 1997, M7A4 NCCLS; Ayensu E. S., 1981, MED PLANTS W INDIES; Bakir M, 2004, ACTA CRYSTALLOGR C, V60, pO798, DOI 10.1107/S0108270104017809; Barry AL, 1999, METHODS DETERMINING; BOEKER R, 1987, PLANTA MED, P105, DOI 10.1055/s-2006-962638; BOHLMANN F, 1984, PHYTOCHEMISTRY, V23, P1099, DOI 10.1016/S0031-9422(00)82617-5; BOHLMANN F, 1982, PHYTOCHEMISTRY, V21, P1349, DOI 10.1016/0031-9422(82)80140-4; BOHLMANN F, 1982, PHYTOCHEMISTRY, V21, P173, DOI 10.1016/0031-9422(82)80037-X; CUENCA MD, 1988, J NAT PROD, V51, P625, DOI 10.1021/np50057a040; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Facey PC, 1999, J PHARM PHARMACOL, V51, P1455, DOI 10.1211/0022357991777119; Feng Hui-ling, 2002, Journal of Tropical and Subtropical Botany, V10, P263; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; GUTIERREZ AB, 1985, PHYTOCHEMISTRY, V24, P2967, DOI 10.1016/0031-9422(85)80037-6; HERZ W, 1970, J ORG CHEM, V35, P1453, DOI 10.1021/jo00830a043; HERZ W, 1975, PHYTOCHEMISTRY, V14, P233, DOI 10.1016/0031-9422(75)85045-X; HERZ W, 1981, PHYTOCHEMISTRY, V20, P1740, DOI 10.1016/S0031-9422(00)98568-6; Huang HJ, 2008, BIOCHEM SYST ECOL, V36, P867, DOI 10.1016/j.bse.2008.09.004; Jiang RW, 2001, CHEM PHARM BULL, V49, P1166, DOI 10.1248/cpb.49.1166; Kruszewska D, 2004, J ANTIMICROB CHEMOTH, V54, P648, DOI 10.1093/jac/dkh387; Li Yan, 2013, African Journal of Microbiology Research, V7, P2409; Lowe S, 2001, 100 WORLDS WORST INV; MATHUR SB, 1973, PHYTOCHEMISTRY, V12, P226, DOI 10.1016/S0031-9422(00)84663-4; NICOLLIER G, 1981, PHYTOCHEMISTRY, V20, P2587, DOI 10.1016/0031-9422(81)83102-0; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; PICMAN AK, 1986, BIOCHEM SYST ECOL, V14, P255, DOI 10.1016/0305-1978(86)90101-8; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Valdes DA, 1998, BIOCHEM SYST ECOL, V26, P685, DOI 10.1016/S0305-1978(98)00026-X; Wang RL, 2009, ALLELOPATHY J, V24, P35; Wei XY, 2004, BIOCHEM SYST ECOL, V32, P1091, DOI 10.1016/j.bse.2004.04.013; YSRAEL MC, 1990, PLANTA MED, V56, P268, DOI 10.1055/s-2006-960953; Zhuang ShiHong, 2010, Journal of Zhejiang University (Agriculture and Life Sciences), V36, P293	33	13	14	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76725	10.1371/journal.pone.0076725	http://dx.doi.org/10.1371/journal.pone.0076725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098556	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500084
J	Nusselder, WJ; Slockers, MT; Krol, L; Slockers, CT; Looman, CWN; van Beeck, EF				Nusselder, Wilma J.; Slockers, Marcel T.; Krol, Luuk; Slockers, Colette T.; Looman, Caspar W. N.; van Beeck, Ed F.			Mortality and Life Expectancy in Homeless Men and Women in Rotterdam: 2001-2010	PLOS ONE			English	Article							FOLLOW-UP; PEOPLE; ADULTS; COHORT; DEATH; DISORDERS; SHELTERS; RISK; RESIDENTS; GENDER	Background: Data on mortality among homeless people are limited. Therefore, this study aimed to describe mortality patterns within a cohort of homeless adults in Rotterdam (the Netherlands) and to assess excess mortality as compared to the general population in that city. Methods: Based on 10-year follow-up of homeless adults aged >= 20 years who visited services for homeless people in Rotterdam in 2001, and on vital statistics, we assessed the association of mortality with age, sex and type of service used (e.g. only day care, convalescence care, other) within the homeless cohort, and also compared mortality between the homeless and general population using Poisson regression. Life tables and decomposition methods were used to examine differences in life expectancy. Results: During follow-up, of the 2096 adult homeless 265 died. Among the homeless, at age 30 years no significant sex differences were found in overall mortality rates and life expectancy. Compared with the general Rotterdam population, mortality rates were 3.5 times higher in the homeless cohort. Excess mortality was larger in women (rate ratio [RR] RR 5.56, 95% CI 3.95-7.82) as compared to men (RR 3.31, 95% CI 2.91-3.77), and decreased with age (RR 7.67, 95% CI 6.87-8.56 for the age group 20-44 and RR 1.63, 95% CI 1.41-1.88 for the age group 60+ years). Life expectancy at age 30 years was 11.0 (95% CI 9.1-12.9) and 15.9 (95% CI 10.3-21.5) years lower for homeless men and women compared to men and women in the general population respectively. Conclusion: Homeless adults face excessive losses in life expectancy, with greatest disadvantages among homeless women and the younger age groups.	[Nusselder, Wilma J.; Slockers, Marcel T.; Slockers, Colette T.; Looman, Caspar W. N.; van Beeck, Ed F.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Krol, Luuk] GGD Rotterdam Rijnmond, Municipal Publ Hlth Serv GGD Rotterdam Rijnmond, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Nusselder, WJ (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	w.nusselder@erasmusmc.nl			Municipal Public Health Service (GGD) Rotterdam-Rijnmond	Municipal Public Health Service (GGD) Rotterdam-Rijnmond	This study was supported by a grant from the Municipal Public Health Service (GGD) Rotterdam-Rijnmond. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun G, 1999, FORENSIC SCI INT, V99, P143, DOI 10.1016/S0379-0738(98)00178-9; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Babidge NC, 2001, ACTA PSYCHIAT SCAND, V103, P105, DOI 10.1034/j.1600-0447.2001.00192.x; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; Beijer U, 2007, NORD J PSYCHIAT, V61, P363, DOI 10.1080/08039480701644637; Beijer U, 2009, SCAND J PUBLIC HEALT, V37, P93, DOI 10.1177/1403494808099972; Beijer U, 2011, SCAND J PUBLIC HEALT, V39, P121, DOI 10.1177/1403494810393554; Beijer U, 2010, EUR J PUBLIC HEALTH, V20, P511, DOI 10.1093/eurpub/ckq033; BRESLOW NE, 1983, J AM STAT ASSOC, V78, P1, DOI 10.2307/2287093; CALLAS PW, 1994, OCCUP ENVIRON MED, V51, P649, DOI 10.1136/oem.51.10.649; Callas PW, 1998, AM J IND MED, V33, P33; Cheung AM, 2004, CAN MED ASSOC J, V170, P1243, DOI 10.1503/cmaj.1031167; Chiang CL, 1984, LIFE TABLE ITS APPL; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Finfgeld-Connett Deborah, 2010, Issues Ment Health Nurs, V31, P461, DOI 10.3109/01612840903586404; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; Hwang S, 2001, ACTA PSYCHIAT SCAND, V103, P81, DOI 10.1034/j.1600-0447.2001.103002081.x; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Hwang SW, 1997, ANN INTERN MED, V126, P625, DOI 10.7326/0003-4819-126-8-199704150-00007; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Hwang SW, 1998, ARCH INTERN MED, V158, P1454, DOI 10.1001/archinte.158.13.1454; Hwang SW, 2012, CMAJ, V164, P229; Jansen H, 2002, DAK EN THUISLOZE MON; Kasprow WJ, 2000, J NERV MENT DIS, V188, P141, DOI 10.1097/00005053-200003000-00003; Lewis JH, 2003, J GEN INTERN MED, V18, P921, DOI 10.1046/j.1525-1497.2003.20909.x; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; Nielsen SF, 2011, LANCET, V377, P2205, DOI 10.1016/S0140-6736(11)60747-2; Nordentoft M, 2003, BRIT MED J, V327, P81, DOI 10.1136/bmj.327.7406.81; Nusselder WJ, 2004, DEMOGRAPHY, V41, P315, DOI 10.1353/dem.2004.0017; O'Connell JJ, 2005, J PUBLIC HEALTH MAN, V11, P311; Rostgaard Klaus, 2008, Epidemiol Perspect Innov, V5, P7, DOI 10.1186/1742-5573-5-7; Shaw M, 1999, ENVIRON PLANN A, V31, P2239, DOI 10.1068/a312239; Shaw M, 1998, LANCET, V352, P743, DOI 10.1016/S0140-6736(05)60868-9; van Laere I, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-208	35	54	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e73979	10.1371/journal.pone.0073979	http://dx.doi.org/10.1371/journal.pone.0073979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098329	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500006
J	Walton, E; Geisler, D; Hass, J; Liu, JY; Turner, J; Yendiki, A; Smolka, MN; Ho, BC; Manoach, DS; Gollub, RL; Roessner, V; Calhoun, VD; Ehrlich, S				Walton, Esther; Geisler, Daniel; Hass, Johanna; Liu, Jingyu; Turner, Jessica; Yendiki, Anastasia; Smolka, Michael N.; Ho, Beng-Choon; Manoach, Dara S.; Gollub, Randy L.; Roessner, Veit; Calhoun, Vince D.; Ehrlich, Stefan			The Impact of Genome-Wide Supported Schizophrenia Risk Variants in the Neurogranin Gene on Brain Structure and Function	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; WORKING-MEMORY; ENCODING NEUROGRANIN; FLIP-FLOP; DYSFUNCTION; METAANALYSIS; RELIABILITY; ASSOCIATION; PERFORMANCE	The neural mechanisms underlying genetic risk for schizophrenia, a highly heritable psychiatric condition, are still under investigation. New schizophrenia risk genes discovered through genome-wide association studies (GWAS), such as neurogranin (NRGN), can be used to identify these mechanisms. In this study we examined the association of two common NRGN risk single nucleotide polymorphisms (SNPs) with functional and structural brain-based intermediate phenotypes for schizophrenia. We obtained structural, functional MRI and genotype data of 92 schizophrenia patients and 114 healthy volunteers from the multisite Mind Clinical Imaging Consortium study. Two schizophrenia-associated NRGN SNPs (rs12807809 and rs12541) were tested for association with working memory-elicited dorsolateral prefrontal cortex (DLPFC) activity and surface-wide cortical thickness. NRGN rs12541 risk allele homozygotes (TT) displayed increased working memory-related activity in several brain regions, including the left DLPFC, left insula, left somatosensory cortex and the cingulate cortex, when compared to non-risk allele carriers. NRGN rs12807809 non-risk allele (C) carriers showed reduced cortical gray matter thickness compared to risk allele homozygotes (TT) in an area comprising the right pericalcarine gyrus, the right cuneus, and the right lingual gyrus. Our study highlights the effects of schizophrenia risk variants in the NRGN gene on functional and structural brain-based intermediate phenotypes for schizophrenia. These results support recent GWAS findings and further implicate NRGN in the pathophysiology of schizophrenia by suggesting that genetic NRGN risk variants contribute to subtle changes in neural functioning and anatomy that can be quantified with neuroimaging methods.	[Walton, Esther; Geisler, Daniel; Hass, Johanna; Roessner, Veit; Ehrlich, Stefan] Tech Univ Dresden, Dept Child & Adolescent Psychiat, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Liu, Jingyu; Turner, Jessica; Calhoun, Vince D.] MIND Res Network, Albuquerque, NM USA; [Liu, Jingyu; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Yendiki, Anastasia; Manoach, Dara S.; Gollub, Randy L.; Ehrlich, Stefan] Massachusetts Gen Hosp, MGH MIT HMS Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Dresden, Germany; [Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, Dept Psychol, Dresden, Germany; [Ho, Beng-Choon] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Manoach, Dara S.; Gollub, Randy L.; Ehrlich, Stefan] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Lovelace Respiratory Research Institute; University of New Mexico; Harvard University; Massachusetts General Hospital; Technische Universitat Dresden; Technische Universitat Dresden; University of Iowa; Harvard University; Massachusetts General Hospital	Ehrlich, S (corresponding author), Tech Univ Dresden, Dept Child & Adolescent Psychiat, Univ Hosp Carl Gustav Carus, Dresden, Germany.	transden.lab@uniklinikum-dresden.de	Turner, Jessica A/N-2228-2017; Walton, Esther/GSN-8429-2022; Calhoun, Vince D./ACN-9399-2022; Turner, Jessica A/H-7282-2015; Roessner, Veit/AAQ-8760-2020; Walton, Esther/P-9832-2019; Smolka, Michael/B-4865-2011; Ehrlich, Stefan/ABB-4650-2020; Ho, Beng-Choon/D-6959-2011	Turner, Jessica A/0000-0003-0076-8434; Calhoun, Vince D./0000-0001-9058-0747; Turner, Jessica A/0000-0003-0076-8434; Walton, Esther/0000-0002-0935-2200; Smolka, Michael/0000-0001-5398-5569; Ehrlich, Stefan/0000-0003-2132-4445; Ho, Beng-Choon/0000-0003-3976-1555; Roessner, Veit/0000-0002-1873-7081; Geisler, Daniel/0000-0003-2076-5329; Liu, Jingyu/0000-0002-1724-7523; Yendiki, Anastasia/0000-0003-1386-3828; Gollub, Randy L./0000-0002-9434-4044	National Institutes of Health (NIH/NCRR) [P41RR14075]; Department of Energy [DE-FG02-99ER62764]; Mind Research Network, Morphometry BIRN [1U24, RR021382A]; Function BIRN [U24RR021992]; NIH.NCRR [MO1 RR025758-01]; NIMH [1RC1MH089257, 2 R01MH067720]; NIH/NIBIB [K99/R00]; Deutsche Forschungsgemeinschaft; NARSAD Young Investigator Grant; Friedrich-Ebert Stiftung;  [EB008129]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, UL1RR025758, U24RR021992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB008129, R00EB008129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH089257, R01MH067720] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy(United States Department of Energy (DOE)); Mind Research Network, Morphometry BIRN; Function BIRN; NIH.NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NARSAD Young Investigator Grant(NARSAD); Friedrich-Ebert Stiftung; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (NIH/NCRR P41RR14075), Department of Energy (DE-FG02-99ER62764), Mind Research Network, Morphometry BIRN (1U24, RR021382A), Function BIRN (U24RR021992-01, NIH.NCRR MO1 RR025758-01, NIMH 1RC1MH089257 to VDC), 2 R01MH067720 (DSM), NIH/NIBIB K99/R00 Pathway to Independence award EB008129 (AY), the Deutsche Forschungsgemeinschaft (research fellowship to SE), the NARSAD Young Investigator Grant (to SE) and the Friedrich-Ebert Stiftung (stipend to EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blokland GAM, 2012, TWIN RES HUM GENET, V15, P351, DOI 10.1017/thg.2012.11; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Carter CS, 1997, AM J PSYCHIAT, V154, P1670, DOI 10.1176/ajp.154.12.1670; Clarke GM, 2010, GENET EPIDEMIOL, V34, P266, DOI 10.1002/gepi.20458; Ehrlich S, 2012, SCHIZOPHRENIA BULL, V38, P1050, DOI 10.1093/schbul/sbr018; Ehrlich S, 2010, NEUROIMAGE, V53, P992, DOI 10.1016/j.neuroimage.2009.12.046; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fusar-Poli P, 2010, ARCH GEN PSYCHIAT, V67, P683, DOI 10.1001/archgenpsychiatry.2010.77; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gur RE, 2007, AM J PSYCHIAT, V164, P442, DOI 10.1176/appi.ajp.164.3.442; Hall MH, 2010, HARVARD REV PSYCHIAT, V18, P67, DOI 10.3109/10673220903523532; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Haznedar MM, 2004, SCHIZOPHR RES, V71, P249, DOI 10.1016/j.schres.2004.02.025; Higo N, 2006, BRAIN RES, V1078, P35, DOI 10.1016/j.brainres.2006.01.062; Higo N, 2004, CEREB CORTEX, V14, P1134, DOI 10.1093/cercor/bhh073; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Karlsgodt KH, 2007, SCHIZOPHR RES, V89, P191, DOI 10.1016/j.schres.2006.08.016; Koch K, 2008, NEUROSCIENCE, V153, P54, DOI 10.1016/j.neuroscience.2008.01.063; Kremen WS, 2010, NEUROIMAGE, V49, P1213, DOI 10.1016/j.neuroimage.2009.09.043; Krug A, 2013, SCHIZOPHRENIA BULL, V39, P141, DOI 10.1093/schbul/sbr076; Li T, 2010, BIOL PSYCHIAT, V68, P671, DOI 10.1016/j.biopsych.2010.06.014; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; MacDonald AW, 2009, SCHIZOPHRENIA BULL, V35, P493, DOI 10.1093/schbul/sbp017; Manoach DS, 1999, BIOL PSYCHIAT, V45, P1128, DOI 10.1016/S0006-3223(98)00318-7; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Manoach DS, 2001, AM J PSYCHIAT, V158, P955, DOI 10.1176/appi.ajp.158.6.955; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Ohi K, 2012, AM J MED GENET B, V159B, P405, DOI 10.1002/ajmg.b.32043; Ohi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029780; Pantelis C, 2007, INT REV PSYCHIATR, V19, P373, DOI 10.1080/09540260701512079; Parent A, 1995, HUMAN NEUROANATOMY; Posner MI, 1998, ATTENTIVE BRAIN, P401; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Roiz-Santianez R, 2012, SCHIZOPHR RES, V141, P22, DOI 10.1016/j.schres.2012.07.014; Rose EJ, 2012, TWIN RES HUM GENET, V15, P296, DOI 10.1017/thg.2012.7; Ruano D, 2008, J PSYCHIATR RES, V42, P125, DOI 10.1016/j.jpsychires.2006.10.008; Schmitt JE, 2008, CEREB CORTEX, V18, P1737, DOI 10.1093/cercor/bhm211; Schultz CC, 2010, SCHIZOPHR RES, V123, P137, DOI 10.1016/j.schres.2010.08.033; Schultz CC, 2010, PSYCHIAT RES-NEUROIM, V182, P134, DOI 10.1016/j.pscychresns.2010.01.008; Shen YC, 2012, SCHIZOPHR RES, V137, P7, DOI 10.1016/j.schres.2012.01.011; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; van Veelen NMJ, 2010, SCHIZOPHR RES, V123, P22, DOI 10.1016/j.schres.2010.07.004; Walton E, 2013, SCHIZOPHRENIA BULL, V39, P703, DOI 10.1093/schbul/sbr190; Wang XJ, 1999, J NEUROSCI, V19, P9587; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zaykin DV, 2008, AM J HUM GENET, V82, P794, DOI 10.1016/j.ajhg.2008.02.001; Zecevic N, 1991, CEREB CORTEX, V1, P510, DOI 10.1093/cercor/1.6.510	70	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76815	10.1371/journal.pone.0076815	http://dx.doi.org/10.1371/journal.pone.0076815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098564	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500086
J	Hoshino, T; Suzuki, K; Matsushima, T; Yamakawa, N; Suzuki, T; Mizushima, T				Hoshino, Tatsuya; Suzuki, Koichiro; Matsushima, Takahide; Yamakawa, Naoki; Suzuki, Toshiharu; Mizushima, Tohru			Suppression of Alzheimer's Disease-Related Phenotypes by Geranylgeranylacetone in Mice	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; AMYLOID-BETA CLEARANCE; KAPPA-B ACTIVATION; PHARMACOLOGICAL INDUCTION; PROSTAGLANDIN E-2; MOUSE MODELS; HEAT-SHOCK-PROTEIN-70; NEURODEGENERATION; IMPAIRMENT; EXPRESSION	Amyloid-beta peptide (A beta) plays an important role in the pathogenesis of Alzheimer's disease (AD). A beta is generated by the secretase-mediated proteolysis of beta-amyloid precursor protein (APP), and cleared by enzyme-mediated degradation and phagocytosis. Transforming growth factor (TGF)-beta 1 stimulates this phagocytosis. We recently reported that the APP23 mouse model for AD showed fewer AD-related phenotypes when these animals were crossed with transgenic mice expressing heat shock protein (HSP) 70. We here examined the effect of geranylgeranylacetone, an inducer of HSP70 expression, on the AD-related phenotypes. Repeated oral administration of geranylgeranylacetone to APP23 mice for 9 months not only improved cognitive function but also decreased levels of A beta, A beta plaque deposition and synaptic loss. The treatment also up-regulated the expression of an A beta-degrading enzyme and TGF-beta 1 but did not affect the maturation of APP and secretase activities. These outcomes were similar to those observed in APP23 mice genetically modified to overexpress HSP70. Although the repeated oral administration of geranylgeranylacetone did not increase the level of HSP70 in the brain, a single oral administration of geranylgeranylacetone significantly increased the level of HSP70 when A beta was concomitantly injected directly into the hippocampus. Since geranylgeranylacetone has already been approved for use as an anti-ulcer drug and its safety in humans has been confirmed, we propose that this drug be considered as a candidate drug for the prevention of AD.	[Hoshino, Tatsuya; Suzuki, Koichiro; Yamakawa, Naoki; Mizushima, Tohru] Keio Univ, Fac Pharm, Minato Ku, Tokyo, Japan; [Matsushima, Takahide; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan	Keio University; Hokkaido University	Mizushima, T (corresponding author), Keio Univ, Fac Pharm, Minato Ku, Tokyo, Japan.	mizushima-th@pha.keio.ac.jp	Suzuki, Toshiharu/B-5342-2013		Ministry of Health, Labour, and Welfare of Japan; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [23390017] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare of Japan, as well as the Japan Science and Technology Agency, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2010, BRAIN RES, V1330, P151, DOI 10.1016/j.brainres.2010.02.074; Adachi H, 2003, J NEUROSCI, V23, P2203; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Chan JYH, 2004, CIRCULATION, V110, P3560, DOI 10.1161/01.CIR.0000143082.63063.33; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2007, J BIOL CHEM, V282, P32676, DOI 10.1074/jbc.M703087200; Hoshino T, 2012, J NEUROCHEM, V120, P795, DOI 10.1111/j.1471-4159.2011.07567.x; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Hoshino T, 2010, J BIOL CHEM, V285, P13254, DOI 10.1074/jbc.M110.103051; Hoshino T, 2009, J BIOL CHEM, V284, P18493, DOI 10.1074/jbc.M109.003269; Ikeda M, 2011, LIVER INT, V31, P873, DOI 10.1111/j.1478-3231.2011.02499.x; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kim DH, 2010, PHARMACOL BIOCHEM BE, V97, P239, DOI 10.1016/j.pbb.2010.08.005; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; KUNISAKI C, 1992, DIGESTION, V53, P45, DOI 10.1159/000200970; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; NISHIZAWA Y, 1983, PROG MED, V3, P1029; OKETANI K, 1983, JPN J PHARMACOL, V33, P593, DOI 10.1254/jjp.33.593; Piermartiri TCB, 2010, EXP NEUROL, V226, P274, DOI 10.1016/j.expneurol.2010.08.030; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SENO K, 1995, J LAB CLIN MED, V126, P287; Sinn DI, 2007, BRAIN RES, V1135, P167, DOI 10.1016/j.brainres.2006.11.098; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; SUMIGAMA K, 1983, PROG MED, V3, P1053; Sun DX, 2005, J SURG RES, V129, P114, DOI 10.1016/j.jss.2005.05.028; Takeshita S, 2012, J GASTROENTEROL, V47, P195, DOI 10.1007/s00535-011-0481-z; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Tanaka KI, 2010, BIOCHEM PHARMACOL, V80, P920, DOI 10.1016/j.bcp.2010.05.025; Tanaka KI, 2010, AM J PHYSIOL-LUNG C, V298, pL348, DOI 10.1152/ajplung.00289.2009; Tanito M, 2005, J NEUROSCI, V25, P2396, DOI 10.1523/JNEUROSCI.4866-04.2005; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Upadhaya AR, 2012, NEUROBIOL AGING, V33, P2641, DOI 10.1016/j.neurobiolaging.2011.12.032; Ushijima H, 2005, MOL PHARMACOL, V68, P1156, DOI 10.1124/mol.105.015784; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yasuda H, 2005, BRAIN RES, V1032, P176, DOI 10.1016/j.brainres.2004.11.009	50	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76306	10.1371/journal.pone.0076306	http://dx.doi.org/10.1371/journal.pone.0076306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098472	Green Published, gold			2022-12-27	WOS:000325427100057
J	Prasad, MK; Bhalla, K; Pan, ZH; O'Connell, JR; Weder, AB; Chakravarti, A; Tian, B; Chang, YPC				Prasad, Megana K.; Bhalla, Kavita; Pan, Zhen Hua; O'Connell, Jeffrey R.; Weder, Alan B.; Chakravarti, Aravinda; Tian, Bin; Chang, Yen-Pei C.			A Polymorphic 3 ' UTR Element in ATP1B1 Regulates Alternative Polyadenylation and Is Associated with Blood Pressure	PLOS ONE			English	Article							PRE-MESSENGER-RNA; INDUCED HYPERTENSION; DOWNSTREAM ELEMENTS; NA,K-ATPASE; GENES; GENETICS; LOCI; RAT; NA; DISEQUILIBRIUM	Although variants in many genes have previously been shown to be associated with blood pressure (BP) levels, the molecular mechanism underlying these associations are mostly unknown. We identified a multi-allelic T-rich sequence (TRS) in the 3'UTR of ATP1B1 that varies in length and sequence composition (T22-27 and T(12)GT (3)GT(6)). The 3'UTR of ATP1B1 contains 2 functional polyadenylation signals and the TRS is downstream of the proximal polyadenylation site (A2). Therefore, we hypothesized that alleles of this TRS might influence ATP1B1 expression by regulating alternative polyadenylation. In vitro, the T(12)GT (3)GT(6) allele increases polyadenylation at the A2 polyadenylation site as compared to the T-23 allele. Consistent with our hypothesis, the relative abundance of the A2-polyadenylated ATP1B1 mRNA was higher in human kidneys with at least one copy of the T(12)GT (3)GT(6) allele than in those lacking this allele. The T(12)GT (3)GT(6) allele is also associated with higher systolic BP (beta = 3.3 mmHg, p = 0.014) and diastolic BP (beta = 2.4 mmHg, p = 0.003) in a European-American population. Therefore, we have identified a novel multi-allelic TRS in the 3'UTR of ATP1B1 that is associated with higher BP and may mediate its effect by regulating the polyadenylation of the ATP1B1 mRNA.	[Prasad, Megana K.; O'Connell, Jeffrey R.; Chang, Yen-Pei C.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Bhalla, Kavita] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Pan, Zhen Hua; Tian, Bin] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Weder, Alan B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Michigan System; University of Michigan; Johns Hopkins University	Chang, YPC (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	cchang@medicine.umaryland.edu		Tian, Bin/0000-0001-8903-8256	National Heart, Lung and Blood Institute [R01HL088120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084089] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grant number R01HL088120 from the National Heart, Lung and Blood Institute awarded to YCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barwe SP, 2009, J MOL CELL CARDIOL, V47, P552, DOI 10.1016/j.yjmcc.2009.07.018; Beyer K, 1997, J BIOL CHEM, V272, P26769, DOI 10.1074/jbc.272.42.26769; Binder A, 2007, CURR OPIN CARDIOL, V22, P176, DOI 10.1097/HCO.0b013e3280d357f9; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; Clausen T, 1998, CLIN SCI, V95, P3, DOI 10.1042/CS19970254; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Danckwardt S, 2004, BLOOD, V104, P428, DOI 10.1182/blood-2003-08-2894; Willige SU, 2007, J THROMB HAEMOST, V5, P1243, DOI 10.1111/j.1538-7836.2007.02566.x; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Faruque MU, 2011, J HYPERTENS, V29, P1906, DOI 10.1097/HJH.0b013e32834b000d; Ferrandi M, 1996, HYPERTENSION, V28, P1018, DOI 10.1161/01.HYP.28.6.1018; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hunt SC, 2002, HYPERTENSION, V40, P1, DOI 10.1161/01.HYP.0000022660.28915.B1; JORGENSEN PL, 1986, KIDNEY INT, V29, P10, DOI 10.1038/ki.1986.3; Kava L, 2012, AM J HYPERTENS, V25, P487, DOI 10.1038/ajh.2011.247; KAWAKAMI K, 1986, NUCLEIC ACIDS RES, V14, P2833, DOI 10.1093/nar/14.7.2833; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kochunov P, 2010, STROKE, V41, P2137, DOI 10.1161/STROKEAHA.110.590943; LANE LK, 1989, GENOMICS, V5, P445, DOI 10.1016/0888-7543(89)90008-6; Lanzani C, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001814; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; MCDONOUGH AA, 1988, AM J PHYSIOL, V254, pC323, DOI 10.1152/ajpcell.1988.254.2.C323; MELZI ML, 1991, PEDIATR NEPHROL, V5, P700, DOI 10.1007/BF00857877; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Pan ZH, 2006, GENE, V366, P325, DOI 10.1016/j.gene.2005.09.024; Pancevac C, 2010, NUCLEIC ACIDS RES, V38, P3119, DOI 10.1093/nar/gkq002; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Shao Y, 1999, EUR J BIOCHEM, V260, P1, DOI 10.1046/j.1432-1327.1999.00111.x; Shao Y, 2001, ARCH BIOCHEM BIOPHYS, V390, P78, DOI 10.1006/abbi.2001.2354; Shen HQ, 2010, ARCH INTERN MED, V170, P1850, DOI 10.1001/archinternmed.2010.384; Simino J, 2012, CURR OPIN NEPHROL HY, V21, P500, DOI 10.1097/MNH.0b013e328354e78f; Sorkin J, 2005, MECH AGEING DEV, V126, P347, DOI 10.1016/j.mad.2004.08.027; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Sugiyama F, 2001, GENOMICS, V71, P70, DOI 10.1006/geno.2000.6401; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Thomas LF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002621; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; van Rijn MJE, 2007, J HYPERTENS, V25, P565, DOI 10.1097/HJH.0b013e32801449fb; Vereninov AA, 2001, CELL PHYSIOL BIOCHEM, V11, P19, DOI 10.1159/000047788; Virlon B, 1999, P NATL ACAD SCI USA, V96, P15286, DOI 10.1073/pnas.96.26.15286; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wei ZY, 2011, CIRC-CARDIOVASC GENE, V4, P381, DOI 10.1161/CIRCGENETICS.111.959767; WILLIGE SUD, 2005, BLOOD, V106, P4176, DOI DOI 10.1182/BL00D-2005-05-2180.PUBMED:16144795; Xiao B, 2009, CLIN CHIM ACTA, V407, P47, DOI 10.1016/j.cca.2009.06.026; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; YOUNG RM, 1987, J BIOL CHEM, V262, P4905; Zapata C, 2001, ANN HUM GENET, V65, P395, DOI 10.1017/S0003480001008697; Zarudnaya MI, 2003, NUCLEIC ACIDS RES, V31, P1375, DOI 10.1093/nar/gkg241; Zhao JH, 2004, BIOINFORMATICS, V20, P1325, DOI 10.1093/bioinformatics/bth071; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76290	10.1371/journal.pone.0076290	http://dx.doi.org/10.1371/journal.pone.0076290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098465	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100054
J	Vo, AH; Swaroop, A; Liu, Y; Norris, ZG; Shavit, JA				Vo, Andy H.; Swaroop, Alok; Liu, Yang; Norris, Zachary G.; Shavit, Jordan A.			Loss of Fibrinogen in Zebrafish Results in Symptoms Consistent with Human Hypofibrinogenemia	PLOS ONE			English	Article							VERTEBRATE BLOOD-COAGULATION; VON-WILLEBRAND-FACTOR; CARDIOVASCULAR-SYSTEM; GENES; THROMBOSIS; EVOLUTION; MODIFIER; SEQUENCE; LIVER; FIBRINOLYSIS	Cessation of bleeding after trauma is a necessary evolutionary vertebrate adaption for survival. One of the major pathways regulating response to hemorrhage is the coagulation cascade, which ends with the cleavage of fibrinogen to form a stable clot. Patients with low or absent fibrinogen are at risk for bleeding. While much detailed information is known about fibrinogen regulation and function through studies of humans and mammalian models, bleeding risk in patients cannot always be accurately predicted purely based on fibrinogen levels, suggesting an influence of modifying factors and a need for additional genetic models. The zebrafish has orthologs to the three components of fibrinogen (fga, fgb, and fgg), but it hasn't yet been shown that zebrafish fibrinogen functions to prevent bleeding in vivo. Here we show that zebrafish fibrinogen is incorporated into an induced thrombus, and deficiency results in hemorrhage. An Fgb-eGFP fusion protein is incorporated into a developing thrombus induced by laser injury, but causes bleeding in adult transgenic fish. Antisense morpholino knockdown results in intracranial and intramuscular hemorrhage at 3 days post fertilization. The observed phenotypes are consistent with symptoms exhibited by patients with hypo-and afibrinogenemia. These data demonstrate that zebrafish possess highly conserved orthologs of the fibrinogen chains, which function similarly to mammals through the formation of a fibrin clot.	[Vo, Andy H.; Swaroop, Alok; Liu, Yang; Norris, Zachary G.; Shavit, Jordan A.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Shavit, JA (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	jshavit@umich.edu		Liu, Yang/0000-0002-0413-5637; Swaroop, Alok/0000-0003-0317-6688	American Society of Hematology Trainee Research Award; Bayer Hemophilia Awards Program; Hemophilia of Georgia Clinical Scientist Development Grant; National Hemophilia Foundation/Novo Nordisk Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER	American Society of Hematology Trainee Research Award; Bayer Hemophilia Awards Program; Hemophilia of Georgia Clinical Scientist Development Grant; National Hemophilia Foundation/Novo Nordisk Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	J.A.S. is the Diane and Larry Johnson Family Scholar of Pediatrics and Communicable Diseases, American Society of Hematology Trainee Research Award (A. S., www.hematology.org), Bayer Hemophilia Awards Program (J.A.S., www.bayer-hemophilia-awards.com), Hemophilia of Georgia Clinical Scientist Development Grant (J.A.S., www.hog.org), National Hemophilia Foundation/Novo Nordisk Career Development Award (J.A.S., www.hemophilia.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, BLOOD, V111, P643, DOI 10.1182/blood-2007-05-091231; ALMONDHIRY H, 1994, AM J HEMATOL, V46, P343, DOI 10.1002/ajh.2830460416; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Bowman TV, 2010, ACS CHEM BIOL, V5, P159, DOI 10.1021/cb100029t; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Carrillo M, 2010, BLOOD CELL MOL DIS, V45, P326, DOI 10.1016/j.bcmd.2010.10.002; Cheli Y, 2008, BLOOD, V111, P1266, DOI 10.1182/blood-2007-09-111369; Chen JN, 1996, DEVELOPMENT, V123, P293; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Davidson CJ, 2003, THROMB HAEMOSTASIS, V89, P420, DOI 10.1055/s-0037-1613369; Davie EW, 2003, J BIOL CHEM, V278, P50819, DOI 10.1074/jbc.X300009200; Day K, 2004, BLOOD CELL MOL DIS, V32, P191, DOI 10.1016/j.bcmd.2003.09.004; de Moerloose P, 2009, SEMIN THROMB HEMOST, V35, P356, DOI 10.1055/s-0029-1225758; Degen JL, 2001, ANN NY ACAD SCI, V936, P276; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P427, DOI 10.1160/TH12-04-0274; Fish RJ, 2012, THROMB HAEMOSTASIS, V107, P158, DOI 10.1160/TH11-04-0221; Fort A, 2011, BLOOD, V117, P276, DOI 10.1182/blood-2010-07-295410; Ghosh A., 2012, ADV HEMATOL, V2012; Ginsburg D, 2002, EMERY RIMOINS PRINCI, VII, P1926; Gregory M, 2002, BLOOD CELL MOL DIS, V29, P286, DOI 10.1006/bcmd.2002.0568; Gulledge AA, 2001, THROMB HAEMOSTASIS, V86, P511, DOI 10.1055/s-0037-1616079; Hanss M, 2001, ANN NY ACAD SCI, V936, P89; Hanumanthaiah R, 2002, BLOOD CELL MOL DIS, V29, P57, DOI 10.1006/bcmd.2002.0534; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Jagadeeswaran P, 2007, J THROMB HAEMOST, V5, P300, DOI 10.1111/j.1538-7836.2007.02518.x; Jagadeeswaran P, 2011, METHOD CELL BIOL, V101, P197, DOI 10.1016/B978-0-12-387036-0.00009-8; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Jones CF, 2012, ACS NANO, V6, P9900, DOI 10.1021/nn303472r; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; La Corte ALC, 2011, ADV PROTEIN CHEM STR, V83, P75, DOI 10.1016/B978-0-12-381262-9.00003-3; Lemmerhirt HL, 2007, J THROMB HAEMOST, V5, P329, DOI 10.1111/j.1538-7836.2007.02325.x; Lemmerhirt HL, 2006, BLOOD, V108, P3061, DOI 10.1182/blood-2006-04-014688; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; Paffett-Lugassy NN, 2004, METH MOLEC MED, V105, P171; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Ploplis VA, 2000, AM J PATHOL, V157, P703, DOI 10.1016/S0002-9440(10)64582-8; Rosen ED, 2006, BLOOD CELL MOL DIS, V36, P131, DOI 10.1016/j.bcmd.2005.12.037; SELTEN GCM, 1982, BIOCHIM BIOPHYS ACTA, V699, P131, DOI 10.1016/0167-4781(82)90146-4; Shavit JA, 2009, BLOOD, V114, P5368, DOI 10.1182/blood-2009-07-233213; Stainier DYR, 1996, DEVELOPMENT, V123, P285; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sullivan-Brown J, 2011, NAT PROTOC, V6, P46, DOI 10.1038/nprot.2010.165; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wolberg AS, 2012, CURR OPIN HEMATOL, V19, P349, DOI 10.1097/MOH.0b013e32835673c2	53	35	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74682	10.1371/journal.pone.0074682	http://dx.doi.org/10.1371/journal.pone.0074682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098662	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500033
J	Wang, S; Dong, XR; Zhu, YQ; Wang, C; Sun, G; Luo, T; Tian, WD; Zheng, HJ; Gao, Q				Wang, Sen; Dong, Xinran; Zhu, Yongqiang; Wang, Chuan; Sun, Gang; Luo, Tao; Tian, Weidong; Zheng, Huajun; Gao, Qian			Revealing of Mycobacterium marinum Transcriptome by RNA-seq	PLOS ONE			English	Article							TUBERCULOSIS GENE-EXPRESSION; VII SECRETION; PATHOGENESIS; ALIGNMENT; INSIGHTS; BIOLOGY; BLAST	Transcriptome analysis has played an essential role for revealing gene expression and the complexity of regulations at transcriptional level. RNA-seq is a powerful tool for transcriptome profiling, which uses deep-sequencing technologies to directly determine the cDNA sequence. Here, we utilized RNA-seq to explore the transcriptome of Mycobacterium marinum (M. marinum), which is a useful model to study the pathogenesis of Mycobacterium tuberculosis (Mtb). Two profiles of exponential and early stationary phase cultures were generated after a physical ribosome RNA removal step. We systematically described the transcriptome and analyzed the functions for the differentiated expressed genes between the two phases. Furthermore, we predicted 360 operons throughout the whole genome, and 13 out of 17 randomly selected operons were validated by qRT-PCR. In general, our study has primarily uncovered M. marinum transcriptome, which could help to gain a better understanding of the regulation system in Mtb that underlines disease pathogenesis.	[Wang, Sen; Wang, Chuan; Sun, Gang; Luo, Tao; Gao, Qian] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Wang, Sen; Wang, Chuan; Sun, Gang; Luo, Tao; Gao, Qian] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Dong, Xinran; Tian, Weidong] Fudan Univ, Sch Life Sci, Inst Biostat, Shanghai 200433, Peoples R China; [Zhu, Yongqiang; Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Gao, Q (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	qgao99@yahoo.com	Dong, Xinran/AAF-7799-2019; , 罗涛/AHA-1191-2022		Ministry of Science and Technology, China [2010DFA34440]; National Natural Science Foundation of China [91231115, 81271790]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants International Cooperation Project of Ministry of Science and Technology, China (2010DFA34440), and National Natural Science Foundation of China Grants (#91231115 and #81271790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Deng WY, 2011, CRIT REV EUKAR GENE, V21, P337, DOI 10.1615/CritRevEukarGeneExpr.v21.i4.40; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Guida A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-628; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Komorowski M, 2009, BIOPHYS J, V96, P372, DOI 10.1016/j.bpj.2008.09.052; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Miotto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051950; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Rachman H, 2006, MICROBES INFECT, V8, P747, DOI 10.1016/j.micinf.2005.09.011; Roback P, 2007, NUCLEIC ACIDS RES, V35, P5085, DOI 10.1093/nar/gkm518; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Triccas JA, 2000, IMMUNOL CELL BIOL, V78, P311, DOI 10.1046/j.1440-1711.2000.00934.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9; 2010, WKLY EPIDEMIOL REC, V85, P69	40	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75828	10.1371/journal.pone.0075828	http://dx.doi.org/10.1371/journal.pone.0075828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098731	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500102
J	Hanson, D; Cooke, S; Hirano, Y; Malaquias, MAE; Crocetta, F; Valdes, A				Hanson, Dieta; Cooke, Samantha; Hirano, Yayoi; Malaquias, Manuel A. E.; Crocetta, Fabio; Valdes, Angel			Slipping through the Cracks: The Taxonomic Impediment Conceals the Origin and Dispersal of Haminoea japonica, an Invasive Species with Impacts to Human Health	PLOS ONE			English	Article							POPULATION-GENETICS; GASTROPODA; OPISTHOBRANCHIA; CEPHALASPIDEA; STRATEGIES; PILSBRY; MODEL	Haminoea japonica is a species of opisthobranch sea slug native to Japan and Korea. Non-native populations have spread unnoticed for decades due to difficulties in the taxonomy of Haminoea species. Haminoea japonica is associated with a schistosome parasite in San Francisco Bay, thus further spread could have consequence to human health and economies. Anecdotal evidence suggests that H. japonica has displaced native species of Haminoea in North America and Europe, becoming locally dominant in estuaries and coastal lagoons. In this paper we study the population genetics of native and non-native populations of H. japonica based on mt-DNA data including newly discovered populations in Italy and France. The conclusions of this study further corroborate a Northeastern Japan origin for the non-native populations and suggest possible independent introductions into North America and Europe. Additionally, the data obtained revealed possible secondary introductions within Japan. Although non-native populations have experienced severe genetic bottlenecks they have colonized different regions with a broad range of water temperatures and other environmental conditions. The environmental tolerance of this species, along with its ability to become dominant in invaded areas and its association with a schistosome parasite, suggest H. japonica could be a dangerous invasive species.	[Hanson, Dieta; Cooke, Samantha; Valdes, Angel] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA; [Hanson, Dieta] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Hanson, Dieta] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Hirano, Yayoi] Chiba Univ, Grad Sch Sci, Chiba, Japan; [Malaquias, Manuel A. E.] Univ Museum Bergen, Phylogenet Systemat & Evolut Res Grp, Bergen, Norway; [Crocetta, Fabio] Staz Zool Anton Dohrn, Naples, Italy	California State University System; California State Polytechnic University Pomona; McGill University; McGill University; Chiba University; University of Bergen; Stazione Zoologica Anton Dohrn di Napoli	Valdes, A (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	aavaldes@csupomona.edu	Valdes, Angel/K-3051-2012; Valdes, Angel/Q-1729-2018; Malaquias, Manuel/N-2450-2019; Crocetta, Fabio/AAA-6927-2022	Valdes, Angel/0000-0002-2347-4896; Valdes, Angel/0000-0002-2347-4896; Malaquias, Manuel/0000-0002-9668-945X; Crocetta, Fabio/0000-0002-2800-3735	California State University Agricultural Research Institute (ARI); Ernest Prete, Jr. Student Environmental Research Fellowship; Southern California Academy of Sciences; Conchologists of America; Houston Conchology Society; Research, Scholarship and Creative Activity (RSCA) Program at California State University; California State University Council on Ocean Affairs, Science, and Technology (COAST)	California State University Agricultural Research Institute (ARI); Ernest Prete, Jr. Student Environmental Research Fellowship; Southern California Academy of Sciences; Conchologists of America; Houston Conchology Society; Research, Scholarship and Creative Activity (RSCA) Program at California State University; California State University Council on Ocean Affairs, Science, and Technology (COAST)	This work was supported by the California State University Agricultural Research Institute (ARI) (http://www.csupomona.edu/similar to ari/), the Ernest Prete, Jr. Student Environmental Research Fellowship, the Southern California Academy of Sciences (http://scas.nhm.org/), Conchologists of America (http://www.conchologistsofamerica.org/home/), the Houston Conchology Society (http://www.houstonshellclub.com/), the Research, Scholarship and Creative Activity (RSCA) Program at California State University (http://www.csupomona.edu/similar to research/rsp/rsca_info.shtml), and the California State University Council on Ocean Affairs, Science, and Technology (COAST) (http://www.calstate.edu/coast/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aranishi Futoshi, 2004, Journal of Applied Genetics, V45, P435; Brant SV, 2010, EMERG INFECT DIS, V16, P1357, DOI 10.3201/eid1609.091664; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Crocetta F, 2013, ZOOKEYS, P91, DOI 10.3897/zookeys.277.4362; Crocetta F, 2012, J MAR BIOL ASSOC UK, V92, P1357, DOI 10.1017/S002531541100186X; Drummond AJ, 2009, GENEIOUS VERSION 4 8; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; GARCIA FJ, 1991, J MOLLUS STUD, V57, P395, DOI 10.1093/mollus/57.4.395; Gosliner Terrence M., 2006, Proceedings of the California Academy of Sciences, V57, P1003; Hanson D, 2013, BIOL INVASIONS, V15, P395, DOI 10.1007/s10530-012-0294-x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Macali A, 2013, SCI MAR, V77, P649, DOI 10.3989/scimar.03858.05M; Maddison D.R., 2000, MACCLADE4 ANAL PHYLO; Malaquias MAE, 2006, J MOLLUS STUD, V72, P89, DOI 10.1093/mollus/eyi052; Malaquias MAE, 2005, ESTUAR COAST SHELF S, V63, P177, DOI 10.1016/j.ecss.2004.11.005; Malaquias MAE, 2009, ZOOL SCR, V38, P23, DOI 10.1111/j.1463-6409.2008.00354.x; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Rambaut A, 2007, TRACER 1 4; Soldanova M, 2013, TRENDS PARASITOL, V29, P65, DOI 10.1016/j.pt.2012.12.002; TALAVERA P, 1987, Bollettino Malacologico, V23, P53; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON TE, 1981, J MOLLUS STUD, V47, P73, DOI 10.1093/oxfordjournals.mollus.a065559; Wheeler QD, 2004, SCIENCE, V303, P285, DOI 10.1126/science.303.5656.285	30	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77457	10.1371/journal.pone.0077457	http://dx.doi.org/10.1371/journal.pone.0077457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098588	gold, Green Submitted, Green Published			2022-12-27	WOS:000325483600087
J	Vuoristo, S; Toivonen, S; Weltner, J; Mikkola, M; Ustinov, J; Trokovic, R; Palgi, J; Lund, R; Tuuri, T; Otonkoski, T				Vuoristo, Sanna; Toivonen, Sanna; Weltner, Jere; Mikkola, Milla; Ustinov, Jarkko; Trokovic, Ras; Palgi, Jaan; Lund, Riikka; Tuuri, Timo; Otonkoski, Timo			A Novel Feeder-Free Culture System for Human Pluripotent Stem Cell Culture and Induced Pluripotent Stem Cell Derivation	PLOS ONE			English	Article							SUPPORTS UNDIFFERENTIATED GROWTH; BASEMENT-MEMBRANES; RESTRICTED DISTRIBUTION; DIFFERENTIATION; INHIBITOR; STABILITY; EXPANSION; LINES	Correct interactions with extracellular matrix are essential to human pluripotent stem cells (hPSC) to maintain their pluripotent self-renewal capacity during in vitro culture. hPSCs secrete laminin 511/521, one of the most important functional basement membrane components, and they can be maintained on human laminin 511 and 521 in defined culture conditions. However, large-scale production of purified or recombinant laminin 511 and 521 is difficult and expensive. Here we have tested whether a commonly available human choriocarcinoma cell line, JAR, which produces high quantities of laminins, supports the growth of undifferentiated hPSCs. We were able to maintain several human pluripotent stem cell lines on decellularized matrix produced by JAR cells using a defined culture medium. The JAR matrix also supported targeted differentiation of the cells into neuronal and hepatic directions. Importantly, we were able to derive new human induced pluripotent stem cell (hiPSC) lines on JAR matrix and show that adhesion of the early hiPSC colonies to JAR matrix is more efficient than to matrigel. In summary, JAR matrix provides a cost-effective and easy-to-prepare alternative for human pluripotent stem cell culture and differentiation. In addition, this matrix is ideal for the efficient generation of new hiPSC lines.	[Vuoristo, Sanna; Toivonen, Sanna; Weltner, Jere; Mikkola, Milla; Ustinov, Jarkko; Trokovic, Ras; Palgi, Jaan; Tuuri, Timo; Otonkoski, Timo] Univ Helsinki, Res Programs Unit, Mol Neurol & Biomedicum Stem Cell Ctr, Helsinki, Finland; [Lund, Riikka] Univ Turku, Turku Ctr Biotechnol, Finnish Microarray & Sequencing Ctr, Turku, Finland; [Lund, Riikka] Abo Akad Univ, Turku, Finland; [Otonkoski, Timo] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland	University of Helsinki; University of Turku; Abo Akademi University; University of Helsinki; Helsinki University Central Hospital	Vuoristo, S (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol & Biomedicum Stem Cell Ctr, Helsinki, Finland.	sanna.vuoristo@helsinki.fi	Lund, Riikka J/F-7320-2014; Lund, Riikka/AAW-7853-2020; Lund, Riikka/K-2441-2019; Trokovic, Ras/AAC-7309-2022	Lund, Riikka/0000-0002-1068-5918; Trokovic, Ras/0000-0002-3065-6663	Academy of Finland; Sigrid Juselius Foundation; Helsinki University Hospital EVO-research funds; Helsinki Biomedical Graduate Program; Instrumentarium Science Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Hospital EVO-research funds; Helsinki Biomedical Graduate Program; Instrumentarium Science Foundation	The work was funded by Academy of Finland, Sigrid Juselius Foundation, Helsinki University Hospital EVO-research funds, Helsinki Biomedical Graduate Program (SV, ST, JW) and Instrumentarium Science Foundation (SV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BRAAM SR, 2008, STEM CELLS; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Dravid G, 2006, METH MOL B, V331, P91; ENGVALL E, 1990, CELL REGUL, V1, P731, DOI 10.1091/mbc.1.10.731; Fukusumi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055226; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Lebkowski JS, 2001, CANCER J, V7, pS83; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Lund RJ, 2012, STEM CELL RES, V9, P192, DOI 10.1016/j.scr.2012.06.008; Lund RJ, 2012, NAT REV GENET, V13, P732, DOI 10.1038/nrg3271; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Mikkola M, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0365; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Virtanen I, 2000, EXP CELL RES, V257, P298, DOI 10.1006/excr.2000.4883; Vuoristo S, 2009, J CELL MOL MED, V13, P2622, DOI 10.1111/j.1582-4934.2008.00643.x; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	33	22	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76205	10.1371/journal.pone.0076205	http://dx.doi.org/10.1371/journal.pone.0076205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098444	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500051
J	Hu, LB; Wang, DD; Liu, L; Chen, J; Xue, YF; Shi, ZQ				Hu, Liangbin; Wang, Dede; Liu, Li; Chen, Jian; Xue, Yanfeng; Shi, Zhiqi			Ca2+ Efflux Is Involved in Cinnamaldehyde-Induced Growth Inhibition of Phytophthora capsici	PLOS ONE			English	Article							CALCIUM HOMEOSTASIS; ANTIFUNGAL ACTIVITY; NEUROSPORA-CRASSA; CANDIDA-ALBICANS; CELL-WALL; IDENTIFICATION; AMIODARONE; INCREASE; EUGENOL; FUNGI	As a destructive fungus-like plant pathogen, the oomycete Phytophthora capsici is unable to synthesize its own ergosterol as the potential target of fungicide cinnamaldehyde (CA). In this study, CA exerted efficient inhibitory effects on both mycelial growth (EC50=0.75 mM) and zoospore germination (MIC=0.4 mM) of P. capsici. CA-induced immediate Ca2+ efflux from zoospores could be confirmed by the rapid decrease in intracellular Ca2+ content determined by using Fluo-3 AM and the increase in extracellular Ca2+ concentration determined by using ICP-AES (inductively coupled plasma atomic emission spectrometry). Blocking Ca2+ influx with ruthenium red and verapamil led to a higher level of CA-induced Ca2+ efflux, suggesting the simultaneous occurrence of Ca2+ influx along with the Ca2+ efflux under CA exposure. Further results showed that EGTA-induced decrease in intracellular Ca2+ gave rise to the impaired vitality of P. capsici while the addition of exogenous Ca2+ could suppress the growth inhibitory effect of CA. These results suggested that Ca2+ efflux played an important role in CA-induced growth inhibition of P. capsici. The application of 3-phenyl-1-propanal, a CA analog without alpha,beta-unsaturated bond, resulted in a marked Ca2+ influx in zoospores but did not show any growth inhibitory effects. In addition, exogenous cysteine, an antagonist against the Michael addition (the nucleophilic addition of a carbanion or another nucleophile) between CA and its targets, could attenuate CA-induced growth inhibition of P. capsici by suppressing Ca2+ efflux. Our results suggest that CA inhibits the growth of P. capsici by stimulating a transient Ca2+ efflux via Michael addition, which provides important new insights into the antimicrobial action of CA.	[Hu, Liangbin; Wang, Dede; Liu, Li; Chen, Jian; Xue, Yanfeng; Shi, Zhiqi] Jiangsu Acad Agr Sci, Inst Food Safety & Monitoring Technol, Nanjing, Jiangsu, Peoples R China; [Wang, Dede] Nanjing Agr Univ, Plant Protect Coll, Nanjing, Jiangsu, Peoples R China; [Liu, Li] Nanjing Normal Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Hu, Liangbin] Henan Inst Sci & Technol, Sch Food Sci, Xinxiang, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University; Nanjing Normal University; Henan Institute of Science & Technology	Shi, ZQ (corresponding author), Jiangsu Acad Agr Sci, Inst Food Safety & Monitoring Technol, Nanjing, Jiangsu, Peoples R China.	jaasinput@gmail.com		Hu, `Liangbin/0000-0003-0747-093X	Jiangsu Agricultural Science Independent Innovation Funds [CX(12)1004]	Jiangsu Agricultural Science Independent Innovation Funds	This research work was financially supported by Jiangsu Agricultural Science Independent Innovation Funds [CX(12)1004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Bang KH, 2000, BIOSCI BIOTECH BIOCH, V64, P1061, DOI 10.1271/bbb.64.1061; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043; Brini  M., 2011, COLD SPRING HARB PER, V3; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; Cai XJ, 2012, MOL BIOL EVOL, V29, P91, DOI 10.1093/molbev/msr149; Cerella Claudia, 2010, Int J Cell Biol, V2010, P546163, DOI 10.1155/2010/546163; Cheng SS, 2008, BIORESOURCE TECHNOL, V99, P5145, DOI 10.1016/j.biortech.2007.09.013; Courchesne WE, 2002, J PHARMACOL EXP THER, V300, P195, DOI 10.1124/jpet.300.1.195; Courchesne WE, 2009, CAN J MICROBIOL, V55, P288, DOI [10.1139/W08-132, 10.1139/w08-132]; Curry MC, 2012, J BIOL CHEM, V287, P28598, DOI 10.1074/jbc.M112.364737; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Enomoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039499; Erwin D. C., 1996, Phytophthora diseases worldwide.; Gaulin E, 2010, PLANT SIGNAL BEHAV, V5, P258, DOI 10.4161/psb.5.3.10551; Gevens AJ, 2007, PHYTOPATHOLOGY, V97, P421, DOI 10.1094/PHYTO-97-4-0421; Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004; Greene V, 2002, CELL SIGNAL, V14, P437, DOI 10.1016/S0898-6568(01)00266-2; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Kallies A, 1998, ARCH MICROBIOL, V170, P191, DOI 10.1007/s002030050633; Kwon JA, 2003, LETT APPL MICROBIOL, V37, P61, DOI 10.1046/j.1472-765X.2003.01350.x; Li HX, 2008, POSTHARVEST BIOL TEC, V47, P239, DOI 10.1016/j.postharvbio.2007.06.022; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Magnone M, 2012, J BIOL CHEM, V287, P21067, DOI 10.1074/jbc.M111.324269; Pang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056513; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shreaz S, 2010, MICROB PATHOGENESIS, V49, P75, DOI 10.1016/j.micpath.2010.03.013; Silvar C, 2005, EUR J PLANT PATHOL, V112, P43, DOI 10.1007/s10658-004-8232-0; Silverman-Gavrila LB, 2002, J CELL SCI, V115, P5013, DOI 10.1242/jcs.00180; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Wang SY, 2005, BIORESOURCE TECHNOL, V96, P813, DOI 10.1016/j.biortech.2004.07.010; Yu QL, 2012, MICROBIOL-SGM, V158, P2272, DOI 10.1099/mic.0.057232-0	36	26	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76264	10.1371/journal.pone.0076264	http://dx.doi.org/10.1371/journal.pone.0076264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098458	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100052
J	Liu, CF; Drocourt, D; Puzo, G; Wang, JY; Riviere, M				Liu, Chia-Fang; Drocourt, Daniel; Puzo, Germain; Wang, Jiu-Yao; Riviere, Michel			Innate Immune Response of Alveolar Macrophage to House Dust Mite Allergen Is Mediated through TLR2/-4 Co-Activation	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; TOLL-LIKE RECEPTORS; IFN-GAMMA RELEASE; T-BET EXPRESSION; DENDRITIC CELLS; AIRWAY INFLAMMATION; CD14 PROMOTER; INDUCTION; ASTHMA; IL-12	House dust mite, Dermatophagoides pteronyssinus (Der p), is one of the major allergens responsible for allergic asthma. However, the putative receptors involved in the signalization of Der p to the innate immune cells are still poorly defined as well as the impact of their activation on the outcome of the allergen-induced cell response. We previously reported that the HDM activation of mouse alveolar macrophages (AM) involves the TLR4/CD14 cell surface receptor complex. Here using a TLR ligand screening essay, we demonstrate that HDM protein extract engages the TLR2, in addition to the TLR4, in engineered TLR-transfected HEK cells but also in the MH-S mouse alveolar macrophage cell line model. Moreover we found that the concomitant recruitment of the MH-S cell's TLR2 and TLR4 receptors by the HDM extract activates the MyD88-dependent signaling pathway and leads to the secretion of the NF-kappa B regulated pro-inflammatory factors NO and TNF-alpha. However unlike with the canonical TLR4 ligand (i.e. the bacterial LPS) mobilization of TLR4 by the HDM extract induces a reduced production of the IL-12 proinflammatory cytokine and fails to trigger the expression of the T-bet transcription factor. Finally we demonstrated that HDM extract down-regulates LPS induced IL-12 and T-bet expression through a TLR2 dependent mechanism. Therefore, we propose that the simultaneous engagement of the TLR2 and TLR4 receptors by the HDM extract results in a cross regulated original activation pattern of the AM which may contribute to the Th2 polarization of the allergen-induced immune response. The deciphering of these cross-regulation networks is of prime importance to open the way for original therapeutic strategies taking advantage of these receptors and their associated signaling pathways to treat allergic asthma.	[Liu, Chia-Fang; Puzo, Germain; Riviere, Michel] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Liu, Chia-Fang; Puzo, Germain; Riviere, Michel] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Liu, Chia-Fang; Wang, Jiu-Yao] Natl Cheng Kung Univ, Inst Basic Med, Tainan 70101, Taiwan; [Drocourt, Daniel] CAYLA Invivogen, Toulouse, France; [Wang, Jiu-Yao] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); National Cheng Kung University; National Cheng Kung University	Riviere, M (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Toulouse, France.	Michel.Riviere@ipbs.fr			CNRS (France); NSC (Taiwan); FIT (French Institute in Taiwan: Fourier Grants); NSC (Grants for Graduate Students Study Abroad Program); NCKU of Tainan (Taiwan); IPBS, Toulouse (France)	CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); NSC (Taiwan)(Ministry of Science and Technology, Taiwan); FIT (French Institute in Taiwan: Fourier Grants); NSC (Grants for Graduate Students Study Abroad Program); NCKU of Tainan (Taiwan); IPBS, Toulouse (France)	This work was supported by an International Joint Project for Scientific Cooperation from the CNRS (France) and the NSC (Taiwan). Chia Fang Liu was supported by the FIT (French Institute in Taiwan: Fourier Grants), the NSC (Grants for Graduate Students Study Abroad Program), the NCKU of Tainan (Taiwan) and the IPBS, Toulouse (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht I, 2004, EMBO REP, V5, P172, DOI 10.1038/sj.embor.7400078; Alcaide P, 2007, J EXP MED, V204, P431, DOI 10.1084/jem.20060626; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Aune TM, 2009, IMMUNOLOGY, V126, P299, DOI 10.1111/j.1365-2567.2008.03026.x; Boasen J, 2005, J ALLERGY CLIN IMMUN, V116, P185, DOI 10.1016/j.jaci.2005.03.015; Bottcher I, 2008, IMMUNOLOGY, V123, P139, DOI 10.1111/j.1365-2567.2007.02754.x; Careau E, 2004, AM J RESP CELL MOL, V31, P22, DOI 10.1165/rcmb.2003-0229OC; Chiou YL, 2009, J CELL PHYSIOL, V220, P311, DOI 10.1002/jcp.21764; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Ferreira DS, 2012, CLIN EXP ALLERGY, V42, P1459, DOI 10.1111/j.1365-2222.2012.04047.x; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Goldman M, 2007, CLIN EXP IMMUNOL, V147, P208, DOI 10.1111/j.1365-2249.2006.03296.x; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heckman KL, 2008, EUR J IMMUNOL, V38, P2464, DOI 10.1002/eji.200737952; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Koch A, 2007, RESP MED, V101, P1321, DOI 10.1016/j.rmed.2006.10.010; Kraan TCTMV, 1997, J IMMUNOL, V158, P5560; Kreutz M, 1997, IMMUNOLOGY, V92, P396, DOI 10.1046/j.1365-2567.1997.00365.x; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Liu CF, 2005, CLIN EXP ALLERGY, V35, P1615, DOI 10.1111/j.1365-2222.2005.02387.x; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Parkinson T, 2008, CURR OPIN MOL THER, V10, P21; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sackesen C, 2005, ALLERGY, V60, P1485, DOI 10.1111/j.1398-9995.2005.00874.x; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Stewart GA, 1996, CLIN EXP ALLERGY, V26, P1020, DOI 10.1111/j.1365-2222.1996.tb00641.x; Tan CY, 2006, J HUM GENET, V51, P59, DOI 10.1007/s10038-005-0323-z; Taylor RC, 2006, J ALLERGY CLIN IMMUN, V117, P1148, DOI 10.1016/j.jaci.2006.02.014; Tesse R, 2011, ALLERGY, V66, P307, DOI 10.1111/j.1398-9995.2010.02489.x; Thomas WR, 2011, J ALLERGY CLIN IMMUN, V127, P855, DOI 10.1016/j.jaci.2010.12.1084; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Ye YL, 2011, AM J PHYSIOL-LUNG C, V300, pL216, DOI 10.1152/ajplung.00165.2010; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183	42	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75983	10.1371/journal.pone.0075983	http://dx.doi.org/10.1371/journal.pone.0075983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098413	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100031
J	Smigielska-Czepiel, K; van den Berg, A; Jellema, P; Slezak-Prochazka, I; Maat, H; van den Bos, H; van der Lei, RJ; Kluiver, J; Brouwer, E; Boots, AMH; Kroesen, BJ				Smigielska-Czepiel, Katarzyna; van den Berg, Anke; Jellema, Pytrick; Slezak-Prochazka, Izabella; Maat, Henny; van den Bos, Hilda; van der Lei, Roelof Jan; Kluiver, Joost; Brouwer, Elisabeth; Boots, Anne Mieke H.; Kroesen, Bart-Jan			Dual Role of miR-21 in CD4+T-Cells: Activation-Induced miR-21 Supports Survival of Memory T-Cells and Regulates CCR7 Expression in Naive T-Cells	PLOS ONE			English	Article							NEGATIVE FEEDBACK; MICRORNA-21; IDENTIFICATION; MODULATOR; EFFECTOR; IMMUNITY; AP-1; RNA	Immune cell-type specific miRNA expression patterns have been described but the detailed role of single miRNAs in the function of T-cells remains largely unknown. We investigated the role of miR-21 in the function of primary human CD4+ T-cells. MiR-21 is substantially expressed in T-cells with a memory phenotype, and is robustly upregulated upon alpha CD3/CD28 activation of both naive and memory T-cells. By inhibiting the endogenous miR-21 function in activated naive and memory T-cells, we showed that miR-21 regulates fundamentally different aspects of T-cell biology, depending on the differentiation status of the T-cell. Stable inhibition of miR-21 function in activated memory T-cells led to growth disadvantage and apoptosis, indicating that the survival of memory T-cells depends on miR-21 function. In contrast, stable inhibition of miR-21 function in activated naive T-cells did not result in growth disadvantage, but led to a significant induction of CCR7 protein expression. Direct interaction between CCR7 and miR-21 was confirmed in a dual luciferase reporter assay. Our data provide evidence for a dual role of miR-21 in CD4+ T cells; Regulation of T-cell survival is confined to activated memory T-cells, while modulation of potential homing properties, through downregulation of CCR7 protein expression, is observed in activated naive T-cells.	[Smigielska-Czepiel, Katarzyna; van den Berg, Anke; Jellema, Pytrick; Slezak-Prochazka, Izabella; Maat, Henny; van den Bos, Hilda; van der Lei, Roelof Jan; Kluiver, Joost; Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Brouwer, Elisabeth; Boots, Anne Mieke H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Smigielska-Czepiel, Katarzyna; Brouwer, Elisabeth; Boots, Anne Mieke H.; Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Initiat Healthy Ageing & Immune Lon, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Kroesen, BJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	b.j.kroesen@umcg.nl	Slezak-Prochazka, Izabella/F-7674-2019; Brouwer, Elisabeth/AAL-9029-2020; Kluiver, Joost/G-6406-2014; van den Berg, Anke/H-1718-2011; Brouwer, Elisabeth/A-3198-2015	Slezak-Prochazka, Izabella/0000-0002-0707-2213; Brouwer, Elisabeth/0000-0002-5652-4423; Kluiver, Joost/0000-0001-7650-2937; van den Berg, Anke/0000-0002-8894-2638; Brouwer, Elisabeth/0000-0002-5652-4423	Jan Kornelis de Cock Foundation; Ubbo Emmius Fellowship	Jan Kornelis de Cock Foundation; Ubbo Emmius Fellowship	This study was supported by a grant from the Jan Kornelis de Cock Foundation and by an Ubbo Emmius Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Garchow BG, 2011, EMBO MOL MED, V3, P605, DOI 10.1002/emmm.201100171; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grigoryev YA, 2011, J IMMUNOL, V187, P2233, DOI 10.4049/jimmunol.1101233; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haining WN, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-44; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Iliopoulos D, 2011, EUR J IMMUNOL, V41, P1754, DOI 10.1002/eji.201040646; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Ma CS, 2004, IMMUNOL CELL BIOL, V82, P67, DOI 10.1046/j.0818-9641.2003.01206.x; Meisgen F, 2012, EXP DERMATOL, V21, P312, DOI 10.1111/j.1600-0625.2012.01462.x; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Rossi RL, 2011, NAT IMMUNOL; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Stagakis E, 2011, ANN RHEUM DIS, V70, P1496, DOI 10.1136/ard.2010.139857; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van der Fits L, 2011, J INVEST DERMATOL, V131, P762, DOI 10.1038/jid.2010.349; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038510; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	35	53	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76217	10.1371/journal.pone.0076217	http://dx.doi.org/10.1371/journal.pone.0076217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098447	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100049
J	Blasius, TL; Reed, N; Slepchenko, BM; Verhey, KJ				Blasius, T. Lynne; Reed, Nathan; Slepchenko, Boris M.; Verhey, Kristen J.			Recycling of Kinesin-1 Motors by Diffusion after Transport	PLOS ONE			English	Article							FAST AXONAL-TRANSPORT; TUG-OF-WAR; LIVING CAENORHABDITIS-ELEGANS; RETROGRADE ENDOSOME MOTILITY; MICROTUBULE PLUS-ENDS; CYTOPLASMIC DYNEIN; MOLECULAR MOTORS; VESICLE TRANSPORT; SCAFFOLD PROTEIN; ORGANELLE TRANSPORT	Kinesin motors drive the long-distance anterograde transport of cellular components along microtubule tracks. Kinesin-dependent transport plays a critical role in neurogenesis and neuronal function due to the large distance separating the soma and nerve terminal. The fate of kinesin motors after delivery of their cargoes is unknown but has been postulated to involve degradation at the nerve terminal, recycling via retrograde motors, and/or recycling via diffusion. We set out to test these models concerning the fate of kinesin-1 motors after completion of transport in neuronal cells. We find that kinesin-1 motors are neither degraded nor returned by retrograde motors. By combining mathematical modeling and experimental analysis, we propose a model in which the distribution and recycling of kinesin-1 motors fits a "loose bucket brigade" where individual motors alter between periods of active transport and free diffusion within neuronal processes. These results suggest that individual kinesin-1 motors are utilized for multiple rounds of transport.	[Blasius, T. Lynne; Reed, Nathan; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Slepchenko, Boris M.] Univ Connecticut, Dept Cell Biol, RD Berlin Ctr Cell Anal & Modeling, Ctr Hlth, Farmington, CT 06030 USA	University of Michigan System; University of Michigan; University of Connecticut	Verhey, KJ (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	kjverhey@umich.edu			NIH [1U54-RR022232, P41-RR13186, GM070862]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013186, U54RR022232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103313, R01GM070862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants to BMS (1U54-RR022232 and P41-RR13186) and KJV (GM070862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Anderson C, 2002, INSECT SOC, V49, P171, DOI 10.1007/s00040-002-8298-7; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; Astanina K, 2010, CELL MOL LIFE SCI, V67, P1331, DOI 10.1007/s00018-009-0253-6; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Barlan K, 2013, CURR OPIN CELL BIOL; Baumann S, 2012, J CELL SCI, V125, P2740, DOI 10.1242/jcs.101212; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Bratcu AI, 2005, J INTELL MANUF, V16, P139, DOI 10.1007/s10845-004-5885-7; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; DAHLSTROM AB, 1991, ACTA PHYSIOL SCAND, V141, P469, DOI 10.1111/j.1748-1716.1991.tb09107.x; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; GIOIO AE, 1994, J NEUROCHEM, V63, P13; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Koushika SP, 2004, J NEUROSCI, V24, P3907, DOI 10.1523/JNEUROSCI.5039-03.2004; Kumar J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001200; Lagache T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.030901; Laib JA, 2009, P NATL ACAD SCI USA, V106, P3190, DOI 10.1073/pnas.0809849106; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Li JY, 1999, J NEUROSCI RES, V58, P226, DOI 10.1002/(SICI)1097-4547(19991015)58:2<226::AID-JNR3>3.3.CO;2-O; Li JY, 2000, J NEUROSCI RES, V61, P151, DOI 10.1002/1097-4547(20000715)61:2<151::AID-JNR6>3.3.CO;2-E; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; LIN SXH, 1994, J CELL BIOL, V127, P1009, DOI 10.1083/jcb.127.4.1009; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Miller KE, 2008, EXP CELL RES, V314, P1981, DOI 10.1016/j.yexcr.2008.03.004; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Muresan V, 1996, J CELL BIOL, V135, P383, DOI 10.1083/jcb.135.2.383; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nedelec F, 2001, PHYS REV LETT, V86, P3192, DOI 10.1103/PhysRevLett.86.3192; NODA Y, 1995, J CELL BIOL, V129, P157, DOI 10.1083/jcb.129.1.157; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedersen LB, 2006, CURR BIOL, V16, P450, DOI 10.1016/j.cub.2006.02.020; POPOV S, 1992, J NEUROSCI, V12, P77; Qi YP, 1997, J NEUROSCI, V17, P1217; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; SABRY J, 1995, NEURON, V14, P1247, DOI 10.1016/0896-6273(95)90271-6; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; Schuster M, 2011, MOL BIOL CELL, V22, P3645, DOI [10.1091/E11-03-0217, 10.1091/mbc.E11-03-0217]; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Silverman MA, 2010, CYTOSKELETON, V67, P784, DOI 10.1002/cm.20487; Slepchenko BM, 2010, INT REV CEL MOL BIO, V283, P1, DOI 10.1016/S1937-6448(10)83001-1; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Szpankowski L, 2012, P NATL ACAD SCI USA, V109, P8582, DOI 10.1073/pnas.1120510109; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; Towns WL, 2009, CELL MOTIL CYTOSKEL, V66, P80, DOI 10.1002/cm.20327; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Uchida A, 2009, MOL BIOL CELL, V20, P4997, DOI 10.1091/mbc.E09-04-0304; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; Veniamin S, 2011, FREE RADICAL BIO MED, V51, P1589, DOI 10.1016/j.freeradbiomed.2011.06.024; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wagner OI, 2009, P NATL ACAD SCI USA, V106, P19605, DOI 10.1073/pnas.0902949106; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZH, 2001, MOL CELL BIOL, V21, P2463, DOI 10.1128/MCB.21.7.2463-2466.2001; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	104	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76081	10.1371/journal.pone.0076081	http://dx.doi.org/10.1371/journal.pone.0076081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098765	gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500135
J	Qu, XY; Randhawa, G; Friedman, C; Kurland, BF; Glaskova, L; Coleman, I; Mostaghel, E; Higano, CS; Porter, C; Vessella, R; Nelson, PS; Fang, M				Qu, Xiaoyu; Randhawa, Grace; Friedman, Cynthia; Kurland, Brenda F.; Glaskova, Lena; Coleman, Ilsa; Mostaghel, Elahe; Higano, Celestia S.; Porter, Christopher; Vessella, Robert; Nelson, Peter S.; Fang, Min			A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors	PLOS ONE			English	Article							ANDROGEN RECEPTOR GENE; IN-SITU HYBRIDIZATION; GENOMIC DELETION; ERG EXPRESSION; FUSION; TMPRSS2-ERG; PROGRESSION; AMPLIFICATION; BONE; HETEROGENEITY	TMPRSS2/ERG rearrangement, PTEN gene deletion, and androgen receptor (AR) gene amplification have been observed in various stages of human prostate cancer. We hypothesized that using these markers as a combined panel would allow better differentiation between low-risk and high-risk prostate cancer. We analyzed 110 primary prostate cancer samples, 70 metastatic tumor samples from 11 patients, and 27 xenograft tissues derived from 22 advanced prostate cancer patients using fluorescence in situ hybridization (FISH) analysis with probes targeting the TMPRSS2/ERG, PTEN, and AR gene loci. Heterogeneity of the aberrations detected was evaluated. Genetic patterns were also correlated with transcript levels. Among samples with complete data available, the three-marker FISH panel detected chromosomal abnormalities in 53% of primary prostate cancers and 87% of metastatic (Met) or castration-resistant (CRPC) tumors. The number of markers with abnormal FISH result had a different distribution between the two groups (P<0.001). At the patient level, Met/CRPC tumors are 4.5 times more likely to show abnormalities than primary cancer patients (P<0.05). Heterogeneity among Met/CRPC tumors is mostly inter-patient. Intra-patient heterogeneity is primarily due to differences between the primary prostate tumor and the metastases while multiple metastatic sites show consistent abnormalities. Intra-tumor variability is most prominent with the AR copy number in primary tumors. AR copy number correlated well with the AR mRNA expression (rho = 0.52, P<0.001). Especially among TMPRSS2: ERG fusion-positive CRPC tumors, AR mRNA and ERG mRNA levels are strongly correlated (rho = 0.64, P<0.001). Overall, the three-marker FISH panel may represent a useful tool for risk stratification of prostate cancer patients.	[Qu, Xiaoyu; Kurland, Brenda F.; Coleman, Ilsa; Mostaghel, Elahe; Higano, Celestia S.; Nelson, Peter S.; Fang, Min] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Randhawa, Grace; Friedman, Cynthia; Glaskova, Lena; Higano, Celestia S.; Fang, Min] Seattle Canc Care Alliance, Seattle, WA USA; [Mostaghel, Elahe; Higano, Celestia S.; Vessella, Robert; Nelson, Peter S.; Fang, Min] Univ Washington, Seattle, WA 98195 USA; [Porter, Christopher] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Vessella, Robert] Puget Sound VA Hlth Care Syst, Seattle, WA USA	Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Virginia Mason Medical Center	Fang, M (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	mfang@fhcrc.org	Kurland, Brenda F/AAM-9239-2020	Kurland, Brenda F/0000-0002-5669-0595	PNW SPORE [P50 CA097186, P50CA138293, P01CA085859, PC093372, PC093509]; National Cancer Institute; NATIONAL CANCER INSTITUTE [P50CA138293, P01CA085859, P50CA097186] Funding Source: NIH RePORTER	PNW SPORE; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by PNW SPORE P50 CA097186, P50CA138293, P01CA085859, PC093372, and PC093509 awarded by the National Cancer Institute. The xenograft generation and clinical specimen collection was supported by Richard M. Lucas Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Brown RSD, 2002, J PATHOL, V198, P237, DOI 10.1002/path.1206; Bubendorf L, 1999, CANCER RES, V59, P803; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chaux A, 2011, AM J SURG PATHOL, V35, P1014, DOI 10.1097/PAS.0b013e31821e8761; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Corey Eva, 2007, P3, DOI 10.1007/978-1-59745-224-3_1; Esgueva R, 2010, MODERN PATHOL, V23, P539, DOI 10.1038/modpathol.2009.193; FitzGerald LM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-230; Ford OH, 2003, J UROLOGY, V170, P1817, DOI 10.1097/01.ju.0000091873.09677.f4; Gallucci M, 2006, CANCER LETT, V237, P76, DOI 10.1016/j.canlet.2005.05.033; Gallucci M, 2009, UROL ONCOL-SEMIN ORI, V27, P502, DOI 10.1016/j.urolonc.2008.04.008; Gopalan A, 2009, CANCER RES, V69, P1400, DOI 10.1158/0008-5472.CAN-08-2467; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Holcomb IN, 2008, CANCER RES, V68, P5599, DOI 10.1158/0008-5472.CAN-08-0812; Holcomb IN, 2009, CANCER RES, V69, P7793, DOI 10.1158/0008-5472.CAN-08-3810; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Lindberg J, 2012, EUR UROL; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Mehra R, 2008, CANCER RES, V68, P3584, DOI 10.1158/0008-5472.CAN-07-6154; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Qu XY, 2013, CANCER GENET-NY, V206, P1, DOI 10.1016/j.cancergen.2012.12.004; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Verhagen PCMS, 2006, J PATHOL, V208, P699, DOI 10.1002/path.1929; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang Y, 2011, ONCOGENE, V30, P4327, DOI 10.1038/onc.2011.144; Yoshimoto M, 2007, BRIT J CANCER, V97, P678, DOI 10.1038/sj.bjc.6603924; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	38	16	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74671	10.1371/journal.pone.0074671	http://dx.doi.org/10.1371/journal.pone.0074671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098661	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500032
J	Shahinas, D; Folefoc, A; Taldone, T; Chiosis, G; Crandall, I; Pillai, DR				Shahinas, Dea; Folefoc, Asongna; Taldone, Tony; Chiosis, Gabriela; Crandall, Ian; Pillai, Dylan R.			A Purine Analog Synergizes with Chloroquine (CQ) by Targeting Plasmodium falciparum Hsp90 (PfHsp90)	PLOS ONE			English	Article							ARTEMISININ-RESISTANT MALARIA; HEAT-SHOCK PROTEINS; IN-VITRO; MOLECULAR CHAPERONE; INHIBITORS; HEAT-SHOCK-PROTEIN-90; GELDANAMYCIN; COMBINATIONS; TOXICITY; REVERSAL	Background: Drug resistance, absence of an effective vaccine, and inadequate public health measures are major impediments to controlling Plasmodium falciparum malaria worldwide. The development of antimalarials to which resistance is less likely is paramount. To this end, we have exploited the chaperone function of P. falciparum Hsp90 (PfHsp90) that serves to facilitate the expression of resistance determinants. Methods: The affinity and activity of a purine analogue Hsp90 inhibitor (PU-H71) on PfHsp90 was determined using surface plasmon resonance (SPR) studies and an ATPase activity assay, respectively. In vitro, antimalarial activity was quantified using flow cytometry. Interactors of PfHsp90 were determined by LC-MS/MS. In vivo studies were conducted using the Plasmodium berghei infection mouse model. Results: PU-H71 exhibited antimalarial activity in the nanomolar range, displayed synergistic activity with chloroquine in vitro. Affinity studies reveal that the PfHsp90 interacts either directly or indirectly with the P. falciparum chloroquine resistance transporter (PfCRT) responsible for chloroquine resistance. PU-H71 synergized with chloroquine in the P. berghei mouse model of malaria to reduce parasitemia and improve survival. Conclusions: We propose that the interaction of PfHsp90 with PfCRT may account for the observed antimalarial synergy and that PU-H71 is an effective adjunct for combination therapy.	[Shahinas, Dea; Crandall, Ian] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Taldone, Tony; Chiosis, Gabriela] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Folefoc, Asongna; Pillai, Dylan R.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Folefoc, Asongna; Pillai, Dylan R.] Univ Calgary, Calgary, AB, Canada; [Pillai, Dylan R.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Toronto; Memorial Sloan Kettering Cancer Center; University of Calgary; University of Calgary; University of Calgary	Pillai, DR (corresponding author), Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada.	drpillai@ucalgary.ca			Ontario Agency for Health Protection and Promotion; NATIONAL CANCER INSTITUTE [R01CA172546, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS050838] Funding Source: NIH RePORTER	Ontario Agency for Health Protection and Promotion; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this project was provided by the Ontario Agency for Health Protection and Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2007, MOL BIOCHEM PARASIT, V153, P85, DOI 10.1016/j.molbiopara.2007.01.009; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Banumathy G, 2004, THESIS DEP BIOCH; Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; Birnby DA, 2000, GENETICS, V155, P85; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Chiosis G, 2006, EXPERT OPIN THER TAR, V10, P37, DOI 10.1517/14728222.10.1.37; Chiosis G, 2002, BIOORGAN MED CHEM, V10, P3555, DOI 10.1016/S0968-0896(02)00253-5; Chiosis G, 2006, CURR OPIN INVEST DR, V7, P534; Corbett KD, 2010, PROTEINS, V78, P2738, DOI 10.1002/prot.22799; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2006, EUKARYOT CELL, V5, P2184, DOI 10.1128/EC.00274-06; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; Dey A, 2007, ARCH BIOCHEM BIOPHYS, V461, P275, DOI 10.1016/j.abb.2007.02.014; Dey A, 2006, J PHARMACOL EXP THER, V317, P1391, DOI 10.1124/jpet.106.101808; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Health UNIo, 2011, 1 IN HUM PHAS 1 TRIA; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; McDonald E, 2006, CURR TOP MED CHEM, V6, P1091, DOI 10.2174/156802606777812004; Min-Oo G, 2010, ANTIMICROB AGENTS CH, V54, P3262, DOI 10.1128/AAC.01719-09; Mishra LC, 2007, AM J TROP MED HYG, V76, P497, DOI 10.4269/ajtmh.2007.76.497; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Noedl H, 2002, ANTIMICROB AGENTS CH, V46, P1658, DOI 10.1128/AAC.46.6.1658-1664.2002; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Oduola AMJ, 1998, AM J TROP MED HYG, V58, P625, DOI 10.4269/ajtmh.1998.58.625; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Pereira MR, 2011, ANTIMICROB AGENTS CH, V55, P3115, DOI 10.1128/AAC.01566-10; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Shahinas D, 2010, J MED CHEM, V53, P3552, DOI 10.1021/jm901796s; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Sidhu ABS, 2007, J BIOL CHEM, V282, P2494, DOI 10.1074/jbc.M608615200; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; SU XZ, 1994, GENE, V151, P225, DOI 10.1016/0378-1119(94)90661-0; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Taldone T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000714; Taldone T, 2009, CURR TOP MED CHEM, V9, P1436, DOI 10.2174/156802609789895737; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Wiesgigl M, 2001, MOL BIOL CELL, V12, P3307, DOI 10.1091/mbc.12.11.3307; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; Zhao RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009934	56	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75446	10.1371/journal.pone.0075446	http://dx.doi.org/10.1371/journal.pone.0075446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098696	Green Published, gold			2022-12-27	WOS:000325423500067
J	Wang, S; Dai, YX; Chen, LL; Dong, ZB; Chen, YP; Li, CG; Zhong, X; Lin, WH; Zhang, JF				Wang, Shen; Dai, Yuxiang; Chen, Lingling; Dong, Zhibing; Chen, Yunpeng; Li, Chenguang; Zhong, Xin; Lin, Wenhui; Zhang, Jifu			Genetic Polymorphism of Angiotensin Converting Enzyme and Risk of Coronary Restenosis after Percutaneous Transluminal Coronary Angioplasties: Evidence from 33 Cohort Studies	PLOS ONE			English	Article							INSERTION DELETION POLYMORPHISM; BALLOON ANGIOPLASTY; STENT RESTENOSIS; ARTERY-DISEASE; WALL THICKNESS; DOUBLE-BLIND; D ALLELE; INHIBITORS; NEOINTIMA; RECEPTOR	Background: In the past decade, a number of cohort studies studies have been carried out to investigate the relationship between the insertion/deletion polymorphism of the gene encoding angiotensin-converting enzyme and risk of restenosis after percutaneous transluminal coronary angioplasties in patients. However, these studies have yielded contradictory results. Genetic association studies addressing this issue are frequently hampered by insufficient power. We therefore performed a meta-analysis of the published studies to clarify this inconsistency and to establish a comprehensive picture of the relationship between ACE I/D polymorphism and post-PTCA restenosis risk. Methods: Databases including Pubmed, EMBASE, ISI Web of Science, EBSCO, Cochrane Library databases and CNKI were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. The random-effects model was applied, addressing heterogeneity and publication bias. Results: A total of 33 cohort studies involving 11,099 subjects were included. In a combined analysis, the OR for post-PTCA restenosis of the ACE DD genotype was 1.61 (95% CI: 1.27-2.04; P<10(-5)). In the subgroup analysis by intervention, significantly increased risks were also found in PTCA-stent and PTCA-balloon for the DD genotype of the polymorphism. Conclusions: Our meta-analysis showed that the DD genotype of ACE I/D polymorphism was significantly associated with increased risk of restenosis, particularly for PTCA-stent.	[Wang, Shen; Chen, Lingling; Dong, Zhibing; Chen, Yunpeng; Lin, Wenhui; Zhang, Jifu] First Peoples Hosp Wenling, Dept Cardiol, Wenling, Zhejiang, Peoples R China; [Dai, Yuxiang; Li, Chenguang; Zhong, Xin] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China	Fudan University	Wang, S (corresponding author), First Peoples Hosp Wenling, Dept Cardiol, Wenling, Zhejiang, Peoples R China.	shen_wang01@163.com	Chen, Ling-Ling/AAY-3547-2021		Nature Scientific Foundation of Wenling [2010WLCA0047]	Nature Scientific Foundation of Wenling	This study was supported by Nature Scientific Foundation of Wenling (2010WLCA0047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; Amant C, 1997, CIRCULATION, V96, P56; BALCON R, 1992, CIRCULATION, V86, P100; BEOHAR N, 1995, J INVEST MED, V43, P275; BONITHONKOPP C, 1994, CIRCULATION, V89, P952, DOI 10.1161/01.CIR.89.3.952; CASTELLANO M, 1995, CIRCULATION, V91, P2721, DOI 10.1161/01.CIR.91.11.2721; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; CURRIER JW, 1995, J AM COLL CARDIOL, V25, P516, DOI 10.1016/0735-1097(95)98445-J; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FAXON DP, 1995, J AM COLL CARDIOL, V25, P362, DOI 10.1016/0735-1097(94)00368-Z; Ferrari M, 2002, CARDIOLOGY, V97, P29, DOI 10.1159/000047416; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; [高璀乡 GAO Cuixiang], 2006, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V26, P351; Gensini F, 1999, Minerva Cardioangiol, V47, P516; Gomma AH, 2002, EUR HEART J, V23, P1955, DOI 10.1053/euhj.2002.3400; Guarda E, 1999, REV ESP CARDIOL, V52, P475, DOI 10.1016/S0300-8932(99)74954-7; Guneri S, 2005, INT HEART J, V46, P889, DOI 10.1536/ihj.46.889; Guo F, 2005, ZHONGGUO YOU SHENG Y, V13, P18; Gurlek A, 2000, J CARDIOVASC RISK, V7, P403; Hamon M, 1998, AM J CARDIOL, V81, P79, DOI 10.1016/S0002-9149(97)00852-7; Jorgensen E, 2001, J AM COLL CARDIOL, V38, P1434, DOI 10.1016/S0735-1097(01)01580-7; KAMITANI A, 1995, HYPERTENSION, V25, P950, DOI 10.1161/01.HYP.25.5.950; Kammerer CM, 2004, HYPERTENSION, V43, P466, DOI 10.1161/01.HYP.0000111830.36999.94; Kaski JC, 1996, AM J CARDIOL, V77, P875, DOI 10.1016/S0002-9149(97)89187-4; Koch W, 2000, CIRCULATION, V102, P197, DOI 10.1161/01.CIR.102.2.197; Lv D, 2012, ZHONGGUO FEN ZI XIN, V12, P76; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meurice T, 2001, LANCET, V357, P1321, DOI 10.1016/S0140-6736(00)04518-9; NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616, DOI 10.1016/S0735-1097(88)80046-9; OHISHI M, 1993, NAT GENET, V5, P324, DOI 10.1038/ng1293-324; Okamura A, 1999, ANGIOLOGY, V50, P811, DOI 10.1177/000331979905001005; Okumura K, 2002, CIRC J, V66, P311, DOI 10.1253/circj.66.311; Peters RJ, 1997, CIRCULATION, V95, P2254, DOI 10.1161/01.CIR.95.9.2254; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; PRESCOTT MF, 1991, AM J PATHOL, V139, P139; Qu Xiufen, 2002, Zhonghua Yi Xue Za Zhi, V82, P474; RAKUGI H, 1994, CIRCULATION, V90, P449, DOI 10.1161/01.CIR.90.1.449; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Ribichini F, 2003, AM J CARDIOL, V91, P154, DOI 10.1016/S0002-9149(02)03101-6; Ribichini F, 1998, CIRCULATION, V97, P147, DOI 10.1161/01.CIR.97.2.147; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Ryu SK, 2002, YONSEI MED J, V43, P461, DOI 10.3349/ymj.2002.43.4.461; SAMANI NJ, 1995, LANCET, V345, P1013, DOI 10.1016/S0140-6736(95)90756-4; Sayed-Tabatabaei FA, 2003, STROKE, V34, P1634, DOI 10.1161/01.STR.0000077926.49330.64; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Shah DM, 2006, CURR HYPERTENS REP, V8, P144, DOI 10.1007/s11906-006-0011-1; Taniguchi I, 2001, JPN CIRC J, V65, P897, DOI 10.1253/jcj.65.897; Tsukada K, 1997, JPN HEART J, V38, P799; Ujiie Y, 2006, INT HEART J, V47, P173, DOI 10.1536/ihj.47.173; VANBOCKXMEER FM, 1995, CIRCULATION, V92, P2066, DOI 10.1161/01.CIR.92.8.2066; VIOLARIS AG, 1995, CIRCULATION, V91, P2140, DOI 10.1161/01.CIR.91.8.2140; VISWANATHAN M, 1992, J CLIN INVEST, V90, P1707, DOI 10.1172/JCI116043; Volzke H, 2000, CLIN SCI, V99, P19; Wang H, 2005, ZHONGGUO LIN CHUANG, V9, P33; Wang SJ, 2005, ZHONGGUO LIN CHUANG, V12, P386; WEINTRAUB WS, 1993, J AM COLL CARDIOL, V21, P6, DOI 10.1016/0735-1097(93)90711-9; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Wijpkema JS, 2006, PHARMACOGENET GENOM, V16, P331, DOI 10.1097/01.fpc.0000205001.07054.fa; Yamamoto J, 1999, HYPERTENS RES-CLIN E, V22, P81, DOI 10.1291/hypres.22.81; Yoshida M, 1999, INT J CARDIOL, V70, P119, DOI 10.1016/S0167-5273(99)00064-9; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zee RYL, 2001, HYPERTENSION, V37, P851, DOI 10.1161/01.HYP.37.3.851	66	22	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75285	10.1371/journal.pone.0075285	http://dx.doi.org/10.1371/journal.pone.0075285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098690	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500061
J	Nikolaou, K; Critchley, H; Duka, T				Nikolaou, Kyriaki; Critchley, Hugo; Duka, Theodora			Alcohol Affects Neuronal Substrates of Response Inhibition but Not of Perceptual Processing of Stimuli Signalling a Stop Response	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INDUCED IMPAIRMENT; COGNITIVE CONTROL; DRUG-ADDICTION; NEURAL BASIS; MODEL; BRAIN; DISSOCIATION; PERFORMANCE; DRINKING	Alcohol impairs inhibitory control, including the ability to terminate an initiated action. While there is increasing knowledge about neural mechanisms involved in response inhibition, the level at which alcohol impairs such mechanisms remains poorly understood. Thirty-nine healthy social drinkers received either 0.4g/kg or 0.8g/kg of alcohol, or placebo, and performed two variants of a Visual Stop-signal task during acquisition of functional magnetic resonance imaging (fMRI) data. The two task variants differed only in their instructions: in the classic variant (VSST), participants inhibited their response to a "Go-stimulus" when it was followed by a "Stop-stimulus". In the control variant (VSST_C), participants responded to the "Go-stimulus" even if it was followed by a "Stop-stimulus". Comparison of successful Stop-trials (Sstop)>Go, and unsuccessful Stop-trials (Ustop)>Sstop between the three beverage groups enabled the identification of alcohol effects on functional neural circuits supporting inhibitory behaviour and error processing. Alcohol impaired inhibitory control as measured by the Stop-signal reaction time, but did not affect other aspects of VSST performance, nor performance on the VSST_C. The low alcohol dose evoked changes in neural activity within prefrontal, temporal, occipital and motor cortices. The high alcohol dose evoked changes in activity in areas affected by the low dose but importantly induced changes in activity within subcortical centres including the globus pallidus and thalamus. Alcohol did not affect neural correlates of perceptual processing of infrequent cues, as revealed by conjunction analyses of VSST and VSST_C tasks. Alcohol ingestion compromises the inhibitory control of action by modulating cortical regions supporting attentional, sensorimotor and action-planning processes. At higher doses the impact of alcohol also extends to affect subcortical nodes of fronto-basal ganglia-thalamo-cortical motor circuits. In contrast, alcohol appears to have little impact on the early visual processing of infrequent perceptual cues. These observations clarify clinically-important effects of alcohol on behaviour.	[Nikolaou, Kyriaki; Critchley, Hugo; Duka, Theodora] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Nikolaou, Kyriaki; Critchley, Hugo; Duka, Theodora] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England; [Critchley, Hugo] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Critchley, Hugo] Sussex Partnership NHS Fdn, Brighton, E Sussex, England; [Critchley, Hugo] Sussex Partnership NHS Fdn, Hove, England	University of Sussex; University of Brighton; University of Sussex; University of Sussex	Duka, T (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	t.duka@sussex.ac.uk	critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284; Nikolaou, Konstantin/0000-0003-2668-7325; Nikolaou, Kyriaki/0000-0003-3856-9182	Medical Research Council Project Grant [G0802642]; The European Regional Development Fund, European Commission INTERREG IVA program [4096]; MRC [G0802642] Funding Source: UKRI; Medical Research Council [G0802642] Funding Source: researchfish	Medical Research Council Project Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The European Regional Development Fund, European Commission INTERREG IVA program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by Medical Research Council Project Grant G0802642, and by The European Regional Development Fund, European Commission INTERREG IVA program No. 4096 "AlcoBinge". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Anderson BM, 2011, ALCOHOL CLIN EXP RES, V35, P156, DOI 10.1111/j.1530-0277.2010.01332.x; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Boehler CN, 2010, NEUROIMAGE, V52, P1621, DOI 10.1016/j.neuroimage.2010.04.276; Boehler CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026386; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Caswell AJ, 2013, PSYCHOPHARMACOLOGY, V229, P21, DOI 10.1007/s00213-013-3079-8; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; de Wit H, 2000, BEHAV NEUROSCI, V114, P830, DOI 10.1037//0735-7044.114.4.830; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Dodds CM, 2011, CEREB CORTEX, V21, P1155, DOI 10.1093/cercor/bhq187; Dougherty DM, 2008, DRUG ALCOHOL DEPEN, V96, P111, DOI 10.1016/j.drugalcdep.2008.02.002; Duka T, 1998, PSYCHOPHARMACOLOGY, V136, P379, DOI 10.1007/s002130050581; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Easdon C, 2005, COGNITIVE BRAIN RES, V25, P873, DOI 10.1016/j.cogbrainres.2005.09.009; Esposito F, 2010, NEUROIMAGE, V53, P534, DOI 10.1016/j.neuroimage.2010.06.061; Field M, 2010, ALCOHOL CLIN EXP RES, V34, P1346, DOI 10.1111/j.1530-0277.2010.01218.x; Fillmore MT, 1999, EXP CLIN PSYCHOPHARM, V7, P49, DOI 10.1037/1064-1297.7.1.49; Fillmore MT, 2005, J STUD ALCOHOL, V66, P663, DOI 10.15288/jsa.2005.66.663; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; FROMME K, 1993, PSYCHOL ASSESSMENT, V5, P7; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Green A, 2009, HUM BRAIN MAPP, V30, P3309, DOI 10.1002/hbm.20753; Guillot CR, 2010, EXP CLIN PSYCHOPHARM, V18, P409, DOI 10.1037/a0021053; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; Katanoda K, 2002, NEUROIMAGE, V17, P1415, DOI 10.1006/nimg.2002.1209; Kenemans JL, 2010, J PSYCHOPHARMACOL, V24, P839, DOI 10.1177/0269881108098868; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Loeber S, 2009, ADDICTION, V104, P2013, DOI 10.1111/j.1360-0443.2009.02718.x; Loeber S, 2009, DRUG ALCOHOL DEPEN, V102, P56, DOI 10.1016/j.drugalcdep.2009.01.014; Loeber S, 2009, PSYCHOPHARMACOLOGY, V205, P577, DOI 10.1007/s00213-009-1565-9; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Logan Gordon D., 1994, P189; Marczinski CA, 2005, PSYCHOPHARMACOLOGY, V182, P452, DOI 10.1007/s00213-005-0116-2; Marczinski CA, 2005, PSYCHOPHARMACOLOGY, V181, P337, DOI 10.1007/s00213-005-2269-4; Marczinski CA, 2003, EXP CLIN PSYCHOPHARM, V11, P110, DOI 10.1037/1064-1297.11.1.110; Marinkovic K, 2012, HUM BRAIN MAPP, V33, P319, DOI 10.1002/hbm.21213; Matthews SC, 2005, NEUROREPORT, V16, P755, DOI 10.1097/00001756-200505120-00020; McCarthy DM, 2012, ADDICTION, V107, P2109, DOI 10.1111/j.1360-0443.2012.03974.x; MEHRABIAN A, 1978, PSYCHOL REP, V43, P803, DOI 10.2466/pr0.1978.43.3.803; Mulvihill LE, 1997, J STUD ALCOHOL, V58, P600, DOI 10.15288/jsa.1997.58.600; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nikolaou K, 2013, NEUROPSYCHOPHARMACOL, V38, P1365, DOI 10.1038/npp.2013.34; Norman AL, 2011, DRUG ALCOHOL DEPEN, V119, P216, DOI 10.1016/j.drugalcdep.2011.06.019; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Penny W., 2003, HUMAN BRAIN FUNCTION; Rey A, 1964, LEXAMEN CLINIQUE PSY; Ross RS, 2008, J COGNITIVE NEUROSCI, V20, P432, DOI 10.1162/jocn.2008.20.3.432; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; SANO M, 1993, J STUD ALCOHOL, V54, P369, DOI 10.15288/jsa.1993.54.369; Schuckit MA, 2012, ALCOHOL CLIN EXP RES, V36, P130, DOI 10.1111/j.1530-0277.2011.01590.x; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; STEELE CM, 1985, J PERS SOC PSYCHOL, V48, P18, DOI 10.1037/0022-3514.48.1.18; Steven MC, 2007, BEHAV BRAIN RES, V181, P12, DOI 10.1016/j.bbr.2007.03.023; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Townshend JM, 2005, ALCOHOL CLIN EXP RES, V29, P317, DOI 10.1097/01.ALC.0000156453.05028.F5; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; VOLKOW ND, 1988, PSYCHIAT RES, V24, P201, DOI 10.1016/0165-1781(88)90063-7; Weafer J, 2008, PSYCHOPHARMACOLOGY, V201, P315, DOI 10.1007/s00213-008-1284-7; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Weissenborn R, 2003, PSYCHOPHARMACOLOGY, V165, P306, DOI 10.1007/s00213-002-1281-1; White CN, 2012, J NEUROSCI, V32, P16716, DOI 10.1523/JNEUROSCI.1744-12.2012	77	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76649	10.1371/journal.pone.0076649	http://dx.doi.org/10.1371/journal.pone.0076649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086758	Green Accepted, Green Published, gold			2022-12-27	WOS:000325218700130
J	Barbu, EM; Shirazi, F; McGrath, DM; Albert, N; Sidman, RL; Pasqualini, R; Arap, W; Kontoyiannis, DP				Barbu, E. Magda; Shirazi, Fazal; McGrath, Danielle M.; Albert, Nathaniel; Sidman, Richard L.; Pasqualini, Renata; Arap, Wadih; Kontoyiannis, Dimitrios P.			An Antimicrobial Peptidomimetic Induces Mucorales Cell Death through Mitochondria-Mediated Apoptosis	PLOS ONE			English	Article							COMBINATORIAL PEPTIDE SELECTION; FACTOR RECEPTOR PATHWAY; AMPHOTERICIN-B; ANTIFUNGAL; RESISTANCE; YEAST; METACASPASES; PATHOGENESIS; MECHANISMS; PROSTATE	The incidence of mucormycosis has dramatically increased in immunocompromised patients. Moreover, the array of cellular targets whose inhibition results in fungal cell death is rather limited. Mitochondria have been mechanistically identified as central regulators of detoxification and virulence in fungi. Our group has previously designed and developed a proteolytically-resistant peptidomimetic motif (D)(KLAKLAK)(2) with pleiotropic action ranging from targeted (i.e., ligand-directed) activity against cancer and obesity to non-targeted activity against antibiotic resistant gram-negative rods. Here we evaluated whether this non-targeted peptidomimetic motif is active against Mucorales. We show that (D)(KLAKLAK)(2) has marked fungicidal action, inhibits germination, and reduces hyphal viability. We have also observed cellular changes characteristic of apoptosis in (D)(KLAKLAK)(2)-treated Mucorales cells. Moreover, the fungicidal activity was directly correlated with vacuolar injury, mitochondrial swelling and mitochondrial membrane depolarization, intracellular reactive oxygen species accumulation (ROS), and increased caspase-like enzymatic activity. Finally, these apoptotic features were prevented by the addition of the ROS scavenger N-acetyl-cysteine indicating mechanistic pathway specificity. Together, these findings indicate that (D)(KLAKLAK)(2) makes Mucorales exquisitely susceptible via mitochondrial injury-induced apoptosis. This prototype may serve as a candidate drug for the development of translational applications against mucormycosis and perhaps other fungal infections.	[Barbu, E. Magda; McGrath, Danielle M.; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, David H Koch Ctr, Houston, TX 77030 USA; [Barbu, E. Magda; Shirazi, Fazal; Albert, Nathaniel; Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Sidman, Richard L.] Harvard Univ, Sch Med, Boston, MA USA; [Sidman, Richard L.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Pasqualini, R (corresponding author), Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA.	rpasqual@salud.unm.edu; warap@salud.unm.edu; dkontoyi@mdanderson.org	Shirazi, Fazal/C-7398-2014	Shirazi, Fazal/0000-0002-6097-1779	National Institutes of Health [AI089812]; AngelWorks; Gillson-Longenbaugh Foundation; Marcus Foundation; NATIONAL CANCER INSTITUTE [U54CA151668, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI089812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AngelWorks; Gillson-Longenbaugh Foundation; Marcus Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI089812 (http://www.niaid.nih.gov/Pages/default.aspx) and awards from AngelWorks (http://myangelworks.org/wp/), the Gillson-Longenbaugh Foundation, and the Marcus Foundation (http://www.marcusfound.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antachopoulos C, 2006, J CLIN MICROBIOL, V44, P553, DOI 10.1128/JCM.44.2.553-560.2006; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Barnhart KF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002621; Ben-Ami R, 2010, ANTIMICROB AGENTS CH, V54, P484, DOI 10.1128/AAC.00956-09; BESSALLE R, 1990, FEBS LETT, V274, P151, DOI 10.1016/0014-5793(90)81351-N; Cardo-Vila M, 2010, P NATL ACAD SCI USA, V107, P5118, DOI 10.1073/pnas.0915146107; Cho J, 2011, BIOCHEM BIOPH RES CO, V405, P422, DOI 10.1016/j.bbrc.2011.01.046; Clinical and Laboratory Standards Institute, 2012, M100S19 CLSI; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Farina C, 2012, MED MYCOL, V50, P427, DOI 10.3109/13693786.2011.614964; Giordano RJ, 2010, P NATL ACAD SCI USA, V107, P5112, DOI 10.1073/pnas.0915141107; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; GROVE SN, 1970, J BACTERIOL, V104, P989, DOI 10.1128/JB.104.2.989-1009.1970; Higgins DL, 2005, ANTIMICROB AGENTS CH, V49, P1127, DOI 10.1128/AAC.49.3.1127-1134.2005; Hof H, 2006, MYCOSES, V49, P2, DOI 10.1111/j.1439-0507.2006.01295.x; Hwang B, 2011, BIOCHEM BIOPH RES CO, V405, P267, DOI 10.1016/j.bbrc.2011.01.026; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kirimura K, 2006, J BIOSCI BIOENG, V102, P210, DOI 10.1263/jbb.102.210; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kontoyiannis DP, 2006, INFECT DIS CLIN N AM, V20, P581, DOI 10.1016/j.idc.2006.06.003; Lahdenranta J, 2007, FASEB J, V21, P3272, DOI 10.1096/fj.07-8273com; Lionakis MS, 2005, INFECT IMMUN, V73, P7747, DOI 10.1128/IAI.73.11.7747-7758.2005; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matejuk A, 2010, DRUG FUTURE, V35, P197, DOI 10.1358/dof.2010.035.03.1452077; McGrath DM, 2013, P NATL ACAD SCI USA, V110, P3477, DOI 10.1073/pnas.1221924110; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Niimi K, 2004, ANTIMICROB AGENTS CH, V48, P1256, DOI 10.1128/AAC.48.4.1256-1271.2004; Onuchic JN, 2013, P NATL ACAD SCI USA, V110, P3212, DOI 10.1073/pnas.1222882110; Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Shirazi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063393; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Tian J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030147, 10.1371/journal.pone.0035164]; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vitale RG, 2003, J ANTIMICROB CHEMOTH, V52, P65, DOI 10.1093/jac/dkg285; Weber SU, 2009, APOPTOSIS, V14, P97, DOI 10.1007/s10495-008-0280-z; Wu XZ, 2009, BIOCHIM BIOPHYS ACTA, V1790, P439; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	48	22	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76981	10.1371/journal.pone.0076981	http://dx.doi.org/10.1371/journal.pone.0076981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098573	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600082
J	Chaudhary, R; Chugh, M; Darokhan, Z; Katreddi, RR; Ramachandra, R; Rema, V				Chaudhary, Rahul; Chugh, Manisha; Darokhan, Ziauddin; Katreddi, Raghu Ram; Ramachandra, Renuka; Rema, V.			Physiological Slowing and Upregulation of Inhibition in Cortex Are Correlated with Behavioral Deficits in Protein Malnourished Rats	PLOS ONE			English	Article							KINDLING-INDUCED ALTERATIONS; GRANULE CELL EXCITABILITY; BARREL FIELD CORTEX; DENTATE GYRUS; INFANT MALNUTRITION; PYRAMIDAL CELLS; HIPPOCAMPAL-FORMATION; CHILD UNDERNUTRITION; INCREASED FREQUENCY; NEURONAL-ACTIVITY	Protein malnutrition during early development has been correlated with cognitive and learning disabilities in children, but the neuronal deficits caused by long-term protein deficiency are not well understood. We exposed rats from gestation up to adulthood to a protein-deficient (PD) diet, to emulate chronic protein malnutrition in humans. The offspring exhibited significantly impaired performance on the 'Gap-crossing' (GC) task after reaching maturity, a behavior that has been shown to depend on normal functioning of the somatosensory cortex. The physiological state of the somatosensory cortex was examined to determine neuronal correlates of the deficits in behavior. Extracellular multi-unit recording from layer 4 (L4) neurons that receive direct thalamocortical inputs and layers 2/3 (L2/3) neurons that are dominated by intracortical connections in the whisker-barrel cortex of PD rats exhibited significantly low spontaneous activity and depressed responses to whisker stimulation. L4 neurons were more severely affected than L2/3 neurons. The response onset was significantly delayed in L4 cells. The peak response latency of L4 and L2/3 neurons was delayed significantly. In L2/3 and L4 of the barrel cortex there was a substantial increase in GAD65 (112% over controls) and much smaller increase in NMDAR1 (12-20%), suggesting enhanced inhibition in the PD cortex. These results show that chronic protein deficiency negatively affects both thalamo-cortical and cortico-cortical transmission during somatosensory information processing. The findings support the interpretation that sustained protein deficiency interferes with features of cortical sensory processing that are likely to underlie the cognitive impairments reported in humans who have suffered from prolonged protein deficiency.	[Chaudhary, Rahul; Chugh, Manisha; Darokhan, Ziauddin; Katreddi, Raghu Ram; Ramachandra, Renuka; Rema, V.] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Rema, V (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	rema.velayudhan@gmail.com		Katreddi, Raghu Ram/0000-0002-6475-9927	Wellcome Trust [GR066676MA]; Wellcome Trust, UK; NBRC; Department of Biotechnology, India [BT/PR6615/MED/14/857/2005]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust, UK(Wellcome Trust); NBRC(Department of Biotechnology (DBT) India); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by Wellcome Trust International Senior Research Fellowship Grant GR066676MA (V. R.). V. R. acknowledges full salary support from the Wellcome Trust, UK for 5 years. Part of this work was funded by NBRC core funds and a grant from Department of Biotechnology, India BT/PR6615/MED/14/857/2005. Z.U.D. was research fellow of the Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL KN, 1989, ACTA PAEDIATR SCAND, V78, P873, DOI 10.1111/j.1651-2227.1989.tb11166.x; Agarwal KN, 1995, ACTA PAEDIATR, V84, P1357, DOI 10.1111/j.1651-2227.1995.tb13568.x; Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; ANDRADE JP, 1991, EXP NEUROL, V112, P119, DOI 10.1016/0014-4886(91)90121-R; ANGELMEZA ARD, 2002, INT J DEV NEUROSCI, V20, P47, DOI DOI 10.1016/S0736-5748(01)00066-1; ARMSTRONGJAMES M, 1991, J COMP NEUROL, V303, P193, DOI 10.1002/cne.903030203; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; Atalabi OM, 2010, INT J NEUROSCI, V120, P23, DOI 10.3109/00207450903315727; AUSTIN KB, 1992, BRAIN RES BULL, V28, P245, DOI 10.1016/0361-9230(92)90186-2; AUSTIN KB, 1986, DEV BRAIN RES, V29, P267, DOI 10.1016/0165-3806(86)90102-1; AUSTIN KB, 1989, EXP BRAIN RES, V77, P594; BARNEOUD P, 1991, BEHAV BRAIN RES, V44, P87, DOI 10.1016/S0166-4328(05)80242-6; BARTEL PR, 1979, AM J CLIN NUTR, V32, P753, DOI 10.1093/ajcn/32.4.753; Benitez-Bribiesca L, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.2.e21; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; BRONZINO JD, 1991, EXP NEUROL, V112, P206, DOI 10.1016/0014-4886(91)90071-J; Bronzino JD, 1996, HIPPOCAMPUS, V6, P109, DOI 10.1002/(SICI)1098-1063(1996)6:2<109::AID-HIPO2>3.0.CO;2-K; BRONZINO JD, 1991, EXP NEUROL, V112, P216, DOI 10.1016/0014-4886(91)90072-K; Bronzino JD, 1999, BRAIN RES, V849, P45, DOI 10.1016/S0006-8993(99)02071-5; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chang YM, 2003, NUTR NEUROSCI, V6, P263, DOI 10.1080/1028415031000151549; CORDERO ME, 1986, EARLY HUM DEV, V14, P245, DOI 10.1016/0378-3782(86)90186-6; CORDERO ME, 1976, AM J CLIN NUTR, V29, P358, DOI 10.1093/ajcn/29.4.358; CORDERO ME, 1993, PEDIATR NEUROL, V9, P457, DOI 10.1016/0887-8994(93)90025-8; Cordero ME, 2003, DEV BRAIN RES, V142, P37, DOI 10.1016/S0165-3806(03)00013-0; CRNIC LS, 1978, J NUTR, V108, P1755, DOI 10.1093/jn/108.11.1755; De Frias V, 2010, NEUROSCI LETT, V482, P203, DOI 10.1016/j.neulet.2010.07.033; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; Diaz-Cintra S, 2007, EXP NEUROL, V208, P47, DOI 10.1016/j.expneurol.2007.07.003; DIAZCINTRA S, 1990, J COMP NEUROL, V292, P117, DOI 10.1002/cne.902920108; Durmaz S, 1999, PEDIATR INT, V41, P615, DOI 10.1046/j.1442-200X.1999.t01-1-01150.x; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Feoli AM, 2006, J NUTR, V136, P2357, DOI 10.1093/jn/136.9.2357; FLINN JM, 1993, PERCEPT MOTOR SKILL, V76, P1359, DOI 10.2466/pms.1993.76.3c.1359; Galler JR, 2010, J CHILD PSYCHOL PSYC, V51, P789, DOI 10.1111/j.1469-7610.2010.02208.x; Galler JR, 2012, NUTR NEUROSCI, V15, P186, DOI 10.1179/1476830512Y.0000000012; Galler JR, 2012, J NUTR, V142, P788, DOI 10.3945/jn.111.145441; GARCIARUIZ M, 1993, BRAIN RES, V625, P203, DOI 10.1016/0006-8993(93)91060-6; Granados-Rojas L, 2004, NUTR NEUROSCI, V7, P301, DOI 10.1080/10284150400017306; Granados-Rojas L, 2002, BRAIN RES, V933, P164, DOI 10.1016/S0006-8993(02)02314-4; GUICROBLES E, 1992, BEHAV BRAIN RES, V48, P145, DOI 10.1016/S0166-4328(05)80150-0; Hazin AN, 2007, INT J NEUROSCI, V117, P1209, DOI 10.1080/00207450600934945; Hernandez Alejandro, 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/646919; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Laus MF, 2011, INT J ENV RES PUB HE, V8, P590, DOI 10.3390/ijerph8020590; Li L, 2005, J NEUROPHYSIOL, V94, P3342, DOI 10.1152/jn.00357.2005; Luebke J, 2000, SYNAPSE, V37, P23, DOI 10.1002/(SICI)1098-2396(200007)37:1&lt;23::AID-SYN3&gt;3.0.CO;2-Y; MORGANE PJ, 1978, NEUROSCI BIOBEHAV R, V2, P137, DOI 10.1016/0149-7634(78)90059-3; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mueller Arthur J., 1946, JOUR NUTRITION, V31, P249, DOI 10.1093/jn/31.2.249; Nassar MF, 2012, J TROP PEDIATRICS, V58, P226, DOI 10.1093/tropej/fmr081; Odabas D, 2005, INT J PEDIATR OTORHI, V69, P923, DOI 10.1016/j.ijporl.2005.01.034; Odabas D, 2005, INT J NEUROSCI, V115, P829, DOI 10.1080/00207450590882082; Palmer AA, 2004, BRAIN RES, V996, P193, DOI 10.1016/j.brainres.2003.09.077; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; PAULABARBOSA MM, 1989, EXP NEUROL, V103, P186, DOI 10.1016/0014-4886(89)90081-2; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; PINE AP, 1994, BRIT J NUTR, V72, P815, DOI 10.1079/BJN19940087; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; Ranade SC, 2008, NEUROSCIENCE, V152, P859, DOI 10.1016/j.neuroscience.2008.01.002; Ranade SC, 2012, BRIT J NUTR, V107, P1167, DOI 10.1017/S0007114511004119; Rema V, 1996, J COMP NEUROL, V368, P165; Rema V, 2003, J NEUROSCI, V23, P10378; Rema V, 1998, J NEUROSCI, V18, P10196; Rema V, 1999, J NEUROSCI, V19, P10993, DOI 10.1523/JNEUROSCI.19-24-10993.1999; RESNICK O, 1982, NEUROSCI BIOBEHAV R, V6, P55, DOI 10.1016/0149-7634(82)90007-0; Schweigert ID, 2005, DEV BRAIN RES, V154, P177, DOI 10.1016/j.devbrainres.2004.10.013; Soto-Moyano R, 2005, J NEUROCHEM, V93, P1099, DOI 10.1111/j.1471-4159.2005.03094.x; Steiger JL, 2003, NEUROREPORT, V14, P1731, DOI 10.1097/00001756-200309150-00015; Steiger JL, 2002, EUR J PHARMACOL, V446, P201, DOI 10.1016/S0014-2999(02)01815-0; STERN WC, 1984, BRAIN RES, V306, P227, DOI 10.1016/0006-8993(84)90372-X; STERN WC, 1983, DEV BRAIN RES, V9, P95, DOI 10.1016/0165-3806(83)90113-X; STRUPP BJ, 1995, J NUTR, V125, pS2221, DOI 10.1093/jn/125.suppl_8.2221S; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; VONGDOKMAI R, 1980, J COMP NEUROL, V191, P283, DOI 10.1002/cne.901910209; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; WEST CD, 1976, BRAIN RES, V107, P221, DOI 10.1016/0006-8993(76)90223-7; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333	84	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76556	10.1371/journal.pone.0076556	http://dx.doi.org/10.1371/journal.pone.0076556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098531	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600066
J	Khaladkar, M; Buckley, PT; Lee, MT; Francis, C; Eghbal, MM; Chuong, T; Suresh, S; Kuhn, B; Eberwine, J; Kim, J				Khaladkar, Mugdha; Buckley, Peter T.; Lee, Miler T.; Francis, Chantal; Eghbal, Mitra M.; Chuong, Tina; Suresh, Sangita; Kuhn, Bernhard; Eberwine, James; Kim, Junhyong			Subcellular RNA Sequencing Reveals Broad Presence of Cytoplasmic Intron-Sequence Retaining Transcripts in Mouse and Rat Neurons	PLOS ONE			English	Article							PRE-MESSENGER-RNA; LARGE GENE LISTS; RETENTION; DATABASE; DNA; ELEMENT; CELLS	Recent findings have revealed the complexity of the transcriptional landscape in mammalian cells. One recently described class of novel transcripts are the Cytoplasmic Intron-sequence Retaining Transcripts (CIRTs), hypothesized to confer post-transcriptional regulatory function. For instance, the neuronal CIRT KCNMA1i16 contributes to the firing properties of hippocampal neurons. Intronic sub-sequence retention within IL1-beta mRNA in anucleate platelets has been implicated in activity-dependent splicing and translation. In a recent study, we showed CIRTs harbor functional SINE ID elements which are hypothesized to mediate dendritic localization in neurons. Based on these studies and others, we hypothesized that CIRTs may be present in a broad set of transcripts and comprise novel signals for post-transcriptional regulation. We carried out a transcriptome-wide survey of CIRTs by sequencing micro-dissected subcellular RNA fractions. We sequenced two batches of 150-300 individually dissected dendrites from primary cultures of hippocampal neurons in rat and three batches from mouse hippocampal neurons. After statistical processing to minimize artifacts, we found a broad prevalence of CIRTs in the neurons in both species (44-60% of the expressed transcripts). The sequence patterns, including stereotypical length, biased inclusion of specific introns, and intron-intron junctions, suggested CIRT-specific nuclear processing. Our analysis also suggested that these cytoplasmic intron-sequence retaining transcripts may serve as a primary transcript for ncRNAs. Our results show that retaining intronic sequences is not isolated to a few loci but may be a genome-wide phenomenon for embedding functional signals within certain mRNA. The results hypothesize a novel source of cis-sequences for post-transcriptional regulation. Our results hypothesize two potentially novel splicing pathways: one, within the nucleus for CIRT biogenesis; and another, within the cytoplasm for removing CIRT sequences before translation. We also speculate that release of CIRT sequences prior to translation may form RNA-based signals within the cell potentially comprising a novel class of signaling pathways.	[Khaladkar, Mugdha; Francis, Chantal; Eghbal, Mitra M.; Chuong, Tina; Kim, Junhyong] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Buckley, Peter T.; Eberwine, James; Kim, Junhyong] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Buckley, Peter T.; Eberwine, James] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Eberwine, James; Kim, Junhyong] Univ Penn, Genom & Computat Biol Program, Philadelphia, PA 19104 USA; [Lee, Miler T.] Yale Univ, Dept Genet, New Haven, CT USA; [Suresh, Sangita; Kuhn, Bernhard] Boston Childrens Hosp, Dept Pediat, Boston, MA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Yale University; Harvard University; Boston Children's Hospital	Eberwine, J (corresponding author), Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA.	eberwine@mail.med.upenn.edu; junhyong@sas.upenn.edu			Pennsylvania Department of Health; Department of Cardiology (Boston Children's Hospital); Translational Research Program (Boston Children's Hospital); NIH [R01HL106302, K08 HL085143]; Children's Cardiomyopathy Foundation;  [NIMH 5R01MH088849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106302, K08HL085143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088849] Funding Source: NIH RePORTER	Pennsylvania Department of Health; Department of Cardiology (Boston Children's Hospital); Translational Research Program (Boston Children's Hospital); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cardiomyopathy Foundation; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by grant NIMH 5R01MH088849 to JK. This paper was also supported in part by a Health Research Formula Funds to Penn Genome Frontiers Institute from the Pennsylvania Department of Health, which disclaims responsibility for any analyses, interpretations or conclusions. BK was supported by the Department of Cardiology and the Translational Research Program (Boston Children's Hospital), the NIH (R01HL106302, K08 HL085143), and the Children's Cardiomyopathy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTIERI DC, 1994, BIOCHEMISTRY-US, V33, P13848, DOI 10.1021/bi00250a039; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Bell TJ, 2010, P NATL ACAD SCI USA, V107, P21152, DOI 10.1073/pnas.1015264107; Blencowe BJ, 2002, CURR BIOL, V12, pR147, DOI 10.1016/S0960-9822(02)00711-X; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Costa E, 2002, Mol Interv, V2, P47, DOI 10.1124/mi.2.1.47; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Djebali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028213; Durr A, 2004, ARCH NEUROL-CHICAGO, V61, P1867, DOI 10.1001/archneur.61.12.1867; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim J, 2010, TRENDS CELL BIOL, V20, P311, DOI 10.1016/j.tcb.2010.03.003; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Korf I, 2001, BIOINFORMATICS, V17, pS140, DOI DOI 10.1093/BI0INF0RMATICS/17.SUPPL_; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Mansilla A, 2005, EMBO REP, V6, P1182, DOI 10.1038/sj.embor.7400539; Marinescu V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000828; Marz P, 2004, J BIOL CHEM, V279, P35542, DOI 10.1074/jbc.M405865200; Melhuish TA, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-2; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MOWRY KL, 1987, SCIENCE, V238, P1682, DOI 10.1126/science.2825355; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Spaethling JM, 2013, J BIOL CHEM; SPYCHER C, 1994, NUCLEIC ACIDS RES, V22, P4023, DOI 10.1093/nar/22.20.4023; Sugnet C W, 2004, Pac Symp Biocomput, P66; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433	43	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76194	10.1371/journal.pone.0076194	http://dx.doi.org/10.1371/journal.pone.0076194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098440	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600029
J	Pinheiro, DS; Rocha, CR; Mundim, CA; de Marco, P; Ulhoa, CJ; Reis, AAS; Ghedini, PC				Pinheiro, Denise S.; Rocha Filho, Cesar R.; Mundim, Claudia A.; de Marco Junior, Paulo; Ulhoa, Cirano J.; Reis, Angela A. S.; Ghedini, Paulo C.			Evaluation of Glutathione S-Transferase GSTM1 and GSTT1 Deletion Polymorphisms on Type-2 Diabetes Mellitus Risk	PLOS ONE			English	Article							OXIDATIVE STRESS; GENETIC POLYMORPHISMS; ASSOCIATION; POPULATION; T1; SUSCEPTIBILITY; GENOTYPES; CANCER; CYP1A1; CELLS	Background: Due to the activity of GSTs in the detoxification of oxidative stress products, deletion polymorphisms of GSTM1 and GSTT1 may contribute to susceptibility to T2DM, since B-cells express very low levels of antioxidant enzymes. Recently, some studies have shown an association between GSTM1-null/GSTT1-null genotypes and an increased susceptibility to T2DM. A relationship between these polymorphisms and changes in the clinical parameters of diabetic patients has also been investigated. However, the results diverge considerably among the studies. Thus, this case-control study was designed to contribute to existing knowledge, as there are no studies on this issue performed in the Brazilian population. Methods and Findings: A total of 120 patients and 147 healthy individuals were included in this study. GSTT1 and GSTM1 deletion polymorphisms were genotyped by multiplex SYBR Green Real-Time PCR. The GSTT1-null genotype conferred a 3.2-fold increased risk to T2DM relative to the present genotype. There was no association between GSTM1-null and T2DM risk. In diabetic patients, GSTT1-null conferred higher levels of triglycerides and VLDL-cholesterol, while GSTM1-null was associated with increased levels of fasting blood glucose, glycated hemoglobin and blood pressure. We emphasized a necessity for applying log-linear analysis in order to explore an interaction between these polymorphisms properly. Conclusion: These results suggest that the GSTT1 polymorphism may play an important role in the pathogenesis of T2DM in the Brazilian population. This gene could then be added to a set of genetic markers to identify individuals with an increased risk for developing T2DM and complications associated with dyslipidemia in diabetic patients. Although there was no association of GSTM1 deletion polymorphism with susceptibility to T2DM, the influence of this polymorphism on important clinical parameters related to glycemia and blood pressure levels was verified. This finding suggests that both GSTM1-null and GSTT1-null may contribute to the clinical course of T2DM patients.	[Pinheiro, Denise S.] Fed Univ Goias UFG, Inst Biol Sci ICB, Goiania, Go, Brazil; [Rocha Filho, Cesar R.] Fed Univ Goias UFG, Inst Trop Pathol IPTSP, Goiania, Go, Brazil; [Mundim, Claudia A.] Fed Univ Goias UFG, Serv Endocrinol, Clin Hosp HC, Goiania, Go, Brazil; [Ulhoa, Cirano J.; Reis, Angela A. S.] Fed Univ Goias UFG, Dept Biochem & Mol Biol DBBM, Inst Biol Sci ICB, Goiania, Go, Brazil; [de Marco Junior, Paulo] Fed Univ Goias UFG, DE, Inst Biol Sci ICB, Goiania, Go, Brazil; [Ghedini, Paulo C.] Fed Univ Goias UFG, Dept Physiol Sci DCIF, Inst Biol Sci ICB, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Reis, AAS (corresponding author), Fed Univ Goias UFG, Dept Biochem & Mol Biol DBBM, Inst Biol Sci ICB, Goiania, Go, Brazil.	angeladamski@gmail.com	da Silva Pinheiro, Denise/Y-9276-2019; Ulhoa, CIRANO/AAV-9374-2020; DA SILVA, ANGELA ADAMSKI/AAJ-1403-2021; De Marco, Paulo/B-2209-2009	da Silva Pinheiro, Denise/0000-0001-7405-6822; DA SILVA, ANGELA ADAMSKI/0000-0002-8281-7334; De Marco, Paulo/0000-0002-3628-6405; Ulhoa, Cirano/0000-0002-4171-6465; Ramos Rocha-Filho, Cesar/0000-0002-7190-0263; Ghedini, Paulo/0000-0003-2104-4064	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)	D.S. Pinheiro received fellowship from Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG). Funder's website: www.fapeg.go.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman SZ, 1998, CANCER DETECT PREV, V22, P129; Amer MA, 2011, GENET MOL RES, V10, P3722, DOI 10.4238/2011.October.31.14; Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018; Arruda VR, 1998, CLIN GENET, V54, P210; Bid HK, 2010, J POSTGRAD MED, V56, P176, DOI 10.4103/0022-3859.68633; Burim RV, 2004, MUTAGENESIS, V19, P291, DOI 10.1093/mutage/geh034; Colombo J, 2004, WORLD J GASTROENTERO, V10, P1240; D'Alo F, 2004, HAEMATOLOGICA, V89, P664; Datta SK, 2010, RENAL FAILURE, V32, P1189, DOI 10.3109/0886022X.2010.517348; Doney ASF, 2005, CIRCULATION, V111, P2927, DOI 10.1161/CIRCULATIONAHA.104.509224; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hori M, 2007, PHARMACOGENOMICS, V8, P1307, DOI 10.2217/14622416.8.10.1307; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Marin F, 2010, J MOL DIAGN, V12, P300, DOI 10.2353/jmoldx.2010.090076; Ramprasath T, 2011, BIOCHEM BIOPH RES CO, V407, P49, DOI 10.1016/j.bbrc.2011.02.097; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Streiner DL, 1998, CAN J PSYCHIAT, V43, P837, DOI 10.1177/070674379804300809; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tiwari AK, 2009, J DIABETES COMPLICAT, V23, P102, DOI 10.1016/j.jdiacomp.2007.10.003; Wang GY, 2006, BIOCHEM BIOPH RES CO, V341, P310, DOI 10.1016/j.bbrc.2005.12.195; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x; Yalin S, 2007, CELL BIOCHEM FUNCT, V25, P509, DOI 10.1002/cbf.1339; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhang JW, 2013, GENE, V518, P405, DOI 10.1016/j.gene.2012.12.086	26	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76262	10.1371/journal.pone.0076262	http://dx.doi.org/10.1371/journal.pone.0076262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098457	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600033
J	van Spronsen, M; van Battum, EY; Kuijpers, M; Vangoor, VR; Rietman, ML; Pothof, J; Gumy, LF; van IJcken, WFJ; Akhmanova, A; Pasterkamp, RJ; Hoogenraad, CC				van Spronsen, Myrrhe; van Battum, Eljo Y.; Kuijpers, Marijn; Vangoor, Vamshidhar R.; Rietman, M. Liset; Pothof, Joris; Gumy, Laura F.; van IJcken, Wilfred F. J.; Akhmanova, Anna; Pasterkamp, R. Jeroen; Hoogenraad, Casper C.			Developmental and Activity-Dependent miRNA Expression Profiling in Primary Hippocampal Neuron Cultures	PLOS ONE			English	Article							REGULATES NEURITE OUTGROWTH; DENDRITIC SPINE MORPHOLOGY; MICRORNA EXPRESSION; AMPA RECEPTORS; MICROARRAY ANALYSIS; CONDITIONAL LOSS; BRAIN; MOUSE; DEGRADATION; GENE	MicroRNAs (miRNAs) are evolutionarily conserved non-coding RNAs of similar to 22 nucleotides that regulate gene expression at the level of translation and play vital roles in hippocampal neuron development, function and plasticity. Here, we performed a systematic and in-depth analysis of miRNA expression profiles in cultured hippocampal neurons during development and after induction of neuronal activity. MiRNA profiling of primary hippocampal cultures was carried out using locked nucleic-acid-based miRNA arrays. The expression of 264 different miRNAs was tested in young neurons, at various developmental stages (stage 2-4) and in mature fully differentiated neurons (stage 5) following the induction of neuronal activity using chemical stimulation protocols. We identified 210 miRNAs in mature hippocampal neurons; the expression of most neuronal miRNAs is low at early stages of development and steadily increases during neuronal differentiation. We found a specific subset of 14 miRNAs with reduced expression at stage 3 and showed that sustained expression of these miRNAs stimulates axonal outgrowth. Expression profiling following induction of neuronal activity demonstrates that 51 miRNAs, including miR-134, miR-146, miR-181, miR-185, miR-191 and miR-200a show altered patterns of expression after NMDA receptor-dependent plasticity, and 31 miRNAs, including miR-107, miR-134, miR-470 and miR-546 were upregulated by homeostatic plasticity protocols. Our results indicate that specific miRNA expression profiles correlate with changes in neuronal development and neuronal activity. Identification and characterization of miRNA targets may further elucidate translational control mechanisms involved in hippocampal development, differentiation and activity-depended processes.	[van Spronsen, Myrrhe; Kuijpers, Marijn; Gumy, Laura F.; Akhmanova, Anna; Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, Utrecht, Netherlands; [van Spronsen, Myrrhe; Kuijpers, Marijn; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [van Battum, Eljo Y.; Vangoor, Vamshidhar R.; Rietman, M. Liset; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Pothof, Joris; Akhmanova, Anna] Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hoogenraad, CC (corresponding author), Univ Utrecht, Fac Sci, Utrecht, Netherlands.	c.hoogenraad@uu.nl	van ijcken, willem/N-9805-2018; Vangoor, Vamshidhar/AAR-3865-2021; kuijpers, marijn/F-2248-2013; Hoogenraad, Casper/B-8866-2011	van ijcken, willem/0000-0002-0421-8301; kuijpers, marijn/0000-0003-1187-0290; Hoogenraad, Casper/0000-0002-2666-0758; Vangoor, Vamshi/0000-0003-0751-9772; Pasterkamp, Jeroen/0000-0003-1631-6440	Netherlands Organization for Scientific Research (NWOALW-VICI); Netherlands Organization for Health Research and Development (ZonMW-TOP); European Science Foundation (EURYI); EMBO Young Investigators Program (YIP); Human Frontier Science Program (HFSP-CDA); CTMM, the Center for Translational Molecular Medicine [EMINENCE(01C-204)]	Netherlands Organization for Scientific Research (NWOALW-VICI); Netherlands Organization for Health Research and Development (ZonMW-TOP)(Netherlands Organization for Health Research and Development); European Science Foundation (EURYI)(European Science Foundation (ESF)); EMBO Young Investigators Program (YIP)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP-CDA)(Human Frontier Science Program); CTMM, the Center for Translational Molecular Medicine	This work was supported by the Netherlands Organization for Scientific Research (NWOALW-VICI, A.A., C.C.H.), the Netherlands Organization for Health Research and Development (ZonMW-TOP, R.J.P., C.C.H.), the European Science Foundation (EURYI, C.C.H.), EMBO Young Investigators Program (YIP, C.C.H.) and the Human Frontier Science Program (HFSP-CDA, R.J.P., C.C.H.). This research was partly performed within the framework of CTMM, the Center for Translational Molecular Medicine, project EMINENCE(01C-204) (R.J.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Dabrowski M, 2003, J NEUROCHEM, V85, P1279, DOI 10.1046/j.1471-4159.2003.01753.x; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Eacker SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025068; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; FLETCHER TL, 1989, DEV BIOL, V136, P446, DOI 10.1016/0012-1606(89)90269-8; Forero DA, 2010, HUM MUTAT, V31, P1195, DOI 10.1002/humu.21344; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Holleman A, 2011, ONCOGENE, V30, P4386, DOI 10.1038/onc.2011.148; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jones EV, 2012, METHODS MOL BIOL, V814, P341, DOI 10.1007/978-1-61779-452-0_22; Juhila J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021495; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kapitein LC, 2010, METHOD CELL BIOL, V97, P111, DOI 10.1016/S0091-679X(10)97007-6; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kye MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024682; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ling KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-176; Lippi G, 2011, J CELL BIOL, V194, P889, DOI 10.1083/jcb.201103006; Liu NK, 2011, PHYSIOL GENOMICS, V43, P571, DOI 10.1152/physiolgenomics.00168.2010; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Park CS, 2009, J MOL NEUROSCI, V38, P50, DOI 10.1007/s12031-008-9158-3; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pitto L, 2009, PHYSIOL GENOMICS, V39, P210, DOI 10.1152/physiolgenomics.00085.2009; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Provost P, 2010, BRAIN RES, V1338, P58, DOI 10.1016/j.brainres.2010.03.069; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Shinohara Y, 2011, BIOCHEM BIOPH RES CO, V409, P293, DOI 10.1016/j.bbrc.2011.05.004; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Swanger SA, 2011, CURR OPIN GENET DEV, V21, P414, DOI 10.1016/j.gde.2011.04.002; Vo NK, 2010, CURR OPIN NEUROBIOL, V20, P457, DOI 10.1016/j.conb.2010.04.002; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wen Z, 2011, CURR OPIN NEUROBIOL, V4, P40; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Yuan Y, 2010, J CLIN NEUROSCI, V17, P774, DOI 10.1016/j.jocn.2009.10.009; Zhang Y, 2013, J NEUROSCI, V33, P6885, DOI 10.1523/JNEUROSCI.5180-12.2013; Zhou SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044768	100	59	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74907	10.1371/journal.pone.0074907	http://dx.doi.org/10.1371/journal.pone.0074907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098357	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600012
J	Mhurchu, CN; Eyles, H; Schilling, C; Yang, Q; Kaye-Blake, W; Genc, M; Blakely, T				Mhurchu, Cliona Ni; Eyles, Helen; Schilling, Chris; Yang, Qing; Kaye-Blake, William; Genc, Murat; Blakely, Tony			Food Prices and Consumer Demand: Differences across Income Levels and Ethnic Groups	PLOS ONE			English	Article							SYSTEMS; INTERVENTIONS; SMOKING; OBESITY; BURDEN; POLICY; TAXES	Background: Targeted food pricing policies may improve population diets. To assess their effects on inequalities, it is important to determine responsiveness to price changes across income levels and ethnic groups. Objective: Our goal was to estimate price elasticity (PE) values for major commonly consumed food groups in New Zealand, by income and ethnicity. PE values represent percentage change in demand associated with 1% change in price of that good (own-PE) or another good (cross-PE). Design: We used food expenditure data from national household economic surveys in 2007/08 and 2009/10 and Food Price Index data from 2007 and 2010. Adopting an Almost Ideal Demand System approach, own-PE and cross-PE estimates were derived for 24 food categories, household income quintiles, and two ethnic groups (Maori and non-Maori). Results: Own-PE estimates (with two exceptions) ranged from -0.44 to -1.78. Cross-PE estimates were generally small; only 31% of absolute values were greater than 0.10. Excluding the outlier 'energy drinks', nine of 23 food groups had significantly stronger own-PEs for the lowest versus highest income quintiles (average regression-based difference across food groups -0.30 (95% CI -0.62 to 0.02)). Six own-PEs were significantly stronger among Maori; the average difference for Maori: non-Maori across food groups was -0.26 (95% CI -0.52 to 0.00). Conclusions: Food pricing policies have potential to improve population diets. The greater sensitivity of low-income households and Maori to price changes suggests the beneficial effects of such policies on health would be greatest for these groups.	[Mhurchu, Cliona Ni; Eyles, Helen] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand; [Schilling, Chris; Yang, Qing; Kaye-Blake, William] New Zealand Inst Econ Res Inc, Wellington, New Zealand; [Genc, Murat] Univ Otago, Dept Econ, Dunedin, New Zealand; [Blakely, Tony] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Auckland; New Zealand Institute for Plant & Food Research Ltd; University of Otago; University of Otago	Mhurchu, CN (corresponding author), Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand.	c.nimhurchu@nihi.auckland.ac.nz	Genc, Murat/AAE-1568-2019	Kaye-Blake, William/0000-0002-9029-2531; Genc, Murat/0000-0002-5443-2146; Blakely, Tony/0000-0002-6995-4369; Ni Mhurchu, Cliona/0000-0002-1144-9167	Health Research Council of New Zealand [10/077]; National Heart Foundation [1380]; Heart Foundation of New Zealand [1463]	Health Research Council of New Zealand(Health Research Council of New Zealand); National Heart Foundation(National Heart Foundation of Australia); Heart Foundation of New Zealand	This research was funded by the Health Research Council of New Zealand (10/077). CNM was supported by the National Heart Foundation Senior Fellowship (Grant 1380). HE was supported by a Heart Foundation of New Zealand research fellowship (Grant 1463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011; Blakely T, 2005, DECADES DISPARITY; Chern W.S., 2002, 0206 ESA UN FAO AGR; Crawford I, 2003, J ECONOMETRICS, V114, P221, DOI 10.1016/S0304-4076(03)00083-6; Davis C, 2010, ANAL US HOUSEHOLD DA; DEATON A, 1980, AM ECON REV, V70, P312; Engelhard C.L., 2009, REDUCING OBESITY POL; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fantuzzi K, 2008, CARBONATED SOFT DRIN; Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703; HEIEN D, 1990, J BUS ECON STAT, V8, P365, DOI 10.2307/1391973; Holt M.T., 2009, QUANTIFYING CONSUMER; *I MED, 2009, LOC GOV ACT PREV CHI; Jha P, 2006, DRUG ALCOHOL REV, V25, P597, DOI 10.1080/09595230600944511; Lawes C, 2006, NEW ZEAL MED J, V119, P16; Ministry of Agriculture Fisheries and Food, 2000, NAT FOOD SURV 2000 A; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Park JL, 1996, AM J AGR ECON, V78, P290, DOI 10.2307/1243703; Perloff J. M., 2007, MICROECONOMICS, V4th; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Seale Jr J., 2003, TECHNICAL B USDA; STIGLER GJ, 1985, J LAW ECON, V28, P555, DOI 10.1086/467101; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; Ulubasoglu M, 2010, FOOD DEMAND ELASTICI; World Health Organization, 2008, 2008 2013 ACT PLAN G; Zheng ZhiHao, 2010, Journal of Agricultural and Applied Economics, V42, P337	30	53	54	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75934	10.1371/journal.pone.0075934	http://dx.doi.org/10.1371/journal.pone.0075934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098408	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500039
J	Tran, S; Wang, Y; Lamba, P; Zhou, X; Boehm, U; Bernard, DJ				Tran, Stella; Wang, Ying; Lamba, Pankaj; Zhou, Xiang; Boehm, Ulrich; Bernard, Daniel J.			The CpG Island in the Murine Foxl2 Proximal Promoter Is Differentially Methylated in Primary and Immortalized Cells	PLOS ONE			English	Article							HORMONE BETA-SUBUNIT; EPICANTHUS INVERSUS SYNDROME; TRANSCRIPTION FACTOR FOXL2; GENOTYPE-PHENOTYPE CORRELATION; ORGANOGENESIS IN-VIVO; HUMAN CANCER-CELLS; DNA METHYLATION; HISTONE DEACETYLASE; FORKHEAD TRANSCRIPTION; CHROMATIN-STRUCTURE	Forkhead box L2 (Foxl2), a member of the forkhead transcription factor family, plays important roles in pituitary follicle-stimulating hormone synthesis and in ovarian maintenance and function. Mutations in the human FOXL2 gene cause eyelid malformations and premature ovarian failure. FOXL2/Foxl2 is expressed in pituitary gonadotrope and thyrotrope cells, the perioptic mesenchyme of the developing eyelid, and ovarian granulosa cells. The mechanisms governing this cell-restricted expression have not been described. We mapped the Foxl2 transcriptional start site in immortalized murine gonadotrope-like cells, L beta T2, by 5' rapid amplification of cDNA ends and then PCR amplified approximately 1 kb of 5' flanking sequence from murine genomic DNA. When ligated into a reporter plasmid, the proximal promoter conferred luciferase activity in both homologous (L beta T2) and, unexpectedly, heterologous (NIH3T3) cells. In silico analyses identified a CpG island in the proximal promoter and 5' untranslated region, suggesting that Foxl2 transcription might be regulated epigenetically. Indeed, pyrosequencing and quantitative analysis of DNA methylation using real-time PCR revealed Foxl2 proximal promoter hypomethylation in homologous compared to some, though not all, heterologous cell lines. The promoter was also hypomethylated in purified murine gonadotropes. In vitro promoter methylation completely silenced reporter activity in heterologous and homologous cells. Collectively, the data suggest that differential proximal promoter DNA methylation may contribute to cell-specific Foxl2 expression in some cellular contexts. However, gonadotrope-specific expression of the gene cannot be explained by promoter hypomethylation alone.	[Tran, Stella; Wang, Ying; Lamba, Pankaj; Zhou, Xiang; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Tran, Stella] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Lamba, Pankaj] St Mary Mercy Hosp, Livonia, MI USA; [Boehm, Ulrich] Univ Saarland, Sch Med, Homburg, Germany; [Bernard, Daniel J.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Bernard, Daniel J.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University; University of California System; University of California Los Angeles; Saarland University; McGill University; McGill University	Bernard, DJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	daniel.bernard@mcgill.ca		Bernard, Daniel/0000-0001-5365-5586	CIHR [MOP-89991]; FRSQ; McGill University Faculty of Medicine	CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); McGill University Faculty of Medicine	This work was funded by CIHR operating grant MOP-89991 to DJB. DJB and ST were supported by salary and fellowship awards from the FRSQ. ST also held a one-year studentship from the McGill University Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao MJ, 2012, EUR J MED GENET, V55, P630, DOI 10.1016/j.ejmg.2012.07.005; Alarid ET, 1996, DEVELOPMENT, V122, P3319; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Asdell S. A., 1944, SCIENCE, V99, P124, DOI 10.1126/science.99.2563.124; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Bernard DJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107797; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Beysen D, 2005, AM J HUM GENET, V77, P205, DOI 10.1086/432083; Beysen D, 2009, HUM MUTAT, V30, P158, DOI 10.1002/humu.20807; Beysen D, 2008, HUM MUTAT, V29, pE205, DOI 10.1002/humu.20819; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Crisponi L, 2004, GENOMICS, V83, P757, DOI 10.1016/j.ygeno.2003.11.010; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; D'haene B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000522; De Baere E, 2000, GENOMICS, V68, P296, DOI 10.1006/geno.2000.6304; De Baere E, 2003, AM J HUM GENET, V72, P478, DOI 10.1086/346118; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; DENAMUR E, 1995, DNA CELL BIOL, V14, P811, DOI 10.1089/dna.1995.14.811; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; El-Osta A, 2000, GENE EXPRESSION, V9, P63; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; FLATAU E, 1983, CANCER RES, V43, P4901; Fortin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059058; FRASER IS, 1988, FERTIL STERIL, V50, P747; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Ghochani Y, 2012, ENDOCRINOLOGY, V153, P2023, DOI 10.1210/en.2011-1763; Gonzalez-Gonzalez C, 2012, OPHTHALMIC GENET, V33, P107, DOI 10.3109/13816810.2011.634879; Han TD, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-183; Hoivik EA, 2008, ENDOCRINOLOGY, V149, P5599, DOI 10.1210/en.2008-0104; Hoivik EA, 2011, ENDOCRINOLOGY, V152, P2100, DOI 10.1210/en.2010-1305; INOUE K, 1992, ENDOCRINOLOGY, V131, P3110, DOI 10.1210/en.131.6.3110; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Justice NJ, 2011, MOL ENDOCRINOL, V25, P1404, DOI 10.1210/me.2011-0093; KAWAI J, 1994, MOL CELL BIOL, V14, P7421, DOI 10.1128/MCB.14.11.7421; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kuck D, 2010, MOL CANCER THER, V9, P3015, DOI 10.1158/1535-7163.MCT-10-0609; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Lee KB, 2007, J MOL ENDOCRINOL, V38, P315, DOI 10.1677/jme.1.02196; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Oakes Christopher C., 2009, V507, P271, DOI 10.1007/978-1-59745-522-0_20; Oka M, 2006, J BIOL CHEM, V281, P9901, DOI 10.1074/jbc.M511100200; Ou JN, 2007, BIOCHEM PHARMACOL, V73, P1297, DOI 10.1016/j.bcp.2006.12.032; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pannetier M, 2005, GENOMICS, V85, P715, DOI 10.1016/j.ygeno.2005.02.011; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rosenfeld MG, 2000, RECENT PROG HORM RES, V55, P1; Samlowski WE, 2005, J CLIN ONCOL, V23, P3897, DOI 10.1200/JCO.2005.06.118; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schlade-Bartusiak K, 2012, AM J MED GENET A, V158A, P2322, DOI 10.1002/ajmg.a.35516; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Stromme PS, 1996, ACTA OPHTHALMOL SCAN, V74, P45; Suzuki-Ishigaki S, 2000, NUCLEIC ACIDS RES, V28, P2627, DOI 10.1093/nar/28.14.2627; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Tran S, 2011, MOL ENDOCRINOL, V25, P1170, DOI 10.1210/me.2010-0480; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Udar N, 2003, HUM MUTAT, V22, P222, DOI 10.1002/humu.10251; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vaiman D, 1996, MAMM GENOME, V7, P133, DOI 10.1007/s003359900033; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yusta B, 1998, ENDOCRINOLOGY, V139, P4476, DOI 10.1210/en.139.11.4476; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	83	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76642	10.1371/journal.pone.0076642	http://dx.doi.org/10.1371/journal.pone.0076642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098544	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500078
J	Silva-Boghossian, CM; Colombo, APV; Tanaka, M; Rayo, C; Xiao, YZ; Siqueira, WL				Silva-Boghossian, Carina M.; Colombo, Ana Paula V.; Tanaka, Marcia; Rayo, Carolina; Xiao, Yizhi; Siqueira, Walter L.			Quantitative Proteomic Analysis of Gingival Crevicular Fluid in Different Periodontal Conditions	PLOS ONE			English	Article							MASS-SPECTROMETRY; ANTIMICROBIAL PEPTIDES; PROTEINS; DISEASES; SEPARATION; DISCOVERY; BACTERIA; HEALTHY; RISK	Aim: To quantify the proteome composition of the GCF in periodontal health (HH) and in sites with different clinical conditions in chronic periodontitis (CP) subjects. Material and Methods: 5 subjects with HH and 5 with CP were submitted to full-mouth periodontal examination, and GCF sampling. Sites in the CP group were classified and sampled as periodontitis (P, probing depth, PD>4 mm), gingivitis (G, PD <= 3mm with bleeding on probing, BOP), and healthy sites (H, PD <= 3mm without BOP). GCF proteins were subjected to liquid chromatography electrospray ionization mass spectrometry for identification, characterization and quantification. Results: 230 proteins were identified; 145 proteins were detected in HH, 214 in P, 154 in G, and 133 in H. Four proteins were exclusively detected at HH, 43 proteins at P, 7 proteins at G, and 1 protein at H. Compared to HH group, 35 and 6 proteins were more abundant in P and G (p<0.001), respectively; and 4, 15 and 37 proteins were less abundant in P, G and H (p <= 0.01), respectively. Conclusions: There are marked differences in the GCF proteome according to disease profile. Comprehension of the role of the identified proteins in the etiopathogenesis of periodontal disease may lead to biomarkers definition.	[Silva-Boghossian, Carina M.; Tanaka, Marcia; Rayo, Carolina; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Silva-Boghossian, Carina M.] Univ Fed Rio de Janeiro, Div Grad Periodont, Dept Dent Clin, Rio De Janeiro, Brazil; [Silva-Boghossian, Carina M.; Colombo, Ana Paula V.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil	Western University (University of Western Ontario); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Siqueira, WL (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada.	walter.siqueira@uwo.ca	Tanaka, Marcia Hiromi/J-7804-2012; Siqueira, Walter/ABE-4069-2021; Silva-Boghossian, Carina Maciel/G-9440-2012; Siqueira, Walter/ABE-8924-2020; Colombo, Ana Paula Vieira/B-9188-2019	Tanaka, Marcia Hiromi/0000-0002-6594-2301; Silva-Boghossian, Carina Maciel/0000-0002-4500-4350; Siqueira, Walter/0000-0003-1921-3658; Colombo, Ana Paula Vieira/0000-0002-2061-1840	Natural Sciences and Engineering Research Council of Canada (NSERC) [371813]; Canadian Institutes of Health Research (CIHR) [106657, 97577]; Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF grant) [25116]; National Council for Scientific and Technological Development (CNPq); Coordination of Improvement of Higher Education Personnel (CAPES); CIHR New Investigator Award [113166]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF grant)(Canada Foundation for Innovation); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC grant #371813), the Canadian Institutes of Health Research (CIHR grant # 106657 and grant # 97577), the Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF grant # 25116), National Council for Scientific and Technological Development (CNPq), and Coordination of Improvement of Higher Education Personnel (CAPES). W. L. S. is recipient of a CIHR New Investigator Award (grant # 113166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Baliban RC, 2012, J CLIN PERIODONTOL, V39, P203, DOI 10.1111/j.1600-051X.2011.01805.x; Bostanci N, 2010, J PROTEOME RES, V9, P2191, DOI 10.1021/pr900941z; Bostanci N, 2013, J PROTEOME RES, V12, P657, DOI 10.1021/pr300761e; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carneiro LG, 2012, J PERIODONTAL RES, V47, P248, DOI 10.1111/j.1600-0765.2011.01429.x; Champagne CME, 2003, PERIODONTOL 2000, V31, P167, DOI 10.1034/j.1600-0757.2003.03110.x; da Silva-Boghossian CM, 2011, ARCH ORAL BIOL, V56, P899, DOI 10.1016/j.archoralbio.2011.02.009; Doerr A, 2013, NAT METHODS, V10, P23, DOI 10.1038/nmeth.2286; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Gillette MA, 2013, NAT METHODS, V10, P28, DOI 10.1038/nmeth.2309; Goodson JM, 2003, PERIODONTOL 2000, V31, P43, DOI 10.1034/j.1600-0757.2003.03104.x; Grant MM, 2012, J PERIODONTAL RES, V47, P2, DOI 10.1111/j.1600-0765.2011.01387.x; Grant MM, 2010, J PROTEOME RES, V9, P4732, DOI 10.1021/pr100446f; Kido J, 2012, J PERIODONTAL RES, V47, P488, DOI 10.1111/j.1600-0765.2011.01458.x; Lee Motoyama, 2007, BIOCHEM BIOPH RES CO, V357, P828, DOI [10.1016/j.bbrc.2007.03.112, DOI 10.1016/J.BBRC.2007.03.112.PUBMED:17448443]; Ngo LH, 2010, J PROTEOME RES, V9, P1683, DOI 10.1021/pr900775s; Nibali L, 2008, J PERIODONTAL RES, V43, P627, DOI 10.1111/j.1600-0765.2007.01039.x; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Puklo M, 2008, ORAL MICROBIOL IMMUN, V23, P328, DOI 10.1111/j.1399-302X.2008.00433.x; Siqueira WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042204; SOCRANSKY SS, 1994, BIOTECHNIQUES, V17, P788; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Tonetti M S, 1999, Ann Periodontol, V4, P39, DOI 10.1902/annals.1999.4.1.39; Tsuchida S, 2013, PROTEOMICS, V13, P2339, DOI 10.1002/pmic.201200510; Tsuchida S, 2012, PROTEOMICS, V12, P2190, DOI 10.1002/pmic.201100655; Vitkov L, 2009, J PERIODONTAL RES, V44, P664, DOI 10.1111/j.1600-0765.2008.01175.x; Weinberg A, 1998, CRIT REV ORAL BIOL M, V9, P399, DOI 10.1177/10454411980090040201	30	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75898	10.1371/journal.pone.0075898	http://dx.doi.org/10.1371/journal.pone.0075898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098404	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100025
J	Bellucci, L; Corni, S; Di Felice, R; Paci, E				Bellucci, Luca; Corni, Stefano; Di Felice, Rosa; Paci, Emanuele			The Structure of Neuronal Calcium Sensor-1 in Solution Revealed by Molecular Dynamics Simulations	PLOS ONE			English	Article							SURFACE SALT BRIDGES; PROTEINS; STABILITY; NCS-1	Neuronal calcium sensor-1 (NCS-1) is a protein able to trigger signal transduction processes by binding a large number of substrates and re-shaping its structure depending on the environmental conditions. The X-ray crystal structure of the unmyristoilated NCS-1 shows a large solvent-exposed hydrophobic crevice (HC); this HC is partially occupied by the C-terminal tail and thus elusive to the surrounding solvent. We studied the native state of NCS-1 by performing room temperature molecular dynamics (MD) simulations starting from the crystal and the solution structures. We observe relaxation to a state independent of the initial structure, in which the C-terminal tail occupies the HC. We suggest that the C-terminal tail shields the HC binding pocket and modulates the affinity of NCS-1 for its natural targets. By analyzing the topology and nature of the inter-residue potential energy, we provide a compelling description of the interaction network that determines the three-dimensional organization of NCS-1.	[Bellucci, Luca; Corni, Stefano; Di Felice, Rosa] CNR Inst Nanosci, Ctr S3, Modena, Italy; [Paci, Emanuele] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Leeds	Bellucci, L (corresponding author), CNR Inst Nanosci, Ctr S3, Modena, Italy.	luca.bellucci_s3@unimore.it	Corni, Stefano/A-6198-2012; Bellucci, Luca/J-9096-2016; Bellucci, Luca/AAB-2834-2021; Paci, Emanuele/B-1893-2010	Bellucci, Luca/0000-0003-2031-064X; Bellucci, Luca/0000-0003-2031-064X; Paci, Emanuele/0000-0002-4891-2768; DIFELICE, ROSA/0000-0002-7772-6550; Corni, Stefano/0000-0001-6707-108X	Italian Institute of Technology; EC through project DNA-NANODEVICES; Research Infrastructure Action HPC-EUROPA2; Fondazione CRMO	Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); EC through project DNA-NANODEVICES; Research Infrastructure Action HPC-EUROPA2; Fondazione CRMO(Fondazione CarifeFondazione Caritro)	This work was funded by the Italian Institute of Technology (project MOPROSURF and Computational Platform), by the EC through project DNA-NANODEVICES and the Research Infrastructure Action HPC-EUROPA2, and by Fondazione CRMO. The authors are grateful to CINECA (Bologna, Italy) for supercomputing time and staff support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison Jane R, 2012, Biophys Rev, V4, P189, DOI 10.1007/s12551-012-0087-6; Allison JR, 2012, J CHEM THEORY COMPUT, V8, P3430, DOI 10.1021/ct300393b; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Amici M, 2009, BIOCHEM SOC T, V37, P1359, DOI 10.1042/BST0371359; Bendova-Biedermannova L, 2008, PROTEINS, V72, P402, DOI 10.1002/prot.21938; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2010, BIOL REP; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burgoyne RD, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-2; Chelli R, 2004, PROTEINS, V55, P139, DOI 10.1002/prot.20030; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fan H, 2003, PROTEINS, V53, P111, DOI 10.1002/prot.10496; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; Handley MTW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010534; Heidarsson PO, 2012, J MOL BIOL, V417, P51, DOI 10.1016/j.jmb.2011.12.049; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Lian LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027779; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schneider M, 2009, PROTEINS, V77, P97, DOI 10.1002/prot.22421; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Seibert MM, 2005, J MOL BIOL, V354, P173, DOI 10.1016/j.jmb.2005.09.030; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Torres KCL, 2009, PROG NEURO-PSYCHOPH, V33, P229, DOI 10.1016/j.pnpbp.2008.11.011; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Weiergraber OH, 2006, J BIOL CHEM, V281, P37594, DOI 10.1074/jbc.M603700200; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7	43	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74383	10.1371/journal.pone.0074383	http://dx.doi.org/10.1371/journal.pone.0074383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098643	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500014
J	Brenk-Franz, K; Hibbard, JH; Herrmann, WJ; Freund, T; Szecsenyi, J; Djalali, S; Steurer-Stey, C; Sonnichsen, A; Tiesler, F; Storch, M; Schneider, N; Gensichen, J				Brenk-Franz, Katja; Hibbard, Judith H.; Herrmann, Wolfram J.; Freund, Tobias; Szecsenyi, Joachim; Djalali, Sima; Steurer-Stey, Claudia; Soennichsen, Andreas; Tiesler, Fabian; Storch, Monika; Schneider, Nico; Gensichen, Jochen			Validation of the German Version of the Patient Activation Measure 13 (PAM13-D) in an International Multicentre Study of Primary Care Patients	PLOS ONE			English	Article							CHRONIC ILLNESS CARE; SELF-MANAGEMENT; CHRONIC DISEASE; MEASURE PAM; SHORT-FORM; HEALTH; INTERVENTION; MODEL	The patients' active participation in their medical care is important for patients with chronic diseases. Measurements of patient activation are needed for studies and in clinical practice. This study aims to validate the Patient Activation Measure 13 (PAM13-D) in German-speaking primary care patients. This international cross-sectional multicentre study enrolled consecutively patients from primary care practices in three German-speaking countries: Germany, Austria, and Switzerland. Patients completed the PAM13-D questionnaire. General Self-Efficacy scale (GSE) was used to assess convergent validity. Furthermore Cronbach's alpha was performed to assess internal consistency. Exploratory factor analysis was used to evaluate the underlying factor structure of the items. We included 508 patients from 16 primary care practices in the final analysis. Results were internally consistent, with a Cronbach's alpha of 0.84. Factor analysis revealed one major underlying factor. The mean values of the PAM13-D correlated significantly (r = 0.43) with those of the GSE. The German PAM13 is a reliable and valid measure of patient activation. Thus, it may be useful in primary care clinical practice and research.	[Brenk-Franz, Katja; Tiesler, Fabian; Storch, Monika; Schneider, Nico; Gensichen, Jochen] Jena Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany; [Hibbard, Judith H.] Univ Oregon, Dept Planning Publ Policy & Management, Eugene, OR 97403 USA; [Hibbard, Judith H.] Univ Oregon, Hlth Policy Res Grp ISE, Eugene, OR 97403 USA; [Herrmann, Wolfram J.] Univ Magdeburg, Inst Gen Practice & Family Med, D-39106 Magdeburg, Germany; [Freund, Tobias; Szecsenyi, Joachim] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Djalali, Sima; Steurer-Stey, Claudia] Univ Zurich, Inst Gen Practice, Zurich, Switzerland; [Soennichsen, Andreas] Univ Witten Herdecke, Dept Hlth, Inst Gen Med & Family Med, Witten, Germany	Friedrich Schiller University of Jena; University of Oregon; University of Oregon; Otto von Guericke University; Ruprecht Karls University Heidelberg; University of Zurich; Witten Herdecke University	Gensichen, J (corresponding author), Jena Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany.	Jochen.gensichen@med.uni-jena.de	Herrmann, Wolfram/C-8972-2013	Herrmann, Wolfram/0000-0002-9505-4911; Sonnichsen, Andreas/0000-0003-2733-4062				Alegria M, 2008, MED CARE, V46, P247, DOI 10.1097/MLR.0b013e318158af52; Anderson G, 2004, PUBLIC HEALTH REP, V119, P263, DOI 10.1016/j.phr.2004.04.005; [Anonymous], 1998, APPL STAT BEHAV SCI; Backhaus K., 2006, MULTIVARIATE ANAL ME; Bandura A., 1977, COGNITIVE THERAPY RE, V1, P287, DOI [10.1007/BF01663995, DOI 10.1007/BF01663995]; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Clark A, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI DOI 10.1037/1040-3590.7.3.309; Cureton E.E., 1983, FACTOR ANAL APPL APP; Fowles JB, 2009, PATIENT EDUC COUNS, V77, P116, DOI 10.1016/j.pec.2009.02.018; Gerber LM, 2011, J AMBUL CARE MANAG, V34, P292, DOI 10.1097/JAC.0b013e31821c63b1; Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2007, J AMBUL CARE MANAG, V30, P2, DOI 10.1097/00004479-200701000-00002; Hollnagel H, 1995, FAM PRACT, V12, P423; Lubetkin EI, 2010, J HEALTH CARE POOR U, V21, P796, DOI 10.1353/hpu.0.0350; Maindal HT, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-209; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Schwarzer R., 1992, SELF EFFICACY THOUGH; Schwentner I, 2006, J CRANIOFAC SURG, V17, P629, DOI 10.1097/00001665-200607000-00004; Sitzia J, 1999, INT J QUAL HEALTH C, V11, P319, DOI 10.1093/intqhc/11.4.319; STIGLER SM, 1973, ANN STAT, V1, P472, DOI 10.1214/aos/1176342412; Von Korff M, 1998, SPINE, V23, P2608, DOI 10.1097/00007632-199812010-00016; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; World Health Organization (WHO), 2007, PROC TRANSL AD INSTR	29	60	61	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74786	10.1371/journal.pone.0074786	http://dx.doi.org/10.1371/journal.pone.0074786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098669	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000325423500040
J	Friend, LR; Landsberg, MJ; Nouwens, AS; Wei, Y; Rothnagel, JA; Smith, R				Friend, Lexie R.; Landsberg, Michael J.; Nouwens, Amanda S.; Wei, Ying; Rothnagel, Joseph A.; Smith, Ross			Arginine Methylation of hnRNP A2 Does Not Directly Govern Its Subcellular Localization	PLOS ONE			English	Article							HETEROGENEOUS-NUCLEAR-RIBONUCLEOPROTEIN; RNA-BINDING PROTEINS; MESSENGER-RNA; RESPONSE ELEMENT; RICH DOMAIN; IN-VIVO; TRAFFICKING; PARTICLES; IDENTIFICATION; RECOGNITION	The hnRNP A/B paralogs A1, A2/B1 and A3 are key components of the nuclear 40S hnRNP core particles. Despite a high degree of sequence similarity, increasing evidence suggests they perform additional, functionally distinct roles in RNA metabolism. Here we identify and study the functional consequences of differential post-translational modification of hnRNPs A1, A2 and A3. We show that while arginine residues in the RGG box domain of hnRNP A1 and A3 are almost exhaustively, asymmetrically dimethylated, hnRNP A2 is dimethylated at only a single residue (Arg-254) and this modification is conserved across cell types. It has been suggested that arginine methylation regulates the nucleocytoplasmic distribution of hnRNP A/B proteins. However, we show that transfected cells expressing an A2(R254A) point mutant exhibit no difference in subcellular localization. Similarly, immunostaining and mass spectrometry of endogenous hnRNP A2 in transformed cells reveals a naturally-occurring pool of unmethylated protein but an exclusively nuclear pattern of localization. Our results suggest an alternative role for post-translational arginine methylation of hnRNPs and offer further evidence that the hnRNP A/B paralogs are not functionally redundant.	[Friend, Lexie R.; Nouwens, Amanda S.; Wei, Ying; Rothnagel, Joseph A.; Smith, Ross] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Landsberg, Michael J.; Rothnagel, Joseph A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Smith, R (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	ross.s@uq.edu.au	Landsberg, Michael/A-3363-2011; Rothnagel, Joe/A-4874-2010	Landsberg, Michael/0000-0002-2464-990X; Rothnagel, Joe/0000-0002-6710-3165; Nouwens, Amanda/0000-0003-4069-8266	Australian National Health and Medical Research Council [ID631551]; Cancer Council of Queensland [ID455870]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland)	This work has been funded in part by grants to RS and JAR from the Australian National Health and Medical Research Council (ID631551) and the Cancer Council of Queensland (ID455870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERO SA, 1992, P NATL ACAD SCI USA, V89, P8409, DOI 10.1073/pnas.89.18.8409; BARNETT SF, 1991, MOL CELL BIOL, V11, P864, DOI 10.1128/MCB.11.2.864; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BENNETT M, 1992, MOL CELL BIOL, V12, P3165, DOI 10.1128/MCB.12.7.3165; BEYER AL, 1980, CELL, V20, P75, DOI 10.1016/0092-8674(80)90236-6; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Blifernez O, 2011, PLANT J, V65, P119, DOI 10.1111/j.1365-313X.2010.04406.x; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Brumwell C, 2002, EXP CELL RES, V279, P310, DOI 10.1006/excr.2002.5604; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; CHRISTENSEN ME, 1977, BIOCHEM BIOPH RES CO, V74, P621, DOI 10.1016/0006-291X(77)90348-5; CONWAY G, 1988, MOL CELL BIOL, V8, P2884, DOI 10.1128/MCB.8.7.2884; Friend LR, 2008, BBA-MOL CELL RES, V1783, P1972, DOI 10.1016/j.bbamcr.2008.05.021; Gehrig PM, 2004, J AM SOC MASS SPECTR, V15, P142, DOI 10.1016/j.jasms.2003.10.002; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Godin KS, 2007, RNA BIOL, V4, P69, DOI 10.4161/rna.4.2.4869; Han SP, 2010, TRAFFIC, V11, P886, DOI 10.1111/j.1600-0854.2010.01072.x; Hatfield JT, 2002, GENE, V295, P33, DOI 10.1016/S0378-1119(02)00800-4; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; KUMAR A, 1986, J BIOL CHEM, V261, P1266; Landsberg MJ, 2006, BIOCHEMISTRY-US, V45, P3943, DOI 10.1021/bi052440e; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Ma ASW, 2002, J BIOL CHEM, V277, P18010, DOI 10.1074/jbc.M200050200; Maggipinto M, 2004, J NEUROSCI RES, V75, P614, DOI 10.1002/jnr.20014; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; RAJPUROHIT R, 1994, BIOCHEM J, V304, P903, DOI 10.1042/bj3040903; Samarina OP, 1968, J MOL BIOL, V14, P251; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Speicher K D, 2000, J Biomol Tech, V11, P74; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; STEITZ JA, 1981, MOL CELL BIOL, V1, P21, DOI 10.1128/MCB.1.1.21; WILLIAMS KR, 1985, P NATL ACAD SCI USA, V82, P5666, DOI 10.1073/pnas.82.17.5666	40	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75669	10.1371/journal.pone.0075669	http://dx.doi.org/10.1371/journal.pone.0075669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098712	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500083
J	Guan, HB; Wu, QJ; Gong, TT; Lin, B; Wang, YL; Liu, CX				Guan, Hong-Bo; Wu, Qi-Jun; Gong, Ting-Ting; Lin, Bei; Wang, Yong-Lai; Liu, Cai-Xia			Parity and Risk of Colorectal Cancer: A Dose-Response Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							ORAL-CONTRACEPTIVE USE; LARGE-BOWEL-CANCER; REPRODUCTIVE FACTORS; COLON-CANCER; MENSTRUAL FACTORS; 1ST BIRTH; WOMEN; HISTORY; AGE; HEALTH	Background: Association between parity and colorectal cancer (CRC) risk has been investigated by several epidemiological studies but results are controversial, yet a comprehensive and quantitative assessment of this association has not been reported so far. Methods: Relevant published studies of parity and CRC were identified using MEDLINE, EMBASE and Web of Science databases through end of April 2013. Two authors independently assessed eligibility and extracted data. Eleven prospective studies reported relative risk (RR) estimates and 95% confidence intervals (CIs) of CRC risk associated with parity. We pooled the RR from individual studies using fixed-or random-effects models and carried out heterogeneity and publication bias analyses. Results: The summary RR for the ever parity vs. nulliparous was 0.95 (95% CI: 0.88-1.02), with no heterogeneity (Q = 9.04, P = 0.443, I-2 = 0.5%). Likewise, no significant association was yielded for the highest vs. lowest parity number (RR = 1.02, 95% CI: 0.89-1.17), with moderate heterogeneity (Q = 17.48, P = 0.094, I-2 = 37.1%). Dose-response analysis still indicated no effect of parity on CRC risk and the summary RR of per one livebirth was 0.99 (95% CI: 0.96-1.02), with moderate of heterogeneity (Q = 16.50, P<0.021, I-2 = 57.6%). Similar results were observed among all the subgroup analyses. No evidence of publication bias and significant heterogeneity between subgroups were detected by meta-regression analyses. Conclusion: Results of this dose-response meta-analysis of prospective studies found that there was little evidence of an association between parity and CRC risk.	[Guan, Hong-Bo; Gong, Ting-Ting; Lin, Bei; Wang, Yong-Lai; Liu, Cai-Xia] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Wu, Qi-Jun] Shanghai Jiao Tong Univ, Sch Med, Dept Epidemiol, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Wu, Qi-Jun] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogene & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China	China Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, CX (corresponding author), China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China.	caixia_liu_sj@163.com						Akhter M, 2008, EUR J CANCER PREV, V17, P515, DOI 10.1097/CEJ.0b013e3282f521f8; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; Boyle P., 2008, World Cancer Report 2008; Broeders MJM, 1996, INT J CANCER, V66, P170, DOI 10.1002/(SICI)1097-0215(19960410)66:2<170::AID-IJC5>3.0.CO;2-#; Chubak J, 2004, CANCER EPIDEM BIOMAR, V13, P1296; CHUTE CG, 1991, EPIDEMIOLOGY, V2, P395, DOI 10.1097/00001648-199109000-00019; Cunningham FG, 2005, WILLIAMS OBSTET; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Giovannucci E, 2006, CANC EPIDEMIOLOGY PR, P809; Goldfien A, 1994, BASIC CLIN ENDOCRINO, P419; Gong TT, 2013, INT J CANCER, V132, P2894, DOI 10.1002/ijc.27952; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; JACOBSEN BK, 1995, J CLIN EPIDEMIOL, V48, P1119, DOI 10.1016/0895-4356(95)00009-S; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kabat GC, 2008, INT J CANCER, V122, P643, DOI 10.1002/ijc.23079; KRAVDAL O, 1993, INT J CANCER, V53, P56, DOI 10.1002/ijc.2910530112; KUNE GA, 1989, AM J EPIDEMIOL, V129, P533, DOI 10.1093/oxfordjournals.aje.a115165; KUNE GA, 1992, EUR J CANCER, V28A, P1484, DOI 10.1016/0959-8049(92)90549-H; Kuo CH, 2012, CANCER SCI, V103, P1553, DOI 10.1111/j.1349-7006.2012.02336.x; KVALE G, 1991, INT J CANCER, V47, P390, DOI 10.1002/ijc.2910470314; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; LAVECCHIA C, 1991, CANCER CAUSE CONTROL, V2, P193, DOI 10.1007/BF00056213; Lin J, 2007, AM J EPIDEMIOL, V165, P794, DOI 10.1093/aje/kwk068; Lo AC, 2010, DIS COLON RECTUM, V53, P830, DOI 10.1007/DCR.0b013e3181d320b1; Martinez ME, 1997, CANCER EPIDEM BIOMAR, V6, P1; MCKEOWNEYSSEN G, 1994, CANCER EPIDEM BIOMAR, V3, P687; MCMICHAEL AJ, 1980, J NATL CANCER I, V65, P1201; Nazeri K, 2006, GYNECOL ENDOCRINOL, V22, P416, DOI 10.1080/09513590600900378; Newcomb PA, 2008, ADV EXP MED BIOL, V617, P259, DOI 10.1007/978-0-387-69080-3_24; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; PETERS RK, 1990, BRIT J CANCER, V61, P741, DOI 10.1038/bjc.1990.166; PLESKO I, 1985, INT J CANCER, V36, P529, DOI 10.1002/ijc.2910360502; POTTER JD, 1983, J NATL CANCER I, V71, P703; Sakauchi F, 2007, ASIAN PAC J CANCER P, V8, P129; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tamakoshi K, 2004, CANCER SCI, V95, P602, DOI 10.1111/j.1349-7006.2004.tb02494.x; Tamakoshi K, 2004, CANCER SCI, V95, P243, DOI 10.1111/j.1349-7006.2004.tb02210.x; Tran TT, 1996, CANCER EPIDEM BIOMAR, V5, P1013; Troisi R, 1997, EPIDEMIOLOGY, V8, P75, DOI 10.1097/00001648-199701000-00012; Tsilidis KK, 2010, BRIT J CANCER, V103, P1755, DOI 10.1038/sj.bjc.6605965; van Wayenburg CAM, 2000, EPIDEMIOLOGY, V11, P304, DOI 10.1097/00001648-200005000-00013; Wells G SB, 2013, NEWCASTLE OTTAWA SCA; Wernli KJ, 2009, J WOMENS HEALTH, V18, P995, DOI 10.1089/jwh.2008.1068; WU AH, 1987, BRIT J CANCER, V55, P687, DOI 10.1038/bjc.1987.140; Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601; Zervoudakis A, 2011, J NATL CANCER I, V103, P826, DOI 10.1093/jnci/djr101	50	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75279	10.1371/journal.pone.0075279	http://dx.doi.org/10.1371/journal.pone.0075279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098689	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500060
J	Shin, D; Richards, SL; Alto, BW; Bettinardi, DJ; Smartt, CT				Shin, Dongyoung; Richards, Stephanie L.; Alto, Barry W.; Bettinardi, David J.; Smartt, Chelsea T.			Genome Sequence Analysis of Dengue Virus 1 Isolated in Key West, Florida	PLOS ONE			English	Article							AEDES-ALBOPICTUS; UNITED-STATES; PUERTO-RICO; RECOMBINATION; COMPETITION; CULICIDAE; INFECTION; MOSQUITOS; OUTBREAK; AEGYPTI	Dengue virus (DENV) is transmitted to humans through the bite of mosquitoes. In November 2010, a dengue outbreak was reported in Monroe County in southern Florida (FL), including greater than 20 confirmed human cases. The virus collected from the human cases was verified as DENV serotype 1 (DENV-1) and one isolate was provided for sequence analysis. RNA was extracted from the DENV-1 isolate and was used in reverse transcription polymerase chain reaction (RT-PCR) to amplify PCR fragments to sequence. Nucleic acid primers were designed to generate overlapping PCR fragments that covered the entire genome. The DENV-1 isolate found in Key West (KW), FL was sequenced for whole genome characterization. Sequence assembly, Genbank searches, and recombination analyses were performed to verify the identity of the genome sequences and to determine percent similarity to known DENV-1 sequences. We show that the KW DENV-1 strain is 99% identical to Nicaraguan and Mexican DENV-1 strains. Phylogenetic and recombination analyses suggest that the DENV-1 isolated in KW originated from Nicaragua (NI) and the KW strain may circulate in KW. Also, recombination analysis results detected recombination events in the KW strain compared to DENV-1 strains from Puerto Rico. We evaluate the relative growth of KW strain of DENV-1 compared to other dengue viruses to determine whether the underlying genetics of the strain is associated with a replicative advantage, an important consideration since local transmission of DENV may result because domestic tourism can spread DENVs.	[Shin, Dongyoung; Alto, Barry W.; Smartt, Chelsea T.] Univ Florida, Dept Entomol & Nematol, Vero Beach, FL USA; [Richards, Stephanie L.] E Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, Greenville, NC USA; [Bettinardi, David J.] Univ Illinois, Dept Mol & Cellular Biol, Urbana, IL 61801 USA	State University System of Florida; University of Florida; University of North Carolina; East Carolina University; University of Illinois System; University of Illinois Urbana-Champaign	Shin, D (corresponding author), Univ Florida, Dept Entomol & Nematol, Vero Beach, FL USA.	dshin@ufl.edu			Department of Agriculture and Consumer Services (DACS) [00090369]; Southeast Regional Center of Excellence for Emerging Infections & Biodefense (SERCEB) [00102092]	Department of Agriculture and Consumer Services (DACS); Southeast Regional Center of Excellence for Emerging Infections & Biodefense (SERCEB)	This study is supported by Department of Agriculture and Consumer Services (DACS: http://www.freshfromflorida.com) 2010 grant 00090369 and Southeast Regional Center of Excellence for Emerging Infections & Biodefense (SERCEB: http://www.serceb.org) 2011 grant 00102092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Anez G, 2012, AM J TROP MED HYG, V87, P548, DOI 10.4269/ajtmh.2012.12-0091; Anoop M, 2010, INDIAN J EXP BIOL, V48, P849; Ayala A., 2006, Morbidity and Mortality Weekly Report, V55, P700; Barrera R., 2006, SCI WORK GROUP M DEN, P92; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Britch SC, 2008, J AM MOSQUITO CONTR, V24, P115, DOI 10.2987/5594.1; Centers for Disease Control, 2006, DENG PUERT RIC; Centers for Disease Control, 2013, DENG TROP SUBTR REG; de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004; EBENHARD T, 1991, BIOL J LINN SOC, V42, P105, DOI 10.1111/j.1095-8312.1991.tb00554.x; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Florida Department of Health, 2010, FLOR ARB SURV; Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419; Griffitts THD, 1935, J FLA MED ASSOC, V21, P395; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1; Hanski I., 1999, METAPOPULATION ECOLO; Hanson H, 1936, AM J PUBLIC HEALTH N, V26, P256, DOI 10.2105/AJPH.26.3.256; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Kuno Goro, 1997, P61; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Mac Donell GN, 1935, J FLA MED ASSOC, V21, P392; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mohammed HP, 2010, J TRAVEL MED, V17, P8, DOI 10.1111/j.1708-8305.2009.00374.x; Munoz-Jordan JL, 2013, EMERG INFECT DIS, V19, P652, DOI 10.3201/eid1904.121295; Nowicki S., 2010, Morbidity and Mortality Weekly Report, V59, P557; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Pan American Health Organization, 1994, PAN AM HLTH ORG PUBL, V548; Pan American Health Organization, 2007, NUMB REP CAS DENG DE; Pickett BE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-165; Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161; Ramos MM, 2008, AM J TROP MED HYG, V78, P364; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283; Tomashek KM, 2009, AM J TROP MED HYG, V81, P467, DOI 10.4269/ajtmh.2009.81.467; United State Geological Survey, 2012, CUM HUM DIS CAS LOC; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535	42	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74582	10.1371/journal.pone.0074582	http://dx.doi.org/10.1371/journal.pone.0074582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098658	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500029
J	Meng, Y; Qian, Y; Gao, L; Cai, LB; Cui, YG; Liu, JY				Meng, Yan; Qian, Yi; Gao, Li; Cai, Ling-Bo; Cui, Yu-Gui; Liu, Jia-Yin			Downregulated Expression of Peroxiredoxin 4 in Granulosa Cells from Polycystic Ovary Syndrome	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; FOLLICULAR-FLUID; GENE-EXPRESSION; FOLLICLES; WOMEN; IV; PEROXIDASE; PROTEINS; PROTECTS	Peroxiredoxin 4 (PRDX4), a member of Peroxiredoxin (PRDX) family, is a typical 2-Cys PRDX. PRDX4 monitors the oxidative burden within cellular compartment and reduces hydrogen peroxide and alkyl hydroperoxide related to oxidative stress and apoptosis. Antioxidant, like PRDX4, may promote follicle development and participate in the pathophysiology of PCOS. In our previous study, we found that PRDX4 was expressed in mice oocyte cumulus oophorus complex, and that PRDX4 could be associated with follicle development. In this study, we explored the expression of PRDX4 in human follicles and possible role of PRDX4 in PCOS pathophysiology. Our data showed that PRDX4 was mainly expressed in granulosa cells in human ovaries. When compared to control group, both PRDX4 mRNA level and protein level decreased in PCOS group. The lowered levels of PRDX4 may relate to oxidative stress in the pathophysiologic progress of PCOS. Furthermore, expression of PRDX4 in the granulosa cells of in vivo or in vitro matured follicles was higher than that in immatured follicles, which suggested that PRDX4 may have a close relationship with follicular development. Altogether, our findings may provide new clues of the pathophysiologic mechanism of PCOS and potential therapeutic strategy using antioxidant, like PRDX4.	[Meng, Yan; Qian, Yi; Gao, Li; Cai, Ling-Bo; Cui, Yu-Gui; Liu, Jia-Yin] Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Liu, JY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	jyliu_nj@126.com		cai, lingbo/0000-0001-5094-0082	China National Nature Foundation [81200439]	China National Nature Foundation	This study was supported by projects from China National Nature Foundation (NO. 81200439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Al-Gubory KH, 2010, INT J BIOCHEM CELL B, V42, P1634, DOI 10.1016/j.biocel.2010.06.001; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; BALEN AH, 1995, HUM REPROD, V10, P2107, DOI 10.1093/oxfordjournals.humrep.a136243; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Catteau-Jonard S, 2008, J CLIN ENDOCR METAB, V93, P4456, DOI 10.1210/jc.2008-1231; Chian RC, 1999, NEW ENGL J MED, V341, P1624, DOI 10.1056/NEJM199911183412118; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; ERICKSON GF, 1992, HUM REPROD, V7, P293, DOI 10.1093/oxfordjournals.humrep.a137638; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; FRANKS S, 1989, CLIN ENDOCRINOL, V31, P87, DOI 10.1111/j.1365-2265.1989.tb00457.x; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Haridas V, 1998, J IMMUNOL, V161, P1; Hennet ML, 2013, J ASSIST REPROD GEN, V30, P333, DOI 10.1007/s10815-012-9925-5; Hughesdon P E, 1982, Obstet Gynecol Surv, V37, P59, DOI 10.1097/00006254-198202000-00001; Iuchi Y, 2009, BIOCHEM J, V419, P149, DOI 10.1042/BJ20081526; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Karuputhula NB, 2013, SYST BIOL REPROD MED, V59, P91, DOI 10.3109/19396368.2012.743197; Lee HC, 2005, J KOREAN MED SCI, V20, P456, DOI 10.3346/jkms.2005.20.3.456; Leyens G, 2004, BIOL REPROD, V71, P1646, DOI 10.1095/biolreprod.104.030155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng Y, 2007, BBA-PROTEINS PROTEOM, V1774, P1477, DOI 10.1016/j.bbapap.2007.08.026; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Murri M, 2013, HUM REPROD UPDATE; Nakahara K, 1997, FERTIL STERIL, V68, P312, DOI 10.1016/S0015-0282(97)81521-X; Palacio JR, 2006, CLIN EXP IMMUNOL, V144, P217, DOI 10.1111/j.1365-2249.2006.03061.x; Palande KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016340; Peter AT, 2003, REPROD DOMEST ANIM, V38, P209, DOI 10.1046/j.1439-0531.2003.00438.x; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Suzuki T, 1999, FERTIL STERIL, V72, P720, DOI 10.1016/S0015-0282(99)00332-5; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Victor VM, 2011, J CLIN ENDOCR METAB, V96, P3115, DOI 10.1210/jc.2011-0651; Webber LJ, 2003, LANCET, V362, P1017, DOI 10.1016/S0140-6736(03)14410-8; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108	40	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76460	10.1371/journal.pone.0076460	http://dx.doi.org/10.1371/journal.pone.0076460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098506	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600056
J	Roy, U; Bulot, C; Bentrup, KHZ; Mondal, D				Roy, Upal; Bulot, Christine; Bentrup, Kerstin Honer Zu; Mondal, Debasis			Specific Increase in MDR1 Mediated Drug-Efflux in Human Brain Endothelial Cells following Co-Exposure to HIV-1 and Saquinavir	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE PROTEIN-1; NECROSIS-FACTOR-ALPHA; IN-VITRO MODEL; PROTEASE INHIBITORS; TRANSPORT ACTIVITY; BARRIER; MODULATION; LIPOPOLYSACCHARIDE; PERMEABILITY	Persistence of HIV-1 reservoirs within the Central Nervous System (CNS) remains a significant challenge to the efficacy of potent anti-HIV-1 drugs. The primary human Brain Microvascular Endothelial Cells (HBMVEC) constitutes the Blood Brain Barrier (BBB) which interferes with anti-HIV drug delivery into the CNS. The ATP binding cassette (ABC) transporters expressed on HBMVEC can efflux HIV-1 protease inhibitors (HPI), enabling the persistence of HIV-1 in CNS. Constitutive low level expression of several ABC-transporters, such as MDR1 (a.k.a. P-gp) and MRPs are documented in HBMVEC. Although it is recognized that inflammatory cytokines and exposure to xenobiotic drug substrates (e.g HPI) can augment the expression of these transporters, it is not known whether concomitant exposure to virus and anti-retroviral drugs can increase drug-efflux functions in HBMVEC. Our in vitro studies showed that exposure of HBMVEC to HIV-1 significantly up-regulates both MDR1 gene expression and protein levels; however, no significant increases in either MRP-1 or MRP-2 were observed. Furthermore, calcein-AM dye-efflux assays using HBMVEC showed that, compared to virus exposure alone, the MDR1 mediated drug-efflux function was significantly induced following concomitant exposure to both HIV-1 and saquinavir (SQV). This increase in MDR1 mediated drug-efflux was further substantiated via increased intracellular retention of radiolabeled [H-3-] SQV. The crucial role of MDR1 in H-3-SQV efflux from HBMVEC was further confirmed by using both a MDR1 specific blocker (PSC-833) and MDR1 specific siRNAs. Therefore, MDR1 specific drug-efflux function increases in HBMVEC following co-exposure to HIV-1 and SQV which can reduce the penetration of HPIs into the infected brain reservoirs of HIV-1. A targeted suppression of MDR1 in the BBB may thus provide a novel strategy to suppress residual viral replication in the CNS, by augmenting the therapeutic efficacy of HAART drugs.	[Roy, Upal; Bulot, Christine; Mondal, Debasis] Tulane Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70118 USA; [Bentrup, Kerstin Honer Zu] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA	Tulane University; Tulane University	Roy, U (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70118 USA.	uroy@fiu.edu	ROY, UPAL/C-6126-2012	Roy, Upal/0000-0002-0325-567X	National Institute of Allergy and Infectious Diseases (NIAID; National Institutes of Health (NIH) [R21-AI064048]; Louisiana Board of Regents (LA-BORSF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064048] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Louisiana Board of Regents (LA-BORSF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the National Institute of Allergy and Infectious Diseases (NIAID; National Institutes of Health (NIH); #R21-AI064048) and Louisiana Board of Regents (LA-BORSF) to DM. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039112; Andras IE, 2011, METHODS MOL BIOL, V762, P355, DOI 10.1007/978-1-61779-185-7_26; Banks WA, 2006, CURR HIV RES, V4, P259, DOI 10.2174/157016206777709447; Bauer B, 2005, EXP BIOL MED, V230, P118; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Bentrup KHZ, 2006, MICROBES INFECT, V8, P1813, DOI 10.1016/j.micinf.2006.02.020; Brandmann M, 2012, J NEUROCHEM, V120, P78, DOI 10.1111/j.1471-4159.2011.07544.x; Chelucci C, 1998, BLOOD, V91, P1225, DOI 10.1182/blood.V91.4.1225; Cooper I, 2012, J BIOL CHEM, V287, P44676, DOI 10.1074/jbc.M112.395384; Dohgu S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-167; Eilers M, 2008, EXP BIOL MED, V233, P1149, DOI 10.3181/0802-RM-59; Golden PL, 1999, BRAIN RES, V819, P143, DOI 10.1016/S0006-8993(98)01305-5; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Hayashi K, 2005, J NEUROCHEM, V93, P1231, DOI 10.1111/j.1471-4159.2005.03114.x; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Hua J, 2005, GYNECOL ONCOL, V98, P31, DOI 10.1016/j.ygyno.2005.03.042; Huang Y, 2005, CELL MOL IMMUNOL, V2, P113; Iqbal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043022; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; Kyosseva SV, 2004, INT REV NEUROBIOL, V59, P201; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Limtrakul P, 2007, MOL CELL BIOCHEM, V296, P85, DOI 10.1007/s11010-006-9302-8; Louboutin JP, 2010, NEUROBIOL DIS, V38, P313, DOI 10.1016/j.nbd.2010.02.007; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; Miller F, 2012, VIRULENCE, V3, P222, DOI 10.4161/viru.19697; Mishra R, 2013, J NEUROSCI, V33, P5992, DOI 10.1523/JNEUROSCI.4796-12.2013; Mizutani T, 2008, CURR DRUG METAB, V9, P167, DOI 10.2174/138920008783571756; Namanja HA, 2012, J AM CHEM SOC, V134, P2976, DOI 10.1021/ja206867t; Pal D, 2011, LIFE SCI, V88, P959, DOI 10.1016/j.lfs.2010.09.012; Poller B, 2010, CELL MOL NEUROBIOL, V30, P63, DOI 10.1007/s10571-009-9431-1; Potschka H, 2010, PHARMACOL THERAPEUT, V125, P118, DOI 10.1016/j.pharmthera.2009.10.004; Price TO, 2005, BRAIN RES, V1045, P57, DOI 10.1016/j.brainres.2005.03.031; Pu H, 2003, MOL CELL NEUROSCI, V24, P224, DOI 10.1016/S1044-7431(03)00171-4; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Shaik N, 2008, J PHARM SCI-US, V97, P5421, DOI 10.1002/jps.21372; Sulova Z, 2008, TOXICOL IN VITRO, V22, P96, DOI 10.1016/j.tiv.2007.08.011; Tang Y, 2007, GENE THER, V14, P523, DOI 10.1038/sj.gt.3302888; Thomas Hilary, 2003, Cancer Control, V10, P159; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Turriziani O, 2008, J MED VIROL, V80, P766, DOI 10.1002/jmv.21152; von Wedel-Parlow M, 2009, J NEUROCHEM, V111, P111, DOI 10.1111/j.1471-4159.2009.06305.x; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052; Zastre JA, 2009, J NEUROSCI RES, V87, P1023, DOI 10.1002/jnr.21898	46	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75374	10.1371/journal.pone.0075374	http://dx.doi.org/10.1371/journal.pone.0075374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098380	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600017
J	Muller, A; Rychli, K; Muhterem-Uyar, M; Zaiser, A; Stessl, B; Guinane, CM; Cotter, PD; Wagner, M; Schmitz-Esser, S				Mueller, Anneliese; Rychli, Kathrin; Muhterem-Uyar, Meryem; Zaiser, Andreas; Stessl, Beatrix; Guinane, Caitriona M.; Cotter, Paul D.; Wagner, Martin; Schmitz-Esser, Stephan			Tn6188 - A Novel Transposon in Listeria monocytogenes Responsible for Tolerance to Benzalkonium Chloride	PLOS ONE			English	Article							PLASMID-BORNE CADMIUM; STAPHYLOCOCCUS-AUREUS; MULTIDRUG-RESISTANCE; COMPARATIVE GENOMICS; GENES; DISINFECTANTS; SENSITIVITY; OUTBREAK; ADAPTATION; EXPRESSION	Controlling the food-borne pathogen Listeria (L.) monocytogenes is of great importance from a food safety perspective, and thus for human health. The consequences of failures in this regard have been exemplified by recent large listeriosis outbreaks in the USA and Europe. It is thus particularly notable that tolerance to quaternary ammonium compounds such as benzalkonium chloride (BC) has been observed in many L. monocytogenes strains. However, the molecular determinants and mechanisms of BC tolerance of L. monocytogenes are still largely unknown. Here we describe Tn6188, a novel transposon in L. monocytogenes conferring tolerance to BC. Tn6188 is related to Tn554 from Staphylococcus (S.) aureus and other Tn554-like transposons such as Tn558, Tn559 and Tn5406 found in various Firmicutes. Tn6188 comprises 5117 bp, is integrated chromosomally within the radC gene and consists of three transposase genes (tnpABC) as well as genes encoding a putative transcriptional regulator and QacH, a small multidrug resistance protein family (SMR) transporter putatively associated with export of BC that shows high amino acid identity to Smr/QacC from S. aureus and to EmrE from Escherichia coli. We screened 91 L. monocytogenes strains for the presence of Tn6188 by PCR and found Tn6188 in 10 of the analyzed strains. These isolates were from food and food processing environments and predominantly from serovar 1/2a. L. monocytogenes strains harboring Tn6188 had significantly higher BC minimum inhibitory concentrations (MICs) (28.5 +/- 4.7 mg/l) than strains without Tn6188 (14 +/- 3.2 mg/l). Using quantitative reverse transcriptase PCR we could show a significant increase in qacH expression in the presence of BC. QacH deletion mutants were generated in two L. monocytogenes strains and growth analysis revealed that Delta qacH strains had lower BC MICs than wildtype strains. In conclusion, our results provide evidence that Tn6188 is responsible for BC tolerance in various L. monocytogenes strains.	[Mueller, Anneliese; Rychli, Kathrin; Muhterem-Uyar, Meryem; Zaiser, Andreas; Stessl, Beatrix; Wagner, Martin; Schmitz-Esser, Stephan] Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria; [Wagner, Martin] Univ Vet Med, Christian Doppler Lab Molecularbiol Food Analyt, Vienna, Austria; [Guinane, Caitriona M.; Cotter, Paul D.] Teagasc Food Res Ctr, Cork, Ireland; [Cotter, Paul D.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Teagasc; University College Cork	Schmitz-Esser, S (corresponding author), Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria.	stephan.schmitz-esser@vetmeduni.ac.at	Schmitz-Esser, Stephan/AAA-7287-2019; STANTON, CATHERINE/A-9549-2015	Schmitz-Esser, Stephan/0000-0002-1907-0709; STANTON, CATHERINE/0000-0002-6724-7011; Kober-Rychli, Kathrin/0000-0001-6147-577X; Guinane, Caitriona/0000-0001-8215-1387; Stessl, Beatrix/0000-0001-6172-0587	Austrian Science Fund (FWF) [P22703-B17]; European Union [036272]; EU [FP7-KBBE-2010-4]; Austrian Science Fund (FWF) [P 22703] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Fund (FWF, http://www.fwf.ac.at/) to SSE (grant no. P22703-B17), by the European Union funded integrated project BIOTRACER (contract no. 036272) under the 6th RTD framework and by the EU grant FP7-KBBE-2010-4 (FOODSEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase B, 2000, INT J FOOD MICROBIOL, V62, P57, DOI 10.1016/S0168-1605(00)00357-3; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Attaiech L, 2008, J BACTERIOL, V190, P5729, DOI 10.1128/JB.00425-08; Aureli P, 2000, NEW ENGL J MED, V342, P1236, DOI 10.1056/NEJM200004273421702; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Bertsch D, 2013, J ANTIMICROB CHEMOTH, V68, P986, DOI 10.1093/jac/dks531; BEST M, 1990, APPL ENVIRON MICROB, V56, P377, DOI 10.1128/AEM.56.2.377-380.1990; Bjorland J, 2003, ANTIMICROB AGENTS CH, V47, P3046, DOI 10.1128/AAC.47.10.3046-3052.2003; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Earnshaw AM, 1998, J APPL MICROBIOL, V84, P642, DOI 10.1046/j.1365-2672.1998.00395.x; Elhanafi D, 2010, APPL ENVIRON MICROB, V76, P8231, DOI 10.1128/AEM.02056-10; FLEMING DW, 1985, NEW ENGL J MED, V312, P404, DOI 10.1056/NEJM198502143120704; Fox EM, 2011, APPL ENVIRON MICROB, V77, P6559, DOI 10.1128/AEM.05529-11; FRETZ R, 2010, EUROSURVEILLANCE, V15, P2; FRETZ R, 2010, EUROSURVEILLANCE, V15, P2; Glaser P, 2001, SCIENCE, V294, P849; Goulet V, 2008, EMERG INFECT DIS, V14, P734, DOI 10.3201/eid1405.071395; GRINIUS LL, 1994, J BIOL CHEM, V269, P29998; Haroche J, 2002, ANTIMICROB AGENTS CH, V46, P2337, DOI 10.1128/AAC.46.8.2337-2343.2002; Heir E, 1998, FEMS MICROBIOL LETT, V163, P49, DOI 10.1111/j.1574-6968.1998.tb13025.x; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Ivanek R, 2006, FOODBORNE PATHOG DIS, V3, P319, DOI 10.1089/fpd.2006.3.319; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P3475, DOI 10.1128/AAC.00464-10; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kehrenberg C, 2005, ANTIMICROB AGENTS CH, V49, P813, DOI 10.1128/AAC.49.2.813-815.2005; KROLEWSKI JJ, 1981, J MOL BIOL, V152, P19, DOI 10.1016/0022-2836(81)90093-0; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Kuenne C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012511; LEBRUN M, 1994, J BACTERIOL, V176, P3040, DOI 10.1128/JB.176.10.3040-3048.1994; LEBRUN M, 1994, J BACTERIOL, V176, P3049, DOI 10.1128/JB.176.10.3049-3061.1994; Lopez M, 2012, MICROB DRUG RESIST, V18, P13, DOI 10.1089/mdr.2011.0073; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mereghetti L, 2000, APPL ENVIRON MICROB, V66, P5083, DOI 10.1128/AEM.66.11.5083-5086.2000; Mullapudi S, 2008, APPL ENVIRON MICROB, V74, P1464, DOI 10.1128/AEM.02426-07; MURPHY E, 1984, NATURE, V307, P292, DOI 10.1038/307292a0; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06; PAULSEN IT, 1995, J BACTERIOL, V177, P2827, DOI 10.1128/jb.177.10.2827-2833.1995; Rajkovic A, 2009, FOOD MICROBIOL, V26, P889, DOI 10.1016/j.fm.2009.06.006; Rakic-Martinez M, 2011, APPL ENVIRON MICROB, V77, P8714, DOI 10.1128/AEM.05941-11; Romanova N, 2002, APPL ENVIRON MICROB, V68, P6405, DOI 10.1128/AEM.68.12.6405-6409.2002; Romanova NA, 2006, APPL ENVIRON MICROB, V72, P3498, DOI 10.1128/AEM.72.5.3498-3503.2006; Ibusquiza PS, 2011, FOOD MICROBIOL, V28, P418, DOI 10.1016/j.fm.2010.09.014; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sauders B.D., 2007, LISTERIA LISTERIOSIS, V161, P21, DOI DOI 10.1201/9781420015188.CH2; SCHLECH WF, 1983, NEW ENGL J MED, V308, P203, DOI 10.1056/NEJM198301273080407; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Soumet C, 2005, LETT APPL MICROBIOL, V41, P291, DOI 10.1111/j.1472-765X.2005.01763.x; Tasara T, 2007, FEMS MICROBIOL LETT, V269, P265, DOI 10.1111/j.1574-6968.2007.00633.x; To MS, 2002, APPL ENVIRON MICROB, V68, P5258, DOI 10.1128/AEM.68.11.5258-5264.2002; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856	55	108	109	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76835	10.1371/journal.pone.0076835	http://dx.doi.org/10.1371/journal.pone.0076835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098567	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500088
J	Takai, E; Tsukimoto, M; Kojima, S				Takai, Erina; Tsukimoto, Mitsutoshi; Kojima, Shuji			TGF-beta 1 Downregulates COX-2 Expression Leading to Decrease of PGE2 Production in Human Lung Cancer A549 Cells, Which Is Involved in Fibrotic Response to TGF-beta 1	PLOS ONE			English	Article							PROSTAGLANDIN E-2; TGF-BETA; CYCLOOXYGENASE-2 EXPRESSION; STIMULATES CYCLOOXYGENASE-2; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; GENE-EXPRESSION; GROWTH; PULMONARY; MIGRATION	Transforming growth factor-beta 1 (TGF-beta 1) is a multifunctional cytokine that is involved in various pathophysiological processes, including cancer progression and fibrotic disorders. Here, we show that treatment with TGF-beta 1 (5 ng/mL) induced downregulation of cyclooxygenase-2 (COX-2), leading to reduced synthesis of prostaglandin E2 (PGE2), in human lung cancer A549 cells. Treatment of cells with specific inhibitors of COX-2 or PGE2 receptor resulted in growth inhibition, indicating that the COX-2/PGE2 pathway contributes to proliferation in an autocrine manner. TGF-beta 1 treatment induced growth inhibition, which was attenuated by exogenous PGE2. TGF-beta 1 is also a potent inducer of epithelial mesenchymal transition (EMT), a phenotype change in which epithelial cells differentiate into fibroblastoid cells. Supplementation with PGE2 or PGE2 receptor EP4 agonist PGE1-alcohol, as compared with EP1/3 agonist sulprostone, inhibited TGF-beta 1-induced expression of fibronectin and collagen I (extracellular matrix components). Exogenous PGE2 or PGE2 receptor agonists also suppressed actin remodeling induced by TGF-beta 1. These results suggest that PGE2 has an anti-fibrotic effect. We conclude that TGF-beta 1-induced downregulation of COX-2/PGE2 signaling is involved in facilitation of fibrotic EMT response in A549 cells.	[Takai, Erina; Tsukimoto, Mitsutoshi; Kojima, Shuji] Tokyo Univ Sci, Dept Radiat Biosci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan	Tokyo University of Science	Tsukimoto, M (corresponding author), Tokyo Univ Sci, Dept Radiat Biosci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan.	tsukim@rs.noda.tus.ac.jp						Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; Cao SQ, 2011, INT J ONCOL, V39, P383, DOI 10.3892/ijo.2011.1053; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen YC, 2005, BBA-MOL CELL RES, V1743, P291, DOI 10.1016/j.bbamcr.2004.10.016; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Cocolakis E, 2008, J BIOL CHEM, V283, P1293, DOI 10.1074/jbc.M707492200; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Diers AR, 2010, BIOCHEM J, V430, P69, DOI 10.1042/BJ20091193; Doherty GA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-207; Eichele K, 2008, ONCOGENE, V27, P3032, DOI 10.1038/sj.onc.1210962; Go C, 1999, CANCER RES, V59, P2861; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2008, CHEST, V133, P1442, DOI 10.1378/chest.08-0306; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Koon HW, 2006, J IMMUNOL, V176, P5050, DOI 10.4049/jimmunol.176.8.5050; Krysan K, 2004, CANCER RES, V64, P6359, DOI 10.1158/0008-5472.CAN-04-1681; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li F, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-27; Li YJ, 2011, AM J RESP CELL MOL, V44, P99, DOI 10.1165/rcmb.2009-0163OC; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Liu JF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-43; Mayoral R, 2005, CARCINOGENESIS, V26, P753, DOI 10.1093/carcin/bgi022; Mumm JB, 2008, ONCOGENE, V27, P5913, DOI 10.1038/onc.2008.275; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; OZAKI T, 1987, J APPL PHYSIOL, V62, P219, DOI 10.1152/jappl.1987.62.1.219; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Rask K, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-62; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P1505, DOI 10.1002/ibd.21255; Riedl K, 2004, DRUG RESIST UPDATE, V7, P169, DOI 10.1016/j.drup.2004.04.003; Sabe H, 2011, J BIOCHEM, V149, P633, DOI 10.1093/jb/mvr044; Sawaoka H, 1998, AM J PHYSIOL-GASTR L, V274, pG1061, DOI 10.1152/ajpgi.1998.274.6.G1061; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sharma SD, 2010, MOL CANCER THER, V9, P569, DOI 10.1158/1535-7163.MCT-09-0638; SHIMOSATO Y, 1980, AM J SURG PATHOL, V4, P365, DOI 10.1097/00000478-198008000-00005; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TODARO GJ, 1981, J SUPRAMOL STR CELL, V15, P287, DOI 10.1002/jsscb.1981.380150306; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Wang ZL, 2013, CARCINOGENESIS, V34, P638, DOI 10.1093/carcin/bgs367; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yano T, 2002, FEBS LETT, V518, P154, DOI 10.1016/S0014-5793(02)02689-3; Zhang AH, 2006, AM J PHYSIOL-RENAL, V291, pF1332, DOI 10.1152/ajprenal.00131.2006; ZHANG K, 1994, AM J PATHOL, V145, P114	54	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76346	10.1371/journal.pone.0076346	http://dx.doi.org/10.1371/journal.pone.0076346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098479	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500062
J	Cui, L; Yang, DB; Yan, XJ; Rui, CH; Wang, ZY; Yuan, HZ				Cui, Li; Yang, Daibin; Yan, Xiaojing; Rui, Changhui; Wang, Zhenying; Yuan, Huizhu			Molecular Cloning, Characterization and Expression Profiling of a Ryanodine Receptor Gene in Asian Corn Borer, Ostrinia furnacalis (Guenee)	PLOS ONE			English	Article							CA2+ RELEASE CHANNEL; MUSCLE SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; ANTHRANILIC DIAMIDES; PLUTELLA-XYLOSTELLA; MESSENGER-RNA; BINDING-SITE; DOMAIN; IDENTIFICATION; FLUBENDIAMIDE	Ryanodine receptor (RyR) Ca2+ release channel is the target of diamide insecticides, which show selective insecticidal activity against lepidopterous insects. To study the molecular mechanisms underlying the species-specific action of diamide insecticides, we have cloned and characterized the entire cDNA sequence of RyR from Ostrinia furnacalis (named as OfRyR). The OfRyR mRNA has an Open Reading Frame of 15324 bp nucleotides and encodes a 5108 amino acid polypeptide that displays 79-97% identity with other insects RyR proteins and shows the greatest identity with Cnaphalocrocis medinalis RyR (97%). Quantitative real-time PCR showed that the OfRyR was expressed at the lowest level in egg and the highest level in adult. The relative expression level of OfRyR in first, third and fifth-instar larva were 1.28, 1.19 and 1.99 times of that in egg. Moreover, two alternative splicing sites were identified in the OfRyR gene. One pair of mutually exclusive exons (a/b) were present in the central part of the predicted SPRY domain, and an optional exon (c) was located between the third and fourth RyR domains. Diagnostic PCR demonstrated that exons a and b existed in all developmental stages of OfRyR cDNA, but exon c was not detected in the egg cDNA. And the usage frequencies of these exons showed a significant difference between different developmental stages. These results provided the crucial basis for the functional expression of OfRyR and for the discovery of compound with potentially selective insect activtity.	[Cui, Li; Yang, Daibin; Yan, Xiaojing; Rui, Changhui; Wang, Zhenying; Yuan, Huizhu] Chinese Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Yuan, HZ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing 100193, Peoples R China.	hzhyuan@ippcaas.cn			National Basic Research Program of China [2010CB126106]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2010CB126106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; Chen WL, 2012, SEED WORLD, V5, P13; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; D'Cruz AA, 2013, PROTEIN SCI, V22, P1, DOI 10.1002/pro.2185; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Dulhunty AF, 2003, CLIN EXP PHARMACOL P, V30, P713, DOI 10.1046/j.1440-1681.2003.03904.x; Ebbinghaus-Kintscher U, 2006, CELL CALCIUM, V39, P21, DOI 10.1016/j.ceca.2005.09.002; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; George CH, 2004, MOL BIOL CELL, V15, P2627, DOI 10.1091/mbc.E03-09-0688; George CH, 2007, CIRC RES, V100, P874, DOI 10.1161/01.RES.0000260804.77807.cf; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Guo L, 2012, PEST MANAG SCI, V68, P1605, DOI 10.1002/ps.3357; INUI M, 1987, J BIOL CHEM, V262, P15637; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kato K, 2009, BIOCHEMISTRY-US, V48, P10342, DOI 10.1021/bi900866s; Kimura T, 2009, CELL CALCIUM, V45, P264, DOI 10.1016/j.ceca.2008.11.005; Lahm GP, 2007, BIOORG MED CHEM LETT, V17, P6274, DOI 10.1016/j.bmcl.2007.09.012; Lahm GP, 2005, BIOORG MED CHEM LETT, V15, P4898, DOI 10.1016/j.bmcl.2005.08.034; Liu S, 2003, NUCLEIC ACIDS RES, V31, P4828, DOI 10.1093/nar/gkg668; Masaki T, 2006, MOL PHARMACOL, V69, P1733, DOI 10.1124/mol.105.020339; Nauen R, 2006, PEST MANAG SCI, V62, P690, DOI 10.1002/ps.1254; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; Ogawa Y, 1999, MOL CELL BIOCH; Ottini L, 1996, BIOCHEM J, V315, P207, DOI 10.1042/bj3150207; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Sun LN, 2012, GENE, V511, P265, DOI 10.1016/j.gene.2012.09.027; Tae H, 2011, CHANNELS, V5, P148, DOI 10.4161/chan.5.2.14407; TAKESHIMA H, 1993, ANN NY ACAD SCI, V707, P165, DOI 10.1111/j.1749-6632.1993.tb38051.x; TAKESHIMA H, 1994, FEBS LETT, V337, P81, DOI 10.1016/0014-5793(94)80634-9; Tohnishi M, 2005, J PESTIC SCI, V30, P354, DOI 10.1584/jpestics.30.354; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036623; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; Xiong H, 1998, BIOCHEMISTRY-US, V37, P4804, DOI 10.1021/bi971198b; Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200; ZARKA A, 1993, EUR J BIOCHEM, V213, P147, DOI 10.1111/j.1432-1033.1993.tb17744.x; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	40	18	22	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75825	10.1371/journal.pone.0075825	http://dx.doi.org/10.1371/journal.pone.0075825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098400	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100022
J	Paccou, J; Boudot, C; Mary, A; Kamel, S; Drueke, TB; Fardellone, P; Massy, Z; Brazier, M; Mentaverri, R				Paccou, Julien; Boudot, Cedric; Mary, Aurelien; Kamel, Said; Drueeke, Tilman Bernhard; Fardellone, Patrice; Massy, Ziad; Brazier, Michel; Mentaverri, Romuald			Determination and Modulation of Total and Surface Calcium-Sensing Receptor Expression in Monocytes In Vivo and In Vitro	PLOS ONE			English	Article							EXTRACELLULAR CALCIUM; CELL-LINE; (CA-O(2+))-SENSING RECEPTOR; RHEUMATOID-ARTHRITIS; VITAMIN-D; GENE	Expression of the calcium-sensing receptor (CaSR) has previously been demonstrated in human circulating monocytes (HCM). The present study was designed to measure CaSR expression in HCM and to examine its potential modulation by pro-inflammatory cytokines, Ca2+, vitamin D sterols in U937 cell line. Twenty healthy volunteers underwent blood sampling with subsequent isolation of peripheral blood mononuclear cells (PBMC) at 3 visits. Flow cytometry analysis (FACS) was performed initially (V1) and 19 days later (V2) to examine intra-and intersubject fluctuations of total and surface CaSR expression in HCM and 15 weeks later (V3) to study the effect of vitamin D supplementation. In vitro experiments were conducted to assess the effects of pro-inflammatory cytokines, calcidiol, calcitriol and Ca2+ on CaSR expression in U937 cell line. By FACS analysis, more than 95% of HCM exhibited cell surface CaSR staining. In contrast, CaSR staining failed to detect surface CaSR expression in other PBMC. After cell permeabilization, total CaSR expression was observed in more than 95% of all types of PBMC. Both total and surface CaSR expression in HCM showed a high degree of intra-assay reproducibility (<3%) and a moderate intersubject fluctuation. In response to vitamin D supplementation, there was no significant change for both total and surface CaSR expression. In the in vitro study, U937 cells showed strong total and surface CaSR expression, and both were moderately increased in response to calcitriol exposure. Neither total nor surface CaSR expression was modified by increasing Ca2+ concentrations. Total CaSR expression was concentration dependently decreased by TNF alpha exposure. In conclusion, CaSR expression can be easily measured by flow cytometry in human circulating monocytes. In the in vitro study, total and surface CaSR expression in the U937 cell line were increased by calcitriol but total CaSR expression was decreased by TNF alpha stimulation.	[Paccou, Julien; Fardellone, Patrice] Univ Hosp Amiens, Dept Rheumatol, Amiens, France; [Paccou, Julien; Boudot, Cedric; Mary, Aurelien; Kamel, Said; Drueeke, Tilman Bernhard; Fardellone, Patrice; Massy, Ziad; Brazier, Michel; Mentaverri, Romuald] Univ Picardie Jules Verne, INSERM, UFR Med Pharm, U1088, Amiens, France; [Massy, Ziad] Univ Hosp Ambroise Pare, Dept Clin Nephrol, Boulogne Billancourt, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Paccou, J (corresponding author), Univ Hosp Amiens, Dept Rheumatol, Amiens, France.	julienpaccou@yahoo.fr	Kamel, Said/HGA-7781-2022; DRUEKE, Tilman B./B-4958-2010	DRUEKE, Tilman B./0000-0002-0700-7681; paccou, julien/0000-0001-6599-8623				Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Brown EM, 1999, VITAM HORM, V55, P1; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Canaff L, 2002, J BIOL CHEM, V277, P30337, DOI 10.1074/jbc.M201804200; Canaff L, 2008, J BIOL CHEM, V283, P13586, DOI 10.1074/jbc.M708087200; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Freichel M, 1996, ENDOCRINOLOGY, V137, P3842, DOI 10.1210/en.137.9.3842; Grant MP, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002208; Gratchev A, 2012, IMMUNOBIOLOGY, V217, P476, DOI 10.1016/j.imbio.2012.01.008; House MG, 1997, J BONE MINER RES, V12, P1959, DOI 10.1359/jbmr.1997.12.12.1959; Kanatani N, 1999, BIOCHEM BIOPH RES CO, V261, P144, DOI 10.1006/bbrc.1999.0932; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Lin KI, 1998, BIOCHEM BIOPH RES CO, V249, P325, DOI 10.1006/bbrc.1998.9124; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Olszak IT, 2000, J CLIN INVEST, V105, P1299, DOI 10.1172/JCI9799; Quinn SJ, 1998, J BIOL CHEM, V273, P19579, DOI 10.1074/jbc.273.31.19579; Rushworth SA, 2011, J IMMUNOL, V187, P702, DOI 10.4049/jimmunol.1004117; Souberbielle JC, 2008, ANN ENDOCRINOL-PARIS, V69, P501, DOI 10.1016/j.ando.2008.07.010; Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034641; Yamaguchi T, 1998, J BONE MINER RES, V13, P1530, DOI 10.1359/jbmr.1998.13.10.1530; Yamaguchi T, 1998, J BONE MINER RES, V13, P1390, DOI 10.1359/jbmr.1998.13.9.1390; Yamaguchi T, 1998, BIOCHEM BIOPH RES CO, V246, P501, DOI 10.1006/bbrc.1998.8648	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74800	10.1371/journal.pone.0074800	http://dx.doi.org/10.1371/journal.pone.0074800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098349	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100009
J	Luque, MCA; Gutierrez, PS; Debbas, V; Martins, WK; Puech-Leao, P; Porto, G; Coelho, V; Boumsell, L; Kalil, J; Stolf, B				Aquino Luque, Maria Carolina; Gutierrez, Paulo Sampaio; Debbas, Victor; Martins, Waleska Kerllen; Puech-Leao, Pedro; Porto, Georgia; Coelho, Veronica; Boumsell, Laurence; Kalil, Jorge; Stolf, Beatriz			Phage Display Identification of CD100 in Human Atherosclerotic Plaque Macrophages and Foam Cells	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; SURFACE EXPRESSION; SCAVENGER RECEPTORS; VASCULAR-LESIONS; SOLUBLE CD100; ARTERIOSCLEROSIS; DEFINITION; ACTIVATION; COMMITTEE; COUNCIL	Atherosclerosis is a complex disease in which vessels develop plaques comprising dysfunctional endothelium, monocyte derived lipid laden foam cells and activated lymphocytes. Considering that humans and animal models of the disease develop quite distinct plaques, we used human plaques to search for proteins that could be used as markers of human atheromas. Phage display peptide libraries were probed to fresh human carotid plaques, and a bound phage homologous to plexin B1, a high affinity receptor for CD100, was identified. CD100 is a member of the semaphorin family expressed by most hematopoietic cells and particularly by activated T cells. CD100 expression was analyzed in human plaques and normal samples. CD100 mRNA and protein were analyzed in cultured monocytes, macrophages and foam cells. The effects of CD100 in oxLDL-induced foam cell formation and in CD36 mRNA abundance were evaluated. Human atherosclerotic plaques showed strong labeling of CD100/SEMA4D. CD100 expression was further demonstrated in peripheral blood monocytes and in in vitro differentiated macrophages and foam cells, with diminished CD100 transcript along the differentiation of these cells. Incubation of macrophages with CD100 led to a reduction in oxLDL-induced foam cell formation probably through a decrease of CD36 expression, suggesting for the first time an atheroprotective role for CD100 in the human disease. Given its differential expression in the numerous foam cells and macrophages of the plaques and its capacity to decrease oxLDL engulfment by macrophages we propose that CD100 may have a role in atherosclerotic plaque development, and may possibly be employed in targeted treatments of these atheromas.	[Aquino Luque, Maria Carolina; Gutierrez, Paulo Sampaio; Debbas, Victor; Puech-Leao, Pedro; Porto, Georgia; Coelho, Veronica; Kalil, Jorge; Stolf, Beatriz] HC FMUSP, Heart Inst Sao Paulo InCor, Sao Paulo, Brazil; [Aquino Luque, Maria Carolina; Coelho, Veronica; Kalil, Jorge; Stolf, Beatriz] Univ Sao Paulo, Sch Med, Dept Clin Med, HC FMUSP, Sao Paulo, Brazil; [Coelho, Veronica; Kalil, Jorge] Natl Inst Sci & Technol, INCT, Inst Invest Immunol, Sao Paulo, Brazil; [Boumsell, Laurence] Univ Paris 05, Inst Cochin, INSERM, U567, Paris, France; [Martins, Waleska Kerllen] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Stolf, Beatriz] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; Universidade de Sao Paulo	Luque, MCA (corresponding author), HC FMUSP, Heart Inst Sao Paulo InCor, Sao Paulo, Brazil.	bstolf@usp.br	Martins, Waleska Kerllen/L-5187-2018; Stolf, Beatriz S/H-7943-2012; Leao, Pedro P/B-5495-2016; PUECH-LEAO, PEDRO/AAW-8801-2020; Gutierrez, Paulo S/E-6783-2012; KALIL, JORGE/C-8029-2012	Martins, Waleska Kerllen/0000-0003-1502-4606; Stolf, Beatriz S/0000-0001-7661-3311; PUECH-LEAO, PEDRO/0000-0002-6974-9509; Gutierrez, Paulo S/0000-0002-9544-2359; KALIL, JORGE/0000-0001-8415-4274; Coelho, Veronica/0000-0002-0989-2581	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; BANKA CL, 1991, J LIPID RES, V32, P35; BOUGERET C, 1992, J IMMUNOL, V148, P318; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Elhabazi A, 2003, CRIT REV IMMUNOL, V23, P65, DOI 10.1615/CritRevImmunol.v23.i12.40; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hong HY, 2008, J CELL MOL MED, V12, P2003, DOI 10.1111/j.1582-4934.2008.00189.x; Houston P, 2001, FEBS LETT, V492, P73, DOI 10.1016/S0014-5793(01)02191-3; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Ji JD, 2009, HUM IMMUNOL, V70, P211, DOI 10.1016/j.humimm.2009.01.026; Kamperidis P, 2011, ARTHRITIS RHEUM-US, V63, P3758, DOI 10.1002/art.30650; Karjalainen K, 2011, BLOOD, V117, P920, DOI 10.1182/blood-2010-05-282921; Kikutani H, 2007, ADV IMMUNOL, V93, P121, DOI 10.1016/S0065-2776(06)93003-X; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Porto G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021702; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Rekhter MD, 2001, CELL BIOCHEM BIOPHYS, V35, P103, DOI 10.1385/CBB:35:1:103; Robert R, 2006, J BIOL CHEM, V281, P40135, DOI 10.1074/jbc.M609344200; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Yacoby I, 2008, EXPERT OPIN DRUG DEL, V5, P321, DOI 10.1517/17425247.5.3.321 ; Yukawa K, 2010, INT J MOL MED, V26, P39, DOI 10.3892/ijmm_00000432; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104; Zhu L, 2009, ARTERIOSCL THROM VAS, V29, P1039, DOI 10.1161/ATVBAHA.109.185405	34	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75772	10.1371/journal.pone.0075772	http://dx.doi.org/10.1371/journal.pone.0075772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098722	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500093
J	Bertrand, C; Blanchet, E; Pessemesse, L; Annicotte, JS; Feillet-Coudray, C; Chabi, B; Levin, J; Fajas, L; Cabello, G; Wrutniak-Cabello, C; Casas, F				Bertrand, Christelle; Blanchet, Emilie; Pessemesse, Laurence; Annicotte, Jean Sebastien; Feillet-Coudray, Christine; Chabi, Beatrice; Levin, Jonathan; Fajas, Lluis; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois			Mice Lacking the p43 Mitochondrial T3 Receptor Become Glucose Intolerant and Insulin Resistant during Aging	PLOS ONE			English	Article							REGULATES MYOBLAST DIFFERENTIATION; SECRETION; EXPRESSION; OVEREXPRESSION; FAT	Thyroid hormones (TH) play an important regulatory role in energy expenditure regulation and are key regulators of mitochondrial activity. We have previously identified a mitochondrial triiodothyronine (T3) receptor (p43) which acts as a mitochondrial transcription factor of the organelle genome, which leads in vitro and in vivo, to a stimulation of mitochondrial biogenesis. Recently, we generated mice carrying a specific p43 invalidation. At 2 months of age, we reported that p43 depletion in mice induced a major defect in insulin secretion both in vivo and in isolated pancreatic islets, and a loss of glucose-stimulated insulin secretion. The present study was designed to determine whether p43 invalidation influences life expectancy and modulates blood glucose and insulin levels as well as glucose tolerance or insulin sensitivity during aging. We report that from 4 months old onwards, mice lacking p43 are leaner than wild-type mice. p43-/- mice also have a moderate reduction of life expectancy compared to wild type. We found no difference in blood glucose levels, excepted at 24 months old where p43-/- mice showed a strong hyperglycemia in fasting conditions compared to controls animals. However, the loss of glucose-stimulated insulin secretion was maintained whatever the age of mice lacking p43. If up to 12 months old, glucose tolerance remained unchanged, beyond this age p43-/- mice became increasingly glucose intolerant. In addition, if up to 12 months old p43 deficient animals were more sensitive to insulin, after this age we observed a loss of this capacity, culminating in 24 months old mice with a decreased sensitivity to the hormone. In conclusion, we demonstrated that during aging the depletion of the mitochondrial T3 receptor p43 in mice progressively induced an increased glycemia in the fasted state, glucose intolerance and an insulin-resistance several features of type-2 diabetes.	[Bertrand, Christelle; Pessemesse, Laurence; Feillet-Coudray, Christine; Chabi, Beatrice; Levin, Jonathan; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois] INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France; [Bertrand, Christelle; Blanchet, Emilie; Pessemesse, Laurence; Annicotte, Jean Sebastien; Feillet-Coudray, Christine; Chabi, Beatrice; Levin, Jonathan; Fajas, Lluis; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois] Univ Montpellier I, Montpellier, France; [Bertrand, Christelle; Blanchet, Emilie; Pessemesse, Laurence; Annicotte, Jean Sebastien; Feillet-Coudray, Christine; Chabi, Beatrice; Levin, Jonathan; Fajas, Lluis; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois] Univ Montpellier 2, Montpellier, France; [Blanchet, Emilie; Annicotte, Jean Sebastien; Fajas, Lluis] CNRS, UMR5535, IGMM, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Casas, F (corresponding author), INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France.	casasf@supagro.inra.fr	Coll, Lluis Fajas/C-8567-2014; Levin, Jonathan/N-3189-2018; Annicotte, Jean-Sébastien/H-4641-2018; Chabi, Beatrice/AAI-6545-2020; BERTRAND-GADAY, Christelle/ABA-8619-2021	Annicotte, Jean-Sébastien/0000-0002-2109-4849; Chabi, Beatrice/0000-0002-5604-5668; BERTRAND-GADAY, Christelle/0000-0003-0461-2402; Francois, Casas/0000-0002-5535-8195; Fajas, Lluis/0000-0002-1283-9503	Institut National de la Recherche Agronomique (INRA); Societe Francophone du Diabete (SFD)	Institut National de la Recherche Agronomique (INRA); Societe Francophone du Diabete (SFD)	This work was supported by grants from the Institut National de la Recherche Agronomique (INRA) and the Societe Francophone du Diabete (SFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Annicotte JS, 2003, MOL CELL BIOL, V23, P6713, DOI 10.1128/MCB.23.19.6713-6724.2003; Blanchet E, 2012, FASEB J, V26, P40, DOI 10.1096/fj.11-186841; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.ph.53.030191.000313; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005631; Casas F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002501; DIAZ GB, 1993, ARCH INT PHYSIOL BIO, V101, P263, DOI 10.3109/13813459309003922; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Grandemange S, 2005, CANCER RES, V65, P4282, DOI 10.1158/0008-5472.CAN-04-3652; Jornayvaz FR, 2012, ENDOCRINOLOGY, V153, P583, DOI 10.1210/en.2011-1793; Kondo T, 2009, MOL ENDOCRINOL, V23, P1281, DOI 10.1210/me.2008-0482; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; LIGGETT SB, 1989, J CLIN INVEST, V83, P803, DOI 10.1172/JCI113961; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Misiti S, 2005, J CELL PHYSIOL, V204, P286, DOI 10.1002/jcp.20293; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P79, DOI 10.1210/jc.76.1.79; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; Pessemesse L, 2012, FASEB J, V26, P748, DOI 10.1096/fj.11-195933; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Seyer P, 2011, EXP CELL RES, V317, P2059, DOI 10.1016/j.yexcr.2011.05.020; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Verga Falzacappa C, 2006, J CELL PHYSIOL, V206, P309, DOI 10.1002/jcp.20460; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067	29	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75111	10.1371/journal.pone.0075111	http://dx.doi.org/10.1371/journal.pone.0075111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098680	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500051
J	Gurwick, NP; Moore, LA; Kelly, C; Elias, P				Gurwick, Noel P.; Moore, Lisa A.; Kelly, Charlene; Elias, Patricia			A Systematic Review of Biochar Research, with a Focus on Its Stability in situ and Its Promise as a Climate Mitigation Strategy	PLOS ONE			English	Review							SOIL CARBON SEQUESTRATION; BLACK CARBON; SUSTAINABLE AGRICULTURE; EMISSIONS; DYNAMICS; IMPACT; PRODUCTIVITY; MANAGEMENT; OXIDATION; NITROGEN	Background: Claims about the environmental benefits of charring biomass and applying the resulting "biochar'' to soil are impressive. If true, they could influence land management worldwide. Alleged benefits include increased crop yields, soil fertility, and water-holding capacity; the most widely discussed idea is that applying biochar to soil will mitigate climate change. This claim rests on the assumption that biochar persists for hundreds or thousands of years, thus storing carbon that would otherwise decompose. We conducted a systematic review to quantify research effort directed toward ten aspects of biochar and closely evaluated the literature concerning biochar's stability. Findings: We identified 311 peer-reviewed research articles published through 2011. We found very few field studies that addressed biochar's influence on several ecosystem processes: one on soil nutrient loss, one on soil contaminants, six concerning non-CO2 greenhouse gas (GHG) fluxes (some of which fail to support claims that biochar decreases non-CO2 GHG fluxes), and 16-19 on plants and soil properties. Of 74 studies related to biochar stability, transport or fate in soil, only seven estimated biochar decomposition rates in situ, with mean residence times ranging from 8 to almost 4,000 years. Conclusions: Our review shows there are not enough data to draw conclusions about how biochar production and application affect whole-system GHG budgets. Wide-ranging estimates of a key variable, biochar stability in situ, likely result from diverse environmental conditions, feedstocks, and study designs. There are even fewer data about the extent to which biochar stimulates decomposition of soil organic matter or affects non-CO2 GHG emissions. Identifying conditions where biochar amendments yield favorable GHG budgets requires a systematic field research program. Finally, evaluating biochar's suitability as a climate mitigation strategy requires comparing its effects with alternative uses of biomass and considering GHG budgets over both long and short time scales.	[Gurwick, Noel P.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Moore, Lisa A.] Environm Def Fund, San Francisco, CA USA; [Kelly, Charlene] Western Carolina Univ, Cullowhee, NC 28723 USA; [Elias, Patricia] Union Concerned Scientists, Washington, DC USA	Smithsonian Institution; Smithsonian Environmental Research Center; Environmental Defense Fund; University of North Carolina; Western Carolina University	Gurwick, NP (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	Noel.Gurwick@Gmail.Com		Moore, Lisa/0000-0003-0239-6080	The Tropical Forest and Climate Initiative at the Union of Concerned Scientists (UCS); Environmental Defense Fund (EDF); UCS	The Tropical Forest and Climate Initiative at the Union of Concerned Scientists (UCS); Environmental Defense Fund (EDF); UCS	The Tropical Forest and Climate Initiative at the Union of Concerned Scientists (UCS) briefly supported CK to perform an initial classification of some of the studies we reviewed. During the initial stages of this study, NPG was on staff at UCS, which paid his salary during that time. LAM is on staff at Environmental Defense Fund (EDF), which has covered her salary. EDF paid for NPG and LAM to attend a 5-day writing retreat that they used to make progress on this study. The material in this paper does not reflect any position of EDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2011, PEDOBIOLOGIA, V54, P309, DOI 10.1016/j.pedobi.2011.07.005; Asai H, 2009, FIELD CROP RES, V111, P81, DOI 10.1016/j.fcr.2008.10.008; Biederman LA, 2013, GCB BIOENERGY, V5, P202, DOI 10.1111/gcbb.12037; Bird MI, 1999, GLOBAL BIOGEOCHEM CY, V13, P923, DOI 10.1029/1999GB900067; Blackwell P, 2010, AUST J SOIL RES, V48, P531, DOI 10.1071/SR10014; Busscher WJ, 2010, SOIL SCI, V175, P10, DOI 10.1097/SS.0b013e3181cb7f46; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Castaldi S, 2011, CHEMOSPHERE, V85, P1464, DOI 10.1016/j.chemosphere.2011.08.031; Chan KY, 2008, AUST J SOIL RES, V46, P437, DOI 10.1071/SR08036; Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010; Cheng CH, 2006, ORG GEOCHEM, V37, P1477, DOI 10.1016/j.orggeochem.2006.06.022; CHENG WX, 1990, SOIL BIOL BIOCHEM, V22, P781, DOI 10.1016/0038-0717(90)90157-U; Cooper JM, 2011, NJAS-WAGEN J LIFE SC, V58, P185, DOI 10.1016/j.njas.2011.05.002; Dai X, 2005, SOIL BIOL BIOCHEM, V37, P1879, DOI 10.1016/j.soilbio.2005.02.021; De Gryze S., 2010, EVALUATION OPPORTUNI, P1, DOI DOI 10.1017/CB09781107415324.004; Dijkstra FA, 2007, ECOL LETT, V10, P1406; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Fraser LH, 2013, FRONT ECOL ENVIRON, V11, P147, DOI 10.1890/110279; Freschet GT, 2012, J ECOL, V100, P161, DOI 10.1111/j.1365-2745.2011.01896.x; Gaskin JW, 2008, T ASABE, V51, P2061, DOI 10.13031/2013.25409; Gaunt JL, 2008, ENVIRON SCI TECHNOL, V42, P4152, DOI 10.1021/es071361i; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Glaser B, 2000, ORG GEOCHEM, V31, P669, DOI 10.1016/S0146-6380(00)00044-9; Haefele SM, 2011, FIELD CROP RES, V121, P430, DOI 10.1016/j.fcr.2011.01.014; Hammes K, 2008, BIOGEOSCIENCES, V5, P1339, DOI 10.5194/bg-5-1339-2008; Hammond J, 2011, ENERG POLICY, V39, P2646, DOI 10.1016/j.enpol.2011.02.033; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; International Biochar Initiative, 2013, WHAT IS BIOCH; International Biochar Initiative, 2013, APR 2013 UPD BIOCH C; International Biochar Initiative, 2013, INT POL; International Biochar Initiative, 2013, MUCH CO2 CAN BIOCH P; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Jeffery S, 2013, GCB BIOENERGY; Kameyama K, 2010, AUST J SOIL RES, V48, P586, DOI 10.1071/SR10008; Kammann CI, 2011, PLANT SOIL, V345, P195, DOI 10.1007/s11104-011-0771-5; Kane ES, 2010, BIOGEOCHEMISTRY, V100, P39, DOI 10.1007/s10533-009-9403-z; Kanter J., 2009, NY TIMES; Karami N, 2011, J HAZARD MATER, V191, P41, DOI 10.1016/j.jhazmat.2011.04.025; Karhu K, 2011, AGR ECOSYST ENVIRON, V140, P309, DOI 10.1016/j.agee.2010.12.005; Kline KL, 2008, SCIENCE, P321; Knoblauch C, 2011, SOIL BIOL BIOCHEM, V43, P1768, DOI 10.1016/j.soilbio.2010.07.012; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Kookana RS, 2011, ADV AGRON, V112, P103, DOI 10.1016/B978-0-12-385538-1.00003-2; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P747, DOI 10.1016/j.soilbio.2005.06.025; Laird DA, 2009, BIOFUEL BIOPROD BIOR, V3, P547, DOI 10.1002/bbb.169; Lal R, 2007, SOIL SCI, V172, P943, DOI 10.1097/ss.0b013e31815cc498; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Larson RW, 2009, USING BIOCHAR COST E, P2462; Lehmann J, 2008, SCIENCE, V321, DOI 10.1126/science.1160005; Likens G. E., 1995, BIOGEOCHEMISTRY FORE; Lovins HL, 2011, BIOCHAR WAY OUT KICK, P390; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Magdoff F., 2009, BUILDING SOILS BETTE, Vthird; Major J, 2010, GLOBAL CHANGE BIOL, V16, P1366, DOI 10.1111/j.1365-2486.2009.02044.x; Matovic D, 2011, ENERGY, V36, P2011, DOI 10.1016/j.energy.2010.09.031; McKone TE, 2011, ENVIRON SCI TECHNOL, V45, P1751, DOI 10.1021/es103579c; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nguyen BT, 2009, BIOGEOCHEMISTRY, V92, P163, DOI 10.1007/s10533-008-9248-x; Ogawa M., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P429, DOI 10.1007/s11027-005-9007-4; Olander LP, 2008, DESIGNING OFFSETS PO; Paustian K, 2000, BIOGEOCHEMISTRY, V48, P147, DOI 10.1023/A:1006271331703; Powlson DS, 2011, FOOD POLICY, V36, pS72, DOI 10.1016/j.foodpol.2010.11.025; Pratt K, 2010, BIOMASS BIOENERG, V34, P1149, DOI 10.1016/j.biombioe.2010.03.004; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reid WV, 2010, SCIENCE, V330, P916, DOI 10.1126/science.1196263; Roberts KG, 2010, ENVIRON SCI TECHNOL, V44, P827, DOI 10.1021/es902266r; Scheer C, 2011, PLANT SOIL, V345, P47, DOI 10.1007/s11104-011-0759-1; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Schowalter T. D., 1992, TROPICAL ECOSYSTEMS, P373; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Skog KE, 2008, FOREST PROD J, V58, P56; Smith P, 2008, ADV AGRON, V97, P1, DOI 10.1016/S0065-2113(07)00001-6; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Spokas K. A., 2009, Annals of Environmental Science, V3, P179; Spokas KA, 2010, CARBON MANAG, V1, P289, DOI 10.4155/CMT.10.32; Streubel JD, 2011, SOIL SCI SOC AM J, V75, P1402, DOI 10.2136/sssaj2010.0325; Vaccari FP, 2011, EUR J AGRON, V34, P231, DOI 10.1016/j.eja.2011.01.006; Wardle DA, 2008, SCIENCE, V320, P629, DOI 10.1126/science.1154960; Weisberg P, 2010, CARBON MARKET INVEST; Whitman T, 2011, ENVIRON SCI TECHNOL, V45, P3687, DOI 10.1021/es103301k; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053; Yanai RD, 2000, FOREST ECOL MANAG, V138, P273, DOI 10.1016/S0378-1127(00)00402-3; Zhang AF, 2010, AGR ECOSYST ENVIRON, V139, P469, DOI 10.1016/j.agee.2010.09.003; Zhang WW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052849, 10.1371/journal.pone.0054779]; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	86	127	129	7	352	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75932	10.1371/journal.pone.0075932	http://dx.doi.org/10.1371/journal.pone.0075932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098746	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500116
J	Liu, QX; Fang, XY; Zhou, ZK; Zhang, JT; Deng, LY				Liu, Qin-Xue; Fang, Xiao-Yi; Zhou, Zong-Kui; Zhang, Jin-Tao; Deng, Lin-Yuan			Perceived Parent-Adolescent Relationship, Perceived Parental Online Behaviors and Pathological Internet Use among Adolescents: Gender-Specific Differences	PLOS ONE			English	Article							DEVELOPMENTAL OUTCOMES; CHINESE ADOLESCENTS; COLLEGE-STUDENTS; RISK BEHAVIORS; SUBSTANCE USE; CHILD; FATHERS; ATTACHMENT; COMMUNICATION; SMOKING	This study examined the associations between adolescents' perceived relationships with their parents, perceived parental online behaviors, and Pathological Internet Use (PIU) among adolescents. Additional testing was carried out to determine the effect of different genders (parent and adolescent). Cross-sectional data was collected from 4,559 students aged 12 to 21 years in the cities of Beijing and Jinan, People's Republic of China. Participants responded to an anonymous questionnaire concerning their Internet use behavior, perceived parental Internet use behaviors, and perceived parent-adolescent relationship. Hierarchical linear regressions controlling for adolescents' age were conducted. Results showed different effects of parent and adolescent gender on perceived parent-adolescent relationship and parent Internet use behavior, as well as some other gender-specific associations. Perceived father-adolescent relationship was the most protective factor against adolescent PIU with perceived maternal Internet use positively predicting PIU for both male and female adolescents. However, perceived paternal Internet use behaviors positively predicted only female adolescent PIU. Results indicated a different effect pathway for fathers and mothers on boys and girls, leading to discussion of the implications for prevention and intervention.	[Liu, Qin-Xue; Zhou, Zong-Kui] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav, Wuhan, Peoples R China; [Liu, Qin-Xue; Zhou, Zong-Kui] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Fang, Xiao-Yi] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China; [Fang, Xiao-Yi; Zhang, Jin-Tao] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Deng, Lin-Yuan] Beijing Normal Univ, Fac Educ, Beijing 100875, Peoples R China	Central China Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Fang, XY (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China.	fangxy@bnu.edu.cn		Liu, Qinxue/0000-0002-7779-2048	China National Science Foundation [31170990]; Program for Changjiang Scholars, Social Sciences Foundation of Ministry of Education in China [10YJCXLX003]; Project of Social Sciences for Young Scholars from Ministry of Education in China [12YJC190023]; Fundamental Research Funds of Central China Normal University [CCNU11C01005]; Key Laboratory of Adolescent Cyberpsychology and Behavior (Central China Normal University)	China National Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars, Social Sciences Foundation of Ministry of Education in China; Project of Social Sciences for Young Scholars from Ministry of Education in China; Fundamental Research Funds of Central China Normal University; Key Laboratory of Adolescent Cyberpsychology and Behavior (Central China Normal University)	This research was supported by China National Science Foundation (Project No. 31170990), Program for Changjiang Scholars, Social Sciences Foundation of Ministry of Education in China (Project No. 10YJCXLX003), Project of Social Sciences for Young Scholars from Ministry of Education in China (Project No. 12YJC190023), the Fundamental Research Funds of Central China Normal University (CCNU11C01005) and support from Key Laboratory of Adolescent Cyberpsychology and Behavior (Central China Normal University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley OS, 2008, ADDICT BEHAV, V33, P1227, DOI 10.1016/j.addbeh.2008.04.012; Bandura Albert, 1977, SOCIAL LEARNING THEO; Bjornstad T. L., 2004, ONLINERS REPORT YOUT; BUCHANAN CM, 1991, CHILD DEV, V62, P1008, DOI 10.2307/1131149; Caplan SE, 2002, COMPUT HUM BEHAV, V18, P553, DOI 10.1016/S0747-5632(02)00004-3; China Internet Network Information Center (CNNIC), STAT REP DEV INT CHI; China Youth, 2010, CHINA YOUTH STUDY, V6, P5; Cho SC, 2008, CYBERPSYCHOL BEHAV, V11, P735, DOI 10.1089/cpb.2007.0285; Coley RL, 2009, CHILD DEV, V80, P808, DOI 10.1111/j.1467-8624.2009.01299.x; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; Donati MA, 2013, J ADOLESCENCE, V36, P129, DOI 10.1016/j.adolescence.2012.10.001; Gilman SE, 2009, PEDIATRICS, V123, pE274, DOI 10.1542/peds.2008-2251; Gray MR, 1999, J MARRIAGE FAM, V61, P574, DOI 10.2307/353561; Grossmann K, 2002, SOC DEV, V11, P307; Hawkins J D, 1985, J Prim Prev, V6, P73, DOI 10.1007/BF01325432; He C. C., 2008, MED J CHINESE PEOPLE, V20, P1988; Hirschi T., 1969, CAUSE OF DELINQUENCY; Kim KS, 2003, KOREAN J HUM ECOL, V6, P15; Kong G, 2012, ADDICT BEHAV, V37, P211, DOI 10.1016/j.addbeh.2011.10.013; LAU RR, 1990, J HEALTH SOC BEHAV, V31, P240, DOI 10.2307/2136890; Lei L, 2007, CYBERPSYCHOL BEHAV, V10, P633, DOI 10.1089/cpb.2007.9976; [雷雳 Lei Li], 2007, [心理学报, Acta Psychologica Sinica], V39, P688; Li CN, 2009, MOD ED RES, V4, P49; Liau AK, 2008, CURR PSYCHOL, V27, P217, DOI 10.1007/s12144-008-9038-6; Liu QX, 2012, COMPUT HUM BEHAV, V28, P1269, DOI 10.1016/j.chb.2012.02.010; Livingstone S., 2004, UK CHILDREN GO ONLIN; Lou G, 2009, MODERN ED SCI, V1, P44; Luk JW, 2010, ADDICT BEHAV, V35, P426, DOI 10.1016/j.addbeh.2009.12.009; [罗辉萍 LUO Huiping], 2008, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V16, P319; Mayseless O, 1998, J ADOLESCENT RES, V13, P101, DOI 10.1177/0743554898131006; Michiels D, 2008, DEV REV, V28, P522, DOI 10.1016/j.dr.2008.08.002; Morahan-Martin J, 2000, COMPUT HUM BEHAV, V16, P13, DOI 10.1016/S0747-5632(99)00049-7; Morrongiello BA, 2000, J EXP CHILD PSYCHOL, V76, P89, DOI 10.1006/jecp.2000.2572; Nam Y-O, 2002, KOREAN J SOC WELF, V50, P173; Niemz K, 2005, CYBERPSYCHOL BEHAV, V8, P562, DOI 10.1089/cpb.2005.8.562; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Paquette D, 2004, HUM DEV, V47, P193, DOI 10.1159/000078723; Patock-Peckham JA, 2006, PSYCHOL ADDICT BEHAV, V20, P117, DOI 10.1037/0893-164X.20.2.117; Patock-Peckham JA, 2009, ADDICT BEHAV, V34, P312, DOI 10.1016/j.addbeh.2008.10.017; Racz SJ, 2011, CLIN CHILD FAM PSYCH, V14, P377, DOI 10.1007/s10567-011-0099-y; Sarkadi A, 2008, ACTA PAEDIATR, V97, P153, DOI 10.1111/j.1651-2227.2007.00572.x; Schneider BH, 2001, DEV PSYCHOL, V37, P86, DOI 10.1037//0012-1649.37.1.86; Shek DTL, 2000, ADOLESCENCE, V35, P135; Smetana JG, 2006, ANNU REV PSYCHOL, V57, P255, DOI 10.1146/annurev.psych.57.102904.190124; STOKER A, 1990, DRUG ALCOHOL DEPEN, V25, P293, DOI 10.1016/0376-8716(90)90154-7; van den Eijnden RJJM, 2008, DEV PSYCHOL, V44, P655, DOI 10.1037/0012-1649.44.3.655; van den Eijnden RJJM, 2010, J ABNORM CHILD PSYCH, V38, P77, DOI 10.1007/s10802-009-9347-8; Wallenius M, 2009, J APPL DEV PSYCHOL, V30, P463, DOI 10.1016/j.appdev.2008.12.021; Wang R, 2005, J MARRIAGE FAM, V67, P1249, DOI 10.1111/j.1741-3737.2005.00214.x; Wang W, 2001, INT J HUM-COMPUT ST, V55, P919, DOI 10.1006/ijhc.2001.0510; Williams SK, 2005, J EARLY ADOLESCENCE, V25, P168, DOI 10.1177/0272431604274178; Yen JY, 2007, CYBERPSYCHOL BEHAV, V10, P323, DOI 10.1089/cpb.2006.9948; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; YOUNISS J, 1985, ADOLESCENTS RELATION; [张国华 ZHANG Guohua], 2008, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V16, P37	55	38	42	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75642	10.1371/journal.pone.0075642	http://dx.doi.org/10.1371/journal.pone.0075642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098710	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500081
J	Raue, A; Schilling, M; Bachmann, J; Matteson, A; Schelke, M; Kaschek, D; Hug, S; Kreutz, C; Harms, BD; Theis, FJ; Klingmuller, U; Timmer, J				Raue, Andreas; Schilling, Marcel; Bachmann, Julie; Matteson, Andrew; Schelke, Max; Kaschek, Daniel; Hug, Sabine; Kreutz, Clemens; Harms, Brian D.; Theis, Fabian J.; Klingmueller, Ursula; Timmer, Jens			Lessons Learned from Quantitative Dynamical Modeling in Systems Biology	PLOS ONE			English	Article							PARAMETER-ESTIMATION; LIKELIHOOD; RANGE	Due to the high complexity of biological data it is difficult to disentangle cellular processes relying only on intuitive interpretation of measurements. A Systems Biology approach that combines quantitative experimental data with dynamic mathematical modeling promises to yield deeper insights into these processes. Nevertheless, with growing complexity and increasing amount of quantitative experimental data, building realistic and reliable mathematical models can become a challenging task: the quality of experimental data has to be assessed objectively, unknown model parameters need to be estimated from the experimental data, and numerical calculations need to be precise and efficient. Here, we discuss, compare and characterize the performance of computational methods throughout the process of quantitative dynamic modeling using two previously established examples, for which quantitative, dose- and time-resolved experimental data are available. In particular, we present an approach that allows to determine the quality of experimental data in an efficient, objective and automated manner. Using this approach data generated by different measurement techniques and even in single replicates can be reliably used for mathematical modeling. For the estimation of unknown model parameters, the performance of different optimization algorithms was compared systematically. Our results show that deterministic derivative-based optimization employing the sensitivity equations in combination with a multi-start strategy based on latin hypercube sampling outperforms the other methods by orders of magnitude in accuracy and speed. Finally, we investigated transformations that yield a more efficient parameterization of the model and therefore lead to a further enhancement in optimization performance. We provide a freely available open source software package that implements the algorithms and examples compared here.	[Raue, Andreas; Schelke, Max; Kaschek, Daniel; Kreutz, Clemens; Timmer, Jens] Univ Freiburg, Inst Phys, D-79106 Freiburg, Germany; [Raue, Andreas; Hug, Sabine; Theis, Fabian J.] Helmholtz Ctr, Inst Computat Biol, Munich, Germany; [Schilling, Marcel; Bachmann, Julie; Klingmueller, Ursula] German Canc Res Ctr, Ctr Mol Biol Alliance, Heidelberg, Germany; [Matteson, Andrew] NYU, Dept Computat Biol, New York, NY USA; [Hug, Sabine; Theis, Fabian J.] Tech Univ Munich, Ctr Math Sci, Garching, Germany; [Harms, Brian D.] Merrimack Pharmaceut, Cambridge, MA USA; [Timmer, Jens] Univ Freiburg, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, Zentrum Biosyst Anal, D-79106 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); New York University; Technical University of Munich; University of Freiburg; University of Freiburg; University of Freiburg	Raue, A (corresponding author), Univ Freiburg, Inst Phys, Hugstetter Str 55, D-79106 Freiburg, Germany.	andreas.raue@fdm.uni-freiburg.de	Theis, Fabian J/ABD-5212-2021; Schilling, Marcel/A-4426-2008; Klingmüller, Ursula/G-8477-2013; Kreutz, Clemens/ABC-9732-2020	Theis, Fabian J/0000-0002-2419-1943; Schilling, Marcel/0000-0002-9517-5166; Klingmüller, Ursula/0000-0001-9845-3099; Kreutz, Clemens/0000-0002-8796-5766	German Federal Ministry of Education and Research [0315766, 0316042G]; Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (SBCancer DKFZ) [I.2, V.2]; Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (CoReNe HMGU); Excellence Initiative of the German Federal and State Governments [EXC 294]; European Research Council (starting grant 'LatentCauses'); Albert Ludwigs University Freiburg	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (SBCancer DKFZ); Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (CoReNe HMGU); Excellence Initiative of the German Federal and State Governments; European Research Council (starting grant 'LatentCauses'); Albert Ludwigs University Freiburg	This work was supported by the German Federal Ministry of Education and Research [Virtual Liver (Grant No. 0315766), LungSys II (Grant No. 0316042G)], the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (SBCancer DKFZ I.2, V.2 and CoReNe HMGU), the Excellence Initiative of the German Federal and State Governments (EXC 294), and the European Research Council (starting grant 'LatentCauses'). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.50; Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; Bluman G.W, 2004, SYMMETRY INTEGRATION; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Egea JA, 2007, J GLOBAL OPTIM, V37, P481, DOI 10.1007/s10898-006-9075-3; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; Hahn B, 2011, PROTEOMICS, V11, P490, DOI 10.1002/pmic.201000569; Heinrich R., 1996, REGULATION CELLULAR; Himmelblau D.M., 1972, APPL NONLINEAR PROGR; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hug S, 2013, MATH BIOSCI IN PRESS; Kreutz C, 2007, BIOINFORMATICS, V23, P2747, DOI 10.1093/bioinformatics/btm397; Kreutz C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-120; Kronfeld M, 2010, LECT NOTES COMPUT SC, V6073, P247, DOI 10.1007/978-3-642-13800-3_27; LEIS JR, 1988, ACM T MATH SOFTWARE, V14, P45, DOI 10.1145/42288.46156; MACDONALD N, 1976, BIOTECHNOL BIOENG, V18, P805, DOI 10.1002/bit.260180604; MEEKER WQ, 1995, AM STAT, V49, P48, DOI 10.2307/2684811; OWEN AB, 1992, J ROY STAT SOC B MET, V54, P541; Press W. H., 1990, NUMERICAL RECIPES FO; Ramachandran R, 2010, CHEM ENG SCI, V65, P4884, DOI 10.1016/j.ces.2010.05.039; Raue A, 2010, CHAOS, V20, DOI 10.1063/1.3528102; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Raue A, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0544; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Rodriguez-Fernandez M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-483; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; Seber G. A. F., 2003, NONLINEAR REGRESSION; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Swameye I, 2003, P NATL ACAD SCI USA, V100, P1028, DOI 10.1073/pnas.0237333100; Vanlier J, 2012, BIOINFORMATICS, V28, P1130, DOI 10.1093/bioinformatics/bts088; Wolkenhauer O., 2008, SYSTEMS BIOL; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109	35	174	176	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74335	10.1371/journal.pone.0074335	http://dx.doi.org/10.1371/journal.pone.0074335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098642	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500013
J	Rooney, J; Byrne, S; Heverin, M; Corr, B; Elamin, M; Staines, A; Goldacre, B; Hardiman, O				Rooney, James; Byrne, Susan; Heverin, Mark; Corr, Bernie; Elamin, Marwa; Staines, Anthony; Goldacre, Ben; Hardiman, Orla			Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995-2010	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; ALS; CHOICE; VENTILATION; MODELS; LIFE	Introduction: The Irish ALS register is a valuable resource for examining survival factors in Irish ALS patients. Cox regression has become the default tool for survival analysis, but recently new classes of flexible parametric survival analysis tools known as Royston-Parmar models have become available. Methods: We employed Cox proportional hazards and Royston-Parmar flexible parametric modeling to examine factors affecting survival in Irish ALS patients. We further examined the effect of choice of timescale on Cox models and the proportional hazards assumption, and extended both Cox and Royston-Parmar models with time varying components. Results: On comparison of models we chose a Royston-Parmar proportional hazards model without time varying covariates as the best fit. Using this model we confirmed the association of known survival markers in ALS including age at diagnosis (Hazard Ratio (HR) 1.34 per 10 year increase; 95% CI 1.26-1.42), diagnostic delay (HR 0.96 per 12 weeks delay; 95% CI 0.94-0.97), Definite ALS (HR 1.47 95% CI 1.17-1.84), bulbar onset disease (HR 1.58 95% CI 1.33-1.87), riluzole use (HR 0.72 95% CI 0.61-0.85) and attendance at an ALS clinic (HR 0.74 95% CI 0.64-0.86). Discussion: Our analysis explored the strengths and weaknesses of Cox proportional hazard and Royston-Parmar flexible parametric methods. By including time varying components we were able to gain deeper understanding of the dataset. Variation in survival between time periods appears to be due to missing data in the first time period. The use of age as timescale to account for confounding by age resolved breaches of the proportional hazards assumption, but in doing so may have obscured deficiencies in the data. Our study demonstrates the need to test for, and fully explore, breaches of the Cox proportional hazards assumption. Royston-Parmar flexible parametric modeling proved a powerful method for achieving this.	[Rooney, James; Byrne, Susan; Heverin, Mark; Elamin, Marwa; Hardiman, Orla] Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland; [Corr, Bernie; Hardiman, Orla] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Staines, Anthony] Dublin City Univ, Sch Nursing & Human Sci, Dublin 9, Ireland; [Goldacre, Ben] London Sch Hyg & Trop Med, Dept Epidemiol, London WC1, England	Dublin City University; University of London; London School of Hygiene & Tropical Medicine	Rooney, J (corresponding author), Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland.	jrooney@rcsi.ie	Staines, Anthony/AFQ-7565-2022; Contreras, Alberto Juan Dorta/AAF-2693-2020; Hardiman, Orla/Y-3441-2019; Rooney, James/J-9190-2019	Staines, Anthony/0000-0001-9161-1357; Contreras, Alberto Juan Dorta/0000-0002-8818-4697; Hardiman, Orla/0000-0003-2610-1291; Rooney, James/0000-0001-6346-0731; Goldacre, Ben/0000-0002-5127-4728; Byrne, Susan/0000-0001-6731-0343	Health Seventh Framework Programme [259867]; ALSA (the ALS Association); HRB (the Health Research Board) [H01300]; Joint Programme in Neurodegeneration and Research Motor Neuron	Health Seventh Framework Programme; ALSA (the ALS Association); HRB (the Health Research Board); Joint Programme in Neurodegeneration and Research Motor Neuron	Funding is from Health Seventh Framework Programme (FP7/2007-2013) under grant agreement no 259867, ALSA (the ALS Association), HRB (the Health Research Board, grant H01300), Joint Programme in Neurodegeneration and Research Motor Neuron (previously named Motor Neuron Disease Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussouan LS, 2001, MUSCLE NERVE, V24, P403, DOI 10.1002/1097-4598(200103)24:3<403::AID-MUS1013>3.3.CO;2-V; Bourke SC, 2006, LANCET NEUROL, V5, P140, DOI 10.1016/S1474-4422(05)70326-4; Cheung YB, 2003, J CLIN EPIDEMIOL, V56, P38, DOI 10.1016/S0895-4356(02)00536-X; Chio A, 2002, NEUROLOGY, V59, P99, DOI 10.1212/WNL.59.1.99; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Cleves M., 2010, INTRO SURVIVAL ANAL; COX DR, 1972, J R STAT SOC B, V34, P187; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Katz MH., 2011, MULTIVARIABLE ANAL A; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lambert P, 2012, BIOSENS BIOELECTRON, V37, P11; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; Paillisse C, 2005, AMYOTROPH LATERAL SC, V6, P37, DOI 10.1080/14660820510027035; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Royston P, 2011, FLEXIBLE PARAMETRIC; StataCorp, 2021, STATA STAT SOFTWARE; StataCorp, 2009, STAT STAT SOFTW REL; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; Traynor BJ, 2003, J NEUROL NEUROSUR PS, V74, P1258, DOI 10.1136/jnnp.74.9.1258; Zoccolella S, 2008, J NEUROL SCI, V268, P28, DOI 10.1016/j.jns.2007.10.023	24	61	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74733	10.1371/journal.pone.0074733	http://dx.doi.org/10.1371/journal.pone.0074733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098664	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500035
J	Souza, C; Davis, WC; Eckstein, TM; Sreevatsan, S; Weiss, DJ				Souza, Cleverson; Davis, William C.; Eckstein, Torsten M.; Sreevatsan, Srinand; Weiss, Douglas J.			Mannosylated Lipoarabinomannans from Mycobacterium Avium Subsp Paratuberculosis Alters the Inflammatory Response by Bovine Macrophages and Suppresses Killing of Mycobacterium Avium Subsp Avium Organisms	PLOS ONE			English	Article							MONONUCLEAR PHAGOCYTES; DIFFERENTIAL RESPONSES; TUBERCULOSIS; INTERLEUKIN-10; RECRUITMENT; PHAGOSOMES; INDUCTION; PATHWAY	Analysis of the mechanisms through which pathogenic mycobacteria interfere with macrophage activation and phagosome maturation have shown that engagement of specific membrane receptors with bacterial ligands is the initiating event. Mannosylated lipoarabinomannan (Man-LAM) has been identified as one of the ligands that modulates macrophage function. We evaluated the effects of Man-LAM derived from Mycobacterium avium subsp. paratuberculosis (MAP) on bovine macrophages. Man-LAM induced a rapid and prolonged expression of IL-10 message as well as transient expression of TNF-alpha. Preincubation with Man-LAM for up to 16 h did not suppress expression of IL-12 in response to interferon-gamma. Evaluation of the effect of Man-LAM on phagosome acidification, phagosome maturation, and killing of Mycobacterium avium subsp. avium (MAA) showed that preincubation of macrophages with Man-LAM before addition of MAA inhibited phagosome acidification, phagolysosome fusion, and reduced killing. Analysis of signaling pathways provided indirect evidence that inhibition of killing was associated with activation of the MAPK-p38 signaling pathway but not the pathway involved in regulation of expression of IL-10. These results support the hypothesis that MAP Man-LAM is one of the virulence factors facilitating survival of MAP in macrophages.	[Souza, Cleverson] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Davis, William C.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Eckstein, Torsten M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Sreevatsan, Srinand] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Weiss, Douglas J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	Washington State University; Washington State University; Colorado State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Souza, C (corresponding author), Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA.	souza@vetmed.wsu.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403	United States Department of Agriculture [CSREES-NRI 2004-35605-14243, CSREES-NRI 2005-35204-16198]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was supported through United States Department of Agriculture grants CSREES-NRI 2004-35605-14243 and CSREES-NRI 2005-35204-16198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2001, CLIN DIAGN LAB IMMUN, V8, P460, DOI 10.1128/CDLI.8.2.460-464.2001; Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; Bernardo J, 1998, INFECT IMMUN, V66, P28, DOI 10.1128/IAI.66.1.28-35.1998; Deretic V, 1999, MOL MICROBIOL, V31, P1603, DOI 10.1046/j.1365-2958.1999.01279.x; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; KHOO KH, 1995, J BIOL CHEM, V270, P12380, DOI 10.1074/jbc.270.21.12380; Kwong LS, 2002, VET IMMUNOL IMMUNOP, V85, P213, DOI 10.1016/S0165-2427(02)00007-7; Maiti D, 2001, J BIOL CHEM, V276, P329, DOI 10.1074/jbc.M002650200; Majumder N, 2008, SCAND J IMMUNOL, V67, P329, DOI 10.1111/j.1365-3083.2008.02070.x; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; ROACH TIA, 1995, IMMUNOLOGY, V85, P106; Souza CD, 2007, MICROBES INFECT, V9, P1545, DOI 10.1016/j.micinf.2007.08.008; Souza CD, 2006, MICROB PATHOGENESIS, V41, P59, DOI 10.1016/j.micpath.2006.04.002; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Weiss DJ, 2002, INFECT IMMUN, V70, P5556, DOI 10.1128/IAI.70.10.5556-5561.2002; Weiss DJ, 2008, J LEUKOCYTE BIOL, V83, P48, DOI 10.1189/jlb.0707490; Wells SJ, 2006, CLIN VACCINE IMMUNOL, V13, P1125, DOI 10.1128/CVI.00236-06	26	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75924	10.1371/journal.pone.0075924	http://dx.doi.org/10.1371/journal.pone.0075924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098744	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500114
J	Olli, S; Rangaraj, N; Nagaraj, R				Olli, Sudar; Rangaraj, Nandini; Nagaraj, Ramakrishnan			Effect of Selectively Introducing Arginine and D-Amino Acids on the Antimicrobial Activity and Salt Sensitivity in Analogs of Human Beta-Defensins	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITIES; STAPHYLOCOCCUS-AUREUS; HUMAN BETA-DEFENSIN-1; MAMMALIAN DEFENSINS; INDUCIBLE PEPTIDE; DISULFIDE BONDS; ALPHA-DEFENSINS; IMMUNE-SYSTEM; HUMAN SKIN; CONFORMATIONS	We have examined the antimicrobial activity of C-terminal analogs of human beta-defensins HBD-1and-3 wherein lysines have been selectively replaced by L- and D-arginines and L-isoleucine substituted with its D-enantiomer. The analogs exhibited antibacterial and antifungal activities. Physiological concentration of NaCl did not attenuate the activity of the peptides against Gram-negative bacteria considerably, while some attenuation of activity was observed against S. aureus. Variable attenuation of activity was observed in the presence of Ca2+ and Mg2+. Introduction of D-amino acids abrogated the need for a disulfide bridge for exhibiting activity. Confocal images of carboxyfluorescein (CF) labeled peptides indicated initial localization on the membrane and subsequent translocation into the cell. Analogs corresponding to cationic rich segments of human defensins substituted with L- and D-arginine, could be attractive candidates for development as future therapeutic drugs.	[Olli, Sudar; Rangaraj, Nandini; Nagaraj, Ramakrishnan] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nagaraj, R (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	nraj@ccmb.res.in			CSIR Network [NWP-05]; Department of Science and Technology, India [SR/WOS-A/LS-197/2010]; JC Bose Fellowship from the Department of Science and Technology, India	CSIR Network(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, India(Department of Science & Technology (India)); JC Bose Fellowship from the Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by funding from CSIR Network project NWP-05 and Department of Science and Technology, India SR/WOS-A/LS-197/2010. RN is the recipient of JC Bose Fellowship from the Department of Science and Technology, India. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Brissette CA, 2002, INFECT IMMUN, V70, P3982, DOI 10.1128/IAI.70.7.3982-3984.2002; Chandrababu KB, 2009, BIOCHEMISTRY-US, V48, P6052, DOI 10.1021/bi900154f; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Fulton C, 1997, LANCET, V350, P1750, DOI 10.1016/S0140-6736(05)63574-X; Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Jung S, 2011, ANTIMICROB AGENTS CH, V55, P954, DOI 10.1128/AAC.00872-10; Kluver E, 2006, J PEPT SCI, V12, P243, DOI 10.1002/psc.749; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Krishnakumari V, 2003, BIOCHEMISTRY-US, V42, P9307, DOI 10.1021/bi034403y; Krishnakumari V, 2006, PEPTIDES, V27, P2607, DOI 10.1016/j.peptides.2006.06.004; Krishnakumari V, 2009, ANTIMICROB AGENTS CH, V53, P256, DOI 10.1128/AAC.00470-08; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; Mandal M, 2002, PEPTIDES, V23, P413, DOI 10.1016/S0196-9781(01)00628-3; Mandal M, 2002, J PEPT RES, V59, P95, DOI 10.1034/j.1399-3011.2002.01945.x; Niyonsaba F, 2006, CRIT REV IMMUNOL, V26, P545, DOI 10.1615/CritRevImmunol.v26.i6.60; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2007, CURR PHARM DESIGN, V13, P3096, DOI 10.2174/138161207782110381; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Scudiero O, 2010, ANTIMICROB AGENTS CH, V54, P2312, DOI 10.1128/AAC.01550-09; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Seo ES, 2010, BIOCHEMISTRY-US, V49, P10486, DOI 10.1021/bi1011749; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Sitaram N, 1999, BBA-BIOMEMBRANES, V1462, P29, DOI 10.1016/S0005-2736(99)00199-6; Starner TD, 2002, INFECT IMMUN, V70, P5287, DOI 10.1128/IAI.70.9.5287-5289.2002; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tomita T, 2000, MICROBIOL IMMUNOL, V44, P749, DOI 10.1111/j.1348-0421.2000.tb02559.x; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Varkey J, 2005, ANTIMICROB AGENTS CH, V49, P4561, DOI 10.1128/AAC.49.11.4561-4566.2005; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yu QT, 2000, J BIOL CHEM, V275, P3943, DOI 10.1074/jbc.275.6.3943; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200; Zucht H D, 1998, Eur J Med Res, V3, P315	55	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77031	10.1371/journal.pone.0077031	http://dx.doi.org/10.1371/journal.pone.0077031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086767	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900111
J	Proctor, CJ; Boche, D; Gray, DA; Nicoll, JAR				Proctor, Carole J.; Boche, Delphine; Gray, Douglas A.; Nicoll, James A. R.			Investigating Interventions in Alzheimer's Disease with Computer Simulation Models	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; GLYCOGEN-SYNTHASE KINASE-3-BETA; IN-VITRO GROWTH; A-BETA; HYPERPHOSPHORYLATED-TAU; MATHEMATICAL-MODEL; TRANSGENIC MODEL; SENILE PLAQUES; FIBRIL GROWTH; IMMUNIZATION	Progress in the development of therapeutic interventions to treat or slow the progression of Alzheimer's disease has been hampered by lack of efficacy and unforeseen side effects in human clinical trials. This setback highlights the need for new approaches for pre-clinical testing of possible interventions. Systems modelling is becoming increasingly recognised as a valuable tool for investigating molecular and cellular mechanisms involved in ageing and age-related diseases. However, there is still a lack of awareness of modelling approaches in many areas of biomedical research. We previously developed a stochastic computer model to examine some of the key pathways involved in the aggregation of amyloid-beta (A beta) and the micro-tubular binding protein tau. Here we show how we extended this model to include the main processes involved in passive and active immunisation against A beta and then demonstrate the effects of this intervention on soluble A beta, plaques, phosphorylated tau and tangles. The model predicts that immunisation leads to clearance of plaques but only results in small reductions in levels of soluble A beta, phosphorylated tau and tangles. The behaviour of this model is supported by neuropathological observations in Alzheimer patients immunised against A beta. Since, soluble A beta, phosphorylated tau and tangles more closely correlate with cognitive decline than plaques, our model suggests that immunotherapy against A beta may not be effective unless it is performed very early in the disease process or combined with other therapies.	[Proctor, Carole J.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Boche, Delphine; Nicoll, James A. R.] Univ Southampton, Southampton, Hants, England; [Gray, Douglas A.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Gray, Douglas A.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Newcastle University - UK; University of Southampton; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Proctor, CJ (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	carole.proctor@ncl.ac.uk	Boche, Delphine/K-9954-2019; Boche, Delphine/A-7589-2011; Nicoll, James/I-9253-2017; /U-3554-2018	Boche, Delphine/0000-0002-5884-130X; Boche, Delphine/0000-0002-5884-130X; Nicoll, James/0000-0002-9444-7246; /0000-0002-8634-4984; Proctor, Carole/0000-0002-1366-1399	Alzheimer Scotland; Alzheimer's Research UK [ART-RF2008-3]; BBSRC; Canadian Institutes of Health Research; Canadian Cancer Society Research Institute; Cancer Research Society, Inc.; MRC [G0501033] Funding Source: UKRI; Alzheimers Research UK [ART-ESG2005-3, ART-PG2006-4, ART-RF2008-3] Funding Source: researchfish; Medical Research Council [G0501033] Funding Source: researchfish	Alzheimer Scotland; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research Society, Inc.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Carole Proctor built the model whilst funded by Alzheimer Scotland and Alzheimer's Research UK (http://www.alzscot.org/; http://www.alzheimersresearchuk.org/), (Grant Ref: ART-RF2008-3). The work was taken forward within the research context of the Centre for Integrated Systems Biology of Ageing and Nutrition (initially funded by BBSRC) and the UK NIHR Biomedical Research Centre for Ageing and Age-related Disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust. Dr. Douglas Gray is funded by the Canadian Institutes of Health Research, the Canadian Cancer Society Research Institute, and the Cancer Research Society, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; Ardiles AO, 2012, P NATL ACAD SCI USA, V109, P13835, DOI 10.1073/pnas.1201209109; Baker AM, 2011, NEUROPATH APPL NEURO, V37, P33; Bales KR, 2012, EXPERT OPIN DRUG DIS, V7, P281, DOI 10.1517/17460441.2012.666234; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Boche D, 2010, ACTA NEUROPATHOL, V120, P369, DOI 10.1007/s00401-010-0719-5; Boche D, 2010, ACTA NEUROPATHOL, V120, P13, DOI 10.1007/s00401-010-0705-y; Chaves RS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-144; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Craft DL, 2002, B MATH BIOL, V64, P1011, DOI 10.1006/bulm.2002.0304; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Cruz L, 1997, P NATL ACAD SCI USA, V94, P7612, DOI 10.1073/pnas.94.14.7612; Dodel RC, 2003, LANCET NEUROL, V2, P215, DOI 10.1016/S1474-4422(03)00349-1; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Esler WP, 1996, BIOCHEMISTRY-US, V35, P749, DOI 10.1021/bi951685w; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Giovanna C, 2010, AMINO ACIDS, V38, P1101, DOI 10.1007/s00726-009-0319-7; Gomez-Sintes R, 2010, J CLIN INVEST, V120, P2432, DOI 10.1172/JCI37873; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; HYMAN BT, 1993, J NEUROPATH EXP NEUR, V52, P594, DOI 10.1097/00005072-199311000-00006; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim JR, 2004, PROTEIN SCI, V13, P2888, DOI 10.1110/ps.04847404; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Maarouf CL, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-39; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McDonald DR, 1997, J NEUROSCI, V17, P2284; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; MORRIS JC, 1991, NEUROLOGY, V41, P469, DOI 10.1212/WNL.41.4.469; NAGY Z, 1995, DEMENTIA, V6, P21, DOI 10.1159/000106918; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P774, DOI 10.1097/NEN.0b013e3181aacbe9; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Ohyagi Y, 2004, FASEB J; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Proctor CJ, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-32; Proctor CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-7; Proctor CJ, 2012, INT J ALZHEIMERS DIS, V2012; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Sato K, 2012, J NEUROSCI RES, V90, P870, DOI 10.1002/jnr.22796; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Tang X, 2007, ONCOGENE, V26, P7302, DOI 10.1038/sj.onc.1210542; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Zotova E, 2011, NEUROPATHOL APPL NEU	86	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73631	10.1371/journal.pone.0073631	http://dx.doi.org/10.1371/journal.pone.0073631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24098635	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000042
J	Bohr, J; Markvorsen, S				Bohr, Jakob; Markvorsen, Steen			Ribbon Crystals	PLOS ONE			English	Article							MOBIUS STRIP; INSTABILITIES; MECHANICS; GEOMETRY; ATOMS; KNOTS; DNA	A repetitive crystal-like pattern is spontaneously formed upon the twisting of straight ribbons. The pattern is akin to a tessellation with isosceles triangles, and it can easily be demonstrated with ribbons cut from an overhead transparency. We give a general description of developable ribbons using a ruled procedure where ribbons are uniquely described by two generating functions. This construction defines a differentiable frame, the ribbon frame, which does not have singular points, whereby we avoid the shortcomings of the Frenet-Serret frame. The observed spontaneous pattern is modeled using planar triangles and cylindrical arcs, and the ribbon structure is shown to arise from a maximization of the end-to-end length of the ribbon, i.e. from an optimal use of ribbon length. The phenomenon is discussed in the perspectives of incompatible intrinsic geometries and of the emergence of long-range order.	[Bohr, Jakob] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Markvorsen, Steen] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Bohr, J (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	jabo@nanotech.dtu.dk	Bohr, Jakob/A-5819-2012; Markvorsen, Steen/L-1717-2017	Bohr, Jakob/0000-0003-4076-2045; Markvorsen, Steen/0000-0002-0061-0672	Villum Foundation	Villum Foundation(Villum Fonden)	This work is supported by the Villum Foundation (villumfoundation.dk). The foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2012, CHEM SOC REV, V41, P6787, DOI 10.1039/c2cs35303b; BAK P, 1986, PHYS REV LETT, V56, P861, DOI 10.1103/PhysRevLett.56.861; Bets KV, 2009, NANO RES, V2, P161, DOI [10.1007/S12274-009-9015-X, 10.1007/s12274-009-9015-x]; Cerda E, 1999, NATURE, V401, P46, DOI 10.1038/43395; Chen Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530441; Chirikjian GS, 2013, BIOCHEM SOC T, V41, P635, DOI 10.1042/BST20120346; Conway JH, 2011, P NATL ACAD SCI USA, V108, P11009, DOI 10.1073/pnas.1105594108; Cranford S, 2011, MODEL SIMUL MATER SC, V19, DOI 10.1088/0965-0393/19/5/054003; Farouki RT, 2013, COMPUT AIDED GEOM D, V30, P226, DOI 10.1016/j.cagd.2012.11.003; Gabbrielli R, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041141; Ghafouri R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138101; Giomi L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.239802; Giomi L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238104; HALPERN B, 1977, T AM MATH SOC, V230, P41, DOI 10.2307/1997711; Han DR, 2010, NAT NANOTECHNOL, V5, P712, DOI 10.1038/nnano.2010.193; Hsu L., 1992, EXP MATH, V1, P191; Hu SW, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061908; Huang W, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045410; Hure J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.174301; Jung J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075418; KAUFFMAN LH, 2005, PHYS NUMERICAL MODEL, V36, P495; Kennedy B, 2008, J KNOT THEOR RAMIF, V17, P13, DOI 10.1142/S0218216508005938; Khaykovich B, 2007, P NATL ACAD SCI USA, V104, P9656, DOI 10.1073/pnas.0702967104; Korte AP, 2011, P ROY SOC A-MATH PHY, V467, P285, DOI 10.1098/rspa.2010.0200; Li B, 2012, SOFT MATTER, V8, P5728, DOI 10.1039/c2sm00011c; Majidi C, 2008, P R SOC A, V464, P1309, DOI 10.1098/rspa.2007.0341; Panyukov S, 2000, PHYS REV E, V62, P7135, DOI 10.1103/PhysRevE.62.7135; Randrup T, 1996, ARCH MATH, V66, P511, DOI 10.1007/BF01268871; Rappaport SM, 2007, J PHYS A-MATH THEOR, V40, P4455, DOI 10.1088/1751-8113/40/17/003; Schenk M, 2011, ORIGAMI(5): FIFTH INTERNATIONAL MEETING OF ORIGAMI SCIENCE, MATHEMATICS, AND EDUCATION, P291; Schenk M, 2013, P NATL ACAD SCI USA, V110, P3276, DOI 10.1073/pnas.1217998110; Starostin EL, 2007, NAT MATER, V6, P563, DOI 10.1038/nmat1929; Starostin EL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.239801; Starostin EL, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.084301; Tanda S, 2002, NATURE, V417, P397, DOI 10.1038/417397a; Wunderlich W., 1962, MONATSH MATH, V66, P276	41	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74932	10.1371/journal.pone.0074932	http://dx.doi.org/10.1371/journal.pone.0074932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098360	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600014
J	Chen, GF; Shi, XJ; Sun, C; Li, M; Zhou, Q; Zhang, C; Huang, J; Qiu, Y; Wen, XY; Zhang, Y; Zhang, YS; Yang, SZ; Lu, LX; Zhang, JP; Yuan, QL; Lu, JW; Xu, GT; Xue, YY; Jin, ZB; Jiang, CZ; Ying, M; Liu, XQ				Chen, Guangfeng; Shi, Xiujuan; Sun, Chen; Li, Min; Zhou, Qing; Zhang, Chen; Huang, Jun; Qiu, Yu; Wen, Xiangyi; Zhang, Yan; Zhang, Yushan; Yang, Shuzhang; Lu, Lixia; Zhang, Jieping; Yuan, Qionglan; Lu, Jianwei; Xu, Guotong; Xue, Yunyun; Jin, Zibing; Jiang, Cizhong; Ying, Ming; Liu, Xiaoqing			VEGF-Mediated Proliferation of Human Adipose Tissue-Derived Stem Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; MICRORNA BIOGENESIS	Human adipose tissue-derived stem cells (ADSCs) are an attractive multipotent stem cell source with therapeutic applicability across diverse fields for the repair and regeneration of acute and chronically damaged tissues. In recent years, there has been increasing interest in ADSC for tissue engineering applications. However, the mechanisms underlying the regulation of ADSC proliferation are not fully understood. Here we show that 47 transcripts are up-regulated while 23 are down-regulated in ADSC compared to terminally differentiated cells based on global mRNA profiling and microRNA profiling. Among the up-regulated genes, the expression of vascular endothelial growth factor (VEGF) is fine-tuned by miR-199a-5p. Further investigation indicates that VEGF accelerates ADSC proliferation whereas the multipotency of ADSC remains stable in terms of adipogenic, chondrogenic and osteogenic potentials after VEGF treatment, suggesting that VEGF may serve as an excellent supplement for accelerating ADSC proliferation during in vitro expansion.	[Chen, Guangfeng; Shi, Xiujuan; Sun, Chen; Zhang, Chen; Huang, Jun; Qiu, Yu; Wen, Xiangyi; Zhang, Yan; Zhang, Yushan; Yang, Shuzhang; Lu, Lixia; Zhang, Jieping; Yuan, Qionglan; Lu, Jianwei; Xu, Guotong; Xue, Yunyun; Ying, Ming; Liu, Xiaoqing] Tongji Univ, Sch Med, Peoples Hosp 10, Shanghai 200092, Peoples R China; [Li, Min; Zhou, Qing; Jiang, Cizhong] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China; [Jin, Zibing] Wenzhou Med Coll, Hosp Eye, Div Ophthalm Genet, Wenzhou, Peoples R China; [Jin, Zibing] Wenzhou Med Coll, Sch Ophthalmol & Optometry, Lab Stem Cell & Retinal Regenerat, Wenzhou, Peoples R China; [Ying, Ming; Liu, Xiaoqing] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Marine Bioresources & Ecol, Shenzhen, Peoples R China	Tongji University; Tongji University; Wenzhou Medical University; Wenzhou Medical University; Shenzhen University	Jiang, CZ (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China.	czjiang@tongji.edu.cn; yingming@szu.edu.cn; xqliu@tongji.edu.cn	Jin, Zi-Bing/AAE-4106-2019; Jin, Zi-Bing/J-6810-2014	Jin, Zi-Bing/0000-0003-0515-698X; Jin, Zi-Bing/0000-0003-0515-698X	Ministry of Science and Technology of China [2010CB945600, 2010CB944901, 2011CB965100]; National Natural Science Foundation of China [91019017, 81202550, 81100673, 81070738]; Shanghai Science Foundation [11PJ1407800]; Ministry of Education of China [IRT1168]; Shenzhen Science and Technology Innovation Committee [JCYJ20120613172906373]; Program for Eastern Scholar at Shanghai	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science Foundation; Ministry of Education of China(Ministry of Education, China); Shenzhen Science and Technology Innovation Committee; Program for Eastern Scholar at Shanghai	This work was supported by the Ministry of Science and Technology of China (2010CB945600, 2010CB944901, 2011CB965100), the National Natural Science Foundation of China (91019017, 81202550, 81100673, 81070738), Shanghai Science Foundation (#11PJ1407800), the Ministry of Education of China (IRT1168), Shenzhen Science and Technology Innovation Committee (JCYJ20120613172906373), and the Program for Eastern Scholar at Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boquest AC, 2006, METH MOL B, V325, P35; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Cawthorn WP, 2012, TRENDS ENDOCRIN MET, V23, P270, DOI 10.1016/j.tem.2012.01.003; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tapp H, 2009, EXP BIOL MED, V234, P1, DOI [10.3181/0805-MR-170, 10.3181/0805/MR-170]; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	33	28	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e73673	10.1371/journal.pone.0073673	http://dx.doi.org/10.1371/journal.pone.0073673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098328	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600002
J	Goris, MGA; Kikken, V; Straetemans, M; Alba, S; Goeijenbier, M; van Gorp, ECM; Boer, KR; Wagenaar, JFP; Hartskeerl, RA				Goris, Marga G. A.; Kikken, Vanessa; Straetemans, Masja; Alba, Sandra; Goeijenbier, Marco; van Gorp, Eric C. M.; Boer, Kimberly R.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.			Towards the Burden of Human Leptospirosis: Duration of Acute Illness and Occurrence of Post-Leptospirosis Symptoms of Patients in The Netherlands	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; STRESS-DISORDER	Background: Leptospirosis is a global zoonotic disease. Although important for the assessment of the burden of leptospirosis, data on the duration of the illness and the occurrence of post-leptospirosis complaints are not well documented. Hence the main objective of this study was to estimate the occurrence of persistent complaints and duration of hospital stay in laboratory confirmed leptospirosis patients in the Netherlands during 1985 to 2010. Additionally, several risk factors potentially impacting on the occurrence of post-leptospirosis complaints were investigated. Methods/Principal Findings: The duration of the acute phase of leptospirosis was 16 days (IQR 12-23); 10 days (IQR 7-16) were spent hospitalized. Eighteen fatal cases were excluded from this analysis. Complaints of leptospirosis patients by passive case investigations (CPC) derived from files on ambulant consultations occurring one month after hospital discharge, revealed persistent complaints in 108 of 236 (45.8%) laboratory confirmed cases. Data on persistent complaints after acute leptospirosis (PCAC), assessed in 225 laboratory confirmed leptospirosis cases collected through questionnaires during 1985-1993, indicated 68 (30.2%) PCAC cases. Frequently reported complaints included (extreme) fatigue, myalgia, malaise, headache, and a weak physical condition. These complaints prolonged in 21.1% of the cases beyond 24 months after onset of disease. There was no association between post-leptospirosis complaints and hospitalization. However, individuals admitted at the intensive care unit (ICU) were twice as likely to have continuing complaints after discharge adjusting for age and dialysis (OR 2.0 95% CI 0.8-4.8). No significant association could be found between prolongation of complaints and infecting serogroup, although subgroup analysis suggest that infection with serogroups Sejroe (OR 4.8, 95% CI 0.9-27.0) and icterohaemorrhagiae (OR 2.0, 95% CI 0.9-4.3 CI) are more likely to result in CPC than infections with serogroup Grippotyphosa. Conclusion/Significance: In addition to the acute disease, persistent complaints have an impact on the burden of leptospirosis.	[Goris, Marga G. A.; Straetemans, Masja; Alba, Sandra; Boer, Kimberly R.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.] KIT Biomed Res, WHO FAO OIE, Amsterdam, Netherlands; [Goris, Marga G. A.; Straetemans, Masja; Alba, Sandra; Boer, Kimberly R.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.] KIT Biomed Res, Natl Leptospirosis Reference Ctr, Amsterdam, Netherlands; [Goris, Marga G. A.; Straetemans, Masja; Alba, Sandra; Boer, Kimberly R.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.] KIT Biomed Res, Epidemiol Sect, Royal Trop Inst, Amsterdam, Netherlands; [Kikken, Vanessa] Free Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Goeijenbier, Marco; van Gorp, Eric C. M.; Wagenaar, Jiri F. P.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Food & Agriculture Organization of the United Nations (FAO); Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Goris, MGA (corresponding author), KIT Biomed Res, WHO FAO OIE, Amsterdam, Netherlands.	m.goris@kit.nl	Alba, Sandra/AAQ-7009-2021	Goeijenbier, Marco/0000-0002-3165-8193	Dutch Government via the Ministry of Foreign Affairs [8027]	Dutch Government via the Ministry of Foreign Affairs	Institutional core funding from the Dutch Government via the Ministry of Foreign Affairs was used, Grant # 8027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GEZONDHEID ZORG CIJF; [Anonymous], 2011, 2 M LEPT BURD EP REF; [Anonymous], 2003, HUM LEPT GUID DIAGN; Boer KR, 2007, THESIS; Botterweck A., 2003, PLAUSIBILITEIT NIEUW; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Dowdy DW, 2009, CRIT CARE MED, V37, P1702, DOI 10.1097/CCM.0b013e31819fea55; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; Goris MGA, 2013, EMERG INFECT DIS, V19, P371, DOI 10.3201/eid1903.111260; Goris MGA, 2008, ANALYSE, V62, P295; Griffiths JA, 2004, CONTIN ED ANAESTH CR, V4, P202, DOI DOI 10.1093/BJACEACCP/MKH054; Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x; Hartskeerl RA, 2008, LCI GUIDELINES INFEC; Hartskeerl RA, 2003, J MED MICROBIOL, V11, P94; Hatch R, 2011, CRIT CARE, V15, DOI 10.1186/cc10054; Huitema S W, 1989, Ned Tijdschr Geneeskd, V133, P1939; Hyre AD, 2007, AM J KIDNEY DIS, V50, P585, DOI 10.1053/j.ajkd.2007.07.013; Jansen A, 2007, CLIN INFECT DIS, V44, pE69, DOI 10.1086/513431; Katz AR, 2001, CLIN INFECT DIS, V33, P1834, DOI 10.1086/324084; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Olszyna D P, 1998, Ned Tijdschr Geneeskd, V142, P1270; POND K, 2005, WATER RECREATION DIS; Rathinam S R, 2002, Curr Opin Ophthalmol, V13, P381, DOI 10.1097/00055735-200212000-00007; Scragg P, 2001, ANAESTHESIA, V56, P9, DOI 10.1046/j.1365-2044.2001.01714.x; Spichler A, 2011, INT J INFECT DIS, V15, pE486, DOI 10.1016/j.ijid.2011.03.020; Tagay S, 2007, AM J KIDNEY DIS, V50, P594, DOI 10.1053/j.ajkd.2007.06.018; Terpstra W J, 1984, Ned Tijdschr Geneeskd, V128, P1040; Van der Stegen RHM, 1981, METHODEBESCHRIJVING; Wunsch H, 2006, J CRIT CARE, V21, P1, DOI 10.1016/j.jcrc.2006.01.004	29	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76549	10.1371/journal.pone.0076549	http://dx.doi.org/10.1371/journal.pone.0076549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098528	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600063
J	Sahdo, B; Fransen, K; Idosa, BA; Eriksson, P; Soderquist, B; Kelly, A; Sarndahl, E				Sahdo, Berolla; Fransen, Karin; Idosa, Berhane Asfaw; Eriksson, Per; Soderquist, Bo; Kelly, Anne; Sarndahl, Eva			Cytokine Profile in a Cohort of Healthy Blood Donors Carrying Polymorphisms in Genes Encoding the NLRP3 Inflammasome	PLOS ONE			English	Article							AUTOINFLAMMATORY DISEASES; RHEUMATOID-ARTHRITIS; CIAS1 MUTATIONS; IL-1 FAMILY; CARD8; SUSCEPTIBILITY; ACTIVATION; NALP3; INTERLEUKIN-1-BETA; DEFICIENCY	Background: The NLRP3 inflammasome has been recognized as one of the key components of the innate immunity by sensing a diversity of insults. Inflammasome activation results in the maturation of the pro-inflammatory cytokines interleukin (IL)-1 beta and IL-18. Increased production of IL-1 beta is found in patients with gain-of-function polymorphisms in genes encoding the NLRP3 inflammasome. Since approximately 5% of the Swedish population are heterozygote carriers of these combined gene variants, their impact on inflammasome status and a relationship on disease development is therefore highly relevant to study. The present study investigates levels of inflammasome-produced cytokines as a measure of inflammasome activation in healthy individuals carrying Q705K polymorphism in the NLRP3 gene combined with C10X in the CARD8 gene. Materials and Methods: Genotyping of 1006 healthy blood donors was performed for the polymorphisms Q705K in the NLRP3 and C10X in the CARD8 genes. IL-1 beta, IL-18, IL-33, as well as a number of other pro-inflammatory cytokines, were analyzed by Luminex or ELISA in plasma from individuals carrying the polymorphisms and in age and gender matched non-carrier controls. Results & Discussion: The prevalence of the polymorphisms was in line with previous studies. Plasma levels of IL-1 beta and IL-33 were elevated among carriers of combined Q705K+C10X polymorphisms compared to controls, whereas no difference was found for IL-18 and the other cytokines measured. Moreover, carriers of C10X or Q705K per se had similar plasma levels of IL-1 beta as non-carriers. These data suggest that the combined polymorphisms create inflammasomes with increased basal activation state, which might provide a more favourable innate immune response. In spite of this, it could also represent the mechanisms by which the inflammatory loop is triggered into a long-term inflammatory phenotype.	[Sahdo, Berolla; Fransen, Karin; Idosa, Berhane Asfaw; Kelly, Anne; Sarndahl, Eva] Univ Orebro, Sch Hlth & Med Sci, Dept Clin Med, Orebro, Sweden; [Eriksson, Per] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Rheumatol, Linkoping, Sweden; [Soderquist, Bo] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden; [Soderquist, Bo; Sarndahl, Eva] Univ Orebro, Fac Med & Hlth, Orebro, Sweden	Orebro University; Linkoping University; Orebro University; Orebro University	Sahdo, B (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Dept Clin Med, Orebro, Sweden.	berolla.sahdo@oru.se; eva.sarndahl@oru.se		Idosa, Berhane Asfaw/0000-0002-8060-2049; Fransen, Karin/0000-0002-9826-0462; Soderquist, Bo/0000-0001-5939-2932	Research committee of the County Council of Orebro; Nyckelfonden at Orebro University Hospital; Sund's Foundation for Rheumatic Research; King Gustaf V Memorial Foundation; Swedish Research Council [ES: K2010-57X-21435-01-3]	Research committee of the County Council of Orebro; Nyckelfonden at Orebro University Hospital; Sund's Foundation for Rheumatic Research; King Gustaf V Memorial Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by grants from the Research committee of the County Council of Orebro, Nyckelfonden at Orebro University Hospital, The Sund's Foundation for Rheumatic Research, King Gustaf V Memorial Foundation and the Swedish Research Council (ES: K2010-57X-21435-01-3; www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Barker BR, 2011, CURR OPIN IMMUNOL, V23, P591, DOI 10.1016/j.coi.2011.07.005; Blomgran R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031326; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chitkara P, 2007, PEDIATR INFECT DIS J, V26, P353, DOI 10.1097/01.inf.0000258777.86510.da; de Menthiere CS, 2003, NUCLEIC ACIDS RES, V31, P282, DOI 10.1093/nar/gkg031; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Eriksson P, 2012, PLOS ONE IN PRESS; Fontalba A, 2008, DEMENT GERIATR COGN, V26, P247, DOI 10.1159/000160956; Fontalba A, 2007, J IMMUNOL, V179, P4867, DOI 10.4049/jimmunol.179.7.4867; Forsblad-D'Elia H, 2013, SCAND J RHEUMATOL; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Hanamsagar R, 2011, J NEUROCHEM; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Henderson C, 2010, CURR OPIN RHEUMATOL, V22, P567, DOI 10.1097/BOR.0b013e32833ceff4; Hoffman HM, 2009, NAT REV RHEUMATOL, V5, P249, DOI 10.1038/nrrheum.2009.40; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kastbom A, 2010, ANN RHEUM DIS, V69, P723, DOI 10.1136/ard.2008.106989; Ko DC, 2009, AM J HUM GENET, V85, P214, DOI 10.1016/j.ajhg.2009.07.012; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P792, DOI 10.1016/j.biocel.2010.01.008; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Paramel GV, 2013, CLIN SCI LOND; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474; Porksen G, 2004, EUR J HAEMATOL, V73, P123, DOI 10.1111/j.1600-0609.2004.00270.x; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; Serrano M, 2009, PEDIATR NEUROL, V41, P448, DOI 10.1016/j.pediatrneurol.2009.06.008; Smith DE, 2011, J LEUKOCYTE BIOL, V89, P383, DOI 10.1189/jlb.0810470; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Ting TV, 2007, PEDIATR NEUROL, V36, P338, DOI 10.1016/j.pediatrneurol.2006.12.008; Ungerback J, 2012, CARCINOGENESIS, V33, P2126, DOI 10.1093/carcin/bgs256; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; Verma D, 2010, ARTHRITIS RHEUM-US, V62, P2138, DOI 10.1002/art.27489; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1	44	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75457	10.1371/journal.pone.0075457	http://dx.doi.org/10.1371/journal.pone.0075457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098386	Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600018
J	Wagner, CS; Grotzke, J; Cresswell, P				Wagner, Claudia S.; Grotzke, Jeff; Cresswell, Peter			Intracellular Regulation of Cross-Presentation during Dendritic Cell Maturation	PLOS ONE			English	Article							LYSOSOMAL THIOL REDUCTASE; MHC CLASS-I; PHAGOSOME MATURATION; ANTIGEN PRESENTATION; RECEPTOR LIGANDS; NADPH OXIDASE; ACTIVATION; RECOGNITION; CAPTURE; GILT	We have investigated the effect of different maturation stimuli on the ability of mature dendritic cells (DCs) to cross-present newly acquired particulate antigens. Cross-presentation was impaired in DCs matured by treatment with TNF-alpha, CpG and LPS, but was less affected upon CD40L-induced maturation. The difference could not be explained by decreased antigen uptake or translocation into the cytosol, but decreased cross-presentation ability did correlate with increased phagosomal/lysosomal acidification. Nevertheless, intra-phagosomal degradation of OVA was not increased in matured samples, suggesting that decreasing phagosomal pH may also regulate cross-presentation by a mechanism other than enhancing degradation.	[Wagner, Claudia S.; Grotzke, Jeff; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	peter.cresswell@yale.edu		Wagner, Claudia/0000-0002-7311-2236	Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Howard Hughes Medical Institute (P. C.) and funding from the Deutsche Forschungsgemeinschaft (C. S. W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Delamarre L, 2011, SEMIN IMMUNOL, V23, P2, DOI 10.1016/j.smim.2011.02.001; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Drutman SB, 2010, J IMMUNOL, V185, P2140, DOI 10.4049/jimmunol.1000642; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Henri S, 2007, EUR J IMMUNOL, V37, P1184, DOI 10.1002/eji.200636793; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Lackman RL, 2007, TRAFFIC, V8, P1179, DOI 10.1111/j.1600-0854.2007.00600.x; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Machy P, 2000, EUR J IMMUNOL, V30, P848, DOI 10.1002/1521-4141(200003)30:3<848::AID-IMMU848>3.3.CO;2-H; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Russell DG, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217a; SALVUCCI LA, 1995, J VIROL, V69, P1122, DOI 10.1128/JVI.69.2.1122-1131.1995; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Segura E, 2011, TRAFFIC, V12, P1677, DOI 10.1111/j.1600-0854.2011.01254.x; Singh R, 2010, SCIENCE, V328, P1394, DOI 10.1126/science.1189176; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; Wagner CS, 2012, J IMMUNOL, V188, P686, DOI 10.4049/jimmunol.1102214; Weck MM, 2007, BLOOD, V109, P3890, DOI 10.1182/blood-2006-04-015719; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yates Robin A., 2008, V445, P311, DOI 10.1007/978-1-59745-157-4_20	48	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76801	10.1371/journal.pone.0076801	http://dx.doi.org/10.1371/journal.pone.0076801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098562	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600078
J	Fassler, M; Weissberg, I; Levy, N; Diaz-Griffero, F; Monsonego, A; Friedman, A; Taube, R				Fassler, Michael; Weissberg, Itai; Levy, Nitzan; Diaz-Griffero, Felipe; Monsonego, Alon; Friedman, Alon; Taube, Ran			Preferential Lentiviral Targeting of Astrocytes in the Central Nervous System	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; IN-VIVO; GENE-TRANSFER; GLUTAMATE TRANSPORTERS; NEUROVASCULAR UNIT; ENDOTHELIAL-CELLS; MAMMALIAN-CELLS; SINDBIS VIRUS; MOUSE MODEL; VECTORS	The ability to visualize and genetically manipulate specific cell populations of the central nervous system (CNS) is fundamental to a better understanding of brain functions at the cellular and molecular levels. Tools to selectively target cells of the CNS include molecular genetics, imaging, and use of transgenic animals. However, these approaches are technically challenging, time consuming, and difficult to control. Viral-mediated targeting of cells in the CNS can be highly beneficial for studying and treating neurodegenerative diseases. Yet, despite specific marking of numerous cell types in the CNS, in vivo selective targeting of astrocytes has not been optimized. In this study, preferential targeting of astrocytes in the CNS was demonstrated using engineered lentiviruses that were pseudotyped with a modified Sindbis envelope and displayed anti-GLAST IgG on their surfaces as an attachment moiety. Viral tropism for astrocytes was initially verified in vitro in primary mixed glia cultures. When injected into the brains of mice, lentiviruses that displayed GLAST IgG on their surface, exhibited preferential astrocyte targeting, compared to pseudotyped lentiviruses that did not incorporate any IgG or that expressed a control isotype IgG. Overall, this approach is highly flexible and can be exploited to selectively target astrocytes or other cell types of the CNS. As such, it can open a window to visualize and genetically manipulate astrocytes or other cells of the CNS as means of research and treatment.	[Fassler, Michael; Levy, Nitzan; Monsonego, Alon; Taube, Ran] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Weissberg, Itai; Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Weissberg, Itai; Friedman, Alon] Ben Gurion Univ Negev, Dept Cognit & Brain Sci, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Ben Gurion University; Ben Gurion University; Ben Gurion University; Yeshiva University; Albert Einstein College of Medicine	Taube, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel.	rantaube@bgu.ac.il	TAUBE, RAN/F-2029-2012; Weissberg, Itai/AGU-9930-2022	TAUBE, RAN/0000-0002-2062-4537; 	Kreitman School for advanced studies at BGU; Faculty of Health Sciences at the Ben Gurion University of the Negev; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087390] Funding Source: NIH RePORTER	Kreitman School for advanced studies at BGU; Faculty of Health Sciences at the Ben Gurion University of the Negev; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MF is supported by the Kreitman School for advanced studies at BGU. Funding for RT is from the Faculty of Health Sciences at the Ben Gurion University of the Negev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Cannon JR, 2011, EXP NEUROL, V228, P41, DOI 10.1016/j.expneurol.2010.10.016; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Choi J, 2010, P NATL ACAD SCI USA, V107, P16703, DOI 10.1073/pnas.1006233107; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Edry E, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00057; Enkirch T, 2012, GENE THER; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Frecha C, 2012, BLOOD, V119, P1139, DOI 10.1182/blood-2011-04-346619; Funke S, 2009, GENE THER, V16, P700, DOI 10.1038/gt.2009.11; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Goyvaerts C, 2012, GENE THER, V19, P1133, DOI 10.1038/gt.2011.206; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Jakobsson J, 2006, MOL THER, V13, P484, DOI 10.1016/j.ymthe.2005.11.012; Jakobsson J, 2006, GENE THER, V13, P966, DOI 10.1038/sj.gt.3302701; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Lai Z, 2002, J NEUROSCI RES, V67, P363, DOI 10.1002/jnr.10137; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Lentz TB, 2012, NEUROBIOL DIS, V48, P179, DOI 10.1016/j.nbd.2011.09.014; Levy C, 2012, MOL THER, V20, P1699, DOI 10.1038/mt.2012.96; Liang M, 2009, J GENE MED, V11, P185, DOI 10.1002/jgm.1290; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Losi G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00132; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Morizono K, 2005, CELL CYCLE, V4, P854, DOI 10.4161/cc.4.7.1789; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Morizono K, 2001, J VIROL, V75, P8016, DOI 10.1128/JVI.75.17.8016-8020.2001; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohno K, 1997, NAT BIOTECHNOL, V15, P763, DOI 10.1038/nbt0897-763; Pariente N, 2008, J GENE MED, V10, P242, DOI 10.1002/jgm.1151; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SCHLEGEL R, 1983, CELL, V32, P639, DOI 10.1016/0092-8674(83)90483-X; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sung BK, 2003, J NEUROSCI, V23, P2899; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Watson DJ, 2002, MOL THER, V5, P528, DOI 10.1006/mthe.2002.0584; Wong LF, 2006, HUM GENE THER, V17, P1, DOI 10.1089/hum.2006.17.1; Xin WJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-15; Xing CH, 2012, NEUROL RES, V34, P325, DOI 10.1179/1743132812Y.0000000019; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390; Zhang L, 2012, TRENDS PHARMACOL SCI, V33, P415, DOI 10.1016/j.tips.2012.04.006; Zhang XY, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-3; Zhou Q, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22566; Ziegler L, 2008, HUM GENE THER, V19, P861, DOI [10.1089/hum.2007.149, 10.1089/hgt.2007.149]	66	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76092	10.1371/journal.pone.0076092	http://dx.doi.org/10.1371/journal.pone.0076092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098426	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500043
J	Gebauer, K; Dickinson, KJM; Whigham, PA; Seddon, PJ				Gebauer, Konstanze; Dickinson, Katharine J. M.; Whigham, Peter A.; Seddon, Philip J.			Matrix Matters: Differences of Grand Skink Metapopulation Parameters in Native Tussock Grasslands and Exotic Pasture Grasslands	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; HABITAT SUITABILITY MODELS; OLIGOSOMA-GRANDE; PATCH OCCUPANCY; SOUTH ISLAND; NEW-ZEALAND; QUALITY; DYNAMICS; CONSERVATION; CONNECTIVITY	Modelling metapopulation dynamics is a potentially very powerful tool for conservation biologists. In recent years, scientists have broadened the range of variables incorporated into metapopulation modelling from using almost exclusively habitat patch size and isolation, to the inclusion of attributes of the matrix and habitat patch quality. We investigated the influence of habitat patch and matrix characteristics on the metapopulation parameters of a highly endangered lizard species, the New Zealand endemic grand skink (Oligosoma grande) taking into account incomplete detectability. The predictive ability of the developed zxmetapopulation model was assessed through cross-validation of the data and with an independent data-set. Grand skinks occur on scattered rock-outcrops surrounded by indigenous tussock (bunch) and pasture grasslands therefore implying a metapopulation structure. We found that the type of matrix surrounding the habitat patch was equally as important as the size of habitat patch for estimating occupancy, colonisation and extinction probabilities. Additionally, the type of matrix was more important than the physical distance between habitat patches for colonisation probabilities. Detection probability differed between habitat patches in the two matrix types and between habitat patches with different attributes such as habitat patch composition and abundance of vegetation on the outcrop. The developed metapopulation models can now be used for management decisions on area protection, monitoring, and the selection of translocation sites for the grand skink. Our study showed that it is important to incorporate not only habitat patch size and distance between habitat patches, but also those matrix type and habitat patch attributes which are vital in the ecology of the target species.	[Gebauer, Konstanze; Whigham, Peter A.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Dickinson, Katharine J. M.] Univ Otago, Dept Informat Sci, Dunedin, New Zealand; [Seddon, Philip J.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Gebauer, K (corresponding author), Univ Otago, Dept Bot, POB 56, Dunedin, New Zealand.	konstanze.gebauer@web.de	Dickinson, Katharine J.M./M-1728-2017; Seddon, Philip/G-8659-2011	Dickinson, Katharine J.M./0000-0001-6769-552X; Seddon, Philip/0000-0001-9076-9566	University of Otago; Hellaby Indigenous Grasslands Research Trust	University of Otago; Hellaby Indigenous Grasslands Research Trust	This work was funded by: University of Otago Research Grant (PJS), University of Otago Doctoral Scholarship (KG), Hellaby Indigenous Grasslands Research Trust (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P23; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Armstrong DP, 2005, CONSERV BIOL, V19, P1402, DOI 10.1111/j.1523-1739.2005.00117.x; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Barbosa AM, 2003, BIOL CONSERV, V114, P377, DOI 10.1016/S0006-3207(03)00066-1; Berry O, 2005, CONSERV BIOL, V19, P855, DOI 10.1111/j.1523-1739.2005.00161.x; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; Berry OF, 2006, CONSERV GENET, V7, P427, DOI 10.1007/s10592-005-9054-0; Blevins E, 2011, LANDSCAPE ECOL, V26, P837, DOI 10.1007/s10980-011-9612-4; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bulman CR, 2007, ECOL APPL, V17, P1460, DOI 10.1890/06-1032.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cianfrani C, 2010, J APPL ECOL, V47, P421, DOI 10.1111/j.1365-2664.2010.01781.x; CLOBERT J, 1994, LIZARD ECOLOGY, P183; Coddington E. J., 1997, PAC CONSERV BIOL, V3, P379, DOI [10.1071/PC980379, DOI 10.1071/PC980379]; CREE A, 1994, NEW ZEAL J ZOOL, V21, P351, DOI 10.1080/03014223.1994.9518005; Dennis RLH, 1997, J INSECT CONSERV, V1, P167, DOI 10.1023/A:1018455714879; Doerr VAJ, 2011, J APPL ECOL, V48, P143, DOI 10.1111/j.1365-2664.2010.01899.x; Driscoll DA, 2007, CAN J ZOOL, V85, P1031, DOI 10.1139/Z07-096; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; HANSKI I, 1997, METAPOPULATION BIOL; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill JK, 1996, J ANIM ECOL, V65, P725, DOI 10.2307/5671; Hines JE, 2006, RESENCE2 SOFTWARE ES; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; HOSMER DW, 1989, APPL LOGISTIC REGRES; Houghton C, 2000, DISPERSAL METAPOPULA; Jaquiery J, 2008, ECOLOGY, V89, P2777, DOI 10.1890/07-1833.1; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McGlone MS, 2001, NEW ZEAL J ECOL, V25, P1; McWethy DB, 2010, P NATL ACAD SCI USA, V107, P21343, DOI 10.1073/pnas.1011801107; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Moilanen A, 1999, ECOLOGY, V80, P1031, DOI 10.1890/0012-9658(1999)080[1031:POMOMD]2.0.CO;2; Murphy TJ, 1994, ACTIVITY RHYTHMS MIC; NCAR-Research Application Program, 2010, VER FOR VER UT R SOF; Norbury G, 2001, J APPL ECOL, V38, P1350, DOI 10.1046/j.0021-8901.2001.00685.x; Patterson GB, 1992, DEV OTAGO SKINK GRAN, P133; Prugh LR, 2009, ECOL APPL, V19, P1300, DOI 10.1890/08-1524.1; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Roughton CM, 2006, WILDLIFE RES, V33, P193, DOI 10.1071/WR05045; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Seddon PJ, 2011, N Z J ECOL, V35; Sjogren-Gulve Per, 2000, Ecological Bulletins, V48, P53; Stanley MC, 1998, J HERPETOL, V32, P461, DOI 10.2307/1565468; THOMAS CD, 1992, J ANIM ECOL, V61, P437, DOI 10.2307/5334; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Tocher MD, 2003, NEW ZEAL J ZOOL, V30, P243, DOI 10.1080/03014223.2003.9518342; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Vogeli M, 2010, BIOL CONSERV, V143, P1057, DOI 10.1016/j.biocon.2009.12.040; Wardle P, 2002, VEGETATION NZ; Whitaker AH, 1996, IMPACT AGR DEV GRAND; Whitaker AH, 1995, OTAGO SKINKS GRAND S; [No title captured]	75	13	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76076	10.1371/journal.pone.0076076	http://dx.doi.org/10.1371/journal.pone.0076076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098423	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500042
J	Habersetzer, J; Larrieu, I; Priault, M; Salin, B; Rossignol, R; Brethes, D; Paumard, P				Habersetzer, Johann; Larrieu, Isabelle; Priault, Muriel; Salin, Benedicte; Rossignol, Rodrigue; Brethes, Daniel; Paumard, Patrick			Human F1F0 ATP Synthase, Mitochondrial Ultrastructure and OXPHOS Impairment: A (Super-)Complex Matter?	PLOS ONE			English	Article							MEMBRANE-SPANNING SEGMENT; INHIBITOR PROTEIN; MAMMALIAN MITOCHONDRIA; CRISTAE MORPHOLOGY; NATIVE PAGE; GXXXG MOTIF; SUBUNIT-E; YEAST; DIMERIZATION; COMPLEX	Mitochondrial morphogenesis is a key process of cell physiology. It is essential for the proper function of this double membrane-delimited organelle, as it ensures the packing of the inner membrane in a very ordered pattern called cristae. In yeast, the mitochondrial ATP synthase is able to form dimers that can assemble into oligomers. Two subunits (e and g) are involved in this supramolecular organization. Deletion of the genes encoding these subunits has no effect on the ATP synthase monomer assembly or activity and only affects its dimerization and oligomerization. Concomitantly, the absence of subunits e and g and thus, of ATP synthase supercomplexes, promotes the modification of mitochondrial ultrastructure suggesting that ATP synthase oligomerization is involved in cristae morphogenesis. We report here that in mammalian cells in culture, the shRNA-mediated down-regulation of subunits e and g affects the stability of ATP synthase and results in a 50% decrease of the available functional enzyme. Comparable to what was shown in yeast, when subunits e and g expression are repressed, ATP synthase dimers and oligomers are less abundant when assayed by native electrophoresis. Unexpectedly, mammalian ATP synthase dimerization/oligomerization impairment has functional consequences on the respiratory chain leading to a decrease in OXPHOS activity. Finally these structural and functional alterations of the ATP synthase have a strong impact on the organelle itself leading to the fission of the mitochondrial network and the disorganization of mitochondrial ultrastructure. Unlike what was shown in yeast, the impairment of the ATP synthase oligomerization process drastically affects mitochondrial ATP production. Thus we propose that mutations or deletions of genes encoding subunits e and g may have physiopathological implications.	[Habersetzer, Johann; Larrieu, Isabelle; Brethes, Daniel; Paumard, Patrick] Univ Bordeaux Segalen, IBGC, UMR 5095, Lab Syst Transducteurs Energie & Morphol Mitochon, Bordeaux, France; [Habersetzer, Johann; Larrieu, Isabelle; Priault, Muriel; Salin, Benedicte; Brethes, Daniel; Paumard, Patrick] CNRS, IBGC, UMR 5095, Bordeaux, France; [Rossignol, Rodrigue] Univ Bordeaux Segalen, Lab Malad Rares Genet & Metab, MRGM, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Paumard, P (corresponding author), Univ Bordeaux Segalen, IBGC, UMR 5095, Lab Syst Transducteurs Energie & Morphol Mitochon, Bordeaux, France.	patrick.paumard@ibgc.cnrs.fr	Priault, Muriel/HHT-0658-2022; Rossignol, Rodrigue/K-7821-2014	Priault, Muriel/0000-0001-8193-0389; 	Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux Segalen; Ministere de la recherche et de l'education nationale; Region Aquitaine Limousin	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux Segalen; Ministere de la recherche et de l'education nationale; Region Aquitaine Limousin	This work was supported by Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux Segalen; Ministere de la recherche et de l'education nationale; Region Aquitaine Limousin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen, 1995, PROTOPLASMA, V189, P1; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Devin A, 2001, EUR J BIOCHEM, V268, P3943, DOI 10.1046/j.1432-1327.2001.02306.x; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; Eskelinen Eeva-Liisa, 2008, V445, P11, DOI 10.1007/978-1-59745-157-4_2; Fronzes R, 2006, BIOCHEMISTRY-US, V45, P6715, DOI 10.1021/bi0601407; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Kao LP, 2012, TOXICOL APPL PHARM, V261, P42, DOI 10.1016/j.taap.2012.03.009; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martin M, 1998, J BIOENERG BIOMEMBR, V30, P565, DOI 10.1023/A:1020584517588; Nath S, 2010, J BIOENERG BIOMEMBR, V42, P293, DOI 10.1007/s10863-010-9296-5; Nath S, 2010, J BIOENERG BIOMEMBR, V42, P301, DOI 10.1007/s10863-010-9295-6; Okabe Makoto, 2001, Journal of Cellular and Molecular Medicine, V5, P92, DOI 10.1111/j.1582-4934.2001.tb00142.x; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200; Rojo M, 2002, J CELL SCI, V115, P1663; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soubannier V, 2002, J BIOL CHEM, V277, P10739, DOI 10.1074/jbc.M111882200; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Suhai T, 2009, ELECTROPHORESIS, V30, P3622, DOI 10.1002/elps.200900114; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Velours J, 2009, INT J BIOCHEM CELL B, V41, P1783, DOI 10.1016/j.biocel.2009.01.011; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910	48	58	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75429	10.1371/journal.pone.0075429	http://dx.doi.org/10.1371/journal.pone.0075429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098383	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500031
J	Hoeks, JCJ; Stowe, LA; Hendriks, P; Brouwer, H				Hoeks, John C. J.; Stowe, Laurie A.; Hendriks, Petra; Brouwer, Harm			Questions Left Unanswered: How the Brain Responds to Missing Information	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; NEURAL MECHANISMS; P600; PREDICTION; AMBIGUITY; SYNTAX	It sometimes happens that when someone asks a question, the addressee does not give an adequate answer, for instance by leaving out part of the required information. The person who posed the question may wonder why the information was omitted, and engage in extensive processing to find out what the partial answer actually means. The present study looks at the neural correlates of the pragmatic processes invoked by partial answers to questions. Two experiments are presented in which participants read mini-dialogues while their Event-Related brain Potentials (ERPs) are being measured. In both experiments, violating the dependency between questions and answers was found to lead to an increase in the amplitude of the P600 component. We interpret these P600-effects as reflecting the increased effort in creating a coherent representation of what is communicated. This effortful processing might include the computation of what the dialogue participant meant to communicate by withholding information. Our study is one of few investigating language processing in conversation, be it that our participants were 'eavesdroppers' instead of real interactants. Our results contribute to the as of yet small range of pragmatic phenomena that modulate the processes underlying the P600 component, and suggest that people immediately attempt to regain cohesion if a question-answer dependency is violated in an ongoing conversation.	[Hoeks, John C. J.; Stowe, Laurie A.; Hendriks, Petra; Brouwer, Harm] Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands; [Hoeks, John C. J.; Stowe, Laurie A.; Hendriks, Petra; Brouwer, Harm] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	Hoeks, JCJ (corresponding author), Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands.	j.c.j.hoeks@rug.nl		Hendriks, Petra/0000-0002-7584-4078; Hoeks, John/0000-0002-6874-1126	NWO (The Netherlands Organization for Scientific Research) [10-26]; NWO Open Access Incentive Fund [036.002.407]	NWO (The Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); NWO Open Access Incentive Fund	This research was funded by NWO (The Netherlands Organization for Scientific Research) PGW grant 10-26 awarded to John Hoeks and Harm Brouwer, and NWO Open Access Incentive Fund (036.002.407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, INFORM STRUCTURE SEN, V71; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Brouwer H, 2013, TIME PLACE LAN UNPUB; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Burkhardt P, 2007, NEUROREPORT, V18, P1851, DOI 10.1097/WNR.0b013e3282f1a999; Burkhardt P, 2006, BRAIN LANG, V98, P159, DOI 10.1016/j.bandl.2006.04.005; Clark HH, 1977, ADV RES THEOR, V1, P1; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Geurts B., 2010, QUANTITY IMPLICATURE; Gouvea AC, 2010, LANG COGNITIVE PROC, V25, P149, DOI 10.1080/01690960902965951; Grice H, 1975, LOGIC CONVERSATION, V1975, P41; Hoeks J, 1999, THESIS U NIJMEGEN NI; Hoeks J. C. J., 2014, OXFORD HDB LANGUAGE; Hoeks JCJ, 2002, J MEM LANG, V46, P99, DOI 10.1006/jmla.2001.2800; Hoeks JCJ, 2006, Q J EXP PSYCHOL, V59, P1581, DOI 10.1080/17470210500268982; Horn L., 2004, HDB PRAGMATICS; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Levinson S. C., 2000, PRESUMPTIVE MEANINGS; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Schumacher P. B., 2011, EXPT PRAGMATICS SEMA, P199, DOI DOI 10.1075/LA.175.10SCH; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Sperber D, 1986, RELEVANCE COGNITION; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; Van Berkum J.J., 2009, SEMANTICS PRAGMATICS, P276; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036	29	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e73594	10.1371/journal.pone.0073594	http://dx.doi.org/10.1371/journal.pone.0073594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098327	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500005
J	Gioia, T; Logozzo, G; Attene, G; Bellucci, E; Benedettelli, S; Negri, V; Papa, R; Zeuli, PS				Gioia, Tania; Logozzo, Giuseppina; Attene, Giovanna; Bellucci, Elisa; Benedettelli, Stefano; Negri, Valeria; Papa, Roberto; Zeuli, Pierluigi Spagnoletti			Evidence for Introduction Bottleneck and Extensive Inter-Gene Pool (Mesoamerica x Andes) Hybridization in the European Common Bean (Phaseolus vulgaris L.) Germplasm	PLOS ONE			English	Article							MICROSATELLITE DIVERSITY; SECONDARY CENTER; SSR MARKERS; LANDRACES; NUCLEAR; WILD; ORIGIN; CHLOROPLAST; VARIABILITY; CENTERS	Common bean diversity within and between Mesoamerican and Andean gene pools was compared in 89 landraces from America and 256 landraces from Europe, to elucidate the effects of bottleneck of introduction and selection for adaptation during the expansion of common bean (Phaseolus vulgaris L.) in Europe. Thirteen highly polymorphic nuclear microsatellite markers (nuSSRs) were used to complement chloroplast microsatellite (cpSSRs) and nuclear markers (phaseolin and Pv-shatterproof1) data from previous studies. To verify the extent of the introduction bottleneck, inter-gene pool hybrids were distinguished from "pure" accessions. Hybrids were identified on the basis of recombination of gene pool specific cpSSR, phaseolin and Pv-shatterproof1 markers with a Bayesian assignments based on nuSSRs, and with STRUCTURE admixture analysis. More hybrids were detected than previously, and their frequency was almost four times larger in Europe (40.2%) than in America (12.3%). The genetic bottleneck following the introduction into Europe was not evidenced in the analysis including all the accessions, but it was significant when estimated only with "pure" accessions, and five times larger for Mesoamerican than for Andean germplasm. The extensive inter-gene pool hybridization generated a large amount of genotypic diversity that mitigated the effects of the bottleneck that occurred when common bean was introduced in Europe. The implication for evolution and the advantages for common bean breeding are discussed.	[Gioia, Tania; Logozzo, Giuseppina; Zeuli, Pierluigi Spagnoletti] Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, I-85100 Potenza, Italy; [Attene, Giovanna] Univ Sassari, Dipartimento Agr, Sez Agron Coltivaz Erbacee & Genet, I-07100 Sassari, Italy; [Bellucci, Elisa; Papa, Roberto] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy; [Benedettelli, Stefano] Univ Florence, Dipartimento Sci Prod Vegetali Suolo & Ambiente A, Florence, Italy; [Negri, Valeria] Univ Perugia, Dipartimento Biol Applicata, I-06100 Perugia, Italy; [Papa, Roberto] Cereal Res Ctr CRA CER, Consiglio Ric & Sperimentaz Agr, Foggia, Italy	University of Basilicata; University of Sassari; Marche Polytechnic University; University of Florence; University of Perugia; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Zeuli, PS (corresponding author), Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, I-85100 Potenza, Italy.	pierluigi.spagnoletti@unibas.it	Benedettelli, Stefano/M-9760-2015; Gioia, Tania/AAT-9961-2021; Bellucci, Elisa/AAS-9237-2021; papa, roberto/F-9510-2014	Benedettelli, Stefano/0000-0002-6035-1801; LOGOZZO, Giuseppina/0000-0002-7951-2425; Gioia, Tania/0000-0001-8980-3034; papa, roberto/0000-0001-9598-3131; Bellucci, Elisa/0000-0002-1636-0719; Negri, Valeria/0000-0003-2941-121X	Italian Government (MIUR) [2002075423]; Universita degli Studi della Basilicata (Potenza, Italy)	Italian Government (MIUR)(Ministry of Education, Universities and Research (MIUR)); Universita degli Studi della Basilicata (Potenza, Italy)	This study was supported by the Italian Government (MIUR) grant no. # 2002075423, Project COFIN 2002: "Beans in Europe: structure of genetic diversity under the effect of colonization and breeding system". TG was supported by a student research fellowship from the Universita degli Studi della Basilicata (Potenza, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rabah'ah MA, 2004, MOL ECOL, V13, P1075, DOI 10.1111/j.1365-294X.2004.02142.x; Angioi SA, 2010, THEOR APPL GENET, V121, P829, DOI 10.1007/s00122-010-1353-2; Angioi SA, 2009, MOL BREEDING, V23, P413, DOI 10.1007/s11032-008-9245-8; Asfaw A, 2009, THEOR APPL GENET, V120, P1, DOI 10.1007/s00122-009-1154-7; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Becerra Velasquez Viviana L., 1994, Genome, V37, P256, DOI 10.1139/g94-036; BERGLUNDBRUCHER O, 1976, ECON BOT, V30, P257, DOI 10.1007/BF02909734; Bitocchi E, 2013, NEW PHYTOL, V197, P300, DOI 10.1111/j.1469-8137.2012.04377.x; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Burle ML, 2010, THEOR APPL GENET, V121, P801, DOI 10.1007/s00122-010-1350-5; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Escribano MR, 1998, PLANT BREEDING, V117, P49, DOI 10.1111/j.1439-0523.1998.tb01447.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Freyre R, 1996, ECON BOT, V50, P195, DOI 10.1007/BF02861451; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Gepts P., 1988, Genetic resources of Phaseolus beans., P375; Gepts P., 1991, Common beans: research for crop improvement., P7; GEPTS P, 1985, J HERED, V76, P447, DOI 10.1093/oxfordjournals.jhered.a110142; GEPTS P, 1988, ECON BOT, V42, P86, DOI 10.1007/BF02859038; GEPTS P, 1986, ECON BOT, V40, P469, DOI [10.1007/BF02859659, 10.1007/BF02859660]; Gepts P, 1998, HORTSCIENCE, V33, P1124, DOI 10.21273/HORTSCI.33.7.1124; Gepts P., 1999, BEAN BREEDING 21 CEN BEAN BREEDING 21 CEN, P389; Guerra-Sanz JM, 2004, PLANT BREEDING, V123, P87, DOI 10.1046/j.0179-9541.2003.00929.x; GUZMAN P, 1995, PHYTOPATHOLOGY, V85, P600, DOI 10.1094/Phyto-85-600; Johnson WC, 1999, EUPHYTICA, V106, P45, DOI 10.1023/A:1003541201923; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KOENIG R, 1989, THEOR APPL GENET, V78, P809, DOI 10.1007/BF00266663; KOINANGE EMK, 1992, J HERED, V83, P135, DOI 10.1093/oxfordjournals.jhered.a111173; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Limongelli G., 1996, PLANT BREEDING, V119, P513, DOI [10.1046/j.1439-0523.2000.00531.x, DOI 10.1046/J.1439-0523.2000.00531.X]; LIOI L, 1989, SEED SCI TECHNOL, V17, P317; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Logozzo G, 2007, GENET RESOUR CROP EV, V54, P1763, DOI 10.1007/s10722-006-9185-2; Masi P, 2009, CROP SCI, V49, P187, DOI 10.2135/cropsci2008.05.0265; Masi P, 2001, THESIS U STUDI BASIL; Mercati F, 2013, GENET RESOUR CROP EV, V60, P839, DOI 10.1007/s10722-012-9879-6; Metais I, 2002, THEOR APPL GENET, V104, P1346, DOI 10.1007/s00122-002-0901-9; NEI M, 1974, GENETICS, V76, P379; Ocampo CH, 2002, ANN REP BEAN IMPROV, V45, P236; Ortwin-Sauer C., 1966, EARLY SPANISH MAN, P51; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Papa R, 2006, DARWINS HARVEST NEW, P121, DOI DOI 10.7312/MOTL13316-007; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PETIT RJ, 1993, HEREDITY, V71, P630, DOI 10.1038/hdy.1993.188; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Piergiovanni AR, 2000, GENET RESOUR CROP EV, V47, P489, DOI 10.1023/A:1008719105895; Pritchard JK, 2000, GENETICS, V155, P945; Rodino AP, 2006, CROP SCI, V46, P2540, DOI 10.2135/cropsci2006.02.0104; Rodino AP, 2003, EUPHYTICA, V131, P165, DOI 10.1023/A:1023973309788; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Roullier C, 2011, MOL ECOL, V20, P3963, DOI 10.1111/j.1365-294X.2011.05229.x; Salimas A. D., 1988, Genetic resources of Phaseolus beans., P163; Santalla M, 2002, THEOR APPL GENET, V104, P934, DOI 10.1007/s00122-001-0844-6; Santalla M, 2010, THEOR APPL GENET, V120, P1635, DOI 10.1007/s00122-010-1282-0; Semerikov VL, 2003, AM J BOT, V90, P1113, DOI 10.3732/ajb.90.8.1113; Sicard D, 2005, PLANT BREEDING, V124, P464, DOI 10.1111/j.1439-0523.2005.01137.x; Singh S. P, 1999, COMMON BEAN IMPROVEM; SINGH SP, 1991, CROP SCI, V31, P23, DOI 10.2135/cropsci1991.0011183X003100010005x; Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yaish MWF, 2003, GENET MOL BIOL, V26, P337, DOI 10.1590/S1415-47572003000300019; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429; Zeven AC, 1997, EUPHYTICA, V94, P319, DOI 10.1023/A:1002940220241; Zhang XY, 2008, THEOR APPL GENET, V117, P629, DOI 10.1007/s00122-008-0807-2	70	39	40	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75974	10.1371/journal.pone.0075974	http://dx.doi.org/10.1371/journal.pone.0075974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098412	Green Published, gold			2022-12-27	WOS:000325427100030
J	Margaret, I; Lucas, MM; Acosta-Jurado, S; Buendia-Claveria, AM; Fedorova, E; Hidalgo, A; Rodriguez-Carvajal, MA; Rodriguez-Navarro, DN; Ruiz-Sainz, JE; Vinardell, JM				Margaret, Isabel; Lucas, M. Mercedes; Acosta-Jurado, Sebastian; Buendia-Claveria, Ana M.; Fedorova, Elena; Hidalgo, Angeles; Rodriguez-Carvajal, Miguel A.; Rodriguez-Navarro, Dulce N.; Ruiz-Sainz, Jose E.; Vinardell, Jose M.			The Sinorhizobium fredii HH103 Lipopolysaccharide Is Not Only Relevant at Early Soybean Nodulation Stages but Also for Symbiosome Stability in Mature Nodules	PLOS ONE			English	Article							BIOFILM FORMATION; BRADYRHIZOBIUM-JAPONICUM; RHIZOBIUM-LEGUMINOSARUM; SYMBIOTIC PROPERTIES; IN-VITRO; MUTANT; POLYSACCHARIDES; BIOSYNTHESIS; INFECTION; LEGUMES	In this work we have characterised the Sinorhizobium fredii HH103 greA lpsB lpsCDE genetic region and analysed for the first time the symbiotic performance of Sinorhizobium fredii lps mutants on soybean. The organization of the S. fredii HH103 greA, lpsB, and lpsCDE genes was equal to that of Sinorhizobium meliloti 1021. S. fredii HH103 greA, lpsB, and lpsE mutant derivatives produced altered LPS profiles that were characteristic of the gene mutated. In addition, S. fredii HH103 greA mutants showed a reduction in bacterial mobility and an increase of auto-agglutination in liquid cultures. RT-PCR and qPCR experiments demonstrated that the HH103 greA gene has a positive effect on the transcription of lpsB. Soybean plants inoculated with HH103 greA, lpsB or lpsE mutants formed numerous ineffective pseudonodules and showed severe symptoms of nitrogen starvation. However, HH103 greA and lps mutants were also able to induce the formation of a reduced number of soybean nodules of normal external morphology, allowing the possibility of studying the importance of bacterial LPS in later stages of the S. fredii HH103-soybean symbiosis. The infected cells of these nodules showed signs of early termination of symbiosis and lytical clearance of bacteroids. These cells also had very thick walls and accumulation of phenolic-like compounds, pointing to induced defense reactions. Our results show the importance of bacterial LPS in later stages of the S. fredii HH103-soybean symbiosis and their role in preventing host cell defense reactions. S. fredii HH103 lpsB mutants also showed reduced nodulation with Vigna unguiculata, although the symbiotic impairment was less pronounced than in soybean.	[Margaret, Isabel; Acosta-Jurado, Sebastian; Buendia-Claveria, Ana M.; Hidalgo, Angeles; Ruiz-Sainz, Jose E.; Vinardell, Jose M.] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Lucas, M. Mercedes; Fedorova, Elena] CSIC, Inst Ciencias Agr, Madrid, Spain; [Rodriguez-Carvajal, Miguel A.] Univ Seville, Fac Quim, Dept Quim Organ, E-41071 Seville, Spain; [Rodriguez-Navarro, Dulce N.] Ctr Torres Tomejil, IFAPA, Alcala Del Rio, Sevilla, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA); University of Sevilla	Vinardell, JM (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	jvinar@us.es	Vinardell, José M/H-5355-2013; Lucas, M Mercedes/H-4529-2016; Oliver, Isabel Maria Margaret/J-8663-2016; Carvajal, Miguel Ángel Rodríguez/F-2577-2012; Fedorova, Elena Erika/U-1069-2017; Jurado, Sebastián Acosta/ABH-3676-2020	Vinardell, José M/0000-0002-7105-5389; Lucas, M Mercedes/0000-0002-3252-0145; Carvajal, Miguel Ángel Rodríguez/0000-0002-2131-6448; Ruiz Sainz, Jose Enrique/0000-0003-0106-3495; Fedorova, Elena/0000-0003-3953-1282; Acosta Jurado, Sebastian/0000-0002-5505-2508; Buendia Claveria, Ana Maria/0000-0002-7058-3497; Margaret Oliver, Isabel Maria/0000-0001-8770-1309	Andalusia Government [P07-CVI-02506]; Spanish Ministry of Science and Innovation [BIO2011-30229-C02-01]; Comunidad de Madrid [S2009/AMB-1511]	Andalusia Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants from the Andalusia Government (P07-CVI-02506), the Spanish Ministry of Science and Innovation (BIO2011-30229-C02-01), and the Comunidad de Madrid (Programa Microambiente S2009/AMB-1511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardissone S, 2011, MOL PLANT MICROBE IN, V24, P1513, DOI 10.1094/MPMI-05-11-0143; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; Becker A, 2005, MOL PLANT MICROBE IN, V18, P899, DOI 10.1094/MPMI-18-0899; Becker A, 1997, J BACTERIOL, V179, P1375, DOI 10.1128/jb.179.4.1375-1384.1997; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; Brewin NJ, 1993, ADV MOL GENETICS PLA, V2, P369; Buendia-Claveria AM, 2003, MICROBIOL-SGM, V149, P1807, DOI 10.1099/mic.0.26099-0; Campbell GRO, 2003, J BACTERIOL, V185, P3853, DOI 10.1128/JB.185.13.3853-3862.2003; Campbell GRO, 2002, P NATL ACAD SCI USA, V99, P3938, DOI 10.1073/pnas.062425699; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; CARLSON RW, 1995, J BIOL CHEM, V270, P11783, DOI 10.1074/jbc.270.20.11783; Chataigne G, 2008, J CHROMATOGR A, V1185, P241, DOI 10.1016/j.chroma.2008.01.065; Collmer A., 1991, Advances in molecular genetics of plant-microbe interactions. Vol. 1. Proceedings of the 5th international symposium on the molecular genetics of plant-microbe interactions, Interlaken, Switzerland, September 9-14, 1990., P65; Crespo-Rivas JC, 2007, INT MICROBIOL, V10, P169, DOI 10.2436/20.1501.01.24; Crespo-Rivas JC, 2009, MOL PLANT MICROBE IN, V22, P575, DOI 10.1094/MPMI-22-5-0575; De Castro C, 2008, CARBOHYD RES, V343, P1924, DOI 10.1016/j.carres.2008.01.036; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Gil-Serrano AM, 1999, BIOCHEM J, V342, P527, DOI 10.1042/0264-6021:3420527; Hidalgo A, 2010, MICROBIOL-SGM, V156, P3398, DOI 10.1099/mic.0.042499-0; KANNENBERG EL, 1998, RHIZOBIACEAE, P119; Lagares A, 2001, J BACTERIOL, V183, P1248, DOI 10.1128/JB.183.4.1248-1258.2001; LAGARES A, 1992, J BACTERIOL, V174, P5941, DOI 10.1128/jb.174.18.5941-5952.1992; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; Madinabeitia N, 2002, MOL PLANT MICROBE IN, V15, P150, DOI 10.1094/MPMI.2002.15.2.150; Margaret I, 2012, MOL PLANT MICROBE IN, V25, P825, DOI 10.1094/MPMI-10-11-0262; Margaret I, 2011, J BIOTECHNOL, V155, P11, DOI 10.1016/j.jbiotec.2011.03.016; Margaret-Oliver I, 2012, ARCH MICROBIOL, V194, P87, DOI 10.1007/s00203-011-0729-2; Moran JF, 1997, FREE RADICAL BIO MED, V22, P861, DOI 10.1016/S0891-5849(96)00426-1; NOEL KD, 1986, J BACTERIOL, V168, P1392, DOI 10.1128/jb.168.3.1392-1401.1986; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oliveira LR, 2013, FUNCT INTEGR GENOMIC, V13, P275, DOI 10.1007/s10142-013-0322-7; Parada M, 2006, MOL PLANT MICROBE IN, V19, P43, DOI 10.1094/MPMI-19-0043; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; PUVANESARAJAH V, 1987, J BACTERIOL, V169, P137, DOI 10.1128/jb.169.1.137-141.1987; REUHS BL, 1994, MOL PLANT MICROBE IN, V7, P240, DOI 10.1094/MPMI-7-0240; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shvaleva A, 2010, PLANT SOIL, V326, P109, DOI 10.1007/s11104-009-9985-1; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; STACEY G, 1991, MOL PLANT MICROBE IN, V4, P332, DOI 10.1094/MPMI-4-332; Stepanova E, 2007, J BACTERIOL, V189, P8772, DOI 10.1128/JB.00911-07; Vanderlinde EM, 2009, MICROBIOL-SGM, V155, P3055, DOI 10.1099/mic.0.025031-0; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vinardell JM, 2004, ARCH MICROBIOL, V181, P144, DOI 10.1007/s00203-003-0635-3; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; Weidner S, 2012, J BACTERIOL, V194, P1617, DOI 10.1128/JB.06729-11	52	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74717	10.1371/journal.pone.0074717	http://dx.doi.org/10.1371/journal.pone.0074717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098345	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100007
J	Imanishi, H; Takibuchi, G; Kobayashi, T; Ishikawa, K; Nakada, K; Mori, M; Kikkawa, Y; Takenaga, K; Toyama-Sorimachi, N; Hayashi, JI				Imanishi, Hirotake; Takibuchi, Gaku; Kobayashi, Toshihiko; Ishikawa, Kaori; Nakada, Kazuto; Mori, Masayuki; Kikkawa, Yoshiaki; Takenaga, Keizo; Toyama-Sorimachi, Noriko; Hayashi, Jun-Ichi			Specific mtDNA Mutations in Mouse Carcinoma Cells Suppress Their Tumor Formation via Activation of the Host Innate Immune System	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; MICE	mammalian species, mitochondrial DNA (mtDNA) with pathogenic mutations that induce mitochondrial respiration defects has been proposed to be involved in tumor phenotypes via induction of enhanced glycolysis under normoxic conditions (the Warburg effects). However, because both nuclear DNA and mtDNA control mitochondrial respiratory function, it is difficult to exclude the possible contribution of nuclear DNA mutations to mitochondrial respiration defects and the resultant expression of tumor phenotypes. Therefore, it is important to generate transmitochondrial cybrids sharing the same nuclear DNA background but carrying mtDNA with and without the mutations by using intercellular mtDNA transfer technology. Our previous studies isolated transmitochondrial cybrids and showed that specific mtDNA mutations enhanced tumor progression as a consequence of overproduction of reactive oxygen species (ROS). This study assessed whether mtDNA mutations inducing ROS overproduction always enhance tumor progression. We introduced mtDNA from senescence-accelerated mice P1 (SAMP1) into C57BL/6J (B6) mice-derived Lewis lung carcinoma P29 cells, and isolated new transmitochondrial cybrids (P29mtSAMP1 cybrids) that overproduced ROS. The inoculation of the cybrids into B6 mice unexpectedly showed that mtDNA from SAMP1 mice conversely induced tumor suppression. Moreover, the tumor suppression of P29mtSAMP1 cybrids in B6 mice occurred as a consequence of innate immune responses of the host B6 mice. Enzyme pretreatment experiments of P29mtSAMP1 cybrids revealed that some peptides encoded by mtDNA and expressed on the cell surface of P29mtSAMP1 cybrids induce increased IL-6 production from innate immune cells (dendritic cells) of B6 mice, and mediate augmented inflammatory responses around the tumor-inoculated environment. These observations indicate presence of a novel role of mtDNA in tumor phenotype, and provide new insights into the fields of mitochondrial tumor biology and tumor immunology.	[Imanishi, Hirotake; Takibuchi, Gaku; Ishikawa, Kaori; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Imanishi, Hirotake] Japan Soc Promot Sci, Tokyo, Japan; [Imanishi, Hirotake; Kobayashi, Toshihiko; Toyama-Sorimachi, Noriko] Natl Ctr Global Hlth & Med, Dept Mol Immunol & Inflammat, Tokyo, Japan; [Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Mori, Masayuki] Shinshu Univ, Sch Med, Res Ctr Aging & Adaptat, Dept Aging Angiol, Matsumoto, Nagano 390, Japan; [Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan; [Takenaga, Keizo] Shimane Univ, Fac Med, Dept Life Sci, Izumo, Shimane, Japan	University of Tsukuba; Japan Society for the Promotion of Science; National Center for Global Health & Medicine - Japan; University of Tsukuba; Shinshu University; Tokyo Metropolitan Institute of Medical Science; Shimane University	Hayashi, JI (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	jih45@biol.tsukuba.ac.jp	Kikkawa, Yoshiaki/AAI-7229-2020	ISHIKAWA, Kaori/0000-0001-9895-5996; Kikkawa, Yoshiaki/0000-0001-8859-4998	Japan Society for the Promotion of Science (JSPS) [25250011, 23240058, 24117503]; World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [25871165] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research A 25250011 (to JIH), Scientific Research A 23240058 (to KN), and Scientific Research on Innovative Areas 24117503 (to JIH) from Japan Society for the Promotion of Science (JSPS). This work was also supported by Grant-in-Aid for JSPS Fellows (to HI) and by World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology, Japan (to KN and JIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Hashizume O, 2012, P NATL ACAD SCI USA, V109, P10528, DOI 10.1073/pnas.1202367109; Ishikawa K, 2008, FEBS LETT, V582, P3525, DOI 10.1016/j.febslet.2008.09.024; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ishikawa K, 2010, J EXP MED, V207, P2297, DOI 10.1084/jem.20092296; Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Mizutani J, 2001, J HERED, V92, P352, DOI 10.1093/jhered/92.4.352; Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0; Okatani Y, 2002, J PINEAL RES, V32, P143, DOI 10.1034/j.1600-079x.2002.1o106.x; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaga K, 1997, ONCOGENE, V14, P331, DOI 10.1038/sj.onc.1200820; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	20	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75981	10.1371/journal.pone.0075981	http://dx.doi.org/10.1371/journal.pone.0075981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098752	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500122
J	Mottaghitalab, F; Farokhi, M; Zaminy, A; Kokabi, M; Soleimani, M; Mirahmadi, F; Shokrgozar, MA; Sadeghizadeh, M				Mottaghitalab, Fatemeh; Farokhi, Mehdi; Zaminy, Arash; Kokabi, Mehrdad; Soleimani, Masoud; Mirahmadi, Fereshteh; Shokrgozar, Mohammad Ali; Sadeghizadeh, Majid			A Biosynthetic Nerve Guide Conduit Based on Silk/SWNT/Fibronectin Nanocomposite for Peripheral Nerve Regeneration	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; SILK FIBROIN; FIBRONECTIN; SCAFFOLDS; FABRICATION; ADSORPTION; DISPERSION; ADHESION; CELLS	As a contribution to the functionality of nerve guide conduits (NGCs) in nerve tissue engineering, here we report a conduit processing technique through introduction and evaluation of topographical, physical and chemical cues. Porous structure of NGCs based on freeze-dried silk/single walled carbon nanotubes (SF/SWNTs) has shown a uniform chemical and physical structure with suitable electrical conductivity. Moreover, fibronectin (FN) containing nanofibers within the structure of SF/SWNT conduits produced through electrospinning process have shown aligned fashion with appropriate porosity and diameter. Moreover, fibronectin remained its bioactivity and influenced the adhesion and growth of U373 cell lines. The conduits were then implanted to 10 mm left sciatic nerve defects in rats. The histological assessment has shown that nerve regeneration has taken places in proximal region of implanted nerve after 5 weeks following surgery. Furthermore, nerve conduction velocities (NCV) and more myelinated axons were observed in SF/SWNT and SF/SWNT/FN groups after 5 weeks post implantation, indicating a functional recovery for the injured nerves. With immunohistochemistry, the higher S-100 expression of Schwann cells in SF/SWNT/FN conduits in comparison to other groups was confirmed. In conclusion, an oriented conduit of biocompatible SF/SWNT/FN has been fabricated with acceptable structure that is particularly applicable in nerve grafts.	[Mottaghitalab, Fatemeh] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran, Iran; [Farokhi, Mehdi] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Tissue Engn, Tehran, Iran; [Zaminy, Arash; Mirahmadi, Fereshteh; Shokrgozar, Mohammad Ali] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran; [Kokabi, Mehrdad] Tarbiat Modares Univ, Fac Chem Engn, Dept Polymer Engn, Tehran, Iran; [Soleimani, Masoud] Tarbiat Modares Univ, Sch Med Sci, Dept Hematol, Tehran, Iran; [Sadeghizadeh, Majid] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran	Tarbiat Modares University; Tehran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tarbiat Modares University; Tarbiat Modares University; Tarbiat Modares University	Shokrgozar, MA (corresponding author), Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.	mashokrgozar@pasteur.ac.ir; sadeghma@modares.ac.ir	Zaminy, Arash/A-1346-2015; Kokabi, Mehrdad/D-1672-2010; Farokhi, Mehdi/P-9672-2017; Mottaghitalab, Fatemeh/AAL-8988-2020; Shokrgozar, Mohammad Ali/HDM-1639-2022; shokrgozar, mohammad ali/L-4149-2017; Farokhi, Mehdi/V-3661-2019; Zaminy, Arash/M-5119-2019	Zaminy, Arash/0000-0002-2388-481X; Kokabi, Mehrdad/0000-0003-1826-1949; Farokhi, Mehdi/0000-0001-7023-2905; shokrgozar, mohammad ali/0000-0001-5123-4155; Farokhi, Mehdi/0000-0001-7023-2905; Zaminy, Arash/0000-0002-2388-481X; , Fatemeh/0000-0003-3850-8902	Pasteur Institute of Iran [2456-65]	Pasteur Institute of Iran	This study has been funded by Pasteur Institute of Iran with grant number 2456-65. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatangelo G, 2002, INTEGRATED BIOMATERIALS SCIENCE, P885, DOI 10.1007/0-306-47583-9_31; AE A, 2008, INFRARED PHYS TECHN, V16, P130; Ahmed Z, 1999, CELL MOTIL CYTOSKEL, V42, P331; Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003; Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030; Belyanskaya LWS, 2011, NEUROTOXICOLOGY, V30, P702; Bian YZ, 2009, BIOMATERIALS, V30, P217, DOI 10.1016/j.biomaterials.2008.09.036; Chang CJ, 2006, BIOMATERIALS, V27, P1035, DOI 10.1016/j.biomaterials.2005.07.003; Chen SM, 2005, CHEM PHYS LETT, V402, P312, DOI 10.1016/j.cplett.2004.12.035; Chennazhy KP, 2005, BIOMATERIALS, V26, P5658, DOI 10.1016/j.biomaterials.2005.02.024; Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008; Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004; de Ruiter GCW, 2009, NEUROSURG CLIN N AM, V20, P91, DOI 10.1016/j.nec.2008.08.001; Dubey G, 2011, ACTA BIOMATER, V7, P1114, DOI 10.1016/j.actbio.2010.11.010; Dyakonov TYC, 2012, J DRUG DELIV, P490; Edwards SL, 2009, BIOMATERIALS, V30, P1725, DOI 10.1016/j.biomaterials.2008.12.031; Fansa H, 2001, PLAST RECONSTR SURG, V107, P485, DOI 10.1097/00006534-200102000-00026; Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003; Gandhi M, 2009, POLYMER, V50, P1918, DOI 10.1016/j.polymer.2009.02.022; Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021; Hsu SH, 2011, BIOMATERIALS, V32, P3764, DOI 10.1016/j.biomaterials.2011.01.065; Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009; Kang M, 2007, COLLOID POLYM SCI, V285, P1163, DOI 10.1007/s00396-007-1668-y; Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030; Kengne-Momo RP, 2012, INT J SPECTROSC, DOI 10.1155/2012/462901; Kim BS, 2011, PROG POLYM SCI, V36, P238, DOI 10.1016/j.progpolymsci.2010.10.001; Kim HS, 2009, BIOMACROMOLECULES, V10, P82, DOI 10.1021/bm800896e; Kim H, 2008, J NANOSCI NANOTECHNO, V8, P5543, DOI 10.1166/jnn.2008.1310; Kokai LE, 2009, ACTA BIOMATER, V5, P2540, DOI 10.1016/j.actbio.2009.03.009; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022; Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007; Lopez-Manchado MA, 2004, J APPL POLYM SCI, V92, P3394, DOI 10.1002/app.20358; Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1; Mhuka V, 2012, INT J BIOL MACROMOLE; Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684; Motta A, 2002, MACROMOL CHEM PHYS, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3; Mottaghitalab F, 2011, CARBOHYD POLYM, V86, P526, DOI 10.1016/j.carbpol.2011.04.066; Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015; Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036; Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001; Roganovic Z, 2007, ACTA NEUROCHIR, V149, P1033, DOI 10.1007/s00701-007-1269-z; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Sakiyama SE, 1999, FASEB J, V13, P2214, DOI 10.1096/fasebj.13.15.2214; Shokrgozar MA, 2011, J BIOMED NANOTECHNOL, V7, P276, DOI 10.1166/jbn.2011.1284; Stang F, 2009, MATERIALS, V2, P1480, DOI 10.3390/ma2041480; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517; Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006; Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007; Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014; Xu HX, 2011, BIOMATERIALS, V32, P4506, DOI 10.1016/j.biomaterials.2011.02.023; Ziabari M, 2008, KOREAN J CHEM ENG, V25, P923, DOI 10.1007/s11814-008-0151-x; Ziabari M, 2007, NANOSCALE RES LETT, V2, P597, DOI 10.1007/s11671-007-9093-1	54	67	67	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74417	10.1371/journal.pone.0074417	http://dx.doi.org/10.1371/journal.pone.0074417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098649	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500020
J	Kubo, M; Imai, A; Nishiyama, T; Ishikawa, M; Sato, Y; Kurata, T; Hiwatashi, Y; Reski, R; Hasebe, M				Kubo, Minoru; Imai, Akihiro; Nishiyama, Tomoaki; Ishikawa, Masaki; Sato, Yoshikatsu; Kurata, Tetsuya; Hiwatashi, Yuji; Reski, Ralf; Hasebe, Mitsuyasu			System for Stable beta-Estradiol-Inducible Gene Expression in the Moss Physcomitrella patens	PLOS ONE			English	Article							SEVERE GROWTH DEFECTS; EVOLUTIONARY INSIGHTS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; LEXA GENE; LAND; GENOME; TRANSCRIPTION; ARABIDOPSIS; INDUCTION	Inducible transgene expression provides a useful tool to analyze gene function. The moss Physcomitrella patens is a model basal land plant with well-developed research tools, including a high efficiency of gene targeting and substantial genomics resources. However, current systems for controlled transgene expression remain limited. Here we report the development of an estrogen receptor mediated inducible gene expression system, based on the system used in flowering plants. After identifying the appropriate promoters to drive the chimeric transducer, we succeeded in inducing transcription over 1,000-fold after 24 h incubation with beta-estradiol. The P. patens system was also effective for high-level long-term induction of gene expression; transcript levels of the activated gene were maintained for at least seven days on medium containing beta-estradiol. We also established two potentially neutral targeting sites and a set of vectors for reproducible expression of two transgenes. This beta-estradiol-dependent system will be useful to test genes individually or in combination, allowing stable, inducible transgenic expression in P. patens.	[Kubo, Minoru; Imai, Akihiro; Nishiyama, Tomoaki; Ishikawa, Masaki; Hiwatashi, Yuji; Hasebe, Mitsuyasu] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; [Kubo, Minoru; Imai, Akihiro; Nishiyama, Tomoaki; Ishikawa, Masaki; Sato, Yoshikatsu; Kurata, Tetsuya; Hasebe, Mitsuyasu] Japan Sci & Technol Agcy, ERATO, Okazaki, Aichi, Japan; [Kubo, Minoru; Reski, Ralf] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Kubo, Minoru; Reski, Ralf] FRIAS Freiburg Inst Adv Studies, Freiburg, Germany; [Imai, Akihiro] Duke Univ, Dept Biol, Durham, NC USA; [Nishiyama, Tomoaki] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Ishikawa, Masaki; Hiwatashi, Yuji; Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan; [Reski, Ralf] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); University of Freiburg; Duke University; Kanazawa University; Graduate University for Advanced Studies - Japan	Kubo, M (corresponding author), Natl Inst Basic Biol, Okazaki, Aichi 444, Japan.	minoru.kubo@biologie.uni-freiburg.de; mhasebe@nibb.ac.jp	Kubo, Minoru/AAH-1689-2019; Ishikawa, Masaki/Q-7598-2018; Sato, Yoshikatsu/I-6129-2014; Ishikawa, Masaki/AAC-8162-2022	Kubo, Minoru/0000-0001-8691-6252; Ishikawa, Masaki/0000-0002-6491-5539; Ishikawa, Masaki/0000-0002-6491-5539; Hasebe, Mitsuyasu/0000-0001-7425-8758; Reski, Ralf/0000-0002-5496-6711; HIWATASHI, YUJI/0000-0002-3996-0549	Japan Science and Technology Agency under the Exploratory Research for Advanced Technology program; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; Ministry of Education, Culture, Sports, Science and Technology	Japan Science and Technology Agency under the Exploratory Research for Advanced Technology program; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japan Science and Technology Agency under the Exploratory Research for Advanced Technology program to MH, the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation to RR and MH, and the Ministry of Education, Culture, Sports, Science and Technology to TN and MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; Amirsadeghi S, 2007, PLANTA, V226, P453, DOI 10.1007/s00425-007-0495-1; Andersen SU, 2003, MOL PLANT MICROBE IN, V16, P1069, DOI 10.1094/MPMI.2003.16.12.1069; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Brand L, 2006, PLANT PHYSIOL, V141, P1194, DOI 10.1104/pp.106.081299; Butaye KMJ, 2005, MOL BREEDING, V16, P79, DOI 10.1007/s11032-005-4929-9; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Core R Team, 2013, R LANG ENV STAT COMP; Corrado G, 2009, BIOTECHNOL ADV, V27, P733, DOI 10.1016/j.biotechadv.2009.05.006; CORUZZI G, 1984, EMBO J, V3, P1671, DOI 10.1002/j.1460-2075.1984.tb02031.x; Cove D, 2006, ANNU REV PLANT BIOL, V57, P497, DOI 10.1146/annurev.arplant.57.032905.105338; DALRYMPLE MA, 1985, NUCLEIC ACIDS RES, V13, P7865, DOI 10.1093/nar/13.21.7865; Decker EL, 2008, BIOPROC BIOSYST ENG, V31, P3, DOI 10.1007/s00449-007-0151-y; Decker EL, 2007, CURR OPIN BIOTECH, V18, P393, DOI 10.1016/j.copbio.2007.07.012; FLUHR R, 1986, EMBO J, V5, P2063, DOI 10.1002/j.1460-2075.1986.tb04467.x; Gitzinger M, 2009, PLANT BIOTECHNOL J, V7, P73, DOI 10.1111/j.1467-7652.2008.00376.x; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Hiwatashi Y, 2008, PLANT CELL, V20, P3094, DOI 10.1105/tpc.108.061705; HORII T, 1981, CELL, V23, P689, DOI 10.1016/0092-8674(81)90432-3; Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; JEFFERSON RA, 1986, P NATL ACAD SCI USA, V83, P8447, DOI 10.1073/pnas.83.22.8447; Judd W. S., 2007, PLANT SYSTEMATICS PH; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kamisugi Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni172; Kang HG, 1999, PLANT J, V20, P127, DOI 10.1046/j.1365-313X.1999.00575.x; Khraiwesh B, 2008, PLANT PHYSIOL, V148, P684, DOI 10.1104/pp.108.128025; Konietschke F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031242; Lang D, 2008, TRENDS PLANT SCI, V13, P542, DOI 10.1016/j.tplants.2008.07.002; MIKI T, 1981, NUCLEIC ACIDS RES, V9, P529, DOI 10.1093/nar/9.3.529; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; Nakaoka Y, 2012, PLANT CELL, V24, P1478, DOI 10.1105/tpc.112.098509; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Nishiyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036471; ODELL J, 1990, MOL GEN GENET, V223, P369, DOI 10.1007/BF00264442; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Okano Y, 2009, P NATL ACAD SCI USA, V106, P16321, DOI 10.1073/pnas.0906997106; Padidam M, 2003, CURR OPIN PLANT BIOL, V6, P169, DOI 10.1016/S1369-5266(03)00005-0; Prigge MJ, 2010, DEVELOPMENT, V137, P3535, DOI 10.1242/dev.049023; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Saidi Y, 2005, PLANT MOL BIOL, V59, P697, DOI 10.1007/s11103-005-0889-z; Saidi Y, 2009, PLANT SIGNAL BEHAV, V4, P457, DOI 10.4161/psb.4.5.8541; Sakakibara K, 2008, EVOL DEV, V10, P555, DOI 10.1111/j.1525-142X.2008.00271.x; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Shinmyo A, 1996, ANN NY ACAD SCI, V782, P97, DOI 10.1111/j.1749-6632.1996.tb40551.x; Srivastava V, 2010, IN VITRO CELL DEV-PL, V46, P219, DOI 10.1007/s11627-009-9274-y; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Zeidler M, 1996, PLANT MOL BIOL, V30, P199, DOI 10.1007/BF00017815; ZHANG WG, 1991, PLANT CELL, V3, P1155, DOI 10.1105/tpc.3.11.1155; Zimmer AD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-498; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	55	49	50	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77356	10.1371/journal.pone.0077356	http://dx.doi.org/10.1371/journal.pone.0077356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086772	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900115
J	Khan, HAA; Shad, SA; Akram, W				Khan, Hafiz Azhar Ali; Shad, Sarfraz Ali; Akram, Waseem			Combination of Phagostimulant and Visual Lure as an Effective Tool in Designing House Fly Toxic Baits: A Laboratory Evaluation	PLOS ONE			English	Article							MUSCA-DOMESTICA L.; FLIES DIPTERA; SUGAR BAITS; MUSCIDAE; RESISTANCE; INSECTICIDES; FIPRONIL; TARGETS; CORDS; (Z)-9-TRICOSENE	House flies (Diptera: Muscidae), potential vectors of a variety of pathogens, characteristically search and feed on sugar sources just after emergence for their survival. Phagostimulants like sugars, and visual characteristics of feeding materials play an important role in foraging success in house flies. Therefore, development of toxic baits by using the combination of phagostimulant and visual lure may prove effective in localized control of house flies. In the present study, visual attraction of house flies to different fabric colors was studied in choice and no choice experiments. Dark blue was the most preferred color in both experiments. In toxicity experiments, insecticide solutions were prepared in 20% sugar solution. Dark blue fabric strips were prepared by moistening with 20% sugar water solution containing median lethal concentrations of one of the four insecticides viz., fipronil, Imidacloprid, indoxacarb and Spinosad. The fabric strips treated with fipronil and Imidacloprid took minimum time (7.66 and 7.81 h, respectively) to cause 50% mortality, while those treated with Spinosad and indoxacarb took relatively more time (13.62 and 17.91 h, respectively) to cause 50% mortality. In conclusion, the combination of phagostimulant and visual lure could be used in designing toxic baits for house flies.	[Khan, Hafiz Azhar Ali] Univ Punjab, Inst Agr Sci, Lahore, Pakistan; [Khan, Hafiz Azhar Ali; Shad, Sarfraz Ali] Bahauddin Zakariya Univ, Dept Entomol, Multan, Pakistan; [Akram, Waseem] Univ Agr Faisalabad, Dept Entomol, Faisalabad, Pakistan	University of Punjab; Bahauddin Zakariya University; University of Agriculture Faisalabad	Khan, HAA (corresponding author), Univ Punjab, Inst Agr Sci, Lahore, Pakistan.	azhar_naturalist@yahoo.com	Khan, Hafiz Azhar Ali/AAI-7476-2021	Khan, Hafiz Azhar Ali/0000-0002-7209-4750				Allan SA, 2011, J VECTOR ECOL, V36, P59, DOI 10.1111/j.1948-7134.2011.00141.x; Alyokhin AV, 2000, J ECON ENTOMOL, V93, P644, DOI 10.1603/0022-0493-93.3.644; Bozsik A, 2006, PEST MANAG SCI, V62, P651, DOI 10.1002/ps.1221; BROCE AB, 1991, J MED ENTOMOL, V28, P730, DOI 10.1093/jmedent/28.5.730; BURG JG, 1984, ENVIRON ENTOMOL, V13, P1083, DOI 10.1093/ee/13.4.1083; Chapman JW, 1998, ENTOMOL EXP APPL, V89, P183, DOI 10.1023/A:1003525629878; Chapman JW, 1999, MED VET ENTOMOL, V13, P132, DOI 10.1046/j.1365-2915.1999.00147.x; Cilek JE, 2003, FLA ENTOMOL, V86, P420, DOI 10.1653/0015-4040(2003)086[0000:AOCPCB]2.0.CO;2; Diclaro JW, 2012, J MED ENTOMOL, V49, P94, DOI 10.1603/ME10257; Diclaro JW, 2012, J ENTOMOL SCI, V47, P56; Geden CJ, 2006, J VECTOR ECOL, V31, P152, DOI 10.3376/1081-1710(2006)31[152:VTFCAM]2.0.CO;2; GREEN CH, 1986, B ENTOMOL RES, V76, P409, DOI 10.1017/S0007485300014905; Hanley ME, 2004, J APPL ENTOMOL, V128, P478, DOI 10.1111/j.1439-0418.2004.00876.x; HERTZ JC, 2007, THESIS U FLORIDA; Hertz JC, 2011, J ENTOMOL SCI, V46, P325, DOI 10.18474/0749-8004-46.4.325; Hogsette JA, 2002, J ECON ENTOMOL, V95, P1110, DOI 10.1603/0022-0493-95.5.1110; Howard JJ, 1998, MED VET ENTOMOL, V12, P322, DOI 10.1046/j.1365-2915.1998.00114.x; Kaufman PE, 2010, J ECON ENTOMOL, V103, P1937, DOI 10.1603/EC10165; KEIDING J, 1976, TECHNICAL REPORT SER, P82; Khan HAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060929; Khan HAA, 2013, PARASITOL RES, V112, P2049, DOI 10.1007/s00436-013-3365-8; Khan HAA, 2013, ECOTOXICOLOGY, V22, P522, DOI 10.1007/s10646-013-1044-2; Khan HAA, 2012, PARASITOL RES, V111, P1165, DOI 10.1007/s00436-012-2947-1; Khan HAA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-146; Khan HMR, 2013, JP J BIOSTAT, V9, P1; KILPATRICK JW, 1956, PUBLIC HEALTH REP, V71, P144, DOI 10.2307/4589378; Kristensen M, 2004, PEST MANAG SCI, V60, P894, DOI 10.1002/ps.883; LINDH JM, 2012, DROSOPHILA INF SERV, V6, pE1661; Mihok S, 2006, B ENTOMOL RES, V96, P387, DOI 10.1079/BER2006443; Moon Roger D., 2002, P279, DOI 10.1016/B978-012510451-7/50016-5; Muller GC, 2008, T ROY SOC TROP MED H, V102, P480, DOI 10.1016/j.trstmh.2008.01.008; Sohail Ahmed, 2005, International Journal of Agriculture and Biology, V7, P424; Stark JD, 2009, J ENTOMOL SCI, V44, P308, DOI 10.18474/0749-8004-44.4.308; THAM CH, 2011, ENVIRON TOXICOL CHEM, V30, P997, DOI DOI 10.1002/ETC.462.PUBMED:21309017; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; White WH, 2007, J ECON ENTOMOL, V100, P155, DOI 10.1603/0022-0493(2007)100[155:KAMCAS]2.0.CO;2; Xue RD, 2008, J AM MOSQUITO CONTR, V24, P415, DOI 10.2987/5683.1; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571; 2005, STAT VERS 8 1 US MAN	39	10	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e77225	10.1371/journal.pone.0077225	http://dx.doi.org/10.1371/journal.pone.0077225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086770	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200079
J	Chen, GQ; Qiu, Y; Sun, LH; Yu, M; Wang, WS; Xiao, WD; Yang, Y; Liu, Y; Yang, SW; Teitelbaum, DH; Ma, YH; Lu, DS; Yang, H				Chen, Guoqing; Qiu, Yuan; Sun, Lihua; Yu, Min; Wang, Wensheng; Xiao, Weidong; Yang, Yang; Liu, Yong; Yang, Songwei; Teitelbaum, Daniel H.; Ma, Yuanhang; Lu, Dingsong; Yang, Hua			The Jagged-2/Notch-1/Hes-1 Pathway Is Involved in Intestinal Epithelium Regeneration after Intestinal Ischemia-Reperfusion Injury	PLOS ONE			English	Article							RAT SMALL-INTESTINE; CELL-PROLIFERATION; PROGENITOR CELLS; NOTCH; EXPRESSION; FATE; DIFFERENTIATION; DECARBOXYLASE; P27(KIP1); PROMOTES	Background: Notch signaling plays a critical role in the maintenance of intestinal crypt epithelial cell proliferation. The aim of this study was to investigate the role of Notch signaling in the proliferation and regeneration of intestinal epithelium after intestinal ischemia reperfusion (I/R) injury. Methods: Male Sprague-Dawley rats were subjected to sham operation or I/R by occlusion of the superior mesenteric artery (SMA) for 20 min. Intestinal tissue samples were collected at 0, 1, 2, 4, and 6 h after reperfusion. Proliferation of the intestinal epithelium was evaluated by immunohistochemical staining of proliferating nuclear antigen (PCNA). The mRNA and protein expression levels of Notch signaling components were examined using Real-time PCR and Western blot analyses. Immunofluorescence was also performed to detect the expression and location of Jagged-2, cleaved Notch-1, and Hes-1 in the intestine. Finally, the gamma-secretase inhibitor DAPT and the siRNA for Jagged-2 and Hes-1 were applied to investigate the functional role of Notch signaling in the proliferation of intestinal epithelial cells in an in vitro IEC-6 culture system. Results: I/R injury caused increased intestinal crypt epithelial cell proliferation and increased mRNA and protein expression of Jagged-2, Notch-1, and Hes-1. The immunofluorescence results further confirmed increased protein expression of Jagged-2, cleaved Notch-1, and Hes-1 in the intestinal crypts. The inhibition of Notch signaling with DAPT and the suppression of Jagged-2 and Hes-1 expression using siRNA both significantly inhibited the proliferation of IEC-6 cells. Conclusion: The Jagged-2/Notch-1/Hes-1 signaling pathway is involved in intestinal epithelium regeneration early after I/R injury by increasing crypt epithelial cell proliferation.	[Chen, Guoqing; Qiu, Yuan; Sun, Lihua; Yu, Min; Wang, Wensheng; Xiao, Weidong; Yang, Yang; Liu, Yong; Yang, Songwei; Ma, Yuanhang; Lu, Dingsong; Yang, Hua] Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Teitelbaum, Daniel H.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA	Army Medical University; University of Michigan System; University of Michigan	Yang, H (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China.	huayang@tmmu.edu.cn		Yu, Min/0000-0002-8845-8977	National Natural Science Foundation of China [NSFC 81020108023, NSFC 81272078, NSFC 81270451]; Chongqing Science and Technology Commission International Key Collaboration Project [CSTC 201110008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission International Key Collaboration Project	This work was supported by the National Natural Science Foundation of China (NSFC 81020108023 and NSFC 81272078 to H.Y., NSFC 81270451 to W.D.X.) and the Chongqing Science and Technology Commission International Key Collaboration Project (CSTC 201110008 to H.Y.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe Christelle, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009890; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Cai YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044772; Chen G, 2013, DIG DIS SCI; Croquelois A, 2008, J EXP MED, V205, P3173, DOI 10.1084/jem.20081427; El-Assal Osama N, 2004, Semin Pediatr Surg, V13, P2, DOI 10.1053/j.sempedsurg.2003.09.002; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; FUJIMOTO K, 1992, J CLIN INVEST, V89, P126, DOI 10.1172/JCI115552; FUJIMOTO K, 1991, AM J PHYSIOL, V261, pG523, DOI 10.1152/ajpgi.1991.261.3.G523; Heath JK, 2010, CURR TOP DEV BIOL, V90, P159, DOI 10.1016/S0070-2153(10)90004-5; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Itoh H, 2002, DIGEST DIS SCI, V47, P2704, DOI 10.1023/A:1021049004188; JOHNSON LR, 1988, PHYSIOL REV, V68, P456, DOI 10.1152/physrev.1988.68.2.456; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Ma XB, 2009, CELL PROLIFERAT, V42, P15, DOI 10.1111/j.1365-2184.2008.00569.x; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Okamoto R, 2004, J GASTROENTEROL, V39, P1, DOI 10.1007/s00535-003-1259-8; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; RIJKE RPC, 1976, GASTROENTEROLOGY, V71, P786; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; Schroeder Natalia, 2002, Gene Expression Patterns, V2, P247, DOI 10.1016/S1567-133X(02)00060-1; Shima Y, 2006, J PEDIATR SURG, V41, P830, DOI 10.1016/j.jpedsurg.2005.12.025; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Tsai S, 2000, BLOOD, V96, P950, DOI 10.1182/blood.V96.3.950.015k43_950_957; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang WS, 2012, PEDIATR SURG INT, V28, P533, DOI 10.1007/s00383-012-3075-9; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Yamamoto S, 2001, J SURG RES, V99, P134, DOI 10.1006/jsre.2001.6106; Yeh KY, 1998, AM J PHYSIOL-GASTR L, V275, pG572, DOI 10.1152/ajpgi.1998.275.3.G572; Yeo SY, 2007, P NATL ACAD SCI USA, V104, P5913, DOI 10.1073/pnas.0607062104	39	15	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76274	10.1371/journal.pone.0076274	http://dx.doi.org/10.1371/journal.pone.0076274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098462	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600035
J	Carver, LF; Vafaei, A; Guerra, R; Freire, A; Phillips, SP				Carver, Lisa F.; Vafaei, Afshin; Guerra, Ricardo; Freire, Aline; Phillips, Susan P.			Gender Differences: Examination of the 12-Item Bem Sex Role Inventory (BSRI-12) in an Older Brazilian Population	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; SCORING ANDROGYNY; MASCULINITY; VALIDATION; FEMININITY; SELF	Objectives: Although gender is often acknowledged as a determinant of health, measuring its components, other than biological sex, is uncommon. The Bem Sex Role Inventory (BSRI) quantifies self-attribution of traits, indicative of gender roles. The BSRI has been used with participants across cultures and countries, but rarely in an older population in Brazil, as we have done in this study. Our primary objective was to determine whether the BSRI-12 can be used to explore gender in an older Brazilian population. Methods: The BSRI was completed by volunteer participants, all community dwelling adults aged 65+ living in Natal, Brazil. Exploratory factor analysis was performed, followed by a varimax rotation (orthogonal solution) for iteration to examine the underlying gender roles of feminine, masculine, androgynous and undifferentiated, and to validate the BSRI in older adults in Brazil. Results: The 278 participants, (80 men, 198 women) were 65-99 years old (average 73.6 for men, 74.7 for women). Age difference between sexes was not significant (p = 0.22). A 12 item version of the BSRI (BSRI-12) previously validated among Spanish seniors was used and showed validity with 5 BSRI-12 items (Cronbach=0.66) loading as feminine, 6 items (Cronbach=0.51) loading onto masculine roles and neither overlapping with the category of biological sex of respondent. Conclusions: Although the BSRI-12 appears to be a valid indicator of gender among elderly Brazilians, the gender role status identified with the BSRI-12 was not correlated with being male or female.	[Carver, Lisa F.] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada; [Vafaei, Afshin] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Phillips, Susan P.] Queens Univ, Dept Family Med, Kingston, ON, Canada; [Phillips, Susan P.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Guerra, Ricardo; Freire, Aline] Univ Fed Rio Grande do Norte, Dept Physiotherapy, BR-59072970 Natal, RN, Brazil	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Universidade Federal do Rio Grande do Norte	Carver, LF (corresponding author), Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada.	4LFC@QUEENSU.CA	GUERRA, Ricardo/J-7586-2015	GUERRA, Ricardo/0000-0003-3824-3713; Phillips, Susan/0000-0003-4798-1742; Carver, L.F./0000-0002-7695-7939	CNPq - Conselho Nacional de Desenvolvimento Tecnologico; FAPERN - Fundacao de Apoio a Pesquisa do Rio Grande do Norte [474728/2009-9]	CNPq - Conselho Nacional de Desenvolvimento Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERN - Fundacao de Apoio a Pesquisa do Rio Grande do Norte	This work was funded by: CNPq - Conselho Nacional de Desenvolvimento Tecnologico (Website: www.cnpq.br), and FAPERN - Fundacao de Apoio a Pesquisa do Rio Grande do Norte Website: www.fapern.rn.gov.br (Project Grant Number: 474728/2009-9.) The total funding for the project was $10,000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrindell WA, 2013, CROSS-CULT RES, V47, P51, DOI 10.1177/1069397112470366; Avlund K, 2003, PSYCHOSOM MED, V65, P771, DOI 10.1097/01.PSY.0000082640.61645.BF; Bem S.L., 1981, BEM SEX ROLE INVENTO; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; BEM SL, 1977, J CONSULT CLIN PSYCH, V45, P196, DOI 10.1037//0022-006X.45.2.196; BLACKMAN S, 1982, PSYCHOL REP, V51, P1100, DOI 10.2466/pr0.1982.51.3f.1100; Campbell T, 1997, EDUC PSYCHOL MEAS, V57, P118, DOI 10.1177/0013164497057001008; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CONSTANTINOPLE A, 1973, PSYCHOL BULL, V80, P389, DOI 10.1037/h0035334; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; De Visser RO, 2007, PSYCHOL HEALTH, V22, P595, DOI 10.1080/14768320600941772; Fernandez J, 2010, SPAN J PSYCHOL, V13, P1000, DOI 10.1017/S113874160000264X; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; FLAHERTY JF, 1980, J PERS SOC PSYCHOL, V38, P984, DOI 10.1037/0022-3514.38.6.984; Gale-Ross R, 2009, CAN J AGING, V28, P135, DOI 10.1017/S0714980809090187; Gorsuch R., 1983, FACTOR ANAL; Gutmann D., 1987, RECLAIMED POWERS NEW; Hatcher L., 1994, STEP BY STEP APPROAC; Hernandez José Augusto Evangelho, 2009, Estud. psicol. (Campinas), V26, P73, DOI 10.1590/S0103-166X2009000100008; HOFFMAN DM, 1979, SEX ROLES, V5, P765, DOI 10.1007/BF00287937; Hunt K, 2004, HEALTH EDUC RES, V19, P239, DOI 10.1093/her/cyg061; Hutz C, 1992, PSICOL-REFLEX CRIT, V5, P15; Huyck MH, 1996, ADULTHOOD AGING RES, P98; HYDE JS, 1979, DEV PSYCHOL, V15, P334; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kamas L, 2012, J ECON BEHAV ORGAN, V83, P82, DOI 10.1016/j.jebo.2011.06.013; Katsurada E, 1999, J CROSS CULT PSYCHOL, V30, P641, DOI 10.1177/0022022199030005005; Lenney E, 1991, MEASURES PERSONALITY, V1, P573; Lott B., 1981, GENDER NONVERBAL BEH, P171; Lyons AC, 2008, SEX ROLES, V59, P694, DOI 10.1007/s11199-008-9475-6; MARTIN HJ, 1988, PSYCHOL REP, V62, P343, DOI 10.2466/pr0.1988.62.2.343; Mateo M., 1991, INVESTIGACIONES PSIC, V9, P95; McCartney G, 2011, TOB CONTROL, V20, P166, DOI 10.1136/tc.2010.037929; Oliveira LSO, 1983, MASCULINIDADE FEMINI; Sabina C, 2012, AM J COMMUN PSYCHOL, V49, P347, DOI 10.1007/s10464-011-9462-x; Schmitz S., 2010, SEX GENDER BIOMEDICI, P57; SEDNEY MA, 1981, SEX ROLES, V7, P217, DOI 10.1007/BF00287807; Sinnott J, 2001, HDB PSYCHOL AGEING, P454; SPENCE JT, 1975, J PERS SOC PSYCHOL, V32, P29, DOI 10.1037/h0076857; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Twenge JM, 1997, SEX ROLES, V36, P305, DOI 10.1007/BF02766650; WILSON D, 1990, PERS INDIV DIFFER, V11, P651, DOI 10.1016/0191-8869(90)90249-Q; WINDLE M, 1985, J GERONTOL, V40, P336, DOI 10.1093/geronj/40.3.336; Woodhill BM, 2003, SEX ROLES, V48, P555, DOI 10.1023/A:1023531530272	46	44	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76356	10.1371/journal.pone.0076356	http://dx.doi.org/10.1371/journal.pone.0076356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098482	gold, Green Submitted, Green Published			2022-12-27	WOS:000325434500063
J	Davidson, MG; Alonso, MN; Kenkel, JA; Suhoski, MM; Gonzalez, JC; Yuan, R; Engleman, EG				Davidson, Matthew G.; Alonso, Michael N.; Kenkel, Justin A.; Suhoski, Megan M.; Gonzalez, Joseph C.; Yuan, Robert; Engleman, Edgar G.			In Vivo T Cell Activation Induces the Formation of CD209(+) PDL-2(+) Dendritic Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; COLONY-STIMULATING FACTOR; TOXIC-SHOCK-SYNDROME; PROGRAMMED DEATH-1; BLOOD MONOCYTES; PD-1; B7-DC; DIFFERENTIATE; RESPONSES; EFFECTOR	Two critical functions of dendritic cells (DC) are to activate and functionally polarize T cells. Activated T cells can, in turn, influence DC maturation, although their effect on de novo DC development is poorly understood. Here we report that activation of T cells in mice, with either an anti-CD3 antibody or super antigen, drives the rapid formation of CD209(+)CD11b(+)CD11c(+) MHC II+ DC from monocytic precursors (Mo-DC). GM-CSF is produced by T cells following activation, but surprisingly, it is not required for the formation of CD209(+) Mo-DC. CD40L, however, is critical for the full induction of Mo-DC following T cell activation. T cell induced CD209(+) Mo-DC are comparable to conventional CD209-DC in their ability to stimulate T cell proliferation. However, in contrast to conventional CD209(-) DC, CD209(+) Mo-DC fail to effectively polarize T cells, as indicated by a paucity of T cell cytokine production. The inability of CD209(+) Mo-DC to polarize T cells is partly explained by increased expression of PDL-2, since blockade of this molecule restores some polarizing capacity to the Mo-DC. These findings expand the range of signals capable of driving Mo-DC differentiation in vivo beyond exogenous microbial factors to include endogenous factors produced following T cell activation.	[Davidson, Matthew G.; Alonso, Michael N.; Kenkel, Justin A.; Suhoski, Megan M.; Gonzalez, Joseph C.; Yuan, Robert; Engleman, Edgar G.] Stanford Univ, Sch Med, Ctr Blood, Dept Pathol, Palo Alto, CA 94304 USA	Stanford University	Engleman, EG (corresponding author), Stanford Univ, Sch Med, Ctr Blood, Dept Pathol, Palo Alto, CA 94304 USA.	edengleman@stanford.edu			National Institutes of Health [HL075462, DK082537, DK096038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082537, R01DK096038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants HL075462, DK082537 and DK096038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MN, 2011, BLOOD, V118, P3311, DOI 10.1182/blood-2011-03-341065; Baban B, 2011, J IMMUNOL, V187, P2329, DOI 10.4049/jimmunol.1100276; Brossart P, 1998, BLOOD, V92, P4238, DOI 10.1182/blood.V92.11.4238.423k16_4238_4247; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Davidson MG, 2013, J IMMUNOL; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; FERRAN C, 1990, EUR J IMMUNOL, V20, P509, DOI 10.1002/eji.1830200308; Ghiotto M, 2010, INT IMMUNOL, V22, P651, DOI 10.1093/intimm/dxq049; Jabara HH, 1996, INT IMMUNOL, V8, P1503, DOI 10.1093/intimm/8.10.1503; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; MIETHKE T, 1993, EUR J IMMUNOL, V23, P1494, DOI 10.1002/eji.1830230715; Novak N, 2012, J ALLERGY CLIN IMMUN, V129, P879, DOI 10.1016/j.jaci.2012.01.062; Ochi A, 1993, Semin Immunol, V5, P57, DOI 10.1006/smim.1993.1008; Pfistershammer K, 2006, EUR J IMMUNOL, V36, P1104, DOI 10.1002/eji.200535344; Pilat N, 2011, SEMIN IMMUNOL, V23, P293, DOI 10.1016/j.smim.2011.04.002; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Rozali EN, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/656340; Santiago-Schwarz F, 2001, J IMMUNOL, V167, P1758, DOI 10.4049/jimmunol.167.3.1758; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Shin T, 2003, J EXP MED, V198, P31, DOI 10.1084/jem.20030242; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Sporri R, 2003, J IMMUNOL, V171, P6406, DOI 10.4049/jimmunol.171.12.6406; Stenger EO, 2012, BLOOD, V119, P5088, DOI 10.1182/blood-2011-11-364091; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Watanabe S, 2007, CLIN IMMUNOL, V122, P288, DOI 10.1016/j.clim.2006.10.013; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Youngnak P, 2003, BIOCHEM BIOPH RES CO, V307, P672, DOI 10.1016/S0006-291X(03)01257-9; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	33	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76258	10.1371/journal.pone.0076258	http://dx.doi.org/10.1371/journal.pone.0076258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098455	gold, Green Submitted, Green Published			2022-12-27	WOS:000325434500056
J	Wu, ZQ; Zhang, XQ; Shen, L; Xiong, YY; Wu, X; Huo, R; Wei, ZY; Cai, L; Qi, GY; Xu, QQ; Cui, DX; Cui, DH; Zhao, GC; He, L; Qin, SY				Wu, Zhenqiang; Zhang, Xiaoqing; Shen, Lu; Xiong, Yuyu; Wu, Xi; Huo, Ran; Wei, Zhiyun; Cai, Lei; Qi, Guoyang; Xu, Qingqing; Cui, Daxiang; Cui, Donghong; Zhao, Gengchun; He, Lin; Qin, Shengying			A Systematically Combined Genotype and Functional Combination Analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in Different Geographic Areas of Mainland China - A Basis for Personalized Therapy	PLOS ONE			English	Article							GENETIC-POLYMORPHISM ANALYSIS; HAN POPULATIONS; DRUG-METABOLISM; CYTOCHROME-P450; PHARMACOGENETICS; MEDICINE; ENZYMES	The cytochrome P450 is the major enzyme involved in drug metabolism. Single CYP genotypes and metabolic phenotypes have been widely studied, but no combination analysis has been conducted in the context of specific populations and geographical areas. This study is the first to systematically analyze the combined genotypes and functional combinations of 400 samples of major CYP genes-CYP2E1, CYP2D6, CYP2C9, and CYP2C19 in four geographical areas of mainland China. 167 different genotype combinations were identified, of which 25 had a greater than 1% frequency in the Chinese Han population. In addition, phenotypes of the four genes for each sample were in line with the predictions of previous studies of the four geographical areas. On the basis of the genotype classification, we were able to produce a systemic functional combinations analysis for the population. 25 of the combinations detected had at least two non-wild phenotypes and four showed a frequency above 1%. A bioinformatics analysis of the relationship between particular drugs and multi-genes was conducted. This is the first systematic study to analyze genotype combinations and functional combinations across whole Chinese population and could make a significant contribution in the field of personalized medicine and therapy.	[Wu, Zhenqiang; Zhang, Xiaoqing; Shen, Lu; Xiong, Yuyu; Wu, Xi; Huo, Ran; Wei, Zhiyun; Cai, Lei; Xu, Qingqing; Cui, Daxiang; Cui, Donghong; He, Lin; Qin, Shengying] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Wu, Zhenqiang; Shen, Lu; Xiong, Yuyu; Wu, Xi; Huo, Ran; Wei, Zhiyun; Xu, Qingqing; He, Lin; Qin, Shengying] Shanghai Geno MePilot Inst Genom & Human Hlth, Shanghai, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhang, Xiaoqing] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Pharm, Shanghai 200092, Peoples R China; [Qi, Guoyang] Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China; [Cui, Daxiang] Shanghai Jiao Tong Univ, Res Inst Micro Nano Sci & Technol, Shanghai 200030, Peoples R China; [Cui, Donghong] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [Zhao, Gengchun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fudan University; Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Qin, SY (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	chinsir@sjtu.edu.cn	Wei, Zhiyun/E-2008-2016; Cai, Lei/H-3972-2017; Lu, Shen/B-2644-2008; cui, donghong/AAV-2619-2020	Wei, Zhiyun/0000-0002-3554-4142; Cai, Lei/0000-0002-5726-2971; Lu, Shen/0000-0002-0659-2399; 	863 Program [2012AA02A515]; 973 Program [2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Nature Science Foundation of China [81273596, 81121001, 30900799, 30972823]; Shanghai Jiao Tong University Med-X Fund [YG2010MS61]; Public Science and Technology Research Funds [201210056]; Shanghai Jiao Tong University Interdisciplinary Research fund; Major Program of Shanghai Committee of Science and Technology [11dz1950300]; Shanghai Leading Academic Discipline Project [B205]	863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University Med-X Fund; Public Science and Technology Research Funds; Shanghai Jiao Tong University Interdisciplinary Research fund; Major Program of Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 863 Program (2012AA02A515), the 973 Program (2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Nature Science Foundation of China (81273596, 81121001, 30900799, 30972823), the Shanghai Jiao Tong University Med-X Fund (YG2010MS61), the Public Science and Technology Research Funds(201210056), the Shanghai Jiao Tong University Interdisciplinary Research fund, the Major Program of Shanghai Committee of Science and Technology (11dz1950300) and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertilsson L, 2002, BRIT J CLIN PHARMACO, V53, P111, DOI 10.1046/j.0306-5251.2001.01548.x; BERTILSSON L, 1992, CLIN PHARMACOL THER, V51, P388, DOI 10.1038/clpt.1992.38; Chen LL, 2008, PHARMACOGENOMICS, V9, P691, DOI 10.2217/14622416.9.6.691; de Leon J, 2006, EXPERT REV MOL DIAGN, V6, P277, DOI 10.1586/14737159.6.3.277; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; EVANS WE, 1993, J CLIN INVEST, V91, P2150, DOI 10.1172/JCI116441; Gardiner SJ, 2006, PHARMACOL REV, V58, P521, DOI 10.1124/pr.58.3.6; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; GUIYUN M, 2005, J CHENGDE MED COLL, V22; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; Marshall A, 1997, NAT BIOTECHNOL, V15, P1249, DOI 10.1038/nbt1197-1249; McGraw J, 2012, EXPERT OPIN DRUG MET, V8, P371, DOI 10.1517/17425255.2012.657626; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Qin SY, 2008, GENOMICS, V92, P152, DOI 10.1016/j.ygeno.2008.05.004; Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591; Tang KF, 2010, GENOMICS, V95, P224, DOI 10.1016/j.ygeno.2010.01.005; WATKINS PB, 1990, SEMIN LIVER DIS, V10, P235, DOI 10.1055/s-2008-1040480; Wolf CR, 2000, BRIT MED J, V320, P987, DOI 10.1136/bmj.320.7240.987; Xiong YY, 2011, GENOMICS, V97, P277, DOI 10.1016/j.ygeno.2010.11.004	20	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e71934	10.1371/journal.pone.0071934	http://dx.doi.org/10.1371/journal.pone.0071934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098323	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500002
J	Aranda, G; Abascal, FJ; Varela, JL; Medina, A				Aranda, Guillermo; Javier Abascal, Francisco; Luis Varela, Jose; Medina, Antonio			Spawning Behaviour and Post-Spawning Migration Patterns of Atlantic Bluefin Tuna (Thunnus thynnus) Ascertained from Satellite Archival Tags	PLOS ONE			English	Article							YELLOWFIN TUNA; DIVING BEHAVIOR; NORTH-ATLANTIC; POPULATION-STRUCTURE; HABITAT UTILIZATION; KATSUWONUS-PELAMIS; THERMAL BIOLOGY; PACIFIC-OCEAN; PELAGIC FISH; L. 1758	Spawning behaviour of Atlantic bluefin tuna (Thunnus thynnus) was investigated using electronic satellite tags deployed in the western Mediterranean spawning ground, around the Balearic Islands (years 2009-2011). All the fish were tagged underwater and released within schools. In general, the fish tagged in the same year/school displayed common migratory trends. Following extended residency around the Balearic Islands, most tagged tuna crossed the Strait of Gibraltar heading for the North Atlantic. Discrepancies between the migratory tracks reconstructed from this and previous electronic tagging studies suggest that the bluefin tuna Mediterranean population may comprise distinct units exhibiting differing migratory behaviours. The diving behaviour varied between oceanic regions throughout the migratory pathways, the shallowest distribution taking place in the spawning ground and the deepest at the Strait of Gibraltar. A unique diving pattern was found on the majority of nights while the fish stayed at the spawning ground; it consisted of frequent and brief oscillatory movements up and down through the mixed layer, resulting in thermal profiles characterized by oscillations about the thermocline. Such a pattern is believed to reflect recent courtship and spawning activity. Reproductive parameters inferred from the analysis of vertical profiles are consistent with those estimated in previous studies based on biological samples.	[Aranda, Guillermo; Luis Varela, Jose; Medina, Antonio] Univ Cadiz, Dept Biol, Fac Ciencias Mar & Ambientales, Cadiz, Spain; [Javier Abascal, Francisco] Inst Espanol Oceanog, Ctr Oceanog Canarias, Santa Cruz De Tenerife, Spain	Universidad de Cadiz; Spanish Institute of Oceanography	Medina, A (corresponding author), Univ Cadiz, Dept Biol, Fac Ciencias Mar & Ambientales, Campus Excelencia Int Mar CEI MAR, Cadiz, Spain.	antonio.medina@uca.es	Aranda, Guillermo/X-7556-2018; Abascal, Francisco/AAF-4118-2019; Medina, Antonio/A-1624-2008; Varela, Jose Luis/AAM-3303-2020; Abascal, Francisco/I-4222-2015	Aranda, Guillermo/0000-0002-9650-0856; Abascal, Francisco/0000-0002-8550-8617; Medina, Antonio/0000-0001-5609-3574; Abascal, Francisco/0000-0002-8550-8617; Varela, Jose Luis/0000-0002-5235-7605	Spanish government; EC FEDER [CTM2007-65178-C02-01/MAR, CTM2011-29525-C04]; Junta de Andalucia [RNM-02469]; Fundacion Migres	Spanish government(Spanish GovernmentEuropean Commission); EC FEDER(European CommissionEuropean Commission Joint Research Centre); Junta de Andalucia(Junta de Andalucia); Fundacion Migres	Grants from the Spanish government and EC FEDER (CTM2007-65178-C02-01/MAR, CTM2011-29525-C04), Junta de Andalucia (RNM-02469) and Fundacion Migres are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Aranda G, 2013, J SEA RES, V76, P154, DOI 10.1016/j.seares.2012.08.005; ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Block BA, 1997, MAR BIOL, V130, P119, DOI 10.1007/s002270050231; Brill R, 2002, FISH B-NOAA, V100, P155; BUSHNELL PG, 1990, CAN J ZOOL, V68, P1857, DOI 10.1139/z90-265; BUSHNELL PG, 1992, J COMP PHYSIOL B, V162, P131, DOI 10.1007/BF00398338; Cayre P, 1993, AQUAT LIVING RESOUR, V6, P1, DOI 10.1051/alr:1993001; Cermeno P, 2012, INT COMM CONS ATL CO, V68, P151; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; De Metrio G., 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P415; De Metrio G., 2005, P161; De Metrio G., 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P776; De Metrio G, 2005, COL VOL SCI PAP ICCA, V58, P1337; Evans K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034550; Fromentin Jean-Marc, 2010, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V65, P812; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garcia H. E., 2010, WORLD OCEAN ATLAS, V3, P1; GORDOA A, 2010, COLLECTIVE VOLUMES S, V65, P837; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hoolihan JP, 2011, ICES J MAR SCI, V68, P880, DOI 10.1093/icesjms/fsr024; Kitagawa T, 2007, FISHERIES SCI, V73, P98, DOI 10.1111/j.1444-2906.2007.01307.x; Klimley AP, 1999, MAR BIOL, V133, P307, DOI 10.1007/s002270050469; Lawson GL, 2010, MAR ECOL PROG SER, V400, P245, DOI 10.3354/meps08394; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Lutcavage Molly, 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P759; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Medina A, 2007, MAR ECOL PROG SER, V337, P221, DOI 10.3354/meps337221; Medina Antonio, 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P874; Muhling BA, 2011, B MAR SCI, V87, P687, DOI 10.5343/bms.2010.1101; Musyl MK, 2011, MAR ECOL PROG SER, V433, P1, DOI 10.3354/meps09202; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; Rooker JR, 2008, MAR ECOL PROG SER, V368, P231, DOI 10.3354/meps07602; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Royer F, 2009, REV-METHODS TECHNOL, V9, P323, DOI 10.1007/978-1-4020-9640-2_20; Sara G, 2007, MAR ECOL PROG SER, V331, P243, DOI 10.3354/meps331243; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Schaefer KM, 2011, FISH RES, V112, P22, DOI 10.1016/j.fishres.2011.08.006; Semba Yasuko, 2009, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V64, P662; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; Simon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048583; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Sumaila UR, 2012, MAR POLICY, V36, P502, DOI 10.1016/j.marpol.2011.08.010; Taylor NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027693; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; TINTORE J, 1988, J PHYS OCEANOGR, V18, P1384, DOI 10.1175/1520-0485(1988)018<1384:ASOAID>2.0.CO;2; Tudela Sergi, 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P1157; Vinas J, 2011, REV FISH BIOL FISHER, V21, P527, DOI 10.1007/s11160-010-9174-6; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Webster DG, 2011, MAR POLICY, V35, P249, DOI 10.1016/j.marpol.2010.08.004; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wilson Steven G., 2010, Endangered Species Research, V10, P355; Yamashita H, 2001, COL VOL SCI PAP ICCA, V52, P809; Zar J. H., 1996, BIOSTATISTICAL ANAL	63	72	72	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76445	10.1371/journal.pone.0076445	http://dx.doi.org/10.1371/journal.pone.0076445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098502	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100067
J	Jennings, RM; Etter, RJ; Ficarra, L				Jennings, Robert M.; Etter, Ron J.; Ficarra, Lynn			Population Differentiation and Species Formation in the Deep Sea: The Potential Role of Environmental Gradients and Depth	PLOS ONE			English	Article							GENETIC-STRUCTURE; MITOCHONDRIAL-DNA; REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; LARVAL DISPERSAL; LOCAL ADAPTATION; HAPLOTYPE RECONSTRUCTION; BATHYMETRIC PATTERNS; PROTOBRANCH BIVALVES; ALTITUDINAL GRADIENT	Ecological speciation probably plays a more prominent role in diversification than previously thought, particularly in marine ecosystems where dispersal potential is great and where few obvious barriers to gene flow exist. This may be especially true in the deep sea where allopatric speciation seems insufficient to account for the rich and largely endemic fauna. Ecologically driven population differentiation and speciation are likely to be most prevalent along environmental gradients, such as those attending changes in depth. We quantified patterns of genetic variation along a depth gradient (1600-3800m) in the western North Atlantic for a protobranch bivalve (Nucula atacellana) to test for population divergence. Multilocus analyses indicated a sharp discontinuity across a narrow depth range, with extremely low gene flow inferred between shallow and deep populations for thousands of generations. Phylogeographical discordance occurred between nuclear and mitochondrial loci as might be expected during the early stages of species formation. Because the geographic distance between divergent populations is small and no obvious dispersal barriers exist in this region, we suggest the divergence might reflect ecologically driven selection mediated by environmental correlates of the depth gradient. As inferred for numerous shallow-water species, environmental gradients that parallel changes in depth may play a key role in the genesis and adaptive radiation of the deep-water fauna.	[Jennings, Robert M.; Etter, Ron J.; Ficarra, Lynn] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	Jennings, RM (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	rob.jennings@umb.edu	Jennings, Robert/D-4393-2009	Jennings, Robert/0000-0003-4714-5824	NSF [OCE0726382, OCE1130541]	NSF(National Science Foundation (NSF))	This research was supported by NSF (nsf.gov) Grants OCE0726382 and OCE1130541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1996, PROG OCEANOGR, V38, P95, DOI 10.1016/S0079-6611(96)00011-0; Avise JC, 2004, TAXON, V53, P893, DOI 10.2307/4135555; Baco AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045555; Baco AR, 2005, ERLANGEN EARTH C SER, P663, DOI 10.1007/3-540-27673-4_33; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Barker JSF, 2011, J EVOLUTION BIOL, V24, P430, DOI 10.1111/j.1420-9101.2010.02180.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; Bird CE, 2011, INTEGR COMP BIOL, V51, pE11; Bongaerts P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-303; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Bower A, 2011, DEEP-SEA RES PT II, V58, P1798, DOI 10.1016/j.dsr2.2010.10.060; Bower AS, 2013, DEEP-SEA RES PT II, V85, P15, DOI 10.1016/j.dsr2.2012.07.029; BOYLE EA, 1982, SCIENCE, V218, P784, DOI 10.1126/science.218.4574.784; Bradbury IR, 2007, MAR ECOL PROG SER, V340, P245, DOI 10.3354/meps340245; Brown A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028562; BUCKLIN A, 1987, DEEP-SEA RES, V34, P1795, DOI 10.1016/0198-0149(87)90054-9; Bulgarella M, 2012, MOL ECOL, V21, P350, DOI 10.1111/j.1365-294X.2011.05400.x; Burgess MD, 2011, J ANIM ECOL, V80, P688, DOI 10.1111/j.1365-2656.2011.01816.x; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Carlon DB, 2002, EVOLUTION, V56, P2227; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Castelin M, 2011, DEEP-SEA RES PT I, V58, P637, DOI 10.1016/j.dsr.2011.03.008; Chase MR, 1998, MAR BIOL, V131, P301, DOI 10.1007/s002270050323; Cheviron ZA, 2009, EVOLUTION, V63, P1593, DOI 10.1111/j.1558-5646.2009.00644.x; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; Clague GE, 2011, BIOL LETTERS, V7, P863, DOI 10.1098/rsbl.2011.0458; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; Cowart DA, 2013, MOL ECOL, V22, P4147, DOI 10.1111/mec.12379; Coyne J.A., 2004, SPECIATION; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007006; Dennis AB, 2010, MOL ECOL, V19, P3206, DOI 10.1111/j.1365-294X.2010.04689.x; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dubey S, 2010, MOL ECOL, V19, P886, DOI 10.1111/j.1365-294X.2010.04539.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards SV, 2000, EVOLUTION, V54, P1839; Ehinger M, 2002, MOL ECOL, V11, P939, DOI 10.1046/j.1365-294X.2002.01487.x; Vega-Vela NE, 2012, ECOL EVOL, V2, P2669, DOI 10.1002/ece3.360; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; Etter RJ, 1999, DEEP-SEA RES PT I, V46, P1095, DOI 10.1016/S0967-0637(98)00100-9; Etter RJ, 2011, MOL ECOL, V20, P829, DOI 10.1111/j.1365-294X.2010.04978.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Eytan RI, 2009, MOL ECOL, V18, P2375, DOI 10.1111/j.1365-294X.2009.04202.x; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; Gage J. D., 1991, DEEP SEA BIOL NATURA; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GANZ HH, 1995, MAR BIOL, V123, P821, DOI 10.1007/BF00349126; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Hare MP, 2005, EVOLUTION, V59, P2509, DOI 10.1554/05-150.1; Harris PT, 2009, OCEAN COAST MANAGE, V52, P22, DOI 10.1016/j.ocecoaman.2008.09.009; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; Hellberg ME, 1999, MOL BIOL EVOL, V16, P839, DOI 10.1093/oxfordjournals.molbev.a026168; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hensen I, 2012, GLOBAL ECOL BIOGEOGR, V21, P455, DOI 10.1111/j.1466-8238.2011.00691.x; Herrera S, 2012, MOL ECOL, V21, P6053, DOI 10.1111/mec.12074; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hudson RR, 2003, EVOLUTION, V57, P182; Garcia-Merchan VH, 2012, MOL PHYLOGENET EVOL, V62, P664, DOI 10.1016/j.ympev.2011.11.009; Irwin DE, 2012, AM NAT, V180, P35, DOI 10.1086/666002; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jennings RM, 2011, MOL ECOL RESOUR, V11, P1102, DOI 10.1111/j.1755-0998.2011.03038.x; Johannesson K, 2010, PHILOS T R SOC B, V365, P1735, DOI 10.1098/rstb.2009.0256; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; Keigwin LD, 1999, SCIENCE, V286, P520, DOI 10.1126/science.286.5439.520; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Keller I, 2011, MOL ECOL, V20, P1888, DOI 10.1111/j.1365-294X.2011.05067.x; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kirk NL, 2009, MAR BIOL, V156, P1609, DOI 10.1007/s00227-009-1196-z; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Laakmann S, 2012, MOL PHYLOGENET EVOL, V65, P535, DOI 10.1016/j.ympev.2012.07.007; LARKIN MA, 2007, CLUSTAL W CLUSTAL X; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lessios HA, 2011, INTEGR COMP BIOL, V51, P456, DOI 10.1093/icb/icr039; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Li N, 2003, GENETICS, V165, P2213; Lozier MS, 2013, DEEP-SEA RES PT II, V85, P147, DOI 10.1016/j.dsr2.2012.07.037; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Marko PB, 2002, MOL BIOL EVOL, V19, P2005, DOI 10.1093/oxfordjournals.molbev.a004024; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; MARUYAMA T, 1984, GENETICS; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; Moura CJ, 2012, ZOOL SCR, V41, P79, DOI 10.1111/j.1463-6409.2011.00503.x; Near TJ, 2004, EVOLUTION, V58, P2798; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2005, EVOLUTION, V59, P705; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Oromi N, 2012, ECOL EVOL, V2, P2018, DOI 10.1002/ece3.323; Palumbi SR, 2009, HEREDITY, V102, P66, DOI 10.1038/hdy.2008.104; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Pritchard JK, 2000, GENETICS, V155, P945; Quattrini AM, 2013, MOL ECOL, V22, P4123, DOI 10.1111/mec.12370; Quattro JM, 2001, MAR BIOL, V139, P1107; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Rex M.A., 2010, BIOSCIENCE; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SCHELTEMA RS, 1986, B MAR SCI, V39, P290; Scheltema RS, 2009, DEEP-SEA RES PT II, V56, P1835, DOI 10.1016/j.dsr2.2009.05.024; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schuller M, 2011, POLAR BIOL, V34, P549, DOI 10.1007/s00300-010-0913-x; Scott JW, 2010, EVOL ECOL, V24, P1061, DOI 10.1007/s10682-010-9352-y; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SNYDER LRG, 1988, EVOLUTION, V42, P689, DOI 10.1111/j.1558-5646.1988.tb02487.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; SOMERO GN, 1992, ANNU REV PHYSIOL, V54, P557, DOI 10.1146/annurev.ph.54.030192.003013; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Toole JM, 2011, DEEP-SEA RES PT II, V58, P1768, DOI 10.1016/j.dsr2.2010.10.058; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Warner RR, 2002, B MAR SCI, V70, P245; White TA, 2011, MAR ECOL PROG SER, V434, P155, DOI 10.3354/meps09207; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x; Zardus JD, 2002, ADV MAR BIOL, V42, P1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; [No title captured]	156	45	45	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e77594	10.1371/journal.pone.0077594	http://dx.doi.org/10.1371/journal.pone.0077594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098590	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100086
J	Ma, XY; Bao, HJ; Cui, L; Zou, J				Ma, Xiao-Yun; Bao, Hui-Jing; Cui, Lei; Zou, Jun			The Graft of Autologous Adipose-Derived Stem Cells in the Corneal Stromal after Mechanic Damage	PLOS ONE			English	Article							AMNIOTIC MEMBRANE; TRANSPLANTATION; TISSUE; RECONSTRUCTION; TRANSPARENCY; ORIENTATION; SCAFFOLDS; THERAPY; LENS	This study was designed to explore the feasibility of using autologous rabbit adipose derived stem cells (rASCs) as seed cells and polylactic-co-glycolic acid (PLGA) as a scaffold for repairing corneal stromal defects. rASCs isolated from rabbit nape adipose tissue were expanded and seeded on a PLGA scaffold to fabricate cell-scaffold constructs. After 1 week of cultivation in vitro, the cell-scaffold complexes were transplanted into corneal stromal defects in rabbits. In vivo, the autologous rASCs-PLGA constructed corneal stroma gradually became transparent without corneal neovascularization after 12 weeks. Hematoxylin and eosin staining and transmission electron microscopy examination revealed that their histological structure and collagen fibril distribution at 24 weeks after implantation were similar to native counterparts. As to the defect treated with PLGA alone, the stromal defects remained. And scar tissue was observed in the untreated-group. The implanted autologous ASCs survived up to 24 weeks post-transplantation and differentiated into functional keratocytes, as assessed by the expression of aldehyde-3-dehydrogenase 1A1 (ALDH1A1) and cornea-specific proteoglycan keratocan. Our results revealed that autologous rASCs could be one of the cell sources for corneal stromal restoration in diseased corneas or for tissue engineering of a corneal equivalent.	[Ma, Xiao-Yun] Guanghua Integrat Med Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Bao, Hui-Jing; Zou, Jun] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Cui, Lei] Henan Sci & Technol Univ, Med Technol & Engn Inst, Luoyang, Henan, Peoples R China	Shanghai Jiao Tong University; Henan University of Science & Technology	Cui, L (corresponding author), Henan Sci & Technol Univ, Med Technol & Engn Inst, Luoyang, Henan, Peoples R China.	cuilei68@hotmail.com; zoujun70@126.com		Cui, Lei/0000-0002-4339-6629	Shanghai Committee of Science and Technology, China [08ZR1411400]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	This project was supported by Shanghai Committee of Science and Technology, China (grant number 08ZR1411400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnalich-Montiel F, 2008, STEM CELLS, V26, P570, DOI 10.1634/stemcells.2007-0653; BENEDEK G, 1983, NATURE, V302, P383, DOI 10.1038/302383a0; BETTELHEIM FA, 1983, BIOPHYS J, V41, P29, DOI 10.1016/S0006-3495(83)84402-6; Borene ML, 2004, ANN BIOMED ENG, V32, P274, DOI 10.1023/B:ABME.0000012747.97620.3a; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042; Doillon CJ, 2003, INT J ARTIF ORGANS, V26, P764, DOI 10.1177/039139880302600810; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Griffith M, 2002, CORNEA, V21, pS54, DOI 10.1097/01.ico.0000263120.68768.f8; Hu XX, 2008, BIOMATERIALS, V29, P3128, DOI 10.1016/j.biomaterials.2008.04.010; Hu XJ, 2005, TISSUE ENG, V11, P1710, DOI 10.1089/ten.2005.11.1710; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Jester JV, 1999, J CELL SCI, V112, P613; Joyce NC, 2012, MOL VIS, V18, P547; Kamma-Lorger CS, 2009, MOL VIS, V15, P378; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; Lan YN, 2012, INVEST OPHTH VIS SCI, V53, P3638, DOI 10.1167/iovs.11-9311; Liu HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010707; Liu LQ, 2010, ARTIF ORGANS, V34, P426, DOI 10.1111/j.1525-1594.2009.00884.x; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3637, DOI 10.1167/iovs.05-0462; Mimura T, 2004, EXP EYE RES, V79, P231, DOI 10.1016/j.exer.2004.05.001; Mimura T, 2007, CURR EYE RES, V32, P617, DOI 10.1080/02713680701530589; Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038; Orwin EJ, 2003, J BIOMECH ENG-T ASME, V125, P439, DOI 10.1115/1.1589773; Gomes JAP, 2010, INVEST OPHTH VIS SCI, V51, P1408, DOI 10.1167/iovs.09-4029; RAWE IM, 1994, BIOPHYS J, V67, P1743, DOI 10.1016/S0006-3495(94)80648-4; SCOTT JE, 1990, BIOCHEM J, V270, P491, DOI 10.1042/bj2700491; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Stull RA, 2000, CYTOMETRY, V40, P126, DOI 10.1002/(SICI)1097-0320(20000601)40:2<126::AID-CYTO6>3.0.CO;2-M; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038; Yao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030842; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	37	14	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76103	10.1371/journal.pone.0076103	http://dx.doi.org/10.1371/journal.pone.0076103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098428	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100042
J	Zhang, Y; He, XC; Yu, F; Xiang, ZM; Li, J; Thorpe, KL; Yu, ZN				Zhang, Yang; He, Xiaocui; Yu, Feng; Xiang, Zhiming; Li, Jun; Thorpe, Karen L.; Yu, Ziniu			Characteristic and Functional Analysis of Toll-like Receptors (TLRs) in the lophotrocozoan, Crassostrea gigas, Reveals Ancient Origin of TLR-Mediated Innate Immunity	PLOS ONE			English	Article							KAPPA-B; MOLECULAR-CLONING; PACIFIC OYSTER; RECOGNITION; MYD88; EXPRESSION; COMPONENTS; EVOLUTION; DEFENSE; PATHWAY	The evolution of TLR-mediated innate immunity is a fundamental question in immunology. Here, we report the characterization and functional analysis of four TLR members in the lophotrochozoans Crassostrea gigas (CgTLRs). All CgTLRs bear a conserved domain organization and have a close relationship with TLRs in ancient non-vertebrate chordates. In HEK293 cells, every CgTLR could constitutively activate NF-kappa B responsive reporter, but none of the PAMPs tested could stimulate CgTLR-activated NF-kappa B induction. Subcellular localization showed that CgTLR members have similar and dual distribution on late endosomes and plasma membranes. Moreover, CgTLRs and CgMyD88 mRNA show a consistent response to multiple PAMP challenges in oyster hemocytes. As CgTLR-mediated NF-kappa B activation is dependent on CgMyD88, we designed a blocking peptide for CgTLR signaling that would inhibit CgTLR-CgMyD88 dependent NF-kappa B activation. This was used to demonstrate that a Vibrio parahaemolyticus infection-induced enhancement of degranulation and increase of cytokines TNF mRNA in hemocytes, could be inhibited by blocking CgTLR signaling. In summary, our study characterized the primitive TLRs in the lophotrocozoan C. gigas and demonstrated a fundamental role of TLR signaling in infection-induced hemocyte activation. This provides further evidence for an ancient origin of TLR-mediated innate immunity.	[Zhang, Yang; Yu, Feng; Xiang, Zhiming; Li, Jun; Yu, Ziniu] Chinese Acad Sci, South China Sea Inst Oceanol, Lab Appl Marine Biol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China; [He, Xiaocui] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Immunol, Greifswald, Germany; [Thorpe, Karen L.] Univ Portsmouth, Inst Marine Sci, Portsmouth, Hants, England	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Friedrich Loeffler Institute; University of Portsmouth	Yu, ZN (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Lab Appl Marine Biol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China.	carlzyu@scsio.ac.cn	Thorpe, Karen/F-9762-2012; Thorpe, Karen/M-8197-2015	Thorpe, Karen/0000-0002-2823-8032; Thorpe, Karen/0000-0002-7548-7189; Zhang, Yang/0000-0002-0789-4938	National Basic Research Program of China [2010CB126404]; National Natural Science Foundation of China [41176150, 31001130]; NSFC-Guangdong of China [U1201215]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (No. 2010CB126404), the National Natural Science Foundation of China (No. 41176150 and 31001130) and Joint Funds of NSFC-Guangdong of China (U1201215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Barcia R, 1999, IUBMB LIFE, V48, P419, DOI 10.1080/152165499306801; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Choi HJ, 2011, KOREAN J PARASITOL, V49, P229, DOI 10.3347/kjp.2011.49.3.229; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; He XC, 2011, FISH SHELLFISH IMMUN, V30, P870, DOI 10.1016/j.fsi.2011.01.009; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang SF, 2011, J IMMUNOL, V186, P2042, DOI 10.4049/jimmunol.1001824; Huang XD, 2012, FISH SHELLFISH IMMUN, V33, P659, DOI 10.1016/j.fsi.2012.06.029; Imler JL, 2004, J LEUKOCYTE BIOL, V75, P18, DOI 10.1189/jlb.0403160; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kanzok SM, 2004, J MOL EVOL, V58, P442, DOI 10.1007/s00239-003-2565-8; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Qiu LM, 2007, FISH SHELLFISH IMMUN, V22, P451, DOI 10.1016/j.fsi.2006.05.003; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sasaki N, 2009, J BIOL CHEM, V284, P27336, DOI 10.1074/jbc.M109.032433; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Toubiana M, 2013, DEV COMP IMMUNOL, V40, P158, DOI 10.1016/j.dci.2013.02.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang LL, 2011, FISH SHELLFISH IMMUN, V30, P653, DOI 10.1016/j.fsi.2010.12.023; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P1354, DOI 10.1016/j.fsi.2011.03.008; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P954, DOI 10.1016/j.fsi.2011.01.031; Zheng L., 2005, ISJ, V2, P105	38	58	60	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76464	10.1371/journal.pone.0076464	http://dx.doi.org/10.1371/journal.pone.0076464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098508	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100069
J	Chen, YC; Lin, YT; Huang, CT; Shih, CL; Yang, ZR; Hwang, IS				Chen, Yi-Ching; Lin, Yen-Ting; Huang, Chien-Ting; Shih, Chia-Li; Yang, Zong-Ru; Hwang, Ing-Shiou			Trajectory Adjustments Underlying Task-Specific Intermittent Force Behaviors and Muscular Rhythms	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; MANUAL TRACKING; VISUAL INFORMATION; MOTOR; RECTIFICATION; VARIABILITY; FEEDBACK; EMG; FREQUENCY; COHERENCE	Force intermittency is one of the major causes of motor variability. Focusing on the dynamics of force intermittency, this study was undertaken to investigate how force trajectory is fine-tuned for static and dynamic force-tracking of a comparable physical load. Twenty-two healthy adults performed two unilateral resistance protocols (static force-tracking at 75% maximal effort and dynamic force-tracking in the range of 50%-100% maximal effort) using the left hand. The electromyographic activity and force profile of the designated hand were monitored. Gripping force was off-line decomposed into a primary movement spectrally identical to the target motion and a force intermittency profile containing numerous force pulses. The results showed that dynamic force-tracking exhibited greater intermittency amplitude and force pulse but a smaller amplitude ratio of primary movement to force intermittency than static force-tracking. Multi-scale entropy analysis revealed that force intermittency during dynamic force-tracking was more complex on a low time scale but more regular on a high time scale than that of static force-tracking. Together with task-dependent force intermittency properties, dynamic force-tracking exhibited a smaller 8-12 Hz muscular oscillation but a more potentiated muscular oscillation at 35-50 Hz than static force-tracking. In conclusion, force intermittency reflects differing trajectory controls for static and dynamic force-tracking. The target goal of dynamic tracking is achieved through trajectory adjustments that are more intricate and more frequent than those of static tracking, pertaining to differing organizations and functioning of muscular oscillations in the alpha and gamma bands.	[Chen, Yi-Ching] Chung Shan Med Univ, Sch Phys Therapy, Taichung, Taiwan; [Chen, Yi-Ching] Chung Shan Med Univ Hosp, Taichung, Taiwan; [Lin, Yen-Ting] Asian Univ, Phys Educ Off, Taichung, Taiwan; [Huang, Chien-Ting; Yang, Zong-Ru; Hwang, Ing-Shiou] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan; [Shih, Chia-Li; Hwang, Ing-Shiou] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Asia University Taiwan; National Cheng Kung University; National Cheng Kung University	Hwang, IS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan.	ishwang@mail.ncku.edu.tw			National Science Council, R.O.C. [NSC-101-2410-H-040-017]	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the National Science Council, R.O.C. (http://web1.nsc.gov.tw/mp.aspx?mp = 7), under Grant No. NSC-101-2410-H-040-017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrykiewicz A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-101; Baweja HS, 2009, EXP BRAIN RES, V197, P35, DOI 10.1007/s00221-009-1883-5; Bedrov YA, 2007, BIOSYSTEMS, V89, P50, DOI 10.1016/j.biosystems.2006.04.011; Boonstra TW, 2012, J NEUROPHYSIOL, V107, P796, DOI 10.1152/jn.00066.2011; Bourguignon M, 2013, NEUROIMAGE, V66, P500, DOI 10.1016/j.neuroimage.2012.10.038; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; ELBLE RJ, 1976, J NEUROPHYSIOL, V39, P370, DOI 10.1152/jn.1976.39.2.370; Erim Z, 1996, MUSCLE NERVE, V19, P563, DOI 10.1002/(SICI)1097-4598(199605)19:5<563::AID-MUS3>3.0.CO;2-9; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hong SL, 2008, EXP BRAIN RES, V189, P61, DOI 10.1007/s00221-008-1403-z; Hong SL, 2008, CHAOS, V18, DOI 10.1063/1.2979695; Hu XG, 2012, EXP BRAIN RES, V221, P191, DOI 10.1007/s00221-012-3161-1; Huang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051417; Hwang IS, 2009, J APPL PHYSIOL, V106, P966, DOI 10.1152/japplphysiol.90851.2008; IYER MB, 1994, NEUROSCI LETT, V170, P94, DOI 10.1016/0304-3940(94)90247-X; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Jordan K, 2004, EXP BRAIN RES, V156, P451, DOI 10.1007/s00221-003-1806-9; Kilner JM, 2000, J NEUROSCI, V20, P8838; Kuznetsov NA, 2010, NEUROSCI LETT, V470, P121, DOI 10.1016/j.neulet.2009.12.068; Liu JE, 2011, IEEE ENG MED BIO, P6335, DOI 10.1109/IEMBS.2011.6091564; McClelland VM, 2012, J NEUROSCI METH, V205, P190, DOI 10.1016/j.jneumeth.2011.11.001; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Muthukumaraswamy SD, 2010, J NEUROPHYSIOL, V104, P2873, DOI 10.1152/jn.00607.2010; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; Omlor W, 2007, NEUROIMAGE, V34, P1191, DOI 10.1016/j.neuroimage.2006.10.018; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Neto OP, 2010, J NEUROPHYSIOL, V103, P1093, DOI 10.1152/jn.00792.2009; Prochazka A, 1997, J NEUROPHYSIOL, V77, P3237, DOI 10.1152/jn.1997.77.6.3237; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; Schoffelen JM, 2011, J NEUROSCI, V31, P6750, DOI 10.1523/JNEUROSCI.4882-10.2011; Selen LPJ, 2006, J NEUROPHYSIOL, V96, P2750, DOI 10.1152/jn.00552.2006; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Sosnoff JJ, 2006, NEUROSCI LETT, V392, P165, DOI 10.1016/j.neulet.2005.09.010; Sosnoff JJ, 2005, J MOTOR BEHAV, V37, P325, DOI 10.3200/JMBR.37.4.325-336; Stegeman DF, 2010, CLIN NEUROPHYSIOL, V121, P1633, DOI 10.1016/j.clinph.2010.03.052; Svendsen JH, 2011, HUM MOVEMENT SCI, V30, P1039, DOI 10.1016/j.humov.2011.02.001; Vaillancourt DE, 2002, CLIN NEUROPHYSIOL, V113, P1325, DOI 10.1016/S1388-2457(02)00167-0; Walker N, 1997, J GERONTOL B-PSYCHOL, V52, pP40, DOI 10.1093/geronb/52B.1.P40; Yao WX, 2000, J NEUROPHYSIOL, V83, P441, DOI 10.1152/jn.2000.83.1.441	47	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74273	10.1371/journal.pone.0074273	http://dx.doi.org/10.1371/journal.pone.0074273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098640	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500011
J	Haase, B; Signer-Hasler, H; Binns, MM; Obexer-Ruff, G; Hauswirth, R; Bellone, RR; Burger, D; Rieder, S; Wade, CM; Leeb, T				Haase, Bianca; Signer-Hasler, Heidi; Binns, Matthew M.; Obexer-Ruff, Gabriela; Hauswirth, Regula; Bellone, Rebecca R.; Burger, Dominik; Rieder, Stefan; Wade, Claire M.; Leeb, Tosso			Accumulating Mutations in Series of Haplotypes at the KIT and MITF Loci Are Major Determinants of White Markings in Franches-Montagnes Horses	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; GENOME-WIDE ASSOCIATION; CAT FELIS-CATUS; COAT COLOR; FACIAL MARKINGS; ARABIAN HORSE; MULTIFACTORIAL INHERITANCE; MELANOCYTE DEVELOPMENT; SUSCEPTIBILITY LOCI; MISSENSE MUTATION	Coat color and pattern variations in domestic animals are frequently inherited as simple monogenic traits, but a number are known to have a complex genetic basis. While the analysis of complex trait data remains a challenge in all species, we can use the reduced haplotypic diversity in domestic animal populations to gain insight into the genomic interactions underlying complex phenotypes. White face and leg markings are examples of complex traits in horses where little is known of the underlying genetics. In this study, Franches-Montagnes (FM) horses were scored for the occurrence of white facial and leg markings using a standardized scoring system. A genome-wide association study (GWAS) was performed for several white patterning traits in 1,077 FM horses. Seven quantitative trait loci (QTL) affecting the white marking score with p-values p <= 10(-4) were identified. Three loci, MC1R and the known white spotting genes, KIT and MITF, were identified as the major loci underlying the extent of white patterning in this breed. Together, the seven loci explain 54% of the genetic variance in total white marking score, while MITF and KIT alone account for 26%. Although MITF and KIT are the major loci controlling white patterning, their influence varies according to the basic coat color of the horse and the specific body location of the white patterning. Fine mapping across the MITF and KIT loci was used to characterize haplotypes present. Phylogenetic relationships among haplotypes were calculated to assess their selective and evolutionary influences on the extent of white patterning. This novel approach shows that KIT and MITF act in an additive manner and that accumulating mutations at these loci progressively increase the extent of white markings.	[Haase, Bianca; Wade, Claire M.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Haase, Bianca; Obexer-Ruff, Gabriela; Hauswirth, Regula; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Signer-Hasler, Heidi] Bern Univ Appl Sci, Dept Agr Forestry Food Sci & Management, Zollikofen, Switzerland; [Binns, Matthew M.] Equine Anal, Midway, KY USA; [Bellone, Rebecca R.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Burger, Dominik] ALP Haras, Swiss Inst Equine Med, Avenches, Switzerland; [Burger, Dominik] Univ Bern, Avenches, Switzerland; [Rieder, Stefan] Swiss Natl Stud Farm, Agroscope ALP Haras Res Stn, Avenches, Switzerland; [Leeb, Tosso] Univ Bern, DermFocus, Bern, Switzerland	University of Sydney; University of Bern; University of Tampa; University of Bern; Swiss Federal Research Station Agroscope; University of Bern	Haase, B (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	bianca.haase@sydney.edu.au	Leeb, Tosso/G-3187-2014	Leeb, Tosso/0000-0003-0553-4880; Bellone, Rebecca/0000-0001-8838-7227; Wade, Claire/0000-0003-3413-4771; Waud, Bianca/0000-0001-6493-9808	Swiss National Science Foundation [31003A_133034]; ALP-Haras Research Station	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ALP-Haras Research Station	This study was funded by the Swiss National Science Foundation grant no. 31003A_133034. The population wide SNP data of the Franches-Montagnes horse breed was generated with funds from the ALP-Haras Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam E, 1998, J BIOL CHEM, V273, P19560, DOI 10.1074/jbc.273.31.19560; Alhaidari Z, 1999, VET DERMATOL, V10, P3, DOI 10.1046/j.1365-3164.1999.00132.x; ALLEN WR, 1984, J REPROD FERTIL, V71, P607, DOI 10.1530/jrf.0.0710607; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellone R, 2006, CYTOGENET GENOME RES, V114, p93A, DOI 10.1159/000091935; Bellone RR, 2010, ANIM GENET, V41, P207, DOI 10.1111/j.1365-2052.2010.02119.x; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Brooks SA, 2007, CYTOGENET GENOME RES, V119, P225, DOI 10.1159/000112065; Brooks SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000909; Cooper MP, 2006, ANIM GENET, V37, P163, DOI 10.1111/j.1365-2052.2005.01389.x; Crane JF, 2006, ANNU REV CELL DEV BI, V22, P267, DOI 10.1146/annurev.cellbio.22.010305.103814; Dobney K, 2006, J ZOOL, V269, P261, DOI 10.1111/j.1469-7998.2006.00042.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Giuffra E, 1999, MAMM GENOME, V10, P1132, DOI 10.1007/s003359901178; Grandin T, 1998, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, P319; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Haase B, 2007, PLOS GENET, V3, P2101, DOI 10.1371/journal.pgen.0030195; Hasler H, 2012, PLOS ONE, V7; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Imes DL, 2006, ANIM GENET, V37, P175, DOI 10.1111/j.1365-2052.2005.01409.x; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; Lyons LA, 2005, ANIM GENET, V36, P119, DOI 10.1111/j.1365-2052.2005.01253.x; Marklund L, 1996, MAMM GENOME, V7, P895, DOI 10.1007/s003359900264; Menotti-Raymond M, 2009, J HERED, V100, pS8, DOI 10.1093/jhered/esp018; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Nebe HD, 1984, THESIS J LIEBIG U GE; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Opdecamp K, 1997, DEVELOPMENT, V124, P2377; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Rieder S, 2008, J HERED, V99, P130, DOI 10.1093/jhered/esm115; Santschi EM, 2001, AM J VET RES, V62, P97, DOI 10.2460/ajvr.2001.62.97; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wen B, 2010, PIGM CELL MELANOMA R, V23, P441, DOI 10.1111/j.1755-148X.2010.00699.x; WOOLF CM, 1990, J HERED, V81, P250, DOI 10.1093/oxfordjournals.jhered.a110987; WOOLF CM, 1989, J HERED, V80, P173, DOI 10.1093/oxfordjournals.jhered.a110831; WOOLF CM, 1991, J HERED, V82, P167, DOI 10.1093/oxfordjournals.jhered.a111053; WOOLF CM, 1992, J HERED, V83, P73, DOI 10.1093/oxfordjournals.jhered.a111163; WOOLF CM, 1995, J HERED, V86, P129, DOI 10.1093/oxfordjournals.jhered.a111542; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	54	29	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75071	10.1371/journal.pone.0075071	http://dx.doi.org/10.1371/journal.pone.0075071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098679	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500050
J	Pollock, NR; McGray, S; Colby, DJ; Noubary, F; Nguyen, H; Nguyen, TA; Khormaee, S; Jain, S; Hawkins, K; Kumar, S; Rolland, JP; Beattie, PD; Chau, NV; Quang, VM; Barfield, C; Tietje, K; Steele, M; Weigl, BH				Pollock, Nira R.; McGray, Sarah; Colby, Donn J.; Noubary, Farzad; Huyen Nguyen; The Anh Nguyen; Khormaee, Sariah; Jain, Sidhartha; Hawkins, Kenneth; Kumar, Shailendra; Rolland, Jason P.; Beattie, Patrick D.; Chau, Nguyen V.; Quang, Vo M.; Barfield, Cori; Tietje, Kathy; Steele, Matt; Weigl, Bernhard H.			Field Evaluation of a Prototype Paper-Based Point-of-Care Fingerstick Transaminase Test	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MICROFLUIDIC DEVICES; 2-DIMENSIONAL PAPER; HEPATOTOXICITY; NEVIRAPINE	Monitoring for drug-induced liver injury (DILI) via serial transaminase measurements in patients on potentially hepatotoxic medications (e. g., for HIV and tuberculosis) is routine in resource-rich nations, but often unavailable in resource-limited settings. Towards enabling universal access to affordable point-of-care (POC) screening for DILI, we have performed the first field evaluation of a paper-based, microfluidic fingerstick test for rapid, semi-quantitative, visual measurement of blood alanine aminotransferase (ALT). Our objectives were to assess operational feasibility, inter-operator variability, lot variability, device failure rate, and accuracy, to inform device modification for further field testing. The paper-based ALT test was performed at POC on fingerstick samples from 600 outpatients receiving HIV treatment in Vietnam. Results, read independently by two clinic nurses, were compared with gold-standard automated (Roche Cobas) results from venipuncture samples obtained in parallel. Two device lots were used sequentially. We demonstrated high inter-operator agreement, with 96.3% (95% C.I., 94.3-97.7%) agreement in placing visual results into clinically-defined "bins" (<3x, 3-5x, and >5x upper limit of normal), >90% agreement in validity determination, and intraclass correlation coefficient of 0.89 (95% C. I., 0.87-0.91). Lot variability was observed in % invalids due to hemolysis (21.1% for Lot 1, 1.6% for Lot 2) and correlated with lots of incorporated plasma separation membranes. Invalid rates <1% were observed for all other device controls. Overall bin placement accuracy for the two readers was 84% (84.3%/83.6%). Our findings of extremely high inter-operator agreement for visual reading-obtained in a target clinical environment, as performed by local practitioners-indicate that the device operation and reading process is feasible and reproducible. Bin placement accuracy and lot-to-lot variability data identified specific targets for device optimization and material quality control. This is the first field study performed with a patterned paper-based microfluidic device and opens the door to development of similar assays for other important analytes.	[Pollock, Nira R.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Pollock, Nira R.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [McGray, Sarah; Hawkins, Kenneth; Barfield, Cori; Tietje, Kathy; Steele, Matt; Weigl, Bernhard H.] PATH, Seattle, WA USA; [Colby, Donn J.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Colby, Donn J.; Huyen Nguyen; The Anh Nguyen] Harvard Med Sch AIDS Initiat Vietnam, Ho Chi Minh City, Vietnam; [Noubary, Farzad] Tufts Univ, Inst Clin Res & Hlth Policy Studies, Tufts Med Ctr, Boston, MA 02111 USA; [Noubary, Farzad] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Huyen Nguyen] Ctr Appl Res Men & Hlth, Ho Chi Minh City, Vietnam; [Khormaee, Sariah] Harvard Univ, Sch Med, Harvard MIT Hlth Sci & Technol Program, Boston, MA USA; [Jain, Sidhartha; Kumar, Shailendra; Rolland, Jason P.; Beattie, Patrick D.] Diagnost All, Cambridge, MA USA; [Chau, Nguyen V.; Quang, Vo M.] Hosp Trop Dis, Ho Chi Minh City, Vietnam	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Tufts Medical Center; Tufts University; Tufts University; Harvard University; Harvard Medical School	Pollock, NR (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	nira.pollock@childrens.harvard.edu		Khormaee, Sariah/0000-0002-5296-0965; colby, donn j./0000-0003-3931-5926	National Institutes of Health through the PATH Center to Advance Point of Care Diagnostics for Global Health [NIBIB U54-EB007949]; NIH [5 K23 AI074638-04]; Bill & Melinda Gates Foundation [51308]; NINDS, NIH [5F30NS06468]; Harvard Medical School (Harvard-MIT Health Sciences and Technology Program); Whitaker Scholars Program via the Whitaker Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI074638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007949] Funding Source: NIH RePORTER	National Institutes of Health through the PATH Center to Advance Point of Care Diagnostics for Global Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Harvard Medical School (Harvard-MIT Health Sciences and Technology Program); Whitaker Scholars Program via the Whitaker Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health through the PATH Center to Advance Point of Care Diagnostics for Global Health (NIBIB U54-EB007949). NRP is supported by an NIH K23 grant (5 K23 AI074638-04). JPR, S. Kumar, PDB, and SJ are supported by a Harvard subcontract of a grant from the Bill & Melinda Gates Foundation (51308-Zero-Cost Diagnostics). S.Khormaee was supported by NINDS, NIH; contract grant number: 5F30NS06468, Contract grant sponsor: Harvard Medical School (Harvard-MIT Health Sciences and Technology Program) and the Whitaker Scholars Program via the Whitaker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIDS CLIN TRIALS, 1996, TABL GRAD SEV AD ADV; [Anonymous], 2007, ANT THER GUID HIV IN; Cheng CM, 2010, ANGEW CHEM INT EDIT, V49, P4771, DOI 10.1002/anie.201001005; Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h; Davern TJ, 2012, CLIN LIVER DIS, V16, P231, DOI 10.1016/j.cld.2012.03.002; Delaney JL, 2011, ANAL CHEM, V83, P1300, DOI 10.1021/ac102392t; Department of agriculture forestry and fisheries, 2012, GUID US ANT AG HIV 1, P1; Dungchai W, 2010, ANAL CHIM ACTA, V674, P227, DOI 10.1016/j.aca.2010.06.019; Fenton EM, 2009, ACS APPL MATER INTER, V1, P124, DOI 10.1021/am800043z; Fu E, 2010, SENSOR ACTUAT B-CHEM, V149, P325, DOI 10.1016/j.snb.2010.06.024; Fu E, 2010, LAB CHIP, V10, P918, DOI 10.1039/b919614e; Grant LM, 2012, CURR OPIN GASTROEN, V28, P198, DOI 10.1097/MOG.0b013e3283528b5d; Harrington T., 2010, Morbidity and Mortality Weekly Report, V59, P224; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Khan MS, 2010, ANAL CHEM, V82, P4158, DOI 10.1021/ac100341n; LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706; Li X, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687398; Li X, 2010, COLLOID SURFACE B, V76, P564, DOI 10.1016/j.colsurfb.2009.12.023; Lutz BR, 2011, LAB CHIP, V11, P4274, DOI 10.1039/c1lc20758j; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; Mckoy JM, 2009, DRUG SAFETY, V32, P147, DOI 10.2165/00002018-200932020-00007; Meintjes G, 2012, S AFR J HIV MED, DOI 10.7196/SAJHIVMED.862; Nie ZH, 2010, LAB CHIP, V10, P3163, DOI [10.1039/c0lc00237b, 10.1039/c01c00237b]; Osborn JL, 2010, LAB CHIP, V10, P2659, DOI 10.1039/c004821f; Pollock NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003981; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shieh FK, 2006, AM J RESP CRIT CARE, V174, P717, DOI 10.1164/rccm.200510-1667OC; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Vella SJ, 2012, ANAL CHEM, V84, P2883, DOI 10.1021/ac203434x; Vietnam Ministry of Health, 2009, GUID DIAGN TREATM HI; WHO, 2010, ANT THER HIV INF AD; WHO, 2009, TREATM TUB GUID	37	36	37	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75616	10.1371/journal.pone.0075616	http://dx.doi.org/10.1371/journal.pone.0075616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098705	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500076
J	Shen, F; Tsuruda, PR; Smith, JAM; Obedencio, GP; Martin, WJ				Shen, Fei; Tsuruda, Pamela R.; Smith, Jacqueline A. M.; Obedencio, Glenmar P.; Martin, William J.			Relative Contributions of Norepinephrine and Serotonin Transporters to Antinociceptive Synergy between Monoamine Reuptake Inhibitors and Morphine in the Rat Formalin Model	PLOS ONE			English	Article							DESCENDING MODULATION; INDUCED NOCICEPTION; POSTOPERATIVE PAIN; 5-HT3 RECEPTORS; DULOXETINE; CLONIDINE; FACILITATION; TRAMADOL; COMBINATIONS; POTENTIATION	Multimodal analgesia is designed to optimize pain relief by coadministering drugs with distinct mechanisms of action or by combining multiple pharmacologies within a single molecule. In clinical settings, combinations of monoamine reuptake inhibitors and opioid receptor agonists have been explored and one currently available analgesic, tapentadol, functions as both a m-opioid receptor agonist and a norepinephrine transporter inhibitor. However, it is unclear whether the combination of selective norepinephrine reuptake inhibition and m-receptor agonism achieves an optimal antinociceptive synergy. In this study, we assessed the pharmacodynamic interactions between morphine and monoamine reuptake inhibitors that possess different affinities and selectivities for norepinephrine and serotonin transporters. Using the rat formalin model, in conjunction with measurements of ex vivo transporter occupancy, we show that neither the norepinephrine-selective inhibitor, esreboxetine, nor the serotonin-selective reuptake inhibitor, fluoxetine, produce antinociceptive synergy with morphine. Atomoxetine, a monoamine reuptake inhibitor that achieves higher levels of norepinephrine than serotonin transporter occupancy, exhibited robust antinociceptive synergy with morphine. Similarly, a fixed-dose combination of esreboxetine and fluoxetine which achieves comparable levels of transporter occupancy potentiated the antinociceptive response to morphine. By contrast, duloxetine, a monoamine reuptake inhibitor that achieves higher serotonin than norepinephrine transporter occupancy, failed to potentiate the antinociceptive response to morphine. However, when duloxetine was coadministered with the 5-HT3 receptor antagonist, ondansetron, potentiation of the antinociceptive response to morphine was revealed. These results support the notion that inhibition of both serotonin and norepinephrine transporters is required for monoamine reuptake inhibitor and opioid-mediated antinociceptive synergy; yet, excess serotonin, acting via 5-HT3 receptors, may reduce the potential for synergistic interactions. Thus, in the rat formalin model, the balance between norepinephrine and serotonin transporter inhibition influences the degree of antinociceptive synergy observed between monoamine reuptake inhibitors and morphine.	[Shen, Fei; Martin, William J.] Theravance Inc, Dept Pharmacol, San Francisco, CA USA; [Tsuruda, Pamela R.; Smith, Jacqueline A. M.; Obedencio, Glenmar P.] Theravance Inc, Dept Mol Biol, San Francisco, CA USA; [Tsuruda, Pamela R.; Smith, Jacqueline A. M.; Obedencio, Glenmar P.] Theravance Inc, Dept Cell Biol, San Francisco, CA USA; Theravance Inc, Dept Drug Metab, San Francisco, CA USA; Theravance Inc, Dept Pharmacokinet, San Francisco, CA USA	Theravance; Theravance; Theravance; Theravance; Theravance	Shen, F (corresponding author), Theravance Inc, Dept Pharmacol, San Francisco, CA USA.	fshen@theravance.com	Martin, William J/L-9033-2017	Martin, William J/0000-0002-2749-3365				ABBOTT FV, 1995, PAIN, V60, P91, DOI 10.1016/0304-3959(94)00095-V; Bajic D, 2010, BRAIN RES, V1306, P29, DOI 10.1016/j.brainres.2009.10.010; Bohn LM, 2000, J NEUROSCI, V20, P9040; Bourdet DL, 2012, J PHARMACOL EXP THER, V341, P137, DOI 10.1124/jpet.111.188417; BURNETT A, 1991, BRAIN RES, V546, P271, DOI 10.1016/0006-8993(91)91491-I; Chen S, 2010, CURR MED RES OPIN, V26, P2507, DOI 10.1185/03007995.2010.518438; Dogrul A, 2009, BRAIN RES, V1280, P52, DOI 10.1016/j.brainres.2009.05.001; DRASNER K, 1988, PAIN, V32, P309, DOI 10.1016/0304-3959(88)90042-5; Fields H., 1994, CENTRAL NERVOUS SYST, V3rd edi; Gao KM, 1998, J NEUROSCI, V18, P1860; GESSNER PK, 1970, J PHARMACOL EXP THER, V174, P247; Green GM, 2000, PAIN, V89, P81, DOI 10.1016/S0304-3959(00)00346-8; Hartrick CT, 2009, EXPERT OPIN PHARMACO, V10, P2687, DOI 10.1517/14656560903313734; Ho KY, 2010, BRIT J ANAESTH, V105, P371, DOI 10.1093/bja/aeq158; HYLDEN JLK, 1983, J PHARMACOL EXP THER, V226, P398; Jones CK, 2007, EUR J PAIN, V11, P208, DOI 10.1016/j.ejpain.2006.02.008; Jones CK, 2006, NEUROPHARMACOLOGY, V51, P1172, DOI 10.1016/j.neuropharm.2006.08.005; Le Bars D, 2001, PHARMACOL REV, V53, P597; LEVINE JD, 1986, PAIN, V27, P45, DOI 10.1016/0304-3959(86)90220-4; LIU MY, 1988, PAIN, V33, P123, DOI 10.1016/0304-3959(88)90211-4; Michelet D, 2012, ANESTH ANALG, V114, P393, DOI 10.1213/ANE.0b013e31823d0b45; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Montes A, 2000, BRIT J ANAESTH, V85, P217, DOI 10.1093/bja/85.2.217; Munro G, 2010, NEUROPHARMACOLOGY, V59, P208, DOI 10.1016/j.neuropharm.2010.05.010; Munro G, 2009, EUR J PHARMACOL, V605, P95, DOI 10.1016/j.ejphar.2009.01.004; Neil Nancy, 2013, J Med Econ, V16, P307, DOI 10.3111/13696998.2012.756401; Obata H, 2010, J PHARMACOL EXP THER, V334, P1059, DOI 10.1124/jpet.110.168336; Omote K, 1998, BRAIN RES, V814, P194, DOI 10.1016/S0006-8993(98)01086-5; OSSIPOV MH, 1990, J PHARMACOL EXP THER, V255, P1107; Paul D, 2001, J PHARMACOL EXP THER, V298, P674; Paul D, 1997, ANALGESIA, V3, P43; Persec J, 2007, COLLEGIUM ANTROPOL, V31, P1065; Pertovaara A, 2006, PROG NEUROBIOL, V80, P53, DOI 10.1016/j.pneurobio.2006.08.001; Pettersen VLA, 2009, ANESTH ANALG, V109, P1312, DOI 10.1213/ane.0b013e3181b16ff5; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Puig MM, 2000, ANESTHESIOLOGY, V93, P219, DOI 10.1097/00000542-200007000-00033; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; Ren K, 2002, PAIN, V100, P1, DOI 10.1016/S0304-3959(02)00368-8; Robinson DA, 2004, CURR NEUROVASC RES, V1, P11, DOI 10.2174/1567202043480189; Schiene K, 2011, J PHARMACOL EXP THER, V339, P537, DOI 10.1124/jpet.111.181263; Schroder W, 2011, J PHARMACOL EXP THER, V337, P312, DOI 10.1124/jpet.110.175042; Snijdelaar DG, 2005, PAIN, V119, P159, DOI 10.1016/j.pain.2005.09.027; Suzuki R, 2005, NEUROSIGNALS, V14, P175, DOI 10.1159/000087656; Suzuki R, 2004, TRENDS PHARMACOL SCI, V25, P613, DOI 10.1016/j.tips.2004.10.002; Svensson CI, 2006, FEBS LETT, V580, P6629, DOI 10.1016/j.febslet.2006.11.012; Takano A, 2006, PSYCHOPHARMACOLOGY, V185, P395, DOI 10.1007/s00213-005-0304-0; Tallarida RJ, 1997, LIFE SCI, V61, pPL417, DOI 10.1016/S0024-3205(97)01030-8; TALLARIDA RJ, 1992, PAIN, V49, P93, DOI 10.1016/0304-3959(92)90193-F; Tallarida RJ., 2000, DRUG SYNERGISM DOSE; Trivedi MH, 2008, INT CLIN PSYCHOPHARM, V23, P161, DOI 10.1097/YIC.0b013e3282f41d7e; Tsuruda PR, 2010, J PHARMACOL TOXICOL, V61, P192, DOI 10.1016/j.vascn.2009.12.003; Tzschentke TM, 2007, J PHARMACOL EXP THER, V323, P265, DOI 10.1124/jpet.107.126052; van Rijn CM, 2004, EPILEPSY RES, V59, P181, DOI 10.1016/j.eplepsyres.2004.04.003; van Rijn CM, 1999, EUR J PHARMACOL, V371, P213, DOI 10.1016/S0014-2999(99)00178-8; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; WILCOX GL, 1987, BRAIN RES, V405, P84, DOI 10.1016/0006-8993(87)90992-9; Wu CT, 2004, ANESTH ANALG, V99, P502, DOI 10.1213/01.ANE.0000117146.46373.51; Yaksh TL, 2001, J APPL PHYSIOL, V90, P2386, DOI 10.1152/jappl.2001.90.6.2386; YEOMANS DC, 1992, PAIN, V48, P449, DOI 10.1016/0304-3959(92)90098-V; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002	61	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74891	10.1371/journal.pone.0074891	http://dx.doi.org/10.1371/journal.pone.0074891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098676	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500047
J	Sundberg, M; Pfister, B; Fulton, D; Bischof, S; Delatte, T; Eicke, S; Stettler, M; Smith, SM; Streb, S; Zeeman, SC				Sundberg, Maria; Pfister, Barbara; Fulton, Daniel; Bischof, Sylvain; Delatte, Thierry; Eicke, Simona; Stettler, Michaela; Smith, Steven M.; Streb, Sebastian; Zeeman, Samuel C.			The Heteromultimeric Debranching Enzyme Involved in Starch Synthesis in Arabidopsis Requires Both Isoamylase1 and Isoamylase2 Subunits for Complex Stability and Activity	PLOS ONE			English	Article							DEVELOPING MAIZE ENDOSPERM; BIOSYNTHETIC-ENZYMES; GRANULE INITIATION; RICE ENDOSPERM; HOMO-OLIGOMER; METABOLISM; MUTANTS; PURIFICATION; AMYLOPECTIN; GLYCOGEN	Isoamylase-type debranching enzymes (ISAs) play an important role in determining starch structure. Amylopectin - a branched polymer of glucose - is the major component of starch granules and its architecture underlies the semi-crystalline nature of starch. Mutants of several species lacking the ISA1-subclass of isoamylase are impaired in amylopectin synthesis. Consequently, starch levels are decreased and an aberrant soluble glucan (phytoglycogen) with altered branch lengths and branching pattern accumulates. Here we use TAP (tandem affinity purification) tagging to provide direct evidence in Arabidopsis that ISA1 interacts with its homolog ISA2. No evidence for interaction with other starch biosynthetic enzymes was found. Analysis of the single mutants shows that each protein is destabilised in the absence of the other. Co-expression of both ISA1 and ISA2 Escherichia coli allowed the formation of the active recombinant enzyme and we show using site-directed mutagenesis that ISA1 is the catalytic subunit. The presence of the active isoamylase alters glycogen biosynthesis in E. coli, resulting in colonies that stain more starch-like with iodine. However, analysis of the glucans reveals that rather than producing an amylopectin like substance, cells expressing the active isoamylase still accumulate small amounts of glycogen together with a population of linear oligosaccharides that stain strongly with iodine. We conclude that for isoamylase to promote amylopectin synthesis it needs to act on a specific precursor (pre-amylopectin) generated by the combined actions of plant starch synthase and branching enzyme isoforms and when presented with an unsuitable substrate (i.e. E. coli glycogen) it simply degrades it.	[Sundberg, Maria; Pfister, Barbara; Bischof, Sylvain; Delatte, Thierry; Eicke, Simona; Stettler, Michaela; Streb, Sebastian; Zeeman, Samuel C.] ETH, Dept Biol, Zurich, Switzerland; [Fulton, Daniel] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Smith, Steven M.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Edinburgh; University of Western Australia	Zeeman, SC (corresponding author), ETH, Dept Biol, Zurich, Switzerland.	szeeman@ethz.ch	Smith, Steven/HDM-9496-2022; Smith, Steven M/G-7183-2015	Smith, Steven M/0000-0001-5661-9994; Zeeman, Samuel/0000-0002-2791-0915; Streb, Sebastian/0000-0002-9095-6596	Swiss National Science Foundation [3100AO-116434/1, 31003A- 518 131074]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	The work was funded by the Swiss National Science Foundation (Grant Nos. 3100AO-116434/1 and 31003A- 518 131074) and ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAMOTTE M, 1968, BIOCHEM BIOPH RES CO, V32, P916, DOI 10.1016/0006-291X(68)90114-9; Dauvillee D, 2005, J BACTERIOL, V187, P1465, DOI 10.1128/JB.187.4.1465-1473.2005; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Fujita N, 1999, PLANTA, V208, P283, DOI 10.1007/s004250050560; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; MACGREGOR EA, 1993, STARCH-STARKE, V45, P232, DOI 10.1002/star.19930450705; Mouille G, 1996, PLANT CELL, V8, P1353; Nakamura Y, 1997, PLANT J, V12, P143, DOI 10.1046/j.1365-313X.1997.12010143.x; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Takashima Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2308, DOI 10.1271/bbb.70215; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Utsumi Y, 2006, PLANTA, V225, P75, DOI 10.1007/s00425-006-0331-z; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wu CY, 2002, ARCH BIOCHEM BIOPHYS, V406, P21, DOI 10.1016/S0003-9861(02)00412-5; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	36	21	21	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75223	10.1371/journal.pone.0075223	http://dx.doi.org/10.1371/journal.pone.0075223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098685	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500056
J	Watanabe, KP; Kawai, YK; Ikenaka, Y; Kawata, M; Ikushiro, SI; Sakaki, T; Ishizuka, M				Watanabe, Kensuke P.; Kawai, Yusuke K.; Ikenaka, Yoshinori; Kawata, Minami; Ikushiro, Shin-Ichi; Sakaki, Toshiyuki; Ishizuka, Mayumi			Avian Cytochrome P450 (CYP) 1-3 Family Genes: Isoforms, Evolutionary Relationships, and mRNA Expression in Chicken Liver	PLOS ONE			English	Article							ENZYMES; RAT; SUBFAMILY; SEQUENCE; RECEPTOR; CDNA; CXR	Cytochrome P450 (CYP) of chicken and other avian species have been studied primarily with microsomes or characterized by cloning and protein expression. However, the overall existing isoforms in avian CYP1-3 families or dominant isoforms in avian xenobiotic metabolism have not yet been elucidated. In this study, we aimed to clarify and classify all of the existing isoforms of CYP1-3 in avian species using available genome assemblies for chicken, zebra finch, and turkey. Furthermore, we performed qRT-PCR assay to identify dominant CYP genes in chicken liver. Our results suggested that avian xenobiotic-metabolizing CYP genes have undergone unique evolution such as CYP2C and CYP3A genes, which have undergone avian-specific gene duplications. qRT-PCR experiments showed that CYP2C45 was the most highly expressed isoform in chicken liver, while CYP2C23b was the most highly induced gene by phenobarbital. Considering together with the result of further enzymatic characterization, CYP2C45 may have a dominant role in chicken xenobiotic metabolism due to the constitutive high expression levels, while CYP2C23a and CYP2C23b can be greatly induced by chicken xenobiotic receptor (CXR) activators. These findings will provide not only novel insights into avian xenobiotic metabolism, but also a basis for the further characterization of each CYP gene.	[Watanabe, Kensuke P.; Kawai, Yusuke K.; Ikenaka, Yoshinori; Kawata, Minami; Ishizuka, Mayumi] Hokkaido Univ, Toxicol Lab, Sch Vet Med, Sapporo, Hokkaido, Japan; [Ikushiro, Shin-Ichi; Sakaki, Toshiyuki] Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizushi, Toyama Prefectu, Japan	Hokkaido University; Toyama Prefectural University	Ishizuka, M (corresponding author), Hokkaido Univ, Toxicol Lab, Sch Vet Med, Sapporo, Hokkaido, Japan.	ishizum@vetmed.hokudai.ac.jp	IKENAKA, Yoshinori/F-8529-2012	Kawai, Yusuke/0000-0002-4942-4432; Ikenaka, Yoshinori/0000-0002-6633-6637	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [24248056, 24405004]; JSPS [231864]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) awarded to Prof. M. Ishizuka (Nos. 24248056 and 24405004) and JSPS Fellowship for KPW (231864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baader M, 2002, J BIOL CHEM, V277, P15647, DOI 10.1074/jbc.M109882200; Blevins S, 2012, POULTRY SCI, V91, P322, DOI 10.3382/ps.2011-01764; Cai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038395; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goldstone HMH, 2006, J MOL EVOL, V62, P708, DOI 10.1007/s00239-005-0134-z; Goriya Harshad V, 2005, J Vet Sci, V6, P279; Gupta RP, 1998, COMP BIOCHEM PHYS C, V121, P73, DOI 10.1016/S0742-8413(98)10031-2; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769; HANSEN AJ, 1989, DNA-J MOLEC CELL BIO, V8, P179, DOI 10.1089/dna.1.1989.8.179; Ikushiro S, 2004, BBA-GEN SUBJECTS, V1672, P86, DOI 10.1016/j.bbagen.2004.02.012; Jonsson ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028257; Kirischian N, 2011, J MOL EVOL, V72, P56, DOI 10.1007/s00239-010-9402-7; Kubota A, 2011, COMP BIOCHEM PHYS C, V153, P280, DOI 10.1016/j.cbpc.2010.11.006; McArthur AG, 2003, J MOL EVOL, V57, P200, DOI 10.1007/s00239-003-2466-x; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; OEDA K, 1985, DNA-J MOLEC CELL BIO, V4, P203, DOI 10.1089/dna.1985.4.203; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ourlin JC, 2000, ARCH BIOCHEM BIOPHYS, V373, P375, DOI 10.1006/abbi.1999.1566; Rawal S, 2009, CYTOGENET GENOME RES, V125, P67, DOI 10.1159/000218748; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temesvari M, 2012, J PHARMACOL EXP THER, V341, P294, DOI 10.1124/jpet.111.189597; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Walker CH, 1998, COMP BIOCHEM PHYS C, V121, P65, DOI 10.1016/S0742-8413(98)10030-0; Watanabe KP, 2010, COMP BIOCHEM PHYS C, V152, P114, DOI 10.1016/j.cbpc.2010.03.006	29	41	42	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75689	10.1371/journal.pone.0075689	http://dx.doi.org/10.1371/journal.pone.0075689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098714	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500085
J	Kelly, JF; Bridge, ES; Frick, WF; Chilson, PB				Kelly, Jeffrey F.; Bridge, Eli S.; Frick, Winifred F.; Chilson, Phillip B.			Ecological Energetics of an Abundant Aerial Insectivore, the Purple Martin	PLOS ONE			English	Article							PROGNE-SUBIS; SURVIVAL; DECLINES; BATS	The atmospheric boundary layer and lower free atmosphere, or aerosphere, is increasingly important for human transportation, communication, environmental monitoring, and energy production. The impacts of anthropogenic encroachment into aerial habitats are not well understood. Insectivorous birds and bats are inherently valuable components of biodiversity and play an integral role in aerial trophic dynamics. Many of these insectivores are experiencing range-wide population declines. As a first step toward gaging the potential impacts of these declines on the aerosphere's trophic system, estimates of the biomass and energy consumed by aerial insectivores are needed. We developed a suite of energetics models for one of the largest and most common avian aerial insectivores in North America, the Purple Martin (Progne subis). The base model estimated that Purple Martins consumed 412 (+/- 104) billion insects*y(-1) with a biomass of 115,860 (+/- 29,192) metric tonnes*y(-1). During the breeding season Purple Martins consume 10.3 (+/- 3.0) kg of prey biomass per km(3) of aerial habitat, equal to about 36,000 individual insects*km(-3). Based on these calculations, the cumulative seasonal consumption of insects*km(-3) is greater in North America during the breeding season than during other phases of the annual cycle, however the maximum daily insect consumption*km(-3) occurs during fall migration. This analysis provides the first range-wide quantitative estimate of the magnitude of the trophic impact of this large and common aerial insectivore. Future studies could use a similar modeling approach to estimate impacts of the entire guild of aerial insectivores at a variety of temporal and spatial scales. These analyses would inform our understanding of the impact of population declines among aerial insectivores on the aerosphere's trophic dynamics.	[Kelly, Jeffrey F.; Bridge, Eli S.] Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA; [Kelly, Jeffrey F.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Kelly, Jeffrey F.; Bridge, Eli S.; Chilson, Phillip B.] Univ Oklahoma, Ecol & Evolutionary Biol Program, Norman, OK 73019 USA; [Frick, Winifred F.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Chilson, Phillip B.] Univ Oklahoma, Sch Meteorol, Norman, OK 73019 USA; [Chilson, Phillip B.] Univ Oklahoma, Adv Radar Res Ctr, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California Santa Cruz; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Kelly, JF (corresponding author), Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA.	jkelly@ou.edu	Bridge, Eli/AAN-1928-2020; Chilson, Phillip B./C-8491-2012; Kelly, Jeffrey F/B-2029-2015; Frick, Winifred/ABA-3519-2020	Kelly, Jeffrey F/0000-0002-8255-7990; Frick, Winifred/0000-0002-9469-1839; Bridge, Eli/0000-0003-3453-2008	National Science Foundation [EPS-0919466]; Direct For Biological Sciences [1340921] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Jeff Kelly was supported by National Science Foundation Grant EPS-0919466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RW, 1952, AM MIDL NAT, V47, P606, DOI 10.2307/2422034; [Anonymous], 2017, BIRDS N AM, DOI 10.2173/bna.cliswa.03%3e; Beal FEL, 1918, USDA B, V619, P3; BOHNINGGAESE K, 1993, CONSERV BIOL, V7, P76, DOI 10.1046/j.1523-1739.1993.07010076.x; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brooks SJ, 1996, ECOSCIENCE, V3, P247, DOI 10.1080/11956860.1996.11682338; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Dunn EH, 2002, CONSERV BIOL, V16, P1632, DOI 10.1046/j.1523-1739.2002.01250.x; Farber SC, 2002, ECOL ECON, V41, P375, DOI 10.1016/S0921-8009(02)00088-5; JOHNSTON RF, 1967, IBIS, V109, P8, DOI 10.1111/j.1474-919X.1967.tb00002.x; Johnston Richard F., 2001, P49; KALE HW, 1968, AUK, V85, P654, DOI 10.2307/4083372; Kunz TH, 2008, INTEGR COMP BIOL, V48, P1, DOI [10.1093/icb/icn030, 10.1093/icb/icn037]; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; MathWorks, 2012, MATL R2012A 7 14 0 7; Nebel S, 2010, AVIAN CONSERV ECOL, V5; Odum HT, 2000, ECOSYSTEMS, V3, P21, DOI 10.1007/s100210000005; Rees M, 2009, ECOL MONOGR, V79, P575, DOI 10.1890/08-1474.1; RICH TD, 2004, PARTNERS FLIGHT N AM; Robillard A, 2013, LANDSCAPE ECOL, V28, P201, DOI 10.1007/s10980-012-9828-y; ROHWER S, 1979, Z TIERPSYCHOL, V51, P282; SAGE RD, 1982, AM MIDL NAT, V108, P407, DOI 10.2307/2425505; Saha N, 2012, BIOL CONTROL, V63, P1, DOI 10.1016/j.biocontrol.2012.05.004; Sauer JR, 2012, N AM BREEDING BIRD S; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Stutchbury BJM, 2009, AUK, V126, P278, DOI 10.1525/auk.2009.08038; Tarof SA, 2011, AUK, V128, P716, DOI 10.1525/auk.2011.11087; UTTER JM, 1973, ECOLOGY, V54, P597, DOI 10.2307/1935345; Wagner RH, 1996, ANIM BEHAV, V52, P123, DOI 10.1006/anbe.1996.0158	30	19	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76616	10.1371/journal.pone.0076616	http://dx.doi.org/10.1371/journal.pone.0076616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086755	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700129
J	Ferguson, L; How, JJ; Agoulnik, AI				Ferguson, Lydia; How, Javier J.; Agoulnik, Alexander I.			The Fate of Spermatogonial Stem Cells in the Cryptorchid Testes of RXFP2 Deficient Mice	PLOS ONE			English	Article							SELF-RENEWAL; MOUSE TESTIS; ADULT MICE; RECEPTOR; SPERMATOGENESIS; DIFFERENTIATION; GERMLINE; NANOS2; GDNF	The environmental niche of the spermatogonial stem cell pool is critical to ensure the continued generation of the germ cell population. To study the consequences of an aberrant testicular environment in cryptorchidism we used a mouse model with a deletion of Rxfp2 gene resulting in a high intra-abdominal testicular position. Mutant males were infertile with the gross morphology of the cryptorchid testis progressively deteriorating with age. Few spermatogonia were identifiable in 12 month old cryptorchid testes. Gene expression analysis showed no difference between mutant and control testes at postnatal day 10. In three month old males a decrease in expression of spermatogonial stem cell (SSC) markers Id4, Nanos2, and Ret was shown. The direct counting of ID4+ cells supported a significant decrease of SSCs. In contrast, the expression of Plzf, a marker for undifferentiated and differentiating spermatogonia was not reduced, and the number of PLZF+ cells in the cryptorchid testis was higher in three month old testes, but equal to control in six month old mutants. The PLZF+ cells did not show a higher rate of apoptosis in cryptorchid testis. The expression of the Sertoli cell FGF2 gene required for SSC maintenance was significantly reduced in mutant testis. Based on these findings we propose that the deregulation of somatic and germ cell genes in the cryptorchid testis, directs the SSCs towards the differentiation pathway. This leads to a depletion of the SSC pool and an increase in the number of PLZF+ spermatogonial cells, which too, eventually decreases with the exhaustion of the stem cell pool. Such a dynamic suggests that an early correction of cryptorchidism is critical for the retention of the SSC pool.	[Ferguson, Lydia; How, Javier J.; Agoulnik, Alexander I.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA; [Agoulnik, Alexander I.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	State University System of Florida; Florida International University; Baylor College of Medicine	Agoulnik, AI (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA.	aagoulni@fiu.edu	Agoulnik, Alexander/AAK-3213-2020	Agoulnik, Alexander/0000-0001-6587-6845; How, Javier/0000-0002-9952-9304				Agoulnik AI, 2012, METHODS MOL BIOL, V825, P127, DOI 10.1007/978-1-61779-436-0_11; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; De Rooij DG, 2012, J ANDROL, V33, P1085, DOI 10.2164/jandrol.112.016832; Ferguson Lydia, 2013, Front Endocrinol (Lausanne), V4, P32, DOI 10.3389/fendo.2013.00032; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Huang ZH, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103382; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Jijiwa M, 2008, GENES CELLS, V13, P365, DOI 10.1111/j.1365-2443.2008.01171.x; Kaftanovskaya EM, 2012, MOL ENDOCRINOL, V26, P598, DOI 10.1210/me.2011-1283; Kaftanovskaya EM, 2011, MOL ENDOCRINOL, V25, P170, DOI 10.1210/me.2010-0330; Kamisawa H, 2012, J UROLOGY, V187, P1047, DOI 10.1016/j.juro.2011.10.170; Kokkinaki M, 2009, BIOL REPROD, V80, P707, DOI 10.1095/biolreprod.108.073809; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Li Y, 2009, J ANDROL, V30, P325, DOI 10.2164/jandrol.108.005934; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; NISHIMUNE Y, 1978, FERTIL STERIL, V29, P95; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Oatley MJ, 2011, BIOL REPROD, V85, P347, DOI 10.1095/biolreprod.111.091330; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Orwig KE, 2008, STEM CELLS, V26, P927, DOI 10.1634/stemcells.2007-0893; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Sada A, 2012, STEM CELLS, V30, P280, DOI 10.1002/stem.790; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655; Taran I, 2006, WORLD J UROL, V24, P231, DOI 10.1007/s00345-006-0056-4; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Yin YZ, 1997, J ANDROL, V18, P159	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77351	10.1371/journal.pone.0077351	http://dx.doi.org/10.1371/journal.pone.0077351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098584	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600086
J	Mascher, M; Wu, SY; St Amand, P; Stein, N; Poland, J				Mascher, Martin; Wu, Shuangye; St Amand, Paul; Stein, Nils; Poland, Jesse			Application of Genotyping-by-Sequencing on Semiconductor Sequencing Platforms: A Comparison of Genetic and Reference-Based Marker Ordering in Barley	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENOMIC SELECTION; ASSOCIATION; MAIZE; DISCOVERY; GENERATION; TRAITS; DESIGN; RICE; MAP	The rapid development of next-generation sequencing platforms has enabled the use of sequencing for routine genotyping across a range of genetics studies and breeding applications. Genotyping-by-sequencing (GBS), a low-cost, reduced representation sequencing method, is becoming a common approach for whole-genome marker profiling in many species. With quickly developing sequencing technologies, adapting current GBS methodologies to new platforms will leverage these advancements for future studies. To test new semiconductor sequencing platforms for GBS, we genotyped a barley recombinant inbred line (RIL) population. Based on a previous GBS approach, we designed bar code and adapter sets for the Ion Torrent platforms. Four sets of 24-plex libraries were constructed consisting of 94 RILs and the two parents and sequenced on two Ion platforms. In parallel, a 96-plex library of the same RILs was sequenced on the Illumina HiSeq 2000. We applied two different computational pipelines to analyze sequencing data; the reference-independent TASSEL pipeline and a reference-based pipeline using SAMtools. Sequence contigs positioned on the integrated physical and genetic map were used for read mapping and variant calling. We found high agreement in genotype calls between the different platforms and high concordance between genetic and reference-based marker order. There was, however, paucity in the number of SNP that were jointly discovered by the different pipelines indicating a strong effect of alignment and filtering parameters on SNP discovery. We show the utility of the current barley genome assembly as a framework for developing very low-cost genetic maps, facilitating high resolution genetic mapping and negating the need for developing de novo genetic maps for future studies in barley. Through demonstration of GBS on semiconductor sequencing platforms, we conclude that the GBS approach is amenable to a range of platforms and can easily be modified as new sequencing technologies, analysis tools and genomic resources develop.	[Mascher, Martin; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany; [Wu, Shuangye; Poland, Jesse] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [St Amand, Paul; Poland, Jesse] ARS, USDA, Hard Winter Wheat Genet Res Unit, Manhattan, KS USA	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Kansas State University; United States Department of Agriculture (USDA)	Poland, J (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	jpoland@ksu.edu	Stein, Nils/F-7507-2017	Stein, Nils/0000-0003-3011-8731; Mascher, Martin/0000-0001-6373-6013; Poland, Jesse/0000-0002-7856-1399	United States Department of Agriculture - Agricultural Research Service [5430-21000-006-00D]; Kansas State University; German Ministry of Education and Research (BMBF) [TRITEX-0315954A]; EU	United States Department of Agriculture - Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Kansas State University; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	This research was supported in part by the United States Department of Agriculture - Agricultural Research Service (Appropriation No. 5430-21000-006-00D) and Kansas State University as well as funds from the German Ministry of Education and Research (BMBF fund TRITEX-0315954A) and EU FP7 project TriticeaeGenome to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067500; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; Monson-Miller J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-72; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245	39	128	130	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76925	10.1371/journal.pone.0076925	http://dx.doi.org/10.1371/journal.pone.0076925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098570	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600081
J	Tkaczyk, C; Hamilton, MM; Datta, V; Yang, XP; Hilliard, JJ; Stephens, GL; Sadowska, A; Hua, L; O'Day, T; Suzich, J; Stover, CK; Sellman, BR				Tkaczyk, Christine; Hamilton, Melissa M.; Datta, Vivekananda; Yang, Xiang Ping; Hilliard, Jamese J.; Stephens, Geoffrey L.; Sadowska, Agnieszka; Hua, Lei; O'Day, Terrence; Suzich, Joann; Stover, Charles Kendall; Sellman, Bret R.			Staphylococcus aureus Alpha Toxin Suppresses Effective Innate and Adaptive Immune Responses in a Murine Dermonecrosis Model	PLOS ONE			English	Article							SOFT-TISSUE INFECTION; HYPER-IGE SYNDROME; NEUTROPHIL RECRUITMENT; SKIN INFECTION; HEMOLYSIN; ACTIVATION; BACTERIAL; CELLS; INFLAMMASOME; RECEPTOR	An optimal host response against Staphylococcus aureus skin and soft tissue infections (SSTI) is dependent on IL-1 beta and IL-17 mediated abscess formation. Alpha toxin (AT), an essential virulence factor for SSTI, has been reported to damage tissue integrity; however its effect on the immune response has not been investigated. Here, we demonstrate that infection with USA300 AT isogenic mutant (Delta hla), or passive immunization with an AT neutralizing mAb, 2A3, 24 h prior to infection with wild type USA300 (WT), resulted in dermonecrotic lesion size reduction, and robust neutrophil infiltration. Infiltration correlates with increase in proinflammatory cytokines and chemokines, as well as enhanced bacterial clearance relative to immunization with a negative control mAb. In addition, infection with Delta hla, or with WT +2A3, resulted in an early influx of innate IL-17(+)gamma delta T cells and a more rapid induction of an adaptive immune response as measured by Th1 and Th17 cell recruitment at the site of infection. These results are the first direct evidence of a role for AT in subverting the innate and adaptive immune responses during a S. aureus SSTI. Further, these effects of AT can be overcome with a high affinity anti-AT mAb resulting in a reduction in disease severity.	[Tkaczyk, Christine; Hamilton, Melissa M.; Hilliard, Jamese J.; Sadowska, Agnieszka; Hua, Lei; Suzich, Joann; Stover, Charles Kendall; Sellman, Bret R.] MedImmune LLC, Dept Infect Dis, Gaithersburg, MD USA; [Datta, Vivekananda] MedImmune LLC, Dept Pathol, Gaithersburg, MD USA; [Yang, Xiang Ping; Stephens, Geoffrey L.] MedImmune LLC, Dept Resp Inflammatory & Autoimmune Dis, Gaithersburg, MD USA; [O'Day, Terrence] MedImmune LLC, Dept Biostat, Gaithersburg, MD USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Sellman, BR (corresponding author), MedImmune LLC, Dept Infect Dis, Gaithersburg, MD USA.	sellmanb@medimmune.com		Stover, Charles/0000-0002-7406-1696	AstraZeneca Pharmaceuticals	AstraZeneca Pharmaceuticals(AstraZeneca)	All authors are employees of MedImmune, LLC, (a wholly owned subsidiary of AstraZeneca Pharmaceuticals) whose company funded this study. The monoclonal antibody described in this manuscript is included in a pending patent application. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Frank KM, 2012, INFECT IMMUN, V80, P3161, DOI 10.1128/IAI.00191-12; Gittler JK, 2012, J ALLERGY CLIN IMMUN; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kernodle DS, 1997, INFECT IMMUN, V65, P179, DOI 10.1128/IAI.65.1.179-184.1997; Kim MH, 2011, BLOOD, V117, P3343, DOI 10.1182/blood-2010-07-296970; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manfredi R, 2002, J CUTAN PATHOL, V29, P168, DOI 10.1034/j.1600-0560.2002.290307.x; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; McLoughlin RM, 2006, P NATL ACAD SCI USA, V103, P10408, DOI 10.1073/pnas.0508961103; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Milner JD, 2010, CURR OPIN HIV AIDS, V5, P179, DOI 10.1097/COH.0b013e328335ed3e; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Molne L, 2003, CLIN EXP IMMUNOL, V132, P209, DOI 10.1046/j.1365-2249.2003.02151.x; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Narita K, 2010, INFECT IMMUN, V78, P4234, DOI 10.1128/IAI.00447-10; Nygaard TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036532; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Powers ME, 2012, J INFECT DIS, V206, P352, DOI 10.1093/infdis/jis192; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Soong G, 2012, J INFECT DIS, V205, P1571, DOI 10.1093/infdis/jis244; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tkaczyk C, 2012, CLIN VACCINE IMMUNOL, V19, P377, DOI 10.1128/CVI.05589-11; Ventura CL, 2008, INFECT IMMUN, V76, P5862, DOI 10.1128/IAI.00865-08; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107	51	54	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75103	10.1371/journal.pone.0075103	http://dx.doi.org/10.1371/journal.pone.0075103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098366	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500020
J	Bishop, T; Turchyn, AV; Sivan, O				Bishop, Tom; Turchyn, Alexandra V.; Sivan, Orit			Fire and Brimstone: The Microbially Mediated Formation of Elemental Sulfur Nodules from an Isotope and Major Element Study in the Paleo-Dead Sea	PLOS ONE			English	Article							DISSIMILATORY SULFATE REDUCTION; ORGANIC-MATTER; LAKE LISAN; REDUCING BACTERIUM; MARINE-SEDIMENTS; FRACTIONATION; CYCLE; IRON; DISPROPORTIONATION; THIOSULFATE	We present coupled sulfur and oxygen isotope data from sulfur nodules and surrounding gypsum, as well as iron and manganese concentration data, from the Lisan Formation near the Dead Sea (Israel). The sulfur isotope composition in the nodules ranges between -9 and -11 parts per thousand, 27 to 29 parts per thousand lighter than the surrounding gypsum, while the oxygen isotope composition of the gypsum is constant around 24 parts per thousand. The constant sulfur isotope composition of the nodule is consistent with formation in an 'open system'. Iron concentrations in the gypsum increase toward the nodule, while manganese concentrations decrease, suggesting a redox boundary at the nodule-gypsum interface during aqueous phase diagenesis. We propose that sulfur nodules in the Lisan Formation are generated through bacterial sulfate reduction, which terminates at elemental sulfur. We speculate that the sulfate-saturated pore fluids, coupled with the low availability of an electron donor, terminates the trithionate pathway before the final two-electron reduction, producing thionites, which then disproportionate to form abundant elemental sulfur.	[Bishop, Tom; Turchyn, Alexandra V.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Sivan, Orit] Ben Gurion Univ Negev, Beer Sheva, Israel	University of Cambridge; Ben Gurion University	Turchyn, AV (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	avt25@cam.ac.uk		Turchyn, Alexandra/0000-0002-9298-2173	British Council grant through BIRAX program [BY2/GEO/04]; NERC [NE/H011595/1]; Natural Environment Research Council [NE/H011595/1] Funding Source: researchfish	British Council grant through BIRAX program; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by a British Council grant through the BIRAX program, BY2/GEO/04, to AVT and OS and NERC, NE/H011595/1, to OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Azcarate J, 2001, CHEM GEOL, V174, P389, DOI 10.1016/S0009-2541(00)00286-2; Avrahamov N, 2010, RADIOCARBON, V52, P1123, DOI 10.1017/S0033822200046208; Bradley AS, 2011, GEOBIOLOGY, V9, P446, DOI 10.1111/j.1472-4669.2011.00292.x; Brandt KK, 2001, MICROBIAL ECOL, V41, P1; Bruchert V, 2001, GEOCHIM COSMOCHIM AC, V65, P763, DOI 10.1016/S0016-7037(00)00557-3; Bruchert V., 2004, SULFUR BIOGEOCHEMIST, V379, P1, DOI [10.1130/0-8137-2379-5.1, DOI 10.1130/0-8137-2379-5.1]; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4759, DOI 10.1016/j.gca.2005.04.015; Canfield DE, 2006, GEOCHIM COSMOCHIM AC, V70, P548, DOI 10.1016/j.gca.2005.10.028; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Cypionka H, 1998, FEMS MICROBIOL LETT, V166, P181, DOI 10.1111/j.1574-6968.1998.tb13888.x; Davidson MM, 2009, APPL ENVIRON MICROB, V75, P5621, DOI 10.1128/AEM.02948-08; Detmers J, 2001, APPL ENVIRON MICROB, V67, P888, DOI 10.1128/AEM.67.2.888-894.2001; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; GAT JR, 1984, EARTH PLANET SC LETT, V71, P361, DOI 10.1016/0012-821X(84)90103-1; Gavrieli I, 2001, EARTH PLANET SC LETT, V186, P199, DOI 10.1016/S0012-821X(01)00247-3; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Habicht KS, 2001, GEOLOGY, V29, P555, DOI 10.1130/0091-7613(2001)029<0555:IFBSRN>2.0.CO;2; Hodell DA, 2008, QUATERNARY SCI REV, V27, P1152, DOI 10.1016/j.quascirev.2008.02.008; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Hunger S, 2007, GEOCHEM T, V8, DOI 10.1186/1467-4866-8-1; Jassim SZ, 1999, J GEOL SOC LONDON, V156, P25, DOI 10.1144/gsjgs.156.1.0025; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; JORGENSEN BB, 1990, LIMNOL OCEANOGR, V35, P1329, DOI 10.4319/lo.1990.35.6.1329; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; Kasten S., 2000, MARINE GEOCHEMISTRY, P263, DOI [10.1007/978-3-662-04242-7-8, DOI 10.1007/978-3-662-04242-7_8, DOI 10.1007/978-3-662-04242-7-8]; LEE JP, 1973, J BACTERIOL, V115, P453, DOI 10.1128/JB.115.1.453-455.1973; Lindtke J, 2011, GEOL MAG, V148, P655, DOI 10.1017/S0016756811000124; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; MACHEL HG, 1992, NATIVE SULFUR DEVELOPMENTS IN GEOLOGY AND EXPLORATION, P3; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; NISSENBAUM A, 1972, GEOCHIM COSMOCHIM AC, V36, P1007, DOI 10.1016/0016-7037(72)90018-X; NRIAGU JO, 1968, LIMNOL OCEANOGR, V13, P430, DOI 10.4319/lo.1968.13.3.0430; Oren A, 2009, HYDROBIOLOGIA, V626, P15, DOI 10.1007/s10750-009-9734-8; REES CE, 1973, GEOCHIM COSMOCHIM AC, V37, P1141, DOI 10.1016/0016-7037(73)90052-5; Ron H, 2006, GEOL SOC AM SPEC PAP, V401, P171, DOI 10.1130/2006.2401(11); Schippers A, 1999, APPL ENVIRON MICROB, V65, P319; SCHREIBER BC, 1975, J SEDIMENT PETROL, V45, P469; Sim MS, 2011, SCIENCE, V333, P74, DOI 10.1126/science.1205103; Sivan O, 2011, LIMNOL OCEANOGR, V56, P1536, DOI 10.4319/lo.2011.56.4.1536; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; Torfstein A, 2008, GEOCHIM COSMOCHIM AC, V72, P2491, DOI 10.1016/j.gca.2008.02.015; Torfstein A, 2005, EARTH PLANET SC LETT, V236, P61, DOI 10.1016/j.epsl.2005.04.026; TROELSEN H, 1982, ESTUAR COAST SHELF S, V15, P255, DOI 10.1016/0272-7714(82)90062-2; Vasconcelos C, 2006, GUAT AM GEOPH UN FAL, P1; Volkov I, 1972, LITOLOGIYA POLEZN IS, V4, P50; Worden RH, 1997, GEOLOGY, V25, P643, DOI 10.1130/0091-7613(1997)025<0643:SCIBE>2.3.CO;2; Wortmann UG, 2007, GEOCHIM COSMOCHIM AC, V71, P4221, DOI 10.1016/j.gca.2007.06.033; Zeng ZG, 2011, J ASIAN EARTH SCI, V40, P661, DOI 10.1016/j.jseaes.2010.10.019	50	14	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75883	10.1371/journal.pone.0075883	http://dx.doi.org/10.1371/journal.pone.0075883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098403	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100024
J	Laskus, T; Kibler, KV; Chmielewski, M; Wilkinson, J; Adair, D; Horban, A; Stanczak, G; Radkowski, M				Laskus, Tomasz; Kibler, Karen V.; Chmielewski, Marcin; Wilkinson, Jeffrey; Adair, Debra; Horban, Andrzej; Stanczak, Grzegorz; Radkowski, Marek			Effect of Hepatitis C Infection on HIV-Induced Apoptosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; T-CELLS; COINFECTION; REPLICATION; PROGRESSION; SURVIVAL; INDIVIDUALS; INHIBITION; INTERACTS	Background: Hepatitis C virus (HCV) coinfection was reported to negatively affect HIV disease and HIV infection has a deleterious effect on HCV-related liver disease. However, despite common occurrence of HCV/HIV coinfection little is known about the mechanisms of interactions between the two viruses. Methods: We studied CD4+ and CD8+ T cell and CD19+ B cell apoptosis in 104 HIV-positive patients (56 were also HCV-positive) and in 22 HCV/HIV-coinfected patients treated for chronic hepatitis C with pegylated interferon and ribavirin. We also analyzed HCV/HIV coinfection in a Daudi B-cell line expressing CD4 and susceptible to both HCV and HIV infection. Apoptosis was measured by AnnexinV staining. Results: HCV/HIV coinfected patients had lower CD4+ and CD8+ T cell apoptosis and higher CD19+ B cell apoptosis than those with HIV monoinfection. Furthermore, anti-HCV treatment of HCV/HIV coinfected patients was followed by an increase of CD4+ and CD8+ T cell apoptosis and a decrease of CD19+ B cell apoptosis. In the Daudi CD4+ cell line, presence of HCV infection facilitated HIV replication, however, decreased the rate of HIV-related cell death. Conclusion: In HCV/HIV coinfected patients T-cells were found to be destroyed at a slower rate than in HIV monoinfected patients. These results suggest that HCV is a molecular-level determinant in HIV disease.	[Laskus, Tomasz; Chmielewski, Marcin; Radkowski, Marek] Med Univ Warsaw, Dept Immunopathol, Warsaw, Poland; [Kibler, Karen V.] Arizona State Univ, Biodesign Inst, Phoenix, AZ USA; [Wilkinson, Jeffrey; Adair, Debra] St Josephs Hosp, Phoenix, AZ USA; [Horban, Andrzej; Stanczak, Grzegorz] Municipal Hosp Infect Dis, Warsaw, Poland	Medical University of Warsaw; Arizona State University; Arizona State University-Downtown Phoenix; St. Joseph's Hospital and Medical Center	Radkowski, M (corresponding author), Med Univ Warsaw, Dept Immunopathol, Warsaw, Poland.	marek.radkowski@wum.edu.pl	Radkowski, Marek/V-3860-2018	Radkowski, Marek/0000-0003-1808-679X	MNiSW [NN401 646740, NN401 646940]	MNiSW(Ministry of Science and Higher Education, Poland)	This study was supported by MNiSW grant Nos. NN401 646740 and NN401 646940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONI BA, 1995, J VIROL, V69, P2384, DOI 10.1128/JVI.69.4.2384-2392.1995; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Beld M, 1998, VIROLOGY, V244, P504, DOI 10.1006/viro.1998.9130; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; De Luca A, 2002, ARCH INTERN MED, V162, P2125, DOI 10.1001/archinte.162.18.2125; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; FREED EO, 1994, J VIROL, V68, P2503, DOI 10.1128/JVI.68.4.2503-2512.1994; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; Kamegaya Y, 2005, HEPATOLOGY, V41, P660, DOI 10.1002/hep.20621; Korner C, 2009, CLIN SCI, V116, P861, DOI 10.1042/CS20080532; KOVACS A, 2004, 15 INT AIDS C JUL 11; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Laskus T, 2004, BLOOD, V103, P3854, DOI 10.1182/blood-2003-08-2923; LeGall S, 1997, VIROLOGY, V229, P295; Machida K, 2001, J BIOL CHEM, V276, P12140, DOI 10.1074/jbc.M010137200; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; MOGENSEN SC, 1979, MICROBIOL REV, V43, P1; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Nakajima N, 1996, J VIROL, V70, P3325, DOI 10.1128/JVI.70.5.3325-3329.1996; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Naora H, 1999, IMMUNOLOGY, V97, P181, DOI 10.1046/j.1365-2567.1999.00807.x; Nunez M, 2006, CLIN INFECT DIS, V43, P1209, DOI 10.1086/508355; Pal S, 2006, GASTROENTEROLOGY, V130, P1107, DOI 10.1053/j.gastro.2005.12.039; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; Ross TM, 2001, LEUKEMIA, V15, P332, DOI 10.1038/sj.leu.2402028; Sansonno D, 1998, BLOOD, V92, P3328, DOI 10.1182/blood.V92.9.3328.421k04_3328_3337; Stebbing J, 2005, CLIN INFECT DIS, V41, P906, DOI 10.1086/432885; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Thomas DL, 2001, J INFECT DIS, V183, P973, DOI 10.1086/319256; Toubi E, 2004, J VIROL, V78, P11379, DOI 10.1128/JVI.78.20.11379-11384.2004; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Yue FY, 2005, J IMMUNOL, V174, P2196, DOI 10.4049/jimmunol.174.4.2196	42	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75921	10.1371/journal.pone.0075921	http://dx.doi.org/10.1371/journal.pone.0075921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098405	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100026
J	Liu, HT; Jiang, YH; Kuo, HC				Liu, Hsin-Tzu; Jiang, Yuan-Hong; Kuo, Hann-Chorng			Increased Serum Adipokines Implicate Chronic Inflammation in the Pathogenesis of Overactive Bladder Syndrome Refractory to Antimuscarinic Therapy	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; QUALITY-OF-LIFE; URINARY-BLADDER; INTRADETRUSOR INJECTIONS; INTERSTITIAL CYSTITIS; DETRUSOR OVERACTIVITY; MEDICAL-TREATMENT; CHEMOKINES; INVOLVEMENT; DYSFUNCTION	Objectives: Recent studies have shown that chronic inflammation is involved in overactive bladder (OAB) syndrome. OAB could be a subtype of neurogenic inflammation. This pilot study investigated serum adipokine levels in patients with OAB refractory to antimuscarinic therapy. Methods: Thirty consecutive patients with OAB-dry (n = 16) or OAB-wet (n = 14) refractory to previous antimuscarinic treatment were prospectively enrolled in this study, a group of 26 normal subjects without lower urinary tract symptoms served as controls. Concentrations of serum C-reactive protein (CRP), nerve growth factor (NGF), and adipokines including interleukins ([IL], IL-1 beta, IL-6, IL-8), tumor necrosis factor (TNF)-alpha, monocyte chemotactic protein (MCP)-1, insulin, and leptin were quantified using a bead-based human serum adipokine panel B kit. Data were analyzed using the LX 200 platform. Patients were further classified as having dry or wet OAB and having medical diseases or not. The serum CRP, NGF, and adipokine levels were compared between OAB patients and the controls, and between OAB subgroups. Results: The serum concentrations of CRP, NGF, IL-1 beta, IL-6, IL-8, and TNF-alpha in OAB-dry and OAB-wet patients were significantly higher than among the controls. There was no significant difference in adipokine levels between OAB-dry and OAB-wet, or between OAB patients with and without medical diseases. Serum CRP and NGF levels were significantly higher only in OAB-wet or OAB patients with medical diseases than among controls. The MCP-1 levels, on the other hand, were significantly higher in OAB-dry or OAB patients with disease, than the controls. Conclusions: Both OAB-dry and OAB-wet patients showed increased serum CRP, NGF, and adipokine levels compared with the controls, suggesting chronic inflammation of the bladder involving both peripheral and central mechanisms in all OAB patients refractory to antimuscarinic therapy. The increased serum adipokine levels were not relevant to medical diseases.	[Liu, Hsin-Tzu; Jiang, Yuan-Hong; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Liu, Hsin-Tzu; Jiang, Yuan-Hong; Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw						Abrams P, 2000, AM J MANAG CARE, V6, pS580; Apostolidis A, 2005, J UROLOGY, V174, P977, DOI 10.1097/01.ju.0000169481.42259.54; Apostolidis A, 2008, EUR UROL, V53, P1245, DOI 10.1016/j.eururo.2008.02.037; Avelino A, 2002, NEUROSCIENCE, V109, P787, DOI 10.1016/S0306-4522(01)00496-1; Bouchelouche K, 2004, J UROLOGY, V171, P462, DOI 10.1097/01.ju.0000090192.36436.d5; Brown JS, 2000, AM J MANAG CARE, V6, pS574; Rodriguez MAB, 2009, J UROLOGY, V182, P2123, DOI 10.1016/j.juro.2009.07.036; Chapple CR, 2000, UROLOGY, V55, P33, DOI 10.1016/S0090-4295(99)00492-6; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Davidoff R, 1997, J UROLOGY, V157, P1980, DOI 10.1016/S0022-5347(01)64914-0; Dupont MC, 2001, J UROLOGY, V166, P1111, DOI 10.1016/S0022-5347(05)65931-9; Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079; Heinrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020792; JACOBSON SH, 1994, NEPHRON, V67, P172, DOI 10.1159/000187923; Kupelian V, 2012, BJU INT, V110, P401, DOI 10.1111/j.1464-410X.2011.10769.x; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Liao CH, 2011, UROLOGY, V78, P1373, DOI 10.1016/j.urology.2011.04.076; Liu HT, 2008, UROLOGY, V72, P104, DOI 10.1016/j.urology.2008.01.069; Liu HT, 2011, NEUROUROL URODYNAM, V30, P1525, DOI 10.1002/nau.21118; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; Melville JL, 2002, AM J OBSTET GYNECOL, V187, P80, DOI 10.1067/mob.2002.124839; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P185, DOI 10.1002/nau.21191; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Segerer S, 2005, THESCIENTIFICWORLDJO, V5, P835, DOI 10.1100/tsw.2005.105; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Serrano-Sanchez T, 2001, REV NEUROLOGIA, V32, P825, DOI 10.33588/rn.3209.2000496; Stanzani L, 2001, CEREBROVASC DIS, V12, P240, DOI 10.1159/000047710; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; STEERS WD, 1991, J CLIN INVEST, V88, P1709, DOI 10.1172/JCI115488; TUTTLE JB, 1994, J AUTONOM NERV SYST, V49, P147, DOI 10.1016/0165-1838(94)90134-1; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Wang W, 2012, MOL MED REP, V6, P434, DOI 10.3892/mmr.2012.928; Wennberg AL, 2009, EUR UROL, V55, P783, DOI 10.1016/j.eururo.2009.01.007; Yiangou Y, 2001, BJU INT, V87, P774, DOI 10.1046/j.1464-410x.2001.02190.x; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	36	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76706	10.1371/journal.pone.0076706	http://dx.doi.org/10.1371/journal.pone.0076706			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098552	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100083
J	Abuelezam, NN; Rough, K; Seage, GR				Abuelezam, Nadia N.; Rough, Kathryn; Seage, George R., III			Individual-Based Simulation Models of HIV Transmission: Reporting Quality and Recommendations	PLOS ONE			English	Article							STOCHASTIC SIMULATION; MALE CIRCUMCISION; POTENTIAL IMPACT; CONDOM USE; RAKAI; PREVENTION; INFECTION; DYNAMICS; HEALTH; STRATEGIES	Background: Individual-based modeling is a growing technique in the HIV transmission and prevention literature, but insufficient attention has been paid to formally evaluate the quality of reporting in this field. We present reporting recommendations for individual-based models for HIV treatment and prevention, assess the quality of reporting in the existing literature, and comment on the contribution of this model type to HIV policy and prediction. Methods: We developed reporting recommendations for individual-based HIV transmission mathematical models, and through a systematic search, used them to evaluate the reporting in the existing literature. We identified papers that employed individual-based simulation models and were published in English prior to December 31, 2012. Articles were included if the models they employed simulated and tracked individuals, simulated HIV transmission between individuals in a particular population, and considered a particular treatment or prevention intervention. The papers were assessed with the reporting recommendations. Findings: Of 214 full text articles examined, 32 were included in the evaluation, representing 20 independent individual-based HIV treatment and prevention mathematical models. Manuscripts universally reported the objectives, context, and modeling conclusions in the context of the modeling assumptions and the model's predictive capabilities, but the reporting of individual-based modeling methods, parameterization and calibration was variable. Six papers discussed the time step used and one discussed efforts to maintain internal validity in coding. Conclusion: Individual-based models represent detailed HIV transmission processes with the potential to contribute to inference and policy making for many different regions and populations. The rigor in reporting of assumptions, methods, and calibration of individual-based models focused on HIV transmission and prevention varies greatly. Higher standards for reporting of statistically rigorous calibration and model assumption testing need to be implemented to increase confidence in existing and future modeling results.	[Abuelezam, Nadia N.; Rough, Kathryn; Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Abuelezam, NN (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	nabuelezam@mail.harvard.edu	Abuelezam, Nadia/AAO-1952-2021	Abuelezam, Nadia/0000-0002-5459-8592	NIAID [AI 007433, RO1MH087328-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087328] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge funding from the following sources: NIAID AI 007433 (http://www.niaid.nih.gov/researchfunding/pages/default.aspx), and RO1MH087328-03 (http://grants.nih.gov/grants/about_grants.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AL, 1998, SIMULATION, V71, P228, DOI 10.1177/003754979807100403; Amirfar S, 2006, JAIDS-J ACQ IMM DEF, V43, P219, DOI 10.1097/01.qai.0000230526.79341.83; Athanasiadis I. N., 2004, Management of Environmental Quality, V15, P238, DOI 10.1108/14777830410531216; Atkinson J, 1996, COMPUT BIOMED RES, V29, P338, DOI 10.1006/cbmr.1996.0025; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Bernstein RS, 1998, INTERFACES, V28, P101, DOI 10.1287/inte.28.3.101; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bracher M, 2004, STUD FAMILY PLANN, V35, P48, DOI 10.1111/j.1728-4465.2004.00005.x; Chu L, 2003, CALIBRATION PROCEDUR, P1574; Delva W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001239; Enns EA, 2011, HEALTH CARE MANAG SC, V14, P174, DOI 10.1007/s10729-011-9150-2; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Fone D, 2003, J PUBLIC HEALTH MED, V25, P325, DOI 10.1093/pubmed/fdg075; Freeman EE, 2009, VACCINE, V27, P940, DOI 10.1016/j.vaccine.2008.11.074; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Gilbert N., 2007, AGENT BASED MODELS; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Gray RT, 2011, VACCINE, V29, P6125, DOI 10.1016/j.vaccine.2011.06.061; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Grimm V., 2005, INDIVIDUAL BASED MOD; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Hallett TB, 2011, SEX TRANSM INFECT, V87, P17, DOI 10.1136/sti.2010.042622; Halpin B, 1999, AM BEHAV SCI, V42, P1488, DOI 10.1177/0002764299042010003; Hoare A, 2012, SEX HEALTH, V9, P144, DOI 10.1071/SH10145; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Hontelez JAC, 2011, VACCINE, V29, P6100, DOI 10.1016/j.vaccine.2011.06.059; Karplus W. J., 1977, Mathematics and Computers in Simulation, V19, P3, DOI 10.1016/0378-4754(77)90034-9; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Korenromp EL, 2005, J INFECT DIS, V191, pS168, DOI 10.1086/425274; Korenromp EL, 2002, AIDS, V16, P2209, DOI 10.1097/00002030-200211080-00014; Korenromp EL, 2002, SEX TRANSM INFECT, V78, pI55, DOI 10.1136/sti.78.suppl_1.i55; Law AM., 1991, SIMULATION MODELING, V2nd; Marshall B, 2012, J INT AIDS SOC, V15, P108; Marshall BDL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044833; McCabe CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010154; McCreesh N, 2011, SEX TRANSM INFECT, V87, pA37, DOI 10.1136/sextrans-2011-050109.35; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Philips Z, 2006, PHARMACOECONOMICS, V24, P355, DOI 10.2165/00019053-200624040-00006; Rauner MS, 2005, J OPER RES SOC, V56, P222, DOI 10.1057/palgrave.jors.2601884; Richiardi M, 2006, JASSS-J ARTIF SOC S, V9; ROBINSON NJ, 1995, AIDS, V9, P1263, DOI 10.1097/00002030-199511000-00008; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Stover J, 2000, SEX TRANSM DIS, V27, P572, DOI 10.1097/00007435-200011000-00005; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; Van Imhoff E, 1998, Popul, V10, P97; van Vliet C, 2001, B WORLD HEALTH ORGAN, V79, P442; Vieira IT, 2010, ANN OPER RES, V178, P173, DOI 10.1007/s10479-009-0571-y; Vissers DCJ, 2011, EPIDEMIOL INFECT, V139, P1845, DOI 10.1017/S0950268811000069; White RG, 2004, JAIDS-J ACQ IMM DEF, V37, P1500, DOI 10.1097/01.qai.0000127062.94627.31; White RG, 2008, AIDS, V22, P1841, DOI 10.1097/QAD.0b013e32830e0137; Wilson DP, 2011, SEX TRANSM INFECT, V87, P588, DOI 10.1136/sextrans-2011-050002	52	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75624	10.1371/journal.pone.0075624	http://dx.doi.org/10.1371/journal.pone.0075624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098707	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500078
J	Simonin-Le Jeune, K; Le Jeune, A; Jouneau, S; Belleguic, C; Roux, PF; Jaguin, M; Dimanche-Boitre, MT; Lecureur, V; Leclercq, C; Desrues, B; Brinchault, G; Gangneux, JP; Martin-Chouly, C				Simonin-Le Jeune, Karin; Le Jeune, Andre; Jouneau, Stephane; Belleguic, Chantal; Roux, Pierre-Francois; Jaguin, Marie; Dimanche-Boitre, Marie-Therese; Lecureur, Valerie; Leclercq, Caroline; Desrues, Benoit; Brinchault, Graziella; Gangneux, Jean-Pierre; Martin-Chouly, Corinne			Impaired Functions of Macrophage from Cystic Fibrosis Patients: CD11b, TLR-5 Decrease and sCD14, Inflammatory Cytokines Increase	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; INNATE IMMUNITY; LUNG-DISEASE; SOLUBLE CD14; MYCOBACTERIUM-TUBERCULOSIS; CEREBROSPINAL-FLUID; NONOPSONIC BINDING; HUMAN MONOCYTES; RECEPTOR; NEUTROPHILS	Background: Early in life, cystic fibrosis (CF) patients are infected with microorganisms. The role of macrophages has largely been underestimated in literature, whereas the focus being mostly on neutrophils and epithelial cells. Macrophages may however play a significant role in the initiating stages of this disease, via an inability to act as a suppressor cell. Yet macrophage dysfunction may be the first step in cascade of events leading to chronic inflammation/infection in CF. Moreover, reports have suggested that CFTR contribute to altered inflammatory response in CF by modification of normal macrophage functions. Objectives: In order to highlight possible intrinsic macrophage defects due to impaired CFTR, we have studied inflammatory cytokines secretions, recognition of pathogens and phagocytosis in peripheral blood monocyte-derived macrophages from stable adult CF patients and healthy subjects (non-CF). Results: In CF macrophage supernatants, concentrations of sCD14, IL-1 beta, IL-6, TNF-alpha and IL-10 were strongly raised. Furthermore expression of CD11b and TLR-5 were sorely decreased on CF macrophages. Beside, no difference was observed for mCD14, CD16, CD64, TLR-4 and TLR1/TLR-2 expressions. Moreover, a strong inhibition of phagocytosis was observed for CF macrophages. Elsewhere CFTR inhibition in non-CF macrophages also led to alterations of phagocytosis function as well as CD11b expression. Conclusions: Altogether, these findings demonstrate excessive inflammation in CF macrophages, characterized by overproduction of sCD14 and inflammatory cytokines, with decreased expression of CD11b and TLR-5, and impaired phagocytosis. This leads to altered clearance of pathogens and non-resolution of infection by CF macrophages, thereby inducing an exaggerated pro-inflammatory response.	[Simonin-Le Jeune, Karin; Le Jeune, Andre; Jouneau, Stephane; Roux, Pierre-Francois; Jaguin, Marie; Dimanche-Boitre, Marie-Therese; Lecureur, Valerie; Leclercq, Caroline; Gangneux, Jean-Pierre; Martin-Chouly, Corinne] Univ Rennes 1, Struct Federat Rech Biosit, F-35043 Rennes, France; [Simonin-Le Jeune, Karin; Roux, Pierre-Francois; Dimanche-Boitre, Marie-Therese; Leclercq, Caroline; Martin-Chouly, Corinne] INSERM, IRSET, U1085, Team Stress Membrane & Signaling, F-35043 Rennes, France; [Le Jeune, Andre] Equipe Microbiol Risques Infect EA 1254, F-35043 Rennes, France; [Jouneau, Stephane; Jaguin, Marie; Lecureur, Valerie] INSERM, IRSET, U1085, Team Chem Contaminant Immun & Inflammat, F-35043 Rennes, France; [Jouneau, Stephane; Belleguic, Chantal; Desrues, Benoit; Brinchault, Graziella; Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Ctr Ressource & Competences Mucoviscidose, F-35064 Rennes, France; [Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Serv Parasitol Mycol, F-35064 Rennes, France	Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Martin-Chouly, C (corresponding author), Univ Rennes 1, Struct Federat Rech Biosit, F-35043 Rennes, France.	corinne.chouly@univ-rennes1.fr	LECUREUR, Valérie/J-9095-2015; MARTIN-CHOULY, Corinne AE/K-4288-2015; Dimanche-Boitrel, Marie-Therese M/I-4642-2015; Gangneux, Jean-Pierre/J-2960-2015; Roux, Pierre-François/J-8875-2019; Jouneau, Stephane/K-9956-2015	Roux, Pierre-François/0000-0002-0695-4206; MARTIN-CHOULY, corinne/0000-0001-7493-0612; Desrues, Benoit/0000-0002-1748-1694; Gangneux, Jean-Pierre/0000-0002-4974-5607	Vaincre La Mucoviscidose (cystic fibrosis association of France); Biosit (federative structure for research, Rennes 1 University, France)	Vaincre La Mucoviscidose (cystic fibrosis association of France); Biosit (federative structure for research, Rennes 1 University, France)	This work was supported by grants from Vaincre La Mucoviscidose (cystic fibrosis association of France) and Biosit (federative structure for research, Rennes 1 University, France) for grant and platform access. We thank the Faculty of Pharmacy of Rennes 1 University (France) for the support given to staff this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa KS, 2006, RESPIROLOGY, V11, pS32, DOI 10.1111/j.1440-1843.2006.00805.x; [Anonymous], 1997, CARDIOVASC RES, V35, P2, DOI DOI 10.1016/S0008-6363(97)00109-0.PUBMED:9302340; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Brettschneider J, 2002, J NEUROIMMUNOL, V133, P193, DOI 10.1016/S0165-5728(02)00353-3; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Carnpodonico VL, 2008, TRENDS MOL MED, V14, P120, DOI 10.1016/j.molmed.2008.01.002; Conese Massimo, 2003, J Cyst Fibros, V2, P129, DOI 10.1016/S1569-1993(03)00063-8; Cywes C, 1996, INFECT IMMUN, V64, P5373, DOI 10.1128/IAI.64.12.5373-5383.1996; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Dooring G, 2009, CELL MICROBIOL, V11, P208, DOI 10.1111/j.1462-5822.2008.01271.x; Douglas TA, 2009, EUR RESPIR J, V33, P305, DOI 10.1183/09031936.00043108; DURIEUX JJ, 1994, EUR J IMMUNOL, V24, P2006, DOI 10.1002/eji.1830240911; Egerer K, 2000, LUPUS, V9, P614, DOI 10.1191/096120300678828749; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Fran R, 2010, EGISTRE FRANCAIS MUC; Hartl D, 2012, J CYST FIBROS, V11, P363, DOI 10.1016/j.jcf.2012.07.003; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Hauber Hans-Peter, 2005, Can Respir J, V12, P13; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; John G, 2011, EXP LUNG RES, V37, P319, DOI 10.3109/01902148.2011.569968; Jouneau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022655; Koller B, 2009, EUR J CLIN INVEST, V39, P535, DOI 10.1111/j.1365-2362.2009.02145.x; KRONBORG G, 1993, PEDIATR PULM, V15, P292, DOI 10.1002/ppul.1950150506; Le-Barillec K, 1999, J CLIN INVEST, V103, P1039, DOI 10.1172/JCI5779; Lin B, 2000, J INFECT DIS, V181, P1185, DOI 10.1086/315357; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Marcos V, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-32; Mogayzel PJ, 2011, AM J RESP CRIT CARE, V183, P1620, DOI 10.1164/rccm.201102-0275UP; Ngan DA, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-3; Nichols D, 2008, CLIN REV ALLERG IMMU, V34, P146, DOI 10.1007/s12016-007-8039-9; Nockher WA, 1999, J NEUROIMMUNOL, V101, P161, DOI 10.1016/S0165-5728(99)00141-1; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; RUSSELL DG, 1988, J EXP MED, V168, P279, DOI 10.1084/jem.168.1.279; Schmitt-Grohe S, 2005, CYTOKINE, V29, P18, DOI 10.1016/j.cyto.2004.09.004; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; STOKES RW, 1993, J IMMUNOL, V151, P7067; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374	48	39	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75667	10.1371/journal.pone.0075667	http://dx.doi.org/10.1371/journal.pone.0075667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098711	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500082
J	Toubarro, D; Avila, MM; Montiel, R; Simoes, N				Toubarro, Duarte; Avila, Monica Martinez; Montiel, Rafael; Simoes, Nelson			A Pathogenic Nematode Targets Recognition Proteins to Avoid Insect Defenses	PLOS ONE			English	Article							PSEUDALETIA-UNIPUNCTA LEPIDOPTERA; STEINERNEMA-FELTIAE; IMMUNE-RESPONSES; BLOOD-CELLS; HOST; INHIBITOR; PROTEASE; COAGULATION; ACTIVATION; BACTERIA	Steinernema carpocapsae is a nematode pathogenic in a wide variety of insect species. The great pathogenicity of this nematode has been ascribed to its ability to overcome the host immune response; however, little is known about the mechanisms involved in this process. The analysis of an expressed sequence tags (EST) library in the nematode during the infective phase was performed and a highly abundant contig homologous to serine protease inhibitors was identified. In this work, we show that this contig is part of a 641-bp cDNA that encodes a BPTI-Kunitz family inhibitor (Sc-KU-4), which is up-regulated in the parasite during invasion and installation. Recombinant Sc-KU-4 protein was produced in Escherichia coli and shown to inhibit chymotrypsin and elastase activities in a dose-dependent manner by a competitive mechanism with K-i values of 1.8 nM and 2.6 nM, respectively. Sc-KU-4 also inhibited trypsin and thrombin activities to a lesser extent. Studies of the mode of action of Sc-KU-4 and its effects on insect defenses suggest that although Sc-KU-4 did not inhibit the activation of hemocytes or the formation of clotting fibers, it did inhibit hemocyte aggregation and the entrapment of foreign particles by fibers. Moreover, Sc-KU-4 avoided encapsulation and the deposition of clotting materials, which usually occurs in response to foreign particles. We show by protein-protein interaction that Sc-KU-4 targets recognition proteins of insect immune system such as masquerade-like and serine protease-like homologs. The interaction of Sc-KU-4 with these proteins explains the ability of the nematode to overcome host reactions and its large pathogenic spectrum, once these immune proteins are well conserved in insects. The discovery of this inhibitor targeting insect recognition proteins opens new avenues for the development of S. carpocapsae as a biological control agent and provides a new tool to study host-pathogen interactions.	[Toubarro, Duarte; Avila, Monica Martinez; Simoes, Nelson] Univ Acores, IBB, CBA, Ponta Delgada, Portugal; [Toubarro, Duarte; Avila, Monica Martinez; Simoes, Nelson] Univ Acores, CIRN, Dept Biol, Ponta Delgada, Portugal; [Montiel, Rafael] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico	Universidade dos Acores; Universidade dos Acores; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Simoes, N (corresponding author), Univ Acores, IBB, CBA, Ponta Delgada, Portugal.	simoes@uac.pt	Montiel, Rafael/A-6774-2008; Simoes, Nelson/K-3843-2013; Toubarro, Duarte/K-3881-2013	Montiel, Rafael/0000-0001-8052-0679; Simoes, Nelson/0000-0003-3612-6759; Toubarro, Duarte/0000-0003-2025-9696	Fundacao para a Ciencia e Tecnologia (FCT) [PDCT/AGR/AAM/104487/2008]; FLAD (Luso-American Foundation) [223/2006]; FCT [PDCT/AGR/AAM/104487/2008]; Regional Government of Acores (RGA) [M3.1.2/F/005/2007]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FLAD (Luso-American Foundation); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Regional Government of Acores (RGA)	This research was supported by Fundacao para a Ciencia e Tecnologia (FCT) (PDCT/AGR/AAM/104487/2008) and by FLAD (Luso-American Foundation) (Proj. 223/2006) awarded to NS. DT received a fellowship from FCT (PDCT/AGR/AAM/104487/2008), and MMA was a recipient of a fellowship from the Regional Government of Acores (RGA) (M3.1.2/F/005/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian N, 2010, PARASITE IMMUNOL, V32, P165, DOI 10.1111/j.1365-3024.2009.01172.x; Balasubramanian N, 2009, INT J PARASITOL, V39, P975, DOI 10.1016/j.ijpara.2009.01.012; Beck M, 2000, J INSECT PHYSIOL, V46, P1275, DOI 10.1016/S0022-1910(00)00048-2; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Brivio MF, 2004, MOL BIOCHEM PARASIT, V135, P111, DOI 10.1016/j.molbiopara.2004.01.012; Castillo JC, 2011, TRENDS PARASITOL, V27, P537, DOI 10.1016/j.pt.2011.09.001; Cruz N, 2001, J INVERTEBR PATHOL, V78, P272, DOI 10.1006/jipa.2001.5033; Dowds Barbara C.A., 2002, P79, DOI 10.1079/9780851995670.0079; Dushay MS, 2009, CELL MOL LIFE SCI, V66, P2643, DOI 10.1007/s00018-009-0036-0; DUTKY SR, 1964, J INSECT PATHOL, V6, P417; Dy CY, 2006, ACTA CRYSTALLOGR D, V62, P980, DOI [10.1107/S0907444906021123, 10.1107/S0907444906021122]; Eleftherianos I, 2007, CELL MICROBIOL, V9, P1137, DOI 10.1111/j.1462-5822.2006.00855.x; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Felfoldi G, 2011, J IMMUNOL, V186, P4828, DOI 10.4049/jimmunol.1003246; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; GHENDLER Y, 1994, EXP PARASITOL, V78, P121, DOI 10.1006/expr.1994.1013; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; GOTZ P, 1981, PROC R SOC SER B-BIO, V212, P333, DOI 10.1098/rspb.1981.0043; Gupta Ayodhya P., 1991, P19; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Hallem EA, 2007, CURR BIOL, V17, P898, DOI 10.1016/j.cub.2007.04.027; Hao YJ, 2010, MOL BIOCHEM PARASIT, V169, P79, DOI 10.1016/j.molbiopara.2009.10.002; Helland R, 1999, ACTA CRYSTALLOGR D, V55, P139, DOI 10.1107/S090744499801052X; Huang TS, 2000, J BIOL CHEM, V275, P9996, DOI 10.1074/jbc.275.14.9996; Jitvaropas R, 2009, COMP BIOCHEM PHYS B, V153, P236, DOI 10.1016/j.cbpb.2009.03.007; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LAUMOND C, 1979, ENTOMOPHAGA, V24, P13, DOI 10.1007/BF02377505; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li D, 2002, INSECT BIOCHEM MOLEC, V32, P919, DOI 10.1016/S0965-1748(02)00030-9; Li XY, 2009, MOL BIOCHEM PARASIT, V165, P162, DOI 10.1016/j.molbiopara.2009.02.001; Liu H, 2012, MOL BIOCHEM PARASIT, V185, P89, DOI 10.1016/j.molbiopara.2012.06.006; Loof TG, 2011, J INNATE IMMUN, V3, P34, DOI 10.1159/000321641; Lu ZQ, 2008, INSECT BIOCHEM MOLEC, V38, P89, DOI 10.1016/j.ibmb.2007.09.011; Medeiros J, 2000, J ECON ENTOMOL, V93, P1403, DOI 10.1603/0022-0493-93.5.1403; Milstone AM, 2000, J BIOL CHEM, V275, P29391, DOI 10.1074/jbc.M002715200; Nardi JB, 2005, J INSECT PHYSIOL, V51, P555, DOI 10.1016/j.jinsphys.2005.02.005; Peters A, 1997, J INVERTEBR PATHOL, V69, P218, DOI 10.1006/jipa.1996.4648; Pugia MJ, 2007, ADV CLIN CHEM, V44, P223, DOI 10.1016/S0065-2423(07)44007-0; Rhoads ML, 2000, EXP PARASITOL, V95, P36, DOI 10.1006/expr.2000.4502; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; Simoes N, 1996, BIOCONTROL SCI TECHN, V6, P403, DOI 10.1080/09583159631370; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Toubarro D, 2010, J BIOL CHEM, V285, P30666, DOI 10.1074/jbc.M110.129346; Toubarro D, 2009, INT J PARASITOL, V39, P1319, DOI 10.1016/j.ijpara.2009.04.013; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Yu XQ, 2002, EUR J BIOCHEM, V269, P1827, DOI 10.1046/j.1432-1033.2002.02830.x; Zang XX, 2001, TRENDS BIOCHEM SCI, V26, P191, DOI 10.1016/S0968-0004(00)01761-8; ZHOU JM, 1989, BIOCHEMISTRY-US, V28, P1070, DOI 10.1021/bi00429a022; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P93, DOI 10.1631/jzus.B1000158	56	35	36	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75691	10.1371/journal.pone.0075691	http://dx.doi.org/10.1371/journal.pone.0075691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098715	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500086
J	Eisenreich, S; Abou-El-Ardat, K; Szafranski, K; Valenzuela, JAC; Rump, A; Nigro, JM; Bjerkvig, R; Gerlach, EM; Hackmann, K; Schrock, E; Krex, D; Kaderali, L; Schackert, G; Platzer, M; Klink, B				Eisenreich, Sophie; Abou-El-Ardat, Khalil; Szafranski, Karol; Valenzuela, Jaime A. Campos; Rump, Andreas; Nigro, Janice M.; Bjerkvig, Rolf; Gerlach, Eva-Maria; Hackmann, Karl; Schroeck, Evelin; Krex, Dietmar; Kaderali, Lars; Schackert, Gabriele; Platzer, Matthias; Klink, Barbara			Novel CIC Point Mutations and an Exon-Spanning, Homozygous Deletion Identified in Oligodendroglial Tumors by a Comprehensive Genomic Approach Including Transcriptome Sequencing	PLOS ONE			English	Article							BINDING-PROTEIN; IDH1 MUTATIONS; C-MYC; GLIOMAS; FUSE; CLASSIFICATION; SURVIVAL; CAPICUA; FUBP1; 19Q	Oligodendroglial tumors form a distinct subgroup of gliomas, characterized by a better response to treatment and prolonged overall survival. Most oligodendrogliomas and also some oligoastrocytomas are characterized by a unique and typical unbalanced translocation, der(1,19), resulting in a 1p/19q co-deletion. Candidate tumor suppressor genes targeted by these losses, CIC on 19q13.2 and FUBP1 on 1p31.1, were only recently discovered. We analyzed 17 oligodendrogliomas and oligoastrocytomas by applying a comprehensive approach consisting of RNA expression analysis, DNA sequencing of CIC, FUBP1, IDH1/2, and array CGH. We confirmed three different genetic subtypes in our samples: i) the "oligodendroglial" subtype with 1p/19q co-deletion in twelve out of 17 tumors; ii) the "astrocytic" subtype in three tumors; iii) the "other" subtype in two tumors. All twelve tumors with the 1p/19q co-deletion carried the most common IDH1 R132H mutation. In seven of these tumors, we found protein-disrupting point mutations in the remaining allele of CIC, four of which are novel. One of these tumors also had a deleterious mutation in FUBP1. Only by integrating RNA expression and array CGH data, were we able to discover an exon-spanning homozygous microdeletion within the remaining allele of CIC in an additional tumor with 1p/19q co-deletion. Therefore we propose that the mutation rate might be underestimated when looking at sequence variants alone. In conclusion, the high frequency and the spectrum of CIC mutations in our 1p/19q-codeleted tumor cohort support the hypothesis that CIC acts as a tumor suppressor in these tumors, whereas FUBP1 might play only a minor role.	[Eisenreich, Sophie; Abou-El-Ardat, Khalil; Rump, Andreas; Gerlach, Eva-Maria; Hackmann, Karl; Schroeck, Evelin; Klink, Barbara] Tech Univ Dresden, Inst Klin Genet, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Szafranski, Karol; Platzer, Matthias] FLI, Leibniz Inst Age Res, Jena, Germany; [Valenzuela, Jaime A. Campos; Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometrie, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Nigro, Janice M.; Bjerkvig, Rolf] Univ Bergen, Dept Biomed, Bergen, Norway; [Krex, Dietmar; Schackert, Gabriele] Tech Univ Dresden, Klin & Poliklin Neurochirurg, Univ Klinikum Carl Gustav Carus, D-01062 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Bergen; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Klink, B (corresponding author), Tech Univ Dresden, Inst Klin Genet, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany.	barbara.klink@tu-dresden.de	Krex, Dietmar/E-6833-2014	Kaderali, Lars/0000-0002-2359-2294; Klink, Barbara/0000-0002-8753-8238; Rump, Andreas/0000-0001-7116-6364	grant (MeDDrive programm) of the Medizinische Fakultat Carl Gustav Carus, TU Dresden; Bundesministerium fur Bildung und Forschung within the framework of the Nationales Genomforschungsnetzwerk [01GS08182]	grant (MeDDrive programm) of the Medizinische Fakultat Carl Gustav Carus, TU Dresden; Bundesministerium fur Bildung und Forschung within the framework of the Nationales Genomforschungsnetzwerk(Federal Ministry of Education & Research (BMBF))	Part of this work was supported by a grant (MeDDrive programm) of the Medizinische Fakultat Carl Gustav Carus, TU Dresden, awarded to BK, and by the Bundesministerium fur Bildung und Forschung within the framework of the Nationales Genomforschungsnetzwerk, grant 01GS08182, to KS and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Bromberg JEC, 2009, ONCOLOGIST, V14, P155, DOI 10.1634/theoncologist.2008-0248; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Hsiao HH, 2010, BIOCHEMISTRY-US, V49, P4620, DOI 10.1021/bi9021445; Idbaih A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045950; Irwin N, 1997, NUCLEIC ACIDS RES, V25, P1281, DOI 10.1093/nar/25.6.1281; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Klink B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059773; Klink B, 2010, ANAL CELL PATHOL, V33, P37, DOI [10.1155/2010/279317, 10.3233/ACP-CLO-2010-0530]; Knudson AG, 2002, AM J MED GENET, V111, P96, DOI 10.1002/ajmg.10320; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Lee CJ, 2002, MOL BRAIN RES, V106, P151, DOI 10.1016/S0169-328X(02)00439-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicholson P, 2010, BIOCHEM SOC T, V38, P1615, DOI 10.1042/BST0381615; Ohgaki H, 2011, BRAIN TUMOR PATHOL, V28, P177, DOI 10.1007/s10014-011-0029-1; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; Ollila J, 1996, FEBS LETT, V396, P119, DOI 10.1016/0014-5793(96)01075-7; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; Roch F, 2002, DEVELOPMENT, V129, P993; Sahm F, 2012, ACTA NEUROPATHOL, V123, P853, DOI 10.1007/s00401-012-0993-5; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; The WHO, 2020, CLASSIFICATION TUMOU; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Weiler M, 2012, CURR OPIN NEUROL, V25, P767, DOI 10.1097/WCO.0b013e32835a0217; Williams BY, 2000, FEBS LETT, V470, P207, DOI 10.1016/S0014-5793(00)01320-X; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang D, 2010, BBA-GENE REGUL MECH, V1799, P157, DOI 10.1016/j.bbagrm.2009.11.002; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995; Zhang J, 2013, ONCOGENE, V32, P2907, DOI 10.1038/onc.2012.350	42	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76623	10.1371/journal.pone.0076623	http://dx.doi.org/10.1371/journal.pone.0076623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086756	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900107
J	Twin, J; Bradshaw, CS; Garland, SM; Fairley, CK; Fethers, K; Tabrizi, SN				Twin, Jimmy; Bradshaw, Catriona S.; Garland, Suzanne M.; Fairley, Christopher K.; Fethers, Katherine; Tabrizi, Sepehr N.			The Potential of Metatranscriptomics for Identifying Screening Targets for Bacterial Vaginosis	PLOS ONE			English	Article							PERIODONTAL PATHOGENS; GARDNERELLA-VAGINALIS; GENITAL-TRACT; RNA; DNA; IDENTIFICATION; COLONIZATION; LACTOBACILLI; DIVERSITY; PRIMERS	Background: The ribosomal RNA content of a sample collected from a woman with bacterial vaginosis (BV) was analysed to determine the active microbial community, and to identify potential targets for further screening. Methodology/Principal Findings: The sample from the BV patient underwent total RNA extraction, followed by physical subtraction of human rRNA and whole transcriptome amplification. The metatranscriptome was sequenced using Roche 454 titanium chemistry. The bioinformatics pipeline MG-RAST and desktop DNA analysis platforms were utilised to analyse results. Bacteria of the genus Prevotella (predominately P. amnii) constituted 36% of the 16S rRNA reads, followed by Megasphaera (19%), Leptotrichia/Sneathia (8%) and Fusobacterium (8%). Comparison of the abundances of several bacteria to quantitative PCR (qPCR) screening of extracted DNA revealed comparable relative abundances. This suggests a correlation between what was present and transcriptionally active in this sample: however distinct differences were seen when compared to the microbiome determined by 16S rRNA gene amplicon sequencing. To assess the presence of P. amnii in a larger pool of samples, 90 sexually active women were screened using qPCR. This bacterium was found to be strongly associated with BV (P < 0.001, OR 23.3 (95% CI: 2.9-190.7)) among the 90 women. Conclusions/Significance: This study highlighted the potential of metatranscriptomics as a tool for characterising metabolically active microbiota and identifying targets for further screening. Prevotella amnii was chosen as an example target, being the most metabolically active species present in the single patient with BV, and was found to be detected at a high concentration by qPCR in 31% of cohort with BV, with an association with both oral and penile-vaginal sex.	[Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bradshaw, Catriona S.; Fairley, Christopher K.; Fethers, Katherine] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bradshaw, Catriona S.; Fairley, Christopher K.; Fethers, Katherine] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.] Royal Childrens Hosp, Dept Microbiol, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Monash University; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne	Twin, J (corresponding author), Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia.	jimmy.twin@mcri.edu.au		bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664	Australian federal government NHMRC [568971]	Australian federal government NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded under the Australian federal government NHMRC program grant 568971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Frias-Lopez J, 2012, J BACTERIOL, V194, P2082, DOI 10.1128/JB.06328-11; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Gauthier S, 2011, J MATERN-FETAL NEO M, V24, P1329, DOI 10.3109/14767058.2010.550977; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Joshi Vinayak M, 2007, Indian J Dent Res, V18, P6; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Lawson PA, 2008, INT J SYST EVOL MICR, V58, P89, DOI 10.1099/ijs.0.65118-0; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Ling ZX, 2011, MICROB ECOL, V61, P704, DOI 10.1007/s00248-011-9813-z; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nadkarni MA, 2012, EUR J CLIN MICROBIOL, V31, P2989, DOI 10.1007/s10096-012-1651-5; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Nikkari S, 2002, EMERG INFECT DIS, V8, P188, DOI 10.3201/eid0802.010150; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pybus V, 1997, J INFECT DIS, V175, P406, DOI 10.1093/infdis/175.2.406; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; StataCorp, 2011, STAT STAT SOFTW REL, P173; Triant DA, 2009, J HERED, V100, P246, DOI 10.1093/jhered/esn083; Turovskiy Y, 2011, J APPL MICROBIOL, V110, P1105, DOI 10.1111/j.1365-2672.2011.04977.x; Winsley T, 2012, APPL ENVIRON MICROB, V78, P5938, DOI 10.1128/AEM.01299-12; Zariffard MR, 2002, FEMS IMMUNOL MED MIC, V34, P277, DOI 10.1111/j.1574-695X.2002.tb00634.x	42	18	20	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76892	10.1371/journal.pone.0076892	http://dx.doi.org/10.1371/journal.pone.0076892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086764	Green Published, gold			2022-12-27	WOS:000325223900109
J	Tu, YF; Wan, L; Fan, YH; Wang, KZ; Bu, LH; Huang, T; Cheng, Z; Shen, BZ				Tu, Yingfeng; Wan, Lin; Fan, Yuhua; Wang, Kezheng; Bu, Lihong; Huang, Tao; Cheng, Zhen; Shen, Baozhong			Ischemic Postconditioning-Mediated miRNA-21 Protects against Cardiac ischemia/reperfusion Injury via PTEN/Akt Pathway	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; NITRIC-OXIDE SYNTHASE; CARDIOMYOCYTE APOPTOSIS; HEART; MICRORNA; EXPRESSION; CARDIOPROTECTION; ATTENUATION; ACTIVATION	Background: Ischemic postconditioning (IPost) protects the reperfused heart from infarction which has drawn much attention recently. However, studies to date have rarely investigated the role of microRNAs (miRNAs) in IPost. The aims of this study were to investigate whether miR-21 is involved in the protective effect of IPost against myocardial ischemia-reperfusion (I/R) injury and disclose the potential molecular mechanisms involved. Methods and Results: We found that miR-21 was remarkably up-regulated in mouse hearts after IPost. To determine the protective role of IPost-induced miR-21 up-regulation, the mice were divided into the following four groups: I/R group; I/R+IPost group (I/R mice treated with IPost); Antagomir-21+IPost+I/R group (I/R mice treated with anagomir-21 and IPost); Scramble+IPost+I/R group (I/R mice treated with scramble and IPost). The results showed IPost could reduce I/R injury-induced infarct size of the left ventricle, improve cardiac function, and prevent myocardial apoptosis, while knockdown of miR-21 with antagomir-21 could reverse these protective effects of IPost against mouse I/R injury. Furthermore, we confirmed that miR-21 plays a protective role in myocardial apoptosis through PTEN/Akt signaling pathway, which was abrogated by the PI3K inhibitor LY294002. The protective effect of miR-21 on myocardial apoptosis was further revealed in mouse hearts after IPost treatment in vivo. Conclusions: Our data clearly demonstrate that miR-21 is involved in IPost-mediated cardiac protection against I/R injury and dysfunction through the PTEN/Akt signaling pathway in vivo. Identifying the beneficial roles of IPost-regulated miRNAs in cardiac protection, which may be a rational target selection for ischemic cardioprotection.	[Tu, Yingfeng; Wan, Lin; Wang, Kezheng; Bu, Lihong; Huang, Tao; Shen, Baozhong] Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Tu, Yingfeng; Wan, Lin; Wang, Kezheng; Bu, Lihong; Huang, Tao; Shen, Baozhong] Harbin Med Univ, Hosp 4, Key Lab Mol Imaging, Harbin, Heilongjiang, Peoples R China; [Tu, Yingfeng] Harbin Med Univ, Hosp 4, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Fan, Yuhua] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Heilongjiang, Peoples R China; [Cheng, Zhen] Stanford Univ, Mol Imaging Program Stanford, Dept Radiol, Stanford, CA 94305 USA; [Cheng, Zhen] Stanford Univ, Biox Program, Stanford, CA 94305 USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Stanford University; Stanford University	Shen, BZ (corresponding author), Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China.	shenbzh@vip.sina.com	Cheng, Zhen/K-2843-2012	Cheng, Zhen/0000-0001-8177-9463	National Natural Science Foundation of China [30970807, 31210103913]; Harbin Medical University [WLD-QN1120]; China Postdoctoral Science Foundation [2012M520765-119186]; Research Fund for the Doctoral Program of Higher Education of China [20112307120025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Medical University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (30970807), National Natural Science Foundation of China (31210103913), "Liande Wu Funding" of Harbin Medical University (WLD-QN1120), China Postdoctoral Science Foundation (2012M520765-119186), Research Fund for the Doctoral Program of Higher Education of China (20112307120025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bai HT, 2011, FEBS LETT, V585, P402, DOI 10.1016/j.febslet.2010.12.027; Chen ZG, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-80; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Duan X, 2012, CARDIOLOGY, V122, P36, DOI 10.1159/000338149; Forouzanfar MH, 2012, GLOB HEART, V7, P331, DOI 10.1016/j.gheart.2012.10.003; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Gross GJ, 2009, AM J PHYSIOL-HEART C, V297, pH47, DOI 10.1152/ajpheart.01084.2008; Guo YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041178; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Jabs A, 2010, CLIN HEMORHEOL MICRO, V45, P185, DOI 10.3233/CH-2010-1297; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Jujo K, 2013, CIRCULATION, V127, P63, DOI 10.1161/CIRCULATIONAHA.112.099242; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lin XM, 2010, CHINESE MED J-PEKING, V123, P1833, DOI 10.3760/cma.j.issn.0366-6999.2010.14.002; Lonborg J, 2010, CIRC-CARDIOVASC INTE, V3, P34, DOI 10.1161/CIRCINTERVENTIONS.109.905521; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; Ma XJ, 2012, CORONARY ARTERY DIS, V23, P245, DOI 10.1097/MCA.0b013e3283526a7d; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Ruan HM, 2009, J MOL CELL CARDIOL, V46, P193, DOI 10.1016/j.yjmcc.2008.10.021; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Somers SJ, 2011, PHYSIOL RES, V60, P971, DOI 10.33549/physiolres.932129; Sumi S, 2010, AM J PHYSIOL-HEART C, V299, pH1174, DOI 10.1152/ajpheart.00116.2010; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Sun HM, 2010, HEART SURG FORUM, V13, pE305, DOI 10.1532/HSF98.20101013; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wu QL, 2012, SHOCK, V38, P165, DOI 10.1097/SHK.0b013e31825b5633; Xu XD, 2012, J CELL PHYSIOL, V227, P1391, DOI 10.1002/jcp.22852; Xue F, 2010, CLIN CARDIOL, V33, P439, DOI 10.1002/clc.20796; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yin C, 2009, CIRC RES, V104, P572, DOI 10.1161/CIRCRESAHA.108.193250; Zhuo CJ, 2011, MOL CELL BIOCHEM, V346, P39, DOI 10.1007/s11010-010-0589-0; Zu LY, 2011, AM J PHYSIOL-HEART C, V300, pH2177, DOI 10.1152/ajpheart.01138.2010	40	98	105	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75872	10.1371/journal.pone.0075872	http://dx.doi.org/10.1371/journal.pone.0075872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098402	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600025
J	Donati, AJ; Lee, HI; Leveau, JHJ; Chang, WS				Donati, Andrew J.; Lee, Hae-In; Leveau, Johan H. J.; Chang, Woo-Suk			Effects of Indole-3-Acetic Acid on the Transcriptional Activities and Stress Tolerance of Bradyrhizobium japonicum	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; AGROBACTERIUM-TUMEFACIENS; PHYSIOLOGICAL-RESPONSES; COLORIMETRIC METHOD; BIOFILM FORMATION; PLANT-GROWTH; NODULATION; AUXIN; EXOPOLYSACCHARIDES; DESICCATION	A genome-wide transcriptional profile of Bradyrhizobium japonicum, the nitrogen-fixing endosymbiont of the soybean plant, revealed differential expression of approximately 15% of the genome after a 1 mM treatment with the phytohormone indole-3-acetic acid (IAA). A total of 1,323 genes were differentially expressed (619 up-regulated and 704 down-regulated) at a two-fold cut off with q value <= 0.05. General stress response genes were induced, such as those involved in response to heat, cold, oxidative, osmotic, and desiccation stresses and in exopolysaccharide (EPS) biosynthesis. This suggests that IAA is effective in activating a generalized stress response in B. japonicum. The transcriptional data were corroborated by the finding that stress tolerance of B. japonicum in cell viability assays was enhanced when pre-treated with 1 mM IAA compared to controls. The IAA treatment also stimulated biofilm formation and EPS production by B. japonicum, especially acidic sugar components in the total EPS. The IAA pretreatment did not influence the nodulation ability of B. japonicum. The data provide a comprehensive overview of the potential transcriptional responses of the symbiotic bacterium when exposed to the ubiquitous hormone of its plant host.	[Donati, Andrew J.; Lee, Hae-In; Chang, Woo-Suk] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Leveau, Johan H. J.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of Texas System; University of Texas Arlington; University of California System; University of California Davis	Chang, WS (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	wschang@uta.edu	Leveau, Johan HJ/C-1096-2012	Leveau, Johan HJ/0000-0002-8376-4553	University of Texas-Arlington; UTA [14-7488-34]	University of Texas-Arlington; UTA	This research was supported in part by a Research Enhancement Program (REP) grant from the University of Texas-Arlington. UTA Grant Number is 14-7488-34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BERGERSEN F, 1961, AUST J BIOL SCI, V14, P349, DOI 10.1071/BI9610349; Bergmaier D, 2001, APPL MICROBIOL BIOT, V57, P401, DOI 10.1007/s002530100764; Bianco C, 2006, MICROBIOL-SGM, V152, P2421, DOI 10.1099/mic.0.28765-0; Bianco C, 2006, ARCH MICROBIOL, V185, P373, DOI 10.1007/s00203-006-0103-y; BINNS AN, 1988, ANNU REV MICROBIOL, V42, P575, DOI 10.1146/annurev.mi.42.100188.003043; Bittner M., 2003, P101; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boiero L, 2007, APPL MICROBIOL BIOT, V74, P874, DOI 10.1007/s00253-006-0731-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Chang WS, 2007, MOL PLANT MICROBE IN, V20, P1298, DOI 10.1094/mpmi-20-10-1298; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chang WS, 2003, J BACTERIOL, V185, P6199, DOI 10.1128/JB.185.20.6199-6204.2003; Cytryn EJ, 2007, J BACTERIOL, V189, P6751, DOI 10.1128/JB.00533-07; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Donati AJ, 2011, APPL ENVIRON MICROB, V77, P3633, DOI 10.1128/AEM.00047-11; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; EGEBO LA, 1991, J BACTERIOL, V173, P4897, DOI 10.1128/jb.173.15.4897-4901.1991; Figueiredo MVB, 2008, WORLD J MICROB BIOT, V24, P1187, DOI 10.1007/s11274-007-9591-4; HALVERSON LJ, 1986, APPL ENVIRON MICROB, V51, P753, DOI 10.1128/AEM.51.4.753-760.1986; HUNTER WJ, 1987, APPL ENVIRON MICROB, V53, P1051, DOI 10.1128/AEM.53.5.1051-1055.1987; Imperlini E, 2009, APPL MICROBIOL BIOT, V83, P727, DOI 10.1007/s00253-009-1974-z; JENSEN JB, 1995, J BACTERIOL, V177, P5762, DOI 10.1128/jb.177.20.5762-5766.1995; Jeon JM, 2011, MOL PLANT MICROBE IN, V24, P1472, DOI 10.1094/MPMI-03-11-0072; Kachlany SC, 2001, ENVIRON MICROBIOL, V3, P774, DOI 10.1046/j.1462-2920.2001.00248.x; KADO CI, 1991, CRIT REV PLANT SCI, V10, P1, DOI 10.1080/07352680490273310; KANESHIRO T, 1985, PLANT SCI, V42, P141, DOI 10.1016/0168-9452(85)90119-0; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; KLINE EL, 1980, P NATL ACAD SCI-BIOL, V77, P1768, DOI 10.1073/pnas.77.4.1768; Lee HI, 2012, APPL ENVIRON MICROB, V78, P2896, DOI 10.1128/AEM.07336-11; MAI XH, 1994, J BIOL CHEM, V269, P16726; MINAMISAWA K, 1991, PLANT CELL PHYSIOL, V32, P1; Niu C, 2004, APPL ENVIRON MICROB, V70, P6951, DOI 10.1128/AEM.70.12.6951-6956.2004; Paponov IA, 2008, MOL PLANT, V1, P321, DOI 10.1093/mp/ssm021; Parniske M, 2003, NATURE, V425, P569, DOI 10.1038/425569a; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pii Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-21; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; PREISIG O, 1993, P NATL ACAD SCI USA, V90, P3309, DOI 10.1073/pnas.90.8.3309; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; READ RR, 1987, CAN J MICROBIOL, V33, P1080, DOI 10.1139/m87-189; SADOWSKY MJ, 1987, APPL ENVIRON MICROB, V53, P2624, DOI 10.1128/AEM.53.11.2624-2630.1987; Salkowski E., 1885, Z PHYSL CHEM, V9, P23; Salunkhe P, 2005, J BACTERIOL, V187, P2565, DOI 10.1128/JB.187.8.2565-2572.2005; Tamaru Y, 2005, APPL ENVIRON MICROB, V71, P7327, DOI 10.1128/AEM.71.11.7327-7333.2005; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Puyvelde S, 2011, MICROB ECOL, V61, P723, DOI 10.1007/s00248-011-9819-6; YAMADA T, 1993, ANNU REV PHYTOPATHOL, V31, P253, DOI 10.1146/annurev.py.31.090193.001345; YAMADA T, 1986, P NATL ACAD SCI USA, V83, P8263, DOI 10.1073/pnas.83.21.8263; Yuan ZC, 2008, CELL MICROBIOL, V10, P2339, DOI 10.1111/j.1462-5822.2008.01215.x; Zakharova EA, 1999, EUR J BIOCHEM, V259, P572, DOI 10.1046/j.1432-1327.1999.00033.x	53	48	50	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76559	10.1371/journal.pone.0076559	http://dx.doi.org/10.1371/journal.pone.0076559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098533	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500074
J	Marjanska, M; Emir, UE; Deelchand, DK; Terpstra, M				Marjanska, Malgorzata; Emir, Uzay E.; Deelchand, Dinesh K.; Terpstra, Melissa			Faster Metabolite H-1 Transverse Relaxation in the Elder Human Brain	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; VIVO H-1-NMR SPECTROSCOPY; PROTON T-2 RELAXATION; WATER; TIME; RAT; QUANTIFICATION; ABNORMALITIES; QUANTITATION; DIFFUSION	H-1 magnetic resonance spectroscopy (MRS) is unique among imaging modalities because signals from several metabolites are measured during a single examination period. Each metabolite reflects a distinct intracellular process. Furthermore transverse (T-2) relaxation times probe the viability of the cell microenvironment, e.g., the viscosity of the cellular fluids, the microscopic susceptibility distribution within the cells, and the iron content. In this study, T(2)s of brain metabolites were measured in the occipital lobe of eighteen young and fourteen elderly subjects at a field strength of 4 tesla. The T(2)s of N-acetylaspartate, total creatine, and total choline were 23%, 16% and 10% shorter in elderly than in young subjects. The findings of this study suggest that noninvasive detection of T-2 provides useful biological information on changes in the cellular microenvironment that take place during aging.	[Marjanska, Malgorzata] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Marjanska, M (corresponding author), Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	gosia@cmrr.umn.edu	Emir, Uzay/ABB-9979-2020; Deelchand, Dinesh/AAV-9776-2021	emir, uzay/0000-0001-5376-0431; Marjanska, Malgorzata/0000-0002-4727-2447; Deelchand, Dinesh/0000-0003-4266-4780	National Institutes of Health [R21 AG029582, RO1 AG039396, P41 RR008079, P41 EB015894, P30 NS057091, P30 NS507608, S10 RR023730]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023730, P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091, P30NS076408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039396, R21AG029582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health through grants R21 AG029582, RO1 AG039396, P41 RR008079, P41 EB015894, P30 NS057091, P30 NS507608, S10 RR023730. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 1997, J MAGN RESON, V125, P178, DOI 10.1006/jmre.1997.1113; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Brooks JCW, 2001, CEREB CORTEX, V11, P598, DOI 10.1093/cercor/11.7.598; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P799, DOI 10.1016/0730-725X(93)90197-L; De Graaf RA, 2007, IN VIVO NMR SPECTROS; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Double KL, 2010, PROG NEUROBIOL, V92, P316, DOI 10.1016/j.pneurobio.2010.06.001; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Henry PG, 2006, MAGN RESON MED, V55, P250, DOI 10.1002/mrm.20764; HETHERINGTON HP, 1994, MAGNET RESON MED, V32, P565, DOI 10.1002/mrm.1910320504; Kaiser LG, 2010, J MAGN RESON, V202, P259, DOI 10.1016/j.jmr.2009.11.013; Kirov II, 2008, MAGN RESON MED, V60, P790, DOI 10.1002/mrm.21715; Kreis R, 2005, MAGN RESON MED, V54, P761, DOI 10.1002/mrm.20673; KRUSE T, 1985, J NEUROL SCI, V70, P129, DOI 10.1016/0022-510X(85)90082-6; Larvaron P, 2006, NMR BIOMED, V19, P180, DOI 10.1002/nbm.997; Lei H, 2003, MAGNET RESON MED, V49, P979, DOI 10.1002/mrm.10490; Michaeli S, 2002, MAGN RESON MED, V47, P629, DOI 10.1002/mrm.10135; Mitsumori F, 2009, MAGN RESON MED, V62, P1326, DOI 10.1002/mrm.22097; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nicolay K, 2001, NMR BIOMED, V14, P94, DOI 10.1002/nbm.686; Ongur D, 2010, MAGN RESON MED, V63, P1, DOI 10.1002/mrm.22148; Onishi J, 2006, J GERIATR PSYCH NEUR, V19, P26, DOI 10.1177/0891988705284725; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; POSSE S, 1995, MAGNET RESON MED, V33, P246, DOI 10.1002/mrm.1910330215; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; SCHENKER C, 1993, NEURORADIOLOGY, V35, P119, DOI 10.1007/BF00593967; Tkac I, 2005, APPL MAGN RESON, V29, P139, DOI 10.1007/BF03166960; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; Tunc-Skarka N, 2009, NEUROIMAGE, V48, P525, DOI 10.1016/j.neuroimage.2009.06.061; Valette J, 2007, J CEREBR BLOOD F MET, V27, P588, DOI 10.1038/sj.jcbfm.9600353; Wang XK, 2010, CURR GENOMICS, V11, P618, DOI 10.2174/138920210793360943	40	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77572	10.1371/journal.pone.0077572	http://dx.doi.org/10.1371/journal.pone.0077572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098589	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500102
J	Neto, LV; Wildemberg, LE; Colli, LM; Kasuki, L; Marques, NV; Moraes, AB; Gasparetto, EL; Takiya, CM; Castro, M; Gadelha, MR				Neto, Leonardo Vieria; Wildemberg, Luiz Eduardo; Colli, Leandro Machado; Kasuki, Leandro; Marques, Nelma Veronica; Moraes, Aline Barbosa; Gasparetto, Emerson L.; Takiya, Christina Maeda; Castro, Margaret; Gadelha, Monica Roberto			ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas	PLOS ONE			English	Article							SOMATOSTATIN ANALOG THERAPY; TUMOR-SUPPRESSOR GENE; EXPRESSION; PCR; HETEROZYGOSITY; OCTREOTIDE; DOPAMINE; GROWTH	Introduction: There are few data regarding ZAC1 expression in clinically non-functioning pituitary adenomas (NFPA). Because somatotropinomas and NFPA behave differently with respect to tumor shrinkage during somatostatin analogs (SA) therapy, we sought to compare the ZAC1 and somatostatin receptor (sstr) types 1, 2, 3 and 5 mRNA expression in these two pituitary adenoma subtypes and in normal human pituitaries. Methods: ZAC1 and SSTR mRNA expression levels were evaluated using real-time RT-PCR (TaqMan) in 20 NFPA and compared with the expression levels in 23 somatotropinomas and five normal pituitaries. The NFPA invasiveness was evaluated using magnetic resonance imaging with Hardy's modified criteria. Ki-67 and p53 were evaluated using immunohistochemistry. Results: A total of 20 patients with NFPA [6 males, median age 56 years (range: 30-78)], 23 with acromegaly [12 males, median age 43 years (range: 24-57)] and five normal pituitaries [4 males, median age 48 years (range: 3654)] were included. Four of the patients (20%) had Hardy's grade 2 tumors; all of the others had Hardy's grade 3 tumors. The Ki-67 median expression was 2.35 (range: 0.2-9.23), and only four of the tumors (20%) were positive for p53. The ZAC1 mRNA expression was significantly lower in NFPA than in somatotropinomas and in normal pituitaries (p<0.001 for both), as well as the SSTR2 (p=0.001 and 0.01, respectively). The SSTR3 expression was higher in the NFPA than in the somatotropinomas and in the normal pituitaries (p=0.03 and 0.02, respectively). No correlation was found between the ZAC1 mRNA expression and the tumor invasiveness, Ki-67 and p53. Conclusion: ZAC1 and SSTR2 are underexpressed and SSTR3 is overexpressed in NFPA compared to those in somatotropinomas and in normal pituitaries, which might explain the lack of tumor shrinkage that is observed in response to commercially available SA therapy in patients with NFPA.	[Neto, Leonardo Vieria; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Marques, Nelma Veronica; Moraes, Aline Barbosa; Gadelha, Monica Roberto] Univ Fed Rio de Janeiro, Dept Internal Med, Sch Med, Rio De Janeiro, Brazil; [Neto, Leonardo Vieria; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Marques, Nelma Veronica; Moraes, Aline Barbosa; Gadelha, Monica Roberto] Univ Fed Rio de Janeiro, Endocrine Unit, Sch Med, Rio De Janeiro, Brazil; [Neto, Leonardo Vieria; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Marques, Nelma Veronica; Moraes, Aline Barbosa; Gasparetto, Emerson L.; Gadelha, Monica Roberto] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Rio De Janeiro, Brazil; [Neto, Leonardo Vieria] Fed Hosp Lagoa, Endocrinol Unit, Rio De Janeiro, Brazil; [Colli, Leandro Machado; Castro, Margaret] Univ Sao Paulo, Dept Internal Med, Med Sch Ribeirao Preto, Sao Paulo, Brazil; [Gasparetto, Emerson L.] Univ Fed Rio de Janeiro, Radiol Unit, Sch Med, Rio De Janeiro, Brazil; [Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Biofis Carlos Chagas Filho Inst, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Dept Internal Med, Sch Med, Rio De Janeiro, Brazil.	mgadelha@hucff.ufrj.br	Colli, Leandro/A-3445-2009; de Castro, Margaret/A-4918-2009; Takiya, Christina/AAU-5959-2021; Kasuki, Leandro/R-8117-2019; wildemberg, luiz/S-4712-2017	Colli, Leandro/0000-0001-6928-1195; de Castro, Margaret/0000-0003-4932-4623; Takiya, Christina/0000-0002-8019-628X; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Novartis Pharmaceuticals	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Novartis Pharmaceuticals(Novartis)	This work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (to LVN) and Novartis Pharmaceuticals (to LVN and MRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates AS, 1997, J CLIN ENDOCR METAB, V82, P818, DOI 10.1210/jc.82.3.818; Bevan JS, 2005, J CLIN ENDOCR METAB, V90, P1856, DOI 10.1210/jc.2004-1093; Bilanges B, 1999, ONCOGENE, V18, P3979, DOI 10.1038/sj.onc.1202933; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Colao A, 2009, REV ENDOCR METAB DIS, V10, P111, DOI 10.1007/s11154-008-9107-z; Cvetkovic D, 2004, GYNECOL ONCOL, V95, P449, DOI 10.1016/j.ygyno.2004.08.051; Florio T, 2003, ENDOCRINOLOGY, V144, P1574, DOI 10.1210/en.2002-220949; Gadelha MR, 2013, TRENDS ENDOCRIN MET, V24, P238, DOI 10.1016/j.tem.2012.11.007; Gatto F, 2013, J CLIN ENDOCR METAB, V98, pE66, DOI 10.1210/jc.2012-2609; de Pinho LKJ, 2011, NEUROENDOCRINOLOGY, V94, P39, DOI 10.1159/000322787; Lemeta S, 2007, J NEUROPATH EXP NEUR, V66, P860, DOI 10.1097/nen.0b013e318149ee64; Lemeta S, 2006, HUM PATHOL, V37, P749, DOI 10.1016/j.humpath.2006.02.002; Michaelis KA, 2011, ENDOCRINOLOGY, V152, P3603, DOI 10.1210/en.2011-0109; Noh TW, 2009, J CLIN ENDOCR METAB, V94, P4406, DOI 10.1210/jc.2009-0471; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Pagotto U, 1999, ENDOCRINOLOGY, V140, P987, DOI 10.1210/en.140.2.987; Pagotto U, 2000, CANCER RES, V60, P6794; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Pyronnet S, 2008, MOL CELL ENDOCRINOL, V286, P230, DOI 10.1016/j.mce.2008.02.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; Theodoropoulou M, 2012, J KLIN ENDOKRINOL ST, V5, P1; Theodoropoulou M, 2010, MOL CELL ENDOCRINOL, V326, P60, DOI 10.1016/j.mce.2010.01.033; Theodoropoulou M, 2009, INT J CANCER, V125, P2122, DOI 10.1002/ijc.24602; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Neto LV, 2011, ARQ BRAS ENDOCRINOL, V55, P725, DOI 10.1590/S0004-27302011000900011; Neto LV, 2009, J CLIN ENDOCR METAB, V94, P1931, DOI 10.1210/jc.2008-1826; Wildemberg LEA, 2013, J ENDOCRINOL INVEST, V36, P38, DOI 10.3275/8305; Wildemberg LEA, 2012, J ENDOCRINOL INVEST, V35, P580, DOI 10.3275/7906	30	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77406	10.1371/journal.pone.0077406	http://dx.doi.org/10.1371/journal.pone.0077406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098585	Green Submitted, gold, Green Published			2022-12-27	WOS:000325434500099
J	Begemann, MB; Zess, EK; Walters, EM; Schmitt, EF; Markley, AL; Pfleger, BF				Begemann, Matthew B.; Zess, Erin K.; Walters, Eric M.; Schmitt, Emily F.; Markley, Andrew L.; Pfleger, Brian F.			An Organic Acid Based Counter Selection System for Cyanobacteria	PLOS ONE			English	Article							SALMONELLA-ENTERICA; SYNECHOCOCCUS; 2-METHYLCITRATE; FERMENTATION; ACCUMULATION; TOXICITY	Cyanobacteria are valuable organisms for studying the physiology of photosynthesis and carbon fixation, as well as metabolic engineering for the production of fuels and chemicals. This work describes a novel counter selection method for the cyanobacterium Synechococcus sp. PCC 7002 based on organic acid toxicity. The organic acids acrylate, 3-hydroxypropionate, and propionate were shown to be inhibitory towards Synechococcus sp. PCC 7002 and other cyanobacteria at low concentrations. Inhibition was overcome by a loss of function mutation in the gene acsA, which is annotated as an acetyl-CoA ligase. Loss of AcsA function was used as a basis for an acrylate counter selection method. DNA fragments of interest were inserted into the acsA locus and strains harboring the insertion were isolated on selective medium containing acrylate. This methodology was also used to introduce DNA fragments into a pseudogene, glpK. Application of this method will allow for more advanced genetics and engineering studies in Synechococcus sp. PCC 7002 including the construction of markerless gene deletions and insertions. The acrylate counter-selection could be applied to other cyanobacterial species where AcsA activity confers acrylate sensitivity (e.g. Synechocystis sp. PCC 6803).	[Begemann, Matthew B.; Pfleger, Brian F.] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI 53715 USA; [Begemann, Matthew B.; Zess, Erin K.; Walters, Eric M.; Schmitt, Emily F.; Markley, Andrew L.; Pfleger, Brian F.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Pfleger, BF (corresponding author), Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI 53715 USA.	pfleger@engr.wisc.edu	Pfleger, Brian Frederick/AAA-2559-2022	Pfleger, Brian Frederick/0000-0002-9232-9959	National Science Foundation [EFRI-1240268, CBET-1149678, SEES 12-15871]; US Air Force Office of Scientific Research [FA9550-11-1-0038]; US Department of Energy Genomics: GTL and SciDAC Programs [DE-FG02-04ER25627]; University of Wisconsin-Madison graduate school; Directorate For Engineering [1240268] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1149678] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Department of Energy Genomics: GTL and SciDAC Programs(United States Department of Energy (DOE)); University of Wisconsin-Madison graduate school; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by the National Science Foundation (EFRI-1240268, CBET-1149678, SEES 12-15871), the US Air Force Office of Scientific Research (FA9550-11-1-0038), the US Department of Energy Genomics: GTL and SciDAC Programs (DE-FG02-04ER25627) and the University of Wisconsin-Madison graduate school. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheah YE, 2013, BIOTECHNOL PROGR, V29, P23, DOI 10.1002/btpr.1661; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Frigaard NU, 2004, METH MOL B, V274, P325; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Green PR, 2001, BIOMACROMOLECULES, V3, P208; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; IHLENFELDT MJA, 1977, ARCH MICROBIOL, V113, P231, DOI 10.1007/BF00492030; JOSET F, 1988, ARCH MICROBIOL, V149, P417, DOI 10.1007/BF00425581; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Rocco CJ, 2010, J BACTERIOL, V192, P771, DOI 10.1128/JB.01301-09; Rosmarie R, 1988, METHOD ENZYMOL, P3; RUSSELL JB, 1992, J APPL BACTERIOL, V73, P363, DOI 10.1111/j.1365-2672.1992.tb04990.x; Schneider K, 2012, J BACTERIOL, V194, P225, DOI 10.1128/JB.05959-11; STEVENS SE, 1973, J PHYCOL, V9, P427, DOI 10.1111/j.1529-8817.1973.tb04116.x; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; THIJSSE GJE, 1964, BIOCHIM BIOPHYS ACTA, V84, P195, DOI 10.1016/0926-6542(64)90078-2; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wang B, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00344; Warnecke TE, 2010, METAB ENG, V12, P241, DOI 10.1016/j.ymben.2009.12.002; Xu Y, 2013, METAB ENG, V16, P56, DOI 10.1016/j.ymben.2012.12.002; Xu Y, 2011, METHODS MOL BIOL, V684, P273, DOI [10.1007/978.1.60761.925.3_21, 10.1007/978-1-60761-925-3_21]; Zaldivar J, 1999, BIOTECHNOL BIOENG, V66, P203, DOI [10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.0.CO;2-#, 10.1002/(SICI)1097-0290(1999)66:4&lt;203::AID-BIT1&gt;3.0.CO;2-#]; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858	30	44	45	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76594	10.1371/journal.pone.0076594	http://dx.doi.org/10.1371/journal.pone.0076594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098537	gold, Green Submitted, Green Published			2022-12-27	WOS:000325427100079
J	Chambers, LE; Altwegg, R; Barbraud, C; Barnard, P; Beaumont, LJ; Crawford, RJM; Durant, JM; Hughes, L; Keatley, MR; Low, M; Morellato, PC; Poloczanska, ES; Ruoppolo, V; Vanstreels, RET; Woehler, EJ; Wolfaardt, AC				Chambers, Lynda E.; Altwegg, Res; Barbraud, Christophe; Barnard, Phoebe; Beaumont, Linda J.; Crawford, Robert J. M.; Durant, Joel M.; Hughes, Lesley; Keatley, Marie R.; Low, Matt; Morellato, Patricia C.; Poloczanska, Elvira S.; Ruoppolo, Valeria; Vanstreels, Ralph E. T.; Woehler, Eric J.; Wolfaardt, Anton C.			Phenological Changes in the Southern Hemisphere	PLOS ONE			English	Article							CLIMATE-CHANGE; BREEDING PHENOLOGY; REPRODUCTIVE SUCCESS; ECOLOGICAL RESEARCH; MIGRATION; MARINE; TERRESTRIAL; PENGUINS; BIRDS; OCEAN	Current evidence of phenological responses to recent climate change is substantially biased towards northern hemisphere temperate regions. Given regional differences in climate change, shifts in phenology will not be uniform across the globe, and conclusions drawn from temperate systems in the northern hemisphere might not be applicable to other regions on the planet. We conduct the largest meta-analysis to date of phenological drivers and trends among southern hemisphere species, assessing 1208 long-term datasets from 89 studies on 347 species. Data were mostly from Australasia (Australia and New Zealand), South America and the Antarctic/subantarctic, and focused primarily on plants and birds. This meta-analysis shows an advance in the timing of spring events (with a strong Australian data bias), although substantial differences in trends were apparent among taxonomic groups and regions. When only statistically significant trends were considered, 82% of terrestrial datasets and 42% of marine datasets demonstrated an advance in phenology. Temperature was most frequently identified as the primary driver of phenological changes; however, in many studies it was the only climate variable considered. When precipitation was examined, it often played a key role but, in contrast with temperature, the direction of phenological shifts in response to precipitation variation was difficult to predict a priori. We discuss how phenological information can inform the adaptive capacity of species, their resilience, and constraints on autonomous adaptation. We also highlight serious weaknesses in past and current data collection and analyses at large regional scales (with very few studies in the tropics or from Africa) and dramatic taxonomic biases. If accurate predictions regarding the general effects of climate change on the biology of organisms are to be made, data collection policies focussing on targeting data-deficient regions and taxa need to be financially and logistically supported.	[Chambers, Lynda E.] Ctr Australian Weather & Climate Res, Melbourne, Vic, Australia; [Altwegg, Res; Barnard, Phoebe] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, South Africa; [Barbraud, Christophe] CNRS, CEBC, UPR 1934, Villiers En Bois, France; [Beaumont, Linda J.; Hughes, Lesley] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Crawford, Robert J. M.] Dept Environm Affairs & Tourism, Cape Town, South Africa; [Durant, Joel M.] Univ Oslo, Ctr Ecol & Evolutionary Synth, Dept Biosci, Oslo, Norway; [Keatley, Marie R.] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia; [Low, Matt] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Morellato, Patricia C.] UNESP Univ Estadual Paulista, Lab Fenol, Dept Bot, Inst Biociencias, Sao Paulo, Brazil; [Poloczanska, Elvira S.] CSIRO Marine & Atmospher Res, Climate Adaptat Flagship, Brisbane, Qld, Australia; [Ruoppolo, Valeria] Int Fund Anim Welf, Yarmouth Port, MA USA; [Ruoppolo, Valeria; Vanstreels, Ralph E. T.] Univ Sao Paulo, Lab Wildlife Comparat Pathol, Fac Vet Med, Sao Paulo, Brazil; [Woehler, Eric J.] Univ Tasmania, Inst Marine & Antarctic Studies, Sandy Bay, Tas, Australia; [Altwegg, Res] Univ Cape Town, Anim Demog Unit, ZA-7700 Rondebosch, South Africa; [Barnard, Phoebe] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa	Commonwealth Scientific & Industrial Research Organisation (CSIRO); South African National Biodiversity Institute; Centre National de la Recherche Scientifique (CNRS); Macquarie University; University of Oslo; University of Melbourne; Swedish University of Agricultural Sciences; Universidade de Sao Paulo; Universidade Estadual Paulista; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade de Sao Paulo; University of Tasmania; University of Cape Town; National Research Foundation - South Africa; University of Cape Town	Chambers, LE (corresponding author), Ctr Australian Weather & Climate Res, Melbourne, Vic, Australia.	L.Chambers@bom.gov.au	Poloczanska, Elvira/F-4366-2014; Morellato, Patricia/B-6026-2013; Barbraud, Christophe/A-5870-2012; Beaumont, Linda J/D-5499-2012; poloczanska, elvira/P-5356-2014; Durant, Joël/D-3821-2013; Vanstreels, Ralph/H-8029-2015	Morellato, Patricia/0000-0001-5265-8988; Barbraud, Christophe/0000-0003-0146-212X; Beaumont, Linda J/0000-0001-6307-1680; Durant, Joël/0000-0002-1129-525X; Low, Matthew/0000-0002-7345-6063; Hughes, Lesley/0000-0003-0313-9780; poloczanska, elvira/0000-0001-8470-0925; Keatley, Marie/0000-0001-5490-576X; Woehler, Eric/0000-0002-1125-0748	National Research Foundation of South Africa; Applied Centre for Climate and Earth System Science; FAPESP (Sao Paulo Research Foundation) [2010/50713-5, 2010/52113-5]; CNPq (National Council for Science); Swedish research council (FORMAS); Macquarie University	National Research Foundation of South Africa(National Research Foundation - South Africa); Applied Centre for Climate and Earth System Science; FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Council for Science)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Swedish research council (FORMAS)(Swedish Research CouncilSwedish Research Council Formas); Macquarie University	This work is based upon research supported by the National Research Foundation of South Africa to RA, PB, and RJMC, and by the Applied Centre for Climate and Earth System Science to RA. LPCM and the Phenology Laboratory at UNESP are supported by FAPESP (Sao Paulo Research Foundation grant # 2010/50713-5 and # 2010/52113-5); LPCM receives a Research Productivity Fellowship and grant from CNPq (National Council for Science). ML is supported by the Swedish research council (FORMAS). LJB was supported by a Macquarie University New Staff Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Aizen MA, 2006, ECOGRAPHY, V29, P357, DOI 10.1111/j.2006.0906-7590.04552.x; Altwegg R, 2012, P ROY SOC B-BIOL SCI, V279, P1485, DOI 10.1098/rspb.2011.1897; Barbraud C, 2006, P NATL ACAD SCI USA, V103, P6248, DOI 10.1073/pnas.0510397103; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Brown CJ, 2011, GLOBAL CHANGE BIOL, V17, P3697, DOI 10.1111/j.1365-2486.2011.02531.x; Brunel T, 2007, FISH OCEANOGR, V16, P336, DOI 10.1111/j.1365-2419.2007.00435.x; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Chambers LE, 2006, B AM METEOROL SOC, V87, P201, DOI 10.1175/BAMS-87-2-201; Chambers LE, INT J BIOMETEOROLOGY; Chambers LE, 2013, PHENOLOGY INTEGRATIV; Chambers LE, 2011, EMU, V111, P235, DOI 10.1071/MU10033; Chan K, 2001, EMU, V101, P281, DOI 10.1071/MU00034; Chou C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030327; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Davis CC, 2010, PHILOS T R SOC B, V365, P3201, DOI 10.1098/rstb.2010.0130; Day TA, 1999, OECOLOGIA, V119, P24, DOI 10.1007/s004420050757; de la Roque S, 2008, REV SCI TECH OIE, V27, P339, DOI 10.20506/rst.27.2.1807; Dickey MH, 2008, GLOBAL CHANGE BIOL, V14, P1973, DOI 10.1111/j.1365-2486.2008.01622.x; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Durant JM, 2010, MAR ECOL PROG SER, V420, P263, DOI 10.3354/meps08857; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Emslie SD, 2005, ANTARCT SCI, V17, P57, DOI 10.1017/S0954102005002427; Encinas-Viso F, 2012, ECOL LETT, V15, P198, DOI 10.1111/j.1461-0248.2011.01726.x; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Frederiksen M, 2004, GLOBAL CHANGE BIOL, V10, P1214, DOI 10.1111/j.1529-8817.2003.00794.x; Gallagher RV, 2009, AUST J BOT, V57, P1, DOI 10.1071/BT08051; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Green K, 2010, J MT SCI-ENGL, V7, P167, DOI 10.1007/s11629-010-1115-2; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hawkins E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050087; Hegerl G.C., 2009, P INT PAN CLIM CHANG; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Henschel J, 2000, NAMIBIAN LONG TERM E; Hindell MA, 2012, ECOL EVOL, V2, P1563, DOI 10.1002/ece3.281; Hinke JT, 2012, MAR ECOL PROG SER, V454, P91, DOI 10.3354/meps09633; Holmgren M., 2006, ADV GEOSCIENCES, V6, P69, DOI [DOI 10.5194/ADGEO-6-69-2006, 10.5194/adgeo-6-69-2006]; Jahn AE, 2012, EMU, V112, P17, DOI 10.1071/MU10091; Keatley MR, 2013, PHENOLOGY INTEGRATIV; Kobori H, 2012, ECOL RES, V27, P173, DOI 10.1007/s11284-011-0891-7; KOCHMER JP, 1986, ECOL MONOGR, V56, P303, DOI 10.2307/1942549; Kopp M, 2011, MAR ECOL PROG SER, V435, P263, DOI 10.3354/meps09229; Koubbi P, 2011, POLAR SCI, V5, P225, DOI 10.1016/j.polar.2011.02.003; Latif M, 2009, P NATL ACAD SCI USA, V106, P20578, DOI 10.1073/pnas.0710860105; Lescroel A, 2009, POLAR BIOL, V32, P1495, DOI 10.1007/s00300-009-0647-9; Lewis S, 2012, OIKOS, V121, P2061, DOI 10.1111/j.1600-0706.2012.20293.x; Linden A, 2011, BOREAL ENVIRON RES, V16, P49; Lynch HJ, 2012, MAR ECOL PROG SER, V454, P135, DOI 10.3354/meps09252; MacNeil MA, 2010, PHILOS T R SOC B, V365, P3753, DOI 10.1098/rstb.2010.0289; Mair L, 2012, GLOBAL CHANGE BIOL, V18, P2439, DOI 10.1111/j.1365-2486.2012.02730.x; McCarthy MA, 2005, J APPL ECOL, V42, P1012, DOI 10.1111/j.1365-2664.2005.01101.x; McClellan K, 2011, THESIS MACQUARIE U; McKone MJ, 1998, GLOB CHANGE BIOL, V4, P591, DOI 10.1046/j.1365-2486.1998.00172.x; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; Miller-Rushing AJ, 2008, AUK, V125, P565, DOI 10.1525/auk.2008.07005; Mintenbeck K, 2012, ADV ECOL RES, V46, P351, DOI 10.1016/B978-0-12-396992-7.00006-X; Moe B, 2009, MAR ECOL PROG SER, V393, P235, DOI 10.3354/meps08222; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2011, CLIM RES, V47, P201, DOI 10.3354/cr01005; Morellato L.P.C., 2013, PHENOLOGY INTEGRATIV, P91, DOI [DOI 10.1007/978-94-007-6925-0_6, 10.1007/978-94-007-6925-0_6]; Morellato LPC, 2000, BIOTROPICA, V32, P811, DOI 10.1111/j.1744-7429.2000.tb00620.x; Moussus JP, 2011, OIKOS, V120, P991, DOI 10.1111/j.1600-0706.2010.18955.x; Moussus JP, 2010, METHODS ECOL EVOL, V1, P140, DOI 10.1111/j.2041-210X.2010.00020.x; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; OLSEN PD, 1989, EMU, V89, P1, DOI 10.1071/MU9890001; Pakhomov EA, 1996, MAR ECOL PROG SER, V134, P1, DOI 10.3354/meps134001; Park IW, 2012, INT J BIOMETEOROL, V56, P1179, DOI 10.1007/s00484-012-0521-2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Parmesan C, 2011, NAT CLIM CHANGE, V1, P2, DOI 10.1038/nclimate1056; Parry ML, 2007, CLIMATE CHANGE 2007; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Petry MV, 2013, POLAR BIOL, V36, P603, DOI 10.1007/s00300-012-1277-1; Poloczanska ES, NATURE CLIMATE CHANG; Potter C, 2008, CLIM DYNAM, V31, P67, DOI 10.1007/s00382-007-0339-5; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sadras VO, 2011, AUST J GRAPE WINE R, V17, P199, DOI 10.1111/j.1755-0238.2011.00138.x; Salido L, 2012, ECOGRAPHY, V35, P604, DOI 10.1111/j.1600-0587.2011.06797.x; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Scharlemann JPW, 2001, INT J BIOMETEOROL, V45, P208, DOI 10.1007/s004840100098; Schauber EM, 2002, ECOLOGY, V83, P1214, DOI 10.1890/0012-9658(2002)083[1214:MBENZP]2.0.CO;2; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Senapathi D, 2011, P ROY SOC B-BIOL SCI, V278, P3184, DOI 10.1098/rspb.2011.0212; Siegal-Causey D., 1990, Current Ornithology, V7, P285; Siegel-Causey D, 1995, COLONIAL BREEDING WA; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Sokolov LV, 2008, RUSS J ECOL+, V39, P56, DOI 10.1134/S1067413608010098; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Sparks TH, 2007, J ORNITHOL, V148, P503, DOI 10.1007/s10336-007-0193-6; Sparks T, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P123, DOI 10.1007/978-90-481-3335-2_6; Staggemeier VG, 2011, INT J BIOMETEOROL, V55, P843, DOI 10.1007/s00484-011-0482-x; Staggemeier VG, 2010, J ECOL, V98, P1409, DOI 10.1111/j.1365-2745.2010.01717.x; Steffen, 2009, AUSTR BIODIVERSITY C; Stine AR, 2009, NATURE, V457, P435, DOI 10.1038/nature07675; Stokes C, 2010, NATURE CLIM IN PRESS; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vegvari Z, 2010, GLOBAL CHANGE BIOL, V16, P1, DOI 10.1111/j.1365-2486.2009.01876.x; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Webb LB, 2012, NAT CLIM CHANGE, V2, P259, DOI [10.1038/nclimate1417, 10.1038/NCLIMATE1417]; Woehler EJ, 2012, PROTECTION 3 POLES, P218; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; YODER JA, 1993, GLOBAL BIOGEOCHEM CY, V7, P181, DOI 10.1029/93GB02358; Ziello C, 2012, ECOGRAPHY, V35, P1017, DOI 10.1111/j.1600-0587.2012.07607.x	116	140	144	3	220	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75514	10.1371/journal.pone.0075514	http://dx.doi.org/10.1371/journal.pone.0075514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098389	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100019
J	Leigh, NR; Schupp, MO; Li, KG; Padmanabhan, V; Gastonguay, A; Wang, L; Chun, CZ; Wilkinson, GA; Ramchandran, R				Leigh, Noah R.; Schupp, Marcus-Oliver; Li, Keguo; Padmanabhan, Vakeel; Gastonguay, Adam; Wang, Ling; Chun, Chang Z.; Wilkinson, George A.; Ramchandran, Ramani			Mmp17b Is Essential for Proper Neural Crest Cell Migration In Vivo	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITOR; TRUNK; CARTILAGE; MT6-MMP; BINDING; SURFACE	The extracellular matrix plays a critical role in neural crest (NC) cell migration. In this study, we characterize the contribution of the novel GPI-linked matrix metalloproteinase (MMP) zebrafish mmp17b. Mmp17b is expressed post-gastrulation in the developing NC. Morpholino inactivation of mmp17b function, or chemical inhibition of MMP activity results in aberrant NC cell migration with minimal change in NC proliferation or apoptosis. Intriguingly, a GPI anchored protein with metalloproteinase inhibitor properties, Reversion-inducing-Cysteine-rich protein with Kazal motifs (RECK), which has previously been implicated in NC development, is expressed in close apposition to NC cells expressing mmp17b, raising the possibility that these two gene products interact. Consistent with this possibility, embryos silenced for mmp17b show defective development of the dorsal root ganglia (DRG), a crest-derived structure affected in RECK mutant fish sensory deprived (sdp). Taken together, this study has identified the first pair of MMP, and their putative MMP inhibitor RECK that functions together in NC cell migration.	[Leigh, Noah R.; Schupp, Marcus-Oliver; Li, Keguo; Padmanabhan, Vakeel; Gastonguay, Adam; Wang, Ling; Wilkinson, George A.; Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Dev Vasc Biol Program, Childrens Res Inst CRI, Milwaukee, WI 53226 USA; [Chun, Chang Z.] Univ Florida, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL USA	Medical College of Wisconsin; State University System of Florida; University of Florida	Ramchandran, R (corresponding author), Med Coll Wisconsin, Dept Pediat, Dev Vasc Biol Program, Childrens Res Inst CRI, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rramchan@mcw.edu			Children's Research Institute (CRI) at Medical College of Wisconsin; National Institutes of Health (NIH) [HL090712]; T32 fellowship from NIH Heart, Lung and Blood Institute; NIH [HL102745, HL112639]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102745, R01HL090712, R01HL112639] Funding Source: NIH RePORTER	Children's Research Institute (CRI) at Medical College of Wisconsin; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 fellowship from NIH Heart, Lung and Blood Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by start-up funds from Children's Research Institute (CRI) at Medical College of Wisconsin, and National Institutes of Health (NIH) HL090712 grant to RR. LW is supported by T32 fellowship from NIH Heart, Lung and Blood Institute. MOS, AG and VP are supported by NIH grants (HL102745, HL112639) to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders only provided resources to help perform the study.	Anderson RB, 2010, INT J DEV BIOL, V54, P63, DOI 10.1387/ijdb.082667ra; Ara T, 2000, J PEDIATR SURG, V35, P432, DOI 10.1016/S0022-3468(00)90208-2; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; BRONNERFRASER M, 1991, J CRAN GENET DEV BIO, V11, P214; BRONNERFRASER M, 1986, DEV BIOL, V117, P528, DOI 10.1016/0012-1606(86)90320-9; BRONNERFRASER M, 1995, PERSPECT DEV NEUROBI, V3, P53; Cai DH, 2002, DEV DYNAM, V224, P441, DOI 10.1002/dvdy.10129; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; Gammill LS, 2010, DEV BIOL, V344, P555, DOI 10.1016/j.ydbio.2010.04.009; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Giambernardi TA, 2001, MATRIX BIOL, V20, P577, DOI 10.1016/S0945-053X(01)00166-4; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Kolkenbrock H, 1999, BIOL CHEM, V380, P1103, DOI 10.1515/BC.1999.137; KRULL CE, 1995, DEVELOPMENT, V121, P3733; Kulesa PM, 2010, DEV BIOL, V344, P566, DOI 10.1016/j.ydbio.2010.05.005; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Maxfield FR, 1997, ADV EXP MED BIOL, V419, P355; Nieto MA, 2001, MECH DEVELOP, V105, P27, DOI 10.1016/S0925-4773(01)00394-X; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Prendergast A, 2012, DEVELOPMENT, V139, P1141, DOI 10.1242/dev.072439; RAIBLE DW, 1994, DEVELOPMENT, V120, P495; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sun L, 2011, BIOMATERIALS, V32, P5581, DOI 10.1016/j.biomaterials.2011.04.028; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Werb Z, 1998, ANN NY ACAD SCI, V857, P110, DOI 10.1111/j.1749-6632.1998.tb10111.x; Wyatt RA, 2009, ZEBRAFISH, V6, P347, DOI 10.1089/zeb.2009.0609; Yamada A, 2000, INFLAMM RES, V49, P144, DOI 10.1007/s000110050573; Zon LI, 2010, ZEBRAFISH, V7, P1, DOI 10.1089/zeb.2010.9996	38	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76484	10.1371/journal.pone.0076484	http://dx.doi.org/10.1371/journal.pone.0076484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098510	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100070
J	Resende, FA; de Oliveira, APS; de Camargo, MS; Vilegas, W; Varanda, EA				Resende, Flavia A.; de Oliveira, Ana Paula S.; de Camargo, Mariana S.; Vilegas, Wagner; Varanda, Eliana A.			Evaluation of Estrogenic Potential of Flavonoids Using a Recombinant Yeast Strain and MCF7/BUS Cell Proliferation Assay	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; RECEPTOR; DERIVATIVES; ISOFLAVONES	Phytoestrogens are of interest because of their reported beneficial effects on many human maladies including cancer, neurodegeneration, cardiovascular disease and diabetes. Furthermore, there is a search for compounds with estrogenic activity that can replace estrogen in hormone replacement therapy during menopause, without the undesirable effects of estrogen, such as the elevation of breast cancer occurrence. Thus, the principal objective of this study was to assess the estrogenic activity of flavonoids with different hydroxylation patterns: quercetin, kaempferol, luteolin, fisetin, chrysin, galangin, flavone, 3-hydroxyflavone, 5-hydroxyflavone and 7-hydroxyflavone via two different in vitro assays, the recombinant yeast assay (RYA) and the MCF-7 proliferation assay (E-screen), since the most potent phytoestrogens are members of the flavonoid family. In these assays, kaempferol was the only compound that showed ER alpha-dependent transcriptional activation activity by RYA, showing 6.74 +/- 1.7 nM EEQ, besides acting as a full agonist for the stimulation of proliferation of MCF-7/BUS cells. The other compounds did not show detectable levels of interaction with ER under the conditions used in the RYA. However, in the E-screen assay, compounds such as galangin, luteolin and fisetin also stimulated the proliferation of MCF-7/BUS cells, acting as partial agonists. In the evaluation of antiestrogenicity, the compounds quercetin, chrysin and 3-hydroxyflavone significantly inhibited the cell proliferation induced by 17-beta-estradiol in the E-screen assay, indicating that these compounds may act as estrogen receptor antagonists. Overall, it became clear in the assay results that the estrogenic activity of flavonoids was affected by small structural differences such as the number of hydroxyl groups, especially those on the B ring of the flavonoid.	[Resende, Flavia A.; de Oliveira, Ana Paula S.; de Camargo, Mariana S.; Varanda, Eliana A.] Univ Estadual Paulista, Fac Pharmaceut Sci, Dept Biol Sci, Sao Paulo, Brazil; [Vilegas, Wagner] Univ Estadual Paulista, Campus Litoral Paulista Unidade Sao Vicente, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Resende, FA (corresponding author), Univ Estadual Paulista, Fac Pharmaceut Sci, Dept Biol Sci, Sao Paulo, Brazil.	flaviabiomed@yahoo.com.br	Vilegas, Wagner/D-3170-2012; Camargo, Mariana/A-9928-2015; Resende, Flávia Aparecida/J-4686-2012; Resende, Flávia/P-1580-2019; Vilegas, Wagner/S-3209-2019	Vilegas, Wagner/0000-0003-3032-2556; Camargo, Mariana/0000-0002-3791-4725; Resende, Flávia Aparecida/0000-0002-9432-5919; Resende, Flávia/0000-0002-9432-5919; Oliveira Hohne, Ana Paula/0000-0002-3260-7275	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian state agency; "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian federal agency	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian state agency; "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian federal agency	This work was supported by "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)'' and "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian state and federal agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; Brix R, 2010, ENVIRON INT, V36, P361, DOI 10.1016/j.envint.2010.02.004; Cespedes R, 2005, CHEMOSPHERE, V61, P1710, DOI 10.1016/j.chemosphere.2005.03.082; Choi SY, 2008, PLANTA MED, V74, P25, DOI 10.1055/s-2007-993760; De Naeyer A, 2004, J NAT PROD, V67, P1829, DOI 10.1021/np040069a; De-Eknamkul W, 2011, J MOL GRAPH MODEL, V29, P784, DOI 10.1016/j.jmgm.2011.01.001; Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y; Ferguson LR, 2001, MUTAT RES-FUND MOL M, V475, P89, DOI 10.1016/S0027-5107(01)00073-2; Garcia-Reyero N, 2004, ENVIRON TOXICOL CHEM, V23, P705, DOI 10.1897/03-141; Garcia-Reyero N, 2001, ENVIRON TOXICOL CHEM, V20, P1152, DOI 10.1002/etc.5620200603; GREEN S, 1991, NUCLEAR HORMONE RECE, P15; Hou DX, 2010, ANTIOXID REDOX SIGN, V13, P691, DOI 10.1089/ars.2009.2816; Kuch B, 2010, ENVIRON SCI POLLUT R, V17, P250, DOI 10.1007/s11356-009-0234-1; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Liu S, 2013, MOL PHARMACOL, V83, P1066, DOI 10.1124/mol.112.084228; Noguerol TN, 2006, TALANTA, V69, P351, DOI 10.1016/j.talanta.2005.09.044; Ogawa T, 2009, BIOORGAN MED CHEM, V17, P1109, DOI 10.1016/j.bmc.2008.12.044; Oh SM, 2009, TOXICOL IN VITRO, V23, P1242, DOI 10.1016/j.tiv.2009.07.032; Schiliro T, 2011, J STEROID BIOCHEM, V127, P139, DOI 10.1016/j.jsbmb.2011.03.002; SCHNEIDER JC, 1991, METHOD ENZYMOL, V194, P373; Sharan S, 2013, TOXICOL APPL PHARM, V269, P176, DOI 10.1016/j.taap.2013.03.009; Silva ID, 2000, CHEM-BIOL INTERACT, V124, P29; SOTO AM, 1992, ADV MOD ENV, V21, P295; Tarnow P, 2013, TOXICOL IN VITRO, V27, P1467, DOI 10.1016/j.tiv.2013.03.003; Tokarz J, 2013, J STEROID BIOCHEM, V137, P165, DOI 10.1016/j.jsbmb.2013.01.003; Vanparys C, 2010, SCI TOTAL ENVIRON, V408, P4451, DOI 10.1016/j.scitotenv.2010.06.049; VILLALOBOS M, 1995, ENVIRON HEALTH PERSP, V103, P844, DOI 10.2307/3432398; Wanda GJMK, 2006, PHYTOMEDICINE, V13, P139, DOI 10.1016/j.phymed.2005.06.003; Ward HA, 2010, ARCH BIOCHEM BIOPHYS, V501, P170, DOI 10.1016/j.abb.2010.05.018; Watanabe Chigusa, 2010, Environmental Health and Preventive Medicine, V15, P319, DOI 10.1007/s12199-010-0146-1; Zand RSR, 2000, BREAST CANCER RES TR, V62, P35, DOI 10.1023/A:1006422302173	31	64	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74881	10.1371/journal.pone.0074881	http://dx.doi.org/10.1371/journal.pone.0074881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098354	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100012
J	Xu, B; Chen, XJ; Mao, ZL; Chen, MJ; Han, XM; Du, GZ; Ji, XL; Chang, CX; Rehan, VK; Wang, XR; Xia, YK				Xu, Bo; Chen, Xiaojiao; Mao, Zhilei; Chen, Minjian; Han, Xiumei; Du, Guizhen; Ji, Xiaoli; Chang, Chunxin; Rehan, Virender K.; Wang, Xinru; Xia, Yankai			Perfluorooctane Sulfonate Disturbs Nanog Expression through miR-490-3p in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; PERFLUORINATED ACIDS; MICRORNA REGULATION; EXPOSURE; PFOS; PLURIPOTENCY; ZEBRAFISH; SERUM; TOXICITY; DICER	Perfluorooctane sulfonate (PFOS) poses potential risks to reproduction and development. Mouse embryonic stem cells (mESCs) are ideal models for developmental toxicity testing of environmental contaminants in vitro. However, the mechanism by which PFOS affects early embryonic development is still unclear. In this study, mESCs were exposed to PFOS for 24 h, and then general cytotoxicity and pluripotency were evaluated. MTT assay showed that neither PFOS (0.2 mu M, 2 mu M, 20 mu M, and 200 mu M) nor control medium (0.1% DMSO) treatments affected cell viability. Furthermore, there were no significant differences in cell cycle and apoptosis between the PFOS treatment and control groups. However, we found that the mRNA and protein levels of pluripotency markers (Sox2, Nanog) in mESCs were significantly decreased following exposure to PFOS for 24 h, while there were no significant changes in the mRNA and protein levels of Oct4. Accordingly, the expression levels of miR-145 and miR-490-3p, which can regulate Sox2 and Nanog expressions were significantly increased. Chrm2, the host gene of miR-490-3p, was positively associated with miR-490-3p expression after PFOS exposure. Dual luciferase reporter assay suggests that miR-490-3p directly targets Nanog. These results suggest that PFOS can disturb the expression of pluripotency factors in mESCs, while miR-145 and miR-490-3p play key roles in modulating this effect.	[Xu, Bo; Chen, Xiaojiao; Mao, Zhilei; Chen, Minjian; Han, Xiumei; Du, Guizhen; Ji, Xiaoli; Chang, Chunxin; Wang, Xinru; Xia, Yankai] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Xu, Bo; Chen, Xiaojiao; Mao, Zhilei; Chen, Minjian; Han, Xiumei; Du, Guizhen; Ji, Xiaoli; Chang, Chunxin; Wang, Xinru; Xia, Yankai] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Chen, Xiaojiao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing Matern & Child Hlth Hosp, Nanjing, Jiangsu, Peoples R China; [Rehan, Virender K.] Harbor UCLA Med Ctr, David Geffen Sch Med, Dept Pediat, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lundquist Institute	Wang, XR (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	xrwang@njmu.edu.cn; yankaixia@njmu.edu.cn	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National 973 Program [2012CBA01306]; National Natural Science Foundation of China [81072328]; Key Project of MOE [211063]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	National 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of MOE; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by National 973 Program (2012CBA01306); National Natural Science Foundation of China (No. 81072328); The Key Project of MOE (No. 211063); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2009, REPROD TOXICOL, V27, P258, DOI 10.1016/j.reprotox.2008.05.061; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Arbuckle TE, 2013, INT J HYG ENVIR HEAL, V216, P184, DOI 10.1016/j.ijheh.2012.03.004; Arzumanyan A, 2009, ALCOHOL CLIN EXP RES, V33, P2172, DOI 10.1111/j.1530-0277.2009.01057.x; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai MH, 2012, J HAZARD MATER, V209, P335, DOI 10.1016/j.jhazmat.2012.01.030; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Case MT, 2001, INT J TOXICOL, V20, P101; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen H, 2012, MAR POLLUT BULL, V64, P902, DOI 10.1016/j.marpolbul.2012.03.012; Chen JF, 2013, ENVIRON TOXICOL CHEM, V32, P201, DOI 10.1002/etc.2031; Cheng W, 2013, TOXICOL IN VITRO, V27, P1503, DOI 10.1016/j.tiv.2013.03.014; Croes K, 2012, CHEMOSPHERE, V89, P988, DOI 10.1016/j.chemosphere.2012.06.058; Ehresman DJ, 2007, ENVIRON RES, V103, P176, DOI 10.1016/j.envres.2006.06.008; Fei CY, 2008, ENVIRON HEALTH PERSP, V116, P1391, DOI 10.1289/ehp.11277; Fuentes S, 2007, TOXICOL SCI, V98, P589, DOI 10.1093/toxsci/kfm121; Goosey E, 2012, ENVIRON INT, V45, P86, DOI 10.1016/j.envint.2012.04.007; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang HH, 2010, AQUAT TOXICOL, V98, P139, DOI 10.1016/j.aquatox.2010.02.003; Huang QS, 2011, AQUAT TOXICOL, V105, P71, DOI 10.1016/j.aquatox.2011.05.012; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ibrahim WNW, 2013, TOXICOL APPL PHARM, V269, P51, DOI 10.1016/j.taap.2013.03.003; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jones PD, 2003, ENVIRON TOXICOL CHEM, V22, P2639, DOI 10.1897/02-553; Jung EM, 2010, TOXICOL IN VITRO, V24, P1538, DOI 10.1016/j.tiv.2010.06.019; Key BD, 1997, ENVIRON SCI TECHNOL, V31, P2445, DOI 10.1021/es961007c; Kraugerud M, 2011, TOXICOL LETT, V205, P62, DOI 10.1016/j.toxlet.2011.05.230; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122; Lee HG, 2012, NEUROTOXICOLOGY, V33, P314, DOI 10.1016/j.neuro.2012.01.017; Li JG, 2013, ENVIRON INT, V53, P47, DOI 10.1016/j.envint.2012.12.002; Liao TT, 2010, J HAZARD MATER, V179, P1055, DOI 10.1016/j.jhazmat.2010.03.113; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P189, DOI [10.1002/etc.5620220125, 10.1897/1551-5028(2003)022&lt;0189:DAOPAI&gt;2.0.CO;2]; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P196, DOI 10.1897/1551-5028(2003)022&lt;0196:BATDOP&gt;2.0.CO;2; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Seacat AM, 2002, TOXICOL SCI, V68, P249, DOI 10.1093/toxsci/68.1.249; Shi XJ, 2008, TOXICOL APPL PHARM, V230, P23, DOI 10.1016/j.taap.2008.01.043; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stein CR, 2012, REPROD TOXICOL, V34, P312, DOI 10.1016/j.reprotox.2012.05.039; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Toft G, 2012, HUM REPROD, V27, P2532, DOI 10.1093/humrep/des185; Wang MY, 2011, ENVIRON TOXICOL CHEM, V30, P2073, DOI 10.1002/etc.594; Washino N, 2009, ENVIRON HEALTH PERSP, V117, P660, DOI 10.1289/ehp.11681; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yahia D, 2008, J TOXICOL SCI, V33, P219, DOI 10.2131/jts.33.219; Yan H, 2012, CHEMOSPHERE, V88, P1300, DOI 10.1016/j.chemosphere.2012.03.105; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang J, 2013, ENVIRON TOXICOL, V28, P322, DOI 10.1002/tox.20723	60	14	15	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74968	10.1371/journal.pone.0074968	http://dx.doi.org/10.1371/journal.pone.0074968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098361	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100013
J	Beck, J; Hennecke, S; Bornemann-Kolatzki, K; Urnovitz, HB; Neumann, S; Strobel, P; Kaup, FJ; Brenig, B; Schutz, E				Beck, Julia; Hennecke, Silvia; Bornemann-Kolatzki, Kirsten; Urnovitz, Howard B.; Neumann, Stephan; Stroebel, Philipp; Kaup, Franz-Josef; Brenig, Bertram; Schuetz, Ekkehard			Genome Aberrations in Canine Mammary Carcinomas and Their Detection in Cell-Free Plasma DNA	PLOS ONE			English	Article							HUMAN BREAST-CANCER; ESTROGEN-RECEPTOR-ALPHA; ANIMAL TUMOR REGISTRY; NUCLEIC-ACIDS; HUMAN-DISEASE; FEMALE DOG; PET DOGS; EXPRESSION; HYBRIDIZATION; ARRAY	Mammary tumors are the most frequent cancers in female dogs exhibiting a variety of histopathological differences. There is lack of knowledge about the genomes of these common dog tumors. Five tumors of three different histological subtypes were evaluated. Massive parallel sequencing (MPS) was performed in comparison to the respective somatic genome of each animal. Copy number and structural aberrations were validated using droplet digital PCR (ddPCR). Using mate-pair sequencing chromosomal aneuploidies were found in two tumors, frequent smaller deletions were found in one, inter-chromosomal fusions in one other, whereas one tumor was almost normal. These aberrations affect several known cancer associated genes such as cMYC, and KIT. One common deletion of the proximal end of CFA27, harboring the tumor suppressor gene PFDN5 was detected in four tumors. Using ddPCR, this deletion was validated and detected in 50% of tumors (N = 20). Breakpoint specific dPCRs were established for four tumors and tumor specific cell-free DNA (cfDNA) was detected in the plasma. In one animal tumor-specific cfDNA was found >1 year after surgery, attributable to a lung metastasis. Paired-end sequencing proved that copy-number imbalances of the tumor are reflected by the cfDNA. This report on chromosomal instability of canine mammary cancers reveals similarities to human breast cancers as well as special canine alterations. This animal model provides a framework for using MPS for screening for individual cancer biomarkers with cost effective confirmation and monitoring using ddPCR. The possibility exists that ddPCR can be expanded to screening for common cancer related variants.	[Beck, Julia; Bornemann-Kolatzki, Kirsten; Urnovitz, Howard B.; Schuetz, Ekkehard] Chronix Biomed, Gottingen, Germany; [Hennecke, Silvia; Neumann, Stephan; Brenig, Bertram; Schuetz, Ekkehard] Univ Gottingen, Inst Vet Med, D-37073 Gottingen, Germany; [Stroebel, Philipp] Univ Med, Dept Pathol, Gottingen, Germany; [Kaup, Franz-Josef] German Primate Ctr, Pathol Unit, Gottingen, Germany	University of Gottingen; Deutsches Primatenzentrum (DPZ)	Beck, J (corresponding author), Chronix Biomed, Gottingen, Germany.			Brenig, Bertram/0000-0002-7635-9656	Chronix Biomedical; Institute of Veterinary Medicine of the University of Gottingen	Chronix Biomedical; Institute of Veterinary Medicine of the University of Gottingen	The study was funded by Chronix Biomedical and the Institute of Veterinary Medicine of the University of Gottingen. Study design, data collection and analysis, decision to publish and preparation of the manuscript was conducted by employees of these institutions.	Aguirre-Hernandez J, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-27; Ahern TE, 1996, AM J VET RES, V57, P693; Allred DC, 1998, MODERN PATHOL, V11, P155; Angstadt AY, 2011, GENE CHROMOSOME CANC, V50, P859, DOI 10.1002/gcc.20908; Beck J, 2010, MOL CANCER RES, V8, P335, DOI 10.1158/1541-7786.MCR-09-0314; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boerkamp Kim M, 2012, Cancers (Basel), V4, P1300, DOI 10.3390/cancers4041300; Bofin AM, 2004, AM J CLIN PATHOL, V122, P110, DOI 10.1309/8A2DJFT07NE6EWHE; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; de las Mulas JM, 2005, VET PATHOL, V42, P200, DOI 10.1354/vp.42-2-200; de las Mulas JM, 2003, BREAST CANCER RES TR, V80, P363, DOI 10.1023/A:1024929730165; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; DORN CR, 1968, JNCI-J NATL CANCER I, V40, P307; Drabsch Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2614; Dunn KA, 2000, VET J, V160, P77, DOI 10.1053/tvjl.2000.0495; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fabarius A, 2003, CANCER GENET CYTOGEN, V143, P59, DOI 10.1016/S0165-4608(03)00003-7; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Gama A, 2008, VIRCHOWS ARCH, V453, P123, DOI 10.1007/s00428-008-0644-3; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Graham JC, 1999, AM J VET RES, V60, P627; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Hagio Y, 2006, J CELL BIOCHEM, V97, P145, DOI 10.1002/jcb.20619; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hellmen E, 2005, J DAIRY RES, V72, P90, DOI 10.1017/S002202990500124X; HELLMEN E, 1988, VET PATHOL, V25, P219, DOI 10.1177/030098588802500306; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Kauraniemi P, 2000, CANCER RES, V60, P5323; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Klopfleisch R, 2011, VET PATHOL, V48, P98, DOI 10.1177/0300985810390826; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Maeda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043355; Maher CA, 2012, CELL, V148, P29, DOI 10.1016/j.cell.2012.01.006; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitelman F, 2012, MITELMAN DATABASE CH; MORRIS JS, 1993, VET REC, V133, P539, DOI 10.1136/vr.133.22.539; Muller MH, 2012, TIERAERZTL PRAX K H, V40, P55; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nieto A, 2000, VET PATHOL, V37, P239, DOI 10.1354/vp.37-3-239; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pierotti MA, 2003, MECH ONCOGENE ACTIVA; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Queiroga FL, 2011, IN VIVO, V25, P455; Rao NAS, 2009, J PHYSIOL PHARMACOL, V60, P73; Reimann-Berg N, 2012, TIERAERZTL PRAX K H, V40, P267; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; RUTTEMAN GR, 1988, CANCER RES, V48, P3411; RUTTEMAN GR, 1988, BRIT J CANCER, V58, P594, DOI 10.1038/bjc.1988.266; Sassi F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-5; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Schweiger MR, 2011, CANCER METAST REV, V30, P199, DOI 10.1007/s10555-011-9278-z; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shaw JA, 2012, GENOME RES, V22, P220, DOI 10.1101/gr.123497.111; Simon D, 2006, J VET INTERN MED, V20, P1184, DOI 10.1892/0891-6640(2006)20[1184:PATIMM]2.0.CO;2; Sleeckx N, 2011, REPROD DOMEST ANIM, V46, P1112, DOI 10.1111/j.1439-0531.2011.01816.x; SORENSON GD, 1994, CANCER EPIDEM BIOMAR, V3, P67; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; STRANDBERG JD, 1974, AM J PATHOL, V75, P225; Tang J, 2010, GENOME RES, V20, P341, DOI 10.1101/gr.092726.109; Thomas R, 2003, CYTOGENET GENOME RES, V102, P249, DOI 10.1159/000075757; Thomas R, 2003, BRIT J CANCER, V89, P1530, DOI 10.1038/sj.bjc.6601275; Thomas R, 2007, J HERED, V98, P474, DOI 10.1093/jhered/esm053; Thomas R, 2009, CHROMOSOME RES, V17, P365, DOI 10.1007/s10577-009-9028-z; Tsuda H, 2009, BREAST CANCER-TOKYO, V16, P186, DOI 10.1007/s12282-009-0124-x; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Vascellari M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-39; VASIOUKHIN V, 1994, BRIT J HAEMATOL, V86, P774, DOI 10.1111/j.1365-2141.1994.tb04828.x; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293	90	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75485	10.1371/journal.pone.0075485	http://dx.doi.org/10.1371/journal.pone.0075485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098698	gold, Green Published			2022-12-27	WOS:000325423500069
J	Camell, C; Smith, CW				Camell, Christina; Smith, C. Wayne			Dietary Oleic Acid Increases M2 Macrophages in the Mesenteric Adipose Tissue	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; PPAR-GAMMA; MESOTHELIAL CELLS; ACTIVATION; EXPRESSION; OBESITY; CYTOKINES; PALMITATE; PROTECTS; ADHESION	Several studies have implicated fatty-acids as inflammatory regulators, suggesting that there may be a direct role for common dietary fatty-acids in regulating innate immune cells. In humans, a single high-fat meal increases systemic cytokines and leukocytes. In mice, short term high-fat feeding increases adipose tissue (AT) leukocytes and alters the inflammatory profile of AT macrophages. We have seen that short term high fat feeding to C57BL/6J male mice increases palmitic and oleic acid within AT depots, but oleic acid increase is highest in the mesenteric AT (MAT). In vitro, oleic acid increases M2 macrophage markers (CD206, MGL1, and ARG1) in a murine macrophage cell line, while addition of palmitic acid is able to inhibit that increase. Three day supplementation of a chow diet, with oleic acid, induced an increase in M2 macrophage markers in the MAT, but not in the epididymal AT. We tested whether increases in M2 macrophages occur during short term ad lib feeding of a high fat diet, containing oleic acid. Experiments revealed two distinct populations of macrophages were altered by a three day high milk-fat diet. One population, phenotypically intermediate for F4/80, showed diet-induced increases in CD206, an anti-inflammatory marker characteristic of M2 macrophages intrinsic to the AT. Evidence for a second population, phenotypically F4/80(HI)CD11b(HI) macrophages, showed increased association with the MAT following short term feeding that is dependent on the adhesion molecule, ICAM-1. Collectively, we have shown that short term feeding of a high-fat diet changes two population of macrophages, and that dietary oleic acid is responsible for increases in M2 macrophage polarization.	[Camell, Christina; Smith, C. Wayne] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Smith, C. Wayne] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Smith, C. Wayne] Childrens Nutr Res Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Camell, C (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	camell@bcm.edu			National Institute of Diabetes and Digestive and Kidney Diseases [F31DK084841]; United States Department of Agriculture/Agricultural Research Service [6250-51000-046];  [DK59637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, F31DK084841, U2CDK059637] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by F31DK084841 from The National Institute of Diabetes and Digestive and Kidney Diseases, and United States Department of Agriculture/Agricultural Research Service grant 6250-51000-046. This funder did data collection but had no role in study design, analysis, decision to publish, or preparation of the manuscript. The MMPC/DRTC Lipid Lab in Vanderbilt is supported by the following award: DK59637. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shudiefat AAR, 2013, MOL CELL BIOCHEM, V372, P75, DOI 10.1007/s11010-012-1447-z; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Brake Danett K., 2008, V456, P221, DOI 10.1007/978-1-59745-245-8_16; Burdge GC, 2005, BRIT J NUTR, V93, P3, DOI 10.1079/BJN20041282; Cardoso CR, 2011, IMMUNOBIOLOGY, V216, P409, DOI 10.1016/j.imbio.2010.06.007; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Laine PS, 2007, BIOCHEM BIOPH RES CO, V358, P150, DOI 10.1016/j.bbrc.2007.04.092; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Li FK, 1998, KIDNEY INT, V54, P2170, DOI 10.1046/j.1523-1755.1998.00174.x; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; MULLER J, 1995, CLIN IMMUNOL IMMUNOP, V75, P231, DOI 10.1006/clin.1995.1076; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Reardon M, 2012, LIPIDS, V47, P1043, DOI 10.1007/s11745-012-3711-0; Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Teres S, 2008, P NATL ACAD SCI USA, V105, P13811, DOI 10.1073/pnas.0807500105; Topley N, 1996, IMMUNOBIOLOGY, V195, P563, DOI 10.1016/S0171-2985(96)80022-2; Turchyn LR, 2007, COMPARATIVE MED, V57, P574; van Rossen MEE, 2001, J PATHOL, V193, P530; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080	39	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75147	10.1371/journal.pone.0075147	http://dx.doi.org/10.1371/journal.pone.0075147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098682	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500053
J	Ghosh, S; Singh, UK; Meli, VS; Kumar, V; Kumar, A; Irfan, M; Chakraborty, N; Chakraborty, S; Datta, A				Ghosh, Sumit; Singh, Upendra Kumar; Meli, Vijaykumar S.; Kumar, Vinay; Kumar, Anil; Irfan, Mohammad; Chakraborty, Niranjan; Chakraborty, Subhra; Datta, Asis			Induction of Senescence and Identification of Differentially Expressed Genes in Tomato in Response to Monoterpene	PLOS ONE			English	Article							CULTURED SHOOT PRIMORDIA; TERPENOID METABOLISM; SIGNAL-TRANSDUCTION; CELL-DEATH; GERANIOL; VOLATILES; DEFENSE; CLONING; PROTEIN; APOPTOSIS	Monoterpenes, which are among the major components of plant essential oils, are known for their ecological roles as well for pharmaceutical properties. Geraniol, an acyclic monoterpene induces cell cycle arrest and apoptosis/senescence in various cancer cells and plants; however, the genes involved in the process and the underlying molecular mechanisms are not well understood. In this study, we demonstrate that treatment of tomato plants with geraniol results in induction of senescence due to a substantial alteration in transcriptome. We have identified several geraniol-responsive protein encoding genes in tomato using suppression subtractive hybridization (SSH) approach. These genes comprise of various components of signal transduction, cellular metabolism, reactive oxygen species (ROS), ethylene signalling, apoptosis and DNA damage response. Upregulation of NADPH oxidase and antioxidant genes, and increase in ROS level after geraniol treatment point towards the involvement of ROS in geraniol-mediated senescence. The delayed onset of seedling death and induced expression of geraniol-responsive genes in geraniol-treated ethylene receptor mutant (Nr) suggest that geraniol-mediated senescence involves both ethylene dependent and independent pathways. Moreover, expression analysis during tomato ripening revealed that geraniol-responsive genes are also associated with the natural organ senescence process.	[Ghosh, Sumit; Singh, Upendra Kumar; Meli, Vijaykumar S.; Kumar, Vinay; Kumar, Anil; Irfan, Mohammad; Chakraborty, Niranjan; Chakraborty, Subhra; Datta, Asis] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Datta, A (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	asis_datta@rediffmail.com	Irfan, Mohammad/AAR-8004-2021; Kumar, Vinay/AAU-6954-2021; KUMAR, ANIL/AES-0347-2022; KUMAR, ANIL/AAH-1077-2022; Meli, Vijaykumar S/A-1879-2018	Irfan, Mohammad/0000-0002-7877-5530; Kumar, Vinay/0000-0002-6751-5741; Meli, Vijaykumar S/0000-0002-8690-4363; Chakraborty, Niranjan/0000-0002-6564-4734	Department of Biotechnology, the Ministry of Science and Technology, Government of India	Department of Biotechnology, the Ministry of Science and Technology, Government of India	This work was supported by the Department of Biotechnology, the Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2002, J EXP BOT, V53, P2073, DOI 10.1093/jxb/erf026; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Antonelli A, 1997, J AGR FOOD CHEM, V45, P4435, DOI 10.1021/jf9702407; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Ashida Y, 2002, BIOSCI BIOTECH BIOCH, V66, P168, DOI 10.1271/bbb.66.168; Ashida Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2511, DOI 10.1271/bbb.66.2511; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; BAYRAK A, 1994, J SCI FOOD AGR, V64, P441, DOI 10.1002/jsfa.2740640408; Besser K, 2009, PLANT PHYSIOL, V149, P499, DOI 10.1104/pp.108.126276; Beyene G, 2006, J EXP BOT, V57, P1431, DOI 10.1093/jxb/erj123; Bohlmann J, 2008, PLANT J, V54, P656, DOI 10.1111/j.1365-313X.2008.03449.x; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Burke YD, 1997, LIPIDS, V32, P151, DOI 10.1007/s11745-997-0019-y; Chaimovitsh D, 2010, PLANT J, V61, P399, DOI 10.1111/j.1365-313X.2009.04063.x; Davidovich-Rikanati R, 2007, NAT BIOTECHNOL, V25, P899, DOI 10.1038/nbt1312; de Godoy A, 2010, SCI HORTIC-AMSTERDAM, V124, P51, DOI 10.1016/j.scienta.2009.12.014; Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117; Dolch R, 2000, OECOLOGIA, V125, P504, DOI 10.1007/s004420000482; Doukhanina EV, 2006, J BIOL CHEM, V281, P18793, DOI 10.1074/jbc.M511794200; Fabi JP, 2010, PLANT SCI, V179, P225, DOI 10.1016/j.plantsci.2010.05.007; Fabi JP, 2009, SCI HORTIC-AMSTERDAM, V121, P159, DOI 10.1016/j.scienta.2009.01.036; Fan J, 2009, PLANT CELL TISS ORG, V98, P281, DOI 10.1007/s11240-009-9561-7; Fonseca S, 2004, PLANT SCI, V167, P457, DOI 10.1016/j.plantsci.2004.03.033; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; Gupta S.K., 2009, J PROTEOM BIOINFORM, V2, P466, DOI DOI 10.4172/JPB; Hadfield KA, 2000, PLANT PHYSIOL, V122, P977, DOI 10.1104/pp.122.3.977; Han L, 2010, PLANT J, V64, P114, DOI 10.1111/j.1365-313X.2010.04318.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Huang XZ, 2010, NEW PHYTOL, V187, P301, DOI 10.1111/j.1469-8137.2010.03275.x; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Iijima Y, 2004, PLANT PHYSIOL, V134, P370, DOI 10.1104/pp.103.032946; Itai A, 2000, J EXP BOT, V51, P1163, DOI 10.1093/jexbot/51.347.1163; Izumi S, 1997, CHEM LETT, P837, DOI 10.1246/cl.1997.837; Izumi S, 1999, BIOCHEM BIOPH RES CO, V259, P519, DOI 10.1006/bbrc.1999.0813; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kishimoto K, 2006, PHYTOCHEMISTRY, V67, P1520, DOI 10.1016/j.phytochem.2006.05.027; LANAHAN MB, 1994, PLANT CELL, V6, P521, DOI 10.1105/tpc.6.4.521; Lange B.M., 2012, PLANT BIOTECHNOL J, P1; LEWINSOHN E, 1991, PLANT PHYSIOL, V96, P38, DOI 10.1104/pp.96.1.38; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Luo M, 2004, ACTA BIOCH BIOPH SIN, V36, P277, DOI 10.1093/abbs/36.4.277; Masoudi-Nejad A, 2006, NUCLEIC ACIDS RES, V34, pW459, DOI 10.1093/nar/gkl066; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Meli VS, 2010, P NATL ACAD SCI USA, V107, P2413, DOI 10.1073/pnas.0909329107; Miao Y, 2008, PLANT BIOLOGY, V10, P110, DOI 10.1111/j.1438-8677.2008.00083.x; Mondal K, 2004, BIOL PLANTARUM, V48, P49, DOI 10.1023/B:BIOP.0000024274.43874.5b; Ohlrogge J, 2000, CURR OPIN PLANT BIOL, V3, P224, DOI 10.1016/S1369-5266(00)00068-6; Pariasca JAT, 2001, POSTHARVEST BIOL TEC, V22, P239, DOI 10.1016/S0925-5214(01)00094-1; Perruc E, 2004, PLANT J, V38, P410, DOI 10.1111/j.1365-313X.2004.02062.x; Picaud S, 2003, FUNCT PLANT BIOL, V30, P621, DOI 10.1071/FP02116; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Qin GZ, 2009, J PROTEOME RES, V8, P2449, DOI 10.1021/pr801046m; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Sarowar S, 2007, PLANT J, V51, P792, DOI 10.1111/j.1365-313X.2007.03174.x; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; SHOFF SM, 1991, CANCER RES, V51, P37; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Sterky F, 1998, P NATL ACAD SCI USA, V95, P13330, DOI 10.1073/pnas.95.22.13330; Tewari M, 1997, CANCER RES, V57, P4063; Tufekci M.A., 2005, J CELL MOL BIOL, V4, P9; Yamasaki Yumiko, 2007, Journal of General Plant Pathology, V73, P168, DOI 10.1007/s10327-007-0013-0; YU SG, 1995, J NUTR, V125, P2763; Zhu HF, 2009, MOL PLANT, V2, P513, DOI 10.1093/mp/ssp001	70	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76029	10.1371/journal.pone.0076029	http://dx.doi.org/10.1371/journal.pone.0076029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098759	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500129
J	Subira, M; Alonso, P; Segalas, C; Real, E; Lopez-Sola, C; Pujol, J; Martinez-Zalacain, I; Harrison, BJ; Menchon, JM; Cardoner, N; Soriano-Mas, C				Subira, Marta; Alonso, Pino; Segalas, Cinto; Real, Eva; Lopez-Sola, Clara; Pujol, Jesus; Martinez-Zalacain, Ignacio; Harrison, Ben J.; Menchon, Jose M.; Cardoner, Narcis; Soriano-Mas, Carles			Brain Structural Alterations in Obsessive-Compulsive Disorder Patients with Autogenous and Reactive Obsessions	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SYMPTOM DIMENSIONS; REPETITIVE BEHAVIORS; NONCLINICAL SUBJECTS; INTRUSIVE THOUGHTS; TOURETTES-SYNDROME; TIC DISORDERS; NEURAL BASIS; SCALE; METAANALYSIS	Obsessive-compulsive disorder (OCD) is a clinically heterogeneous condition. Although structural brain alterations have been consistently reported in OCD, their interaction with particular clinical subtypes deserves further examination. Among other approaches, a two-group classification in patients with autogenous and reactive obsessions has been proposed. The purpose of the present study was to assess, by means of a voxel-based morphometry analysis, the putative brain structural correlates of this classification scheme in OCD patients. Ninety-five OCD patients and 95 healthy controls were recruited. Patients were divided into autogenous (n = 30) and reactive (n = 65) sub-groups. A structural magnetic resonance image was acquired for each participant and pre-processed with SPM8 software to obtain a volume-modulated gray matter map. Whole-brain and voxel-wise comparisons between the study groups were then performed. In comparison to the autogenous group, reactive patients showed larger gray matter volumes in the right Rolandic operculum. When compared to healthy controls, reactive patients showed larger volumes in the putamen (bilaterally), while autogenous patients showed a smaller left anterior temporal lobe. Also in comparison to healthy controls, the right middle temporal gyrus was smaller in both patient subgroups. Our results suggest that autogenous and reactive obsessions depend on partially dissimilar neural substrates. Our findings provide some neurobiological support for this classification scheme and contribute to unraveling the neurobiological basis of clinical heterogeneity in OCD.	[Subira, Marta; Alonso, Pino; Segalas, Cinto; Real, Eva; Lopez-Sola, Clara; Martinez-Zalacain, Ignacio; Menchon, Jose M.; Cardoner, Narcis; Soriano-Mas, Carles] Bellvitge Univ Hosp, Bellvitge Biomed Res Inst IDIBELL, Dept Psychiat, Barcelona, Spain; [Subira, Marta; Alonso, Pino; Segalas, Cinto; Real, Eva; Lopez-Sola, Clara; Menchon, Jose M.; Cardoner, Narcis; Soriano-Mas, Carles] Ctr Invest Biomed Red Salud Mental CIBERSAM, Carlos Hlth Inst 3, Barcelona, Spain; [Alonso, Pino; Lopez-Sola, Clara; Menchon, Jose M.; Cardoner, Narcis] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Pujol, Jesus] Hosp del Mar, CRC, Magnet Resonance Unit, Barcelona, Spain; [Harrison, Ben J.] Univ Melbourne, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Melbourne	Soriano-Mas, C (corresponding author), Bellvitge Univ Hosp, Bellvitge Biomed Res Inst IDIBELL, Dept Psychiat, Barcelona, Spain.	csoriano@idibell.cat	Alonso, Pino/AAI-3439-2020; Harrison, Ben J/I-2940-2014; Cardoner, Narcis/H-8436-2015; Soriano-Mas, Carles/E-4028-2019; Cardoner, Narcis/AAD-5449-2022; Menchon, Jose/A-5242-2009	Soriano-Mas, Carles/0000-0003-4574-6597; Cardoner, Narcis/0000-0001-9633-0888; Segalas, Cinto/0000-0002-0959-0356; Alonso, Pino/0000-0002-5779-9111; Menchon, Jose/0000-0002-6231-6524; Martinez-Zalacain, Ignacio/0000-0002-4036-0284	Carlos III Health Institute [PI09/01331 PI10/01753, PI10/01003, CP10/00604, CIBER-CB06/03/0034, CM11/00077]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2009SGR1554]; Bellvitge Biomedical Research Institute (IDIBELL); Spanish Ministry of Education, Culture and Sport [FPU12/01636]; National Health and Medical Research Council of Australia (NHMRC) [628509]	Carlos III Health Institute(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Bellvitge Biomedical Research Institute (IDIBELL); Spanish Ministry of Education, Culture and Sport(Spanish Government); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported in part by the Carlos III Health Institute (PI09/01331 PI10/01753, PI10/01003, CP10/00604, CIBER-CB06/03/0034) and by the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; 2009SGR1554). M. S. is funded by the Bellvitge Biomedical Research Institute (IDIBELL). E. R. is supported by a 'Rio Hortega' contract from the Carlos III Health Institute (I. D. CM11/00077). C. L-S. is supported by the Spanish Ministry of Education, Culture and Sport (FPU12/01636). B. H. is supported by a National Health and Medical Research Council of Australia (NHMRC) Clinical Career Development Award (I. D. 628509). C.S-M. is funded by a 'Miguel Servet' contract from the Carlos III Health Institute (CP10/00604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga PG, 2012, J PSYCHIATR RES, V46, P1635, DOI 10.1016/j.jpsychires.2012.09.002; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BAER L, 1994, J CLIN PSYCHIAT, V55, P18; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Belloch A, 2010, J ANXIETY DISORD, V24, P573, DOI 10.1016/j.janxdis.2010.03.017; Besiroglu L, 2006, CNS SPECTRUMS, V11, P179, DOI 10.1017/S1092852900014292; Besiroglu L, 2011, ACTA PSYCHIAT SCAND, V124, P141, DOI 10.1111/j.1600-0447.2011.01726.x; Besiroglu L, 2007, DEPRESS ANXIETY, V24, P461, DOI 10.1002/da.20240; Cardoner N, 2007, NEUROIMAGE, V38, P413, DOI 10.1016/j.neuroimage.2007.07.039; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; COHEN AJ, 1992, J CLIN PSYCHIAT, V53, P319; de Mathis MA, 2006, CNS SPECTRUMS, V11, P762, DOI 10.1017/S1092852900014899; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Ferrao YA, 2012, PSYCHIAT RES, V197, P253, DOI 10.1016/j.psychres.2011.09.017; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Gilbert AR, 2008, J AFFECT DISORDERS, V109, P117, DOI 10.1016/j.jad.2007.12.223; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harrison BJ, 2013, BIOL PSYCHIAT, V73, P321, DOI 10.1016/j.biopsych.2012.10.006; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Kashyap H, 2012, J PSYCHIATR RES, V46, P1146, DOI 10.1016/j.jpsychires.2012.04.022; Leckman JE, 2010, DEPRESS ANXIETY, V27, P507, DOI 10.1002/da.20669; Leckman JF, 2003, BRAIN DEV-JPN, V25, pS24, DOI 10.1016/S0387-7604(03)90004-0; Lee HJ, 2010, BEHAV RES THER, V48, P571, DOI 10.1016/j.brat.2010.03.006; Lee HJ, 2009, BEHAV RES THER, V47, P294, DOI 10.1016/j.brat.2009.01.002; Lee HJ, 2005, DEPRESS ANXIETY, V21, P118, DOI 10.1002/da.20063; Lee HJ, 2005, BEHAV RES THER, V43, P999, DOI 10.1016/j.brat.2004.06.017; Lee HJ, 2003, BEHAV RES THER, V41, P11, DOI 10.1016/S0005-7967(01)00101-2; Lochner C, 2010, PSYCHOPATHOLOGY, V43, P389, DOI 10.1159/000321070; Mataix-Cols D, 2006, CURR OPIN PSYCHIATR, V19, P84, DOI 10.1097/01.yco.0000194809.98967.49; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228; Miguel EC, 2005, MOL PSYCHIATR, V10, P258, DOI 10.1038/sj.mp.4001617; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185; Moulding R, 2007, J ANXIETY DISORD, V21, P677, DOI 10.1016/j.janxdis.2006.10.001; Murayama K, 2013, PROG NEURO-PSYCHOPH, V40, P160, DOI 10.1016/j.pnpbp.2012.09.002; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; PURDON C, 1994, BEHAV RES THER, V32, P403, DOI 10.1016/0005-7967(94)90003-5; PURDON C, 1993, BEHAV RES THER, V31, P713, DOI 10.1016/0005-7967(93)90001-B; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Ramos-Brieva J A, 1986, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V14, P324; Rosario MC, 2009, CNS SPECTRUMS, V14, P315, DOI 10.1017/S1092852900020319; Rosario-Campos MC, 2006, MOL PSYCHIATR, V11, P495, DOI 10.1038/sj.mp.4001798; Rosas HJSY, 2002, ACTAS ESP PSIQUIATRI, V30, P30; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Roth RM, 2009, EPILEPSY BEHAV, V14, P677, DOI 10.1016/j.yebeh.2009.01.011; Ruge H, 2013, NEUROIMAGE, V68, P162, DOI 10.1016/j.neuroimage.2012.12.003; SANAVIO E, 1988, BEHAV RES THER, V26, P169, DOI 10.1016/0005-7967(88)90116-7; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Soriano-Mas C, 2007, NEUROIMAGE, V35, P1028, DOI 10.1016/j.neuroimage.2007.01.011; Szeszko PR, 2008, AM J PSYCHIAT, V165, P1299, DOI 10.1176/appi.ajp.2008.08010033; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; Wang ZS, 2011, AM J PSYCHIAT, V168, P1326, DOI 10.1176/appi.ajp.2011.09111692; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Williams MT, 2011, DEPRESS ANXIETY, V28, P495, DOI 10.1002/da.20820; Yoo SY, 2008, J KOREAN MED SCI, V23, P24, DOI 10.3346/jkms.2008.23.1.24; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	62	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75273	10.1371/journal.pone.0075273	http://dx.doi.org/10.1371/journal.pone.0075273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098688	gold, Green Published			2022-12-27	WOS:000325423500059
J	Huang, CH; Chang, CC; Huang, CS; Kuo, CL; Chen, CP; Hsia, CH; Chang, YM; Chen, HT; Feng, CC; Lin, LS; Yang, PT; Tsai, CD; Lin, CS; Liu, CS				Huang, Ching-Hui; Chang, Chia-Chu; Huang, Ching-Shan; Kuo, Chen-Ling; Chen, Ching-Pei; Hsia, Chien-Hsun; Chang, Yung-Ming; Chen, Hung-Te; Feng, Chih-Chung; Lin, Lee-Shin; Yang, Po-Ta; Tsai, Chen-Dao; Lin, Chih-Sheng; Liu, Chin-San			Using Oxidized Low-Density Lipoprotein Autoantibodies to Predict Restenosis after Balloon Angioplasty in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; HEALTHY-SUBJECTS; LDL; ATHEROSCLEROSIS; SEVERITY; PLASMA; CHOLESTEROL; ANTIBODIES; MORTALITY; DISEASE	Objectives: Oxidized low-density lipoproteins (oxLDL) and oxidized low-density lipoprotein autoantibodies (OLAB) have been detected in human plasma and atherosclerotic lesions. OLAB appear to play a role in the clearance of oxLDL from circulation. Higher levels of OLAB appear to be associated with a reduced risk of a wide range of cardiovascular diseases. We investigated the prognostic value of plasma oxLDL and OLAB in patients undergoing primary coronary balloon angioplasty for acute ST-elevation myocardial infarction (STEMI). Methods: Plasma oxLDL and OLAB concentrations were measured in 56 patients with acute STEMI before primary angioplasty, and then 3 days, 7 days and 1 month after the acute event. Follow-up angiography was repeated 6 months later to detect the presence of restensosis (defined as >50% luminal diameter stenosis). The thrombolysis in myocardial infarction (TIMI) risk score was calculated to determine the relationship between OLAB/oxLDL ratio and TIMI risk scores. Results: Of the 56 patients, 18 (31%) had angiographic evidence of restenosis. Plasma OLAB concentrations were significantly lower in the restenosis group before angioplasty (181 +/- 114 vs. 335 +/- 257 U/L, p = 0.003), and at day 3 (155 +/- 92 vs. 277 +/- 185 U/L, p<0.001) and day 7 (177 +/- 110 vs. 352 +/- 279 U/L, p<0.001) after the acute event. There was no difference in oxLDL concentration between the two groups. The ratio of OLAB/oxLDL positively correlated with TIMI risk scores before angioplasty (p for trend analysis, p = 0.004), at day 3 (p = 0.008) and day 7 (p<0.001) after STEMI. Significance: A relative deficit of OLAB, and hence likely impaired clearance of oxLDL, is associated with the risk of arterial restenosis after primary angioplasty for acute STEMI.	[Huang, Ching-Hui; Chen, Ching-Pei; Hsia, Chien-Hsun; Chang, Yung-Ming; Chen, Hung-Te; Feng, Chih-Chung; Lin, Lee-Shin; Yang, Po-Ta; Tsai, Chen-Dao] Changhua Christian Hosp, Div Cardiol, Dept Internal Med, Changhua, Taiwan; [Huang, Ching-Hui; Lin, Chih-Sheng] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chang, Chia-Chu] Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan; [Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Huang, Ching-Shan; Kuo, Chen-Ling; Liu, Chin-San] Changhua Christian Hosp, Vasc & Genom Res Ctr, Changhua, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Liu, Chin-San] China Med Univ, Grad Inst Integrat Med, Taichung, Taiwan	Changhua Christian Hospital; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Chung Shan Medical University; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan	Lin, CS (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	lincs@mail.nctu.edu.tw; liu48111@gmail.com			Changhua Christian Hospital Research Foundation [100-CCH-IRP-08]	Changhua Christian Hospital Research Foundation	The work was funded by grants 100-CCH-IRP-08 from the Changhua Christian Hospital Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brizzi P, 2004, CLIN CHEM LAB MED, V42, P164, DOI 10.1515/CCLM.2004.030; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Che JJ, 2011, CARDIOL J, V18, P364; Chen HW, 2008, CARDIOLOGY, V110, P252, DOI 10.1159/000112409; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125; Hulthe J, 2004, CLIN CHIM ACTA, V348, P1, DOI 10.1016/j.cccn.2004.05.021; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Iughetti L, 1999, PEDIATR RES, V45, P94, DOI 10.1203/00006450-199901000-00016; Izar MC, 2013, DIABETES VASC DIS RE, V10, P32, DOI 10.1177/1479164112443374; Karabinos I, 2007, ATHEROSCLEROSIS, V192, P448, DOI 10.1016/j.atherosclerosis.2007.03.033; Kullo IJ, 1998, ANN INTERN MED, V129, P1050, DOI 10.7326/0003-4819-129-12-199812150-00010; Li YH, 2012, ACTA CARDIOL SIN, V28, P63; Liu CS, 2007, EUR J CLIN NUTR, V61, P996, DOI 10.1038/sj.ejcn.1602606; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Nishi K, 2002, ARTERIOSCL THROM VAS, V22, P1649, DOI 10.1161/01.ATV.0000033829.14012.18; Pawlak K, 2012, ATHEROSCLEROSIS, V224, P252, DOI 10.1016/j.atherosclerosis.2012.07.011; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; Shoji T, 2000, ATHEROSCLEROSIS, V148, P171, DOI 10.1016/S0021-9150(99)00218-X; Strom A, 2007, ATHEROSCLEROSIS, V190, P298, DOI 10.1016/j.atherosclerosis.2006.03.032; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Virella G, 2003, CLIN DIAGN LAB IMMUN, V10, P499, DOI 10.1128/CDLI.10.4.499-505.2003; Virella G, 2008, ATHEROSCLEROSIS, V200, P239, DOI 10.1016/j.atherosclerosis.2008.03.025; Wiviott SD, 2004, J AM COLL CARDIOL, V44, P783, DOI 10.1016/j.jacc.2004.05.045	27	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74726	10.1371/journal.pone.0074726	http://dx.doi.org/10.1371/journal.pone.0074726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098346	Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600009
J	Kobayashi, H; Kumagai, K; Eguchi, T; Shigematsu, H; Kitaura, K; Kawano, M; Horikawa, T; Suzuki, S; Matsutani, T; Ogasawara, K; Hamada, Y; Suzuki, R				Kobayashi, Hiroshi; Kumagai, Kenichi; Eguchi, Takanori; Shigematsu, Hiroaki; Kitaura, Kazutaka; Kawano, Mitsuko; Horikawa, Tatsuya; Suzuki, Satsuki; Matsutani, Takaji; Ogasawara, Kouetsu; Hamada, Yoshiki; Suzuki, Ryuji			Characterization of T Cell Receptors of Th1 Cells Infiltrating Inflamed Skin of a Novel Murine Model of Palladium-Induced Metal Allergy	PLOS ONE			English	Article							CONTACT-DERMATITIS; NICKEL; RECOGNITION; REGION; USAGE; HYPERSENSITIVITY; REPERTOIRES; REACTIVITY; CD4(+); VIRUS	Metal allergy is categorized as a delayed-type hypersensitivity reaction, and is characterized by the recruitment of lymphocytes into sites of allergic inflammation. Because of the unavailability of suitable animal models for metal allergy, the role of T cells in the pathogenesis of metal allergy has not been explored. Thus, we developed a novel mouse model for metal allergy associated with infiltration of T cells by multiple injections of palladium (Pd) plus lipopolysaccharide into the footpad. Using this model, we characterized footpad-infiltrating T cells in terms of phenotypic markers, T cell receptor (TCR) repertoires and cytokine expression. CD3+ CD4+ T cells accumulated in the allergic footpads 7 days after Pd challenge. The expression levels of CD25, interleukin-2, interferon-gamma and tumor necrosis factor, but not interleukin-4 and interleukin-5, increased in the footpads after challenge, suggesting CD4+ T helper 1 (Th1) cells locally expanded in response to Pd. Infiltrated T cells in the footpads frequently expressed AV18-1 and BV8-2 T cell receptor (TCR) chains compared with T cells in the lymph nodes and exhibited oligoclonality. T-cell clones identified from Pd-allergic mouse footpads shared identical CDR3 sequences containing AV18-1 and BV8-2. These results suggest that TCR AV18-1 and BV8-2 play dominant and critical parts in the antigen specificity of Pd-specific Th1 cells.	[Kobayashi, Hiroshi; Kumagai, Kenichi; Eguchi, Takanori; Shigematsu, Hiroaki; Hamada, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan; [Kobayashi, Hiroshi; Kumagai, Kenichi; Eguchi, Takanori; Shigematsu, Hiroaki; Kitaura, Kazutaka; Matsutani, Takaji; Suzuki, Ryuji] Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Rheumatol & Allergy, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan; [Kobayashi, Hiroshi] Nagano Matsushiro Gen Hosp, Dept Oral & Maxillofacial Surg, Nagano, Japan; [Eguchi, Takanori] Toshiba Rinkan Hosp, Dept Oral & Maxillofacial Surg, Sagamihara, Kanagawa, Japan; [Kawano, Mitsuko; Ogasawara, Kouetsu] Tohoku Univ, Dept Immunobiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Horikawa, Tatsuya] Nishi Kobe Med Ctr, Dept Dermatol, Kobe, Hyogo, Japan; [Suzuki, Satsuki] Nippon Dent Univ Tokyo, Sect Biol Sci, Res Ctr Odontol, Tokyo, Japan	Tsurumi University; Toshiba Corporation; Tohoku University; Kobe City Medical Center General Hospital; Nippon Dental University	Suzuki, R (corresponding author), Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Rheumatol & Allergy, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan.	r-suzuki@sagamihara-hosp.gr.jp	Suzuki, Satsuki/ABE-1283-2020; Ogasawara, Kouetsu/G-9892-2011	Eguchi, Takanori/0000-0003-4608-1347	Japan Society for the Promotion of Science (JSPS) KAKENHI [23593004, 23790352]; Ministry of Health, Labour and Welfare of Japan [H22-meneki-ippan-004]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23593004 (H.Y. K. K. and S. S.) and 23790352(M. K.), and by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan H22-meneki-ippan-004 (K.O. and R. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, J VIROL, V72, P8032, DOI 10.1128/JVI.72.10.8032-8036.1998; Budinger L, 2001, J IMMUNOL, V167, P6038, DOI 10.4049/jimmunol.167.10.6038; Faurschou A, 2011, CONTACT DERMATITIS, V64, P185, DOI 10.1111/j.1600-0536.2011.01878.x; Gamerdinger K, 2003, J EXP MED, V197, P1345, DOI 10.1084/jem.20030121; Hashizume H, 2008, J IMMUNOL, V181, P8096, DOI 10.4049/jimmunol.181.11.8096; Hosoki M, 2009, BIO-MED MATER ENG, V19, P53, DOI 10.3233/BME-2009-0563; Ishihara K, 2009, INT ARCH ALLERGY IMM, V149, P57, DOI 10.1159/000210655; Kim JY, 2009, EXP MOL MED, V41, P288, DOI 10.3858/emm.2009.41.4.032; Kitaura K, 2011, J IMMUNOL, V187, P3919, DOI 10.4049/jimmunol.1100442; Kumagai K, 2010, ORAL SURG ORAL MED O, V110, P341, DOI 10.1016/j.tripleo.2010.03.030; Matsutani T, 1997, HUM IMMUNOL, V56, P57, DOI 10.1016/S0198-8859(97)00102-X; Minang JT, 2006, CLIN EXP IMMUNOL, V146, P417, DOI 10.1111/j.1365-2249.2006.03226.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Niiyama S, 2010, INT ARCH ALLERGY IMM, V153, P303, DOI 10.1159/000314372; Nikhil V, 2001, J CLIN DENT, V2, P94; Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767; Raap U, 2009, CONTACT DERMATITIS, V60, P339, DOI 10.1111/j.1600-0536.2009.01524.x; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Silvennoinen-Kassinen S, 1998, SCAND J IMMUNOL, V48, P99, DOI 10.1046/j.1365-3083.1998.00367.x; Takayama Kaoru, 2012, Arerugi, V61, P175; Thierse HJ, 2005, TOXICOLOGY, V209, P101, DOI 10.1016/j.tox.2004.12.015; TSURUTA Y, 1993, J IMMUNOL METHODS, V161, P7, DOI 10.1016/0022-1759(93)90193-B; Vollmer J, 1997, EUR J IMMUNOL, V27, P1865, DOI 10.1002/eji.1830270808; Vollmer J, 1999, J IMMUNOL, V163, P2723; Wataha JC, 2010, EXPERT REV MED DEVIC, V7, P489, DOI 10.1586/ERD.10.25; Yoshida R, 2000, IMMUNOGENETICS, V52, P35, DOI 10.1007/s002510000248	26	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76385	10.1371/journal.pone.0076385	http://dx.doi.org/10.1371/journal.pone.0076385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098486	gold, Green Submitted, Green Published			2022-12-27	WOS:000325483600041
J	Fahrbach, KM; Malykhina, O; Stieh, DJ; Hope, TJ				Fahrbach, Kelly M.; Malykhina, Olga; Stieh, Daniel J.; Hope, Thomas J.			Differential Binding of IgG and IgA to Mucus of the Female Reproductive Tract	PLOS ONE			English	Article							HUMAN CERVICAL-MUCUS; HUMAN ENDOCERVIX; MUCOSAL BARRIER; MUCIN; EXPRESSION; PROTEIN; CELLS; IMMUNOGLOBULINS; IDENTIFICATION; ANTIBODIES	Cells of the endocervix are responsible for the secretion of mucins, which provide an additional layer of protection to the female reproductive tract (FRT). This barrier is likely fortified with IgA as has previously been shown in the gastrointestinal tract and lungs of mice. Mucus associated IgA can facilitate clearance of bacteria. While a similar function for IgG has been proposed, an association with mucus has not yet been demonstrated. Here we find that IgA and IgG are differentially associated with the different types of mucus of the FRT. We observed that while both IgA and IgG are stably associated with cervical mucus, only IgG is associated with cervicovaginal mucus. These findings reveal that antibodies can bind tightly to mucus, where they can play a significant role in the fortification of the mucus barriers of the FRT. It may be possible to harness this interaction in the development of vaccines designed to protect the FRT mucosal barriers from sexually transmitted diseases such as HIV.	[Fahrbach, Kelly M.; Malykhina, Olga; Stieh, Daniel J.; Hope, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hope, TJ (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA.	thope@northwestern.edu			CAVD Global Health Grant [OPP1031734]; NIH [NIH R21 AI094584, NIH P01 AI082971]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094584, P01AI082971, R33AI094584] Funding Source: NIH RePORTER	CAVD Global Health Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by CAVD Global Health Grant OPP1031734, NIH grants Cervical/Vaginal Mucus and Microbicides NIH R21 AI094584, and Rush NIH P01 AI082971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersch-Bjorkman Y, 2007, MOL CELL PROTEOMICS, V6, P708, DOI 10.1074/mcp.M600439-MCP200; AUDIE JP, 1995, HUM REPROD, V10, P98, DOI 10.1093/humrep/10.1.98; BARROS C, 1985, GAMETE RES, V12, P85, DOI 10.1002/mrd.1120120110; BIESBROCK AR, 1991, INFECT IMMUN, V59, P3492, DOI 10.1128/IAI.59.10.3492-3497.1991; Bonilla-Musoles F, 1983, Clin Exp Obstet Gynecol, V10, P151; BRONSON RA, 1987, FERTIL STERIL, V47, P985; Cohen M, 2012, JOVE-J VIS EXP, DOI 10.3791/3928; DAUNTER B, 1976, BRIT J OBSTET GYNAEC, V83, P738, DOI 10.1111/j.1471-0528.1976.tb00925.x; Gipson IK, 1997, BIOL REPROD, V56, P999, DOI 10.1095/biolreprod56.4.999; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Harada N, 1997, J BIOL CHEM, V272, P15232, DOI 10.1074/jbc.272.24.15232; Hovenberg HW, 1996, GLYCOCONJUGATE J, V13, P839, DOI 10.1007/BF00702348; HUGGINS G R, 1981, Clinical Obstetrics and Gynecology, V24, P355, DOI 10.1097/00003081-198106000-00005; Ito R, 2003, VACCINE, V21, P2362, DOI 10.1016/S0264-410X(03)00078-1; JAGER S, 1981, FERTIL STERIL, V36, P792; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Junqueira LC, 2003, BASIC HISTOLOGY; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; Kutteh WH, 1998, AIDS RES HUM RETROV, V14, pS51; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LINFORD E, 1974, J REPROD FERTIL, V37, P239, DOI 10.1530/jrf.0.0370239; MAGNUSSON KE, 1982, IMMUNOLOGY, V45, P239; MCSWEEGAN E, 1987, INFECT IMMUN, V55, P1431, DOI 10.1128/IAI.55.6.1431-1435.1987; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Wickstrom C, 2000, BIOCHEM J, V351, P421, DOI 10.1042/0264-6021:3510421; Zhang MQ, 2007, AM J CLIN PATHOL, V128, P808, DOI 10.1309/JAF3KVGJHQCJ1QF9	29	65	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76176	10.1371/journal.pone.0076176	http://dx.doi.org/10.1371/journal.pone.0076176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098437	gold, Green Submitted, Green Published			2022-12-27	WOS:000325434500048
J	Lum, DWK; Perel, P; Hingorani, AD; Holmes, MV				Lum, Danny W. K.; Perel, Pablo; Hingorani, Aroon D.; Holmes, Michael V.			CYP2D6 Genotype and Tamoxifen Response for Breast Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PROGRESSION-FREE SURVIVAL; SURROGATE END-POINTS; POSTMENOPAUSAL WOMEN; ADJUVANT TAMOXIFEN; GENETIC POLYMORPHISMS; CLINICAL-TRIALS; ASSOCIATION; OUTCOMES; RECURRENCE; CYP2D6-ASTERISK-10	Objective: To evaluate evidence on the association between CYP2D6 genotype and tamoxifen response through. Design: Systematic review and meta-analysis of prospective, cross-sectional and case-control studies published to 2012. For each study, relative risks and 95% confidence intervals were extracted and pooled with a fixed and random effects model. Heterogeneity, publication bias, subgroup, and meta-regression analyses were performed. Data Sources: PubMed (inception-2012) and EMBASE (inception-2012). Eligibility Criteria for Selecting Studies: Criteria for inclusion were studies reporting breast cancer outcomes in patients treated with tamoxifen and genotyped for polymorphisms in the CYP2D6 gene. Results: Twenty-five studies of 13,629 individuals were identified, of which 22 investigated the association of CYP2D6 genotype with outcomes in breast cancer women all receiving tamoxifen treatment ("treatment-only" design). Three randomized trials evaluated the effect of CYP2D6 genotype on tamoxifen response ("effect modification" design). In analysis of treatment-only studies, the relative risk (RR) of all-cause mortality (>307 events in 4,936 patients) for carriers of a CYP2D6 reduced function allele was 1.11 (95% confidence interval (CI): 0.94 to 1.31) compared to individuals with normal/increased function CYP2D6 alleles. When we investigated a composite outcome including all-cause mortality and surrogate endpoints for overall survival (>307 events in 6,721 patients), carriers of a CYP2D6 reduced function allele had a RR of 1.27 (95% CI: 1.11 to 1.45). From two randomized trials that permitted effect-modification analysis, one had only 154 patients and showed evidence of effect modification of tamoxifen by CYP2D6 genotype for distant recurrence but was directionally opposite to that predicted, whereas a larger trial of 2,537 patients failed to show evidence of effect modification for breast cancer-free interval (P values for interaction 0.02 and 0.44, respectively). Conclusions: Based on these findings, there is insufficient evidence to recommend CYP2D6 genotyping to guide tamoxifen treatment.	[Lum, Danny W. K.] UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London, England; [Perel, Pablo] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London WC1, England; [Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, Div Med, London, England; [Hingorani, Aroon D.; Holmes, Michael V.] UCL, Genet Epidemiol Grp, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London	Lum, DWK (corresponding author), UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London, England.	wai.lum.10@ucl.ac.uk; mvholmes@gmail.com	Holmes, Michael/AAA-2208-2021	Hingorani, Aroon/0000-0001-8365-0081; /0000-0002-2342-301X	MRC Population Health Scientist Fellowship [G0802432]; NIHR UCL Biomedical Research Centre; MRC [G0902393, G0802432] Funding Source: UKRI; Medical Research Council [G0902393, G0802432] Funding Source: researchfish	MRC Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR UCL Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Holmes is funded by a MRC Population Health Scientist Fellowship (G0802432). Professor Hingorani is supported by the NIHR UCL Biomedical Research Centre. Professor Hingorani and Dr. Perel are members of the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership [G0902393/99558]. The funding bodies had no role in study design, collection, analysis, interpretation of data, writing of report or in the decision to submit the article for publication. The study authors were completely independent of the funding bodies.	Abraham JE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2629; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Baker SG, 2006, JNCI-J NATL CANCER I, V98, P502, DOI 10.1093/jnci/djj153; Baker Stuart G, 2003, BMC Med Res Methodol, V3, P16, DOI 10.1186/1471-2288-3-16; Bijl MJ, 2009, BREAST CANCER RES TR, V118, P125, DOI 10.1007/s10549-008-0272-2; Booth CM, 2012, J CLIN ONCOL, V30, P1030, DOI 10.1200/JCO.2011.38.7571; Brauch H, 2013, J CLIN ONCOL, V31, P176, DOI 10.1200/JCO.2012.44.6625; COEZY E, 1982, CANCER RES, V42, P317; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Coller JK, 2002, BRIT J CLIN PHARMACO, V54, P157, DOI 10.1046/j.1365-2125.2002.01614.x; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2012, LONG TERM EFFECTS CO; Di Leo A, 2003, J CLIN ONCOL, V21, P2045, DOI 10.1200/JCO.2003.99.089; FDA, 2006, SUMM MIN ADV COMM PH; FDA U.S, 2006, TAM BACKGR SUMM; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Freidlin B, 2007, J CLIN ONCOL, V25, P2122, DOI 10.1200/JCO.2006.09.6198; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Gonzalez-Santiago S, 2007, J CLIN ONCOL, V25; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2011, OCHRANE HDB SYSTEMAT; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Kelly CM, 2012, J NATL CANCER I, V104, P427, DOI 10.1093/jnci/djs139; Kiyotani K, 2012, HUM MOL GENET; Lammers L A, 2010, Br J Cancer, V103, P765, DOI 10.1038/sj.bjc.6605800; Lash TL, 2011, JNCI-J NATL CANCER I, V103, P489, DOI 10.1093/jnci/djr010; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madlensky L, 2009, SYMPOSIUM, P69; Markman M, 2007, GYNECOL ONCOL, V106, P279, DOI 10.1016/j.ygyno.2007.06.005; Miksad RA, 2008, INT J TECHNOL ASSESS, V24, P371, DOI 10.1017/S0266462308080495; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morrow PK, 2011, CANCER, V118, P1221; Murai K, 2009, XENOBIOTICA, V39, P795, DOI 10.3109/00498250903171395; Nakamura Y, 2012, J NATL CANCER I, V104, P1264, DOI 10.1093/jnci/djs304; Newman WG, 2008, CLIN CANCER RES, V14, P5913, DOI 10.1158/1078-0432.CCR-07-5235; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Okishiro M, 2009, CANCER-AM CANCER SOC, V115, P952, DOI 10.1002/cncr.24111; Park HS, 2011, J KOREAN MED SCI, V26, P1007, DOI 10.3346/jkms.2011.26.8.1007; Park IH, 2012, BREAST CANCER RES TR, V131, P455, DOI 10.1007/s10549-011-1425-2; Patsner B, 2008, GYNECOL ONCOL, V108, P254, DOI 10.1016/j.ygyno.2007.09.021; Rae JM, 2012, JNCI-J NATL CANCER I, V104, P452, DOI 10.1093/jnci/djs126; Regan MM, 2012, JNCI-J NATL CANCER I, V104, P441, DOI 10.1093/jnci/djs125; Saad ED, 2010, ANN ONCOL, V21, P7, DOI 10.1093/annonc/mdp523; Sargent Daniel, 2006, Oncology (Williston Park), V20, P5; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Schroth W, 2009, JAMA-J AM MED ASSOC, V302, P1429, DOI 10.1001/jama.2009.1420; Seruga B, 2010, BREAST CANCER RES TR, V122, P609, DOI 10.1007/s10549-010-0902-3; Smith I, 2006, SEMIN ONCOL, V33, pS2, DOI 10.1053/j.seminoncol.2005.07.030; Stingl JC, 2010, CURR MED RES OPIN, V26, P2535, DOI 10.1185/03007995.2010.518304; Teh LK, 2012, AAPS J, V14, P52, DOI 10.1208/s12248-011-9313-6; Thompson AM, 2011, BREAST CANCER RES TR, V125, P279, DOI 10.1007/s10549-010-1139-x; van Schaik RHN, 2011, PHARMACOGENOMICS, V12, P1137, DOI [10.2217/PGS.11.54, 10.2217/pgs.11.54]; Wegman P, 2005, BREAST CANCER RES, V7, pR284, DOI 10.1186/bcr993; Wegman P, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1640; Wittes J, 2009, CIRCULATION, V119, P912, DOI 10.1161/CIRCULATIONAHA.108.836601; Xu Y, 2008, ANN ONCOL, V19, P1423, DOI 10.1093/annonc/mdn155; Zeng ZY, 2013, CANCER CHEMOTH PHARM, V72, P287, DOI 10.1007/s00280-013-2195-9	58	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76648	10.1371/journal.pone.0076648	http://dx.doi.org/10.1371/journal.pone.0076648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098545	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500079
J	Bao, P; Shen, HW; Chen, W; Cheng, XQ				Bao, Peng; Shen, Hua-Wei; Chen, Wei; Cheng, Xue-Qi			Cumulative Effect in Information Diffusion: Empirical Study on a Microblogging Network	PLOS ONE			English	Article							FLOW	Cumulative effect in social contagion underlies many studies on the spread of innovation, behavior, and influence. However, few large-scale empirical studies are conducted to validate the existence of cumulative effect in information diffusion on social networks. In this paper, using the population-scale dataset from the largest Chinese microblogging website, we conduct a comprehensive study on the cumulative effect in information diffusion. We base our study on the diffusion network of message, where nodes are the involved users and links characterize forwarding relationship among them. We find that multiple exposures to the same message indeed increase the possibility of forwarding it. However, additional exposures cannot further improve the chance of forwarding when the number of exposures crosses its peak at two. This finding questions the cumulative effect hypothesis in information diffusion. Furthermore, to clarify the forwarding preference among users, we investigate both structural motif in the diffusion network and temporal pattern in information diffusion process. Findings provide some insights for understanding the variation of message popularity and explain the characteristics of diffusion network.	[Bao, Peng; Shen, Hua-Wei; Chen, Wei; Cheng, Xue-Qi] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Computing Technology, CAS	Shen, HW (corresponding author), Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China.	shenhuawei@ict.ac.cn	Cheng, Xueqi/F-1706-2010; Shen, Hua-Wei/E-8028-2010; Chen, Wei/O-7697-2015	Shen, Hua-Wei/0000-0002-1081-8119; Chen, Wei/0000-0003-0065-3610	National Basic Research Program of China (973 program) [2013CB329602, 2012CB316303]; National Natural Science Foundation of China [61232010, 61202215]; Beijing Natural Science Foundation [4122077]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was funded by the National Basic Research Program of China (973 program) under grant numbers 2013CB329602 and 2012CB316303, and the National Natural Science Foundation of China under grant numbers 61232010 and 61202215. This work was also partly funded by the Beijing Natural Science Foundation under grant number 4122077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar E., 2004, WORKSH WEBL, V13, P16989; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Backstrom L., 2006, P SIGKDD, P44, DOI DOI 10.1145/1150402.1150412; Bao P, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P177; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Cheng XQ, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10011; Cosley D., 2010, AAAI INT C WEBL SOC, V10, P26; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GRUHL D., 2004, SIGKDD EXPLORATIONS, V13, P491, DOI DOI 10.1145/1046456.1046462; Hong L., 2011, WWW, P57, DOI DOI 10.1145/1963192.1963222; Jin X., 2012, P 5 ACM INT C WEB SE; KATZ E, 1957, PUBLIC OPIN QUART, V21, P61, DOI 10.1086/266687; Kempe D., 2003, P 9 ACM SIGKDD INT C, V11, P105, DOI DOI 10.1145/956750.956769; Lazarsfeld P, 1968, PEOPLES CHOICE VOTER; Lerman K., 2010, P 19 INT C WORLD WID, P621, DOI DOI 10.1145/1772690.1772754; Leskovec J, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P551; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Liben-Nowell D, 2008, P NATL ACAD SCI USA, V105, P4633, DOI 10.1073/pnas.0708471105; Marvel SA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198701; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Perotti JI, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108701; Rogers E.M., 2010, DIFFUSION INNOVATION; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; Shen HW, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056111; Strang D, 1998, ANNU REV SOCIOL, V24, P265, DOI 10.1146/annurev.soc.24.1.265; Sun E., 2009, P 3 INT ICWSM C, P146; Szabo G, 2010, COMMUN ACM, V53, P80, DOI 10.1145/1787234.1787254; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Yang J., 2011, P 4 ACM INT C WEB SE, P177; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055437	34	48	52	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76027	10.1371/journal.pone.0076027	http://dx.doi.org/10.1371/journal.pone.0076027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098422	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100038
J	Chockalingam, K; Vedhachalam, C; Rangasamy, S; Sekar, G; Adinarayanan, S; Swaminathan, S; Menon, PA				Chockalingam, Kolappan; Vedhachalam, Chandrasekaran; Rangasamy, Subramani; Sekar, Gomathi; Adinarayanan, Srividya; Swaminathan, Soumya; Menon, Pradeep Aravindan			Prevalence of Tobacco Use in Urban, Semi Urban and Rural Areas in and around Chennai City, India	PLOS ONE			English	Article								Background: Tobacco use leads to many health complications and is a risk factor for the occurrence of cardio vascular diseases, lung and oral cancers, chronic bronchitis etc. Almost 6 million people die from tobacco-related causes every year. This study was conducted to measure the prevalence of tobacco use in three different areas around Chennai city, south India. Methods: A survey of 7510 individuals aged > = 15 years was undertaken covering Chennai city (urban), Ambattur (semi-urban) and Sriperumbudur (rural) taluk. Details on tobacco use were collected using a questionnaire adapted from both Global Youth Tobacco Survey and Global Adults Tobacco Survey. Results: The overall prevalence of tobacco use was significantly higher in the rural (23.7%) compared to semi-urban (20.9%) and urban (19.4%) areas (P value < 0.001) Tobacco smoking prevalence was 14.3%, 13.9% and 12.4% in rural, semi-urban and urban areas respectively. The corresponding values for smokeless tobacco use were 9.5%, 7.0% and 7.0% respectively. Logistic regression analysis showed that the odds of using tobacco (with smoke or smokeless forms) was significantly higher among males, older individuals, alcoholics, in rural areas and slum localities. Behavioural pattern analysis of current tobacco users led to three groups (1) those who were not reached by family or friends to advice on harmful effects (2) those who were well aware of harmful effects of tobacco and even want to quit and (3) those are exposed to second hand/passive smoking at home and outside. Conclusions: Tobacco use prevalence was significantly higher in rural areas, slum dwellers, males and older age groups in this region of south India. Women used mainly smokeless tobacco. Tobacco control programmes need to develop strategies to address the different subgroups among tobacco users. Public health facilities need to expand smoking cessation counseling services as well as provide pharmacotherapy where necessary.	[Chockalingam, Kolappan; Vedhachalam, Chandrasekaran; Rangasamy, Subramani; Sekar, Gomathi; Adinarayanan, Srividya; Swaminathan, Soumya; Menon, Pradeep Aravindan] Natl Inst Res TB, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Menon, PA (corresponding author), Natl Inst Res TB, Madras, Tamil Nadu, India.	docpradeep@yahoo.com			United States Agency for International Development (USAID) under the Model DOTS Project [MDP TSA-2010/103409]	United States Agency for International Development (USAID) under the Model DOTS Project(United States Agency for International Development (USAID))	The analysis and presentation of the data was supported in part by the World Health Organization with financial assistance provided by the United States Agency for International Development (USAID) under the Model DOTS Project (Grant no: MDP TSA-2010/103409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejuwon G A, 2009, Afr J Med Med Sci, V38 Suppl 2, P21; Chaly Preetha Elizabeth, 2007, Indian J Dent Res, V18, P2; Critchley JA, 2003, THORAX, V58, P435, DOI 10.1136/thorax.58.5.435; Gajalakshmi V, 2010, TOB USE INSIGHTS, V3, P23; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; GIOVINO GA, 1995, EPIDEMIOL REV, V17, P48, DOI 10.1093/oxfordjournals.epirev.a036185; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Gupta PC, INDIAN J CANC, V49, P393; International Institute for Population Sciences (IIPS), 2007, NAT FAM HLTH SURV NF; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; MOHFW, 2010, GLOB AD TOB SURV FAC; Neufeld KJ, 2005, DRUG ALCOHOL DEPEN, V77, P283, DOI 10.1016/j.drugalcdep.2004.08.022; NFHS-2, 1998, IND NAT FAM HLTH SUR, P1; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Rooban T, 2010, Indian J Cancer, V47 Suppl 1, P53, DOI 10.4103/0019-509X.63869; Subramanian SV, 2004, BMJ-BRIT MED J, V328, P801, DOI 10.1136/bmj.328.7443.801; WHO, 1997, TOB HLTH GLOB STAT R; WHO, 2006, IND GLOB YOUTH TOB S; WHO, 2011, WHO REP GLOB TOB EP	19	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76005	10.1371/journal.pone.0076005	http://dx.doi.org/10.1371/journal.pone.0076005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098418	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100035
J	Khajah, MA; Almohri, I; Mathew, PM; Luqmani, YA				Khajah, Maitham A.; Almohri, Iman; Mathew, Princy M.; Luqmani, Yunus A.			Extracellular Alkaline pH Leads to Increased Metastatic Potential of Estrogen Receptor Silenced Endocrine Resistant Breast Cancer Cells	PLOS ONE			English	Article							NA-H EXCHANGER; EPITHELIAL-MESENCHYMAL TRANSITION; MELANOMA-CELLS; MATRIX-METALLOPROTEINASE-9 EXPRESSION; ANTIESTROGEN ICI-182,780; TUMOR MICROENVIRONMENT; SIGNALING PATHWAYS; NA+/H+ EXCHANGE; GENE-EXPRESSION; ACTIN-BINDING	Introduction: Endocrine resistance in breast cancer is associated with enhanced metastatic potential and poor clinical outcome, presenting a significant therapeutic challenge. We have established several endocrine insensitive breast cancer lines by shRNA induced depletion of estrogen receptor (ER) by transfection of MCF-7 cells which all exhibit enhanced expression profile of mesenchymal markers with reduction of epithelial markers, indicating an epithelial to mesenchymal transition. In this study we describe their behaviour in response to change in extracellular pH, an important factor controlling cell motility and metastasis. Methods: Morphological changes associated with cell exposure to extracellular alkaline pH were assessed by live cell microscopy and the effect of various ion pumps on this behavior was investigated by pretreatment with chemical inhibitors. The activity and expression profile of key signaling molecules was assessed by western blotting. Cell motility and invasion were examined by scratch and under-agarose assays respectively. Total matrix metalloproteinase (MMP) activity and specifically of MMP2/9 was assessed in conditioned medium in response to brief alkaline pH exposure. Results: Exposure of ER -ve but not ER +ve breast cancer cells to extracellular alkaline pH resulted in cell shrinkage and spherical appearance (termed contractolation); this was reversed by returning the pH back to 7.4. Contractolation was blocked by targeting the Na+/K+ and Na+/H+ pumps with specific chemical inhibitors. The activity and expression profile of key signaling molecules critical for cell adhesion were modulated by the exposure to alkaline pH. Brief exposure to alkaline pH enhanced MMP2/9 activity and the invasive potential of ER -ve cells in response to serum components and epithelial growth factor stimulation without affecting unhindered motility. Conclusions: Endocrine resistant breast cancer cells behave very differently to estrogen responsive cells in alkaline pH, with enhanced invasive potential; these studies emphasise the crucial influence of extracellular pH and caution against indiscriminate application of alkalinising drug therapy.	[Khajah, Maitham A.; Almohri, Iman; Mathew, Princy M.; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, Safat, Kuwait	Kuwait University	Luqmani, YA (corresponding author), Kuwait Univ, Fac Pharm, Safat, Kuwait.	yunus@hsc.edu.kw	Khajah, Maitham/AAZ-8841-2020		Kuwait University [PT02/11]; Kuwait University Research Administration [GM01/01, GM01/05]	Kuwait University; Kuwait University Research Administration	This work was supported by Kuwait University research grant No. PT02/11. Parts of this work were supported by Grants GM01/01 and GM01/05 to the Research Core Facility from Kuwait University Research Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Bartsch JE, 2003, J SURG RES, V110, P383, DOI 10.1016/S0022-4804(03)00007-6; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; BRUNNER N, 1993, CANCER RES, V53, P3229; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; Cereijido M, 2012, AM J PHYSIOL-CELL PH, V302, pC473, DOI 10.1152/ajpcell.00083.2011; Chiang YH, 2008, J CELL PHYSIOL, V214, P810, DOI 10.1002/jcp.21277; Dai Y, 2010, MOL CANCER THER, V9, P1554, DOI 10.1158/1535-7163.MCT-10-0359; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Garamszegi N, 2009, MOL CANCER RES, V7, P319, DOI 10.1158/1541-7786.MCR-08-0227; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Goldmann WH, 1999, EUR J BIOCHEM, V260, P439, DOI 10.1046/j.1432-1327.1999.00177.x; Grey MJ, 2006, J MOL BIOL, V355, P1078, DOI 10.1016/j.jmb.2005.11.001; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; Hirtenlehner K, 2002, EUR CYTOKINE NETW, V13, P234; Hiscox S, 2000, BREAST CANCER RES TR, V59, P245, DOI 10.1023/A:1006348317841; Hosogi S, 2012, CELL PHYSIOL BIOCHEM, V30, P1241, DOI 10.1159/000343315; Hung CM, 2011, J AGR FOOD CHEM, V59, P9683, DOI 10.1021/jf2021489; Johnson LL, 2000, J BIOL CHEM, V275, P11026, DOI 10.1074/jbc.275.15.11026; Kato Y, 2005, J BIOL CHEM, V280, P10938, DOI 10.1074/jbc.M411313200; Kato Y, 2007, FEBS J, V274, P3171, DOI 10.1111/j.1742-4658.2007.05848.x; Khajah MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041847; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Kumar AP, 2009, CANCER RES, V69, P8636, DOI 10.1158/0008-5472.CAN-09-0219; Larre I, 2011, P NATL ACAD SCI USA, V108, P20591, DOI 10.1073/pnas.1102617108; Larre I, 2011, METHODS MOL BIOL, V763, P155, DOI 10.1007/978-1-61779-191-8_10; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Larre I, 2006, P NATL ACAD SCI USA, V103, P10911, DOI 10.1073/pnas.0604496103; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Lee WJ, 2008, TOXICOL APPL PHARM, V226, P178, DOI 10.1016/j.taap.2007.09.013; Li HC, 2004, BREAST CANCER RES TR, V88, P75, DOI 10.1007/s10549-004-1200-8; Liang CC, 2001, J BIOL CHEM, V276, P21146, DOI 10.1074/jbc.M010669200; Lin H, 2004, J BIOL CHEM, V279, P29302, DOI 10.1074/jbc.M403664200; Lucien F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028851; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Maulik G, 2002, CLIN CANCER RES, V8, P620; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; McConkey DJ, 2000, CANCER RES, V60, P3807; McLachlan GD, 2007, BIOCHEMISTRY-US, V46, P6931, DOI 10.1021/bi0602359; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Miraglia E, 2005, INT J CANCER, V115, P924, DOI 10.1002/ijc.20959; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; Onishi I, 2012, ONCOL REP, V27, P311, DOI 10.3892/or.2011.1542; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Patel H, 2005, J CELL BIOL, V169, P321, DOI 10.1083/jcb.200412145; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Reshkin SJ, 2000, J BIOL CHEM, V275, P5361, DOI 10.1074/jbc.275.8.5361; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; ROZHIN J, 1994, CANCER RES, V54, P6517; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Somiari SB, 2006, CANCER LETT, V233, P98, DOI 10.1016/j.canlet.2005.03.003; Somiari SB, 2006, INT J CANCER, V119, P1403, DOI 10.1002/ijc.21989; Song RX, 2002, MOL CELL ENDOCRINOL, V193, P29, DOI 10.1016/S0303-7207(02)00093-X; Stella MC, 1999, INT J BIOCHEM CELL B, V31, P1357, DOI 10.1016/S1357-2725(99)00089-8; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Thiery JP, 2013, CANCER CELL, V23, P272, DOI 10.1016/j.ccr.2013.03.004; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Vasaturo F, 2005, ONCOL REP, V13, P745; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wertz IE, 2000, J BIOL CHEM, V275, P11470, DOI 10.1074/jbc.275.15.11470; WILHELM SM, 1993, J BIOL CHEM, V268, P21906; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Winnicka K, 2008, BIOL PHARM BULL, V31, P1131, DOI 10.1248/bpb.31.1131; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	82	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76327	10.1371/journal.pone.0076327	http://dx.doi.org/10.1371/journal.pone.0076327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098477	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100060
J	Wang, Z; Zhang, XX; Huang, KL; Miao, Y; Shi, P; Liu, B; Long, C; Li, AM				Wang, Zhu; Zhang, Xu-Xiang; Huang, Kailong; Miao, Yu; Shi, Peng; Liu, Bo; Long, Chao; Li, Aimin			Metagenomic Profiling of Antibiotic Resistance Genes and Mobile Genetic Elements in a Tannery Wastewater Treatment Plant	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; SEWAGE-TREATMENT PLANTS; COMMUNITY STRUCTURE; LIQUID-CHROMATOGRAPHY; PROTEIN-DEGRADATION; MICROBIAL DIVERSITY; ACTIVATED-SLUDGE; METAL RESISTANCE; SOIL; SEQUENCE	Antibiotics are often used to prevent sickness and improve production in animal agriculture, and the residues in animal bodies may enter tannery wastewater during leather production. This study aimed to use Illumina high-throughput sequencing to investigate the occurrence, diversity and abundance of antibiotic resistance genes (ARGs) and mobile genetic elements (MGEs) in aerobic and anaerobic sludge of a full-scale tannery wastewater treatment plant (WWTP). Metagenomic analysis showed that Proteobacteria, Firmicutes, Bacteroidetes and Actinobacteria dominated in the WWTP, but the relative abundance of archaea in anaerobic sludge was higher than in aerobic sludge. Sequencing reads from aerobic and anaerobic sludge revealed differences in the abundance of functional genes between both microbial communities. Genes coding for antibiotic resistance were identified in both communities. BLAST analysis against Antibiotic Resistance Genes Database (ARDB) further revealed that aerobic and anaerobic sludge contained various ARGs with high abundance, among which sulfonamide resistance gene sul1 had the highest abundance, occupying over 20% of the total ARGs reads. Tetracycline resistance genes (tet) were highly rich in the anaerobic sludge, among which tet33 had the highest abundance, but was absent in aerobic sludge. Over 70 types of insertion sequences were detected in each sludge sample, and class 1 integrase genes were prevalent in the WWTP. The results highlighted prevalence of ARGs and MGEs in tannery WWTPs, which may deserve more public health concerns.	[Wang, Zhu; Zhang, Xu-Xiang; Huang, Kailong; Miao, Yu; Shi, Peng; Liu, Bo; Long, Chao; Li, Aimin] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Zhang, XX (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.	zhangxx@nju.edu.cn; liaimin@nju.edu.cn	Zhu, Wang/AAT-1740-2021; 王, 铸/I-3824-2016; Zhang, xiaoyu/GXA-3206-2022; Miao, Yu/AAY-4453-2020; zhang, xu/GYE-3558-2022; zhang, xian/GYA-0290-2022; Peng, Shi/AAP-7926-2021; zhang, xu/GRX-9733-2022	王, 铸/0000-0002-6763-8194; Miao, Yu/0000-0002-1145-7298; Peng, Shi/0000-0002-3333-0458; 	National Natural Science Foundation of China [51278240, 51008153]; National Science and Technology Major Project of China [2011ZX07210-001-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China	This study was financially supported by National Natural Science Foundation of China (Grant No. 51278240 and 51008153; URL: http://www.nsfc.gov.cn) and National Science and Technology Major Project of China (Grant No. 2011ZX07210-001-1; URL: http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MZ, 2011, ENVIRON MONIT ASSESS, V178, P281, DOI 10.1007/s10661-010-1689-8; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Bittencourt MS, 2012, FOOD ADDIT CONTAM A, V29, P508, DOI 10.1080/19440049.2011.606228; Borras S, 2012, J SEP SCI, V35, P2048, DOI 10.1002/jssc.201200302; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001; Chen J, 2012, GEOMICROBIOL J, V29, P226, DOI 10.1080/01490451.2011.558562; Cheong DY, 2006, APPL MICROBIOL BIOT, V72, P635, DOI 10.1007/s00253-006-0313-x; Depardieu F, 2003, ANTIMICROB AGENTS CH, V47, P7, DOI 10.1128/AAC.47.1.7-18.2003; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomez-Alvarez V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-122; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goto T, 2005, J CHROMATOGR A, V1100, P193, DOI 10.1016/j.chroma.2005.09.056; Gratacos-Cubarsi M, 2006, J CHROMATOGR B, V832, P121, DOI 10.1016/j.jchromb.2006.01.002; Hauser LJ, 2011, J BACTERIOL, V193, P4268, DOI 10.1128/JB.05400-11; Heise J, 2006, CHEMOSPHERE, V65, P2352, DOI 10.1016/j.chemosphere.2006.04.084; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kim S, 2005, ENVIRON SCI TECHNOL, V39, P5816, DOI 10.1021/es050006u; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Lefebvre O, 2006, EXTREMOPHILES, V10, P505, DOI 10.1007/s00792-006-0524-1; Leon G, 2003, J BACTERIOL, V185, P2036, DOI 10.1128/JB.185.6.2036-2041.2003; Li J, 2012, ENVIRON HEALTH PERSP, V120, P1144, DOI 10.1289/ehp.1104776; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Luo Y, 2011, ENVIRON SCI TECHNOL, V45, P1827, DOI 10.1021/es104009s; Ma LP, 2011, ECOTOXICOLOGY, V20, P968, DOI 10.1007/s10646-011-0652-y; Marcelino M, 2011, WATER SCI TECHNOL, V64, P1142, DOI 10.2166/wst.2011.398; Monier JM, 2011, CURR OPIN MICROBIOL, V14, P229, DOI 10.1016/j.mib.2011.04.010; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Moura A, 2010, RES MICROBIOL, V161, P58, DOI 10.1016/j.resmic.2009.11.004; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Murugananthan M, 2004, SEP PURIF TECHNOL, V40, P69, DOI 10.1016/j.seppur.2004.01.005; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 2004, PEER TO PEER ENV ANN; Pender S, 2004, WATER RES, V38, P619, DOI 10.1016/j.watres.2003.10.055; Pfister CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010518; Port JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048000; REEVE CA, 1984, J BACTERIOL, V157, P758, DOI 10.1128/JB.157.3.758-763.1984; Santegoeds CM, 1999, APPL ENVIRON MICROB, V65, P4618; Schleinitz KM, 2010, ANTIMICROB AGENTS CH, V54, P4321, DOI 10.1128/AAC.00006-10; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Silva CC, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-18; Singh KM, 2012, GENE, V507, P146, DOI 10.1016/j.gene.2012.07.037; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Tariq SR, 2006, J ENVIRON MANAGE, V79, P20, DOI 10.1016/j.jenvman.2005.05.009; Tennstedt T, 2005, PLASMID, V53, P218, DOI 10.1016/j.plasmid.2004.09.004; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tisler T, 2004, WATER RES, V38, P3503, DOI 10.1016/j.watres.2004.05.011; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Vejmelkova D, 2012, APPL MICROBIOL BIOT, V93, P401, DOI 10.1007/s00253-011-3409-x; Verma T, 2001, BIORESOURCE TECHNOL, V78, P31, DOI 10.1016/S0960-8524(00)00168-1; Xia SQ, 2010, ENVIRON SCI TECHNOL, V44, P7391, DOI 10.1021/es101554m; Xu WH, 2007, WATER RES, V41, P4526, DOI 10.1016/j.watres.2007.06.023; Yu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059831; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zhao L, 2010, SCI TOTAL ENVIRON, V408, P1069, DOI 10.1016/j.scitotenv.2009.11.014	66	54	64	3	199	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76079	10.1371/journal.pone.0076079	http://dx.doi.org/10.1371/journal.pone.0076079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098424	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100039
J	Peterson, JS; McCall, K				Peterson, Jeanne S.; McCall, Kimberly			Combined Inhibition of Autophagy and Caspases Fails to Prevent Developmental Nurse Cell Death in the Drosophila melanogaster Ovary	PLOS ONE			English	Article							PRIMARY PHAGOCYTOSIS; DEGRADATION; REQUIREMENT; ENGULFMENT; APOPTOSIS; GROWTH	During the final stages of Drosophila melanogaster oogenesis fifteen nurse cells, sister cells to the oocyte, degenerate as part of normal development. This process involves at least two cell death mechanisms, caspase-dependent cell death and autophagy, as indicated by apoptosis and autophagy markers. In addition, mutations affecting either caspases or autophagy partially reduce nurse cell removal, leaving behind end-stage egg chambers with persisting nurse cell nuclei. To determine whether apoptosis and autophagy work in parallel to degrade and remove these cells as is the case with salivary glands during pupariation, we generated mutants doubly affecting caspases and autophagy. We found no significant increase in either the number of late stage egg chambers containing persisting nuclei or in the number of persisting nuclei per egg chamber in the double mutants compared to single mutants. These findings suggest that there is another cell death mechanism functioning in the ovary to remove all nurse cell remnants from late stage egg chambers.	[Peterson, Jeanne S.; McCall, Kimberly] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	McCall, K (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	kmccall@bu.edu			NIH [R01 GM060574]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH R01 GM060574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2007, DEV CELL, V12, P73, DOI 10.1016/j.devcel.2006.11.012; Barger AJ, 1998, J NEUROSCI, V18, P2871; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Barth JMI, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-35; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bass BP, 2009, CELL DEATH DIFFER, V16, P1362, DOI 10.1038/cdd.2009.79; Baum JS, 2007, CELL DEATH DIFFER, V14, P1508, DOI 10.1038/sj.cdd.4402155; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Cavaliere V, 1998, DEV GENES EVOL, V208, P106, DOI 10.1007/s004270050160; Chou TB, 1996, GENETICS, V144, P1673; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Etchegaray JI, 2012, DEVELOPMENT, V139, P4029, DOI 10.1242/dev.082776; Foley K, 1998, DEVELOPMENT, V125, P1075; GIORGI F, 1976, J EMBRYOL EXP MORPH, V35, P521; Hall DH, 1997, J NEUROSCI, V17, P1033; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; King R. C., 1970, OVARIAN DEV DROSOPHI; Laundrie B, 2003, GENETICS, V165, P1881; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Nezis IP, 2010, J CELL BIOL, V190, P523, DOI 10.1083/jcb.201002035; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Peterson JS, 2007, GENESIS, V45, P396, DOI 10.1002/dvg.20306; Peterson JS, 2003, DEV BIOL, V260, P113, DOI 10.1016/S0012-1606(03)00240-9; Pritchett TL, 2009, APOPTOSIS, V14, P969, DOI 10.1007/s10495-009-0369-z; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Spradling Allan C., 1993, P1; Varkey J, 1999, J CELL BIOL, V144, P701, DOI 10.1083/jcb.144.4.701	38	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76046	10.1371/journal.pone.0076046	http://dx.doi.org/10.1371/journal.pone.0076046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098761	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500131
J	Shi, Q; Stell, WK				Shi, Qing; Stell, William K.			Die Fledermaus: Regarding Optokinetic Contrast Sensitivity and Light-Adaptation, Chicks Are Mice with Wings	PLOS ONE			English	Article							SCOTOPIC THRESHOLD RESPONSE; FORM-DEPRIVATION MYOPIA; PARAXIAL SCHEMATIC EYE; VISUAL-ACUITY; OPTOMOTOR RESPONSE; GANGLION-CELLS; AMACRINE CELLS; CAT RETINA; VISION; ROD	Background: Through adaptation, animals can function visually under an extremely broad range of light intensities. Light adaptation starts in the retina, through shifts in photoreceptor sensitivity and kinetics plus modulation of visual processing in retinal circuits. Although considerable research has been conducted on retinal adaptation in nocturnal species with rod-dominated retinas, such as the mouse, little is known about how cone-dominated avian retinas adapt to changes in mean light intensity. Methodology/Principal Findings: We used the optokinetic response to characterize contrast sensitivity (CS) in the chick retina as a function of spatial frequency and temporal frequency at different mean light intensities. We found that: 1) daytime, cone-driven CS was tuned to spatial frequency; 2) nighttime, presumably rod-driven CS was tuned to temporal frequency and spatial frequency; 3) daytime, presumably cone-driven CS at threshold intensity was invariant with temporal and spatial frequency; and 4) daytime photopic CS was invariant with clock time. Conclusion/Significance: Light-and dark-adaptational changes in CS were investigated comprehensively for the first time in the cone-dominated retina of an avian, diurnal species. The chick retina, like the mouse retina, adapts by using a "day/night" or "cone/rod" switch in tuning preference during changes in lighting conditions. The chick optokinetic response is an attractive model for noninvasive, behavioral studies of adaptation in retinal circuitry in health and disease.	[Shi, Qing] Univ Calgary, Fac Med, Grad Program Neurosci, Calgary, AB, Canada; [Stell, William K.] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB, Canada; [Stell, William K.] Univ Calgary, Fac Med, Dept Surg, Calgary, AB, Canada; [Stell, William K.] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Stell, William K.] Univ Calgary, Fac Med, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Stell, WK (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB, Canada.	wstell@ucalgary.ca		Shi, Qing/0000-0003-0690-7669	Natural Sciences and Engineering Research Coouncil of Canada (NSERC) [RGPIN 131-2013]; FFB (Foundation Fighting Blindness of Canada)-EYEGEYE Research Training Fund	Natural Sciences and Engineering Research Coouncil of Canada (NSERC); FFB (Foundation Fighting Blindness of Canada)-EYEGEYE Research Training Fund	This work was supported by (1) Natural Sciences and Engineering Research Coouncil of Canada (NSERC), #RGPIN 131-2013, "Retinal Control of Eye Growth and Myopia", W. K. Stell, PI. (2) FFB (Foundation Fighting Blindness of Canada)-EYEGEYE Research Training Fund, W. K. Stell, PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Avila NV, 2010, J COMP PHYSIOL A, V196, P825, DOI 10.1007/s00359-010-0562-0; Bloomfield SA, 1997, VISUAL NEUROSCI, V14, P565, DOI 10.1017/S0952523800012220; BONAVENTURE N, 1992, VISION RES, V32, P601, DOI 10.1016/0042-6989(92)90176-J; BONAVENTURE N, 1992, VISION RES, V32, P611, DOI 10.1016/0042-6989(92)90177-K; Bonfield S, 2008, ARVO M APR 11 2008, V49, P3838; Bonfield SP, 2009, THESIS U CALGARY; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Burroughs SL, 2011, INVEST OPHTH VIS SCI, V52, P3654, DOI 10.1167/iovs.10-7106; Cahill H, 2011, J CLIN INVEST, V121, P3528, DOI 10.1172/JCI45557; Cajal S.L.C., 1892, CELLULE, V9, P17; Cameron MA, 2009, MOL VIS, V15, P2209; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Cantrup R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032795; COHEN B, 1992, ANN NY ACAD SCI, V656, P277; CROOKS J, 1992, J COMP NEUROL, V315, P287, DOI 10.1002/cne.903150305; DEVALOIS RL, 1974, VISION RES, V14, P75, DOI 10.1016/0042-6989(74)90118-7; Diether S, 2001, INVEST OPHTH VIS SCI, V42, P3072; Doering CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002538; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Emran F, 2007, P NATL ACAD SCI USA, V104, P19126, DOI 10.1073/pnas.0709337104; Fischer AJ, 1998, BRAIN RES, V794, P48, DOI 10.1016/S0006-8993(98)00188-7; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; FRISHMAN LJ, 1989, J NEUROPHYSIOL, V61, P1221, DOI 10.1152/jn.1989.61.6.1221; Gaillard F, 2008, J COMP NEUROL, V510, P525, DOI 10.1002/cne.21798; Ghim MM, 2006, J COMP PHYSIOL A, V192, P523, DOI 10.1007/s00359-005-0090-5; GHIM MM, 2003, THESIS U MARYLAND CO; Gover N, 2009, VISION RES, V49, P2747, DOI 10.1016/j.visres.2009.08.011; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; JARDON B, 1992, VISION RES, V32, P541, DOI 10.1016/0042-6989(92)90246-F; Jarvis JR, 2009, VISION RES, V49, P1448, DOI 10.1016/j.visres.2009.02.019; Katti C, 2013, INVEST OPHTH VIS SCI, V54, P821, DOI 10.1167/iovs.12-10375; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; KOLB H, 1983, VISION RES, V23, P301, DOI 10.1016/0042-6989(83)90078-0; Lisney TJ, 2012, VISION RES, V62, P125, DOI 10.1016/j.visres.2012.04.002; Lodha N, 2010, ADV EXP MED BIOL, V664, P549, DOI 10.1007/978-1-4419-1399-9_63; Manglapus MK, 1998, J NEUROSCI, V18, P4775; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; McGill TJ, 2012, EXP EYE RES, V104, P65, DOI 10.1016/j.exer.2012.09.006; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Mora-Ferrer C, 2005, BRAIN RES, V1058, P17, DOI 10.1016/j.brainres.2005.07.073; MORRIS VB, 1970, J COMP NEUROL, V140, P359, DOI 10.1002/cne.901400308; NAARENDORP F, 1991, VISION RES, V31, P1, DOI 10.1016/0042-6989(91)90068-G; Prescott NB, 1999, BRIT POULTRY SCI, V40, P332, DOI 10.1080/00071669987412; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Qian HH, 2005, ZEBRAFISH, V2, P189, DOI 10.1089/zeb.2005.2.189; QUESADA A, 1988, J MORPHOL, V197, P337, DOI 10.1002/jmor.1051970308; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ribelayga C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011020; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; SCHAEFFEL F, 1991, VISUAL NEUROSCI, V6, P641, DOI 10.1017/S0952523800002637; SCHAEFFEL F, 1988, J OPT SOC AM A, V5, P2080, DOI 10.1364/JOSAA.5.002080; Schmid KL, 1998, VISION RES, V38, P2629, DOI 10.1016/S0042-6989(97)00446-X; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Shi Q, 2012, ARVO M, V53, P2451; SIEVING PA, 1986, J NEUROPHYSIOL, V56, P1049, DOI 10.1152/jn.1986.56.4.1049; Stockman A, 2006, OPHTHAL PHYSL OPT, V26, P225, DOI 10.1111/j.1475-1313.2006.00325.x; Tappeiner C, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-10; THOMPSON DA, 1994, INT J PSYCHOPHYSIOL, V16, P219, DOI 10.1016/0167-8760(89)90049-4; TROILO D, 1995, VISION RES, V35, P1211, DOI 10.1016/0042-6989(94)00230-J; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Umino Y, 2013, INVEST OPHTH VIS SCI, V54, P1536, DOI 10.1167/iovs.12-10825; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Vessey KA, 2005, INVEST OPHTH VIS SCI, V46, P3932, DOI 10.1167/iovs.04-1027; WALLMAN J, 1990, CIBA F SYMP, V155, P126; WALLMAN J, 1993, PROG RETIN RES, V12, P133, DOI 10.1016/0278-4327(93)90007-G; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	74	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75375	10.1371/journal.pone.0075375	http://dx.doi.org/10.1371/journal.pone.0075375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098693	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500064
J	Abraham, DM; Wolf, MJ				Abraham, Dennis M.; Wolf, Matthew J.			Disruption of Sarcoendoplasmic Reticulum Calcium ATPase Function in Drosophila Leads to Cardiac Dysfunction	PLOS ONE			English	Article							MYOCARDIAL-CONTRACTILITY; MUSCLE DYSFUNCTION; HEART; GENE; PHOSPHOLAMBAN; MELANOGASTER; CA2+-ATPASE; EXPRESSION; CARDIOMYOPATHY; PHOSPHORYLATION	Abnormal sarcoendoplasmic reticulum Calcium ATPase (SERCA) function has been associated with poor cardiac function in humans. While modifiers of SERCA function have been identified and studied using animal models, further investigation has been limited by the absence of a model system that is amenable to large-scale genetic screens. Drosophila melanogaster is an ideal model system for the investigation of SERCA function due to the significant homology to human SERCA and the availability of versatile genetic screening tools. To further the use of Drosophila as a model for examining the role of SERCA in cardiac function, we examined cardiac function in adult flies. Using optical coherence tomography (OCT) imaging in awake, adult Drosophila, we have been able to characterize cardiac chamber dimensions in flies with disrupted in Drosophila SERCA (CaP60A). We found that the best studied CaP60A mutant, the conditional paralytic mutant CaP60A(kum170), develops marked bradycardia and chamber enlargement that is closely linked to the onset of paralysis and dependent on extra cardiac CaP60A. In contrast to prior work, we show that disruption of CaP60A in a cardiac specific manner results in cardiac dilation and dysfunction rather than alteration in heart rate. In addition, the co-expression of a calcium release channel mutation with CaP60A (kum170) is sufficient to rescue the cardiac phenotype but not paralysis. Finally, we show that CaP60A overexpression is able to rescue cardiac function in a model of Drosophila cardiac dysfunction similar to what is observed in mammals. Thus, we present a cardiac phenotype associated with Drosophila SERCA dysfunction that would serve as additional phenotyping for further large-scale genetic screens for novel modifiers of SERCA function.	[Abraham, Dennis M.; Wolf, Matthew J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University	Wolf, MJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	matthew.j.wolf@dm.duke.edu	WOLF, MATTHEW/AHC-5201-2022	Wolf, Matthew/0000-0001-8004-4852	NIH [T32 HL007101-35, R01 HL116581-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007101, R01HL116581] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the NIH (T32 HL007101-35 to DMA and R01 HL116581-01 to MJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Casad ME, 2011, GENETICS, V189, P861, DOI 10.1534/genetics.111.131482; FUJII J, 1989, J BIOL CHEM, V264, P12950; FUJII J, 1987, J CLIN INVEST, V79, P301, DOI 10.1172/JCI112799; Goldstein JA, 2011, HUM MOL GENET, V20, P894, DOI 10.1093/hmg/ddq528; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kim IM, 2010, CIRC RES, V106, P1233, DOI 10.1161/CIRCRESAHA.109.213785; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Loukianov E, 1998, CIRC RES, V83, P889; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; MAGYAR A, 1995, BIOCHEM J, V310, P757, DOI 10.1042/bj3100757; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Misquitta CM, 1999, BIOCHEM J, V338, P167, DOI 10.1042/0264-6021:3380167; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH2356, DOI 10.1152/ajpheart.01310.2006; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Sanyal S, 2005, GENETICS, V169, P737, DOI 10.1534/genetics.104.031930; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; Vazquez-Martinez O, 2003, J CELL SCI, V116, P2483, DOI 10.1242/jcs.00455; Wolf MJ, 2011, CIRC RES, V109, P794, DOI 10.1161/CIRCRESAHA.111.244897; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Yin ZZ, 1998, DEV GENET, V22, P187; Yu L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000969	28	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77785	10.1371/journal.pone.0077785	http://dx.doi.org/10.1371/journal.pone.0077785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098595	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600089
J	Al-Shorbagy, MY; El Sayeh, BM; Abdallah, DM				Al-Shorbagy, Muhammad Y.; El Sayeh, Bahia M.; Abdallah, Dalaal M.			Additional Antiepileptic Mechanisms of Levetiracetam in Lithium-Pilocarpine Treated Rats	PLOS ONE			English	Article							INDUCED STATUS EPILEPTICUS; OXIDATIVE STRESS; INTRAVENOUS LEVETIRACETAM; SEIZURE SUSCEPTIBILITY; SUPEROXIDE-DISMUTASE; DRUG LEVETIRACETAM; BRAIN; MODEL; INFLAMMATION; HIPPOCAMPUS	Several studies have addressed the antiepileptic mechanisms of levetiracetam (LEV); however, its effect on catecholamines and the inflammatory mediators that play a role in epilepsy remain elusive. In the current work, lithium (Li) pretreated animals were administered LEV (500 mg/kg i.p) 30 min before the induction of convulsions by pilocarpine (PIL). Li-PIL-induced seizures were accompanied by increased levels of hippocampal prostaglandin (PG) E-2, myeloperoxidase (MPO), tumor necrosis factor-a, and interleukin-10. Moreover, it markedly elevated hippocampal lipid peroxides and nitric oxide levels, while it inhibited the glutathione content. Li-PIL also reduced hippocampal noradrenaline, as well as dopamine contents. Pretreatment with LEV protected against Li-PIL-induced seizures, where it suppressed the severity and delayed the onset of seizures in Li-PIL treated rats. Moreover, LEV reduced PGE(2) and MPO, yet it did not affect the level of both cytokines in the hippocampus. LEV also normalized hippocampal noradrenaline, dopamine, glutathione, lipid peroxides, and nitric oxide contents. In conclusion, alongside its antioxidant property, LEV anticonvulsive effect involves catecholamines restoration, as well as inhibition of PGE(2), MPO, and nitric oxide.	[Al-Shorbagy, Muhammad Y.; El Sayeh, Bahia M.; Abdallah, Dalaal M.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University	Abdallah, DM (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	dalabdallah@staff.cu.edu.eg	Al-Shorbagy, Muhammad/R-3968-2019; Abdallah, Dalaal/GVT-0783-2022	Al-Shorbagy, Muhammad/0000-0002-5104-6821; 				Abdallah DM, 2010, BRAIN RES, V1351, P246, DOI 10.1016/j.brainres.2010.06.034; Ahishali B, 2010, LIFE SCI, V87, P609, DOI 10.1016/j.lfs.2010.09.014; Aiguabella M, 2011, SEIZURE-EUR J EPILEP, V20, P60, DOI 10.1016/j.seizure.2010.10.009; ALAM AM, 1993, NEUROSCIENCE, V53, P425, DOI 10.1016/0306-4522(93)90206-U; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Barczynski B, 2011, EUR J PHARMACOL, V650, P550, DOI 10.1016/j.ejphar.2010.10.039; Bellissimo MI, 2001, EPILEPSY RES, V46, P121, DOI 10.1016/S0920-1211(01)00269-8; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Cai F, 2007, FOLIA BIOL-PRAGUE, V53, P164; Chachua T, 2010, Georgian Med News, P34; Chuang YC, 2010, J NEUROSCI RES, V88, P1898, DOI 10.1002/jnr.22369; Clinckers R, 2010, J NEUROCHEM, V115, P1595, DOI 10.1111/j.1471-4159.2010.07065.x; ELHAMDI G, 1992, INT J DEV NEUROSCI, V10, P301; FEE JA, 1972, BIOCHEM BIOPH RES CO, V49, P150, DOI 10.1016/0006-291X(72)90022-8; Fornai F, 2011, EUR J NEUROSCI, V33, P2169, DOI 10.1111/j.1460-9568.2011.07707.x; Freitas RM, 2010, NEUROSCI LETT, V477, P129, DOI 10.1016/j.neulet.2010.04.048; Glien M, 2002, EPILEPSIA, V43, P350, DOI 10.1046/j.1528-1157.2002.18101.x; Gower AJ, 1995, EPILEPSY RES, V22, P207, DOI 10.1016/0920-1211(95)00077-1; Gurses C, 2009, BRAIN RES, V1281, P71, DOI 10.1016/j.brainres.2009.05.033; HSU KS, 1995, BRAIN RES, V690, P264, DOI 10.1016/0006-8993(95)00734-8; Husum H, 2004, EPILEPSY BEHAV, V5, P204, DOI 10.1016/j.yebeh.2003.12.004; Institute for Laboratory Animal Research (ILAR), 1996, GUIDE CARE USE LAB A; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jobe PC, 1999, CRIT REV NEUROBIOL, V13, P317, DOI 10.1615/CritRevNeurobiol.v13.i4.10; Kaminski RM, 2008, NEUROPHARMACOLOGY, V54, P715, DOI 10.1016/j.neuropharm.2007.11.021; Lee CY, 2009, BRIT J PHARMACOL, V158, P1753, DOI 10.1111/j.1476-5381.2009.00463.x; Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Lyseng-Williamson KA, 2011, DRUGS, V71, P489, DOI 10.2165/11204490-000000000-00000; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Marini H, 2004, LIFE SCI, V74, P1253, DOI 10.1016/j.lfs.2003.08.006; Mark KS, 2001, J PHARMACOL EXP THER, V297, P1051; Meehan AL, 2012, EPILEPSIA, V53, P469, DOI 10.1111/j.1528-1167.2011.03392.x; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; NAFFAHMAZZACORATTI MG, 1995, NEUROCHEM INT, V27, P461, DOI 10.1016/0197-0186(95)00053-B; Niespodziany I, 2001, NEUROSCI LETT, V306, P5, DOI 10.1016/S0304-3940(01)01884-5; Nogawa S, 1997, J NEUROSCI, V17, P2746; Oliveira AA, 2007, CELL MOL NEUROBIOL, V27, P395, DOI 10.1007/s10571-006-9132-y; OLNEY JW, 1990, EXP NEUROL, V108, P269, DOI 10.1016/0014-4886(90)90134-E; Page KM, 1998, J NEUROSCI, V18, P4815; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rigo JM, 2002, BRIT J PHARMACOL, V136, P659, DOI 10.1038/sj.bjp.0704766; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; Sliva J, 2008, NEUROENDOCRINOL LETT, V29, P953; Szot P, 1999, J NEUROSCI, V19, P10985, DOI 10.1523/JNEUROSCI.19-24-10985.1999; Tariq M, 2008, EPILEPSY BEHAV, V12, P354, DOI 10.1016/j.yebeh.2007.12.004; Ueda Y, 2007, BRAIN RES, V1151, P55, DOI 10.1016/j.brainres.2007.03.021; Ueda Y, 2009, BRAIN RES, V1266, P1, DOI 10.1016/j.brainres.2009.02.040; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Voutsinos-Porche B, 2004, NEUROBIOL DIS, V17, P385, DOI 10.1016/j.nbd.2004.07.023; Weinshenker D, 2002, PHARMACOL THERAPEUT, V94, P213, DOI 10.1016/S0163-7258(02)00218-8; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Yu X, 2008, BRAIN RES, V1200, P146, DOI 10.1016/j.brainres.2008.01.047; Zhang ZH, 2003, MOL BRAIN RES, V115, P29, DOI 10.1016/S0169-328X(03)00175-X; Zheng Y, 2010, NEUROPHARMACOLOGY, V58, P793, DOI 10.1016/j.neuropharm.2009.12.007	59	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76735	10.1371/journal.pone.0076735	http://dx.doi.org/10.1371/journal.pone.0076735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098559	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600076
J	Leiszter, K; Galamb, O; Sipos, F; Krenacs, T; Veres, G; Wichmann, B; Kalmar, A; Patai, AV; Toth, K; Valcz, G; Molnar, B; Tulassay, Z				Leiszter, Katalin; Galamb, Orsolya; Sipos, Ferenc; Krenacs, Tibor; Veres, Gabor; Wichmann, Barnabas; Kalmar, Alexandra; Patai, Arpad V.; Toth, Kinga; Valcz, Gabor; Molnar, Bela; Tulassay, Zsolt			Sporadic Colorectal Cancer Development Shows Rejuvenescence Regarding Epithelial Proliferation and Apoptosis	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; INTESTINAL EPITHELIUM; INVITRO SENESCENCE; HUMAN-FIBROBLASTS; PERIPHERAL-BLOOD; SELF-RENEWAL; COLON-CANCER; EXPRESSION; AGE; P53	Background and Aims: Sporadic colorectal cancer (CRC) development is a sequential process showing age-dependency, uncontrolled epithelial proliferation and decreased apoptosis. During juvenile growth cellular proliferation and apoptosis are well balanced, which may be perturbed upon aging. Our aim was to correlate proliferative and apoptotic activities in aging human colonic epithelium and colorectal cancer. We also tested the underlying molecular biology concerning the proliferation- and apoptosis-regulating gene expression alterations. Materials and Methods: Colorectal biopsies from healthy children (n(1) = 14), healthy adults (n(2) = 10), adult adenomas (n(3) = 10) and CRCs (n(4) = 10) in adults were tested for Ki-67 immunohistochemistry and TUNEL apoptosis assay. Mitosis- and apoptosis-related gene expression was also studied in healthy children (n1 = 6), adult (n2 = 41) samples and in CRC (n3 = 34) in HGU133plus2.0 microarray platform. Measured alterations were confirmed with RT-PCR both on dependent and independent sample sets (n(1)= 6, n(2)= 6, n(3) = 6). Results: Mitotic index (MI) was significantly higher (p<0.05) in intact juvenile (MI = 0.33 +/- 0.06) and CRC samples (MI = 0.42 +/- 0.10) compared to healthy adult samples (MI = 0.15 +/- 0.06). In contrast, apoptotic index (AI) was decreased in children (0.13 +/- 0.06) and significantly lower in cancer (0.06 +/- 0.03) compared to healthy adult samples (0.17 +/- 0.05). Eight proliferation- (e.g. MKI67, CCNE1) and 11 apoptosis-associated genes (e.g. TNFSF10, IFI6) had altered mRNA expression both in the course of normal aging and carcinogenesis, mainly inducing proliferation and reducing apoptosis compared to healthy adults. Eight proliferation- associated genes including CCND1, CDK1, CDK6 and 26 apoptosis- regulating genes (e.g. SOCS3) were differently expressed between juvenile and cancer groups mostly supporting the pronounced cell growth in CRC. Conclusion: Colorectal samples from children and CRC patients can be characterized by similarly increased proliferative and decreased apoptotic activities compared to healthy colonic samples from adults. Therefore, cell kinetic alterations during colorectal cancer development show uncontrolled rejuvenescence as opposed to the controlled cell growth in juvenile colonic epithelium.	[Leiszter, Katalin; Galamb, Orsolya; Sipos, Ferenc; Wichmann, Barnabas; Kalmar, Alexandra; Patai, Arpad V.; Toth, Kinga; Valcz, Gabor; Molnar, Bela; Tulassay, Zsolt] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Galamb, Orsolya; Molnar, Bela; Tulassay, Zsolt] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary; [Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Veres, Gabor] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University	Leiszter, K (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	leiszterkata@gmail.com	Sipos, Ferenc/GYV-6182-2022	Valcz, Gabor/0000-0002-7109-3529	Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogram/OTKA-K/) [105530]	Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogram/OTKA-K/)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogram/OTKA-K/) 105530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 1998, J IMMUNOL, V160, P1627; Arai T, 2007, PATHOL INT, V57, P303, DOI 10.1111/j.1440-1827.2007.02101.x; Bingham S, 2004, NAT REV CANCER, V4, P206, DOI 10.1038/nrc1298; Carvalho B, 2012, CELL ONCOL, V35, P53, DOI 10.1007/s13402-011-0065-1; DEAN R, 1986, BIOCHEM BIOPH RES CO, V135, P105, DOI 10.1016/0006-291X(86)90948-4; DELGADO D, 1986, BIOCHEM BIOPH RES CO, V137, P917, DOI 10.1016/0006-291X(86)90312-8; Diamond SJ, 2011, GASTROINTEST ENDOSC, V74, P135, DOI 10.1016/j.gie.2011.03.1178; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048547; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Grimberg A, 2004, CANCER BIOL THER, V3, P731, DOI 10.4161/cbt.3.8.1030; HALL PA, 1994, J CELL SCI, V107, P3569; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Herman JG, 1996, CANCER RES, V56, P722; Kikuchi Y, 1997, VIRCHOWS ARCH, V431, P111, DOI 10.1007/s004280050076; Kim HJ, 2008, BMB REP, V41, P685, DOI 10.5483/BMBRep.2008.41.10.685; Kolligs FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020076; Koornstra JJ, 2003, CRIT REV ONCOL HEMAT, V45, P37, DOI 10.1016/S1040-8428(01)00228-1; KULJU KS, 1995, EXP CELL RES, V217, P336, DOI 10.1006/excr.1995.1095; Lee HM, 2000, MECH AGEING DEV, V115, P139, DOI 10.1016/S0047-6374(00)00120-2; Leiszter K, 2010, MAGYAR BELORVOSI ARC, V63, P19; Leiszter Katalin, 2010, Orvosi Hetilap, V151, P885, DOI 10.1556/OH.2010.28882; LIPKIN M, 1963, J CLIN INVEST, V42, P767, DOI 10.1172/JCI104769; Mandir N, 2005, INT J EXP PATHOL, V86, P125, DOI 10.1111/j.0959-9673.2005.00422.x; MIYAWAKI T, 1992, J IMMUNOL, V149, P3753; Moss SF, 1996, DIGEST DIS SCI, V41, P2238, DOI 10.1007/BF02071407; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; Reenstra WR, 1996, EXP CELL RES, V227, P252, DOI 10.1006/excr.1996.0274; Salh B, 1999, ANTICANCER RES, V19, P741; Soussi T, 2000, CANCER RES, V60, P1777; Takano Y, 1996, J CANCER RES CLIN, V122, P166, DOI 10.1007/BF01366957; Theodosiou NA, 2003, DEV BIOL, V259, P258, DOI 10.1016/S0012-1606(03)00185-4; Ukraintseva SV, 2004, ANN NY ACAD SCI, V1019, P200, DOI 10.1196/annals.1297.032; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Xiao ZQ, 2001, MECH AGEING DEV, V122, P1849, DOI 10.1016/S0047-6374(01)00323-2; Zhang T, 1997, CANCER RES, V57, P169	42	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74140	10.1371/journal.pone.0074140	http://dx.doi.org/10.1371/journal.pone.0074140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098334	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325483600003
J	Won, EY; Yoon, MK; Kim, SW; Jung, Y; Bae, HW; Lee, D; Park, SG; Lee, CH; Hwang, GS; Chi, SW				Won, Eun-Young; Yoon, Mi-Kyung; Kim, Sang-Woo; Jung, Youngae; Bae, Hyun-Whee; Lee, Daeyoup; Park, Sung Goo; Lee, Chul-Ho; Hwang, Geum-Sook; Chi, Seung-Wook			Gender-Specific Metabolomic Profiling of Obesity in Leptin-Deficient ob/ob Mice by H-1 NMR Spectroscopy	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; DIET-INDUCED OBESITY; FATTY-ACID; L-ARGININE; LIQUID-CHROMATOGRAPHY; INSULIN-RESISTANCE; MISSENSE MUTATION; SYSTEMS BIOLOGY; SKELETAL-MUSCLE; GUT MICROBIOTA	Despite the numerous metabolic studies on obesity, gender bias in obesity has rarely been investigated. Here, we report the metabolomic analysis of obesity by using leptin-deficient ob/ob mice based on the gender. Metabolomic analyses of urine and serum from ob/ob mice compared with those from C57BL/6J lean mice, based on the H-1 NMR spectroscopy in combination with multivariate statistical analysis, revealed clear metabolic differences between obese and lean mice. We also identified 48 urine and 22 serum metabolites that were statistically significantly altered in obese mice compared to lean controls. These metabolites are involved in amino acid metabolism (leucine, alanine, ariginine, lysine, and methionine), tricarbocylic acid cycle and glucose metabolism (pyruvate, citrate, glycolate, acetoacetate, and acetone), lipid metabolism (cholesterol and carnitine), creatine metabolism (creatine and creatinine), and gut-microbiome-derived metabolism (choline, TMAO, hippurate, p-cresol, isobutyrate, 2-hydroxyisobutyrate, methylamine, and trigonelline). Notably, our metabolomic studies showed distinct gender variations. The obese male mice metabolism was specifically associated with insulin signaling, whereas the obese female mice metabolism was associated with lipid metabolism. Taken together, our study identifies the biomarker signature for obesity in ob/ob mice and provides biochemical insights into the metabolic alteration in obesity based on gender.	[Won, Eun-Young; Yoon, Mi-Kyung; Park, Sung Goo; Chi, Seung-Wook] KRIBB, Med Prote Res Ctr, Taejon, South Korea; [Kim, Sang-Woo; Lee, Chul-Ho] KRIBB, Lab Anim Ctr, Taejon, South Korea; [Won, Eun-Young; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Jung, Youngae; Bae, Hyun-Whee; Hwang, Geum-Sook] Korea Basic Sci Inst, Integrated Metabol Res Grp, Seoul, South Korea; [Bae, Hyun-Whee; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI); Chungnam National University	Lee, CH (corresponding author), KRIBB, Lab Anim Ctr, Taejon, South Korea.	chullee@kribb.re.kr; gshwang@kbsi.re.kr; swchi@kribb.re.kr	Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823	National Research Foundation of Korea (NRF); Korea government (MSIP) [NRF-2011-0016011, NRF-2012M3C1A3671508, NRF-2013M3A9B6046418]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIP) (No. NRF-2011-0016011, No. NRF-2012M3C1A3671508, and No. NRF-2013M3A9B6046418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2012, J BIOMED BIOTECHNOL; [Anonymous], 2009, AMINO ACIDS, DOI DOI 10.1007/s00726-008-0210-y; BACKMAN L, 1975, SCAND J GASTROENTERO, V10, P811; Bae KH, 2012, BMB REP, V45, P700, DOI 10.5483/BMBRep.2012.45.12.235; Brosnan JT, 2010, MOL GENET METAB, V100, pS49, DOI 10.1016/j.ymgme.2010.02.020; CALLESESCANDON J, 1984, METABOLISM, V33, P364, DOI 10.1016/0026-0495(84)90200-2; Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44; Cao J, 2012, AGING MALE, V15, P85, DOI 10.3109/13685538.2012.666585; Cha YS, 2008, ASIA PAC J CLIN NUTR, V17, P306; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Conway B, 2004, Obes Rev, V5, P145, DOI 10.1111/j.1467-789X.2004.00144.x; D'Eon T, 2002, J WOMEN HEALTH GEN-B, V11, P225, DOI 10.1089/152460902753668439; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; DEVILLIERS DC, 1966, METABOLIS, V15, P458, DOI 10.1016/0026-0495(66)90088-6; Dey J, 2002, J UROLOGY, V167, P169, DOI 10.1016/S0022-5347(05)65405-5; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fu WJJ, 2005, J NUTR, V135, P714, DOI 10.1093/jn/135.4.714; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Garlick PJ, 2005, J NUTR, V135, p1553S, DOI 10.1093/jn/135.6.1553S; Gipson GT, 2008, MOL BIOSYST, V4, P1015, DOI 10.1039/b807332e; GOLAY A, 1986, J CLIN ENDOCR METAB, V63, P481, DOI 10.1210/jcem-63-2-481; Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Holecek M, 2001, NUTRITION, V17, P70, DOI 10.1016/S0899-9007(00)00483-4; Jobgen WJ, 2009, J NUTR, V139, P230, DOI 10.3945/jn.108.096362; Jung JY, 2012, BMB REP, V45, P419, DOI 10.5483/BMBRep.2012.45.7.248; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kimball SR, 2001, CURR OPIN CLIN NUTR, V4, P39, DOI 10.1097/00075197-200101000-00008; Kochhar S, 2006, ANAL BIOCHEM, V352, P274, DOI 10.1016/j.ab.2006.02.033; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Larsen FH, 2006, J CHEMOMETR, V20, P198, DOI 10.1002/cem.991; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Lees HJ, 2013, J PROTEOME RES, V12, P1527, DOI 10.1021/pr300900b; Li HK, 2008, J PROTEOME RES, V7, P4775, DOI 10.1021/pr800352k; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lynch CJ, 2001, J NUTR, V131, p861S, DOI 10.1093/jn/131.3.861S; MACFARLANE GT, 1992, FEMS MICROBIOL ECOL, V101, P81, DOI 10.1111/j.1574-6968.1992.tb05764.x; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; McKnight JR, 2010, AMINO ACIDS, V39, P349, DOI 10.1007/s00726-010-0598-z; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Piloquet H, 2003, AM J PHYSIOL-ENDOC M, V285, pE561, DOI 10.1152/ajpendo.00042.2003; Plumb R, 2003, ANALYST, V128, P819, DOI 10.1039/b304296k; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; SATOH H, 1994, ADV EXP MED BIOL, V359, P181; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Serkova NJ, 2006, J HEPATOL, V44, P956, DOI 10.1016/j.jhep.2005.07.009; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Sun J, 2008, J CHROMATOGR B, V871, P328, DOI 10.1016/j.jchromb.2008.04.008; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; WALKER JB, 1961, J BIOL CHEM, V236, P493; Williams RE, 2005, J PHARMACEUT BIOMED, V38, P465, DOI 10.1016/j.jpba.2005.01.013; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang M, 2004, AMINO ACIDS, V26, P267, DOI 10.1007/s00726-003-0059-z; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao LC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/431894; Zyromski NJ, 2009, PANCREATOLOGY, V9, P410, DOI 10.1159/000199436	81	45	47	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75998	10.1371/journal.pone.0075998	http://dx.doi.org/10.1371/journal.pone.0075998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098417	gold, Green Submitted, Green Published			2022-12-27	WOS:000325483600026
J	Dunner, N; Quezada, C; Berndt, FA; Canovas, J; Rojas, CV				Duenner, Natalia; Quezada, Carolina; Andres Berndt, F.; Canovas, Jose; Rojas, Cecilia V.			Angiotensin II Signaling in Human Preadipose Cells: Participation of ERK1,2-Dependent Modulation of Akt	PLOS ONE			English	Article							PROTEIN-KINASE KINASE; DIET-INDUCED OBESITY; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; IN-VITRO; GENE-EXPRESSION; SMOOTH-MUSCLE; PHOSPHORYLATION; RECEPTORS; SYSTEM	The renin-angiotensin system expressed in adipose tissue has been implicated in the modulation of adipocyte formation, glucose metabolism, triglyceride accumulation, lipolysis, and the onset of the adverse metabolic consequences of obesity. As we investigated angiotensin II signal transduction mechanisms in human preadipose cells, an interplay of extracellular-signal-regulated kinases 1 and 2 (ERK1,2) and Akt/PKB became evident. Angiotensin II caused attenuation of phosphorylated Akt (p-Akt), at serine 473; the p-Akt/Akt ratio decreased to 0.5 +/- 0.2-fold the control value without angiotensin II (p<0.001). Here we report that the reduction of phosphorylated Akt associates with ERK1,2 activities. In the absence of angiotensin II, inhibition of ERK1,2 activation with U0126 or PD98059 resulted in a 2.1 +/- 0.5 (p < 0.001) and 1.4 +/- 0.2-fold (p<0.05) increase in the p-Akt/Akt ratio, respectively. In addition, partial knockdown of ERK1 protein expression by the short hairpin RNA technique also raised phosphorylated Akt in these cells (the p-Akt/Akt ratio was 1.5 +/- 0.1-fold the corresponding control; p<0.05). Furthermore, inhibition of ERK1,2 activation with U0126 prevented the reduction of p-Akt/Akt by angiotensin II. An analogous effect was found on the phosphorylation status of Akt downstream effectors, the forkhead box (Fox) proteins O1 and O4. Altogether, these results indicate that angiotensin II signaling in human preadipose cells involves an ERK1,2-dependent attenuation of Akt activity, whose impact on the biological functions under its regulation is not fully understood.	[Duenner, Natalia; Quezada, Carolina; Andres Berndt, F.; Canovas, Jose; Rojas, Cecilia V.] Univ Chile, Fac Med, Inst Biomed Sci, Santiago 7, Chile; [Rojas, Cecilia V.] Univ Chile, Inst Nutr & Food Technol, Santiago 7, Chile	Universidad de Chile; Universidad de Chile	Rojas, CV (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Santiago 7, Chile.	crojas@inta.uchile.cl	Quezada, Carolina Paz/AAG-1981-2019	Quezada, Carolina Paz/0000-0002-0260-5754	CONICYT; FONDECYT/Regular [1100126]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT/Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by CONICYT, FONDECYT/Regular 1100126. http://www.conicyt.cl/fondecyt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Arellano-Plancarte A, 2010, BIOCHEM PHARMACOL, V79, P733, DOI 10.1016/j.bcp.2009.10.014; Aurelie NDC, 2011, CURR HYPERTENS REP, V13, P122, DOI 10.1007/s11906-011-0187-x; Bhattacharya I, 2006, FEBS LETT, V580, P5765, DOI 10.1016/j.febslet.2006.09.032; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Brucher R, 2007, OBESITY, V15, P1643, DOI 10.1038/oby.2007.196; Carvalho E, 2000, DIABETOLOGIA, V43, P1107, DOI 10.1007/s001250051501; Chai WD, 2011, DIABETES, V60, P2939, DOI 10.2337/db10-1691; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Cook JL, 2012, AM J PHYSIOL-REG I, V302, pR482, DOI 10.1152/ajpregu.00493.2011; Crandall DL, 1999, ENDOCRINOLOGY, V140, P154, DOI 10.1210/en.140.1.154; CRANDALL DL, 1994, J LIPID RES, V35, P1378; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010070; Diamond-Stanic Maggie K., 2010, Archives of Physiology and Biochemistry, V116, P88, DOI 10.3109/13813451003758703; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Fritsche L, 2011, AM J PHYSIOL-ENDOC M, V300, pE824, DOI 10.1152/ajpendo.00409.2010; Fuentes P, 2010, J ENDOCRINOL, V206, P75, DOI 10.1677/JOE-10-0049; Giacchetti G, 2002, AM J HYPERTENS, V15, P381, DOI 10.1016/S0895-7061(02)02257-4; Gwathmey TM, 2012, AM J PHYSIOL-REG I, V302, pR518, DOI 10.1152/ajpregu.00525.2011; Hashikawa-Hobara N, 2012, DIABETES, V61, P925, DOI 10.2337/db11-1468; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Iwai M, 2009, AM J HYPERTENS, V22, P784, DOI 10.1038/ajh.2009.85; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Kalupahana NS, 2012, CRIT REV BIOCHEM MOL, V47, P379, DOI 10.3109/10409238.2012.694843; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; Khundmiri SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1171, DOI 10.1152/ajpcell.00535.2006; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lardizabal Joel A, 2010, Curr Cardiol Rep, V12, P464, DOI 10.1007/s11886-010-0138-1; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Massiera F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje; Matsushita K, 2006, HYPERTENSION, V48, P1095, DOI 10.1161/01.HYP.0000248211.82232.a7; Merighi Stefania, 2006, Purinergic Signal, V2, P627, DOI 10.1007/s11302-006-9020-4; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Patel CB, 2010, MOL PHARMACOL, V78, P983, DOI 10.1124/mol.110.067066; Punn A, 2006, MOL ENDOCRINOL, V20, P3179, DOI 10.1210/me.2006-0255; Rahmouni K, 2004, AM J PHYSIOL-ENDOC M, V286, pE891, DOI 10.1152/ajpendo.00551.2003; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; Schling P, 2002, J BIOL CHEM, V277, P48066, DOI 10.1074/jbc.M204058200; Schling P, 2001, HORM METAB RES, V33, P189, DOI 10.1055/s-2001-14951; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; Shah BH, 2002, TRENDS ENDOCRIN MET, V13, P1, DOI 10.1016/S1043-2760(01)00539-2; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Tanski W, 2002, J SURG RES, V108, P98, DOI 10.1006/jsre.2002.6529; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Tomono Y, 2008, AM J HYPERTENS, V21, P206, DOI 10.1038/ajh.2007.50; van Harmelen V, 2000, OBES RES, V8, P337, DOI 10.1038/oby.2000.40; van Harmelen V, 2000, INT J OBESITY, V24, P673, DOI 10.1038/sj.ijo.0801217; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang T, 2008, ENDOCRINOLOGY, V149, P358, DOI 10.1210/en.2007-0467; Yang SJ, 2010, EUR J PHARMACOL, V638, P21, DOI 10.1016/j.ejphar.2010.04.016; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263; Ye ZW, 2009, METABOLISM, V58, P1288, DOI 10.1016/j.metabol.2009.04.014; Yoshiga D, 2007, MOL ENDOCRINOL, V21, P1120, DOI 10.1210/me.2006-0413; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	64	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75440	10.1371/journal.pone.0075440	http://dx.doi.org/10.1371/journal.pone.0075440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098385	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500033
J	Pietraszek, K; Brezillon, S; Perreau, C; Malicka-Blaszkiewicz, M; Maquart, FX; Wegrowski, Y				Pietraszek, Katarzyna; Brezillon, Stephane; Perreau, Corinne; Malicka-Blaszkiewicz, Maria; Maquart, Francois-Xavier; Wegrowski, Yanusz			Lumican - Derived Peptides Inhibit Melanoma Cell Growth and Migration	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; ACTIVATION; INVASION; PROTEOGLYCAN; ANGIOGENESIS; PROGRESSION; METASTASIS; EXPRESSION; IDENTIFICATION; KERATINOCYTES	Lumican, a small leucine-rich proteoglycan of the extracellular matrix, presents potent anti-tumor properties. Previous works from our group showed that lumican inhibited melanoma cell migration and tumor growth in vitro and in vivo. Melanoma cells adhered to lumican, resulting in a remodeling of their actin cytoskeleton and preventing their migration. In addition, we identified a sequence of 17 amino acids within the lumican core protein, named lumcorin, which was able to inhibit cell chemotaxis and reproduce anti-migratory effect of lumican in vitro. The aim of the present study was to characterize the anti-tumor mechanism of action of lumcorin. Lumcorin significantly decreased the growth in monolayer and in soft agar of two melanoma cell lines - mice B16F1 and human SK-MEL-28 cells - in comparison to controls. Addition of lumcorin to serum free medium significantly inhibited spontaneous motility of these two melanoma cell lines. To characterize the mechanisms involved in the inhibition of cell migration by lumcorin, the status of the phosphorylation/dephosphorylation of proteins was examined. Inhibition of focal adhesion kinase phosphorylation was observed in presence of lumcorin. Since cancer cells have been shown to migrate and to invade by mechanisms that involve matrix metalloproteinases (MMPs), the expression and activity of MMPs were analyzed. Lumcorin induced an accumulation of an intermediate form of MMP-14 (similar to 59kDa), and inhibited MMP-14 activity. Additionally, we identified a short, 10 amino acids peptide within lumcorin sequence, which was able to reproduce its anti-tumor effect on melanoma cells. This peptide may have potential pharmacological applications.	[Pietraszek, Katarzyna; Brezillon, Stephane; Perreau, Corinne; Maquart, Francois-Xavier; Wegrowski, Yanusz] Univ Reims, Lab Biochim Med & Biol Mol, CNRS FRE 3481, Reims, France; [Malicka-Blaszkiewicz, Maria] Univ Wroclaw, Dept Cell Pathol, Fac Biotechnol, PL-50138 Wroclaw, Poland; [Maquart, Francois-Xavier] CHU Reims, Reims, France	Universite de Reims Champagne-Ardenne; University of Wroclaw; CHU de Reims	Brezillon, S (corresponding author), Univ Reims, Lab Biochim Med & Biol Mol, CNRS FRE 3481, Reims, France.	stephane.brezillon@univ-reims.fr	Pietraszek-Gremplewicz, Katarzyna/AAM-2454-2020	Pietraszek-Gremplewicz, Katarzyna/0000-0002-4081-5314; BREZILLON, stephane/0000-0001-7954-8340	Region Champagne-Ardenne; Fonds Europeen de Developpement Regional (FEDER); Les Contrats de Projets Etat-Region (CPER); PHC Polonium of the Ministry Foreign Affairs; Ligue Nationale contre le Cancer (comite de la Marne)	Region Champagne-Ardenne(Region Grand-Est); Fonds Europeen de Developpement Regional (FEDER)(European Commission); Les Contrats de Projets Etat-Region (CPER); PHC Polonium of the Ministry Foreign Affairs; Ligue Nationale contre le Cancer (comite de la Marne)(Ligue nationale contre le cancer)	The authors thank the Region Champagne-Ardenne, the Fonds Europeen de Developpement Regional (FEDER), Les Contrats de Projets Etat-Region (CPER 2007-2013), PHC Polonium of the Ministry Foreign Affairs and the Ligue Nationale contre le Cancer (comite de la Marne) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Baumann P, 2000, BRIT J CANCER, V83, P1387, DOI 10.1054/bjoc.2000.1454; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Brassart-Pasco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029587; Brezillon S, 2009, J PHYSIOL PHARMACOL, V60, P15; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; CHAKRAVARTI S, 1995, GENOMICS, V27, P481, DOI 10.1006/geno.1995.1080; D'Onofrio MF, 2008, BIOCHEM BIOPH RES CO, V365, P266, DOI 10.1016/j.bbrc.2007.10.155; Han J, 1997, J BIOL CHEM, V272, P20395, DOI 10.1074/jbc.272.33.20395; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Iida J, 2004, J INVEST DERMATOL, V122, P167, DOI 10.1046/j.0022-202X.2003.22114.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Johnson J, 2006, MOL VIS, V12, P1057; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Leeman MF, 2003, J PATHOL, V201, P528, DOI 10.1002/path.1466; Li YY, 2004, CANCER RES, V64, P7058, DOI 10.1158/0008-5472.CAN-04-1038; Malinowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050709; Nagase H, 1998, Cell Res, V8, P179; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Pasco S, 2000, CANCER RES, V60, P467; Pasco S, 2004, CRIT REV ONCOL HEMAT, V49, P221, DOI 10.1016/j.critrevonc.2003.09.006; Radwanska A, 2008, LIFE SCI, V83, P651, DOI 10.1016/j.lfs.2008.09.008; Santibanez JF, 2002, BIOCHEM BIOPH RES CO, V296, P267; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; Sulochana KN, 2005, J BIOL CHEM, V280, P27935, DOI 10.1074/jbc.M414320200; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Vivinus-Nebot M, 2004, J IMMUNOL, V172, P1397, DOI 10.4049/jimmunol.172.3.1397; Vuillermoz B, 2004, EXP CELL RES, V296, P294, DOI 10.1016/j.yexcr.2004.02.005; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620; Zeltz C, 2010, EXP CELL RES, V316, P2922, DOI 10.1016/j.yexcr.2010.08.002; Zeltz C, 2009, FEBS LETT, V583, P3027, DOI 10.1016/j.febslet.2009.08.012	36	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76232	10.1371/journal.pone.0076232	http://dx.doi.org/10.1371/journal.pone.0076232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098450	gold, Green Submitted, Green Published			2022-12-27	WOS:000325434500054
J	Vlasova, AN; Chattha, KS; Kandasamy, S; Liu, Z; Esseili, M; Shao, LL; Rajashekara, G; Saif, LJ				Vlasova, Anastasia N.; Chattha, Kuldeep S.; Kandasamy, Sukumar; Liu, Zhe; Esseili, Malak; Shao, Lulu; Rajashekara, Gireesh; Saif, Linda J.			Lactobacilli and Bifidobacteria Promote Immune Homeostasis by Modulating Innate Immune Responses to Human Rotavirus in Neonatal Gnotobiotic Pigs	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; COMMENSAL BACTERIA; CYTOKINE RESPONSES; DENDRITIC CELLS; GUT MICROBIOTA; GENE-EXPRESSION; COLONIZATION; PROBIOTICS; INFECTION; PROLIFERATION	The effects of co-colonization with Lactobacillus rhamnosus GG (LGG) and Bifidobacterium lactis Bb12 (Bb12) on 3-dose vaccination with attenuated HRV and challenge with virulent human rotavirus (VirHRV) were assessed in 4 groups of gnotobiotic (Gn) pigs: Pro+Vac (probiotic-colonized/ vaccinated), Vac (vaccinated), Pro (probiotic-colonized, non-vaccinated) and Control (non-colonized, non-vaccinated). Subsets of pigs were euthanized pre- [post-challenge day (PCD) 0] and post (PCD7)-VirHRV challenge to assess diarrhea, fecal HRV shedding and dendritic cell/innate immune responses. Post-challenge, Pro+Vac and Vac groups were completely protected from diarrhea; protection rates against HRV shedding were 100% and 83%, respectively. Diarrhea and HRV shedding were reduced in Pro compared to Control pigs following VirHRV challenge. Diarrhea scores and virus shedding were significantly higher in Controls, compared to all other groups, coincident with significantly higher serum interferon-alpha levels post-challenge. LGG+Bb12 colonization +/- vaccine promoted immunomaturation as reflected by increased frequencies of CD4, SWC3a, CD11R1, MHCII expressing mononuclear cells (MNCs) and conventional dendritic cells in intestinal tissues and blood post-challenge. Colonization decreased frequencies of toll-like receptors (TLR) 2 and TLR4 expressing MNCs from vaccinated pigs (Pro+Vac) pre-challenge and increased frequencies of TLR3 expressing MNCs from Pro pigs post-challenge, suggesting that probiotics likely exert anti-inflammatory (TLR2 and 4 down-regulation) and antiviral (TLR3 up-regulation by HRV dsRNA) actions via TLR signaling. Probiotic colonization alone (Pro) increased frequencies of intestinal and systemic apoptotic MNCs pre-challenge, thereby regulating immune hyperreactivity and tolerance. However, these frequencies were decreased in intestinal and systemic tissues post-challenge, moderating HRV-induced apoptosis. Additionally, post-challenge, Pro+Vac and Pro groups had significantly decreased MNC proliferation, suggesting that probiotics control excessive lymphoproliferative reactions upon VirHRV challenge. We conclude that in the neonatal Gn pig disease model, selected probiotics contribute to immunomaturation, regulate immune homeostasis and modulate vaccine and virulent HRV effects, thereby moderating HRV diarrhea.	[Vlasova, Anastasia N.; Chattha, Kuldeep S.; Kandasamy, Sukumar; Liu, Zhe; Esseili, Malak; Shao, Lulu; Rajashekara, Gireesh; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA	University System of Ohio; Ohio State University	Vlasova, AN (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA.	vlasova.1@osu.edu; saif.2@osu.edu	Vlasova, Anastasia N/C-2062-2016; Shao, Lulu/I-4425-2019	Vlasova, Anastasia N/0000-0002-1447-6283; Shao, Lulu/0000-0002-1441-4744; Esseili, Malak/0000-0002-1024-0468	NIH, NCCAM [R21AT004716]; NIAID [R01 A1099451]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099451] Funding Source: NIH RePORTER	NIH, NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the NIH, NCCAM grant R21AT004716 (Linda J. Saif-PI), NIAID grant # R01 A1099451 and federal funds appropriated to the Ohio Agricultural Research and Development Center (OARDC) of The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Azevedo MSP, 2006, J VIROL, V80, P372, DOI 10.1128/JVI.80.1.372-382.2006; Bailey M, 2001, P NUTR SOC, V60, P427, DOI 10.1079/PNS2001118; Boshuizen JA, 2003, J VIROL, V77, P13005, DOI 10.1128/JVI.77.24.13005-13016.2003; Brown K, 2012, NUTRIENTS, V4, P1552, DOI [10.3390/nu4081095, 10.3390/nu4111552]; Butler JE, 2002, J IMMUNOL, V169, P6822, DOI 10.4049/jimmunol.169.12.6822; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chattha KS, 2013, J IMMUNOL; Chattha KS, 2013, VACCINE, V31, P1916, DOI 10.1016/j.vaccine.2013.02.020; CRABBE PA, 1968, INT ARCH ALLER A IMM, V34, P362, DOI 10.1159/000230130; CROUCH CF, 1978, J MED MICROBIOL, V11, P325, DOI 10.1099/00222615-11-3-325; Fang SB, 2009, J TROP PEDIATRICS, V55, P297, DOI 10.1093/tropej/fmp001; FERGUSON A, 1994, GUT, V35, pS10, DOI 10.1136/gut.35.1_Suppl.S10; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Foye OT, 2012, FEMS IMMUNOL MED MIC, V65, P467, DOI 10.1111/j.1574-695X.2012.00978.x; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Grandy G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-253; Gray J, 2011, J INTERN MED, V270, P206, DOI 10.1111/j.1365-2796.2011.02409.x; Guandalini S, 2011, J CLIN GASTROENTEROL, V45, pS149, DOI 10.1097/MCG.0b013e3182257e98; Ichikawa H, 1999, DIGEST DIS SCI, V44, P2119, DOI 10.1023/A:1026647024077; Ismail IH, 2012, PEDIAT ALLERGY IMMUN; Lorne E, 2010, INTENS CARE MED, V36, P1826, DOI 10.1007/s00134-010-1983-5; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; MEYER RC, 1964, APPL MICROBIOL, V12, P295, DOI 10.1128/AEM.12.4.295-300.1964; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nelson AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048224; Orlando A, 2009, IMMUNOPHARM IMMUNOT, V31, P108, DOI 10.1080/08923970802443631; Otani K, 2012, BIOCHEM BIOPH RES CO, V426, P342, DOI 10.1016/j.bbrc.2012.08.080; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Preidis GA, 2011, GASTROENTEROLOGY, V140, P8, DOI 10.1053/j.gastro.2010.11.010; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rosenfeldt V, 2002, PEDIATR INFECT DIS J, V21, P411, DOI 10.1097/00006454-200205000-00012; Saif L, 1997, ADV EXP MED BIOL, V412, P397; Saif LJ, 1996, ARCH VIROL, P153; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Solano-Aguilar G, 2008, APPL ENVIRON MICROB, V74, P6338, DOI 10.1128/AEM.00309-08; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; Vlasova AN, 2013, J IMMUNOL; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Ward LA, 1996, J GEN VIROL, V77, P1431, DOI 10.1099/0022-1317-77-7-1431; Wen K, 2009, VET IMMUNOL IMMUNOP, V127, P304, DOI 10.1016/j.vetimm.2008.10.322; Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320; Xu J, 2006, CLIN EXP IMMUNOL, V144, P376, DOI 10.1111/j.1365-2249.2006.03079.x; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Zhang W, 2008, VACCINE, V26, P3655, DOI 10.1016/j.vaccine.2008.04.070; Zhang W, 2008, VET IMMUNOL IMMUNOP, V122, P175, DOI 10.1016/j.vetimm.2007.10.003; Zhang W, 2008, VET IMMUNOL IMMUNOP, V121, P222, DOI 10.1016/j.vetimm.2007.10.001	55	78	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76962	10.1371/journal.pone.0076962	http://dx.doi.org/10.1371/journal.pone.0076962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098572	Green Submitted, gold, Green Published			2022-12-27	WOS:000325434500091
J	Guo, YF; Lee, CL; So, KH; Gao, J; Yeung, WSB; Yao, YQ; Lee, KF				Guo, YiFan; Lee, Cheuk-Lun; So, Kam-Hei; Gao, Jing; Yeung, William S. B.; Yao, YuanQing; Lee, Kai-Fai			Soluble Human Leukocyte Antigen-G5 Activates Extracellular Signal-Regulated Protein Kinase Signaling and Stimulates Trophoblast Invasion	PLOS ONE			English	Article							HLA-G; GLYCODELIN-A; EXPRESSION; KIR2DL4; CELLS; PREECLAMPSIA; MACROPHAGES; SECRETION; MIGRATION; RECEPTOR	Soluble human leukocyte antigen-G (HLA-G) is a non-classical class Ib HLA molecule that is secreted from blastocysts. Soluble HLA-G modulates the immune tolerance of the mother and can be used as a prognostic factor for the clinical pregnancy rate. However, the underlying mechanism of how soluble HLA-G5 affects pregnancy remains largely unknown. We hypothesized that soluble HLA-G5 promotes successful implantation and pregnancy by modulating trophoblast invasion through receptor binding and activation of extracellular signal-regulated protein kinase (ERK) signaling pathway. Recombinant HLA-G5 protein over-expressed in E. coli BL21 was purified to near homogeneity. We studied the expression of HLA-G5 and its receptors, the leukocyte immunoglobulin-like receptor subfamily B1 (LILRB1) and killer cell immunoglobulin-like receptor 2DL4 (KIR2DL4), in primary trophoblasts and trophoblastic (JAr and JEG-3) cell lines by florescence-labeled HLA-G5. HLA-G5 was detected in the primary trophoblasts and JEG-3 cells. The LILRB1 and KIR2DL4 receptors were expressed in both primary trophoblasts and trophoblastic cell lines. HLA-G5 stimulated cell invasion (p<0.05) and increased urokinase (uPA) and matrix metalloproteinases (MMPs) transcripts and their activity (p<0.05) in trophoblastic cells. HLA-G5 activated the ERK signaling pathway and induced ERK1/2 phosphorylation in the trophoblastic cell lines. Addition of ERK inhibitors (U0126 and PD98059) nullified the stimulatory effect of HLA-G5 on trophoblastic cell invasion. Taken together, HLA-G5 induced trophoblast invasion by binding to KIR2DL4 and LILRB1, by increasing uPA and MMPs expressions and by activating the ERK signaling pathway.	[Guo, YiFan; Yao, YuanQing] Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynaecol, Beijing, Peoples R China; [Guo, YiFan; Lee, Cheuk-Lun; So, Kam-Hei; Gao, Jing; Yeung, William S. B.; Lee, Kai-Fai] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Lee, Cheuk-Lun; Yeung, William S. B.; Lee, Kai-Fai] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China	Chinese People's Liberation Army General Hospital; University of Hong Kong; University of Hong Kong	Yao, YQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynaecol, Beijing, Peoples R China.	yqyao@126.com; ckflee@hku.hk	Lee, Cheuk Lun/AGX-5720-2022; Lee, Calvin Kai Fai/C-4328-2009	Lee, Cheuk Lun/0000-0003-1553-3478; So, Karl Kam Hei/0000-0002-3154-2940; Lee, Calvin Kai Fai/0000-0001-5957-439X; Yeung, Shu Biu William/0000-0003-0670-0879; YAO, YUANQING/0000-0001-5942-4121				[Anonymous], [No title captured]; Apps R, 2011, MOL HUM REPROD, V17, P577, DOI 10.1093/molehr/gar022; Bai SX, 2005, REPRODUCTION, V129, P103, DOI 10.1530/rep.1.00283; Biyik I, 2013, J MATERN FETAL NEONA; Blanco O, 2008, HUM REPROD, V23, P144, DOI 10.1093/humrep/dem326; Carosella ED, 2011, IMMUNOL LETT, V138, P22, DOI 10.1016/j.imlet.2011.02.011; Cartwright JE, 2005, EXP CELL RES, V304, P328, DOI 10.1016/j.yexcr.2004.11.013; Das C, 2002, J REPROD IMMUNOL, V53, P257, DOI 10.1016/S0165-0378(01)00099-7; Du MR, 2007, HUM REPROD, V22, P2528, DOI 10.1093/humrep/dem222; ELLIS SA, 1986, IMMUNOLOGY, V59, P595; Fitzgerald JS, 2005, CHEM IMMUNOL ALLERGY, V88, P181, DOI 10.1159/000087834; Fons P, 2006, BLOOD, V108, P2608, DOI 10.1182/blood-2005-12-019919; Forbes K, 2013, PLACENTA, V34, pS27, DOI 10.1016/j.placenta.2012.12.011; Goldman-Wohl D, 2009, J REPROD IMMUNOL, V82, P96, DOI 10.1016/j.jri.2009.05.002; Holling TM, 2009, ANN NY ACAD SCI, V1173, P538, DOI 10.1111/j.1749-6632.2009.04660.x; Hunt JS, 2009, CURR OPIN PHARMACOL, V9, P462, DOI 10.1016/j.coph.2009.05.007; Kawashima M, 2009, FERTIL STERIL, V91, P343, DOI 10.1016/j.fertnstert.2007.12.005; Lam KKW, 2011, J BIOL CHEM, V286, P37118, DOI 10.1074/jbc.M111.233841; Lam KKW, 2009, HUM REPROD, V24, P2093, DOI 10.1093/humrep/dep205; Le Bouteiller P, 2003, J REPROD IMMUNOL, V59, P219, DOI 10.1016/S0165-0378(03)00049-4; Lee CL, 2012, J BIOL CHEM, V287, P36999, DOI 10.1074/jbc.M112.385336; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; Male Victoria, 2012, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0740s97; Marlin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030017; McCormick J, 2009, HUM REPROD, V24, P1339, DOI 10.1093/humrep/dep026; Morandi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011763; Naruse K, 2009, PLACENTA, V30, P398, DOI 10.1016/j.placenta.2009.02.002; Pearson H, 2002, NATURE, V420, P265, DOI 10.1038/420265a; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Rebmann V, 2007, TISSUE ANTIGENS, V69, P143, DOI 10.1111/j.1399-0039.2006.763_5.x; Rebmann V, 1999, TISSUE ANTIGENS, V53, P14, DOI 10.1034/j.1399-0039.1999.530102.x; Rebmann V, 2010, HUM REPROD, V25, P1691, DOI 10.1093/humrep/deq120; Rizzo R, 2007, HUM IMMUNOL, V68, P244, DOI 10.1016/j.humimm.2006.10.012; Roussev RG, 2007, J ASSIST REPROD GEN, V24, P288, DOI 10.1007/s10815-007-9148-3; Sargent IL, 2006, REPROD BIOMED ONLINE, V13, P680, DOI 10.1016/S1472-6483(10)60659-1; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; So KH, 2012, REPROD BIOMED ONLINE, V24, P639, DOI 10.1016/j.rbmo.2012.03.004; Tang CL, 2012, PLACENTA, V33, P704, DOI 10.1016/j.placenta.2012.06.007; van der Meer A, 2007, MOL HUM REPROD, V13, P123, DOI 10.1093/molehr/gal100; Wong BST, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103903; Yao YQ, 2005, J IMMUNOL, V175, P8379, DOI 10.4049/jimmunol.175.12.8379	42	22	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76023	10.1371/journal.pone.0076023	http://dx.doi.org/10.1371/journal.pone.0076023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098421	gold, Green Submitted, Green Published			2022-12-27	WOS:000325427100037
J	Liu, PY; Lin, LY; Lin, HJ; Hsia, CH; Hung, YR; Yeh, HI; Wu, TC; Chen, JY; Chien, KL; Chen, JW				Liu, Ping-Yen; Lin, Liang-Yu; Lin, Hung-Ju; Hsia, Chien-Hsun; Hung, Yi-Ren; Yeh, Hung-I; Wu, Tao-Cheng; Chen, Ju-Yi; Chien, Kuo-Liong; Chen, Jaw-Wen			Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study)	PLOS ONE			English	Article							COENZYME-A REDUCTASE; CARDIOVASCULAR-DISEASE; INHIBITOR; EVENTS; CHOLESTEROL; LIPOPROTEIN; PREVENTION; EFFICACY	Background: Evidence about the efficacy and safety of statin treatment in high-risk patients with hypercholesterolemia is available for some populations, but not for ethnic Chinese. To test the hypothesis that treatment with pitavastatin (2 mg/day) is not inferior to treatment with atorvastatin (10 mg/day) for reducing low-density lipoprotein cholesterol (LDL-C), a 12-week multicenter collaborative randomized parallel-group comparative study of high-risk ethnic Chinese patients with hypercholesterolemia was conducted in Taiwan. In addition, the effects on other lipid parameters, inflammatory markers, insulin-resistance-associated biomarkers and safety were evaluated. Methods and Results: Between July 2011 and April 2012, 251 patients were screened, 225 (mean age: 58.7 +/- 8.6; women 38.2% [86/225]) were randomized and treated with pitavastatin (n = 112) or atorvastatin (n = 113) for 12 weeks. Baseline characteristics in both groups were similar, but after 12 weeks of treatment, LDL-C levels were significantly lower: pitavastatin group = -35.0 +/- 14.1% and atorvastatin group = -38.4 +/- 12.8% (both: p < 0.001). For the subgroup with diabetes mellitus (DM) (n = 125), LDL-C levels (-37.1 +/- 12.9% vs. -38.0 +/- 13.1%, p = 0.62) were similarly lowered after either pitavastatin (n = 63) or atorvastatin (n = 62) treatment. Triglycerides, non-high density lipoprotein cholesterol, and apoprotein B were similarly and significantly lower in both treatment groups. In non-lipid profiles, HOMA-IR and insulin levels were higher to a similar degree in both statin groups. Hemoglobin A(1)C was significantly (p = 0.001) higher in the atorvastatin group but not in the pitavastatin group. Both statins were well tolerated, and both groups had a similar low incidence of treatment-emergent adverse events. Conclusion: Both pitavastatin (2 mg/day) and atorvastatin (10 mg/day) were well tolerated, lowered LDL-C, and improved the lipid profile to a comparable degree in high-risk Taiwanese patients with hypercholesterolemia.	[Liu, Ping-Yen; Chen, Ju-Yi] Natl Cheng Kung Univ Hosp, Div Cardiol, Tainan 70428, Taiwan; [Liu, Ping-Yen] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Lin, Liang-Yu] Natl Yang Ming Univ, Div Endocrinol & Metab, Taipei 112, Taiwan; [Lin, Liang-Yu; Wu, Tao-Cheng] Taipei Vet Gen Hosp, Taipei, Taiwan; [Lin, Hung-Ju] Natl Taiwan Univ Hosp, Div Cardiol, Taipei, Taiwan; [Hsia, Chien-Hsun] Changhua Christian Hosp, Div Cardiol, Changhua, Taiwan; [Hung, Yi-Ren] Tri Serv Gen Hosp, Div Endocrinol & Metab, Taipei, Taiwan; [Yeh, Hung-I] Mackay Mem Hosp, Div Cardiol, Taipei, Taiwan; [Wu, Tao-Cheng] Natl Yang Ming Univ, Div Cardiol, Taipei 112, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; Changhua Christian Hospital; Tri-Service General Hospital; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chien, KL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	klchien@ntu.edu.tw; jwchen@vghtpe.gov.tw	Lin, Liang-Yu/R-8480-2017	Lin, Liang-Yu/0000-0003-0334-790X; CHIEN, KUO-LIONG/0000-0003-4979-8351	Kowa company from Japan	Kowa company from Japan	Kowa company from Japan funded the medicine for the clinical trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2005, BRIT J CLIN PHARMACO, V60, P494, DOI 10.1111/j.1365-2125.2005.02462.x; CHEN JW, 2011, 12 WEEK RANDOMIZED M, P99152; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Egawa T, 2003, LIPIDS, V38, P519, DOI 10.1007/s11745-003-1093-x; Fujino H, 2004, ARZNEIMITTEL-FORSCH, V54, P382; Fujino H, 2002, ARZNEIMITTELFORSCH, V52, P745; Hanyu O, 2004, ATHEROSCLEROSIS, V174, P385, DOI 10.1016/j.atherosclerosis.2004.01.034; Hsu HP, 2011, ACTA CARDIOL SIN, V27, P145; *J CLAS GROUP, 1999, PROG MED, V19, P2123; Kuzuya T, 2002, DIABETES RES CLIN PR, V55, P65, DOI 10.1016/S0168-8227(01)00365-5; Li CY, 2012, ACTA CARDIOL SIN, V28, P17; Lu WQ, 2003, DIABETES CARE, V26, P16, DOI 10.2337/diacare.26.1.16; Maejima T, 2004, BIOCHEM BIOPH RES CO, V324, P835, DOI 10.1016/j.bbrc.2004.09.122; Morikawa S, 2000, J Atheroscler Thromb, V7, P138; PEDERSEN TR, 1994, LANCET, V344, P1383; Poolsup N, 2012, J CLIN PHARM THER, V37, P166, DOI 10.1111/j.1365-2710.2011.01274.x; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Saiki A, 2005, J ATHEROSCLER THROMB, V12, P163, DOI 10.5551/jat.12.163; Saito Y, 2002, ARZNEIMITTELFORSCH, V52, P251; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sone H, 2002, LIFE SCI, V71, P2403, DOI 10.1016/S0024-3205(02)02038-6; TERAMOTO T, 2001, CLIN THER MED, V17, P885; Yokote K, 2008, ATHEROSCLEROSIS, V201, P345, DOI 10.1016/j.atherosclerosis.2008.02.008	27	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76298	10.1371/journal.pone.0076298	http://dx.doi.org/10.1371/journal.pone.0076298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098467	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100055
J	Potter, C; McKay, J; Groom, A; Ford, D; Coneyworth, L; Mathers, JC; Relton, CL				Potter, Catherine; McKay, Jill; Groom, Alexandra; Ford, Dianne; Coneyworth, Lisa; Mathers, John C.; Relton, Caroline L.			Influence of DNMT Genotype on Global and Site Specific DNA Methylation Patterns in Neonates and Pregnant Women	PLOS ONE			English	Article							DE-NOVO METHYLATION; LUNG-CANCER; RISK; EPIGENETICS; METHYLTRANSFERASES; POLYMORPHISMS; ENVIRONMENT; PROMOTER; GENES	This study examines the relationship between common genetic variation within DNA methyltransferase genes and inter-individual variation in DNA methylation. Eleven polymorphisms spanning DNMT1 and DNMT3B were genotyped. Global and gene specific (IGF2, IGFBP3, ZNT5) DNA methylation was quantified by LUMA and bisulfite Pyrosequencing assays, respectively, in neonatal cord blood and in maternal peripheral blood. Associations between maternal genotype and maternal methylation (n approximate to 333), neonatal genotype and neonatal methylation (n approximate to 454), and maternal genotype and neonatal methylation (n approximate to 137) were assessed. The findings of this study provide some support to the hypothesis that genetic variation in DNA methylating enzymes influence DNA methylation at global and gene-specific levels; however observations were not robust to correction for multiple testing. More comprehensive analysis of the influence of genetic variation on global and site specific DNA methylation is warranted.	[Potter, Catherine; Groom, Alexandra; Relton, Caroline L.] Newcastle Univ, Human Nutr Res Ctr, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McKay, Jill] Newcastle Univ, Human Nutr Res Ctr, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ford, Dianne; Coneyworth, Lisa] Newcastle Univ, Human Nutr Res Ctr, Inst Cell & Mol Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Relton, Caroline L.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Bristol	Relton, CL (corresponding author), Newcastle Univ, Human Nutr Res Ctr, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	caroline.relton@newcastle.ac.uk	Relton, Caroline/AAC-5904-2019	McKay, Jill Ann/0000-0002-2711-0301; Mathers, John/0000-0003-3406-3002; Relton, Caroline/0000-0003-2052-4840	NIHR Newcastle Biomedical Research Centre; European Nutrigenomics Organisation (NuGO): linking genomics, nutrition and health research; FP6 European [CT-2004-505944]; Biotechnology and Biological Sciences Research Council (BBSRC) [BH081097, BB/G007993/1]; BBSRC [BB/G007993/1, BB/I025263/1] Funding Source: UKRI; MRC [MC_UU_12013/2, G0700718] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025263/1, BB/G007993/1] Funding Source: researchfish; Medical Research Council [MC_UU_12013/2, G0700718] Funding Source: researchfish	NIHR Newcastle Biomedical Research Centre; European Nutrigenomics Organisation (NuGO): linking genomics, nutrition and health research; FP6 European(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the NIHR Newcastle Biomedical Research Centre and The European Nutrigenomics Organisation (NuGO): linking genomics, nutrition and health research. NuGO was a FP6 European funded Network of Excellence (CT-2004-505944). The Biotechnology and Biological Sciences Research Council (BBSRC) are also acknowledged for support (grant nos. BH081097 and BB/G007993/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Babenko O, 2012, BRAIN RES, V1444, P96, DOI 10.1016/j.brainres.2012.01.038; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berdasco M, 2013, HUM GENET; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Cebrian A, 2006, CARCINOGENESIS, V27, P1661, DOI 10.1093/carcin/bgi375; Chase DS, 1998, J MED GENET, V35, P413, DOI 10.1136/jmg.35.5.413; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Coolen MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025590; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Fan H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-12; Feil R, 2006, MUTAT RES-FUND MOL M, V600, P46, DOI 10.1016/j.mrfmmm.2006.05.029; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Gauderman WJ, 2003, GENET EPIDEMIOL, V25, P327, DOI 10.1002/gepi.10262; Gauderman WJ, 2006, UANTO 1 1 COMPUTER P; Gillio-Tos A, 2012, CANCER CAUSE CONTROL, V23, P1549, DOI 10.1007/s10552-012-0032-9; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kile ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013730; Lee SJ, 2005, CARCINOGENESIS, V26, P403, DOI 10.1093/carcin/bgh307; Lei H, 1996, DEVELOPMENT, V122, P3195; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; McKay JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033290; Murphy TM, 2013, GENES BRAIN BEHAV, V12, P125, DOI 10.1111/j.1601-183X.2012.00865.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Quon G, 2013, NUCLEIC ACIDS RES, V41, P2095, DOI 10.1093/nar/gks1449; Relton CL, 2012, INT J EPIDEMIOL, V41, P5, DOI 10.1093/ije/dys006; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Shen HB, 2002, CANCER RES, V62, P4992; Singal R, 2005, ONCOL REP, V14, P569; Smith GD, 2012, INT J EPIDEMIOL, V41, P236, DOI 10.1093/ije/dys016; Tobi EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037933; Wang L, 2004, P AM ASSOC CANC RES, V45; White Helen E, 2006, Clin Chem, V52, P1005, DOI 10.1373/clinchem.2005.065086	41	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76506	10.1371/journal.pone.0076506	http://dx.doi.org/10.1371/journal.pone.0076506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098518	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100073
J	Pryde, DC; Jones, LH; Gervais, DP; Stead, DR; Blakemore, DC; Selby, MD; Brown, AD; Coe, JW; Badland, M; Beal, DM; Glen, R; Wharton, Y; Miller, GJ; White, P; Zhang, NL; Benoit, M; Robertson, K; Merson, JR; Davis, HL; McCluskie, MJ				Pryde, David C.; Jones, Lyn H.; Gervais, David P.; Stead, David R.; Blakemore, David C.; Selby, Matthew D.; Brown, Alan D.; Coe, Jotham W.; Badland, Matthew; Beal, David M.; Glen, Rebecca; Wharton, Yvonne; Miller, Gavin J.; White, Phil; Zhang, Ningli; Benoit, Michelle; Robertson, Karen; Merson, James R.; Davis, Heather L.; McCluskie, Michael J.			Selection of a Novel Anti-Nicotine Vaccine: Influence of Antigen Design on Antibody Function in Mice	PLOS ONE			English	Article							SMOKING-CESSATION; HAPTEN DESIGN; IMMUNOGENICITY; IMMUNIZATION; (S)-NICOTINE; LITHIATION; ADDICTION; SMOKERS; BRAIN; RATS	Anti-nicotine vaccines may aid smoking cessation via the induction of anti-nicotine antibodies (Ab) which reduce nicotine entering the brain, and hence the associated reward. Ab function depends on both the quantity (titer) and the quality (affinity) of the Ab. Anti-nicotine vaccines tested previously in clinical studies had poor efficacy despite high Ab titer, and this may be due to inadequate function if Ab of low affinity were induced. In this study, we designed and synthesized a series of novel nicotine-like haptens which were all linked to diphtheria toxoid (DT) as carrier, but which differed in the site of attachment of linker to nicotine, the nature of linker used, and the handle used to attach the hapten to DT. The resulting hapten conjugates were evaluated in a mouse model, using CpG (a TLR9 agonist) and aluminum hydroxide (Al(OH)(3)) as adjuvants, whereby Ab titers, affinity and function were evaluated using a radiolabeled nicotine challenge model. A series of additional linkers varying in length, rigidity and polarity were used with a single hapten to generate additional DT-conjugates, which were also tested in mice. Conjugates made with different haptens resulted in various titers of anti-nicotine Ab. Several haptens gave similarly high Ab titers, but among these, Ab affinity and hence function varied considerably. Linker also influenced Ab titer, affinity and function. These results demonstrate that immune responses induced in mice by nicotine-conjugate antigens are greatly influenced by hapten design including site of attachment of linker to nicotine, the nature of linker used, and the handle used to attach the hapten to DT. While both Ab titer and affinity contributed to function, affinity was more sensitive to antigen differences.	[Pryde, David C.; Blakemore, David C.; Brown, Alan D.] Pfizer Worldwide Med Chem, Cambridge, England; [Jones, Lyn H.; Selby, Matthew D.; Beal, David M.] Pfizer Worldwide Med Chem, BioTherapeut Chem, Cambridge, MA USA; [Gervais, David P.; Stead, David R.; White, Phil; Merson, James R.] Pfizer Vaccine Res, La Jolla, CA USA; [Coe, Jotham W.] Pfizer Worldwide Med Chem, Groton, CT USA; [Zhang, Ningli; Benoit, Michelle; Robertson, Karen; Davis, Heather L.; McCluskie, Michael J.] Pfizer Vaccine Res, Ottawa, ON, Canada; [Glen, Rebecca; Wharton, Yvonne; Miller, Gavin J.] Peakdale Mol Ltd, Chapel En Le Frith, Derby, England; [Badland, Matthew] Pfizer Chem Res & Dev, Sandwich, Kent, England	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	McCluskie, MJ (corresponding author), Pfizer Vaccine Res, Ottawa, ON, Canada.	michael.mccluskie@pfizer.com	Gervais, David/H-5183-2019; Beal, David M/Q-7314-2017; Miller, Gavin J/AAL-5783-2021	Gervais, David/0000-0002-4996-3217; Beal, David M/0000-0002-1819-315X; Miller, Gavin J/0000-0001-6533-3306; White, Phil/0000-0002-6078-9061; Jones, Lyn/0000-0002-8388-5865				BENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499, DOI 10.1038/clpt.1984.67; Carroll FI, 2011, J MED CHEM, V54, P5221, DOI 10.1021/jm2004943; Carroll FI, 2009, J MED CHEM, V52, P7301, DOI 10.1021/jm901134w; Cerny EH, 2002, ONKOLOGIE, V25, P406, DOI 10.1159/000067433; Chen XY, 2012, VACCINE, V31, P159, DOI 10.1016/j.vaccine.2012.10.069; Choppin S, 2000, ORG LETT, V2, P803, DOI 10.1021/ol005538o; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; de Villiers SHL, 2010, VACCINE, V28, P2161, DOI 10.1016/j.vaccine.2009.12.051; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Fevrier FC, 2005, ORG LETT, V7, P5457, DOI 10.1021/ol052196j; Gros PC, 2006, ORG BIOMOL CHEM, V4, P4331, DOI 10.1039/b612786j; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hatsukami DK, 2011, CLIN PHARMACOL THER, V89, P392, DOI 10.1038/clpt.2010.317; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Hieda Y, 2000, INT J IMMUNOPHARMACO, V22, P809, DOI 10.1016/S0192-0561(00)00042-4; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Isomura S, 2001, J ORG CHEM, V66, P4115, DOI 10.1021/jo001442w; Jones LH, 2002, ANGEW CHEM INT EDIT, V41, P4241, DOI 10.1002/1521-3773(20021115)41:22<4241::AID-ANIE4241>3.0.CO;2-N; Keyler DE, 2008, INT IMMUNOPHARMACOL, V8, P1589, DOI 10.1016/j.intimp.2008.07.001; LANGONE JJ, 1973, BIOCHEMISTRY-US, V12, P5025, DOI 10.1021/bi00748a032; MATSUKURA S, 1975, BIOCHEM BIOPH RES CO, V64, P574, DOI 10.1016/0006-291X(75)90360-5; McCluskie MJ, 2013, INT IMMUNOPHARMACOL, V16, P50, DOI 10.1016/j.intimp.2013.03.021; McCluskie MJ, 2013, 19 ANN M SOC RES NIC; Meijler MM, 2003, J AM CHEM SOC, V125, P7164, DOI 10.1021/ja034805t; Moreno AY, 2012, VACCINE, V30, P6665, DOI 10.1016/j.vaccine.2012.08.064; Moreno AY, 2011, J AM CHEM SOC, V133, P6587, DOI 10.1021/ja108807j; Moreno AY, 2010, MOL PHARMACEUT, V7, P431, DOI 10.1021/mp900213u; Murphy JM, 2007, J AM CHEM SOC, V129, P15434, DOI 10.1021/ja076498n; Nides M, 2008, AM J HEALTH BEHAV, V32, P664, DOI 10.5555/ajhb.2008.32.6.664; Pentel PR, 2000, PHARMACOL BIOCHEM BE, V65, P191, DOI 10.1016/S0091-3057(99)00206-3; Peterson EC, 2007, J PHARMACOL EXP THER, V322, P30, DOI 10.1124/jpet.106.117150; Pravetoni M, 2012, BIOCHEM PHARMACOL, V83, P543, DOI 10.1016/j.bcp.2011.11.004; Raupach Tobias, 2012, Drugs, V72, pe1, DOI 10.2165/11599900-000000000-00000; Storer RI, 2011, CHEM SOC REV, V40, P2330, DOI 10.1039/c0cs00200c; Ullrich T, 2002, J MED CHEM, V45, P4047, DOI 10.1021/jm020916b; World Health Organization, 2019, WHO REPORT GLOBAL TO; Xu Y, 2005, BIOORG MED CHEM LETT, V15, P4304, DOI 10.1016/j.bmcl.2005.06.052	37	58	64	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76557	10.1371/journal.pone.0076557	http://dx.doi.org/10.1371/journal.pone.0076557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098532	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000325427100076
J	Matsubayashi, Y; Takeshita, K; Sumitani, M; Oshima, Y; Tonosu, J; Kato, S; Ohya, J; Oichi, T; Okamoto, N; Tanaka, S				Matsubayashi, Yoshitaka; Takeshita, Katsushi; Sumitani, Masahiko; Oshima, Yasushi; Tonosu, Juichi; Kato, So; Ohya, Junichi; Oichi, Takeshi; Okamoto, Naoki; Tanaka, Sakae			Validity and Reliability of the Japanese Version of the painDETECT Questionnaire: A Multicenter Observational Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CROSS-CULTURAL ADAPTATION; NEUROPATHIC PAIN; DIABETIC POLYNEUROPATHY; COST-EFFECTIVENESS; CLINICAL-TESTS; EPIDEMIOLOGY; SF-36	Objectives: The aim of this study was to evaluate the validity and reliability of the Japanese version of the painDETECT questionnaire (PDQ-J). Materials and Methods: The translation of the original PDQ into Japanese was achieved according to the published guidelines. Subsequently, a multicenter observational study was performed to evaluate the validity and reliability of PDQ-J, including 113 Japanese patients suffering from pain. Results: Factor analysis revealed that the main component of PDQ-J comprises two determinative factors, which account for 62% of the variance observed. Moreover, PDQ-J revealed statistically significant correlation with the intensity of pain (Numerical Rating Scale), Physical Component Score, and Mental Component Score of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36). The Cronbach alpha for the total score was 0.78 and for the main component was 0.80. In the analysis of test-retest method, the intraclass correlation coefficient between the two scores was 0.94. Conclusions: We demonstrated the validity and reliability of PDQ-J. We encourage researchers and clinicians to use this tool for the assessment of patients who suffer suspected neuropathic pain.	[Matsubayashi, Yoshitaka; Takeshita, Katsushi; Oshima, Yasushi; Tonosu, Juichi; Kato, So; Ohya, Junichi; Oichi, Takeshi; Okamoto, Naoki; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Sumitani, Masahiko] Univ Tokyo, Dept Anesthesiol, Tokyo, Japan; [Sumitani, Masahiko] Univ Tokyo, Pain Relief Ctr, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Matsubayashi, Y (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan.	ymatsubayashi-tky@umin.ac.jp	Ohya, Junichi/L-5987-2019; Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414; Matsubayashi, Yoshitaka/0000-0002-2087-5774	Health and Labour Sciences Research Grant	Health and Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan)	This study received financial funds from the "Health and Labour Sciences Research Grant." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal N, 2008, PAIN, V138, P343, DOI 10.1016/j.pain.2008.01.006; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; De Andres J, 2012, CLIN J PAIN, V28, P243, DOI 10.1097/AJP.0b013e31822bb35b; Feise RJ, 2001, SPINE, V26, P78, DOI 10.1097/00007632-200101010-00015; Freynhagen R, 2005, AKTUEL NEUROL, V34, P641; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Galvez R, 2007, EUR J PAIN, V11, P244, DOI 10.1016/j.ejpain.2006.02.002; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; McCarberg B, 2006, AM J MANAG CARE, V12, pS263; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Connor AB, 2009, PHARMACOECONOMICS, V27, P95, DOI 10.2165/00019053-200927020-00002; Rodriguez MJ, 2007, CURR MED RES OPIN, V23, P2585, DOI 10.1185/030079907X233151; Schmidt CO, 2009, EUR J PAIN, V13, P1030, DOI 10.1016/j.ejpain.2008.12.003; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sumitani M, 2007, NEUROPATHIC PAIN MAN, P7; Timmerman H, 2013, PAIN PRACT, V13, P206, DOI 10.1111/j.1533-2500.2012.00577.x; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59	23	62	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e68013	10.1371/journal.pone.0068013	http://dx.doi.org/10.1371/journal.pone.0068013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098629	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500001
J	Vajn, K; Viljetic, B; Degmecic, IV; Schnaar, RL; Heffer, M				Vajn, Katarina; Viljetic, Barbara; Degmecic, Ivan Veceslav; Schnaar, Ronald L.; Heffer, Marija			Differential Distribution of Major Brain Gangliosides in the Adult Mouse Central Nervous System	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; ANTIGANGLIOSIDE ANTIBODIES; TISSUE SECTIONS; MONOCLONAL-ANTIBODIES; MASS-SPECTROMETRY; NOGO-66 RECEPTOR; NEURITE OUTGROWTH; ANCHORED PROTEINS; RAT CEREBELLUM; LOCALIZATION	Gangliosides - sialic acid-bearing glycolipids - are major cell surface determinants on neurons and axons. The same four closely related structures, GM1, GD1a, GD1b and GT1b, comprise the majority of total brain gangliosides in mammals and birds. Gangliosides regulate the activities of proteins in the membranes in which they reside, and also act as cell-cell recognition receptors. Understanding the functions of major brain gangliosides requires knowledge of their tissue distribution, which has been accomplished in the past using biochemical and immunohistochemical methods. Armed with new knowledge about the stability and accessibility of gangliosides in tissues and new IgG-class specific monoclonal antibodies, we investigated the detailed tissue distribution of gangliosides in the adult mouse brain. Gangliosides GD1b and GT1b are widely expressed in gray and white matter. In contrast, GM1 is predominately found in white matter and GD1a is specifically expressed in certain brain nuclei/tracts. These findings are considered in relationship to the hypothesis that gangliosides GD1a and GT1b act as receptors for an important axon-myelin recognition protein, myelin-associated glycoprotein (MAG). Mediating axon-myelin interactions is but one potential function of the major brain gangliosides, and more detailed knowledge of their distribution may help direct future functional studies.	[Vajn, Katarina; Heffer, Marija] Univ Osijek Sch Med, Dept Med Biol, Osijek, Croatia; [Viljetic, Barbara] Univ Osijek Sch Med, Dept Chem Biochem & Clin Chem, Osijek, Croatia; [Degmecic, Ivan Veceslav] Univ Osijek Sch Med, Anim Facil, Osijek, Croatia; [Schnaar, Ronald L.] Johns Hopkins Sch Med, Dept Pharmacol, Baltimore, MD USA; [Schnaar, Ronald L.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Heffer, M (corresponding author), Univ Osijek Sch Med, Dept Med Biol, Osijek, Croatia.	marija.heffer.lauc@mefos.hr	Heffer, Marija/ABA-4694-2020; Schnaar, Ronald L/S-8967-2016	Schnaar, Ronald L/0000-0002-7701-5484; Heffer, Marija/0000-0001-6770-7359	Ministry of Science, Education and Sports of the Republic of Croatia [219-0061194-2157]; NIH [NS037096]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037096, R01NS037096] Funding Source: NIH RePORTER	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by Ministry of Science, Education and Sports of the Republic of Croatia grant #219-0061194-2157 ("Role of lipid rafts and glycoconjugates in development and regeneration of nervous system") to M. H. and NIH Grant NS037096 to R. L. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2002, CURR OPIN STRUC BIOL, V12, P587, DOI 10.1016/S0959-440X(02)00376-7; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Byers DM, 2002, DEV NEUROSCI-BASEL, V24, P478, DOI 10.1159/000069358; Colsch B, 2011, ACS CHEM NEUROSCI, V2, P213, DOI 10.1021/cn100096h; Colsch B, 2010, GLYCOBIOLOGY, V20, P661, DOI 10.1093/glycob/cwq031; DEBAECQUE C, 1976, BRAIN RES, V114, P117, DOI 10.1016/0006-8993(76)91011-8; DEVRIES GH, 1980, J NEUROCHEM, V34, P424, DOI 10.1111/j.1471-4159.1980.tb06613.x; Giger RJ, 2008, RESTOR NEUROL NEUROS, V26, P97; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Gong Y, 2002, BRAIN, V125, P2491, DOI 10.1093/brain/awf258; Goto-Inoue N, 2010, J AM SOC MASS SPECTR, V21, P1940, DOI 10.1016/j.jasms.2010.08.002; Heffer-Lauc M, 2005, BBA-MOL CELL BIOL L, V1686, P200, DOI 10.1016/j.bbalip.2004.10.002; Heffer-Lauc M, 2007, J HISTOCHEM CYTOCHEM, V55, P805, DOI 10.1369/jhc.7A7195.2007; KOTANI M, 1993, GLYCOBIOLOGY, V3, P137, DOI 10.1093/glycob/3.2.137; LAEV H, 1978, BRAIN RES, V157, P136, DOI 10.1016/0006-8993(78)91002-8; LAEV H, 1989, NEUROSCI LETT, V102, P7, DOI 10.1016/0304-3940(89)90299-1; Lee JK, 2012, EXP NEUROL, V235, P33, DOI 10.1016/j.expneurol.2011.05.001; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LLOYD KO, 1992, CANCER RES, V52, P4948; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Lunn MPT, 2000, J NEUROCHEM, V75, P404, DOI 10.1046/j.1471-4159.2000.0750404.x; Mehta NR, 2007, J BIOL CHEM, V282, P27875, DOI 10.1074/jbc.M704055200; Molander M, 2000, J NEUROSCI RES, V60, P531, DOI 10.1002/(SICI)1097-4547(20000515)60:4<531::AID-JNR12>3.0.CO;2-6; NORES GA, 1987, J IMMUNOL, V139, P3171; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; Schnaar RL, 2002, ANAL BIOCHEM, V302, P276, DOI 10.1006/abio.2001.5540; Schnaar RL, 2009, J NEUROSCI RES, V87, P3267, DOI 10.1002/jnr.21992; Schwarz A, 1997, J HISTOCHEM CYTOCHEM, V45, P611, DOI 10.1177/002215549704500413; Schwarz A, 1996, BBA-REV BIOMEMBRANES, V1286, P247, DOI 10.1016/S0304-4157(96)00011-1; Schwarz A, 2000, METHOD ENZYMOL, V312, P179; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; SVENNERHOLM L, 1994, PROG BRAIN RES, V101, pR11; Tagawa Y, 2002, NEUROCHEM RES, V27, P847, DOI 10.1023/A:1020221410895; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Venkatesh K, 2007, J CELL BIOL, V177, P393, DOI 10.1083/jcb.200702102; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699	40	57	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75720	10.1371/journal.pone.0075720	http://dx.doi.org/10.1371/journal.pone.0075720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098718	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500089
J	Eguchi, H; Wada, K				Eguchi, Hisashi; Wada, Koji			Knowledge of HBV and HCV and Individuals' Attitudes Toward HBV- and HCV-Infected Colleagues: A National Cross-Sectional Study among a Working Population in Japan	PLOS ONE			English	Article							HEPATITIS-C; HEALTH-PROFESSIONALS; HIV/AIDS STIGMA; AWARENESS; WORKPLACE; PAKISTAN; VIETNAM; PEOPLE; HIV	Prejudice and discrimination in the workplace regarding the risk of transmission of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are increased by excess concerns due to a lack of relevant knowledge. Education to increase knowledge about HBV and HCV and their prevention could be the first step to reduce prejudice and discrimination. This study aimed to determine the association between the level of knowledge and negative attitudes toward HBV- and HCV-infected colleagues among the Japanese working population. An online anonymous nationwide survey involving about 3,000 individuals was conducted in Japan. The questionnaire consisted of knowledge of HBV and HCV, and attitudes toward HBV- and HCV-infected colleagues in the workplace. Knowledge was divided into three categories: "ensuring daily activities not to be infected"; "risk of infection"; and "characteristics of HBV/HCV hepatitis", based on the result of factor analysis. Multiple logistic regression analysis was applied. A total of 3,129 persons responded to the survey: 36.0% reported they worried about the possibility of transmission of HBV and HCV from infected colleagues; 32.1% avoided contact with infected colleagues; and 23.7% had prejudiced opinions about HBV and HCV infection. The participants were classified into tertiles. A higher level of knowledge of HBV and HCV was significantly associated with these three negative attitudes (P for trend < 0.005). This study suggests that increasing knowledge may decrease individuals' negative attitudes towards HBV- and HCV-infected colleagues. Thus, we should promote increased knowledge of HBV and HCV in stages to reduce negative attitudes toward HBV- and HCV-infected colleagues.	[Eguchi, Hisashi] Kyocera Corp Shiga Gamou Plant, Environm & Safety Div, Higashiomi, Shiga, Japan; [Wada, Koji] Natl Inst Global Hlth & Med, Shinjuku Ku, Tokyo, Japan	Kyocera	Wada, K (corresponding author), Natl Inst Global Hlth & Med, Shinjuku Ku, Tokyo, Japan.	kwada-sgy@umin.ac.jp			Health Labour Sciences Research Grant from The Ministry of Health, Labour, and Welfare [H23-Hepatitis-general-001]	Health Labour Sciences Research Grant from The Ministry of Health, Labour, and Welfare	This study was funded by a Health Labour Sciences Research Grant from The Ministry of Health, Labour, and Welfare (H23-Hepatitis-general-001). The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Arikan K, 1999, ISRAEL J PSYCHIAT, V36, P95; Balfour L, 2009, SCAND J CARING SCI, V23, P801, DOI 10.1111/j.1471-6712.2008.00668.x; Bashir S, 2011, SAHARA J-J SOC ASP H, V8, P156, DOI 10.1080/17290376.2011.9724998; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Chao J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-98; Corrigan PW, 2004, PSYCHIAT SERV, V55, P577, DOI 10.1176/appi.ps.55.5.577; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Hoa NR, 2004, INT J TUBERC LUNG D, V8, P603; Janke EA, 2008, PSYCHOSOMATICS, V49, P494, DOI 10.1176/appi.psy.49.6.494; Kontos EZ, 2012, AM J PUBLIC HEALTH, V102, P1911, DOI 10.2105/AJPH.2011.300435; Krauskopf K, 2011, J VIRAL HEPATITIS, V18, P785, DOI 10.1111/j.1365-2893.2010.01383.x; Lee S, 2005, SOC SCI MED, V61, P2038, DOI 10.1016/j.socscimed.2005.04.010; Lim V. K. G., 1999, SMJ, V40, P410; Minuk GY, 2005, J VIRAL HEPATITIS, V12, P51, DOI 10.1111/j.1365-2893.2005.00553.x; Narai R, 2007, J OCCUP HEALTH, V49, P9, DOI 10.1539/joh.49.9; Richmond JA, 2007, J VIRAL HEPATITIS, V14, P624, DOI 10.1111/j.1365-2893.2007.00849.x; Sastre MTM, 2002, PREV MED, V34, P596, DOI 10.1006/pmed.2002.1023; Thi MDA, 2008, AIDS BEHAV, V12, pS63, DOI 10.1007/s10461-008-9374-4; ul Haq N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-692; van der Veen YJJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-512; Zacks S, 2006, J CLIN GASTROENTEROL, V40, P220, DOI 10.1097/00004836-200603000-00009; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	23	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76921	10.1371/journal.pone.0076921	http://dx.doi.org/10.1371/journal.pone.0076921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086765	gold, Green Published, Green Submitted			2022-12-27	WOS:000325220000074
J	Devereaux, K; Dall'Armi, C; Alcazar-Roman, A; Ogasawara, Y; Zhou, X; Wang, F; Yamamoto, A; De Camilli, P; Di Paolo, G				Devereaux, Kelly; Dall'Armi, Claudia; Alcazar-Roman, Abel; Ogasawara, Yuta; Zhou, Xiang; Wang, Fan; Yamamoto, Akitsugu; De Camilli, Pietro; Di Paolo, Gilbert			Regulation of Mammalian Autophagy by Class II and III PI 3-Kinases through PI3P Synthesis	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; KINASE VPS34; BECLIN 1; PROTEIN; COMPLEX; LOCALIZATION; 3-PHOSPHATE; DELETION; VACUOLE; MACROAUTOPHAGY	Synthesis of phosphatidylinositol-3-phosphate (PI3P) by Vps34, a class III phosphatidylinositol 3-kinase (PI3K), is critical for the initial steps of autophagosome (AP) biogenesis. Although Vps34 is the sole source of PI3P in budding yeast, mammalian cells can produce PI3P through alternate pathways, including direct synthesis by the class II PI3Ks; however, the physiological relevance of these alternate pathways in the context of autophagy is unknown. Here we generated Vps34 knockout mouse embryonic fibroblasts (MEFs) and using a higher affinity 4x-FYVE finger PI3P-binding probe found a Vps34-independent pool of PI3P accounting for (similar to)35% of the total amount of this lipid species by biochemical analysis. Importantly, WIPI-1, an autophagy-relevant PI3P probe, still formed some puncta upon starvation-induced autophagy in Vps34 knockout MEFs. Additional characterization of autophagy by electron microscopy as well as protein degradation assays showed that while Vps34 is important for starvation-induced autophagy there is a significant component of functional autophagy occurring in the absence of Vps34. Given these findings, class II PI3Ks (alpha and beta isoforms) were examined as potential positive regulators of autophagy. Depletion of class II PI3Ks reduced recruitment of WIPI-1 and LC3 to AP nucleation sites and caused an accumulation of the autophagy substrate, p62, which was exacerbated upon the concomitant ablation of Vps34. Our studies indicate that while Vps34 is the main PI3P source during autophagy, class II PI3Ks also significantly contribute to PI3P generation and regulate AP biogenesis.	[Devereaux, Kelly; Dall'Armi, Claudia; Di Paolo, Gilbert] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Devereaux, Kelly; Dall'Armi, Claudia; Di Paolo, Gilbert] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY USA; [Alcazar-Roman, Abel; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Alcazar-Roman, Abel; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Ogasawara, Yuta; Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Fac Biosci, Nagahama, Shiga, Japan; [Zhou, Xiang; Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Zhou, Xiang; Wang, Fan] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Columbia University; Columbia University; Yale University; Howard Hughes Medical Institute; Yale University; Duke University; Duke University	Di Paolo, G (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.	gil.dipaolo@columbia.edu	Ogasawara, Yuta/C-4021-2016	Alcazar-Roman, Abel R./0000-0003-1668-1886; Ogasawara, Yuta/0000-0001-5345-6472	NIH [R01 NS056049, R01 DE016550, P50 AG08702, P30 DK063608, T32 GM07367, DA018343, RO1 DK082700]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG045020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01 NS056049 (to G. D. P.), R01 DE016550 (to F. W.), P50 AG08702 (to Michael Shelanski, G. D. P. and C. D. A. projects), and P30 DK063608 (to Domenico Accili, G. D. P pilot project). K. A. D. is supported by NIH training grant T32 GM07367 (to Michael Shelanski). The work was also funded by NIH grants P30 DA018343 and RO1 DK082700 to P. D. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bechtel W, 2013, AUTOPHAGY, V9, P1097, DOI 10.4161/auto.24634; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bohdanowicz M, 2010, J CELL BIOL, V191, P999, DOI 10.1083/jcb.201004005; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Cebollero E, 2012, CURR BIOL, V22, P1545, DOI 10.1016/j.cub.2012.06.029; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hakim S, 2012, CURR TOP MICROBIOL, V362, P246, DOI 10.1007/978-94-007-5025-8_12; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaber N, 2012, AUTOPHAGY, V8, P707, DOI 10.4161/auto.19627; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kiel JAKW, 1999, YEAST, V15, P741, DOI 10.1002/(SICI)1097-0061(19990630)15:9<741::AID-YEA416>3.0.CO;2-O; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; KIRK CJ, 1990, EPTIDE HORMONE ACTIO, P45237; Knaevelsrud H, 2013, J CELL BIOL, V202, P331, DOI 10.1083/jcb.201205129; Knaevelsrud H, 2012, BBA-MOL CELL BIOL L, V1821, P1133, DOI 10.1016/j.bbalip.2012.01.001; Lu N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001245; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; McLeod IX, 2011, J IMMUNOL, V187, P5051, DOI 10.4049/jimmunol.1100710; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Morishita H, 2013, J BIOL CHEM, V288, P11436, DOI 10.1074/jbc.M112.437103; Nemazanyy I, 2013, EMBO MOL MED, V5, P870, DOI 10.1002/emmm.201202057; Noda T, 2010, SEMIN CELL DEV BIOL, V21, P671, DOI 10.1016/j.semcdb.2010.04.002; NORRIS FA, 1994, J BIOL CHEM, V269, P8716; Norris FA, 1997, J BIOL CHEM, V272, P23859, DOI 10.1074/jbc.272.38.23859; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Parekh VV, 2013, J IMMUNOL, V190, P5086, DOI 10.4049/jimmunol.1202071; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Stenmark H, 1999, J CELL SCI, V112, P4175; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Willinger T, 2012, P NATL ACAD SCI USA, V109, P8670, DOI 10.1073/pnas.1205305109; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	80	119	121	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76405	10.1371/journal.pone.0076405	http://dx.doi.org/10.1371/journal.pone.0076405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098492	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600044
J	Li, HT; Zhu, F; Sun, YW; Li, B; Oi, NM; Chen, HY; Lubet, RA; Bode, AM; Dong, ZG				Li, Haitao; Zhu, Feng; Sun, Yanwen; Li, Bing; Oi, Naomi; Chen, Hanyong; Lubet, Ronald A.; Bode, Ann M.; Dong, Zigang			Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EPITHELIAL-CELLS; CYCLOOXYGENASE-2 TRANSCRIPTION; CARDIOVASCULAR-DISEASE; SOYBEAN ISOFLAVONES; CANCER PREVENTION; PHARMACOKINETICS; BIOAVAILABILITY; ASPIRIN; RATS	Recent clinical trials raised concerns regarding the cardiovascular toxicity of selective cyclooxygenase-2 (COX-2) inhibitors. Many active dietary factors are reported to suppress carcinogenesis by targeting COX-2. A major question was accordingly raised: why has the lifelong use of phytochemicals that likely inhibit COX-2 presumably not been associated with adverse cardiovascular side effects. To answer this question, we selected a library of dietary-derived phytochemicals and evaluated their potential cardiovascular toxicity in human umbilical vein endothelial cells. Our data indicated that the possibility of cardiovascular toxicity of these dietary phytochemicals was low. Further mechanistic studies revealed that the actions of these phytochemicals were similar to aspirin in that they mainly inhibited COX-1 rather than COX-2, especially at low doses.	[Li, Haitao; Zhu, Feng; Sun, Yanwen; Li, Bing; Oi, Naomi; Chen, Hanyong; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Lubet, Ronald A.] NCI, NIH, Bethesda, MD 20892 USA	University of Minnesota System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/C-1303-2010	Zhu, Feng/0000-0003-1172-0102	Hormel Foundation and National Institutes of Health [R37 CA081064, ES016548]; NCI [HHSN-261200533001C-NO1-CN9 53301, N01-CN-43309-18018-01WA 13B]; NATIONAL CANCER INSTITUTE [R21CA172457, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation and National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The Hormel Foundation and National Institutes of Health grants R37 CA081064 and ES016548 and NCI Contract Numbers HHSN-261200533001C-NO1-CN9 53301 and N01-CN-43309-18018-01WA 13B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja R, 2004, MOL MED, V10, P55, DOI 10.2119/2004-00032.Aneja; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Chen ZP, 2010, FITOTERAPIA, V81, P1045, DOI 10.1016/j.fitote.2010.06.028; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; Chulada PC, 2000, CANCER RES, V60, P4705; Chun KS, 2003, CARCINOGENESIS, V24, P1515, DOI 10.1093/carcin/bgg107; Chun Kyung-Soo, 2006, Cancer Res Treat, V38, P152, DOI 10.4143/crt.2006.38.1.152; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Gradolatto A, 2005, DRUG METAB DISPOS, V33, P49, DOI 10.1124/dmd.104.000893; Graefe EU, 1999, INT J CLIN PHARM TH, V37, P219; Gray PA, 2002, BRIT J PHARMACOL, V137, P1031, DOI 10.1038/sj.bjp.0704927; Hall MN, 2007, CANCER EPIDEM BIOMAR, V16, P314, DOI 10.1158/1055-9965.EPI-06-0346; Inserte J, 2009, J MOL CELL CARDIOL, V46, P160, DOI 10.1016/j.yjmcc.2008.11.011; Kanaze FI, 2007, EUR J CLIN NUTR, V61, P472, DOI 10.1038/sj.ejcn.1602543; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Lee KW, 2005, ANTIOXID REDOX SIGN, V7, P1612, DOI 10.1089/ars.2005.7.1612; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Moon YJ, 2007, MOL PHARM, V4, P865, DOI 10.1021/mp7000928; Mutoh H, 2000, JPN J CANCER RES, V91, P686; Na HK, 2004, BIOFACTORS, V21, P149, DOI 10.1002/biof.552210130; Narko K, 1997, J BIOL CHEM, V272, P21455, DOI 10.1074/jbc.272.34.21455; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; Perrone MG, 2010, CURR MED CHEM, V17, P3769; Reese J, 2000, P NATL ACAD SCI USA, V97, P9759, DOI 10.1073/pnas.97.17.9759; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; Takeda H, 2003, CANCER RES, V63, P4872; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Wang DR, 2009, P NATL ACAD SCI USA, V106, P7548, DOI 10.1073/pnas.0805806106; XU X, 1995, J NUTR, V125, P2307, DOI 10.1093/jn/125.9.2307; Zhang F, 1999, CARCINOGENESIS, V20, P445, DOI 10.1093/carcin/20.3.445; Zubik L, 2003, AM J CLIN NUTR, V77, P1459, DOI 10.1093/ajcn/77.6.1459	35	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76452	10.1371/journal.pone.0076452	http://dx.doi.org/10.1371/journal.pone.0076452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098505	Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600055
J	Marimuthu, K; Muthu, N; Xavier, R; Arockiaraj, J; Rahman, MA; Subramaniam, S				Marimuthu, Kasi; Muthu, Narmataa; Xavier, Rathinam; Arockiaraj, Jesu; Rahman, M. Aminur; Subramaniam, Sreeramanan			Toxicity of Buprofezin on the Survival of Embryo and Larvae of African Catfish, Clarias gariepinus (Bloch)	PLOS ONE			English	Article							INSECT GROWTH-REGULATORS; ORYZIAS-LATIPES; LIFE STAGES; PYRIPROXYFEN; PARAMETERS; MECHANISM	Buprofezin is an insect growth regulator and widely used insecticide in Malaysia. The present study evaluated the toxic effects of buprofezin on the embryo and larvae of African catfish (Clarias gariepinus) as a model organism. The embryos and larvae were exposed to 7 different concentrations (0, 0.05, 0.5, 5, 25, 50 and 100 mg/L) of buprofezin. Each concentration was assessed in five replicates. Eggs were artificially fertilized and 200 eggs and larvae were subjected to a static bath treatment for all the concentrations. The mortality of embryos was significantly increased with increasing buprofezin concentrations from 5 to 100 mg/L (p< 0.05). However, the mortality was not significantly different (p< 0.05) among the following concentrations: 0 (control), 0.05, 0.5 and 5 mg/L. Data obtained from the buprofezin acute toxicity tests were evaluated using probit analysis. The 24 h LC50 value (with 95% confidence limits) of buprofezin for embryos was estimated to be 6.725 (3.167-15.017) mg/L. The hatching of fish embryos was recorded as 68.8, 68.9, 66.9, 66.4, 26.9, 25.1 and 0.12% in response to 7 different concentrations of buprofezin, respectively. The mortality rate of larvae significantly (p< 0.05) increased with increasing buprofezin concentrations exposed to 24-48 h. The 24 and 48 h LC50 values (with 95% confidence limits) of buprofezin for the larvae was estimated to be 5.702 (3.198-8.898) and 4.642 (3.264-6.287) mg/L respectively. There were no significant differences (p>0.05) in the LC50 values obtained at 24 and 48 h exposure times. Malformations were observed when the embryos and larvae exposed to more than 5 mg/L. The results emerged from the study suggest that even the low concentration (5 mg/L) of buprofezin in the aquatic environment may have adverse effect on the early embryonic and larval development of African catfish.	[Marimuthu, Kasi; Muthu, Narmataa; Xavier, Rathinam] AIMST Univ, Fac Sci Appl, Dept Biotechnol, Bedong, Kedah Darul Ama, Malaysia; [Arockiaraj, Jesu] SRM Univ, Fac Sci & Humanities, Dept Biotechnol, Div Fisheries Biotechnol & Mol Biol, Madras 603203, Tamil Nadu, India; [Rahman, M. Aminur] Univ Putra Malaysia, Inst Biosci, Lab Marine Biotechnol, Upm Serdang 43400, Selangor, Malaysia; [Subramaniam, Sreeramanan] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia	AIMST University; SRM Institute of Science & Technology Chennai; Universiti Putra Malaysia; Universiti Sains Malaysia	Marimuthu, K (corresponding author), AIMST Univ, Fac Sci Appl, Dept Biotechnol, Bedong, Kedah Darul Ama, Malaysia.	aquamuthu2k@yahoo.com	Subramaniam, Sreeramanan Sree/I-1130-2012; Arockiaraj, Jesu/A-6227-2013; Subramaniam, Sreeramanan/AAA-5094-2022	Subramaniam, Sreeramanan Sree/0000-0003-4392-285X; Arockiaraj, Jesu/0000-0002-0240-7141; 	University (AIMST University, Malaysia)	University (AIMST University, Malaysia)	The authors received internal funds from the University (AIMST University, Malaysia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash PC, 2009, J HAZARD MATER, V165, P1, DOI 10.1016/j.jhazmat.2008.10.061; Adhikari S, 2004, ECOTOX ENVIRON SAFE, V58, P220, DOI 10.1016/j.ecoenv.2003.12.003; American Public Health Association (APHA), 1985, STANDARD METHODS EXA, V16th ed., P1268; [Anonymous], 2010, EFSA J, V8, P1624; [Anonymous], 2007, EFSA J, V620, P1; Aydin R, 2005, PESTIC BIOCHEM PHYS, V82, P220, DOI 10.1016/j.pestbp.2005.03.001; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; CRANE M, 1991, ENVIRON TOXICOL CHEM, V10, P1331, DOI 10.1002/etc.5620101012; DIMICHELE L, 1981, J EXP ZOOL, V217, P73, DOI 10.1002/jez.1402170108; FENT K, 1994, ARCH ENVIRON CON TOX, V27, P224; Gaikowski MP, 1996, ECOTOX ENVIRON SAFE, V34, P252, DOI 10.1006/eesa.1996.0070; Guideline for Testing of Chemicals, 1998, DAPHN MAGN REPR TEST, V211; Haniffa M.A., 2003, Indian Journal of Fisheries, V50, P355; Haniffa MA, 2004, CURR SCI INDIA, V86, P1375; HATAKOSHI M, 1992, J INSECT PHYSIOL, V38, P793, DOI 10.1016/0022-1910(92)90032-9; Ishaaya I, 1998, APPL AGR, P1; John PJ, 2003, B ENVIRON CONTAM TOX, V70, P1013, DOI 10.1007/s00128-003-0083-4; Kanno H. K., 1981, P BRIGHT CROP PROT C, P56; Katzung BG, 1992, BASIC CLIN PHARM, P1017; Marimuthu K., 2001, Naga, V24, P21; Marimuthu K, 2012, INFOFISH INT, V4, P28; Marimuthu K., 2000, FISHING CHIMES, V19, P105; MARTY GD, 1990, AQUAT TOXICOL, V17, P45, DOI 10.1016/0166-445X(90)90011-D; Nasr HM, 2010, PESTIC BIOCHEM PHYS, V98, P198, DOI 10.1016/j.pestbp.2010.06.007; NRA, 2001, EV NEW ACT BUPR PROD; OH HS, 1991, AM SOC TEST MATER, V1124, P343, DOI 10.1520/STP23584S; Rendon-von Osten, 2005, CHEMOSPHERE, V58, P627, DOI 10.1016/j.chemosphere.2004.08.065; SCHOOTS AFM, 1983, DEV BIOL, V100, P59, DOI 10.1016/0012-1606(83)90200-2; SVENSSON BG, 1994, INT ARCH OCC ENV HEA, V65, P351, DOI 10.1007/BF00383243; TAKIMOTO Y, 1984, J PESTIC SCI, V9, P463; Toscano NC, 2001, J ECON ENTOMOL, V94, P1538, DOI 10.1603/0022-0493-94.6.1538; Zhu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046286	32	34	34	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75545	10.1371/journal.pone.0075545	http://dx.doi.org/10.1371/journal.pone.0075545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098390	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600020
J	Bienenstock, J; Buck, RH; Linke, H; Forsythe, P; Stanisz, AM; Kunze, WA				Bienenstock, John; Buck, Rachael H.; Linke, Hawley; Forsythe, Paul; Stanisz, Andrew M.; Kunze, Wolfgang A.			Fucosylated but Not Sialylated Milk Oligosaccharides Diminish Colon Motor Contractions	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; LONG-TERM POTENTIATION; BREAST-FED INFANTS; IN-VITRO; URINARY-EXCRETION; BOVINE-MILK; VAGUS NERVE; FED BABIES; FUCOSE; EXPRESSION	Human milk oligosaccharides (HMO) are being studied by different groups exploring a broad range of potential beneficial effects to the breastfed infant. Many of these effects have been attributed to a growth promotion effect on certain gut organisms such as bifidobacteria. Additionally, evidence indicates that HMO are able to directly promote positive changes in gut epithelium and immune responses under certain conditions. This study utilizes a standardized ex vivo murine colon preparation to examine the effects of sialylated, fucosylated and other HMO on gut motor contractions. Only the fucosylated molecules, 2'FL and 3'FL, decreased contractility in a concentration dependent fashion. On the basis of IC50 determinations 3'FL was greater than 2 times more effective than 2'FL. The HMO 3'SL and 6'SL, lacto-N-neotetraose (LNnT), and galactooligosaccharides (GOS) elicited no effects. Lactose was used as a negative control. Fucosylation seems to underlie this functional regulation of gut contractility by oligosaccharides, and L-fucose, while it was also capable of reducing contractility, was substantially less effective than 3'FL and 2'FL. These results suggest that specific HMO are unlikely to be having these effects via bifidogenesis, but though direct action on neuronally dependent gut migrating motor complexes is likely and fucosylation is important in providing this function, we cannot conclusively shown that this is not indirectly mediated. Furthermore they support the possibility that fucosylated sugars and fucose might be useful as therapeutic or preventative adjuncts in disorders of gut motility, and possibly also have beneficial central nervous system effects.	[Bienenstock, John; Stanisz, Andrew M.; Kunze, Wolfgang A.] St Josephs Healthcare, McMaster Brain Body Inst, Hamilton, ON, Canada; [Buck, Rachael H.; Linke, Hawley] Abbott Nutr, Columbus, OH USA; [Bienenstock, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Forsythe, Paul] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Forsythe, Paul] Firestone Inst Resp Hlth, Hamilton, ON, Canada; [Kunze, Wolfgang A.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Kunze, Wolfgang A.] Farncombe Family Digest Hlth Inst, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Bienenstock, J (corresponding author), St Josephs Healthcare, McMaster Brain Body Inst, Hamilton, ON, Canada.	bienens@mcmaster.ca			Abbott Nutrition; Giovanni and Concetta Giulietti Family Foundation; St Joseph's Healthcare Hamilton Foundation; NSERC [371513-2009, 371955-2009]	Abbott Nutrition(Abbott Laboratories); Giovanni and Concetta Giulietti Family Foundation; St Joseph's Healthcare Hamilton Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported in part by a research grant from Abbott Nutrition who had no involvement in the conduct or execution of the project or the analysis of the data. Support was also provided by the The Giovanni and Concetta Giulietti Family Foundation, St Joseph's Healthcare Hamilton Foundation, NSERC 371513-2009 (PF) and NSERC 371955-2009 (WAK). The funders also had no role in study design or data collection, decision to publish, or preparation of the manuscript, but reviewed it before submission.	Albrecht S, 2011, CARBOHYD RES, V346, P2540, DOI 10.1016/j.carres.2011.08.009; Albrecht S, 2011, CARBOHYD RES, V346, P2173, DOI 10.1016/j.carres.2011.06.034; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; BABA T, 1979, J IMMUNOL, V122, P838; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; Chichlowski M, 2012, J PEDIATR GASTR NUTR, V55, P321, DOI 10.1097/MPG.0b013e31824fb899; Chow WL, 2008, BRIT J NUTR, V99, P449, DOI 10.1017/S0007114507812062; COPPA GV, 1993, PEDIATRICS, V91, P637; Coppa GV, 2001, ADV EXP MED BIOL, V501, P307; Cote M, 2011, BRAIN BEHAV IMMUN, V25, P1143, DOI 10.1016/j.bbi.2011.02.017; de Kivit S, 2011, EUR J PHARMACOL, V668, pS124, DOI 10.1016/j.ejphar.2011.05.086; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Gensel JC, 2012, CELL TISSUE RES, V349, P201, DOI 10.1007/s00441-012-1425-5; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gnoth MJ, 2001, J BIOL CHEM, V276, P34363, DOI 10.1074/jbc.M104805200; Jantscher-Krenn E, 2012, BR J NUTR, P1; Keating C, 2010, TOXICOL APPL PHARM, V245, P299, DOI 10.1016/j.taap.2010.03.014; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Kuntz S, 2009, BRIT J NUTR, V101, P1306, DOI 10.1017/S0007114508079622; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Mao YK, 2013, NATURE COMM IN PRESS; Mao YK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2478; Matthies H, 1996, BRAIN RES, V725, P276, DOI 10.1016/0006-8993(96)00406-4; Matthies H, 2000, LEARN MEMORY, V7, P227, DOI 10.1101/lm.7.4.227; MCCABE NR, 1985, NEUROCHEM RES, V10, P1083, DOI 10.1007/BF00965883; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Nelson ED, 2012, NUTR NEUROSCI, V15, P149, DOI 10.1179/1476830512Y.0000000004; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; POHLE W, 1987, BRAIN RES, V410, P245, DOI 10.1016/0006-8993(87)90321-0; PRIETO PA, 1995, J BIOL CHEM, V270, P29515, DOI 10.1074/jbc.270.49.29515; Prieto PA, 2005, FOODS FOODS INGREDIE, V219, P1018; ROCKLIN RE, 1976, J IMMUNOL, V116, P816; Rudloff S, 1996, ACTA PAEDIATR, V85, P598, DOI 10.1111/j.1651-2227.1996.tb14095.x; Rudloff S, 2012, BRIT J NUTR, V107, P957, DOI 10.1017/S0007114511004016; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sarna SK, 2007, AM J PHYSIOL-GASTR L, V292, pG572, DOI 10.1152/ajpgi.00332.2006; Sela DA, 2012, APPL ENVIRON MICROB, V78, P795, DOI 10.1128/AEM.06762-11; Sotgiu S, 2006, Int J Biomed Sci, V2, P114; Sundekilde UK, 2012, J AGR FOOD CHEM, V60, P6188, DOI 10.1021/jf300015j; Wang BX, 2010, FASEB J, V24, P4078, DOI 10.1096/fj.09-153841; Wu RY, 2013, NEUROGASTROENT MOTIL, V25, pE205, DOI 10.1111/nmo.12072; Zivkovic AM, 2011, ADV NUTR, V2, P284, DOI 10.3945/an.111.000455	48	52	54	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76236	10.1371/journal.pone.0076236	http://dx.doi.org/10.1371/journal.pone.0076236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098451	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500055
J	Lin, H; Liu, XB; Yu, JJ; Hua, F; Hu, ZW				Lin, Heng; Liu, Xiao-bo; Yu, Jiao-jiao; Hua, Fang; Hu, Zhuo-wei			Antioxidant N-Acetylcysteine Attenuates Hepatocarcinogenesis by Inhibiting ROS/ER Stress in TLR2 Deficient Mouse	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TOLL-LIKE RECEPTORS; HEPATOCELLULAR-CARCINOMA; COMPENSATORY PROLIFERATION; ADENOMATOUS HYPERPLASIA; OXIDATIVE STRESS; AUTOPHAGIC FLUX; LIVER; CANCER; TUMORIGENESIS	Hepatocellular carcinoma (HCC) remains one of the most deadly solid tumor malignancies worldwide. We recently find that the loss of toll-like receptor 2 (TLR2) activities promotes the diethylnitrosamine (DEN) induced hepatocellular carcinogenesis and tumor progression, which associates with an abundant accumulation of reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress. This finding suggests that the ROS/ER stress plays a role in TLR2 modulated carcinogenesis of HCC. To investigate the mechanism of TLR2 activity defending against hepatocarcinogenesis, the TLR2-deficient mice were treated with or without antioxidant N-acetylcysteine (NAC) before DEN administration. We found that pretreatment of these animals with NAC attenuated carcinogenesis and progression of HCC in the TLR2-deficient mice, declined ROS/ER stress, and alleviated the unfold protein response and inflammatory response in TLR2-deficient liver tissue. Moreover, the NAC treatment significantly reduced the enhanced aggregation of p62 and Mallory-Denk bodies in the DEN-induced HCC liver tissue, suggesting that NAC treatment improves the suppressive autophagic flux in the TLR2-deficient liver. These findings indicate that TLR2 activity defends against hepatocarcinogenesis through diminishing the accumulation of ROS and alleviating ER stress and unfold protein response mediated inflammatory response in the liver.	[Hu, Zhuo-wei] Peking Union Med Coll, Beijing Key Lab New Drug Mech & Pharmacol Evaluat, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Grp,Inst Mat Med, Beijing 100021, Peoples R China; Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Hu, ZW (corresponding author), Peking Union Med Coll, Beijing Key Lab New Drug Mech & Pharmacol Evaluat, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Grp,Inst Mat Med, Beijing 100021, Peoples R China.	huzhuowei@imm.ac.cn		Liu, Xiaobo/0000-0002-8256-6002	National Natural Science Foundation of China [30973557, 81101595]; National Natural Science Foundation [81030056]; International Corporation Project; Ministry of Science and Technology [2010DFB32900]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1007]; Institute of Materia Medica [2013CHX17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); International Corporation Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Institute of Materia Medica	This work was supported by grants from the National Natural Science Foundation of China (30973557), the Major Program of the National Natural Science Foundation (81030056), the International Corporation Project supported by the Ministry of Science and Technology (2010DFB32900), and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, No. IRT1007). Dr. Fang Hua is supported by a grant from the National Natural Science Foundation of China (81101595). Dr. Heng Lin is supported by a grant from the Basic Research Program of the Institute of Materia Medica (2013CHX17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardag-Gorce F, 2010, EXP MOL PATHOL, V88, P376, DOI 10.1016/j.yexmp.2010.02.004; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Junjie Xie, 2012, BMC Cancer, V12, P57, DOI 10.1186/1471-2407-12-57; Kimbro K, 2009, RECENT PAT ANTI-CANC, V4, P189, DOI 10.2174/157489209789206904; Kudo M, 2009, J GASTROENTEROL, V44, P112, DOI 10.1007/s00535-008-2274-6; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Lin H, 2013, HEPATOLOGY, V57, P171, DOI 10.1002/hep.25991; Lin H, 2012, AUTOPHAGY, V8, P1859, DOI 10.4161/auto.22094; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marra M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-171; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsumura T, 2003, IMMUNOLOGY, V109, P127, DOI 10.1046/j.1365-2567.2003.01627.x; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nischalke HD, 2012, INT J CANCER, V130, P1470, DOI 10.1002/ijc.26143; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; SAKAMOTO M, 1991, HUM PATHOL, V22, P172, DOI 10.1016/0046-8177(91)90039-R; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Schneider C, 2004, GUT, V53, P355, DOI 10.1136/gut.2003.026005; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Shingu K, 2003, AM J RESP CELL MOL, V28, P316, DOI 10.1165/rcmb.2002-0106OC; Sia D, 2011, ONCOLOGY-BASEL, V81, P18, DOI 10.1159/000333254; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; Wang ZY, 2013, AUTOPHAGY, V9, P925, DOI 10.4161/auto.24229; Wang ZY, 2013, HEPATOLOGY, V57, P1869, DOI 10.1002/hep.26234; Yan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024705; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	41	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74130	10.1371/journal.pone.0074130	http://dx.doi.org/10.1371/journal.pone.0074130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098333	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500011
J	Mielecki, D; Saumaa, S; Wrzesinski, M; Maciejewska, AM; Zuchniewicz, K; Sikora, A; Piwowarski, J; Nieminuszczy, J; Kivisaar, M; Grzesiuk, E				Mielecki, Damian; Saumaa, Signe; Wrzesinski, Michal; Maciejewska, Agnieszka M.; Zuchniewicz, Karolina; Sikora, Anna; Piwowarski, Jan; Nieminuszczy, Jadwiga; Kivisaar, Maia; Grzesiuk, Elzbieta			Pseudomonas putida AlkA and AlkB Proteins Comprise Different Defense Systems for the Repair of Alkylation Damage to DNA - In Vivo, In Vitro, and In Silico Studies	PLOS ONE			English	Article							STATIONARY-PHASE MUTAGENESIS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; ADAPTIVE RESPONSE; ADA PROTEIN; 3-METHYLADENINE DNA; TRANSCRIPTIONAL ACTIVATION; OXIDATIVE DEMETHYLATION; CHROMOSOMAL INSERTION; GLYCOSYLASE-II	Alkylating agents introduce cytotoxic and/or mutagenic lesions to DNA bases leading to induction of adaptive (Ada) response, a mechanism protecting cells against deleterious effects of environmental chemicals. In Escherichia coli, the Ada response involves expression of four genes: ada, alkA, alkB, and aidB. In Pseudomonas putida, the organization of Ada regulon is different, raising questions regarding regulation of Ada gene expression. The aim of the presented studies was to analyze the role of AlkA glycosylase and AlkB dioxygenase in protecting P. putida cells against damage to DNA caused by alkylating agents. The results of bioinformatic analysis, of survival and mutagenesis of methyl methanesulfonate (MMS) or N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) treated P. putida mutants in ada, alkA and alkB genes as well as assay of promoter activity revealed diverse roles of Ada, AlkA and AlkB proteins in protecting cellular DNA against alkylating agents. We found AlkA protein crucial to abolish the cytotoxic but not the mutagenic effects of alkylans since: (i) the mutation in the alkA gene was the most deleterious for MMS/MNNG treated P. putida cells, (ii) the activity of the alkA promoter was Ada-dependent and the highest among the tested genes. P. putida AlkB (PpAlkB), characterized by optimal conditions for in vitro repair of specific substrates, complementation assay, and M13/MS2 survival test, allowed to establish conservation of enzymatic function of P. putida and E. coli AlkB protein. We found that the organization of P. putida Ada regulon differs from that of E. coli. AlkA protein induced within the Ada response is crucial for protecting P. putida against cytotoxicity, whereas Ada prevents the mutagenic action of alkylating agents. In contrast to E. coli AlkB (EcAlkB), PpAlkB remains beyond the Ada regulon and is expressed constitutively. It probably creates a backup system that protects P. putida strains defective in other DNA repair systems against alkylating agents of exo-and endogenous origin.	[Mielecki, Damian; Wrzesinski, Michal; Maciejewska, Agnieszka M.; Zuchniewicz, Karolina; Sikora, Anna; Piwowarski, Jan; Nieminuszczy, Jadwiga; Grzesiuk, Elzbieta] Polish Acad Sci, Inst Biochem & Biophys, Dept Mol Biol, Warsaw, Poland; [Saumaa, Signe; Kivisaar, Maia] Univ Tartu, Dept Genet, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Tartu	Kivisaar, M (corresponding author), Univ Tartu, Dept Genet, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	maia.kivisaar@ut.ee; elag@ibb.waw.pl	Sikora, Anna/Y-4216-2019; Maciejewska, Agnieszka M/B-2287-2012; Wrzesiński, Michał/H-4820-2011	Sikora, Anna/0000-0002-9464-6851; Wrzesiński, Michał/0000-0002-6092-9431; Grzesiuk, Elzbieta/0000-0002-7833-7602; Maciejewska, Agnieszka M./0000-0002-1268-2606; Zuchniewicz, Karolina/0000-0002-7097-4025; Mielecki, Damian/0000-0003-2929-4500	National Center of Science, Poland [UMO-2012/05/B/NZ1/00693]; Estonian Science Foundation [9114]; Estonian Ministry of Research Targeted Financing Project [SF0180031s08]	National Center of Science, Poland; Estonian Science Foundation; Estonian Ministry of Research Targeted Financing Project	This work was funded by National Center of Science, Poland, grant number UMO-2012/05/B/NZ1/00693 to AS, DM, MW, and EG; by Estonian Science Foundation, grant number 9114 to MK, and by Estonian Ministry of Research Targeted Financing Project SF0180031s08 to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Abella M, 2004, MOL MICROBIOL, V54, P212, DOI 10.1111/j.1365-2958.2004.04260.x; Abril N, 1996, CARCINOGENESIS, V17, P1609, DOI 10.1093/carcin/17.8.1609; Adams MH, 1959, BACTERIOPHAGES; AKIMARU H, 1990, J MOL BIOL, V216, P261, DOI 10.1016/S0022-2836(05)80318-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BACHMANN BJ, 1987, ESCHERICHIA COLI SAL; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BAYLEY SA, 1977, MOL GEN GENET, V154, P203, DOI 10.1007/BF00330838; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; CLARKE PH, 1982, A VAN LEEUW J MICROB, V48, P105, DOI 10.1007/BF00405197; DEHENESTROSA ARF, 1991, J BACTERIOL, V173, P7736, DOI 10.1128/jb.173.23.7736-7740.1991; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Erill I, 2006, NUCLEIC ACIDS RES, V34, P66, DOI 10.1093/nar/gkj412; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; HAKURA A, 1991, J BACTERIOL, V173, P3663, DOI 10.1128/JB.173.12.3663-3672.1991; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Horak R, 2004, MOL MICROBIOL, V54, P795, DOI 10.1111/j.1365-2958.2004.04311.x; Iyer LM, 2001, GENOME BIOL, V2; Kivisaar M, 2010, FEMS MICROBIOL LETT, V312, P1, DOI 10.1111/j.1574-6968.2010.02027.x; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; Koorits L, 2007, DNA REPAIR, V6, P863, DOI 10.1016/j.dnarep.2007.01.010; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Landini P, 1998, J BIOL CHEM, V273, P13307, DOI 10.1074/jbc.273.21.13307; LANDINI P, 1995, J BIOL CHEM, V270, P8285, DOI 10.1074/jbc.270.14.8285; Landini P, 2000, J BACTERIOL, V182, P6543, DOI 10.1128/JB.182.23.6543-6549.2000; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leiros I, 2007, EMBO J, V26, P2206, DOI 10.1038/sj.emboj.7601662; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Maciejewska AM, 2013, J BIOL CHEM, V288, P432, DOI 10.1074/jbc.M112.353342; Maciejewska AM, 2011, MUTAGENESIS, V26, P401, DOI 10.1093/mutage/geq107; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margison GP, 2007, DNA REPAIR, V6, P1222, DOI 10.1016/j.dnarep.2007.03.014; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Mielecki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030588; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Moe E, 2012, ACTA CRYSTALLOGR D, V68, P703, DOI 10.1107/S090744491200947X; MOROHOSHI F, 1995, MUTAT RES-DNA REPAIR, V337, P97, DOI 10.1016/0921-8777(95)00013-A; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nieminuszczy J, 2006, DNA REPAIR, V5, P181, DOI 10.1016/j.dnarep.2005.09.007; Nieminuszczy J, 2007, ACTA BIOCHIM POL, V54, P459, DOI 10.18388/abp.2007_3221; Nieminuszczy J, 2009, ENVIRON MOL MUTAGEN, V50, P791, DOI 10.1002/em.20497; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; PAVEL H, 1994, J BACTERIOL, V176, P7550, DOI 10.1128/JB.176.24.7550-7557.1994; Regenhardt D, 2002, ENVIRON MICROBIOL, V4, P912, DOI 10.1046/j.1462-2920.2002.00368.x; Rippa V, 2011, DNA REPAIR, V10, P934, DOI 10.1016/j.dnarep.2011.06.001; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; SAGET BM, 1994, P NATL ACAD SCI USA, V91, P9730, DOI 10.1073/pnas.91.21.9730; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; SEDGWICK B, 1992, CANCER RES, V52, P3693; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; SEDGWICK B, 1991, MUTAT RES, V250, P211, DOI 10.1016/0027-5107(91)90178-Q; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; TAKAHASHI K, 1988, J BIOL CHEM, V263, P13490; Taverna P, 1996, J BACTERIOL, V178, P5105, DOI 10.1128/jb.178.17.5105-5111.1996; TEO I, 1986, CELL, V45, P315, DOI 10.1016/0092-8674(86)90396-X; Terato H, 2002, NUCLEIC ACIDS RES, V30, P4975, DOI 10.1093/nar/gkf630; Timmis KN, 1999, TRENDS BIOTECHNOL, V17, P201, DOI 10.1016/S0167-7799(98)01295-5; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wong SM, 2000, P NATL ACAD SCI USA, V97, P10191, DOI 10.1073/pnas.97.18.10191	72	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76198	10.1371/journal.pone.0076198	http://dx.doi.org/10.1371/journal.pone.0076198			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098441	Green Submitted, gold, Green Published			2022-12-27	WOS:000325434500049
J	Sun, M; Gao, ZQ; Zhao, WF; Deng, LF; Deng, Y; Zhao, HM; Ren, AX; Li, G; Yang, ZP				Sun, Min; Gao, ZhiQiang; Zhao, WeiFeng; Deng, LianFeng; Deng, Yan; Zhao, HongMei; Ren, AiXia; Li, Gang; Yang, ZhenPing			Effect of Subsoiling in Fallow Period on Soil Water Storage and Grain Protein Accumulation of Dryland Wheat and Its Regulatory Effect by Nitrogen Application	PLOS ONE			English	Article							CONSERVATION TILLAGE; RESIDUE MANAGEMENT; USE EFFICIENCY; LONG-TERM; LOESS PLATEAU; PROLINE ACCUMULATION; YIELD; FERTILIZATION; STRESS; CHINA	To provide a new way to increase water storage and retention of dryland wheat, a field study was conducted at Wenxi experimental site of Shanxi Agricultural University. The effect of subsoiling in fallow period on soil water storage, accumulation of proline, and formation of grain protein after anthesis were determined. Our results showed that subsoiling in fallow period could increase water storage in the 0-300 cm soil at pre-sowing stage and at anthesis stage with low or medium N application, especially for the 60-160 cm soil. However, the proline content, glutamine synthetase (GS) activity, glutamate dehydrogenase (GDH) activity in flag leaves and grains were all decreased by subsoiling in fallow period. In addition, the content of albumin, gliadin, and total protein in grains were also decreased while globulin content, Glu/Gli, protein yield, and glutelin content were increased. With N application increasing, water storage of soil layers from 20 to 200 cm was decreased at anthesis stage. High N application resulted in the increment of proline content and GS activity in grains. Besides, correlation analysis showed that soil storage in 40-160 cm soil was negatively correlated with proline content in grains; proline content in grains was positively correlated with GS and GDH activity in flag leaves. Contents of albumin, globulin and total protein in grains were positively correlated with proline content in grains and GDH activity in flag leaves. In conclusion, subsoiling in fallow period, together with N application at 150 kg.hm(-2), was beneficial to increase the protein yield and Glu/Gli in grains which improve the quality of wheat.	[Sun, Min; Gao, ZhiQiang; Zhao, WeiFeng; Deng, LianFeng; Deng, Yan; Zhao, HongMei; Ren, AiXia; Li, Gang; Yang, ZhenPing] Shanxi Agr Univ, Coll Crop Sci, Taigu, Shanxi Province, Peoples R China	Shanxi Agricultural University	Gao, ZQ (corresponding author), Shanxi Agr Univ, Coll Crop Sci, Taigu, Shanxi Province, Peoples R China.	sm_sunmin@126.com			Modern Agriculture Industry Technology System Construction [CARS-03-01-24]; NSFC (Natural Science Foundation of China) [31101112]; Scientific Research Project of Shanxi Province for Returned Oversea Students [2009037]; Youth Fund of Shanxi Province [2010021028-3]; Shanxi Province for Scientific and Technical Key Projects [20110311001-4]	Modern Agriculture Industry Technology System Construction; NSFC (Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Shanxi Province for Returned Oversea Students; Youth Fund of Shanxi Province; Shanxi Province for Scientific and Technical Key Projects	This work was supported by Modern Agriculture Industry Technology System Construction [CARS-03-01-24]; NSFC (Natural Science Foundation of China) [31101112]; Scientific Research Project of Shanxi Province for Returned Oversea Students [2009037]; Youth Fund of Shanxi Province [2010021028-3]; and the assistance from Shanxi Province for Scientific and Technical Key Projects [20110311001-4]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Baumhardt RL, 2002, SOIL TILL RES, V68, P71, DOI 10.1016/S0167-1987(02)00097-1; Baumhardt RL, 2002, SOIL TILL RES, V65, P19, DOI 10.1016/S0167-1987(01)00273-2; BHAGAT RM, 1994, SOIL TILL RES, V29, P323, DOI 10.1016/0167-1987(94)90106-6; BLEVINS RL, 1993, ADV AGRON, V51, P33, DOI 10.1016/S0065-2113(08)60590-8; BLUM A, 1983, AGR WATER MANAGE, V7, P195, DOI 10.1016/0378-3774(83)90083-5; DAY AD, 1971, AGRON J, V63, P115, DOI 10.2134/agronj1971.00021962006300010035x; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; [邓志英 DENG ZhiYing], 2006, [生态学报, Acta Ecologica Sinica], V26, P2757; Fan TL, 2005, AGR ECOSYST ENVIRON, V106, P313, DOI 10.1016/j.agee.2004.09.003; Fan XueMei, 2004, Acta Phytoecologica Sinica, V28, P680; Fu Xue-li, 2008, Yingyong Shengtai Xuebao, V19, P317; Halvorson AD, 2004, AGRON J, V96, P1196, DOI 10.2134/agronj2004.1196; Huang MB, 2003, SOIL TILL RES, V72, P95, DOI 10.1016/S0167-1987(03)00065-5; Huang YL, 2005, AGR WATER MANAGE, V72, P209, DOI 10.1016/j.agwat.2004.09.012; Ireland R. J, 1999, ENZYMES GLUTAMINE GL; Jiang Dong, 2004, Acta Agronomica Sinica, V30, P175; Johansson E, 2001, CEREAL CHEM, V78, P19, DOI 10.1094/CCHEM.2001.78.1.19; LAL R, 1989, SOIL TILL RES, V14, P359, DOI 10.1016/0167-1987(89)90055-X; Lu BB, 2005, PLANT SCI, V169, P295, DOI 10.1016/j.plantsci.2004.09.031; Maiorana M, 2001, J AGR ENG RES, V79, P231, DOI 10.1006/jaer.2000.0693; MORIN J, 1984, SOIL TILL RES, V4, P215, DOI 10.1016/0167-1987(84)90021-7; Reynolds M, 2005, AGRON J, V97, P1062; Shipitalo MJ, 2000, SOIL TILL RES, V53, P167, DOI 10.1016/S0167-1987(99)00104-X; Sijtsma CH, 1998, SOIL TILL RES, V49, P223, DOI 10.1016/S0167-1987(98)00175-5; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; Sun Min, 2010, Acta Agronomica Sinica, V36, P486, DOI 10.3724/SP.J.1006.2010.00486; Verslues PE, 2006, J EXP BOT, V57, P201, DOI 10.1093/jxb/erj026; Wang XB, 2006, PEDOSPHERE, V16, P587, DOI 10.1016/S1002-0160(06)60092-1; Wang ZQ, 2007, J PLANT PHYSIOL, V164, P695, DOI 10.1016/j.jplph.2006.05.001; Xu D., 2000, J SOIL WATER CONSERV, V14, P64; Zhao BQL, 1997, ACTA AGRONOMICA SINI, V5; Zhao Hui, 2007, Acta Agronomica Sinica, V33, P2021; Zhu J, 1999, CEREAL CHEM, V76, P915, DOI 10.1094/CCHEM.1999.76.6.915; Zhu W, 1997, MAICHA FIELD CROPS, V4, P26	35	19	22	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75191	10.1371/journal.pone.0075191	http://dx.doi.org/10.1371/journal.pone.0075191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098371	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500024
J	Ferranti, F; D'Anselmi, F; Caruso, M; Lei, V; Dinicola, S; Pasqualato, A; Cucina, A; Palombo, A; Ricci, G; Catizone, A; Bizzarri, M				Ferranti, Francesca; D'Anselmi, Fabrizio; Caruso, Maria; Lei, Vittorio; Dinicola, Simona; Pasqualato, Alessia; Cucina, Alessandra; Palombo, Alessandro; Ricci, Giulia; Catizone, Angela; Bizzarri, Mariano			TCam-2 Seminoma Cells Exposed to Egg-Derived Microenvironment Modify Their Shape, Adhesive Pattern and Migratory Behaviour: A Molecular and Morphometric Analysis	PLOS ONE			English	Article							CARCINOMA-IN-SITU; TUMOR MICROENVIRONMENT; EMBRYONIC-DEVELOPMENT; MATURATION ARREST; FRACTAL ANALYSIS; CELLULAR-ORIGIN; E-CADHERIN; CANCER; TESTIS; CONNEXIN-43	Seminoma is one of the most common Testicular Germ Cell Tumours that originates during embryonic development due to an alteration of the local niche that in turn results in a delayed or blocked differentiation of Primordial Germ Cells. The block of differentiation is actually a common way to develop cancer disease as postulated by the "embryonic rest theory of cancer". In agreement with this theory different studies have demonstrated that embryonic cues display the capacity of reprogramming aggressive cancer cells towards a less aggressive phenotype. Herein we investigate the ability of a culture medium added with 10% egg albumen (EW, Egg White) to modulate seminoma cell phenotype and behaviour, by ensuring a proper set of morphogenetic signals. We chose to use the TCam-2 seminoma cell line that has been established as the only available cell line, obtained from a primary testicular seminoma. EW is able to: 1) modify TCam-2 cell spreading rate and cell-substrate adhesion without affecting proliferation and survival indexes; 2) modulate TCam-2 actin distribution pattern increasing cortical localization of actin filaments; 3) increase TCam-2 cell-cell junction capability; 4) decrease both chemo-sensitive and collective TCam-2 migratory behaviour. According to these observations morphometric fractal analysis revealed the ability of EW to increase Circularity and Solidity parameters and, consequently, to decrease Fractal dimension. Prompted by these observations we hypothesize that EW treatment could rescue, at least in part, the neoplastic-metastatic behaviour of seminoma cells.	[Ferranti, Francesca; Caruso, Maria; Catizone, Angela] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Sect Histol & Med Embryol, I-00185 Rome, Italy; [D'Anselmi, Fabrizio; Cucina, Alessandra] Univ Roma La Sapienza, Dept Surg PietroValdoni, I-00185 Rome, Italy; [D'Anselmi, Fabrizio; Palombo, Alessandro; Bizzarri, Mariano] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Lei, Vittorio] Farnia Srl, Rome, Italy; [Dinicola, Simona] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00185 Rome, Italy; [Pasqualato, Alessia] G DAnnunzio Univ Chieti Pescara, Dept Neurosci & Imaging, Sect Physiol & Physiopathol, Chieti, Italy; [Ricci, Giulia] Univ Naples 2, Dept Expt Med, Naples, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; Universita della Campania Vanvitelli	Ricci, G (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	giulia.ricci@unina2.it	Tavecchia, Giacomo/N-3961-2014; Bizzarri, Mariano/U-8300-2017; Tanferna, Alessandro/L-6648-2015; Preatoni, Damiano G./A-8621-2010; Ricci, Giulia/AAO-1856-2020; Sergio, Fabrizio/B-3952-2015; Blas, Julio/A-2487-2012	Tavecchia, Giacomo/0000-0001-5435-2691; Bizzarri, Mariano/0000-0003-0408-4136; Tanferna, Alessandro/0000-0003-0799-301X; Preatoni, Damiano G./0000-0001-8760-1316; Ricci, Giulia/0000-0002-2199-170X; Sergio, Fabrizio/0000-0002-8024-1773; Blas, Julio/0000-0003-0589-3322; ferranti, francesca/0000-0002-4648-4069; catizone, angela/0000-0002-7836-9495; Cucina, Alessandra/0000-0001-5469-6419; caruso, maria/0000-0002-6221-1108	PRIN [2008NE3XPK_002]; Ateneo Federato [C26F09AHLB]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ateneo Federato	The present study was supported by PRIN 2008 - Angela Catizone (grant number 2008NE3XPK_002; http://sito.cineca.it/) and by Ateneo Federato 2009 - Angela Catizone (grant number C26F09AHLB; http://uniroma1.cineca.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bizzarri M, 2011, SEMIN CANCER BIOL, V21, P175, DOI 10.1016/j.semcancer.2011.04.002; Brehm R, 2006, NEOPLASIA, V8, P499, DOI 10.1593/neo.05847; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Cucina A, 2006, APOPTOSIS, V11, P1617, DOI 10.1007/s10495-006-8895-4; D'Anselmi F, 2011, INT J BIOCHEM CELL B, V43, P1052, DOI 10.1016/j.biocel.2010.05.002; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; Di Florio A, 2007, ENDOCR-RELAT CANCER, V14, P111, DOI 10.1677/erc.1.01318; Eckert D, 2008, CELL TISSUE RES, V331, P529, DOI 10.1007/s00441-007-0527-y; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferranti F, 2012, INT J ANDROL, V35, P758, DOI 10.1111/j.1365-2605.2012.01267.x; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Goddard NC, 2007, INT J ANDROL, V30, P337, DOI 10.1111/j.1365-2605.2007.00769.x; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Honecker F, 2004, J PATHOL, V204, P167, DOI 10.1002/path.1614; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Lee JT, 2006, NAT MED, V12, P882, DOI 10.1038/nm0806-882; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Looijenga LHJ, 2010, BEST PRACT RES CL EN, V24, P291, DOI 10.1016/j.beem.2009.10.002; Mann K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-7; McSherry EA, 2007, CELL MOL LIFE SCI, V64, P3201, DOI 10.1007/s00018-007-7388-0; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; PIERCE GB, 1982, CANCER RES, V42, P1082; Pointis G, 2005, TRENDS ENDOCRIN MET, V16, P300, DOI 10.1016/j.tem.2005.07.001; Qiu N, 2012, J PROTEOMICS, V75, P1895, DOI 10.1016/j.jprot.2011.12.037; RISLEY MS, 1992, J CELL SCI, V103, P81; Risley MS, 2000, BIOL REPROD, V62, P748, DOI 10.1095/biolreprod62.3.748; Roger C, 2004, J PATHOL, V202, P241, DOI 10.1002/path.1509; Rohrschneider M, 2007, P ANN INT IEEE EMBS, P6272; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; SELL S, 1994, LAB INVEST, V70, P6; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Siu MKY, 2003, ENDOCRINOLOGY, V144, P2141, DOI 10.1210/en.2002-221035; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Steger K, 1999, HISTOCHEM CELL BIOL, V112, P215, DOI 10.1007/s004180050409; TIMMER A, 1994, AM J PATHOL, V144, P1035; Ulbright TM, 2005, MODERN PATHOL, V18, pS61, DOI 10.1038/modpathol.3800310; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76192	10.1371/journal.pone.0076192	http://dx.doi.org/10.1371/journal.pone.0076192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098438	gold, Green Submitted, Green Published			2022-12-27	WOS:000325427100045
J	Jiang, W; Fang, YJ; Wu, XJ; Wang, FL; Lu, ZH; Zhang, RX; Ding, PR; Fan, WH; Pan, ZZ; Wan, DS				Jiang, Wu; Fang, Yu-Jing; Wu, Xiao-Jun; Wang, Fu-Long; Lu, Zhen-Hai; Zhang, Rong-Xin; Ding, Pei-Rong; Fan, Wen-Hua; Pan, Zhi-Zhong; Wan, De-Sen			Intraoperative Blood Loss Independently Predicts Survival and Recurrence after Resection of Colorectal Cancer Liver Metastasis	PLOS ONE			English	Article							HEPATIC METASTASES; TRANSFUSIONS; HEMORRHAGE	Background: Although numerous prognostic factors have been reported for colorectal cancer liver metastasis (CRLM), few studies have reported intraoperative blood loss (IBL) effects on clinical outcome after CRLM resection. Methods: We retrospectively evaluated the clinical and histopathological characteristics of 139 patients who underwent liver resection for CRLM. The IBL cutoff volume was calculated using receiver operating characteristic curves. Overall survival (OS) and recurrence free survival (RFS) were assessed using the Kaplan-Meier and Cox regression methods. Results: All patients underwent curative resection. The median follow up period was 25.0 months (range, 2.1-88.8). Body mass index (BMI) and CRLM number and tumor size were associated with increased IBL. BMI (P=0.01; 95% CI = 1.3-8.5) and IBL (P<0.01; 95% CI = 1.6-12.5) were independent OSOs predictors. Five factors, including IBL (P=0.02; 95% CI = 1.1-4.1), were significantly related to RFS via multivariate Cox regression analysis. In addition, OSOs and RFS significantly decreased with increasing IBL volumes. The 5-year OSOs of patients with IBL <= 250, 250-500, and >500mL were 71%, 33%, and 0%, respectively (P<0.01). RFS of patients within three IBL volumes at the end of the first year were 67%, 38%, and 18%, respectively (P<0.01). Conclusions: IBL during CRLM resection is an independent predictor of long term survival and tumor recurrence, and its prognostic value was confirmed by a dose-response relationship.	[Jiang, Wu; Fang, Yu-Jing; Wu, Xiao-Jun; Wang, Fu-Long; Lu, Zhen-Hai; Zhang, Rong-Xin; Ding, Pei-Rong; Fan, Wen-Hua; Pan, Zhi-Zhong; Wan, De-Sen] Sun Yat Sen Univ, Dept Colorectal Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Yu-Jing] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Wu; Fang, Yu-Jing; Wu, Xiao-Jun; Wang, Fu-Long; Lu, Zhen-Hai; Zhang, Rong-Xin; Ding, Pei-Rong; Fan, Wen-Hua; Pan, Zhi-Zhong; Wan, De-Sen] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Pan, ZZ (corresponding author), Sun Yat Sen Univ, Dept Colorectal Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	panzhzh@sysucc.org.cn; wds@medmail.com.cn			National Natural Science Foundation of the Republic of China [81101861]; Doctoral Fund of the Ministry of Education of China [20110171120100]; Natural Science Foundation of Guangdong Province, China [S2012010011132]	National Natural Science Foundation of the Republic of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of the Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of the Republic of China (Grant No. 81101861) and the Doctoral Fund of the Ministry of Education of China (Grant No. 20110171120100) to Dr. Yu-Jing Fang, the Natural Science Foundation of Guangdong Province, China (Grant No. S2012010011132) to Dr. Xiao-Jun Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71; ABRAHAM E, 1986, CIRC SHOCK, V18, P205; ABRAHAM E, 1984, ARCH SURG-CHICAGO, V119, P1154; Achavanuntakul K, 2012, ARCH GYNECOL OBSTET, V286, P1001, DOI 10.1007/s00404-012-2387-2; Acheson AG, 2012, ANN SURG, V256, P235, DOI 10.1097/SLA.0b013e31825b35d5; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; BUSCH ORC, 1993, NEW ENGL J MED, V328, P1372, DOI 10.1056/NEJM199305133281902; Fernandez FG, 2004, ANN SURG, V240, P438, DOI 10.1097/01.sla.0000138076.72547.b1; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; Kohne CH, 2010, ANN ONCOL, V21, P134, DOI 10.1093/annonc/mdq374; Leo C, 2004, SEMIN RADIAT ONCOL, V14, P207, DOI 10.1016/j.semradonc.2004.04.007; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R; Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d; Qiu HB, 2011, WORLD J GASTROENTERO, V17, P804, DOI 10.3748/wjg.v17.i6.804; Quan D, 2012, SURGERY, V151, P860, DOI 10.1016/j.surg.2011.12.018; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Reynolds TY, 1996, CANCER RES, V56, P5754; TARTTER PI, 1992, ANN SURG, V216, P633, DOI 10.1097/00000658-199212000-00004; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; WAGNER JS, 1984, ANN SURG, V199, P502, DOI 10.1097/00000658-198405000-00002; Wood C B, 1976, Clin Oncol, V2, P285; Yan TD, 2007, ANN SURG ONCOL, V14, P2069, DOI 10.1245/s10434-007-9388-6; YOUNES RN, 1991, ANN SURG, V214, P107, DOI 10.1097/00000658-199108000-00003	25	25	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76125	10.1371/journal.pone.0076125	http://dx.doi.org/10.1371/journal.pone.0076125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098431	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100043
J	Nascimbene, J; Marini, L; Ivan, D; Zottini, M				Nascimbene, Juri; Marini, Lorenzo; Ivan, Diego; Zottini, Michela			Management Intensity and Topography Determined Plant Diversity in Vineyards	PLOS ONE			English	Article							SPECIES-DIVERSITY; GRASSLANDS; RICHNESS; MEADOWS	Vineyards are amongst the most intensive forms of agriculture often resulting in simplified landscapes where semi-natural vegetation is restricted to small scattered patches. However, a tendency toward a more sustainable management is stimulating research on biodiversity in these poorly investigated agro-ecosystems. The main aim of this study was to test the effect on plant diversity of management intensity and topography in vineyards located in a homogenous intensive hilly landscape. Specifically, this study evaluated the role of slope, mowing and herbicide treatments frequency, and nitrogen supply in shaping plant diversity and composition of life-history traits. The study was carried out in 25 vineyards located in the area of the Conegliano-Valdobbiadene DOCG (Veneto, NE Italy). In each vineyard, 10 plots were placed and the abundance of all vascular plants was recorded in each plot. Linear multiple regression was used to test the effect of management and topography on plant diversity. Management intensity and topography were both relevant drivers of plant species diversity patterns in our vineyards. The two most important factors were slope and mowing frequency that respectively yielded positive and negative effects on plant diversity. A significant interaction between these two factors was also demonstrated, warning against the detrimental effects of increasing mowing intensity on steep slope where plant communities are more diverse. The response of plant communities to mowing frequency is mediated by a process of selection of resistant growth forms, such in the case of rosulate and reptant species. The other two management-related factors tested in this study, number of herbicide treatments and N fertilization, were less influential. In general, our study corroborates the idea that some simple changes in farming activities, which are compatible with grape production, should be encouraged for improving the natural and cultural value of the landscape by maintaining and improving wild plant diversity.	[Nascimbene, Juri; Ivan, Diego; Zottini, Michela] Univ Padua, Dept Biol, Padua, Italy; [Marini, Lorenzo] Univ Padua, DAFNAE Dept Agron, Padua, Italy	University of Padua; University of Padua	Nascimbene, J (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	junasc@libero.it	Zottini, Michela/Y-3763-2019; Marini, Lorenzo/B-1119-2009	Marini, Lorenzo/0000-0001-7429-7685; zottini, michela/0000-0001-8930-2969	Veneto Region (Mis. 124 PSR Veneto)	Veneto Region (Mis. 124 PSR Veneto)	This research was conducted in the framework of the "Biodivigna" project funded by the Veneto Region (Mis. 124 PSR Veneto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JD, 1975, OECOLOGIA, V18, P359, DOI 10.1007/BF00345855; Arlettaz R, 2012, J ORNITHOL, V153, P229, DOI 10.1007/s10336-011-0737-7; BALME OE, 1953, J ECOL, V41, P331, DOI 10.2307/2257045; Bennie J, 2006, J ECOL, V94, P355, DOI 10.1111/j.1365-2745.2006.01104.x; Bruggisser OT, 2010, BIOL CONSERV, V143, P1521, DOI 10.1016/j.biocon.2010.03.034; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Catorci A, 2011, POL J ECOL, V59, P115; Drobnik J, 2011, AGR ECOSYST ENVIRON, V145, P29, DOI 10.1016/j.agee.2010.12.021; Gago P, 2007, CROP PROT, V26, P584, DOI 10.1016/j.cropro.2006.05.012; Gillespie M, 2012, J INSECT CONSERV, V16, P13, DOI 10.1007/s10841-011-9390-y; Kramberger B, 2008, POL J ECOL, V56, P33; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Marini L, 2008, BASIC APPL ECOL, V9, P365, DOI 10.1016/j.baae.2007.06.011; Marini L, 2008, J APPL ECOL, V45, P361, DOI 10.1111/j.1365-2664.2007.01402.x; Nascimbene J, 2012, ENVIRON MANAGE, V49, P1054, DOI 10.1007/s00267-012-9834-5; Pignatti S, 1982, BOLOGNA EDAGRICOLE, V1-3, P2302; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Sanguankeo PP, 2011, WEED RES, V51, P404, DOI 10.1111/j.1365-3180.2011.00853.x; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Zechmeister HG, 2003, BIOL CONSERV, V114, P165, DOI 10.1016/S0006-3207(03)00020-X	22	25	25	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76167	10.1371/journal.pone.0076167	http://dx.doi.org/10.1371/journal.pone.0076167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098435	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100044
J	Sitkiewicz, E; Tarnowski, K; Poznanski, J; Kulma, M; Dadlez, M				Sitkiewicz, Ewa; Tarnowski, Krzysztof; Poznanski, Jaroslaw; Kulma, Magdalena; Dadlez, Michal			Oligomerization Interface of RAGE Receptor Revealed by MS-Monitored Hydrogen Deuterium Exchange	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; DITYROSINE CROSS-LINKS; AMYLOID-BETA; ALZHEIMERS-DISEASE; CELL-SURFACE; PATTERN-RECOGNITION; SIGNAL-TRANSDUCTION; SOLUBLE RECEPTOR; STRUCTURAL BASIS; PROTEINS	Activation of the receptor for advanced glycation end products ( RAGE) leads to a chronic proinflammatory signal, affecting patients with a variety of diseases. Potentially beneficial modification of RAGE activity requires understanding the signal transduction mechanism at the molecular level. The ligand binding domain is structurally uncoupled from the cytoplasmic domain, suggesting receptor oligomerization is a requirement for receptor activation. In this study, we used hydrogen-deuterium exchange and mass spectrometry to map structural differences between the monomeric and oligomeric forms of RAGE. Our results indicated the presence of a region shielded from exchange in the oligomeric form of RAGE and led to the identification of a new oligomerization interface localized at the linker region between domains C1 and C2. Based on this finding, a model of a RAGE dimer and higher oligomeric state was constructed.	[Sitkiewicz, Ewa; Tarnowski, Krzysztof; Poznanski, Jaroslaw; Kulma, Magdalena; Dadlez, Michal] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Dadlez, Michal] Warsaw Univ, Dept Biol, Inst Genet & Biotechnol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Dadlez, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	michald@ibb.waw.pl	Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Sitkiewicz, Ewa/0000-0002-9511-8575; Dadlez, Michal/0000-0001-8811-5176	Foundation for Polish Science TEAM program [TEAM/2011-7/1]; CEPT [POIG.02.02.00-14-024/08-00]; NanoFun [POIGT.02.02.00-00-025/09-00]; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy [CRP/08/011]	Foundation for Polish Science TEAM program; CEPT; NanoFun; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy	Financial support was received from the Foundation for Polish Science TEAM program (TEAM/2011-7/1), CEPT (POIG.02.02.00-14-024/08-00), and NanoFun (POIGT.02.02.00-00-025/09-00). The molecular modeling was partially supported by grant CRP/08/011 (to JP) from the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH R, 1976, BIOCHIM BIOPHYS ACTA, V439, P292, DOI 10.1016/0005-2795(76)90064-7; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Brady JD, 1996, BIOCHEM J, V315, P323, DOI 10.1042/bj3150323; Brady JD, 1998, PHYTOCHEMISTRY, V47, P349, DOI 10.1016/S0031-9422(97)00592-X; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen X, 2007, CURR MOL MED, V7, P735; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Endrizzi BJ, 2006, LANGMUIR, V22, P11305, DOI 10.1021/la0618216; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kloniecki M, 2011, J MOL BIOL, V407, P110, DOI 10.1016/j.jmb.2011.01.012; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kupniewska-Kozak A, 2010, J MOL BIOL, V403, P52, DOI 10.1016/j.jmb.2010.08.027; L-J Yan, 2009, CURRENT PROTOCOLS PR, DOI DOI 10.1002/0471140864.PS1404S55.ACCESSED; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454; Marcsisin SR, 2010, ANAL BIOANAL CHEM, V397, P967, DOI 10.1007/s00216-010-3556-4; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Sarkany Z, 2011, J BIOL CHEM, V286, P37525, DOI 10.1074/jbc.M111.223438; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Sevillano N, 2009, J BIOCHEM, V145, P21, DOI 10.1093/jb/mvn137; Sousa MM, 2000, LAB INVEST, V80, P1101, DOI 10.1038/labinvest.3780116; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; van Zoelen Marieke A D, 2011, Front Biosci (Schol Ed), V3, P1119; Win MTT, 2012, EXP DIABETES RES, DOI 10.1155/2012/894605; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	60	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76353	10.1371/journal.pone.0076353	http://dx.doi.org/10.1371/journal.pone.0076353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098480	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100061
J	Wang, C; Qiu, WY; Zheng, YQ; Li, H; Li, YJ; Feng, B; Guo, S; Yan, L; Cao, JM				Wang, Chen; Qiu, Wenying; Zheng, Yiqing; Li, Hui; Li, Yijia; Feng, Bing; Guo, Shu; Yan, Li; Cao, Ji-Min			Extraneuronal Monoamine Transporter Mediates the Permissive Action of Cortisol in the Guinea Pig Trachea: Possible Involvement of Tracheal Chondrocytes	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN BRONCHIAL ARTERIAL; NOREPINEPHRINE TRANSPORTER; NONGENOMIC ACTIONS; HUMAN SPERM; IN-VITRO; ASTHMA; RAT; FAMOTIDINE; AIRWAY	Cortisol, a member of glucocorticoids, could potentiate the action of catecholamine by a non-genomic mechanism. Although this permissive effect has been well appreciated in the anti-asthmatic medication, the underlying signaling pathway has remained mysterious. Here, we show that extraneuronal monoamine transporter (EMT), a membraneous reuptake transporter for circulating catecholamine clearance, is the direct target of cortisol in its permissive effect. We found that BSA-conjugated cortisol, which functions as a cortisol but cannot penetrate cell membrane, enhanced the spasmolytic effect of beta-adrenoceptor agonist (isoprenaline) in histamine-sensitized tracheal spirals of guinea pigs, and pharmacological inhibition of EMT with famotidine was powerful enough to imitate the permissive action of cortisol. To our surprise, EMT protein expression was high in the chondrocytes of tracheal cartilage, but was undetectable in tracheal smooth muscle cells. The functionality of EMT was further confirmed with measurement of catecholamine uptake by tracheal chondrocytes. Moreover, cortisol-initiated membrane signaling could activate protein kinase C (PKC), which phosphorylates EMT and induces its internalization via a lipid raft-dependent pathway. Both of the mechanisms slow down the reuptake process by chondrocytes, leading to extracellular catecholamine accumulation and results in a more profound adrenergic signaling activation in tracheal smooth muscle cells. Thus, an EMT-centered pathway was proposed to explain the permissive action of cortisol. Collectively, our results highlight the role of EMT in the crosstalk between glucocorticoid and catecholamine. EMT may represent a promising target for adrenergic signaling modulation.	[Wang, Chen; Zheng, Yiqing; Li, Yijia; Feng, Bing] Peking Union Med Coll, Dept Med, Chinese Acad Med Sci, Beijing 100021, Peoples R China; [Qiu, Wenying] Peking Union Med Coll, Dept Anat Histol & Embryol, Inst Basic Med Sci, Chinese Acad Med Sci,Sch Basic Med, Beijing 100021, Peoples R China; [Li, Hui; Guo, Shu; Yan, Li; Cao, Ji-Min] Peking Union Med Coll, Dept Physiol & Pathophysiol, Inst Basic Med Sci, Chinese Acad Med,Sci Sch Basic Med, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cao, JM (corresponding author), Peking Union Med Coll, Dept Physiol & Pathophysiol, Inst Basic Med Sci, Chinese Acad Med,Sci Sch Basic Med, Beijing 100021, Peoples R China.	caojimin@126.com	Li, Yijia/AAD-6744-2022; Wang, Chen/ABF-4024-2020	Li, Yijia/0000-0001-5300-0571; Wang, Chen/0000-0003-4055-7391	grants of Scientific Research and Entrepreneurship for Undergraduates in Beijing City; Natural Science Foundation of China (NSFC) [81071072]	grants of Scientific Research and Entrepreneurship for Undergraduates in Beijing City; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants of Scientific Research and Entrepreneurship for Undergraduates in Beijing City, and a grant (81071072 to JMC) from the Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNING EN, 1979, BRIT J PHARMACOL, V65, P175, DOI 10.1111/j.1476-5381.1979.tb07816.x; BACHMANN K, 1995, J CLIN PHARMACOL, V35, P529, DOI 10.1002/j.1552-4604.1995.tb04100.x; Bai J, 2008, CAN J PHYSIOL PHARM, V86, P700, DOI [10.1139/Y08-075, 10.1139/y08-075]; Bourdet DL, 2005, J PHARMACOL EXP THER, V315, P1288, DOI 10.1124/jpet.105.091223; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Choi JS, 2009, LUNG, V187, P165, DOI 10.1007/s00408-009-9142-x; Chu XP, 2007, J ETHNOPHARMACOL, V111, P490, DOI 10.1016/j.jep.2006.12.013; Contopoulos-Ioannidis DG, 2005, J ALLERGY CLIN IMMUN, V115, P963, DOI 10.1016/j.jaci.2004.12.1119; DeLano WL, 2002, PYMOL USERS MANUAL; DELATORRE JC, 1976, HISTOCHEMISTRY, V49, P81, DOI 10.1007/BF00495672; DRAZEN JM, 1978, J CLIN INVEST, V61, P1441, DOI 10.1172/JCI109063; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; HOLGATE ST, 1989, J ALLERGY CLIN IMMUN, V83, P537, DOI 10.1016/0091-6749(89)90035-3; Horvath G., 2003, Archives of Physiology and Biochemistry, V111, P341; Horvath G, 2003, AM J PHYSIOL-LUNG C, V285, pL829, DOI 10.1152/ajplung.00054.2003; Horvath G, 2001, AM J RESP CELL MOL, V25, P500, DOI 10.1165/ajrcmb.25.4.4559; Horvath G, 2011, PULM PHARMACOL THER, V24, P654, DOI 10.1016/j.pupt.2011.08.002; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; IVERSEN LL, 1965, BRIT J PHARM CHEMOTH, V25, P18, DOI 10.1111/j.1476-5381.1965.tb01753.x; IVERSEN LL, 1970, BRIT J PHARMACOL, V40, P528, DOI 10.1111/j.1476-5381.1970.tb10637.x; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; KALSNER S, 1969, CIRC RES, V24, P383, DOI 10.1161/01.RES.24.3.383; Kino T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003333; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kummer W, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-65; LIN JH, 1987, BRIT J CLIN PHARMACO, V24, P669, DOI 10.1111/j.1365-2125.1987.tb03228.x; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Matsuse H, 2001, J ALLERGY CLIN IMMUN, V108, P715, DOI 10.1067/mai.2001.118791; Menger GJ, 2007, PHYSIOL GENOMICS, V29, P280, DOI 10.1152/physiolgenomics.00199.2006; MONTESANO R, 1979, P NATL ACAD SCI USA, V76, P6391, DOI 10.1073/pnas.76.12.6391; Nelson HS, 2003, J ALLERGY CLIN IMMUN, V112, P29, DOI 10.1067/mai.2003.1558; ODONNELL SR, 1976, BRIT J PHARMACOL, V57, P369, DOI 10.1111/j.1476-5381.1976.tb07675.x; ODONNELL SR, 1983, BRIT J PHARMACOL, V78, P417, DOI 10.1111/j.1476-5381.1983.tb09406.x; ODONNELL SR, 1984, N-S ARCH PHARMACOL, V325, P54, DOI 10.1007/BF00507054; ODONNELL SR, 1973, BRIT J PHARMACOL, V49, P267, DOI 10.1111/j.1476-5381.1973.tb08372.x; Richman JG, 1998, AM J PHYSIOL-CELL PH, V274, pC654, DOI 10.1152/ajpcell.1998.274.3.C654; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Saito Y, 2001, INTERNAL MED, V40, P643, DOI 10.2169/internalmedicine.40.643; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Wang C, 2012, RESP PHYSIOL NEUROBI, V183, P10, DOI 10.1016/j.resp.2012.05.008; Yamauchi K, 2011, YAKUGAKU ZASSHI, V131, P185, DOI 10.1248/yakushi.131.185	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76193	10.1371/journal.pone.0076193	http://dx.doi.org/10.1371/journal.pone.0076193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098439	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100046
J	Laws, TR; Nelson, M; Bonnafous, C; Sicard, H; Taylor, C; Salguero, FJ; Atkins, TP; Oyston, PCF; Rowland, CA				Laws, Thomas R.; Nelson, Michelle; Bonnafous, Cecile; Sicard, Helene; Taylor, Christopher; Salguero, Francisco Javier; Atkins, Timothy P.; Oyston, Petra C. F.; Rowland, Caroline A.			In Vivo Manipulation of gamma 9(+) T Cells in the Common Marmoset (Callithrix Jacchus) with Phosphoantigen and Effect on the Progression of Respiratory Melioidosis	PLOS ONE			English	Article							LETHAL INHALATIONAL INFECTION; BURKHOLDERIA-PSEUDOMALLEI; FRANCISELLA-TULARENSIS; INTRACELLULAR MULTIPLICATION; MYCOBACTERIUM-TUBERCULOSIS; BRUCELLA-SUIS; MODEL; ACTIVATION; RESPONSES; VITRO	Burkholderia pseudomallei is a dangerous human pathogen. Phosphoantigens specifically the target primate specific gamma 9(+)delta 2(+) T cells subset and some have been developed as potential immunotherapeutics. Previously, we demonstrated that, when stimulated with the phosphoantigen CHDMAPP, gamma 9(+)delta 2(+) T cells aid in the killing of intracellular B. pseudomallei bacteria. Moreover, we found that common marmoset (Callithrix Jacchus) gamma 9(+) T cells increase in frequency and respond to the phosphoantigen CHDMAPP and/or B. pseudomallei, in combination with IL-2, in a similar manner to human gamma 9(+) delta 2(+) T cells. Here we evaluate the efficacy of the phosphoantigen CHDMAPP, in combination with IL-2, as a therapy against B. pseudomallei infection, in vivo. We found that the previous studies predicted the in vivo responsiveness of gamma 9(+) T cells to the CHDMAPP+IL-2 treatment and significant expansion of the numbers of peripheral and splenic gamma 9(+) T cells were observed. This effect was similar to those reported in other primate species treated with phosphoantigen. Furthermore, splenocytes were retrieved 7 days post onset of treatment, restimulated with CHDMAPP or heat-killed B. pseudomallei and the cultured gamma 9(+) T cells demonstrated no reduction in IFN-gamma response when CHDMAPP+IL-2 animals were compared to IL-2 only treated animals. Using an established model of B. pseudomallei infection in the marmoset, we assessed the potential for using phosphoantigen as a novel immunotherapy. The CHDMAPP treatment regime had no effect on the progression of respiratory melioidosis and this was despite the presence of elevated numbers of gamma 9(+) T cells in the spleen, liver and lung and an increased proportion of IFN-gamma(+) cells in response to infection. We therefore report that the common marmoset has proven a good model for studying the effect in vivo of gamma 9(+) T cell stimulation; however, gamma 9(+) T cells have little or no effect on the progression of lethal, respiratory B. pseudomallei infection.	[Laws, Thomas R.; Nelson, Michelle; Taylor, Christopher; Atkins, Timothy P.; Oyston, Petra C. F.; Rowland, Caroline A.] Def Sci & Technol Lab DSTL Porton Down, Dept Biomed Sci, Salisbury, Wilts, England; [Bonnafous, Cecile; Sicard, Helene] Innate Pharma, Marseille, France; [Salguero, Francisco Javier] AHVLA, Weybridge, Surrey, England		Rowland, CA (corresponding author), Def Sci & Technol Lab DSTL Porton Down, Dept Biomed Sci, Salisbury, Wilts, England.	carowland@dstl.gov.uk	Salguero, Francisco J/A-7336-2010; Laws, Thomas/L-2935-2018	Laws, Thomas/0000-0002-0142-9162; Salguero, Francisco Javier/0000-0002-5315-3882	British Ministry of Defence	British Ministry of Defence	This work was funded by the British Ministry of Defence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2011, AIDS REV, V13, P3; Ali Z, 2007, J IMMUNOL, V179, P8287, DOI 10.4049/jimmunol.179.12.8287; Ali Z, 2009, J IMMUNOL, V183, P5407, DOI 10.4049/jimmunol.0901760; Boedec A, 2008, J MED CHEM, V51, P1747, DOI 10.1021/jm701101g; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chierakul W, 2005, CLIN INFECT DIS, V41, P982, DOI 10.1086/432942; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dieli F, 2000, EUR J IMMUNOL, V30, P1512, DOI 10.1002/(SICI)1521-4141(200005)30:5<1512::AID-IMMU1512>3.0.CO;2-3; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Elkins KL, 2010, MICROBES INFECT, V12, P28, DOI 10.1016/j.micinf.2009.09.012; Gioia C, 2002, J IMMUNOL, V168, P1484, DOI 10.4049/jimmunol.168.3.1484; Gong GM, 2009, BLOOD, V113, P837, DOI 10.1182/blood-2008-06-162792; Huang D, 2008, INFECT IMMUN, V76, P426, DOI 10.1128/IAI.01008-07; Huang D, 2009, P NATL ACAD SCI USA, V106, P7553, DOI 10.1073/pnas.0811250106; INNATE Pharma, 2009, IPH1101 HCV PHAS 2A; JouenBeades F, 1997, INFECT IMMUN, V65, P4267, DOI 10.1128/IAI.65.10.4267-4272.1997; Lever MS, 2008, INT J EXP PATHOL, V89, P171, DOI 10.1111/j.1365-2613.2008.00581.x; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; Nelson M, 2011, INT J EXP PATHOL, V92, P428, DOI 10.1111/j.1365-2613.2011.00791.x; Nelson M, 2010, J MED MICROBIOL, V59, P1107, DOI 10.1099/jmm.0.020669-0; Nelson M, 2009, INT J EXP PATHOL, V90, P109, DOI 10.1111/j.1365-2613.2008.00631.x; Ottones F, 2000, IMMUNOLOGY, V100, P252, DOI 10.1046/j.1365-2567.2000.00024.x; Ottones F, 2000, J IMMUNOL, V165, P7133, DOI 10.4049/jimmunol.165.12.7133; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Poquet Y, 1998, INFECT IMMUN, V66, P2107, DOI 10.1128/IAI.66.5.2107-2114.1998; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; RAJCHANUVONG A, 1995, T ROY SOC TROP MED H, V89, P546, DOI 10.1016/0035-9203(95)90104-3; Rowland CA, 2006, INFECT IMMUN, V74, P5333, DOI 10.1128/IAI.02046-05; Rowland CA, 2012, CELL IMMUNOL, V280, P132, DOI 10.1016/j.cellimm.2012.12.002; Rowland CA, 2012, MICROBES INFECT, V14, P584, DOI 10.1016/j.micinf.2012.02.001; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Shao LY, 2009, J VIROL, V83, P11959, DOI 10.1128/JVI.00689-09; Sicard H, 2005, J IMMUNOL, V175, P5471, DOI 10.4049/jimmunol.175.8.5471; Smither S.J., 2012, INT J EXP PATH UNPUB; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yeager JJ, 2012, INFECT IMMUN, V80, P3332, DOI 10.1128/IAI.00675-12	37	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74789	10.1371/journal.pone.0074789	http://dx.doi.org/10.1371/journal.pone.0074789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098670	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500041
J	Skelsey, P; With, KA; Garrett, KA				Skelsey, Peter; With, Kimberly A.; Garrett, Karen A.			Pest and Disease Management: Why We Shouldn't Go against the Grain	PLOS ONE			English	Article							POTATO LATE BLIGHT; PHYTOPHTHORA-INFESTANS; DISPERSAL KERNELS; SPATIAL-PATTERN; SPATIOTEMPORAL MODEL; ANIMAL MOVEMENT; SPREAD; BACTERIA; DYNAMICS; TOMATO	Given the wide range of scales and mechanisms by which pest or disease agents disperse, it is unclear whether there might exist a general relationship between scale of host heterogeneity and spatial spread that could be exploited by available management options. In this model-based study, we investigate the interaction between host distributions and the spread of pests and diseases using an array of models that encompass the dispersal and spread of a diverse range of economically important species: a major insect pest of coniferous forests in western North America, the mountain pine beetle (Dendroctonus ponderosae); the bacterium Pseudomonas syringae, one of the most-widespread and best-studied bacterial plant pathogens; the mosquito Culex erraticus, an important vector for many human and animal pathogens, including West Nile Virus; and the oomycete Phytophthora infestans, the causal agent of potato late blight. Our model results reveal an interesting general phenomenon: a unimodal ('humpbacked') relationship in the magnitude of infestation (an index of dispersal or population spread) with increasing grain size (i.e., the finest scale of patchiness) in the host distribution. Pest and disease management strategies targeting different aspects of host pattern (e.g., abundance, aggregation, isolation, quality) modified the shape of this relationship, but not the general unimodal form. This is a previously unreported effect that provides insight into the spatial scale at which management interventions are most likely to be successful, which, notably, do not always match the scale corresponding to maximum infestation. Our findings could provide a new basis for explaining historical outbreak events, and have implications for biosecurity and public health preparedness.	[Skelsey, Peter] James Hutton Inst, Dundee, Scotland; [With, Kimberly A.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Garrett, Karen A.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	James Hutton Institute; Kansas State University; Kansas State University	Skelsey, P (corresponding author), James Hutton Inst, Dundee, Scotland.	peter.skelsey@hutton.ac.uk	With, Kimberly/AAA-2637-2021; With, Kimberly/J-5124-2014; Skelsey, Peter/L-7786-2013	With, Kimberly/0000-0001-5570-1515; Skelsey, Peter/0000-0002-7316-1951	Scottish Government; National Science Foundation-National Institutes of Health Ecology of Infectious Disease program [EF-0525712]	Scottish Government; National Science Foundation-National Institutes of Health Ecology of Infectious Disease program	This research was supported by the Scottish Government and by the National Science Foundation-National Institutes of Health Ecology of Infectious Disease program (EF-0525712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JC, 2001, CHAOS SOLITON FRACT, V12, P333, DOI 10.1016/S0960-0779(00)00092-8; ANDERSEN M, 1991, MATH BIOSCI, V104, P135, DOI 10.1016/0025-5564(91)90034-G; Aylor DE, 2003, ECOLOGY, V84, P1989, DOI 10.1890/01-0619; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Bianchi FJJA, 2009, BIOL CONTROL, V50, P267, DOI 10.1016/j.biocontrol.2009.04.014; BIDLINGMAYER WL, 1994, J AM MOSQUITO CONTR, V10, P272; Birch PRJ, 2001, MOL PLANT PATHOL, V2, P257, DOI 10.1046/j.1464-6722.2001.00073.x; Blochl F, 2007, THESIS U REGENSBURG; Bock CH, 2012, PLANT PATHOL, V61, P829, DOI 10.1111/j.1365-3059.2011.02588.x; BOURKE PMA, 1964, NATURE, V203, P805, DOI 10.1038/203805a0; Brewster CC, 1997, ENVIRON ENTOMOL, V26, P473, DOI 10.1093/ee/26.3.473; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; BUTTERWORTH J, 1991, J APPL BACTERIOL, V71, P484, DOI 10.1111/j.1365-2672.1991.tb03822.x; Centers for Disease Control and Prevention, 2012, 2012 W NIL VIR UPD S; Cevallos-Cevallos JM, 2012, INT J FOOD MICROBIOL, V160, P58, DOI 10.1016/j.ijfoodmicro.2012.09.021; Cevallos-Cevallos JM, 2012, J FOOD PROTECT, V75, P472, DOI 10.4315/0362-028X.JFP-11-399; Chen HP, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00172.1; Chipperfield JD, 2011, METHODS ECOL EVOL, V2, P668, DOI 10.1111/j.2041-210X.2011.00117.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; CRANS W J, 1986, Bulletin of the Society of Vector Ecologists, V11, P178; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Devroye L., 1986, NONUNIFORM RANDOM VA; Duncan J., 1999, Microbiology Today, V26, P114; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Evans HC, 2010, PLANT PATH 21ST, P53, DOI 10.1007/978-1-4020-8932-9_5; FADDOUL GP, 1965, AVIAN DIS, V9, P530, DOI 10.2307/1588135; Fahse L, 2011, ECOL MODEL, V222, P1833, DOI 10.1016/j.ecolmodel.2011.03.014; FERRANDINO FJ, 1993, PHYTOPATHOLOGY, V83, P795, DOI 10.1094/Phyto-83-795; Finckh MR, 2008, EUR J PLANT PATHOL, V121, P399, DOI 10.1007/s10658-008-9273-6; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; GILLIES MT, 1969, B ENTOMOL RES, V59, P441, DOI 10.1017/S0007485300003412; Graham John H., 2011, International Journal of Ecology, V2011, P1; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hastings A, 2012, ENCY THEORETICAL ECO, Vxxiv; HAYES RO, 1962, AM J TROP MED HYG, V11, P115, DOI 10.4269/ajtmh.1962.11.115; Heavilin J, 2008, NAT RESOUR MODEL, V21, P489, DOI 10.1111/j.1939-7445.2008.00021.x; Jacob BG, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-12; Keitt TH, 2000, LANDSCAPE ECOL, V15, P479, DOI 10.1023/A:1008193015770; KOT M, 1986, MATH BIOSCI, V80, P109, DOI 10.1016/0025-5564(86)90069-6; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Kuuluvainen T, 2000, J VEG SCI, V11, P801, DOI 10.2307/3236550; LETSON GW, 1993, AM J TROP MED HYG, V49, P677, DOI 10.4269/ajtmh.1993.49.677; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Lutaladio N, 2009, J FOOD COMPOS ANAL, V22, P491, DOI 10.1016/j.jfca.2009.05.002; Madden L.V., 2007, STUDY PLANT DIS EPID; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; May F, 2013, ECOGRAPHY, V36, P842, DOI 10.1111/j.1600-0587.2012.07793.x; Mizubuti ESG, 2000, PHYTOPATHOLOGY, V90, P78, DOI 10.1094/PHYTO.2000.90.1.78; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Mundt CC, 2011, ECOL APPL, V21, P321, DOI 10.1890/10-1004.1; Mundt CC, 2009, AM NAT, V173, P456, DOI 10.1086/597220; O'neill J. R., 2009, IRISH POTATO FAMINE; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; PETERSON CJ, 1995, J ECOL, V83, P847, DOI 10.2307/2261421; Press W. H., 1992, ART SCI COMPUTING; Reynolds A, 2013, LECT NOTES MATH, V2071, P53, DOI 10.1007/978-3-642-35497-7_3; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; SHAW MW, 1995, P ROY SOC B-BIOL SCI, V259, P243, DOI 10.1098/rspb.1995.0036; Shenge KC, 2007, PLANT DIS, V91, P462, DOI 10.1094/PDIS-91-4-0462C; Skelsey P, 2009, AGR FOREST METEOROL, V149, P419, DOI 10.1016/j.agrformet.2008.09.005; Skelsey P, 2008, AGR FOREST METEOROL, V148, P1383, DOI 10.1016/j.agrformet.2008.04.006; Skelsey P, 2005, PHYTOPATHOLOGY, V95, P328, DOI 10.1094/PHYTO-95-0328; Skelsey P, 2009, PHYTOPATHOLOGY, V99, P887, DOI 10.1094/PHYTO-99-7-0887; Skelsey P, 2009, PHYTOPATHOLOGY, V99, P290, DOI 10.1094/PHYTO-99-3-0290; Skelsey P, 2013, THEOR ECOL-NETH, V6, P203, DOI 10.1007/s12080-012-0171-3; Skelsey P, 2010, PHYTOPATHOLOGY, V100, P1146, DOI 10.1094/PHYTO-06-09-0148; Slone DH, 2011, ECOL MODEL, V222, P573, DOI 10.1016/j.ecolmodel.2010.11.023; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Voss R. F., 1985, FUNDAMENTAL ALGORITH, P805; Winder Richard S., 2010, Journal of the Entomological Society of British Columbia, V107, P43; With KA, 2004, RISK ANAL, V24, P803, DOI 10.1111/j.0272-4332.2004.00480.x; With KA, 1997, OIKOS, V79, P219, DOI 10.2307/3546007; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; Zadoks JC, 2008, POTATO RES, V51, P5, DOI 10.1007/s11540-008-9091-4	81	8	8	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75892	10.1371/journal.pone.0075892	http://dx.doi.org/10.1371/journal.pone.0075892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098739	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500110
J	Slapeta, J; Linares, MC				Slapeta, Jan; Linares, Marjorie C.			Combined Amplicon Pyrosequencing Assays Reveal Presence of the Apicomplexan "type-N" (cf. Gemmocystis cylindrus) and Chromera velia on the Great Barrier Reef, Australia	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; MICROBIAL COMMUNITY; SEQUENCING REVEALS; CORAL; DIVERSITY; DISEASE; WATER; ASSOCIATIONS; PHYLOGENY; PATHOGENS	Background: The coral is predominantly composed of the metabolically dependent coral host and the photosynthetic dinoflagellate Symbiodinium sp. The system as a whole interacts with symbiotic eukaryotes, bacteria and viruses. Gemmocystis cylindrus (cf. "type-N" symbiont) belonging to the obligatory parasitic phylum Apicomplexa (Alveolata) is ubiquitous in the Caribbean coral, but its presence in the Great Barrier Reef coral has yet to be documented. Approaches allowing identification of the healthy community from the pathogenic or saprobic organisms are needed for sustainable coral reef monitoring. Methods & Principal Findings: We investigated the diversity of eukaryotes associated with a common reef-building corals from the southern Great Barrier Reef. We used three tag encoded 454 amplicon pyrosequencing assays targeting eukaryote small-subunit rRNA gene to demonstrate the presence of the apicomplexan type-N and a photosynthetic sister species to Apicomplexa - Chromera velia. Amplicon pyrosequencing revealed presence of the small-subunit rRNA genes of known eukaryotic pathogens (Cryptosporidium and Cryptococcus). We therefore conducted bacterial tag encoded amplicon pyrosequencing assay for small-subunit rRNA gene to support effluent exposure of the coral. Bacteria of faecal origin (Enterobacteriales) formed 41% of total sequences in contrast to 0-2% of the coral-associated bacterial communities with and without C. velia, respectively. Significance: This is the first time apicomplexan type-N has been detected in the Great Barrier Reef. Eukaryote tag encoded amplicon pyrosequencing assays demonstrate presence of apicomplexan type-N and C. Velia in total coral DNA. The data highlight the need for combined approaches for eukaryotic diversity studies coupled with bacterial community assessment to achieve a more realistic goals of defining the holobiont community and assessing coral disease. With increasing evidence of Apicomplexa in coral reef environments, it is important not only to understand the evolution of these organisms but also identify their potential as pathogens.	[Slapeta, Jan] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Linares, Marjorie C.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Slapeta, J (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	jan.slapeta@sydney.edu.au		Slapeta, Jan/0000-0003-1459-9117	Australian Research Council [DP0986372]; School of Molecular Bioscience, University of Sydney	Australian Research Council(Australian Research Council); School of Molecular Bioscience, University of Sydney(University of Sydney)	This study was financially supported by the Australian Research Council, Discovery Project DP0986372. MCL was supported by the WG Murrell International Research Scholarship (School of Molecular Bioscience, University of Sydney). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2011, ISME J, V5, P42, DOI 10.1038/ismej.2010.101; Barta JR, 2006, TRENDS PARASITOL, V22, P463, DOI 10.1016/j.pt.2006.08.001; Bongaerts P, 2011, MAR ECOL PROG SER, V439, P117, DOI 10.3354/meps09315; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Cumbo VR, 2013, PROTIST, V164, P237, DOI 10.1016/j.protis.2012.08.003; DUVAL B, 1995, SYMBIOSIS, V18, P181; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holligan P M, 1975, Symp Soc Exp Biol, P205; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Janouskovec J, 2013, ISME J, V7, P444, DOI 10.1038/ismej.2012.129; Janouskovec J, 2012, CURR BIOL, V22, pR518, DOI 10.1016/j.cub.2012.04.047; Kirk NL, 2013, CORAL REEFS, V32, P847, DOI 10.1007/s00338-013-1038-9; Kumar S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-182; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768; Lee JJ, 2003, J EUKARYOT MICROBIOL, V50, P439, DOI 10.1111/j.1550-7408.2003.tb00270.x; Lee OO, 2012, APPL ENVIRON MICROB, V78, P7173, DOI 10.1128/AEM.01111-12; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lynn DH, 2002, J EUKARYOT MICROBIOL, V49, P460, DOI 10.1111/j.1550-7408.2002.tb00229.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Morin-Adeline V, 2012, FEMS MICROBIOL LETT, V328, P144, DOI 10.1111/j.1574-6968.2011.02489.x; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Robertson LJ, 2007, INT J FOOD MICROBIOL, V120, P201, DOI 10.1016/j.ijfoodmicro.2007.07.058; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Scholthof KBG, 2007, NAT REV MICROBIOL, V5, P152, DOI 10.1038/nrmicro1596; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Slapeta J, 2009, GIARDIA AND CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE, P31, DOI 10.1079/9781845933913.0031; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Sun Y, 2011, METHODS MOL BIOL, V733, P129, DOI 10.1007/978-1-61779-089-8_9; Sweet M, 2012, J MAR BIOL ASSOC UK, V92, P791, DOI 10.1017/S0025315411001688; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toller WW, 2002, CORAL REEFS, V21, P143, DOI 10.1007/s00338-002-0220-2; UPTON SJ, 1986, J INVERTEBR PATHOL, V47, P184, DOI 10.1016/0022-2011(86)90045-5	48	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76095	10.1371/journal.pone.0076095	http://dx.doi.org/10.1371/journal.pone.0076095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098768	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500138
J	Uchitomi, H; Ota, L; Ogawa, K; Orimo, S; Miyake, Y				Uchitomi, Hirotaka; Ota, Leo; Ogawa, Ken-ichiro; Orimo, Satoshi; Miyake, Yoshihiro			Interactive Rhythmic Cue Facilitates Gait Relearning in Patients with Parkinson's Disease	PLOS ONE			English	Article							FRACTAL DYNAMICS; BASAL GANGLIA; MOTOR ACTS; SYNCHRONIZATION; OSCILLATORS; MODEL; PREDICTABILITY; FLUCTUATIONS; COORDINATION; LOCOMOTION	To develop a method for cooperative human gait training, we investigated whether interactive rhythmic cues could improve the gait performance of Parkinson's disease patients. The interactive rhythmic cues ware generated based on the mutual entrainment between the patient's gait rhythms and the cue rhythms input to the patient while the patient walked. Previously, we found that the dynamic characteristics of stride interval fluctuation in Parkinson's disease patients were improved to a healthy 1/f fluctuation level using interactive rhythmic cues and that this effect was maintained in the short term. However, two problems remained in our previous study. First, it was not clear whether the key factor underpinning the effect was the mutual entrainment between the gait rhythms and the cue rhythms or the rhythmic cue fluctuation itself. Second, it was not clear whether or not the gait restoration was maintained longitudinally and was relearned after repeating the cue-based gait training. Thus, the present study clarified these issues using 32 patients who participated in a four-day experimental program. The patients were assigned randomly to one of four experimental groups with the following rhythmic cues: (a) interactive rhythmic cue, (b) fixed tempo cue, (c) 1/f fluctuating tempo cue, and (d) no cue. It has been reported that the 1/f fluctuation of stride interval in healthy gait is absent in Parkinson's disease patients. Therefore, we used this dynamic characteristic as an evaluation index to analyze gait relearning in the four different conditions. We observed a significant effect in condition (a) that the gait fluctuation of the patients gradually returned to a healthy 1/f fluctuation level, whereas this did not occur in the other conditions. This result suggests that the mutual entrainment can facilitate gait relearning effectively. It is expected that interactive rhythmic cues will be widely applicable in the fields of rehabilitation and assistive technology.	[Uchitomi, Hirotaka; Ota, Leo; Ogawa, Ken-ichiro; Miyake, Yoshihiro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Orimo, Satoshi] Kanto Cent Hosp, Dept Neurol, Setagaya Ku, Tokyo, Japan	Tokyo Institute of Technology	Uchitomi, H (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.	uchitomi@myk.dis.titech.ac.jp	Ota, Leo/H-8456-2012	Ota, Leo/0000-0002-1891-5095				Bartsch R, 2007, PHYSICA A, V383, P455, DOI 10.1016/j.physa.2007.04.120; CUNNINGTON R, 1995, BRAIN, V118, P935, DOI 10.1093/brain/118.4.935; Delignieres D, 2009, J APPL PHYSIOL, V106, P1272, DOI 10.1152/japplphysiol.90757.2008; Fisher NI, 1995, STAT ANAL CIRCULAR D; GEORGIOU N, 1994, J NEUROL NEUROSUR PS, V57, P368, DOI 10.1136/jnnp.57.3.368; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; Hasegawa A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00120; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Jankovic JJ, 2006, PARKINSONS DIS MOVEM; Kaipust JP, 2012, ANN BIOMED ENG, V40, P2507; Kello CT, 2010, TRENDS COGN SCI, V14, P223, DOI 10.1016/j.tics.2010.02.005; KOPELL N, 1988, MATH BIOSCI, V90, P87, DOI 10.1016/0025-5564(88)90059-4; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; MATES J, 1994, BIOL CYBERN, V70, P463, DOI 10.1007/BF00203239; Miyake Y, 2004, ACTA NEUROBIOL EXP, V64, P415; Miyake Y., 1994, Proceedings. 3rd IEEE International Workshop on Robot and Human Communication. RO-MAN '94 Nagoya (Cat. No.94TH0679-1), P118, DOI 10.1109/ROMAN.1994.365945; Miyake Y, 1997, IEEE SYS MAN CYBERN, P293, DOI 10.1109/ICSMC.1997.625765; Miyake Y., 2002, T SOC INSTRUMENT CON, VE-2, P195; Miyake Y, 2009, IEEE T ROBOT, V25, P638, DOI 10.1109/TRO.2009.2020350; Muto T, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P1240, DOI 10.1109/ICCME.2007.4381942; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Orlovsky G, 1999, NEURAL CONTROL LOCOM; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schwartze M, 2011, BEHAV BRAIN RES, V216, P685, DOI 10.1016/j.bbr.2010.09.015; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Strogatz S.H., 2003, SYNC EMERGING SCI SP; TAGA G, 1995, BIOL CYBERN, V73, P97, DOI 10.1007/BF00204048; TAGA G, 1991, BIOL CYBERN, V65, P147, DOI 10.1007/BF00198086; Takano K, 2007, NEUROSCI LETT, V417, P196, DOI 10.1016/j.neulet.2007.02.044; Takenaka T, 2006, ADV ENG INFORM, V20, P321, DOI 10.1016/j.aei.2006.01.004; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Thornton TL, 2005, PSYCHON B REV, V12, P409, DOI 10.3758/BF03193785; Uchitomi H, 2012, BIOMEDICAL ENG COGNI, P38; YUASA H, 1990, BIOL CYBERN, V63, P177, DOI 10.1007/BF00195856; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, P1	50	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e72176	10.1371/journal.pone.0072176	http://dx.doi.org/10.1371/journal.pone.0072176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098631	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500003
J	Zhou, Y; Wang, YQ; Schreader, BA; Nambu, JR				Zhou, Ying; Wang, Yiqin; Schreader, Barbara A.; Nambu, John R.			Drosophila Morgue Associates with SkpA and Polyubiquitin In Vivo	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYME; STRUCTURAL BASIS; PROTEIN UBIQUITINATION; BINDING PROTEINS; CELL-DEATH; CHAINS; MELANOGASTER; DEGRADATION; PATHWAY; LIGASES	Morgue is a unique ubiquitination protein that influences programmed cell death and circadian rhythms in Drosophila. We have found that over-expression of wild-type Morgue results in organismal lethality. This over-expression phenotype was used as the basis for an in vivo functional assay to investigate the importance of the Morgue zinc finger, F box, Ubiquitin E2 Conjugase Variant (UEV) domain, and active site Glycine residue. Removal of the zinc finger or UEV domain reduced Morgue's ability to induce lethality and enhance cell death. In contrast, lack of the F box as well as several different substitutions of the active site Glycine did not alter Morgue-induced lethality or cell death enhancement. To further characterize Morgue functions, a Flag: Morgue protein was used to isolate Morgue-associated proteins from whole adult Drosophila. Mass spectrometry analysis of the Morgue-associated proteins identified SkpA as well as a ubiquitin multimer. The identification of SkpA is consistent with previous in vitro studies and further suggests Morgue acts in an SCF-type ubiquitin E3 ligase complex. The identification of poly-ubiquitin was unexpected and this interaction had not been previously identified. The associated poly-ubiquitin was found to exhibit a Lys-48 topology, consistent with distinct functions of Morgue in proteasome-mediated protein turnover. Multiple regions of Morgue were subsequently shown to be required for poly-ubiquitin binding. Overall, Morgue is a novel multi-functional ubiquitin-binding protein.	[Zhou, Ying; Wang, Yiqin; Schreader, Barbara A.; Nambu, John R.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Zhou, Ying; Nambu, John R.] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	University of Massachusetts System; University of Massachusetts Amherst; State University System of Florida; Florida Atlantic University	Nambu, JR (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	jnambu@fau.edu			National Institutes of Health [AG025866]; NATIONAL INSTITUTE ON AGING [R01AG025866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health award AG025866 to JRN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIBAS C, 1986, BIOCHIM BIOPHYS ACTA, V868, P119, DOI 10.1016/0167-4781(86)90014-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hau DD, 2006, BIOCHEMISTRY-US, V45, P9866, DOI 10.1021/bi060631r; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kaiser P, 2005, METHOD ENZYMOL, V399, P266, DOI 10.1016/S0076-6879(05)99018-6; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; LEE HS, 1988, MOL CELL BIOL, V8, P4727, DOI 10.1128/MCB.8.11.4727; Lewis MJ, 2006, J BIOMOL NMR, V34, P89, DOI 10.1007/s10858-005-5583-6; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Metzger MB, 2010, NAT CELL BIOL, V12, P1124, DOI 10.1038/ncb1210-1124; Mohseni N, 2009, AUTOPHAGY, V5, P329, DOI 10.4161/auto.5.3.7444; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PATEL NH, 1994, DROSOPHILA MELANOGAS, V44, P446; Patushok L, 2007, FEBS LETT, V581, P5343; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Schreader BA, 2003, APOPTOSIS, V8, P129, DOI 10.1023/A:1022914524601; Schreader BA, 2010, INT J DEV BIOL, V54, P1425, DOI 10.1387/ijdb.092979bs; SINHA SK, 1981, J BIOL CHEM, V256, P4193; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Trempe JF, 2011, CURR OPIN STRUC BIOL, V21, P792, DOI 10.1016/j.sbi.2011.09.009; Tsui C, 2005, J BIOL CHEM, V280, P19829, DOI 10.1074/jbc.M414060200; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; VAESSIN H, 1994, DEVELOPMENT, V120, P935; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; VanDemark AP, 2002, CURR OPIN STRUC BIOL, V12, P822, DOI 10.1016/S0959-440X(02)00389-5; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhou Y, 2009, MOL BIOL EVOL, V26, P2245, DOI 10.1093/molbev/msp147	50	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74860	10.1371/journal.pone.0074860	http://dx.doi.org/10.1371/journal.pone.0074860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098672	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500043
J	Quinlan, ME; Hirasawa, M				Quinlan, Michelle E.; Hirasawa, Michiru			Multivesicular Release Underlies Short Term Synaptic Potentiation Independent of Release Probability Change in the Supraoptic Nucleus	PLOS ONE			English	Article							OXYTOCIN NEURONS; IN-VITRO; VASOPRESSIN NEURONS; RAT HYPOTHALAMUS; RIBBON SYNAPSE; MAGNOCELLULAR NEURONS; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; LAMINA TERMINALIS; BURSTING ACTIVITY	Magnocellular neurons of the supraoptic nucleus receive glutamatergic excitatory inputs that regulate the firing activity and hormone release from these neurons. A strong, brief activation of these excitatory inputs induces a lingering barrage of tetrodotoxin-resistant miniature EPSCs (mEPSCs) that lasts for tens of minutes. This is known to accompany an immediate increase in large amplitude mEPSCs. However, it remains unknown how long this amplitude increase can last and whether it is simply a byproduct of greater release probability. Using in vitro patch clamp recording on acute rat brain slices, we found that a brief, high frequency stimulation (HFS) of afferents induced a potentiation of mEPSC amplitude lasting up to 20 min. This amplitude potentiation did not correlate with changes in mEPSC frequency, suggesting that it does not reflect changes in presynaptic release probability. Nonetheless, neither postsynaptic calcium chelator nor the NMDA receptor antagonist blocked the potentiation. Together with the known calcium dependency of HFS-induced potentiation of mEPSCs, our results imply that mEPSC amplitude increase requires presynaptic calcium. Further analysis showed multimodal distribution of mEPSC amplitude, suggesting that large mEPSCs were due to multivesicular glutamate release, even at late post-HFS when the frequency is no longer elevated. In conclusion, high frequency activation of excitatory synapses induces lasting multivesicular release in the SON, which is independent of changes in release probability. This represents a novel form of synaptic plasticity that may contribute to prolonged excitatory tone necessary for generation of burst firing of magnocellular neurons.	[Quinlan, Michelle E.; Hirasawa, Michiru] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland	Hirasawa, M (corresponding author), Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF, Canada.	michiru@mun.ca			Natural Sciences and Engineering Research Council of Canada [298916-2011]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant 298916-2011). (http://www.nserc-crsng.gc.ca/index_eng.asp) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Boudaba C, 1997, J NEUROPHYSIOL, V77, P3396, DOI 10.1152/jn.1997.77.6.3396; Boudaba C, 2006, AM J PHYSIOL-REG I, V291, pR102, DOI 10.1152/ajpregu.00795.2005; Brown CH, 2006, TRENDS NEUROSCI, V29, P108, DOI 10.1016/j.tins.2005.11.005; Brown CH, 2004, EUR J NEUROSCI, V19, P2977, DOI 10.1111/j.0953-816X.2004.03408.x; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Csaki A, 2002, EUR J NEUROSCI, V16, P55, DOI 10.1046/j.1460-9568.2002.02059.x; DUDEK FE, 1987, J PHYSIOL-LONDON, V387, P273, DOI 10.1113/jphysiol.1987.sp016573; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Gordon GRJ, 2005, J NEUROSCI, V25, P11385, DOI 10.1523/JNEUROSCI.2378-05.2005; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; Hirasawa M, 2003, P NATL ACAD SCI USA, V100, P6139, DOI 10.1073/pnas.0936131100; Hirasawa M, 2003, J NEUROSCI, V23, P4270; HU B, 1992, J PHYSIOL-LONDON, V458, P667, DOI 10.1113/jphysiol.1992.sp019440; Inenaga K, 1998, J NEUROENDOCRINOL, V10, P1, DOI 10.1046/j.1365-2826.1998.00662.x; Iremonger KJ, 2008, PROG BRAIN RES, V170, P119, DOI 10.1016/S0079-6123(08)00411-1; Israel JM, 2003, EUR J NEUROSCI, V17, P2619, DOI 10.1046/j.1460-9568.2003.02705.x; Jourdain P, 1998, J NEUROSCI, V18, P6641; Kabashima N, 1997, J PHYSIOL-LONDON, V504, P113, DOI 10.1111/j.1469-7793.1997.113bf.x; Kombian SB, 2000, J NEUROPHYSIOL, V83, P2542, DOI 10.1152/jn.2000.83.5.2542; Moos F, 2004, NEUROSCIENCE, V125, P391, DOI 10.1016/j.neuroscience.2004.01.033; NISSEN R, 1995, J PHYSIOL-LONDON, V484, P415, DOI 10.1113/jphysiol.1995.sp020674; Panatier A, 2006, J PHYSIOL-LONDON, V573, P711, DOI 10.1113/jphysiol.2006.109447; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; Quinlan ME, 2008, J PHYSIOL-LONDON, V586, P3147, DOI 10.1113/jphysiol.2007.148957; RENAUD LP, 1993, ANN NY ACAD SCI, V689, P122, DOI 10.1111/j.1749-6632.1993.tb55542.x; Richard D, 1995, J PHYSIOL-LONDON, V489, P567, DOI 10.1113/jphysiol.1995.sp021073; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; STERN JE, 1995, J PHYSIOL-LONDON, V488, P701, DOI 10.1113/jphysiol.1995.sp021001; VANDENPOL AN, 1982, J COMP NEUROL, V206, P317, DOI 10.1002/cne.902060402	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e77402	10.1371/journal.pone.0077402	http://dx.doi.org/10.1371/journal.pone.0077402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086774	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200080
J	Zhao, LX; Huang, YL; Zheng, JL				Zhao, Lixia; Huang, Yunlong; Zheng, Jialin			STAT1 Regulates Human Glutaminase 1 Promoter Activity through Multiple Binding Sites in HIV-1 Infected Macrophages	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYROSINE PHOSPHORYLATION; NEUROCOGNITIVE DISORDER; UNPHOSPHORYLATED STAT1; GLUTAMATE PRODUCTION; IFN-GAMMA; GENE; NEUROTOXICITY; EXPRESSION; PROTEIN	Mononuclear phagocytes (MP, macrophages and microglia), the main targets of HIV-1 infection in the brain, play a pathogenic role in HIV-associated neurocognitive disorders (HAND) through the production and release of various soluble neurotoxic factors including glutamate. We have previously reported that glutaminase (GLS), the glutamate-generating enzyme, is upregulated in HIV-1 infected MP and in the brain tissues of HIV dementia individuals, and that HIV-1 or interferon-alpha (IFN-alpha) regulates human glutaminase 1 (GLS1) promoter through signal transducer and activator of transcription 1 (STAT1) phosphorylation in macrophages. However, there are multiple putative STAT1 binding sites in human GLS1 promoter, the exact molecular mechanism of how HIV-1 or IFN-alpha regulates human GLS1 promoter remains unclear. To further study the function of the putative STAT1 binding sites, we mutated the sequence of each binding site to ACTAGTCTC and found that six mutants (mut 1,3,4,5,7,8) had significantly higher promoter activity and two mutants (mut 2 and mut 6) completely lost the promoter activity compared with the wild type. To determine whether sites 2 and 6 could interfere with other inhibitory sites, particularly the nearby inhibitory sites 3 and 5, we made double mutants dmut 2/3 and dmut 5/6, and found that both the double mutants had significantly higher activity than the wild type, indicating that sites 3 and 5 are critical inhibitory elements, while sites 2 and 6 are excitatory elements. ChIP assay verified that STAT1 could bind with sites 2/3 and 5/6 within human GLS1 promoter in IFN-alpha stimulated or HIV-1-infected monocyte-derived macrophages. Interestingly, we found that rat Gls1 promoter was regulated through a similar way as human GLS1 promoter. Together, our data identified critical elements that regulate GLS1 promoter activity.	[Zhao, Lixia; Zheng, Jialin] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Ctr Translat Neurodegenerat & Regenerat Therapy, Shanghai 200092, Peoples R China; [Zhao, Lixia; Huang, Yunlong; Zheng, Jialin] Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA; [Zhao, Lixia; Huang, Yunlong; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	Tongji University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Huang, YL (corresponding author), Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA.	yhuan1@unmc.edu; jzheng@unmc.edu	Huang, Yunlong/J-6554-2015	Huang, Yunlong/0000-0002-3328-1924	National Institute of Health [R01 NS 041858, R01 NS 061642, P01 NS 043985]; China National Science and Technology major project [2014CB965001]; National Natural Science Foundation of China (NSFC) [81028007, 81329002, 81301468]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061642, R01NS041858, P01NS043985] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China National Science and Technology major project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by research grants by the National Institute of Health: R01 NS 041858, R01 NS 061642, P01 NS 043985, the China National Science and Technology major project (2014CB965001), and the National Natural Science Foundation of China (NSFC) # 81028007 and # 81329002 to JCZ, and NSFC # 81301468 to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Andratsch M, 2007, AM J PHYSIOL-RENAL, V293, pF846, DOI 10.1152/ajprenal.00139.2007; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Constantino AA, 2011, NEUROTOX RES, V20, P277, DOI 10.1007/s12640-011-9241-3; Cui M, 2009, ADV EXP MED BIOL, V665, P143; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Erdmann N, 2007, J NEUROCHEM, V102, P539, DOI 10.1111/j.1471-4159.2007.04594.x; Erdmann N, 2009, J NEUROCHEM, V109, P551, DOI 10.1111/j.1471-4159.2009.05989.x; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Ferrando S J, 2000, New Dir Ment Health Serv, P25; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Ghazawi I, 2005, J INTERF CYTOK RES, V25, P92, DOI 10.1089/jir.2005.25.92; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Huang YL, 2011, J NEUROSCI, V31, P15195, DOI 10.1523/JNEUROSCI.2051-11.2011; Huang YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005397; Jiang ZG, 2001, J NEUROIMMUNOL, V117, P97, DOI 10.1016/S0165-5728(01)00315-0; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; LIPTON SA, 1994, DEV NEUROSCI-BASEL, V16, P145, DOI 10.1159/000112101; Marquez J, 2006, NEUROCHEM INT, V48, P465, DOI 10.1016/j.neuint.2005.10.015; Mizuno T, 2008, FASEB J, V22, P1797, DOI 10.1096/fj.07-099499; MOCK B, 1989, GENOMICS, V5, P291, DOI 10.1016/0888-7543(89)90060-8; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Perez-Gomez C, 2003, BIOCHEM J, V370, P771, DOI 10.1042/BJ20021445; Phipps T, 2008, NATURE ED, V1; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; Saransaari P, 1998, NEUROCHEM RES, V23, P563, DOI 10.1023/A:1022494921018; Taylor L, 2001, BBA-GENE STRUCT EXPR, V1518, P132, DOI 10.1016/S0167-4781(01)00183-X; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2; Yuasa K, 2012, FEBS LETT, V586, P3464, DOI 10.1016/j.febslet.2012.07.074; Zhao JX, 2004, J NEUROCHEM, V88, P169, DOI 10.1046/j.1471-4159.2003.02146.x; Zhao LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032995	38	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76581	10.1371/journal.pone.0076581	http://dx.doi.org/10.1371/journal.pone.0076581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086752	gold, Green Published, Green Submitted			2022-12-27	WOS:000325025200077
J	Ogawa, M; Okamura, T; Ishikura, S; Doi, K; Matsuzaki, H; Tanaka, Y; Ota, T; Hayakawa, K; Suzuki, H; Tsunoda, T; Sasazuki, T; Shirasawa, S				Ogawa, Masahiro; Okamura, Tadashi; Ishikura, Shuhei; Doi, Keiko; Matsuzaki, Hiroshi; Tanaka, Yoko; Ota, Takeharu; Hayakawa, Kunihiro; Suzuki, Harumi; Tsunoda, Toshiyuki; Sasazuki, Takehiko; Shirasawa, Senji			Zfat-Deficiency Results in a Loss of CD3 xi Phosphorylation with Dysregulation of ERK and Egr Activities Leading to Impaired Positive Selection	PLOS ONE			English	Article							T-CELL DEVELOPMENT; AUTOIMMUNE THYROID-DISEASE; GENOME-WIDE ASSOCIATION; THYMOCYTE DEVELOPMENT; NEGATIVE SELECTION; TCR EXPRESSION; SURVIVAL; GENES; INDUCTION; THYMUS	The human ZFAT gene was originally identified as a susceptibility gene for autoimmune thyroid disease. Mouse Zfat is a critical transcriptional regulator for primitive hematopoiesis and required for peripheral T cell homeostasis. However, its physiological roles in T cell development remain poorly understood. Here, we generated Zfat(f/f)-LckCre mice and demonstrated that T cell-specific Zfat-deletion in Zfat(f/f)-LckCre mice resulted in a reduction in the number of CD4(+)CD8(+) double-positive (DP) cells, CD4(+) single positive cells and CD8(+) single positive cells. Indeed, in Zfat(f/f)-LckCre DP cells, positive selection was severely impaired. Defects of positive selection in Zfat-deficient thymocytes were not restored in the presence of the exogenous TCR by using TCR-transgenic mice. Furthermore, Zfat-deficient DP cells showed a loss of CD3 xi phosphorylation in response to T cell antigen receptor (TCR)-stimulation concomitant with dysregulation of extracellular signal-related kinase (ERK) and early growth response protein (Egr) activities. These results demonstrate that Zfat is required for proper regulation of the TCR-proximal signalings, and is a crucial molecule for positive selection through ERK and Egr activities, thus suggesting that a full understanding of the precise molecular mechanisms of Zfat will provide deeper insight into T cell development and immune regulation.	[Ogawa, Masahiro; Ishikura, Shuhei; Doi, Keiko; Matsuzaki, Hiroshi; Tanaka, Yoko; Ota, Takeharu; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Dept Cell Biol, Fac Med, Jonan Ku, Fukuoka 81401, Japan; [Ogawa, Masahiro; Ishikura, Shuhei; Doi, Keiko; Ota, Takeharu; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Cent Res Inst Adv Mol Med, Jonan Ku, Fukuoka 81401, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Div Anim Models, Dept Infect Dis, Res Inst, Tokyo, Japan; [Hayakawa, Kunihiro; Suzuki, Harumi] Natl Inst Global Hlth & Med, Dept Pathol & Immunol, Chiba, Japan; [Sasazuki, Takehiko] Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan	Fukuoka University; Fukuoka University; National Center for Global Health & Medicine - Japan; Kyushu University	Shirasawa, S (corresponding author), Fukuoka Univ, Dept Cell Biol, Fac Med, Jonan Ku, Fukuoka 81401, Japan.	sshirasa@fukuoka-u.ac.jp	Suzuki, Harumi/L-1271-2013	Suzuki, Harumi/0000-0003-3616-9361; HAYAKAWA, Kunihiro/0000-0002-8053-746X	Japan Society for the Promotion of the Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Society for the Promotion of the Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of the Science and a Grant-in-Aid for the FCAM from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Basson MA, 2000, J IMMUNOL, V165, P2444, DOI 10.4049/jimmunol.165.5.2444; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Bettini ML, 2007, P NATL ACAD SCI USA, V104, P16257, DOI 10.1073/pnas.0705321104; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Comabella M, 2009, ARCH NEUROL-CHICAGO, V66, P972, DOI 10.1001/archneurol.2009.150; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Doi K, 2012, BIOCHEM BIOPH RES CO, V425, P107, DOI 10.1016/j.bbrc.2012.07.065; Doi K, 2011, CELL MOL BIOL LETT, V16, P89, DOI 10.2478/s11658-010-0041-1; Falahati R, 2008, J IMMUNOL, V181, P6082, DOI 10.4049/jimmunol.181.9.6082; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fujimoto T, 2009, FEBS LETT, V583, P568, DOI 10.1016/j.febslet.2008.12.063; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hamrouni A, 2007, EUR J IMMUNOL, V37, P1978, DOI 10.1002/eji.200636632; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Inoue N, 2012, J CLIN IMMUNOL, V32, P1243, DOI 10.1007/s10875-012-9721-0; Koyanagi M, 2008, GENOMICS, V91, P451, DOI 10.1016/j.ygeno.2008.01.009; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Lawson VJ, 2010, EUR J IMMUNOL, V40, P232, DOI 10.1002/eji.200939567; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Miyazaki M, 2005, J IMMUNOL, V174, P2507, DOI 10.4049/jimmunol.174.5.2507; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stojakovic M, 2008, J IMMUNOL, V181, P6770, DOI 10.4049/jimmunol.181.10.6770; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Takeuchi F, 2009, J HUM GENET, V54, P749, DOI 10.1038/jhg.2009.99; Tsunoda T, 2010, P NATL ACAD SCI USA, V107, P14199, DOI 10.1073/pnas.1002494107; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76254	10.1371/journal.pone.0076254	http://dx.doi.org/10.1371/journal.pone.0076254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098453	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600032
J	Takahashi, T; Takigami, S; Sunada, H; Lukowiak, K; Sakakibara, M				Takahashi, Tomoyo; Takigami, Satoshi; Sunada, Hiroshi; Lukowiak, Ken; Sakakibara, Manabu			Critical Period of Memory Enhancement during Taste Avoidance Conditioning in Lymnaea stagnalis	PLOS ONE			English	Article							LONG-TERM-MEMORY; INDUCED RETROGRADE-AMNESIA; PROTEIN-KINASE-C; INTERMEDIATE-TERM; BEHAVIORAL SENSITIZATION; SYNAPTIC FACILITATION; MOLECULAR-MECHANISMS; RESPIRATORY BEHAVIOR; WITHDRAWAL REFLEX; GILL-WITHDRAWAL	The present study investigated the optimal training procedure leading to long-lasting taste avoidance behavior in Lymnaea. A training procedure comprising 5 repeated pairings of a conditional stimulus (CS, sucrose), with an unconditional stimulus (US, a tactile stimulation to the animal's head), over a 4-day period resulted in an enhanced memory formation than 10 CS-US repeated pairings over a 2-day period or 20 CS-US repeated pairings on a single day. Backward conditioning (US-CS) pairings did not result in conditioning. Thus, this taste avoidance conditioning was CS-US pairing specific. Food avoidance behavior was not observed following training, however, if snails were immediately subjected to a cold-block (4 degrees C for 10 min). It was critical that the cold-block be applied within 10 min to block long-term memory (LTM) formation. Further, exposure to the cold-block 180 min after training also blocked both STM and LTM formation. The effects of the cold-block on subsequent learning and memory formation were also examined. We found no long lasting effects of the cold-block on subsequent memory formation. If protein kinase C was activated before the conditioning paradigm, snails could still acquire STM despite exposure to the cold-block.	[Takahashi, Tomoyo; Sakakibara, Manabu] Tokai Univ, Sch High Technol Human Welf, Shizuoka, Japan; [Takigami, Satoshi; Sakakibara, Manabu] Tokai Univ, Grad Sch High Technol Human Welf, Shizuoka, Japan; [Takigami, Satoshi; Sakakibara, Manabu] Tokai Univ, Grad Sch Biosci, Shizuoka, Japan; [Sunada, Hiroshi; Lukowiak, Ken] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB, Canada	Tokai University; Tokai University; Tokai University; University of Calgary	Sakakibara, M (corresponding author), Tokai Univ, Sch High Technol Human Welf, Shizuoka, Japan.	manabu@tokai.ac.jp						Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; Alkon D. L., 1987, MEMORY TRACES BRAIN; ALKON DL, 1985, BEHAV NEURAL BIOL, V44, P278, DOI 10.1016/S0163-1047(85)90296-1; ALKON DL, 1988, SCIENCE, V239, P998, DOI 10.1126/science.2830669; Alkon DL, 2005, P NATL ACAD SCI USA, V102, P16432, DOI 10.1073/pnas.0508001102; Alkon DL, 1998, ADV EXP MED BIOL, V446, P1; ANOKHIN KV, 1991, EUR J NEUROSCI, V3, P162, DOI 10.1111/j.1460-9568.1991.tb00076.x; Azami S, 2006, J NEUROSCI RES, V84, P1610, DOI 10.1002/jnr.21045; BANK B, 1988, P NATL ACAD SCI USA, V85, P1988, DOI 10.1073/pnas.85.6.1988; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Botzer D, 1998, LEARN MEMORY, V5, P204; Braun MH, 2011, NEUROBIOL LEARN MEM, V96, P403, DOI 10.1016/j.nlm.2011.06.016; Browning K, 2008, NEUROSCIENCE, V155, P613, DOI 10.1016/j.neuroscience.2008.06.012; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Commins S, 2003, BEHAV BRAIN RES, V139, P215, DOI 10.1016/S0166-4328(02)00270-X; Crow T, 2011, NEUROSCIENCE, V192, P102, DOI 10.1016/j.neuroscience.2011.06.063; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Epstein HT, 2004, NEUROBIOL LEARN MEM, V81, P12, DOI 10.1016/S1074-7427(03)00074-1; Epstein HT, 2003, NEUROBIOL LEARN MEM, V79, P127, DOI 10.1016/S1074-7427(02)00020-5; FLEXNER LB, 1966, P NATL ACAD SCI USA, V55, P369, DOI 10.1073/pnas.55.2.369; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; Fulton D, 2005, EUR J NEUROSCI, V21, P1347, DOI 10.1111/j.1460-9568.2005.03970.x; Fulton D, 2008, J NEUROPHYSIOL, V100, P108, DOI 10.1152/jn.90389.2008; Fulton D, 2008, NEUROBIOL LEARN MEM, V90, P651, DOI 10.1016/j.nlm.2008.08.006; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hawkins RD, 2006, BIOL BULL-US, V210, P174, DOI 10.2307/4134556; Hintzman D. L., 1974, THEORIES COGNITIVE P, P77; Hovland CI, 1940, J EXP PSYCHOL, V26, P568, DOI 10.1037/h0055061; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kawai R, 2004, NEUROBIOL LEARN MEM, V82, P164, DOI 10.1016/j.nlm.2004.06.003; Kawai R, 2004, J NEUROPHYSIOL, V91, P728, DOI 10.1152/jn.00757.2003; Kawai R, 2002, NEUROSCI RES, V43, P363, DOI 10.1016/S0168-0102(02)00061-5; Kuzirian AM, 2006, BIOL BULL-US, V210, P201, DOI 10.2307/4134558; Lukowiak K, 1998, J EXP BIOL, V201, P877; Lukowiak K, 2000, LEARN MEMORY, V7, P140, DOI 10.1101/lm.7.3.140; Marra V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2591; Martens K, 2007, NEUROBIOL LEARN MEM, V88, P232, DOI 10.1016/j.nlm.2007.04.009; Michel M, 2012, J NEUROSCI, V32, P4581, DOI 10.1523/JNEUROSCI.6264-11.2012; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Mozzachiodi R, 2008, NAT NEUROSCI, V11, P1146, DOI 10.1038/nn.2184; Murakami J, 2013, J NEUROSCI, V33, P371, DOI 10.1523/JNEUROSCI.0679-12.2013; Nelson TJ, 1996, P NATL ACAD SCI USA, V93, P13808, DOI 10.1073/pnas.93.24.13808; NELSON TJ, 1990, P NATL ACAD SCI USA, V87, P269, DOI 10.1073/pnas.87.1.269; OLDS JL, 1989, SCIENCE, V245, P866, DOI 10.1126/science.2772638; Ono M, 2002, NEUROBIOL LEARN MEM, V78, P53, DOI 10.1006/nlme.2001.4066; Parvez K, 2005, J EXP BIOL, V208, P1525, DOI 10.1242/jeb.01545; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Quattrone A, 2001, P NATL ACAD SCI USA, V98, P11668, DOI 10.1073/pnas.191388398; Ramirez RR, 1998, LEARN MEMORY, V4, P462, DOI 10.1101/lm.4.6.462; Rosenegger D, 2008, NEUROBIOL LEARN MEM, V90, P544, DOI 10.1016/j.nlm.2008.06.005; ROSENZWEIG MR, 1993, BEHAV BRAIN RES, V57, P193, DOI 10.1016/0166-4328(93)90135-D; Sakakibara M, 1998, NEUROBIOL LEARN MEM, V69, P1, DOI 10.1006/nlme.1997.3805; Sakakibara M, 2006, BIOL BULL-US, V210, P298, DOI 10.2307/4134566; Sakakibara Manabu, 2008, P131; Sangha S, 2003, NEUROBIOL LEARN MEM, V80, P130, DOI 10.1016/S1074-7427(03)00065-0; Sangha S, 2003, J NEUROSCI, V23, P9842; Sangha S, 2003, J NEUROSCI, V23, P8034; Sangha S, 2003, J EXP BIOL, V206, P71, DOI 10.1242/jeb.00061; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; SEKIGUCHI T, 1994, NEUROSCI RES, V18, P267, DOI 10.1016/0168-0102(94)90162-7; Sherff CM, 2004, P NATL ACAD SCI USA, V101, P7463, DOI 10.1073/pnas.0402163101; Sommerville J, 1999, BIOESSAYS, V21, P319, DOI 10.1002/(SICI)1521-1878(199904)21:4<319::AID-BIES8>3.3.CO;2-V; Staras K, 1998, J NEUROPHYSIOL, V79, P3030, DOI 10.1152/jn.1998.79.6.3030; Stough S, 2006, CURR OPIN NEUROBIOL, V16, P672, DOI 10.1016/j.conb.2006.10.009; Sunada H, 2012, ACTA BIOL HUNG, V63, P190, DOI 10.1556/ABiol.63.2012.Suppl.2.24; Sunada H, 2010, J EXP BIOL, V213, P3409, DOI 10.1242/jeb.043521; Sunada H, 2010, NEUROBIOL LEARN MEM, V94, P269, DOI 10.1016/j.nlm.2010.06.005; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Timbers TA, 2011, BEHAV NEUROSCI, V125, P560, DOI 10.1037/a0024370; Wustenberg D, 1998, EUR J NEUROSCI, V10, P2742, DOI 10.1046/j.1460-9568.1998.t01-1-00319.x; Xia SZ, 1999, PHYSIOL BEHAV, V65, P617; YAMADA A, 1992, J NEUROSCI, V12, P729	80	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75276	10.1371/journal.pone.0075276	http://dx.doi.org/10.1371/journal.pone.0075276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098373	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600015
J	Fresia, P; Azeredo-Espin, AML; Lyra, ML				Fresia, Pablo; Azeredo-Espin, Ana Maria L.; Lyra, Mariana L.			The Phylogeographic History of the New World Screwworm Fly, Inferred by Approximate Bayesian Computation Analysis	PLOS ONE			English	Article							POPULATION-GENETICS; MITOCHONDRIAL-DNA; SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; FLIES DIPTERA; SPECIATION; PATTERNS; COASTAL; MODELS; CALLIPHORIDAE	Insect pest phylogeography might be shaped both by biogeographic events and by human influence. Here, we conducted an approximate Bayesian computation (ABC) analysis to investigate the phylogeography of the New World screwworm fly, Cochliomyia hominivorax, with the aim of understanding its population history and its order and time of divergence. Our ABC analysis supports that populations spread from North to South in the Americas, in at least two different moments. The first split occurred between the North/Central American and South American populations in the end of the Last Glacial Maximum (15,300-19,000 YBP). The second split occurred between the North and South Amazonian populations in the transition between the Pleistocene and the Holocene eras (9,100-11,000 YBP). The species also experienced population expansion. Phylogenetic analysis likewise suggests this north to south colonization and Maxent models suggest an increase in the number of suitable areas in South America from the past to present. We found that the phylogeographic patterns observed in C. hominivorax cannot be explained only by climatic oscillations and can be connected to host population histories. Interestingly we found these patterns are very coincident with general patterns of ancient human movements in the Americas, suggesting that humans might have played a crucial role in shaping the distribution and population structure of this insect pest. This work presents the first hypothesis test regarding the processes that shaped the current phylogeographic structure of C. hominivorax and represents an alternate perspective on investigating the problem of insect pests.	[Fresia, Pablo] Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil; [Azeredo-Espin, Ana Maria L.] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Sao Paulo, Brazil; [Azeredo-Espin, Ana Maria L.] Univ Estadual Campinas, Inst Biol, Sao Paulo, Brazil; [Lyra, Mariana L.] Univ Estadual Paulista, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual Paulista	Fresia, P (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil.	pfresia@gmail.com	FRESIA, pablo/AGF-5679-2022; Lyra, Mariana Lucio/O-6405-2014; Espin, Ana Maria Azeredo/N-2213-2015	Lyra, Mariana Lucio/0000-0002-7863-4965; Azeredo-Espin, Ana Maria/0000-0002-9664-6791	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [03/13598-0]; FAO/IAEA [11822/RO]; FAPESP	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAO/IAEA(International Atomic Energy Agency); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Pablo Fresia was supported by a fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES. Mariana Lucio Lyra was supported by a fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (grant no 03/13598-0). This work was supported by grants from FAO/IAEA (11822/RO) and FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anducho-Reyes MA, 2008, MOL PHYLOGENET EVOL, V49, P930, DOI 10.1016/j.ympev.2008.09.005; Antonelli A, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P386; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Beaumont MA, 2010, MOL ECOL, V19, P436, DOI 10.1111/j.1365-294X.2009.04515.x; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Castoe TA, 2009, J BIOGEOGR, V36, P88, DOI 10.1111/j.1365-2699.2008.01991.x; Chan LM, 2011, MOL PHYLOGENET EVOL, V59, P523, DOI 10.1016/j.ympev.2011.01.020; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Da Silva MNF, 1998, MOL ECOL, V7, P475, DOI 10.1046/j.1365-294x.1998.00276.x; Daza JM, 2010, ECOGRAPHY, V33, P343, DOI 10.1111/j.1600-0587.2010.06281.x; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; de Vivo M, 2004, J BIOGEOGR, V31, P943, DOI 10.1111/j.1365-2699.2004.01068.x; Dick CW, 2003, AM NAT, V162, P691, DOI 10.1086/379795; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Fix AG, 2005, AM J PHYS ANTHROPOL, V128, P430, DOI 10.1002/ajpa.20230; Fresia P, 2011, J MED ENTOMOL, V48, P280, DOI 10.1603/ME10153; Garcia R., 2007, P393, DOI 10.1007/978-1-4020-6059-5_37; Guimaraes J.H., 1983, Revista Brasileira de Zoologia, V1, P239; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 2001, AMAZONIANA, V16, P579; He YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044788; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hubbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011105; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Knowles LL, 2010, MOL ECOL, V19, P3727, DOI 10.1111/j.1365-294X.2010.04702.x; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Krafsur ES, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P389, DOI 10.1007/1-4020-4051-2_14; Lande R., 2003, OXFORD SERIES ECOLOG; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Loaiza JR, 2010, MOL PHYLOGENET EVOL, V57, P1341, DOI 10.1016/j.ympev.2010.09.016; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Lyra ML, 2009, MED VET ENTOMOL, V23, P32, DOI 10.1111/j.1365-2915.2008.00776.x; Lyra ML, 2005, J MED ENTOMOL, V42, P589, DOI 10.1603/0022-2585(2005)042[0589:AOMDVA]2.0.CO;2; MANGAN RL, 1989, ANN ENTOMOL SOC AM, V82, P332, DOI 10.1093/aesa/82.3.332; Martino LA, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031923; Matlock RB, 2009, MED VET ENTOMOL, V23, P111, DOI 10.1111/j.1365-2915.2009.00774.x; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Mirabello L, 2006, HEREDITY, V96, P311, DOI 10.1038/sj.hdy.6800805; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Otranto D, 2006, TRENDS PARASITOL, V22, P209, DOI 10.1016/j.pt.2006.03.003; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; PARKER FD, 1993, J ECON ENTOMOL, V86, P1359, DOI 10.1093/jee/86.5.1359; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pennington RT, 2004, PHILOS T R SOC B, V359, P515, DOI 10.1098/rstb.2003.1435; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Phillips PL, 2004, J MED ENTOMOL, V41, P121, DOI 10.1603/0022-2585-41.1.121; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quijada-Mascarenas JA, 2007, J BIOGEOGR, V34, P1296, DOI 10.1111/j.1365-2699.2007.01707.x; Rambaut A., 2007, TRACER V1 4; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Roderick GK, 1996, ANNU REV ENTOMOL, V41, P325, DOI 10.1146/annurev.en.41.010196.001545; ROEHRDANZ RL, 1989, BIOCHEM GENET, V27, P551, DOI 10.1007/BF02396152; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; SILVA JMC, 2002, BIOSCIENCE, V52, P225, DOI DOI 10.1641/0006-3568(2002)052[; Slatkin M, 2012, GENETICS, V191, P171, DOI 10.1534/genetics.112.139022; Streicher JW, 2009, MOL PHYLOGENET EVOL, V53, P620, DOI 10.1016/j.ympev.2009.07.011; Suarez-Seoane S, 2008, ECOL MODEL, V219, P17, DOI 10.1016/j.ecolmodel.2008.07.035; Surovell TA, 2003, CURR ANTHROPOL, V44, P580, DOI 10.1086/377651; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor DB, 1996, MED VET ENTOMOL, V10, P63, DOI 10.1111/j.1365-2915.1996.tb00083.x; Torres TT, 2009, MED VET ENTOMOL, V23, P23, DOI 10.1111/j.1365-2915.2008.00786.x; Torres T. T., 2007, P183, DOI 10.1007/978-1-4020-6059-5_16; Vanzolini P. E, 1970, Archos Zool. S. Paulo, V19, P1; Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wuster W, 2005, MOL ECOL, V14, P1095, DOI 10.1111/j.1365-294X.2005.02471.x; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x	97	19	21	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76168	10.1371/journal.pone.0076168	http://dx.doi.org/10.1371/journal.pone.0076168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098436	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500047
J	Liu, JL; Dong, JC; Wang, L; Su, Y; Yan, P; Sun, SG				Liu, Jinling; Dong, Jiangchuan; Wang, Lei; Su, Ying; Yan, Peng; Sun, Shenggang			Comparative Efficacy and Acceptability of Antidepressants in Parkinson's Disease: A Network Meta-Analysis	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; PROVISIONAL DIAGNOSTIC-CRITERIA; DOUBLE-BLIND; TRICYCLIC ANTIDEPRESSANTS; DEPRESSIVE SYMPTOMS; RANDOMIZED-TRIALS; DOPAMINE RELEASE; PRAMIPEXOLE; INTERVENTIONS; EXPECTATION	Background: Depression is a common non-motor symptom in patients with Parkinson's disease (PD). There are many kinds of antidepressants being used, such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and Dopamine agonists which are suggested as alternative antidepressants for the treatment of depression in PD. Which one should we choose first? Literatures have shown inconsistent results. Methods: We conducted a network meta-analysis of randomized controlled trials to compare the efficacy and acceptability of therapeutic methods for the treatment of depression in Parkinson's disease. Results: We used the odds ratios (OR) as effect size firstly and the results indicated no statistical significance between each compared intervention. Then we used the logarithm of the individual odds ratios as effect size. With efficacy of TCAs as the standard of comparison, the degree of incoherence (a measure of how closely the entire network fits together) was small (omega = 4.824827e-05). The logor were: SSRIs -0.69 (95% CI -1.28- -0.10); Pramipexole -0.73 (-1.71- -0.26); Pergolide -1.97 (-3.67- 0.27); SNRIs -0.86 (-1.86- 0.15); Placebo -1.24 (-1.99- -0.50). With Placebo as the standard of comparison, the logor were: TCAs 1.24 (0.50- 1.99); SSRIs 0.55 (-0.03-1.13); Pramipexole 0.51 (20.12- 1.15); Pergolide -0.73 (-2.25- 0.80); SNRIs 0.38 (-0.42- 1.19); TCAs, pramipexole, pergolide and SNRIs showed better profile of acceptability, leading to significant fewer discontinuations than that of SSRIs. Conclusions: There is insufficient evidence to support antidepressant efficacy for SSRIs, pramipexole, pergolide and SNRIs. TCAs might be the best choice when starting antidepressant treatment in patients of Parkinson's disease because it has the most favorable balance between benefits and acceptability, followed by pramipexole and SNRIs, SSRIs might be the last choice.	[Liu, Jinling; Su, Ying; Yan, Peng; Sun, Shenggang] Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Dong, Jiangchuan] Chongqing Med Univ, Dept Tradit Chinese Med, Chongqing, Peoples R China; [Wang, Lei] Weifang Peoples Hosp, Dept Neurol, Weifang, Shandong, Peoples R China	Huazhong University of Science & Technology; Chongqing Medical University	Su, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	suying0110@126.com						Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; Antonini A, 2006, MOVEMENT DISORD, V21, P1119, DOI 10.1002/mds.20895; Avila A, 2003, J CLIN PSYCHOPHARM, V23, P509, DOI 10.1097/01.jcp.0000088908.24613.db; Barone P, 2006, J NEUROL, V253, P601, DOI 10.1007/s00415-006-0067-5; Barone P, 2011, EUR J NEUROL, V18, P11, DOI 10.1111/j.1468-1331.2010.03325.x; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chen P, 2007, J GERIATR PSYCH NEUR, V20, P161, DOI 10.1177/0891988707301866; Chung TH, 2003, PARKINSONISM RELAT D, V10, P59, DOI 10.1016/S1353-8020(03)00108-1; Colloca L, 2005, NAT REV NEUROSCI, V6, P545, DOI 10.1038/nrn1705; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; Fernandez HH, 2010, LANCET NEUROL, V9, P556, DOI 10.1016/S1474-4422(10)70114-9; Furukawa TA, 2002, BMJ-BRIT MED J, V325, P991, DOI 10.1136/bmj.325.7371.991; Goetz CG, 2002, MOVEMENT DISORD, V17, P283, DOI 10.1002/mds.10024; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Kupfer DJ, 2002, JAMA-J AM MED ASSOC, V287, P1853, DOI 10.1001/jama.287.14.1853; Leentjens AFG, 2003, INT J GERIATR PSYCH, V18, P552, DOI 10.1002/gps.865; Leentjens AFG, 2011, DRUGS, V71, P273, DOI 10.2165/11585380-000000000-00000; Lidstone SC, 2010, ARCH GEN PSYCHIAT, V67, P857, DOI 10.1001/archgenpsychiatry.2010.88; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Marsh L, 2006, MOVEMENT DISORD, V21, P148, DOI 10.1002/mds.20723; Menza M, 2009, NEUROLOGY, V72, P886, DOI 10.1212/01.wnl.0000336340.89821.b3; Moncrieff J, 2004, COCHRANE DB SYST REV, pD3012; Okun MS, 2009, NEUROLOGY, V72, P868, DOI 10.1212/01.wnl.0000338145.24512.02; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125; Rabey Jose Martin, 1996, Neurology, V46, pA374; Rektorova I, 2003, EUR J NEUROL, V10, P399, DOI 10.1046/j.1468-1331.2003.00612.x; Richard IH, 2012, NEUROLOGY, V78, P1229, DOI 10.1212/WNL.0b013e3182516244; Richard IH, 1997, NEUROLOGY, V49, P1168, DOI 10.1212/WNL.49.4.1168; Rutherford BR, 2012, J PSYCHIATR RES, V46, P697, DOI 10.1016/j.jpsychires.2012.02.008; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; SHABNAM GN, 2003, COCHRANE DB SYST REV, V3, P3465; Shetty N, 1999, CLIN NEUROPHARMACOL, V22, P207; Skapinakis P, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-49; Thijs V, 2008, EUR HEART J, V29, P1086, DOI 10.1093/eurheartj/ehn106; Veazey C, 2005, J NEUROPSYCH CLIN N, V17, P310, DOI 10.1176/appi.neuropsych.17.3.310; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Weintraub D, 2005, MOVEMENT DISORD, V20, P1161, DOI 10.1002/mds.20555; Weintraub D, 2010, NEUROLOGY, V75, P448, DOI 10.1212/WNL.0b013e3181ebdd79; Wermuth L, 1998, NORD J PSYCHIAT, V52, P163, DOI 10.1080/08039489850139049; Williams JR, 2012, NEUROLOGY, V78, P998, DOI 10.1212/WNL.0b013e31824d587f; Yang S, 2012, J GERIATR PSYCH NEUR, V25, P113, DOI 10.1177/0891988712445096	49	112	113	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76651	10.1371/journal.pone.0076651	http://dx.doi.org/10.1371/journal.pone.0076651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098546	Green Submitted, gold, Green Published			2022-12-27	WOS:000325434500080
J	Maiga, B; Dolo, A; Toure, O; Dara, V; Tapily, A; Campino, S; Sepulveda, N; Risley, P; Silva, N; Corran, P; Rockett, KA; Kwiatkowski, D; Clark, TG; Troye-Blomberg, M; Doumbo, OK				Maiga, Bakary; Dolo, Amagana; Toure, Ousmane; Dara, Victor; Tapily, Amadou; Campino, Susana; Sepulveda, Nuno; Risley, Paul; Silva, Nipula; Corran, Patrick; Rockett, Kirk A.; Kwiatkowski, Dominic; Clark, Taane G.; Troye-Blomberg, Marita; Doumbo, Ogobara K.		MalariaGEN Consortium	Human Candidate Polymorphisms in Sympatric Ethnic Groups Differing in Malaria Susceptibility in Mali	PLOS ONE			English	Article							HUMORAL RESPONSE; FATAL MALARIA; CYTOKINES; CYTOADHERENCE; ASSOCIATIONS; INFECTIONS; PREVALENCE; PROTECTION; RESISTANCE; GENETICS	Malaria still remains a major public health problem in Mali, although disease susceptibility varies between ethnic groups, particularly between the Fulani and Dogon. These two sympatric groups share similar socio-cultural factors and malaria transmission rates, but Fulani individuals tend to show significantly higher spleen enlargement scores, lower parasite prevalence, and seem less affected by the disease than their Dogon neighbours. We have used genetic polymorphisms from malaria-associated genes to investigate associations with various malaria metrics between the Fulanai and Dogon groups. Two cross sectional surveys (transmission season 2006, dry season 2007) were performed. Healthy volunteers from the both ethnic groups (n=939) were recruited in a rural setting. In each survey, clinical (spleen enlargement, axillary temperature, weight) and parasitological data (malaria parasite densities and species) were collected, as well as blood samples. One hundred and sixty six SNPs were genotyped and 5 immunoassays (AMA1, CSP, MSP1, MSP2, total IgE) were performed on the DNA and serum samples respectively. The data confirm the reduced malaria susceptibility in the Fulani, with a higher level of the protective O-blood group, and increased circulating antibody levels to several malaria antigens (p<10(-15)). We identified SNP allele frequency differences between the 2 ethnic groups in CD36, IL4, RTN3 and ADCY9. Moreover, polymorphisms in FCER1A, RAD50, TNF, SLC22A4, and IL13 genes were correlated with antibody production (p-value<0.003). Further work is required to understand the mechanisms underpinning these genetic factors.	[Maiga, Bakary; Dolo, Amagana; Toure, Ousmane; Dara, Victor; Tapily, Amadou; Doumbo, Ogobara K.] Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med Pharm & Odonto Stomatol, Bamako, USTTB, Mali; [Campino, Susana; Rockett, Kirk A.; Kwiatkowski, Dominic] Wellcome Trust Sanger Inst, Hinxton, England; [Sepulveda, Nuno; Corran, Patrick; Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Sepulveda, Nuno] Univ Lisbon, Ctr Stat & Applicat, P-1699 Lisbon, Portugal; [Risley, Paul; Silva, Nipula; Corran, Patrick] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Rockett, Kirk A.; Kwiatkowski, Dominic; MalariaGEN Consortium] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	University of Science & Technology of Bamako; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; Universidade de Lisboa; National Institute for Biological Standards & Control; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine; Stockholm University	Maiga, B (corresponding author), Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med Pharm & Odonto Stomatol, BP 1805, Bamako, USTTB, Mali.	bmaiga@icermali.org; adolo@icermali.org	Campino, Susana/AAM-2577-2020; Clark, Taane G./AAM-2570-2020; Sepulveda, Nuno/AAA-5544-2021; Sepulveda, Nuno/S-9936-2019; Risley, Paul/E-2489-2013; Troye-Blomberg, Marita/B-9210-2016	Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Troye-Blomberg, Marita/0000-0002-2804-0325; Kwiatkowski, Dominic/0000-0002-5023-0176; Sepulveda, Nuno/0000-0002-8542-1706	Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 075491/Z/04, 090532/Z/09/Z, 098051]; Foundation of the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative [566]; Medical Research Council [G0600718, G0600230]; Fundacao para Ciencia e Tecnologia, Portugal [Pest-OE/MAT/UI0006/2011]; MRC [G0600230, G0600718] Funding Source: UKRI; Medical Research Council [G0600718B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Foundation of the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z), and by the Foundation of the National Institutes of Health (566), as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative. The Resource Centre for Genomic Epidemiology of Malaria is supported by the Wellcome Trust (090770/Z/09/Z). This research was supported by the Medical Research Council (G0600718; G0600230). The Wellcome Trust provides core awards to Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z) and the Wellcome Trust Sanger Institute (098051). TGC is funded by the Medical Research Council and the Wellcome Trust. Sepulveda Nuno acknowledges partial funding from Fundacao para Ciencia e Tecnologia, Portugal, through the project Pest-OE/MAT/UI0006/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Al-Sherbiny M, 2003, ACTA TROP, V88, P117, DOI 10.1016/S0001-706X(03)00195-5; [Anonymous], 2008, WORLD MAL REP 2008; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Bryceson ADM, 1976, ACTA TROP, V33, P424; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Cserti-Gazdewich CM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-233; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Diallo D, 2005, CLIN INFECT DIS, V41, P920; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Eid NA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-119; Fry AE, 2009, HUM MOL GENET, V18, P2683, DOI 10.1093/hmg/ddp192; Gazzinelli RT, 2006, NAT REV IMMUNOL, V12, P2006, DOI [10.1038/nm1469, DOI 10.1038/NM1469]; GREENWOOD BM, 1987, ANN TROP MED PARASIT, V81, P345, DOI 10.1080/00034983.1987.11812130; Hackett LW, 1944, J NAT MAL SOC, V3, P11; HASLER T, 1990, BLOOD, V76, P1845; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Kouriba B, 2005, J IMMUNOL, V174, P6274, DOI 10.4049/jimmunol.174.10.6274; Kwiatkowski D, 2000, CURR OPIN GENET DEV, V10, P320, DOI 10.1016/S0959-437X(00)00087-3; Leenstra T, 2006, INFECT IMMUN, V74, P370, DOI 10.1128/IAI.74.1.370-381.2006; LOPEZ AF, 1988, BLOOD, V72, P1797; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Manjurano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047463; Meyer CG, 2011, HUM MOL GENET, V20, P1173, DOI 10.1093/hmg/ddq562; Modiano D, 1998, AM J TROP MED HYG, V58, P220, DOI 10.4269/ajtmh.1998.58.220; Modiano D, 1999, AM J TROP MED HYG, V61, P663, DOI 10.4269/ajtmh.1999.61.663; Modiano D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P193; Ohashi J, 2003, GENES IMMUN, V4, P528, DOI 10.1038/sj.gene.6364010; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; SCHLEIMER RP, 1989, J IMMUNOL, V143, P1310; SNYDER DB, 1983, AVIAN DIS, V27, P161, DOI 10.2307/1590381; Toure O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043987; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Vafa M, 2007, MICROBES INFECT, V9, P1043, DOI 10.1016/j.micinf.2007.04.011; Vafa M, 2009, MICROBES INFECT, V11, P779, DOI 10.1016/j.micinf.2009.04.017; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	46	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75675	10.1371/journal.pone.0075675	http://dx.doi.org/10.1371/journal.pone.0075675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098393	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325434500036
J	Ferri, F; Ardizzi, M; Ambrosecchia, M; Gallese, V				Ferri, Francesca; Ardizzi, Martina; Ambrosecchia, Marianna; Gallese, Vittorio			Closing the Gap between the Inside and the Outside: Interoceptive Sensitivity and Social Distances	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; CARDIAC VAGAL TONE; HEART-RATE-VARIABILITY; PERIPERSONAL SPACE; PERIARCUATE NEURONS; AFFERENT PROPERTIES; MACAQUE MONKEYS; BEAT PERCEPTION; PANIC DISORDER; SHORT-TERM	Humans' ability to represent their body state from within through interoception has been proposed to predict different aspects of human cognition and behaviour. We focused on the possible contribution of interoceptive sensitivity to social behaviour as mediated by adaptive modulation of autonomic response. We, thus, investigated whether interoceptive sensitivity to one's heartbeat predicts participants' autonomic response at different social distances. We measured respiratory sinus arrhythmia (RSA) during either a Social or a Non-social task. In the Social task each participant viewed an experimenter performing a caress-like movement at different distances from their hand. In the Non-social task a metal stick was moved at the same distances from the participant's hand. We found a positive association between interoceptive sensitivity and autonomic response only for the social setting. Moreover, only good heartbeat perceivers showed higher autonomic response 1) in the social compared to the non-social setting, 2) specifically, when the experimenter's hand was moving at boundary of their peripersonal space (20 cm from the participant's hand). Our findings suggest that interoceptive sensitivity might contribute to interindividual differences concerning social attitudes and interpersonal space representation via recruitment of different adaptive autonomic response strategies.	[Ferri, Francesca; Ardizzi, Martina; Ambrosecchia, Marianna; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gallese, Vittorio] IIT, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT	Ferri, F (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	francesca.ferri@nemo.unipr.it; vittorio.gallese@unipr.it	Gallese, Vittorio/ABD-5097-2021; Ghiami, Zeinab/G-5492-2016; Ferri, Francesca/AAC-2527-2022	Gallese, Vittorio/0000-0003-4815-3607; Ferri, Francesca/0000-0003-1821-5870; Ardizzi, Martina/0000-0001-9185-6784	EU grant TESIS	EU grant TESIS	This work was supported by the EU grant TESIS to VG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley V, 2012, PSYCHOPHYSIOLOGY, V49, P1672, DOI 10.1111/j.1469-8986.2012.01468.x; Allen JJB, 2007, BIOL PSYCHOL, V74, P243, DOI 10.1016/j.biopsycho.2006.08.005; Bar KJ, 2010, SCHIZOPHRENIA BULL, V36, P1050, DOI 10.1093/schbul/sbp024; Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bassolino M, 2010, NEUROPSYCHOLOGIA, V48, P803, DOI 10.1016/j.neuropsychologia.2009.11.009; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BESTLER M, 1990, Z EXP ANGEW PSYCHOL, V37, P361; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P759, DOI 10.1016/0028-3932(86)90075-8; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Centomo C, PADUA INVENTORY BECK; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; DEGEUS EJC, 1990, PSYCHOPHYSIOLOGY, V27, P457; Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; Ehlers A, 1996, BIOL PSYCHOL, V42, P165, DOI 10.1016/0301-0511(95)05153-8; Ferri F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1140; Fogassi L, 1999, EXP BRAIN RES, V128, P194, DOI 10.1007/s002210050835; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; Gorka SM, 2013, J PSYCHOPHYSIOL, V27, P95, DOI 10.1027/0269-8803/a000091; Gorka SM, 2013, BIOL PSYCHOL, V93, P334, DOI 10.1016/j.biopsycho.2013.03.003; Graziano MSA, 2001, NEURON, V29, P4, DOI 10.1016/S0896-6273(01)00174-X; Graziano PA, 2007, CHILD DEV, V78, P264, DOI 10.1111/j.1467-8624.2007.00996.x; Grossman P, 2001, RESPIRATION AND EMOTION, P43; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; HAYANO J, 1990, AM J CARDIOL, V65, P84, DOI 10.1016/0002-9149(90)90030-5; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036646; Herbert BM, 2012, BIOL PSYCHOL, V89, P71, DOI 10.1016/j.biopsycho.2011.09.004; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; Herbert BM, 2012, TOP COGN SCI; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; HOROWITZ MJ, 1964, ARCH GEN PSYCHIAT, V11, P651; Jones G. E., 1994, ADV PSYCHOP, V5, P55; Jurca R, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.024; KNOLL JF, 1992, PSYCHOPHYSIOLOGY, V29, P218, DOI 10.1111/j.1469-8986.1992.tb01689.x; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Mathewson KJ, 2013, INT J PSYCHOPHYSIOL, V88, P171, DOI 10.1016/j.ijpsycho.2013.03.016; Matthias E, 2009, INT J PSYCHOPHYSIOL, V72, P154, DOI 10.1016/j.ijpsycho.2008.12.001; MONTGOMERY WA, 1984, PSYCHOPHYSIOLOGY, V21, P459, DOI 10.1111/j.1469-8986.1984.tb00227.x; Mussgay L, 1999, J PSYCHOPHYSIOL, V13, P27, DOI 10.1027//0269-8803.13.1.27; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panksepp J, 1997, ANN NY ACAD SCI, V807, P78, DOI 10.1111/j.1749-6632.1997.tb51914.x; Patriquin MA, 2011, DEV PSYCHOBIOL; Pedrabissi L, 1989, INVENTARIO ANSIA STA; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Pollatos O, 2007, J ANXIETY DISORD, V21, P931, DOI 10.1016/j.janxdis.2006.12.004; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V65, P167, DOI 10.1016/j.ijpsycho.2007.03.005; Pollatos O, 2009, DEPRESS ANXIETY, V26, P167, DOI 10.1002/da.20504; Porges S W, 1994, Monogr Soc Res Child Dev, V59, P167, DOI 10.2307/1166144; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; PORGES SW, 1995, PSYCHOPHYSIOLOGY, V32, P301, DOI 10.1111/j.1469-8986.1995.tb01213.x; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Ruta L, 2012, J AUTISM DEV DISORD, V42, P625, DOI 10.1007/s10803-011-1290-1; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Stevens S, 2011, BEHAV RES THER, V49, P138, DOI 10.1016/j.brat.2010.11.009; SUESS PE, 1994, PSYCHOPHYSIOLOGY, V31, P17, DOI 10.1111/j.1469-8986.1994.tb01020.x; Tajadura-Jimenez A, 2013, J EXPT PSYCHOL GEN; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043; Terasawa Y, 2013, SOC COGN AFFECT NEUR, V8, P259, DOI 10.1093/scan/nss108; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Van der Does AJW, 2000, BEHAV RES THER, V38, P47, DOI 10.1016/S0005-7967(98)00184-3; van Ede F, 2011, J NEUROSCI, V31, P2016, DOI 10.1523/JNEUROSCI.5630-10.2011; WHITEHEAD WE, 1980, PSYCHOPHYSIOLOGY, V17, P552, DOI 10.1111/j.1469-8986.1980.tb02296.x; World Health Organization web site, BMI CLASS TABL 1 INT; Yaroslavsky I, 2013, BIOL PSYCHOL, V94, P272, DOI 10.1016/j.biopsycho.2013.06.008; Yaroslavsky I, 2013, J ABNORM PSYCHOL, V122, P314, DOI 10.1037/a0032385; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012	84	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75758	10.1371/journal.pone.0075758	http://dx.doi.org/10.1371/journal.pone.0075758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231OR	24098397	gold, Green Submitted, Green Published			2022-12-27	WOS:000325427100021
J	White, DA; Fang, L; Chan, W; Morand, EF; Kiriazis, H; Duffy, SJ; Taylor, AJ; Dart, AM; Du, XJ; Gao, XM				White, David A.; Fang, Lu; Chan, William; Morand, Eric F.; Kiriazis, Helen; Duffy, Stephen J.; Taylor, Andrew J.; Dart, Anthony M.; Du, Xiao-Jun; Gao, Xiao-Ming			Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; TARGETED DELETION; PLASMA-LEVELS; EXPRESSION; RECEPTOR; ELEVATION; CYTOKINE; THERAPY; RUPTURE; PROFILE	Objectives: Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, has been implicated in the pathogenesis of multiple inflammatory disorders. We determined changes in circulating MIF levels, explored the cellular source of MIF, and studied the role of MIF in mediating inflammatory responses following acute myocardial infarction (MI). Methods and Results: We recruited 15 patients with MI, 10 patients with stable angina and 10 healthy volunteers and measured temporal changes of MIF in plasma. Expression of MIF, matrix metalloproteinase-9 (MMP-9) and interleukin-6 (IL-6) in cultured peripheral blood mononuclear cells (PBMCs) and the media were measured by ELISA or real-time PCR. Compared to controls, plasma levels of MIF and IL-6 were significantly elevated at admission and 72 h post-MI. In contrast, expression of MIF, MMP-9 and IL-6 by PBMCs from MI patients was unchanged at admission, but significantly increased at 72 h. Addition of MIF activated cultured PBMCs by upregulating expression of inflammatory molecules and also synergistically enhanced stimulatory action of IL-1 beta which were inhibited by anti-MIF interventions. In a mouse MI model we observed similar changes in circulating MIF as seen in patients, with reciprocal significant increases in plasma MIF and reduction of MIF content in the infarct myocardium at 3 h after MI. MIF content in the infarct myocardium was restored at 72 h post-MI and was associated with robust macrophage infiltration. Further, anti-MIF intervention significantly reduced inflammatory cell infiltration and expression of monocyte chemoattractant protein-1 at 24 h and incidence of cardiac rupture in mice post-MI. Conclusion: MI leads to a rapid release of MIF from the myocardium into circulation. Subsequently MIF facilitates PBMC production of pro-inflammatory mediators and myocardial inflammatory infiltration. Attenuation of these events, and post-MI cardiac rupture, by anti-MIF interventions suggests that MIF could be a potential therapeutic target following MI.	[White, David A.; Fang, Lu; Kiriazis, Helen; Dart, Anthony M.; Du, Xiao-Jun; Gao, Xiao-Ming] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Chan, William; Duffy, Stephen J.; Taylor, Andrew J.; Dart, Anthony M.] Alfred Hosp, Dept Cardiovasc Med, Melbourne, Vic, Australia; [Morand, Eric F.] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic 3004, Australia; [White, David A.; Duffy, Stephen J.; Taylor, Andrew J.; Dart, Anthony M.; Du, Xiao-Jun] Monash Univ, Dept Med, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Gao, Xiao-Ming] Monash Univ, Dept Surg, Cent Clin Sch, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Monash University	Du, XJ (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	xiao-jun.du@bakeridi.edu.au; xiaoming.gao@bakeridi.edu.au	Morand, Eric F/I-4718-2013; Morand, Eric/AAT-3259-2021	Morand, Eric F/0000-0002-9507-3338; Morand, Eric/0000-0002-9507-3338; Taylor, Andrew/0000-0001-8920-7670	National Health and Medical Research Council (NHMRC) of Australia [ID472628, ID1004235, ID47260]; Victorian Government's Operational Infrastructure Support Program; Australian National Heart Foundation [PB 10M 5481]; NHMRC of Australia Early Career Fellowship [APP1052960]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Australian National Heart Foundation(National Heart Foundation of Australia); NHMRC of Australia Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants (ID472628 to XMG, ID1004235 to XJD) and a program grant (ID47260) from National Health and Medical Research Council (NHMRC) of Australia and also supported in part by the Victorian Government's Operational Infrastructure Support Program. DW is a recipient of an Australian National Heart Foundation PhD Scholarship (PB 10M 5481). WC is supported by the NHMRC of Australia Early Career Fellowship (Neil Hamilton Fairley - Clinical Overseas Fellowship) (APP1052960). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benigni F, 2000, J CLIN INVEST, V106, P1291, DOI 10.1172/JCI9900; BULKLEY BH, 1974, AM J MED, V56, P244, DOI 10.1016/0002-9343(74)90603-2; Buratti T, 2001, INFLAMMATION, V25, P97, DOI 10.1023/A:1007166521791; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cao WG, 2005, BIOL REPROD, V73, P565, DOI 10.1095/biolreprod.104.038331; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Cvetkovic I, 2006, INT IMMUNOPHARMACOL, V6, P1527, DOI 10.1016/j.intimp.2006.06.009; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Fang L, 2010, CLIN SCI, V119, P175, DOI 10.1042/CS20100011; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Gao XM, 2000, CARDIOVASC RES, V45, P330, DOI 10.1016/S0008-6363(99)00274-6; Gao XM, 2005, AM J PHYSIOL-HEART C, V288, pH2702, DOI 10.1152/ajpheart.00836.2004; Gao XM, 2005, CARDIOVASC RES, V65, P469, DOI 10.1016/j.cardiores.2004.10.014; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Grzybowski M, 2004, ACAD EMERG MED, V11, P1049, DOI 10.1197/j.aem.2004.06.005; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Hoi Alberta Y., 2007, Inflammation & Allergy Drug Targets, V6, P183, DOI 10.2174/187152807781696455; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Kong YZ, 2005, ATHEROSCLEROSIS, V178, P207, DOI 10.1016/j.atherosclerosis.2004.08.030; Lindsey M, 2001, CIRCULATION, V103, P2181; Liu Y, 2011, ARTERIOSCL THROM VAS, V31, P834, DOI 10.1161/ATVBAHA.110.220467; Lu F, 2007, J MOL CELL CARDIOL, V43, P535, DOI 10.1016/j.yjmcc.2007.06.011; Maekawa Y, 2002, J AM COLL CARDIOL, V39, P241, DOI 10.1016/S0735-1097(01)01721-1; Makino A, 2010, ATHEROSCLEROSIS, V213, P573, DOI 10.1016/j.atherosclerosis.2010.09.004; Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Muller II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038376; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Ren Guofeng, 2003, Current Drug Targets - Inflammation and Allergy, V2, P242, DOI 10.2174/1568010033484098; ROBERTS R, 1976, CIRCULATION, V53, P204; Sobierajski J, 2013, FREE RADICAL BIO MED, V63, P236, DOI 10.1016/j.freeradbiomed.2013.05.018; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Takahashi M, 2002, AM J CARDIOL, V89, P248, DOI 10.1016/S0002-9149(01)02251-2; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Webb CS, 2006, CIRCULATION, V114, P1020, DOI 10.1161/CIRCULATIONAHA.105.600353; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Yu CM, 2003, J HISTOCHEM CYTOCHEM, V51, P625, DOI 10.1177/002215540305100508; Yu CM, 2001, AM J CARDIOL, V88, P774, DOI 10.1016/S0002-9149(01)01850-1	48	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76206	10.1371/journal.pone.0076206	http://dx.doi.org/10.1371/journal.pone.0076206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098445	Green Published, gold			2022-12-27	WOS:000325427100048
J	Chopra, M; Lang, I; Salzmann, S; Pachel, C; Kraus, S; Bauerlein, CA; Brede, C; Garrote, ALJ; Mattenheimer, K; Ritz, M; Schwinn, S; Graf, C; Schafer, V; Frantz, S; Einsele, H; Wajant, H; Beilhack, A				Chopra, Martin; Lang, Isabell; Salzmann, Steffen; Pachel, Christina; Kraus, Sabrina; Baeuerlein, Carina A.; Brede, Christian; Garrote, Ana-Laura Jordan; Mattenheimer, Katharina; Ritz, Miriam; Schwinn, Stefanie; Graf, Carolin; Schaefer, Viktoria; Frantz, Stefan; Einsele, Hermann; Wajant, Harald; Beilhack, Andreas			Tumor Necrosis Factor Induces Tumor Promoting and Anti-Tumoral Effects on Pancreatic Cancer via TNFR1	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; DUCTAL ADENOCARCINOMA; INCREASED EXPRESSION; EXPERIMENTAL METASTASIS; SIGNALING PATHWAYS; ADJUVANT TREATMENT; FACTOR RECEPTOR; T-CELLS; CARCINOMA	Multiple activities are ascribed to the cytokine tumor necrosis factor (TNF) in health and disease. In particular, TNF was shown to affect carcinogenesis in multiple ways. This cytokine acts via the activation of two cell surface receptors, TNFR1, which is associated with inflammation, and TNFR2, which was shown to cause anti-inflammatory signaling. We assessed the effects of TNF and its two receptors on the progression of pancreatic cancer by in vivo bioluminescence imaging in a syngeneic orthotopic tumor mouse model with Panc02 cells. Mice deficient for TNFR1 were unable to spontaneously reject Panc02 tumors and furthermore displayed enhanced tumor progression. In contrast, a fraction of wild type (37.5%), TNF deficient (12.5%), and TNFR2 deficient mice (22.2%) were able to fully reject the tumor within two weeks. Pancreatic tumors in TNFR1 deficient mice displayed increased vascular density, enhanced infiltration of CD4(+) T cells and CD4(+) forkhead box P3 (FoxP3)(+) regulatory T cells (T-reg) but reduced numbers of CD8(+) T cells. These alterations were further accompanied by transcriptional upregulation of IL4. Thus, TNF and TNFR1 are required in pancreatic ductal carcinoma to ensure optimal CD8(+) T cell-mediated immunosurveillance and tumor rejection. Exogenous systemic administration of human TNF, however, which only interacts with murine TNFR1, accelerated tumor progression. This suggests that TNFR1 has basically the capability in the Panc02 model to trigger pro-and anti-tumoral effects but the spatiotemporal availability of TNF seems to determine finally the overall outcome.	[Chopra, Martin; Kraus, Sabrina; Baeuerlein, Carina A.; Brede, Christian; Garrote, Ana-Laura Jordan; Mattenheimer, Katharina; Ritz, Miriam; Schwinn, Stefanie; Graf, Carolin; Einsele, Hermann; Beilhack, Andreas] Wurzburg Univ Clin, Dept Internal Med 2, Wurzburg, Germany; [Chopra, Martin; Kraus, Sabrina; Baeuerlein, Carina A.; Brede, Christian; Garrote, Ana-Laura Jordan; Mattenheimer, Katharina; Ritz, Miriam; Schwinn, Stefanie; Graf, Carolin; Beilhack, Andreas] Univ Wurzburg, Ctr Interdisciplinary Clin Res, D-97070 Wurzburg, Germany; [Lang, Isabell; Salzmann, Steffen; Schaefer, Viktoria; Wajant, Harald] Wurzburg Univ Clin, Dept Internal Med 2, Div Mol Internal Med, Wurzburg, Germany; [Pachel, Christina; Frantz, Stefan] Wurzburg Univ Clin, Dept Internal Med 1, Wurzburg, Germany; [Pachel, Christina; Frantz, Stefan] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Beilhack, A (corresponding author), Wurzburg Univ Clin, Dept Internal Med 2, Wurzburg, Germany.	beilhack_a@ukw.de	Wajant, Harald/A-3020-2017; Frantz, Stefan/G-1723-2012	Wajant, Harald/0000-0002-2005-3949; Kraus, Sabrina/0000-0001-8954-4220; Lang, Isabell/0000-0002-6369-4973	Interdisziplinare Zentrum fur Klinische Forschung der Universitat Wurzburg [B-149, B-233]; Deutsche Jose Carreras Leukamie-Stiftung e.V. [R/06/17]; Deutsche Forschungsgemeinschaft [SFBTR 52 Z2, Wa 1025/18-1, KFO 216 TP8, Ma 760/19-1]; Else-Kroner-Fresenius-Stiftung [2010_Kolleg.52]	Interdisziplinare Zentrum fur Klinische Forschung der Universitat Wurzburg; Deutsche Jose Carreras Leukamie-Stiftung e.V.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung	This work was supported by the Interdisziplinare Zentrum fur Klinische Forschung der Universitat Wurzburg [grants B-149, B-233], Deutsche Jose Carreras Leukamie-Stiftung e.V. (R/06/17), the Deutsche Forschungsgemeinschaft [grants SFBTR 52 Z2, Wa 1025/18-1, KFO 216 TP8, and Ma 760/19-1] and the Else-Kroner-Fresenius-Stiftung (2010_Kolleg.52). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariapart P, 2002, PANCREATOLOGY, V2, P491, DOI 10.1159/000064719; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Chandler NM, 2004, J SURG RES, V118, P9, DOI 10.1016/S0022-4804(03)00354-8; Chee J, 2011, J IMMUNOL, V187, P1702, DOI 10.4049/jimmunol.1100511; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Chopra M, 2013, CARCINOGENESIS, V34, P1296, DOI 10.1093/carcin/bgt038; Conroy T, 2011, CURR OPIN ONCOL, V23, P390, DOI 10.1097/CCO.0b013e3283473610; CORBETT TH, 1984, CANCER RES, V44, P717; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Franco L, 2004, PROSTAG OTH LIPID M, V73, P51, DOI 10.1016/j.prostaglandins.2003.12.001; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Furukawa K, 2011, CANCER LETT, V306, P92, DOI 10.1016/j.canlet.2011.02.036; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hafner M, 1996, INT J CANCER, V66, P388; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kawakami K, 2002, CANCER RES, V62, P3575; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; McCleary-Wheeler AL, 2012, MOL CARCINOGEN, V51, P25, DOI 10.1002/mc.20827; Mochizuki Y, 2004, CLIN EXP METASTAS, V21, P39, DOI 10.1023/B:CLIN.0000017181.01474.35; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Murugesan SR, 2009, CANCER GENE THER, V16, P841, DOI 10.1038/cgt.2009.32; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; OROSZ P, 1993, J EXP MED, V177, P1391, DOI 10.1084/jem.177.5.1391; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Prokopchuk O, 2005, BRIT J CANCER, V92, P921, DOI 10.1038/sj.bjc.6602416; Roder C, 2011, EUR J CELL BIOL, V90, P450, DOI 10.1016/j.ejcb.2010.10.008; Schneider G, 2008, ANTICANCER RES, V28, P1541; Takahashi M, 2008, CARCINOGENESIS, V29, P1608, DOI 10.1093/carcin/bgn152; Tepel J, 2004, PANCREAS, V28, P1, DOI 10.1097/00006676-200401000-00001; Tepel J, 2006, PANCREATOLOGY, V6, P240, DOI 10.1159/000092027; Van Laethem JL, 2012, ANN ONCOL, V23, P570, DOI 10.1093/annonc/mdr351; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Wang WX, 1999, CLIN CANCER RES, V5, P119	40	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75737	10.1371/journal.pone.0075737	http://dx.doi.org/10.1371/journal.pone.0075737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098720	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500091
J	Comer, C; Redmond, AC; Bird, HA; Hensor, EMA; Conaghan, PG				Comer, Christine; Redmond, Anthony C.; Bird, Howard A.; Hensor, Elizabeth M. A.; Conaghan, Philip G.			A Home Exercise Programme Is No More Beneficial than Advice and Education for People with Neurogenic Claudication: Results from a Randomised Controlled Trial	PLOS ONE			English	Article							LUMBAR SPINAL STENOSIS; OSWESTRY DISABILITY INDEX; MANAGEMENT; SURGERY; WELL	Objective: To compare the effectiveness of a physiotherapy programme with a control treatment of advice and education in patients with neurogenic claudication symptoms. Design: Pragmatic randomised controlled clinical trial. Setting: Primary care-based musculoskeletal service. Patients: Adults aged 50 or over with neurogenic claudication symptoms causing limitation of walking. Interventions: Condition-specific home exercises combined with advice and education, or advice and education alone. Main outcome measures: The primary outcome was the difference in improvement of symptom severity scores on the Swiss Spinal Stenosis Scale at eight weeks. Secondary outcomes included measures of physical function, pain and general well-being at eight weeks and 12 months. Results: There was no significant difference between groups in the Swiss Spinal Stenosis symptom severity scale at eight weeks (t = 0.47, p = 0.643): mean change (SD) control group -0.18 (0.47), treatment group -0.10 (0.66), difference (95% CI) 0.08 (-0.19, 0.35); baseline-adjusted difference 0.06 (-0.19, 0.31)]. An unplanned subgroup analysis suggested that for patients with the top 25% of baseline symptom severity scores, the physiotherapy exercise programme resulted in an improvement in the primary outcome, and modest but consistently better secondary outcomes at both time-points compared to the control group. The effectiveness in different subgroups requires further direct evaluation. Conclusions: In the treatment of patients with neurogenic claudication symptoms, a physiotherapist-prescribed home exercise programme is no more effective than advice and education. Ethical approval: The study was approved by Leeds Central Ethics Committee and informed consent was given by all participating patients. Copyright: The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, a worldwide licence to the Publishers and its licensees in perpetuity, in all forms, formats and media (whether known now or created in the future), to i) publish, reproduce, distribute, display and store the Contribution, ii) translate the Contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or, abstracts of the Contribution, iii) create any other derivative work(s) based on the Contribution, iv) to exploit all subsidiary rights in the Contribution, v) the inclusion of electronic links from the Contribution to third party material where-ever it may be located; and, vi) licence any third party to do any or all of the above. Trial registration: ISRCTN 78288224 - doi10.1186/ISRCTN35836727; UKCRN 4814.	[Comer, Christine] Leeds Community Healthcare, Leeds Musculoskeletal & Rehabil Serv, Leeds, W Yorkshire, England; [Comer, Christine; Redmond, Anthony C.; Bird, Howard A.; Hensor, Elizabeth M. A.; Conaghan, Philip G.] Univ Leeds, Fac Hlth, Leeds Inst Rheumat & Musculoskeletal Dis, Leeds, W Yorkshire, England; [Redmond, Anthony C.; Hensor, Elizabeth M. A.; Conaghan, Philip G.] Leeds Teaching Hosp Natl Hlth Serv Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England	University of Leeds; Leeds Biomedical Research Centre	Conaghan, PG (corresponding author), Univ Leeds, Fac Hlth, Leeds Inst Rheumat & Musculoskeletal Dis, Leeds, W Yorkshire, England.	p.conaghan@leeds.ac.uk	Redmond, Anthony C/E-2452-2018	Hensor, Elizabeth/0000-0002-5245-4755; Conaghan, Philip/0000-0002-3478-5665	Arthritis Research UK [18183]; National Institute for Health Research [PDA/03/07/047] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by project grant 18183 from Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMUNDSEN T, 1995, SPINE, V20, P1178, DOI 10.1097/00007632-199505150-00013; Berger VW, 1999, CONTROL CLIN TRIALS, V20, P319, DOI 10.1016/S0197-2456(99)00014-8; Bodack MP, 2001, CLIN ORTHOP RELAT R, P144; Campbell H, 2006, SPINE, V31, P815, DOI 10.1097/01.brs.0000207257.64215.03; Comer CM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-121; Deyle GD, 2005, PHYS THER, V85, P1301, DOI 10.1093/ptj/85.12.1301; Duarte M, 2002, J AM CHIROPRACTIC AS, V39, P18; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Gaston JE, 2005, QUAL LIFE RES, V14, P71, DOI 10.1007/s11136-004-0793-z; Houedakor J., 2003, Annales de Readaptation et de Medecine Physique, V46, P227, DOI 10.1016/S0168-6054(03)00083-7; Nagler W, 1998, POSTGRAD MED, V103, P69, DOI 10.3810/pgm.1998.04.452; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; Porter RW, 1996, SPINE, V21, P2046, DOI 10.1097/00007632-199609010-00024; Pratt RK, 2002, SPINE, V27, P84, DOI 10.1097/00007632-200201010-00020; Rittenberg Joshua D, 2003, Phys Med Rehabil Clin N Am, V14, P111, DOI 10.1016/S1047-9651(02)00082-7; Scannell JP, 2003, PHYS THER, V83, P907, DOI 10.1093/ptj/83.10.907; Simotas AC, 2001, CLIN ORTHOP RELAT R, P153; Stucki G, 1996, SPINE, V21, P796, DOI 10.1097/00007632-199604010-00004; Taylor S, 2001, Physiother Res Int, V6, P170, DOI 10.1002/pri.225; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tuli SK, 2006, SPINE, V31, P1276, DOI 10.1097/01.brs.0000217615.20018.6c; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981; Whitman JM, 2006, SPINE, V31, P2541, DOI 10.1097/01.brs.0000241136.98159.8c; Zeifang F, 2003, ORTHOPADE, V32, P906, DOI 10.1007/s00132-003-0567-2; Zigmond AS, 1983, PSYCHIAT SCAND, V76, P361, DOI [DOI 10.1111/J.1600-0447.1983.TB09716.X, DOI 10.1111/J.1600-0447.1983.TB09716.X.PUBMED:6880820]; Zucherman JF, 2005, SPINE, V30, P1351, DOI 10.1097/01.brs.0000166618.42749.d1	27	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e72878	10.1371/journal.pone.0072878	http://dx.doi.org/10.1371/journal.pone.0072878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098633	gold, Green Published			2022-12-27	WOS:000325423500005
J	Huang, HL; Cheng, F; Wang, RA; Zhang, DB; Yang, LT				Huang, Huali; Cheng, Fang; Wang, Ruoan; Zhang, Dabing; Yang, Litao			Evaluation of Four Endogenous Reference Genes and Their Real-Time PCR Assays for Common Wheat Quantification in GMOs Detection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENETICALLY-MODIFIED ORGANISMS; QUANTITATION; CHALLENGES; BARLEY; RICE	Proper selection of endogenous reference genes and their real-time PCR assays is quite important in genetically modified organisms (GMOs) detection. To find a suitable endogenous reference gene and its real-time PCR assay for common wheat (Triticum aestivum L.) DNA content or copy number quantification, four previously reported wheat endogenous reference genes and their real-time PCR assays were comprehensively evaluated for the target gene sequence variation and their real-time PCR performance among 37 common wheat lines. Three SNPs were observed in the PKABA1 and ALMT1 genes, and these SNPs significantly decreased the efficiency of real-time PCR amplification. GeNorm analysis of the real-time PCR performance of each gene among common wheat lines showed that the Waxy-D1 assay had the lowest M values with the best stability among all tested lines. All results indicated that the Waxy-D1 gene and its real-time PCR assay were most suitable to be used as an endogenous reference gene for common wheat DNA content quantification. The validated Waxy-D1 gene assay will be useful in establishing accurate and creditable qualitative and quantitative PCR analysis of GM wheat.	[Huang, Huali; Cheng, Fang; Wang, Ruoan; Zhang, Dabing; Yang, Litao] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, SJTU Bor Luh Food Safety Ctr, Natl Ctr Mol Characterizat Genetically Modified O, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yang, LT (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, SJTU Bor Luh Food Safety Ctr, Natl Ctr Mol Characterizat Genetically Modified O, Shanghai 200030, Peoples R China.	yylltt@sjtu.edu.cn	Zhang, Dabing/AAR-6473-2020	Yang, Litao/0000-0002-4515-5722	National Transgenic Plant Special Fund 339 [2013ZX08012-003]; Shanghai Ring Star project [11QA1403300]	National Transgenic Plant Special Fund 339; Shanghai Ring Star project	This work was supported by the National Transgenic Plant Special Fund 339 (2013ZX08012-003) and Shanghai Ring Star project (11QA1403300). The funders joined the experiment design and sample collection.	Ahmed FE, 2002, TRENDS BIOTECHNOL, V20, P215, DOI 10.1016/S0167-7799(01)01920-5; Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110; [Anonymous], 2003, OFF J EUR UNION, V46, P268; Bhalla PL, 2006, TRENDS BIOTECHNOL, V24, P305, DOI 10.1016/j.tibtech.2006.04.008; Broothaerts W, 2008, J AGR FOOD CHEM, V56, P8825, DOI 10.1021/jf801636d; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Elenis DS, 2008, ANAL BIOANAL CHEM, V392, P347, DOI 10.1007/s00216-008-1868-4; Ghedira R, 2009, J AGR FOOD CHEM, V57, P9370, DOI 10.1021/jf901976a; Guo JC, 2011, ANAL CHEM, V83, P1579, DOI 10.1021/ac103266w; Hernandez M, 2005, J AGR FOOD CHEM, V53, P7003, DOI 10.1021/jf050797j; Hernandez M, 2001, J AGR FOOD CHEM, V49, P3622, DOI 10.1021/jf010173n; Iida M, 2005, J AGR FOOD CHEM, V53, P6294, DOI 10.1021/jf0505731; Jones HD, 2005, J CEREAL SCI, V41, P137, DOI 10.1016/j.jcs.2004.08.009; Klungthong C, 2010, J CLIN VIROL, V48, P91, DOI 10.1016/j.jcv.2010.03.012; Obert JC, 2004, J AGR FOOD CHEM, V52, P1375, DOI 10.1021/jf035218u; Papazova N, 2010, ANAL BIOANAL CHEM, V396, P2189, DOI 10.1007/s00216-009-3386-4; Querci M, 2010, ANAL BIOANAL CHEM, V396, P1991, DOI 10.1007/s00216-009-3237-3; Ronning SB, 2006, J AGR FOOD CHEM, V54, P682, DOI 10.1021/jf052328n; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vautrin S, 2007, J AOAC INT, V90, P794; Wang C, 2010, J AGR FOOD CHEM, V58, P11543, DOI 10.1021/jf102092c; Xia LQ, 2012, J EXP BOT, V63, P1785, DOI 10.1093/jxb/err342; Zhang DB, 2011, J INTEGR PLANT BIOL, V53, P539, DOI 10.1111/j.1744-7909.2011.01060.x; Zhang M, 2013, ANAL CHEM, V85, P75, DOI 10.1021/ac301640p	25	5	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75850	10.1371/journal.pone.0075850	http://dx.doi.org/10.1371/journal.pone.0075850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098735	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500106
J	Jung, CH; Lee, MJ; Hwang, JY; Jang, JE; Leem, J; Park, JY; Lee, J; Kim, HK; Lee, WJ				Jung, Chang Hee; Lee, Min Jung; Hwang, Jenie Yoonoo; Jang, Jung Eun; Leem, Jaechan; Park, Joong-Yeol; Lee, JungBok; Kim, Hong-Kyu; Lee, Woo Je			Elevated Serum Ferritin Level Is Associated with the Incident Type 2 Diabetes in Healthy Korean Men: A 4 Year Longitudinal Study	PLOS ONE			English	Article							BODY IRON STORES; INSULIN-RESISTANCE SYNDROME; METABOLIC SYNDROME; RISK; POPULATION; WOMEN; TRANSFERRIN; NUTRITION; MELLITUS; ADULTS	Background: Elevated ferritin concentration has been implicated in the etiology of type 2 diabetes. Accumulating evidence, mostly from studies conducted on western populations, has demonstrated a strong association between the elevated ferritin concentrations and incident type 2 diabetes. In Asian populations, however, the longitudinal studies investigating the association of elevated serum ferritin levels and type 2 diabetes are lacking. In present study, we aimed to determine whether elevated serum ferritin levels are related to the incident type 2 diabetes in healthy Korean men. Methodology/Principal Findings: This 4 year longitudinal observational study was conducted at the Asan Medical Center, Seoul, Republic of Korea. The study population consisted of 2,029 men without type 2 diabetes who underwent routine health examination in 2007 (baseline) and 2011 (follow-up). Baseline serum ferritin concentrations were measured by chemiluminescent two-site sandwich immunoassay. In multiple-adjusted model, the relative risk (RR) for incident type 2 diabetes was significantly higher in highest compared with the lowest ferritin quartile category, even after adjusting for confounding variables including homeostasis model assessment of insulin resistance (RR = 2.17, 95% confidence interval 1.27-3.72, P for trend = 0.013). Conclusions/Significance: These results demonstrated that elevated level of serum ferritin at baseline was associated with incident type 2 diabetes in an Asian population.	[Jung, Chang Hee; Lee, Min Jung; Jang, Jung Eun; Leem, Jaechan; Park, Joong-Yeol; Lee, Woo Je] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Hwang, Jenie Yoonoo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Int Healthcare Ctr, Seoul, South Korea; [Lee, JungBok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Kim, Hong-Kyu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening & Promot Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, HK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hlth Screening & Promot Ctr, Seoul, South Korea.	hkkim0801@amc.seoul.kr; lwjatlas@naver.com	Leem, Jaechan/AAQ-6648-2020; Jung, Chang Hee/AAU-7897-2020	Jung, Chang Hee/0000-0003-4043-2396; Leem, Jaechan/0000-0003-2329-4374				Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bao W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-119; Carlson MDA, 2009, J PALLIAT MED, V12, P77, DOI 10.1089/jpm.2008.9690; Dekker LH, 2013, DIABETES CARE, V36, P965, DOI 10.2337/dc12-1243; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Fumeron F, 2006, DIABETES CARE, V29, P2090, DOI 10.2337/dc06-0093; Furusyo N, 2011, DIABETOLOGIA, V54, P3028, DOI 10.1007/s00125-011-2310-6; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Harris EL, 2007, ARCH INTERN MED, V167, P722, DOI 10.1001/archinte.167.7.722; Jehn ML, 2007, AM J EPIDEMIOL, V165, P1047, DOI 10.1093/aje/kwk093; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Jung CH, 2013, DIABETIC MED, V30, P428, DOI 10.1111/dme.12104; Kim BJ, 2012, J BONE MINER RES, V27, P2279, DOI 10.1002/jbmr.1692; Kim CH, 2011, METABOLISM, V60, P414, DOI 10.1016/j.metabol.2010.03.007; Kunutsor SK, 2013, DIABETES-METAB RES, V29, P308, DOI 10.1002/dmrr.2394; Lee BK, 2011, METABOLISM, V60, P1416, DOI 10.1016/j.metabol.2011.02.008; Luan DC, 2008, DIABETES CARE, V31, P285, DOI 10.2337/dc07-0921; Ma J, 2002, CLIN CHEM, V48, P601; Malczewska J, 2004, INT J SPORTS MED, V25, P516, DOI 10.1055/s-2004-820952; MERKEL PA, 1988, NEW ENGL J MED, V318, P809, DOI 10.1056/NEJM198803313181303; Montonen J, 2012, DIABETOLOGIA, V55, P2613, DOI 10.1007/s00125-012-2633-y; NIEDERAU C, 1984, DIABETOLOGIA, V26, P441; OBERLEY LW, 1988, FREE RADICAL BIO MED, V5, P113, DOI 10.1016/0891-5849(88)90036-6; Opara EC, 2004, J INVEST MED, V52, P19, DOI 10.1136/jim-52-01-22; Park SK, 2012, DIABETES CARE, V35, P2521, DOI 10.2337/dc12-0543; Piperno A, 2002, J HYPERTENS, V20, P1513, DOI 10.1097/00004872-200208000-00013; Rajpathak SN, 2009, DIABETES OBES METAB, V11, P472, DOI 10.1111/j.1463-1326.2008.00985.x; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; Rushton DH, 2001, BMJ-BRIT MED J, V322, P1355, DOI 10.1136/bmj.322.7298.1355; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; Sheu WHH, 2003, CLIN ENDOCRINOL, V58, P380, DOI 10.1046/j.1365-2265.2003.01729.x; Shi ZM, 2006, DIABETES CARE, V29, P1878, DOI 10.2337/dc06-0327; Shi ZM, 2010, PUBLIC HEALTH NUTR, V13, P1319, DOI 10.1017/S1368980009991868; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Trombini P, 2007, J HEPATOL, V46, P549, DOI 10.1016/j.jhep.2007.01.004; Warnecke RB, 2008, AM J PUBLIC HEALTH, V98, P1608, DOI 10.2105/AJPH.2006.102525; Whitfield JB, 2001, ALCOHOL CLIN EXP RES, V25, P1037, DOI 10.1097/00000374-200107000-00014; Williams KH, 2012, ENDOCR REV, V13, P13; Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004; Zhao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041641	42	37	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75250	10.1371/journal.pone.0075250	http://dx.doi.org/10.1371/journal.pone.0075250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098686	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500057
J	Lepais, O; Muller, SD; Ben Saad-Limam, S; Benslama, M; Rhazi, L; Belouahem-Abed, D; Daoud-Bouattour, A; Gammar, AM; Ghrabi-Gammar, Z; Bacles, CFE				Lepais, Olivier; Muller, Serge D.; Ben Saad-Limam, Samia; Benslama, Mohamed; Rhazi, Laila; Belouahem-Abed, Djamila; Daoud-Bouattour, Amina; Gammar, Amor Mokhtar; Ghrabi-Gammar, Zeineb; Bacles, Cecile Fanny Emilie			High Genetic Diversity and Distinctiveness of Rear-Edge Climate Relicts Maintained by Ancient Tetraploidisation for Alnus glutinosa	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; VEGETATION HISTORY; GLACIAL REFUGIA; POPULATION HISTORY; SEED DISPERSAL; DI-MONTICCHIO; R-PACKAGE; L GAERTN; INFERENCE; ALDER	Populations located at the rear-edge of a species' distribution may have disproportionate ecological and evolutionary importance for biodiversity conservation in a changing global environment. Yet genetic studies of such populations remain rare. This study investigates the evolutionary history of North-African low latitude marginal populations of Alnus glutinosa Gaertn., a European tree species that plays a significant ecological role as a keystone of riparian ecosystems. We genotyped 551 adults from 19 populations located across North Africa at 12 microsatellite loci and applied a coalescent-based simulation approach to reconstruct the demographic and evolutionary history of these populations. Surprisingly, Moroccan trees were tetraploids demonstrating a strong distinctiveness of these populations within a species otherwise known as diploid. Best-fitting models of demographic reconstruction revealed the relict nature of Moroccan populations that were found to have withstood past climate change events and to be much older than Algerian and Tunisian populations. This study highlights the complex demographic history that can be encountered in rear-edge distribution margins that here consist of both old stable climate relict and more recent populations, distinctively diverse genetically both quantitatively and qualitatively. We emphasize the high evolutionary and conservation value of marginal rear-edge populations of a keystone riparian species in the context of on-going climate change in the Mediterranean region.	[Lepais, Olivier; Bacles, Cecile Fanny Emilie] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Lepais, Olivier] INRA, UMR 1224, St Pee Sur Nivelle, France; [Lepais, Olivier] Univ Pau & Pays Adour, UMR 1224, Anglet, France; [Muller, Serge D.] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France; [Ben Saad-Limam, Samia; Daoud-Bouattour, Amina] Univ Tunis El Manar, Fac Sci Tunis, Dept Biol, Tunis, Tunisia; [Ben Saad-Limam, Samia; Daoud-Bouattour, Amina; Gammar, Amor Mokhtar; Ghrabi-Gammar, Zeineb] Univ Manouba, UR Biogeog Climatol Appl & Dynam Eros, Fac Lettres Arts & Humanites Manouba, Manouba, Tunisia; [Benslama, Mohamed] Univ Badji Mokhtar, Lab Biol Veg & Environm, Annaba, Algeria; [Rhazi, Laila] Univ Hassan II Casablanca, Fac Sci Ain Chock, Lab Ecol Aquat & Environm, Casablanca, Morocco; [Belouahem-Abed, Djamila] Inst Natl Rech Forestiere, Stn Rech, El Kala, Algeria; [Ghrabi-Gammar, Zeineb] Univ Carthage, Inst Natl Agron Tunisie, Tunis, Tunisia	University of Stirling; INRAE; Universite de Pau et des Pays de l'Adour; Universite de Pau et des Pays de l'Adour; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite de la Manouba; Universite Badji Mokhtar - Annaba; Hassan II University of Casablanca; Universite de Carthage	Lepais, O (corresponding author), Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland.	olepais@st-pee.inra.fr	Lepais, Olivier/D-1849-2009; Rhazi, Laila/AAQ-1459-2020; Bacles, Cecile FE/D-3093-2010	Lepais, Olivier/0000-0002-6102-9478; Bacles, Cecile FE/0000-0002-1061-1898	Leverhulme Trust; University of Stirling Strategic Research Development Fund [ECF/2010/0166]; Natural Environmental Research Council [NE/H012435/1]; Projects Hubert Curien	Leverhulme Trust(Leverhulme Trust); University of Stirling Strategic Research Development Fund; Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Projects Hubert Curien	Molecular analyses and manuscript elaboration benefited from funding by the Leverhulme Trust (http://www.leverhulme.ac.uk/) and the University of Stirling Strategic Research Development Fund (http://www.stir.ac.uk/) in the form of a Leverhulme Early Career Fellowship ECF/2010/0166 awarded to OL and a Natural Environmental Research Council (http://www.nerc.ac.uk/) Grant NE/H012435/1 awarded to CFEB. Material collection in North Africa was funded by three Projects Hubert Curien (http://www.egide.asso.fr/jahia/Jahia/accueil/appels/phc/general) coordinated by SDM, together with SBSL, MB and LR, respectively in Tunisia (PHC Utique 07G0908), Algeria (PHC Tassili 09mdu786) and Morocco (PHC Volubilis MA/07/172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2009, J HERED, V100, P394, DOI 10.1093/jhered/esn110; [Anonymous], 2010, R LANG ENV STAT COMP; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Barthelmes A, 2006, REV PALAEOBOT PALYNO, V141, P33, DOI 10.1016/j.revpalbo.2006.04.002; Beaumont MA, 2002, GENETICS, V162, P2025; Ben Tiba B., 1982, ECOL MEDITERR, V8, P75; BENNETT KD, 1990, J QUATERNARY SCI, V5, P123, DOI 10.1002/jqs.3390050204; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Benslama M, 2010, CR BIOL, V333, P744, DOI 10.1016/j.crvi.2010.08.002; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; BURJACHS F, 1994, QUATERNARY RES, V42, P308, DOI 10.1006/qres.1994.1081; CHAKRABORTY R, 1993, EXS, V67, P153; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; DAVID F, 1993, CR ACAD SCI II, V316, P1815; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hampe A, 2011, ACTA OECOL, V37, P666, DOI 10.1016/j.actao.2011.05.001; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hofstetter S, 2006, VEG HIST ARCHAEOBOT, V15, P87, DOI 10.1007/s00334-005-0005-y; Husband BC, 1997, EVOLUTION, V51, P737, DOI [10.2307/2411150, 10.1111/j.1558-5646.1997.tb03657.x]; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; JOHNSSON H, 1950, HEREDITAS, V36, P205; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; King RA, 1998, MOL ECOL, V7, P1151, DOI 10.1046/j.1365-294x.1998.00432.x; Landergott U, 2006, THEOR APPL GENET, V113, P453, DOI 10.1007/s00122-006-0310-6; Lepais O, 2011, J HERED, V102, P627, DOI 10.1093/jhered/esr062; Loader CR, 1996, ANN STAT, V24, P1602; LYNCH M, 1990, MOL BIOL EVOL, V7, P478; Macaya-Sanz D, 2012, MOL ECOL, V21, P3593, DOI 10.1111/j.1365-294X.2012.05619.x; MCVEAN DN, 1953, J ECOL, V41, P447, DOI 10.2307/2257070; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; PONS A, 1988, PALAEOGEOGR PALAEOCL, V66, P243, DOI 10.1016/0031-0182(88)90202-7; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rausch JH, 2005, EVOLUTION, V59, P1867; Reille M, 1997, NEW PHYTOL, V135, P547, DOI 10.1046/j.1469-8137.1997.00683.x; Reille M., 1977, B AFEQ INQUA S, V50, P53; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stambouli-Essassi S., 2007, Geo-Eco-Trop, V31, P171; STEBBINS GL, 1984, BOT HELV, V94, P1; Stift M, 2008, GENETICS, V179, P2113, DOI 10.1534/genetics.107.085027; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TALLANTIRE PA, 1974, NEW PHYTOL, V73, P529, DOI 10.1111/j.1469-8137.1974.tb02131.x; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Vallejo-Marin M, 2013, HEREDITY, V110, P111, DOI 10.1038/hdy.2012.91; Van Zeist W., 1975, PALAEOHISTORIA, V17, P53; Watts WA, 1996, QUATERNARY SCI REV, V15, P133, DOI 10.1016/0277-3791(95)00093-3; Watts WA, 1996, QUATERNARY SCI REV, V15, P113, DOI 10.1016/0277-3791(95)00038-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; WIJMSTRA TA, 1969, ACTA BOT NEERL, V18, P511, DOI 10.1111/j.1438-8677.1969.tb00591.x; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002	74	42	43	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75029	10.1371/journal.pone.0075029	http://dx.doi.org/10.1371/journal.pone.0075029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098677	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500048
J	Liao, YWK; Sun, ZH; Zhou, YH; Shi, K; Li, X; Zhang, GQ; Xia, XJ; Chen, ZX; Yu, JQ				Liao, Yang-Wen-Ke; Sun, Zeng-Hui; Zhou, Yan-Hong; Shi, Kai; Li, Xin; Zhang, Guan-Qun; Xia, Xiao-Jian; Chen, Zhi-Xiang; Yu, Jing-Quan			The Role of Hydrogen Peroxide and Nitric Oxide in the Induction of Plant-Encoded RNA-Dependent RNA Polymerase 1 in the Basal Defense against Tobacco Mosaic Virus	PLOS ONE			English	Article							SALICYLIC-ACID; ARABIDOPSIS; H2O2; CATALASE; LEVEL; GENE; TRANSCRIPTION; ACCUMULATION; GENERATION; RESISTANCE	Plant RNA-dependent RNA Polymerase 1 (RDR1) is an important element of the RNA silencing pathway in the plant defense against viruses. RDR1 expression can be elicited by viral infection and salicylic acid (SA), but the mechanisms of signaling during this process remains undefined. The involvement of hydrogen peroxide (H2O2) and nitric oxide (NO) in RDR1 induction in the compatible interactions between Tobacco mosaic tobamovirus (TMV) and Nicotiana tabacum, Nicotiana benthamiana, and Arabidopsis thaliana was examined. TMV inoculation onto the lower leaves of N. tabacum induced the rapid accumulation of H2O2 and NO followed by the increased accumulation of RDR1 transcripts in the non-inoculated upper leaves. Pretreatment with exogenous H2O2 and NO on upper leaf led to increased RDR1 expression and systemic TMV resistance. Conversely, dimethylthiourea (an H2O2 scavenger) and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (an NO scavenger) partly blocked TMV- and SA-induced RDR1 expression and increased TMV susceptibility, whereas pretreatment with exogenous H2O2 and NO failed to diminish TMV infection in N. benthamiana plants with naturally occurring RDR1 loss-of-function. Furthermore, in N. tabacum and A. thaliana, TMV-induced H2O2 accumulation was NO-dependent, whereas NO generation was not affected by H2O2. These results suggest that, in response to TMV infection, H2O2 acts downstream of NO to mediate induction of RDR1, which plays a critical role in strengthening RNA silencing to restrict systemic viral infection.	[Liao, Yang-Wen-Ke; Sun, Zeng-Hui; Zhou, Yan-Hong; Shi, Kai; Li, Xin; Zhang, Guan-Qun; Xia, Xiao-Jian; Chen, Zhi-Xiang; Yu, Jing-Quan] Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Jing-Quan] Agr Minist China, Key Lab Hort Plants Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China; [Chen, Zhi-Xiang] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Zhejiang University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shi, K (corresponding author), Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China.	kaishi@zju.edu.cn	Yu, J.Q./C-9509-2015	Yu, J.Q./0000-0002-7626-1165	National Basic Research Program of China [2009CB119000]; National Natural Science Foundation of China [31071832]; National Key Technology R&D Program of China [2011BAD12B04, 2013AA102406]; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (2009CB119000), the National Natural Science Foundation of China (31071832), the National Key Technology R&D Program of China (2011BAD12B04, 2013AA102406) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Clark D, 2000, MOL PLANT MICROBE IN, V13, P1380, DOI 10.1094/MPMI.2000.13.12.1380; Cui JX, 2011, PLANT CELL ENVIRON, V34, P347, DOI 10.1111/j.1365-3040.2010.02248.x; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Floryszak-Wieczorek J, 2007, NEW PHYTOL, V175, P718, DOI 10.1111/j.1469-8137.2007.02142.x; Fu LJ, 2010, MOL PLANT MICROBE IN, V23, P39, DOI 10.1094/MPMI-23-1-0039; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Liao YWK, 2012, PLANTA, V235, P225, DOI 10.1007/s00425-011-1483-z; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Liu Y, 2009, PLANT PHYSIOL BIOCH, V47, P359, DOI 10.1016/j.plaphy.2008.12.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; OKUDA T, 1991, PLANT PHYSIOL, V97, P1265, DOI 10.1104/pp.97.3.1265; Pasqualini S, 2009, NEW PHYTOL, V181, P860, DOI 10.1111/j.1469-8137.2008.02711.x; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qu F, 2010, MOL PLANT MICROBE IN, V23, P1248, DOI 10.1094/MPMI-06-10-0124; Rakhshandehroo F, 2012, J PHYTOPATHOL, V160, P187, DOI 10.1111/j.1439-0434.2012.01882.x; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Siddiqui SA, 2008, MOL PLANT MICROBE IN, V21, P178, DOI 10.1094/MPMI-21-2-0178; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zhou BY, 2005, J EXP BOT, V56, P3223, DOI 10.1093/jxb/eri319; Zottini M, 2007, J EXP BOT, V58, P1397, DOI 10.1093/jxb/erm001	41	33	33	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76090	10.1371/journal.pone.0076090	http://dx.doi.org/10.1371/journal.pone.0076090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098767	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500137
J	Weis, AJ; Huxlin, KR; Callan, CL; DeMagistris, MA; Hindman, HB				Weis, Adam J.; Huxlin, Krystel R.; Callan, Christine L.; DeMagistris, Margaret A.; Hindman, Holly B.			Keratocyte Apoptosis and Not Myofibroblast Differentiation Mark the Graft/Host Interface at Early Time-Points Post-DSAEK in a Cat Model	PLOS ONE			English	Article							STRIPPING ENDOTHELIAL KERATOPLASTY; POSTERIOR LAMELLAR KERATOPLASTY; OPTICAL COHERENCE TOMOGRAPHY; LASER CONFOCAL MICROSCOPY; SMOOTH MUSCLE ACTIN; PHOTOREFRACTIVE KERATECTOMY; CORNEAL WOUNDS; VISUAL-ACUITY; LIGHT-SCATTERING; HAZE DEVELOPMENT	Purpose: To evaluate myofibroblast differentiation as an etiology of haze at the graft-host interface in a cat model of Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK). Methods: DSAEK was performed on 10 eyes of 5 adult domestic short-hair cats. In vivo corneal imaging with slit lamp, confocal, and optical coherence tomography (OCT) were performed twice weekly. Cats were sacrificed and corneas harvested 4 hours, and 2, 4, 6, and 9 days post-DSAEK. Corneal sections were stained with the TUNEL method and immunohistochemistry was performed for a-smooth muscle actin (alpha-SMA) and fibronectin with DAPI counterstain. Results: At all in vivo imaging time-points, corneal OCT revealed an increase in backscatter of light and confocal imaging revealed an acellular zone at the graft-host interface. At all post-mortem time-points, immunohistochemistry revealed a complete absence of alpha-SMA staining at the graft-host interface. At 4 hours, extracellular fibronectin staining was identified along the graft-host interface and both fibronectin and TUNEL assay were positive within adjacent cells extending into the host stroma. By day 2, fibronectin and TUNEL staining diminished and a distinct acellular zone was present in the region of previously TUNEL-positive cells. Conclusions: OCT imaging consistently showed increased reflectivity at the graft-host interface in cat corneas in the days post-DSAEK. This was not associated with myofibroblast differentiation at the graft-host interface, but rather with apoptosis and the development of a subsequent acellular zone. The roles of extracellular matrix changes and keratocyte cell death and repopulation should be investigated further as potential contributors to the interface optical changes.	[Weis, Adam J.] Univ Rochester Sch Med & Dent, Rochester, NY USA; [Huxlin, Krystel R.; Callan, Christine L.; DeMagistris, Margaret A.; Hindman, Holly B.] Univ Rochester Med Ctr, Flaum Eye Inst, Rochester, NY USA; [Huxlin, Krystel R.; Hindman, Holly B.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	University of Rochester; University of Rochester; University of Rochester	Hindman, HB (corresponding author), Univ Rochester Med Ctr, Flaum Eye Inst, Rochester, NY USA.	holly_hindman@urmc.rochester.edu		Huxlin, Krystel/0000-0001-7138-6156	Research to Prevent Blindness; CTSI [5 TL1 RR024135-05]; University of Rochester CTSA from the National Center for Research Resources [L1 RR024135]; National Center for Advancing Translational Sciences of the National Institutes of Health;  [K23EY019353];  [K23EY019353-01S1];  [EY015836]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015836, P30EY001319, K23EY019353] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); CTSI; University of Rochester CTSA from the National Center for Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Grant Support: K23EY019353 (HBH) K23EY019353-01S1 (HBH), EY015836 (KRH), Research to Prevent Blindness, CTSI grant 5 TL1 RR024135-05 (AJW, PI - Thomas A. Pearson, Director of CTSI, Rochester, NY). Funding acknowledgment: The project described in this publication was supported by the University of Rochester CTSA award number TL1 RR024135 from the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2010, AM J OPHTHALMOL, V150, P490, DOI 10.1016/j.ajo.2010.05.011; BAHN CF, 1982, INVEST OPHTH VIS SCI, V22, P73; BAHN CF, 1982, OPHTHALMOLOGY, V89, P687; Baratz KH, 2012, ARCH OPHTHALMOL-CHIC, V130, P868, DOI 10.1001/archophthalmol.2012.73; Brunette I, 2011, VET OPHTHALMOL, V14, P365, DOI 10.1111/j.1463-5224.2011.00886.x; Buhren J, 2009, INVEST OPHTH VIS SCI, V50, P634, DOI 10.1167/iovs.08-2277; Caldwell MC, 2009, AM J OPHTHALMOL, V148, P277, DOI 10.1016/j.ajo.2009.03.025; Chaurasia SS, 2009, EXP EYE RES, V89, P133, DOI 10.1016/j.exer.2009.02.022; Chen J, 2007, CLIN EXP OPTOM, V90, P317, DOI 10.1111/j.1444-0938.2007.00151.x; COHEN KL, 1990, CURR EYE RES, V9, P445, DOI 10.3109/02713689008999610; Dawson DG, 2005, ARCH OPHTHALMOL-CHIC, V123, P741, DOI 10.1001/archopht.123.6.741; DESMOULIERE A, 1992, EXP CELL RES, V201, P64, DOI 10.1016/0014-4827(92)90348-C; DESMOULIERE A, 1992, LAB INVEST, V67, P716; Ferrari G, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-32; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; GIPSON IK, 1993, INT OPHTHALMOL CLIN, V33, P149; HABIB MS, 1995, ARCH OPHTHALMOL-CHIC, V113, P499, DOI 10.1001/archopht.1995.01100040121037; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Haydari MN, 2012, INVEST OPHTH VIS SCI, V53, P6343, DOI 10.1167/iovs.12-9708; Hindman HB, 2013, CORNEA IN PRESS; Hindman HB, 2007, OPHTHALMOLOGY, V114, P2006, DOI 10.1016/j.ophtha.2007.01.009; HUANG PT, 1989, INVEST OPHTH VIS SCI, V30, P1794; Hughes A., 1977, HDB SENSORY PHYSL, V7/5; Ivarsen A, 2005, CURR EYE RES, V30, P363, DOI 10.1080/02713680590964848; Ivarsen A, 2003, BRIT J OPHTHALMOL, V87, P1272, DOI 10.1136/bjo.87.10.1272; Jester JV, 2012, INVEST OPHTH VIS SCI, V53, P770, DOI 10.1167/iovs.11-9092; JESTER JV, 1987, AM J PATHOL, V127, P140; Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Kapur R, 2006, CORNEA, V25, P851, DOI 10.1097/01.ico.0000214223.13615.ff; KLOUCEK F., 1966, FOLIA MORPHOL, V14, P200; Kobayashi A, 2008, AM J OPHTHALMOL, V145, P977, DOI 10.1016/j.ajo.2008.02.009; Landry H, 2011, INVEST OPHTH VIS SCI, V52, P2279, DOI 10.1167/iovs.10-6187; Li JY, 2012, OPHTHALMOLOGY, V119, P1126, DOI 10.1016/j.ophtha.2011.12.037; Lord RK, 2006, CORNEA, V25, P1093, DOI 10.1097/01.ico.0000230322.21332.20; LUTTRULL JK, 1985, INVEST OPHTH VIS SCI, V26, P1449; MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758; McCally RL, 2007, INVEST OPHTH VIS SCI, V48, P157, DOI 10.1167/iovs.06-0935; McLaren JW, 2009, AM J OPHTHALMOL, V147, P959, DOI 10.1016/j.ajo.2008.12.039; Meek KM, 2003, EYE, V17, P927, DOI 10.1038/sj.eye.6700574; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Moller-Pedersen T, 1998, INVEST OPHTH VIS SCI, V39, P487; Moller-Pedersen T, 2000, OPHTHALMOLOGY, V107, P1235, DOI 10.1016/S0161-6420(00)00142-1; Moller-Pedersen T, 1998, CURR EYE RES, V17, P736, DOI 10.1076/ceyr.17.7.736.5163; Nagy LJ, 2007, J CATARACT REFR SURG, V33, P1051, DOI 10.1016/j.jcrs.2007.02.021; Ohno K, 2002, CRYOBIOLOGY, V44, P142, DOI 10.1016/S0011-2240(02)00016-0; Ohno K, 2002, INVEST OPHTH VIS SCI, V43, P1025; Pantanelli SM, 2012, INVEST OPHTH VIS SCI, V53, P4797, DOI 10.1167/iovs.12-10003; Patel SV, 2009, ARCH OPHTHALMOL-CHIC, V127, P153, DOI 10.1001/archophthalmol.2008.581; Ramos JLB, 2009, CLIN EXP OPHTHALMOL, V37, P81, DOI 10.1111/j.1442-9071.2008.01823.x; Seery LS, 2011, AM J OPHTHALMOL, V152, P910, DOI 10.1016/j.ajo.2011.05.003; Shinton AJ, 2012, BRIT J OPHTHALMOL, V96, P246, DOI 10.1136/bjophthalmol-2011-300462; Short BG, 2008, TOXICOL PATHOL, V36, P49, DOI 10.1177/0192623307310955; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Telfair WB, 2000, J REFRACT SURG, V16, P32; Terry MA, 2012, OPHTHALMOLOGY, V119, P1988, DOI 10.1016/j.ophtha.2012.05.021; Tripoli N K, 1992, Refract Corneal Surg, V8, P196; Uchino Y, 2011, CORNEA, V30, P287, DOI 10.1097/ICO.0b013e3181eeafd6; van der Meulen IJE, 2012, CORNEA, V31, P380, DOI 10.1097/ICO.0b013e31823f8ab7; van der Meulen IJE, 2011, ARCH OPHTHALMOL-CHIC, V129, P1537, DOI 10.1001/archophthalmol.2011.247; VANHORN DL, 1977, INVEST OPHTH VIS SCI, V16, P597; Wilson SE, 2000, CORNEA, V19, pS7, DOI 10.1097/00003226-200005001-00003; Wilson SE, 2003, EXP EYE RES, V76, P193, DOI 10.1016/S0014-4835(02)00277-4; Wilson SE, 2007, EXP EYE RES, V85, P305, DOI 10.1016/j.exer.2007.06.009; Woodward MA, 2012, CORNEA; Zaniolo K, 2006, INVEST OPHTH VIS SCI, V47, P4199, DOI 10.1167/iovs.06-0176; Zhang CR, 2008, CLIN OPHTHALMOL, V2, P217	67	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75623	10.1371/journal.pone.0075623	http://dx.doi.org/10.1371/journal.pone.0075623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098706	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500077
J	Yin, HY; Guo, Y; Zeng, T; Zhao, XL; Xie, KQ				Yin, Hongyin; Guo, Ying; Zeng, Tao; Zhao, Xiulan; Xie, Keqin			Correlation between Levels of 2, 5-Hexanedione and Pyrrole Adducts in Tissues of Rats Exposure to n-Hexane for 5-Days	PLOS ONE			English	Article							PROTEIN CROSS-LINKING; MOLECULAR PATHOGENESIS; URINARY-EXCRETION; INHALATION EXPOSURE; 2,5-HEXANEDIONE; METABOLITES; NEUROTOXICITY; BINDING; AUTOXIDATION; INHIBITION	Background: The formation of pyrrole adducts might be responsible for peripheral nerve injury caused by n-hexane. The internal dose of pyrrole adducts would supply more information for the neurotoxicity of n-hexane. The current study was designed to investigate the tissue distributions of 2, 5-hexanedione (2,5-HD) and pyrrole adducts in rats exposed to n-hexane, and analyze the correlation between pyrrole adducts and 2,5-HD in tissues. Methods: Male Wistar rats were given daily dose of 500,1000, 2000, 4000 mg/kg bw n-hexane by gavage for 5 days. The rats were sacrificed 24 hours after the last administration. The levels of 2, 5-hexanedione and pyrrole adducts in tissues were measured by gas chromatography and Ehrlich's reagent, respectively. The correlations between 2, 5-hexanedione and pyrrole adducts were analyzed by linear regression Results: Dose-dependent effects were observed between the dosage of n-hexane and 2, 5-hexanedione, and pyrrole adducts in tissues. The highest level of 2, 5-hexanedione was found in urine and the lowest in sciatic nerve, while the highest level of pyrrole adducts was seen in liver and the lowest in serum. There were significant correlations among the free 2, 5-hexanedione, total 2, 5-hexanedione and pyrrole adducts within the same tissues. Pyrrole adducts in serum showed the most significant correlation with free 2, 5-hexanedione or pyrrole adducts in tissues. Conclusion: The findings suggested that pyrrole adducts in serum might be a better indicator for the internal dose of free 2, 5-hexanedione and pyrrole adducts in tissues.	[Yin, Hongyin; Guo, Ying; Zeng, Tao; Zhao, Xiulan; Xie, Keqin] Shandong Univ, Inst Toxicol, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Yin, Hongyin] Jinan Municipal Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China	Shandong University	Xie, KQ (corresponding author), Shandong Univ, Inst Toxicol, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China.	keqinx@sdu.edu.cn			Doctoral Fund of Ministry of Education of China [20120131110058]	Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This research was supported by grants from Doctoral Fund of Ministry of Education of China (20120131110058). http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/2012/12/1354173228937804.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TS, 1981, TOXICOL APPL PHARM, V61, P414, DOI 10.1016/0041-008X(81)90364-1; Bus J S, 1982, Fundam Appl Toxicol, V2, P226, DOI 10.1016/S0272-0590(82)80031-6; BUS JS, 1979, TOXICOL APPL PHARM, V51, P295, DOI 10.1016/0041-008X(79)90472-1; BUS JS, 1981, DRUG METAB DISPOS, V9, P386; COURI D, 1982, ANNU REV PHARMACOL, V22, P145, DOI 10.1146/annurev.pa.22.040182.001045; CROSBIE SJ, 1994, BIOCHEM SOC T, V22, pS130, DOI 10.1042/bst022130s; DeCaprio AP, 2009, J TOXICOL ENV HEAL A, V72, P861, DOI 10.1080/15287390902959508; DECAPRIO AP, 1982, TOXICOL APPL PHARM, V65, P440, DOI 10.1016/0041-008X(82)90389-1; DECAPRIO AP, 1983, TOXICOL APPL PHARM, V68, P297, DOI 10.1016/0041-008X(83)90014-5; DECAPRIO AP, 1988, TOXICOL APPL PHARM, V92, P75, DOI 10.1016/0041-008X(88)90229-3; DECAPRIO AP, 1987, NEUROTOXICOLOGY, V8, P199; DECAPRIO AP, 1986, MOL PHARMACOL, V30, P452; dos Santos CR, 2002, J CHROMATOGR B, V778, P237, DOI 10.1016/S1570-0232(02)00036-3; FEDTKE N, 1986, INT ARCH OCC ENV HEA, V57, P149, DOI 10.1007/BF00381383; GRAHAM DG, 1980, J TOXICOL ENV HEALTH, V6, P621, DOI 10.1080/15287398009529880; GRAHAM DG, 1982, NEUROBEH TOXICOL TER, V4, P629; GRAHAM DG, 1982, TOXICOL APPL PHARM, V64, P415, DOI 10.1016/0041-008X(82)90237-X; IWATA M, 1983, INT ARCH OCC ENV HEA, V53, P1, DOI 10.1007/BF00406172; KAWAI T, 1991, INT ARCH OCC ENV HEA, V63, P285, DOI 10.1007/BF00386379; KESSLER W, 1990, ARCH TOXICOL, V64, P242, DOI 10.1007/BF02010731; Manini P, 1999, TOXICOL LETT, V108, P225, DOI 10.1016/S0378-4274(99)00093-4; Mateus ML, 2002, NEUROTOXICOLOGY, V23, P747, DOI 10.1016/S0161-813X(02)00011-6; MATTOCKS AR, 1970, ANAL BIOCHEM, V38, P529, DOI 10.1016/0003-2697(70)90478-1; PERBELLINI L, 1979, INT ARCH OCC ENV HEA, V42, P349, DOI 10.1007/BF00377790; Perbellini L, 1981, Ann Ist Super Sanita, V17, P615; PERBELLINI L, 1993, INT ARCH OCC ENV HEA, V65, P49, DOI 10.1007/BF00586058; PERBELLINI L, 1981, BRIT J IND MED, V38, P20; PERBELLINI L, 1982, ARCH TOXICOL, V50, P203, DOI 10.1007/BF00310852; SANZ P, 1995, TOXICOL IN VITRO, V9, P783, DOI 10.1016/0887-2333(95)00017-3; SCHAUMBURG HH, 1976, BRAIN, V99, P183, DOI 10.1093/brain/99.2.183; Song FY, 2008, BIOCHEM PHARMACOL, V75, P737, DOI 10.1016/j.bcp.2007.10.001; Soriano T, 1996, HUM EXP TOXICOL, V15, P497, DOI 10.1177/096032719601500607; STCLAIR MBG, 1988, CHEM RES TOXICOL, V1, P179, DOI 10.1021/tx00003a009; ZHU MS, 1995, CHEM RES TOXICOL, V8, P764, DOI 10.1021/tx00047a017; ZHU MS, 1994, CHEM RES TOXICOL, V7, P551, DOI 10.1021/tx00040a011	35	21	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76011	10.1371/journal.pone.0076011	http://dx.doi.org/10.1371/journal.pone.0076011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098756	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500126
J	Yu, ACL; Abrego-Collier, C; Sonderegger, M				Yu, Alan C. L.; Abrego-Collier, Carissa; Sonderegger, Morgan			Phonetic Imitation from an Individual-Difference Perspective: Subjective Attitude, Personality and "Autistic" Traits	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; VOICE-ONSET-TIME; SPEECH-PERCEPTION; WORKING-MEMORY; FUNCTIONING AUTISM; TALKER DIFFERENCES; EMPATHY QUOTIENT; COGNITIVE STYLES; CONVERGENCE; ATTENTION	Numerous studies have documented the phenomenon of phonetic imitation: the process by which the production patterns of an individual become more similar on some phonetic or acoustic dimension to those of her interlocutor. Though social factors have been suggested as a motivator for imitation, few studies has established a tight connection between language-external factors and a speaker's likelihood to imitate. The present study investigated the phenomenon of phonetic imitation using a within-subject design embedded in an individual-differences framework. Participants were administered a phonetic imitation task, which included two speech production tasks separated by a perceptual learning task, and a battery of measures assessing traits associated with Autism-Spectrum Condition, working memory, and personality. To examine the effects of subjective attitude on phonetic imitation, participants were randomly assigned to four experimental conditions, where the perceived sexual orientation of the narrator (homosexual vs. heterosexual) and the outcome (positive vs. negative) of the story depicted in the exposure materials differed. The extent of phonetic imitation by an individual is significantly modulated by the story outcome, as well as by the participant's subjective attitude toward the model talker, the participant's personality trait of openness and the autistic-like trait associated with attention switching.	[Yu, Alan C. L.; Abrego-Collier, Carissa] Univ Chicago, Dept Linguist, Phonol Lab, Chicago, IL 60637 USA; [Sonderegger, Morgan] McGill Univ, Dept Linguist, Montreal, PQ, Canada	University of Chicago; McGill University	Yu, ACL (corresponding author), Univ Chicago, Dept Linguist, Phonol Lab, Chicago, IL 60637 USA.	aclyu@uchicago.edu		Sonderegger, Morgan/0000-0001-7675-2370				Abdelli-Beruh NB, 2004, PHONETICA, V61, P201, DOI 10.1159/000084158; Abrego-Collier C., 2011, ICPHS, P192; Allen JS, 2003, J ACOUST SOC AM, V113, P544, DOI 10.1121/1.1528172; AUSBURN LJ, 1978, ECTJ-EDUC COMMUN TEC, V26, P337; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; Babel M., 2009, THESIS U CALIFORNIA; Babel M, 2012, J PHONETICS, V40, P177, DOI 10.1016/j.wocn.2011.09.001; Babel M, 2010, LANG SOC, V39, P437, DOI 10.1017/S0047404510000400; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2011, PACKAGE LME4 LINEAR; Benor Sarah., 2001, PENN WORKING PAPERS, V7, P1; BOERSMA P, 2007, PRAAT; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Bourhis R. Y., 1977, LANGUAGE ETHNICITY I, P119; Bucholtz Mary, 2001, J LINGUIST ANTHROPOL, V11, P84, DOI DOI 10.1525/JLIN.2001.11.1.84; Cheshire Jenny, 2008, SOCIOLINGUISTICA, V22, P1, DOI DOI 10.1515/9783484605299.1; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; CONWAY ARA, 1994, J EXP PSYCHOL GEN, V123, P354, DOI 10.1037/0096-3445.123.4.354; Delvaux V, 2007, PHONETICA, V64, P145, DOI 10.1159/000107914; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Eckert P, 2008, J SOCIOLING, V12, P453, DOI 10.1111/j.1467-9841.2008.00374.x; Ettlinger M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00211; Fischer E, 2010, J COMMUN DISORD, V43, P21, DOI 10.1016/j.jcomdis.2009.07.004; Flemming E., 2004, PHONETIC BASES MARKE, P232, DOI DOI 10.1017/CBO9780511486401; Flemming E, 2001, AUDITORY REPRESENTAT; Francis AL, 2002, J EXP PSYCHOL HUMAN, V28, P349, DOI 10.1037//0096-1523.28.2.349; Francis AL, 2009, ATTEN PERCEPT PSYCHO, V71, P1360, DOI 10.3758/APP.71.6.1360; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; GILES H, 1973, ANTHROPOL LINGUIST, V15, P87; Giles H, 1991, LANGUAGE CONTEXTS CO; Giles Howard, 1973, LANG SOC, V2, P177, DOI [10.1017/S0047404500000701, DOI 10.1017/S0047404500000701]; Goldinger SD, 1998, PSYCHOL REV, V105, P251, DOI 10.1037/0033-295X.105.2.251; Goldinger SD, 2003, J PHONETICS, V31, P305, DOI 10.1016/S0095-4470(03)00030-5; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Happe F, 2001, J CHILD PSYCHOL PSYC, V42, P299, DOI 10.1111/1469-7610.00723; Harald Baayen R., 1996, CELEX2; Hay J, 2006, J PHONETICS, V34, P458, DOI 10.1016/j.wocn.2005.10.001; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Jaffe J., 1970, RHYTHMS DIALOGUE, V8; John O, 1991, BIG 5 INVENTORY VERS; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Johnson K., 1997, TALKER VARIABILITY S, P146; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kim Midam, 2011, Lab Phonol, V2, P125; Kirby J., 2013, ORIGINS SOUND CHANGE, P228, DOI [10.1093/acprof:oso/9780199573745.003.0011, DOI 10.1093/ACPROF:OSO/9780199573745.003.0011]; LABOV W, 1963, WORD, V19, P273, DOI 10.1080/00437956.1963.11659799; Lewandowski N, 2007, COGNITIVE SCI 2007; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; Lubowicz A., 2003, THESIS U MASSACHUSET; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; Messick S., 1976, INDIVIDUALITY LEARNI; MILLER JL, 1986, PHONETICA, V43, P106, DOI 10.1159/000261764; Misyak JB, 2012, LANG LEARN, V62, P302, DOI 10.1111/j.1467-9922.2010.00626.x; Mitterer H, 2008, COGNITION, V109, P168, DOI 10.1016/j.cognition.2008.08.002; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Namy LL, 2002, J LANG SOC PSYCHOL, V21, P422, DOI 10.1177/026192702237958; NATALE M, 1975, J PERS SOC PSYCHOL, V32, P790, DOI 10.1037/0022-3514.32.5.790; Nettle D, 2007, BRIT J PSYCHOL, V98, P237, DOI 10.1348/000712606X117612; Nielsen K, 2008, THESIS UCLA; Nielsen K. Y., 2007, P 16 INT C PHON SCI, P1961; Nielsen K, 2011, J PHONETICS, V39, P132, DOI 10.1016/j.wocn.2010.12.007; Pardo JS, 2010, ATTEN PERCEPT PSYCHO, V72, P2254, DOI 10.3758/APP.72.8.2254; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Podesva RJ, LANGUAGE VA IN PRESS; Podesva RJ, 2007, J SOCIOLING, V11, P478, DOI 10.1111/j.1467-9841.2007.00334.x; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Shockley K, 2004, PERCEPT PSYCHOPHYS, V66, P422, DOI 10.3758/BF03194890; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Sonderegger M, 2012, THESIS U CHICAGO; Stewart ME, 2008, COGNITION, V109, P157, DOI 10.1016/j.cognition.2008.07.010; Stuart-Smith J, 2009, LANGUAGE IDENTITIES, P39; Summerfield Q., 1975, SPEECH PERC, V2, P61; Theodore RM, 2009, J ACOUST SOC AM, V125, P3974, DOI 10.1121/1.3106131; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P873, DOI 10.1016/j.paid.2006.04.003; Webb JT, 1970, STUDIES DYADIC COMMU, P115; Welsch R, 1980, REGRESSION DIAGNOSTI; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; WITKIN HA, 1977, REV EDUC RES, V47, P1; Yu A. C. L., 2011, P INT C PHON SCI 17, P2236; Yu Alan, 2013, ORIGINS SOUND CHANGE, P201, DOI DOI 10.1093/ACPROF:OSO/9780199573745.003.0010; Yu ACL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011950; Yuan J, 2008, J ACOUST SOC AM, V124, P2078, DOI 10.1121/1.2968700	86	66	66	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74746	10.1371/journal.pone.0074746	http://dx.doi.org/10.1371/journal.pone.0074746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098665	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500036
J	Kruk, JS; Vasefi, MS; Heikkila, JJ; Beazely, MA				Kruk, Jeff S.; Vasefi, Maryam S.; Heikkila, John J.; Beazely, Michael A.			Reactive Oxygen Species Are Required for 5-HT-Induced Transactivation of Neuronal Platelet-Derived Growth Factor and TrkB Receptors, but Not for ERK1/2 Activation	PLOS ONE			English	Article							FACTOR-BETA RECEPTOR; NEUTROPHIL NADPH OXIDASE; PROTEIN-KINASE; HYDROGEN-PEROXIDE; PHOSPHORYLATION; SEROTONIN; STIMULATION; EXPRESSION; DOPAMINE; PATHWAY	High concentrations of reactive oxygen species (ROS) induce cellular damage, however at lower concentrations ROS act as intracellular second messengers. In this study, we demonstrate that serotonin (5-HT) transactivates the platelet-derived growth factor (PDGF) type beta receptor as well as the TrkB receptor in neuronal cultures and SH-SY5Y cells, and that the transactivation of both receptors is ROS-dependent. Exogenous application of H2O2 induced the phosphorylation of these receptors in a dose-dependent fashion, similar to that observed with 5-HT. However the same concentrations of H2O2 failed to increase ERK1/2 phosphorylation. Yet, the NADPH oxidase inhibitors diphenyleneiodonium chloride and apocynin blocked both 5-HT-induced PDGF beta receptor phosphorylation and ERK1/2 phosphorylation. The increases in PDGF beta receptor and ERK1/2 phosphorylation were also dependent on protein kinase C activity, likely acting upstream of NADPH oxidase. Additionally, although the ROS scavenger N-acetyl-L-cysteine abrogated 5-HT-induced PDGF beta and TrkB receptor transactivation, it was unable to prevent 5-HT-induced ERK1/2 phosphorylation. Thus, the divergence point for 5-HT-induced receptor tyrosine kinase (RTK) transactivation and ERK1/2 phosphorylation occurs at the level of NADPH oxidase in this system. The ability of 5-HT to induce the production of ROS resulting in transactivation of both PDGF beta and TrkB receptors may suggest that instead of a single GPCR to single RTK pathway, a less selective, more global RTK response to GPCR activation is occurring.	[Kruk, Jeff S.; Vasefi, Maryam S.; Heikkila, John J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Beazely, Michael A.] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Beazely, MA (corresponding author), Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada.	mbeazely@uwaterloo.ca		Beazely, Michael/0000-0002-8722-460X	University of Waterloo, Faculty of Science; National Science and Engineering Research Council of Canada; Queen Elizabeth II Graduate Scholarship in Science and Technology	University of Waterloo, Faculty of Science; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship in Science and Technology	This research was funded through generous start-up funding from the University of Waterloo, Faculty of Science, by the National Science and Engineering Research Council of Canada, and by the Queen Elizabeth II Graduate Scholarship in Science and Technology awarded to JSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Bayraktutan U, 2000, ARTERIOSCL THROM VAS, V20, P1903, DOI 10.1161/01.ATV.20.8.1903; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Callsen D, 1999, FREE RADICAL BIO MED, V26, P1544, DOI 10.1016/S0891-5849(99)00015-5; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Catarzi S, 2007, BBA-GEN SUBJECTS, V1770, P872, DOI 10.1016/j.bbagen.2007.01.008; Chen CH, 2006, MOL PHARMACOL, V69, P1347, DOI 10.1124/mol.105.017558; Chen K, 2004, J BIOL CHEM, V279, P35079, DOI 10.1074/jbc.M404859200; Clark MA, 2007, REGUL PEPTIDES, V144, P115, DOI 10.1016/j.regpep.2007.07.001; Dusting GJ, 2005, MEM I OSWALDO CRUZ, V100, P97, DOI 10.1590/S0074-02762005000900016; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Geldenhuys WJ, 2009, EXPERT REV NEUROTHER, V9, P1073, DOI 10.1586/ERN.09.51; George A, 2010, BLOOD CELL MOL DIS, V45, P41, DOI 10.1016/j.bcmd.2010.02.006; Gill RS, 2010, CELL SIGNAL, V22, P285, DOI 10.1016/j.cellsig.2009.09.031; Goppelt-Struebe M, 2000, BIOCHEM J, V345, P217, DOI 10.1042/0264-6021:3450217; Guo DG, 2010, MOL CELL BIOCHEM, V334, P99, DOI 10.1007/s11010-009-0327-7; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P4; Hu YY, 2007, CELL SIGNAL, V19, P410, DOI 10.1016/j.cellsig.2006.07.017; Huang YZ, 2012, J NEUROSCI, V32, P15521, DOI 10.1523/JNEUROSCI.0755-12.2012; Kim YK, 2006, CELL SIGNAL, V18, P236, DOI 10.1016/j.cellsig.2005.04.008; Kleniewska P, 2012, ARCH IMMUNOL THER EX, V60, P277, DOI 10.1007/s00005-012-0176-z; Kruk JS, 2013, CELL SIGNAL, V25, P133, DOI 10.1016/j.cellsig.2012.09.021; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Li BM, 2008, PSYCHOPHARMACOLOGY, V201, P443, DOI 10.1007/s00213-008-1306-5; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Liu Bo, 2003, V237, P99; Liu YL, 2007, FASEB J, V21, P2725, DOI 10.1096/fj.06-8058com; Mbong N, 2012, AM J PHYSIOL-HEART C, V302, pH1591, DOI 10.1152/ajpheart.00627.2011; McMahon B, 2002, FASEB J, V16, P1817, DOI 10.1096/fj.02-0416fje; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Moody TW, 2012, J PHARMACOL EXP THER, V341, P873, DOI 10.1124/jpet.111.190033; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; OHNO Y, 1985, J BIOL CHEM, V260, P8438; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Rantamaki T, 2008, EXPERT OPIN THER TAR, V12, P705, DOI [10.1517/14728222.12.6.705 , 10.1517/14728220802121472]; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; Steiner JA, 2008, TRAFFIC, V9, P1393, DOI 10.1111/j.1600-0854.2008.00757.x; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Tseng HY, 2012, ARCH TOXICOL, V86, P935, DOI 10.1007/s00204-012-0856-9; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Vasefi MS, 2013, J NEUROCHEM, V125, P26, DOI 10.1111/jnc.12157; Vasefi MS, 2012, NEUROSCI LETT, V511, P65, DOI 10.1016/j.neulet.2012.01.016; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200	61	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77027	10.1371/journal.pone.0077027	http://dx.doi.org/10.1371/journal.pone.0077027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086766	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900110
J	Amer, AAA; Costa, TRD; Farag, SI; Avican, U; Forsberg, A; Francis, MS				Amer, Ayad A. A.; Costa, Tiago R. D.; Farag, Salah I.; Avican, Ummehan; Forsberg, Ake; Francis, Matthew S.			Genetically Engineered Frameshifted YopN-TyeA Chimeras Influence Type III Secretion System Function in Yersinia pseudotuberculosis	PLOS ONE			English	Article							SHINE-DALGARNO SEQUENCE; SUBSTRATE-SPECIFICITY; INNER-ROD; EFFECTOR PROTEINS; SHIGELLA-FLEXNERI; GENE-EXPRESSION; MESSENGER-RNA; PESTIS-YOPN; TRANSLOCATION; BACTERIAL	Type III secretion is a tightly controlled virulence mechanism utilized by many gram negative bacteria to colonize their eukaryotic hosts. To infect their host, human pathogenic Yersinia spp. translocate protein toxins into the host cell cytosol through a preassembled Ysc-Yop type III secretion device. Several of the Ysc-Yop components are known for their roles in controlling substrate secretion and translocation. Particularly important in this role is the YopN and TyeA heterodimer. In this study, we confirm that Y. pseudotuberculosis naturally produce a 42 kDa YopN-TyeA hybrid protein as a result of a +1 frame shift near the 3 prime of yopN mRNA, as has been previously reported for the closely related Y. pestis. To assess the biological role of this YopN-TyeA hybrid in T3SS by Y. pseudotuberculosis, we used in cis site-directed mutagenesis to engineer bacteria to either produce predominately the YopN-TyeA hybrid by introducing +1 frame shifts to yopN after codon 278 or 287, or to produce only singular YopN and TyeA polypeptides by introducing yopN sequence from Y. enterocolitica, which is known not to produce the hybrid. Significantly, the engineered 42 kDa YopN-TyeA fusions were abundantly produced, stable, and were efficiently secreted by bacteria in vitro. Moreover, these bacteria could all maintain functionally competent needle structures and controlled Yops secretion in vitro. In the presence of host cells however, bacteria producing the most genetically altered hybrids (+1 frameshift after 278 codon) had diminished control of polarized Yop translocation. This corresponded to significant attenuation in competitive survival assays in orally infected mice, although not at all to the same extent as Yersinia lacking both YopN and TyeA proteins. Based on these studies with engineered polypeptides, most likely a naturally occurring YopN-TyeA hybrid protein has the potential to influence T3S control and activity when produced during Yersinia-host cell contact.	[Amer, Ayad A. A.; Costa, Tiago R. D.; Farag, Salah I.; Avican, Ummehan; Forsberg, Ake; Francis, Matthew S.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Amer, Ayad A. A.; Costa, Tiago R. D.; Avican, Ummehan; Forsberg, Ake; Francis, Matthew S.] Umea Univ, UCMR, Umea, Sweden; [Avican, Ummehan; Forsberg, Ake] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden	Umea University; Umea University; Umea University	Francis, MS (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	matthew.francis@molbiol.umu.se	Costa, Tiago/V-8203-2017; Costa, Tiago/K-8999-2019	Costa, Tiago/0000-0003-2716-9669; Costa, Tiago/0000-0003-2716-9669; Francis, Matthew/0000-0001-6817-9535	Swedish Research Council; Foundation for Medical Research at Umea University; J C Kempe Memorial Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Medical Research at Umea University; J C Kempe Memorial Fund	This work was supported by grants from the Swedish Research Council (AF, MSF) (http://www.vr.se/), Foundation for Medical Research at Umea University (MSF) and J C Kempe Memorial Fund (AAA, TRC, UA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Amer AAA, 2011, J BACTERIOL, V193, P6683, DOI 10.1128/JB.00210-11; Anderson DM, 2002, J BACTERIOL, V184, P1287, DOI 10.1128/JB.184.5.1287-1295.2002; Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; Bartra S, 2001, BMC Microbiol, V1, P22, DOI 10.1186/1471-2180-1-22; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; BOLIN I, 1984, INFECT IMMUN, V43, P72; Botteaux A, 2009, MOL MICROBIOL, V71, P449, DOI 10.1111/j.1365-2958.2008.06537.x; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Chen YQ, 2011, MOL MICROBIOL, V80, P966, DOI 10.1111/j.1365-2958.2011.07623.x; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; Cheng LW, 2001, J BACTERIOL, V183, P5293, DOI 10.1128/JB.183.18.5293-5301.2001; Cherradi Y, 2013, MOL MICROBIOL, V87, P1183, DOI 10.1111/mmi.12158; Costa TRD, 2013, CELL MICROBIOL, V15, P1088, DOI 10.1111/cmi.12100; Costa TRD, 2012, INFECT GENET EVOL, V12, P1729, DOI 10.1016/j.meegid.2012.07.016; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Dewoody RS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00004; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Edgren T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002669; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x; Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x; Ferracci F, 2004, J BACTERIOL, V186, P5160, DOI [10.1128/JB.186.15.5160-5166.2004, 10.1128/jb.186.15.5160-5166.2004]; Flores-Kim J, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00125; FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x; Francis MS, 2011, ADV M C M, P185, DOI 10.1079/9781845937607.0185; Francis MS, 2010, CELL BIO RES PROG, P79; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; Frost S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049349; Galan JE, 2007, CELL, V130, P192, DOI 10.1016/j.cell.2007.06.042; Goss JW, 2004, J BACTERIOL, V186, P6320, DOI 10.1128/JB.186.18.6320-6324.2004; Hansen TM, 2007, P NATL ACAD SCI USA, V104, P5830, DOI 10.1073/pnas.0608668104; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Joseph SS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00001; Kim JS, 2013, MICROBIOL-SGM, V159, P446, DOI 10.1099/mic.0.061689-0; Kontos H, 2001, MOL CELL BIOL, V21, P8657, DOI 10.1128/MCB.21.24.8657-8670.2001; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lorenz C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000094; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MARIOVITS T, 2006, NATURE, V441, P637, DOI DOI 10.1038/NATURE04822; Martinez-Argudo I, 2010, MOL MICROBIOL, V78, P1365, DOI 10.1111/j.1365-2958.2010.07413.x; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Feria JM, 2012, J BACTERIOL, V194, P6029, DOI 10.1128/JB.01215-12; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; O'Connell CB, 2004, MOL MICROBIOL, V52, P1613, DOI 10.1111/j.1365-2958.2004.04101.x; Osborne SE, 2011, FUTURE MICROBIOL, V6, P193, DOI 10.2217/FMB.10.172; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; PORTNOY DA, 1981, INFECT IMMUN, V31, P775, DOI 10.1128/IAI.31.2.775-782.1981; ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Sal-Man N, 2012, BIOCHEM J, V442, P119, DOI 10.1042/BJ20111620; Schiano CA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00129; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Schwartz R, 1997, NUCLEIC ACIDS RES, V25, P2005, DOI 10.1093/nar/25.10.2005; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sundberg L, 2003, CELL MICROBIOL, V5, P187, DOI 10.1046/j.1462-5822.2003.00267.x; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Thomassin JL, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-205; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wang D, 2008, MOL MICROBIOL, V69, P1499, DOI 10.1111/j.1365-2958.2008.06377.x; WEISS RB, 1988, EMBO J, V7, P1503, DOI 10.1002/j.1460-2075.1988.tb02969.x; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Yang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054121; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832; Zhou L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001291	91	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77767	10.1371/journal.pone.0077767	http://dx.doi.org/10.1371/journal.pone.0077767			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098594	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600088
J	Crickenberger, S; Moran, A				Crickenberger, Sam; Moran, Amy			Rapid Range Shift in an Introduced Tropical Marine Invertebrate	PLOS ONE			English	Article							MEGABALANUS-COCCOPOMA DARWIN; SOUTHEASTERN UNITED-STATES; CLIMATE-CHANGE; CIRRIPEDIA BALANOMORPHA; THERMAL TOLERANCE; CONTINENTAL-SHELF; MASS MORTALITY; PERNA-VIRIDIS; SEVERE WINTER; FLORIDA-KEYS	The barnacle Megabalanus coccopoma is native to shorelines from Baja California to Peru and has been introduced to a number of other locations including the Atlantic US SE coast, where it was first recorded in 2006. In 2009, the range of M. coccopoma in the SE US extended from Ft. Pierce, FL north to Cape Hatteras, NC with seasonal populations found as far north as Kitty Hawk, NC. During the exceptionally cold winter of 2009/2010, the range of M. coccopoma shifted dramatically due to the dieback of all monitored populations north of Florida. We examined body size, distribution, and density of M. coccopoma during the summers of 2010, 2011, and 2012 to describe the extent of the range retraction and the rate of range re-expansion. In 2010, recruits were found as far north as Tybee Island, Ga, but no established populations were found north of Florida. In 2011 recruits were found at Rodanthe, NC but established populations were still limited to Florida. By 2012 populations were established in Rodanthe, NC, slightly north of its previously known range limit. Estimated rates of range re-expansion were 255.8 km/yr in 2010 and 794.1 km/yr in 2011. Rates of re-expansion to the north in 2010 and 2011 were faster than have previously been reported for any marine species, and are one of the few rates published for any tropical marine invertebrate.	[Crickenberger, Sam; Moran, Amy] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Moran, Amy] Univ Hawaii, Dept Biol, Honolulu, HI 96822 USA	Clemson University; University of Hawaii System	Crickenberger, S (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	scricke@gmail.com	Crickenberger, Sam/U-8139-2019	Moran, Amy/0000-0002-0604-5096; Crickenberger, Sam/0000-0001-9359-8782	Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration; NSF [OCE-0961996]	Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF))	This research was conducted under an award from the Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration and NSF OCE-0961996 to ALM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker P, 2007, J SHELLFISH RES, V26, P345, DOI 10.2983/0730-8000(2007)26[345:RADOAT]2.0.CO;2; Bennie J, 2013, ECOL LETT, V16, P921, DOI 10.1111/ele.12129; Blanton BO, 2003, J GEOPHYS RES, V108, P2156, DOI [10.1029/2002JB001929, DOI 10.1029/2002JB001929]; BLANTON JO, 1985, COAST ESTUAR STUD, V2, P10, DOI DOI 10.1029/C0002P0010; BOHNSACK JA, 1983, ENVIRON BIOL FISH, V9, P41, DOI 10.1007/BF00001057; Bourget E., 1987, BARNACLE BIOL; Breves-Ramos A, 2005, BRAZ ARCH BIOL TECHN, V48, P951, DOI 10.1590/S1516-89132005000800012; Camargo R., 2007, J BRAZ SOC ECOTOXICO, V2, P7; Canning-Clode J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0029657, DOI 10.1371/J0URNAL.P0NE.0029657]; Carlton JT, 2011, ENCY BIOL INVASIONS, P385; Carolina South Department of Natural Resources, 2008, S C AQ INV SPEC MAN, P95; Celis A, 2007, REV MEX BIODIVERS, V78, P325; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; CRISP DJ, 1958, J MAR BIOL ASSOC UK, V37, P483, DOI 10.1017/S0025315400023833; CRISP DJ, 1964, J ANIM ECOL, V33, P165, DOI 10.2307/2355; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Edwards KP, 2006, CONT SHELF RES, V26, P1375, DOI 10.1016/j.csr.2006.01.020; Epifanio CE, 2001, ESTUAR COAST SHELF S, V52, P51, DOI 10.1006/ecss.2000.0727; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Firth LB, 2011, J EXP MAR BIOL ECOL, V400, P250, DOI 10.1016/j.jembe.2011.02.007; Gilg MR, 2010, J CRUSTACEAN BIOL, V30, P146, DOI 10.1651/09-3148.1; Hare JA, 2007, CAN J FISH AQUAT SCI, V64, P1234, DOI 10.1139/F07-089; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harley CDG, 2008, MAR ECOL PROG SER, V371, P37, DOI 10.3354/meps07711; Harrison JR, 2007, SOUTHEAST NAT, V6, P173, DOI 10.1656/1528-7092(2007)6[173:OOMOAC]2.0.CO;2; Hartman M, 2001, 16 BIENN C EST RES F; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Henry D. P., 1986, ZOOLOGISCHE VERHANDE, V235, P69; Innocenti G., 2006, Atti della Societa Toscana di Scienze Naturali Residente in Pisa Memorie Serie B, V113, P1; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Kent A, 2003, J ANIM ECOL, V72, P941, DOI 10.1046/j.1365-2656.2003.00762.x; Kerckhof F, 2010, AFR J MAR SCI, V32, P265, DOI 10.2989/1814232X.2010.501573; Kerckhof F, 2001, SENCK MARIT, V31, P245, DOI 10.1007/BF03043033; Kerckhof F., 2002, B I R SCI NAT BELG B, V72, P93; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; Laboy-Nieves EN, 2001, B MAR SCI, V68, P163; LACOMBE D, 1974, Revista Brasileira de Biologia, V34, P633; Lacombe D, 1977, RIO DE JANEIRO, V129, P1; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Meister HS, 2005, SOUTHEAST NAT, V4, P193, DOI 10.1656/1528-7092(2005)004[0193:FEFTIA]2.0.CO;2; Mieszkowska N, 2007, J MAR BIOL ASSOC UK, V87, P537, DOI 10.1017/S0025315407053799; National Climate Data Center, 2009, NAT CLIM DAT CTR 200, P2010; NEWMAN W A, 1987, Pacific Science, V41, P31; Nilsson-Cantell C. A., 1932, Verhandlungen der Naturforschenden Gesellschaft in Basel, V42, P103; Parry M. L., 2007, CLIMATE CHANGE 2007; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrault R. T., 2004, P LA ACAD SCI, V66, P13; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Farrapeira CMR, 2007, BRAZ J OCEANOGR, V55, P207, DOI 10.1590/S1679-87592007000300005; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silveira NG, 2007, BIOCIENCIAS, P14; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Spinuzzi Samantha, 2013, Marine Biodiversity Records, V6, pe55, DOI 10.1017/S1755267213000316; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Storey M, 1936, ECOLOGY, V17, P640, DOI 10.2307/1932762; Strasser M, 2001, HELGOLAND MAR RES, V55, P176, DOI 10.1007/s101520100081; Szuchy MTM., 2000, REV BRASILEIRA BOT, V23, P121, DOI [10.1590/S0100-84042000000200002, DOI 10.1590/S0100-84042000000200002]; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Urian AG, 2011, J EXP ZOOL PART A, V315A, P12, DOI 10.1002/jez.644; Vincenty T., 1975, SURV REV, V23, P88, DOI [10.1179/sre.1975.23.176.88, DOI 10.1179/SRE.1975.23.176.88]; Walker N.D., 1982, Coral Reefs, V1, P83, DOI 10.1007/BF00301689; Wang CZ, 2010, ATMOS SCI LETT, V11, P161, DOI 10.1002/asl.278; WEBER AH, 1980, J PHYS OCEANOGR, V10, P1256, DOI 10.1175/1520-0485(1980)010<1256:MMWFFT>2.0.CO;2; Wethey DS, 2011, J EXP MAR BIOL ECOL, V400, P132, DOI 10.1016/j.jembe.2011.02.008; WITHERINGTON BE, 1989, COPEIA, P696; Wolff W. J., 2005, Zoologische Mededelingen (Leiden), V79, P1; Yamaguchi T, 2009, BIOFOULING, V25, P325, DOI 10.1080/08927010902738048; Young Paulo S., 2000, Zoosystema, V22, P85; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	75	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e78008	10.1371/journal.pone.0078008	http://dx.doi.org/10.1371/journal.pone.0078008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098598	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600091
J	Feliciano, A; Castellvi, J; Artero-Castro, A; Leal, JA; Romagosa, C; Hernandez-Losa, J; Peg, V; Fabra, A; Vidal, F; Kondoh, H; Cajal, SRY; LLeonart, ME				Feliciano, Andrea; Castellvi, Josep; Artero-Castro, Ana; Leal, Jose A.; Romagosa, Cleofe; Hernandez-Losa, Javier; Peg, Vicente; Fabra, Angels; Vidal, Francisco; Kondoh, Hiroshi; Ramon y Cajal, Santiago; LLeonart, Matilde E.			miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-alpha, CCNJ, and MEGF9	PLOS ONE			English	Article							PROTEIN-KINASE CK2; CELL-PROLIFERATION; AMINOPEPTIDASE-A; METASTATIC BEHAVIOR; MESSENGER-RNAS; IN-VITRO; MICRORNA; EXPRESSION; CANCER; GENE	MicroRNAs (miRNAs) play important roles in diverse biological processes and are emerging as key regulators of tumorigenesis and tumor progression. To explore the dysregulation of miRNAs in breast cancer, a genome-wide expression profiling of 939 miRNAs was performed in 50 breast cancer patients. A total of 35 miRNAs were aberrantly expressed between breast cancer tissue and adjacent normal breast tissue and several novel miRNAs were identified as potential oncogenes or tumor suppressor miRNAs in breast tumorigenesis. miR-125b exhibited the largest decrease in expression. Enforced miR-125b expression in mammary cells decreased cell proliferation by inducing G2/M cell cycle arrest and reduced anchorage-independent cell growth of cells of mammary origin. miR-125b was found to perform its tumor suppressor function via the direct targeting of the 3'-UTRs of ENPEP, CK2-alpha, CCNJ, and MEGF9 mRNAs. Silencing these miR-125b targets mimicked the biological effects of miR-125b overexpression, confirming that they are modulated by miR-125b. Analysis of ENPEP, CK2-alpha, CCNJ, and MEGF9 protein expression in breast cancer patients revealed that they were overexpressed in 56%, 40-56%, 20%, and 32% of the tumors, respectively. The expression of ENPEP and CK2-alpha was inversely correlated with miR-125b expression in breast tumors, indicating the relevance of these potential oncogenic proteins in breast cancer patients. Our results support a prognostic role for CK2-alpha, whose expression may help clinicians predict breast tumor aggressiveness. In particular, our results show that restoration of miR-125b expression or knockdown of ENPEP, CK2-alpha, CCNJ, or MEGF9 may provide novel approaches for the treatment of breast cancer.	[Feliciano, Andrea; Castellvi, Josep; Artero-Castro, Ana; Leal, Jose A.; Romagosa, Cleofe; Hernandez-Losa, Javier; Peg, Vicente; Ramon y Cajal, Santiago; LLeonart, Matilde E.] Inst Recerca Hosp Vall dHebron, Oncol & Mol Pathol Grp, Dept Pathol, Barcelona, Spain; [Fabra, Angels] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Vidal, Francisco] Banc Sang & Teixits, Barcelona, Spain; [Kondoh, Hiroshi] Kyoto Univ, Dept Geriatr Med, Grad Sch Med, Kyoto, Japan	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Kyoto University	LLeonart, ME (corresponding author), Inst Recerca Hosp Vall dHebron, Oncol & Mol Pathol Grp, Dept Pathol, Barcelona, Spain.	melleona@ir.vhebron.net	Peg., Vicente/AAC-9447-2020; LLeonart, Matilde E./Q-2662-2019; Javier, Hernandez Losa/C-1173-2008; Pérez-Portabell, Cleofé Romagosa/Q-3342-2016; Peg, Vicente/E-9160-2018; Ramon y Cajal, Santiago/H-4955-2016; Artero, Ana/AAD-2247-2022; Castellvi, Josep/C-5092-2014	Peg., Vicente/0000-0002-5203-6166; LLeonart, Matilde E./0000-0002-6196-7405; Javier, Hernandez Losa/0000-0003-1526-3201; Peg, Vicente/0000-0002-5203-6166; Ramon y Cajal, Santiago/0000-0002-3867-1390; Castellvi, Josep/0000-0001-5745-9996; Vidal, Francisco/0000-0001-8089-4945; Feliciano, Andrea/0000-0002-3189-3441	"Banco Bilbao Vizcaya Argentaria" (BBVA) Foundation [056/09]; FIS fellowship; Grants-in-Aid for Scientific Research [23390186] Funding Source: KAKEN	"Banco Bilbao Vizcaya Argentaria" (BBVA) Foundation(BBVA Foundation); FIS fellowship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the "Banco Bilbao Vizcaya Argentaria" (BBVA) Foundation Grant number 056/09. MLL is an FIS investigator (CP03/00101). A. Feliciano is funded by a FIS fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061064; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Brandt-Bohne U, 2007, BIOCHEM J, V401, P447, DOI 10.1042/BJ20060691; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Cui Y, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-116; Cunha IW, 2010, TRANSL ONCOL, V3, P23, DOI 10.1593/tlo.09166; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Drukker M, 2012, NAT BIOTECHNOL, V30, P531, DOI 10.1038/nbt.2239; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Finley RL, 1996, P NATL ACAD SCI USA, V93, P3011, DOI 10.1073/pnas.93.7.3011; Giusiano S, 2011, EUR J CANCER, V47, P792, DOI 10.1016/j.ejca.2010.11.028; Gong J, 2013, ONCOGENE, V32, P3071, DOI 10.1038/onc.2012.318; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kolonin MG, 2000, DEV BIOL, V227, P661, DOI 10.1006/dbio.2000.9916; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Liu LH, 2011, BIOCHEM BIOPH RES CO, V416, P31, DOI 10.1016/j.bbrc.2011.10.117; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lukiw WJ, 2012, MOL NEUROBIOL, V46, P11, DOI 10.1007/s12035-012-8234-4; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mandke P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042034; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mohri T, 2009, INT J CANCER, V125, P1328, DOI 10.1002/ijc.24459; Morrell NW, 1999, AM J PHYSIOL-LUNG C, V277, pL440, DOI 10.1152/ajplung.1999.277.3.L440; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Saini S, 2012, CANCER RES, V72, P3618, DOI 10.1158/0008-5472.CAN-12-0540; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Song LJ, 1999, HYPERTENSION, V33, P746, DOI 10.1161/01.HYP.33.2.746; Stockler M, 2000, CANCER TREAT REV, V26, P151, DOI 10.1053/ctrv.1999.0161; Suganuma T, 2004, LAB INVEST, V84, P639, DOI 10.1038/labinvest.3700072; Ting HJ, 2013, J BIOL CHEM, V288, P1, DOI 10.1074/jbc.M112.395947; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Xu N, 2011, J INVEST DERMATOL, V131, P1521, DOI 10.1038/jid.2011.55; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao AH, 2012, J GENET GENOMICS, V39, P29, DOI 10.1016/j.jgg.2011.12.003; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	66	113	120	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76247	10.1371/journal.pone.0076247	http://dx.doi.org/10.1371/journal.pone.0076247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098452	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600031
J	Gokulan, K; Khare, S; Rooney, AW; Han, J; Lynne, AM; Foley, SL				Gokulan, Kuppan; Khare, Sangeeta; Rooney, Anthony W.; Han, Jing; Lynne, Aaron M.; Foley, Steven L.			Impact of Plasmids, Including Those EncodingVirB4/D4 Type IV Secretion Systems, on Salmonella enterica serovar Heidelberg Virulence in Macrophages and Epithelial Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; BRUCELLA-ABORTUS; INTRACELLULAR SURVIVAL; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSE; UNITED-STATES; VIRB OPERON; INFECTION; MICE	Salmonella enterica serovar Heidelberg (S. Heidelberg) can cause foodborne illness in humans following the consumption of contaminated meat and poultry products. Recent studies from our laboratory have demonstrated that certain S. Heidelberg isolated from food-animal sources harbor multiple transmissible plasmids with genes that encode antimicrobial resistance, virulence and a VirB4/D4 type-IV secretion system. This study examines the potential role of these transmissible plasmids in bacterial uptake and survival in intestinal epithelial cells and macrophages, and the molecular basis of host immune system modulation that may be associated with disease progression. A series of transconjugant and transformant strains were developed with different combinations of the plasmids to determine the roles of the individual and combinations of plasmids on virulence. Overall the Salmonella strains containing the VirB/D4 T4SS plasmids entered and survived in epithelial cells and macrophages to a greater degree than those without the plasmid, even though they carried other plasmid types. During entry in macrophages, the VirB/D4 T4SS encoding genes are up-regulated in a time-dependent fashion. When the potential mechanisms for increased virulence were examined using an antibacterial Response PCR Array, the strain containing the T4SS down regulated several host innate immune response genes which likely contributed to the increased uptake and survival within macrophages and epithelial cells.	[Gokulan, Kuppan; Khare, Sangeeta; Rooney, Anthony W.; Han, Jing; Foley, Steven L.] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Rooney, Anthony W.] Univ Minnesota, Dept Chem, Morris, MN 56267 USA; [Lynne, Aaron M.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA	US Food & Drug Administration (FDA); University of Minnesota System; University of Minnesota Morris; Texas State University System; Sam Houston State University	Foley, SL (corresponding author), US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA.	steven.foley@fda.hhs.gov	Khare, SangeetA/Q-5470-2019	Khare, SangeetA/0000-0002-9496-6636; Foley, Steven/0000-0003-3146-4548; Gokulan, Kuppan/0000-0003-4045-5993	FDA-National Center for Toxicological Research	FDA-National Center for Toxicological Research	The research is internally funded through the FDA-National Center for Toxicological Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2004, ANTIMICROB AGENTS CH, V48, P1916, DOI 10.1128/AAC.48.5.1916-1917.2004; APPELMELK BJ, 1994, INFECT IMMUN, V62, P2628, DOI 10.1128/IAI.62.6.2628-2632.1994; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bessler HC, 2006, MICROBIOL IMMUNOL, V50, P877, DOI 10.1111/j.1348-0421.2006.tb03863.x; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Centers for Disease Control and Prevention, 2011, SALM SURV ANN SUMM; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; David DE, 2010, APPL ENVIRON MICROB, V76, P7509, DOI 10.1128/AEM.00726-10; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Debbabi H, 1998, J DAIRY RES, V65, P283, DOI 10.1017/S0022029997002732; Del Olmo A, 2010, J DAIRY SCI, V93, P3965, DOI 10.3168/jds.2010-3152; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Drago-Serrano ME, 2010, IMMUNOL LETT, V134, P35, DOI 10.1016/j.imlet.2010.08.007; FDA, 2010, NAT ANT RES MON SYST; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fluit AC, 2005, FEMS IMMUNOL MED MIC, V43, P1, DOI 10.1016/j.femsim.2004.10.007; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gomez Thomas M., 1997, World Health Statistics Quarterly, V50, P81; Han J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051160; Han J, 2011, J CLIN MICROBIOL, V49, P1130, DOI 10.1128/JCM.01931-10; Health Canada, 2009, COMMUN DISORD REP S3, V35, P1; Hoffmann M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00004-12; Hoffmann M, 2012, J BACTERIOL, V194, P3274, DOI 10.1128/JB.00419-12; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; Johnson TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015524; Kaldhone P, 2008, APPL ENVIRON MICROB, V74, P5038, DOI 10.1128/AEM.00409-08; Kennedy M, 2004, CLIN INFECT DIS, V38, pS142, DOI 10.1086/381580; Khare S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042127; Lynne AM, 2009, FOODBORNE PATHOG DIS, V6, P207, DOI 10.1089/fpd.2008.0172; Nolan LK, 2003, VET RES COMMUN, V27, P101, DOI 10.1023/A:1022854902700; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pegues DA, 2005, PRINCIPLES PRACTICE, V2, P2636; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39; Rotger R, 1999, Int Microbiol, V2, P177; Roux CM, 2007, CELL MICROBIOL, V9, P1851, DOI 10.1111/j.1462-5822.2007.00922.x; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; Russell MW, 2005, INNATE HUMORAL DEFEN; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Sajjan SU, 2008, INFECT IMMUN, V76, P5447, DOI 10.1128/IAI.00451-08; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x; Sieira R, 2004, MOL MICROBIOL, V54, P808, DOI 10.1111/j.1365-2958.2004.04316.x; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; WANG ZL, 1994, BIOTECHNIQUES, V16, P460; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; WILMSHURST P, 1995, CLIN INFECT DIS, V21, P1065, DOI 10.1093/clinids/21.4.1065; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; Zhao S, 2006, FOODBORNE PATHOG DIS, V3, P106, DOI 10.1089/fpd.2006.3.106	62	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77866	10.1371/journal.pone.0077866	http://dx.doi.org/10.1371/journal.pone.0077866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098597	Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600090
J	Han, L; Wu, CJ; Riaz, H; Bai, LY; Chen, JG; Zhen, YH; Guo, AZ; Yang, LG				Han, Li; Wu, Canjie; Riaz, Hasan; Bai, Liya; Chen, Jianguo; Zhen, Yanhong; Guo, Aizhen; Yang, Liguo			Characterization of the Mechanism of Inhibin alpha-Subunit Gene in Mouse Anterior Pituitary Cells by RNA Interference	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; RAT PITUITARY; FSH-BETA; BINDING-SITES; EXPRESSION; ACTIVIN; TRANSCRIPTION; FOLLISTATIN; BETAGLYCAN; SECRETION	Inhibin, a member of the transforming growth factor-beta [TGF-beta] superfamily, is a suppressor of follicle-stimulating hormone [FSH] release through pituitary-gonadal negative feedback loop to regulate follicular development. In this study, Inhibin alpha-subunit [Inha] gene was knocked down successfully in mice primary anterior pituitary cells at both transcriptional and translational levels by RNAi-Ready pSIREN-RetroQ-ZsGreen Vector mediated recombinant pshRNA vectors. The results indicated that inhibin silencing significantly promoted apoptosis by up-regulating Caspase-3, Bax and Bcl-2 genes without affecting p53 both at transcriptional and translational levels. Furthermore, it markedly impaired the progression of G1 phase of cell cycle and decreased the amount of cells in S phase [as detected by flow cytometry]. Inhibin silencing resulted in significant up-regulation of mRNA and protein expressions of Gondotropin releasing hormone receptors [GnRHR] and down-regulated mRNA levels of beta-glycans with parellel change in the amount of its protein expression. Silencing of inhibin-a significantly increased [P<0.05] activin-beta concentration without affecting FSH and LH levels in anterior pituitary cells. These findings revealed that up regulation of GnRH receptors by silencing inhibin a-subunit gene might increase the concentration of activin-b in the culture medium. Inhibin a silencing resulted in increased mRNA and protein expressions of inhibin beta which may demonstrate that both inhibin subunits co-participate in the regulation of reproductive events in anterior pituitary cells. This study concludes that inhibin is a broad regulatory marker in anterior pituitary cells by regulating apoptosis, cellular progression and simultaneously by vital fluctuations in the hormonal signaling.	[Han, Li; Guo, Aizhen] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Lab Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Han, Li; Wu, Canjie; Riaz, Hasan; Bai, Liya; Chen, Jianguo; Zhen, Yanhong; Yang, Liguo] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Guo, AZ (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Vet Med, Lab Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	aizhen@mail.hzau.edu.cn; yangliguo2006@yahoo.com.cn	Riaz, Hasan/AAE-5698-2019; Riaz, Hasan/D-2940-2014		National Natural Science Foundation of China [30972099]; China Postdoctoral Science Foundation [20100471194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (30972099) and the China Postdoctoral Science Foundation (20100471194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADEN TD, 1990, ENDOCRINOLOGY, V127, P2387, DOI 10.1210/endo-127-5-2387; Burger LL, 2004, ENDOCRINOLOGY, V145, P71, DOI 10.1210/en.2003-1047; Cai KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025585; Chapman SC, 2003, ENDOCRINOLOGY, V144, P5640, DOI 10.1210/en.2003-0670; Chen Fengjian, 2007, Journal of Genetics and Genomics, V34, P1106, DOI 10.1016/S1673-8527(07)60126-X; Childs GV, 1997, ENDOCRINOLOGY, V138, P1577, DOI 10.1210/en.138.4.1577; CHILDS GV, 1994, ENDOCRINOLOGY, V134, P990, DOI 10.1210/en.134.2.990; Ciccone NA, 2004, J NEUROENDOCRINOL, V16, P999, DOI 10.1111/j.1365-2826.2005.01260.x; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; de Kretser DM, 2002, HUM REPROD UPDATE, V8, P529, DOI 10.1093/humupd/8.6.529; Demura R, 1996, ENDOCR J, V43, P403, DOI 10.1507/endocrj.43.403; Denkova R, 2004, Endocr Regul, V38, P51; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; FORAGE RG, 1986, P NATL ACAD SCI USA, V83, P3091, DOI 10.1073/pnas.83.10.3091; Gray PC, 2005, RES PERSPECT END INT, P1, DOI 10.1007/3-540-26940-1_1; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han L, 2008, ANIM REPROD SCI, V109, P251, DOI 10.1016/j.anireprosci.2007.12.012; Kananen K, 1996, MOL CELL ENDOCRINOL, V119, P135, DOI 10.1016/0303-7207(96)03802-6; Klockel BJ, 2002, CELL DEATH DIFFER, V9, P1063, DOI 10.1038/sj.cdd.4401067; KOTSUJI F, 1988, ENDOCRINOLOGY, V123, P2683, DOI 10.1210/endo-123-6-2683; Kumar TR, 2003, MOL CELL ENDOCRINOL, V212, P19, DOI 10.1016/j.mce.2003.09.019; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Pierson TM, 2000, MOL ENDOCRINOL, V14, P1075, DOI 10.1210/me.14.7.1075; Sari IP, 2009, ENDOCRINOLOGY, V150, P5549, DOI 10.1210/en.2009-0775; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Vitale AM, 2002, BIOL REPROD, V67, P1989, DOI 10.1095/biolreprod.102.003673; WANG QF, 1989, ENDOCRINOLOGY, V124, P363, DOI 10.1210/endo-124-1-363; Wang SL, 2012, THERIOGENOLOGY, V78, P393, DOI 10.1016/j.theriogenology.2012.02.019; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Wiater E, 2006, J BIOL CHEM, V281, P17011, DOI 10.1074/jbc.M601459200; WOODRUFF TK, 1993, ENDOCRINOLOGY, V132, P2332, DOI 10.1210/en.132.6.2332; WOODRUFF TK, 1987, MOL ENDOCRINOL, V1, P561, DOI 10.1210/mend-1-8-561; WOODRUFF TK, 1995, ANNU REV PHYSIOL, V57, P219; ZATZ M, 1985, P NATL ACAD SCI USA, V82, P1286, DOI 10.1073/pnas.82.4.1286	38	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74596	10.1371/journal.pone.0074596	http://dx.doi.org/10.1371/journal.pone.0074596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098340	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600007
J	Lee, CH; Sugiyama, T; Kataoka, A; Kudo, A; Fujino, F; Chen, YW; Mitsuyama, Y; Nomura, S; Yoshioka, T				Lee, Chih-Hung; Sugiyama, Takashi; Kataoka, Aiko; Kudo, Ayako; Fujino, Fukue; Chen, Yu-Wen; Mitsuyama, Yuki; Nomura, Shinobu; Yoshioka, Tohru			Analysis for Distinctive Activation Patterns of Pain and Itchy in the Human Brain Cortex Measured Using Near Infrared Spectroscopy (NIRS)	PLOS ONE			English	Article							HISTAMINE-INDUCED ITCH; POSITRON-EMISSION-TOMOGRAPHY; CROSS-CORRELATION; CEREBRAL HEMODYNAMICS; MUSCLE OXYGENATION; PERCEPTION; FMRI; CONNECTIVITY; OSCILLATIONS; MODULATION	Pain and itch are closely related sensations, yet qualitatively quite distinct. Despite recent advances in brain imaging techniques, identifying the differences between pain and itch signals in the brain cortex is difficult due to continuous temporal and spatial changes in the signals. The high spatial resolution of positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) has substantially advanced research of pain and itch, but these are uncomfortable because of expensiveness, importability and the limited operation in the shielded room. Here, we used near infrared spectroscopy (NIRS), which has more conventional usability. NIRS can be used to visualize dynamic changes in oxygenated hemoglobin and deoxyhemoglobin concentrations in the capillary networks near activated neural circuits in real-time as well as fMRI. We observed distinct activation patterns in the frontal cortex for acute pain and histamine-induced itch. The prefrontal cortex exhibited a pain-related and itch-related activation pattern of blood flow in each subject. Although it looked as though that activation pattern for pain and itching was different in each subject, further cross correlation analysis of NIRS signals between each channels showed an overall agreement with regard to prefrontal area involvement. As a result, pain-related and itch-related blood flow responses (delayed responses in prefrontal area) were found to be clearly different between pain (tau = +18.7 sec) and itch (tau = +0.63 sec) stimulation. This is the first pilot study to demonstrate the temporal and spatial separation of a pain-induced blood flow and an itch-induced blood flow in human cortex during information processing.	[Lee, Chih-Hung] Kaohsiung Chang Gung Mem Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lee, Chih-Hung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Sugiyama, Takashi] Waseda Univ, Adv Res Inst Biosci, Tokyo, Japan; [Kataoka, Aiko; Kudo, Ayako; Fujino, Fukue] Kanagawa Dent Univ, Jr Coll, Dept Dent Hyg, Yokosuka, Kanagawa, Japan; [Chen, Yu-Wen] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Mitsuyama, Yuki] Waseda Univ, Grad Sch Human Sci, Saitama, Japan; [Nomura, Shinobu] Waseda Univ, Fac Human Sci, Saitama, Japan; [Yoshioka, Tohru] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Waseda University; Kanagawa Dental College; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Waseda University; Waseda University; Kaohsiung Medical University	Yoshioka, T (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.	yoshioka@kmu.edu.tw	Lee, Chih-Hung/AAJ-5551-2020	Lee, Chih-Hung/0000-0001-9804-3874	National Science Council [NSC95-2314-B-037-024, NSC96-2314-B-037-043, NSC97-2320-B-010-013-MY3]; National Health Research Institute [NHRI-EO-096-PP-11, NHRI CN-PD-9611P]; Kaohsiung Medical University (KMU) [KMU-QA096005]; KMU Center of Excellence for Environmental Medicine [98.2b]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Kaohsiung Medical University (KMU); KMU Center of Excellence for Environmental Medicine	This work was supported by grants from the National Science Council (NSC95-2314-B-037-024, NSC96-2314-B-037-043 and NSC97-2320-B-010-013-MY3); National Health Research Institute (NHRI-EO-096-PP-11; NHRI CN-PD-9611P); Kaohsiung Medical University (KMU)(KMU-QA096005); and KMU Center of Excellence for Environmental Medicine (98.2b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2008, CURR OPIN NEUROBIOL, V18, P464, DOI 10.1016/j.conb.2008.09.012; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Darsow U, 2000, J INVEST DERMATOL, V115, P1029, DOI 10.1046/j.1523-1747.2000.00193.x; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Duncan JS, 1999, REV NEUROL, V155, P482; Durkin JL, 2006, ERGONOMICS, V49, P28, DOI 10.1080/00140130500356882; Elwell CE, 1999, ADV EXP MED BIOL, V471, P57; Ganong WF, 2005, REV MED PHYSL, Vxii; Hamill TG, 2009, SYNAPSE, V63, P1122, DOI 10.1002/syn.20689; Herde L, 2007, J NEUROPHYSIOL, V98, P2347, DOI 10.1152/jn.00475.2007; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Kell RT, 2006, EUR J APPL PHYSIOL, V96, P241, DOI 10.1007/s00421-005-0072-x; Klede M, 2003, J NEUROPHYSIOL, V90, P353, DOI 10.1152/jn.01136.2002; KOLTZENBURG M, 1993, NEUROSCI LETT, V150, P219, DOI 10.1016/0304-3940(93)90540-2; Kulkarni B, 2007, ARTHRITIS RHEUM, V56, P1345, DOI 10.1002/art.22460; Leknes SG, 2007, J NEUROPHYSIOL, V97, P415, DOI 10.1152/jn.00070.2006; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Mochizuki H, 2003, PAIN, V105, P339, DOI 10.1016/S0304-3959(03)00249-5; Mochizuki H, 2007, NEUROIMAGE, V36, P706, DOI 10.1016/j.neuroimage.2007.04.003; Mochizuki H, 2009, J NEUROPHYSIOL, V102, P2657, DOI 10.1152/jn.00460.2009; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Ostojic S, 2009, J NEUROSCI, V29, P10234, DOI 10.1523/JNEUROSCI.1275-09.2009; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Peyron R, 2011, M S-MED SCI, V27, P82, DOI 10.1051/medsci/201127182; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Schmelz M, 2003, NEUROLOGY, V61, P564, DOI 10.1212/01.WNL.0000078193.64949.08; Sprenger T, 2005, EUR J PAIN, V9, P117, DOI 10.1016/j.ejpain.2004.07.010; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; Valet M, 2008, J INVEST DERMATOL, V128, P426, DOI 10.1038/sj.jid.5701002; Walter B, 2005, J INVEST DERMATOL, V125, P380, DOI 10.1111/j.0022-202X.2005.23817.x; Yosipovitch G, 2005, J INVEST DERMATOL, V125, P1268, DOI 10.1111/j.0022-202X.2005.23942.x; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	36	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75360	10.1371/journal.pone.0075360	http://dx.doi.org/10.1371/journal.pone.0075360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098378	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600016
J	Roussin, A; Bouyssi, A; Pouche, L; Pourcel, L; Lapeyre-Mestre, M				Roussin, Anne; Bouyssi, Annabelle; Pouche, Lucie; Pourcel, Laure; Lapeyre-Mestre, Maryse			Misuse and Dependence on Non-Prescription Codeine Analgesics or Sedative H1 Antihistamines by Adults: A Cross-Sectional Investigation in France	PLOS ONE			English	Article							THE-COUNTER MEDICINES; COMMUNITY PHARMACIES; ABUSE; ABUSE/MISUSE; MEDICATION; INSOMNIA; DRUGS; MODEL	Background: Given the growing worldwide market of non-prescription drugs, monitoring their misuse in the context of self-medication represents a particular challenge in Public Health. The aim of this study was to investigate the prevalence of misuse, abuse, and dependence on non-prescription psychoactive drugs. Method: During one month, in randomly solicited community pharmacies, an anonymous questionnaire was offered to adults requesting paracetamol (control group), codeine combined with paracetamol in analgesics, or sedative H1 antihistamines. Responses about misuse (drug use not in agreement with the Patient Information Leaflet) abuse (excessive drug use having detrimental consequences), and dependence (established according to questions adapted from the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition criteria) on psychoactive drugs were compared to those of the paracetamol control group. Results: 295 patients (mean age 48.5 years, 68.5% of women) having used one of the studied drugs during the previous month were included. Misuse and dependence to codeine analgesics concerned 6.8% and 17.8% of the patients exposed to these drugs, respectively, (n = 118), which was significantly higher than for paracetamol. 19.5% had used codeine analgesics daily for more than six months. Headache was the most frequent reason for persistent daily use. A high prevalence of persistent daily users of sedative H1 antihistamines was also observed. Whereas these drugs are recommended only for short treatment courses of occasional insomnia, 72.2% of the participants having taken doxylamine (n = 36) were daily users, predominantly for more than six months. Conclusions: Results on misuse and dependence on non-prescription codeine analgesics suggest that chronic pain, in particular chronic cephalalgia, requires better medical care. In addition, as for hypnotics on prescription, persistent use of doxylamine for self-medication is not justified until an acceptable benefit-risk ratio for chronic sleep disturbance is shown by clinical data.	[Roussin, Anne; Bouyssi, Annabelle; Pouche, Lucie; Pourcel, Laure; Lapeyre-Mestre, Maryse] Univ Toulouse 3, Equipe Pharmacoepidemiol, INSERM, UMR1027, F-31062 Toulouse, France; [Roussin, Anne; Lapeyre-Mestre, Maryse] Hop Toulouse, Serv Pharmacol Clin, Addictovigilance Ctr, Ctr Evaluat & Informat Pharmacodependance, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Roussin, A (corresponding author), Univ Toulouse 3, Equipe Pharmacoepidemiol, INSERM, UMR1027, F-31062 Toulouse, France.	anne.roussin@univ-tlse3.fr	Roussin, Anne/E-3557-2018; Lapeyre-Mestre, Maryse/C-8710-2012	Lapeyre-Mestre, Maryse/0000-0002-5494-5873	Mission Interministerielle de la Lutte contre les Drogues et Toxicomanies (MILDT);  [0802707]	Mission Interministerielle de la Lutte contre les Drogues et Toxicomanies (MILDT); 	This work was supported by the Mission Interministerielle de la Lutte contre les Drogues et Toxicomanies (MILDT) (http://www.drogues.gouv.fr/) in relationship with the French Health Products Safety Agency (Afssaps) which has been renamed the Agence Nationale de Securite des Medicaments et Produits de Sante (ANSM) (http://www.ansm.sante.fr/Activites/Appels-a-projets-de-recherche). The reference grant number was: 0802707. The Scientific Commission of Afssaps has had a role in the study design by recommending to randomly select community pharmacies instead to use national sentinel network of pharmacies. Afssaps gave its agreement to publish results. However the funders did not have any role in data collection and analysis as well as preparation of the manuscript.	AFIPA, CHIFFR MARCH AUT FRA; Afssaps, 2011, ANAL VENTES MEDICAME; [Anonymous], 2008, PRESCRIRE INT, V97, P206; Bendtsen L, 2012, J HEADACHE PAIN, V13, pS1, DOI 10.1007/s10194-011-0402-9; CRAIG DF, 1990, CAN MED ASSOC J, V142, P970; Djezzar S, 2009, INT J LEGAL MED, V123, P213, DOI 10.1007/s00414-008-0291-x; Ferrari A, 2006, CEPHALALGIA, V26, P187, DOI 10.1111/j.1468-2982.2005.01020.x; Fleming GF, 2004, PHARM WORLD SCI, V26, P282, DOI 10.1023/B:PHAR.0000042891.66983.60; Frei MY, 2010, MED J AUSTRALIA, V193, P294, DOI 10.5694/j.1326-5377.2010.tb03911.x; Gauvin DV, 1995, EUR J PHARMACOL, V294, P281, DOI 10.1016/0014-2999(95)00550-1; Gonzales R, 2011, J SUBST ABUSE TREAT, V40, P224, DOI 10.1016/j.jsat.2010.11.003; Gracious B, 2010, J CHILD ADOL PSYCHOP, V20, P521, DOI 10.1089/cap.2010.0031; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; Hughes GF, 1999, PHARM WORLD SCI, V21, P251, DOI 10.1023/A:1008788726842; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Lusher J, 2006, CLIN J PAIN, V22, P316, DOI 10.1097/01.ajp.0000176360.94644.41; MATHESON C, 2002, PHARM J, V269, P66; McDonough MA, 2011, MED J AUSTRALIA, V194, P486, DOI 10.5694/j.1326-5377.2011.tb03069.x; Meoli AL, 2005, J CLIN SLEEP MED, V1, P173; MHRA (No author listed), 2009, DRUG SAFETY UPDATE, V3, P6; Morin AK, 2007, PHARMACOTHERAPY, V27, P89, DOI 10.1592/phco.27.1.89; Orriols L, 2010, PLOS MED, V7, DOI [10.1371/journal.pmed.1000366, DOI 10.1371/J0URNAL.PMED.1000366]; Orriols L, 2009, DRUG SAFETY, V32, P859, DOI 10.2165/11316590-000000000-00000; Pates R, 2002, PHARM J, V268, P179; Richardson GS, 2002, J CLIN PSYCHOPHARM, V22, P511, DOI 10.1097/00004714-200210000-00012; Schadeck B, 1996, SEM HOP PARIS, V72, P428; Sinclair HK, 1999, PHARMACOEPIDEM DR S, V8, P479, DOI 10.1002/(SICI)1099-1557(199912)8:7<479::AID-PDS462>3.3.CO;2-2; Skurtveit S, 2011, PAIN, V152, P1555, DOI 10.1016/j.pain.2011.02.045; Thomas A, 2009, J PSYCHOPHARMACOL, V23, P101, DOI 10.1177/0269881107083809; Vallejo R, 2011, PAIN PHYSICIAN, V14, pE343; Wazaify M, 2006, PATIENT EDUC COUNS, V64, P136, DOI 10.1016/j.pec.2005.12.008; Weiler JM, 2000, ANN INTERN MED, V133, P657, DOI 10.7326/0003-4819-133-8-200010170-00024	32	56	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76499	10.1371/journal.pone.0076499	http://dx.doi.org/10.1371/journal.pone.0076499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098516	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600059
J	Shaw, J; Izu, L; Chen-Izu, Y				Shaw, John; Izu, Leighton; Chen-Izu, Ye			Mechanical Analysis of Single Myocyte Contraction in a 3-D Elastic Matrix	PLOS ONE			English	Article							ELLIPSOIDAL INCLUSION; SARCOMERE LENGTH; HEART; STRESS; MUSCLE; FIELD	Background: Cardiac myocytes experience mechanical stress during each heartbeat. Excessive mechanical stresses under pathological conditions cause functional and structural remodeling that lead to heart diseases, yet the precise mechanisms are still incompletely understood. To study the cellular and molecular level mechanotransduction mechanisms, we developed a new 'cell-in-gel' experimental system to exert multiaxial (3-D) stresses on a single myocyte during active contraction. Methods: Isolated myocytes are embedded in an elastic hydrogel to simulate the mechanical environment in myocardium (afterload). When electrically stimulated, the in-gel myocyte contracts while the matrix resists shortening and broadening of the cell, exerting normal and shear stresses on the cell. Here we provide a mechanical analysis, based on the Eshelby inclusion problem, of the 3-D strain and stress inside and outside the single myocyte during contraction in an elastic matrix. Results: (1) The fractional shortening of the myocyte depends on the cell's geometric dimensions and the relative stiffness of the cell to the gel. A slender or softer cell has less fractional shortening. A myocyte of typical dimensions embedded in a gel of similar elastic stiffness can contract only 20% of its load-free value. (2) The longitudinal stress inside the cell is about 15 times the transverse stress level. (3) The traction on the cell surface is highly non-uniform, with a maximum near its ends, showing 'hot spots' at the location of intercalated disks. (4) The mechanical energy expenditure of the myocyte increases with the matrix stiffness in a monotonic and nonlinear manner. Conclusion: Our mechanical analyses provide analytic solutions that readily lend themselves to parametric studies. The resulting 3-D mapping of the strain and stress states serve to analyze and interpret ongoing cell-in-gel experiments, and the mathematical model provides an essential tool to decipher and quantify mechanotransduction mechanisms in cardiac myocytes.	[Shaw, John] Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA; [Izu, Leighton] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Chen-Izu, Ye] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of Michigan System; University of Michigan; University of California System; University of California Davis; University of California System; University of California Davis	Shaw, J (corresponding author), Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA.	jashaw@umich.edu	Izu, Leighton/C-4066-2015	Chen-Izu, Ye/0000-0003-4818-9570	University of Michigan; National Institutes of Health (NIH) [R01 HL90880]; University of California; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090880] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the University of Michigan sabbatical funding to JS; the National Institutes of Health (NIH) R01 HL90880 to LI and YC; and the University of California startup funds to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1982, J PHYSIOL-LONDON, V327, P79, DOI 10.1113/jphysiol.1982.sp014221; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Bollensdorff C, 2011, PFLUG ARCH EUR J PHY, V462, P39, DOI 10.1007/s00424-011-0964-z; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; ESHELBY JD, 1959, PROC R SOC LON SER-A, V252, P561, DOI 10.1098/rspa.1959.0173; ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133; EVANS SJ, 1995, CARDIOVASC RES, V29, P555, DOI 10.1016/S0008-6363(96)88534-8; GAUTEL M, 2011, J PHYSL, V462, P119, DOI DOI 10.1007/S00424-011-0946-1; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7; HILL R, 1965, J MECH PHYS SOLIDS, V13, P213, DOI 10.1016/0022-5096(65)90010-4; Hill R, 1961, PROGR SOLID MECHANIC, V2, P89; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Luo JT, 2009, ADV EXP MED BIOL, V611, P19, DOI 10.1007/978-0-387-73657-0_9; MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3; Mura T., 1991, MICROMECHANICS DEFEC; Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Prosser BL, 2012, J MOL CELLU IN PRESS; Rodin GJ, 1996, J MECH PHYS SOLIDS, V44, P1977, DOI 10.1016/S0022-5096(96)00066-X; SONNENBLICK EH, 1967, CIRC RES, V21, P423, DOI 10.1161/01.RES.21.4.423; von Anrep G, 1912, J PHYSIOL-LONDON, V45, P307; Wineman A.S., 2000, MECH RESPONSE POLYM	25	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75492	10.1371/journal.pone.0075492	http://dx.doi.org/10.1371/journal.pone.0075492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098388	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600019
J	Abujamel, T; Cadnum, JL; Jury, LA; Sunkesula, VCK; Kundrapu, S; Jump, RL; Stintzi, AC; Donskey, CJ				Abujamel, Turki; Cadnum, Jennifer L.; Jury, Lucy A.; Sunkesula, Venkata C. K.; Kundrapu, Sirisha; Jump, Robin L.; Stintzi, Alain C.; Donskey, Curtis J.			Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; RESISTANT ENTEROCOCCI; INTRAVENOUS THERAPY; DISEASE; ANTIBIOTICS	Background: Clostridium difficile is an anaerobic, spore-forming bacterium that is the most common cause of healthcare-associated diarrhea in developed countries. A significant proportion of patients receiving oral vancomycin or metronidazole for treatment of Clostridium difficile infection (CDI) develop recurrences. However, the period of vulnerability to re-establishment of colonization by C. difficile after therapy is not well defined. Principal Findings: In a prospective study of CDI patients, we demonstrated that most vancomycin-treated patients maintained inhibitory concentrations of vancomycin in stool for 4 to 5 days after therapy, whereas metronidazole was only detectable during therapy. From the time of elimination of the antibiotics to 14 to 21 days after therapy, a majority of stool suspensions supported growth of C. difficile and deep 16S rRNA sequencing demonstrated persistent marked alteration of the indigenous microbiota. By 21 to 28 days after completion of CDI treatment, a majority of stool suspensions inhibited growth of C. difficile and there was evidence of some recovery of the microbiota. Conclusions: These data demonstrate that there is a vulnerable period for re-establishment of C. difficile colonization after CDI treatment that begins within a few days after discontinuation of treatment and extends for about 3 weeks in most patients.	[Abujamel, Turki; Stintzi, Alain C.] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1N 6N5, Canada; [Cadnum, Jennifer L.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Jury, Lucy A.; Jump, Robin L.; Donskey, Curtis J.] Geriatr Res Educ & Clin Ctr, Cleveland, OH USA; [Sunkesula, Venkata C. K.; Kundrapu, Sirisha; Donskey, Curtis J.] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA	University of Ottawa; Geriatric Research Education & Clinical Center; Case Western Reserve University	Stintzi, AC (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1N 6N5, Canada.	astintzi@uottawa.ca; curtisd123@yahoo.com	Abujamel, Turki/GRS-5606-2022; Jump, Robin/AAD-8364-2019		ViroPharma, Incorporated by the Canadian Institutes of Health Research (CIHR); King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada	ViroPharma, Incorporated by the Canadian Institutes of Health Research (CIHR); King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada	This work was supported by a grant from ViroPharma, Incorporated to CJD by the Canadian Institutes of Health Research (CIHR) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TA was supported by a scholarship from King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada.	Al-Nassir WN, 2008, ANTIMICROB AGENTS CH, V52, P2403, DOI 10.1128/AAC.00090-08; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bidet P, 2000, J CLIN MICROBIOL, V38, P2484, DOI 10.1128/JCM.38.7.2484-2487.2000; BOLTON RP, 1986, GUT, V27, P1169, DOI 10.1136/gut.27.10.1169; BORRIELLO SP, 1986, J MED MICROBIOL, V21, P299, DOI 10.1099/00222615-21-4-299; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Currie BP, 2004, ANTIMICROB AGENTS CH, V48, P4427, DOI 10.1128/AAC.48.11.4427-4429.2004; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Edlund C, 1997, CLIN INFECT DIS, V25, P729, DOI 10.1086/513755; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; JOHNSON S, 1992, ANN INTERN MED, V117, P297, DOI 10.7326/0003-4819-117-4-297; Lau SKP, 2007, J CLIN MICROBIOL, V45, P395, DOI 10.1128/JCM.01831-06; Lau SKP, 2012, J CLIN MICROBIOL, V50, P2239, DOI 10.1128/JCM.00128-12; Louie TJ, 2009, ANTIMICROB AGENTS CH, V53, P261, DOI 10.1128/AAC.01443-07; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Malaguarnera G, 2012, J NUTR HEALTH AGING, V16, P402, DOI 10.1007/s12603-011-0357-1; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Robinson CJ, 2010, GUT MICROBES, V1, P279, DOI 10.4161/gmic.1.4.12614; ROLFE RD, 1983, J INFECT DIS, V147, P227, DOI 10.1093/infdis/147.2.227; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sethi AK, 2009, INFECT CONT HOSP EP, V30, P13, DOI 10.1086/592710; Sommer MOA, 2011, CURR OPIN MICROBIOL, V14, P556, DOI 10.1016/j.mib.2011.07.005; Terhes G, 2004, J CLIN MICROBIOL, V42, P4316, DOI 10.1128/JCM.42.9.4316-4318.2004; Villano SA, 2012, ANTIMICROB AGENTS CH, V56, P5224, DOI 10.1128/AAC.00913-12	26	64	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76269	10.1371/journal.pone.0076269	http://dx.doi.org/10.1371/journal.pone.0076269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098459	Green Submitted, gold, Green Published			2022-12-27	WOS:000325434500057
J	Bjork, S; Hurt, CM; Ho, VK; Angelotti, T				Bjork, Susann; Hurt, Carl M.; Ho, Vincent K.; Angelotti, Timothy			REEPs Are Membrane Shaping Adapter Proteins That Modulate Specific G Protein-Coupled Receptor Trafficking by Affecting ER Cargo Capacity	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM EXIT; GLUTAMATE TRANSPORTER; YEAST HOMOLOG; GENE; ORGANIZATION; MUTATIONS; YIP1P; RAB; IDENTIFICATION	Receptor expression enhancing proteins (REEPs) were identified by their ability to enhance cell surface expression of a subset of G protein-coupled receptors (GPCRs), specifically GPCRs that have proven difficult to express in heterologous cell systems. Further analysis revealed that they belong to the Yip (Ypt-interacting protein) family and that some REEP subtypes affect ER structure. Yip family comparisons have established other potential roles for REEPs, including regulation of ER-Golgi transport and processing/neuronal localization of cargo proteins. However, these other potential REEP functions and the mechanism by which they selectively enhance GPCR cell surface expression have not been clarified. By utilizing several REEP family members (REEP1, REEP2, and REEP6) and model GPCRs (alpha 2A and alpha 2C adrenergic receptors), we examined REEP regulation of GPCR plasma membrane expression, intracellular processing, and trafficking. Using a combination of immunolocalization and biochemical methods, we demonstrated that this REEP subset is localized primarily to ER, but not plasma membranes. Single cell analysis demonstrated that these REEPs do not specifically enhance surface expression of all GPCRs, but affect ER cargo capacity of specific GPCRs and thus their surface expression. REEP co-expression with alpha 2 adrenergic receptors (ARs) revealed that this REEP subset interacts with and alter glycosidic processing of alpha 2C, but not alpha 2A ARs, demonstrating selective interaction with cargo proteins. Specifically, these REEPs enhanced expression of and interacted with minimally/non-glycosylated forms of alpha 2C ARs. Most importantly, expression of a mutant REEP1 allele (hereditary spastic paraplegia SPG31) lacking the carboxyl terminus led to loss of this interaction. Thus specific REEP isoforms have additional intracellular functions besides altering ER structure, such as enhancing ER cargo capacity, regulating ER-Golgi processing, and interacting with select cargo proteins. Therefore, some REEPs can be further described as ER membrane shaping adapter proteins.	[Bjork, Susann] Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Bjork, Susann; Hurt, Carl M.; Ho, Vincent K.; Angelotti, Timothy] Stanford Univ, Dept Anesthesia CCM, Sch Med, Stanford, CA 94305 USA	University of Turku; Stanford University	Angelotti, T (corresponding author), Stanford Univ, Dept Anesthesia CCM, Sch Med, Stanford, CA 94305 USA.	timangel@stanford.edu	Angelotti, Timothy/AAD-3714-2022	Angelotti, Timothy/0000-0002-0100-2011	NINDS National Institute of Neurological Disorders and Stroke (NINDS) [K08NS050654-01A1]; Finnish Cultural Foundation; Swedish Cultural Foundation; Magnus Ehrnrooth Foundation; Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS050654] Funding Source: NIH RePORTER	NINDS National Institute of Neurological Disorders and Stroke (NINDS); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Swedish Cultural Foundation; Magnus Ehrnrooth Foundation; Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from NINDS National Institute of Neurological Disorders and Stroke (NINDS) K08NS050654-01A1 (TA) and supported by grants from the Finnish Cultural Foundation, the Swedish Cultural Foundation, The Magnus Ehrnrooth Foundation, the Maud Kuistila Memorial Foundation as well as the Emil Aaltonen Foundation (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelotti T, 2010, TRAFFIC, V11, P560, DOI 10.1111/j.1600-0854.2010.01033.x; Barrowman J, 2003, J BIOL CHEM, V278, P19878, DOI 10.1074/jbc.M302406200; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Brands A, 2002, PLANT PHYSIOL, V130, P1121, DOI 10.1104/pp.007716; Brum PC, 2006, NEUROPHARMACOLOGY, V51, P397, DOI 10.1016/j.neuropharm.2006.03.032; Butchbach MER, 2002, GENE, V292, P81, DOI 10.1016/S0378-1119(02)00669-8; Calero M, 2002, FEBS LETT, V515, P89, DOI 10.1016/S0014-5793(02)02442-0; Calero M, 2001, J BIOL CHEM, V276, P12100, DOI 10.1074/jbc.M008439200; Carrel D, 2008, J NEUROSCI, V28, P8063, DOI 10.1523/JNEUROSCI.4487-07.2008; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Goizet C, 2011, HUM MUTAT, V32, P1118, DOI 10.1002/humu.21542; Heidtman M, 2003, J CELL BIOL, V163, P57, DOI 10.1083/jcb.200306118; Hinners I, 1999, ANAL BIOCHEM, V276, P1, DOI 10.1006/abio.1999.4325; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hurt CM, 2013, METHOD ENZYMOL, V521, P171, DOI 10.1016/B978-0-12-391862-8.00009-0; Hurt CM, 2000, J BIOL CHEM, V275, P35424, DOI 10.1074/jbc.M006241200; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Liu SG, 2009, SYNAPSE, V63, P201, DOI 10.1002/syn.20602; Liu YW, 2011, TRAFFIC, V12, P1620, DOI 10.1111/j.1600-0854.2011.01250.x; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nishikawa M, 2007, GENE, V386, P42, DOI 10.1016/j.gene.2006.06.030; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Ruggiero AM, 2008, J BIOL CHEM, V283, P6175, DOI 10.1074/jbc.M701008200; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Schlaitz AL, 2013, DEV CELL; Schlang KJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-71; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Soderblom C, 2006, PHARMACOL THERAPEUT, V109, P42, DOI 10.1016/j.pharmthera.2005.06.001; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Tang BL, 2001, J BIOL CHEM, V276, P40008, DOI 10.1074/jbc.M106189200; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; VONZASTROW M, 1993, J BIOL CHEM, V268, P763; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Yang XP, 1998, EMBO J, V17, P4954, DOI 10.1093/emboj/17.17.4954; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	53	52	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76366	10.1371/journal.pone.0076366	http://dx.doi.org/10.1371/journal.pone.0076366			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098485	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500064
J	Gorman, E; Ashe, MC; Dunstan, DW; Hanson, HM; Madden, K; Winkler, EAH; McKay, HA; Healy, GN				Gorman, Erin; Ashe, Maureen C.; Dunstan, David W.; Hanson, Heather M.; Madden, Ken; Winkler, Elisabeth A. H.; McKay, Heather A.; Healy, Genevieve N.			Does an 'Activity-Permissive' Workplace Change Office Workers' Sitting and Activity Time?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY TIME; CARDIOVASCULAR-DISEASE; ACTIVITY MONITOR; US ADULTS; INTERVENTION; OPPORTUNITIES; ENVIRONMENT; BEHAVIORS; OBESITY	Introduction: To describe changes in workplace physical activity, and health-, and work-related outcomes, in workers who transitioned from a conventional to an 'activity-permissive' workplace. Methods: A natural pre-post experiment conducted in Vancouver, Canada in 2011. A convenience sample of office-based workers (n=24, 75% women, mean [SD] age = 34.5 [8.1] years) were examined four months following relocation from a conventional workplace (pre) to a newly-constructed, purpose-built, movement-oriented physical environment (post). Workplace activity-(activPAL3-derived stepping, standing, and sitting time), health-(body composition and fasting cardio-metabolic blood profile), and work-(performance; job satisfaction) related outcomes were measured pre- and post-move and compared using paired t-tests. Results: Pre-move, on average (mean [SD]) the majority of the day was spent sitting (364 [43.0] mins/8-hr workday), followed by standing (78.2 [32.1] mins/8-hr workday) and stepping (37.7 [15.6] mins/8-hr workday). The transition to the 'activity-permissive' workplace resulted in a significant increase in standing time (+18.5, 95% CI: 1.8, 35.2 mins/8hr workday), likely driven by reduced sitting time (-19.7, 95% CI: -42.1, 2.8 mins/8-hr workday) rather than increased stepping time (+1.2, 95% CI: -6.2, 8.5 mins/8-hr workday). There were no statistically significant differences observed in health-or work-related outcomes. Discussion: This novel, opportunistic study demonstrated that the broader workplace physical environment can beneficially impact on standing time in office workers. The long-term health and work-related benefits, and the influence of individual, organizational, and social factors on this change, requires further evaluation.	[Gorman, Erin; Ashe, Maureen C.; Hanson, Heather M.; McKay, Heather A.] Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Gorman, Erin; Ashe, Maureen C.; Hanson, Heather M.; McKay, Heather A.] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; [Dunstan, David W.; Healy, Genevieve N.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Madden, Ken] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [McKay, Heather A.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada; [Dunstan, David W.; Winkler, Elisabeth A. H.; Healy, Genevieve N.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Dunstan, David W.] Monash Univ, Melbourne, Vic 3004, Australia; [Dunstan, David W.] Univ Western Australia, Sch Sports Sci Exercise & Hlth, Perth, WA 6009, Australia	University of British Columbia; Baker Heart and Diabetes Institute; University of British Columbia; University of British Columbia; University of Queensland; Monash University; University of Western Australia	Healy, GN (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	g.healy@uq.edu.au	ashe, maureen/AAI-1350-2021; Dunstan, David Wayne/E-8473-2010; Healy, Genevieve/A-7408-2008; Winkler, Elisabeth/AAD-7153-2022	Dunstan, David Wayne/0000-0003-2629-9568; Healy, Genevieve/0000-0001-7093-7892; Winkler, Elisabeth/0000-0003-1452-6102; Ashe, Maureen C./0000-0002-6820-4435; Hanson, Heather M./0000-0003-2297-7253	University of Queensland Early Career Research Grant; Canadian Institutes of Health Research (CIHR); CIHR New Investigator Award; Michael Smith for Health Research Scholar Award; RC Future Fellowship; NHMRC [569861]	University of Queensland Early Career Research Grant; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Michael Smith for Health Research Scholar Award; RC Future Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a University of Queensland Early Career Research Grant. Gorman was supported through a Canadian Institutes of Health Research (CIHR) Masters' Award. Ashe was supported through a CIHR New Investigator Award and a Michael Smith for Health Research Scholar Award. Dunstan was supported by an ARC Future Fellowship. Madden is supported by a CIHR Operating Grant. Healy was supported by an NHMRC [#569861] training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhajah TA, 2012, AM J PREV MED, V43, P298, DOI 10.1016/j.amepre.2012.05.027; [Anonymous], 2010, ACTIVE DESIGN GUIDEL; [Anonymous], 2012, REDUCING PROLONGED S; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Duvivier BMFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055542; Evans RE, 2012, AM J PREV MED, V43, P293, DOI 10.1016/j.amepre.2012.05.010; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421; Healy GN, 2013, PREV MED, V57, P43, DOI 10.1016/j.ypmed.2013.04.004; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hologic Inc, 2000, OL QDR SER US GUID; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; LaMontagne A.D., 2012, IMPROVING ORG INTERV; Lanningham-Foster L, 2008, OBESITY, V16, P1849, DOI 10.1038/oby.2008.282; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Ryan CG, 2011, ERGONOMICS, V54, P531, DOI 10.1080/00140139.2011.570458; SUNDSTROM E, 1994, ENVIRON BEHAV, V26, P195, DOI 10.1177/001391659402600204; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tikkanen O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052228; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Wells NM, 2007, ENVIRON BEHAV, V39, P6, DOI 10.1177/0013916506295570; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Zimring C, 2005, AM J PREV MED, V28, P186, DOI 10.1016/j.amepre.2004.10.025	29	65	65	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76723	10.1371/journal.pone.0076723	http://dx.doi.org/10.1371/journal.pone.0076723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098555	Green Published, gold			2022-12-27	WOS:000325434500083
J	Leclerc, D; Rivest, M; Babin, C; Lopez-Macias, C; Savard, P				Leclerc, Denis; Rivest, Marie; Babin, Cindy; Lopez-Macias, Constantino; Savard, Pierre			A Novel M2e Based Flu Vaccine Formulation for Dogs	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; INTEGRAL MEMBRANE-PROTEIN; SALMONELLA-TYPHI; INFLUENZA; EPITOPE; CELL; PEPTIDE; MICE; IMMUNOGENICITY; EXPRESSION	Background: The USA 2004 influenza virus outbreak H3N8 in dogs heralded the emergence of a new disease in this species. A new inactivated H3N8 vaccine was developed to control the spread of the disease but, as in humans and swine, it is anticipated that the virus will mutate shift and drift in the dog population. Therefore, there is a need for a vaccine that can trigger a broad protection to prevent the spread of the virus and the emergence of new strains. Methodology and Principal Findings: The universal M2e peptide is identical in almost all the H3N8 influenza strains sequenced to date and known to infect dogs. This epitope is therefore a good choice for development of a vaccine to provide broad protection. Malva mosaic virus (MaMV) nanoparticles were chosen as a vaccine platform to improve the stability of the M2e peptide and increase its immunogenicity in animals. The addition of an adjuvant (OmpC) purified from Salmonella typhi membrane in the vaccine formulation increased the immune response directed to the M2e peptide significantly and enlarged the protection to include the heterosubtypic strain of influenza in a mouse model. An optimal vaccine formulation was also shown to be immunogenic in dogs. Conclusions and Significance: The MaMV vaccine platform triggered an improved immune response directed towards the universal M2e peptide. The adjuvant OmpC increased the immune response to the M2e peptide and protection to a heterosubtypic influenza strain that harbors a different M2e peptide in a mouse model. Antibodies generated by the vaccine formulation showed cross-reactivity with M2e peptides derived from influenza strains H9N2, H5N1 and H1N1. The vaccine formulation shows a potential for commercialization of a new M2e based vaccine in dogs.	[Leclerc, Denis; Rivest, Marie; Babin, Cindy] Univ Laval, Microbiol Infectiol & Immunol Infect Dis Res Ctr, Quebec City, PQ, Canada; [Lopez-Macias, Constantino] Specialties Hosp, Med Res Unit Immunochem, Natl Med Ctr Siglo 21, IMSS, Mexico City, DF, Mexico; [Savard, Pierre] Univ Laval, Quebec City, PQ, Canada	Laval University; Instituto Mexicano del Seguro Social; Laval University	Leclerc, D (corresponding author), Univ Laval, Microbiol Infectiol & Immunol Infect Dis Res Ctr, Quebec City, PQ, Canada.	Denis.Leclerc@crchul.ulaval.ca	Leclerc, Denis/P-1604-2019; Leclerc, Denis/AAG-6112-2019; López Macías, Constatino III Roberto/ABG-3414-2021	López Macías, Constatino III Roberto/0000-0003-0530-492X; savard, pierre/0000-0003-4134-0709; Lopez-Macias, Constantino III Roberto/0000-0002-7756-8468	'Ministere du Developpement economique, de l'innovation et de l'exportation (MDEIE)' of Quebec/Canada; Natural Sciences and Engineering Research Council (NSERC)-Canada [269445 - 03]	'Ministere du Developpement economique, de l'innovation et de l'exportation (MDEIE)' of Quebec/Canada; Natural Sciences and Engineering Research Council (NSERC)-Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research project was funded by the 'Programme de soutient a la valorisation et au transfert (PSVT)' of the 'Ministere du Developpement economique, de l'innovation et de l'exportation (MDEIE)' of Quebec/Canada and the grant Natural Sciences and Engineering Research Council (NSERC)-Canada (grant # 269445 - 03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alurkar V, 1997, INFECT IMMUN, V65, P2382, DOI 10.1128/IAI.65.6.2382-2388.1997; Babin C, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-10; Cervantes-Barragan L, 2009, EUR J IMMUNOL, V39, P126, DOI 10.1002/eji.200838185; Cote F, 2008, INFECT GENET EVOL, V8, P83, DOI 10.1016/j.meegid.2007.10.006; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Daly JM, 2008, EMERG INFECT DIS, V14, P461, DOI 10.3201/eid1403.070643; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; Deshpande MS, 2009, VET THER, V10, P29; Ebrahimi SM, 2011, VIRUS GENES, V42, P1, DOI 10.1007/s11262-010-0547-7; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Gao X, 2013, ANTIVIR RES, V98, P4, DOI 10.1016/j.antiviral.2013.01.010; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Hanafi LA, 2010, VACCINE, V28, P5617, DOI 10.1016/j.vaccine.2010.06.024; Hashemi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045765; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Leclerc D, 2011, CURR TOP MICROBIOL I, V183, P2; Leclerc D, 2007, J VIROL, V81, P1319, DOI 10.1128/JVI.01720-06; Lico C, 2006, J GEN VIROL, V87, P3103, DOI 10.1099/vir.0.82097-0; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Martinez-Flores I, 1999, J BACTERIOL, V181, P556; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Mathieu C, 2013, NANOMEDECINE; Matic S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-106; O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009; Rioux G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031925; Savard C, 2012, VACCINE, V30, P2535, DOI 10.1016/j.vaccine.2012.01.085; Savard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021522; Secundino I, 2006, IMMUNOLOGY, V117, P59, DOI 10.1111/j.1365-2567.2005.02263.x; Seidel UJE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00076; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Stuart-Harris CH, 1939, LANCET, V1, P497; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Uhde K, 2005, ARCH VIROL, V150, P327, DOI 10.1007/s00705-004-0402-z	41	11	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77084	10.1371/journal.pone.0077084	http://dx.doi.org/10.1371/journal.pone.0077084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098576	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500094
J	Vasishth, S; Chen, Z; Li, Q; Guo, GL				Vasishth, Shravan; Chen, Zhong; Li, Qiang; Guo, Gueilan			Processing Chinese Relative Clauses: Evidence for the Subject-Relative Advantage	PLOS ONE			English	Article							SERIAL; COMPREHENSION; PARALLEL; COMPLEXITY; PREFERENCE; ANIMACY; MODELS	A general fact about language is that subject relative clauses are easier to process than object relative clauses. Recently, several self-paced reading studies have presented surprising evidence that object relatives in Chinese are easier to process than subject relatives. We carried out three self-paced reading experiments that attempted to replicate these results. Two of our three studies found a subject-relative preference, and the third study found an object-relative advantage. Using a random effects bayesian meta-analysis of fifteen studies (including our own), we show that the overall current evidence for the subject-relative advantage is quite strong (approximate posterior probability of a subject-relative advantage given the data: 78-80%). We argue that retrieval/integration based accounts would have difficulty explaining all three experimental results. These findings are important because they narrow the theoretical space by limiting the role of an important class of explanation-retrieval/integration cost-at least for relative clause processing in Chinese.	[Vasishth, Shravan; Guo, Gueilan] Univ Potsdam, Potsdam, Brandenburg, Germany; [Vasishth, Shravan] Univ Sheffield, Sch Math & Stat, Sheffield, S Yorkshire, England; [Chen, Zhong] Cornell Univ, Ithaca, NY USA; [Li, Qiang] Dalian Univ Technol, Inst Language & Cognit, Dalian, Liaoning Provin, Peoples R China	University of Potsdam; University of Sheffield; Cornell University; Dalian University of Technology	Vasishth, S (corresponding author), Univ Potsdam, Potsdam, Brandenburg, Germany.	vasishth@uni-potsdam.de	Li, Qiang/C-1671-2015	Li, Qiang/0000-0001-9311-9817; Vasishth, Shravan/0000-0003-2027-1994; Chen, Zhong/0000-0001-9621-0560	University of Potsdam	University of Potsdam	The funding source is The University of Potsdam (website:http://www.uni-potsdam.de). The money for the study came from the first author's annual budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Barr DJ, 2013, J MEMORY LANGUAGE; Bartek B, 2011, J EXP PSYCHOL LEARN, V37, P1178, DOI 10.1037/a0024194; Bates D., 2007, LME4 LINEAR MIXED EF, P9975; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Caplan D, 2002, HUM BRAIN MAPP, V15, P26, DOI 10.1002/hbm.1059; Carreiras M, 2010, COGNITION, V115, P79, DOI 10.1016/j.cognition.2009.11.012; Chen BG, 2008, ACTA PSYCHOL, V129, P61, DOI 10.1016/j.actpsy.2008.04.005; Chen Z, 2012, ANN CUNY SENT PROC C; Clemens LE, 2013, ERGATIVITY COM UNPUB; Cooke A, 2002, HUM BRAIN MAPP, V15, P80, DOI 10.1002/hbm.10006; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; FERREIRA F, 1990, J EXP PSYCHOL LEARN, V16, P555, DOI 10.1037/0278-7393.16.4.555; FORD M, 1983, J VERB LEARN VERB BE, V22, P203, DOI 10.1016/S0022-5371(83)90156-1; FRAUENFELDER U, 1980, J VERB LEARN VERB BE, V19, P328, DOI 10.1016/S0022-5371(80)90257-1; FRAZIER L, 1987, NAT LANG LINGUIST TH, V5, P519, DOI 10.1007/BF00138988; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gibson E, 2000, J PSYCHOLINGUIST RES, V29, P231, DOI 10.1023/A:1005153330168; Gibson E, 2005, COGN LINGUIST, V16, P313, DOI 10.1515/cogl.2005.16.2.313; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Gibson E, 2013, LANGUAGE CO IN PRESS; Grodner D, 2005, COGNITIVE SCI, V29, P261, DOI 10.1207/s15516709cog0000_7; Grodzinsky Y., 1990, THEORETICAL PERSPECT; Hale J., 2001, P 2 M N AM CHAPT ASS; Hopf JM, 2003, COGNITIVE BRAIN RES, V15, P165, DOI 10.1016/S0926-6410(02)00149-0; Hsiao F, 2003, COGNITION, V90, P3, DOI 10.1016/S0010-0277(03)00124-0; Hsiao Franny Pai-Fang, 2003, THESIS MIT CAMBRIDGE; Husain S, 2013, P AMLAP C MARS FRANC; Jager L, 2013, SUBJECT RELATI UNPUB; Jager L, 2013, ANN CUNY SENT PROC C; Jurafsky D, 1996, COGNITIVE SCI, V20, P137, DOI 10.1207/s15516709cog2002_1; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kanno K, 2007, STUD SECOND LANG ACQ, V29, P197, DOI 10.1017/S0272263107070118; Keenan EL, 1977, LINGUISTIC INQUIRY; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; Korthals C, 2001, P 6 ESSLLI STUD SESS, P179; Kovacs N, 2013, P C ARCH MECH LANG P; Kwon N, 2006, P 25 W COAST C FORM; Kwon N, 2010, LANGUAGE, V86, P546; Levy R, 2012, J MEMORY LANGUAGE; Levy R, 2013, J MEMORY LANGUAGE; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Lewis RL, 2000, J PSYCHOLINGUIST RES, V29, P241, DOI 10.1023/A:1005105414238; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; Lin C.-J. C., 2007, INTERDISCIPLINARY AP; Lin CJC, 2008, LANG LINGUIST-TAIWAN, V9, P813; Lin CJC, 2011, STUD THEOR PSYCHOLIN, V38, P277, DOI 10.1007/978-90-481-9213-7_13; Lin CJC, 2010, P 22 N AM C CHIN LIN, V1, P413; Lin YB, 2007, P CUNY SCI PROC C; Lin YY, 2011, STUD THEOR PSYCHOLIN, V38, P241, DOI 10.1007/978-90-481-9213-7_12; Mak WM, 2002, J MEM LANG, V47, P50, DOI 10.1006/jmla.2001.2837; MECKLINGER A, 1995, MEM COGNITION, V23, P477, DOI 10.3758/BF03197249; MITCHELL DC, 1995, J PSYCHOLINGUIST RES, V24, P469, DOI 10.1007/BF02143162; Miyamoto Edson., 2003, P 22 W COAST C FORMA, P342; O'Grady William., 2003, STUD SECOND LANG ACQ, V25, P433, DOI DOI 10.1017/S0272263103000172; Packard JL, 2011, STUD THEOR PSYCHOLIN, V38, P219, DOI 10.1007/978-90-481-9213-7_11; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Patil U, 2013, SENTENCE COMPR UNPUB; Plummer M, 2011, JAGS VERSION 3 1 0 M; Polinsky M, 2012, LINGUA, V122, P267, DOI 10.1016/j.lingua.2011.11.004; Qiao XM, 2012, LANG COGNITIVE PROC, V27, P611, DOI 10.1080/01690965.2011.578394; R Development Core Team, 2006, R LANG ENV STAT COMP; Scanlon M., 2006, P 25 W COAST C FORM, P254; SCHRIEFERS H, 1995, J MEM LANG, V34, P499, DOI 10.1006/jmla.1995.1023; Skut W, 2002, P 5 C APPL NAT LANG, DOI [10.3115/974557.974571, DOI 10.3115/974557.974571]; SPIEGELHALTER D. J., 2004, BAYESIAN APPROACHES, V13; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Su YC, 2007, BRAIN LANG, V101, P1, DOI 10.1016/j.bandl.2006.12.001; Traxler MJ, 2002, J MEM LANG, V47, P69, DOI 10.1006/jmla.2001.2836; TRUESWELL JC, 1993, J EXP PSYCHOL LEARN, V19, P528, DOI 10.1037/0278-7393.19.3.528; Vasishth S., 2011, DIALOGUE DISCOURSE, V2, P59, DOI [10.5087/dad.2011.104, DOI 10.5087/DAD.2011.104]; Wu F., 2009, THESIS; Wu F, 2011, LANGUAGE COGNITIVE P	77	69	69	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77006	10.1371/journal.pone.0077006	http://dx.doi.org/10.1371/journal.pone.0077006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	231RG	24098575	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500093
J	Wansink, B; Just, DR; Patterson, RW; Smith, LE				Wansink, Brian; Just, David R.; Patterson, Richard W.; Smith, Laura E.			Nutrition Report Cards: An Opportunity to Improve School Lunch Selection	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; PREVENTION; PREVALENCE; HEALTH	Objective: To explore the feasibility and implementation efficiency of Nutritional Report Cards(NRCs) in helping children make healthier food choices at school. Methods: Pilot testing was conducted in a rural New York school district (K-12). Over a five-week period, 27 parents received a weekly e-mail containing a NRC listing how many meal components (fruits, vegetables, starches, milk), snacks, and a-la-carte foods their child selected. We analyzed choices of students in the NRC group vs. the control group, both prior to and during the intervention period. Point-of-sale system data for a-la-carte items was analyzed using Generalized Least Squares regressions with clustered standard errors. Results: NRCs encouraged more home conversations about nutrition and more awareness of food selections. Despite the small sample, the NRC was associated with reduced selection of some items, such as the percentage of those selecting cookies which decreased from 14.3 to 6.5 percent. Additionally, despite requiring new keys on the check-out registers to generate the NRC, checkout times increased by only 0.16 seconds per transaction, and compiling and sending the NRCs required a total weekly investment of 30 minutes of staff time. Conclusions: This test of concept suggests that NRCs are a feasible and inexpensive tool to guide children towards healthier choices.	[Wansink, Brian; Just, David R.] Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA; [Patterson, Richard W.; Smith, Laura E.] Cornell Univ, Ithaca, NY USA	Cornell University; Cornell University	Wansink, B (corresponding author), Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA.	foodandbrandlab@cornell.edu	Just, David/K-7302-2012; Smith, Laura/R-4615-2018	Just, David/0000-0002-7471-5178; Smith, Laura/0000-0002-4793-2791				Ackard DM, 2003, PEDIATRICS, V111, P67, DOI 10.1542/peds.111.1.67; Blaylock J, 1999, FOOD POLICY, V24, P269, DOI 10.1016/S0306-9192(99)00029-9; Colavito EA, 1996, J NUTR EDUC, V28, P321, DOI 10.1016/S0022-3182(96)70121-8; Contento IR, 2002, J NUTR EDUC BEHAV, V34, P2, DOI 10.1016/S1499-4046(06)60220-0; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Gross SM, 2010, J NUTR EDUC BEHAV, V42, P235, DOI 10.1016/j.jneb.2009.05.007; Kaplan M, 2006, J NUTR EDUC BEHAV, V38, P298, DOI 10.1016/j.jneb.2006.02.010; KLESGES RC, 1991, AM J CLIN NUTR, V54, pR4; Moshfegh A, 2005, WHAT WE EAT AM NHANE, P1; Nihiser AJ, 2009, PEDIATRICS, V124, pS89, DOI 10.1542/peds.2008-3586L; PERRI MG, 1984, J CONSULT CLIN PSYCH, V52, P404, DOI 10.1037/0022-006X.52.3.404; Portilla MG, 2011, J AM DIET ASSOC, V111, P442, DOI 10.1016/j.jada.2010.11.018; Raczynski JM, 2009, J PUBLIC HEALTH POL, V30, pS124, DOI 10.1057/jphp.2008.54; Roseman MG, 2011, J NUTR EDUC BEHAV, V43, P2, DOI 10.1016/j.jneb.2010.07.009	14	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e72008	10.1371/journal.pone.0072008	http://dx.doi.org/10.1371/journal.pone.0072008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098324	Green Published, gold			2022-12-27	WOS:000325434500003
J	Scorza, R; Kriss, AB; Callahan, AM; Webb, K; Demuth, M; Gottwald, T				Scorza, Ralph; Kriss, Alissa B.; Callahan, Ann M.; Webb, Kevin; Demuth, Mark; Gottwald, Tim			Spatial and Temporal Assessment of Pollen- and Seed-Mediated Gene Flow from Genetically Engineered Plum Prunus domestica	PLOS ONE			English	Article							POX-VIRUS; RISK-ASSESSMENT; MODIFIED CROPS; RESISTANCE; RELEASE; PLANTS; BEES	Pollen flow from a 0.46 ha plot of genetically engineered (GE) Prunus domestica located in West Virginia, USA was evaluated from 2000-2010. Sentinel plum trees were planted at distances ranging from 132 to 854 m from the center of the GE orchard. Plots of mixed plum varieties and seedlings were located at 384, 484 and 998 m from the GE plot. Bee hives (Apis mellifera) were dispersed between the GE plum plot and the pollen flow monitoring sites. Pollen-mediated gene flow from out of the GE plum plot to non-GE plums under the study conditions was low, only occurring at all in 4 of 11 years and then in only 0.31% of the 12,116 seeds analyzed. When it occurred, gene flow, calculated as the number of GUS positive embryos/total embryos sampled, ranged from 0.215% at 132 m from the center of the GE plum plot (28 m from the nearest GE plum tree) to 0.033-0.017% at longer distances (384-998 m). Based on the percentage of GUS positive seeds per individual sampled tree the range was 0.4% to 12%. Within the GE field plot, gene flow ranged from 4.9 to 39%. Gene flow was related to distance and environmental conditions. A single year sample from a sentinel plot 132 m from the center of the GE plot accounted for 65% of the total 11-year gene flow. Spatial modeling indicated that gene flow dramatically decreased at distances over 400 m from the GE plot. Air temperature and rainfall were, respectively, positively and negatively correlated with gene flow, reflecting the effects of weather conditions on insect pollinator activity. Seed-mediated gene flow was not detected. These results support the feasibility of coexistence of GE and non-GE plum orchards.	[Scorza, Ralph; Callahan, Ann M.; Webb, Kevin; Demuth, Mark] ARS, USDA, Kearneysville, WV USA; [Kriss, Alissa B.; Gottwald, Tim] ARS, USDA, US Hort Res Lab, Ft Pierce, FL USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Scorza, R (corresponding author), ARS, USDA, Kearneysville, WV USA.	Ralph.Scorza@ars.usda.gov			USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA-ARS funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, CROP POLLINATION BEE; Armstrong TT, 2005, MOL ECOL, V14, P2111, DOI 10.1111/j.1365-294X.2005.02572.x; Benedek P, 1996, FLORAL BIOL TEMPERAT, P287; Biddinger D, 2011, PENNSYLVANIA ST 0927; BURRILL RM, 1981, APIDOLOGIE, V12, P319, DOI 10.1051/apido:19810402; Calzoni GL, 1998, SCI HORTIC-AMSTERDAM, V72, P227, DOI 10.1016/S0304-4238(97)00132-5; Cambra M., 2006, Bulletin OEPP, V36, P202; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Chandler S, 2008, CRIT REV PLANT SCI, V27, P25, DOI 10.1080/07352680802053916; DARLINGTON C. D., 1927, NATURE [LONDON], V119, P390, DOI 10.1038/119390a0; Deckers B, 2008, BIOL INVASIONS, V10, P717, DOI 10.1007/s10530-007-9164-3; Di Nicola-Negri E, 2005, TRANSGENIC RES, V14, P989, DOI 10.1007/s11248-005-1773-y; DiFazio SP, 2004, PLANTATION FOREST BIOTECHNOLOGY FOR THE 21ST CENTURY 2004, P405; DOLGOV S, 2010, JULIUS KUHN ARCH, V427, P133; EASTMAN K, 2002, 28 EUR ENV AG; Ellstrand NC, 2003, PHILOS T R SOC B, V358, P1163, DOI 10.1098/rstb.2003.1299; ENIKEEV H. K., 1957, Agrobiologija (Agrobiology), P139; Enikeev HK, 1962, ABSTRACT BIBLIO FRUI, P81; Enikeyev, 1963, Genetics today. Proceedings of the XI International Congress of Genetics, The Hague, The Netherlands, September 1963., V1, pp; FISCHER A., 1938, ZUCHTER, V10, P157, DOI 10.1007/BF01812347; Ford CS, 2006, P R SOC B, V273, P3111, DOI 10.1098/rspb.2006.3686; Fuchs Marc, 2004, Environmental Biosafety Research, V3, P5, DOI 10.1051/ebr:2004003; Gonsalves D, 2012, TROP PLANT BIOL, V5, P153, DOI 10.1007/s12042-011-9090-5; Hails RS, 2005, TRENDS ECOL EVOL, V20, P245, DOI 10.1016/j.tree.2005.02.006; Hegedus A., 2006, J HORTIC SCI, V12, P137; Henry M, 2012, ECOL MODEL, V225, P103, DOI 10.1016/j.ecolmodel.2011.11.015; Heuberger S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014128; JACKSON JF, 1991, THEOR APPL GENET, V82, P169, DOI 10.1007/BF00226208; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kobayashi N., 1998, PLANT TISSUE CULT BI, V4, P76; Larsen AS, 2009, CONSERV GENET, V10, P1637, DOI 10.1007/s10592-008-9713-z; Macoun WT, 1925, ABSTRACT BIBLIO FRUI; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; Marshall RE, 1919, P AM SOC HORTIC SCI, V16, P42; Muhammad N, 2010, J AGR SCI TECHNOL, V4, P1; Okie WR, 1996, FRUIT BREEDING, VI, P559; OLDEN E. J., 1955, Sveriges Pomologiska Forenings Arsskrift, P155; Olden EJ, 1965, 1 BALSG FRUIT BREED, V1; Peat J, 2005, BEHAV ECOL SOCIOBIOL, V58, P152, DOI 10.1007/s00265-005-0916-8; Pfeiffer DG, 2012, JULIUS KUHN ARCH; Pons E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025810; Poppy GM, 2005, BIOL SCI SER, P1, DOI 10.1002/9780470988497; RAYBOULD AF, 1993, J APPL ECOL, V30, P199, DOI 10.2307/2404623; Reim Stefanie, 2006, Environmental Biosafety Research, V5, P89, DOI 10.1051/ebr:2006016; Schulze J, 2012, FLORA, V207, P762, DOI 10.1016/j.flora.2012.07.007; SCORZA R, 1994, PLANT CELL REP, V14, P18, DOI 10.1007/BF00233291; SCORZA R, 1995, J AM SOC HORTIC SCI, V120, P943, DOI 10.21273/JASHS.120.6.943; Scorza R., 2013, REGULATION AGR BIOTE, P269, DOI 10.1007/1978-1094-1007-2156-1002_1012.; Smouse PE, 2007, TREE GENET GENOMES, V3, P141, DOI 10.1007/s11295-006-0075-8; Soejima J, 2007, ACTA HORTIC, P341, DOI 10.17660/ActaHortic.2007.738.40; Somerville D, 1999, DAI126 NEW S WAL AGR, V126; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Szabo Z, 1996, ACTA HORTIC, P23, DOI 10.17660/ActaHortic.1996.423.2; Tyson RC, 2011, ECOL MODEL, V222, P2084, DOI 10.1016/j.ecolmodel.2011.03.039; Viljoen Chris, 2011, Environmental Sciences Europe, V23, P8, DOI 10.1186/2190-4715-23-8; Waugh FA, 1898, B VT AGR EXP STN, V67; Wellington R, 1927, TECH B NY ST AGR EXP, V127; Williams NM, 2007, ECOL APPL, V17, P910, DOI 10.1890/06-0269; Yoshimura Yasuyuki, 2006, Environmental Biosafety Research, V5, P169, DOI 10.1051/ebr:2007003; Zahra S., 2010, Environmental Biosafety Research, V9, P75, DOI 10.1051/ebr/2010011; Zhang SC, 2006, CAN J PLANT PATHOL, V28, P263, DOI 10.1080/07060660609507295	61	20	21	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75291	10.1371/journal.pone.0075291	http://dx.doi.org/10.1371/journal.pone.0075291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098374	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100017
J	Hamajima, N; Johmura, Y; Suzuki, S; Nakanishi, M; Saitoh, S				Hamajima, Naoki; Johmura, Yoshikazu; Suzuki, Satoshi; Nakanishi, Makoto; Saitoh, Shinji			Increased Protein Stability of CDKN1C Causes a Gain-of-Function Phenotype in Patients with IMAGe Syndrome	PLOS ONE			English	Article							BECKWITH-WIEDEMANN SYNDROME; DEPENDENT KINASE INHIBITOR; CELL NUCLEAR ANTIGEN; PROTEASOMAL DEGRADATION; ADRENAL HYPOPLASIA; GROWTH-RETARDATION; MICE LACKING; P57(KIP2); ASSOCIATION; BINDING	Mutations in the proliferating cell nuclear antigen (PCNA)-binding domain of the CDKN1C gene were recently identified in patients with IMAGe syndrome. However, loss of PCNA binding and suppression of CDKN1C monoubiquitination by IMAGe-associated mutations hardly explain the reduced-growth phenotype characteristic of IMAGe syndrome. We demonstrate here that IMAGe-associated mutations in the CDKN1C gene dramatically increased the protein stability. We identified a novel heterozygous mutation, c.815T>G (p.Ile272Ser), in the CDKN1C gene in three siblings manifesting clinical symptoms associated with IMAGe syndrome and their mother (unaffected carrier). PCNA binding to CDKN1C was disrupted in the case of p.Ile272Ser, and for two other IMAGe-associated mutations, p.Asp274Asn and p.Phe276Val. Intriguingly, the IMAGe-associated mutant CDKN1C proteins were fairly stable even in the presence of cycloheximide, whereas the wild-type protein was almost completely degraded via the proteasome pathway, as shown by the lack of degradation with addition of a proteasome inhibitor, MG132. These results thus suggested that the reduced-growth phenotype of IMAGe syndrome derives from CDKN1C gain-of-function due to IMAGe-associated mutations driving increased protein stability.	[Hamajima, Naoki; Suzuki, Satoshi] Nagoya City West Med Ctr, Dept Pediat, Nagoya, Aichi, Japan; [Johmura, Yoshikazu; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Nagoya, Aichi, Japan; [Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University	Hamajima, N (corresponding author), Nagoya City West Med Ctr, Dept Pediat, Nagoya, Aichi, Japan.	nhamajim@med.nagoya-cu.ac.jp		Saitoh, Shinji/0000-0001-6911-3351	Grants-in-Aid for Scientific Research [24659137] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amano N, 2008, AM J MED GENET A, V146A, P2130, DOI 10.1002/ajmg.a.32425; Arboleda VA, 2012, NAT GENET, V44, P788, DOI 10.1038/ng.2275; Balasubramanian M, 2010, AM J MED GENET A, V152A, P3138, DOI 10.1002/ajmg.a.33716; Bergada I, 2005, J CLIN ENDOCR METAB, V90, P3186, DOI 10.1210/jc.2004-1589; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; Hutz JE, 2006, MOL GENET METAB, V88, P66, DOI 10.1016/j.ymgme.2006.01.006; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kim M, 2008, EMBO REP, V9, P878, DOI 10.1038/embor.2008.125; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Lienhardt A, 2002, HORM RES, V57, P71, DOI 10.1159/000058105; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; NAKANISHI M, 1995, J BIOL CHEM, V270, P17060, DOI 10.1074/jbc.270.29.17060; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; Pedreira CC, 2004, J PEDIATR-US, V144, P274, DOI 10.1016/j.jpeds.2003.09.052; Sarostina NG, 2012, TRENDS CELL BIOL, V22, P33; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Tan TY, 2006, AM J MED GENET A, V140A, P1778, DOI 10.1002/ajmg.a.31365; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Vilain E, 1999, J CLIN ENDOCR METAB, V84, P4335, DOI 10.1210/jc.84.12.4335; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Watanabe H, 1998, P NATL ACAD SCI USA, V95, P1392, DOI 10.1073/pnas.95.4.1392; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	25	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75137	10.1371/journal.pone.0075137	http://dx.doi.org/10.1371/journal.pone.0075137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098681	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500052
J	Lo, TF; Tsai, WC; Chen, ST				Lo, Ting-Fang; Tsai, Wei-Chung; Chen, Shui-Tein			MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth	PLOS ONE			English	Article							LIVER-CANCER CELLS; ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE; HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; COPTIDIS-RHIZOMA; GENE-EXPRESSION; UP-REGULATION; MAT2A GENE; PROLIFERATION	Methionine adenosyltransferase (MAT) is the cellular enzyme that catalyzes the synthesis of S-adenosylmethionine (SAM), the principal biological methyl donor and a key regulator of hepatocyte proliferation, death and differentiation. Two genes, MAT1A and MAT2A, encode 2 distinct catalytic MAT isoforms. A third gene, MAT2B, encodes a MAT2A regulatory subunit. In hepatocellular carcinoma (HCC), MAT1A downregulation and MAT2A upregulation occur, known as the MAT1A: MAT2A switch. The switch is accompanied with an increasing expression of MAT2B, which results in decreased SAM levels and facilitates cancer cell growth. Berberine, an isoquinoline alkaloid isolated from many medicinal herbs such as Coptis chinensis, has a wide range of pharmacological effects including anti-cancer effects. Because drug-induced microRNAs have recently emerged as key regulators in guiding their pharmacological effects, we examined whether microRNA expression is differentially altered by berberine treatment in HCC. In this study, we used microRNA microarrays to find that the expression level of miR-21-3p (previously named miR-21*) increased after berberine treatment in the HepG2 human hepatoma cell line. To predict the putative targets of miR-21-3p, we integrated the gene expression profiles of HepG2 cells after berberine treatment by comparing with a gene list generated from sequence-based microRNA target prediction software. We then confirmed these predictions through transfection of microRNA mimics and a 3' UTR reporter assay. Our findings provide the first evidence that miR-21-3p directly reduces the expression of MAT2A and MAT2B by targeting their 3' UTRs. In addition, an overexpression of miR-21-3p increased intracellular SAM contents, which have been proven to be a growth disadvantage for hepatoma cells. The overexpression of miR-21-3p suppresses growth and induces apoptosis in HepG2 cells. Overall, our results demonstrate that miR-21-3p functions as a tumor suppressor by directly targeting both MAT2A and MAT2B, indicating its therapeutic potential in HCC.	[Lo, Ting-Fang; Tsai, Wei-Chung; Chen, Shui-Tein] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan; [Lo, Ting-Fang; Tsai, Wei-Chung; Chen, Shui-Tein] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lo, Ting-Fang; Tsai, Wei-Chung; Chen, Shui-Tein] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Chen, ST (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan.	bcchen@gate.sinica.edu.tw			National Science Council; National Health Research Institutes	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan)	Funded by National Science Council (http://web1.nsc.gov.tw/) and National Health Research Institutes (http://www.nhri.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Auyeung KKW, 2009, INT J MOL MED, V24, P571, DOI 10.3892/ijmm_00000267; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Braig S, 2013, ONCOGENE, V32, P837, DOI 10.1038/onc.2012.115; Cai JX, 1998, CANCER RES, V58, P1444; Frau M, 2012, HEPATOLOGY, V56, P165, DOI 10.1002/hep.25643; GARCEA R, 1989, CANCER RES, V49, P1850; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hu HY, 2013, ACTA PHARMACOL SIN, V34, P157, DOI 10.1038/aps.2012.161; Huang ZZ, 1999, HEPATOLOGY, V29, P1471, DOI 10.1002/hep.510290525; Huang ZZ, 1998, AM J PHYSIOL-GASTR L, V275, pG14, DOI 10.1152/ajpgi.1998.275.1.G14; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Iizuka N, 2000, CANCER LETT, V148, P19, DOI 10.1016/S0304-3835(99)00264-5; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jansson MD, 2012, MOL ONCOLOGY; Kim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; LeGros L, 2001, J BIOL CHEM, V276, P24918, DOI 10.1074/jbc.M102816200; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021416; Liu QY, 2007, HEPATOL RES, V37, P376, DOI 10.1111/j.1872-034X.2007.00041.x; Liu XY, 2012, CHINESE MED J-PEKING, V125, P2908, DOI 10.3760/cma.j.issn.0366-6999.2012.16.020; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Ma C, 2013, CHEM BIOL DRUG DESIG; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Martinez-Chantar ML, 2002, FASEB J, V16, P1292, DOI 10.1096/fj.02-0078fje; Martinez-Chantar ML, 2003, METHIONINE ADENOSYLT; Martinez-Sanchez Aida, 2013, Biology (Basel), V2, P189, DOI 10.3390/biology2010189; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; Molloy A, 2011, BIOINFORMATIC GENETI; Okamura K, 2008, CELL CYCLE, V7, P2840, DOI 10.4161/cc.7.18.6734; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Paneda C, 2002, HEPATOLOGY, V35, P1381, DOI 10.1053/jhep.2002.32538; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Rodrigues AC, 2011, BIOPHARM DRUG DISPOS, V32, P355, DOI 10.1002/bdd.764; Rodriguez JL, 2007, INT J BIOCHEM CELL B, V39, P842, DOI 10.1016/j.biocel.2007.01.009; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056666; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang N, 2010, J CELL BIOCHEM, V111, P1426, DOI 10.1002/jcb.22869; Wang Q, 2008, WORLD J GASTROENTERO, V14, P4633, DOI 10.3748/wjg.14.4633; Wang Q, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-72; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yan GR, 2011, PROTEOMICS, V11, P912, DOI 10.1002/pmic.201000539; Yang HP, 2004, HEPATOLOGY, V40, P221, DOI 10.1002/hep.20274; Yang HP, 2001, FASEB J, V15, P1507, DOI 10.1096/fj.01-0040com; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yokoi T, 2013, ANNU REV PHARMACOL, V53, P377, DOI 10.1146/annurev-pharmtox-011112-140250; Zhu MF, 2011, EXP THER MED, V2, P27, DOI 10.3892/etm.2010.164	60	84	87	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75628	10.1371/journal.pone.0075628	http://dx.doi.org/10.1371/journal.pone.0075628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098708	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500079
J	Marquard, E; Schmid, B; Roscher, C; De Luca, E; Nadrowski, K; Weisser, WW; Weigelt, A				Marquard, Elisabeth; Schmid, Bernhard; Roscher, Christiane; De Luca, Enrica; Nadrowski, Karin; Weisser, Wolfgang W.; Weigelt, Alexandra			Changes in the Abundance of Grassland Species in Monocultures versus Mixtures and Their Relation to Biodiversity Effects	PLOS ONE			English	Article							PLANT-SOIL FEEDBACKS; PRODUCTIVITY RELATIONSHIP; TEMPORAL STABILITY; DIVERSITY; COMMUNITIES; PATHOGENS; PATTERNS; COMPLEMENTARITY; COMPETITION; POPULATION	Numerous studies have reported positive effects of species richness on plant community productivity. Such biodiversity effects are usually quantified by comparing the performance of plant mixtures with reference monocultures. However, several mechanisms, such as the lack of resource complementarity and facilitation or the accumulation of detrimental agents, suggest that monocultures are more likely than mixtures to deteriorate over time. Increasing biodiversity effects over time could therefore result from declining monocultures instead of reflecting increases in the functioning of mixtures. Commonly, the latter is assumed when positive trends in biodiversity effects occur. Here, we analysed the performance of 60 grassland species growing in monocultures and mixtures over 9 years in a biodiversity experiment to clarify whether their temporal biomass dynamics differed and whether a potential decline of monocultures contributed significantly to the positive net biodiversity effect observed. Surprisingly, individual species' populations produced, on average, significantly more biomass per unit area when growing in monoculture than when growing in mixture. Over time, productivity of species decreased at a rate that was, on average, slightly more negative in monocultures than in mixtures. The mean net biodiversity effect across all mixtures was continuously positive and ranged between 64-217 g per m(2). Short-term increases in the mean net biodiversity effect were only partly due to deteriorating monocultures and were strongly affected by particular species gaining dominance in mixtures in the respective years. We conclude that our species performed, on average, comparably in monocultures and mixtures; monoculture populations being slightly more productive than mixture populations but this trend decreased over time. This suggested that negative feedbacks had not yet affected monocultures strongly but could potentially become more evident in the future. Positive biodiversity effects on aboveground productivity were heavily driven by a small, but changing, set of species that behaved differently from the average species.	[Marquard, Elisabeth] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Schmid, Bernhard; De Luca, Enrica] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmid, Bernhard; De Luca, Enrica] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Nadrowski, Karin; Weigelt, Alexandra] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany; [Weisser, Wolfgang W.] Tech Univ Munich, Terr Ecol Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany; [Weigelt, Alexandra] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Zurich; University of Zurich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Technical University of Munich	Marquard, E (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	lisa.marquard@ufz.de	Schmid, Bernhard/C-8625-2009; Weisser, Wolfgang W/B-9718-2014	Schmid, Bernhard/0000-0002-8430-3214; Weisser, Wolfgang W/0000-0002-2757-8959; Nadrowski, Karin/0000-0001-5358-5469; Marquard, Elisabeth/0000-0002-3418-9396	German Research Foundation [FOR 456, FOR 1451]; Friedrich Schiller University of Jena; Max Planck Institute for Biogeochemistry, Jena; Swiss National Science Foundation [31-65224-01]	German Research Foundation(German Research Foundation (DFG)); Friedrich Schiller University of Jena; Max Planck Institute for Biogeochemistry, Jena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Jena Experiment is funded by the German Research Foundation (FOR 456, FOR 1451) and supported by the Friedrich Schiller University of Jena and the Max Planck Institute for Biogeochemistry, Jena. Additional support was provided by the Swiss National Science Foundation (grant no. 31-65224-01 to B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2011, P NATL ACAD SCI; Bartelt-Ryser J, 2005, PERSPECT PLANT ECOL, V7, P27, DOI 10.1016/j.ppees.2004.11.002; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bonanomi G, 2008, PLANT ECOL, V197, P207, DOI 10.1007/s11258-007-9371-0; Burdon JJ., 1987, DIS PLANT POPULATION; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Casper BB, 2007, ECOL LETT, V10, P394, DOI 10.1111/j.1461-0248.2007.01030.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; de la Pena E, 2010, BIOL INVASIONS, V12, P3637, DOI 10.1007/s10530-010-9756-1; Diez JM, 2010, ECOL LETT, V13, P803, DOI 10.1111/j.1461-0248.2010.01474.x; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Heisse K, 2007, OECOLOGIA, V152, P435, DOI 10.1007/s00442-007-0666-6; Hendriks M, 2013, J ECOL, V101, P287, DOI 10.1111/1365-2745.12032; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Kulmatiski A, 2012, P ROY SOC B-BIOL SCI, V279, P3020, DOI 10.1098/rspb.2012.0285; Latz E, 2012, J ECOL, V100, P597, DOI 10.1111/j.1365-2745.2011.01940.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Mwangi PN, 2007, J ECOL, V95, P65, DOI 10.1111/j.1365-2745.2006.01189.x; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; Roscher C, 2011, J ECOL, V99, P1460, DOI 10.1111/j.1365-2745.2011.01875.x; Roscher C, 2011, PERSPECT PLANT ECOL, V13, P1, DOI 10.1016/j.ppees.2010.11.001; Schenk HJ, 2006, J ECOL, V94, P725, DOI 10.1111/j.1365-2745.2006.01124.x; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Singh HP, 1999, CRIT REV PLANT SCI, V18, P757, DOI 10.1080/07352689991309478; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Suding KN, 2013, J ECOL, V101, P298, DOI 10.1111/1365-2745.12057; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TOFT CA, 1983, AM NAT, V122, P618, DOI 10.1086/284162; Troumbis AY, 2000, OIKOS, V90, P549, DOI 10.1034/j.1600-0706.2000.900313.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; van Ruijven J, 2007, OIKOS, V116, P1323, DOI [10.1111/j.2007.0030-1299.16005.x, 10.1111/j.0030-1299.2007.16005.x]; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1	54	25	25	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75599	10.1371/journal.pone.0075599	http://dx.doi.org/10.1371/journal.pone.0075599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098704	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500075
J	Zhang, Y; Cheng, SQ; Zhang, MY; Zhen, LN; Pang, D; Zhang, QY; Li, ZG				Zhang, Yue; Cheng, Shaoqiang; Zhang, Mingyan; Zhen, Lina; Pang, Da; Zhang, Qingyuan; Li, Zhigao			High-Infiltration of Tumor-Associated Macrophages Predicts Unfavorable Clinical Outcome for Node-Negative Breast Cancer	PLOS ONE			English	Article							VEGF EXPRESSION; T-CELLS; MICROENVIRONMENT; PROGRESSION; PLASTICITY; BIOMARKERS; SUBSETS; STROMA	The tumor microenvironment is composed of tumor cells, fibroblasts, endothelial cells and infiltrating immune cells, which may inhibit or promote tumor growth and progression. The objectives of this retrospective study were to characterize the density of tumor-associated macrophages (TAMs) in breast cancer, and to correlate the density of TAMs with clinicopathological parameters. Paraffin-embedded specimens and clinicopathological data, including up to 5 years follow-up information, were obtained from 172 breast cancer patients. Immunohistochemical staining for CD68 (marker for macrophages) was performed and evaluated in a blinded fashion. We found that TAMs were significantly frequent in high histopathological grade breast cancer patients. Breast cancer patients with a high density of TAMs had significantly lower rates of disease-free survival and 5-year overall survival than patients with low density of TAMs. Furthermore, high-infiltration of TAMs indicated worse survival rate for patients with node-negative breast cancer. In conclusion, the number of TAMs in the tumor stroma is an independent predictor of survival time for breast cancer patients. High-infiltration of TAMs is a significant unfavorable prognostic factor for patients with invasive breast cancer and, as such, is a potentially useful prognostic marker for breast cancer.	[Zhang, Yue; Cheng, Shaoqiang; Zhang, Mingyan; Zhen, Lina; Pang, Da; Zhang, Qingyuan; Li, Zhigao] Harbin Med Univ, Affiliated Tumor Hosp, Harbin, Peoples R China	Harbin Medical University	Zhang, QY (corresponding author), Harbin Med Univ, Affiliated Tumor Hosp, Harbin, Peoples R China.	zhangqingyuan96@hotmail.com; zhigaoLi909@163.com	cheng, sq/GPT-4112-2022	LI, ZHIGAO/0000-0002-4169-143X	Foundation of Educational Commission of Heilongjiang Province for Returned Overseas Chinese Scholars [1154h19]	Foundation of Educational Commission of Heilongjiang Province for Returned Overseas Chinese Scholars	The study was supported by Foundation of Educational Commission of Heilongjiang Province for Returned Overseas Chinese Scholars (1154h19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Becker JC, 2013, CANC IMMUNOL IMMUNOT; Biswas S.K., 2013, SEMIN IMMUNOPATHOL; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bolat F, 2006, J EXP CLIN CANC RES, V25, P365; Brouckaert O, 2013, ANN ONCOL; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Connelly L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2935; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Harbeck N, 2011, ONCOLOGIST, V16, P51, DOI 10.1634/theoncologist.2011-S1-51; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karlsson E, 2007, CANCER GENET CYTOGEN, V172, P139, DOI 10.1016/j.cancergencyto.2006.09.019; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Kong LQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059771, 10.1371/journal.pone.0078275]; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; Maciejczyk A, 2013, ADV CLIN EXP MED, V22, P5; Mahmoud SMA, 2012, J CLIN PATHOL, V65, P159, DOI 10.1136/jclinpath-2011-200355; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ong SM, 2012, EUR J IMMUNOL, V42, P89, DOI 10.1002/eji.201141825; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith RA, 2012, ONCOLOGY-NY, V26, P471; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Tsutsui S, 2005, ONCOL REP, V14, P425; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005; Yoshikawa K, 2012, CANCER SCI, V103, P2012, DOI 10.1111/j.1349-7006.2012.02411.x; Zhang QL, 2012, LECT NOTES CONTR INF, V421, P7	36	74	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76147	10.1371/journal.pone.0076147	http://dx.doi.org/10.1371/journal.pone.0076147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098773	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500143
J	Lofthouse, EK; Wheeler, PR; Beste, DJV; Khatri, BL; Wu, HH; Mendum, TA; Kierzek, AM; McFadden, J				Lofthouse, Emma K.; Wheeler, Paul R.; Beste, Dany J. V.; Khatri, Bhagwati L.; Wu, Huihai; Mendum, Tom A.; Kierzek, Andrzej M.; McFadden, Johnjoe			Systems-Based Approaches to Probing Metabolic Variation within the Mycobacterium tuberculosis Complex	PLOS ONE			English	Article							METHOXYMYCOLIC ACID PRODUCTION; COMPLETE GENOME SEQUENCE; BOVIS BCG VACCINES; NITRATE REDUCTION; ISOCITRATE LYASE; GENE; EXPRESSION; BIOSYNTHESIS; MUTATION; NETWORK	The Mycobacterium tuberculosis complex includes bovine and human strains of the tuberculosis bacillus, including Mycobacterium tuberculosis, Mycobacterium bovis and the Mycobacterium bovis BCG vaccine strain. M. bovis has evolved from a M. tuberculosis-like ancestor and is the ancestor of the BCG vaccine. The pathogens demonstrate distinct differences in virulence, host range and metabolism, but the role of metabolic differences in pathogenicity is poorly understood. Systems biology approaches have been used to investigate the metabolism of M. tuberculosis, but not to probe differences between tuberculosis strains. In this study genome scale metabolic networks of M. bovis and M. bovis BCG were constructed and interrogated, along with a M. tuberculosis network, to predict substrate utilisation, gene essentiality and growth rates. The models correctly predicted 87-88% of high-throughput phenotype data, 75-76% of gene essentiality data and in silico-predicted growth rates matched measured rates. However, analysis of the metabolic networks identified discrepancies between in silico predictions and in vitro data, highlighting areas of incomplete metabolic knowledge. Additional experimental studies carried out to probe these inconsistencies revealed novel insights into the metabolism of these strains. For instance, that the reduction in metabolic capability observed in bovine tuberculosis strains, as compared to M. tuberculosis, is not reflected by current genetic or enzymatic knowledge. Hence, the in silico networks not only successfully simulate many aspects of the growth and physiology of these mycobacteria, but also provide an invaluable tool for future metabolic studies.	[Lofthouse, Emma K.; Wheeler, Paul R.; Khatri, Bhagwati L.] Anim Hlth & Vet Labs Agcy Weybridge, Dept Bovine TB, New Haw, Surrey, England; [Lofthouse, Emma K.; Beste, Dany J. V.; Wu, Huihai; Mendum, Tom A.; Kierzek, Andrzej M.; McFadden, Johnjoe] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Guildford GU2 5XH, Surrey, England	Veterinary Laboratories Agency; University of Surrey	McFadden, J (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Stag Hill, Guildford GU2 5XH, Surrey, England.	j.mcfadden@surrey.ac.uk		Kierzek, Andrzej/0000-0002-2605-9057; Beste, Dany/0000-0001-6579-1366; McFadden, Johnjoe/0000-0003-2145-0046	Animal Health and Veterinary Laboratories Agency (AHVLA) [SC1003, SC0205]; Wellcome Trust [088677]	Animal Health and Veterinary Laboratories Agency (AHVLA); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Animal Health and Veterinary Laboratories Agency (AHVLA) studentship fund (project SC1003, http://www.defra.gov.uk/ahvla-en/); AHVLA Seedcorn programme (project SC0205, http://www.defra.gov.uk/ahvla-en/); and the Wellcome Trust (grant reference number 088677, www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Belley A, 2004, INFECT IMMUN, V72, P2803, DOI 10.1128/IAI.72.5.2803-2809.2004; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BONICKE R, 1959, Tuberkulosearzt, V13, P377; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Chaturvedi S, 2003, J BIOL CHEM, V278, P40793, DOI 10.1074/jbc.M306192200; Chavadi S, 2009, J BACTERIOL, V191, P7545, DOI 10.1128/JB.00619-09; Chen JM, 2003, INFECT IMMUN, V71, P708, DOI 10.1128/IAI.71.2.708-716.2003; Chindelevitch L, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r6; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; DAVID HL, 1977, J CLIN MICROBIOL, V5, P383; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; de Lisle GW, 2001, REV SCI TECH OIE, V20, P86, DOI 10.20506/rst.20.1.1262; Fang X, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-160; Garcia Pelayo MC, 2009, INFECT IMMUN, V77, P2230, DOI [10.1128/IAI.01099-08, DOI 10.1128/IAI.01099-08.PUBMED:19289514]; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gevorgyan A, 2011, BIOINFORMATICS, V27, P433, DOI 10.1093/bioinformatics/btq679; Giffin MM, 2012, J BACTERIOL, V194, P1045, DOI 10.1128/JB.05914-11; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Honaker RW, 2008, INFECT IMMUN, V76, P2587, DOI 10.1128/IAI.01235-07; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Khatri B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052673; Kozak RA, 2011, INFECT IMMUN, V79, P59, DOI 10.1128/IAI.00824-10; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lechat P, 2008, NUCLEIC ACIDS RES, V36, pD469, DOI 10.1093/nar/gkm1042; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; LYON R H, 1970, Infection and Immunity, V1, P513; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Marri PR, 2006, FEMS MICROBIOL REV, V30, P906, DOI 10.1111/j.1574-6976.2006.00041.x; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Perez E, 2004, J BIOL CHEM, V279, P42574, DOI 10.1074/jbc.M406246200; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Rivera-Marrero CA, 2002, MICROBIOL-SGM, V148, P783, DOI 10.1099/00221287-148-3-783; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHAEFER WB, 1952, J EXP MED, V96, P207, DOI 10.1084/jem.96.3.207; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shi SP, 2006, INFECT IMMUN, V74, P56, DOI 10.1128/IAI.74.1.56-63.2006; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Sohaskey CD, 2009, FEMS MICROBIOL LETT, V290, P129, DOI 10.1111/j.1574-6968.2008.01424.x; Stermann M, 2004, J BACTERIOL, V186, P2856, DOI 10.1128/JB.186.9.2856-2861.2004; Stermann M, 2003, J CLIN MICROBIOL, V41, P3252, DOI 10.1128/JCM.41.7.3252-3259.2003; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	55	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75913	10.1371/journal.pone.0075913	http://dx.doi.org/10.1371/journal.pone.0075913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24098743	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300096
J	Dutra, SGV; Pereira, APM; Tezini, GCSV; Mazon, JH; Martins-Pinge, MC; Souza, HCD				Dutra, Sabrina G. V.; Pereira, Ana Paula M.; Tezini, Geisa C. S. V.; Mazon, Jose H.; Martins-Pinge, Marli C.; Souza, Hugo C. D.			Cardiac Autonomic Modulation Is Determined by Gender and Is Independent of Aerobic Physical Capacity in Healthy Subjects	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ALL-CAUSE MORTALITY; BLOOD-PRESSURE; CARDIORESPIRATORY FITNESS; NITRIC-OXIDE; NEURAL REGULATION; ENDURANCE; EXERCISE; HYPERTENSION; WOMEN	Background: Aerobic physical capacity plays an important role in reducing morbidity and mortality rates in subjects with cardiovascular diseases. This action is often related to an improvement in the autonomic modulation of heart rate variability (HRV). However, controversies remain regarding the effects of physical training on cardiac autonomic control in healthy subjects. Therefore, our objective was to investigate whether aerobic capacity interferes with the autonomic modulation of HRV and whether gender differences exist. Methods: Healthy men and women (N=96) were divided into groups according to aerobic capacity: low (VO2: 22-38 ml/kg(-1) min(-1)), moderate (VO2: 38-48 ml/kg(-1) min(-1)) and high (VO2 >48 ml/kg(-1) min(-1).) We evaluated the hemodynamic parameters and body composition. The autonomic modulation of HRV was investigated using spectral analysis. This procedure decomposes the heart rate oscillatory signal into frequency bands: low frequency (LF=0.04-0.15Hz) is mainly related to sympathetic modulation, and high frequency (HF=0.15-0.5Hz) corresponds to vagal modulation. Results: Aerobic capacity, regardless of gender, determined lower values of body fat percentage, blood pressure and heart rate. In turn, the spectral analysis of HRV showed that this parameter did not differ when aerobic capacity was considered. However, when the genders were compared, women had lower LF values and higher HF values than the respective groups of men. Conclusion: The results suggest that aerobic physical capacity does not interfere with HRV modulation; however, the cardiac modulatory balance differs between genders and is characterized by a greater influence of the autonomic vagal component in women and by the sympathetic component in men.	[Dutra, Sabrina G. V.; Pereira, Ana Paula M.; Tezini, Geisa C. S. V.; Mazon, Jose H.; Souza, Hugo C. D.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biomech Med & Rehabil, Sao Paulo, Brazil; [Martins-Pinge, Marli C.] Univ Estadual Londrina, Dept Physiol Sci, Londrina, Parana, Brazil	Universidade de Sao Paulo; Universidade Estadual de Londrina	Souza, HCD (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biomech Med & Rehabil, Sao Paulo, Brazil.	hugocds@fmrp.usp.br	Pinge, Marli C Martins/C-4417-2014; Souza, Hugo/C-5818-2012; de Souza, Hugo Celso Dutra/N-7434-2019; Mazon, Jose/I-7949-2015	Pinge, Marli C Martins/0000-0002-9444-1530; Souza, Hugo/0000-0002-0009-0005; de Souza, Hugo Celso Dutra/0000-0002-0009-0005; Veloso Dutra Malvar, Sabrina Graziani/0000-0003-1603-9797; Mazon, Jose/0000-0002-2157-1430	FAPESP [2011/07878-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the FAPESP (2011/07878-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862; Baumert M, 2006, CLIN J SPORT MED, V16, P412, DOI 10.1097/01.jsm.0000244610.34594.07; BEASTONWIMMER P, 1991, DEV BRAIN RES, V58, P123, DOI 10.1016/0165-3806(91)90244-D; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Boegli Y, 2003, J INVEST DERMATOL, V121, P1197, DOI 10.1046/j.1523-1747.2003.12518.x; Bosquet L, 2007, EUR J APPL PHYSIOL, V100, P363, DOI 10.1007/s00421-007-0438-3; Brunetto AF, 2005, PEDIATR CARDIOL, V26, P418, DOI 10.1007/s00246-004-0808-0; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Calhoun, 1998, Cardiol Rev, V6, P356, DOI 10.1097/00045415-199811000-00012; Camm AJ, 1996, CIRCULATION, V93, P1043; Chase NL, 2009, AM J HYPERTENS, V22, P417, DOI 10.1038/ajh.2009.6; Christou DD, 2005, CIRCULATION, V111, P494, DOI 10.1161/01.CIR.0000153864.24034.A6; Collier SR, 2009, ACTA PHYSIOL, V195, P339, DOI 10.1111/j.1748-1716.2008.01897.x; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Cozza IC, 2012, HYPERTENS RES, V35, P82, DOI 10.1038/hr.2011.162; DIXON EM, 1992, CARDIOVASC RES, V26, P713, DOI 10.1093/cvr/26.7.713; DU XJ, 1994, CLIN EXP PHARMACOL P, V21, P485, DOI 10.1111/j.1440-1681.1994.tb02545.x; Ellestad M.H., 1986, J OCCUP ENVIRON MED, V28, P1142; Ettinger SM, 1996, J APPL PHYSIOL, V80, P245, DOI 10.1152/jappl.1996.80.1.245; Evans JM, 2001, J APPL PHYSIOL, V91, P2611, DOI 10.1152/jappl.2001.91.6.2611; Fagard RH, 2007, EUR J CARDIOV PREV R, V14, P12, DOI 10.1097/HJR.0b013e3280128bbb; Figueroa A, 2007, EUR J APPL PHYSIOL, V100, P437, DOI 10.1007/s00421-007-0446-3; Goulopoulou S, 2010, METABOLISM, V59, P901, DOI 10.1016/j.metabol.2009.10.011; Hautala AJ, 2003, AM J PHYSIOL-HEART C, V285, pH1747, DOI 10.1152/ajpheart.00202.2003; Huikuri HV, 1996, CIRCULATION, V94, P122, DOI 10.1161/01.CIR.94.2.122; JAMES GD, 1986, J HYPERTENS, V4, pS387; Kienitz T, 2008, KIDNEY BLOOD PRESS R, V31, P71, DOI 10.1159/000119417; Kiviniemi AM, 2006, EUR J APPL PHYSIOL, V96, P686, DOI 10.1007/s00421-005-0130-4; Kiviniemi AM, 2007, EUR J APPL PHYSIOL, V101, P743, DOI 10.1007/s00421-007-0552-2; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kokkinos P, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/924945; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Martinelli FS, 2005, BRAZ J MED BIOL RES, V38, P639, DOI 10.1590/S0100-879X2005000400019; Mazon J, 2013, SCAND J MED SCI SPOR, V23, P114, DOI 10.1111/j.1600-0838.2011.01357.x; Melanson EL, 2000, MED SCI SPORT EXER, V32, P1894, DOI 10.1097/00005768-200011000-00012; Middleton N, 2005, CLIN PHYSIOL FUNCT I, V25, P83, DOI 10.1111/j.1475-097X.2004.00594.x; Migliaro ER, 2001, BRAZ J MED BIOL RES, V34, P493, DOI 10.1590/S0100-879X2001000400009; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; PERONNET F, 1989, J APPL PHYSIOL, V67, P453, DOI 10.1152/jappl.1989.67.1.453; Perseguini NM, 2011, BRAZ J MED BIOL RES, V44, P29, DOI 10.1590/S0100-879X2011000100005; Piotrowicz E, 2009, PACING CLIN ELECT S1, V32, pS113, DOI [10.1111/j.1540-8159.2008.02266.x, DOI 10.1111/J.1540-8159.2008.02266.X]; Poveda JJ, 1997, EUR J CLIN INVEST, V27, P967, DOI 10.1046/j.1365-2362.1997.2220763.x; Reckelhoff JF, 1998, HYPERTENSION, V31, P435, DOI 10.1161/01.HYP.31.1.435; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Reckelhoff JF, 2000, HYPERTENSION, V35, P480, DOI 10.1161/01.HYP.35.1.480; Rogers J, 2004, J APPL PHYSIOL, V97, P756, DOI 10.1152/japplphysiol.00115.2004; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; Seely EW, 1999, HYPERTENSION, V33, P1190, DOI 10.1161/01.HYP.33.5.1190; Sloan RP, 2009, AM J PUBLIC HEALTH, V99, P921, DOI 10.2105/AJPH.2007.133165; Souza HCD, 2009, AUTON NEUROSCI-BASIC, V150, P38, DOI 10.1016/j.autneu.2009.04.007; Sztajzel J, 2008, J SPORT MED PHYS FIT, V48, P495; Tezini GCSV, 2009, MENOPAUSE, V16, P110, DOI [10.1097/gme.0b013e318182d352, 10.1097/GME.0b013e318182d352]; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH424, DOI 10.1152/ajpheart.1998.274.2.H424; van Ittersum FJ, 1998, AM J HYPERTENS, V11, P1147, DOI 10.1016/S0895-7061(98)00165-4	60	48	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77092	10.1371/journal.pone.0077092	http://dx.doi.org/10.1371/journal.pone.0077092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098577	gold, Green Submitted, Green Published			2022-12-27	WOS:000325483600083
J	Fonseca, LS; da Silva, JB; Milanez, JS; Monteiro-Vitorello, CB; Momo, L; de Morais, ZM; Vasconcellos, SA; Marques, MV; Ho, PL; da Costa, RMA				Fonseca, Luciane S.; da Silva, Josefa B.; Milanez, Juliana S.; Monteiro-Vitorello, Claudia B.; Momo, Leonardo; de Morais, Zenaide M.; Vasconcellos, Silvio A.; Marques, Marilis V.; Ho, Paulo L.; da Costa, Renata M. A.			Leptospira interrogans serovar Copenhageni Harbors Two lexA Genes Involved in SOS Response	PLOS ONE			English	Article							DNA-DAMAGE; ESCHERICHIA-COLI; RECA; EXPRESSION; BINDING; PROTEIN; MUTAGENESIS; REPRESSOR; INSIGHTS; CLEAVAGE	Bacteria activate a regulatory network in response to the challenges imposed by DNA damage to genetic material, known as the SOS response. This system is regulated by the RecA recombinase and by the transcriptional repressor lexA. Leptospira interrogans is a pathogen capable of surviving in the environment for weeks, being exposed to a great variety of stress agents and yet retaining its ability to infect the host. This study aims to investigate the behavior of L. interrogans serovar Copenhageni after the stress induced by DNA damage. We show that L. interrogans serovar Copenhageni genome contains two genes encoding putative LexA proteins (lexA1 and lexA2) one of them being potentially acquired by lateral gene transfer. Both genes are induced after DNA damage, but the steady state levels of both LexA proteins drop, probably due to auto-proteolytic activity triggered in this condition. In addition, seven other genes were up-regulated following UV-C irradiation, recA, recN, dinP, and four genes encoding hypothetical proteins. This set of genes is potentially regulated by LexA1, as it showed binding to their promoter regions. All these regions contain degenerated sequences in relation to the previously described SOS box, TTTGN (5)CAAA. On the other hand, LexA2 was able to bind to the palindrome TTGTAN (10)TACAA, found in its own promoter region, but not in the others. Therefore, the L. interrogans serovar Copenhageni SOS regulon may be even more complex, as a result of LexA1 and LexA2 binding to divergent motifs. New possibilities for DNA damage response in Leptospira are expected, with potential influence in other biological responses such as virulence.	[Fonseca, Luciane S.; da Silva, Josefa B.; Milanez, Juliana S.; Ho, Paulo L.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Fonseca, Luciane S.; Ho, Paulo L.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Monteiro-Vitorello, Claudia B.] Escola Super Agr Luis Dequeiroz, Dept Genet, Piracicaba, Brazil; [Momo, Leonardo; da Costa, Renata M. A.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil; [de Morais, Zenaide M.; Vasconcellos, Silvio A.] Univ Sao Paulo, Dept Med Vet Prevent & Saude Anim, BR-05508 Sao Paulo, Brazil; [Marques, Marilis V.] Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade de Sao Paulo	Ho, PL (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	hoplee@butantan.gov.br; renata.costa@ufabc.edu.br	Marques, Marilis V/C-3085-2013; Ho, Paulo/P-8267-2015; Monteiro-Vitorello, Claudia B/F-2436-2012; da Silva, Josefa Bezerra/I-3515-2015	Ho, Paulo/0000-0003-3652-241X; Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; Marques, Marilis/0000-0003-1542-8221	Fundacao Instituto Butantan; FAPESP [2010/51365-0, 2009/17123-2]; CNPq [482043/2009-1]	Fundacao Instituto Butantan; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Fundacao Instituto Butantan (www.butantan.gov.br), FAPESP (projects 2010/51365-0; 2009/17123-2, www.fapesp.br) and CNPq (project 482043/2009-1), www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M, 2004, MOL MICROBIOL, V54, P212, DOI 10.1111/j.1365-2958.2004.04260.x; Abella M, 2007, J BACTERIOL, V189, P8855, DOI 10.1128/JB.01213-07; Adler B, 2006, PROKARYOTES, V7, P294; Aertsen A, 2006, TRENDS MICROBIOL, V14, P421, DOI 10.1016/j.tim.2006.08.006; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aranda J, 2011, J BACTERIOL, V193, P3740, DOI 10.1128/JB.00389-11; Bisognano C, 2004, J BIOL CHEM, V279, P9064, DOI 10.1074/jbc.M309836200; BURATOWSKI S, 2001, MOBILITY SHIFT DNA B, P45237; Butala M, 2011, NUCLEIC ACIDS RES, V39, P6546, DOI 10.1093/nar/gkr265; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Campoy S, 2005, J BACTERIOL, V187, P5367, DOI 10.1128/JB.187.15.5367-5375.2005; CAREY MF, 2012, COLD SPRING HARBOR P, V2012, P67470; Courcelle J, 2001, GENETICS, V158, P41; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; Cune J, 2005, J BACTERIOL, V187, P5841, DOI 10.1128/JB.187.16.5841-5845.2005; da Rocha RP, 2008, J BACTERIOL, V190, P1209, DOI 10.1128/JB.01419-07; da Silva JB, 2012, MICROB PATHOGENESIS, V52, P206, DOI 10.1016/j.micpath.2012.01.002; da Silva JB, 2011, CURR MICROBIOL, V62, P518, DOI 10.1007/s00284-010-9738-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichenbaum Z, 1998, GENETICS, V149, P1173; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Faine S., 1998, BACT INFECT HUMANS, V3rth, P395; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gawel D, 2011, VIRULENCE, V2, P222, DOI 10.4161/viru.2.3.16143; Giese KC, 2008, J MOL BIOL, V377, P148, DOI 10.1016/j.jmb.2007.12.025; Goranov AI, 2006, J BACTERIOL, V188, P5595, DOI 10.1128/JB.00342-06; GRANGERSCHNARR M, 1988, FEBS LETT, V231, P437, DOI 10.1016/0014-5793(88)80866-4; Groban ES, 2005, NUCLEIC ACIDS RES, V33, P6287, DOI 10.1093/nar/gki939; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamoen LW, 2011, MOL MICROBIOL, V81, P1, DOI 10.1111/j.1365-2958.2011.07693.x; Hauk P, 2005, BIOCHEM BIOPH RES CO, V333, P1341, DOI 10.1016/j.bbrc.2005.06.045; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Jara M, 2003, J BACTERIOL, V185, P2493, DOI 10.1128/JB.185.8.2493-2502.2003; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Kameni APT, 2002, J BACTERIOL, V184, P452, DOI 10.1128/JB.184.2.452-458.2002; Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x; LEFEBVRE RB, 2004, VET MICROBIOL, P536; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; Liveris D, 2008, INFECT IMMUN, V76, P4009, DOI 10.1128/IAI.00027-08; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mazon G, 2006, MICROBIOL-SGM, V152, P1109, DOI 10.1099/mic.0.28376-0; Mazon G, 2004, MICROBIOL-SGM, V150, P3783, DOI 10.1099/mic.0.27315-0; Mazon G, 2006, ANTON LEEUW INT J G, V90, P123, DOI 10.1007/s10482-006-9066-x; Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Ni M, 2008, CURR MICROBIOL, V57, P521, DOI 10.1007/s00284-008-9235-4; NICHOLAS KB, 1997, EMBNEW, P45237; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Simmons LA, 2007, P NATL ACAD SCI USA, V104, P1360, DOI 10.1073/pnas.0607123104; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; SMOLLETT KL, 2012, J BIOL CHEM, P45237; STAMM LV, 1988, APPL ENVIRON MICROB, V54, P728, DOI 10.1128/AEM.54.3.728-733.1988; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Toshima H, 2007, APPL ENVIRON MICROB, V73, P7582, DOI 10.1128/AEM.01326-07; Yang MK, 2008, MOL GENET GENOMICS, V280, P49, DOI 10.1007/s00438-008-0344-3; Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200; Zhong Y, 2011, CELL RES, V21, P1210, DOI 10.1038/cr.2011.46	65	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76419	10.1371/journal.pone.0076419	http://dx.doi.org/10.1371/journal.pone.0076419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098496	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600048
J	Hales, PW; Phipps, KP; Kaur, R; Clark, CA				Hales, Patrick W.; Phipps, Kim P.; Kaur, Ramneek; Clark, Christopher A.			A Two-Stage Model for In Vivo Assessment of Brain Tumor Perfusion and Abnormal Vascular Structure Using Arterial Spin Labeling	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ROUTINE CLINICAL-PRACTICE; IMAGING TECHNIQUES; VESSEL TORTUOSITY; VOLUME; MRI; PERMEABILITY; WATER; QUANTIFICATION; INVERSION	The ability to assess brain tumor perfusion and abnormalities in the vascular structure in vivo could provide significant benefits in terms of lesion diagnosis and assessment of treatment response. Arterial spin labeling (ASL) has emerged as an increasingly viable methodology for non-invasive assessment of perfusion. Although kinetic models have been developed to describe perfusion in healthy tissue, the dynamic behaviour of the ASL signal in the brain tumor environment has not been extensively studied. We show here that dynamic ASL data acquired in brain tumors displays an increased level of 'biphasic' behaviour, compared to that seen in healthy tissue. A new two-stage model is presented which more accurately describes this behaviour, and provides measurements of perfusion, pre-capillary blood volume fraction and transit time, and capillary bolus arrival time. These biomarkers offer a novel contrast in the tumor and surrounding tissue, and provide a means for measuring tumor perfusion and vascular structural abnormalities in a fully non-invasive manner.	[Hales, Patrick W.; Kaur, Ramneek; Clark, Christopher A.] UCL, Inst Child Hlth, Imaging & Biophys Unit, London, England; [Phipps, Kim P.] Great Ormond St Hosp Sick Children, Dept Neurooncol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Hales, PW (corresponding author), UCL, Inst Child Hlth, Imaging & Biophys Unit, London, England.	p.hales@ucl.ac.uk		Hales, Patrick/0000-0002-4269-0252	Cancer Research UK [C7809/A10342]; Cancer Research UK [10342] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK (http://www.cancerresearchuk.org/home/), Grant Number C7809/A10342. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broome DR, 2008, EUR J RADIOL, V66, P230, DOI 10.1016/j.ejrad.2008.02.011; Bullitt E, 2005, ACAD RADIOL, V12, P1232, DOI 10.1016/j.acra.2005.05.027; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Chappell MA, 2010, MAGN RESON MED, V63, P1357, DOI 10.1002/mrm.22320; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Chen TY, 2012, CLIN IMAG, V36, P345, DOI 10.1016/j.clinimag.2011.11.003; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Fidler IJ, 2002, LANCET ONCOL, V3, P53, DOI 10.1016/S1470-2045(01)00622-2; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Golay X, 2012, MAGN RESON MATER PHY, V25, P79, DOI 10.1007/s10334-012-0308-9; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Hales PW, 2013, J CEREBR BLOOD F MET, V33, P67, DOI 10.1038/jcbfm.2012.125; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hendrikse J, 2008, RADIOLOGY, V246, P572, DOI 10.1148/radiol.2461062100; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Kim HS, 2007, AM J NEURORADIOL, V28, P1693, DOI 10.3174/ajnr.A0674; Knopp EA, 1999, RADIOLOGY, V211, P791, DOI 10.1148/radiology.211.3.r99jn46791; Kremer S, 2002, J NEURORADIOLOGY, V29, P105; Law M, 2004, AM J NEURORADIOL, V25, P746; Law M, 2004, MAGN RESON IMAGING, V22, P599, DOI 10.1016/j.mri.2004.01.031; Li CY, 2000, JNCI-J NATL CANCER I, V92, P143, DOI 10.1093/jnci/92.2.143; Li KL, 2005, MAGN RESON MED, V53, P511, DOI 10.1002/mrm.20390; MacIntosh BJ, 2008, J CEREBR BLOOD F MET, V28, P1514, DOI 10.1038/jcbfm.2008.46; MacIntosh BJ, 2010, MAGN RESON MED, V63, P641, DOI 10.1002/mrm.22256; Noguchi T, 2008, AM J NEURORADIOL, V29, P688, DOI 10.3174/ajnr.A0903; Parikh AH, 2004, TECHNOL CANCER RES T, V3, P585, DOI 10.1177/153303460400300608; Parkes LM, 2002, MAGN RESON MED, V48, P27, DOI 10.1002/mrm.10180; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Shin JH, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790783; St Lawrence KS, 2000, MAGN RESON MED, V44, P440, DOI 10.1002/1522-2594(200009)44:3<440::AID-MRM15>3.0.CO;2-6; Stewart G N, 1893, J Physiol, V15, P1; STILLER C, 2007, CHILDHOOD CANC BRIT; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Ye FQ, 1997, MAGN RESON MED, V37, P226, DOI 10.1002/mrm.1910370215; Zhou JY, 2001, J CEREBR BLOOD F MET, V21, P440, DOI 10.1097/00004647-200104000-00013	41	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75717	10.1371/journal.pone.0075717	http://dx.doi.org/10.1371/journal.pone.0075717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098395	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500037
J	Behrens, C; Binotti, B; Schmidt, C; Robinson, CV; Chua, JJE; Kuhnel, K				Behrens, Caroline; Binotti, Beyenech; Schmidt, Carla; Robinson, Carol V.; Chua, John Jia En; Kuehnel, Karin			Crystal Structure of the Human Short Coiled Coil Protein and Insights into SCOC-FEZ1 Complex Formation	PLOS ONE			English	Article							GCN4 LEUCINE-ZIPPER; AXONAL-TRANSPORT; HUMAN FEZ1; SEQUENCE; INTERACTS; ROTATION; STRATEGY; REVEALS; UNC-76	The short coiled coil protein (SCOC) forms a complex with fasciculation and elongation protein zeta 1 (FEZ1). This complex is involved in autophagy regulation. We determined the crystal structure of the coiled coil domain of human SCOC at 2.7 angstrom resolution. SCOC forms a parallel left handed coiled coil dimer. We observed two distinct dimers in the crystal structure, which shows that SCOC is conformationally flexible. This plasticity is due to the high incidence of polar and charged residues at the core a/d-heptad positions. We prepared two double mutants, where these core residues were mutated to either leucines or valines (E93V/K97L and N125L/N132V). These mutations led to a dramatic increase in stability and change of oligomerisation state. The oligomerisation state of the mutants was characterized by multi-angle laser light scattering and native mass spectrometry measurements. The E93V/K97 mutant forms a trimer and the N125L/N132V mutant is a tetramer. We further demonstrate that SCOC forms a stable homogeneous complex with the coiled coil domain of FEZ1. SCOC dimerization and the SCOC surface residue R117 are important for this interaction.	[Behrens, Caroline; Binotti, Beyenech; Chua, John Jia En; Kuehnel, Karin] Max Planck Inst Biophys Chem, Dept Neurobiol, Gottingen, Germany; [Schmidt, Carla; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	Max Planck Society; University of Oxford	Kuhnel, K (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, POB 2841, Gottingen, Germany.	kkuehne@gwdg.de	Chua, John Jia En/G-8639-2012	Chua, John Jia En/0000-0002-5615-1014; Schmidt, Carla/0000-0001-9410-1424; robinson, carol/0000-0001-7829-5505; Kuehnel, Karin/0000-0002-2663-703X	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); Wellcome Trust; European Union (PROSPECTS grant) [HEALTH-F4-2008-201648]; Royal Society	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); Wellcome Trust(Wellcome Trust); European Union (PROSPECTS grant); Royal Society(Royal Society of London)	CB was funded by an excellence stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB). CS and CVR acknowledge funding from the Wellcome Trust and the European Union (PROSPECTS grant number HEALTH-F4-2008-201648) together with funding from the Royal Society (CVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alborghetti MR, 2010, J PROTEOME RES, V9, P4595, DOI 10.1021/pr100314q; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Chua JJE, 2012, P NATL ACAD SCI USA, V109, P5862, DOI 10.1073/pnas.1113819109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gindhart JG, 2003, MOL BIOL CELL, V14, P3356, DOI 10.1091/mbc.E02-12-0800; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lanza DCF, 2010, MOL CELL BIOCHEM, V338, P35, DOI 10.1007/s11010-009-0317-9; Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McKnight NC, 2012, EMBO J, V31, P1931, DOI 10.1038/emboj.2012.36; Morgner N, 2012, ANAL CHEM, V84, P2939, DOI 10.1021/ac300056a; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Schrodinger L., 2020, PYMOL; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Su Cheng-Wen, 2006, J Biol, V5, P9, DOI 10.1186/jbiol39; Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang YQ, 2012, MOL BIOL CELL, V23, P3911, DOI 10.1091/mbc.E12-05-0396; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	36	5	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76355	10.1371/journal.pone.0076355	http://dx.doi.org/10.1371/journal.pone.0076355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098481	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100062
J	Dole, M; Meunier, F; Hoen, M				Dole, Marjorie; Meunier, Fanny; Hoen, Michel			Gray and White Matter Distribution in Dyslexia: A VBM Study of Superior Temporal Gyrus Asymmetry	PLOS ONE			English	Article							ALTERED HEMISPHERIC-ASYMMETRY; VOXEL-BASED MORPHOMETRY; DEVELOPMENTAL DYSLEXIA; SPEECH-PERCEPTION; PLANUM-TEMPORALE; SPOKEN LANGUAGE; BRAIN RESPONSES; CHILDREN; ADULTS; ACTIVATION	In the present study, we investigated brain morphological signatures of dyslexia by using a voxel-based asymmetry analysis. Dyslexia is a developmental disorder that affects the acquisition of reading and spelling abilities and is associated with a phonological deficit. Speech perception disabilities have been associated with this deficit, particularly when listening conditions are challenging, such as in noisy environments. These deficits are associated with known neurophysiological correlates, such as a reduction in the functional activation or a modification of functional asymmetry in the cortical regions involved in speech processing, such as the bilateral superior temporal areas. These functional deficits have been associated with macroscopic morphological abnormalities, which potentially include a reduction in gray and white matter volumes, combined with modifications of the leftward asymmetry along the perisylvian areas. The purpose of this study was to investigate gray/white matter distribution asymmetries in dyslexic adults using automated image processing derived from the voxel-based morphometry technique. Correlations with speech-in-noise perception abilities were also investigated. The results confirmed the presence of gray matter distribution abnormalities in the superior temporal gyrus (STG) and the superior temporal Sulcus (STS) in individuals with dyslexia. Specifically, the gray matter of adults with dyslexia was symmetrically distributed over one particular region of the STS, the temporal voice area, whereas normal readers showed a clear rightward gray matter asymmetry in this area. We also identified a region in the left posterior STG in which the white matter distribution asymmetry was correlated to speech-in-noise comprehension abilities in dyslexic adults. These results provide further information concerning the morphological alterations observed in dyslexia, revealing the presence of both gray and white matter distribution anomalies and the potential involvement of these defects in speech-in-noise deficits.	[Dole, Marjorie] Univ Pierre Mendes France, CNRS UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France; [Meunier, Fanny] Inst Cognit Sci, CNRS UMR 5304, L2C2, Lyon, France; [Hoen, Michel] INSERM U1028, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, Lyon, France; [Hoen, Michel] CNRS UMR 5292, Lyon Neuroscience Res Ctr, Brain Dynam & Cognit Team, Lyon, France; [Meunier, Fanny; Hoen, Michel] Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Dole, M (corresponding author), Univ Pierre Mendes France, CNRS UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France.	marjorie.dole@isc.cnrs.fr	Michel, Hoen/C-7721-2012	Michel, Hoen/0000-0003-2099-8130	Rhone-Alpes Region, France through the "Cluster regional de recherche Handicap, Vieillissement et Neurosciences; European Research Council [209234]	Rhone-Alpes Region, France through the "Cluster regional de recherche Handicap, Vieillissement et Neurosciences(Region Auvergne-Rhone-Alpes); European Research Council(European Research Council (ERC)European Commission)	The first author is funded by a PhD grant from the Rhone-Alpes Region, France, attributed through the "Cluster regional de recherche Handicap, Vieillissement et Neurosciences. This research was supported by a European Research Council grant to the SpiN project (n degrees 209234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2008, NEUROIMAGE, V41, P69, DOI 10.1016/j.neuroimage.2008.02.013; Altmann CF, 2007, NEUROIMAGE, V35, P1192, DOI 10.1016/j.neuroimage.2007.01.007; [Anonymous], 2003, OVERCOMING DYSLEXIA; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Best M, 1999, NEUROREPORT, V10, P607, DOI 10.1097/00001756-199902250-00030; Bloom JS, 2013, NEUROPSYCHOLOGIA, V51, P1684, DOI 10.1016/j.neuropsychologia.2013.05.012; Boets B, 2007, BRAIN LANG, V101, P19, DOI 10.1016/j.bandl.2006.06.009; Boets B, 2007, NEUROPSYCHOLOGIA, V45, P1608, DOI 10.1016/j.neuropsychologia.2007.01.009; Bradlow AR, 2003, J SPEECH LANG HEAR R, V46, P80, DOI 10.1044/1092-4388(2003/007); BRADY S, 1983, J EXP CHILD PSYCHOL, V35, P345, DOI 10.1016/0022-0965(83)90087-5; Brambati SM, 2004, NEUROLOGY, V63, P742, DOI 10.1212/01.WNL.0000134673.95020.EE; Brett M, 2002, NEUROIMAGE, V16; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Cao F, 2006, J CHILD PSYCHOL PSYC, V47, P1041, DOI 10.1111/j.1469-7610.2006.01684.x; Charest I, 2013, CEREB CORTEX, V23, P958, DOI 10.1093/cercor/bhs090; Dalby MA, 1998, BRAIN LANG, V62, P51, DOI 10.1006/brln.1997.1887; Darwin CJ, 2003, J ACOUST SOC AM, V114, P2913, DOI 10.1121/1.1616924; Davis MH, 2003, J NEUROSCI, V23, P3423; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Derflinger S, 2011, J ALZHEIMERS DIS, V25, P347, DOI 10.3233/JAD-2011-110041; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Dole M, 2012, NEUROPSYCHOLOGIA, V50, P1543, DOI 10.1016/j.neuropsychologia.2012.03.007; Eckert MA, 2008, NEUROIMAGE, V41, P813, DOI 10.1016/j.neuroimage.2008.03.002; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; FRAUENHEIM JG, 1978, J LEARN DISABIL, V11, P476, DOI 10.1177/002221947801100803; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Glasel H, 2011, NEUROIMAGE, V58, P716, DOI 10.1016/j.neuroimage.2011.06.016; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Grataloup C, 2009, J SPEECH LANG HEAR R, V52, P827, DOI [10.1044/1092-4388(2008/06-0235), 10.1044/1092-4388(2008/06-0235]; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Hamalainen JA, 2012, NEUROIMAGE, V59, P2952, DOI 10.1016/j.neuroimage.2011.09.075; Heiervang E, 2000, NEUROPSYCHOLOGIA, V38, P1704, DOI 10.1016/S0028-3932(00)00085-3; Heim S, 2003, EUR J NEUROSCI, V17, P1715, DOI 10.1046/j.1460-9568.2003.02596.x; Heim S, 2003, NEUROREPORT, V14, P501, DOI 10.1097/01.wnr.0000058778.36017.f0; Herve PY, 2006, NEUROIMAGE, V29, P1066, DOI 10.1016/j.neuroimage.2005.08.031; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hugdahl K, 2003, NEUROPSYCHOLOGIA, V41, P666, DOI 10.1016/S0028-3932(02)00224-5; HUMPHREYS P, 1990, ANN NEUROL, V28, P727, DOI 10.1002/ana.410280602; Jacquier-Roux M., 2017, LABORATOIRE SCI LEDU, V5; Kast M, 2011, BRAIN LANG, V119, P136, DOI 10.1016/j.bandl.2011.04.002; Klein ME, 2011, NEUROPSYCHOLOGIA, V49, P878, DOI 10.1016/j.neuropsychologia.2011.01.008; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kronbichler M, 2008, HUM BRAIN MAPP, V29, P613, DOI 10.1002/hbm.20425; Kronbichler M, 2006, NEUROPSYCHOLOGIA, V44, P1822, DOI 10.1016/j.neuropsychologia.2006.03.010; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Lefavrais P., 1967, TEST ALOUETTE; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; Leonard C, 2006, BRAIN, V129, P3329, DOI 10.1093/brain/awl262; LEONARD CM, 1993, ARCH NEUROL-CHICAGO, V50, P461, DOI 10.1001/archneur.1993.00540050013008; LIEM F, 2013, HUM BRAIN M IN PRESS, P99152; Lorenzi C, 2000, J SPEECH LANG HEAR R, V43, P1367, DOI 10.1044/jslhr.4306.1367; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; NELSON HE, 1980, BRIT J PSYCHOL, V71, P487, DOI 10.1111/j.2044-8295.1980.tb01762.x; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Perre L, 2009, BRAIN RES, V1275, P73, DOI 10.1016/j.brainres.2009.04.018; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Raven J.C., 1938, PROGR MATRICES PERCE; Richards T, 2008, AM J NEURORADIOL, V29, P1134, DOI 10.3174/ajnr.A1007; Rimrodt SL, 2010, CORTEX, V46, P739, DOI 10.1016/j.cortex.2009.07.008; Robichon F, 2000, EUR J NEUROL, V7, P35, DOI 10.1046/j.1468-1331.2000.00020.x; Rocheron I, 2002, NEUROREPORT, V13, P1683, DOI 10.1097/00001756-200209160-00023; Salo E, 2013, BRAIN RES, V1496, P55, DOI 10.1016/j.brainres.2012.12.013; Sarkari Shirin, 2002, Semin Pediatr Neurol, V9, P229, DOI 10.1053/spen.2002.35506; Scott SK, 2009, J ACOUST SOC AM, V125, P1737, DOI 10.1121/1.3050255; Sharda M, 2012, NEUROSCIENCE, V214, P49, DOI 10.1016/j.neuroscience.2012.03.053; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Silani G, 2005, BRAIN, V128, P2453, DOI 10.1093/brain/awh579; Spironelli C, 2010, BRAIN, V133, P3385, DOI 10.1093/brain/awq199; Sprenger-Charolles L, 2000, CAN J EXP PSYCHOL, V54, P87, DOI 10.1037/h0087332; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Takao H, 2011, HUM BRAIN MAPP, V32, P1762, DOI 10.1002/hbm.21145; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Trecy MP, 2013, RES DEV DISABIL, V34, P2211, DOI 10.1016/j.ridd.2013.04.005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vestergaard MD, 2009, J ACOUST SOC AM, V125, P1114, DOI 10.1121/1.3050321; Veuillet E, 2007, BRAIN, V130, P2915, DOI 10.1093/brain/awm235; Vinckenbosch E, 2005, NEUROPSYCHOLOGIA, V43, P324, DOI 10.1016/j.neuropsychologia.2004.06.023; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075); Zatorre RJ, 2004, J NEUROSCI, V24, P3637, DOI 10.1523/JNEUROSCI.5458-03.2004; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zekveld AA, 2006, NEUROIMAGE, V32, P1826, DOI 10.1016/j.neuroimage.2006.04.199; Zhang LJ, 2010, HUM BRAIN MAPP, V31, P1106, DOI 10.1002/hbm.20922; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	104	17	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76823	10.1371/journal.pone.0076823	http://dx.doi.org/10.1371/journal.pone.0076823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098565	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100085
J	Khan, F; Kumari, M; Cameotra, SS				Khan, Fazlurrahman; Kumari, Munesh; Cameotra, Swaranjit Singh			RETRACTED: Biodegradation of the Allelopathic Chemical m-Tyrosine by Bacillus aquimaris SSC5 Involves the Homogentisate Central Pathway (Retracted article. See vol. 9, e102854, 2014)	PLOS ONE			English	Article; Retracted Publication							META-TYROSINE; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; L-PHENYLALANINE; PHENOLIC-ACIDS; SP NOV.; DEGRADATION; CATABOLISM; PROTEIN; 3-HYDROXYPHENYLACETATE; HYDROXYLATION	m-Tyrosine is an amino acid analogue, exuded from the roots of fescue grasses, which acts as a potent allelopathic and a broad spectrum herbicidal chemical. Although the production and toxic effects of m-tyrosine are known, its microbial degradation has not been documented yet. A soil microcosm study showed efficient degradation of m-tyrosine by the inhabitant microorganisms. A bacterial strain designated SSC5, that was able to utilize m-tyrosine as the sole source of carbon, nitrogen, and energy, was isolated from the soil microcosm and was characterized as Bacillus aquimaris. Analytical methods such as HPLC, GC-MS, and H-1-NMR performed on the resting cell samples identified the formation of 3-hydroxyphenylpyruvate (3-OH-PPA), 3-hydroxyphenylacetate (3-OH-PhAc), and homogentisate (HMG) as major intermediates in the m-tyrosine degradation pathway. Enzymatic assays carried out on cell-free lysates of m-tyrosine-induced cells confirmed transamination reaction as the first step of m-tyrosine degradation. The intermediate 3-OH-PhAc thus obtained was further funneled into the HMG central pathway as revealed by a hydroxylase enzyme assay. Subsequent degradation of HMG occurred by ring cleavage catalyzed by the enzyme homogentisate 1, 2-dioxygenase. This study has significant implications in terms of understanding the environmental fate of m-tyrosine as well as regulation of its phytotoxic effect by soil microorganisms.	[Khan, Fazlurrahman; Kumari, Munesh; Cameotra, Swaranjit Singh] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Cameotra, SS (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	ssc@imtech.res.in			UGC, India	UGC, India(University Grants Commission, India)	We thank the reviewers and the editor for their helpful suggestions to improve our paper. FK thanks DBT for the Research Associateship and MK acknowledges her research fellowship from UGC, India. This is the IMTECH communication number 16/2013.	Anderson J.P.E., 1982, RESPIRATION, DOI 10.2134/agronmonogr9.2.2-d.c41; Arias-Barrau E, 2005, J BIOL CHEM, V280, P26435, DOI 10.1074/jbc.M501988200; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; ARONSON JN, 1965, J BACTERIOL, V90, P38, DOI 10.1128/JB.90.1.38-46.1965; ARONSON JN, 1967, J BACTERIOL, V93, P1174, DOI 10.1128/JB.93.3.1174-1176.1967; ARUNACHALAM U, 1992, J BIOL CHEM, V267, P25848; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; BLAKLEY ER, 1972, CAN J MICROBIOL, V18, P1247, DOI 10.1139/m72-193; BLUM U, 1988, SOIL BIOL BIOCHEM, V20, P793, DOI 10.1016/0038-0717(88)90084-3; Blum U, 1998, J CHEM ECOL, V24, P685, DOI 10.1023/A:1022394203540; Carreira A, 2001, APPL ENVIRON MICROB, V67, P3463, DOI 10.1128/AEM.67.8.3463-3468.2001; DEBOER L, 1988, ARCH MICROBIOL, V149, P459, DOI 10.1007/BF00425588; DENOYA CD, 1994, J BACTERIOL, V176, P5312, DOI 10.1128/JB.176.17.5312-5319.1994; Deutsch JC, 1997, J CHROMATOGR B, V690, P1, DOI 10.1016/S0378-4347(96)00411-2; Duke SO, 2007, P NATL ACAD SCI USA, V104, P16729, DOI 10.1073/pnas.0707837104; Ehlers BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026321; Fazlurrahman, 2009, LETT APPL MICROBIOL, V49, P721, DOI 10.1111/j.1472-765X.2009.02724.x; FernandezCanon JM, 1997, ANAL BIOCHEM, V245, P218, DOI 10.1006/abio.1996.9957; Gurer-Orhan H, 2006, BIOCHEM J, V395, P277, DOI 10.1042/BJ20051964; Haney RL, 2008, RENEW AGR FOOD SYST, V23, P171, DOI 10.1017/S174217050800224X; Huang TF, 2012, PHYTOCHEMISTRY, V75, P60, DOI 10.1016/j.phytochem.2011.09.018; HUGGINS TG, 1993, J BIOL CHEM, V268, P12341; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; Inderjit, 1996, BOT REV, V62, P186, DOI 10.1007/BF02857921; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 2005, PLANT SOIL, V274, P227, DOI 10.1007/s11104-004-0159-x; Inderjit, 2001, AGRON J, V93, P79; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Kaur I, 2012, INT J SYST EVOL MICR, V62, P2897, DOI 10.1099/ijs.0.035691-0; Khan F, 2013, J HAZARD MATER, V254, P72, DOI 10.1016/j.jhazmat.2013.03.021; Khan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062178; KITTELL BL, 1989, J BACTERIOL, V171, P5458, DOI 10.1128/jb.171.10.5458-5466.1989; Levy E, 1994, BIOL CONTROL PLANT P, P300; LINDSTEDT S, 1977, BIOCHEMISTRY-US, V16, P3369, DOI 10.1021/bi00634a013; Macias FA, 2005, J AGR FOOD CHEM, V53, P554, DOI 10.1021/jf048702l; Matayatsuk C, 2007, REDOX REP, V12, P219, DOI 10.1179/135100007X200272; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; Molnar GA, 2005, FREE RADICAL RES, V39, P1359, DOI 10.1080/10715760500307107; NAIR MG, 1990, J CHEM ECOL, V16, P353, DOI 10.1007/BF01021770; Nishino SF, 2006, APPL ENVIRON MICROB, V72, P1040, DOI 10.1128/AEM.72.2.1040-1044.2006; OLIVERA ER, 1994, EUR J BIOCHEM, V221, P375, DOI 10.1111/j.1432-1033.1994.tb18749.x; Perreault NN, 2012, ENVIRON SCI TECHNOL, V46, P6035, DOI 10.1021/es301047d; Perry LG, 2007, J CHEM ECOL, V33, P2337, DOI 10.1007/s10886-007-9383-1; POMETTO AL, 1985, APPL ENVIRON MICROB, V49, P727, DOI 10.1128/AEM.49.3.727-729.1985; Prakash D, 2011, APPL ENVIRON MICROB, V77, P6606, DOI 10.1128/AEM.00685-11; RETTENMAIER H, 1983, FEMS MICROBIOL LETT, V19, P193, DOI 10.1016/0378-1097(83)90058-7; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; SCHMIDT SK, 1988, J CHEM ECOL, V14, P1561, DOI 10.1007/BF01012522; SEEGMILLER J, 1961, J BIOL CHEM, V236, P774; Serre L, 1999, STRUCTURE, V7, P977, DOI 10.1016/S0969-2126(99)80124-5; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P1867, DOI 10.1111/j.1462-2920.2006.01141.x; Shettigar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051162; SMITH LC, 1964, ARCH BIOCHEM BIOPHYS, V105, P424, DOI 10.1016/0003-9861(64)90026-8; SPARNINS VL, 1976, J BACTERIOL, V127, P362, DOI 10.1128/JB.127.1.362-366.1976; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; VANBERKEL WJH, 1991, EUR J BIOCHEM, V201, P585; VANDERVLIET A, 1994, FEBS LETT, V339, P89, DOI 10.1016/0014-5793(94)80391-9; Weston LA, 2003, CRIT REV PLANT SCI, V22, P367, DOI 10.1080/713610861; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; YABUUCHI E, 1972, International Journal of Systematic Bacteriology, V22, P53; Yoon JH, 2003, INT J SYST EVOL MICR, V53, P1297, DOI 10.1099/ijs.0.02365-0	63	6	6	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75928	10.1371/journal.pone.0075928	http://dx.doi.org/10.1371/journal.pone.0075928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098407	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100027
J	Ogiso-Tanaka, E; Matsubara, K; Yamamoto, S; Nonoue, Y; Wu, JZ; Fujisawa, H; Ishikubo, H; Tanaka, T; Ando, T; Matsumoto, T; Yano, M				Ogiso-Tanaka, Eri; Matsubara, Kazuki; Yamamoto, Shin-ichi; Nonoue, Yasunori; Wu, Jianzhong; Fujisawa, Hiroko; Ishikubo, Harumi; Tanaka, Tsuyoshi; Ando, Tsuyu; Matsumoto, Takashi; Yano, Masahiro			Natural Variation of the RICE FLOWERING LOCUS T 1 Contributes to Flowering Time Divergence in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CONTROLLING HEADING DATE; PHOTOPERIOD SENSITIVITY; GENE; FT; HD3A; ARABIDOPSIS; PROTEIN; HD1; DIVERSIFICATION	In rice (Oryza sativa L.), there is a diversity in flowering time that is strictly genetically regulated. Some indica cultivars show extremely late flowering under long-day conditions, but little is known about the gene(s) involved. Here, we demonstrate that functional defects in the florigen gene RFT1 are the main cause of late flowering in an indica cultivar, Nona Bokra. Mapping and complementation studies revealed that sequence polymorphisms in the RFT1 regulatory and coding regions are likely to cause late flowering under long-day conditions. We detected polymorphisms in the promoter region that lead to reduced expression levels of RFT1. We also identified an amino acid substitution (E105K) that leads to a functional defect in Nona Bokra RFT1. Sequencing of the RFT1 region in rice accessions from a global collection showed that the E105K mutation is found only in indica, and indicated a strong association between the RFT1 haplotype and extremely late flowering in a functional Hd1 background. Furthermore, SNPs in the regulatory region of RFT1 and the E105K substitution in 1,397 accessions show strong linkage disequilibrium with a flowering time-associated SNP. Although the defective E105K allele of RFT1 (but not of another florigen gene, Hd3a) is found in many cultivars, relative rate tests revealed no evidence for differential rate of evolution of these genes. The ratios of nonsynonymous to synonymous substitutions suggest that the E105K mutation resulting in the defect in RFT1 occurred relatively recently. These findings indicate that natural mutations in RFT1 provide flowering time divergence under long-day conditions.	[Ogiso-Tanaka, Eri; Matsubara, Kazuki; Yamamoto, Shin-ichi; Nonoue, Yasunori; Wu, Jianzhong; Fujisawa, Hiroko; Ishikubo, Harumi; Tanaka, Tsuyoshi; Ando, Tsuyu; Matsumoto, Takashi; Yano, Masahiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Kannondai Tsukuba, Ibaraki, Japan		Yano, M (corresponding author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Kannondai Tsukuba, Ibaraki, Japan.	myano@affrc.go.jp	Matsubara, Kazuki/S-9378-2019; Ogiso-Tanaka, Eri/GWR-3103-2022; Yano, Masahiro/AAC-5441-2019; Ogiso-Tanaka, Eri/P-3518-2019	Matsubara, Kazuki/0000-0002-2084-8362; Ogiso-Tanaka, Eri/0000-0002-7655-3408; Wu, Jianzhong/0000-0002-4033-852X	Ministry of Agriculture, Forestry and Fishery [IP1001]; Genomics for Agricultural Innovation [GPN0001, QTL5003]	Ministry of Agriculture, Forestry and Fishery; Genomics for Agricultural Innovation	This work was supported by the Ministry of Agriculture, Forestry and Fishery (Integrated Research Project for Plant, Insect, and Animal using Genome Technology, IP1001); and Genomics for Agricultural Innovation (GPN0001 and QTL5003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Best R., 1959, Field Crop Abstracts, V12, P85; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Bonnin I, 2008, THEOR APPL GENET, V116, P383, DOI 10.1007/s00122-007-0676-0; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Coustham V, 2012, SCIENCE, V337, P584, DOI 10.1126/science.1221881; Dai XD, 2012, J INTEGR PLANT BIOL, V54, P790, DOI 10.1111/j.1744-7909.2012.01166.x; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Dung LV, 1998, THEOR APPL GENET, V97, P714, DOI 10.1007/s001220050947; Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041; Ebana K, 2011, THEOR APPL GENET, V122, P1199, DOI 10.1007/s00122-010-1524-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujino K, 2013, THEOR APPL GENET, V126, P611, DOI 10.1007/s00122-012-2005-5; Fujino K, 2010, MOL GENET GENOMICS, V284, P137, DOI 10.1007/s00438-010-0555-2; Fuse T., 2001, PLANT BIOTECHNOL, V18, P219, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.219; Garner WW, 1919, J AGRIC RES, V18, P0553; Hagiwara WE, 2009, MOL ECOL, V18, P1537, DOI 10.1111/j.1365-294X.2009.04119.x; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Holden J., 1993, GENES CROPS ENV; Hori K, 2013, PLANT J, V76, P36, DOI 10.1111/tpj.12268; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Inoue H, 1998, BREEDING SCI, V48, P103; Ishikawa R, 2011, MOL GENET GENOMICS, V285, P461, DOI 10.1007/s00438-011-0621-4; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Jing L, 2011, POLYMORPHISM ANAL RI; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Lu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034021; Matsubara K, 2008, THEOR APPL GENET, V117, P935, DOI 10.1007/s00122-008-0833-0; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Minobe Y, 2004, Japan Patent Kokai, Patent No. [2004-003122 (2004-09-23), 2004003122]; Monna L, 2002, THEOR APPL GENET, V104, P772, DOI 10.1007/s00122-001-0813-0; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nonoue Y, 2008, THEOR APPL GENET, V116, P715, DOI 10.1007/s00122-007-0704-0; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; OKUMOTO Y, 1991, JPN J BREED, V41, P135; Okumoto Y, 2000, BREED RES, V2, P2000; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Saito H, 2012, PLANT CELL PHYSIOL, V53, P717, DOI 10.1093/pcp/pcs029; Saito H, 2009, THEOR APPL GENET, V119, P315, DOI 10.1007/s00122-009-1040-3; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; SANO Y, 1992, JPN J BREED, V42, P561; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Schwartz C, 2009, GENETICS, V183, P723, DOI 10.1534/genetics.109.104984; Seshu D. V., 1976, International Rice Research Newsletter, P5; Sobrizal P.L. Sanchez, 2000, RICE GENET NEWSLETT, V17, P46; Subedi M, 2013, RES DEV, V22, P54; Sun CH, 2012, PLANT CELL, V24, P3235, DOI 10.1105/tpc.112.101436; TAJIMA F, 1993, GENETICS, V135, P599; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takahashi Y, 2011, GENES GENET SYST, V86, P175, DOI 10.1266/ggs.86.175; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Takai T, 2007, BREEDING SCI, V57, P257, DOI 10.1270/jsbbs.57.257; Takeuchi Y, 2006, BREEDING SCI, V56, P405, DOI 10.1270/jsbbs.56.405; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; The International Rice Research Institute, 1985, FLOW RESP RIC PLANT; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Uga Y, 2007, THEOR APPL GENET, V114, P1457, DOI 10.1007/s00122-007-0534-0; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yano M, 2001, PLANT PHYSIOL, V127, P1425, DOI 10.1104/pp.010710; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yokoo M., 1980, B NATL I AGR SCI D, V31, P95	82	69	75	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75959	10.1371/journal.pone.0075959	http://dx.doi.org/10.1371/journal.pone.0075959			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098411	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100029
J	Qin, R; Shen, HL; Cao, Y; Fang, Y; Li, H; Chen, QY; Xu, WL				Qin, Rong; Shen, Huiling; Cao, Yuan; Fang, Yue; Li, Hao; Chen, Qiaoyun; Xu, Wenlin			Tetrandrine Induces Mitochondria-Mediated Apoptosis in Human Gastric Cancer BGC-823 Cells	PLOS ONE			English	Article							IN-VITRO; ACTIVATION; RESISTANCE; INDUCTION; PATHWAYS; REVERSAL; CASCADE; PROTEIN	Tetrandrine, a bis-benzylisoquinoline alkaloid isolated from the dried root of Hang-Fang-Chi (Stephania tetrandra S. Moore), has been reported to possess anti-cancer effects on many tumors. In this study, we investigated tetrandrine-induced apoptosis on human gastric cancer BGC-823 cells in vitro and in vivo. The results showed that tetrandrine significantly inhibited cell viability in a dose- and time-dependent manner and induced apoptosis. It increased the apoptosis; upregulation of Bax, Bak, and Bad; and downregulation of Bcl-2 and Bcl-xl in BGC-823 cells. Moreover, tetrandrine increased the activation of caspase-3 and -9, release of cytochrome c, and upregulation of apaf-1, suggesting that tetrandrine-induced apoptosis was related to the mitochondrial pathway. Meanwhile, pretreatment with the pan-caspase inhibitor z-VAD-fmk in BGC-823 cells reduced tetrandrine-induced apoptosis by blocking activation of caspases. Furthermore, tetrandrine effectively inhibited tumor growth via apoptosis induction, which was verified by immunohistochemical analysis in a nude mouse xenograft model. Taken together, we concluded that tetrandrine significantly inhibited the proliferation of gastric cancer BGC-823 cells through mitochondria-dependent apoptosis, which may play a promising role in gastric cancer therapy.	[Qin, Rong; Shen, Huiling; Cao, Yuan; Fang, Yue; Chen, Qiaoyun] Jiangsu Univ, Affiliated Peoples Hosp, Dept Oncol, Zhenjiang, Jiangsu, Peoples R China; [Li, Hao; Xu, Wenlin] Jiangsu Univ, Affiliated Peoples Hosp 4, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Xu, WL (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp 4, Zhenjiang, Jiangsu, Peoples R China.	xuwenlin0511@163.com			National Natural Science Foundation of China [81070423, 81101677]; Natural Science Foundation of Jiangsu Province [BK 2010332]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the following grants: the grants from National Natural Science Foundation of China (81070423 and 81101677), the grants from the Natural Science Foundation of Jiangsu Province (BK 2010332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi T, 2007, PATHOL INT, V57, P635, DOI 10.1111/j.1440-1827.2007.02152.x; BISSERY MC, 1995, ANTI-CANCER DRUG, V6, P339, DOI 10.1097/00001813-199506000-00001; Chen BA, 2008, INT J NANOMED, V3, P277; Chen Y, 2009, INT J CANCER, V124, P2260, DOI 10.1002/ijc.24208; Cho HS, 2009, J VET SCI, V10, P23, DOI 10.4142/jvs.2009.10.1.23; Dai CL, 2007, CANCER CHEMOTH PHARM, V60, P741, DOI 10.1007/s00280-007-0420-0; Dorr R T, 1994, Ann Pharmacother, V28, pS11; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FORD AC, 2011, CLIN GASTROENTEROLOG, V25, P581, DOI DOI 10.1016/J.BPG.2011.09.002.PUBMED:22122773; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gu WJ, 2013, ANTI-CANCER DRUG, V24, P566, DOI 10.1097/CAD.0b013e3283608bc5; Hirsch T, 1997, BIOSCIENCE REP, V17, P67, DOI 10.1023/A:1027339418683; Jang BC, 2004, BIOCHEM PHARMACOL, V67, P1819, DOI 10.1016/j.bcp.2004.01.018; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang M, 2009, AM J PHYSIOL-RENAL, V296, pF983, DOI 10.1152/ajprenal.90579.2008; Lee HJ, 2008, CANCER LETT, V270, P342, DOI 10.1016/j.canlet.2008.05.040; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li XL, 2012, MOL PHARMACEUT, V9, P222, DOI 10.1021/mp2002736; Li XD, 2011, J SURG RES, V166, pE45, DOI 10.1016/j.jss.2010.10.034; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Meyer HJ, 2011, DTSCH ARZTEBL INT, V108, P698, DOI 10.3238/arztebl.2011.0698; Ng LT, 2006, AM J CHINESE MED, V34, P125, DOI 10.1142/S0192415X06003692; Pan XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056679; Pang LH, 1997, BIOCHEM PHARMACOL, V53, P773, DOI 10.1016/S0006-2952(96)00817-9; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Rogalska A, 2013, TOXICOL IN VITRO, V27, P239, DOI 10.1016/j.tiv.2012.09.006; Roukos DH, 2005, NAT CLIN PRACT ONCOL, V2, P98, DOI 10.1038/ncponc0099; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Tabuchi Y, 2009, INT J ONCOL, V34, P313, DOI 10.3892/ijo_00000153; Vogiatzi P, 2007, J CELL PHYSIOL, V211, P287, DOI 10.1002/jcp.20982; Wei J, 2007, CANCER CHEMOTH PHARM, V60, P703, DOI 10.1007/s00280-007-0416-9; Wei N, 2011, BIOCHEM PHARMACOL, V82, P1593, DOI 10.1016/j.bcp.2011.08.012; Wu JM, 2010, CANCER LETT, V287, P187, DOI 10.1016/j.canlet.2009.06.009; Wu YY, 2007, APOPTOSIS, V12, P593, DOI 10.1007/s10495-006-0007-y; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang L, 2012, ASIAN PAC J CANCER P, V13, P3803, DOI 10.7314/APJCP.2012.13.8.3803; Zhu XM, 2005, ANTICANCER RES, V25, P1953	40	40	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76486	10.1371/journal.pone.0076486	http://dx.doi.org/10.1371/journal.pone.0076486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098511	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100071
J	Rodrigues, TB; Ceballos, A; Grijota-Martinez, C; Nunez, B; Refetoff, S; Cerdan, S; Morte, B; Bernal, J				Rodrigues, Tiago B.; Ceballos, Ainhoa; Grijota-Martinez, Carmen; Nunez, Barbara; Refetoff, Samuel; Cerdan, Sebastian; Morte, Beatriz; Bernal, Juan			Increased Oxidative Metabolism and Neurotransmitter Cycling in the Brain of Mice Lacking the Thyroid Hormone Transporter Slc16a2 (Mct8)	PLOS ONE			English	Article							C6 GLIOMA-CELLS; MONOCARBOXYLATE TRANSPORTER-8; CEREBRAL METABOLISM; CLINICAL PHENOTYPE; GENE-EXPRESSION; DEFICIENCY; MUTATIONS; C-13; HYPOTHYROIDISM; LACTATE	Mutations of the monocarboxylate transporter 8 (MCT8) cause a severe X-linked intellectual deficit and neurological impairment. MCT8 is a specific thyroid hormone (T-4 and T-3) transporter and the patients also present unusual abnormalities in the serum profile of thyroid hormone concentrations due to altered secretion and metabolism of T-4 and T-3. Given the role of thyroid hormones in brain development, it is thought that the neurological impairment is due to restricted transport of thyroid hormones to the target neurons. In this work we have investigated cerebral metabolism in mice with Mct8 deficiency. Adult male mice were infused for 30 minutes with (1-C-13) glucose and brain extracts prepared and analyzed by C-13 nuclear magnetic resonance spectroscopy. Genetic inactivation of Mct8 resulted in increased oxidative metabolism as reflected by increased glutamate C4 enrichment, and of glutamatergic and GABAergic neurotransmissions as observed by the increases in glutamine C4 and GABA C2 enrichments, respectively. These changes were distinct to those produced by hypothyroidism or hyperthyroidism. Similar increments in glutamate C4 enrichment and GABAergic neurotransmission were observed in the combined inactivation of Mct8 and D2, indicating that the increased neurotransmission and metabolic activity were not due to increased production of cerebral T-3 by the D2-encoded type 2 deiodinase. In conclusion, Mct8 deficiency has important metabolic consequences in the brain that could not be correlated with deficiency or excess of thyroid hormone supply to the brain during adulthood.	[Rodrigues, Tiago B.; Ceballos, Ainhoa; Grijota-Martinez, Carmen; Nunez, Barbara; Cerdan, Sebastian; Morte, Beatriz; Bernal, Juan] CSIC, Inst Invest Biomed, Madrid, Spain; [Rodrigues, Tiago B.; Ceballos, Ainhoa; Grijota-Martinez, Carmen; Nunez, Barbara; Cerdan, Sebastian; Morte, Beatriz; Bernal, Juan] Univ Autonoma Madrid, Madrid, Spain; [Rodrigues, Tiago B.] Univ Cambridge, CRUK, Cambridge Inst, Cambridge, England; [Rodrigues, Tiago B.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Grijota-Martinez, Carmen; Morte, Beatriz; Bernal, Juan] Ctr Biomed Res Rare Dis, Madrid, Spain; [Refetoff, Samuel] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Refetoff, Samuel] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Refetoff, Samuel] Univ Chicago, Dept Genet, Chicago, IL 60637 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Chicago; University of Chicago; University of Chicago	Morte, B (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	bmorte@iib.uam.es; jbernal@iib.uam.es	Refetoff, Samuel/ABB-1263-2021; Bernal, Juan/J-6086-2014; Grijota-Martinez, Carmen/P-5093-2017	Refetoff, Samuel/0000-0003-0164-8231; Bernal, Juan/0000-0002-5867-4951; Grijota-Martinez, Carmen/0000-0003-2656-9062; Morte, Beatriz/0000-0003-0702-7815; Rodrigues, Tiago/0000-0002-4474-0639	Plan Nacional de I+D [SAF2008-01168, SAF2011-25608, SAF2011-23622]; Ramon Areces Foundation; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain; Community of Madrid [S2010/BMD-2349]; National Institutes of Health, USA [DK15070]; EMBO fellowship [EMBO-ALT-1145-2009]; Intra-European Marie Curie Fellowship [FP7-PEOPLE-2009-IEF]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015070, R37DK015070] Funding Source: NIH RePORTER	Plan Nacional de I+D; Ramon Areces Foundation; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain; Community of Madrid(Comunidad de Madrid); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO fellowship(European Molecular Biology Organization (EMBO)); Intra-European Marie Curie Fellowship(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported with grants from Plan Nacional de I+D SAF2008-01168 and SAF2011-25608 (BM and JB) and SAF2011-23622 (SC), the Ramon Areces Foundation (BM and JB), the Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain (BM and JB), S2010/BMD-2349 from the Community of Madrid (SC), grant DK15070 (SR) from the National Institutes of Health, USA, an Intra-European Marie Curie (FP7-PEOPLE-2009-IEF, Imaging Lymphoma) and a Long-term EMBO (EMBO-ALT-1145-2009) fellowships (TBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan W, 1944, AM J MENT DEF, V48, P325; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Biebermann H, 2005, EUR J ENDOCRINOL, V153, P359, DOI 10.1530/eje.1.01980; Bouzier AK, 1998, J BIOL CHEM, V273, P27162, DOI 10.1074/jbc.273.42.27162; Bouzier AK, 1998, DEV NEUROSCI-BASEL, V20, P331, DOI 10.1159/000017328; Boyages SC, 2000, WERNER INGBARS THYRO, V8th, P803; Brockmann K, 2005, J NEUROL, V252, P663, DOI 10.1007/s00415-005-0713-3; CERDAN S, 1990, J BIOL CHEM, V265, P12916; CHAPA F, 1995, ENDOCRINOLOGY, V136, P296, DOI 10.1210/en.136.1.296; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; DEESCOBAR GM, 1985, ENDOCRINOLOGY, V117, P1890, DOI 10.1210/endo-117-5-1890; DELONG GR, 1985, DEV MED CHILD NEUROL, V27, P317; Di Cosmo C, 2010, J CLIN INVEST, V120, P3377, DOI 10.1172/JCI42113; Di Cosmo C, 2009, ENDOCRINOLOGY, V150, P4450, DOI 10.1210/en.2009-0209; Diez D, 2008, ENDOCRINOLOGY, V149, P3989, DOI 10.1210/en.2008-0350; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; Dumitrescu Alexandra M., 2007, V10, P127, DOI 10.1159/000106824; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Ferrara AM, 2013, ENDOCRINOLO IN PRESS; Friesema ECH, 2005, VITAM HORM, V70, P137, DOI 10.1016/S0083-6729(05)70005-4; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2006, NAT CLIN PRACT ENDOC, V2, P512, DOI 10.1038/ncpendmet0262; Fuchs O, 2008, DEV MED CHILD NEUROL, V50, P1; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Gika AD, 2009, DEV MED CHILD NEUROL; Grueters Annette, 2007, V10, P118, DOI 10.1159/000106823; Hernandez A, 2012, ENDOCRINOLOGY, V153, P2919, DOI 10.1210/en.2011-1905; Heuer H, 2013, BBA-GEN SUBJECTS, V1830, P3974, DOI 10.1016/j.bbagen.2012.04.009; Holden KR, 2005, J CHILD NEUROL, V20, P852, DOI 10.1177/08830738050200101601; Ito K, 2011, J PHARM SCI-US, V100, P3939, DOI 10.1002/jps.22487; James SR, 2009, ENDOCRINOLOGY, V150, P1961, DOI 10.1210/en.2008-1031; Kinne A, 2010, J BIOL CHEM, V285, P28054, DOI 10.1074/jbc.M110.129577; Knerr I, 2007, J INHERIT METAB DIS, V30, P279, DOI 10.1007/s10545-007-0574-2; Legrand J, 1984, NEUROBEHAVIORAL TERA, P331; Martinez B, 2009, ENDOCRINOLOGY, V150, P3953, DOI 10.1210/en.2008-1755; Mayerl S, 2012, ENDOCRINOLOGY, V153, P1528, DOI 10.1210/en.2011-1633; MOORE S, 1958, FED PROC, V17, P1107; Morte B, 2010, ENDOCRINOLOGY, V151, P2381, DOI 10.1210/en.2009-0944; Namba N, 2008, EUR J PEDIATR, V167, P785, DOI 10.1007/s00431-007-0589-6; Palha JA, 2000, ENDOCRINOLOGY, V141, P3267; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Rodrigues TB, 2005, MAGN RESON MED, V54, P1014, DOI 10.1002/mrm.20620; Rodrigues TB, 2005, J NEUROSCI RES, V79, P119, DOI 10.1002/jnr.20308; Rodrigues TB, 2009, J NEUROCHEM, V109, P237, DOI 10.1111/j.1471-4159.2009.05935.x; Schwartz CE, 2007, BEST PRACT RES CL EN, V21, P307, DOI 10.1016/j.beem.2007.03.009; Sijens PE, 2008, J CLIN ENDOCR METAB, V93, P1854, DOI 10.1210/jc.2007-2441; SRIVASTAVA LK, 1985, BIOCHEM INT, V11, P491; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Trajkovic-Arsic M, 2010, ENDOCRINOLOGY, V151, P5053, DOI 10.1210/en.2010-0593; Wirth EK, 2009, J NEUROSCI, V29, P9439, DOI 10.1523/JNEUROSCI.6055-08.2009	52	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74621	10.1371/journal.pone.0074621	http://dx.doi.org/10.1371/journal.pone.0074621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098341	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100005
J	Jagielska, A; Wilhite, KD; Van Vliet, KJ				Jagielska, Anna; Wilhite, Kristen D.; Van Vliet, Krystyn J.			Extracellular Acidic pH Inhibits Oligodendrocyte Precursor Viability, Migration, and Differentiation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; DIRECTIONAL CELL-MIGRATION; CENTRAL-NERVOUS-SYSTEM; NA+/H+ EXCHANGER NHE1; GROWTH-FACTOR BINDING; HUMAN-MELANOMA CELLS; INTRACELLULAR PH; PROGENITOR CELLS; IN-VIVO; DEMYELINATING LESIONS	Axon remyelination in the central nervous system requires oligodendrocytes that produce myelin. Failure of this repair process is characteristic of neurodegeneration in demyelinating diseases such as multiple sclerosis, and it remains unclear how the lesion microenvironment contributes to decreased remyelination potential of oligodendrocytes. Here, we show that acidic extracellular pH, which is characteristic of demyelinating lesions, decreases the migration, proliferation, and survival of oligodendrocyte precursor cells (OPCs), and reduces their differentiation into oligodendrocytes. Further, OPCs exhibit directional migration along pH gradients toward acidic pH. These in vitro findings support a possible in vivo scenario whereby pH gradients attract OPCs toward acidic lesions, but resulting reduction in OPC survival and motility in acid decreases progress toward demyelinated axons and is further compounded by decreased differentiation into myelin-producing oligodendrocytes. As these processes are integral to OPC response to nerve demyelination, our results suggest that lesion acidity could contribute to decreased remyelination.	[Jagielska, Anna; Van Vliet, Krystyn J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Wilhite, Kristen D.; Van Vliet, Krystyn J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Van Vliet, KJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	krystyn@mit.edu			Human Frontier Science Program [RGP0015]	Human Frontier Science Program(Human Frontier Science Program)	This work was funded by the Human Frontier Science Program, RGP0015; http://www.hfsp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Amat JA, 1998, GLIA, V22, P64, DOI 10.1002/(SICI)1098-1136(199801)22:1<64::AID-GLIA6>3.0.CO;2-8; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Bernard F, 2006, J NEUROSCI RES, V84, P1392, DOI 10.1002/jnr.21051; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; BLUMENTHAL SS, 1989, AM J PHYSIOL, V257, pC419, DOI 10.1152/ajpcell.1989.257.3.C419; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Boussouf A, 2000, J NEUROSCI RES, V59, P731, DOI 10.1002/(SICI)1097-4547(20000315)59:6<731::AID-JNR5>3.0.CO;2-G; Boussouf A, 1997, GLIA, V19, P74, DOI 10.1002/(SICI)1098-1136(199701)19:1<74::AID-GLIA8>3.0.CO;2-A; Boyd A, 2013, ACTA NEUROPATHOL, V125, P841, DOI 10.1007/s00401-013-1112-y; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; CARROLL WM, 1994, BRAIN, V117, P563, DOI 10.1093/brain/117.3.563; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chari DM, 2003, J NEUROPATH EXP NEUR, V62, P908, DOI 10.1093/jnen/62.9.908; Chari DM, 2002, GLIA, V37, P307, DOI 10.1002/glia.10038; Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1989, J NEUROSCI, V9, P2011; CHOPP M, 1990, STROKE, V21, P463, DOI 10.1161/01.STR.21.3.463; Cutaia M, 2005, APOPTOSIS, V10, P1457, DOI 10.1007/s10495-005-1402-5; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Deng WB, 2003, P NATL ACAD SCI USA, V100, P6801, DOI 10.1073/pnas.1136624100; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; DeStefano N, 1995, ANN NEUROL, V38, P901, DOI 10.1002/ana.410380610; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Eble JA, 2003, BIOCHEM J, V376, P77, DOI 10.1042/BJ20030373; Edgar JM, 2009, CURR OPIN NEUROBIOL, V19, P498, DOI 10.1016/j.conb.2009.08.003; Faff L, 2000, BRAIN RES, V853, P22, DOI 10.1016/S0006-8993(99)02221-0; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feldman DH, 2008, GLIA, V56, P1238, DOI 10.1002/glia.20693; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Freire E, 2000, J BIOL CHEM, V275, P817, DOI 10.1074/jbc.275.2.817; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Frost EE, 1999, CURR BIOL, V9, P1251, DOI 10.1016/S0960-9822(99)80506-5; Fulton D, 2010, ASN NEURO, V2, DOI 10.1042/AN20090051; Gallo V, 2008, CURR OPIN NEUROL, V21, P278, DOI 10.1097/WCO.0b013e3282fd1875; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; GIFFARD RG, 1992, STROKE, V23, P1817, DOI 10.1161/01.STR.23.12.1817; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Goerges AL, 2004, J BIOL CHEM, V279, P2307, DOI 10.1074/jbc.M308482200; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; HERTZ H, 1881, J REINE ANGEW MATH, V92, P155; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Hinks GL, 2000, MOL CELL NEUROSCI, V16, P542, DOI 10.1006/mcne.2000.0897; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; HUNT TK, 1969, AM J SURG, V118, P521, DOI 10.1016/0002-9610(69)90174-3; HUTCHISON C, 1995, CELL CYCLE CONTROL; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Jagielska A, 2012, STEM CELLS DEV; Jarjour AA, 2004, NEUROSCIENTIST, V10, P99, DOI 10.1177/1073858403260751; Jeffery ND, 1999, EUR J NEUROSCI, V11, P1508, DOI 10.1046/j.1460-9568.1999.00564.x; JOHNSON ES, 1981, ACTA NEUROPATHOL, V53, P93, DOI 10.1007/BF00689988; KATO Y, 1992, J BIOL CHEM, V267, P11424; KETTENMANN H, 1988, J PHYSIOL-LONDON, V406, P147, DOI 10.1113/jphysiol.1988.sp017373; Kippert A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-71; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; KRAIG RP, 1985, BRAIN RES, V342, P281, DOI 10.1016/0006-8993(85)91127-8; KRAIG RP, 1986, AM J PHYSIOL, V250, pR348, DOI 10.1152/ajpregu.1986.250.3.R348; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; KUHNE HH, 1985, INFECTION, V13, P52, DOI 10.1007/BF01660413; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; LARSSON SH, 1990, AM J PHYSIOL, V258, pF697, DOI 10.1152/ajprenal.1990.258.3.F697; Lassmann H, 2007, J NEUROL SCI, V259, P3, DOI 10.1016/j.jns.2006.08.016; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lauritzen G, 2012, CANCER LETT, V317, P172, DOI 10.1016/j.canlet.2011.11.023; Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Liebetanz D, 2006, EXP NEUROL, V202, P217, DOI 10.1016/j.expneurol.2006.05.032; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; LUDWIN SK, 1980, LAB INVEST, V43, P382; MABE H, 1983, J CEREBR BLOOD F MET, V3, P109, DOI 10.1038/jcbfm.1983.13; Majima HJ, 1998, J BIOL CHEM, V273, P8217, DOI 10.1074/jbc.273.14.8217; Marta M, 2012, CNS NEUROL DISORD-DR, V11, P610, DOI 10.2174/187152712801661301; MARTIN GR, 1994, CANCER RES, V54, P5670; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Milner R, 1997, GLIA, V19, P85, DOI 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9; Milner R, 1996, J NEUROSCI, V16, P7240; Milner R, 1997, CLIN SCI, V92, P113, DOI 10.1042/cs0920113; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Niehaus A, 1999, J NEUROSCI, V19, P4948; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; O'Meara Ryan W, 2011, J Signal Transduct, V2011, P354091, DOI 10.1155/2011/354091; Palecek SP, 1998, J CELL SCI, V111, P929; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PAPPAS CA, 1994, NEUROREPORT, V6, P193, DOI 10.1097/00001756-199412300-00049; Paradise RK, 2013, EXP CELL RES, V319, P487, DOI 10.1016/j.yexcr.2012.11.006; Paradise RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015746; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; PERONA R, 1988, NATURE, V334, P438, DOI 10.1038/334438a0; PFAFF M, 1994, EUR J BIOCHEM, V225, P975, DOI 10.1111/j.1432-1033.1994.0975b.x; Piao JH, 2013, GLIA, V61, P361, DOI 10.1002/glia.22438; Piaton G, 2009, PROG BRAIN RES, V175, P453, DOI 10.1016/S0079-6123(09)17530-1; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; PRINEAS JW, 1993, BRAIN, V116, P681, DOI 10.1093/brain/116.3.681; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; REMENSNYDER JP, 1968, AM J PATHOL, V52, P301; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Saidha S, 2012, ANN NY ACAD SCI, V1247, P117, DOI 10.1111/j.1749-6632.2011.06272.x; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Schwab A, 2005, J PHYSIOL-LONDON, V568, P445, DOI 10.1113/jphysiol.2005.092957; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shields SA, 1999, GLIA, V28, P77, DOI 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; SOBEL RA, 1989, AM J PATHOL, V135, P161; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; TOURBAH A, 1992, J NEUROSCI RES, V33, P47, DOI 10.1002/jnr.490330107; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; VONHANWEHR R, 1986, J NEUROCHEM, V46, P331; Waxman SG, 2006, TRENDS MOL MED, V12, P192, DOI 10.1016/j.molmed.2006.03.001; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Wolswijk G, 1998, J NEUROSCI, V18, P601; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; XIE DC, 1995, J NEUROCYTOL, V24, P435, DOI 10.1007/BF01181605; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YIM SH, 1993, J NEUROSCI RES, V34, P401, DOI 10.1002/jnr.490340405; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	159	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76048	10.1371/journal.pone.0076048	http://dx.doi.org/10.1371/journal.pone.0076048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098762	Green Published, gold			2022-12-27	WOS:000325423500132
J	Tian, L; Fang, YX; Xue, JL; Chen, JZ				Tian, Ling; Fang, Yu-xiang; Xue, Jing-lun; Chen, Jin-zhong			Four MicroRNAs Promote Prostate Cell Proliferation with Regulation of PTEN and Its Downstream Signals In Vitro	PLOS ONE			English	Article							KEY ONCOGENIC COMPONENT; CANCER; EXPRESSION; CARCINOMA; GROWTH; CLUSTER; GENE; DIFFERENTIATION; 3-KINASES; RADIATION	Background: Phosphatase and tensin homologue (PTEN), as a tumor suppressor, plays vital roles in tumorigenesis and progression of prostate cancer. However, the mechanisms of PTEN regulation still need further investigation. We here report that a combination of four microRNAs (miR-19b, miR-23b, miR-26a and miR-92a) promotes prostate cell proliferation by regulating PTEN and its downstream signals in vitro. Methodology/Principal Findings: We found that the four microRNAs (miRNAs) could effectively suppress PTEN expression by directly interacting with its 3' UTR in prostate epithelial and cancer cells. Under-expression of the four miRNAs by antisense neutralization up-regulates PTEN expression, while overexpression of the four miRNAs accelerates epithelial and prostate cancer cell proliferation. Furthermore, the expression of the four miRNAs could, singly or jointly, alter the expression of the key components in the phosphoinositide 3-kinase (PI3K)/Akt pathway, including PIK3CA, PIK3CD, PIK3R1 and Akt, along with their downstream signal, cyclin D1. Conclusions: These results suggested that the four miRNAs could promote prostate cancer cell proliferation by co-regulating the expression of PTEN, PI3K/Akt pathway and cyclin D1 in vitro. These findings increase understanding of the molecular mechanisms of prostate carcinogenesis and progression, even provide valuable insights into the diagnosis, prognosis, and rational design of novel therapeutics for prostate cancer.	[Tian, Ling; Fang, Yu-xiang; Xue, Jing-lun; Chen, Jin-zhong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Tian, Ling; Fang, Yu-xiang; Xue, Jing-lun; Chen, Jin-zhong] Fudan Univ, Sch Life Sci, Inst Genet, Shanghai 200433, Peoples R China; [Tian, Ling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Expt Res Ctr, Shanghai 200030, Peoples R China; [Tian, Ling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Ctr Canc, Shanghai 200030, Peoples R China; [Fang, Yu-xiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Stem Cell Res Ctr, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tian, L (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	TL09168@hotmail.com; kingbellchen@fudan.edu.cn			National Natural Science Foundation of China [81172030]; National High Technology Research and Development Program of China (863 Program) [2012AA020810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by grants from National Natural Science Foundation of China (Grant No. 81172030) and National High Technology Research and Development Program of China (863 Program) (Grant No. 2012AA020810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHON P, 1995, INT J ONCOL, V6, P333; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Chen Zhao-li, 2011, J Biol Chem, V286, P10725, DOI 10.1074/jbc.M110.165654; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; DEGEORGES A, 1995, INT J CANCER, V62, P724, DOI 10.1002/ijc.2910620613; Drobnjak M, 2000, CLIN CANCER RES, V6, P1891; Dunn Mary Weinstein, 2011, Semin Oncol Nurs, V27, P241, DOI 10.1016/j.soncn.2011.07.002; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fang YX, 2010, MOL BIOTECHNOL, V45, P71, DOI 10.1007/s12033-010-9244-y; Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146pe39; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hughes C, 2005, J CLIN PATHOL, V58, P673, DOI 10.1136/jcp.2002.003954; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang XN, 2010, J BIOL CHEM, V285, P14980, DOI 10.1074/jbc.M109.085696; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kurokawa K, 2012, J GASTROENTEROL, V47, P883, DOI 10.1007/s00535-012-0547-6; Lee CYF, 2010, MOL THER, V18, P929, DOI 10.1038/mt.2010.26; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P1, DOI [10.1093/jnci/djs001, DOI 10.1093/JNCI/DJS001.PUBMED:22395642]; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Shand RL, 2006, CURR OPIN UROL, V16, P123, DOI 10.1097/01.mou.0000193384.39351.64; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Tan GY, 2012, BIOCHEM BIOPH RES CO, V417, P546, DOI 10.1016/j.bbrc.2011.11.160; Tsuchida A, 2011, CANCER SCI, V102, P2264, DOI 10.1111/j.1349-7006.2011.02081.x; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; Wilmott JS, 2011, PATHOLOGY, V43, P657, DOI 10.1097/PAT.0b013e32834a7358; Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang CZ, 2011, INT J RADIAT ONCOL, V80, P240, DOI 10.1016/j.ijrobp.2010.12.049; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	61	88	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75885	10.1371/journal.pone.0075885	http://dx.doi.org/10.1371/journal.pone.0075885			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098737	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500108
J	Williamson, TE; Brusatte, SL				Williamson, Thomas E.; Brusatte, Stephen L.			New Specimens of the Rare Taeniodont Wortmania (Mammalia: Eutheria) from the San Juan Basin of New Mexico and Comments on the Phylogeny and Functional Morphology of "Archaic" Mammals	PLOS ONE			English	Article							POSTCRANIAL SKELETON; PALEOCENE	Background: Taeniodonta is a clade of Late Cretaceous - Paleogene mammals remarkable for their relatively extreme cranial, dental, and postcranial adaptations and notable for being among the first mammals to achieve relatively large size following the Cretaceous-Paleogene mass extinction. Previous workers have hypothesized that taeniodonts can be divided into two clades: Conoryctidae, a group of small-bodied taeniodonts with supposedly "generalized" postcranial skeletons, and Stylinodontidae, a group of large-bodied, robust animals with massive forelimbs and claws adapted for scratch-digging. However, many taeniodont taxa are poorly known and few are represented by postcranial material, leaving many details about their anatomy, biology, and evolution ambiguous. Methodology/Principal Findings: In this paper, we describe three new specimens of the rare taxon Wortmania otariidens from the early Paleocene (Puercan) of New Mexico. Among these specimens is one that includes remarkably complete cranial and dental material, including associated upper and lower teeth, and another that consists of partial forelimbs. These specimens allow for an updated anatomical description of this unusual taxon, supply new data for phylogenetic analyses, and enable a more constrained discussion of taeniodont biology and functional morphology. Conclusions/Significance: The new specimen of Wortmania that includes associated upper and lower teeth indicates that previous interpretations of the upper dentition of this taxon were not accurate and the taxon Robertschochia sullivani is a junior synonym of W. otariidens. New specimens that include partial forelimbs indicate that Wortmania is very similar to later, large-bodied taeniodonts, with marked and distinctive adaptations for scratch-digging. Comparisons with other taeniodont taxa that include postcranial material suggest that all taeniodonts may have had scratch-digging adaptations. A phylogenetic analysis shows that Schowalteria and Onychodectes are basal taeniodonts, Stylinodontidae (including Wortmania) is monophyletic, and a monophyletic Conoryctidae (but not including Onychodectes) is only recovered when certain characters are ordered.	[Williamson, Thomas E.] New Mexico Museum Nat Hist & Sci, Dept Res & Collect, Albuquerque, NM USA; [Brusatte, Stephen L.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Brusatte, Stephen L.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Brusatte, Stephen L.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY USA	University of Edinburgh; American Museum of Natural History (AMNH); Columbia University	Williamson, TE (corresponding author), New Mexico Museum Nat Hist & Sci, Dept Res & Collect, Albuquerque, NM USA.	thomas.williamson@state.nm.us	Williamson, Thomas/AAW-9320-2020; Brusatte, Stephen/O-9663-2014	Brusatte, Stephen/0000-0001-7525-7319; Williamson, Thomas/0000-0002-2856-9632	The Bureau of Land Management, National Landscapes Conservation System [L10AC20135-0005]; National Science Foundation [EAR 0207750]; Directorate For Geosciences [1325612, 1325544] Funding Source: National Science Foundation	The Bureau of Land Management, National Landscapes Conservation System; National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Bureau of Land Management, National Landscapes Conservation System (L10AC20135-0005) and the National Science Foundation (EAR 0207750 to TEW) for support of fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, ANAL VERTEBRATE STRU; Argot C, 2012, J MAMM EVOL, P1; Bergqvist LP, 2010, J PALEONTOL, V84, P858, DOI 10.1666/09-084.1; COOMBS MC, 1983, T AM PHILOS SOC, V73, P1, DOI 10.2307/3137420; Cope E. D., 1888, Transactions of the American Philosophical Society, Vxvi, P298; Cope E. D., 1885, American Naturalist, Vxix, P493; Cope E.D., 1876, P NATL ACAD SCI PHIL, V28, P39; Eberle JJ, 1999, J PALEONTOL, V73, P936, DOI 10.1017/S0022336000040762; Fox RC, 2003, NEUES JAHRB GEOL P-A, V229, P393, DOI 10.1127/njgpa/229/2003/393; Gasin C. L., 1936, Proceedings of the American Philosophical Society, V76, P597; Gill T., 1872, SMITHSONIAN MISCELL, V11, P1, DOI DOI 10.5962/BHL.TITLE.14607; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hay O P, 1899, Science, V9, P593, DOI 10.1126/science.9.225.593; Hildebrand M., 1985, P89; Horovitz I, 2003, J VERTEBR PALEONTOL, V23, P857, DOI 10.1671/2399-10; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Lofgren Donald L., 2004, P43; LUCAS SG, 1993, J MAMMAL, V74, P175, DOI 10.2307/1381918; Lucas SG, 2011, J PALEONTOL, V85, P1216; Lucas Spencer G., 1998, P260; MACPHEE RDE, 1994, B AM MUS NAT HIST, P1; MARSH O. C, 1875, AM J SCI, V3, 9, P221; Matthew WD, 1937, T AM PHILOS SOC, V30, P510; Miller M.E., 1964, ANATOMY DOG; OLEARY MA, 1995, J VERTEBR PALEONTOL, V15, P401, DOI 10.1080/02724634.1995.10011238; Patterson B., 1949, Genetics Paleontology and Evolution, P243; Rook DL, 2011, J VERTEBR PALEONTOL, V31, P422, DOI 10.1080/02724634.2011.550364; Rose KD, 1999, J VERTEBR PALEONTOL, V19, P355, DOI 10.1080/02724634.1999.10011147; Rose KD, 2000, J VERTEBR PALEONTOL, V20, P139, DOI 10.1671/0272-4634(2000)020[0139:AEPPMP]2.0.CO;2; ROSE KD, 2006, BEGINNING AGE MAMMAL; Schoch RM, 1986, B PEABODY MUS NAT HI, V42, P1; Simpson G.G., 1981, P3; Simpson GG, 1959, AM MUSEUM NOTIVATES; Sinclair WJ, 1914, B AM MUS NAT HIST, V33, P297; THEWISSEN JGM, 1986, ANAT ANZEIGER, V162, P109; Tidwell LS, 1981, ADV SAN JUAN BASIN P; Turnbull William D., 2004, Bulletin of Carnegie Museum of Natural History, V36, P302; Von Koenigswald W, 2010, J VERTEBR PALEONTOL, V30, P1797, DOI 10.1080/02724634.2010.521931; West R. M., 1971, AM MUS NOVIT, V2461, P1; Williamson T. E., 1992, B NEW MEXICO MUSEUM, V1, P1; Williamson T. E., 1993, NEW MEXICO MUSEUM NA, P105; Williamson TE, 1996, B NEW MEXICO MUSEUM, V8, P1; Wortman J. L., 1897, Bulletin of the American Museum, Vix, P59	43	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75886	10.1371/journal.pone.0075886	http://dx.doi.org/10.1371/journal.pone.0075886			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098738	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500109
J	Giraud, I; Valette, V; Bech, N; Grandjean, F; Cordaux, R				Giraud, Isabelle; Valette, Victorien; Bech, Nicolas; Grandjean, Frederic; Cordaux, Richard			Isolation and Characterization of Microsatellite Loci for the Isopod Crustacean Armadillidium vulgare and Transferability in Terrestrial Isopods	PLOS ONE			English	Article							SEX-RATIO DISTORTERS; MITOCHONDRIAL-DNA POLYMORPHISM; FEMINIZING WOLBACHIA; LATR CRUSTACEA; POPULATION; INFECTION; EVOLUTION; TRANSMISSION; MECHANISMS; ONISCIDEA	Armadillidium vulgare is a terrestrial isopod (Crustacea, Oniscidea) which harbors Wolbachia bacterial endosymbionts. A. vulgare is the major model for the study of Wolbachia-mediated feminization of genetic males in crustaceans. As a consequence of their impact on host sex determination mechanisms, Wolbachia endosymbionts are thought to significantly influence A. vulgare evolution on various grounds, including population genetic structure, diversity and reproduction strategies. To provide molecular tools for examining these questions, we isolated microsatellite loci through 454 pyrosequencing of a repeat-enriched A. vulgare genomic library. We selected 14 markers and developed three polymorphic microsatellite multiplex kits. We tested the kits on two A. vulgare natural populations and found high genetic variation, thereby making it possible to investigate the impact of Wolbachia endosymbionts on A. vulgare nuclear variation at unprecedented resolution. In addition, we tested the transferability of these kits by cross-species amplification in five other terrestrial isopod species harboring Wolbachia endosymbionts. The microsatellite loci showed good transferability in particular in Armadillidium nasatum and Chaetophiloscia elongata, for which these markers represent promising tools for future genetic studies.	[Giraud, Isabelle; Valette, Victorien; Bech, Nicolas; Grandjean, Frederic; Cordaux, Richard] Univ Poitiers, UMR CNRS Ecol & Biol Interact 7267, Equipe Ecol Evolut Symbiose, Poitiers, France	Universite de Poitiers	Cordaux, R (corresponding author), Univ Poitiers, UMR CNRS Ecol & Biol Interact 7267, Equipe Ecol Evolut Symbiose, Poitiers, France.	richard.cordaux@univ-poitiers.fr	Bech, Nicolas/F-7253-2010; grandjean, frederic/H-2017-2012	grandjean, frederic/0000-0002-8494-0985; BECH, Nicolas/0000-0003-3625-3686	European Research Council [260729 EndoSexDet]	European Research Council(European Research Council (ERC)European Commission)	This work was funded by a European Research Council Starting Grant (FP7/2007-2013, grant 260729 EndoSexDet) to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchon D, 2008, INSECT SYMBIOSIS, V3, P273, DOI DOI 10.1201/9781420064117.CH12; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; Cordaux R, 2001, J EVOLUTION BIOL, V14, P237, DOI 10.1046/j.1420-9101.2001.00279.x; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GRANDJEAN F, 1993, GENETICA, V92, P55, DOI 10.1007/BF00057507; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LEGRAND JJ, 1984, GENET SEL EVOL, V16, P57, DOI 10.1186/1297-9686-16-1-57; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Michel-Salzat A, 2001, HEREDITY, V87, P428, DOI 10.1046/j.1365-2540.2001.00920.x; NEI M, 1978, GENETICS, V89, P583; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rigaud T, 1997, INFLUENTIAL PASSENGERS, P81; RIGAUD T, 1992, HEREDITY, V68, P47, DOI 10.1038/hdy.1992.6; Rigaud T, 1997, BIOESSAYS, V19, P409, DOI 10.1002/bies.950190508; RIGAUD T, 1993, GENETICS, V133, P247; Rigaud T, 1999, GENETICS, V152, P1669; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Verne S, 2006, MOL ECOL NOTES, V6, P328, DOI 10.1111/j.1471-8286.2006.01220.x; Verne S, 2012, J EVOLUTION BIOL, V25, P264, DOI 10.1111/j.1420-9101.2011.02413.x; Verne S, 2007, GENE, V397, P58, DOI 10.1016/j.gene.2007.04.006; Verne S, 2007, J CRUSTACEAN BIOL, V27, P217, DOI 10.1651/S-2752.1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969	27	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76639	10.1371/journal.pone.0076639	http://dx.doi.org/10.1371/journal.pone.0076639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098543	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600068
J	Moehring, RW; Sloane, R; Chen, LF; Smathers, EC; Schmader, KE; Fowler, VG; Weber, DJ; Sexton, DJ; Anderson, DJ				Moehring, Rebekah W.; Sloane, Richard; Chen, Luke F.; Smathers, Emily C.; Schmader, Kenneth E.; Fowler, Vance G., Jr.; Weber, David J.; Sexton, Daniel J.; Anderson, Deverick J.			Delays in Appropriate Antibiotic Therapy for Gram-Negative Bloodstream Infections: A Multicenter, Community Hospital Study	PLOS ONE			English	Article							INADEQUATE ANTIMICROBIAL TREATMENT; RISK-FACTORS; IMPACT; MORTALITY; SURVIVAL; BACTEREMIA; INITIATION; OUTCOMES; TRIAL	Background: Gram-negative bacterial bloodstream infection (BSI) is a serious condition with estimated 30% mortality. Clinical outcomes for patients with severe infections improve when antibiotics are appropriately chosen and given early. The objective of this study was to estimate the association of prior healthcare exposure on time to appropriate antibiotic therapy in patients with gram-negative BSI. Method: We performed a multicenter cohort study of adult, hospitalized patients with gram-negative BSI using time to event analysis in nine community hospitals from 2003-2006. Event time was defined as the first administration of an antibiotic with in vitro activity against the infecting organism. Healthcare exposure status was categorized as community-acquired, healthcare-associated, or hospital-acquired. Time to appropriate therapy among groups of patients with differing healthcare exposure status was assessed using Kaplan-Meier analyses and multivariate Cox proportional hazards models. Results: The cohort included 578 patients with gram-negative BSI, including 320 (55%) healthcare-associated, 217 (38%) community-acquired, and 41 (7%) hospital-acquired infections. 529 (92%) patients received an appropriate antibiotic during their hospitalization. Time to appropriate therapy was significantly different among the groups of healthcare exposure status (log-rank p=0.02). Time to first antibiotic administration regardless of drug appropriateness was not different between groups (p=0.3). The unadjusted hazard ratios (HR) (95% confidence interval) were 0.80 (0.65-0.98) for healthcare-associated and 0.72 (0.63-0.82) for hospital-acquired, relative to patients with community-acquired BSI. In multivariable analysis, interaction was found between the main effect and baseline Charlson comorbidity index. When Charlson index was 3, adjusted HRs were 0.66 (0.48-0.92) for healthcare-associated and 0.57 (0.44-0.75) for hospital-acquired, relative to patients with community-acquired infections. Conclusions: Patients with healthcare-associated or hospital-acquired BSI experienced delays in receipt of appropriate antibiotics for gram-negative BSI compared to patients with community-acquired BSI. This difference was not due to delayed initiation of antibiotic therapy, but due to the inappropriate choice of antibiotic.	[Moehring, Rebekah W.; Chen, Luke F.; Smathers, Emily C.; Fowler, Vance G., Jr.; Sexton, Daniel J.; Anderson, Deverick J.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; [Sloane, Richard; Schmader, Kenneth E.] Duke Univ, Med Ctr, Div Geriatr, Durham, NC USA; [Schmader, Kenneth E.] Durham Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC USA; [Moehring, Rebekah W.] Durham Vet Affairs Med Ctr, Dept Med, Div Infect Dis, Durham, NC USA; [Weber, David J.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	Duke University; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Moehring, RW (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA.	rebekah.moehring@duke.edu		Sexton, Daniel J/0000-0001-9604-5948; Anderson, Deverick/0000-0001-6882-5496	Robert Wood Johnson Foundation [66327]; NIH [K23 AI095357, K24 AI093969, R01 AI068804]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068804, K23AI095357, K24AI093969] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a grant from the Robert Wood Johnson Foundation (66327) to DJA. DJA was supported by NIH K23 AI095357. VGF was supported by NIH K24 AI093969 and R01 AI068804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bouza E, 2004, CLIN INFECT DIS, V39, P1161, DOI 10.1086/424520; Byl B, 1999, CLIN INFECT DIS, V29, P60, DOI 10.1086/520182; Centers for Disease Control and Prevention, NAT HEALTHC SAF NETW; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dickinson John D, 2011, Curr Infect Dis Rep, V13, P399, DOI 10.1007/s11908-011-0206-8; Dupla ML, 2005, J INTERN MED, V258, P172, DOI 10.1111/j.1365-2796.2005.01513.x; Fishman N, 2012, INFECT CONT HOSP EP, V33, P322, DOI 10.1086/665010; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; *HLTH US, 2011, HLTH US; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LEE EW, 1992, NATO ADV SCI I E-APP, V211, P237; LEIBOVICI L, 1992, J INTERN MED, V231, P371, DOI 10.1111/j.1365-2796.1992.tb00946.x; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3510, DOI 10.1128/AAC.00338-07; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marschall J, 2008, J ANTIMICROB CHEMOTH, V61, P1376, DOI 10.1093/jac/dkn104; Marschall J, 2009, INFECT CONT HOSP EP, V30, P1050, DOI 10.1086/606165; McDonald JR, 2005, ARCH INTERN MED, V165, P308, DOI 10.1001/archinte.165.3.308; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Pittet D, 1997, CLIN INFECT DIS, V24, P1068, DOI 10.1086/513640; Retamar P, 2012, ANTIMICROB AGENTS CH, V56, P472, DOI 10.1128/AAC.00462-11; Scarsi KK, 2006, ANTIMICROB AGENTS CH, V50, P3355, DOI 10.1128/AAC.00466-06; Schweizer ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011432; Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7	33	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76225	10.1371/journal.pone.0076225	http://dx.doi.org/10.1371/journal.pone.0076225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098449	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600030
J	Scolaro, L; Parrino, C; Coroniti, R; Otvos, L; Surmacz, E				Scolaro, Laura; Parrino, Cristina; Coroniti, Roberta; Otvos, Laszlo, Jr.; Surmacz, Eva			Exploring Leptin Antagonism in Ophthalmic Cell Models	PLOS ONE			English	Article							CHOROIDAL ENDOTHELIAL-CELLS; BREAST-CANCER; DIABETIC-RETINOPATHY; VITREOUS LEPTIN; EXPRESSION; RECEPTOR; GROWTH; VEGF; NEOVASCULARIZATION; PROLIFERATION	Background: Emerging evidence suggests that angiogenic and pro-inflammatory cytokine leptin might be implicated in ocular neovascularization. However, the potential of inhibiting leptin function in ophthalmic cells has never been explored. Here we assessed mitogenic, angiogenic, and signaling leptin activities in retinal and corneal endothelial cells and examined the capability of a specific leptin receptor (ObR) antagonist, Allo-aca, to inhibit these functions. Methods and Results: The experiments were carried out in monkey retinal (RF/6A) and bovine corneal (BCE) endothelial cells. Leptin at 50-250 ng/mL stimulated the growth of both cell lines in a dose-dependent manner. The maximal mitogenic response (35+/-7 and 27+/-3% in RF6A and BCE cells, respectively) was noted at 24 h of 250 ng/mL leptin treatments. Leptin-dependent proliferation was reduced to base levels with 10 and 100 nM Allo-aca in BCE and RF6A cells, respectively. In both cell lines, leptin promoted angiogenic responses, with the maximal increase in tube formation (163+/-10 and 133+/-8% in RF6A and BCE cultures, respectively) observed under a 250 ng/mL leptin treatment for 3 h. Furthermore, in both cell lines 250 ng/mL leptin modulated the activity or expression of several signaling molecules involved in proliferation, inflammatory activity and angiogenesis, such as STAT3, Akt, and ERK1/2, COX2, and NF kappa B. In both cell lines, leptin-induced angiogenic and signaling responses were significantly inhibited with 100 nM Allo-aca. We also found that leptin increased its own mRNA and protein expression in both cell lines, and this autocrine effect was abolished by 100-250 nM Allo-aca. Conclusions: Our data provide new insights into the role of leptin in ocular endothelial cells and represent the first original report on targeting ObR in ophthalmic cell models.	[Scolaro, Laura; Parrino, Cristina; Coroniti, Roberta; Surmacz, Eva] Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Otvos, Laszlo, Jr.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Surmacz, E (corresponding author), Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA.	surmacz@temple.edu	Parrino, Cristina/ABA-7496-2020; Parrino, Cristina/H-4009-2018	Parrino, Cristina/0000-0002-1367-6208; Parrino, Cristina/0000-0002-1367-6208	Novo Nordisk Diabetes Innovation Award	Novo Nordisk Diabetes Innovation Award	The work was supported by the Novo Nordisk Diabetes Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Truong A, 2011, J MOL MED, V89, P343, DOI 10.1007/s00109-010-0709-z; Anagnostoulis S, 2008, CYTOKINE, V42, P353, DOI 10.1016/j.cyto.2008.03.009; Artwohl M, 2002, INT J OBESITY, V26, P577, DOI 10.1038/sj.ijo.0801947; Balaiya S, 2012, MOL VIS, V18, P114; Basak S, 2012, EUR J OBSTET GYN R B, V164, P24, DOI 10.1016/j.ejogrb.2012.05.033; Beccari S, 2013, PEPTIDES; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Cascio S, 2008, ONCOGENE, V27, P540, DOI 10.1038/sj.onc.1210660; Chang JH, 2012, SURV OPHTHALMOL, V57, P415, DOI 10.1016/j.survophthal.2012.01.007; Dong X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018481; Ferla R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-303; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gariano RF, 2000, INVEST OPHTH VIS SCI, V41, P3576; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Garofalo C, 2004, CLIN CANCER RES, V10, P6466, DOI 10.1158/1078-0432.CCR-04-0203; Garonna E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018823; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Hernandez C, 2004, RETINA-J RET VIT DIS, V24, P30, DOI 10.1097/00006982-200402000-00005; Huang LZ, 2009, MOL VIS, V15, P1057; Kovalszky I, 2010, DIABETES OBES METAB, V12, P393, DOI 10.1111/j.1463-1326.2009.01170.x; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Lukiw WJ, 2003, INVEST OPHTH VIS SCI, V44, P4163, DOI 10.1167/iovs.02-0655; Maberley D, 2006, EYE, V20, P801, DOI 10.1038/sj.eye.6702011; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Misra GP, 2010, EDINBURGH RETINAL PH, V2010, P133; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oda Akihiko, 2001, Kobe Journal of Medical Sciences, V47, P141; Ottino P, 2004, MOL VIS, V10, P341; Otvos L, 2011, EXPERT REV ANTICANC, V11, P1147, DOI [10.1586/era.11.109, 10.1586/ERA.11.109]; Otvos L, 2011, PEPTIDES, V32, P1567, DOI 10.1016/j.peptides.2011.06.015; Otvos L, 2011, EUR J CANCER, V47, P1578, DOI 10.1016/j.ejca.2011.01.018; Otvos L, 2011, BIOPOLYMERS, V96, P117, DOI 10.1002/bip.21377; Otvos L, 2009, ADV EXP MED BIOL, V611, P497, DOI 10.1007/978-0-387-73657-0_215; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Praidou A, 2010, CURR DIABETES REV, V6, P304, DOI 10.2174/157339910793360815; Qazi Y, 2009, J GENET, V88, P495, DOI 10.1007/s12041-009-0068-0; Ricker LJAG, 2012, EXP EYE RES, V94, P56, DOI 10.1016/j.exer.2011.11.006; Rouet-Benzineb R, 2004, J BIOL CHEM, V279, P16495, DOI 10.1074/jbc.M312999200; Rusovici R, 2013, CLIN OPHTHALMOL, V7, P321, DOI 10.2147/OPTH.S41556; Rusovici R, 2011, MOL VIS, V17, P3339; Scolaro L, 2010, EXPERT REV ENDOCRINO, V5, P875, DOI [10.1586/eem.10.61, 10.1586/EEM.10.61]; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Stewart MW, 2012, MAYO CLIN PROC, V87, P77, DOI 10.1016/j.mayocp.2011.10.001; Suganami E, 2004, DIABETES, V53, P2443, DOI 10.2337/diabetes.53.9.2443; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Sweeney G, 2010, NAT REV CARDIOL, V7, P22, DOI 10.1038/nrcardio.2009.224; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Wauters M, 2000, EUR J ENDOCRINOL, V143, P293, DOI 10.1530/eje.0.1430293; Willard AL, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/209538; Xu Y, 2010, MOL VIS, V16, P1982; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773; Zabeau L, 2003, FEBS LETT, V546, P45, DOI 10.1016/S0014-5793(03)00440-X; Zhang FM, 2005, VITAM HORM, V71, P345, DOI 10.1016/S0083-6729(05)71012-8	57	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76437	10.1371/journal.pone.0076437	http://dx.doi.org/10.1371/journal.pone.0076437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098500	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600051
J	Alfred, RL; Palombo, EA; Panozzo, JF; Bhave, M				Alfred, Rebecca L.; Palombo, Enzo A.; Panozzo, Joseph F.; Bhave, Mrinal			The Antimicrobial Domains of Wheat Puroindolines Are Cell-Penetrating Peptides with Possible Intracellular Mechanisms of Action	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; FORM ION CHANNELS; GRAIN HARDNESS; SACCHAROMYCES-CEREVISIAE; MOLECULAR-GENETICS; TRYPTOPHAN-RICH; MEMBRANES; INDOLICIDIN; EXPRESSION; RESISTANCE	The puroindoline proteins (PINA and PINB) of wheat display lipid-binding properties which affect the grain texture, a critical parameter for wheat quality. Interestingly, the same proteins also display antibacterial and antifungal properties, attributed mainly to their Tryptophan-rich domain (TRD). Synthetic peptides based on this domain also display selectivity towards bacterial and fungal cells and do not cause haemolysis of mammalian cells. However, the mechanisms of these activities are unclear, thus limiting our understanding of the in vivo roles of PINs and development of novel applications. This study investigated the mechanisms of antimicrobial activities of synthetic peptides based on the TRD of the PINA and PINB proteins. Calcein dye leakage tests and transmission electron microscopy showed that the peptides PuroA, Pina-M and Pina-W -> F selectively permeabilised the large unilamellar vesicles (LUVs) made with negatively charged phospholipids mimicking bacterial membranes, but were ineffective against LUVs made with zwitterionic phospholipids mimicking eukaryotic membranes. Propidium iodide fluorescence tests of yeast (Saccharomyces cerevisiae) cells showed the peptides were able to cause loss of membrane integrity, PuroA and Pina-M being more efficient. Scanning electron micrographs of PINA-based peptide treated yeast cells showed the formation of pits or pores in cell membranes and release of cellular contents. Gel retardation assays indicated the peptides were able to bind to DNA in vitro, and the induction of filamental growth of E. coli cells indicated in vivo inhibition of DNA synthesis. Together, the results strongly suggest that the PIN-based peptides exert their antimicrobial effects by pore formation in the cell membrane, likely by a carpet-like mechanism, followed by intracellular mechanisms of activity.	[Alfred, Rebecca L.; Palombo, Enzo A.; Bhave, Mrinal] Swinburne Univ Technol, Fac Life & Social Sci, Environm & Biotechnol Ctr, Melbourne, Vic, Australia; [Panozzo, Joseph F.] Dept Environm & Primary Ind, Horsham, Vic, Australia	Swinburne University of Technology	Bhave, M (corresponding author), Swinburne Univ Technol, Fac Life & Social Sci, Environm & Biotechnol Ctr, Melbourne, Vic, Australia.	mbhave@swin.edu.au	Palombo, Enzo/AAV-8632-2021	Palombo, Enzo/0000-0001-5889-1393; /0000-0003-3011-9953	Australian Research Council (ARC) Linkage Grant [LP0989191]	Australian Research Council (ARC) Linkage Grant(Australian Research Council)	This research was supported by the Australian Research Council (ARC) Linkage Grant LP0989191. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfred RL, 2013, WORLD J MICROB BIOT, P1; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bhave M, 2008, PLANT MOL BIOL, V66, P221, DOI 10.1007/s11103-007-9264-6; Bhave M, 2008, PLANT MOL BIOL, V66, P205, DOI 10.1007/s11103-007-9263-7; Capparelli R, 2005, PLANT MOL BIOL, V58, P857, DOI 10.1007/s11103-005-8270-9; Capparelli R, 2007, J BIOTECHNOL, V128, P606, DOI 10.1016/j.jbiotec.2006.11.004; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Charnet P, 2003, BIOPHYS J, V84, P2416, DOI 10.1016/S0006-3495(03)75046-2; Chen F, 2006, THEOR APPL GENET, V112, P400, DOI 10.1007/s00122-005-0095-z; Chen F, 2005, J CEREAL SCI, V42, P267, DOI 10.1016/j.jcs.2005.03.004; Chen P, 2008, TALANTA, V77, P262, DOI 10.1016/j.talanta.2008.06.018; Chou HT, 2010, PEPTIDES, V31, P1811, DOI 10.1016/j.peptides.2010.06.021; Davey HM, 2011, ENVIRON MICROBIOL, V13, P163, DOI 10.1111/j.1462-2920.2010.02317.x; Donachie W. D., 1987, ESCHERICHIA COLI SAL, P1578; Dubreil L, 1998, PLANT SCI, V138, P121, DOI 10.1016/S0168-9452(98)00121-6; Espinel-Ingroff A, 2007, ANTIMICROBIAL SUSCEP, P173; Evrard A, 2008, J CEREAL SCI, V48, P379, DOI 10.1016/j.jcs.2007.11.001; Faize M, 2004, PLANT SCI, V167, P347, DOI 10.1016/j.plantsci.2004.04.003; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fang B, 2013, FEBS J, V280, P1007, DOI 10.1111/febs.12093; GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Gonzalez CF, 2002, PHYTOPATHOLOGY, V92, P917, DOI 10.1094/PHYTO.2002.92.8.917; Gunderson CW, 2006, MOL MICROBIOL, V59, P1129, DOI 10.1111/j.1365-2958.2005.05009.x; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x; Jing WG, 2003, J BACTERIOL, V185, P4938, DOI 10.1128/JB.185.16.4938-4947.2003; Kim KH, 2012, J PHYTOPATHOL, V160, P243, DOI 10.1111/j.1439-0434.2012.01881.x; Kooijman M, 1998, J CEREAL SCI, V28, P43, DOI 10.1006/jcrs.1998.0193; Krishnamurthy K, 2001, MOL PLANT MICROBE IN, V14, P1255, DOI 10.1094/MPMI.2001.14.10.1255; Le Guerneve C, 1998, ARCH BIOCHEM BIOPHYS, V360, P179, DOI 10.1006/abbi.1998.0931; Lillemo M, 2000, THEOR APPL GENET, V100, P1100, DOI 10.1007/s001220051392; Llanos P, 2006, FEBS J, V273, P1710, DOI 10.1111/j.1742-4658.2006.05185.x; Lundblad V, 2008, CURRENT PROTOCOLS MO; Luo L, 2008, MOL BIOL REP, V35, P195, DOI 10.1007/s11033-007-9070-x; LUTKENHAUS J, 1990, TRENDS GENET, V6, P22, DOI 10.1016/0168-9525(90)90045-8; Marion D, 1994, WHEAT KERNEL PROTEIN, P175; Miao Y, 2012, AMINO ACIDS, P1; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Nan YH, 2009, FEMS MICROBIOL LETT, V292, P134, DOI 10.1111/j.1574-6968.2008.01484.x; Pan Z, 2004, CEREAL CHEM, V81, P287, DOI 10.1094/CCHEM.2004.81.2.287; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Pauly A, 2013, COMPR REV FOOD SCI F, V12, P413, DOI 10.1111/1541-4337.12019; Pauly A, 2013, COMPR REV FOOD SCI F, V12, P427, DOI 10.1111/1541-4337.12018; Phillips RL, 2011, J CEREAL SCI, V53, P112, DOI 10.1016/j.jcs.2010.10.005; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Schibli DJ, 2006, BIOPHYS J, V91, P4413, DOI 10.1529/biophysj.106.085837; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Yu LL, 2012, CHEM J CHINESE U, V33, P2681, DOI 10.7503/cjcu20120476	56	38	39	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75488	10.1371/journal.pone.0075488	http://dx.doi.org/10.1371/journal.pone.0075488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098387	Green Published, gold			2022-12-27	WOS:000325434500034
J	Cao, WQ; Cao, J; Huang, JM; Yao, J; Yan, GQ; Xu, HQ; Yang, PY				Cao, Weiqian; Cao, Jing; Huang, Jiangming; Yao, Jun; Yan, Guoquan; Xu, Haoqi; Yang, Pengyuan			Discovery and Confirmation of O-GlcNAcylated Proteins in Rat Liver Mitochondria by Combination of Mass Spectrometry and Immunological Methods	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC PROTEINS; POSTTRANSLATIONAL MODIFICATIONS; GLOBAL IDENTIFICATION; CYTOSKELETAL PROTEINS; PHOSPHORYLATION; GLYCOSYLATION; NUCLEAR; PROTEOME; ROLES	O-linked beta-N-acetylglucosamine (O-GlcNAc) is an important post-translational modification (PTM) consisting of a single N-acetylglucosamine moiety attached via an O-beta-glycosidic linkage to serine and threonine residues. Glycosylation with O-GlcNAc occurs on myriad nuclear and cytosolic proteins from almost all functional classes. However, with respect to O-GlcNAcylated proteins special in mitochondria, little attention has been paid. In this study, we combined mass spectrometry and immunological methods to perform global exploration of O-GlcNAcylated proteins specific in mitochondria of rat liver. First, highly purified mitochondrial proteins were obviously shown to be O-GlcNAcylated by immunoblot profiling. Then, beta-elimination followed by Michael Addition with Dithiothreitol (BEMAD) treatment and LC-MS/MS were performed to enrich and identify O-GlcNAcylated mitochondrial proteins, resulting in an unambiguous assignment of 14 O-GlcNAcylation sites, mapping to 11 O-GlcNAcylated proteins. Furthermore, the identified O-GlcNAcylated mitochondrial proteins were fully validated by both electron transfer dissociation tandem mass spectrometry (ETD/MS/MS) and western blot. Thus, for the first time, our study definitely not only identified but also validated that some mitochondrial proteins in rat liver are O-GlcNAcylated. Interestingly, all of these O-GlcNAcylated mitochondrial proteins are enzymes, the majority of which are involved in a wide variety of biological processes, such as urea cycle, tricarboxylic acid cycle and lipid metabolism, indicating a role for protein O-GlcNAcylation in mitochondrial function.	[Yang, Pengyuan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yang, PY (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China.	pyyang@fudan.edu.cn			National Key Scientific Program of China [2008ZX10208, 2008ZX10207]; National Science and Technology Key Project of China [2011CB910600]; National Natural Science Foundation of China [31100590, 20975024]; Shanghai Municipal Natural Science Foundation [11ZR1403000]	National Key Scientific Program of China; National Science and Technology Key Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation	This work was supported in part by National Key Scientific Program of China (2008ZX10208, 2008ZX10207), National Science and Technology Key Project of China (2011CB910600), National Natural Science Foundation of China (31100590 and 20975024), Shanghai Municipal Natural Science Foundation (11ZR1403000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Ande SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004586; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cao J, 2009, J PROTEOME RES, V8, P662, DOI 10.1021/pr800826u; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Colaert N, 2011, J PROTEOME RES, V10, P3840, DOI 10.1021/pr2005154; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Gu YY, 2011, ARCH BIOCHEM BIOPHYS, V505, P98, DOI 10.1016/j.abb.2010.09.024; Guinez C, 2005, INT J BIOCHEM CELL B, V37, P765, DOI 10.1016/j.biocel.2004.12.001; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2013, CELL METAB, V17, P155, DOI 10.1016/j.cmet.2013.01.008; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hart GW, 1996, GLYCOBIOLOGY, V6, P711, DOI 10.1093/glycob/6.7.711; Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Issad T, 2010, M S-MED SCI, V26, P753, DOI 10.1051/medsci/2010268-9753; Jiang XS, 2004, MOL CELL PROTEOMICS, V3, P441, DOI 10.1074/mcp.M300117-MCP200; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Medina L, 1998, GLYCOBIOLOGY, V8, P383, DOI 10.1093/glycob/8.4.383; Mishra S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-1; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; Park J, 2009, BBA-PROTEINS PROTEOM, V1794, P254, DOI 10.1016/j.bbapap.2008.10.003; Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Virginia LJ, 2012, PHYSIOL GENOMICS, V45, P17; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Vosseller K, 2005, PROTEOMICS, V5, P388, DOI 10.1002/pmic.200401066; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhao P, 2011, J PROTEOME RES, V10, P4088, DOI 10.1021/pr2002726; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299	57	34	45	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76399	10.1371/journal.pone.0076399	http://dx.doi.org/10.1371/journal.pone.0076399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098488	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500065
J	Claassens, MM; Van Schalkwyk, C; du Toit, E; Roest, E; Lombard, CJ; Enarson, DA; Beyers, N; Borgdorff, MW				Claassens, Mareli M.; Van Schalkwyk, Cari; du Toit, Elizabeth; Roest, Eline; Lombard, Carl J.; Enarson, Donald A.; Beyers, Nulda; Borgdorff, Martien W.			Tuberculosis in Healthcare Workers and Infection Control Measures at Primary Healthcare Facilities in South Africa	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; MULTIDRUG-RESISTANT; INCREASED RISK; PREVALENCE; DISEASE; IMPACT; CHINA; TB	Background: Challenges exist regarding TB infection control and TB in hospital-based healthcare workers in South Africa. However, few studies report on TB in non-hospital based healthcare workers such as primary or community healthcare workers. Our objectives were to investigate the implementation of TB infection control measures at primary healthcare facilities, the smear positive TB incidence rate amongst primary healthcare workers and the association between TB infection control measures and all types of TB in healthcare workers. Methods: One hundred and thirty three primary healthcare facilities were visited in five provinces of South Africa in 2009. At each facility, a TB infection control audit and facility questionnaire were completed. The number of healthcare workers who had had TB during the past three years was obtained. Results: The standardised incidence ratio of smear positive TB in primary healthcare workers indicated an incidence rate of more than double that of the general population. In a univariable logistic regression, the infection control audit score was significantly associated with reported cases of TB in healthcare workers (OR=1.04, 95% CI 1.01-1.08, p=0.02) as was the number of staff (OR=3.78, 95% CI 1.77-8.08). In the multivariable analysis, the number of staff remained significantly associated with TB in healthcare workers (OR=3.33, 95% CI 1.37-8.08). Conclusion: The high rate of TB in healthcare workers suggests a substantial nosocomial transmission risk, but the infection control audit tool which was used did not perform adequately as a measure of this risk. Infection control measures should be monitored by validated tools developed and tested locally. Different strategies, such as routine surveillance systems, could be used to evaluate the burden of TB in healthcare workers in order to calculate TB incidence, monitor trends and implement interventions to decrease occupational TB.	[Claassens, Mareli M.; du Toit, Elizabeth; Roest, Eline; Lombard, Carl J.; Enarson, Donald A.; Beyers, Nulda] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Parow, South Africa; [Van Schalkwyk, Cari] Univ Stellenbosch, South African Dept Sci & Technol, Natl Res Fdn Ctr Excellence Epidemiol Modelling &, ZA-7600 Stellenbosch, South Africa; [Lombard, Carl J.] MRC, Biostat Unit, Parow, South Africa; [Enarson, Donald A.] Int Union TB & Lung Dis, Paris, France; [Claassens, Mareli M.; Borgdorff, Martien W.] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; University of Amsterdam	Claassens, MM (corresponding author), Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Parow, South Africa.	mcla@sun.ac.za	Claassens, Mareli/Y-3544-2019	Claassens, Mareli/0000-0002-5927-284X; van Schalkwyk, Cari/0000-0001-5154-1390; Lombard, Carl/0000-0002-2136-6533	University Research Corporation (URC) under USAID [FY09-G03-4710, GHS-I-00-03-00032-00]	University Research Corporation (URC) under USAID(United States Agency for International Development (USAID))	This study was funded by University Research Corporation (URC) Grant FY09-G03-4710 under USAID Contract No. GHS-I-00-03-00032-00 (TASCII TB South Africa). The authors had full control over the data and did not have an agreement with the funders that may have limited the completion of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balt E, 1998, S AFR MED J, V88, P1363; Bamford CM, 2010, SAMJ S AFR MED J, V100, P438, DOI 10.7196/SAMJ.3501; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Buregyeya E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046069; BURRILL D, 1985, CAN MED ASSOC J, V132, P137; Chai SJ, 2013, HEALTH POLICY PLANN, V28, P100, DOI 10.1093/heapol/czs029; Churchyard G, 2008, S AFR J HIV MED  SUM, P23; Claassens MM, 2010, INT J TUBERC LUNG D, V14, P1576; Connelly D, 2007, SAMJ S AFR MED J, V97, P115; Dimitrova B, 2005, INT J TUBERC LUNG D, V9, P43; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Farley JE, 2012, INT J TUBERC LUNG D, V16, P82, DOI 10.5588/ijtld.10.0791; FRENCH GL, 1993, J HOSP INFECT, V24, P301, DOI 10.1016/0195-6701(93)90062-5; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kehinde AO, 2011, INDIAN J MED RES, V133, P613; Kranzer K, 2010, SAMJ S AFR MED J, V100, P224, DOI 10.7196/SAMJ.3903; Mathew A, 2013, J CLIN EPIDEMIOL, V66, P67, DOI 10.1016/j.jclinepi.2011.12.010; McCarthy K, 2009, IMPLEMENTING TB INFE, P23; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Mhlongo-Sigwebela N, 2009, TASC 2 TUBERCULOSIS, P1; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; Naidoo S, 2012, INT J TUBERC LUNG D, V16, P1600, DOI 10.5588/ijtld.12.0041; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Padayatchi N, 2010, INT J TUBERC LUNG D, V14, P960; Partnership Stop TB, 2011, ACC IMPL 3 IS HIV TB, P1; Reid MJA, 2012, INT J TUBERC LUNG D, V16, P1605, DOI 10.5588/ijtld.12.0033; Scano F., 2009, WHO POLICY TB INFECT; Shisana O, 2004, SAMJ S AFR MED J, V94, P846; Sissolak D, 2010, INT J INFECT DIS, V14, pE423, DOI 10.1016/j.ijid.2009.06.030; SMITH T, 1990, BRIT MED J, V300, P65, DOI 10.1136/bmj.300.6717.65; South African National Department of Health, 2007, NAT INF PREV CONTR P, P1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Wilkinson D, 1998, T ROY SOC TROP MED H, V92, P500, DOI 10.1016/S0035-9203(98)90889-6; World Health Organization, 2012, GUID MEAS PREV ACT T	36	55	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76272	10.1371/journal.pone.0076272	http://dx.doi.org/10.1371/journal.pone.0076272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098461	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500058
J	Woo, CC; Hsu, A; Kumar, AP; Sethi, G; Tan, KHB				Woo, Chern Chiuh; Hsu, Annie; Kumar, Alan Prem; Sethi, Gautam; Tan, Kwong Huat Benny			Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROS	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTIONAL REPRESSOR; CELL-DEATH; IN-VITRO; PATHWAY; CISPLATIN; PROLIFERATION; SUPPRESSION; MECHANISM; PRODUCTS	Due to narrow therapeutic window of cancer therapeutic agents and the development of resistance against these agents, there is a need to discover novel agents to treat breast cancer. The antitumor activities of thymoquinone (TQ), a compound isolated from Nigella sativa oil, were investigated in breast carcinoma in vitro and in vivo. Cell responses after TQ treatment were assessed by using different assays including MTT assay, annexin V-propidium iodide staining, Mitosox staining and Western blot. The antitumor effect was studied by breast tumor xenograft mouse model, and the tumor tissues were examined by histology and immunohistochemistry. The level of antioxidant enzymes/molecules in mouse liver tissues was measured by commercial kits. Here, we show that TQ induced p38 phosphorylation and ROS production in breast cancer cells. These inductions were found to be responsible for TQ's anti-proliferative and pro-apoptotic effects. Moreover, TQ-induced ROS production regulated p38 phosphorylation but not vice versa. TQ treatment was found to suppress the tumor growth and this effect was further enhanced by combination with doxorubicin. TQ also inhibited the protein expression of anti-apoptotic genes, such as XIAP, survivin, Bcl-xL and Bcl-2, in breast cancer cells and breast tumor xenograft. Reduced Ki67 and increased TUNEL staining were observed in TQ-treated tumors. TQ was also found to increase the level of catalase, superoxide dismutase and glutathione in mouse liver tissues. Overall, our results demonstrated that the anti-proliferative and pro-apoptotic effects of TQ in breast cancer are mediated through p38 phosphorylation via ROS generation.	[Woo, Chern Chiuh; Hsu, Annie; Kumar, Alan Prem; Sethi, Gautam; Tan, Kwong Huat Benny] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Kumar, Alan Prem; Sethi, Gautam] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117595, Singapore; [Kumar, Alan Prem] Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Perth, WA 6845, Australia; [Kumar, Alan Prem] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	National University of Singapore; National University of Singapore; Curtin University; University of North Texas System; University of North Texas Denton	Sethi, G (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore.	phcgs@nus.edu.sg; benny_tan@nuhs.edu.sg	Sethi, Gautam/F-2372-2011; Kumar, Alan Prem/ABE-7492-2020	Sethi, Gautam/0000-0002-8677-8475; Kumar, Alan Prem/0000-0002-3754-5712	NUS Academic Research Fund [R-184-000-207-112]; National Medical Research Council of Singapore [R-184-000-211-213]	NUS Academic Research Fund; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by grants from NUS Academic Research Fund (R-184-000-207-112) and National Medical Research Council of Singapore (R-184-000-211-213) to GS. (http://www.nuhs.edu.sg/research/funding/funding-opportunities/individual-research-grants/academic-research-fund-tier-1-university-research-committee.html) (http://www.nmrc.gov.sg/content/nmrc_internet/home.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe JI, 2000, J BIOL CHEM, V275, P1739, DOI 10.1074/jbc.275.3.1739; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Al-Shabanah OA, 1998, J EXP CLIN CANC RES, V17, P193; Alhosin M, 2010, BIOCHEM PHARMACOL, V79, P1251, DOI 10.1016/j.bcp.2009.12.015; Attoub S, 2013, FUND CLIN PHARMACOL, V27, P557, DOI 10.1111/j.1472-8206.2012.01056.x; Badary OA, 1997, CAN J PHYSIOL PHARM, V75, P1356, DOI 10.1139/cjpp-75-12-1356; Banerjee S, 2009, CANCER RES, V69, P5575, DOI 10.1158/0008-5472.CAN-08-4235; Behr Thomas M, 2003, Curr Opin Investig Drugs, V4, P1059; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Choi SY, 2012, INFLAMM RES, V61, P493, DOI 10.1007/s00011-012-0437-7; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; El-Najjar N, 2010, APOPTOSIS, V15, P183, DOI 10.1007/s10495-009-0421-z; Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857; Gali-Muhtasib H, 2008, CANCER RES, V68, P5609, DOI 10.1158/0008-5472.CAN-08-0884; Gali-Muhtasib H, 2008, J CELL MOL MED, V12, P330, DOI 10.1111/j.1582-4934.2007.00095.x; Hussain AR, 2011, FREE RADICAL BIO MED, V50, P978, DOI 10.1016/j.freeradbiomed.2010.12.034; Jafri SH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-87; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Kaseb AO, 2007, CANCER RES, V67, P7782, DOI 10.1158/0008-5472.CAN-07-1483; Koka PS, 2010, EXP BIOL MED, V235, P751, DOI 10.1258/ebm.2010.009369; Lei XF, 2012, BIOCHEM BIOPH RES CO, V417, P864, DOI 10.1016/j.bbrc.2011.12.063; Li F, 2010, BRIT J PHARMACOL, V161, P541, DOI 10.1111/j.1476-5381.2010.00874.x; Liao Y, 2003, MOL CELL BIOL, V23, P6836, DOI 10.1128/MCB.23.19.6836-6848.2003; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Mansour MA, 2002, CELL BIOCHEM FUNCT, V20, P143, DOI 10.1002/cbf.968; Martin-Cordero C, 2012, CURR DRUG TARGETS, V13, P1006, DOI 10.2174/138945012802009044; Mohamed A, 2003, BIOMED SCI INSTRUM, V39, P440; Molnar A, 1997, J BIOL CHEM, V272, P13229, DOI 10.1074/jbc.272.20.13229; Nadeau PJ, 2012, MOL IMMUNOL, V49, P582, DOI 10.1016/j.molimm.2011.10.007; Naviaux RK, 2012, J PHARMACOL EXP THER, V342, P608, DOI 10.1124/jpet.112.192120; Pan JS, 2009, WORLD J GASTROENTERO, V15, P1702, DOI 10.3748/wjg.15.1702; Pargellis Christopher, 2003, Curr Opin Investig Drugs, V4, P566; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sankaranarayanan C, 2011, CHEM-BIOL INTERACT, V190, P148, DOI 10.1016/j.cbi.2011.02.029; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Woo CC, 2011, BIOCHEM PHARMACOL, V82, P464, DOI 10.1016/j.bcp.2011.05.030; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003	43	118	120	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75356	10.1371/journal.pone.0075356	http://dx.doi.org/10.1371/journal.pone.0075356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098377	Green Published, gold			2022-12-27	WOS:000325434500027
J	Akhouayri, IG; Habtewold, T; Christophides, GK				Akhouayri, Idir G.; Habtewold, Tibebu; Christophides, Georges K.			Melanotic Pathology and Vertical Transmission of the Gut Commensal Elizabethkingia meningoseptica in the Major Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							GENE-BASED IDENTIFICATION; PLASMODIUM-FALCIPARUM; INSECTICIDE RESISTANCE; MELANIZATION REACTION; IMMUNE ACTIVATION; MOSQUITO; DROSOPHILA; STEPHENSI; BACTERIA; INFECTION	Background: The resident gut flora is known to have significant impacts on the life history of the host organism. Endosymbiotic bacterial species in the Anopheles mosquito gut are potent modulators of sexual development of the malaria parasite, Plasmodium, and thus proposed as potential control agents of malaria transmission. Results: Here we report a melanotic pathology in the major African malaria vector Anopheles gambiae, caused by the dominant mosquito endosymbiont Elizabethkingia meningoseptica. Transfer of melanised tissues into the haemolymph of healthy adult mosquitoes or direct haemolymph inoculation with isolated E. meningoseptica bacteria were the only means for transmission and de novo formation of melanotic lesions, specifically in the fat body tissues of recipient individuals. We show that E. meningoseptica can be vertically transmitted from eggs to larvae and that E. meningoseptica-mono-associated mosquitoes display significant mortality, which is further enhanced upon Plasmodium infection, suggesting a synergistic impact of E. meningoseptica and Plasmodium on mosquito survival. Conclusion: The high pathogenicity and permanent association of E. meningoseptica with An. Gambiae through vertical transmission constitute attractive characteristics towards the potential design of novel mosquito/malaria biocontrol strategies.	[Akhouayri, Idir G.; Habtewold, Tibebu; Christophides, Georges K.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London, England	Imperial College London	Akhouayri, IG (corresponding author), Univ Grenoble 1, CNRS UMR 5553, Lab Ecol Alpine, Grenoble, France.	ig.akhouayri@yahoo.com		Christophides, George/0000-0002-3323-1687	EU TransMalariaBlock; Wellcome Trust [093587/Z/10/Z];  [BBSRC S19551]; Biotechnology and Biological Sciences Research Council [S19551] Funding Source: researchfish	EU TransMalariaBlock; Wellcome Trust(Wellcome TrustEuropean Commission); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partially supported by a PhD studentship (BBSRC S19551) to IA and EU TransMalariaBlock to TH. This work was funded by the Wellcome Trust (093587/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; Avet-Rochex A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-65; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Beard CB, 1998, EMERG INFECT DIS, V4, P581, DOI 10.3201/eid0404.980408; BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bisi DC, 2011, APPL ENVIRON MICROB, V77, P4669, DOI 10.1128/AEM.00514-11; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Curtis CF, 2002, AM J TROP MED HYG, V66, P1; Damiani C, 2010, MICROB ECOL, V60, P644, DOI 10.1007/s00248-010-9704-8; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Dias M, 2012, J CLIN DIAGN RES, V6, P1550, DOI 10.7860/JCDR/2012/4076.2557; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Harrison G, 1978, MOSQUITOES MALARIA M; HARSHBAR.JC, 1968, ANNU REV ENTOMOL, V13, P159, DOI 10.1146/annurev.en.13.010168.001111; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kim KK, 2005, INT J SYST EVOL MICR, V55, P1287, DOI 10.1099/ijs.0.63541-0; KING EO, 1959, AM J CLIN PATHOL, V31, P241; Lee WJ, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe24; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li JY, 1996, INSECT BIOCHEM MOLEC, V26, P309, DOI 10.1016/0965-1748(95)00099-2; Lindblade KA, 2006, J MED ENTOMOL, V43, P428, DOI 10.1093/jmedent/43.2.428; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; NAPPI AJ, 1973, EXP PARASITOL, V33, P285, DOI 10.1016/0014-4894(73)90034-9; Ngwa CJ, 2013, J MED ENTOMOL, V50, P404, DOI 10.1603/ME12180; Noden BH, 2011, PARASITOL INT, V60, P440, DOI 10.1016/j.parint.2011.07.007; Paddibhatla I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001234; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3; Rodriguez A, 1996, GENETICS, V143, P929; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; SUGUMARAN M, 1991, FEBS LETT, V295, P233, DOI 10.1016/0014-5793(91)81431-7; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; Tetreau G, 2013, AQUAT TOXICOL, V140, P389, DOI 10.1016/j.aquatox.2013.07.004; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; WANG YH, 2011, PLOS ONE; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO, 1982, WHO SER RAPP TECHN, V679	67	24	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e77619	10.1371/journal.pone.0077619	http://dx.doi.org/10.1371/journal.pone.0077619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098592	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100088
J	Jeong, W; Lim, W; Ahn, SE; Lim, CH; Lee, JY; Bae, SM; Kim, J; Bazer, FW; Song, G				Jeong, Wooyoung; Lim, Whasun; Ahn, Suzie E.; Lim, Chul-Hong; Lee, Jin-Young; Bae, Seung-Min; Kim, Jinyoung; Bazer, Fuller W.; Song, Gwonhwa			Recrudescence Mechanisms and Gene Expression Profile of the Reproductive Tracts from Chickens during the Molting Period	PLOS ONE			English	Article							HIGH DIETARY ZINC; JAK-STAT PATHWAY; BETA-DEFENSIN 11; LAYING HENS; CAGED LAYERS; FORCED MOLT; EGGSHELL QUALITY; EGG-PRODUCTION; BODY-WEIGHT; SALMONELLA-ENTERITIDIS	The reproductive system of chickens undergoes dynamic morphological and functional tissue remodeling during the molting period. The present study identified global gene expression profiles following oviductal tissue regression and regeneration in laying hens in which molting was induced by feeding high levels of zinc in the diet. During the molting and recrudescence processes, progressive morphological and physiological changes included regression and re-growth of reproductive organs and fluctuations in concentrations of testosterone, progesterone, estradiol and corticosterone in blood. The cDNA microarray analysis of oviductal tissues revealed the biological significance of gene expression-based modulation in oviductal tissue during its remodeling. Based on the gene expression profiles, expression patterns of selected genes such as, TF, ANGPTL3, p20K, PTN, AvBD11 and SERPINB3 exhibited similar patterns in expression with gradual decreases during regression of the oviduct and sequential increases during resurrection of the functional oviduct. Also, miR-1689* inhibited expression of Sp1, while miR-17-3p, miR-22* and miR-1764 inhibited expression of STAT1. Similarly, chicken miR-1562 and miR-138 reduced the expression of ANGPTL3 and p20K, respectively. These results suggest that these differentially regulated genes are closely correlated with the molecular mechanism(s) for development and tissue remodeling of the avian female reproductive tract, and that miRNA-mediated regulation of key genes likely contributes to remodeling of the avian reproductive tract by controlling expression of those genes post-transcriptionally. The discovered global gene profiles provide new molecular candidates responsible for regulating morphological and functional recrudescence of the avian reproductive tract, and provide novel insights into understanding the remodeling process at the genomic and epigenomic levels.	[Jeong, Wooyoung; Lim, Whasun; Ahn, Suzie E.; Lim, Chul-Hong; Lee, Jin-Young; Bae, Seung-Min] Seoul Natl Univ, Dept Anim Biotechnol, Seoul, South Korea; [Kim, Jinyoung] Dankook Univ, Dept Anim Resources Sci, Cheonan, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Song, Gwonhwa] Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea	Seoul National University (SNU); Dankook University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Korea University	Song, G (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea.	ghsong@korea.ac.kr	Bazer, Fuller/AAF-4317-2021; gwonhwa, song/H-3208-2015; Song, Gwonhwa/H-3647-2015; Lim, Whasun/AAP-3156-2020	Bazer, Fuller/0000-0002-5823-5086; Lim, Whasun/0000-0002-1328-0465	Next-Generation BioGreen 21 Program through Rural Development Administration, Republic of Korea [PJ008142]	Next-Generation BioGreen 21 Program through Rural Development Administration, Republic of Korea	This research was funded by the Next-Generation BioGreen 21 Program (No. PJ008142) through Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; ALBATSHAN HA, 1994, POULTRY SCI, V73, P1590, DOI 10.3382/ps.0731590; Alodan MA, 1999, POULTRY SCI, V78, P171, DOI 10.1093/ps/78.2.171; Ariyadi B, 2012, POULTRY SCI, V91, P1173, DOI 10.3382/ps.2011-02079; BAKER M, 1981, POULTRY SCI, V60, P1594; Berman DM, 2004, CANCER RES, V64, P6820, DOI 10.1158/0008-5472.CAN-04-1916; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; BERRY WD, 1985, POULTRY SCI, V64, P2027, DOI 10.3382/ps.0642027; Berry WD, 2003, POULTRY SCI, V82, P971, DOI 10.1093/ps/82.6.971; BERRY WD, 1987, POULTRY SCI, V66, P218, DOI 10.3382/ps.0660218; BRAKE J, 1979, POULTRY SCI, V58, P707, DOI 10.3382/ps.0580707; BRAKE J, 1979, POULTRY SCI, V58, P699, DOI 10.3382/ps.0580699; BREEDING SW, 1992, POULTRY SCI, V71, P168, DOI 10.3382/ps.0710168; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; CHEN LH, 1987, J BIOL CHEM, V262, P17247; Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041; CREGER CR, 1977, POULTRY SCI, V56, P1706; D'Alessandro A, 2010, J PROTEOMICS, V73, P1028, DOI 10.1016/j.jprot.2010.01.002; DAMME K, 1987, POULTRY SCI, V66, P881, DOI 10.3382/ps.0660881; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DESJARDINS E, 1993, MOL CELL BIOL, V13, P5710, DOI 10.1128/MCB.13.9.5710; Dunn IC, 2009, GEN COMP ENDOCR, V163, P225, DOI 10.1016/j.ygcen.2009.03.006; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GARLICH J, 1984, POULTRY SCI, V63, P339, DOI 10.3382/ps.0630339; Geva E, 2000, OBSTET GYNECOL SURV, V55, P511, DOI 10.1097/00006254-200008000-00024; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; Herve-Grepinet V, 2010, ANTIMICROB AGENTS CH, V54, P4401, DOI 10.1128/AAC.00204-10; Heryanto B, 1997, POULTRY SCI, V76, P67, DOI 10.1093/ps/76.1.67; Heryanto B, 1997, POULTRY SCI, V76, P1580, DOI 10.1093/ps/76.11.1580; HOLT PS, 1994, POULTRY SCI, V73, P1267, DOI 10.3382/ps.0731267; HOSHINO S, 1988, COMP BIOCHEM PHYS A, V90, P355, DOI 10.1016/0300-9629(88)91128-0; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Jeong W, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098186; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kavurma MM, 2003, J BIOL CHEM, V278, P32537, DOI 10.1074/jbc.M305650200; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kondoh M, 2002, EUR J BIOCHEM, V269, P6204, DOI 10.1046/j.1432-1033.2002.03339.x; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; LEE DC, 1978, J BIOL CHEM, V253, P3494; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034215; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lim W, 2013, MOL CELL ENDOCRINOL, V366, P1, DOI 10.1016/j.mce.2012.10.031; Lim W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049869; Lim W, 2012, GEN COMP ENDOCR, V175, P65, DOI 10.1016/j.ygcen.2011.09.019; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maity B, 2011, J BIOL CHEM, V286, P1409, DOI 10.1074/jbc.M110.186700; MAO PL, 1993, J BIOL CHEM, V268, P8131; MASTRANGELO IA, 1991, P NATL ACAD SCI USA, V88, P5670, DOI 10.1073/pnas.88.13.5670; MCCORMICK CC, 1984, POULTRY SCI, V63, P1201, DOI 10.3382/ps.0631201; MCLENNAN CE, 1965, OBSTET GYNECOL, V26, P605; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; Monroe DG, 2002, MOL ENDOCRINOL, V16, P1322, DOI 10.1210/me.16.6.1322; Moore RW, 2004, POULTRY SCI, V83, P1276, DOI 10.1093/ps/83.8.1276; MROSOVSKY N, 1980, SCIENCE, V207, P837, DOI 10.1126/science.6928327; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; PAGEAUX JF, 1986, BIOL REPROD, V35, P657, DOI 10.1095/biolreprod35.3.657; Park SY, 2004, POULTRY SCI, V83, P24, DOI 10.1093/ps/83.1.24; Ponka P, 1998, SEMIN HEMATOL, V35, P35; Ponnampalam AP, 2004, MOL HUM REPROD, V10, P879, DOI 10.1093/molehr/gah121; RAULAIS D, 1991, BIOCHEM BIOPH RES CO, V174, P708, DOI 10.1016/0006-291X(91)91475-R; Ruszler PL, 1998, POULTRY SCI, V77, P1789, DOI 10.1093/ps/77.12.1789; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCOTT JT, 1976, POULTRY SCI, V55, P2089; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHIPPEE RL, 1979, POULTRY SCI, V58, P949, DOI 10.3382/ps.0580949; Silphaduang U, 2006, BIOCHEM BIOPH RES CO, V340, P648, DOI 10.1016/j.bbrc.2005.12.054; Song GH, 2006, ENDOCRINOLOGY, V147, P3478, DOI 10.1210/en.2006-0122; Song G, 2011, BIOL REPROD, V85, P306, DOI 10.1095/biolreprod.110.089227; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Sundaresan NR, 2008, CELL TISSUE RES, V332, P543, DOI 10.1007/s00441-008-0599-3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; VIGNY M, 1989, EUR J BIOCHEM, V186, P733, DOI 10.1111/j.1432-1033.1989.tb15267.x; Webster AB, 2003, POULTRY SCI, V82, P992, DOI 10.1093/ps/82.6.992; WILLIAMS JB, 1985, BRIT POULTRY SCI, V26, P25, DOI 10.1080/00071668508416783; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Yuan L, 2007, J MED FOOD, V10, P657, DOI 10.1089/jmf.2006.123	86	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76784	10.1371/journal.pone.0076784	http://dx.doi.org/10.1371/journal.pone.0076784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098561	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100084
J	Karunakaran, DKP; Banday, AR; Wu, Q; Kanadia, R				Karunakaran, Devi Krishna Priya; Banday, Abdul Rouf; Wu, Qian; Kanadia, Rahul			Expression Analysis of an Evolutionarily Conserved Alternative Splicing Factor, Sfrs10, in Age-Related Macular Degeneration	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; RNA-RECOGNITION MOTIF; CPG ISLANDS; FACTOR TRA2-BETA-1; GENE-EXPRESSION; HUMAN GENOME; SR PROTEINS; CELLS; REGULATORS; PATTERNS	Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly population. Hypoxic stress created in the micro-environment of the photoreceptors is thought to be the underlying cause that results in the pathophysiology of AMD. However, association of AMD with alternative splicing mediated gene regulation is not well explored. Alternative Splicing is one of the primary mechanisms in humans by which fewer protein coding genes are able to generate a vast proteome. Here, we investigated the expression of a known stress response gene and an alternative splicing factor called Serine-Arginine rich splicing factor 10 (Sfrs10). Sfrs10 is a member of the serine-arginine (SR) rich protein family and is 100% identical at the amino acid level in most mammals. Immunoblot analysis on retinal extracts from mouse, rat, and chicken showed a single immunoreactive band. Further, immunohistochemistry on adult mouse, rat and chicken retinae showed pan-retinal expression. However, SFRS10 was not detected in normal human retina but was observed as distinct nuclear speckles in AMD retinae. This is in agreement with previous reports that show Sfrs10 to be a stress response gene, which is upregulated under hypoxia. The difference in the expression of Sfrs10 between humans and lower mammals and the upregulation of SFRS10 in AMD is further reflected in the divergence of the promoter sequence between these species. Finally, SFRS10+ speckles were independent of the SC35+ SR protein speckles or the HSF1+ stress granules. In all, our data suggests that SFRS10 is upregulated and forms distinct stress-induced speckles and might be involved in AS of stress response genes in AMD.	[Karunakaran, Devi Krishna Priya; Banday, Abdul Rouf; Kanadia, Rahul] Univ Connecticut, Storrs, CT 06260 USA; [Wu, Qian] Univ Connecticut, Ctr Hlth, Dept Pathol & Lab Med, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Kanadia, R (corresponding author), Univ Connecticut, Storrs, CT 06260 USA.	rahul.kanadia@uconn.edu	BANDAY, ABDUL R/A-9555-2014; Banday, A. Rouf/AAB-9082-2022	BANDAY, ABDUL ROUF/0000-0002-1521-340X	National Institute of Neurological Disorders and Stroke [5P30NS069266]; National Eye Institute [4R00EY019547]; NATIONAL EYE INSTITUTE [K99EY019547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069266] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Resources for this project were provided by P30 from National Institute of Neurological Disorders and Stroke-5P30NS069266 (http://www.ninds.nih.gov/) and K99-R00 from National Eye Institute-4R00EY019547 (http://www.nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Arden GB, 2005, BRIT J OPHTHALMOL, V89, P764, DOI 10.1136/bjo.2004.062547; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BERMAN ER, 1994, BRIT J OPHTHALMOL, V78, P82, DOI 10.1136/bjo.78.2.82; Bird A, 1996, BRIT J OPHTHALMOL, V80, P2, DOI 10.1136/bjo.80.1.2; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; BOULTON M, 1986, BRIT J OPHTHALMOL, V70, P808, DOI 10.1136/bjo.70.11.808; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Campochiaro PA, 2004, EXPERT OPIN BIOL TH, V4, P1395, DOI 10.1517/14712598.4.9.1395; Cotto JJ, 1997, J CELL SCI, V110, P2925; Curcio CA, 2009, PROG RETIN EYE RES, V28, P393, DOI 10.1016/j.preteyeres.2009.08.001; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; Daoud R, 2002, J NEUROSCI, V22, P5889; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1691; Fang AM, 2009, MOL VIS, V15, P2710; Feigl B, 2009, PROG RETIN EYE RES, V28, P63, DOI 10.1016/j.preteyeres.2008.11.004; FU XD, 1992, P NATL ACAD SCI USA, V89, P11224, DOI 10.1073/pnas.89.23.11224; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Grellscheid S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002390; Guymer R, 1999, PROG RETIN EYE RES, V18, P59, DOI 10.1016/S1350-9462(98)00012-3; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; HOGAN M J, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P64; Holz FG, 1999, GRAEF ARCH CLIN EXP, V237, P145, DOI 10.1007/s004170050209; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Kajita K, 2013, J GASTROENTEROL; Kaur I, 2013, MOL VIS, V19, P822; Kiryu-Seo S, 1998, MOL BRAIN RES, V62, P220, DOI 10.1016/S0169-328X(98)00255-1; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; LANDSMAN D, 1992, NUCLEIC ACIDS RES, V20, P2861, DOI 10.1093/nar/20.11.2861; LARSEN F, 1992, GENET ANAL-BIOMOL E, V9, P80, DOI 10.1016/1050-3862(92)90002-M; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lazzeri S, 2012, SCI WORLD J, DOI 10.1100/2012/420190; Li SJ, 2013, J BIOL CHEM, V288, P8898, DOI 10.1074/jbc.M113.456715; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lu F, 2013, INVEST OPHTHALMOL VI; MATSUO N, 1995, J BIOL CHEM, V270, P28216, DOI 10.1074/jbc.270.47.28216; Nakata I, 2012, INVEST OPHTH VIS SCI, V53, P6576, DOI 10.1167/iovs.12-10219; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Ricci F, 2009, ARCH OPHTHALMOL-CHIC, V127, P1368, DOI 10.1001/archophthalmol.2009.237; Segade F, 1996, FEBS LETT, V387, P152, DOI 10.1016/0014-5793(96)00496-6; Shelley EJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P483, DOI 10.1001/archophthalmol.2008.622; Snodderly DM, 2002, INVEST OPHTH VIS SCI, V43, P2815; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Tsukamoto Y, 2001, AM J PATHOL, V158, P1685, DOI 10.1016/S0002-9440(10)64124-7; Verhoeff F H, 1937, Trans Am Ophthalmol Soc, V35, P262; Watermann DO, 2006, CANCER RES, V66, P4774, DOI 10.1158/0008-5472.CAN-04-3294; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154; ZHANG GH, 1994, NATURE, V372, P809; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	59	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75964	10.1371/journal.pone.0075964	http://dx.doi.org/10.1371/journal.pone.0075964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098751	gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500121
J	McFeat, GD; Allinson, SL; McMillan, TJ				McFeat, Gillian D.; Allinson, Sarah L.; McMillan, Trevor J.			Characterisation of the p53-Mediated Cellular Responses Evoked in Primary Mouse Cells Following Exposure to Ultraviolet Radiation	PLOS ONE			English	Article							DNA-DAMAGE RESPONSES; CYCLE ARREST; PYRIMIDINE DIMERS; UVA-RADIATION; P53; INDUCTION; ACCUMULATION; INSTABILITY; ACTIVATION; LIGHT	Exposure to ultraviolet (UV) light can cause significant damage to mammalian cells and, although the spectrum of damage produced varies with the wavelength of UV, all parts of the UV spectrum are recognised as being detrimental to human health. Characterising the cellular response to different wavelengths of UV therefore remains an important aim so that risks and their moderation can be evaluated, in particular in relation to the initiation of skin cancer. The p53 tumour suppressor protein is central to the cellular response that protects the genome from damage by external agents such as UV, thus reducing the risk of tumorigenesis. In response to a variety of DNA damaging agents including UV light, wild-type p53 plays a role in mediating cell-cycle arrest, facilitating apoptosis and stimulating repair processes, all of which prevent the propagation of potentially mutagenic defects. In this study we examined the induction of p53 protein and its influence on the survival of primary mouse fibroblasts exposed to different wavelengths of UV light. UVC was found to elevate p53 protein and its sequence specific DNA binding capacity. Unexpectedly, UVA treatment failed to induce p53 protein accumulation or sequence specific DNA binding. Despite this, UVA exposure of wild-type cells induced a p53 dependent G1 cell cycle arrest followed by a wave of p53 dependent apoptosis, peaking 12 hours post-insult. Thus, it is demonstrated that the elements of the p53 cellular response evoked by exposure to UV radiation are wavelength dependent. Furthermore, the interrelationship between various endpoints is complex and not easily predictable. This has important implications not only for understanding the mode of action of p53 but also for the use of molecular endpoints in quantifying exposure to different wavelengths of UV in the context of human health protection.	[McFeat, Gillian D.; Allinson, Sarah L.; McMillan, Trevor J.] Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster, England	Lancaster University	McMillan, TJ (corresponding author), Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster, England.	t.mcmillan@lancaster.ac.uk	Allinson, Sarah/AAM-6064-2021	Allinson, Sarah/0000-0003-1937-5550	Eleanor Peel Trust; North West Cancer Research Fund	Eleanor Peel Trust; North West Cancer Research Fund	The work was funded by the Eleanor Peel Trust and the North West Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; AGRAWAL RS, 1994, CYTOMETRY, V17, P237, DOI 10.1002/cyto.990170307; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Beattie PE, 2005, BRIT J DERMATOL, V152, P1001, DOI 10.1111/j.1365-2133.2005.06557.x; Burren R, 1998, INT J CANCER, V76, P201, DOI 10.1002/(SICI)1097-0215(19980413)76:2<201::AID-IJC6>3.0.CO;2-0; CAMPBELL C, 1993, CANCER RES, V53, P2697; Dahle J, 2003, CANCER RES, V63, P1464; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; FRITSCHE M, 1993, ONCOGENE, V8, P307; Haapajarvi T, 1997, MOL CELL BIOL, V17, P3074, DOI 10.1128/MCB.17.6.3074; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; Marrot L, 2005, MUTAT RES-FUND MOL M, V571, P175, DOI 10.1016/j.mrfmmm.2004.07.020; Matsumura Y, 2002, FRONT BIOSCI-LANDMRK, V7, pD765, DOI 10.2741/matsumur; McMillan TJ, 2008, J PHARM PHARMACOL, V60, P969, DOI 10.1211/jpp.60.8.0004; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Novarina D, 2011, DNA REPAIR, V10, P751, DOI 10.1016/j.dnarep.2011.04.030; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Runger TM, 2012, PHOTOCH PHOTOBIO SCI, V11, P207, DOI 10.1039/c1pp05232b; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano MA, 2011, THEOR APPL CLIMATOL, V103, P95, DOI 10.1007/s00704-010-0284-9; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tornaletti S, 1996, MOL CARCINOGEN, V17, P192, DOI 10.1002/(SICI)1098-2744(199612)17:4<192::AID-MC2>3.0.CO;2-G; TYRRELL RM, 1990, J PHOTOCH PHOTOBIO B, V4, P349, DOI 10.1016/1011-1344(90)85014-N; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Waster PK, 2009, J INVEST DERMATOL, V129, P1769, DOI 10.1038/jid.2008.421	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75800	10.1371/journal.pone.0075800	http://dx.doi.org/10.1371/journal.pone.0075800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098727	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500098
J	Rotte, A; Bhandaru, M; Cheng, YB; Sjoestroem, C; Martinka, M; Li, G				Rotte, Anand; Bhandaru, Madhuri; Cheng, Yabin; Sjoestroem, Cecilia; Martinka, Magdalena; Li, Gang			Decreased Expression of Nuclear p300 Is Associated with Disease Progression and Worse Prognosis of Melanoma Patients	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR P300; NUCLEOTIDE EXCISION-REPAIR; HISTONE DEACETYLASE INHIBITORS; METASTATIC MELANOMA; PROTEIN-KINASE; BREAST-CANCER; PHOSPHORYLATION; ACETYLTRANSFERASE; ACETYLATION; MUTATIONS	Background: Genomic instability due to UV radiation is one of the leading causes for melanoma. Histone acetyltransferase p300 plays an indispensible role in DNA repair and maintenance of genomic integrity. The present study was performed to analyze the correlation between p300 expression, melanoma progression and patient survival. Methods: Tissue microarray and immunohistochemical analysis was employed to study the expression of p300 in melanoma patients. A total of 358 melanoma patients (250 primary melanoma and 108 metastatic melanoma) were used for the study. Kaplan-Meier, univariate and multivariate Cox regression analysis, and receiver-operating characteristic curves, were used to elucidate the prognostic significance of p300 expression. Results: Our results demonstrate that p300 is expressed in both nucleus and cytoplasm but the nuclear expression of p300 is predominant. The progression of disease from dysplastic nevi to primary melanoma and to metastatic melanoma was associated with decreased nuclear and increased cytoplasmic p300 expression. Especially, the loss of nuclear and gain in cytoplasmic p300 was correlated with the progression of melanoma from AJCC stage II to stage III, which requires the migration and metastasis of cancer cells from primary sites to lymph nodes. Similarly, decrease in nuclear, and increase in cytoplasmic p300 expression correlated with worse survival of melanoma patients. Nuclear p300 but not cytoplasmic p300 could predict the patient survival independent of AJCC stage, age and gender. Conclusion: Loss of nuclear p300 expression is an indicator of worse patient survival and is an independent prognostic marker for melanoma.	[Rotte, Anand; Bhandaru, Madhuri; Cheng, Yabin; Sjoestroem, Cecilia; Li, Gang] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Martinka, Magdalena] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Rotte, A (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	anand.rotte@ubc.ca	Cheng, Yabin/AAY-2178-2020; Rotte, Anand/H-4774-2019; Cheng, Yabin/P-7071-2015	Cheng, Yabin/0000-0002-6205-3648; Cheng, Yabin/0000-0002-6205-3648; Rotte, Anand/0000-0002-3452-7068	Canadian Institutes of Health Research [MOP-93810, MOP-110974, CCI-117958]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project is funded by grants from the Canadian Institutes of Health Research (MOP-93810, MOP-110974 and CCI-117958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; BYERS HR, 1991, AM J PATHOL, V139, P423; Chen GD, 2011, CANCER EPIDEM BIOMAR, V20, P2212, DOI 10.1158/1055-9965.EPI-11-0472; Chen GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017578; Chen J, 2004, CELL MOL LIFE SCI, V61, P1675, DOI 10.1007/s00018-004-4103-9; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; Finn L, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-23; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Giannini G, 2012, FUTURE MED CHEM, V4, P1439, DOI [10.4155/FMC.12.80, 10.4155/fmc.12.80]; Gonzaga Evelyn R, 2009, Am J Clin Dermatol, V10 Suppl 1, P19, DOI 10.2165/0128071-200910001-00004; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Landreville S, 2012, CLIN CANCER RES, V18, P408, DOI 10.1158/1078-0432.CCR-11-0946; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Li Y, 2011, ANN THORAC SURG, V91, P1531, DOI 10.1016/j.athoracsur.2010.12.012; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Murakami T, 2008, J INVEST DERMATOL, V128, P1506, DOI 10.1038/sj.jid.5701216; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Reed SH, 2011, DNA REPAIR, V10, P734, DOI 10.1016/j.dnarep.2011.04.029; REMMELE W, 1987, PATHOLOGE, V8, P138; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Tillhon M, 2012, DNA REPAIR, V11, P844, DOI 10.1016/j.dnarep.2012.08.001; Wang QE, 2013, NUCLEIC ACIDS RES, V41, P1722, DOI 10.1093/nar/gks1312; Yan G, 2013, J INVEST DERMATOL; Yokomizo C, 2011, CANCER LETT, V310, P140, DOI 10.1016/j.canlet.2011.06.030; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zhang GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045037; Zhang ZZ, 2011, CANCER-AM CANCER SOC, V117, P2719, DOI 10.1002/cncr.25838	40	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75405	10.1371/journal.pone.0075405	http://dx.doi.org/10.1371/journal.pone.0075405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098694	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500065
J	Schob, S; Schicht, M; Sel, S; Stiller, D; Kekule, A; Paulsen, F; Maronde, E; Brauer, L				Schob, Stefan; Schicht, Martin; Sel, Saadettin; Stiller, Dankwart; Kekule, Alexander; Paulsen, Friedrich; Maronde, Erik; Braeuer, Lars			The Detection of Surfactant Proteins A, B, C and D in the Human Brain and Their Regulation in Cerebral Infarction, Autoimmune Conditions and Infections of the CNS	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNE-SYSTEM; PULMONARY SURFACTANT; IN-VIVO; IMMUNOLOGICAL PRIVILEGE; APOPTOTIC NEUTROPHILS; BIOPHYSICAL ACTIVITY; LUNG INFLAMMATION; CHOROID-PLEXUS; DEFICIENCY	Surfactant proteins (SP) have been studied intensively in the respiratory system. Surfactant protein A and surfactant protein D are proteins belonging to the family of collectins each playing a major role in the innate immune system. The ability of surfactant protein A and surfactant protein D to bind various pathogens and facilitate their elimination has been described in a vast number of studies. Surfactant proteins are very important in modulating the host's inflammatory response and participate in the clearance of apoptotic cells. Surfactant protein B and surfactant protein C are proteins responsible for lowering the surface tension in the lungs. The aim of this study was an investigation of expression of surfactant proteins in the central nervous system to assess their specific distribution patterns. The second aim was to quantify surfactant proteins in cerebrospinal fluid of healthy subjects compared to patients suffering from different neuropathologies. The expression of mRNA for the surfactant proteins was analyzed with RT-PCR done with samples from different parts of the human brain. The production of the surfactant proteins in the brain was verified using immunohistochemistry and Western blot. The concentrations of the surfactant proteins in cerebrospinal fluid from healthy subjects and patients suffering from neuropathologic conditions were quantified using ELISA. Our results revealed that surfactant proteins are present in the central nervous system and that the concentrations of one or more surfactant proteins in healthy subjects differed significantly from those of patients affected by central autoimmune processes, CNS infections or cerebral infarction. Based on the localization of the surfactant proteins in the brain, their different levels in normal versus pathologic samples of cerebrospinal fluid and their well-known functions in the lungs, it appears that the surfactant proteins may play roles in host defense of the brain, facilitation of cerebrospinal fluid secretion and maintenance of the latter's rheological properties.	[Schob, Stefan] Univ Halle Wittenberg, Inst Anat & Cell Biol, D-06108 Halle, Saale, Germany; [Schicht, Martin; Paulsen, Friedrich; Braeuer, Lars] Univ Erlangen Nurnberg, Inst Anat, Dept 2, D-91054 Erlangen, Germany; [Maronde, Erik] Goethe Univ Frankfurt, Inst Anat, Dept 3, D-60054 Frankfurt, Germany; [Sel, Saadettin] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Stiller, Dankwart] Univ Halle Wittenberg, Inst Forens Med, D-06108 Halle, Saale, Germany; [Kekule, Alexander] Univ Halle Wittenberg, Inst Med Microbiol, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; University of Erlangen Nuremberg; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Schob, S (corresponding author), Univ Halle Wittenberg, Inst Anat & Cell Biol, D-06108 Halle, Saale, Germany.	schob.stefan@googlemail.com	Maronde, Erik/J-1915-2019	Maronde, Erik/0000-0002-5574-6323; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305; Paulsen, Friedrich/0000-0002-0527-0953; schob, stefan/0000-0003-2846-5443; Schicht, Martin/0000-0001-5155-5477	German Research Foundation (DFG) [1329/12-1 BR, BR 3681/2-1]; Wilhelm Roux Program, Halle, Germany [FKZ 17/20]	German Research Foundation (DFG)(German Research Foundation (DFG)); Wilhelm Roux Program, Halle, Germany	The study was supported by the German Research Foundation (DFG, Program Grants 1329/12-1 BR and BR 3681/2-1) and the Wilhelm Roux Program, Halle, Germany (Program Grants FKZ 17/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlen A, 2008, J APPL PHYSIOL, V104, P1101, DOI 10.1152/japplphysiol.00865.2007; Augusto L, 2001, AM J PHYSIOL-LUNG C, V281, pL776, DOI 10.1152/ajplung.2001.281.4.L776; Brauer L, 2007, CURR EYE RES, V32, P931, DOI 10.1080/02713680701694369; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Brauer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053705; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; Brauer L, 2012, BIOMED TECH, V2011, P0113; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P663, DOI 10.1080/14767050802215664; Chang RCC, 2009, CELL MOL IMMUNOL, V6, P317, DOI 10.1038/cmi.2009.42; Chroneos ZC, 2009, TUBERCULOSIS, V89, pS10, DOI 10.1016/S1472-9792(09)70005-8; Chuang CY, 2009, TOXICOL LETT, V191, P132, DOI 10.1016/j.toxlet.2009.08.015; Clark H, 2002, J IMMUNOL, V169, P2892, DOI 10.4049/jimmunol.169.6.2892; CURSTEDT T, 1987, EUR J BIOCHEM, V168, P255, DOI 10.1111/j.1432-1033.1987.tb13414.x; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; Epaud R, 2003, AM J RESP CELL MOL, V28, P373, DOI 10.1165/rcmb.2002-0071OC; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gander R, 2002, J LIPID RES, V43, P636; Gortner L, 2004, Z Geburtshilfe Neonatol, V208, P91, DOI 10.1055/s-2004-819002; Hamvas A, 2006, SEMIN PERINATOL, V30, P316, DOI 10.1053/j.semperi.2005.11.002; Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x; Harrod KS, 1999, AM J PHYSIOL-LUNG C, V277, pL580, DOI 10.1152/ajplung.1999.277.3.L580; Ikegami M, 2005, AM J PHYSIOL-LUNG C, V289, pL962, DOI 10.1152/ajplung.00214.2005; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Jakel A, 2010, PROTEIN CELL, V1, P563, DOI 10.1007/s13238-010-0076-0; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kiefer M, 2012, DTSCH ARZTEBL INT, V109, P15, DOI 10.3238/arztebl.2012.0015; Lee EB, 2005, FEBS LETT, V579, P2564, DOI 10.1016/j.febslet.2005.03.070; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; LUMB RH, 1989, AM J PHYSIOL, V257, pL190, DOI 10.1152/ajplung.1989.257.4.L190; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; Motzkus D, 2006, FASEB J, V20, P1701, DOI 10.1096/fj.05-4970fje; Moya F, 2011, SEMIN FETAL NEONAT M, V16, P269, DOI 10.1016/j.siny.2011.03.006; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; NOTTER RH, 1987, CHEM PHYS LIPIDS, V44, P1, DOI 10.1016/0009-3084(87)90002-8; O'Keeffe J, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1827; Ofek I, 2001, INFECT IMMUN, V69, P24, DOI 10.1128/IAI.69.1.24-33.2001; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Reinke E, 2006, IMMUNOL LETT, V104, P102, DOI 10.1016/j.imlet.2005.11.009; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727; Schicht M, 2013, AM J RHINOL ALLERGY, V27, P24, DOI 10.2500/ajra.2013.27.3838; Sever-Chroneos Z, 2011, J BIOL CHEM, V286, P4854, DOI 10.1074/jbc.M110.125567; Speake T, 2001, MICROSC RES TECHNIQ, V52, P49, DOI 10.1002/1097-0029(20010101)52:1<49::AID-JEMT7>3.0.CO;2-C; Stadelmann C, 2011, BBA-MOL BASIS DIS, V1812, P275, DOI 10.1016/j.bbadis.2010.07.007; Tolle A, 2002, CHEM PHYS LIPIDS, V114, P159, DOI 10.1016/S0009-3084(01)00204-3; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Wemhoner A, 2009, METHOD FIND EXP CLIN, V31, P317, DOI [10.1358/mf.2009.31.5.1386592, 10.1358/mf.2009.31.5.1380462]; Willander H, 2012, P NATL ACAD SCI US; Williams WM, 2012, SCI WORLD J, DOI 10.1100/2012/905785; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang L, 2010, J IMMUNOL, V184, P975, DOI 10.4049/jimmunol.0900650; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102	59	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74412	10.1371/journal.pone.0074412	http://dx.doi.org/10.1371/journal.pone.0074412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098648	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500019
J	Sonmez, M; Ince, HY; Yalcin, O; Ajdzanovic, V; Spasojevic, I; Meiselman, HJ; Baskurt, OK				Sonmez, Melda; Ince, Huseyin Yavuz; Yalcin, Ozlem; Ajdzanovic, Vladimir; Spasojevic, Ivan; Meiselman, Herbert J.; Baskurt, Oguz K.			The Effect of Alcohols on Red Blood Cell Mechanical Properties and Membrane Fluidity Depends on Their Molecular Size	PLOS ONE			English	Article							DIFFUSIONAL WATER PERMEABILITY; SPONTANEOUSLY HYPERTENSIVE RATS; ERYTHROCYTE-MEMBRANE; LIPID-BILAYER; ALIPHATIC-ALCOHOLS; BENZYL ALCOHOL; IN-VITRO; ETHANOL; DEFORMABILITY; RELEVANCE	The role of membrane fluidity in determining red blood cell (RBC) deformability has been suggested by a number of studies. The present investigation evaluated alterations of RBC membrane fluidity, deformability and stability in the presence of four linear alcohols (methanol, ethanol, propanol and butanol) using ektacytometry and electron paramagnetic resonance (EPR) spectroscopy. All alcohols had a biphasic effect on deformability such that it increased then decreased with increasing concentration; the critical concentration for reversal was an inverse function of molecular size. EPR results showed biphasic changes of near-surface fluidity (i.e., increase then decrease) and a decreased fluidity of the lipid core; rank order of effectiveness was butanol > propanol > ethanol > methanol, with a significant correlation between near-surface fluidity and deformability (r = 0.697; p<0.01). The presence of alcohol enhanced the impairment of RBC deformability caused by subjecting cells to 100 Pa shear stress for 300 s, with significant differences from control being observed at higher concentrations of all four alcohols. The level of hemolysis was dependent on molecular size and concentration, whereas echinocytic shape transformation (i.e., biconcave disc to crenated morphology) was observed only for ethanol and propanol. These results are in accordance with available data obtained on model membranes. They document the presence of mechanical links between RBC deformability and near-surface membrane fluidity, chain length-dependence of the ability of alcohols to alter RBC mechanical behavior, and the biphasic response of RBC deformability and near-surface membrane fluidity to increasing alcohol concentrations.	[Sonmez, Melda; Ince, Huseyin Yavuz; Yalcin, Ozlem; Baskurt, Oguz K.] Koc Univ, Sch Med, Istanbul, Turkey; [Ajdzanovic, Vladimir] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Belgrade, Serbia; [Spasojevic, Ivan] Univ Belgrade, Inst Multidisciplinary Res, Belgrade, Serbia; [Meiselman, Herbert J.] Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA	Koc University; University of Belgrade; University of Belgrade	Meiselman, HJ (corresponding author), Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA.	meiselma@usc.edu	Ince, Yavuz/AFX-0433-2022; Yalcin, Ozlem/AAF-4036-2019	Spasojevic, Ivan/0000-0002-3150-3087; Yalcin, Ozlem/0000-0001-5547-6653; Ajdzanovic, Vladimir/0000-0002-6540-9603	Turkish Academy of Sciences, NIH [HL015722, HL090511]; Ministry of Science, Education and Technological Development of the Republic of Serbia [173009, 173014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090511, R01HL015722, R37HL015722] Funding Source: NIH RePORTER	Turkish Academy of Sciences, NIH(Turkish Academy of Sciences); Ministry of Science, Education and Technological Development of the Republic of Serbia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Turkish Academy of Sciences, NIH research Grants HL015722 and HL090511 and Ministry of Science, Education and Technological Development of the Republic of Serbia, Grant numbers 173009 and 173014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdzanovic V, 2011, J MEMBRANE BIOL, V239, P131, DOI 10.1007/s00232-010-9332-8; Ajdzanovic V, 2010, CAN J PHYSIOL PHARM, V88, P497, DOI [10.1139/y10-020, 10.1139/Y10-020]; ALMEIDA LM, 1986, BIOCHEMISTRY-US, V25, P4832, DOI 10.1021/bi00365a017; BARRY JA, 1994, BIOCHEMISTRY-US, V33, P8082, DOI 10.1021/bi00192a013; Baskurt OK, 2013, CLIN HEMORHEOL MICRO, V54, P99, DOI 10.3233/CH-2012-1616; Baskurt OK, 2012, SEMIN THROMB HEMOST, V38, P854, DOI 10.1055/s-0032-1325616; Baskurt OK, 2009, SCAND J CLIN LAB INV, V69, P777, DOI 10.3109/00365510903266069; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Baskurt OK, 2013, ENDOTHELIUM MOL ASPE, P72; BEAUGE F, 1994, ALCOHOL ALCOHOLISM, V29, P59; Benga G, 1995, COMP BIOCHEM PHYS B, V112, P653, DOI 10.1016/0305-0491(95)00116-6; Blanc L, 2010, BIOCHEMISTRY-US, V49, P4516, DOI 10.1021/bi1003684; BOIGEGRAIN RA, 1984, CHEM PHYS LIPIDS, V35, P321, DOI 10.1016/0009-3084(84)90075-6; BRAHM J, 1983, J GEN PHYSIOL, V81, P283, DOI 10.1085/jgp.81.2.283; CHABANEL A, 1985, BIOCHIM BIOPHYS ACTA, V816, P142, DOI 10.1016/0005-2736(85)90402-X; CHASIS JA, 1986, J CELL BIOL, V103, P343, DOI 10.1083/jcb.103.2.343; CHIEN DY, 1977, BIOCHIM BIOPHYS ACTA, V464, P45, DOI 10.1016/0005-2736(77)90369-8; CHIEN S, 1987, ANNU REV PHYSIOL, V49, P177, DOI 10.1146/annurev.ph.49.030187.001141; Chmiel B, 1999, CLIN HEMORHEOL MICRO, V21, P325; Cicco G, 1999, CLIN HEMORHEOL MICRO, V21, P169; COLLANDER R, 1954, PHYSIOL PLANTARUM, V7, P420, DOI 10.1111/j.1399-3054.1954.tb07589.x; Dickey AN, 2007, BIOPHYS J, V92, P2366, DOI 10.1529/biophysj.106.097022; Fehr M, 2008, CLIN HEMORHEOL MICRO, V39, P351, DOI 10.3233/CH-2008-1102; Gurtovenko AA, 2009, J PHYS CHEM B, V113, P1983, DOI 10.1021/jp808041z; Ingolfsson HI, 2011, BIOPHYS J, V101, P847, DOI 10.1016/j.bpj.2011.07.013; Johnson RM, 1989, METHOD ENZYMOL, V173, P35, DOI [10.1016/S0076-6879(89)73004-4, DOI 10.1016/S0076-6879(89)73004-4, 10.1016/s0076-6879(89)73004-4]; Kaye MD, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.050907; Kleszczynska H, 2005, J FLUORESC, V15, P137, DOI 10.1007/s10895-005-2521-7; Koter M, 2004, INT J BIOCHEM CELL B, V36, P205, DOI 10.1016/S1357-2725(03)00195-X; Lahajnar G, 2000, BIOELECTROCHEMISTRY, V52, P179, DOI 10.1016/S0302-4598(00)00100-8; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Ly HV, 2004, BIOPHYS J, V87, P1013, DOI 10.1529/biophysj.103.034280; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Mesquita R, 1999, CLIN HEMORHEOL MICRO, V21, P95; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; MOHANDAS N, 1982, BLOOD, V59, P768; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nagai Y, 2001, CLIN HEMORHEOL MICRO, V25, P135; Oonishi T, 2000, ALCOHOL CLIN EXP RES, V24, P352, DOI 10.1097/00000374-200003000-00017; ORLOV SN, 1982, CLIN SCI, V63, P43, DOI 10.1042/cs0630043; Patra M, 2006, BIOPHYS J, V90, P1121, DOI 10.1529/biophysj.105.062364; Rabai M, 2014, CLIN HEMORHEOL MICRO, V56, P87, DOI 10.3233/CH-2012-1632; Rabai M, 2010, CLIN HEMORHEOL MICRO, V44, P227, DOI 10.3233/CH-2010-1267; REED K W, 1987, Journal of Parenteral Science and Technology, V41, P37; Reinhart WH, 2011, CLIN HEMORHEOL MICRO, V49, P11, DOI 10.3233/CH-2011-1453; SCHREIER S, 1978, BIOCHIM BIOPHYS ACTA, V515, P395, DOI DOI 10.1016/0304-4157(78)90011-4; Spasojevic I, 2011, CRIT REV CL LAB SCI, V48, P114, DOI 10.3109/10408363.2011.591772; Subczynski WK, 2000, ACTA BIOCHIM POL, V47, P613, DOI 10.18388/abp.2000_3983; TSUDA K, 1987, HYPERTENSION, V9, P19; Uyuklu M, 2007, CLIN HEMORHEOL MICRO, V36, P25; VERTESSY BG, 1989, BIOPHYS J, V55, P255, DOI 10.1016/S0006-3495(89)82800-0; WIDMER J, 1987, NEUROPSYCHOBIOLOGY, V18, P60, DOI 10.1159/000118394; Zicha J, 1999, AM J HYPERTENS, V12, P315, DOI 10.1016/S0895-7061(98)00178-2	54	36	37	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76579	10.1371/journal.pone.0076579	http://dx.doi.org/10.1371/journal.pone.0076579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086751	Green Published, gold			2022-12-27	WOS:000326520200139
J	Werfel, J; Krause, S; Bischof, AG; Mannix, RJ; Tobin, H; Bar-Yam, Y; Bellin, RM; Ingber, DE				Werfel, Justin; Krause, Silva; Bischof, Ashley G.; Mannix, Robert J.; Tobin, Heather; Bar-Yam, Yaneer; Bellin, Robert M.; Ingber, Donald E.			How Changes in Extracellular Matrix Mechanics and Gene Expression Variability Might Combine to Drive Cancer Progression	PLOS ONE			English	Article							NONLINEAR SIMULATION; BREAST-CANCER; TUMOR-GROWTH; CELL-SHAPE; STEM-CELL; DIFFERENTIATION; APOPTOSIS; DISEASE; MODEL; MICROENVIRONMENT	Changes in extracellular matrix (ECM) structure or mechanics can actively drive cancer progression; however, the underlying mechanism remains unknown. Here we explore whether this process could be mediated by changes in cell shape that lead to increases in genetic noise, given that both factors have been independently shown to alter gene expression and induce cell fate switching. We do this using a computer simulation model that explores the impact of physical changes in the tissue microenvironment under conditions in which physical deformation of cells increases gene expression variability among genetically identical cells. The model reveals that cancerous tissue growth can be driven by physical changes in the microenvironment: when increases in cell shape variability due to growth-dependent increases in cell packing density enhance gene expression variation, heterogeneous autonomous growth and further structural disorganization can result, thereby driving cancer progression via positive feedback. The model parameters that led to this prediction are consistent with experimental measurements of mammary tissues that spontaneously undergo cancer progression in transgenic C3(1)-SV40Tag female mice, which exhibit enhanced stiffness of mammary ducts, as well as progressive increases in variability of cell-cell relations and associated cell shape changes. These results demonstrate the potential for physical changes in the tissue microenvironment (e.g., altered ECM mechanics) to induce a cancerous phenotype or accelerate cancer progression in a clonal population through local changes in cell geometry and increased phenotypic variability, even in the absence of gene mutation.	[Werfel, Justin; Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Krause, Silva; Bischof, Ashley G.; Mannix, Robert J.; Tobin, Heather; Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Krause, Silva; Bischof, Ashley G.; Mannix, Robert J.; Tobin, Heather; Ingber, Donald E.] Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Krause, Silva; Bischof, Ashley G.; Mannix, Robert J.; Tobin, Heather; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA USA; [Bischof, Ashley G.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Bar-Yam, Yaneer] New England Complex Syst Inst, Cambridge, MA USA; [Bellin, Robert M.] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; College of the Holy Cross; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019		DOD Breast Cancer Innovator Award [BC074986]; DOD Breast Cancer Multi-Team Award [W81XWH-10-1-0565]; Susan G. Komen postdoctoral fellowship [KG101329]; Wyss Institute for Biologically Inspired Engineering at Harvard University	DOD Breast Cancer Innovator Award(United States Department of Defense); DOD Breast Cancer Multi-Team Award; Susan G. Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); Wyss Institute for Biologically Inspired Engineering at Harvard University	This work was supported by a DOD Breast Cancer Innovator Award (BC074986 to DEI), a DOD Breast Cancer Multi-Team Award (W81XWH-10-1-0565 to DEI), a Susan G. Komen postdoctoral fellowship (KG101329 to SK), and the Wyss Institute for Biologically Inspired Engineering at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahangar R, 2004, BIODYNAMIC MODELING; Amyot F, 2009, MICROVASC RES, V77, P87, DOI 10.1016/j.mvr.2007.11.001; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bissell MJ, 1999, CANCER RES, V59, p1763S; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Cai Y, 2009, ACTA MECH SINICA-PRC, V25, P889, DOI 10.1007/s10409-009-0301-3; Capp JP, 2005, BIOESSAYS, V27, P1277, DOI 10.1002/bies.20326; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CRAWLEY WA, 1978, PLAST RECONSTR SURG, V62, P407, DOI 10.1097/00006534-197809000-00012; Cristini V, 2003, J MATH BIOL, V46, P191, DOI 10.1007/s00285-002-0174-6; DECOSSE JJ, 1975, J NATL CANCER I, V54, P913; DECOSSE JJ, 1973, SCIENCE, V181, P1057, DOI 10.1126/science.181.4104.1057; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; GOWING N F, 1961, J Forensic Med, V8, P116; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Haddow A, 1974, Adv Cancer Res, V20, P343, DOI 10.1016/S0065-230X(08)60113-X; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Huang Sui, 2006, Breast Dis, V26, P27; Huang S, 2012, PROG BIOPHYS MOL BIO, V110, P69, DOI 10.1016/j.pbiomolbio.2012.05.001; Ingber DE, 2002, DIFFERENTIATION, V70, P547, DOI 10.1046/j.1432-0436.2002.700908.x; INGBER DE, 1981, P NATL ACAD SCI-BIOL, V78, P3901, DOI 10.1073/pnas.78.6.3901; Ingber DE., 1985, GENE EXPRESSION NORM, P13; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Jeon J, 2010, BIOPHYS J, V98, P37, DOI 10.1016/j.bpj.2009.10.002; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; KEENAN KP, 1989, CANCER RES, V49, P1528; Laforge B, 2005, PROG BIOPHYS MOL BIO, V89, P93, DOI 10.1016/j.pbiomolbio.2004.11.004; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Macklin P, 2007, J THEOR BIOL, V245, P677, DOI 10.1016/j.jtbi.2006.12.004; Maffini MV, 2005, AM J PATHOL, V167, P1405, DOI 10.1016/S0002-9440(10)61227-8; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; McCullough KD, 1998, P NATL ACAD SCI USA, V95, P15333, DOI 10.1073/pnas.95.26.15333; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PIENTA KJ, 1989, CANCER RES, V49, P2525; Polte TR, 2004, AM J PHYSIOL-CELL PH, V286, pC518, DOI 10.1152/ajpcell.00280.2003; Quaranta V, 2008, SEMIN CANCER BIOL, V18, P338, DOI 10.1016/j.semcancer.2008.03.018; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Venugopalan G, 2012, BREAST CANC CELLS GR; WATANABE TK, 1984, CANCER RES, V44, P5361; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; WITTELSBERGER SC, 1981, CELL, V24, P859, DOI 10.1016/0092-8674(81)90111-2; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	57	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76122	10.1371/journal.pone.0076122	http://dx.doi.org/10.1371/journal.pone.0076122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098430	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600028
J	Komaki, R; Togashi, H; Takai, Y				Komaki, Ryouhei; Togashi, Hideru; Takai, Yoshimi			Regulation of Dendritic Filopodial Interactions by ZO-1 and Implications for Dendrite Morphogenesis	PLOS ONE			English	Article							CELL-ADHESION; SELF-AVOIDANCE; ALPHA-CATENIN; NECTIN; PROTEIN; PROTOCADHERINS; IDENTIFICATION; ESTABLISHMENT; INVOLVEMENT; MECHANISMS	Neuronal dendrites dynamically protrude many fine filopodia in the early stages of neuronal development and gradually establish complex structures. The importance of the dendritic filopodia in the formation of axo-dendritic connections is established, but their role in dendrite morphogenesis remains unknown. Using time-lapse imaging of cultured rat hippocampal neurons, we revealed here that many filopodia dynamically protruded from dendrites and transiently interacted with each other to form dendritic filopodia-filopodia contacts in the early stages of neuronal development. The MAGUK family member, Zonula Occludens-1 (ZO-1), which is known to be associated with the nectin and cadherin cell adhesion systems, was concentrated at these dendritic filopodia-filopodia contact sites and also at the tips of free dendritic filopodia. Overexpression of ZO-1 increased the formation of dendritic filopodia and their interactions, and induced abnormal dendrite morphology. Conversely, knockdown of ZO-1 decreased the formation of dendritic filopodia and their interactions, and induced abnormal dendrite morphology which was different from that induced by the overexpression of ZO-1. The components of the nectin and cadherin systems were co-localized with ZO-1 at the dendritic filopodia-filopodia contact sites, but not at the tips of free dendritic filopodia. Overexpression of ZO-1 increased the accumulation of these cell adhesive components at the dendritic filopodia-filopodia contact sites and stabilized their interactions, whereas knockdown of ZO-1 reduced their accumulation at the dendritic filopodia-filopodia contact sites. These results indicate that ZO-1 regulates dendritic filopodial dynamics, which is implicated in dendrite morphogenesis cooperatively with the nectin and cadherin systems in cultured neurons.	[Komaki, Ryouhei; Togashi, Hideru; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Takai, Yoshimi] Japan Sci & Technol Agcy, CREST, Kobe, Hyogo, Japan	Kobe University; Kobe University; Japan Science & Technology Agency (JST)	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan.	ytakai@med.kobe-u.ac.jp		Togashi, Hideru/0000-0002-3967-5940	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"; Japan Society for the Promotion of Science	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Global COE Program "Global Center for Education and Research in Integrative Membrane Biology" (to YT) and Grants-in-Aid for Scientific Research (S) (to YT) and (C) (to HT) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dailey ME, 1996, J NEUROSCI, V16, P2983; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; GOSLIN K, 1998, CULTURING NERVE CELL; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Inagaki M, 2003, J COMP NEUROL, V460, P514, DOI 10.1002/cne.10653; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	34	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76201	10.1371/journal.pone.0076201	http://dx.doi.org/10.1371/journal.pone.0076201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098443	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500050
J	Nguyen, VL; Kooi, ME; Backes, WH; van Hoof, RHM; Saris, AECM; Wishaupt, MCJ; Hellenthal, FAMVI; van der Geest, RJ; Kessels, AGH; Schurink, GWH; Leiner, T				Nguyen, V. Lai; Kooi, M. Eline; Backes, Walter H.; van Hoof, Raf H. M.; Saris, Anne E. C. M.; Wishaupt, Mirthe C. J.; Hellenthal, Femke A. M. V. I.; van der Geest, Rob J.; Kessels, Alfons G. H.; Schurink, Geert Willem H.; Leiner, Tim			Suitability of Pharmacokinetic Models for Dynamic Contrast-Enhanced MRI of Abdominal Aortic Aneurysm Vessel Wall: A Comparison	PLOS ONE			English	Article							CAROTID ATHEROSCLEROTIC PLAQUE; BRAIN TRANSFER CONSTANTS; FOR-VASCULAR-SURGERY; MEDIAL NEOVASCULARIZATION; MAGNETIC-RESONANCE; METAANALYSIS; GUIDELINES; INJECTION; EXPANSION; RUPTURE	Purpose: Increased microvascularization of the abdominal aortic aneurysm (AAA) vessel wall has been related to AAA progression and rupture. The aim of this study was to compare the suitability of three pharmacokinetic models to describe AAA vessel wall enhancement using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Materials and Methods: Patients with AAA underwent DCE-MRI at 1.5 Tesla. The volume transfer constant (K-trans), which reflects microvascular flow, permeability and surface area, was calculated by fitting the blood and aneurysm vessel wall gadolinium concentration curves. The relative fit errors, parameter uncertainties and parameter reproducibilities for the Patlak, Tofts and Extended Tofts model were compared to find the most suitable model. Scan-rescan reproducibility was assessed using the interclass correlation coefficient and coefficient of variation (CV). Further, the relationship between K-trans and AAA size was investigated. Results: DCE-MRI examinations from thirty-nine patients (mean age +/- SD: 72 +/- 6 years; M/F: 35/4) with an mean AAA maximal diameter of 49 +/- 6 mm could be included for pharmacokinetic analysis. Relative fit uncertainties for K-trans based on the Patlak model (17%) were significantly lower compared to the Tofts (37%) and Extended Tofts model (42%) (p < 0.001). K-trans scan-rescan reproducibility for the Patlak model (ICC = 0.61 and CV = 22%) was comparable with the Tofts (ICC = 0.61, CV = 23%) and Extended Tofts model (ICC = 0.76, CV = 22%). K-trans was positively correlated with maximal AAA diameter (Spearman's rho = 0.38, p = 0.02) using the Patlak model. Conclusion: Using the presented imaging protocol, the Patlak model is most suited to describe DCE-MRI data of the AAA vessel wall with good K-trans scan-rescan reproducibility.	[Nguyen, V. Lai; Wishaupt, Mirthe C. J.; Hellenthal, Femke A. M. V. I.; Schurink, Geert Willem H.] Maastricht Univ, Med Ctr, Dept Vasc Surg, Maastricht, Netherlands; [Nguyen, V. Lai; Kooi, M. Eline; Backes, Walter H.; van Hoof, Raf H. M.; Wishaupt, Mirthe C. J.; Schurink, Geert Willem H.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Kooi, M. Eline; Backes, Walter H.; van Hoof, Raf H. M.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Backes, Walter H.] Maastricht Univ, Med Ctr, Res Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Saris, Anne E. C. M.] Univ Med Ctr Nijmegen, Dept Radiol, Nijmegen, Netherlands; [van der Geest, Rob J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Kessels, Alfons G. H.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; [Schurink, Geert Willem H.] European Vasc Ctr Maastricht Aachen, Dept Vasc Surg, Maastricht, Netherlands; [Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Utrecht University; Utrecht University Medical Center	Nguyen, VL (corresponding author), Maastricht Univ, Med Ctr, Dept Vasc Surg, Maastricht, Netherlands.	lai_van_nguyen@hotmail.com	van der Geest, Rob J/J-8193-2015; Saris, Anne E.C.M./T-7173-2018; Kooi, M. Eline/D-3848-2016	van der Geest, Rob J/0000-0002-9084-5597; Saris, Anne E.C.M./0000-0002-3402-3302; Kooi, M. Eline/0000-0001-7562-5724; van Hoof, Raf/0000-0003-3153-3101	Dutch Heart Foundation [2008B042]	Dutch Heart Foundation(Netherlands Heart Foundation)	This study is founded by the Dutch Heart Foundation. Grant number 2008B042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2008, MAGN RESON MED, V59, P1111, DOI 10.1002/mrm.21575; BENGTSSON H, 1993, J VASC SURG, V18, P74, DOI 10.1067/mva.1993.42107; Brewster DC, 2003, J VASC SURG, V37, P1106, DOI 10.1067/mva.2003.363; Chen HJ, 2013, MAGN RESON MED, V69, P1712, DOI 10.1002/mrm.24415; Chen HJ, 2011, MAGN RESON MED, V66, P868, DOI 10.1002/mrm.22819; Choke E, 2006, ARTERIOSCL THROM VAS, V26, P2077, DOI 10.1161/01.ATV.0000234944.22509.f9; ERNST RR, 1966, REV SCI INSTRUM, V37, P93, DOI 10.1063/1.1719961; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Guessous I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001895; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; HOLMES DR, 1995, J VASC SURG, V21, P761, DOI 10.1016/S0741-5214(05)80007-2; JOHANSSON G, 1986, BRIT J SURG, V73, P101, DOI 10.1002/bjs.1800730205; Kajimoto K, 2009, ATHEROSCLEROSIS, V206, P505, DOI 10.1016/j.atherosclerosis.2009.03.028; Kerwin W, 2003, CIRCULATION, V107, P851, DOI 10.1161/01.CIR.0000048145.52309.31; Kerwin WS, 2008, MAGN RESON MED, V59, P507, DOI 10.1002/mrm.21532; Kerwin WS, 2006, RADIOLOGY, V241, P459, DOI 10.1148/radiol.2412051336; KOCH AE, 1990, AM J PATHOL, V137, P1199; Lopata RGP, 2007, MAGN RESON MED, V58, P425, DOI 10.1002/mrm.21336; Loveless ME, 2012, MAGN RESON MED, V67, P226, DOI 10.1002/mrm.22988; Nicholls SC, 1998, J VASC SURG, V28, P884, DOI 10.1016/S0741-5214(98)70065-5; Padhani AR, 2001, CLIN RADIOL, V56, P607, DOI 10.1053/crad.2001.0762; Paik DC, 2004, EXP MOL MED, V36, P524, DOI 10.1038/emm.2004.67; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Reeps C, 2009, PATHOBIOLOGY, V76, P243, DOI 10.1159/000228900; Richards JMJ, 2011, CIRC-CARDIOVASC IMAG, V4, P274, DOI 10.1161/CIRCIMAGING.110.959866; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Takagi H, 2010, J VASC SURG, V52, P1675, DOI 10.1016/j.jvs.2010.04.082; Tanaka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057398; Thompson AR, 2010, BRIT J SURG, V97, P37, DOI 10.1002/bjs.6779; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; WEINMANN HJ, 1984, PHYSIOL CHEM PHYS ME, V16, P167	33	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75173	10.1371/journal.pone.0075173	http://dx.doi.org/10.1371/journal.pone.0075173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098370	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500023
J	O'Brien, CE; Price, ET				O'Brien, Catherine E.; Price, Elvin T.			The Blood Neutrophil to Lymphocyte Ratio Correlates with Clinical Status in Children with Cystic Fibrosis: A Retrospective Study	PLOS ONE			English	Article							LONG-TERM MORTALITY; PREOPERATIVE NEUTROPHIL; NEUTROPHIL/LYMPHOCYTE RATIO; CURATIVE RESECTION; PULMONARY-FUNCTION; ASSOCIATION; SURVIVAL; INFLAMMATION; RECURRENCE; PROFILES	Purpose: The blood neutrophil to lymphocyte ratio (NLR) has been identified as a potentially useful marker of clinical outcome in disease states with an inflammatory component. The objective of this study was to evaluate the relationship between NLR and clinical status in children with cystic fibrosis. Methods: This was a retrospective chart review. Data collected included NLR, body mass index, and forced expiratory volume in 1 second (FEV1) while asymptomatic, and during hospitalizations for pulmonary exacerbation. An NLR breakpoint of 3 was used for comparisons of body mass index and FEV1. Results: A total of 159 charts were reviewed. An NLR >= 3 was significantly associated with lower body mass index and lower FEV1. NLR during hospitalization was significantly higher than NLR while asymptomatic. NLR measured during the first 3 months of life was negatively correlated with FEV1 at age 12. Conclusion: NLR correlates with clinical status in children with cystic fibrosis and may be a useful biomarker in this population.	[O'Brien, Catherine E.] Univ Arkansas Med Sci, Coll Pharm, Dept Pharm Practice, Little Rock, AR 72205 USA; [O'Brien, Catherine E.] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Div Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Price, Elvin T.] Univ Arkansas Med Sci, Coll Pharm, Dept Pharmaceut Sci, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	O'Brien, CE (corresponding author), Univ Arkansas Med Sci, Coll Pharm, Dept Pharm Practice, Little Rock, AR 72205 USA.	OBrienCatherineE@uams.edu						Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Bhutta H, 2011, VASC ENDOVASC SURG, V45, P227, DOI 10.1177/1538574410396590; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Cystic Fibrosis Foundation Patient Registry, 2011, ANN DAT REP 2011 BET; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Farrell PM, 2003, PEDIATR PULM, V36, P230, DOI 10.1002/ppul.10336; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Hung HY, 2011, INT J COLORECTAL DIS, V26, P1059, DOI 10.1007/s00384-011-1192-x; Keizman D, 2012, EUR J CANCER, V48, P202, DOI 10.1016/j.ejca.2011.09.001; Kim JS, 2006, CHEST, V129, P1148, DOI 10.1378/chest.129.5.1148; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Kocyigit I, 2013, J NEPHROL, V26, P358, DOI 10.5301/jn.5000152; Lee YY, 2012, ANTICANCER RES, V32, P1555; Marguet C, 1999, AM J RESP CRIT CARE, V159, P1533, DOI 10.1164/ajrccm.159.5.9805028; Markar SR, 2010, ACTA CHIR BELG, V110, P543, DOI 10.1080/00015458.2010.11680673; Mayer-Hamblett N, 2007, AM J RESP CRIT CARE, V175, P822, DOI 10.1164/rccm.200609-1354OC; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Ohno Y, 2012, J UROLOGY, V187, P411, DOI 10.1016/j.juro.2011.10.026; Sagel SD, 2002, J PEDIATR-US, V141, P811, DOI 10.1067/mpd.2002.129847; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Tomita M, 2011, ANTICANCER RES, V31, P2995; Uthamalingam S, 2011, AM J CARDIOL, V107, P433, DOI 10.1016/j.amjcard.2010.09.039	25	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77420	10.1371/journal.pone.0077420	http://dx.doi.org/10.1371/journal.pone.0077420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098587	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500101
J	Pocewicz, A; Estes-Zumpf, WA; Andersen, MD; Copeland, HE; Keinath, DA; Griscom, HR				Pocewicz, Amy; Estes-Zumpf, Wendy A.; Andersen, Mark D.; Copeland, Holly E.; Keinath, Douglas A.; Griscom, Hannah R.			Modeling the Distribution of Migratory Bird Stopovers to Inform Landscape-Scale Siting of Wind Development	PLOS ONE			English	Article							SEASONAL MOVEMENTS; SPRING-MIGRATION; SANDHILL CRANES; AVIAN USE; MORTALITY; CONSERVATION; ECOLOGY; SITES; AREA	Conservation of migratory birds requires understanding the distribution of and potential threats to their migratory habitats. However, although migratory birds are protected under international treaties, few maps have been available to represent migration at a landscape scale useful to target conservation efforts or inform the siting of wind energy developments that may affect migratory birds. To fill this gap, we developed models that predict where four groups of birds concentrate or stopover during their migration through the state of Wyoming, USA: raptors, wetland, riparian and sparse grassland birds. The models were based on existing literature and expert knowledge concerning bird migration behavior and ecology and validated using expert ratings and known occurrences. There was significant agreement between migratory occurrence data and migration models for all groups except raptors, and all models ranked well with experts. We measured the overlap between the migration concentration models and a predictive model of wind energy development to assess the potential exposure of migratory birds to wind development and illustrate the utility of migratory concentration models for landscape-scale planning. Wind development potential is high across 15% of Wyoming, and 73% of this high potential area intersects important migration concentration areas. From 5.2% to 18.8% of each group's important migration areas was represented within this high wind potential area, with the highest exposures for sparse grassland birds and the lowest for riparian birds. Our approach could be replicated elsewhere to fill critical data gaps and better inform conservation priorities and landscape-scale planning for migratory birds.	[Pocewicz, Amy; Copeland, Holly E.] Nature Conservancy, Wyoming Chapter, Lander, WY USA; [Estes-Zumpf, Wendy A.; Andersen, Mark D.; Keinath, Douglas A.; Griscom, Hannah R.] Univ Wyoming, Wyoming Nat Div Database, Laramie, WY 82071 USA	Nature Conservancy; University of Wyoming	Pocewicz, A (corresponding author), Nature Conservancy, Wyoming Chapter, Lander, WY USA.	apocewicz@tnc.org			Mayer and Morris Kaplan Family Foundation	Mayer and Morris Kaplan Family Foundation	This study was funded by a grant from the Mayer and Morris Kaplan Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration U.E.I., 2011, ANN ENERGY OUTLOOK 2; Alexander SA, 1997, SHOREBIRD MIGRATION; American Wind Energy Association, 2012, WIND EN FACTS WYOMIN; Arnett EB, 2007, WILDLIFE SOC TECHNIC, P49; Beason RC, 1995, BIRDS N AM ONLINE; Bechard M. J., 2010, BIRDS N AM ONLINE, DOI [10.2173/bow.swahaw.01, DOI 10.2173/BOW.SWAHAW.01]; Bechard MJ, 1995, BIRDS N AM ONLINE; Beier P., 2007, CONCEPTUAL STEPS DES; Bellrose F, 1980, DUCKS GEESE SWANS N; BINGMAN VP, 1982, ANIM BEHAV, V30, P49, DOI 10.1016/S0003-3472(82)80236-4; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Carlisle JD, 2009, CONDOR, V111, P211, DOI 10.1525/cond.2009.080096; Comer P., 2003, ECOLOGICAL SYSTEMS U; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Copeland H, 2011, ENERGY DEV WILDLIFE; Copeland HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067261; Copeland HE, 2010, ECOL INDIC, V10, P869, DOI 10.1016/j.ecolind.2010.01.011; Cottam Clarence, 1944, CONDOR, V46, P127; Davidson A, 2009, DIGITAL LAND COVER M; DeLong JP, 2005, J FIELD ORNITHOL, V76, P326, DOI 10.1648/0273-8570-76.4.326; Department of Energy, 2008, 20 WIND EN 2030 INCR; Desholm M, 2009, J ENVIRON MANAGE, V90, P2672, DOI 10.1016/j.jenvman.2009.02.005; Dinsmore SJ, 2005, J WILDLIFE MANAGE, V69, P1546, DOI 10.2193/0022-541X(2005)69[1546:MPPRTB]2.0.CO;2; Dinsmore SJ, 2003, ECOL APPL, V13, P1013, DOI 10.1890/01-5311; Downs JA, 2008, INT J GEOGR INF SCI, V22, P687, DOI 10.1080/13658810701674962; Drewien RC, 1999, J WILDLIFE MANAGE, V63, P126, DOI 10.2307/3802493; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Energy Information Administration, 2011, ANN EN REV 2010; Erickson WP, 2001, AVIAN COLLISIONS WIN; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Fargione J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041468; Faulkner D. W., 2010, BIRDS WYOMING; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Fink D., 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1.; Franklin J, 2009, MAPPING SPECIES DIST; Galle AM, 2009, WEST N AM NATURALIST, V69, P491, DOI 10.3398/064.069.0409; Gammonley JH, 1996, BIRDS N AM ONLINE; Goodrich LJ, 2008, STATE N AM BIRDS PRE; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heintzelman DS, 1986, MIGRATION HAWKS; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Hill D. P., 1997, BIRDS N AM ONLINE; HOPKINS LD, 1977, J AM I PLANNERS, V43, P386, DOI 10.1080/01944367708977903; Hothem RL, 2010, BIRDS N AM ONLINE; Hutto RL, 2000, STUD AVIAN BIOL-SER, P109; Jenness J., 2006, TOPOGRAPHIC POSITION; Keinath D. A., 2010, RANGE MODELED DISTRI; Kerlinger P., 1989, FLIGHT STRATEGIES MI; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kingsley A, 2003, WIND TURBIN IN PRESS, P79; Knopf FL, 2006, BIRDS N AM ONLINE; Knopf FL, 2004, BIRDS N AM ONLINE; Krueper D, 2003, CONSERV BIOL, V17, P607, DOI 10.1046/j.1523-1739.2003.01546.x; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; McClelland BR, 1994, WILDLIFE MONOGR, V125, P3; Mitchell CD, 2010, BIRDS N AM ONLINE; Munson M Arthur, 2011, EBIRD REFERENCE DATA; National Renewable Energy Laboratory, 2008, ANN AV WIND RES POT; Neal M. C., 2009, FALL 2009 RAPTOR MIG; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; O'Donnell MS, 2010, SPATIAL MAPPING ATTR; Obermeyer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026698; Ott, 2012, MONITORING LEMMING A; Parrish JD, 2000, STUD AVIAN BIOL-SER, P53; Pearse AT, 2011, WATERBIRDS, V34, P10, DOI 10.1675/063.034.0102; Petit DR, 2000, STUD AVIAN BIOL-SER, P15; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Piorkowski MD, 2012, J WILDLIFE MANAGE, V76, P451, DOI 10.1002/jwmg.327; Poulin R, 2011, BIRDS N AM ONLINE; Pugesek BH, 1999, WATERBIRDS, V22, P29, DOI 10.2307/1521990; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reed JM, 2013, BIRDS N AM ONLINE; REINECKE KJ, 1986, J WILDLIFE MANAGE, V50, P71, DOI 10.2307/3801490; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rubega M. A., 2000, BIRDS N AM ONLINE; Ryder R. A., 1994, BIRDS N AM ONLINE; RYDER RA, 1967, BIRD BANDING, V38, P257, DOI 10.2307/4511410; SKAGEN SK, 1993, CONSERV BIOL, V7, P533, DOI 10.1046/j.1523-1739.1993.07030533.x; Skagen SK, 1998, CONSERV BIOL, V12, P896, DOI 10.1046/j.1523-1739.1998.96384.x; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1082, DOI 10.2193/2008-555; Smith JP, 2001, FALL 2000 EXPLORATOR; Steenhof K, 2005, CONDOR, V107, P481, DOI 10.1650/0010-5422(2005)107[0481:LMABDO]2.0.CO;2; Steenhof K, 1998, BIRDS N AM ONLINE; Stevens LE, 1977, IMPORTANCE PRESERVAT, P156; Tankersley R, 2003, ECOL SOC, V7; The White House, 2011, BLUEPR SEC EN FUT; U. S. Environmental Protection Agency, 2010, LEV 3 EC CONT US REV; van Riper CI, 2008, PROTECTED AREAS PARK, P312; Vickery PD, 1996, BIRDS N AM ONLINE; Wethington Susan M., 2005, U S Forest Service General Technical Report PSW, V191, P646; White C.M., 2020, BIRDS OF THE WORLD; Williams C. S., 1944, AUK, V61, P251; Yong W, 1997, SOUTHWEST NAT, V42, P137	99	10	12	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75363	10.1371/journal.pone.0075363	http://dx.doi.org/10.1371/journal.pone.0075363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098379	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500028
J	Zhai, CZ; Zhao, L; Yin, LJ; Chen, M; Wang, QY; Li, LC; Xu, ZS; Ma, YZ				Zhai, Chao-Zeng; Zhao, Lei; Yin, Li-Juan; Chen, Ming; Wang, Qing-Yu; Li, Lian-Cheng; Xu, Zhao-Shi; Ma, You-Zhi			Two Wheat Glutathione Peroxidase Genes Whose Products Are Located in Chloroplasts Improve Salt and H2O2 Tolerances in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID; HYDROGEN-PEROXIDE; MOLECULAR CHARACTERIZATION; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; FREE-RADICALS; DROUGHT; EXPRESSION; PROMOTER; PLANTS	Oxidative stress caused by accumulation of reactive oxygen species (ROS) is capable of damaging effects on numerous cellular components. Glutathione peroxidases (GPXs, EC 1.11.1.9) are key enzymes of the antioxidant network in plants. In this study, W69 and W106, two putative GPX genes, were obtained by de novo transcriptome sequencing of salt-treated wheat (Triticum aestivum) seedlings. The purified His-tag fusion proteins of W69 and W106 reduced H2O2 and t-butyl hydroperoxide (t-BHP) using glutathione (GSH) or thioredoxin (Trx) as an electron donor in vitro, showing their peroxidase activity toward H2O2 and toxic organic hydroperoxide. GFP fluorescence assays revealed that W69 and W106 are localized in chloroplasts. Quantitative real-time PCR (Q-RT-PCR) analysis showed that two GPXs were differentially responsive to salt, drought, H2O2, or ABA. Isolation of the W69 and W106 promoters revealed some cis-acting elements responding to abiotic stresses. Overexpression of W69 and W106 conferred strong tolerance to salt, H2O2, and ABA treatment in Arabidopsis. Moreover, the expression levels of key regulator genes (SOS1, RbohD and ABI1/ABI2) involved in salt, H2O2 and ABA signaling were altered in the transgenic plants. These findings suggest that W69 and W106 not only act as scavengers of H2O2 in controlling abiotic stress responses, but also play important roles in salt and ABA signaling.	[Zhai, Chao-Zeng; Yin, Li-Juan; Chen, Ming; Li, Lian-Cheng; Xu, Zhao-Shi; Ma, You-Zhi] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Key Lab Biol & Genet Improvement Triticeae Crops, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China; [Zhao, Lei; Wang, Qing-Yu] Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Jilin University	Xu, ZS (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Key Lab Biol & Genet Improvement Triticeae Crops, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China.	xuzhaoshi@caas.cn; mayouzhi@caas.cn			Natural Science Foundation of China [31171546]; National 863 High-tech Project [2012AA10A309]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 High-tech Project(National High Technology Research and Development Program of China)	This research was financially supported by the Natural Science Foundation of China (31171546) and the National 863 High-tech Project (2012AA10A309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; Aitken RJ, 2009, J CLIN INVEST, V119, P1849, DOI 10.1172/JCI39688; Avsian-Kretchmer O, 2004, PLANT PHYSIOL, V135, P1685, DOI 10.1104/pp.104.041921; Bae YA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-72; Baek IJ, 2011, IN VITRO CELL DEV-AN, V47, P535, DOI 10.1007/s11626-011-9438-z; Bartoli CG, 1999, J EXP BOT, V50, P375, DOI 10.1093/jexbot/50.332.373; Bhattacharjee S, 2005, CURR SCI INDIA, V89, P1113; Bonetta D, 1998, TRENDS PLANT SCI, V3, P231, DOI 10.1016/S1360-1385(98)01241-2; Chang CCC, 2009, PLANT PHYSIOL, V150, P670, DOI 10.1104/pp.109.135566; Chen SR, 2004, PLANT PHYSIOL, V135, P1630, DOI 10.1104/pp.103.038091; Churin Y, 1999, FEBS LETT, V459, P33, DOI 10.1016/S0014-5793(99)01208-9; CRIQUI MC, 1992, PLANT MOL BIOL, V18, P623, DOI 10.1007/BF00040684; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; Depege N, 2000, PHYSIOL PLANTARUM, V110, P209, DOI 10.1034/j.1399-3054.2000.110210.x; Depege N, 1998, EUR J BIOCHEM, V253, P445, DOI 10.1046/j.1432-1327.1998.2530445.x; Desikan R, 1998, HARPIN HYDROGEN PERO; El-Shabrawi H, 2010, PROTOPLASMA, V245, P85, DOI 10.1007/s00709-010-0144-6; Eshdat Y, 1997, PHYSIOL PLANTARUM, V100, P234, DOI 10.1034/j.1399-3054.1997.1000204.x; Faltin Z, 2010, PLANT CELL PHYSIOL, V51, P1151, DOI 10.1093/pcp/pcq082; Gaber A, 2012, PLANT CELL PHYSIOL, V53, P1596, DOI 10.1093/pcp/pcs100; George S, 2010, J PLANT PHYSIOL, V167, P311, DOI 10.1016/j.jplph.2009.09.004; GURLEY WB, 1991, BIOCHEMISTRY-US, V30, P1, DOI 10.1021/bi00215a001; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Haluskova L, 2009, PLANT PHYSIOL BIOCH, V47, P1069, DOI 10.1016/j.plaphy.2009.08.003; Herbette S, 2005, BBA-GEN SUBJECTS, V1724, P108, DOI 10.1016/j.bbagen.2005.04.018; Herbette S, 2007, FEBS J, V274, P2163, DOI 10.1111/j.1742-4658.2007.05774.x; Herbette S, 2011, PLANT SCI, V180, P548, DOI 10.1016/j.plantsci.2010.12.002; Himmelbach A, 1998, PHILOS T R SOC B, V353, P1439, DOI 10.1098/rstb.1998.0299; HOLLAND D, 1993, PLANT MOL BIOL, V21, P923, DOI 10.1007/BF00027124; Hu XL, 2006, PLANT CELL PHYSIOL, V47, P1484, DOI 10.1093/pcp/pcl014; Imai H, 1998, J BIOL CHEM, V273, P1990, DOI 10.1074/jbc.273.4.1990; Iqbal A, 2006, FEBS J, V273, P5589, DOI 10.1111/j.1742-4658.2006.05548.x; ITZHAKI H, 1993, PLANT MOL BIOL, V22, P43, DOI 10.1007/BF00038994; Jannat R, 2011, J PLANT PHYSIOL, V168, P1919, DOI 10.1016/j.jplph.2011.05.006; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Li SW, 2007, PLANT GROWTH REGUL, V52, P173, DOI 10.1007/s10725-007-9188-9; Li WJ, 2000, BBA-GENE STRUCT EXPR, V1493, P225, DOI 10.1016/S0167-4781(00)00152-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAIORINO M, 1990, METHOD ENZYMOL, V186, P448; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Qi YC, 2010, RUSS J PLANT PHYSL+, V57, P233, DOI 10.1134/S102144371002010X; Ramos J, 2009, NEW PHYTOL, V181, P103, DOI 10.1111/j.1469-8137.2008.02629.x; Roeckel-Drevet P, 1998, PHYSIOL PLANTARUM, V103, P385, DOI 10.1034/j.1399-3054.1998.1030312.x; Rouhier N, 2004, PLANT PHYSIOL, V134, P1027, DOI 10.1104/pp.103.035865; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Sakai T, 1996, PLANT CELL PHYSIOL, V37, P906, DOI 10.1093/oxfordjournals.pcp.a029038; Scandalios J.G., 1997, OXIDATIVE STRESS MOL, V34, P343, DOI [DOI 10.1101/087969502.34.343, 10.1101/0.343-406, DOI 10.1101/0.343-406]; Schneider M, 2006, GENE EXPR PATTERNS, V6, P489, DOI 10.1016/j.modgep.2005.11.002; Sheen J., 2002, TRANSIENT EXPRESSION; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Slesak I, 2007, ACTA BIOCHIM POL, V54, P39, DOI 10.18388/abp.2007_3267; Sugimoto M, 1997, GENES GENET SYST, V72, P311, DOI 10.1266/ggs.72.311; SUTLIFF TD, 1993, PLANT CELL, V5, P1681, DOI 10.1105/tpc.5.11.1681; Toppo S, 2008, ANTIOXID REDOX SIGN, V10, P1501, DOI 10.1089/ars.2008.2057; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Vernet P, 2004, MOL CELL ENDOCRINOL, V216, P31, DOI 10.1016/j.mce.2003.10.069; Victor VM, 2004, INT IMMUNOPHARMACOL, V4, P327, DOI 10.1016/j.intimp.2004.01.020; Wang MA, 2010, COMP BIOCHEM PHYS C, V152, P75, DOI 10.1016/j.cbpc.2010.03.003; Wang X, 2011, J PLANT PHYSIOL, V168, P585, DOI 10.1016/j.jplph.2010.09.016; Xu ZS, 2008, MOL GENET GENOMICS, V280, P497, DOI 10.1007/s00438-008-0382-x; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Xue ZY, 2004, PLANT SCI, V167, P849, DOI 10.1016/j.plantsci.2004.05.034; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yang XD, 2006, PLANT MOL BIOL, V62, P951, DOI 10.1007/s11103-006-9068-0; Ye NH, 2011, PLANT CELL PHYSIOL, V52, P689, DOI 10.1093/pcp/pcr028; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zorb C, 2013, J PLANT PHYSIOL, V170, P220, DOI 10.1016/j.jplph.2012.09.012	86	48	55	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e73989	10.1371/journal.pone.0073989	http://dx.doi.org/10.1371/journal.pone.0073989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098330	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500007
J	Boudil, A; Skhiri, L; Candeias, S; Pasqualetto, V; Legrand, A; Bedora-Faure, M; Gautreau-Rolland, L; Rocha, B; Ezine, S				Boudil, Amine; Skhiri, Lamia; Candeias, Serge; Pasqualetto, Valerie; Legrand, Agnes; Bedora-Faure, Marie; Gautreau-Rolland, Laetitia; Rocha, Benedita; Ezine, Sophie			Single-Cell Analysis of Thymocyte Differentiation: Identification of Transcription Factor Interactions and a Major Stochastic Component in alpha beta-Lineage Commitment	PLOS ONE			English	Article							ADULT-MOUSE THYMUS; T-CELL; GAMMA-DELTA; IMMUNE-SYSTEM; FATE; GENE; TCR; BCL11B; SPECIFICATION; CHECKPOINT	T cell commitment and alpha beta/gamma delta lineage specification in the thymus involves interactions between many different genes. Characterization of these interactions thus requires a multiparameter analysis of individual thymocytes. We developed two efficient single-cell methods: (i) the quantitative evaluation of the co-expression levels of nine different genes, with a plating efficiency of 99-100% and a detection limit of 2 mRNA molecules/cell; and (ii) single-cell differentiation cultures, in the presence of OP9 cells transfected with the thymus Notch1 ligand DeltaL4. We show that during T cell commitment, Gata3 has a fundamental, dose-dependent role in maintaining Notch1 expression, with thymocytes becoming T-cell-committed when they co-express Notch1, Gata3 and Bc11b. Of the transcription factor expression patterns studied here, only that of Bcl11b was suggestive of a role in Pu1 down-regulation. Individual thymocytes became alpha beta/gamma delta lineage-committed at very different stages (from the TN2a stage onwards). However, 20% of TN3 cells are not alpha beta/gamma delta-lineage committed and TN4 cells comprise two main subpopulations with different degrees of maturity. The existence of a correlation between differentiation potential and expression of the pre-TCR showed that 83% of alpha beta-committed cells do not express the pre-TCR and revealed a major stochastic component in alpha beta-lineage specification.	[Boudil, Amine; Skhiri, Lamia; Pasqualetto, Valerie; Legrand, Agnes; Bedora-Faure, Marie; Gautreau-Rolland, Laetitia; Rocha, Benedita; Ezine, Sophie] Inst Natl Sante & Rech Med, Unite 1020, Paris, France; [Boudil, Amine; Skhiri, Lamia; Pasqualetto, Valerie; Legrand, Agnes; Bedora-Faure, Marie; Gautreau-Rolland, Laetitia; Rocha, Benedita; Ezine, Sophie] Univ Paris 05, Unite Mixte Rech, Paris, France; [Candeias, Serge] Univ Grenoble 1, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, Ctr Natl Rech Sci,UMR 549, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Ezine, S (corresponding author), Inst Natl Sante & Rech Med, Unite 1020, Paris, France.	sophie.ezine@inserm.fr	Ricoux, Valerie/X-1921-2019; Gautreau-Rolland, Laetitia/AAC-8059-2019; Rolland, Laetitia Gautreau/L-3081-2015	Ricoux, Valerie/0000-0002-9812-8701; Gautreau-Rolland, Laetitia/0000-0003-0113-488X; Candeias, Serge/0000-0003-2257-5529; Marie, BEDORA-FAURE/0000-0002-4350-7683	Institut National de la Sante et de la Recherche Medicale; La Ligue Contre le Cancer; European Research Council (ERC); Societe Francaise d'Hematologie; Fondation pour la Recherche Medicale (FRM); Ministere de la Recherche et de la Technologie; Association de la Recherche sur le Cancer (ARC); ERC; ARC; FRM; Association Francaise contre les Myopathies; Agence de la BioMedecine	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); European Research Council (ERC)(European Research Council (ERC)European Commission); Societe Francaise d'Hematologie; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Ministere de la Recherche et de la Technologie; Association de la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); ERC(European Research Council (ERC)European Commission); ARC(Australian Research Council); FRM(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence de la BioMedecine	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Unit 1020 receives basic funding from the Institut National de la Sante et de la Recherche Medicale. AB was funded by La Ligue Contre le Cancer, the European Research Council (ERC), and the Societe Francaise d'Hematologie. LS was funded by the Fondation pour la Recherche Medicale (FRM). LGR was funded by the Ministere de la Recherche et de la Technologie and the Association de la Recherche sur le Cancer (ARC). This project was funded by grants from the ERC, ARC, FRM, Association Francaise contre les Myopathies and Agence de la BioMedecine.	Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Gautreau L, 2007, J IMMUNOL, V179, P2925, DOI 10.4049/jimmunol.179.5.2925; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Hozumi K, 2008, EUR J IMMUNOL, V38, P977, DOI 10.1002/eji.200737688; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2010, IMMUNOL REV, V238, P169, DOI 10.1111/j.1600-065X.2010.00947.x; Lambolez F, 2002, J EXP MED, V195, P437, DOI 10.1084/jem.20010798; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Mancini SJC, 2001, J IMMUNOL, V167, P4485, DOI 10.4049/jimmunol.167.8.4485; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Narayan K, 2010, SEMIN IMMUNOL, V22, P222, DOI 10.1016/j.smim.2010.04.003; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; PENIT C, 1995, J IMMUNOL, V154, P5103; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rothenberg EV, 2010, IMMUNOL REV, V238, P5, DOI 10.1111/j.1600-065X.2010.00965.x; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641; Xu W, 2007, BLOOD, V109, P4406, DOI 10.1182/blood-2006-08-043331; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679	35	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e73098	10.1371/journal.pone.0073098	http://dx.doi.org/10.1371/journal.pone.0073098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098325	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100003
J	Renganathan, K; Gu, JY; Rayborn, ME; Crabb, JS; Salomon, RG; Collier, RJ; Kapin, MA; Romano, C; Hollyfield, JG; Crabb, JW				Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Salomon, Robert G.; Collier, Robert J.; Kapin, Michael A.; Romano, Carmelo; Hollyfield, Joe G.; Crabb, John W.			CEP Biomarkers as Potential Tools for Monitoring Therapeutics	PLOS ONE			English	Article							5-HT1A RECEPTOR AGONIST; TRAUMATIC BRAIN-INJURY; FACTOR-H POLYMORPHISM; FACTOR-KAPPA-B; MACULAR DEGENERATION; BRUCHS MEMBRANE; SUPEROXIDE-DISMUTASE; DONOR EYES; DAMAGE; RAT	Background: Carboxyethylpyrrole (CEP) adducts are oxidative modifications derived from docosahexaenoate-containing lipids that are elevated in ocular tissues and plasma in age-related macular degeneration (AMD) and in rodents exposed to intense light. The goal of this study was to determine whether light-induced CEP adducts and autoantibodies are modulated by pretreatment with AL-8309A under conditions that prevent photo-oxidative damage of rat retina. AL-8309A is a serotonin 5-HT1A receptor agonist. Methods: Albino rats were dark adapted prior to blue light exposure. Control rats were maintained in normal cyclic light. Rats were injected subcutaneously 3x with 10 mg/kg AL-8309A (2 days, 1 day and 0 hours) before light exposure for 6 h (3.1 mW/cm(2), lambda=450 nm). Animals were sacrificed immediately following light exposure and eyes, retinas and plasma were collected. CEP adducts and autoantibodies were quantified by Western analysis or ELISA. Results: ANOVA supported significant differences in mean amounts of CEP adducts and autoantibodies among the light + vehicle, light + drug and dark control groups from both retina and plasma. Light-induced CEP adducts in retina were reduced similar to 20% following pretreatment with AL-8309A (n = 62 rats, p = 0.006) and retinal CEP immunoreactivity was less intense by immunohistochemistry. Plasma levels of light-induced CEP adducts were reduced at least 30% (n = 15 rats, p = 0.004) by drug pretreatment. Following drug treatment, average CEP autoantibody titer in light exposed rats (n = 22) was unchanged from dark control levels, and similar to 20% (p = 0.046) lower than in vehicle-treated rats. Conclusions: Light-induced CEP adducts in rat retina and plasma were significantly decreased by pretreatment with AL-8309A. These results are consistent with and extend previous studies showing AL-8309A reduces light-induced retinal lesions in rats and support CEP biomarkers as possible tools for monitoring the efficacy of select therapeutics.	[Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Hollyfield, Joe G.; Crabb, John W.] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Hollyfield, Joe G.; Crabb, John W.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Renganathan, Kutralanathan; Gu, Jiayin; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Collier, Robert J.; Kapin, Michael A.; Romano, Carmelo; Crabb, John W.] Novartis Inst Biomed Res, Ft Worth, TX USA; [Hollyfield, Joe G.; Crabb, John W.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Hollyfield, Joe G.; Crabb, John W.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Novartis; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Crabb, JW (corresponding author), Cleveland Clin Fdn, Cole Eye Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	crabbj@ccf.org		Salomon, Robert/0000-0001-9456-3557	National Institutes of Health (NIH) [GM21249, EY14239, EY14240, EY15638]; Ohio Biomedical Research Technology Transfer grant [05-29]; Research Center grant from The Foundation Fighting Blindness; Llura and Gordon Gund Foundation; Research to Prevent Blindness (RPB); Macular Vision Research Foundation award; RPB Senior Investigator Award; Steinbach Award; Alcon Research Ltd; Cleveland Clinic Foundation; NATIONAL EYE INSTITUTE [R21EY022134, R56EY014240, R01EY014239, R01EY014240, R01EY016813, R24EY015638, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Biomedical Research Technology Transfer grant; Research Center grant from The Foundation Fighting Blindness; Llura and Gordon Gund Foundation; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Macular Vision Research Foundation award; RPB Senior Investigator Award; Steinbach Award; Alcon Research Ltd(Novartis); Cleveland Clinic Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Institutes of Health (NIH) grants GM21249, EY14239, EY14240, EY15638, Ohio Biomedical Research Technology Transfer grant 05-29, a Research Center grant from The Foundation Fighting Blindness, the Llura and Gordon Gund Foundation, an unrestricted grant from Research to Prevent Blindness (RPB), a Macular Vision Research Foundation award to JGH, an RPB Senior Investigator Award to JWC, a Steinbach Award to JWC, Alcon Research Ltd, and The Cleveland Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adayev T, 2003, BBA-MOL CELL RES, V1640, P85, DOI 10.1016/S0167-4889(03)00023-5; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; ALVAREZ RA, 1994, INVEST OPHTH VIS SCI, V35, P402; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bando H, 2007, EXP EYE RES, V84, P135, DOI 10.1016/j.exer.2006.09.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradford MM, 1976, CNS DRUGS, V72, P248, DOI 10.1016/0003-2697(76) 90527-3; Collier RJ, 2010, INVEST OPHTH VIS SCI, V52, P2118; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418; Cosi C, 2005, BRAIN RES, V1043, P32, DOI 10.1016/j.brainres.2005.02.072; Cowen DS, 1997, MOL PHARMACOL, V52, P221, DOI 10.1124/mol.52.2.221; Crabb JW, 2012, OXID STRESS APPL BAS, P65, DOI 10.1007/978-1-61779-606-7_3; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DELMELLE M, 1975, EXP EYE RES, V21, P369, DOI 10.1016/0014-4835(75)90047-0; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Druse MJ, 2006, BRAIN RES, V1092, P79, DOI 10.1016/j.brainres.2006.02.065; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fulton B, 1997, CNS DRUGS, V7, P68, DOI 10.2165/00023210-199707010-00007; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; Guo Z, 2003, J BIOL CHEM, V278, P23570, DOI 10.1074/jbc.M303431200; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Johnson LR, 2000, IEEE ANN HIST COMPUT, V22, P70; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Marc RE, 2008, MOL VIS, V14, P782; Mauler F, 2005, J CEREBR BLOOD F MET, V25, P451, DOI 10.1038/sj.jcbfm.9600038; Miyagi M, 2002, MOL CELL PROTEOMICS, V1, P293, DOI 10.1074/mcp.M100034-MCP200; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Oosterink BJ, 2003, NEUROREPORT, V14, P57, DOI 10.1097/00001756-200301200-00011; Organisciak D, 2012, PHOTOCHEM PHOTOBIOL, V88, P1396, DOI 10.1111/j.1751-1097.2012.01134.x; *R DEV TEAM, 2008, R LANG ENV STAT COMP; Ramos AJ, 2004, BRAIN RES, V1030, P201, DOI 10.1016/j.brainres.2004.10.019; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; RORABACHER DB, 1991, J ANAL CHEM+, V83, P139, DOI DOI 10.1021/AC00003A730; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; WANG N, 1992, CURR EYE RES, V11, P783, DOI 10.3109/02713689209000751; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200	56	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76325	10.1371/journal.pone.0076325	http://dx.doi.org/10.1371/journal.pone.0076325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098476	Green Submitted, Green Published, gold			2022-12-27	WOS:000325427100059
J	Shashikala, S; Kumar, R; Thomas, NE; Sivadasan, D; James, J; Sengupta, S				Shashikala, Sasidharan; Kumar, Rohith; Thomas, Nisha E.; Sivadasan, Dhanesh; James, Jackson; Sengupta, Suparna			Fodrin in Centrosomes: Implication of a Role of Fodrin in the Transport of Gamma-Tubulin Complex in Brain	PLOS ONE			English	Article							MICROTUBULE-ORGANIZING CENTERS; INTERSTRAND CROSS-LINKS; RING COMPLEX; BETA-SPECTRIN; NONERYTHROID SPECTRIN; MEMBRANE SKELETON; AXONAL-TRANSPORT; ACTIN-BINDING; GOLGI-COMPLEX; CELL-CYCLE	Gamma-tubulin is the major protein involved in the nucleation of microtubules from centrosomes in eukaryotic cells. It is present in both cytoplasm and centrosome. However, before centrosome maturation prior to mitosis, gamma-tubulin concentration increases dramatically in the centrosome, the mechanism of which is not known. Earlier it was reported that cytoplasmic gamma-tubulin complex isolated from goat brain contains non-erythroid spectrin/fodrin. The major role of erythroid spectrin is to help in the membrane organisation and integrity. However, fodrin or non-erythroid spectrin has a distinct pattern of localisation in brain cells and evidently some special functions over its erythroid counterpart. In this study, we show that fodrin and gamma-tubulin are present together in both the cytoplasm and centrosomes in all brain cells except differentiated neurons and astrocytes. Immunoprecipitation studies in purified centrosomes from brain tissue and brain cell lines confirm that fodrin and gamma-tubulin interact with each other in centrosomes. Fodrin dissociates from centrosome just after the onset of mitosis, when the concentration of gamma-tubulin attains a maximum at centrosomes. Further it is observed that the interaction between fodrin and gamma-tubulin in the centrosome is dependent on actin as depolymerisation of microfilaments stops fodrin localization. Image analysis revealed that gamma-tubulin concentration also decreased drastically in the centrosome under this condition. This indicates towards a role of fodrin as a regulatory transporter of gamma-tubulin to the centrosomes for normal progression of mitosis.	[Shashikala, Sasidharan; Kumar, Rohith; Thomas, Nisha E.; Sengupta, Suparna] Rajiv Gandhi Ctr Biotechnol, Canc Res Programme 3, Thiruvananthapuram, Kerala, India; [Sivadasan, Dhanesh; James, Jackson] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Sengupta, S (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Programme 3, Thiruvananthapuram, Kerala, India.	sengupta_suparna@hotmail.com	S B, Dr. Dhanesh/AAZ-6786-2021	S B, Dr. Dhanesh/0000-0002-1545-1547; Sengupta, Suparna/0000-0003-3639-4630; James, Jackson/0000-0002-7038-2687	RGCB; University Grants Commission, Government of India [10-2(5)/2006(i)-E.U.II.]	RGCB; University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by RGCB core funding and University Grants Commission, Government of India for fellowships to S. Shashikala (F. No. 10-2(5)/2006(i)-E.U.II.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2005, BIOCHEMISTRY-US, V44, P10681, DOI 10.1021/bi047331z; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Currle D Spencer, 2007, J Vis Exp, P152, DOI 10.3791/152; Das A, 2008, J BIOL CHEM, V283, P12643, DOI 10.1074/jbc.M800094200; De Matteis MA, 2000, J CELL SCI, V113, P2331; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Drykova D, 2003, PLANT CELL, V15, P465, DOI 10.1105/tpc.007005; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; FLANAGAN MD, 1980, J BIOL CHEM, V255, P835; GLENNEY JR, 1982, J BIOL CHEM, V257, P9781; GOODMAN SR, 1983, AM J PHYSIOL, V244, pC121, DOI 10.1152/ajpcell.1983.244.3.C121; GOODMAN SR, 1986, AM J PHYSIOL, V250, pC347, DOI 10.1152/ajpcell.1986.250.3.C347; GRATZER WB, 1975, EUR J BIOCHEM, V58, P403, DOI 10.1111/j.1432-1033.1975.tb02387.x; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; HERIOT K, 1985, J CELL BIOL, V100, P1167, DOI 10.1083/jcb.100.4.1167; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Honda S, 2004, J BIOL CHEM, V279, P10615, DOI 10.1074/jbc.M308841200; Hubert T, 2011, BIOCHEM BIOPH RES CO, V408, P248, DOI 10.1016/j.bbrc.2011.04.007; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; ISHIKAWA M, 1983, J BIOCHEM-TOKYO, V94, P1209, DOI 10.1093/oxfordjournals.jbchem.a134466; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Leask A, 1997, NEUROSCI LETT, V229, P17, DOI 10.1016/S0304-3940(97)00412-6; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; McMahon LW, 2001, BIOCHEMISTRY-US, V40, P7025, DOI 10.1021/bi002917g; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Mogensen MM, 2000, J CELL SCI, V113, P3013; Moudjou M, 1996, J CELL SCI, V109, P875; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Perez-Ferreiro CM, 2004, J CELL SCI, V117, P6197, DOI 10.1242/jcs.01544; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Santella L, 1998, CELL CALCIUM, V23, P123, DOI 10.1016/S0143-4160(98)90110-5; Sato K, 2004, J BIOCHEM, V136, P777, DOI 10.1093/jb/mvh187; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; Sridharan D, 2003, J CELL SCI, V116, P823, DOI 10.1242/jcs.00294; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; SUNKEL CE, 1995, EMBO J, V14, P28, DOI 10.1002/j.1460-2075.1995.tb06972.x; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Thomas NE, 2010, J CELL BIOCHEM, V110, P1334, DOI 10.1002/jcb.22647; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; VERTESSY BG, 1989, BIOPHYS J, V55, P255, DOI 10.1016/S0006-3495(89)82800-0; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Watabe H, 2008, J INVEST DERMATOL, V128, P162, DOI 10.1038/sj.jid.5701019; Wiese C, 1999, CURR OPIN STRUC BIOL, V9, P250, DOI 10.1016/S0959-440X(99)80035-9; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	64	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76613	10.1371/journal.pone.0076613	http://dx.doi.org/10.1371/journal.pone.0076613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098540	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100080
J	Annaratone, L; Marchio, C; Russo, R; Ciardo, L; Rondon-Lagos, SM; Goia, M; Scalzo, MS; Bolla, S; Castellano, I; di Cantogno, LV; Bussolati, G; Sapino, A				Annaratone, Laura; Marchio, Caterina; Russo, Rosalia; Ciardo, Luigi; Rondon-Lagos, Sandra Milena; Goia, Margherita; Scalzo, Maria Stella; Bolla, Stefania; Castellano, Isabella; di Cantogno, Ludovica Verdun; Bussolati, Gianni; Sapino, Anna			A Collection of Primary Tissue Cultures of Tumors from Vacuum Packed and Cooled Surgical Specimens: A Feasibility Study	PLOS ONE			English	Article							COLD ISCHEMIC TIME; IMMUNOHISTOCHEMICAL EVALUATION; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; FORMALIN FIXATION; HER2 EXPRESSION; WARM ISCHEMIA; TRANSPLANTATION; PRESERVATION; VIMENTIN	Primary cultures represent an invaluable tool to set up functional experimental conditions; however, creation of tissue cultures from solid tumors is troublesome and often unproductive. Several features can affect the success rate of primary cultures, including technical issues from pre-analytical procedures employed in surgical theaters and pathology laboratories. We have recently introduced a new method of collection, transfer, and preservation of surgical specimens that requires immediate vacuum sealing of excised specimens at surgical theaters, followed by time-controlled transferring at 4 degrees C to the pathology laboratory. Here we investigate the feasibility and performance of short-term primary cell cultures derived from vacuum packed and cooled (VPAC) preserved tissues. Tissue fragments were sampled from 52 surgical specimens of tumors larger than 2 cm for which surgical and VPAC times (the latter corresponding to cold ischemia time) were recorded. Cell viability was determined by trypan blue dye-exclusion assay and hematoxylin and eosin and immunohistochemical stainings were performed to appreciate morphological and immunophenotypical features of cultured cells. Cell viability showed a range of 84-100% in 44 out of 52 (85%) VPAC preserved tissues. Length of both surgical and VPAC times affected cell viability: the critical surgical time was set around 1 hour and 30 minutes, while cells preserved a good viability when kept for about 24 hours of vacuum at 4 degrees C. Cells were maintained in culture for at least three passages. Immunocytochemistry confirmed the phenotype of distinct populations, that is, expression of cytokeratins in epithelioid cells and of vimentin in spindle cells. Our results suggest that VPAC preserved tissues may represent a reliable source for creation of primary cell cultures and that a careful monitoring of surgical and cold ischemia times fosters a good performance of primary tissue cultures.	[Annaratone, Laura; Marchio, Caterina; Russo, Rosalia; Ciardo, Luigi; Rondon-Lagos, Sandra Milena; Goia, Margherita; Scalzo, Maria Stella; Bolla, Stefania; Castellano, Isabella; Bussolati, Gianni; Sapino, Anna] Univ Turin, Dept Med Sci, Turin, Italy; [Marchio, Caterina; Scalzo, Maria Stella; Bolla, Stefania; Castellano, Isabella; di Cantogno, Ludovica Verdun; Sapino, Anna] Azienda Osped Citta Salute & Sci Torino, Dept Lab Med, Turin, Italy; [Bussolati, Gianni] Victor Babes Inst, R-76201 Bucharest, Romania	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Victor Babes National Institute of Pathology	Sapino, A (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	anna.sapino@unito.it	Sapino, Anna/J-4113-2018; Castellano, Isabella/K-1888-2018; Sapino, Anna/AGY-9901-2022; Marchio, Caterina/J-9152-2016; Annaratone, Laura/J-9261-2016	Sapino, Anna/0000-0003-3542-9571; Sapino, Anna/0000-0003-3542-9571; Marchio, Caterina/0000-0003-2024-6131; Annaratone, Laura/0000-0001-5750-1445; Castellano, isabella/0000-0002-9072-1615; Rondon Lagos, Milena/0000-0002-3160-9316	Ricerca Sanitaria Finalizzata [RF-2010-2310674]; AIRC [IG 10787, MFAG 13310]; Persother [SMIS-CSRN:549/12.024]	Ricerca Sanitaria Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); AIRC(Fondazione AIRC per la ricerca sul cancro); Persother	This work was supported by Ricerca Sanitaria Finalizzata RF-2010-2310674 and AIRC Grants (IG 10787 to AS and MFAG 13310 to CM). GB is funded in part by Persother (SMIS-CSRN:549/12.024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x; Berton F, 2012, J OCCUP HEALTH, V54, P74, DOI 10.1539/joh.11-0089-OA; Bussolati G, 2008, VIRCHOWS ARCH, V452, P229, DOI 10.1007/s00428-007-0529-x; Bussolati G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021043; Chung JY, 2008, J HISTOCHEM CYTOCHEM, V56, P1033, DOI 10.1369/jhc.2008.951863; Comanescu Maria, 2012, Recent Pat DNA Gene Seq, V6, P22; D'Alessandro AM, 2002, AM J TRANSPLANT, V2, P689, DOI 10.1034/j.1600-6143.2002.20718.x; DAIRKEE SH, 1985, IN VITRO CELL DEV B, V21, P321; Di Novi C, 2010, SCI TOTAL ENVIRON, V408, P3092, DOI 10.1016/j.scitotenv.2010.04.022; Halazun KJ, 2007, TRANSPL P, V39, P1329, DOI 10.1016/j.transproceed.2007.02.061; Hicks David G., 2011, Journal of the National Cancer Institute Monographs, P43, DOI 10.1093/jncimonographs/lgr003; Kristensen T, 2011, APPL IMMUNOHISTO M M, V19, P460, DOI 10.1097/PAI.0b013e318214e523; Lin DW, 2006, J CLIN ONCOL, V24, P3763, DOI 10.1200/JCO.2005.05.1458; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Mukherjee S, 2011, DRUGS DIS PROCEDURES; Neumeister VM, 2012, JNCI-J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438; Pekmezci M, 2012, PATHOLOG RES INT; Piazza O, 2013, TRENDS ANAESTH CRIT, V3, P72, DOI 10.1016/j.tacc.2013.01.002; PIEPER FR, 1992, EUR J BIOCHEM, V210, P509, DOI 10.1111/j.1432-1033.1992.tb17449.x; Portier BP, 2013, MODERN PATHOL, V26, P1, DOI 10.1038/modpathol.2012.123; Speirs V, 2004, CULTURE TUMOR CELLS, P205; Thepot A, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/936546; Wang CS, 2000, CANCER GENET CYTOGEN, V120, P58, DOI 10.1016/S0165-4608(99)00253-8; Yildiz-Aktas IZ, 2012, MODERN PATHOL, V25, P1098, DOI 10.1038/modpathol.2012.59; Yildiz-Aktas IZ, 2012, AM J CLIN PATHOL, V137, P691, DOI 10.1309/AJCPQRAG67GJRPMT	26	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75193	10.1371/journal.pone.0075193	http://dx.doi.org/10.1371/journal.pone.0075193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098684	Green Published, gold			2022-12-27	WOS:000325423500055
J	Paul, CD; Kiss, C; Traore, DAK; Gong, L; Wilce, MCJ; Devenish, RJ; Bradbury, A; Prescott, M				Paul, Craig Don; Kiss, Csaba; Traore, Daouda A. K.; Gong, Lan; Wilce, Matthew C. J.; Devenish, Rodney J.; Bradbury, Andrew; Prescott, Mark			Phanta: A Non-Fluorescent Photochromic Acceptor for pcFRET	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SEQUENCE SPACE; FRET; GFP; EVOLUTION; NANOSCOPY; DRONPA; CELLS	We have developed an orange non-fluorescent photochromic protein (quantum yield, 0.003) we call Phanta that is useful as an acceptor in pcFRET applications. Phanta can be repeatedly inter-converted between the two absorbing states by alternate exposure to cyan and violet light. The absorption spectra of Phanta in one absorbing state shows excellent overlap with the emission spectra of a number of donor green fluorescent proteins including the commonly used EGFP. We show that the Phanta-EGFP FRET pair is suitable for monitoring the activation of caspase 3 in live cells using readily available instrumentation and a simple protocol that requires the acquisition of two donor emission images corresponding to Phanta in each of its photoswitched states. This the first report of a genetically encoded non-fluorescent acceptor for pcFRET.	[Paul, Craig Don; Wilce, Matthew C. J.; Devenish, Rodney J.; Prescott, Mark] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Kiss, Csaba; Traore, Daouda A. K.; Gong, Lan; Bradbury, Andrew] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	Monash University; United States Department of Energy (DOE); Los Alamos National Laboratory	Prescott, M (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3004, Australia.	Mark.Prescott@monash.edu	Gong, Lan/J-6368-2016; Traore, Daouda/B-5242-2013; Gong, Lan/O-7886-2019	Gong, Lan/0000-0003-3136-1565; Traore, Daouda/0000-0003-1001-4716; Gong, Lan/0000-0003-3136-1565; Bradbury, Andrew/0000-0002-5567-8172				Adam V, 2011, CHEM BIOL, V18, P1241, DOI 10.1016/j.chembiol.2011.08.007; Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; Brakemann T, 2011, NAT BIOTECHNOL, V29, P942, DOI 10.1038/nbt.1952; Cho S., 2013, SCI REP, V3; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Higgins GC, 2009, CELL MOL LIFE SCI, V66, P2773, DOI 10.1007/s00018-009-0079-2; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Kiss C, 2009, PROTEIN ENG DES SEL, V22, P313, DOI 10.1093/protein/gzp006; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Paul CD, 2011, ACTA CRYSTALLOGR F, V67, P1266, DOI 10.1107/S1744309111028156; Pettikiriarachchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041028; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Wilmann PG, 2006, J MOL BIOL, V364, P213, DOI 10.1016/j.jmb.2006.08.089; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	30	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75835	10.1371/journal.pone.0075835	http://dx.doi.org/10.1371/journal.pone.0075835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098733	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325423500104
J	Venkataraman, K; Khoo, CM; Leow, MKS; Khoo, EYH; Isaac, AV; Zagorodnov, V; Sadananthan, SA; Velan, SS; Chong, YS; Gluckman, P; Lee, J; Salim, A; Tai, ES; Lee, YS				Venkataraman, Kavita; Khoo, Chin Meng; Leow, Melvin K. S.; Khoo, Eric Y. H.; Isaac, Anburaj V.; Zagorodnov, Vitali; Sadananthan, Suresh A.; Velan, Sendhil S.; Chong, Yap Seng; Gluckman, Peter; Lee, Jeannette; Salim, Agus; Tai, E. Shyong; Lee, Yung Seng			New Measure of Insulin Sensitivity Predicts Cardiovascular Disease Better than HOMA Estimated Insulin Resistance	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; TYPE-2 DIABETES-MELLITUS; RISK-FACTORS; HIP RATIO; HYPERTENSION; INDIVIDUALS; GLUCOSE; INDEX; PLASMA	Context: Accurate assessment of insulin sensitivity may better identify individuals at increased risk of cardio-metabolic diseases. Objectives: To examine whether a combination of anthropometric, biochemical and imaging measures can better estimate insulin sensitivity index (ISI) and provide improved prediction of cardio-metabolic risk, in comparison to HOMA-IR. Design and participants: Healthy male volunteers (96 Chinese, 80 Malay, 77 Indian), 21 to 40 years, body mass index 18230 kg/m(2). Predicted ISI (ISI-cal) was generated using 45 randomly selected Chinese through stepwise multiple linear regression, and validated in the rest using non-parametric correlation (Kendall's tau tau). In an independent longitudinal cohort, ISI-cal and HOMA-IR were compared for prediction of diabetes and cardiovascular disease (CVD), using ROC curves. Setting: The study was conducted in a university academic medical centre. Outcome measures: ISI measured by hyperinsulinemic euglycemic glucose clamp, along with anthropometric measurements, biochemical assessment and imaging; incident diabetes and CVD. Results: A combination of fasting insulin, serum triglycerides and waist-to-hip ratio (WHR) provided the best estimate of clamp-derived ISI (adjusted R-2 0.58 versus 0.32 HOMA-IR). In an independent cohort, ROC areas under the curve were 0.77 +/- 0.02 ISI-cal versus 0.76 +/- 0.02 HOMA-IR (p>0.05) for incident diabetes, and 0.74 +/- 0.03 ISI-cal versus 0.61 +/- 0.03 HOMA-IR (p<0.001) for incident CVD. ISI-cal also had greater sensitivity than defined metabolic syndrome in predicting CVD, with a four-fold increase in the risk of CVD independent of metabolic syndrome. Conclusions: Triglycerides and WHR, combined with fasting insulin levels, provide a better estimate of current insulin resistance state and improved identification of individuals with future risk of CVD, compared to HOMA-IR. This may be useful for estimating insulin sensitivity and cardio-metabolic risk in clinical and epidemiological settings.	[Venkataraman, Kavita; Lee, Jeannette; Salim, Agus] Natl Univ Singapore, Yong Loo Lin Sch Med, Saw Swee Hock Sch Publ Hlth, Singapore 117595, Singapore; [Venkataraman, Kavita; Khoo, Chin Meng; Khoo, Eric Y. H.; Sadananthan, Suresh A.; Chong, Yap Seng; Lee, Jeannette; Salim, Agus; Tai, E. Shyong; Lee, Yung Seng] NUHS, Singapore, Singapore; [Venkataraman, Kavita; Sadananthan, Suresh A.; Chong, Yap Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117595, Singapore; [Khoo, Chin Meng; Khoo, Eric Y. H.; Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Leow, Melvin K. S.] Tan Tock Seng Hosp, Dept Endocrinol, Singapore, Singapore; [Leow, Melvin K. S.; Sadananthan, Suresh A.; Velan, Sendhil S.; Gluckman, Peter; Lee, Yung Seng] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Isaac, Anburaj V.] Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore; [Zagorodnov, Vitali] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [Velan, Sendhil S.] NUS A STAR, Singapore BioImaging Consortium, Singapore, Singapore; [Velan, Sendhil S.] NUS A STAR, Clin Imaging Res Ctr, Singapore, Singapore; [Lee, Yung Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Tan Tock Seng Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore	Lee, YS (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.	yung_seng_lee@nuhs.edu.sg	Leow, Melvin/AAJ-1168-2020; Khoo, Eric YH/K-1146-2013; Venkataraman, Kavita/Q-8956-2019; Salim, Agus/P-1407-2014; Isaac, Vivian/B-5581-2017; Leow, Melvin/H-3129-2019; Khoo, Chin Meng/AAD-8790-2022; Lee, Yung Seng/F-2169-2014; Velan, S. Sendhil/B-6374-2017; Isaac, Vivian/AAG-9223-2019	Venkataraman, Kavita/0000-0002-3139-6998; Salim, Agus/0000-0003-3999-7701; Isaac, Vivian/0000-0003-1525-8090; Leow, Melvin/0000-0002-2837-5889; Lee, Yung Seng/0000-0002-1253-0557; Velan, S. Sendhil/0000-0002-4096-0722; Isaac, Vivian/0000-0003-1525-8090; Chong, Yap Seng/0000-0002-7232-8473; Tai, E Shyong/0000-0003-2929-8966	Translational Clinical Research (TCR) Flagship Programme on Developmental Pathways to Metabolic Disease [NMRC/TCR/004-NUS/2008]; National Research Foundation (NRF); National Medical Research Council, Singapore [0838/2004, IRG07nov013, NMRC/0863/2004]; Biomedical Research Council [03/1/27/18/216, 08/1/35/19/550]; Diabetes Research Fund, National University of Singapore	Translational Clinical Research (TCR) Flagship Programme on Developmental Pathways to Metabolic Disease; National Research Foundation (NRF); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Diabetes Research Fund, National University of Singapore(National University of Singapore)	This work was supported under the Translational Clinical Research (TCR) Flagship Programme on Developmental Pathways to Metabolic Disease (NMRC/TCR/004-NUS/2008) funded by the National Research Foundation (NRF) and administered by the National Medical Research Council (NMRC), Singapore, as well as grants from the National Medical Research Council, Singapore (Grant number: 0838/2004, IRG07nov013, and NMRC/0863/2004); the Biomedical Research Council (Grant number: 03/1/27/18/216 and 08/1/35/19/550) and the Diabetes Research Fund, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Bonora E, 2002, DIABETIC MED, V19, P535, DOI 10.1046/j.1464-5491.2002.00764.x; Cox BD, 1998, INT J OBESITY, V22, P966, DOI 10.1038/sj.ijo.0800705; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Deurenberg-Yap M., 2003, INT J BODY COMPOS RE, V1, P103; Disse E, 2008, DIABETES METAB, V34, P457, DOI 10.1016/j.diabet.2008.02.009; Esmaillzadeh A, 2004, INT J OBESITY, V28, P1325, DOI 10.1038/sj.ijo.0802757; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Liew CF, 2003, INT J OBESITY, V27, P784, DOI 10.1038/sj.ijo.0802307; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Rutter MK, 2008, CIRCULATION, V117, P1003, DOI 10.1161/CIRCULATIONAHA.107.727727; Sarafidis PA, 2007, J HUM HYPERTENS, V21, P709, DOI 10.1038/sj.jhh.1002201; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yokoyama H, 2003, DIABETES CARE, V26, P2426, DOI 10.2337/diacare.26.8.2426	25	12	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74410	10.1371/journal.pone.0074410	http://dx.doi.org/10.1371/journal.pone.0074410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098646	Green Published, gold			2022-12-27	WOS:000325423500017
J	Wang, L; Liao, WB; Chen, CQ; Fan, Q				Wang, Lei; Liao, Wenbo; Chen, Chunquan; Fan, Qiang			The Seed Plant Flora of the Mount Jinggangshan Region, Southeastern China	PLOS ONE			English	Article								The Mount Jinggangshan region is located between Jiangxi and Hunan provinces in southeastern China in the central section of the Luoxiao Mountains. A detailed investigation of Mount Jinggangshan region shows that the seed plant flora comprises 2,958 species in 1,003 genera and 210 families (Engler's system adjusted according to Zhengyi Wu's concept). Among them, 23 species of gymnospermae belong to 17 genera and 9 families, and 2,935 species of angiosperms are in 986 genera and 201 families. Moreover, they can also be sorted into woody plants (350 genera and 1,295 species) and herbaceous plants (653 genera and 1,663 species). The dominant families are mainly Fagaceae, Lauraceae, Theaceae, Hamamelidaceae, Magnoliaceae, Ericaceae, Styracaceae, Aquifoliaceae, Elaeocarpaceae, Aceraceae, Rosaceae, Corylaceae, Daphniphyllaceae, Symplocaceae, Euphorbiaceae, Pinaceae, Taxodiaceae, Cupressaceae and Taxaceae. Ancient and relic taxa include Ginkgo biloba, Fokienia hodginsii, Amentotaxus argotaenia, Disanthus cercidifolia subsp. longipes, Hamamelis mollis, Manglietia fordiana, Magnolia officinalis, Tsoongiodendron odorum, Fortunearia sinensis, Cyclocarya paliurus, Eucommia ulmoides, Sargentodoxa cuneata, Bretschneidera sinensis, Camptotheca acuminata, Tapiscia sinensis, etc. The flora of Mount Jinggangshan region includes 79 cosmopolitan genera and 924 non-cosmopolitan genera, which are 7.88% and 92.12% of all genera. The latter includes 452 tropical genera (48.92%) and 472 temperate genera (51.08%). The temperate elements include 44 genera endemic to China, accounting for 4.76% of all genera. Among 1,003 genera, 465 have only a single species and 401 are oligotypic genera (with 2-5 species). These genera account for 86.34% of all genera. The floristic analysis indicates that the flora of Mount Jinggangshan region is closely related to the flora of Mount Wuyishan region in southeastern China. The flora of Mount Jinggangshan region also contains many elements of central and southern China. Mount Jinggangshan region is an important north-south floristic passageway and is also a boundary between the floras of eastern, central and south China.	[Wang, Lei] Capital Normal Univ, Coll Resource Environm & Tourism, Beijing, Peoples R China; [Liao, Wenbo; Fan, Qiang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Wenbo; Fan, Qiang] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Chunquan] Jinggangshan Adm Jiangxi Prov, Jinggangshan, Jiangxi, Peoples R China	Capital Normal University; Sun Yat Sen University; Sun Yat Sen University; Jinggangshan University	Liao, WB (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsslwb@mail.sysu.edu.cn			integrated scientific survey of the biodiversity of Jinggang Shan, Jiangxi Province, China; National Natural Science Foundation of China [31170202, 31061160184]; Doctor Station foundation project of the Ministry of Education [20110171110032]	integrated scientific survey of the biodiversity of Jinggang Shan, Jiangxi Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor Station foundation project of the Ministry of Education	This project was partially funded by the integrated scientific survey of the biodiversity of Jinggang Shan, Jiangxi Province, China, and by the National Natural Science Foundation of China (31170202, 31061160184) and Doctor Station foundation project of the Ministry of Education (20110171110032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang HT, 1994, ACTA SCI NATURALIUM, V33, P1; China Vegetation Editorial Committee, 1980, VEGETATION CHINA, P1; He JY, 1994, WUYISHAN RES SERIES, P222; He LZ, 2010, SCI SURVEY STUDY BIO, P60; Hou BQ, 1993, COMPREHENSIVE INVEST, P1; Hsieh Chang-Fu, 2002, Taiwania, V47, P298; Huang XF, 2008, JIANGXI NANFENGMIAN, P1; Li H, 2000, FLORA GAOLIGONG MOUN, P1; Li Xi-Wen, 1996, Acta Botanica Yunnanica, V18, P363; Li ZY, 2007, PLANTS MOUNT EMEI, P225; Liao WB, 2013, COMPREHENSI IN PRESS, P1; Lin Y, 1993, FLORA JIANGXI, V1, P1; Lin Y, 2004, FLORA JIANGXI, V2, P1; Lin Y. J., 1990, Special Publication - Taichung District Agricultural Improvement Station, P1; Ling LK, 1981, J WUYI SCI, V12, P17; Liu RL, 2010, LIST JIANGXI SEED PL, P1; Liu RL, 1995, J WUHAN BOT RES, V13, P210; Liu X., 2010, COLLECTION SCI EXPLO, P1; Liu XZ, 2010, SCI SURVEY STUDY BIO, P539; Liu XZ, 2001, SCI SURVEY WUYISHAN, P1; Mabberley DJ, 2008, PORTABLE DICT PLANTS, P1; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Ren Y, 2006, BIODIVERS CONSERV, P157; Tahktajan AL, 1978, REGIONALIZATION FLOR, P1; TIFFNEY BH, 1986, ANN MO BOT GARD, V73, P394, DOI 10.2307/2399119; Wang WC, 1995, KEYS VASCULAR PLANTS, P1; Wu DL, 1994, CHECKLIST FLOWERING, P1; Wu Z., 2003, FLORA CHINA, P1; Wu Z. Y., 1993, ACTA BOT YUNNANICA A, VIV, P141; Wu Z. Y., 1996, FLORISTIC CHARACTERI, P1; Wu Z.-Y., 2006, AREAL TYPES SEED PLA, P1; Wu Zheng-Yi, 2003, Acta Botanica Yunnanica, V25, P245; Wu ZY, 1995, FLORA CHINA, V1-25; Wu ZY, 2011, FLORISTICS SEED PLAN, P74; WU ZY, 1991, ACTA BOT YUNNAN S, V4, P1; Xiang QP, 2001, GUIHAIA, V21, P113, DOI DOI 10.3969/J.ISSN.1000-3142.2001.02.007; Xing FW, 2011, INVENTORY PLANT SPEC, P1; Zhang MZ, 1993, SPECIES CHECKLIST 5, P1; Zhang Zhiyun, 1995, ACTA PHYTOTAX SINICA, V33, P313; Zhu H., 2012, NATIVE SEED PLANTS X, P1; Zhu Z.C, 1999, STRUCTURAL GEOLOGY, P1; 吴征镒, 2003, [云南植物研究, Acta Botanica Yunnanica], V25, P535	42	4	7	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75834	10.1371/journal.pone.0075834	http://dx.doi.org/10.1371/journal.pone.0075834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098732	gold, Green Published			2022-12-27	WOS:000325423500103
J	Wang, P; McInnes, C; Zhu, BT				Wang, Pan; McInnes, Campbell; Zhu, Bao Ting			Structural Characterization of the Binding Interactions of Various Endogenous Estrogen Metabolites with Human Estrogen Receptor alpha and beta Subtypes: A Molecular Modeling Study	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BREAST-CANCER; ANTAGONISM; PREVENTION; DOMAIN	In the present study, we used the molecular docking approach to study the binding interactions of various derivatives of 17 beta-estradiol (E-2) with human estrogen receptor (ER) alpha and beta. First, we determined the suitability of the molecular docking method to correctly predict the binding modes and interactions of two representative agonists (E-2 and diethylstilbesterol) in the ligand binding domain (LBD) of human ER alpha. We showed that the docked structures of E-2 and diethylstilbesterol in the ER alpha LBD were almost exactly the same as the known crystal structures of ER alpha in complex with these two estrogens. Using the same docking approach, we then characterized the binding interactions of 27 structurally similar E-2 derivatives with the LBDs of human ER alpha and ER beta. While the binding modes of these E-2 derivatives are very similar to that of E-2, there are distinct subtle differences, and these small differences contribute importantly to their differential binding affinities for ERs. In the case of A-ring estrogen derivatives, there is a strong inverse relationship between the length of the hydrogen bonds formed with ERs and their binding affinity. We found that a better correlation between the computed binding energy values and the experimentally determined logRBA values could be achieved for various A-ring derivatives by re-adjusting the relative weights of the van der Waals interaction energy and the Coulomb interaction energy in computing the overall binding energy values.	[Wang, Pan] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [McInnes, Campbell] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA; [Zhu, Bao Ting] Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Zhu, Bao Ting] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Kansas; University of Kansas Medical Center; Southern University of Science & Technology	Zhu, BT (corresponding author), Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu	McInnes, Campbell/A-6721-2009		National Institutes of Health [RO1CA97109]; Department of Defense Breast Cancer Research Program [W81XWH-09-1-0035]; NATIONAL CANCER INSTITUTE [R01CA097109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (Grant No. RO1CA97109) and an award from the Department of Defense Breast Cancer Research Program (W81XWH-09-1-0035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci Ayhan, 2009, Pediatr Endocrinol Rev, V6, P464; BARNEA ER, 1983, STEROIDS, V41, P643, DOI 10.1016/0039-128X(83)90030-2; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2667, DOI 10.1002/cncr.22655; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Enyedy IJ, 2008, J COMPUT AID MOL DES, V22, P161, DOI 10.1007/s10822-007-9165-4; FALCK F, 1992, ARCH ENVIRON HEALTH, V47, P143; HENDERSON BE, 1991, SCIENCE, V254, P1131, DOI 10.1126/science.1957166; LEWIS PJ, 1994, BRIT MED J, V309, P1662, DOI 10.1136/bmj.309.6969.1662a; Ma L, 2009, TRENDS ENDOCRIN MET, V20, P357, DOI 10.1016/j.tem.2009.03.009; Manas ES, 2004, STRUCTURE, V12, P2197, DOI 10.1016/j.str.2004.09.015; Manas ES, 2004, J AM CHEM SOC, V126, P15106, DOI 10.1021/ja047633o; Mocklinghoff S, 2010, CHEMBIOCHEM, V11, P2251, DOI 10.1002/cbic.201000532; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Pike ACW, 2000, J STEROID BIOCHEM, V74, P261, DOI 10.1016/S0960-0760(00)00102-3; Rogan WJ, 2003, PEDIATRICS, V112, P247; Roncaglioni A, 2008, CHEM SOC REV, V37, P441, DOI 10.1039/b616276m; Rudel RA, 2007, CANCER-AM CANCER SOC, V109, P2635, DOI 10.1002/cncr.22653; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Warren GL, 2012, DRUG DISCOV TODAY, V17, P1270, DOI 10.1016/j.drudis.2012.06.011; Zhu BT, 2006, ENDOCRINOLOGY, V147, P4132, DOI 10.1210/en.2006-0113; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	24	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74615	10.1371/journal.pone.0074615	http://dx.doi.org/10.1371/journal.pone.0074615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098659	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500030
J	Zyriax, BC; Salazar, R; Hoeppner, W; Vettorazzi, E; Herder, C; Windler, E				Zyriax, Birgit-Christiane; Salazar, Ramona; Hoeppner, Wolfgang; Vettorazzi, Eik; Herder, Christian; Windler, Eberhard			The Association of Genetic Markers for Type 2 Diabetes with Prediabetic Status - Cross-Sectional Data of a Diabetes Prevention Trial	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; GENOME-WIDE ASSOCIATION; LARGE-SCALE ASSOCIATION; FASTING GLUCOSE; INSULIN-RESISTANCE; LIFE-STYLE; SUSCEPTIBILITY LOCI; ADIPONECTIN LEVELS; PLASMA-GLUCOSE; RISK-FACTORS	Objective: To investigate the association of risk alleles for type 2 diabetes with prediabetes accounting for age, anthropometry, inflammatory markers and lifestyle habits. Design: Cross-sectional study of 129 men and 157 women of medium-sized companies in northern Germany in the Delay of Impaired Glucose Tolerance by a Healthy Lifestyle Trial (DELIGHT). Methods: Besides established risk factors, 41 single nucleotide polymorphisms (SNPs) that have previously been found to be associated with type 2 diabetes were analyzed. As a nonparametric test a random forest approach was used that allows processing of a large number of predictors. Variables with the highest impact were entered into a multivariate logistic regression model to estimate their association with prediabetes. Results: Individuals with prediabetes were characterized by a slightly, but significantly higher number of type 2 diabetes risk alleles (42.5 +/- 4.1 vs. 41.3 +/- 4.1, p = 0.013). After adjustment for age and waist circumference 6 SNPs with the highest impact in the random forest analysis were associated with risk for prediabetes in a logistic regression model. At least 5 of these SNPs were positively related to prediabetic status (odds ratio for prediabetes 1.57 per allele (Cl 1.21-2.10, p = 0.001)). Conclusions: This explorative analysis of data of DELIGHT demonstrates that at least 6 out of 41 genetic variants characteristic of individuals with type 2 diabetes may also be associated with prediabetes. Accumulation of these risk alleles may markedly increase the risk for prediabetes. However, prospective studies are required to corroborate these findings and to demonstrate the predictive value of these genetic variants for the risk to develop prediabetes.	[Zyriax, Birgit-Christiane; Windler, Eberhard] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Salazar, Ramona; Hoeppner, Wolfgang] Bioglobe GmbH, Med Genet, Hamburg, Germany; [Vettorazzi, Eik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Zyriax, BC (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.	bzyriax@uke.de	Vettorazzi, Eik/B-8130-2019; Windler, Eberhard/AAN-3249-2020	Vettorazzi, Eik/0000-0002-3737-6402; 	legal health insurence AOK NordWest, Kiel-Wellsee, Germany; Merck KGaA, Darmstadt, Germany	legal health insurence AOK NordWest, Kiel-Wellsee, Germany; Merck KGaA, Darmstadt, Germany	Basic funding was provided by the legal health insurence AOK NordWest, Kiel-Wellsee, Germany. Additional support for the analysis of this paper came from Merck KGaA, Darmstadt, Germany as an unrestricted research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, DIABETES CARE, V33, P557, DOI 10.2337/dc09-1145; Abdul-Ghani MA, 2009, DIABETES CARE, V32, P281, DOI 10.2337/dc08-1264; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Balion CM, 2007, CLIN CHEM LAB MED, V45, P1180, DOI 10.1515/CCLM.2007.250; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS71, DOI 10.1093/ije/26.suppl_1.S71; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS59, DOI 10.1093/ije/26.suppl_1.S59; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Cardellini M, 2007, DIABETES-METAB RES, V23, P141, DOI 10.1002/dmrr.679; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chen GJ, 2012, HUM MOL GENET, V21, P4530, DOI 10.1093/hmg/dds282; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fukuda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046263; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Herder C, 2011, EUR J CLIN INVEST, V41, P679, DOI 10.1111/j.1365-2362.2010.02454.x; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Janghorbani Mohsen, 2009, Rev Diabet Stud, V6, P117, DOI 10.1900/RDS.2009.6.117; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Linder K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038224; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Marques-Vidal P, 2002, DIABETES CARE, V25, P1371, DOI 10.2337/diacare.25.8.1371; Marques-Vidal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051768; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Molarius A, 1999, INT J OBESITY, V23, P116, DOI 10.1038/sj.ijo.0800772; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Ng MCY, 2013, DIABETES, V62, P965, DOI 10.2337/db12-0266; Oeth P, 2009, METHODS MOL BIOL, V578, P307, DOI 10.1007/978-1-60327-411-1_20; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Ortega-Azorin C, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-137; Port SC, 2005, AM HEART J, V150, P209, DOI 10.1016/j.ahj.2004.09.031; Qi L, 2006, DIABETES CARE, V29, P1501, DOI 10.2337/dc06-0221; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi L, 2010, CURR OPIN LIPIDOL, V21, P31, DOI 10.1097/MOL.0b013e3283346cb6; Qiao Q, 2003, DIABETES CARE, V26, P2910, DOI 10.2337/diacare.26.10.2910; R Core Team, 2012, R LANG ENV STAT COMP; Raynor LA, 2013, DIABETES CARE, V36, P70, DOI 10.2337/dc12-0609; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Rijkelijkhuizen JM, 2007, DIABETES CARE, V30, P332, DOI 10.2337/dc06-1238; Ruchat SM, 2009, J NUTRIGENET NUTRIGE, V2, P225, DOI 10.1159/000259341; Schottker B, 2013, DIABETES CARE, V36, P1703, DOI 10.2337/dc12-1416; Schulze MB, 2002, BLOOD PRESS MONIT, V7, P95, DOI 10.1097/00126097-200204000-00002; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Stephanie-May R, 2009, DIABETES RES CLIN PR, V84, P211, DOI 10.1016/j.diabres.2009.03.012; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Vimaleswaran KS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001389; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Zhang J, 2011, J MOL BIOL, V411, P537, DOI 10.1016/j.jmb.2011.06.011; Zhang Z, 2011, EUR J CLIN NUTR, V65, P415, DOI 10.1038/ejcn.2010.273; Zyriax BC, 2005, EUR J CLIN NUTR, V59, P1201, DOI 10.1038/sj.ejcn.1602233; Zyriax BC, 2008, ATHEROSCLEROSIS, V200, P403, DOI 10.1016/j.atherosclerosis.2007.12.033; Zyriax BC, 2012, PUBLIC HEALTH NUTR, V15, P860, DOI 10.1017/S1368980011002370	79	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75807	10.1371/journal.pone.0075807	http://dx.doi.org/10.1371/journal.pone.0075807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098730	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500101
J	Kolton, M; Sela, N; Elad, Y; Cytryn, E				Kolton, Max; Sela, Noa; Elad, Yigal; Cytryn, Eddie			Comparative Genomic Analysis Indicates that Niche Adaptation of Terrestrial Flavobacteria Is Strongly Linked to Plant Glycan Metabolism	PLOS ONE			English	Article							SP-NOV.; COMMUNITY STRUCTURE; SEQUENCE; RHIZOSPHERE; DIVERSITY; PEPPER; FISH; SOIL; BACTERIA; BIOCHAR	Flavobacteria are important members of aquatic and terrestrial bacterial communities, displaying extreme variations in lifestyle, geographical distribution and genome size. They are ubiquitous in soil, but are often strongly enriched in the rhizosphere and phyllosphere of plants. In this study, we compared the genome of a root-associated Flavobacterium that we recently isolated, physiologically characterized and sequenced, to 14 additional Flavobacterium genomes, in order to pinpoint characteristics associated with its high abundance in the rhizosphere. Interestingly, flavobacterial genomes vary in size by approximately two-fold, with terrestrial isolates having predominantly larger genomes than those from aquatic environments. Comparative functional gene analysis revealed that terrestrial and aquatic Flavobacteria generally segregated into two distinct clades. Members of the aquatic clade had a higher ratio of peptide and protein utilization genes, whereas members of the terrestrial clade were characterized by a significantly higher abundance and diversity of genes involved in metabolism of carbohydrates such as xylose, arabinose and pectin. Interestingly, genes encoding glycoside hydrolase (GH) families GH78 and GH106, responsible for rhamnogalacturonan utilization (exclusively associated with terrestrial plant hemicelluloses), were only present in terrestrial clade genomes, suggesting adaptation of the terrestrial strains to plant-related carbohydrate metabolism. The Peptidase/GH ratio of aquatic clade Flavobacteria was significantly higher than that of terrestrial strains (1.7+/-0.7 and 9.7+/-4.7, respectively), supporting the concept that this relation can be used to infer Flavobacterium lifestyles. Collectively, our research suggests that terrestrial Flavobacteria are highly adapted to plant carbohydrate metabolism, which appears to be a key to their profusion in plant environments.	[Kolton, Max; Cytryn, Eddie] Agr Res Org, Volcani Ctr, Inst Soil Water & Environm Sci, IL-50250 Bet Dagan, Israel; [Sela, Noa; Elad, Yigal] Agr Res Org, Volcani Ctr, Dept Plant Pathol & Weed Res, IL-50250 Bet Dagan, Israel; [Kolton, Max] Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem	Cytryn, E (corresponding author), Agr Res Org, Volcani Ctr, Inst Soil Water & Environm Sci, IL-50250 Bet Dagan, Israel.	Eddie@volcani.agri.gov.il	Kolton, Max/J-1753-2019; Sela, Noa/C-5133-2008	Kolton, Max/0000-0002-8166-3572; Sela, Noa/0000-0002-8282-215X	Ministry of Agriculture and Rural Development of Israel [301-0693-10]	Ministry of Agriculture and Rural Development of Israel	This research was supported by The Chief Scientist of the Ministry of Agriculture and Rural Development of Israel, project Number 301-0693-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 1997, P NATL ACAD SCI USA, V94, P12139, DOI 10.1073/pnas.94.22.12139; Ali Z, 2009, INT J SYST EVOL MICR, V59, P2610, DOI 10.1099/ijs.0.008771-0; Alonso C, 2007, ENVIRON MICROBIOL, V9, P1253, DOI 10.1111/j.1462-2920.2007.01244.x; Aziz RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048053; Barbier P, 2012, J BACTERIOL, V194, P3024, DOI 10.1128/JB.00420-12; Beric T, 2009, ARCH BIOL SCI, V61, P645, DOI 10.2298/ABS0904645B; Bernardet J.F., 2011, BERGEYS MANUAL SYSTE, V4, P112; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Brown SD, 2012, J BACTERIOL, V194, P5991, DOI 10.1128/JB.01243-12; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cousin S, 2009, CURR MICROBIOL, V58, P409, DOI 10.1007/s00284-008-9323-5; Declercq AM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-27; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elad Y, 2010, PHYTOPATHOLOGY, V100, P913, DOI 10.1094/PHYTO-100-9-0913; Ettema TJG, 2009, BIOL LETTERS, V5, P429, DOI 10.1098/rsbl.2008.0793; Fernandez-Gomez B, 2013, ISME J, V7, P1026, DOI 10.1038/ismej.2012.169; Fu YY, 2011, INT J SYST EVOL MICR, V61, P205, DOI 10.1099/ijs.0.018846-0; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Pereira PR, 2012, ENVIRON MICROBIOL, V14, P52, DOI 10.1111/j.1462-2920.2011.02555.x; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Gonzalez JM, 2011, APPL ENVIRON MICROB, V77, P8676, DOI 10.1128/AEM.06152-11; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Jit S, 2008, INT J SYST EVOL MICR, V58, P1665, DOI 10.1099/ijs.0.65578-0; Johansen JE, 2002, MICROB ECOL, V43, P298, DOI 10.1007/s00248-002-2006-z; Johansen JE, 2009, CAN J MICROBIOL, V55, P234, DOI [10.1139/W08-116, 10.1139/w08-116]; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kolton M, 2012, J BACTERIOL, V194, P5462, DOI 10.1128/JB.01249-12; Kolton M, 2011, APPL ENVIRON MICROB, V77, P4924, DOI 10.1128/AEM.00148-11; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; McBride MJ, 1996, J BACTERIOL, V178, P583, DOI 10.1128/jb.178.3.583-590.1996; Nagata T., 2008, MICROBIAL ECOLOGY OC, P207, DOI DOI 10.1002/9780470281840.CH7; Naumoff DG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P622, DOI 10.1134/S0006297911060022; Niklas KJ, 2004, BIOSCIENCE, V54, P831, DOI 10.1641/0006-3568(2004)054[0831:TCWTBT]2.0.CO;2; Ochman H, 2006, SCIENCE, V311, P1730, DOI 10.1126/science.1119966; Ogawa H, 2003, J OCEANOGR, V59, P129, DOI 10.1023/A:1025528919771; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Raymond JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035968; REICHENBACH H, 1980, ARCH MICROBIOL, V126, P291, DOI 10.1007/BF00409934; Riedel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057487; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Sang MK, 2012, J APPL MICROBIOL, V113, P383, DOI 10.1111/j.1365-2672.2012.05330.x; Sang MK, 2008, BIOL CONTROL, V46, P424, DOI 10.1016/j.biocontrol.2008.03.017; Soltani A. A., 2010, Journal of Agricultural Science (Toronto), V2, P106; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tekedar HC, 2012, J BACTERIOL, V194, P2763, DOI 10.1128/JB.00281-12; Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029149; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Yi H, 2005, INT J SYST EVOL MICR, V55, P637, DOI 10.1099/ijs.0.63423-0; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yoon JH, 2006, INT J SYST EVOL MICR, V56, P997, DOI 10.1099/ijs.0.64119-0; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Yu Y, 2011, MAR DRUGS, V9, P184, DOI 10.3390/md9020184	69	54	55	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76704	10.1371/journal.pone.0076704	http://dx.doi.org/10.1371/journal.pone.0076704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086761	Green Submitted, gold, Green Published			2022-12-27	WOS:000325220000072
J	Shepherd, AJ; Loo, L; Mohapatra, DP				Shepherd, Andrew J.; Loo, Lipin; Mohapatra, Durga P.			Chemokine Co-Receptor CCR5/CXCR4-Dependent Modulation of Kv2.1 Channel Confers Acute Neuroprotection to HIV-1 Glycoprotein gp120 Exposure	PLOS ONE			English	Article							DEPENDENT MODULATION; K+ CHANNEL; NEURONAL APOPTOSIS; POTASSIUM CHANNEL; CELL-DEATH; MECHANISMS; LOCALIZATION; CXCR4; EXCITABILITY; PHOSPHORYLATION	Infection with human immunodeficiency virus-1 (HIV-1) within the brain has long been known to be associated with neurodegeneration and neurocognitive disorder (referred as HAND), a condition characterized in its early stages by declining cognitive function and behavioral disturbances. Mechanistically, the HIV-1 coat glycoprotein 120 (gp120) has been suggested to be a critical factor inducing apoptotic cell death in neurons via the activation of p38 mitogenactivated protein kinase (MAPK), upon chronic exposure to the virus. Here we show that acute exposure of neurons to HIV-1 gp120 elicits a homeostatic response, which provides protection against non-apoptotic cell death, involving the major somatodendritic voltage-gated K+ (Kv) channel Kv2.1 as the key mediator. The Kv2.1 channel has recently been shown to provide homeostatic control of neuronal excitability under conditions of seizures, ischemia and neuromodulation/neuroinflammation. Following acute exposure to gp120, cultured rat hippocampal neurons show rapid dephosphorylation of the Kv2.1 protein, which ultimately leads to changes in specific sub-cellular localization and voltage-dependent channel activation properties of Kv2.1. Such modifications in Kv2.1 are dependent on the activation of the chemokine co-receptors CCR5 and CXCR4, and subsequent activation of the protein phosphatase calcineurin. This leads to the overall suppression of neuronal excitability and provides neurons with a homeostatic protective mechanism. Specific blockade of calcineurin and Kv2.1 channel activity led to significant enhancement of non-apoptotic neuronal death upon acute gp120 treatment. These observations shed new light on the intrinsic homeostatic mechanisms of neuronal resilience during the acute stages of neuro-HIV infections.	[Shepherd, Andrew J.; Loo, Lipin; Mohapatra, Durga P.] Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Mohapatra, Durga P.] Univ Iowa, Dept Anesthesia, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Mohapatra, DP (corresponding author), Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	dp-mohapatra@uiowa.edu	Mohapatra, Durga/M-2133-2017	Mohapatra, Durga/0000-0001-5016-1281; Loo, Lipin/0000-0002-4112-1816; Shepherd, Andrew/0000-0002-8440-6192	University of Iowa Office of the Vice President of Research; Department of Pharmacology, Roy J. Lucille A. Carver College of Medicine; Epilepsy Foundation; American Epilepsy Society [Pc-190423]; NIH/NINDS [NS069898]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069898] Funding Source: NIH RePORTER	University of Iowa Office of the Vice President of Research; Department of Pharmacology, Roy J. Lucille A. Carver College of Medicine; Epilepsy Foundation; American Epilepsy Society; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by start-up funds from the University of Iowa Office of the Vice President of Research, and the Department of Pharmacology, Roy J. Lucille A. Carver College of Medicine; and partly by research grants from the Epilepsy Foundation and American Epilepsy Society (Pc-190423), and NIH/NINDS (NS069898) to DPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Chen LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025994; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Grovit-Ferbas K, 2010, IMMUNOL RES, V48, P40, DOI 10.1007/s12026-010-8166-x; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Guyon A, 2007, J MOL ENDOCRINOL, V38, P365, DOI 10.1677/JME-06-0013; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Li W, 2005, NEUROTOX RES, V8, P119, DOI 10.1007/BF03033824; Liner Kevin J 2nd, 2008, Curr HIV/AIDS Rep, V5, P64, DOI 10.1007/s11904-008-0011-7; Lipton SA, 1991, BRAIN PATHOL, V1, P193, DOI 10.1111/j.1750-3639.1991.tb00659.x; LO TM, 1992, BRAIN RES, V594, P189, DOI 10.1016/0006-8993(92)91125-X; Loo L, 2012, J NEUROSCI, V32, P11942, DOI 10.1523/JNEUROSCI.1330-12.2012; Malin SA, 2002, J NEUROSCI, V22, P10094; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Maxwell CJ, 2013, DRUG AGING, V30, P569, DOI 10.1007/s40266-013-0083-y; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Mohapatra DP, 2007, BIOCHEM SOC T, V35, P1064, DOI 10.1042/BST0351064; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Murakoshi H, 1999, J NEUROSCI, V19, P1728; NOTTET HSLM, 1995, IMMUNOL TODAY, V16, P441, DOI 10.1016/0167-5699(95)80022-0; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Potter MC, 2013, J NEUROIMMUNE PHARM, V8, P594, DOI 10.1007/s11481-013-9442-z; Pujol F, 2005, J CELL SCI, V118, P1071, DOI 10.1242/jcs.01694; RICHARDSON C, 2013, INT J GERIATR PSYCH, DOI DOI 10.1002/GPS.3966.PUBMED:23585364; Shepherd AJ, 2012, J NEUROSCI, V32, P17725, DOI 10.1523/JNEUROSCI.3029-12.2012; Shiau YS, 2003, CHEM RES TOXICOL, V16, P1217, DOI 10.1021/tx0341097; Shin AH, 2012, BRIT J PHARMACOL, V166, P1002, DOI 10.1111/j.1476-5381.2011.01805.x; Shin AH, 2013, MOL CELL NEUROSCI, V54, P22, DOI 10.1016/j.mcn.2012.12.005; Song XY, 2013, EUR J PHARMACOL, V710, P29, DOI 10.1016/j.ejphar.2013.03.051; Turchan J, 2003, CURR HIV RES, V1, P373, DOI 10.2174/1570162033485113; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Xu CS, 2011, GLIA, V59, P997, DOI 10.1002/glia.21171; Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1	47	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76698	10.1371/journal.pone.0076698	http://dx.doi.org/10.1371/journal.pone.0076698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086760	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200078
J	Cheng, J; Wang, S; Su, XO				Cheng, Jie; Wang, Shi; Su, Xiao-Ou			Simultaneous Identification and Quantification of 20 beta-Receptor Agonists in Feed Using Gas Chromatography-Tandem Mass Spectrometry	PLOS ONE			English	Article							URINE	"Lean meat powder" is a class of toxic chemicals that have structures similar to that of beta-adrenergic receptor agonists. At least 16 chemicals from this class have been specifically banned by the 176th bulletin of the Chinese Department of Agriculture on breeding animals, and methods for monitoring the illicit use of beta-agonists in animal feed are required. Herein, a method to quantify 20 beta-agonists in feed, via analyte derivatization followed by gas chromatography-tandem mass spectrometry, has been developed. The optimized method has a good linear correlation (calibration coefficient > 0.99) between the quantitative ion peak area and the concentration of beta-agonists over a large working range (0.05-1 mg/kg). The limit of detection (LOD) was 0.01 mg/kg, the recoveries for three beta-agonists spikes (0.05, 0.1, and 1 mu g/g) in feed ranged from 75.6 to 102.4%, repeatability ranged from 1.2 to 9.4% for all of the compounds, and intermediate precisions were lower than 13.8%. This precise, accurate method was applied to quantify 20 beta-agonists in actual feed samples and represents an excellent complement to existing quantification methods.	[Cheng, Jie; Wang, Shi; Su, Xiao-Ou] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Su, XO (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China.	suxiaoou@caas.cn	Li, Xiaomin/ABI-2638-2020		Chinese Agro-scientific Research in the Public Interest [201203088-01]	Chinese Agro-scientific Research in the Public Interest	This work was supported in part by a special fund for Chinese Agro-scientific Research in the Public Interest (No. 201203088-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullet 1063-6-2008, 2008, DET BET REC AG FEEDS, P5; Bullet 1063-7-2008, 2008, SIM DET 8 KINDS BET, V4; Caban M, 2011, J CHROMATOGR A, V1218, P8110, DOI 10.1016/j.chroma.2011.08.093; Christine W, 2004, J CHROMATOGR B, V804, P85, DOI [10.1016/j.jchromb. 2003.12.034, DOI 10.1016/J.JCHR0MB.2003.12.034]; Commission European, 2002, OFF J EUR COMMUN L, VL221, P15; Commission European, 2007, CRL VIEW STAT ART AN; Daniele DC, 2010, CHROMATOGR BIOMED, V24, P358; DEGAND G, 1993, ANAL CHIM ACTA, V275, P241, DOI 10.1016/0003-2670(93)80298-Y; Fernando R, 1998, J CHROMATOGR B, V716, P366, DOI [10.1016/S0378-4347(98)00292-8, DOI 10.1016/S0378-4347(98)00292-8]; He LM, 2007, ANIM FEED SCI TECH, V132, P316, DOI 10.1016/j.anifeedsci.2006.03.013; Juan C, 2010, J CHROMATOGR A, V1217, P6061, DOI 10.1016/j.chroma.2010.07.034; Li C, 2010, J CHROMATOGR A, V1217, P7873, DOI 10.1016/j.chroma.2010.10.055; Lucia D, 2002, J CHROMATOGR B, V780, P61, DOI [10.1016/S1570-0232(02)00414-2, DOI 10.1016/S1570-0232(02)00414-2]; Lucia D, 2000, J MASS SPECTROM, V35, P1285, DOI [10.1002/1096-9888(200011)35:11, DOI 10.1002/1096-9888(200011)35:11.PUBMED:11114086]; Nielen MWF, 2008, ANAL BIOANAL CHEM, V391, P199, DOI 10.1007/s00216-007-1760-7; Philipson L. H., 2002, Journal of Allergy and Clinical Immunology, V110, pS313, DOI 10.1067/mai.2002.129702; [王建平 Wang Jianping], 2005, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V36, P397; Wang PL, 2012, CHINESE J ANAL CHEM, V40, P470, DOI 10.3724/SP.J.1096.2012.10414; Wang XJ, 2013, J CHROMATOGR A, V1278, P82, DOI 10.1016/j.chroma.2012.12.060; Zhu J, 2005, J CHINESE MASS SPECT, V3, P129	20	75	76	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76400	10.1371/journal.pone.0076400	http://dx.doi.org/10.1371/journal.pone.0076400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098489	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600042
J	Bowtell, JL; Avenell, G; Hunter, SP; Mileva, KN				Bowtell, Joanna L.; Avenell, Gareth; Hunter, Steven P.; Mileva, Katya N.			Effect of Hypohydration on Peripheral and Corticospinal Excitability and Voluntary Activation	PLOS ONE			English	Article							LOWER-LIMB MUSCLES; NEUROMUSCULAR FUNCTION; MOTOR CORTEX; HEAT-STRESS; EMG CHANGES; EXERCISE; FATIGUE; CONTRACTIONS; DEHYDRATION; HYPERTHERMIA	We investigated whether altered peripheral and/or corticospinal excitatory output and voluntary activation are implicated in hypohydration-induced reductions in muscle isometric and isokinetic (90 degrees.s(-1)) strength. Nine male athletes completed two trials (hypohydrated, euhydrated) comprising 90 min cycling at 40 degrees C, with body weight losses replaced in euhydrated trial. Peripheral nerve and transcranial magnetic stimulations were applied during voluntary contractions pre- and 40 min post-exercise to quantify voluntary activation and peripheral (M-wave) and corticospinal (motor evoked potential) evoked responses in m. vastus medialis. Both maximum isometric (-15.3 +/- 3.1 vs -5.4 +/- 3.5%) and isokinetic eccentric (-24.8 +/- 4.6 vs -7.3 +/- 7.2%) torque decreased to a greater extent in hypohydrated than euhydrated trials (p<0.05). Half relaxation time of the twitch evoked by peripheral nerve stimulation during maximal contractions increased after exercise in the hypohydrated (21.8 +/- 9.3%) but stayed constant in the euhydrated (1.6 +/- 10.7%; p = 0.017) condition. M-wave amplitude during maximum voluntary contraction increased after exercise in the heat in hypohydrated (10.7 +/- 18.0%) but decreased in euhydrated condition (-17.4 +/- 16.9%; p = 0.067). Neither peripheral nor cortical voluntary activation were significantly different between conditions. Motor evoked potential amplitude increased similarly in both conditions (hypohydrated: 25.7 +/- 28.5%; euhydrated: 52.9 +/- 33.5%) and was accompanied by lengthening of the cortical silent period in euhydrated but not hypohydrated condition (p = 0.019). Different neural strategies seem to be adopted to regulate neural drive in the two conditions, with increases in inhibitory input of either intracortical or corticospinal origin during the euhydrated trial. Such changes were absent in the hypohydrated condition, yet voluntary activation was similar to the euhydrated condition, perhaps due to smaller increases in excitatory drive rather than increased inhibition. Despite this maximal isometric and eccentric strength were impaired in the hypohydrated condition. The increase in peripheral muscle excitability evident in the hypohydrated condition was not sufficient to preserve performance in the face of reduced muscle contractility or impaired excitation-contraction coupling.	[Bowtell, Joanna L.; Avenell, Gareth; Hunter, Steven P.; Mileva, Katya N.] London S Bank Univ, London, England; [Bowtell, Joanna L.] Univ Exeter, Exeter, Devon, England	London South Bank University; University of Exeter	Bowtell, JL (corresponding author), London S Bank Univ, London, England.	j.bowtell@exeter.ac.uk			European Hydration Institute	European Hydration Institute	This work was funded in part by a graduate research student grant from the European Hydration Institute. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigard AX, 2001, MED SCI SPORT EXER, V33, P1694, DOI 10.1097/00005768-200110000-00013; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; Cheuvront SN, 2010, EUR J APPL PHYSIOL, V109, P1163, DOI 10.1007/s00421-010-1458-y; Coburn JW, 2006, MUSCLE NERVE, V33, P664, DOI 10.1002/mus.20509; Del Coso J, 2008, MED SCI SPORT EXER, V40, P744, DOI 10.1249/MSS.0b013e3181621336; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dimitrova NA, 2003, J ELECTROMYOGR KINES, V13, P13, DOI 10.1016/S1050-6411(02)00083-4; Evetovich TK, 2002, MUSCLE NERVE, V26, P225, DOI 10.1002/mus.10203; Ftaiti F, 2001, EUR J APPL PHYSIOL, V84, P87, DOI 10.1007/s004210000339; Green HJ, 2011, ACTA PHYSIOL, V203, P441, DOI 10.1111/j.1748-1716.2011.02335.x; Gruet M, 2013, NEUROSCIENCE, V231, P384, DOI 10.1016/j.neuroscience.2012.10.058; Hackney KJ, 2012, EXTREME PHYSIOL MED, V1, DOI 10.1186/2046-7648-1-3; Hayes LD, 2010, EUR J APPL PHYSIOL, V108, P701, DOI 10.1007/s00421-009-1288-y; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Kossev AR, 1998, MUSCLE NERVE, V21, P413, DOI 10.1002/(SICI)1097-4598(199803)21:3<413::AID-MUS20>3.0.CO;2-Z; LAWRENCE JH, 1983, J APPL PHYSIOL, V54, P1653, DOI 10.1152/jappl.1983.54.6.1653; Marino FE, 2010, BRIT J SPORT MED, V44, P961, DOI 10.1136/bjsm.2009.054973; McKenna MJ, 2008, J APPL PHYSIOL, V104, P288, DOI 10.1152/japplphysiol.01037.2007; Mileva KN, 2012, EUR J APPL PHYSIOL, V112, P3959, DOI 10.1007/s00421-012-2381-1; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P371, DOI 10.1113/jphysiol.1973.sp010193; Montain SJ, 2010, APPL PHYSIOL NUTR ME, V35, P456, DOI 10.1139/H10-032; Morrison S, 2004, EUR J APPL PHYSIOL, V91, P729, DOI 10.1007/s00421-004-1063-z; Periard JD, 2011, MED SCI SPORT EXER, V43, P1657, DOI 10.1249/MSS.0b013e3182148a9a; Racinais S, 2008, J PHYSIOL-LONDON, V586, P4751, DOI 10.1113/jphysiol.2008.157420; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01204.x; Rainoldi A, 2004, J NEUROSCI METH, V134, P37, DOI 10.1016/j.jneumeth.2003.10.014; Saboisky J, 2003, EXP PHYSIOL, V88, P783, DOI 10.1113/eph8802611; Shirreffs SM, 2011, J SPORT SCI, V29, pS39, DOI 10.1080/02640414.2011.614269; Stevens-Lapsley JE, 2013, ARCH GERONTOL GERIAT, V56, P279, DOI 10.1016/j.archger.2012.06.017; Todd G, 2005, J PHYSIOL-LONDON, V563, P621, DOI 10.1113/jphysiol.2004.077115; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Vallier JM, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.012393; Verges S, 2009, J APPL PHYSIOL, V106, P701, DOI 10.1152/japplphysiol.01051.2007	33	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77004	10.1371/journal.pone.0077004	http://dx.doi.org/10.1371/journal.pone.0077004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098574	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500092
J	Fujiwara, N; Tateishi, R; Akahane, M; Taguri, M; Minami, T; Mikami, S; Sato, M; Uchino, K; Enooku, K; Kondo, Y; Asaoka, Y; Yamashiki, N; Goto, T; Shiina, S; Yoshida, H; Ohtomo, K; Koike, K				Fujiwara, Naoto; Tateishi, Ryosuke; Akahane, Masaaki; Taguri, Masataka; Minami, Tatsuya; Mikami, Shintaro; Sato, Masaya; Uchino, Kouji; Enooku, Kenichiro; Kondo, Yuji; Asaoka, Yoshinari; Yamashiki, Noriyo; Goto, Tadashi; Shiina, Shuichiro; Yoshida, Haruhiko; Ohtomo, Kuni; Koike, Kazuhiko			Changes in Risk of Immediate Adverse Reactions to Iodinated Contrast Media by Repeated Administrations in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; ANAPHYLACTOID REACTION; HIGH-OSMOLALITY; EXPERIENCE; COMMITTEE; DISEASE; SAFETY; AGENTS	Background: To elucidate whether repeated exposures to iodinated contrast media increase the risk of adverse reaction. Materials and Methods: We retrospectively reviewed 1,861 patients with hepatocellular carcinoma who visited authors' institution, a tertiary referral center, between 2004 and 2008. We analyzed cumulative probability of adverse reactions and risk factors. We categorized all symptoms into hypersensitivity reactions, physiologic reactions, and other reactions, according to the American College of Radiology guidelines, and evaluated each category as an event. We estimated the association between hazard for adverse reactions and the number of cumulative exposures to contrast media. We also evaluated subsequent contrast media injections and adverse reactions. Results: There were 23,684 contrast media injections in 1,729 patients. One hundred and thirty-two patients were excluded because they were given no contrast media during the study period. Adverse reactions occurred in 196 (0.83%) patients. The cumulative incidence at 10th, 20th, and 30th examination was 7.9%, 15.2%, and 24.1%, respectively. Presence of renal impairment was found to be one of risk factors for adverse reactions. The estimated hazard of overall adverse reaction gradually decreased until around 10th exposure and rose with subsequent exposures. The estimated hazard of hypersensitivity showed V-shaped change with cumulative number of exposures. The estimated hazard of physiologic reaction had a tendency toward decreasing and that of other reaction had a tendency toward increasing. Second adverse reaction was more severe than the initial in only one among 130 patients receiving subsequent injections. Conclusion: Repeated exposures to iodinated contrast media increase the risk of adverse reaction.	[Fujiwara, Naoto; Tateishi, Ryosuke; Minami, Tatsuya; Mikami, Shintaro; Sato, Masaya; Uchino, Kouji; Enooku, Kenichiro; Kondo, Yuji; Asaoka, Yoshinari; Yamashiki, Noriyo; Goto, Tadashi; Shiina, Shuichiro; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan; [Akahane, Masaaki; Ohtomo, Kuni] Univ Tokyo, Dept Radiol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan	University of Tokyo; University of Tokyo; Yokohama City University	Tateishi, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan.	tateishi-tky@umin.ac.jp	Tateishi, Ryosuke/G-7758-2014; Asaoka, Yoshinari/ABC-5412-2021; Fujiwara, Naoto/Y-5938-2019	Tateishi, Ryosuke/0000-0003-3021-2517; Asaoka, Yoshinari/0000-0002-2805-8226; Fujiwara, Naoto/0000-0002-4109-3421; YAMASHIKI, Noriyo/0000-0002-9274-0000	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis); Grants-in-Aid for Scientific Research [23590962] Funding Source: KAKEN	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; American Civil Liberties Union, 2012, ADV EV INTR IOD CONT, P21; Andrew E, 2004, J TOXICOL-CLIN TOXIC, V42, P325, DOI 10.1081/CLT-120037430; BARRETT BJ, 1992, RADIOLOGY, V183, P105, DOI 10.1148/radiology.183.1.1549654; Bettmann MA, 1997, RADIOLOGY, V203, P611, DOI 10.1148/radiology.203.3.9169677; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; CARO JJ, 1991, AM J ROENTGENOL, V156, P825, DOI 10.2214/ajr.156.4.1825900; DAHLSTROM K, 1985, INVEST RADIOL, V20, pS117, DOI 10.1097/00004424-198501002-00028; Davenport MS, 2009, RADIOLOGY, V253, P372, DOI 10.1148/radiol.2532090465; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freed KS, 2001, AM J ROENTGENOL, V176, P1389, DOI 10.2214/ajr.176.6.1761389; GREENBERGER PA, 1985, ARCH INTERN MED, V145, P2197, DOI 10.1001/archinte.145.12.2197; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hagan JB, 2004, IMMUNOL ALLERGY CLIN, V24, P507, DOI 10.1016/j.iac.2004.03.005; Hwang J, 2012, BRIT J RADIOL, V85, pE314, DOI 10.1259/bjr/27727228; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; KATAYAMA H, 1990, RADIOLOGY, V175, P621, DOI 10.1148/radiology.175.3.2343107; Khalili K, 2011, J HEPATOL, V54, P723, DOI 10.1016/j.jhep.2010.07.025; Kopp AF, 2008, ACTA RADIOL, V49, P902, DOI 10.1080/02841850802282811; LANG DM, 1991, ANN INTERN MED, V115, P270, DOI 10.7326/0003-4819-115-4-270; LANG DM, 1993, ARCH INTERN MED, V153, P2033, DOI 10.1001/archinte.153.17.2033; LASSER EC, 1987, NEW ENGL J MED, V317, P845, DOI 10.1056/NEJM198710013171401; Lencioni R, 2008, J HEPATOL, V48, P848, DOI 10.1016/j.jhep.2008.02.005; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mikami S, 2012, J VASC INTERV RADIOL, V23, P1269, DOI 10.1016/j.jvir.2012.06.032; Morcos SK, 2001, EUR RADIOL, V11, P1267, DOI 10.1007/s003300000729; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Thomsen HS, 2006, ABDOM IMAGING, V31, P131, DOI 10.1007/s00261-005-0380-y; Tramer MR, 2006, BRIT MED J, V333, P675, DOI 10.1136/bmj.38905.634132.AE; WOLF GL, 1991, INVEST RADIOL, V26, P404, DOI 10.1097/00004424-199105000-00003	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76018	10.1371/journal.pone.0076018	http://dx.doi.org/10.1371/journal.pone.0076018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098420	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500041
J	Pellegrino, AC; Penaflor, MFGV; Nardi, C; Bezner-Kerr, W; Guglielmo, CG; Bento, JMS; McNeil, JN				Pellegrino, Ana Cristina; Gomes Villalba Penaflor, Maria Fernanda; Nardi, Cristiane; Bezner-Kerr, Wayne; Guglielmo, Christopher G.; Simoes Bento, Jose Mauricio; McNeil, Jeremy N.			Weather Forecasting by Insects: Modified Sexual Behaviour in Response to Atmospheric Pressure Changes	PLOS ONE			English	Article							VIRGIFERA-VIRGIFERA COLEOPTERA; CORN-ROOTWORM COLEOPTERA; BAROMETRIC-PRESSURE; POTATO APHID; CALLING BEHAVIOR; MATING-BEHAVIOR; FLIGHT ACTIVITY; WIND-SPEED; PHEROMONE; ECOLOGY	Prevailing abiotic conditions may positively or negatively impact insects at both the individual and population levels. For example while moderate rainfall and wind velocity may provide conditions that favour development, as well as movement within and between habitats, high winds and heavy rains can significantly decrease life expectancy. There is some evidence that insects adjust their behaviours associated with flight, mating and foraging in response to changes in barometric pressure. We studied changes in different mating behaviours of three taxonomically unrelated insects, the curcurbit beetle, Diabrotica speciosa (Coleoptera), the true armyworm moth, Pseudaletia unipuncta (Lepidoptera) and the potato aphid, Macrosiphum euphorbiae (Hemiptera), when subjected to natural or experimentally manipulated changes in atmospheric pressure. In response to decreasing barometric pressure, male beetles exhibited decreased locomotory activity in a Y-tube olfactometer with female pheromone extracts. However, when placed in close proximity to females, they exhibited reduced courtship sequences and the precopulatory period. Under the same situations, females of the true armyworm and the potato aphid exhibited significantly reduced calling behaviour. Neither the movement of male beetles nor the calling of armyworm females differed between stable and increasing atmospheric pressure conditions. However, in the case of the armyworm there was a significant decrease in the incidence of mating under rising atmospheric conditions, suggesting an effect on male behaviour. When atmospheric pressure rose, very few M. euphorbiae oviparae called. This was similar to the situation observed under decreasing conditions, and consequently very little mating was observed in this species except under stable conditions. All species exhibited behavioural modifications, but there were interspecific differences related to size-related flight ability and the diel periodicity of mating activity. We postulate that the observed behavioral modifications, especially under decreasing barometric pressure would reduce the probability of injury or death under adverse weather conditions.	[Pellegrino, Ana Cristina; Gomes Villalba Penaflor, Maria Fernanda; Simoes Bento, Jose Mauricio] Univ Sao Paulo, ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil; [Nardi, Cristiane] Univ Estadual Ctr Oeste UNICTR, Dept Agron, Guarapuava, PR, Brazil; [Bezner-Kerr, Wayne; Guglielmo, Christopher G.; McNeil, Jeremy N.] Univ Western Ontario, Dept Biol, London, ON, Canada	Universidade de Sao Paulo; Western University (University of Western Ontario)	Bento, JMS (corresponding author), Univ Sao Paulo, ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil.	jmsbento@usp.br	Pellegrino, Ana Cristina/AAO-4737-2020; Peñaflor, Maria Fernanda G.V./F-7591-2013; Nardi, Cristiane/J-8158-2014; Bento, José Maurício Simões/A-9759-2008; Morbey, Yolanda/F-9035-2013	Peñaflor, Maria Fernanda G.V./0000-0001-8240-8840; Bento, José Maurício Simões/0000-0001-8655-5178; Nardi, Cristiane/0000-0003-4264-5379	INCT Semioquimicos na Agricultura; FAPESP; CNPq; NSERC; CFI	INCT Semioquimicos na Agricultura; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation)	Funders: INCT Semioquimicos na Agricultura, FAPESP, CNPq, NSERC and CFI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMENT JW, 1961, BIOL REV, V36, P281, DOI 10.1111/j.1469-185X.1961.tb01291.x; Breuner CW, 2013, J EXP BIOL, V216, P1982, DOI 10.1242/jeb.081067; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; CONNER WE, 1988, PHYSIOL ENTOMOL, V13, P15, DOI 10.1111/j.1365-3032.1988.tb00904.x; Crespo JE, 2012, J INSECT PHYSIOL, V58, P1562, DOI 10.1016/j.jinsphys.2012.09.010; Dickerson AK, 2012, P NATL ACAD SCI USA, V109, P9822, DOI 10.1073/pnas.1205446109; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Fournier F, 2005, ENVIRON ENTOMOL, V34, P1534, DOI 10.1603/0046-225X-34.6.1534; Goldansaz SH, 2006, J CHEM ECOL, V32, P1719, DOI 10.1007/s10886-006-9104-1; Goldansaz SH, 2003, ECOL ENTOMOL, V28, P291, DOI 10.1046/j.1365-2311.2003.00515.x; Heupel MR, 2003, J FISH BIOL, V63, P1357, DOI 10.1046/j.1095-8649.2003.00250.x; Isard SA, 2000, ENVIRON ENTOMOL, V29, P226, DOI 10.1603/0046-225X(2000)029[0226:AMOWCR]2.0.CO;2; Isard SA, 2004, ENVIRON ENTOMOL, V33, P650, DOI 10.1603/0046-225X-33.3.650; Isard SA, 1999, AEROBIOLOGIA, V15, P95; JANZEN DH, 1968, ECOLOGY, V49, P96, DOI 10.2307/1933565; KAAE RS, 1972, ANN ENTOMOL SOC AM, V65, P436, DOI 10.1093/aesa/65.2.436; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; LANIER GN, 1978, J CHEM ECOL, V4, P139, DOI 10.1007/BF00988050; Liu YL, 2010, MAR BIOL, V157, P2369, DOI 10.1007/s00227-010-1501-x; Marchand D, 2000, J INSECT BEHAV, V13, P187, DOI 10.1023/A:1007732113390; Marquardt PT, 2009, ENVIRON ENTOMOL, V38, P176, DOI 10.1603/022.038.0122; McIver SB, 1984, COMPREHENSIVE INSECT, V6, P71; MCNEIL JN, 1991, ANNU REV ENTOMOL, V36, P407, DOI 10.1146/annurev.en.36.010191.002203; Nardi C, 2012, ENVIRON ENTOMOL, V41, P562, DOI 10.1603/EN10284; PAIGE KN, 1995, FUNCT ECOL, V9, P463, DOI 10.2307/2390010; QUIRING DT, 1990, J APPL ECOL, V27, P965, DOI 10.2307/2404390; ROITBERG BD, 1993, NATURE, V364, P108, DOI 10.1038/364108a0; ROITBERG BD, 1978, CAN J ZOOL, V56, P103, DOI 10.1139/z78-014; Rousse P, 2009, ENVIRON ENTOMOL, V38, P896, DOI 10.1603/022.038.0344; Shaman J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000331; Spencer JL, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P121, DOI 10.1079/9780851998176.0121; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; TANAKA LK, 1982, BIOTROPICA, V14, P114, DOI 10.2307/2387740; TANNER EVJ, 1991, BIOTROPICA, V23, P513, DOI 10.2307/2388274; Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009; TURGEON J, 1982, ENTOMOL EXP APPL, V31, P402, DOI 10.1111/j.1570-7458.1982.tb03168.x; VANROERMUND HJW, 1995, J APPL ENTOMOL, V119, P465, DOI 10.1111/j.1439-0418.1995.tb01319.x; WALKER GP, 1984, ENVIRON ENTOMOL, V13, P724, DOI 10.1093/ee/13.3.724; Walsh GC, 2008, J APPL ENTOMOL, V132, P205, DOI 10.1111/j.1439-0418.2008.01272.x; WEAVER RJ, 1984, J INSECT PHYSIOL, V30, P831, DOI 10.1016/0022-1910(84)90020-9; Weisser WW, 1997, J ANIM ECOL, V66, P386, DOI 10.2307/5984; Wellington W. G., 1946, CANADIAN JOUR RES SECT D ZOOL SCI, V24, P51; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789	44	52	55	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75004	10.1371/journal.pone.0075004	http://dx.doi.org/10.1371/journal.pone.0075004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098362	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000325434500018
J	Chen, Y; Dorjgochoo, T; Bao, PP; Zheng, Y; Cai, H; Lu, W; Shu, XO				Chen, Yong; Dorjgochoo, Tsogzolmaa; Bao, Ping-Ping; Zheng, Ying; Cai, Hui; Lu, Wei; Shu, Xiao-Ou			Menopausal Symptoms among Breast Cancer Patients: A Potential Indicator of Favorable Prognosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; VASOMOTOR SYMPTOMS; HOT FLASH; WOMEN; PREVALENCE; ESTROGEN; HORMONES; METABOLITES; MANAGEMENT; RECURRENCE	Menopausal symptoms have been suggested to be an indicator of better prognosis among patients treated for breast cancer, because women who experience these symptoms usually have a lower level of estrogen. We tested this hypothesis in a population-based, prospective cohort study involving 4,842 women with stage 0 to III primary breast cancer who were enrolled in the Shanghai Breast Cancer Survival Study between March 2002 and April 2006, were aged 20 to 75 years, and were recruited 6 months post-diagnosis. They were followed-up by in-person surveys and record linkages with the vital statistics registry. Cox regression analysis was used to evaluate the association of menopausal symptoms at baseline with breast cancer recurrence. Approximately 56% of patients experienced at least one menopausal symptom, including hot flashes, night sweats, and/or vaginal dryness at baseline. During a median follow-up period of 5.3 years, 720 women had a recurrence. Experiencing hot flashes or having >= 2 menopausal symptoms was associated with lower risk of recurrence among premenopausal women (hazard ratio [HR]=0.77, 95% confidence interval [CI]: 0.62-0.96 for hot flashes; 0.73, 0.56-0.96 for >= 2 menopausal symptoms). Lower recurrence risk in relation to hot flashes was also observed among women who were not overweight/obese (HR=0.78, 95% CI: 0.64-0.99), those with relatively low waist-to-hip ratio (WHR) (HR=0.77, 95% CI: 0.61-0.97), and those who used tamoxifen (HR=0.75, 95% CI: 0.58-0.98). Consistently experiencing multiple menopausal symptoms was associated with lower recurrence risk among women with low WHR or who used tamoxifen. This large, population-based cohort study of women with breast cancer confirms that experiencing menopausal symptoms is an indicator of favorable breast cancer prognosis.	[Chen, Yong] Shanghai Municipal Ctr Dis Control & Prevent, Dept Sci & Educ, Shanghai, Peoples R China; [Dorjgochoo, Tsogzolmaa; Cai, Hui; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA; [Dorjgochoo, Tsogzolmaa; Cai, Hui; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Bao, Ping-Ping] Shanghai Municipal Ctr Dis Control & Prevent, Dept Canc Prevent & Control, Shanghai, Peoples R China; [Zheng, Ying; Lu, Wei] Shanghai Inst Prevent Med, Dept Canc Prevent & Control, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Vanderbilt University; Vanderbilt University; Shanghai Center for Disease Control & Prevention	Shu, XO (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA.	xiao-ou.shu@vanderbilt.edu	Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	Department of Defense Breast Cancer Research Program [DAMD 17-02-1-0607]; National Cancer Institute [R01 CA118229]; Fogarty International Center [D43 TW008313]; FOGARTY INTERNATIONAL CENTER [D43TW008313] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA118229] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the Department of Defense Breast Cancer Research Program (DAMD 17-02-1-0607 to XOS) and the National Cancer Institute (R01 CA118229 to XOS). YC and PPB were supported by a training grant from the Fogarty International Center (D43 TW008313 to XOS). The content of this manuscript does not necessarily reflect the position or the policy of the United States Government, and no official endorsement should be inferred. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, J AM MED REC ASS S, V61, P1; BOULET MJ, 1994, MATURITAS, V19, P157, DOI 10.1016/0378-5122(94)90068-X; Brown Kristy A, 2012, Front Biosci (Elite Ed), V4, P2515; Carney PI, 2010, MENOPAUSE, V17, P678, DOI 10.1097/gme.0b013e3181e3a10a; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Clemons M, 2002, CANCER TREAT REV, V28, P321, DOI 10.1016/S0305-7372(02)00089-0; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dorjgochoo T, 2011, BREAST CANCER RES TR, V130, P879, DOI 10.1007/s10549-010-1096-4; Dorjgochoo T, 2010, BREAST CANCER RES TR, V119, P725, DOI 10.1007/s10549-009-0434-x; Dorjgochoo T, 2009, MENOPAUSE, V16, P1205, DOI 10.1097/gme.0b013e3181aac32b; FELDMAN BM, 1985, RES NURS HEALTH, V8, P261, DOI 10.1002/nur.4770080308; Fenlon D R, 2007, Cancer Nurs, V30, pE19, DOI 10.1097/01.NCC.0000281731.95113.a3; Ganz Patricia A, 2005, Am J Med, V118 Suppl 12B, P136, DOI 10.1016/j.amjmed.2005.09.047; Glaus A, 2006, ANN ONCOL, V17, P801, DOI 10.1093/annonc/mdl030; Goetz MP, 2003, JNCI-J NATL CANCER I, V95, P1734, DOI 10.1093/jnci/djg129; Gupta P, 2006, CLIMACTERIC, V9, P49, DOI 10.1080/13697130500487224; Harris PF, 2002, J PAIN SYMPTOM MANAG, V23, P501, DOI 10.1016/S0885-3924(02)00395-0; Hoda Daanish, 2003, Breast J, V9, P431, DOI 10.1046/j.1524-4741.2003.09526.x; Howlader N, 1975, SEER CANC STAT REV 1; Hwang CS, 2006, J STEROID BIOCHEM, V101, P246, DOI 10.1016/j.jsbmb.2006.06.020; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Loprinzi CL, 2008, LANCET ONCOL, V9, P993, DOI 10.1016/S1470-2045(08)70256-0; McTiernan A, 2003, J CLIN ONCOL, V21, P1961, DOI 10.1200/JCO.2003.07.057; Moore HCF, 2001, CLEV CLIN J MED, V68, P243; Mortimer JE, 2008, BREAST CANCER RES TR, V108, P421, DOI 10.1007/s10549-007-9612-x; Nelson HD, 2008, LANCET, V371, P760, DOI 10.1016/S0140-6736(08)60346-3; Oleske DM, 2004, ONCOL NURS FORUM, V31, P1081, DOI 10.1188/04.ONF.1081-1088; Randolph JF, 2005, J CLIN ENDOCR METAB, V90, P6106, DOI 10.1210/jc.2005-1374; Rock CL, 2008, CANCER EPIDEM BIOMAR, V17, P614, DOI 10.1158/1055-9965.EPI-07-0761; Roy SS, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/654698; Ruiter R, 2010, PHARMACOGENOMICS, V11, P1367, DOI 10.2217/PGS.10.112; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Shen W, 2009, EXPERT OPIN PHARMACO, V10, P1133, DOI [10.1517/14656560902868217, 10.1517/14656560902868217 ]; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Shyu YK, 2012, J NURS RES, V20, P208, DOI 10.1097/jnr.0b013e318265619b; Sievert LL, 2007, MENOPAUSE, V14, P261, DOI 10.1097/01.gme.0000233496.13088.24; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Yang Y. X., 2002, CHINA FOOD COMPOSITI; Zollner YF, 2005, QUAL LIFE RES, V14, P309, DOI 10.1007/s11136-004-0688-z	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75926	10.1371/journal.pone.0075926	http://dx.doi.org/10.1371/journal.pone.0075926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098745	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500115
J	Diaz-Nieto, LM; Macia, A; Parisi, G; Farina, JL; Vidal-Dominguez, ME; Perotti, MA; Beron, CM				Diaz-Nieto, Leonardo M.; Macia, Arnaldo; Parisi, Gustavo; Farina, Juan L.; Vidal-Dominguez, Maria E.; Perotti, M. Alejandra; Beron, Corina M.			Distribution of Mosquitoes in the South East of Argentina and First Report on the Analysis Based on 18S rDNA and COI Sequences	PLOS ONE			English	Article							WEST-NILE-VIRUS; LOUIS ENCEPHALITIS-VIRUS; OCHLEROTATUS-ALBIFASCIATUS DIPTERA; CULEX-QUINQUEFASCIATUS DIPTERA; BUENOS-AIRES PROVINCE; AEDES-AEGYPTI; MAXIMUM-LIKELIHOOD; UNITED-STATES; CULICIDAE; DNA	Although Mar del Plata is the most important city on the Atlantic coast of Argentina, mosquitoes inhabiting such area are almost uncharacterized. To increase our knowledge in their distribution, we sampled specimens of natural populations. After the morphological identification based on taxonomic keys, sequences of DNA from small ribosomal subunit (18S rDNA) and cytochrome c oxidase I (COI) genes were obtained from native species and the phylogenetic analysis of these sequences were done. Fourteen species from the genera Uranotaenia, Culex, Ochlerotatus and Psorophora were found and identified. Our 18S rDNA and COI-based analysis indicates the relationships among groups at the supra-species level in concordance with mosquito taxonomy. The introduction and spread of vectors and diseases carried by them are not known in Mar del Plata, but some of the species found in this study were reported as pathogen vectors.	[Diaz-Nieto, Leonardo M.; Vidal-Dominguez, Maria E.; Beron, Corina M.] Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol INBIOTEC, Mar Del Plata, Argentina; [Macia, Arnaldo] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Entomol, La Plata, Argentina; [Parisi, Gustavo] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina; [Farina, Juan L.] Museo Municipal Ciencias Nat Lorenzo Scaglia, Area Entomol, Mar Del Plata, Argentina; [Perotti, M. Alejandra] Univ Reading, Sch Biol Sci, Ecol & Evolutionary Biol Sect, Reading, Berks, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; University of Reading	Beron, CM (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol INBIOTEC, Mar Del Plata, Argentina.	cberon@fiba.org.ar	Nieto, Leonardo Díaz/AAK-8763-2020	Nieto, Leonardo Díaz/0000-0003-4661-7084; Beron, Corina/0000-0002-0365-3571; parisi, gustavo/0000-0001-7444-1624; Macia, Arnaldo/0000-0002-3729-1425	Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT PICT-2007-02069]; Universidad Nacional de Mar del Plata [15E/329 EXA 382/07]; CONICET; Fundacion para Investigaciones Biologicas Aplicadas (FIBA)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion para Investigaciones Biologicas Aplicadas (FIBA)	This investigation was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT-2007-02069), by the Universidad Nacional de Mar del Plata (grant 15E/329 EXA 382/07), CONICET and Fundacion para Investigaciones Biologicas Aplicadas (FIBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diaz LA, 2006, EMERG INFECT DIS, V12, P1752, DOI 10.3201/eid1211.060486; Diaz LA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001177; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALMIRON WR, 1995, MEM I OSWALDO CRUZ, V90, P469, DOI 10.1590/S0074-02761995000400007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachmann AO, 1963, REV SOC ENTOMOL ARGE, V25, P21; Beebe NW, 2000, MOL PHYLOGENET EVOL, V17, P430, DOI 10.1006/mpev.2000.0853; Belkin JN., 1970, CONTRIB AM ENTOMOL I, V6, P1; BRAM R. A., 1967, Proceedings of the United States National Museum, V120, P1; Brewer M., 1987, REV PER ENTOMOL, V29, P69; Campos Raul E., 1995, Acta Entomologica Chilena, V19, P113; Campos RE, 2004, HYDROBIOLOGIA, V524, P91, DOI 10.1023/B:HYDR.0000036122.10578.d0; Campos RE, 2003, MEM I OSWALDO CRUZ, V98, P199, DOI 10.1590/S0074-02762003000200006; Carpenter S. J., 1955, MOSQUITOES N AM N ME; Cionchi JL, 2000, EXPLOTACION RACIONAL, P72; Crans WJ, 2004, J VECTOR ECOL, V29, P1; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; DARSIE R F JR, 1985, Mosquito Systematics, V17, P153; Demari-Silva B, 2011, J MED ENTOMOL, V48, P272, DOI 10.1603/ME09293; Diaz LA, 2009, THESIS U NACL CORDOB; Diaz-Nieto Leonardo M, 2013, PLoS Negl Trop Dis, V7, pe1963, DOI 10.1371/journal.pntd.0001963; Diez Fernando, 2012, Check List, V8, P251; DURET J P, 1953, Rev Sanid Milit Argent, V52, P272; Farina JL, 2006, TALARES BONAERENSES, P166; Fischer S, 2011, J VECTOR ECOL, V36, P94, DOI 10.1111/j.1948-7134.2011.00145.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francia Analía, 2011, Rev. Soc. Entomol. Argent., V70, P305; GALINDO PEDRO, 1954, ANN ENT SOC AMER, V47, P107; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Harbach RE, 2007, ZOOTAXA, P591; Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x; Harbach RE, 2013, CULEX CLASSIFICATION; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Hribar LJ, 2004, CARIBB J SCI, V40, P362; Huang SM, 2011, AM J TROP MED HYG, V85, P434, DOI 10.4269/ajtmh.2011.10-0679; Humeres SG, 1998, MEM I OSWALDO CRUZ, V93, P57, DOI 10.1590/S0074-02761998000100011; Ishii T, 1991, AKAIEKA NEWSLETTER, V14, P5; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kilpatrick AM, 2007, AM J TROP MED HYG, V77, P667, DOI 10.4269/ajtmh.2007.77.667; LANE J., 1953, Neotropical Culioidae. Volumes I & II.; Macia Arnaldo, 1995, Neotropica (La Plata), V41, P43; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Micieli MV, 2013, J MED ENTOMOL, V50, P853, DOI 10.1603/ME12226; MITCHELL C J, 1984, Mosquito Systematics, V16, P308; MITCHELL CJ, 1987, AM J TROP MED HYG, V36, P107, DOI 10.4269/ajtmh.1987.36.107; Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852; Munstermann LE, 1997, ANNU REV ENTOMOL, V42, P351, DOI 10.1146/annurev.ento.42.1.351; OPS/OMS, 2010, DENG GUIAS DIAGN TRA; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pisano MB, 2010, TROP MED INT HEALTH, V15, P865, DOI 10.1111/j.1365-3156.2010.02541.x; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; Rossi G, 2002, PROBIOTA, V3, P1; Sambrook J., 2001, MOL CLONING LAB MANU, P2344; Shepard JJ, 2006, J MED ENTOMOL, V43, P443, DOI 10.1603/0022-2585(2006)43[443:MPAERA]2.0.CO;2; SIRIVANAKARN S, 1978, P ENTOMOL SOC WASH, V80, P360; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Spinsanti L, 2003, EMERG INFECT DIS, V9, P271; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tauro L, 2012, MEM I OSWALDO CRUZ, V107, P553, DOI 10.1590/S0074-02762012000400019; Turell MJ, 2005, J MED ENTOMOL, V42, P891, DOI 10.1603/0022-2585(2005)042[0891:IOVFMD]2.0.CO;2; Unlu I, 2010, J MED ENTOMOL, V47, P625, DOI 10.1603/ME09087; Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN	70	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75516	10.1371/journal.pone.0075516	http://dx.doi.org/10.1371/journal.pone.0075516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098700	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000325423500071
J	Pusic, K; Clements, D; Kobuch, S; Hui, G				Pusic, Kae; Clements, Danielle; Kobuch, Sophie; Hui, George			Antibody and T Cell Responses in Reciprocal Prime-Boost Studies with Full-Length and Truncated Merozoite Surface Protein 1-42 Vaccines	PLOS ONE			English	Article							C-TERMINAL FRAGMENT; PLASMODIUM-FALCIPARUM; INHIBITORY ANTIBODIES; ADJUVANT FORMULATIONS; AOTUS MONKEYS; MALARIA; PARASITE; ANTIGEN; IMMUNITY; YOELII	The P. falciparum Merozoite Surface Protein 1-42 (MSP1-42) is one of the most studied malaria subunit vaccine candidates. The N-terminal fragment of MSP1-42, MSP1-33, is primarily composed of allelic sequences, and has been shown to possess T helper epitopes that influence protective antibody responses toward the C-terminal region, MSP1-19. A truncated MSP1-42 vaccine, Construct 33-I, consisting of exclusively conserved T epitope regions of MSP1-33 expressed in tandem with MSP1-19, was previously shown to be a more effective immunogen than the full-length MSP1-42 vaccine. Here, by way of reciprocal priming/boosting immunization regimens, we studied the immunogenicity of Construct 33-I in the context of recognition by immune responses induced by the full-length native MSP1-42 protein, in order to gauge the effects of pre- and post-exposures to MSP1-42 on vaccine induced responses. Judging by immune responsiveness, antibody and T cell responses, Construct 33-I was effective as the priming antigen followed by full-length MSP1-42 boosting, as well as the boosting antigen following full-length MSP1-42 priming. In particular, Construct 33-I priming elicited the broadest responsiveness in immunized animals subsequently exposed to MSP1-42. Moreover, Construct 33-I, with its conserved MSP1-33 specific T cell epitopes, was equally well recognized by homologous and heterologous allelic forms of MSP1-42. Serum antibodies raised against Construct 33-I efficiently inhibited the growth of parasites carrying the heterologous MSP1-42 allele. These results suggest that Construct 33-I maintains and/or enhances its immunogenicity in an allelic or strain transcending fashion when deployed in populations having prior or subsequent exposures to native MSP1-42s.	[Pusic, Kae; Clements, Danielle; Kobuch, Sophie; Hui, George] Univ Hawaii, Dept Trop Med, Sch Med, Honolulu, HI 96822 USA	University of Hawaii System	Pusic, K (corresponding author), Univ Hawaii, Dept Trop Med, Sch Med, Honolulu, HI 96822 USA.	kae@hawaii.edu			National Institutes of Health/National Institute of Allergy and Infectious [A1076955]; NIH/National Institute of General Medical Sciences [P20GM103516]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [DK078386]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK078386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from National Institutes of Health/National Institute of Allergy and Infectious (A1076955) and NIH/National Institute of General Medical Sciences:(P20GM103516). KPusic was supported by NIH/National Institute of Diabetes and Digestive and Kidney Diseases (DK078386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Bergmann-Leitner ES, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-315; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BURNS JM, 1988, P NATL ACAD SCI USA, V85, P602, DOI 10.1073/pnas.85.2.602; BURNS JM, 1989, J IMMUNOL, V142, P2835; CHANG SP, 1994, J IMMUNOL, V152, P3483; Chang SP, 1996, INFECT IMMUN, V64, P253, DOI 10.1128/IAI.64.1.253-261.1996; CHANG SP, 1992, J IMMUNOL, V149, P548; CHANG SP, 1989, P NATL ACAD SCI USA, V86, P6343, DOI 10.1073/pnas.86.16.6343; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; HOLDER AA, 1984, J EXP MED, V160, P624, DOI 10.1084/jem.160.2.624; HOLDER AA, 1985, NATURE, V317, P270, DOI 10.1038/317270a0; HOLDER AA, 1994, BIOCHEM SOC T, V22, P291, DOI 10.1042/bst0220291; Hui G, 2008, CLIN VACCINE IMMUNOL, V15, P1145, DOI 10.1128/CVI.00058-08; Hui G, 2007, VACCINE, V25, P8549, DOI 10.1016/j.vaccine.2007.10.010; HUI GSN, 1991, INFECT IMMUN, V59, P1585, DOI 10.1128/IAI.59.5.1585-1591.1991; HUI GSN, 1994, J IMMUNOL, V153, P2544; HUI GSN, 1993, INFECT IMMUN, V61, P3403, DOI 10.1128/IAI.61.8.3403-3411.1993; HUI GSN, 1992, INFECT IMMUN, V60, P1422, DOI 10.1128/IAI.60.4.1422-1433.1992; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Kumar S, 2000, INFECT IMMUN, V68, P2215, DOI 10.1128/IAI.68.4.2215-2223.2000; Lee EAM, 2001, AM J TROP MED HYG, V64, P194, DOI 10.4269/ajtmh.2001.64.194; Leung WH, 2004, BBA-GEN SUBJECTS, V1675, P62, DOI 10.1016/j.bbagen.2004.08.005; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Malhotra I, 2008, J IMMUNOL, V180, P3383, DOI 10.4049/jimmunol.180.5.3383; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Ouattara A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-175; Pang ALY, 2002, INFECT IMMUN, V70, P2772, DOI 10.1128/IAI.70.6.2772-2779.2002; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Pusic KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024782; Renia L, 1997, INFECT IMMUN, V65, P4419; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stanisic DI, 2003, INFECT IMMUN, V71, P5700, DOI 10.1128/IAI.71.10.5700-5713.2003; Stephens R, 2005, BLOOD, V106, P1676, DOI 10.1182/blood-2004-10-4047; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Tian JH, 1998, PARASITE IMMUNOL, V20, P263, DOI 10.1046/j.1365-3024.1998.00138.x; Tian JH, 1996, J IMMUNOL, V157, P1176; UDHAYAKUMAR V, 1995, J IMMUNOL, V154, P6022; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223	46	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75939	10.1371/journal.pone.0075939	http://dx.doi.org/10.1371/journal.pone.0075939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098747	gold, Green Published, Green Submitted			2022-12-27	WOS:000325423500117
J	Reyskens, KMSE; Fisher, TL; Schisler, JC; O'Connor, WG; Rogers, AB; Willis, MS; Planesse, C; Rondeau, P; Bourdon, E; Essop, MF				Reyskens, Kathleen M. S. E.; Fisher, Tarryn-Lee; Schisler, Jonathan C.; O'Connor, Wendi G.; Rogers, Arlin B.; Willis, Monte S.; Planesse, Cynthia; Rondeau, Philippe; Bourdon, Emmanuel; Essop, M. Faadiel			The Maladaptive Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir) on the Rat Heart	PLOS ONE			English	Article							ELEMENT-BINDING PROTEINS; INSULIN SENSITIVITY; PERIPHERAL LIPODYSTROPHY; T-LYMPHOCYTES; ATHEROSCLEROSIS; HYPERLIPIDEMIA; DEGRADATION; PGC-1-ALPHA; PREVALENCE; MECHANISMS	Although antiretroviral treatment decreases HIV-AIDS morbidity/mortality, long-term effects include onset of insulin resistance and cardiovascular diseases. Increased oxidative stress and dysregulation of the ubiquitin-proteasome system (UPS) are implicated in protease-inhibitor (PI)-mediated cardio-metabolic pathophysiology. We hypothesized that PI treatment (Lopinavir/Ritonavir) elevates myocardial oxidative stress and concomitantly inhibits the UPS, thereby attenuating cardiac function. Lopinavir/Ritonavir was dissolved in 1% ethanol (vehicle) and injected into mini-osmotic pumps that were surgically implanted into Wistar rats for 8 weeks vs. vehicle and sham controls. Subsequently, we evaluated metabolic parameters and heart function (ex vivo Langendorff perfusions) at baseline and following ischemia-reperfusion. PI-treated rats exhibited weight gain, increased serum LDL-cholesterol, higher tissue triglycerides (heart, liver), but no evidence of insulin resistance. It also upregulated hepatic gene expression of acetyl-CoA carboxylase beta and 3-hydroxy-3-methylglutaryl-CoA-reductase, key regulators of fatty acid oxidation and cholesterol synthesis, respectively. PI-treated hearts displayed impaired UPS, increased SOD activity and unaltered superoxide levels, and elevated peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1 alpha) peptide levels. Perfusion data revealed contractile dysfunction at baseline and following ischemia-reperfusion, while post-ischemic hearts exhibited decreased ATPase specific activity vs. matched controls. Early changes initiated by PI treatment resemble the metabolic syndrome and reflect a pre-atherogenic profile. Moreover, the effects of PIs on cardiac contractile function may in part be triggered by impaired UPS activity together with strain on the mitochondrial energetic system. Our study alerts to cardio-metabolic side effects of PI treatment and raises the question of the most appropriate co-therapies for patients on chronic antiretroviral treatment.	[Reyskens, Kathleen M. S. E.; Fisher, Tarryn-Lee; Essop, M. Faadiel] Univ Stellenbosch, Dept Physiol Sci, Cardiometab Res Grp, ZA-7600 Stellenbosch, South Africa; [Schisler, Jonathan C.; O'Connor, Wendi G.; Rogers, Arlin B.; Willis, Monte S.] Univ N Carolina, Dept Pathol & Lab Med, McAllister Heart Inst, Chapel Hill, NC USA; [Planesse, Cynthia; Rondeau, Philippe; Bourdon, Emmanuel] Univ Reunion, Grp Etud Inflammat Chron & Obes, Plateforme CYROI, St Denis, Reunion, France	Stellenbosch University; University of North Carolina; University of North Carolina Chapel Hill; University of La Reunion	Essop, MF (corresponding author), Univ Stellenbosch, Dept Physiol Sci, Cardiometab Res Grp, ZA-7600 Stellenbosch, South Africa.	mfessop@sun.ac.za	Bourdon, Emmanuel/P-8455-2019; rondeau, philippe/Q-1967-2019; Willis, Monte S/J-9994-2015; rondeau, philippe/F-6755-2015; Schisler, Jonathan C./C-1301-2008	rondeau, philippe/0000-0002-4652-1376; Willis, Monte S/0000-0002-0769-5816; Schisler, Jonathan C./0000-0001-7382-2783; Essop, Faadiel/0000-0002-8434-4294; Bourdon, Emmanuel/0000-0003-3731-150X	South African National Research Foundation; Stellenbosch University; Conseil Regional de La Reunion; l'Europethe Jefferson; Pilot Fellowship in Academic Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104129] Funding Source: NIH RePORTER	South African National Research Foundation(National Research Foundation - South Africa); Stellenbosch University; Conseil Regional de La Reunion; l'Europethe Jefferson; Pilot Fellowship in Academic Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the South African National Research Foundation and Stellenbosch University (MFE), the Conseil Regional de La Reunion and l'Europethe Jefferson (EB), and a Pilot Fellowship in Academic Medicine (MSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Armstrong W, 2005, CLEV CLIN J MED, V72, P73, DOI 10.3949/ccjm.72.1.73; Becker AC, 2010, J INTERV CARDIOL, V23, P70, DOI 10.1111/j.1540-8183.2009.00520.x; Bernal E, 2012, MED CLIN-BARCELONA, V139, P561, DOI 10.1016/j.medcli.2012.03.037; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Carr A, 2008, AIDS, V22, P2313, DOI 10.1097/QAD.0b013e328315a7a5; Darley-Usmar VM, 2012, J MOL CELL CARDIOL, V52, P538, DOI 10.1016/j.yjmcc.2011.08.009; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Farhoud MH, 2012, PROTEOMICS, V12, P1349, DOI 10.1002/pmic.201100326; Ferrer E, 2011, AIDS RES HUM RETROV, V27, P1061, DOI [10.1089/aid.2010.0254, 10.1089/AID.2010.0254]; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gan SK, 2002, DIABETES, V51, P3163, DOI 10.2337/diabetes.51.11.3163; GREENSPAN HC, 1994, IMMUNOL TODAY, V15, P209, DOI 10.1016/0167-5699(94)90245-3; Grinspoon SK, 2008, JAIDS-J ACQ IMM DEF, V48, P369, DOI 10.1161/CIRCULATIONAHA.107.189622; Hecker PA, 2012, AM J PHYSIOL-ENDOC M, V303, pE959, DOI 10.1152/ajpendo.00202.2012; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Hui DY, 2003, PROG LIPID RES, V42, P81, DOI 10.1016/S0163-7827(02)00046-2; Jeon HB, 2007, BIOCHEM BIOPH RES CO, V357, P731, DOI 10.1016/j.bbrc.2007.04.015; Jerico C, 2006, STROKE, V37, P812, DOI 10.1161/01.STR.0000204037.26797.7f; Jiang B, 2007, TOXICOL APPL PHARM, V224, P60, DOI 10.1016/j.taap.2007.06.010; Lagathu C, 2005, BIOCHIMIE, V87, P65, DOI 10.1016/j.biochi.2004.12.007; Lekakis J, 2008, CLIN SCI, V115, P189, DOI 10.1042/CS20070353; Levine RL, 2000, METH MOL B, V99, P15; Liang JS, 2001, NAT MED, V7, P1327, DOI 10.1038/nm1201-1327; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; MACHO A, 1995, BLOOD, V86, P2481; Mapanga RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047322; Matarrese P, 2003, J IMMUNOL, V170, P6006, DOI 10.4049/jimmunol.170.12.6006; Melekhin VV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006961; Mondy KE, 2011, CLIN INFECT DIS, V52, P378, DOI 10.1093/cid/ciq066; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Panther LA, 2002, AM J PHYSIOL-HEART C, V283, pH1, DOI 10.1152/ajpheart.00212.2002; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Riddle TM, 2001, J BIOL CHEM, V276, P37514, DOI 10.1074/jbc.M104557200; Rudich A, 2005, ACTA PHYSIOL SCAND, V183, P75, DOI 10.1111/j.1365-201X.2004.01383.x; Schmidtke G, 1999, J BIOL CHEM, V274, P35734, DOI 10.1074/jbc.274.50.35734; Sivitz W, 2010, ANTIOXID REDOX SIGN, V12, P1; Spiegelman BM, 2007, NOVART FDN SYMP, V287, P60; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vernochet C, 2005, J BIOL CHEM, V280, P2238, DOI 10.1074/jbc.M408687200; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, CIRC RES, V105, P80, DOI 10.1161/CIRCRESAHA.109.194928	54	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e73347	10.1371/journal.pone.0073347	http://dx.doi.org/10.1371/journal.pone.0073347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098634	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500006
J	Wang, LP; Fobert, PR				Wang, Lipu; Fobert, Pierre R.			Arabidopsis Clade I TGA Factors Regulate Apoplastic Defences against the Bacterial Pathogen Pseudomonas syringae through Endoplasmic Reticulum-Based Processes	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; UNFOLDED PROTEIN RESPONSE; DNA-BINDING ACTIVITY; SALICYLIC-ACID INDUCTION; TRANSCRIPTION FACTOR; NONHOST RESISTANCE; DISEASE RESISTANCE; SECRETORY PATHWAY; CALLOSE SYNTHASE; QUALITY-CONTROL	During the plant immune response, large-scale transcriptional reprogramming is modulated by numerous transcription (co) factors. The Arabidopsis basic leucine zipper transcription factors TGA1 and TGA4, which comprise the clade I TGA factors, have been shown to positively contribute to disease resistance against virulent strains of the bacterial pathogen Pseudomonas syringae. Despite physically interacting with the key immune regulator, NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES 1 (NPR1), following elicitation with salicylic acid (SA), clade I function was shown to be largely independent of NPR1. Unlike mutants in NPR1, tga1-1 tga4-1 plants do not display reductions in steady-state levels of SA-pathway marker genes following treatment with this phenolic signaling metabolite or after challenge with virulent or avirulent P. syringae. By exploiting bacterial strains that have limited capacity to suppress Arabidopsis defence responses, the present study demonstrates that tga1-1 tga4-1 plants are compromised in basal resistance and defective in several apoplastic defence responses, including the oxidative burst of reactive oxygen species, callose deposition, as well as total and apoplastic PATHOGENESIS-RELATED 1 (PR-1) protein accumulation. Furthermore, analysis of npr1-1 and the tga1-1 tga4-1 npr1-1 triple mutant indicates that clade I TGA factors act substantially independent of NPR1 in mediating disease resistance against these strains of P. syringae. Increased sensitivity to the N-glycosylation inhibitor tunicamycin and elevated levels of endoplasmic reticulum (ER) stress marker genes encoding ER-resident chaperones in mutant seedlings suggest that loss of apoplastic defence responses is associated with aberrant protein secretion and implicate clade I TGA factors as positive regulators of one or more ER-related secretion pathways.	[Wang, Lipu] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Wang, Lipu; Fobert, Pierre R.] Natl Res Council Canada, Saskatoon, SK, Canada	University of Saskatchewan; National Research Council Canada	Fobert, PR (corresponding author), Natl Res Council Canada, Saskatoon, SK, Canada.	Pierre.Fobert@nrc-cnrc.gc.ca			National Science and Engineering Research Council of Canada (NSERC); NRC; University of Saskatchewan	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NRC(National Research Centre (NRC)); University of Saskatchewan	This research was supported by funding from the National Science and Engineering Research Council of Canada (NSERC) Discovery Grants program and NRC to PRF, and Graduate scholarships from the University of Saskatchewan to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 1971, STAT METHODS MED RES, V1; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chen YN, 2012, PLANT J, V69, P266, DOI 10.1111/j.1365-313X.2011.04788.x; Choi J, 2010, DEV CELL, V19, P284, DOI 10.1016/j.devcel.2010.07.011; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Dempsey DA, 2012, TRENDS PLANT SCI, V17, P538, DOI 10.1016/j.tplants.2012.05.011; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Dong XY, 2008, PLANTA, V229, P87, DOI 10.1007/s00425-008-0812-3; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Forsyth A, 2010, MOL PLANT MICROBE IN, V23, P1545, DOI 10.1094/MPMI-02-10-0047; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Ham JH, 2007, PLANT J, V51, P604, DOI 10.1111/j.1365-313X.2007.03165.x; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Iwata Y, 2012, TRENDS PLANT SCI, V17, P720, DOI 10.1016/j.tplants.2012.06.014; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Koizumi N, 1999, PLANT PHYSIOL, V121, P353, DOI 10.1104/pp.121.2.353; Kwon C, 2008, PLANT PHYSIOL, V147, P1575, DOI 10.1104/pp.108.121566; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Mishina TE, 2007, PHYSIOL PLANTARUM, V131, P448, DOI 10.1111/j.1399-3054.2007.00977.x; Moreno AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031944; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nomura K, 2011, P NATL ACAD SCI USA, V108, P10774, DOI 10.1073/pnas.1103338108; Pajerowska-Mukhtar KM, 2012, CURR BIOL, V22, P103, DOI 10.1016/j.cub.2011.12.015; Rochon A, 2006, PLANT CELL, V18, P3670, DOI 10.1105/tpc.106.046953; Rodriguez-Herva JJ, 2012, CELL MICROBIOL, V14, P669, DOI 10.1111/j.1462-5822.2012.01749.x; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shearer HL, 2012, MOL PLANT MICROBE IN, V25, P1459, DOI 10.1094/MPMI-09-11-0256; Shearer HL, 2009, BOTANY, V87, P561, DOI 10.1139/B08-143; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang D, 2011, MOL PLANT, V4, P581, DOI 10.1093/mp/ssr053; Williams B, 2010, P NATL ACAD SCI USA, V107, P6088, DOI 10.1073/pnas.0912670107; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Zhang HR, 2008, PLANT CELL, V20, P1879, DOI 10.1105/tpc.108.061150; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	76	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77378	10.1371/journal.pone.0077378	http://dx.doi.org/10.1371/journal.pone.0077378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086773	Green Published, gold			2022-12-27	WOS:000325223900116
J	Dissard, R; Klein, J; Caubet, C; Breuil, B; Siwy, J; Hoffman, J; Sicard, L; Ducasse, L; Rascalou, S; Payre, B; Buleon, M; Mullen, W; Mischak, H; Tack, I; Bascands, JL; Buffin-Meyer, B; Schanstra, JP				Dissard, Romain; Klein, Julie; Caubet, Cecile; Breuil, Benjamin; Siwy, Justyna; Hoffman, Janosch; Sicard, Laurent; Ducasse, Laure; Rascalou, Simon; Payre, Bruno; Buleon, Marie; Mullen, William; Mischak, Harald; Tack, Ivan; Bascands, Jean-Loup; Buffin-Meyer, Benedicte; Schanstra, Joost P.			Long Term Metabolic Syndrome Induced by a High Fat High Fructose Diet Leads to Minimal Renal Injury in C57BL/6 Mice	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; SUGAR-SWEETENED BEVERAGES; US ADULTS; URINARY PROTEOMICS; HEPATIC STEATOSIS; LIPID-METABOLISM; MOUSE MODEL; OBESITY; PROGRESSION	Metabolic syndrome can induce chronic kidney disease in humans. Genetically engineered mice on a C57BL/6 background are highly used for mechanistic studies. Although it has been shown that metabolic syndrome induces cardiovascular lesions in C57BL/6 mice, in depth renal phenotyping has never been performed. Therefore in this study we characterized renal function and injury in C57BL/6 mice with long-term metabolic syndrome induced by a high fat and fructose diet (HFFD). C57BL/6 mice received an 8 months HFFD diet enriched with fat (45% energy from fat) and drinking water enriched with fructose (30%). Body weight, food/water consumption, energy intake, fat/lean mass ratio, plasma glucose, HDL, LDL, triglycerides and cholesterol levels were monitored. At 3, 6 and 8 months, renal function was determined by inulin clearance and measure of albuminuria. At sacrifice, kidneys and liver were collected. Metabolic syndrome in C57BL/6 mice fed a HFFD was observed as early 4 weeks with development of type 2 diabetes at 8 weeks after initiation of diet. However, detailed analysis of kidney structure and function showed only minimal renal injury after 8 months of HFFD. HFFD induced moderate glomerular hyperfiltration (436,4 mu L/min vs 289,8 mu L/min; p-value=0.0418) together with a 2-fold increase in albuminuria only after 8 months of HFFD. This was accompanied by a 2-fold increase in renal inflammation (p-value=0.0217) but without renal fibrosis or mesangial matrix expansion. In addition, electron microscopy did not show alterations in glomeruli such as basal membrane thickening and foot process effacement. Finally, comparison of the urinary peptidome of these mice with the urinary peptidome from humans with diabetic nephropathy also suggested absence of diabetic nephropathy in this model. This study provides evidence that the HFFD C57BL/6 model is not the optimal model to study the effects of metabolic syndrome on the development of diabetic kidney disease.	[Dissard, Romain; Caubet, Cecile; Breuil, Benjamin; Sicard, Laurent; Ducasse, Laure; Rascalou, Simon; Buleon, Marie; Tack, Ivan; Bascands, Jean-Loup; Buffin-Meyer, Benedicte; Schanstra, Joost P.] Fac Med Toulouse, INSERM, U1048, Inst Cardiovasc & Metab Dis, F-31073 Toulouse, France; [Dissard, Romain; Caubet, Cecile; Sicard, Laurent; Ducasse, Laure; Rascalou, Simon; Buleon, Marie; Tack, Ivan; Bascands, Jean-Loup; Buffin-Meyer, Benedicte; Schanstra, Joost P.] Univ Toulouse 3, F-31062 Toulouse, France; [Klein, Julie; Breuil, Benjamin] Inst Cardiovasc & Metab Dis, Toulouse, France; [Siwy, Justyna; Hoffman, Janosch; Mischak, Harald] Mosaiques Diagnost GmbH, Hannover, Germany; [Siwy, Justyna] Charite, D-13353 Berlin, Germany; [Payre, Bruno] Ctr Microscopie Elect Appl Biol, Toulouse, France; [Mullen, William; Mischak, Harald] Univ Glasgow, Dept Prote & Syst Med, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci,Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Mosaiques Diagnostics GmbH (MOS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Glasgow	Schanstra, JP (corresponding author), Fac Med Toulouse, INSERM, U1048, Inst Cardiovasc & Metab Dis, U317, F-31073 Toulouse, France.	joost-peter.schanstra@inserm.fr	Schanstra, Joost P/X-7724-2018; Buffin-Meyer, Bénédicte/X-7705-2018; Klein, Julie/ABE-2622-2020; Mullen, William/GWC-8078-2022; Klein, Julie/M-7088-2017	Schanstra, Joost P/0000-0002-7471-372X; Buffin-Meyer, Bénédicte/0000-0002-4805-1558; Klein, Julie/0000-0002-3279-0559; Klein, Julie/0000-0002-3279-0559; Bascands, Jean-loup/0000-0002-1667-5913; Mullen, William/0000-0002-5685-1563; Siwy, Justyna/0000-0003-1407-2534; Mischak, Harald/0000-0003-0323-0306	FP7 program "Improvement of tools and portability of mass spectrometry based clinical proteomics as applied to chronic kidney disease" (Protoclin) [PEOPLE-2009-IAPP, GA 251368]; French Ministry of Education, Research and Technology	FP7 program "Improvement of tools and portability of mass spectrometry based clinical proteomics as applied to chronic kidney disease" (Protoclin); French Ministry of Education, Research and Technology	Part of this work was supported by the FP7 program "Improvement of tools and portability of mass spectrometry based clinical proteomics as applied to chronic kidney disease" (Protoclin, PEOPLE-2009-IAPP, GA 251368). Romain Dissard is a recipient of a research grant from the French Ministry of Education, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuaisha B, 1998, DIABETES RES CLIN PR, V39, P93, DOI 10.1016/S0168-8227(97)00111-3; Aoyama M, 2012, BIOCHEM BIOPH RES CO, V419, P244, DOI 10.1016/j.bbrc.2012.02.001; Axelsen LN, 2010, AM J PHYSIOL-REG I, V298, pR1560, DOI 10.1152/ajpregu.00392.2009; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; BOUBY N, 1990, AM J PHYSIOL, V258, pF973, DOI 10.1152/ajprenal.1990.258.4.F973; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Buleon M, 2008, AM J PHYSIOL-RENAL, V294, pF1249, DOI 10.1152/ajprenal.00501.2007; Calderan L, 2006, OBESITY, V14, P405, DOI 10.1038/oby.2006.54; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Couturier K, 2011, METABOLISM, V60, P1590, DOI 10.1016/j.metabol.2011.03.016; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gersch MS, 2007, AM J PHYSIOL-RENAL, V293, pF1256, DOI 10.1152/ajprenal.00181.2007; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Han BG, 2008, AM J PHYSIOL-ENDOC M, V295, pE981, DOI 10.1152/ajpendo.90283.2008; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Levine DZ, 2008, AM J PHYSIOL-REG I, V294, pR1840, DOI 10.1152/ajpregu.00457.2007; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Menard SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE1049, DOI 10.1152/ajpendo.00560.2009; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2012, PROTEOM CLIN APPL, V6, P437, DOI 10.1002/prca.201200027; MOGENSEN CE, 1983, DIABETES, V32, P64, DOI 10.2337/diab.32.2.S64; Molin L, 2012, J PROTEOMICS, V75, P5888, DOI 10.1016/j.jprot.2012.07.024; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Mullen W, 2011, CURR OPIN NEPHROL HY, V20, P654, DOI 10.1097/MNH.0b013e32834b7ffa; National Diabetes Fact Sheet, 2011, NAT DIAB FACT SHEET; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Puri TS, 2010, AM J PHYSIOL-RENAL, V298, pF1024, DOI 10.1152/ajprenal.00384.2009; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y; Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010; Roscioni SS, 2013, DIABETOLOGIA, V56, P259, DOI 10.1007/s00125-012-2755-2; Rossing K, 2008, PROTEOM CLIN APPL, V2, P997, DOI 10.1002/prca.200780166; Rowley Kevin, 2003, Curr Diab Rep, V3, P80, DOI 10.1007/s11892-003-0058-1; Siwy J, 2011, PROTEOM CLIN APPL, V5, P367, DOI 10.1002/prca.201000155; Stalmach A, 2013, ELECTROPHORESIS, V34, P1452, DOI 10.1002/elps.201200708; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; von zur Muhlen C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013847; Wada T, 2010, ENDOCRINOLOGY, V151, P2040, DOI 10.1210/en.2009-0869; Wittke S, 2003, J CHROMATOGR A, V1013, P173, DOI 10.1016/S0021-9673(03)00713-1; World Health Organization, 2011, DIAB FACT SHEET; Yilmaz Y, 2012, ALIMENT PHARM THER, V35, P1135, DOI 10.1111/j.1365-2036.2012.05080.x; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827; Zurbig P, 2012, DIABETES, V61, P3304, DOI 10.2337/db12-0348	68	37	39	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76703	10.1371/journal.pone.0076703	http://dx.doi.org/10.1371/journal.pone.0076703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098551	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600071
J	Ferreira, D; Rocha, HC; Kreutz, LC; Loro, VL; Marqueze, A; Koakoski, G; da Rosa, JGS; Gusso, D; Oliveira, TA; de Abreu, MS; Barcellos, LJG				Ferreira, Daiane; Rocha, Helio Carlos; Kreutz, Luiz Carlos; Loro, Vania Lucia; Marqueze, Alessandra; Koakoski, Gessi; Santos da Rosa, Joao Gabriel; Gusso, Darlan; Oliveira, Thiago Acosta; de Abreu, Murilo Sander; Gil Barcellos, Leonardo Jose			Bee Products Prevent Agrichemical-Induced Oxidative Damage in Fish	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; JUNDIA RHAMDIA-QUELEN; FRESH-WATER FISH; SUBLETHAL CONCENTRATIONS; HYDROGEN-PEROXIDE; EXPOSURE; STRESS; ACID; ANTIOXIDANTS; BIOMARKERS	In southern South America and other parts of the world, aquaculture is an activity that complements agriculture. Small amounts of agrichemicals can reach aquaculture ponds, which results in numerous problems caused by oxidative stress in non-target organisms. Substances that can prevent or reverse agrichemical-induced oxidative damage may be used to combat these effects. This study includes four experiments. In each experiment, 96 mixed-sex, 6-month-old Rhamdia quelen (118 +/- 15 g) were distributed into eight experimental groups: a control group that was not exposed to contaminated water, three groups that were exposed to various concentrations of bee products, three groups that were exposed to various concentrations of bee products plus tebuconazole (TEB; Folicur 200 CE (TM)) and a group that was exposed to 0.88 mg L-1 of TEB alone (corresponding to 16.6% of the 96-h LC50). We show that waterborne bee products, including royal jelly (RJ), honey (H), bee pollen (BP) and propolis (P), reversed the oxidative damage caused by exposure to TEB. These effects were likely caused by the high polyphenol contents of these bee-derived compounds. The most likely mechanism of action for the protective effects of bee products against tissue oxidation and the resultant damage is that the enzymatic activities of superoxide dismutase (SOD), catalase (CAT) and glutathione-S-transferase (GST) are increased.	[Ferreira, Daiane; Koakoski, Gessi; Santos da Rosa, Joao Gabriel; Gusso, Darlan; Oliveira, Thiago Acosta; de Abreu, Murilo Sander] Univ Fed Santa Maria, Programa Posgrad Farmacol, Santa Maria, RS, Brazil; [Rocha, Helio Carlos; Kreutz, Luiz Carlos; Gil Barcellos, Leonardo Jose] Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil; [Loro, Vania Lucia] Univ Fed Santa Maria, Programa Posgrad Bioquim Toxicol, Santa Maria, RS, Brazil; [Marqueze, Alessandra] Ctr Univ La Salle Unilasalle, Programa Posgrad Avaliacao & Impactos Ambientais, Canoas, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade de Passo Fundo; Universidade Federal de Santa Maria (UFSM); Centro Universitario La Salle	Barcellos, LJG (corresponding author), Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil.	lbarcellos@upf.br	Sander de Abreu, Murilo/J-9756-2015; Kreutz, Luiz C/A-3729-2015; Gusso, Darlan/ABA-6552-2021; Loro, Vania/E-9387-2015	Sander de Abreu, Murilo/0000-0001-5562-0715; Kreutz, Luiz C/0000-0002-7685-7401; Gusso, Darlan/0000-0003-0293-239X; Loro, Vania/0000-0003-2440-8791				Ahmad I, 2000, BBA-GEN SUBJECTS, V1523, P37, DOI 10.1016/S0304-4165(00)00098-2; Ahmad I, 2004, ECOTOX ENVIRON SAFE, V57, P290, DOI 10.1016/S0147-6513(03)00080-0; Almroth BC, 2005, AQUAT TOXICOL, V73, P171, DOI 10.1016/j.aquatox.2005.03.007; ANGELO P. M., 2007, REV I A LUTZ, V66, P232; [Anonymous], 2013, FICHA DADOS SEGURANC; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARR RS, 1983, ANAL CHEM, V55, P1229, DOI 10.1021/ac00259a012; Cericato L, 2008, COMP BIOCHEM PHYS C, V148, P281, DOI 10.1016/j.cbpc.2008.06.008; Cericato L, 2009, COMP BIOCHEM PHYS C, V149, P363, DOI 10.1016/j.cbpc.2008.09.002; Ferreira D, 2012, NEOTROP ICHTHYOL, V10, P215, DOI 10.1590/S1679-62252012000100021; Ferreira D, 2010, CHEMOSPHERE, V79, P914, DOI 10.1016/j.chemosphere.2010.03.024; FOURNIER D, 1992, J BIOL CHEM, V267, P1840; GAETANI GF, 1989, BLOOD, V73, P334; Gheldof N, 2002, J AGR FOOD CHEM, V50, P3050, DOI 10.1021/jf0114637; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Kreutz LC, 2008, CIENC RURAL, V38, P1050, DOI 10.1590/S0103-84782008000400022; Lushchak OV, 2009, AQUAT TOXICOL, V93, P45, DOI 10.1016/j.aquatox.2009.03.007; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MORSE RA, 1990, ABC XYZ BEE CULTURE; Nakajima Y, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-4; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Neves LC, 2009, BRAZIL J FOOD TECHN; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oruc EO, 2004, COMP BIOCHEM PHYS C, V137, P43, DOI 10.1016/j.cca.2003.11.006; Sancho E, 2010, ECOTOX ENVIRON SAFE, V73, P370, DOI 10.1016/j.ecoenv.2009.09.020; Sayeed I, 2003, ECOTOX ENVIRON SAFE, V56, P295, DOI 10.1016/S0147-6513(03)00009-5; Schonbaum G. R., 1976, ENZYMES, V13, P363, DOI [10.1016/S1874-6047(08)60245-0, DOI 10.1016/S1874-6047(08)60245-0]; Secretaria da Agricultura e do Abastecimento, INT TRIFL TEB; Shallaja MS, 2003, CHEMOSPHERE, V53, P835, DOI 10.1016/S0045-6535903)00667-2; Simonato JD, 2006, B ENVIRON CONTAM TOX, V76, P505, DOI 10.1007/s00128-006-0949-3; Soso AB, 2007, ENVIRON TOXICOL PHAR, V23, P308, DOI 10.1016/j.etap.2006.11.008; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P381, DOI 10.1016/S0025-6196(12)64861-7; Toni C, 2011, CHEMOSPHERE, V83, P579, DOI 10.1016/j.chemosphere.2010.12.022; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3; Zanella R, 2003, J SEP SCI, V26, P935, DOI 10.1002/jssc.200301309; Zhao YG, 2008, J CHINA NAT KNOWL IN, V4	41	11	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74499	10.1371/journal.pone.0074499	http://dx.doi.org/10.1371/journal.pone.0074499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098336	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600004
J	Osorio, FL; Salum, GA; Donadon, MF; Forni-dos-Santos, L; Loureiro, SR; Crippa, JAS				Osorio, Flavia L.; Salum, Giovanni Abrahao; Donadon, Mariana Fortunata; Forni-dos-Santos, Larissa; Loureiro, Sonia Regina; Crippa, Jose Alexandre S.			Psychometrics Properties of Early Trauma Inventory Self Report - Short Form (ETISR-SR) for the Brazilian Context	PLOS ONE			English	Article							COMORBID SUBSTANCE-ABUSE; CHILDHOOD-TRAUMA; INITIAL RELIABILITY; LIFE EVENTS; EXPERIENCES; VALIDITY; RISK; PERSONALITY; VALIDATION; DEPENDENCE	This study aims to translate and validate Early Trauma Inventory Self Report - Short Form (ETISR-SF) to Brazilian Portuguese. 253 adult subjects answered the ETISR-SF, Beck Anxiety Inventory (BAI), Fagerstrom Test for Nicotine Dependence (FTND), Patient Health Questionnaire (PHQ-9) and Fast Alcohol Screening Test (FAST). The instrument showed good internal consistency (0.83). Correlations with the PHQ-9 and BAI were moderate (r=0.26-0.47) and showed the expected associations with psychiatric constructs. No associations were found for FTND and FAST. Confirmatory Factor Analysis revealed that a correlated four-factor model as well as a second order model subsuming four lower order components presented the best model fit. Test-retest reliability was also excellent (ICC=0.78-0.90). ETISR-SF is suitable for assessing traumatic experiences in a Brazilian community sample. Given the importance of trauma as a public health problem, tools such as ETISR-SF may help clinicians/researchers to better evaluate and measure such events and further advance clinical care of trauma victims.	[Osorio, Flavia L.; Donadon, Mariana Fortunata; Forni-dos-Santos, Larissa; Loureiro, Sonia Regina; Crippa, Jose Alexandre S.] Univ Sao Paulo, Dept Neurosci & Behav, Med Sch Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Osorio, Flavia L.; Loureiro, Sonia Regina; Crippa, Jose Alexandre S.] CNPq Translat Med, Inst Technol, INCT, Ribeirao Preto, Brazil; [Salum, Giovanni Abrahao] CNPq, Natl Inst Dev Psychiat Children & Adolescents, Sao Paulo, Brazil; [Salum, Giovanni Abrahao] Univ Fed Rio Grande do Sul, BR-90046900 Porto Alegre, RS, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul	Osorio, FL (corresponding author), Univ Sao Paulo, Dept Neurosci & Behav, Med Sch Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	flaliosorio@ig.com.br	Donadon, Mariana Fortunata/AAK-3960-2020; Osório, Flávia L./H-6079-2012; Salum, Giovanni Abrahao/A-7849-2010; Loureiro, Sonia R/L-1579-2016; donadon, mariana fortunata/D-4141-2018; de Souza Crippa, José Alexandre/A-1215-2008; Santos, Larissa Forni dos/AAW-9418-2020; Osório, Flávia L./T-5001-2019	Salum, Giovanni Abrahao/0000-0002-7537-7289; Loureiro, Sonia R/0000-0001-9423-2897; donadon, mariana fortunata/0000-0002-0759-3879; L. Osorio, Flavia/0000-0003-1396-555X; Forni dos Santos, Larissa/0000-0002-2657-4972	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2012/02260-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (Processo 2012/02260-7; http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001; Beck A., 1993, BECK ANXIETY INVENTO; BERGER AM, 1988, CHILD ABUSE NEGLECT, V12, P251, DOI 10.1016/0145-2134(88)90033-6; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W; Carmo J.T., 2002, RBM REV BRAS MED, V59, P73, DOI DOI 10.1590/S1806-37132009000100011; Chu AT, 2010, ANNU REV CLIN PSYCHO, V6, P469, DOI 10.1146/annurev.clinpsy.121208.131204; Cong E, 2011, PSYCHOL MED, V11, P1; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Cunha JA., 2001, MANUAL VERSAO PORTUG; de Mello MF, 2010, CAD SAUDE PUBLICA, V26, P713, DOI 10.1590/S0102-311X2010000400014; de Meneses-Gaya C, 2009, NICOTINE TOB RES, V11, P1160, DOI 10.1093/ntr/ntp114; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; DUBE SR, 2006, J ADOLESCENT HEALTH, V444, P49308; FAGERSTROM KO, 1978, ADDICT BEHAV, V3, P235, DOI 10.1016/0306-4603(78)90024-2; Fenton MC, 2013, PSYCHOL MED, V43, P1045, DOI 10.1017/S0033291712001729; FINK LA, 1995, AM J PSYCHIAT, V152, P1329, DOI 10.1176/ajp.152.9.1329; GALLAGHER RE, 1992, J PERS DISORD, V6, P99, DOI 10.1521/pedi.1992.6.2.99; GEORGE D, 2003, SSPS WINDOWS STEP ST, P45237; Grassi-Oliveira R, 2006, REV SAUDE PUBL, V40, P249, DOI 10.1590/S0034-89102006000200010; Green BL, 1996, MEASUREMENT STRESS T, P366; HERMAN JL, 1989, AM J PSYCHIAT, V146, P490; Hovens JGFM, 2010, ACTA PSYCHIAT SCAND, V122, P66, DOI 10.1111/j.1600-0447.2009.01491.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyman SM, 2005, ADDICT BEHAV, V30, P847, DOI 10.1016/j.addbeh.2004.08.009; Igarashi H, 2010, PSYCHIAT RES, V180, P120, DOI 10.1016/j.psychres.2010.04.029; Jeon JR, 2012, PSYCHIAT INVEST, V9, P229, DOI 10.4306/pi.2012.9.3.229; Kendler KS, 2004, PSYCHOL MED, V34, P1475, DOI 10.1017/S003329170400265X; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Neigh GN, 2009, TRAUMA VIOLENCE ABUS, V10, P389, DOI 10.1177/1524838009339758; Osorio FD, 2009, PERSPECT PSYCHIATR C, V45, P216, DOI 10.1111/j.1744-6163.2009.00224.x; Plaza A, 2011, J NERV MENT DIS, V199, P280, DOI 10.1097/NMD.0b013e31821245b9; Rademaker AR, 2008, J CLIN PSYCHOL, V64, P863, DOI 10.1002/jclp.20495; Scheller-Gilkey G, 2002, SCHIZOPHRENIA BULL, V28, P223, DOI 10.1093/oxfordjournals.schbul.a006933; Spinhoven P, 2010, J AFFECT DISORDERS, V126, P103, DOI 10.1016/j.jad.2010.02.132; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Strine TW, 2012, AM J HEALTH BEHAV, V36, P408, DOI 10.5993/AJHB.36.3.11; Tucci AM, 2010, CHILD ABUSE NEGLECT, V34, P95, DOI 10.1016/j.chiabu.2009.07.001; Wang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015882; Wu NS, 2010, ADDICT BEHAV, V35, P68, DOI 10.1016/j.addbeh.2009.09.003	42	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76337	10.1371/journal.pone.0076337	http://dx.doi.org/10.1371/journal.pone.0076337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232HM	24098478	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600040
J	Wiesner, D; Merdian, I; Lewerenz, J; Ludolph, AC; Dupuis, L; Witting, A				Wiesner, Diana; Merdian, Irma; Lewerenz, Jan; Ludolph, Albert C.; Dupuis, Luc; Witting, Anke			Fumaric Acid Esters Stimulate Astrocytic VEGF Expression through HIF-1 alpha and Nrf2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIMETHYL FUMARATE; KAPPA-B; HYPOXIA; ACTIVATION; CELLS; ANGIOGENESIS; DEGRADATION; DELIVERY; STRESS	Fumaric acid esters (FAE) are oral analogs of fumarate that have recently been shown to decrease relapse rate and disease progression in multiple sclerosis (MS), prompting to investigate their protective potential in other neurological diseases such as amyotrophic lateral sclerosis (ALS). Despite efficacy in MS, mechanisms of action of FAEs are still largely unknown. FAEs are known to activate the transcription factor Nrf2 and downstream anti-oxidant responses through the succination of Nrf2 inhibitor KEAP1. However, fumarate is also a known inhibitor of prolyl-hydroxylases domain enzymes (PhD), and PhD inhibition might lead to stabilization of the HIF-1 alpha transcription factor under normoxic conditions and subsequent activation of a pseudo hypoxic response. Whether Nrf2 activation is associated with HIF-1 alpha stabilization in response to FAEs in cell types relevant to MS or ALS remains unknown. Here, we show that FAEs elicit HIF-1 alpha accumulation, and VEGF release as its expected consequence, in astrocytes but not in other cell types of the central nervous system. Reporter assays demonstrated that increased astrocytic VEGF release in response to FAEs was dependent upon both HIF-1 alpha and Nrf2 activation. Last, astrocytes of transgenic mice expressing SOD1(G93A), an animal model of ALS, displayed reduced VEGF release in response to FAEs. These studies show that FAEs elicit different signaling pathways in cell types from the central nervous system, in particular a pseudo-hypoxic response in astrocytes. Disease relevant mutations might affect this response.	[Wiesner, Diana; Merdian, Irma; Lewerenz, Jan; Ludolph, Albert C.; Witting, Anke] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Dupuis, Luc] INSERM, Mecanismes Cent & Peripher Neurodegenerescence U1, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, Federat Med Translat, UMRS1118, Strasbourg, France	Ulm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dupuis, L (corresponding author), INSERM, Mecanismes Cent & Peripher Neurodegenerescence U1, Strasbourg, France.	ldupuis@unistra.fr; anke.witting@uni-ulm.de	Dupuis, Luc/A-6981-2012		Biogen Idec Germany	Biogen Idec Germany(Biogen)	Partial support to this work was provided by Biogen Idec Germany. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2003, AM J PHYSIOL-RENAL, V284, pF743, DOI 10.1152/ajprenal.00376.2002; Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arbiser JL, 2011, J INVEST DERMATOL, V131, P1189, DOI 10.1038/jid.2011.45; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Dungwa JV, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-390; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Ferger AI, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-45; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Kim HL, 2006, INT J ONCOL, V29, P255; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee JM, 2003, BBA-GENE STRUCT EXPR, V1629, P92, DOI 10.1016/j.bbaexp.2003.08.006; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Linker RA, 2010, BRAIN, V133, P2248, DOI 10.1093/brain/awq179; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Moreau C, 2006, J NEUROL NEUROSUR PS, V77, P255, DOI 10.1136/jnnp.2005.070904; Moreau C, 2011, NEUROSCIENCE, V172, P110, DOI 10.1016/j.neuroscience.2010.10.040; Nagara Y, 2013, BRAIN PATHOL; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Peng HY, 2012, J BIOL CHEM, V287, P28017, DOI 10.1074/jbc.M112.383380; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Serra-Perez A, 2010, J BIOL CHEM, V285, P18217, DOI 10.1074/jbc.M110.101048; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027798; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	39	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76670	10.1371/journal.pone.0076670	http://dx.doi.org/10.1371/journal.pone.0076670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098549	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600070
J	Kramer, M; Sponholz, C; Slaba, M; Wissuwa, B; Claus, RA; Menzel, U; Huse, K; Platzer, M; Bauer, M				Kramer, Marcel; Sponholz, Christoph; Slaba, Monique; Wissuwa, Bianka; Claus, Ralf A.; Menzel, Uwe; Huse, Klaus; Platzer, Matthias; Bauer, Michael			Alternative 5 ' Untranslated Regions Are Involved in Expression Regulation of Human Heme Oxygenase-1	PLOS ONE			English	Article							GENE PROMOTER; MICROSATELLITE POLYMORPHISM; SUSCEPTIBILITY; INDUCTION; CELLS	The single nucleotide polymorphism rs2071746 and a (GT)(n) microsatellite within the human gene encoding heme oxygenase-1 (HMOX1) are associated with incidence or outcome in a variety of diseases. Most of these associations involve either release of heme or oxidative stress. Both polymorphisms are localized in the promoter region, but previously reported correlations with heme oxygenase-1 expression remain not coherent. This ambiguity suggests a more complex organization of the 5' gene region which we sought to investigate more fully. We evaluated the 5` end of HMOX1 and found a novel first exon 1a placing the two previously reported polymorphisms in intronic or exonic positions within the 5' untranslated region respectively. Expression of exon 1a can be induced in HepG2 hepatoma cells by hemin and is a repressor of heme oxygenase-1 translation as shown by luciferase reporter assays. Moreover, minigene approaches revealed that the quantitative outcome of alternative splicing within the 5' untranslated region is affected by the (GT)(n) microsatellite. This data supporting an extended HMOX1 gene model and provide further insights into expression regulation of heme oxygenase-1. Alternative splicing within the HMOX1 5' untranslated region contributes to translational regulation and is a mechanistic feature involved in the interplay between genetic variations, heme oxygenase-1 expression and disease outcome.	[Kramer, Marcel; Sponholz, Christoph; Slaba, Monique; Wissuwa, Bianka; Claus, Ralf A.; Bauer, Michael] Jena Univ Hosp, Integrated Res & Treatment Ctr, CSCC, Jena, Germany; [Kramer, Marcel; Sponholz, Christoph; Huse, Klaus; Platzer, Matthias] Leibniz Inst Age Res Fritz Lipmann Inst, Jena, Germany; [Sponholz, Christoph; Bauer, Michael] Jena Univ Hosp, Dept Anaesthesiol & Intens Care Therapy, Jena, Germany; [Menzel, Uwe] Leibniz Inst, Hans Knoll Inst Nat Prod Res & Infect Biol, Jena, Germany	Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Kramer, M (corresponding author), Jena Univ Hosp, Integrated Res & Treatment Ctr, CSCC, Jena, Germany.	Marcel.Kramer@med.uni-jena.de	Sponholz, Christoph/I-3585-2019; Claus, Ralf A./Q-4035-2016	Sponholz, Christoph/0000-0002-1746-7024; Claus, Ralf A./0000-0001-7232-4088; Bauer, Michael/0000-0002-1521-3514; Huse, Klaus/0000-0003-3854-1884	Federal Ministry of Education and Research (BMBF, Germany) [FKZ: 01EO1002]; Deutsche Forschungsgemeinschaft [DFG Hu498/3, Ba1601/8-1]	Federal Ministry of Education and Research (BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research (BMBF, Germany, FKZ: 01EO1002 to MB) and by the Deutsche Forschungsgemeinschaft (DFG Hu498/3 to KH and Ba1601/8-1 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; Bao W, 2010, AM J EPIDEMIOL, V172, P631, DOI 10.1093/aje/kwq162; Bauer I, 2003, SHOCK, V20, P116, DOI 10.1097/01.shk.0000075568.93053.fa; Bauer M, 2008, INTENS CARE MED, V34, P640, DOI 10.1007/s00134-008-1010-2; Blydt-Hansen TD, 2003, J AM SOC NEPHROL, V14, P745, DOI 10.1097/01.ASN.0000050760.87113.25; Brosius J, 2005, CYTOGENET GENOME RES, V110, P8, DOI 10.1159/000084934; Buis CI, 2008, AM J TRANSPLANT, V8, P377, DOI 10.1111/j.1600-6143.2007.02048.x; Doberer D, 2010, BRIT J PHARMACOL, V161, P1751, DOI 10.1111/j.1476-5381.2010.00990.x; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Hirai H, 2003, BLOOD, V102, P1619, DOI 10.1182/blood-2002-12-3733; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Kramer M, 2011, GENETICS, V187, P761, DOI 10.1534/genetics.110.125096; Krull M, 2007, GENOME RES, V17, P1139, DOI 10.1101/gr.6320607; KUTTY RK, 1994, GENOMICS, V20, P513, DOI 10.1006/geno.1994.1213; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; Ono K, 2004, ATHEROSCLEROSIS, V173, P315, DOI 10.1016/j.atherosclerosis.2003.11.021; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Rosenstiel P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-472; Scott JR, 2007, TRENDS PHARMACOL SCI, V28, P200, DOI 10.1016/j.tips.2007.03.006; Sheu CC, 2009, INTENS CARE MED, V35, P1343, DOI 10.1007/s00134-009-1504-6; SHIBAHARA S, 1989, EUR J BIOCHEM, V179, P557, DOI 10.1111/j.1432-1033.1989.tb14583.x; Sponholz C, 2012, SHOCK, V38, P459, DOI 10.1097/SHK.0b013e31826ae951; Tanaka G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-117; Vesely MJJ, 1998, AM J PHYSIOL-CELL PH, V275, pC1087, DOI 10.1152/ajpcell.1998.275.4.C1087; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	31	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77224	10.1371/journal.pone.0077224	http://dx.doi.org/10.1371/journal.pone.0077224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098580	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500096
J	Pochon, S; Simoneau, P; Pigne, S; Balidas, S; Bataille-Simoneau, N; Campion, C; Jaspard, E; Calmes, B; Hamon, B; Berruyer, R; Juchaux, M; Guillemette, T				Pochon, Stephanie; Simoneau, Philippe; Pigne, Sandrine; Balidas, Samuel; Bataille-Simoneau, Nelly; Campion, Claire; Jaspard, Emmanuel; Calmes, Benoit; Hamon, Bruno; Berruyer, Romain; Juchaux, Marjorie; Guillemette, Thomas			Dehydrin-like Proteins in the Necrotrophic Fungus Alternaria brassicicola Have a Role in Plant Pathogenesis and Stress Response	PLOS ONE			English	Article							FILAMENTOUS FUNGI; GENE; IDENTIFICATION; KINASE; PATHOGENICITY; PHYTOALEXINS; ARABIDOPSIS; METABOLISM; PATHWAYS; REGIONS	In this study, the roles of fungal dehydrin-like proteins in pathogenicity and protection against environmental stresses were investigated in the necrotrophic seed-borne fungus Alternaria brassicicola. Three proteins (called AbDhn1, AbDhn2 and AbDhn3), harbouring the asparagine-proline-arginine (DPR) signature pattern and sharing the characteristic features of fungal dehydrin-like proteins, were identified in the A. brassicicola genome. The expression of these genes was induced in response to various stresses and found to be regulated by the AbHog1 mitogen-activated protein kinase (MAPK) pathway. A knock-out approach showed that dehydrin-like proteins have an impact mainly on oxidative stress tolerance and on conidial survival upon exposure to high and freezing temperatures. The subcellular localization revealed that AbDhn1 and AbDhn2 were associated with peroxisomes, which is consistent with a possible perturbation of protective mechanisms to counteract oxidative stress and maintain the redox balance in AbDhn mutants. Finally, we show that the double deletion mutant Delta Delta abdhn1-abdhn2 was highly compromised in its pathogenicity. By comparison to the wild-type, this mutant exhibited lower aggressiveness on B. oleracea leaves and a reduced capacity to be transmitted to Arabidopsis seeds via siliques. The double mutant was also affected with respect to conidiation, another crucial step in the epidemiology of the disease.	[Pochon, Stephanie; Simoneau, Philippe; Pigne, Sandrine; Balidas, Samuel; Bataille-Simoneau, Nelly; Campion, Claire; Jaspard, Emmanuel; Calmes, Benoit; Hamon, Bruno; Berruyer, Romain; Guillemette, Thomas] Univ Angers, UMR IRHS 1345, SFR QUASAV, Angers, France; [Pochon, Stephanie; Simoneau, Philippe; Pigne, Sandrine; Balidas, Samuel; Bataille-Simoneau, Nelly; Campion, Claire; Jaspard, Emmanuel; Calmes, Benoit; Hamon, Bruno; Berruyer, Romain; Guillemette, Thomas] INRA, UMR IRHS 1345, F-49000 Angers, France; [Pochon, Stephanie; Simoneau, Philippe; Pigne, Sandrine; Balidas, Samuel; Bataille-Simoneau, Nelly; Campion, Claire; Jaspard, Emmanuel; Calmes, Benoit; Hamon, Bruno; Berruyer, Romain; Guillemette, Thomas] Agrocampus Ouest, UMR IRHS 1345, Angers, France; [Juchaux, Marjorie] Univ Angers, SFR QUASAV, IMAC, Beaucouze, France	Universite d'Angers; INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers	Guillemette, T (corresponding author), Univ Angers, UMR IRHS 1345, SFR QUASAV, Angers, France.	thomas.guillemette@univ-angers.fr	Simoneau, Philippe/GPG-0546-2022; guillemette, thomas/H-2097-2011; Simoneau, Philippe/AAV-4324-2021	guillemette, thomas/0000-0002-5649-974X; Simoneau, Philippe/0000-0002-3890-9848; Simoneau, Nelly/0000-0001-6200-4259	French Region Pays de la Loire (QUALISEM research program)	French Region Pays de la Loire (QUALISEM research program)(Region Pays de la Loire)	This work was supported by the French Region Pays de la Loire (QUALISEM research program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba' S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-39; AYER WA, 1992, TETRAHEDRON, V48, P2919, DOI 10.1016/S0040-4020(01)90973-1; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Calmes B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00131; Chen KT, 2012, PLANT SCI, V183, P27, DOI 10.1016/j.plantsci.2011.11.002; Cho YR, 2006, MOL PLANT MICROBE IN, V19, P7, DOI 10.1094/MPMI-19-0007; Close TJ, 1993, CUR TOP PL, V10, P104; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dongo A, 2009, APPL ENVIRON MICROB, V75, P127, DOI 10.1128/AEM.00993-08; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Eaton CJ, 2008, CURR GENET, V53, P163, DOI 10.1007/s00294-007-0174-6; Elleuche S, 2008, FUNGAL GENET BIOL, V45, P1458, DOI 10.1016/j.fgb.2008.08.005; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Hoi JWS, 2012, FUNGAL GENET BIOL, V49, P210, DOI 10.1016/j.fgb.2012.01.005; Hoi JWS, 2011, MOL BIOL CELL, V22, P1896, DOI 10.1091/mbc.E10-11-0914; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Joubert A, 2011, MOL MICROBIOL, V79, P1305, DOI 10.1111/j.1365-2958.2010.07522.x; Joubert A, 2011, CELL MICROBIOL, V13, P62, DOI 10.1111/j.1462-5822.2010.01520.x; Joubert A, 2010, BIOTECHNIQUES, V48, P399, DOI 10.2144/000113399; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Kutschy P, 1998, TETRAHEDRON, V54, P3549, DOI 10.1016/S0040-4020(98)00088-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Parent C, 2008, CR BIOL, V331, P255, DOI 10.1016/j.crvi.2008.02.001; Pochon S, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-16; Rahman LN, 2010, BIOCHEM CELL BIOL, V88, P791, DOI [10.1139/O10-026, 10.1139/o10-026]; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; SWEIGARD JA, 1995, PLANT CELL, V7, P1221, DOI 10.1105/tpc.7.8.1221; TAKASUGI M, 1988, B CHEM SOC JPN, V61, P285, DOI 10.1246/bcsj.61.285; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; van den Bosch F, 2010, P ROY SOC B-BIOL SCI, V277, P1735, DOI 10.1098/rspb.2009.2211; Wartenberg D, 2012, J PROTEOMICS, V75, P4038, DOI 10.1016/j.jprot.2012.05.023; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Yang YZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-140	43	16	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75143	10.1371/journal.pone.0075143	http://dx.doi.org/10.1371/journal.pone.0075143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098369	gold, Green Submitted, Green Published			2022-12-27	WOS:000325434500022
J	Wright, DW; Deuzing, IP; Flandre, P; van den Eede, P; Govaert, M; Setiawan, L; Coveney, PV; Marcelin, AG; Calvez, V; Boucher, CAB; Beerens, N				Wright, David W.; Deuzing, Ilona P.; Flandre, Philippe; van den Eede, Peter; Govaert, Micheline; Setiawan, Laurentia; Coveney, Peter V.; Marcelin, Anne-Genevieve; Calvez, Vincent; Boucher, Charles A. B.; Beerens, Nancy			A Polymorphism at Position 400 in the Connection Subdomain of HIV-1 Reverse Transcriptase Affects Sensitivity to NNRTIs and RNaseH Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEOSIDE ANALOG INHIBITORS; NUCLEIC-ACID STRUCTURES; DRUG-RESISTANCE; NONNUCLEOSIDE INHIBITORS; H DOMAINS; MOLECULAR-MECHANISMS; PRIMER UNBLOCKING; CRYSTAL-STRUCTURE; DUAL RESISTANCE	Reverse transcriptase (RT) plays an essential role in HIV-1 replication, and inhibition of this enzyme is a key component of HIV-treatment. However, the use of RT inhibitors can lead to the emergence of drug-resistant variants. Until recently, most clinically relevant resistance mutations were found in the polymerase domain of RT. Lately, an increasing number of resistance mutations has been identified in the connection and RNaseH domain. To further explore the role of these domains we analyzed the complete RT sequence of HIV-1 subtype B patients failing therapy. Position A/T400 in the connection subdomain is polymorphic, but the proportion of T400 increases from 41% in naive patients to 72% in patients failing therapy. Previous studies suggested a role for threonine in conferring resistance to nucleoside RT inhibitors. Here we report that T400 also mediates resistance to non-nucleoside RT inhibitors. The susceptibility to NVP and EFV was reduced 5-fold and 2-fold, respectively, in the wild-type subtype B NL4.3 background. We show that substitution A400T reduces the RNaseH activity. The changes in enzyme activity are remarkable given the distance to both the polymerase and RNaseH active sites. Molecular dynamics simulations were performed, which provide a novel atomistic mechanism for the reduction in RNaseH activity induced by T400. Substitution A400T was found to change the conformation of the RNaseH primer grip region. Formation of an additional hydrogen bond between residue T400 and E396 may play a role in this structural change. The slower degradation of the viral RNA genome may provide more time for dissociation of the bound NNRTI from the stalled RT-template/primer complex, after which reverse transcription can resume.	[Wright, David W.; Coveney, Peter V.] UCL, Dept Chem, Ctr Computat Sci, London WC1E 6BT, England; [Deuzing, Ilona P.; Setiawan, Laurentia; Boucher, Charles A. B.; Beerens, Nancy] Erasmus MC, Dept Virol, ViroscienceLab, Rotterdam, Netherlands; [Flandre, Philippe; Marcelin, Anne-Genevieve; Calvez, Vincent] INSERM, UMR S 943, Paris, France; [Flandre, Philippe; Marcelin, Anne-Genevieve; Calvez, Vincent] Univ Paris 06, Paris, France; [van den Eede, Peter; Govaert, Micheline] Janssen Diagnost BVBA, Beerse, Belgium	University of London; University College London; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Beerens, N (corresponding author), Erasmus MC, Dept Virol, ViroscienceLab, Rotterdam, Netherlands.	n.beerens@erasmusmc.nl	Marcelin, Anne-Genevieve/D-8272-2014; Flandre, Philippe/N-6314-2017	Marcelin, Anne-Genevieve/0000-0003-4808-8999; Flandre, Philippe/0000-0002-2612-3522; Wright, David/0000-0002-5124-8044	EU FP7 CHAIN [HEALTH-2007 223131]; National Science Foundation under NRAC B CHAIN [MCA04N014]; Office of Science and Technology through EPSRC's High End Computing Programme; VPH-SHARE [FP7-ICT 269978]; EPSRC [EP/I034602/1, EP/L00030X/1] Funding Source: UKRI; Medical Research Council [MR/K006584/1] Funding Source: researchfish	EU FP7 CHAIN; National Science Foundation under NRAC B CHAIN; Office of Science and Technology through EPSRC's High End Computing Programme; VPH-SHARE; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research project was funded by EU FP7 CHAIN (HEALTH-2007 223131). This work made use of the facilities of HECToR, the UK's national high-performance computing service and the Kraken machine on the U.S. TeraGrid/XSEDE (access to which was made available by the National Science Foundation under NRAC B CHAIN grant MCA04N014). HECToR is provided by UoE HPCx Ltd at the University of Edinburgh, Cray Inc and NAG Ltd, and funded by the Office of Science and Technology through EPSRC's High End Computing Programme. Additional computation was performed on the UCL Legion cluster. DWW and PVC would also like to acknowledge the support of the VPH-SHARE (FP7-ICT 269978) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Biondi MJ, 2010, J BIOL CHEM, V285, P26966, DOI 10.1074/jbc.M110.105775; BOUCHER CAB, 1992, J INFECT DIS, V165, P105, DOI 10.1093/infdis/165.1.105; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; BOYER PL, 1995, ANTIMICROB AGENTS CH, V39, P1624, DOI 10.1128/AAC.39.7.1624; Braz VA, 2010, BIOCHEMISTRY-US, V49, P601, DOI 10.1021/bi901579y; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Buxton P, 2005, J VIROL, V79, P6338, DOI 10.1128/JVI.79.10.6338-6348.2005; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Ceccherini-Silberstein F, 2007, J VIROL, V81, P11507, DOI 10.1128/JVI.00303-07; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; Das K, 2004, J MED CHEM, V47, P2550, DOI 10.1021/jm030558s; Dash C, 2008, NUCLEIC ACIDS RES, V36, P6363, DOI 10.1093/nar/gkn678; de Bethune MP, 2010, ANTIVIR RES, V85, P75, DOI 10.1016/j.antiviral.2009.09.008; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; deJong MD, 1996, P NATL ACAD SCI USA, V93, P5501, DOI 10.1073/pnas.93.11.5501; Delviks-Frankenberry KA, 2013, VIROLOGY, V435, P433, DOI 10.1016/j.virol.2012.09.021; Delviks-Frankenberry KA, 2010, VIRUSES-BASEL, V2, P1476, DOI 10.3390/v2071476; Delviks-Frankenberry KA, 2009, J VIROL, V83, P8502, DOI 10.1128/JVI.00859-09; Domaoal RA, 2004, INT J BIOCHEM CELL B, V36, P1735, DOI 10.1016/j.biocel.2004.02.026; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Ehteshami M, 2008, AIDS REV, V10, P224; Frankel FA, 2007, AIDS, V21, P665, DOI 10.1097/QAD.0b013e3280187505; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Gonzales MJ, 2003, AIDS, V17, P791, DOI 10.1097/00002030-200304110-00003; GU ZX, 1995, P NATL ACAD SCI USA, V92, P2760, DOI 10.1073/pnas.92.7.2760; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Harrigan PR, 2002, J VIROL, V76, P6836, DOI 10.1128/JVI.76.13.6836-6840.2002; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kemp SD, 1998, J VIROL, V72, P5093, DOI 10.1128/JVI.72.6.5093-5098.1998; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Marcelin AG, 2006, ANTIVIR THER, V11, P693; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Menendez-Arias L, 2011, ANTIVIR RES, V92, P139, DOI 10.1016/j.antiviral.2011.08.020; Menendez-Arias Luis, 2003, Current Drug Targets - Infectious Disorders, V3, P355, DOI 10.2174/1568005033481033; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2010, J VIROL, V84, P5238, DOI 10.1128/JVI.01545-09; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Noy A, 2005, J AM CHEM SOC, V127, P4910, DOI 10.1021/ja043293v; Painter GR, 2004, CURR TOP MED CHEM, V4, P1035, DOI 10.2174/1568026043388358; Pattery T, 2012, INTERVIROLOGY, V55, P138, DOI 10.1159/000332013; Pelemans H, 1998, J BIOL CHEM, V273, P34234, DOI 10.1074/jbc.273.51.34234; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Radzio J, 2010, AIDS, V24, P659, DOI 10.1097/QAD.0b013e328336781d; Ren JS, 2008, VIRUS RES, V134, P157, DOI 10.1016/j.virusres.2007.12.018; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V61, P973, DOI 10.1093/jac/dkn060; Roquebert B, 2007, J MED VIROL, V79, P207, DOI 10.1002/jmv.20788; Santos AFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001781; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; Selmi B, 2003, ANTIVIR THER, V8, P143; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; Sluis-Cremer N, 2010, AIDS, V24, P317, DOI 10.1097/QAD.0b013e3283315697; Tanuma J, 2010, MICROBES INFECT, V12, P1170, DOI 10.1016/j.micinf.2010.08.003; Turner KB, 2009, RNA, V15, P1605, DOI 10.1261/rna.1615409; UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605; van Westen GJP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002899; von Wyl V, 2010, J INFECT DIS, V201, P1054, DOI 10.1086/651168; Wainberg Mark A, 2004, Expert Rev Anti Infect Ther, V2, P147, DOI 10.1586/14787210.2.1.147; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; Wright David W, 2012, Biology (Basel), V1, P222, DOI 10.3390/biology1020222; Xia Q, 2007, PROTEIN SCI, V16, P1728, DOI 10.1110/ps.072829007; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	76	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74078	10.1371/journal.pone.0074078	http://dx.doi.org/10.1371/journal.pone.0074078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098331	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500008
J	Jiao, WC; Zhang, FH; Zhao, XQ; Hu, JH; Suh, JW				Jiao, Wence; Zhang, Fenghua; Zhao, Xinqing; Hu, Jiehan; Suh, Joo-Won			RETRACTED: A Novel Alkaloid from Marine-Derived Actinomycete Streptomyces xinghaiensis with Broad-Spectrum Antibacterial and Cytotoxic Activities (Retracted article. See vol. 13, art no e0200376, 2018)	PLOS ONE			English	Article; Retracted Publication							ACINETOBACTER-BAUMANNII; CHIRAL SULFUR; SULFOXIDE; METABOLITES; ALLIUM	Due to the increasing emergence of drug-resistant bacteria and tumor cell lines, novel antibiotics with antibacterial and cytotoxic activities are urgently needed. Marine actinobacteria are rich sources of novel antibiotics, and here we report the discovery of a novel alkaloid, xinghaiamine A, from a marine-derived actinomycete Streptomyces xinghaiensis NRRL B24674(T). Xinghaiamine A was purified from the fermentation broth, and its structure was elucidated based on extensive spectroscopic analysis, including 1D and 2D NMR spectrum as well as mass spectrometry. Xinghaiamine A was identified to be a novel alkaloid with highly symmetric structure on the basis of sulfoxide functional group, and sulfoxide containing compound has so far never been reported in microorganisms. Biological assays revealed that xinghaiamine A exhibited broad-spectrum antibacterial activities to both Gram-negative persistent hospital pathogens (e. g. Acinetobacter baumannii, Pseudomonas aeruginosa and Escherichia coli) and Gram-positive ones, which include Staphylococcus aureus and Bacillus subtilis. In addition, xinghaiamine A also exhibited potent cytotoxic activity to human cancer cell lines of MCF-7 and U-937 with the IC50 of 0.6 and 0.5 mu M, respectively.	[Jiao, Wence; Zhao, Xinqing] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China; [Zhang, Fenghua] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China; [Hu, Jiehan] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Peoples R China; [Suh, Joo-Won] Myongji Univ, Div Biosci & Bioinformat, Yongin, South Korea	Dalian University of Technology; Dalian Medical University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Myongji University	Zhao, XQ (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China.	xqzhao@dlut.edu.cn			Next-Generation BioGreen 21 program of the rural development Administration, Republic of Korea [PJ0080932011]; Key Laboratory of Marine Bio-resources Sustainable Utilization [LMB111002]; state key laboratory open program from Key Laboratory of Bioreactor Engineering, East China University of Science and Technology	Next-Generation BioGreen 21 program of the rural development Administration, Republic of Korea; Key Laboratory of Marine Bio-resources Sustainable Utilization; state key laboratory open program from Key Laboratory of Bioreactor Engineering, East China University of Science and Technology	This work was supported by the Next-Generation BioGreen 21 program of the rural development Administration, Republic of Korea (No. PJ0080932011). The authors also acknowledge the financial support by the state key laboratory open program from Key Laboratory of Marine Bio-resources Sustainable Utilization (No. LMB111002), and the state key laboratory open program from Key Laboratory of Bioreactor Engineering, East China University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello A, 2012, MAR DRUGS, V10, P51, DOI 10.3390/md10010051; Barber JM, 2011, J NAT PROD, V74, P809, DOI 10.1021/np100868t; Blunt JW, 2013, NAT PROD REP, V30, P237, DOI [10.1039/c2np20112g, 10.1039/d0np00089b]; BURRES NS, 1989, CANCER RES, V49, P2935; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Graham SK, 2010, AUST J CHEM, V63, P867, DOI 10.1071/CH09617; Hornickova J, 2009, CZECH J FOOD SCI, V27, pS232, DOI 10.17221/610-CJFS; Jensen PR, 2005, ANTON LEEUW INT J G, V87, P43, DOI 10.1007/s10482-004-6540-1; Kondratyuk TP, 2012, MAR DRUGS, V10, P451, DOI 10.3390/md10020451; Kubec R, 2002, J NAT PROD, V65, P960, DOI 10.1021/np020064i; Kwon HC, 2006, J AM CHEM SOC, V128, P1622, DOI 10.1021/ja0558948; LAKE RJ, 1988, TETRAHEDRON LETT, V29, P2255, DOI 10.1016/S0040-4039(00)86725-8; Lee KH, 2010, J MICROBIOL BIOTECHN, V20, P1672, DOI 10.4014/jmb.1007.07035; MAKARIEVA TN, 1995, J NAT PRODUCTS, V58, P254, DOI 10.1021/np50116a015; Maldonado LA, 2005, INT J SYST EVOL MICR, V55, P1759, DOI 10.1099/ijs.0.63625-0; Manivasagan P, 2013, MICROBIOL RES, V168, P311, DOI 10.1016/j.micres.2013.02.002; MARKS HS, 1992, J AGR FOOD CHEM, V40, P2098, DOI 10.1021/jf00023a012; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; MURATA O, 1991, TETRAHEDRON LETT, V32, P3539, DOI 10.1016/0040-4039(91)80827-S; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Prilezhaeva E.N., 2000, RUSS CHEM REV, V69, P367, DOI DOI 10.1002/CHIN.200045296; Raju R, 2010, ORG LETT, V12, P5158, DOI 10.1021/ol102162d; Rose P, 2005, NAT PROD REP, V22, P351, DOI 10.1039/b417639c; Wang F, 2012, J MICROBIOL, V50, P770, DOI 10.1007/s12275-012-2154-x; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Williams PG, 2005, J ORG CHEM, V70, P6196, DOI 10.1021/jo050511+; Xu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057050; Zhao XQ, 2009, INT J SYST EVOL MICR, V59, P2870, DOI 10.1099/ijs.0.009878-0; Zotchev SB, 2012, J BIOTECHNOL, V158, P168, DOI 10.1016/j.jbiotec.2011.06.002	30	21	23	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75994	10.1371/journal.pone.0075994	http://dx.doi.org/10.1371/journal.pone.0075994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098415	Green Published, gold			2022-12-27	WOS:000325427100033
J	Lee, S; O'Neill, AH; Ihara, ES; Chae, DH				Lee, Sunmin; O'Neill, Allison H.; Ihara, Emily S.; Chae, David H.			Change in Self-Reported Health Status among Immigrants in the United States: Associations with Measures of Acculturation	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; BODY-MASS INDEX; NATIONAL LATINO; ASIAN-AMERICANS; RACIAL/ETHNIC DISCRIMINATION; ETHNIC IDENTIFICATION; UNFAIR TREATMENT; MENTAL-HEALTH; RATED HEALTH; LIFE	Although acculturation may have positive effects for immigrants, including better socioeconomic profiles and increased occupational opportunities, their health profiles deteriorate with longer duration in the U.S. Prior research indicates that increasing acculturation is associated with some poorer health outcomes among immigrants in the U.S. However, most of these studies have used length of stay or English language proficiency as proxies for acculturation, and have mainly examined self-reported "current" health outcomes. This study advances knowledge on associations between acculturation and health among immigrants by explicitly examining self-reported "change" in health since immigration, in relation to acculturation-related variables. We use data from the New Immigrant Survey (NIS; 2003-2004), a cross-sectional study of legal immigrants to the U.S. In addition to testing more conventionally examined proxies of acculturation (length of stay and English proficiency), we also examine English language use and self-reported change in diet. Multivariable logistic regression analyses on 5,982 participants generally supported previous literature indicating a deleterious impact of acculturation, with increasing duration of stay and greater self-reported change in diet being associated with a poorer change in health since moving to the U.S. Although English language proficiency and use were associated with greater odds of reporting a worse change in health when examined individually, they were non-significant in multivariable models including all acculturation measures. Findings from this study suggest that when taking into account multiple measures of acculturation, language may not necessarily indicate unhealthy assimilation and dietary change may be a pathway leading to declines in immigrant health. Increasing duration in the U.S. may also reflect the adoption of unhealthy behaviors, as well as greater exposure to harmful sources of psychosocial stress including racial and anti-immigrant discrimination. Our study suggests that multiple indicators of acculturation may be useful in examining the effect of acculturation on changes in health among immigrants.	[Lee, Sunmin; O'Neill, Allison H.; Chae, David H.] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Ihara, Emily S.] George Mason Univ, Dept Social Work, Fairfax, VA 22030 USA	University System of Maryland; University of Maryland College Park; George Mason University	Lee, S (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.	sunmin@umd.edu	Chae, David/F-6956-2015	Ihara, Emily/0000-0002-3163-2380; Lee, Sunmin/0000-0001-9652-9475				Abraido-Lanza AF, 2006, AM J PUBLIC HEALTH, V96, P1342, DOI 10.2105/AJPH.2005.064980; ABRAIDOLANZA AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI DOI 10.2105/AJPH.89.10.1543; Acevedo-Garcia D, 2010, SOC SCI MED, V71, P1161, DOI 10.1016/j.socscimed.2010.05.034; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Ahn Min Kyung, 2008, Prev Chronic Dis, V5, pA75; Akresh IR, 2007, J HEALTH SOC BEHAV, V48, P404, DOI 10.1177/002214650704800405; Antecol H, 2006, DEMOGRAPHY, V43, P337, DOI 10.1353/dem.2006.0011; Ayala GX, 2008, J AM DIET ASSOC, V108, P1330, DOI 10.1016/j.jada.2008.05.009; Berrigan D, 2006, RES Q EXERCISE SPORT, V77, P147; BERRY JW, 1979, J CROSS CULT PSYCHOL, V10, P415, DOI 10.1177/0022022179104002; Brown William Michael, 2006, J Immigr Minor Health, V8, P347, DOI 10.1007/s10903-006-9005-y; Chae DH, 2008, J EPIDEMIOL COMMUN H, V62, P973, DOI 10.1136/jech.2007.066811; Chae DH, 2008, AM J PUBLIC HEALTH, V98, P485, DOI 10.2105/AJPH.2006.102012; Chae DH, 2006, PUBLIC HEALTH REP, V121, P755, DOI 10.1177/003335490612100616; Cho Juhee, 2006, Prev Chronic Dis, V3, pA79; Cho YT, 2004, INT MIGR REV, V38, P184, DOI 10.1111/j.1747-7379.2004.tb00193.x; de Castro AB, 2010, PUBLIC HEALTH NURS, V27, P492, DOI 10.1111/j.1525-1446.2010.00891.x; de Castro AB, 2008, J IMMIGR MINOR HEALT, V10, P551, DOI 10.1007/s10903-008-9138-2; de Castro AB, 2006, ARCH ENVIRON OCCUP H, V61, P249, DOI 10.3200/AEOH.61.6.249-258; Dey Achintya N, 2006, Adv Data, P1; DEYO RA, 1985, AM J PUBLIC HEALTH, V75, P51, DOI 10.2105/AJPH.75.1.51; Frisbie WP, 2001, AM J EPIDEMIOL, V153, P372, DOI 10.1093/aje/153.4.372; Gee EM, 2004, CAN J AGING, V23, pS61; Gee GC, 2010, AM J PUBLIC HEALTH, V100, P888, DOI 10.2105/AJPH.2009.178012; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Hummer RA, 1999, SOC SCI QUART, V80, P136; Hummer RA, 1999, SOC FORCES, V77, P1083, DOI 10.2307/3005972; Hunt LM, 2004, SOC SCI MED, V59, P973, DOI 10.1016/j.socscimed.2003.12.009; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jasso G., 2005, EC POLICY REV, P127; Juon HS, 2003, YONSEI MED J, V44, P875, DOI 10.3349/ymj.2003.44.5.875; KRIEGER N, 1993, AM J PUBLIC HEALTH, V83, P1086, DOI 10.2105/AJPH.83.8.1086; LAFROMBOISE T, 1993, PSYCHOL BULL, V114, P395, DOI 10.1037/0033-2909.114.3.395; Landale NS, 2001, J HEALTH SOC BEHAV, V42, P166, DOI 10.2307/3090176; Landale NS, 1999, SOC FORCES, V78, P613, DOI 10.2307/3005569; Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615; LEE S, 2009, J IMMIGR MINOR HEALT, V13, P244; Lee SK, 2000, SOC SCI MED, V51, P159, DOI 10.1016/S0277-9536(99)00446-3; Lee S, 2012, J IMMIGR MINOR HEALT, V14, P345, DOI 10.1007/s10903-010-9411-z; Lee S, 2009, J COMMUN HEALTH, V34, P144, DOI 10.1007/s10900-008-9137-1; Macintyre S, 1997, J Health Psychol, V2, P315, DOI 10.1177/135910539700200304; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Markides KS, 2005, J GERONTOL B-PSYCHOL, V60, P68, DOI 10.1093/geronb/60.Special_Issue_2.S68; MARMOT MG, 1984, LANCET, V1, P1455, DOI 10.1016/S0140-6736(84)91943-3; MARMOT MG, 1976, AM J EPIDEMIOL, V104, P225, DOI 10.1093/oxfordjournals.aje.a112296; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004; McGee DL, 1999, AM J EPIDEMIOL, V149, P41; Otiniano AD, 2012, J IMMIGR MINOR HEALT, V14, P189, DOI 10.1007/s10903-011-9473-6; PALINKAS LA, 1995, SOC SCI MED, V40, P1643, DOI 10.1016/0277-9536(94)00344-S; Palloni A, 2004, DEMOGRAPHY, V41, P385, DOI 10.1353/dem.2004.0024; Park RE., 1921, OLD WORLD TRAITS TRA; Perez-Escamilla R, 2007, J NUTR, V137, P860, DOI 10.1093/jn/137.4.860; Portes A., 1995, EC SOCIOLOGY IMMIGRA; Princeton University, 2005, NEW IMM SURV; Roshania R, 2008, OBESITY, V16, P2669, DOI 10.1038/oby.2008.425; Ruiz RJ, 2007, ETHNIC DIS, V17, P338; Sanchez-Vaznaugh EV, 2008, SOC SCI MED, V67, P1300, DOI 10.1016/j.socscimed.2008.06.015; Satia JA, 2010, APPL PHYSIOL NUTR ME, V35, P219, DOI 10.1139/H10-007; Scribner R, 1996, AM J PUBLIC HEALTH, V86, P303, DOI 10.2105/AJPH.86.3.303; SCRIBNER R, 1989, AM J PUBLIC HEALTH, V79, P1263, DOI 10.2105/AJPH.79.9.1263; Setia MS, 2009, EUR J EPIDEMIOL, V24, P611, DOI 10.1007/s10654-009-9373-4; Singh GK, 2001, AM J PUBLIC HEALTH, V91, P392, DOI 10.2105/AJPH.91.3.392; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011; Singh GK, 2008, ARCH PEDIAT ADOL MED, V162, P756, DOI 10.1001/archpedi.162.8.756; Uretsky Mathew Cory, 2007, J Immigr Minor Health, V9, P125, DOI 10.1007/s10903-006-9017-7; VEGA WA, 1994, ANNU REV PUBL HEALTH, V15, P39, DOI 10.1146/annurev.pu.15.050194.000351; WILLIAMS DR, 1990, SOC PSYCHOL QUART, V53, P81, DOI 10.2307/2786672; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Yang Kyeongra, 2007, Health Care Women Int, V28, P329, DOI 10.1080/07399330601179836; Yoo HC, 2009, SOC SCI MED, V68, P726, DOI 10.1016/j.socscimed.2008.11.013	72	65	65	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76494	10.1371/journal.pone.0076494	http://dx.doi.org/10.1371/journal.pone.0076494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231OR	24098515	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100072
J	Lin, L; Cao, KJ; Chen, WH; Pan, XF; Zhao, H				Lin, Ling; Cao, Kejian; Chen, Wenhu; Pan, Xufeng; Zhao, Heng			Four Common Vascular Endothelial Growth Factor Polymorphisms (-2578C > A,-460C > T,+936C > T, and+405G > C) in Susceptibility to Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							FACTOR GENE; BREAST-CANCER; FACTOR VEGF; TUMOR ANGIOGENESIS; COLORECTAL-CANCER; RISK; EXPRESSION; BEVACIZUMAB; NICOTINE; SMOKING	Background and Objective: Vascular endothelial growth factor (VEGF) is one of the key initiators and regulators of angiogenesis and it plays a vital role in the onset and development of malignancy. The association between VEGF gene polymorphisms and lung cancer risk has been extensively studied in recent years, but currently available results remain controversial or ambiguous. The aim of this meta-analysis is to investigate the associations between four common VEGF polymorphisms (i.e., -2578C > A, -460C > T, +936C > T and +405C > G) and lung cancer risk. Methods: A comprehensive search was conducted to identify all eligible studies to estimate the association between VEGF polymorphisms and lung cancer risk. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate the strength of this association. Results: A total of 14 published case-control studies with 4,664 cases and 4,571 control subjects were identified. Our meta-analysis provides strong evidence that VEGF -2578C > A polymorphism is capable of increasing lung cancer susceptibility, especially among smokers and lung squamous cell carcinoma (SCC) patients. Additionally, for +936C > T polymorphism, increased lung cancer susceptibility was only observed among lung adenocarcinoma patients. In contrast, VEGF -460C > T polymorphism may be a protective factor among nonsmokers and SCC patients. Nevertheless, we did not find any association between +405C > G polymorphism and lung cancer risk, even when the groups were stratified by ethnicity, smoking status or histological type. Conclusion: This meta-analysis recommends more investigations into the relationship between -2578C > A and -460C > T lung cancer risks. More detailed and well-designed studies should be conducted to identify the causal variants and the underlying mechanisms of the possible associations.	[Lin, Ling; Cao, Kejian; Chen, Wenhu; Pan, Xufeng; Zhao, Heng] Shanghai Jiao Tong Univ, Dept Thorac Surg, Shanghai Chest Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhao, H (corresponding author), Shanghai Jiao Tong Univ, Dept Thorac Surg, Shanghai Chest Hosp, Sch Med, Shanghai 200030, Peoples R China.	h_zhao24@126.com						Andersen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019773; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Barbera-Guillem E, 2002, CANCER RES, V62, P7042; Conklin BS, 2002, AM J PATHOL, V160, P413, DOI 10.1016/S0002-9440(10)64859-6; D'Amico A, 2010, LUNG CANCER, V68, P170, DOI 10.1016/j.lungcan.2009.11.003; da Costa BR, 2011, STAT MED, V1; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Gao F, 2012, CHIN J CANC PREV TRE, P575; Gu DY, 2011, BREAST CANCER RES TR, V125, P489, DOI 10.1007/s10549-010-0991-z; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin QR, 2005, CLIN CANCER RES, V11, P3647, DOI 10.1158/1078-0432.CCR-04-1803; Kanda Y, 2007, LIFE SCI, V80, P1409, DOI 10.1016/j.lfs.2006.12.033; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Li PX, 2012, J GUANGXI MED U, P100; Li Y, 2012, EXP THER MED, V3, P673, DOI 10.3892/etm.2012.453; Liang J, 2009, CHINESE GERMAN J CLI, V8, P269, DOI DOI 10.1007/s10330-009-0054-2; Liu CJ, 2012, STUDY ASS VEGF GENET; Liu H, 2011, ASIAN PAC J CANCER P, V12, P1979; Miller DL, 1998, FEBS LETT, V434, P417, DOI 10.1016/S0014-5793(98)01025-4; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Naik NA, 2012, TUMOR BIOL, V33, P833, DOI 10.1007/s13277-011-0306-y; Naykoo NA, 2013, GENE; PARKIN DM, 1994, INT J CANCER, V59, P494, DOI 10.1002/ijc.2910590411; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Ruggiero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016982; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Sun SF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0410-x; Tan H, 2008, AC C; TANG DL, 1995, CANCER EPIDEM BIOMAR, V4, P341; Toh CK, 2006, J CLIN ONCOL, V24, P2245, DOI 10.1200/JCO.2005.04.8033; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; Wang K, 2011, CYTOKINE, V56, P167, DOI 10.1016/j.cyto.2011.06.018; Wang T, 2008, AC C; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Welch S, 2010, ANN ONCOL, V21, P1152, DOI 10.1093/annonc/mdp533; Yang DS, 2011, BREAST CANCER RES TR, V125, P849, DOI 10.1007/s10549-010-1070-1; Yoshiji H, 1996, CANCER RES, V56, P2013; Yuan JJ, 2011, STUDY ASS VEGF GENET; Zhai RH, 2008, CLIN CANCER RES, V14, P612, DOI 10.1158/1078-0432.CCR-07-1655; Zhang C, 2011, INT J BIOL MARKER, V26, P274, DOI 10.5301/JBM.2011.8829; Zhou LP, 2011, GENET MOL RES, V10, P3674, DOI 10.4238/2011.October.31.13; Zhou LP, 2011, EXP THER MED, V2, P931, DOI 10.3892/etm.2011.278; Zhou Y, 2010, INT J BIOL MARKER, V25, P213, DOI 10.5301/JBM.2010.6110; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	47	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75123	10.1371/journal.pone.0075123	http://dx.doi.org/10.1371/journal.pone.0075123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098368	Green Submitted, gold, Green Published			2022-12-27	WOS:000325427100016
J	Maliniemi, P; Vincendeau, M; Mayer, J; Frank, O; Hahtola, S; Karenko, L; Carlsson, E; Mallet, F; Seifarth, W; Leib-Mosch, C; Ranki, A				Maliniemi, Pilvi; Vincendeau, Michelle; Mayer, Jens; Frank, Oliver; Hahtola, Sonja; Karenko, Leena; Carlsson, Emilia; Mallet, Francois; Seifarth, Wolfgang; Leib-Moesch, Christine; Ranki, Annamari			Expression of Human Endogenous Retrovirus-W Including Syncytin-1 in Cutaneous T-Cell Lymphoma	PLOS ONE			English	Article							MYCOSIS-FUNGOIDES; SEZARY-SYNDROME; MULTIPLE-SCLEROSIS; ENVELOPE PROTEIN; HERV-W; TRANSCRIPTIONAL ACTIVITY; TRANSPOSABLE ELEMENTS; HUMAN TISSUES; COPY NUMBER; NO EVIDENCE	The pathomechanism of mycosis fungoides (MF), the most common type of primary cutaneous T-cell lymphomas (CTCLs) and a malignancy of non-recirculating, skin-resident T-cells, is unknown albeit underlying viral infections have been sought for. Human endogenous retroviruses (HERVs) are ancient retroviral sequences in the human genome and their transcription is often deregulated in cancers. We explored the transcriptional activity of HERV sequences in a total of 34 samples comprising MF and psoriasis skin lesions, as well as corresponding nonmalignant skin using a retrovirus-specific microarray and quantitative RT-PCR. To identify active HERV-W loci, we cloned the HERV-W specific RT-PCR products, sequenced the cDNA clones and assigned the sequences to HERV-W loci. Finally, we used immunohistochemistry on MF patient and non-malignant inflammatory skin samples to confirm specific HERV-encoded protein expression. Firstly, a distinct, skin-specific transcription profile consisting of five constitutively active HERV groups was established. Although individual variability was common, HERV-W showed significantly increased transcription in MF lesions compared to clinically intact skin from the same patient. Predominantly transcribed HERV-W loci were found to be located in chromosomes 6q21 and 7q21.2, chromosomal regions typically altered in CTCL. Surprisingly, we also found the expression of 7q21.2/ERVWE1-encoded Syncytin-1 (Env) protein in MF biopsies and expression of Syncytin-1 was seen in malignant lymphocytes, especially in the epidermotropic ones, in 15 of 30 cases studied. Most importantly, no Syncytin-1 expression was detected in inflammatory dermatosis (Lichen ruber planus) with skin-homing, non-malignant T lymphocytes. The expression of ERVWE1 mRNA was further confirmed in 3/7 MF lesions analyzed. Our observations strengthen the association between activated HERVs and cancer. The study offers a new perspective into the pathogenesis of CTCL since we demonstrate that differences in HERV-W transcription levels between lesional MF and non-malignant skin are significant, and that ERVWE1-encoded Syncytin-1 is expressed in MF lymphoma cells.	[Maliniemi, Pilvi; Hahtola, Sonja; Karenko, Leena; Carlsson, Emilia; Ranki, Annamari] Univ Helsinki, Helsinki Univ Cent Hosp, Dept Dermatol & Allergol, Helsinki, Finland; [Vincendeau, Michelle; Leib-Moesch, Christine] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany; [Mayer, Jens] Univ Saarland, Fac Med, Dept Human Genet, Ctr Human & Mol Biol, Homburg, Germany; [Frank, Oliver; Seifarth, Wolfgang; Leib-Moesch, Christine] Heidelberg Univ, Dept Hematol & Oncol, Mannheim Med Ctr, Mannheim, Germany; [Mallet, Francois] Ctr Hosp Lyon Sud, Canc Biomarkers Res Grp, Joint Unit Hosp Civils Lyon BioMerieux, F-69310 Pierre Benite, France; [Vincendeau, Michelle] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Toxicol & Pharmacol, Res Unit Cellular Signal Integrat, Neuherberg, Germany	University of Helsinki; Helsinki University Central Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Saarland University; Ruprecht Karls University Heidelberg; CHU Lyon; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Maliniemi, P (corresponding author), Univ Helsinki, Helsinki Univ Cent Hosp, Dept Dermatol & Allergol, Helsinki, Finland.	pilvi.maliniemi@helsinki.fi	Maliniemi, Pilvi Helena/J-1001-2016; Mayer, Jens/P-4777-2019; Vincendeau, Michelle/AAD-4320-2022; Mallet, Francois/G-4812-2014; Mayer, Jens/B-8506-2013	Maliniemi, Pilvi Helena/0000-0002-7360-154X; Mayer, Jens/0000-0002-1090-5765; Mayer, Jens/0000-0002-1090-5765; MALLET, Francois/0000-0002-1331-096X	Helsinki University Hospital Research funds (EVO); Finnish Cancer Foundation; Sigrid Juselius Foundation; Helsinki University Research Fund/Tiedesaatio and Finska Lakaresallskapet/Doctorandstipendium; Deutsche Forschungsgemeinschaft	Helsinki University Hospital Research funds (EVO); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Research Fund/Tiedesaatio and Finska Lakaresallskapet/Doctorandstipendium; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This investigation was supported by Helsinki University Hospital Research funds (EVO), Finnish Cancer Foundation and Sigrid Juselius Foundation. P.M. also acknowledged support from the Helsinki University Research Fund/Tiedesaatio and Finska Lakaresallskapet/Doctorandstipendium. J.M. is supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Antony JM, 2011, BBA-MOL BASIS DIS, V1812, P162, DOI 10.1016/j.bbadis.2010.07.016; Batista DAS, 2006, GENE CHROMOSOME CANC, V45, P383, DOI 10.1002/gcc.20302; Bazarbachi A, 1997, BRIT J HAEMATOL, V98, P927, DOI 10.1046/j.1365-2141.1997.3213138.x; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Beyer M, 2011, J DTSCH DERMATOL GES, V9, P594, DOI 10.1111/j.1610-0387.2011.07635.x; Bhat RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019176; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Brudek T, 2008, SCAND J IMMUNOL, V67, P295, DOI 10.1111/j.1365-3083.2007.02067.x; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Cheynet V, 2005, J VIROL, V79, P5585, DOI 10.1128/JVI.79.9.5585-5593.2005; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Costas J, 2002, MOL BIOL EVOL, V19, P526, DOI 10.1093/oxfordjournals.molbev.a004108; Dereure O, 2013, J INVEST DERMATOL, V133, P853, DOI 10.1038/jid.2012.371; Espinet B, 2004, HAEMATOLOGICA, V89, P165; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Fischer TC, 2004, J INVEST DERMATOL, V122, P579, DOI 10.1111/j.0022-202X.2004.22301.x; Flockerzi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-354; Frank O, 2005, J VIROL, V79, P10890, DOI 10.1128/JVI.79.17.10890-10901.2005; Frank O, 2008, J VIROL, V82, P1808, DOI 10.1128/JVI.02115-07; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Gosenca D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049341; Greenwood AD, 2005, VIROLOGY, V334, P203, DOI 10.1016/j.virol.2005.01.045; Handwerger S, 2010, MOL CELL ENDOCRINOL, V323, P94, DOI 10.1016/j.mce.2009.12.015; Haupt S, 2011, J GEN VIROL, V92, P2356, DOI 10.1099/vir.0.031518-0; Hohenadl C, 1999, J INVEST DERMATOL, V113, P587, DOI 10.1046/j.1523-1747.1999.00728.x; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; Karenko L, 2005, CANCER RES, V65, P8101, DOI 10.1158/0008-5472.CAN-04-0366; Karenko L, 1999, J INVEST DERMATOL, V112, P392, DOI 10.1038/sj.jid.5600444; Katsumata K, 1999, CLIN IMMUNOL, V93, P75, DOI 10.1006/clim.1999.4762; Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004; Kempf W, 2010, HISTOPATHOLOGY, V56, P57, DOI 10.1111/j.1365-2559.2009.03455.x; Kikuchi A, 1997, BLOOD, V89, P1529, DOI 10.1182/blood.V89.5.1529.1529_1529_1532; Kozeretska I. A., 2011, Experimental Oncology, V33, P198; Laharanne E, 2010, MODERN PATHOL, V23, P547, DOI 10.1038/modpathol.2009.196; Laufer G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-37; Lin WM, 2010, J INVEST DERMATOL, V130, P926, DOI 10.1038/jid.2009.370; MAGER DL, 2003, ANONYMOUS ENCY HUMAN, V5, P57; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Mameli G, 2007, VIROLOGY, V362, P120, DOI 10.1016/j.virol.2006.12.019; Mao X, 2003, GENE CHROMOSOME CANC, V36, P250, DOI 10.1002/gcc.10152; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moles JP, 2005, BRIT J DERMATOL, V153, P83, DOI 10.1111/j.1365-2133.2005.06555.x; Moyes D, 2007, TRENDS GENET, V23, P326, DOI 10.1016/j.tig.2007.05.004; Muche JM, 2003, DIAGN MOL PATHOL, V12, P142, DOI 10.1097/00019606-200309000-00005; Mullins CS, 2012, WORLD J GASTROENTERO, V18, P6027, DOI 10.3748/wjg.v18.i42.6027; NOWELL PC, 1986, CANCER GENET CYTOGEN, V19, P219, DOI 10.1016/0165-4608(86)90050-6; PANCAKE BA, 1995, J CLIN INVEST, V95, P547, DOI 10.1172/JCI117697; Parker SRS, 2009, GIORN ITAL DERMAT V, V144, P467; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; Perot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040194; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Perron H, 2009, J NEUROL SCI, V286, P65, DOI 10.1016/j.jns.2009.04.034; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichon JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl086; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; RANKI A, 1990, ARCH DERMATOL RES, V282, P532, DOI 10.1007/BF00371949; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Roebke C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-69; Rolland A, 2006, J IMMUNOL, V176, P7636, DOI 10.4049/jimmunol.176.12.7636; Romanish MT, 2010, SEMIN CANCER BIOL, V20, P246, DOI 10.1016/j.semcancer.2010.05.005; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; Ruprecht K, 2006, J NEUROVIROL, V12, P65, DOI 10.1080/13550280600614973; SAXINGER WC, 1985, SCAND J HAEMATOL, V34, P455; Schechner JS, 1999, LAB INVEST, V79, P601; Seifarth W, 2005, J VIROL, V79, P341, DOI 10.1128/JVI.79.1.341-352.2005; Seifarth W, 2003, J VIROL METHODS, V112, P79, DOI 10.1016/S0166-0934(03)00194-0; Seifarth W, 2000, AIDS RES HUM RETROV, V16, P721, DOI 10.1089/088922200308729; Seifarth W, 2011, ENCY DNA RES; Stauffer Yves, 2004, Cancer Immun, V4, P2; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; TAN RSH, 1974, BRIT J DERMATOL, V91, P607, DOI 10.1111/j.1365-2133.1974.tb12449.x; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Wood GS, 1997, AM J PATHOL, V150, P667; Zeilfelder U, 2007, GENE, V390, P175, DOI 10.1016/j.gene.2006.08.019; Zendri E, 2008, J INVEST DERMATOL, V128, P489, DOI 10.1038/sj.jid.5701034	84	39	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76281	10.1371/journal.pone.0076281	http://dx.doi.org/10.1371/journal.pone.0076281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098463	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100053
J	Dartnell, LR; Roberts, TA; Moore, G; Ward, JM; Muller, JP				Dartnell, Lewis R.; Roberts, Tom A.; Moore, Ginny; Ward, John M.; Muller, Jan-Peter			Fluorescence Characterization of Clinically-Important Bacteria	PLOS ONE			English	Article							FLOW-CYTOMETRY; CLOSTRIDIUM-DIFFICILE; SPECTROSCOPY; IDENTIFICATION; CLASSIFICATION; WATER; MICROORGANISMS; OUTBREAK; SPECTRA; LIFE	Healthcare-associated infections (HCAI/HAI) represent a substantial threat to patient health during hospitalization and incur billions of dollars additional cost for subsequent treatment. One promising method for the detection of bacterial contamination in a clinical setting before an HAI outbreak occurs is to exploit native fluorescence of cellular molecules for a hand-held, rapid-sweep surveillance instrument. Previous studies have shown fluorescence-based detection to be sensitive and effective for food-borne and environmental microorganisms, and even to be able to distinguish between cell types, but this powerful technique has not yet been deployed on the macroscale for the primary surveillance of contamination in healthcare facilities to prevent HAI. Here we report experimental data for the specification and design of such a fluorescence-based detection instrument. We have characterized the complete fluorescence response of eleven clinically-relevant bacteria by generating excitation-emission matrices (EEMs) over broad wavelength ranges. Furthermore, a number of surfaces and items of equipment commonly present on a ward, and potentially responsible for pathogen transfer, have been analyzed for potential issues of background fluorescence masking the signal from contaminant bacteria. These include bedside handrails, nurse call button, blood pressure cuff and ward computer keyboard, as well as disinfectant cleaning products and microfiber cloth. All examined bacterial strains exhibited a distinctive double-peak fluorescence feature associated with tryptophan with no other cellular fluorophore detected. Thus, this fluorescence survey found that an emission peak of 340nm, from an excitation source at 280nm, was the cellular fluorescence signal to target for detection of bacterial contamination. The majority of materials analysed offer a spectral window through which bacterial contamination could indeed be detected. A few instances were found of potential problems of background fluorescence masking that of bacteria, but in the case of the microfiber cleaning cloth, imaging techniques could morphologically distinguish between stray strands and bacterial contamination.	[Dartnell, Lewis R.] UCL, UCL Inst Origins, London, England; [Dartnell, Lewis R.; Muller, Jan-Peter] UCL, UCL Birkbeck, Ctr Planetary Sci, London, England; [Roberts, Tom A.] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Moore, Ginny] Univ Coll London Hosp NHS Fdn Trust, London, England; [Ward, John M.] UCL, Adv Ctr Biochem Engn, London, England; [Muller, Jan-Peter] Univ Coll London, Mullard Space Sci Lab, Surrey, England	University of London; University College London; University of London; Birkbeck University London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London	Dartnell, LR (corresponding author), UCL, UCL Inst Origins, London, England.	lewis@lewisdartnell.com	Muller, Jan-Peter/Q-8886-2019	Muller, Jan-Peter/0000-0002-5077-3736; Roberts, Tom/0000-0003-0385-1057; Ward, John/0000-0002-4415-5544; Moore, Ginny/0000-0001-6969-3528	Science and Technology Facilities Council (STFC) Challenge Led Applied Systems Programme (CLASP) [ST/I003258/1]; STFC [ST/H00260X/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H00260X/1, ST/J00216X/1] Funding Source: researchfish	Science and Technology Facilities Council (STFC) Challenge Led Applied Systems Programme (CLASP)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the Science and Technology Facilities Council (STFC; www.stfc.ac.uk) Challenge Led Applied Systems Programme (CLASP) Grant ST/I003258/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JJ, 2004, ORG GEOCHEM, V35, P1141, DOI 10.1016/j.orggeochem.2004.06.010; Ammor MS, 2007, J FLUORESC, V17, P455, DOI 10.1007/s10895-007-0180-6; Ammor S, 2004, J MICROBIOL METH, V59, P271, DOI 10.1016/j.mimet.2004.07.014; Bhartia R, 2008, APPL SPECTROSC, V62, P1070, DOI 10.1366/000370208786049123; Bhatta H, 2006, APPL MICROBIOL BIOT, V71, P121, DOI 10.1007/s00253-005-0309-y; CAMPBELL L, 1988, LIMNOL OCEANOGR, V33, P1196, DOI 10.4319/lo.1988.33.5.1196; Chapman GV, 2000, J IMMUNOL METHODS, V243, P3, DOI 10.1016/S0022-1759(00)00224-6; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Dartnell LR, 2012, METEORIT PLANET SCI, V47, P806, DOI 10.1111/j.1945-5100.2012.01351.x; Dartnell LR, 2011, ASTROBIOLOGY, V11, P997, DOI 10.1089/ast.2011.0663; Dartnell LR, 2010, INT J ASTROBIOL, V9, P245, DOI 10.1017/S1473550410000224; Diagaradjane P, 2005, LASER SURG MED, V37, P382, DOI 10.1002/lsm.20248; Elliott S, 2006, WATER RES, V40, P2075, DOI 10.1016/j.watres.2006.03.017; Engelhart S, 2002, J HOSP INFECT, V52, P93, DOI 10.1053/jhin.2002.1279; Estes C, 2003, BIOSENS BIOELECTRON, V18, P511, DOI 10.1016/S0956-5663(03)00008-3; Georgakoudi I, 2002, CANCER RES, V62, P682; Giana HE, 2003, J FLUORESC, V13, P489, DOI 10.1023/B:JOFL.0000008059.74052.3c; Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845; Health Protection Agency, 2012, HEALTHC ASS INF ANT, P2010; Hua B, 2007, INT J ENVIRON AN CH, V87, P135, DOI 10.1080/03067310600922154; Jiji RD, 1999, ANAL CHIM ACTA, V397, P61, DOI 10.1016/S0003-2670(99)00392-X; LAYTON MC, 1993, INFECT CONT HOSP EP, V14, P369; Leblanc L, 2002, FEMS MICROBIOL LETT, V211, P147, DOI 10.1111/j.1574-6968.2002.tb11217.x; Manian FA, 1996, INFECT CONT HOSP EP, V17, P180; McNamara L, 2009, AM J CRIT CARE, V18, P41, DOI 10.4037/ajcc2009483; MUIRHEAD KA, 1985, BIO-TECHNOL, V3, P337, DOI 10.1038/nbt0485-337; Nadeau JL, 2008, ASTROBIOLOGY, V8, P859, DOI 10.1089/ast.2007.0043; NATO, 2010, SET098RTG55 NATO, P1; OLDHAM PB, 1985, J MAR RES, V43, P893; Palmer GM, 2003, PHOTOCHEM PHOTOBIOL, V78, P462, DOI 10.1562/0031-8655(2003)078<0462:ASONAM>2.0.CO;2; Pan YL, 1999, OPT LETT, V24, P116, DOI 10.1364/OL.24.000116; Patra D, 2001, TALANTA, V55, P143, DOI 10.1016/S0039-9140(01)00404-0; Pratt RJ, 2007, J HOSP INFECT, V65, pS1, DOI 10.1016/S0195-6701(07)60002-4; Rohde RA, 2007, P NATL ACAD SCI USA, V104, P16592, DOI 10.1073/pnas.0708183104; Rosenstein R, 2013, CURR TOP MICROBIOL, V358, P33, DOI 10.1007/82_2012_286; SHELLY DC, 1980, CLIN CHEM, V26, P1127; SHELLY DC, 1980, CLIN CHEM, V26, P1419; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020; Sohn M, 2009, APPL SPECTROSC, V63, P1251, DOI 10.1366/000370209789806993; Stone PW, 2005, AM J INFECT CONTROL, V33, P501, DOI 10.1016/j.ajic.2005.04.246; Storrie-Lombardi MC, 2009, ASTROBIOLOGY, V9, P659, DOI 10.1089/ast.2009.0351; Veal DA, 2000, J IMMUNOL METHODS, V243, P191, DOI 10.1016/S0022-1759(00)00234-9; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Weinstein S, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2006JG000319; Zhang QQ, 2006, SPECTROCHIM ACTA A, V63, P361, DOI 10.1016/j.saa.2005.05.041; Ziegmann M, 2010, WATER RES, V44, P195, DOI 10.1016/j.watres.2009.09.035	48	47	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75270	10.1371/journal.pone.0075270	http://dx.doi.org/10.1371/journal.pone.0075270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098687	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500058
J	Houze, S; Boutron, I; Marmorat, A; Dalichampt, M; Choquet, C; Poilane, I; Godineau, N; Le Guern, AS; Thellier, M; Broutier, H; Fenneteau, O; Millet, P; Dulucq, S; Hubert, V; Houze, P; Tubach, F; Le Bras, J; Matheron, S				Houze, Sandrine; Boutron, Isabelle; Marmorat, Anne; Dalichampt, Marie; Choquet, Christophe; Poilane, Isabelle; Godineau, Nadine; Le Guern, Anne-Sophie; Thellier, Marc; Broutier, Helene; Fenneteau, Odile; Millet, Pascal; Dulucq, Stephanie; Hubert, Veronique; Houze, Pascal; Tubach, Florence; Le Bras, Jacques; Matheron, Sophie			Performance of Rapid Diagnostic Tests for Imported Malaria in Clinical Practice: Results of a National Multicenter Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; LACTATE-DEHYDROGENASE; COMBINATION THERAPY; TRAVELERS; PARASITE; ACCURACY; FIELD; REGION; PFHRP2	We compared the performance of four rapid diagnostic tests (RDTs) for imported malaria, and particularly Plasmodium falciparum infection, using thick and thin blood smears as the gold standard. All the tests are designed to detect at least one protein specific to P. falciparum (Plasmodium histidine-rich protein 2 (PfHRP2) or Plasmodium LDH (PfLDH)) and one pan-Plasmodium protein (aldolase or Plasmodium LDH (pLDH)). 1,311 consecutive patients presenting to 9 French hospitals with suspected malaria were included in this prospective study between April 2006 and September 2008. Blood smears revealed malaria parasites in 374 cases (29%). For the diagnosis of P. falciparum infection, the three tests detecting PfHRP2 showed high and similar sensitivity (96%), positive predictive value (PPV) (90%) and negative predictive value (NPV) (98%). The PfLDH test showed lower sensitivity (83%) and NPV (80%), despite good PPV (98%). For the diagnosis of non-falciparum species, the PPV and NPV of tests targeting pLDH or aldolase were 94-99% and 52-64%, respectively. PfHRP2-based RDTs are thus an acceptable alternative to routine microscopy for diagnosing P. falciparum malaria. However, as malaria may be misdiagnosed with RDTs, all negative results must be confirmed by the reference diagnostic method when clinical, biological or other factors are highly suggestive of malaria.	[Houze, Sandrine; Marmorat, Anne; Hubert, Veronique; Le Bras, Jacques] Hop Bichat Claude Bernard, AP HP, Parasitol Lab, Ctr Natl Reference Paludisme, F-75877 Paris, France; [Houze, Sandrine; Le Bras, Jacques] Univ Paris 05, UMR 216, Paris, France; [Houze, Sandrine] Inst Rech Dev, UMR 216, Paris, France; [Boutron, Isabelle; Dalichampt, Marie] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Boutron, Isabelle; Dalichampt, Marie] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Choquet, Christophe] Hop Bichat Claude Bernard, AP HP, Serv Urgences, F-75877 Paris, France; [Poilane, Isabelle] CHU Jean Verdier, AP HP, Microbiol Lab, Bondy, France; [Godineau, Nadine] Hop Delafontaine, Parasitol Lab, St Denis, France; [Le Guern, Anne-Sophie] Inst Pasteur, Lab Ctr Med, Paris, France; [Thellier, Marc] Hop La Pitie Salpetriere, AP HP, Parasitol Lab, Paris, France; [Broutier, Helene] Hop Robert Ballenger, Lab Polyvalent, Aulnay Sous Bois, France; [Fenneteau, Odile] Hop Robert Debre, AP HP, Hematol Lab, F-75019 Paris, France; [Millet, Pascal] Hop St Andre, Lab Parasitol Mycol, Bordeaux, France; [Millet, Pascal] Univ Bordeaux Segalen, EA 4575, Bordeaux, France; [Dulucq, Stephanie] Hop Pellegrin, Biol Lab, F-33076 Bordeaux, France; [Houze, Pascal] Hop St Louis, AP HP, Biochim Lab, Paris, France; [Tubach, Florence] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris, France; [Tubach, Florence; Matheron, Sophie] Univ Paris 07, Paris, France; [Tubach, Florence] INSERM 801, Paris, France; [Matheron, Sophie] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, F-75877 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Houze, S (corresponding author), Hop Bichat Claude Bernard, AP HP, Parasitol Lab, Ctr Natl Reference Paludisme, F-75877 Paris, France.	sandrine.houze@bch.aphp.fr	Thellier, Marc/AAI-3311-2021; Matheron, Sophie/D-7420-2017; sandrine, houze/M-3260-2017	Thellier, Marc/0000-0003-4867-2423; Matheron, Sophie/0000-0001-7879-6553; sandrine, houze/0000-0001-9016-3847; Boutron, Isabelle/0000-0002-5263-6241	French Ministry of Health [PHRC AOR06066]	French Ministry of Health	The study was supported by a grant from the French Ministry of Health (PHRC AOR06066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2011, COCHRANE DB SYST REV, V7; Altman DG., 2000, STAT CONFIDENCE CONF; Alunni-perret V, 2010, AM J FOREN MED PATH, V31, P269, DOI 10.1097/PAF.0b013e3181e2efe4; [Anonymous], 2008, MAL RAP DIAGN TEST P; Ashton RA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-297; Askling HH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-328; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Bendezu J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-154; Bjorkman A, 2010, CLIN INFECT DIS, V51, P512, DOI 10.1086/655689; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bronner U, 2011, APMIS, V119, P88, DOI 10.1111/j.1600-0463.2010.02696.x; Casalino E, 2002, ARCH INTERN MED, V162, P1625, DOI 10.1001/archinte.162.14.1625; Chilton D, 2006, J CLIN PATHOL, V59, P862, DOI 10.1136/jcp.2005.032904; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; De Monbrison F, 2004, EUR J CLIN MICROBIOL, V23, P784, DOI 10.1007/s10096-004-1202-9; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; El-Moamly Amal M. Abdul-Rasheed, 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P1017; European Centre for Disease Prevention and Control, 2010, ANN EP REP COMM DIS; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Hayward RE, 2000, EXP PARASITOL, V96, P139, DOI 10.1006/expr.2000.4557; Hendriksen ICE, 2011, CLIN INFECT DIS, V52, P1100, DOI 10.1093/cid/cir143; Hermans V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-331; Houze S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-211; Iqbal J, 2004, J CLIN MICROBIOL, V42, P4237, DOI 10.1128/JCM.42.9.4237-4241.2004; Jelinek T, 2000, J TRAVEL MED, V7, P175, DOI 10.2310/7060.2000.00055; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Laferi H, 1997, NEW ENGL J MED, V337, P1635, DOI 10.1056/NEJM199711273372219; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P408, DOI 10.1111/1469-0691.12152; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Meena M, 2009, T ROY SOC TROP MED H, V103, P1237, DOI 10.1016/j.trstmh.2009.04.011; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mueller I, 2007, J CLIN MICROBIOL, V45, P627, DOI 10.1128/JCM.00816-06; MURRAY CK, 2009, INTERDISCIP PERSPECT; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; Piper RC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-213; Playford EG, 2002, J CLIN MICROBIOL, V40, P4166, DOI 10.1128/JCM.40.11.4166-4171.2002; Ratsimbasoa A, 2007, AM J TROP MED HYG, V76, P481, DOI 10.4269/ajtmh.2007.76.481; Rosenthal PJ, 2012, AM J TROP MED HYG, V86, P192, DOI 10.4269/ajtmh.2012.11-0619; Rossi IA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-377; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-191; Snounou G, 1996, Methods Mol Biol, V50, P263; Stauffer WM, 2009, CLIN INFECT DIS, V49, P908, DOI 10.1086/605436; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; van Dijk DPJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-293; van Gool T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-300; WHO, WHO GLOB MAL PROGR W; World Health Organization, 2009, MAN MICR QUAL ASS MA; World Health Organization, 2009, PAR CONF MAL DIAGN W; World Health Organization WHO Global Malaria Programme, GOOD PRACT SEL PROC	53	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75486	10.1371/journal.pone.0075486	http://dx.doi.org/10.1371/journal.pone.0075486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098699	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500070
J	Lu, H; Yang, ST; Lin, LN; Li, BM; Wei, H				Lu, Hu; Yang, Shengtao; Lin, Longnian; Li, Baoming; Wei, Hui			Prediction of Rat Behavior Outcomes in Memory Tasks Using Functional Connections among Neurons	PLOS ONE			English	Article							MODULAR ORGANIZATION; COMMUNITY STRUCTURE; CORTICAL-NEURONS; UNIT-ACTIVITY; SMALL-WORLD; BRAIN; NETWORKS; PATTERNS; HIPPOCAMPUS	Background: Analyzing the neuronal organizational structures and studying the changes in the behavior of the organism is key to understanding cognitive functions of the brain. Although some studies have indicated that spatiotemporal firing patterns of neuronal populations have a certain relationship with the behavioral responses, the issues of whether there are any relationships between the functional networks comprised of these cortical neurons and behavioral tasks and whether it is possible to take advantage of these networks to predict correct and incorrect outcomes of single trials of animals are still unresolved. Methodology/Principal Findings: This paper presents a new method of analyzing the structures of whole-recorded neuronal functional networks (WNFNs) and local neuronal circuit groups (LNCGs). The activity of these neurons was recorded in several rats. The rats performed two different behavioral tasks, the Y-maze task and the U-maze task. Using the results of the assessment of the WNFNs and LNCGs, this paper describes a realization procedure for predicting the behavioral outcomes of single trials. The methodology consists of four main parts: construction of WNFNs from recorded neuronal spike trains, partitioning the WNFNs into the optimal LNCGs using social community analysis, unsupervised clustering of all trials from each dataset into two different clusters, and predicting the behavioral outcomes of single trials. The results show that WNFNs and LNCGs correlate with the behavior of the animal. The U-maze datasets show higher accuracy for unsupervised clustering results than those from the Y-maze task, and these datasets can be used to predict behavioral responses effectively. Conclusions/Significance: The results of the present study suggest that a methodology proposed in this paper is suitable for analysis of the characteristics of neuronal functional networks and the prediction of rat behavior. These types of structures in cortical ensemble activity may be critical to information representation during the execution of behavior.	[Lu, Hu; Wei, Hui] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Yang, Shengtao; Li, Baoming] Fudan Univ, Inst Neurobiol, Shanghai 200433, Peoples R China; [Yang, Shengtao; Li, Baoming] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Lin, Longnian] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Labs, MOE, Shanghai 200062, Peoples R China; [Lin, Longnian] E China Normal Univ, Shanghai Inst Brain Funct Genom, STCSM, Shanghai 200062, Peoples R China	Fudan University; Fudan University; Fudan University; East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM)	Li, BM (corresponding author), Fudan Univ, Inst Neurobiol, Shanghai 200433, Peoples R China.	bmli@fudan.edu.cn; weihui@fudan.edu.cn	Wei, Hui/K-5819-2019; Yang, Shengtao/ACP-5447-2022		National Natural Science Foundation of China [30990260, 61375122, 61105042]; 973 Program [2010CB327900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (No. 30990260, 61375122, 61105042) and 973 Program (No. 2010CB327900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Ahmadlou M, 2011, NEUROIMAGE, V58, P401, DOI 10.1016/j.neuroimage.2011.04.070; Ahmadlou M, 2011, CLIN EEG NEUROSCI, V42, P6, DOI 10.1177/155005941104200105; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chapin JK, 2004, NAT NEUROSCI, V7, P452, DOI 10.1038/nn1234; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Laurienti P, 2009, NATURE PRECEDINGS, V4; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022357; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Lopes-dos-Santos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020996; Lu H, 2012, PHYSICA A, V391, P6156, DOI 10.1016/j.physa.2012.06.062; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Ng AY, 2002, ADV NEUR IN, V14, P849; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Paiva A, 2009, NEURAL COMPUT APPL, V18, P1; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; Schwarz AJ, 2009, NEUROIMAGE, V47, P302, DOI 10.1016/j.neuroimage.2009.03.064; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Shmiel T, 2005, P NATL ACAD SCI USA, V102, P18655, DOI 10.1073/pnas.0509346102; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Villa AEP, 1999, P NATL ACAD SCI USA, V96, P1106, DOI 10.1073/pnas.96.3.1106; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	53	10	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74298	10.1371/journal.pone.0074298	http://dx.doi.org/10.1371/journal.pone.0074298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098641	Green Submitted, gold, Green Published			2022-12-27	WOS:000325423500012
J	Qin, X; Peng, QL; Tang, WZ; Lao, XJ; Chen, ZP; Lai, H; Deng, Y; Mo, CJ; Sui, JZ; Wu, JR; Zhai, LM; Yang, S; Li, S; Zhao, JM				Qin, Xue; Peng, Qiliu; Tang, Weizhong; Lao, Xianjun; Chen, Zhiping; Lai, Hao; Deng, Yan; Mo, Cuiju; Sui, Jingzhe; Wu, Junrong; Zhai, Limin; Yang, Shi; Li, Shan; Zhao, Jinmin			An Updated Meta-Analysis on the Association of MDM2 SNP309 Polymorphism with Colorectal Cancer Risk	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; HARDY-WEINBERG EQUILIBRIUM; ACCELERATES TUMOR-FORMATION; PROMOTER POLYMORPHISM; P53-INDEPENDENT ROLE; GENOTYPING ERRORS; TP53 R72P; P53; GENE; AGE	Background: The mouse double minute 2 (MDM2) gene encodes a phosphoprotein that interacts with P53 and negatively regulates its activity. The SNP309 polymorphism (T-G) in the promoter of MDM2 gene has been reported to be associated with enhanced MDM2 expression and tumor development. Studies investigating the association between MDM2 SNP309 polymorphism and colorectal cancer (CRC) risk reported conflicting results. We performed a meta-analysis of all available studies to explore the association of this polymorphism with CRC risk. Methods: All studies published up to July 2013 on the association between MDM2 SNP309 polymorphism and CRC risk were identified by searching electronic databases PubMed, EMBASE, and Chinese Biomedical Literature database (CBM) databases. The association between the MDM2 SNP309 polymorphism and CRC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). Results: A total of 14 case-control studies including 4460 CRC cases and 4828 controls were identified. We did not find a significant association between the MDM2 SNP309 polymorphism and CRC risk in all genetic models in overall population. However, in subgroup analysis by ethnicity, significant associations were found in Asians (TG vs. TT: OR = 1.197, 95% CI = 1.055-1.358, P=0.005; GG+TG vs. TT: OR = 1.246, 95% CI = 1.106-1.404, P=0.000) and Africans. When stratified by HWE in controls, significantly increased risk was also found among the studies consistent with HWE (TG vs. TT: OR = 1.166, 95% CI = 1.037-1.311, P=0.010). In subgroup analysis according to p53 mutation status, and gender, no any significant association was detected. Conclusions: The present meta-analysis suggests that the MDM2 is a candidate gene for CRC susceptibility. The MDM2 SNP309 polymorphism may be a risk factor for CRC in Asians.	[Qin, Xue; Peng, Qiliu; Lao, Xianjun; Deng, Yan; Mo, Cuiju; Sui, Jingzhe; Wu, Junrong; Zhai, Limin; Yang, Shi; Li, Shan] Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Tang, Weizhong] Guangxi Med Univ, Dept Anal & Colorectal Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Chen, Zhiping] Guangxi Med Univ, Dept Occupat Hlth & Environm Hlth, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Lai, Hao] Guangxi Med Univ, Dept Gastrointestinal Surg, Tumor Hosp, Nanning, Guangxi, Peoples R China; [Zhao, Jinmin] Guangxi Med Univ, Dept Orthoped Trauma Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, S (corresponding author), Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	lis8858@126.com; zhaojinmin@126.com		Zhao, Jinmin/0000-0002-1047-8820	National Natural Science Foundation of China [81260302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (No. 81260302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzouzi H, 2007, J MED GENET, V44, P75, DOI 10.1136/jmg.2006.042572; Alhopuro P, 2005, J MED GENET, V42, P694, DOI 10.1136/jmg.2005.031260; Bogush TA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1421, DOI 10.1134/S0006297910120011; Bond GL, 2006, J MED GENET, V43, P950, DOI 10.1136/jmg.2006.043539; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.037952; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; Cao XM, 2012, DNA CELL BIOL, V31, P354, DOI 10.1089/dna.2011.1338; Chaar I, 2013, APPL IMMUNOHISTO M M, V21, P228, DOI 10.1097/PAI.0b013e31825f4e20; Chaar I, 2012, EUR J GASTROEN HEPAT, V24, P320, DOI 10.1097/MEG.0b013e32834bdf84; Chen YL, 2009, ANAL BIOANAL CHEM, V394, P1291, DOI 10.1007/s00216-008-2416-y; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang F, 2011, MED ONCOL, V28, P981, DOI 10.1007/s12032-010-9577-1; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin M, 2013, CHIN J DIG, V32, P703; Joshi AM, 2011, JPN J CLIN ONCOL, V41, P232, DOI 10.1093/jjco/hyq200; Khan SA, 2008, J SURG ONCOL, V97, P621, DOI 10.1002/jso.20996; Kury S, 2007, CANCER EPIDEM BIOMAR, V16, P1460, DOI 10.1158/1055-9965.EPI-07-0236; Le Marchand L, 2002, CANCER EPIDEM BIOMAR, V11, P1019; Levav-Cohen Y, 2005, GROWTH FACTORS, V23, P183, DOI 10.1080/08977190500196218; Lind H, 2006, INT J CANCER, V119, P718, DOI 10.1002/ijc.21872; Liu Jun-niao, 2008, Zhonghua Zhongliu Zazhi, V30, P335; MANTEL N, 1959, J NATL CANCER I, V22, P719; Menin C, 2006, J NATL CANCER I, V98, P285, DOI 10.1093/jnci/djj054; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; Ohmiya N, 2006, J CLIN ONCOL, V24, P4434, DOI 10.1200/JCO.2005.04.1459; Olivier Magali, 2004, IARC Sci Publ, P247; Petz LN, 2004, J STEROID BIOCHEM, V88, P113, DOI 10.1016/j.jsbmb.2003.11.008; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Ruijs MWG, 2007, EUR J HUM GENET, V15, P110, DOI 10.1038/sj.ejhg.5201715; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Sotamaa K, 2005, CLIN CANCER RES, V11, P6840, DOI 10.1158/1078-0432.CCR-05-1139; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sugano N, 2010, GENE CHROMOSOME CANC, V49, P620, DOI 10.1002/gcc.20774; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Talseth BA, 2007, INT J CANCER, V120, P563, DOI 10.1002/ijc.22339; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Tuna G, 2013, DNA CELL BIOL, V32, P400, DOI 10.1089/dna.2012.1933; Verma MK, 2011, J STEROID BIOCHEM, V127, P216, DOI 10.1016/j.jsbmb.2011.07.013; Wu H, 2011, CELL CYCLE, V10, P1912, DOI 10.4161/cc.10.12.15882; Zhang YX, 2012, MOL BIOL REP, V39, P9661, DOI 10.1007/s11033-012-1831-5; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	53	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76031	10.1371/journal.pone.0076031	http://dx.doi.org/10.1371/journal.pone.0076031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098760	gold, Green Submitted, Green Published			2022-12-27	WOS:000325423500130
J	Ryoo, HD; Li, J; Kang, MJ				Ryoo, Hyung Don; Li, Josepher; Kang, Min-Ji			Drosophila XBP1 Expression Reporter Marks Cells under Endoplasmic Reticulum Stress and with High Protein Secretory Load	PLOS ONE			English	Article							ACCESSORY-GLAND; ER STRESS; MESSENGER-RNAS; ACTIVATION; SIGNALS; MODEL; DECAY	Expression of genes in the endoplasmic reticulum (ER) beyond its protein folding capacity activates signaling pathways that are collectively referred to as the Unfolded Protein Response (UPR). A major branch of the UPR pathway is mediated by IRE1, an ER-tethered endonuclease. Upon ER stress-induced activation, IRE1 splices the mRNA of XBP1, thereby generating an active isoform of this transcription factor. During normal Drosophila development, tissues with high protein secretory load show signs of IRE1/XBP1 activity indicative of inherent ER stress associated with those cell types. Here, we report that the XBP1 promoter activity itself is enhanced in secretory tissues of Drosophila, and it can be induced by excessive ER stress. Specifically, we developed a Drosophila XBP1 transcription reporter by placing dsRed under the control of the XBP1 intergenic sequence. DsRed expression in these xbp1(p)>dsRed transgenic flies showed patterns similar to that of xbp1 transcript distribution. In healthy developing flies, the reporter expression was highest in salivary glands and the intestine. In the adult, the male reproductive organs showed high levels of dsRed. These tissues are known to have high protein secretory load. Consistently, the xbp1(p)>dsRed reporter was induced by excessive ER stress caused by mutant Rhodopsin-1 overexpression. These results suggest that secretory cells suffer from inherent ER stress, and the xbp1(p)>dsRed flies provide a useful tool in studying the function and homeostasis of those cells.	[Ryoo, Hyung Don; Li, Josepher; Kang, Min-Ji] New York Univ Sch Med, Dept Cell Biol, New York, NY USA; [Kang, Min-Ji] Univ Ulsan Coll Med, Dept Biomed Sci, Seoul, South Korea	New York University; University of Ulsan	Ryoo, HD (corresponding author), New York Univ Sch Med, Dept Cell Biol, New York, NY USA.	hyungdon.ryoo@nyumc.org; mjkang@amc.seoul.kr			National Institutes of Health (NIH) [R01 EY020866]; NATIONAL EYE INSTITUTE [R01EY020866] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (NIH) grant R01 EY020866. The web address for NIH is http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; CHOU TB, 1992, GENETICS, V131, P643; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Kang MJ, 2012, NAT CELL BIOL, V14, P409, DOI 10.1038/ncb2447; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kumita JR, 2012, FASEB J, V26, P192, DOI 10.1096/fj.11-185983; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lung O, 2001, J INSECT PHYSIOL, V47, P617, DOI 10.1016/S0022-1910(00)00151-7; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; Mueller JL, 2005, GENETICS, V171, P131, DOI 10.1534/genetics.105.043844; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sone M, 2013, CELL STRESS CHAPERON, V18, P307, DOI 10.1007/s12192-012-0383-x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001	33	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75774	10.1371/journal.pone.0075774	http://dx.doi.org/10.1371/journal.pone.0075774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098723	Green Published, Green Submitted, gold			2022-12-27	WOS:000325423500094
J	Wall, KM; Haddad, L; Vwalika, B; Khu, NH; Brill, I; Kilembe, W; Stephenson, R; Chomba, E; Vwalika, C; Tichacek, A; Allen, S				Wall, Kristin M.; Haddad, Lisa; Vwalika, Bellington; Khu, Naw Htee; Brill, Ilene; Kilembe, William; Stephenson, Rob; Chomba, Elwyn; Vwalika, Cheswa; Tichacek, Amanda; Allen, Susan			Unintended Pregnancy among HIV Positive Couples Receiving Integrated HIV Counseling, Testing, and Family Planning Services in Zambia	PLOS ONE			English	Article							DISCORDANT COUPLES; CONTRACEPTIVE USE; YOUNG-PEOPLE; WOMEN; INFECTION; PREVENTION; FERTILITY; BEHAVIORS; MEN	Objective: We describe rates of unintended pregnancy among HIV positive couples in Lusaka, Zambia. We also identify factors associated with unintended pregnancy among oral contraceptive pill (OCP) using couples in this cohort. Design: Data were analyzed from couples randomized in a factorial design to two family planning intervention videos. Methods: Rates of unintended pregnancy were stratified by contraceptive method used at time of pregnancy. Predictors of time to unintended pregnancy among OCP users were determined via multivariate Cox modeling. Results: The highest rates of unintended pregnancy were observed among couples requesting condoms only (26.4/100CY) or OCPs (20.7/100CY); these rates were not significantly different. OCP users accounted for 37% of the couple-years (CY) observed and 87% of unintended pregnancies. Rates of unintended pregnancy for injectable (0.7/100CY) and intrauterine device (1.6/100CY) users were significantly lower relative to condom only users. No pregnancies occurred among contraceptive implant users or after tubal ligation. Factors associated (p<0.05) with time to unintended pregnancy among OCP users in multivariate analysis included the man wanting more children, the woman being HIV negative versus having stage IV HIV disease, and the woman reporting: younger age, no previous OCP use, missed OCPs, or sex without a condom. Conclusions: Long-acting reversible contraceptive methods were effective in the context of integrated couples HIV prevention and contraceptive services. Injectable methods were also effective in this context. Given the high user failure rate of OCPs, family planning efforts should promote longer-acting methods among OCP users wishing to avoid pregnancy. Where other methods are not available or acceptable, OCP adherence counseling is needed, especially among younger and new OCP users.	[Wall, Kristin M.; Haddad, Lisa; Vwalika, Bellington; Khu, Naw Htee; Kilembe, William; Chomba, Elwyn; Vwalika, Cheswa; Tichacek, Amanda; Allen, Susan] Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA; [Wall, Kristin M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Haddad, Lisa] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA; [Vwalika, Bellington] Univ Zambia, Sch Med, Dept Gynecol & Obstet, Lusaka, Zambia; [Brill, Ilene] Univ Alabama Birmingham, Dept Epidemiol, Ryals Sch Publ Hlth, Birmingham, AL USA; [Stephenson, Rob] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Chomba, Elwyn] Minist Community Dev Mother & Child Hlth, Lusaka, Zambia	Emory University; Emory University; Rollins School Public Health; Emory University; University of Zambia; University of Alabama System; University of Alabama Birmingham; Emory University; Rollins School Public Health	Wall, KM (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA.	kmwall@emory.edu	D'Albuquerque, Luiz A Carneiro/I-4011-2012	D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168; Haddad, Lisa/0000-0002-7631-6760	National Institutes of Child Health and Development [NICHD RO1 HD40125]; National Institute of Mental Health [NIMH R01 66767]; AIDS International Training and Research Program Fogarty International Center [D43 TW001042]; Emory Center for AIDS Research [P30 AI050409]; National Institute of Allergy and Infectious Diseases [NIAID R01 AI51231]; International AIDS Vaccine Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040125] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051231, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066767] Funding Source: NIH RePORTER	National Institutes of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AIDS International Training and Research Program Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Emory Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the National Institutes of Child Health and Development (NICHD RO1 HD40125); National Institute of Mental Health (NIMH R01 66767); the AIDS International Training and Research Program Fogarty International Center (D43 TW001042); the Emory Center for AIDS Research (P30 AI050409); National Institute of Allergy and Infectious Diseases (NIAID R01 AI51231); and the International AIDS Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinma E. D., 2011, Asian Pacific Journal of Tropical Disease, V1, P71; Agha S, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-20; Allen S, 2005, JAIDS-J ACQ IMM DEF, V38, pS7, DOI 10.1097/01.qai.0000167024.10654.a6; ALLEN S, 1993, AM J PUBLIC HEALTH, V83, P705, DOI 10.2105/AJPH.83.5.705; Allen S, 2007, J WOMENS HEALTH, V16, P1017, DOI 10.1089/jwh.2006.0151; Bongaarts J, 2013, POPUL DEV REV, V38, P153, DOI 10.1111/j.1728-4457.2013.00557.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; Delvaux T, 2007, REPROD HEALTH MATTER, V15, P46, DOI 10.1016/S0968-8080(07)29031-7; Demographic and Health Surveys, 2008, STATCOMPILER 2008; Dube ALN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051861; Grabbe K, 2009, J WOMENS HEALTH, V18, P1449, DOI 10.1089/jwh.2008.1160; Gribble J, 2010, SUPPLY CHAIN GETTING; Hageman KM, 2009, PSYCHOL RES BEHAV MA, V2, P47; Hobcraft J, 2003, POPULATION POVERTY A; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Imbuki Kennedy, 2010, Afr J Reprod Health, V14, P98; Janowitz B, 2009, INT C FAM PLANN RES; Jones D, 2010, P I CIVIL ENG-GEOTEC, V163, P1, DOI 10.1680/geng.2010.163.1.1; Kassa N, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-1; Khu NH, 2013, CONTRACEPTION, V88, P74, DOI 10.1016/j.contraception.2012.10.004; Kikuchi K, 2011, BIOSCI TRENDS, V5, P255, DOI 10.5582/bst.2011.v5.6.255; KING R, 1995, AIDS, V9, pS45; Nalwadda G, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-220; Nalwadda G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-530; Ngure K, 2012, AIDS, V26, P513, DOI 10.1097/QAD.0b013e32834f981c; Nte AR, 2009, NIGER J CLIN PRACT, V12, P306; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Pinter B, 2002, EUR J CONTRACEP REPR, V7, P178, DOI 10.1080/713604343; Policar M., 2011, CONTRACEPTIVE TECHNO; Population Council, 2010, JAD; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; Rowe PJ, 1997, CONTRACEPTION, V56, P341; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Stephenson R, 2008, AIDS CARE, V20, P395, DOI 10.1080/09540120701593497; Stephenson R, 2008, AIDS CARE, V20, P150, DOI 10.1080/09540120701534681; Stephenson R, 2011, J WOMENS HEALTH, V20, P567, DOI 10.1089/jwh.2010.2113; Stephenson R, 2010, STUD FAMILY PLANN, V41, P217, DOI 10.1111/j.1728-4465.2010.00245.x; Stuart GS, 2009, CONTRACEPTION, V80, P108, DOI 10.1016/j.contraception.2009.02.009; TRUSSELL J, 1995, ARCH DERMATOL, V131, P1064, DOI 10.1001/archderm.131.9.1064; Trussell J., 2018, CONTRACEPTIVE TECHNO, V21st, P26; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; UNAIDS/WHO, 2009, EP FACT SHEET HIV AI; Utoo B T, 2010, Niger J Med, V19, P214; Wall KM, 2012, J ACQ IMMUN DEF SYND, V63, P86; Wilcher R, 2008, SEX TRANSM INFECT, V84, pII54, DOI 10.1136/sti.2008.030098; Yeatman S, 2009, STUD FAMILY PLANN, V40, P261, DOI 10.1111/j.1728-4465.2009.00210.x; Zuehlke Eric, 2009, REDUCING UNINTENDED	50	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75353	10.1371/journal.pone.0075353	http://dx.doi.org/10.1371/journal.pone.0075353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098692	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500063
J	Li, YP; Aparicio, C				Li, Yuping; Aparicio, Conrado			Discerning the Subfibrillar Structure of Mineralized Collagen Fibrils: A Model for the Ultrastructure of Bone	PLOS ONE			English	Article							AMORPHOUS CALCIUM-PHOSPHATE; 3 DIMENSIONS; CRYSTALS; ZEBRAFISH; COMPONENT; CELL	Biomineralization templated by organic molecules to produce inorganic-organic nanocomposites is a fascinating example of nature using bottom-up strategies at nanoscale to accomplish highly ordered multifunctional materials. One such nanocomposite is bone, composed primarily of hydroxyapatite (HA) nanocrystals that are embedded within collagen fibrils with their c-axes arranged roughly parallel to the long axis of the fibrils. Here we discern the ultrastructure of biomimetic mineralized collagen fibrils (MCFs) as consisting of bundles of subfibrils with approximately 10 nm diameter; each one with an organic-inorganic core-shell structure. Through an amorphous calcium phosphate precursor phase the HA nanocrystals were specifically grown along the longitudinal direction of the collagen microfibrils and encapsulated them within the crystal lattice. They intercalated throughout the collagen fibrils such that the mineral phase surrounded the surface of collagen microfibrils forming an interdigitated network. It appears that this arrangement of collagen microfibrils in collagen fibrils is responsible for the observed ultrastructure. Such a subfibrillar nanostructure in MCFs was identified in both synthetic and natural bone, suggesting this is the basic building block of collagen-based hard tissues. Insights into the ultrastructure of mineralized collagen fibrils have the potential to advance our understanding on the biomineralization principles and the relationship between bone's structure and mechanical properties, including fracture toughness mechanisms. We anticipate that these principles from biological systems can be applied to the rational design of new nanocomposites with improved performance.	[Li, Yuping; Aparicio, Conrado] Univ Minnesota, Sch Dent, Dept Restorat Sci, MDRCBB, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Aparicio, C (corresponding author), Univ Minnesota, Sch Dent, Dept Restorat Sci, MDRCBB, Minneapolis, MN 55455 USA.	apari003@umn.edu	Li, Yuping/H-5259-2013; Aparicio, Conrado/J-9903-2012	Li, Yuping/0000-0002-2506-1155; Aparicio, Conrado/0000-0003-2969-6067	3M Foundation through a 3M Non-tenured Faculty Award; NSF through the MRSEC program	3M Foundation through a 3M Non-tenured Faculty Award(3M); NSF through the MRSEC program(National Science Foundation (NSF))	The work was supported by 3M Foundation through a 3M Non-tenured Faculty Award (CA). Parts of this work were carried out in the University of Minnesota I.T. Characterization Facility, which receives partial support from NSF through the MRSEC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buehler MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295102; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Eppell SJ, 2001, J ORTHOPAED RES, V19, P1027, DOI 10.1016/S0736-0266(01)00034-1; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; FRATZL P, 1992, J BONE MINER RES, V7, P329; Fratzl P, 1996, J CLIN INVEST, V97, P396, DOI 10.1172/JCI118428; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Goh MC, 1997, PHYSICA A, V239, P95, DOI 10.1016/S0378-4371(96)00472-4; GOWER LB, 2010, ACTA BIOMATER, V6, P3676, DOI DOI 10.1016/J.ACTBI0.2010.03.036.PUBMED:20359554; Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; LANDIS WJ, 1991, J STRUCT BIOL, V107, P116, DOI 10.1016/1047-8477(91)90015-O; LEES S, 1986, CALCIFIED TISSUE INT, V39, P291, DOI 10.1007/BF02555221; Li YP, 2012, BIOMACROMOLECULES, V13, P49, DOI 10.1021/bm201070g; Liu Y, 2011, ADV MATER, V23, P975, DOI 10.1002/adma.201003882; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107; NIMNI ME, 1988, MOL STRUCTURES FUNCT, P1; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; PIEZ KA, 1981, BIOSCIENCE REP, V1, P801, DOI 10.1007/BF01114803; ROBINSON RA, 1952, J BONE JOINT SURG AM, V34-A, P389, DOI 10.2106/00004623-195234020-00013; Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271	31	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76782	10.1371/journal.pone.0076782	http://dx.doi.org/10.1371/journal.pone.0076782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086763	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200140
J	Bendjilali, N; Kim, H; Weinsheimer, S; Guo, DE; Kwok, PY; Zaroff, JG; Sidney, S; Lawton, MT; McCulloch, CE; Koeleman, BPC; Klijn, CJM; Young, WL; Pawlikowska, L				Bendjilali, Nasrine; Kim, Helen; Weinsheimer, Shantel; Guo, Diana E.; Kwok, Pui-Yan; Zaroff, Jonathan G.; Sidney, Stephen; Lawton, Michael T.; McCulloch, Charles E.; Koeleman, Bobby P. C.; Klijn, Catharina J. M.; Young, William L.; Pawlikowska, Ludmila			A Genome-Wide Investigation of Copy Number Variation in Patients with Sporadic Brain Arteriovenous Malformation	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; POLYMORPHISMS; RISK; GENE; ASSOCIATION; SUSCEPTIBILITY; MUTATIONS; IMPACT; NUCLEOTIDE; EXPRESSION	Background: Brain arteriovenous malformations (BAVM) are clusters of abnormal blood vessels, with shunting of blood from the arterial to venous circulation and a high risk of rupture and intracranial hemorrhage. Most BAVMs are sporadic, but also occur in patients with Hereditary Hemorrhagic Telangiectasia, a Mendelian disorder caused by mutations in genes in the transforming growth factor beta (TGF beta) signaling pathway. Methods: To investigate whether copy number variations (CNVs) contribute to risk of sporadic BAVM, we performed a genome-wide association study in 371 sporadic BAVM cases and 563 healthy controls, all Caucasian. Cases and controls were genotyped using the Affymetrix 6.0 array. CNVs were called using the PennCNV and Birdsuite algorithms and analyzed via segment-based and gene-based approaches. Common and rare CNVs were evaluated for association with BAVM. Results: A CNV region on 1p36.13, containing the neuroblastoma breakpoint family, member 1 gene (NBPF1), was significantly enriched with duplications in BAVM cases compared to controls (P = 2.2x10(-9)); NBPF1 was also significantly associated with BAVM in gene-based analysis using both PennCNV and Birdsuite. We experimentally validated the 1p36.13 duplication; however, the association did not replicate in an independent cohort of 184 sporadic BAVM cases and 182 controls (OR = 0.81, P = 0.8). Rare CNV analysis did not identify genes significantly associated with BAVM. Conclusion: We did not identify common CNVs associated with sporadic BAVM that replicated in an independent cohort. Replication in larger cohorts is required to elucidate the possible role of common or rare CNVs in BAVM pathogenesis.	[Bendjilali, Nasrine; Kim, Helen; Weinsheimer, Shantel; Guo, Diana E.; Young, William L.; Pawlikowska, Ludmila] Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Kim, Helen; Kwok, Pui-Yan; Pawlikowska, Ludmila] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Kim, Helen; McCulloch, Charles E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Zaroff, Jonathan G.; Sidney, Stephen] Kaiser Northern Calif Div Res, San Francisco, CA USA; [Lawton, Michael T.; Young, William L.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Koeleman, Bobby P. C.] Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands; [Klijn, Catharina J. M.] Univ Med Ctr, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Young, William L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco	Pawlikowska, L (corresponding author), Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	pawlikowskal@anesthesia.ucsf.edu	Klijn, C.J.M./E-1700-2016; s, s/GYR-2278-2022; s, s/HIK-1178-2022; Kwok, Pui-Yan/F-7725-2014; s, s/HHD-0404-2022	Klijn, C.J.M./0000-0002-8495-4578; Kwok, Pui-Yan/0000-0002-5087-3059; Weinsheimer, Shantel/0000-0001-7486-9110; Bendjilali, Nasrine/0000-0003-1000-0605; Kim, Helen/0000-0002-1937-354X	National Institutes of Health (NIH) [P01 NS044155, R01 NS034949, K23 NS058357]; private Dutch foundation; NIH [P50 NS2372, U19 AI063603]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044155, K23NS058357, R01NS034949] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); private Dutch foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants: P01 NS044155 (WLY), R01 NS034949 (WLY), and K23 NS058357 (HK). Additional support was provided by "Running for Nona,'' a private Dutch foundation (CJMK). Control cohorts were supported by NIH grants P50 NS2372 (to E. Mignot) and U19 AI063603 (to D. Salomon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrol AS, 2006, STROKE, V37, P231, DOI 10.1161/01.STR.0000195133.98378.4b; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P463, DOI 10.1002/ajmg.a.31101; Blauw Hylke M, 2008, Lancet Neurol, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Bremer A, 2011, AM J MED GENET B, V156B, P115, DOI 10.1002/ajmg.b.31142; Cox D.G., 2012, J BIOTECHNOL BIOMATE, V1, P7, DOI [10.4172/2155-952x.1000119, DOI 10.4172/2155-952X.1000119]; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Eckel-Passow JE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-220; Flechner SM, 2007, TRANSPLANTATION, V83, P883, DOI 10.1097/01.tp.0000258586.52777.4c; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Hao Q, 2010, TRANSL STROKE RES, V1, P197, DOI 10.1007/s12975-010-0020-x; Inoue S, 2007, STROKE, V38, P1368, DOI 10.1161/01.STR.0000260094.03782.59; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kim H, 2011, ACTA NEUROCHIR SUPPL, V111, P83, DOI 10.1007/978-3-7091-0693-8_14; Kim H, 2009, CEREBROVASC DIS, V27, P176, DOI 10.1159/000185609; Kim H, 2009, STROKE, V40, pS95, DOI 10.1161/STROKEAHA.108.533216; Kim J, 2012, J APPL TOXICOL, V32, P342, DOI 10.1002/jat.1677; Koike A, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-29; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lesca G, 2008, EUR J HUM GENET, V16, P742, DOI 10.1038/ejhg.2008.3; Letteboer TGW, 2005, HUM GENET, V116, P8, DOI 10.1007/s00439-004-1196-5; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32; Mikhak B, 2011, CEREBROVASC DIS, V31, P338, DOI 10.1159/000322601; Murphy PA, 2008, P NATL ACAD SCI USA, V105, P10901, DOI 10.1073/pnas.0802743105; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Oikawa M, 2010, EUR J MED GENET, V53, P244, DOI 10.1016/j.ejmg.2010.06.007; Pawlikowska L, 2005, STROKE, V36, P2278, DOI 10.1161/01.STR.0000182253.91167.fa; Pawlikowska L, 2004, STROKE, V35, P2294, DOI 10.1161/01.STR.0000141932.44613.b1; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SABA HI, 1994, NEW ENGL J MED, V330, P1789, DOI 10.1056/NEJM199406233302504; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sturiale CL, 2013, BRAIN, V136, P665, DOI 10.1093/brain/aws180; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Tsuang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014456; van Beijnum J, 2007, J NEUROL NEUROSUR PS, V78, P1213, DOI 10.1136/jnnp.2006.112227; Vandepoele K, 2010, EXP CELL RES, V316, P1225, DOI 10.1016/j.yexcr.2010.01.019; Wain LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008175; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511; ZhuGe QC, 2009, BRAIN, V132, P3231, DOI 10.1093/brain/awp246	56	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e71434	10.1371/journal.pone.0071434	http://dx.doi.org/10.1371/journal.pone.0071434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098321	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600001
J	Lau, DH; Middeldorp, ME; Brooks, AG; Ganesan, AN; Roberts-Thomson, KC; Stiles, MK; Leong, DP; Abed, HS; Lim, HS; Wong, CX; Willoughby, SR; Young, GD; Kalman, JM; Abhayaratna, WP; Sanders, P				Lau, Dennis H.; Middeldorp, Melissa E.; Brooks, Anthony G.; Ganesan, Anand N.; Roberts-Thomson, Kurt C.; Stiles, Martin K.; Leong, Darryl P.; Abed, Hany S.; Lim, Han S.; Wong, Christopher X.; Willoughby, Scott R.; Young, Glenn D.; Kalman, Jonathan M.; Abhayaratna, Walter P.; Sanders, Prashanthan			Aortic Stiffness in Lone Atrial Fibrillation: A Novel Risk Factor for Arrhythmia Recurrence	PLOS ONE			English	Article							ARTERY FUNCTION EVALUATION; BLOOD-PRESSURE; EUROPEAN-SOCIETY; FOLLOW-UP; PREVENTION; IMPACT; HEART; RECOMMENDATIONS; HEMODYNAMICS; ASSOCIATION	Background: Recent community-based research has linked aortic stiffness to the development of atrial fibrillation. We posit that aortic stiffness contributes to adverse atrial remodeling leading to the persistence of atrial fibrillation following catheter ablation in lone atrial fibrillation patients, despite the absence of apparent structural heart disease. Here, we aim to evaluate aortic stiffness in lone atrial fibrillation patients and determine its association with arrhythmia recurrence following radio-frequency catheter ablation. Methods: We studied 68 consecutive lone atrial fibrillation patients who underwent catheter ablation procedure for atrial fibrillation and 50 healthy age-and sex-matched community controls. We performed radial artery applanation tonometry to obtain central measures of aortic stiffness: pulse pressure, augmentation pressure and augmentation index. Following ablation, arrhythmia recurrence was monitored at months 3, 6, 9, 12 and 6 monthly thereafter. Results: Compared to healthy controls, lone atrial fibrillation patients had significantly elevated peripheral pulse pressure, central pulse pressure, augmentation pressure and larger left atrial dimensions (all P<0.05). During a mean follow-up of 2.9 +/- 1.4 years, 38 of the 68 lone atrial fibrillation patients had atrial fibrillation recurrence after initial catheter ablation procedure. Neither blood pressure nor aortic stiffness indices differed between patients with and without atrial fibrillation recurrence. However, patients with highest levels (>= 75th percentile) of peripheral pulse pressure, central pulse pressure and augmentation pressure had higher atrial fibrillation recurrence rates (all P<0.05). Only central aortic stiffness indices were associated with lower survival free from atrial fibrillation using Kaplan-Meier analysis. Conclusion: Aortic stiffness is an important risk factor in patients with lone atrial fibrillation and contributes to higher atrial fibrillation recurrence following catheter ablation procedure.	[Lau, Dennis H.; Middeldorp, Melissa E.; Brooks, Anthony G.; Ganesan, Anand N.; Roberts-Thomson, Kurt C.; Stiles, Martin K.; Leong, Darryl P.; Abed, Hany S.; Lim, Han S.; Wong, Christopher X.; Willoughby, Scott R.; Young, Glenn D.; Sanders, Prashanthan] Univ Adelaide, Ctr Heart Rhythm Disorders, Adelaide, SA, Australia; [Lau, Dennis H.; Middeldorp, Melissa E.; Brooks, Anthony G.; Ganesan, Anand N.; Roberts-Thomson, Kurt C.; Stiles, Martin K.; Leong, Darryl P.; Abed, Hany S.; Lim, Han S.; Wong, Christopher X.; Willoughby, Scott R.; Young, Glenn D.; Sanders, Prashanthan] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Kalman, Jonathan M.] Royal Melbourne Hosp, Dept Cardiol, Melbourne, Vic, Australia; [Kalman, Jonathan M.] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Abhayaratna, Walter P.] Canberra Hosp, Acad Unit Internal Med, Canberra, ACT, Australia	University of Adelaide; Royal Adelaide Hospital; Royal Melbourne Hospital; University of Melbourne; Australian National University; Canberra Hospital	Sanders, P (corresponding author), Univ Adelaide, Ctr Heart Rhythm Disorders, Adelaide, SA, Australia.	prash.sanders@adelaide.edu.au	Lau, Dennis H/G-6234-2013; Ganesan, Anand/AAG-9125-2021; Ganesan, Anand N/A-4902-2019; Middeldorp, Melissa/C-6414-2019; Sanders, Prashanthan/D-7641-2013; Wong, Christopher X/A-3227-2011	Lau, Dennis H/0000-0001-7753-1318; Ganesan, Anand/0000-0002-2734-3025; Ganesan, Anand N/0000-0002-2734-3025; Middeldorp, Melissa/0000-0002-4106-9771; Sanders, Prashanthan/0000-0003-3803-8429; Abhayaratna, Walter/0000-0002-4908-0641; Wong, Christopher/0000-0002-1913-6675	National Health and Medical Research Council of Australia (NHMRC); Heart Foundation of Australia (HFA); CVL from Pfizer Australia; University of Adelaide; NHMRC; Rhodes scholarship; Tom Simpson Trust Fund, HFA	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation of Australia (HFA); CVL from Pfizer Australia(PfizerPfizer Australia); University of Adelaide; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Rhodes scholarship; Tom Simpson Trust Fund, HFA	Drs. Lau and Leong are supported by a Postdoctoral Fellowship from the National Health and Medical Research Council of Australia (NHMRC). Drs. Brooks, Roberts-Thomson and Sanders are supported by the Heart Foundation of Australia (HFA). Dr. Ganesan is supported by a CVL grant from Pfizer Australia. Dr. Abed is supported by an Australian Postgraduate Award and an Earl Bakken Fellowship from the University of Adelaide. Dr. Lim is supported by a Postgraduate Scholarship from NHMRC. Dr. Wong is supported by the Rhodes scholarship. Dr. Willoughby is supported by the NHMRC. This work is supported by an equipment grant from Tom Simpson Trust Fund, HFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Belluzzi F, 2009, J AM COLL CARDIOL, V53, P24, DOI 10.1016/j.jacc.2008.08.071; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Celik T, 2009, AM J HYPERTENS, V22, P1270, DOI 10.1038/ajh.2009.157; Chen CH, 1997, CIRCULATION, V95, P1827; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Conen D, 2009, CIRCULATION, V119, P2146, DOI 10.1161/CIRCULATIONAHA.108.830042; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gedikli O, 2010, CLIN EXP HYPERTENS, V32, P84, DOI 10.3109/10641960902993103; Jais P, 2000, J CARDIOVASC ELECTR, V11, P623, DOI 10.1111/j.1540-8167.2000.tb00023.x; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lau DH, 2010, HEART RHYTHM, V7, P1282, DOI 10.1016/j.hrthm.2010.05.010; Lau DH, 2010, HEART RHYTHM, V7, P396, DOI 10.1016/j.hrthm.2009.11.031; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mahnkopf C, 2010, HEART RHYTHM, V7, P1475, DOI 10.1016/j.hrthm.2010.06.030; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; McEniery CM, 2010, HYPERTENSION, V56, P591, DOI 10.1161/HYPERTENSIONAHA.110.156950; McEniery CM, 2010, HYPERTENSION, V56, P36, DOI 10.1161/HYPERTENSIONAHA.110.150896; Mitchell GF, 2007, JAMA-J AM MED ASSOC, V297, P709, DOI 10.1001/jama.297.7.709; Sakuragi S, 2010, INT J CARDIOL, V138, P112, DOI 10.1016/j.ijcard.2009.04.027; Schnabel R, 2008, HYPERTENSION, V51, P1651, DOI 10.1161/HYPERTENSIONAHA.107.105668; Schneider MP, 2010, J AM COLL CARDIOL, V55, P2299, DOI 10.1016/j.jacc.2010.01.043; Stiles MK, 2009, J AM COLL CARDIOL, V53, P1182, DOI 10.1016/j.jacc.2008.11.054; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Williams B, 2009, J AM COLL CARDIOL, V54, P705, DOI [10.1016/j.jacc.2009.02.088, 10.1016/j.jacc.2009.06.043]; Wong CX, 2010, HEART RHYTHM, V7, P1192, DOI 10.1016/j.hrthm.2010.05.037; Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173	32	39	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76776	10.1371/journal.pone.0076776	http://dx.doi.org/10.1371/journal.pone.0076776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098560	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600077
J	Mitchell, RJ; Wilson, WG; Holmquist, KG; Karron, JD				Mitchell, Randall J.; Wilson, William G.; Holmquist, Karsten G.; Karron, Jeffrey D.			Influence of Pollen Transport Dynamics on Sire Profiles and Multiple Paternity in Flowering Plants	PLOS ONE			English	Article							FLORAL DISPLAY SIZE; REPRODUCTIVE SUCCESS; GENE FLOW; BUMBLEBEES; POPULATIONS; EVOLUTION; PATTERNS; FRUITS; PERSPECTIVES; POLLINATORS	In many flowering plants individual fruits contain a mixture of half- and full-siblings, reflecting pollination by several fathers. To better understand the mechanisms generating multiple paternity within fruits we present a theoretical framework linking pollen carryover with patterns of pollinator movement. This 'sire profile' model predicts that species with more extensive pollen carryover will have a greater number of mates. It also predicts that flowers on large displays, which are often probed consecutively during a single pollinator visitation sequence, will have a lower effective number of mates. We compared these predictions with observed values for bumble bee-pollinated Mimulus ringens, which has restricted carryover, and hummingbird-pollinated Ipomopsis aggregata, which has extensive carryover. The model correctly predicted that the effective number of mates is much higher in the species with more extensive carryover. This work extends our knowledge of plant mating systems by highlighting mechanisms influencing the genetic composition of sibships.	[Mitchell, Randall J.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Wilson, William G.] Duke Univ, Dept Biol, Durham, NC USA; [Holmquist, Karsten G.; Karron, Jeffrey D.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	University System of Ohio; University of Akron; Duke University; University of Wisconsin System; University of Wisconsin Milwaukee	Mitchell, RJ (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	rjm2@uakron.edu	Mitchell, Randall J/G-6380-2010	Mitchell, Randall J/0000-0001-7961-3560	NSF [DEB 9816712, DEB 9903308]; University of Akron; Glenny Endowment; Department of Biology	NSF(National Science Foundation (NSF)); University of Akron; Glenny Endowment; Department of Biology	This research was supported by NSF Grants DEB 9816712 to JDK, and DEB 9903308 to RJM. RJM also received support from the University of Akron's Faculty Summer Research Grant Faculty Improvement Leave, the Glenny Endowment, and the Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Bernasconi G, 2004, PERSPECT PLANT ECOL, V6, P149, DOI 10.1078/1433-8319-00075; Bernasconi G, 2004, SCIENCE, V303, P971, DOI 10.1126/science.1092180; Brunet J, 2006, EVOLUTION, V60, P234, DOI 10.1111/j.0014-3820.2006.tb01102.x; Brunet J, 2009, MOL ECOL, V18, P3745, DOI 10.1111/j.1365-294X.2009.04304.x; Campbell DR, 1998, AM J BOT, V85, P1022, DOI 10.2307/2446369; CAMPBELL DR, 1991, EVOLUTION, V45, P1965, DOI 10.1111/j.1558-5646.1991.tb02702.x; Castellanos MC, 2003, EVOLUTION, V57, P2742, DOI 10.1111/j.0014-3820.2003.tb01516.x; Cresswell JE, 2002, OIKOS, V98, P375, DOI 10.1034/j.1600-0706.2002.980302.x; CRESSWELL JE, 1990, OECOLOGIA, V82, P450, DOI 10.1007/BF00319785; DUDASH MR, 1991, AM J BOT, V78, P1746, DOI 10.2307/2444854; ELLSTRAND NC, 1986, EVOLUTION, V40, P837, DOI 10.1111/j.1558-5646.1986.tb00543.x; Falconer D. S., 1989, Introduction to quantitative genetics.; Flanagan RJ, 2009, AM J BOT, V96, P809, DOI 10.3732/ajb.0800317; Harder LD, 2008, INT J PLANT SCI, V169, P59, DOI 10.1086/523364; Harder LD, 1997, ACTA HORTIC, P83, DOI 10.17660/ActaHortic.1997.437.7; Harder LD, 1996, FLORAL BIOL STUDIES, P140, DOI DOI 10.1007/978-1-4613-1165-2_6; Holmquist KG, 2012, PLANT SPEC BIOL, V27, P77, DOI 10.1111/j.1442-1984.2011.00329.x; Holmquist KG, 2005, EFFECT FLORAL DISPLA; Karron JD, 2006, AM J BOT, V93, P1306, DOI 10.3732/ajb.93.9.1306; Karron JD, 2012, ANN BOT-LONDON, V109, P493, DOI 10.1093/aob/mcr319; Karron JD, 2012, ANN BOT-LONDON, V109, P563, DOI 10.1093/aob/mcr193; Karron JD, 2009, ANN BOT-LONDON, V103, P1379, DOI 10.1093/aob/mcp030; Krauss SL, 1999, MOL ECOL, V8, P217, DOI 10.1046/j.1365-294X.1999.00552.x; Llaurens V, 2008, MOL ECOL, V17, P1577, DOI 10.1111/j.1365-294X.2007.03683.x; MARSHALL DL, 1991, AM J BOT, V78, P1404, DOI 10.2307/2445279; MARSHALL DL, 1991, ANNU REV ECOL SYST, V22, P37, DOI 10.1146/annurev.es.22.110191.000345; Mayfield MM, 2001, ANN BOT-LONDON, V88, P591, DOI 10.1006/anbo.2001.1500; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1403, DOI 10.1093/aob/mcp062; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1355, DOI 10.1093/aob/mcp122; Mitchell RJ, 2005, AM J BOT, V92, P885, DOI 10.3732/ajb.92.5.885; Mitchell RJ, 2004, FUNCT ECOL, V18, P116, DOI 10.1111/j.1365-2435.2004.00812.x; MORRIS WF, 1994, OIKOS, V71, P431, DOI 10.2307/3545831; Paschke M, 2002, AM J BOT, V89, P1250, DOI 10.3732/ajb.89.8.1250; RITLAND K, 1989, EVOLUTION, V43, P848, DOI [10.2307/2409312, 10.1111/j.1558-5646.1989.tb05182.x]; ROBERTSON AW, 1992, BIOL J LINN SOC, V46, P333, DOI 10.1111/j.1095-8312.1992.tb00868.x; Smouse PE, 2005, HEREDITY, V94, P640, DOI 10.1038/sj.hdy.6800674; Spira TP, 1996, OECOLOGIA, V105, P230, DOI 10.1007/BF00328551; Teixeira S, 2007, MOL ECOL, V16, P4370, DOI 10.1111/j.1365-294X.2007.03493.x; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Waser NM, 1988, FUNCT ECOL, V2, P41, DOI 10.2307/2389458	41	22	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76312	10.1371/journal.pone.0076312	http://dx.doi.org/10.1371/journal.pone.0076312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098473	gold, Green Published			2022-12-27	WOS:000325483600039
J	Odinot, G; Memon, A; La Rooy, D; Millen, A				Odinot, Geralda; Memon, Amina; La Rooy, David; Millen, Ailsa			Are Two Interviews Better Than One? Eyewitness Memory across Repeated Cognitive Interviews	PLOS ONE			English	Article							HYPERMNESIA; CHILDRENS; RECALL; REMINISCENCE; CONSISTENCY; ACCURACY; SUGGESTIBILITY; CONFIDENCE; EVENT	Eyewitnesses to a filmed event were interviewed twice using a Cognitive Interview to examine the effects of variations in delay between the repeated interviews (immediately & 2 days; immediately & 7 days; 7 & 9 days) and the identity of the interviewers (same or different across the two repeated interviews). Hypermnesia (an increase in total amount of information recalled in the repeated interview) occurred without any decrease in the overall accuracy. Reminiscence (the recall of new information in the repeated interview) was also found in all conditions but was least apparent in the longest delay condition, and came with little cost to the overall accuracy of information gathered. The number of errors, increased across the interviews, but the relative accuracy of participants' responses was unaffected. However, when accuracy was calculated based on all unique details provided across both interviews and compared to the accuracy of recall in just the first interview it was found to be slightly lower. The identity of the interviewer (whether the same or different across interviews) had no effects on the number of correct details. There was an increase in recall of new details with little cost to the overall accuracy of information gathered. Importantly, these results suggest that witnesses are unlikely to report everything they remember during a single Cognitive Interview, however exhaustive, and a second opportunity to recall information about the events in question may provide investigators with additional information.	[Odinot, Geralda] Minist Secur & Justice, Res & Documentat Ctr, The Hague, Netherlands; [Memon, Amina] Univ London, London, England; [La Rooy, David] Univ Abertey Dundee, Sch Psychol, Dundee, Scotland; [Millen, Ailsa] Univ Portsmouth, Sch Psychol, Portsmouth, Hants, England	University of London; University of Abertay Dundee; University of Portsmouth	Odinot, G (corresponding author), Minist Secur & Justice, Res & Documentat Ctr, The Hague, Netherlands.	Geralda.odinot@gmail.com			University of Abertey Dundee, Dundee, United Kingdom	University of Abertey Dundee, Dundee, United Kingdom	The publication fee is funded by the University of Abertey Dundee, Dundee, United Kingdom. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjork R. A., 1988, PRACTICAL ASPECTS ME, V1, P396; Bjorklund DF, 2000, APPL COGNITIVE PSYCH, V14, P421, DOI 10.1002/1099-0720(200009)14:5<421::AID-ACP659>3.0.CO;2-4; Bluck S, 1999, PSYCHOL AGING, V14, P671, DOI 10.1037/0882-7974.14.4.671; Brewer N, 1999, APPL COGNITIVE PSYCH, V13, P297, DOI 10.1002/(SICI)1099-0720(199908)13:4<297::AID-ACP578>3.3.CO;2-J; Brock P, 1999, PSYCHOL CRIME LAW, V5, P29, DOI 10.1080/10683169908414992; CECI SJ, 1994, CONSCIOUS COGN, V3, P388, DOI 10.1006/ccog.1994.1022; Chan JC, 2009, PSYCHOL SCI, V20, P66, DOI 10.1111/j.1467-9280.2008.02245.x; Crighton, 2010, FORENSIC PSYCHOL, P195; Davis D., 2007, HDB EYEWITNESS PSYCH, V1, P195; DUNNING D, 1992, APPL COGNITIVE PSYCH, V6, P643, DOI 10.1002/acp.2350060707; Ebbinghaus H., 1964, MEMORY CONTRIBUTION; Erdelyi Matthew H., 1996, RECOVERY UNCONSCIOUS; *EX SCOTT, 2007, REC EV VIS REC JOINT, P45237; Fisher R.P., 2009, HDB PSYCHOL INVESTIG, P121, DOI DOI 10.1002/9780470747599.CH8; Fisher RP, 1995, PSYCHOLOGY, LAW, AND CRIMINAL JUSTICE, P21; Fisher RP, 1995, PSYCHOL PUBLIC POL L, V1, P732, DOI 10.1037/1076-8971.1.4.732; Fisher RP, 1992, MEMORY ENHANCING TEC; GABBERT F, 2010, ANN M EUR ASS PSYCH, P45237; Gabbert F, 2012, APPL COGNITIVE PSYCH, V26, P568, DOI 10.1002/acp.2828; Gabbert F, 2009, LAW HUMAN BEHAV, V33, P298, DOI 10.1007/s10979-008-9146-8; Gilbert JAE, 2006, APPL COGNITIVE PSYCH, V20, P723, DOI 10.1002/acp.1232; Hershkowitz I, 2007, APPL COGNITIVE PSYCH, V21, P1131, DOI 10.1002/acp.1319; La Rooy D, 2005, J EXP CHILD PSYCHOL, V90, P235, DOI 10.1016/j.jecp.2004.11.002; La Rooy D, 2010, PSYCHOL PUBLIC POL L, V16, P373, DOI 10.1037/a0019909; LAROOY D, 2008, CHILD SEXUAL ABUSE R, P327; MCCAULEY MR, 1995, J APPL PSYCHOL, V80, P510, DOI 10.1037/0021-9010.80.4.510; McNally Richard J., 2003, REMEMBERING TRAUMA; Memon A, 1997, BRIT J PSYCHOL, V88, P179, DOI 10.1111/j.2044-8295.1997.tb02629.x; Memon A, 2006, HANDBOOK OF COMMUNICATION SKILLS, THIRD EDITION, P531; Memon A, 2010, PSYCHOL PUBLIC POL L, V16, P340, DOI 10.1037/a0020518; Memon A, 2010, LAW HUMAN BEHAV, V34, P105, DOI 10.1007/s10979-008-9172-6; Odinot G, 2012, PSYCHOL CRIME LAW, V18, P27, DOI DOI 10.1080/1068316X.2012.660152.PUBMED:22523466; Odinot G, 2006, APPL COGNITIVE PSYCH, V20, P973, DOI 10.1002/acp.1263; Odinot G, 2009, APPL COGNITIVE PSYCH, V23, P90, DOI 10.1002/acp.1443; PAYNE DG, 1987, PSYCHOL BULL, V101, P5, DOI 10.1037/0033-2909.101.1.5; Read J.D., 2007, HDB EYEWITNESS PSYCH, P117; SCRIVNER E, 1988, J APPL PSYCHOL, V73, P371, DOI 10.1037/0021-9010.73.3.371; SHAW JS, 1995, PSYCHON B REV, V2, P249, DOI 10.3758/BF03210965; Shaw JS, 1996, J EXP PSYCHOL-APPL, V2, P126, DOI 10.1037/1076-898X.2.2.126; Smeets T, 2004, AM J PSYCHOL, V117, P595, DOI 10.2307/4148994; Talarico JM, 2003, PSYCHOL SCI, V14, P455, DOI 10.1111/1467-9280.02453; Tinsley HEA, 2000, HDB APPL MULTIVARIAT, P95, DOI DOI 10.1016/B978-012691360-6/50005-7; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x	44	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76305	10.1371/journal.pone.0076305	http://dx.doi.org/10.1371/journal.pone.0076305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232HM	24098471	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600038
J	Chen, FF; Hao, FH; Li, CF; Gou, JB; Lu, DY; Gong, FJ; Tang, HR; Zhang, YS				Chen, Fangfang; Hao, Fuhua; Li, Changfu; Gou, Junbo; Lu, Dayan; Gong, Fujun; Tang, Huiru; Zhang, Yansheng			Identifying Three Ecological Chemotypes of Xanthium strumarium Glandular Trichomes Using a Combined NMR and LC-MS Method	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITIES; MEDICINAL-PLANTS; ARTEMISIA-ANNUA; BIOSYNTHESIS; XANTHATIN; LOCALIZATION; INHIBITORS; L.	Xanthanolides, as the sesquiterpene lactones, are reportedly the major components for the pharmacological properties of X. strumarium L. species. Phytochemical studies indicated that the glandular structures on the surface of plant tissues would form the primary sites for the accumulation of this class of the compounds. As the interface between plants and their natural enemies, glandular trichomes may vary with respect to which of their chemicals are sequestered against different herbivores in different ecologies. However, to date, no data are available on the chemical characterisation of X. strumarium glandular cells. In this study, the trichome secretions of the X. strumarium species originating from nineteen unique areas across eleven provinces in China, were analysed by HPLC, LC-ESI-MS and NMR. For the first time three distinct chemotypes of X. strumarium glandular trichomes were discovered along with the qualitative and quantitative evaluations of their presence of xanthanolides; these were designated glandular cell Types I, II, and III, respectively. The main xanthanolides in Type I cells were 8-epi-xanthatin and xanthumin while no xanthatin was detected. Xanthatin, 8-epi-xanthatin, and xanthumin dominated in Type II cells with comparable levels of each being present. For Type III cells, significantly higher concentrations of 8-epi-xanthatin or xanthinosin (relative to xanthatin) were detected with xanthinosin only being observed in this type. Further research will focus on understanding the ecological and molecular mechanism causing these chemotype differences in X. strumarium glandular structures.	[Chen, Fangfang; Li, Changfu; Gou, Junbo; Lu, Dayan; Gong, Fujun; Zhang, Yansheng] Chinese Acad Sci, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan Bot Garden, Wuhan, Peoples R China; [Hao, Fuhua; Tang, Huiru] Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Gou, Junbo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tang, HR (corresponding author), Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan, Peoples R China.	huiru.tang@wipm.ac.cn; zhangys@wbgcas.cn	Hao, Fuhua/ABC-6062-2021; Tang, Huiru/F-9849-2011	Hao, Fuhua/0000-0002-0865-5269; Tang, Huiru/0000-0002-7139-2756	Chinese Academy of Science, China [Y129441R01]; National Natural Science Foundation of China [31270341]	Chinese Academy of Science, China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by the Grant for One Hundred Talents Program of the Chinese Academy of Science, China (project no. Y129441R01) and the National Natural Science Foundation of China (project no. 31270341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjoo Kamboj, 2010, International Journal of Green Pharmacy, V4, P129; Chandel S, 2012, PARASITOL RES, V110, P1179, DOI 10.1007/s00436-011-2611-1; Chen FF, 2011, J PROTEOME RES, V10, P2273, DOI 10.1021/pr101095t; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; Dai H, 2010, J PROTEOME RES, V9, P1565, DOI 10.1021/pr901045c; Dai H, 2010, J PROTEOME RES, V9, P1460, DOI 10.1021/pr900995m; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031; GINESTAPERIS E, 1994, LETT APPL MICROBIOL, V18, P206, DOI 10.1111/j.1472-765X.1994.tb00848.x; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Hammerschmidt DE, 1998, J LAB CLIN MED, V132, P86, DOI 10.1016/S0022-2143(98)90030-0; KAWAZU K, 1979, EXPERIENTIA, V35, P1294, DOI 10.1007/BF01963966; Kim YS, 2003, PLANTA MED, V69, P375, DOI 10.1055/s-2003-38879; Klecakova-Karlickova J, 2005, Ceska Slov Farm, V54, P141; Kovacs A, 2009, Z NATURFORSCH C, V64, P343; KUPCHAN SM, 1971, J MED CHEM, V14, P1147, DOI 10.1021/jm00294a001; Ma YT, 1998, PHYTOCHEMISTRY, V48, P1083, DOI 10.1016/S0031-9422(98)00084-3; Majdi M, 2011, PHYTOCHEMISTRY, V72, P1739, DOI 10.1016/j.phytochem.2011.04.021; Mcmillan C., 1975, BIOCHEM SYST ECOL, V2, P181, DOI [10.1016/0305-1978(75)90059-9, DOI 10.1016/0305-1978(75)90059-9]; Nibret E, 2011, PHYTOTHER RES, V25, P1883, DOI 10.1002/ptr.3651; Polichuk DR, 2010, PHYTOCHEMISTRY, V71, P1264, DOI 10.1016/j.phytochem.2010.04.026; Ramirez AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065030; Ramirez-Erosa I, 2007, CAN J PHYSIOL PHARM, V85, P1160, DOI 10.1139/Y07-104; RODRIGUEZ E, 1976, PHYTOCHEMISTRY, V15, P1573, DOI 10.1016/S0031-9422(00)97430-2; Sato Y, 1997, J PHARM PHARMACOL, V49, P1042, DOI 10.1111/j.2042-7158.1997.tb06038.x; Soo Kim Hyun, 2003, Korean Society for Biotechnology and Bioengineering Journal, V18, P324; Wallaart TE, 2000, PLANTA MED, V66, P57, DOI 10.1055/s-2000-11115; Wang HH, 2009, PLANTA MED, V75, P1625, DOI 10.1055/s-0029-1185814; Xiao CN, 2008, J AGR FOOD CHEM, V56, P10142, DOI 10.1021/jf8016833; Yin MH, 2005, J ETHNOPHARMACOL, V99, P113, DOI 10.1016/j.jep.2005.02.013	30	17	20	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76621	10.1371/journal.pone.0076621	http://dx.doi.org/10.1371/journal.pone.0076621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098541	Green Submitted, gold, Green Published			2022-12-27	WOS:000325434500077
J	Palm, S; Daoura, L; Roman, E; Nylander, I				Palm, Sara; Daoura, Loudin; Roman, Erika; Nylander, Ingrid			Effects of Rearing Conditions on Behaviour and Endogenous Opioids in Rats with Alcohol Access during Adolescence	PLOS ONE			English	Article							MALE WISTAR RATS; NEONATAL MATERNAL SEPARATION; CONCENTRIC SQUARE FIELD; ETHANOL INTAKE; ADULT RATS; POSTNATAL ENVIRONMENT; RISK PREFERENCE; PEPTIDE LEVELS; SOCIAL PLAY; STRESS	Causal links between early-life stress, genes and later psychiatric diagnoses are not possible to fully address in human studies. Animal models therefore provide an important complement in which conditions can be well controlled and are here used to study and distinguish effects of early-life stress and alcohol exposure. The objective of this study was to investigate the impact of rearing conditions on behaviour in young rats and if these changes could be followed over time and to examine interaction effects between early-life environment and adolescent alcohol drinking on behaviour and immunoreactive levels of the opioid peptides dynorphin B, met-enkephalin-Arg(6)Phe(7) and beta-endorphin. We employed a rodent model, maternal separation, to study the impact of rearing conditions on behaviour, voluntary alcohol consumption and alcohol-induced effects. The consequences of short, 15 min (MS 15), and long, 360 min (MS 360), maternal separation in combination with adolescent voluntary alcohol consumption on behaviour and peptides were examined. A difference in the development of risk taking behaviour was found between the MS15 and MS360 while the development of general activity was found to differ between intake groups. Beta-endorphin levels in the pituitary and the periaqueductal gray area was found to be higher in the MS15 than the MS360. Adolescent drinking resulted in higher dynorphin B levels in the hippocampus and higher met-enkephalin-Arg(6)Phe(7) levels in the amygdala. Amygdala and hippocampus are involved in addiction processes and changes in these brain areas after adolescent alcohol drinking may have consequences for cognitive function and drug consumption behaviour in adulthood. The study shows that individual behavioural profiling over time in combination with neurobiological investigations provides means for studies of causality between early-life stress, behaviour and vulnerability to psychiatric disorders.	[Palm, Sara; Daoura, Loudin; Roman, Erika; Nylander, Ingrid] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden	Uppsala University	Palm, S (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	Sara.Palm@farmbio.uu.se	Roman, Erika/AAG-3089-2020	Roman, Erika/0000-0001-5418-8289	Alcohol Research Council of the Swedish Alcohol Retailing Monopoly [SRA 2011-0062, SRA 10-21:1, SRA 2011-0056]; Swedish Medical Research Council [2012-61X-22090-01-3]; European Research Area Board [EA 11 30]; Facias foundation	Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Research Area Board; Facias foundation	Financial support came from the Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (SRA 2011-0062; ER, SRA 10-21:1 and SRA 2011-0056; IN), the Swedish Medical Research Council (2012-61X-22090-01-3; IN), the European Research Area Board (EA 11 30; IN) and the Facias foundation (SP) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux-Cantin S, 2013, NEUROPHARMACOLOGY, V67, P521, DOI 10.1016/j.neuropharm.2012.12.007; ALTSHULER HL, 1980, LIFE SCI, V26, P679, DOI 10.1016/0024-3205(80)90257-X; Andersen SL, 2009, NEUROSCI BIOBEHAV R, V33, P516, DOI 10.1016/j.neubiorev.2008.09.009; Bazov I, 2013, ADDICT BIOL, V18, P161, DOI 10.1111/j.1369-1600.2011.00366.x; Becker HC, 2011, PSYCHOPHARMACOLOGY, V218, P131, DOI 10.1007/s00213-011-2443-9; Bilkei-Gorzo A, 2004, PSYCHOPHARMACOLOGY, V176, P343, DOI 10.1007/s00213-004-1904-9; Chang GQ, 2010, ALCOHOL CLIN EXP RES, V34, P761, DOI 10.1111/j.1530-0277.2010.01148.x; CHRISTENSSONNYLANDER I, 1985, REGUL PEPTIDES, V11, P65, DOI 10.1016/0167-0115(85)90032-1; Clark JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037357; CLONINGER C R, 1988, Advances in Alcohol and Substance Abuse, V7, P3; Cowen MS, 2001, ALCOHOL CLIN EXP RES, V25, P1126, DOI 10.1111/j.1530-0277.2001.tb02326.x; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Daoura L, 2011, PHARMACOL BIOCHEM BE, V99, P626, DOI 10.1016/j.pbb.2011.06.004; Daoura L, 2011, ALCOHOL CLIN EXP RES, V35, P506, DOI 10.1111/j.1530-0277.2010.01367.x; Drews E, 2010, PROG NEUROBIOL, V90, P1, DOI 10.1016/j.pneurobio.2009.09.004; Farkas J, 2009, BRAIN RES BULL, V79, P208, DOI 10.1016/j.brainresbull.2008.12.011; FENTON MC, 2012, PSYCHOL MED, V43, P1; FLEMING AS, 1974, J COMP PHYSIOL PSYCH, V86, P957, DOI 10.1037/h0036414; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Garcia-Burgos D, 2009, ALCOHOL CLIN EXP RES, V33, P722, DOI 10.1111/j.1530-0277.2008.00889.x; Gianoulakis C, 2004, CURR TOP MED CHEM, V4, P39, DOI 10.2174/1568026043451573; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Goepfrich AA, 2013, PHYSIOL BEHAV, V110, P102, DOI 10.1016/j.physbeh.2012.12.019; Gonzales RA, 1998, J NEUROSCI, V18, P10663; GROTA LJ, 1969, ANIM BEHAV, V17, P722, DOI 10.1016/S0003-3472(69)80019-9; Gustafsson L, 2007, NEUROSCIENCE, V146, P1137, DOI 10.1016/j.neuroscience.2007.02.037; Gustafsson L, 2008, NEUROPEPTIDES, V42, P177, DOI 10.1016/j.npep.2007.10.006; Gustafsson L, 2006, ALCOHOL CLIN EXP RES, V30, P2008, DOI 10.1111/j.1530-0277.2006.00247.x; Heilig M, 2011, NAT REV NEUROSCI, V12, P670, DOI 10.1038/nrn3110; Hopf FW, 2010, ALCOHOL CLIN EXP RES, V34, P1565, DOI 10.1111/j.1530-0277.2010.01241.x; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Hyytia P, 2001, ALCOHOL CLIN EXP RES, V25, P25, DOI 10.1097/00000374-200101000-00005; Jaworski JN, 2005, PSYCHOPHARMACOLOGY, V181, P8, DOI 10.1007/s00213-005-2232-4; JIANG HK, 1989, P NATL ACAD SCI USA, V86, P2948, DOI 10.1073/pnas.86.8.2948; Kalinichev M, 2001, BRAIN RES BULL, V54, P649, DOI 10.1016/S0361-9230(01)00485-3; Kang W, 2000, NEUROPSYCHOPHARMACOL, V22, P77, DOI 10.1016/S0893-133X(99)00090-1; KISSLER JL, 2013, BIOL PSYCHIAT, P11261; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kosten TA, 2012, NEUROSCI BIOBEHAV R, V36, P1985, DOI 10.1016/j.neubiorev.2012.07.003; Langeland W, 2004, ALCOHOL CLIN EXP RES, V28, P441, DOI 10.1097/01.ALC.0000117831.17383.72; Leggio L, 2009, NEUROPSYCHOL REV, V19, P115, DOI 10.1007/s11065-008-9080-z; LESCH OM, 1990, PSYCHOPATHOLOGY, V23, P88, DOI 10.1159/000284644; Lesscher HMB, 2010, ALCOHOL CLIN EXP RES, V34, P1219, DOI 10.1111/j.1530-0277.2010.01199.x; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048; Meyerson BJ, 2006, BEHAV BRAIN RES, V168, P100, DOI 10.1016/j.bbr.2005.10.020; MEYERSON BJ, 2013, BEHAV BRAIN IN PRESS; Moffett MC, 2007, BIOCHEM PHARMACOL, V73, P321, DOI 10.1016/j.bcp.2006.08.003; Monti PM, 2005, ALCOHOL CLIN EXP RES, V29, P207, DOI 10.1097/01.ALC.0000153551.11000.F3; Nasrallah NA, 2011, P NATL ACAD SCI USA, V108, P5466, DOI 10.1073/pnas.1017732108; Nasrallah NA, 2009, P NATL ACAD SCI USA, V106, P17600, DOI 10.1073/pnas.0906629106; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Nguyen XV, 2005, BEHAV BRAIN RES, V161, P254, DOI 10.1016/j.bbr.2005.02.010; Nylander I, 1997, NEUROPEPTIDES, V31, P357, DOI 10.1016/S0143-4179(97)90072-X; NYLANDER I, 1998, PROGR HPLC, V7, P171; Nylander I, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00077; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Oswald LM, 2004, PHYSIOL BEHAV, V81, P339, DOI 10.1016/j.physbeh.2004.02.008; Palm S, 2011, APPL ANIM BEHAV SCI, V135, P128, DOI 10.1016/j.applanim.2011.08.010; PANKSEPP J, 1980, NEUROSCI BIOBEHAV R, V4, P473, DOI 10.1016/0149-7634(80)90036-6; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Ploj K, 2003, NEUROPEPTIDES, V37, P149, DOI 10.1016/S0143-4179(03)00043-X; Ploj K, 2002, PHARMACOL BIOCHEM BE, V73, P123, DOI 10.1016/S0091-3057(02)00778-5; Ploj K, 2003, NEUROSCIENCE, V121, P787, DOI 10.1016/S0306-4522(03)00499-8; Poulin JF, 2006, J COMP NEUROL, V496, P859, DOI 10.1002/cne.20956; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; Randall-Thompson JF, 2010, PSYCHOPHARMACOLOGY, V212, P585, DOI 10.1007/s00213-010-1980-y; Roman E, 2005, STRESS, V8, P157, DOI 10.1080/10253890500188666; Roman E, 2007, BEHAV BRAIN RES, V183, P195, DOI 10.1016/j.bbr.2007.06.009; Roman E, 2006, HORM BEHAV, V50, P736, DOI 10.1016/j.yhbeh.2006.06.016; Roman E, 2012, ADDICT BIOL, V17, P33, DOI 10.1111/j.1369-1600.2011.00327.x; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Sanchis-Segura C, 2005, ALCOHOL CLIN EXP RES, V29, P1522, DOI 10.1097/01.alc.0000174913.60384.e8; Sandin J, 1998, NEUROSCIENCE, V85, P375, DOI 10.1016/S0306-4522(97)00605-2; Seif T, 2013, NAT NEUROSCI, V16, P1094, DOI 10.1038/nn.3445; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Sprow GM, 2012, PHYSIOL BEHAV, V106, P325, DOI 10.1016/j.physbeh.2011.12.026; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Trezza V, 2008, EUR NEUROPSYCHOPHARM, V18, P519, DOI 10.1016/j.euroneuro.2008.03.001; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Unterwald EM, 2001, BRAIN RES, V900, P103, DOI 10.1016/S0006-8993(01)02269-7; VANDERSCHUREN LJMJ, 1995, EUR J PHARMACOL, V276, P257, DOI 10.1016/0014-2999(95)00040-R; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vetter CS, 2007, ALCOHOL CLIN EXP RES, V31, P1159, DOI 10.1111/j.1530-0277.2007.00417.x; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; White AM, 2000, ALCOHOL CLIN EXP RES, V24, P1251, DOI 10.1111/j.1530-0277.2000.tb02091.x; Wiedenmayer CP, 2009, NEUROSCI BIOBEHAV R, V33, P432, DOI 10.1016/j.neubiorev.2008.11.004; Wilson MA, 2003, ANN NY ACAD SCI, V985, P472	92	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76591	10.1371/journal.pone.0076591	http://dx.doi.org/10.1371/journal.pone.0076591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098535	Green Published, gold, Green Submitted			2022-12-27	WOS:000325434500075
J	Ramos, A; Santos, C; Mateiu, L; Gonzalez, MD; Alvarez, L; Azevedo, L; Amorim, A; Aluja, MP				Ramos, Amanda; Santos, Cristina; Mateiu, Ligia; del Mar Gonzalez, Maria; Alvarez, Luis; Azevedo, Luisa; Amorim, Antonio; Pilar Aluja, Maria			Frequency and Pattern of Heteroplasmy in the Complete Human Mitochondrial Genome	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; DNA CONTROL REGION; NONCODING REGIONS; POINT MUTATION; PROTEIN MODELS; TRANSFER-RNA; HAIR ROOTS; MTDNA; EVOLUTION; SELECTION	Determining the levels of human mitochondrial heteroplasmy is of utmost importance in several fields. In spite of this, there are currently few published works that have focused on this issue. In order to increase the knowledge of mitochondrial DNA (mtDNA) heteroplasmy, the main goal of this work is to investigate the frequency and the mutational spectrum of heteroplasmy in the human mtDNA genome. To address this, a set of nine primer pairs designed to avoid co-amplification of nuclear DNA (nDNA) sequences of mitochondrial origin (NUMTs) was used to amplify the mitochondrial genome in 101 individuals. The analysed individuals represent a collection with a balanced representation of genders and mtDNA haplogroup distribution, similar to that of a Western European population. The results show that the frequency of heteroplasmic individuals exceeds 61%. The frequency of point heteroplasmy is 28.7%, with a widespread distribution across the entire mtDNA. In addition, an excess of transitions in heteroplasmy were detected, suggesting that genetic drift and/or selection may be acting to reduce its frequency at population level. In fact, heteroplasmy at highly stable positions might have a greater impact on the viability of mitochondria, suggesting that purifying selection must be operating to prevent their fixation within individuals. This study analyses the frequency of heteroplasmy in a healthy population, carrying out an evolutionary analysis of the detected changes and providing a new perspective with important consequences in medical, evolutionary and forensic fields.	[Ramos, Amanda; Santos, Cristina; del Mar Gonzalez, Maria; Pilar Aluja, Maria] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, E-08193 Barcelona, Spain; [Mateiu, Ligia] Katholieke Univ Leuven, Dept Human Genet, Lab Reprod Genom, Louvain, Belgium; [Alvarez, Luis; Azevedo, Luisa; Amorim, Antonio] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Amorim, Antonio] Univ Porto, Fac Sci, P-4100 Oporto, Portugal	Autonomous University of Barcelona; KU Leuven; Universidade do Porto; Universidade do Porto	Ramos, A (corresponding author), Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, E-08193 Barcelona, Spain.	amanda.ramos.reche@gmail.com; cristina.santos@uab.cat	Santos, Cristina/AAE-7665-2020; santos, cristina/K-2348-2014; Mateiu, Ligia/Z-2118-2019; Aluja, Maria Pilar/K-1952-2014; Alvarez, Luis/J-6022-2013; Amorim, Antonio/A-7938-2008; Ramos, Amanda/K-3739-2014; Azevedo, Luisa/J-4051-2013	Santos, Cristina/0000-0002-7014-8014; santos, cristina/0000-0002-7014-8014; Mateiu, Ligia/0000-0002-2655-3581; Aluja, Maria Pilar/0000-0002-0407-9356; Alvarez, Luis/0000-0003-1311-4536; Amorim, Antonio/0000-0002-7518-6247; Ramos, Amanda/0000-0002-9806-6651; Azevedo, Luisa/0000-0002-3157-7342	MEC [CGL2009-08205, CGL2006-07374, CGL2008-03408-E]; Generalitat de Catalunya [2009 SGR 566]; Fundacao para a Ciencia e a Tecnologia; FCT; POPH - QREN - Typology 4.2 - Promoting Scientific Employment; MCTES; European Social Fund	MEC(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH - QREN - Typology 4.2 - Promoting Scientific Employment; MCTES; European Social Fund(European Social Fund (ESF))	This work was supported by MEC (projects: CGL2009-08205; CGL2006-07374; CGL2008-03408-E) and by Generalitat de Catalunya (Ref. 2009 SGR 566). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Education and Science, and is partially supported by Fundacao para a Ciencia e a Tecnologia. L. Alvarez is a FCT postdoctoral fellow (SFRH/BPD/65000/2009) at the IPATIMUP. L. Azevedo is supported by FCT through the program Ciencia2007 (Hiring of PhDs forthe SCTN - financed by POPH - QREN - Typology 4.2 - Promoting Scientific Employment, co-financed by MCTES national funding and The European Social Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 1998, J FORENSIC SCI, V43, P453; Alvarez L, 2010, AM J PHYS ANTHROPOL, V142, P531, DOI 10.1002/ajpa.21252; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245; Azevedo L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-266; Bendall KE, 1997, AM J HUM GENET, V61, P1303, DOI 10.1086/301636; Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844; Cavelier L, 2000, HUM GENET, V107, P45, DOI 10.1007/s004390050009; de Camargo MA, 2011, MOL BIOL REP, V38, P1219, DOI 10.1007/s11033-010-0220-1; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1; Gasparre G, 2013, COLD SPRING HARB PER, V5; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Grzybowski T, 2003, ELECTROPHORESIS, V24, P1159, DOI 10.1002/elps.200390149; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; HOLM L, 1992, J MOL BIOL, V225, P93, DOI 10.1016/0022-2836(92)91028-N; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Howell N, 2000, J NEUROL SCI, V172, P1, DOI 10.1016/S0022-510X(99)00207-5; Irwin JA, 2009, J MOL EVOL, V68, P516, DOI 10.1007/s00239-009-9227-4; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Leo-Kottler B, 2002, GRAEF ARCH CLIN EXP, V240, P758, DOI 10.1007/s00417-002-0494-7; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Miller WG, 2008, OPENSTAT; Nachman MW, 1996, GENETICS, V142, P953; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Parr RL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-185; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; Ramos A, 2011, ELECTROPHORESIS, V32, P782, DOI 10.1002/elps.201000583; Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Raymond M, 2001, GENEPOP 3 3 POPULATI; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Santos C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-167; Santos C, 2008, J MOL EVOL, V67, P191, DOI 10.1007/s00239-008-9138-9; Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X; Schrodinger L., 2020, PYMOL; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Sobenin IA, 2013, CURR PHARM DES; *SPSS INC, 1989, SPSS 15 0 1 WIND; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; Wei YL, 2009, CLIN EXP PHARMACOL P, V36, P933, DOI 10.1111/j.1440-1681.2009.05183.x; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606	60	57	60	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74636	10.1371/journal.pone.0074636	http://dx.doi.org/10.1371/journal.pone.0074636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098342	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500013
J	Willis, ML; Dodd, HF; Palermo, R				Willis, Megan L.; Dodd, Helen F.; Palermo, Romina			The Relationship between Anxiety and the Social Judgements of Approachability And Trustworthiness	PLOS ONE			English	Article							FACIAL EXPRESSIONS; WILLIAMS-SYNDROME; FACES; HYPERSOCIABILITY; DISORDERS; CHILDREN; INFORMATION; PERCEPTION; DIRECTION; AMYGDALA	The aim of the current study was to examine the relationship between individual differences in anxiety and the social judgements of trustworthiness and approachability. We assessed levels of state and trait anxiety in eighty-two participants who rated the trustworthiness and approachability of a series of unexpressive faces. Higher levels of trait anxiety (controlling for age, sex and state anxiety) were associated with the judgement of faces as less trustworthy. In contrast, there was no significant association between trait anxiety and judgements of approachability. These findings indicate that trait anxiety is a significant predictor of trustworthiness evaluations and illustrate the importance of considering the role of individual differences in the evaluation of trustworthiness. We propose that trait anxiety may be an important variable to control for in future studies assessing the cognitive and neural mechanisms underlying trustworthiness. This is likely to be particularly important for studies involving clinical populations who often experience atypical levels of anxiety.	[Willis, Megan L.] Australian Catholic Univ, Sch Psychol, Sydney, NSW, Australia; [Willis, Megan L.] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia; [Dodd, Helen F.] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Palermo, Romina] Univ Western Australia, Sch Psychol, Crawley, WA, Australia; [Palermo, Romina] Univ Western Australia, ARC Ctr Cognit & Its Disorders CCD, Crawley, WA, Australia	Australian Catholic University; Macquarie University; University of Reading; University of Western Australia; University of Western Australia	Willis, ML (corresponding author), Australian Catholic Univ, Sch Psychol, Sydney, NSW, Australia.	dr.megan.willis@gmail.com	Dodd, Helen/L-1430-2019; Palermo, Romina/G-2533-2014	Palermo, Romina/0000-0002-8678-4592; Dodd, Helen/0000-0003-1446-5338; Willis, Megan/0000-0002-2310-0018	Australian Research Council [DP0986420]	Australian Research Council(Australian Research Council)	This research was partially supported by an Australian Research Council Discovery Grant DP0986420 (http://www.arc.gov.au/ncgp/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Altemus M, 2006, HORM BEHAV, V50, P534, DOI 10.1016/j.yhbeh.2006.06.031; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Bellugi U, 1999, NEUROREPORT, V10, P1653, DOI 10.1097/00001756-199906030-00006; Blanchette I, 2010, COGNITION EMOTION, V24, P561, DOI 10.1080/02699930903132496; Campbell DW, 2009, DEPRESS ANXIETY, V26, P419, DOI 10.1002/da.20474; Dodd HF, 2009, J MENT HEALTH RES IN, V2, P89, DOI 10.1080/19315860902725867; Doyle TF, 2004, AM J MED GENET A, V124A, P263, DOI 10.1002/ajmg.a.20416; Ewbank MP, 2009, NEUROIMAGE, V44, P1144, DOI 10.1016/j.neuroimage.2008.09.056; EYSENCK MW, 1991, J ABNORM PSYCHOL, V100, P144, DOI 10.1037/0021-843X.100.2.144; Field A., 2013, DISCOVERING STAT USI; Hadwin J, 1997, J ABNORM PSYCHOL, V106, P486, DOI 10.1037/0021-843X.106.3.486; Knyazev GG, 2008, PERS INDIV DIFFER, V44, P1093, DOI 10.1016/j.paid.2007.11.001; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mathews A, 2012, J COGN PSYCHOL, V24, P92, DOI 10.1080/20445911.2011.584527; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Porter MA, 2007, NEUROPSYCHOLOGIA, V45, P2839, DOI 10.1016/j.neuropsychologia.2007.05.006; Slessor G, 2010, EMOTION, V10, P555, DOI 10.1037/a0019152; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Todorov A, 2013, CURRENT OPINION NEUR, V23, P1; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P303, DOI 10.1093/scan/nsn033; Weisbrot DM, 2005, J CHILD ADOL PSYCHOP, V15, P477, DOI 10.1089/cap.2005.15.477; Willis ML, 2011, SOC COGNITION, V29, P415, DOI 10.1521/soco.2011.29.4.415; Willis ML, 2011, EMOTION, V11, P514, DOI 10.1037/a0022571; Willis ML, 2010, NEUROPSYCHOLOGIA, V48, P2182, DOI 10.1016/j.neuropsychologia.2010.04.010; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Wood JJ, 2010, CLIN PSYCHOL-SCI PR, V17, P281, DOI 10.1111/j.1468-2850.2010.01220.x; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	34	17	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76825	10.1371/journal.pone.0076825	http://dx.doi.org/10.1371/journal.pone.0076825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098566	gold, Green Accepted, Green Published			2022-12-27	WOS:000325434500087
J	Yang, YQ; Wang, Z; Yang, H; Wang, LY; Gillespie, SR; Wolosin, JM; Bernstein, AM; Reinach, PS				Yang, Yuanquan; Wang, Zheng; Yang, Hua; Wang, Lingyan; Gillespie, Stephanie R.; Wolosin, J. Mario; Bernstein, Audrey M.; Reinach, Peter S.			TRPV1 Potentiates TGF beta-Induction of Corneal Myofibroblast Development through an Oxidative Stress-Mediated p38-SMAD2 Signaling Loop	PLOS ONE			English	Article							POSITIVE FEEDBACK; OXIDASE EXPRESSION; TISSUE FIBROSIS; MAP KINASE; FIBROBLASTS; DIFFERENTIATION; RECEPTOR; CELLS; KERATOCYTES; ACTIVATION	Injuring mouse corneas with alkali causes myofibroblast expression leading to tissue opacification. However, in transient receptor potential vanilloid 1 channel (TRPV1-/-) knockout mice healing results in transparency restoration. Since TGF beta is the primary inducer of the myofibroblast phenotype, we examined the mechanism by which TRPV1 affects TGF beta-induced myofibroblast development. Experiments were performed in pig corneas and human corneal fibroblasts (HCFs). Immunohistochemical staining of a-smooth muscle actin (alpha-SMA) stress fibers was used to visualize myofibroblasts. Protein and phosphoprotein were determined by Western blotting. siRNA transfection silenced TRPV1 gene expression. Flow cytometry with a reactive oxygen species (ROS) reporting dye analyzed intracellular ROS. [Ca2+] I was measured by loading HCF with fura2. In organ cultured corneas, the TRPV1 antagonist capsazepine drastically reduced by 75% wound-induced myofibroblast development. In HCF cell culture, TGF-beta 1 elicited rapid increases in Ca2+ influx, phosphorylation of SMAD2 and MAPKs (ERK1/2, JNK1/2 and p38), ROS generation and, after 72 hrs myofibroblast development. SMAD2 and p38 activation continued for more than 16 h, whereas p-ERK1/2 and p-JNK1/2 waned within 90 min. The long-lived SMAD2 activation was dependent on activated p38 and vice versa, and it was essential to generate a > 13-fold increase in a-SMA protein and a fully developed myofibroblast phenotype. These later changes were markedly reduced by inhibition of TRPV1 or reduction of the ROS generation rate. Taken together our results indicate that in corneal derived fibroblasts, TGF beta-induced myofibroblast development is highly dependent on a positive feedback loop where p-SMAD2-induced ROS activates TRPV1, TRPV1 causes activation of p38, the latter in turn further enhances the activation of SMAD2 to establish a recurrent loop that greatly extends the residency of the activated state of SMAD2 that drives myofibroblast development.	[Yang, Yuanquan; Yang, Hua; Reinach, Peter S.] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; [Wang, Zheng; Wang, Lingyan; Gillespie, Stephanie R.; Wolosin, J. Mario; Bernstein, Audrey M.] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY USA	State University of New York (SUNY) System; SUNY Optometry; Icahn School of Medicine at Mount Sinai	Bernstein, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY USA.	audrey.bernstein@mssm.edu; preinach@sunyopt.edu	Reinach, Peter/AAI-3582-2021	Bernstein, Audrey/0000-0002-2537-2594; wolosin, j. mario/0000-0002-6751-2794	National Eye Institute [EY04795 (PSR), EY01478]; NYSTEM CO [26540, EY09414]; NEI [P30-EY01867]; Research to Prevent Blindness grant; Resolvyx Pharmaceuticals; National Disease Research Interchange; NIH [5 U42 RR006042, 1S10RR09145-01]; NIH National Cancer Institute [5R24CA095823-04]; National Science Foundation Major Research Instrumentation [DBI-9724504]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042, S10RR009145] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY004795, R56EY009414, R01EY014878, R01EY009414, R56EY004795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NYSTEM CO; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness grant(Research to Prevent Blindness (RPB)); Resolvyx Pharmaceuticals; National Disease Research Interchange; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Eye Institute Grants EY04795 (PSR), EY01478 and NYSTEM CO 26540 (JMW), EY09414 (AMB), and by NEI core Grant P30-EY01867 and a Research to Prevent Blindness grant. In addition, the financial support provided by Resolvyx Pharmaceuticals to PSR is deeply appreciated. The authors acknowledge use of human tissues provided by the National Disease Research Interchange, supported by NIH Grant 5 U42 RR006042. Microscopy was performed at the Icahn School of Medicine Microscopy Shared Resource Facility, supported by NIH National Cancer Institute shared resources Grant 5R24CA095823-04, National Science Foundation Major Research Instrumentation Grant DBI-9724504 and NIH shared instrumentation Grant 1S10RR09145-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Barbosa FL, 2010, EXP EYE RES, V91, P92, DOI 10.1016/j.exer.2010.04.007; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bernstein AM, 2004, INVEST OPHTH VIS SCI, V45, P2967, DOI 10.1167/iovs.04-0030; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Buss DG, 2010, VET OPHTHALMOL, V13, P37, DOI 10.1111/j.1463-5224.2009.00755.x; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Gilleron M, 2009, BIOCHEM BIOPH RES CO, V388, P727, DOI 10.1016/j.bbrc.2009.08.085; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Huang W, 2010, J HYPERTENS, V28, P367, DOI 10.1097/HJH.0b013e328333af48; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jester JV, 1996, CORNEA, V15, P505; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Junn E, 2000, J IMMUNOL, V165, P2190, DOI 10.4049/jimmunol.165.4.2190; Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914; Kurosaka H, 1998, INVEST OPHTH VIS SCI, V39, P699; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Matten WT, 1996, DEV BIOL, V179, P485, DOI 10.1006/dbio.1996.0277; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; O'Brien WJ, 2009, MOL VIS, V15, P2535; Okada Y, 2011, AM J PATHOL, V178, P2654, DOI 10.1016/j.ajpath.2011.02.043; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shukla A, 2013, ONCOGENE; Singh V, 2011, EXP EYE RES, V93, P810, DOI 10.1016/j.exer.2011.09.012; Spanakis SG, 1998, INVEST OPHTH VIS SCI, V39, P1320; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Utreras E, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-24; Utreras E, 2012, J BIOL CHEM, V287, P16917, DOI 10.1074/jbc.M111.329979; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Wang S, 2011, J BIOL CHEM, V286, P40601, DOI 10.1074/jbc.M111.256669; Wang YP, 2011, MOL MED, V17, P1204, DOI 10.2119/molmed.2011.00063; Wilson SE, 2012, EXP EYE RES, V99, P78, DOI 10.1016/j.exer.2012.03.018; Yang YQ, 2013, EXP EYE RES, V107, P121, DOI 10.1016/j.exer.2012.11.004	41	30	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77300	10.1371/journal.pone.0077300	http://dx.doi.org/10.1371/journal.pone.0077300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098582	Green Published, Green Submitted, gold			2022-12-27	WOS:000325434500098
J	Bland, M				Bland, Martin			Do Baseline P-Values Follow a Uniform Distribution in Randomised Trials?	PLOS ONE			English	Article							CLINICAL-TRIALS	Background: The theory has been put forward that if a null hypothesis is true, P-values should follow a Uniform distribution. This can be used to check the validity of randomisation. Method: The theory was tested by simulation for two sample t tests for data from a Normal distribution and a Lognormal distribution, for two sample t tests which are not independent, and for chi-squared and Fisher's exact test using small and using large samples. Results: For the two sample t test with Normal data the distribution of P-values was very close to the Uniform. When using Lognormal data this was no longer true, and the distribution had a pronounced mode. For correlated tests, even using data from a Normal distribution, the distribution of P-values varied from simulation run to simulation run, but did not look close to Uniform in any realisation. For binary data in a small sample, only a few probabilities were possible and distribution was very uneven. With a sample of two groups of 1,000 observations, there was great unevenness in the histogram and a poor fit to the Uniform. Conclusions: The notion that P-values for comparisons of groups using baseline data in randomised clinical trials should follow a Uniform distribution if the randomisation is valid has been found to be true only in the context of independent variables which follow a Normal distribution, not for Lognormal data, correlated variables, or binary data using either chisquared or Fisher's exact tests. This should not be used as a check for valid randomisation.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK	Bland, M (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	martin.bland@york.ac.uk			University of York	University of York(European Commission)	There is no specific funding for the project, which comes from the central research funding of the University of York. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1985, J ROY STAT SOC D-STA, V34, P125; ALTMAN DG, 1990, LANCET, V335, P149, DOI 10.1016/0140-6736(90)90014-V; Berger VW, 2010, J CLIN EPIDEMIOL, V63, P939, DOI 10.1016/j.jclinepi.2010.02.014; Berger VW, 1999, CONTROL CLIN TRIALS, V20, P319, DOI 10.1016/S0197-2456(99)00014-8; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Kennedy A, 1997, CONTROL CLIN TRIA S3, V18, pS77; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Roberts C, 1999, BRIT MED J, V319, P185, DOI 10.1136/bmj.319.7203.185; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703	10	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76010	10.1371/journal.pone.0076010	http://dx.doi.org/10.1371/journal.pone.0076010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098419	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100036
J	Carvalho, SB; Botelho, HM; Leal, SS; Cardoso, I; Fritz, G; Gomes, CM				Carvalho, Sofia B.; Botelho, Hugo M.; Leal, Sonia S.; Cardoso, Isabel; Fritz, Guenter; Gomes, Claudio M.			Intrinsically Disordered and Aggregation Prone Regions Underlie beta-Aggregation in S100 Proteins	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; CRYSTAL-STRUCTURE; OLIGOMERS; PREDICTION; CONFORMATION; CALPROTECTIN; CA2+-FREE; MECHANISM; TOXICITY; INSIGHTS	S100 proteins are small dimeric calcium-binding proteins which control cell cycle, growth and differentiation via interactions with different target proteins. Intrinsic disorder is a hallmark among many signaling proteins and S100 proteins have been proposed to contain disorder-prone regions. Interestingly, some S100 proteins also form amyloids: S100A8/A9 forms fibrils in prostatic inclusions and S100A6 fibrillates in vitro and seeds SOD1 aggregation. Here we report a study designed to investigate whether beta-aggregation is a feature extensive to more members of S100 family. In silico analysis of seven human S100 proteins revealed a direct correlation between aggregation and intrinsic disorder propensity scores, suggesting a relationship between these two independent properties. Averaged position-specific analysis and structural mapping showed that disorder-prone segments are contiguous to aggregation-prone regions and that whereas disorder is prominent on the hinge and target protein-interaction regions, segments with high aggregation propensity are found in ordered regions within the dimer interface. Acidic conditions likely destabilize the seven S100 studied by decreasing the shielding of aggregation-prone regions afforded by the quaternary structure. In agreement with the in silico analysis, hydrophobic moieties become accessible as indicated by strong ANS fluorescence. ATR-FTIR spectra support a structural inter-conversion from alpha-helices to intermolecular beta-sheets, and prompt ThT-binding takes place with no noticeable lag phase. Dot blot analysis using amyloid conformational antibodies denotes a high diversity of conformers; subsequent analysis by TEM shows fibrils as dominant species. Altogether, our data suggests that beta-aggregation and disorder-propensity are related properties in S100 proteins, and that the onset of aggregation is likely triggered by loss of protective tertiary and quaternary interactions.	[Carvalho, Sofia B.; Botelho, Hugo M.; Leal, Sonia S.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Cardoso, Isabel] Inst Biol Mol & Celular, Mol Neurobiol Unit, Oporto, Portugal; [Cardoso, Isabel] Escola Super Tecnol Saude Porto, Inst Politecn, Oporto, Vila Nova De Ga, Portugal; [Fritz, Guenter] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany	Universidade Nova de Lisboa; Universidade do Porto; Polytechnic Institute of Porto; University of Freiburg	Gomes, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	gomes@itqb.unl.pt	Botelho, Hugo M/B-3092-2008; Gomes, Cláudio M./A-8152-2008; de Carvalho, Sofia Baptista/V-7549-2017; Fritz, Guenter/E-2933-2013; Cardoso, Isabel/K-3903-2013; Leal, Sónia/F-1129-2015	Botelho, Hugo M/0000-0002-4208-1086; Gomes, Cláudio M./0000-0003-4662-6933; de Carvalho, Sofia Baptista/0000-0001-5000-7217; Fritz, Guenter/0000-0002-4571-8812; Cardoso, Isabel/0000-0003-2472-7055; Leal, Sónia/0000-0001-8445-0065	Fundacao para a Ciencia e a Tecnologia (FCT/MCTES, Portugal) [PTDC/EBB-BIO/117793/2010, PTDC/QUIBIQ/117789/2010, SFRH/BD/31126/2006, B017/BI-BI/2012, SFRH/BPD/47477/2008, PEst-OE/EQB/LA0004/2011]; Liga Portuguesa contra o Cancro - LPCC-NRS (Portugal); Heisenberg fellowship of the Deutsche Forschungsgemeinschaft [FR 1488/3-2]	Fundacao para a Ciencia e a Tecnologia (FCT/MCTES, Portugal)(Portuguese Foundation for Science and Technology); Liga Portuguesa contra o Cancro - LPCC-NRS (Portugal); Heisenberg fellowship of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Fundacao para a Ciencia e a Tecnologia (FCT/MCTES, Portugal) through research grants PTDC/EBB-BIO/117793/2010 and PTDC/QUIBIQ/117789/2010 (to CMG) and doctoral fellowship SFRH/BD/31126/2006 (to HMB), Research fellowship B017/BI-BI/2012 (to SBC), post-doctoral fellowship(SFRH/BPD/47477/2008 (to SSL) and by the strategic Grant PEst-OE/EQB/LA0004/2011 (to the ITQB Laboratorio Associado) and partly by a Terry Fox research grant from Liga Portuguesa contra o Cancro - LPCC-NRS (Portugal). GF is supported by a Heisenberg fellowship of the Deutsche Forschungsgemeinschaft (FR 1488/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; Botelho HM, 2012, J BIOL CHEM, V287, P42233, DOI 10.1074/jbc.M112.396416; Botelho HM, 2012, METHODS MOL BIOL, V849, P373, DOI 10.1007/978-1-61779-551-0_25; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Calero M, 2012, METHODS MOL BIOL, V849, P53, DOI 10.1007/978-1-61779-551-0_5; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; de Groot NS, 2012, BIOCHEM SOC T, V40, P1032, DOI 10.1042/BST20120160; DiCostanzo AC, 2012, J BIOL CHEM, V287, P27997, DOI 10.1074/jbc.M112.362921; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Fritz G, 2002, J BIOL CHEM, V277, P33092, DOI 10.1074/jbc.M200574200; Fritz G., 2004, HDB METALLOPROTEINS; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Ghodke S, 2012, FEBS J, V279, P752, DOI 10.1111/j.1742-4658.2011.08465.x; Hadley KC, 2011, CELL STRESS CHAPERON, V16, P549, DOI 10.1007/s12192-011-0266-6; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ismail TM, 2008, CARCINOGENESIS, V29, P2259, DOI 10.1093/carcin/bgn217; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khare SD, 2006, AMYLOID, V13, P226, DOI 10.1080/13506120600960486; Kizawa K, 2008, J BIOL CHEM, V283, P5004, DOI 10.1074/jbc.M709357200; Koch M, 2008, J MOL BIOL, V378, P933, DOI 10.1016/j.jmb.2008.03.019; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Leal SS, 2012, COORDIN CHEM REV, V256, P2253, DOI 10.1016/j.ccr.2012.04.004; LEE SW, 1992, P NATL ACAD SCI USA, V89, P2504, DOI 10.1073/pnas.89.6.2504; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Liu HN, 2012, J NEUROSCI, V32, P8791, DOI 10.1523/JNEUROSCI.5053-11.2012; Malik S, 2008, PROTEINS, V73, P28, DOI 10.1002/prot.22037; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 2006, BBA-MOL CELL RES, V1763, P1282, DOI 10.1016/j.bbamcr.2006.07.013; Marlatt NM, 2009, BIOCHEMISTRY-US, V48, P1954, DOI 10.1021/bi802086a; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Mittl PRE, 2002, ACTA CRYSTALLOGR D, V58, P1255, DOI 10.1107/S0907444902008430; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otterbein LR, 2002, STRUCTURE, V10, P557, DOI 10.1016/S0969-2126(02)00740-2; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Permyakov SE, 2011, MOL BIOSYST, V7, P2164, DOI 10.1039/c0mb00305k; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tompa P., 2010, STRUCTURE FUNCTION I; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562	62	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76629	10.1371/journal.pone.0076629	http://dx.doi.org/10.1371/journal.pone.0076629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098542	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100082
J	Khattar, SK; Samal, S; LaBranche, CC; Montefiori, DC; Collins, PL; Samal, SK				Khattar, Sunil K.; Samal, Sweety; LaBranche, Celia C.; Montefiori, David C.; Collins, Peter L.; Samal, Siba K.			Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector	PLOS ONE			English	Article							TYPE-1 ENVELOPE GLYCOPROTEIN; NEUTRALIZING ANTIBODY-RESPONSE; VACCINE DEVELOPMENT; MONOMERIC GP120; FOREIGN GENE; IMMUNODEFICIENCY; IMMUNIZATION; PROTEIN; ELICITS; TRIMERS	The development of a vaccine against human immunodeficiency virus-1 (HIV-1) capable of inducing broad humoral and cellular responses at both the systemic and mucosal levels will be critical for combating the global AIDS epidemic. We previously demonstrated the ability of Newcastle disease virus (NDV) as a vaccine vector to express oligomeric Env protein gp160 and induce potent humoral and mucosal immune responses. In the present study, we used NDV vaccine strain LaSota as a vector to compare the biochemical and immunogenic properties of vector-expressed gp160, gp120, and two versions of gp140 (a derivative of gp160 made by deleting the transmembrane and cytoplasmic domains), namely: gp140L, which contained the complete membrane-proximal external region (MPER), and gp140S, which lacks the distal half of MPER. We show that, similar to gp160, NDV-expressed gp140S and gp120, but not gp140L, formed higher-order oligomers that retained recognition by conformationally sensitive monoclonal antibodies. Immunization of guinea pigs by the intranasal route with rLaSota/gp140S resulted in significantly greater systemic and mucosal antibody responses compared to the other recombinants. Immunization with rLaSota/140S, rLaSota/140L rLaSota/120 resulted in mixed Th1/Th2 immune responses as compared to Th1-biased immune responses induced by rLaSota/160. Importantly, rLaSota/gp140S induced neutralizing antibody responses to homologous HIV-1 strain BaL.26 and laboratory adapted HIV-1 strain MN.3 that were stronger than those elicited by the other NDV recombinants. Additionally, rLaSota/gp140S induced greater CD4+ and CD8+ T-cell responses in mice. These studies illustrate that rLaSota/gp140S is a promising vaccine candidate to elicit potent mucosal, humoral and cellular immune responses to the HIV-1 Env protein.	[Khattar, Sunil K.; Samal, Sweety; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Div Surg Sci, Durham, NC USA; [Collins, Peter L.] NIAID, Infect Dis Lab, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Samal, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu	SAMAL, SWEETY/GQS-6704-2022		NIH [AI-093198]; NIAID Primate Central Immunology Laboratory [HHSN27201100016C]; NIAID, NIH Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093198, ZIAAI000938] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Primate Central Immunology Laboratory; NIAID, NIH Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH R21 grant AI-093198 awarded to S.K.S and by the NIAID Primate Central Immunology Laboratory Contract HHSN27201100016C awarded to D.C.M. P.L.C. was supported by the NIAID, NIH Intramural Research Program. The views expressed herein neither necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D.J., 1997, DIS POULTRY; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, J INFECT DIS, V207, P248, DOI 10.1093/infdis/jis671; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blankson JN, 2010, DISCOV MED, V9, P261; Bower JF, 2004, J VIROL, V78, P4710, DOI 10.1128/JVI.78.9.4710-4719.2004; Bu ZG, 2004, VIROLOGY, V328, P62, DOI 10.1016/j.virol.2004.06.041; Bukreyev A, 2005, J VIROL, V79, P13275, DOI 10.1128/JVI.79.21.13275-13284.2005; Bultmann A, 2001, J VIROL, V75, P5263, DOI 10.1128/JVI.75.11.5263-5276.2001; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Carnero E, 2009, J VIROL, V83, P584, DOI 10.1128/JVI.01443-08; Chakrabarti BK, 2002, J VIROL, V76, P5357, DOI 10.1128/JVI.76.11.5357-5368.2002; COONEY EL, 1991, LANCET, V337, P567, DOI 10.1016/0140-6736(91)91636-9; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; DECROLY E, 1994, J BIOL CHEM, V269, P12240; Demers KR, 2013, IMMUNOL REV, V254, P190, DOI 10.1111/imr.12069; DiNapoli JM, 2007, P NATL ACAD SCI USA, V104, P9788, DOI 10.1073/pnas.0703584104; DiNapoli JM, 2010, VACCINE, V29, P17, DOI 10.1016/j.vaccine.2010.10.024; DiNapoli JM, 2010, J VIROL, V84, P1489, DOI 10.1128/JVI.01946-09; Du SX, 2009, VIROLOGY, V395, P33, DOI 10.1016/j.virol.2009.07.042; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; FRANZUSOFF A, 1995, J BIOL CHEM, V270, P3154, DOI 10.1074/jbc.270.7.3154; Graham BS, 1998, J INFECT DIS, V177, P310, DOI 10.1086/514209; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Huang ZH, 2001, J GEN VIROL, V82, P1729, DOI 10.1099/0022-1317-82-7-1729; Khattar SK, 2011, J VIROL, V85, P10529, DOI 10.1128/JVI.05050-11; Kim JH, 2003, AIDS RES HUM RETROV, V19, P807, DOI 10.1089/088922203769232601; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Krishnamurthy S, 1998, J GEN VIROL, V79, P2419, DOI 10.1099/0022-1317-79-10-2419; Krishnamurthy S, 2000, VIROLOGY, V278, P168, DOI 10.1006/viro.2000.0618; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Maamary J, 2011, J VIROL, V85, P2235, DOI 10.1128/JVI.02036-10; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; MATTHEWS TJ, 1994, AIDS RES HUM RETROV, V10, P631, DOI 10.1089/aid.1994.10.631; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Papp Z, 1999, VACCINE, V17, P933, DOI 10.1016/S0264-410X(98)00279-5; Phogat S, 2008, VIROLOGY, V373, P72, DOI 10.1016/j.virol.2007.11.005; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Porichis F, 2011, CURR OPIN HIV AIDS, V6, P174, DOI 10.1097/COH.0b013e3283454058; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104	57	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e78521	10.1371/journal.pone.0078521	http://dx.doi.org/10.1371/journal.pone.0078521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098600	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100089
J	Smith, RC; Kizito, C; Rasgon, JL; Jacobs-Lorena, M				Smith, Ryan C.; Kizito, Christopher; Rasgon, Jason L.; Jacobs-Lorena, Marcelo			Transgenic Mosquitoes Expressing a Phospholipase A(2) Gene Have a Fitness Advantage When Fed Plasmodium falciparum-Infected Blood	PLOS ONE			English	Article							MALARIA PARASITE DEVELOPMENT; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; TRANSMISSION; MIDGUT; COSTS; TRANSFORMATION; MANIPULATION; ANTIBODIES; FECUNDITY	Background: Genetically modified mosquitoes have been proposed as an alternative strategy to reduce the heavy burden of malaria. In recent years, several proof-of-principle experiments have been performed that validate the idea that mosquitoes can be genetically modified to become refractory to malaria parasite development. Results: We have created two transgenic lines of Anopheles stephensi, a natural vector of Plasmodium falciparum, which constitutively secrete a catalytically inactive phospholipase A(2) (mPLA(2)) into the midgut lumen to interfere with Plasmodium ookinete invasion. Our experiments show that both transgenic lines expressing mPLA2 significantly impair the development of rodent malaria parasites, but only one line impairs the development of human malaria parasites. In addition, when fed on malaria-infected blood, mosquitoes from both transgenic lines are more fecund than non-transgenic mosquitoes. Consistent with these observations, cage experiments with mixed populations of transgenic and non-transgenic mosquitoes show that the percentage of transgenic mosquitoes increases when maintained on Plasmodium-infected blood. Conclusions: Our results suggest that the expression of an anti-Plasmodium effector gene gives transgenic mosquitoes a fitness advantage when fed malaria-infected blood. These findings have important implications for future applications of transgenic mosquito technology in malaria control.	[Smith, Ryan C.; Kizito, Christopher; Jacobs-Lorena, Marcelo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Malaria Res Inst, Baltimore, MD USA; [Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Jacobs-Lorena, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Malaria Res Inst, Baltimore, MD USA.	mlorena@jhsph.edu	Smith, Ryan C./H-9360-2019	Smith, Ryan C./0000-0003-0245-2265; Rasgon, Jason/0000-0002-4050-8429	National Research Service Award [F32AI088835]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01AI031478]; Johns Hopkins Malaria Research Institute Parasite and Insectary Core facilities; Bloomberg Family Foundation; National Institutes of Health [RR00052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031478, F32AI088835] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins Malaria Research Institute Parasite and Insectary Core facilities; Bloomberg Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a National Research Service Award F32AI088835 (to RCS) and by grant R01AI031478 (to MJL) from the National Institutes of Health/National Institute of Allergy and Infectious Diseases. Additional support was provided by a Calvin S. and Helen H. Lang Post-doctoral fellowship (to RCS), from the Johns Hopkins Malaria Research Institute Parasite and Insectary Core facilities and from the Bloomberg Family Foundation. Supply of human blood was supported by National Institutes of Health Grant RR00052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, INSECT MOL BIOL, V14, P271, DOI 10.1111/j.1365-2583.2004.00557.x; Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; Catteruccia F, 2000, P NATL ACAD SCI USA, V97, P2157, DOI 10.1073/pnas.040568397; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Hogg JC, 1997, PARASITOLOGY, V114, P325, DOI 10.1017/S0031182096008542; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Li CY, 2008, J HERED, V99, P275, DOI 10.1093/jhered/esn004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; Ramakrishnan Chandra, 2013, Methods Mol Biol, V923, P51; Rodrigues FG, 2008, INSECT MOL BIOL, V17, P175, DOI 10.1111/j.1365-2583.2008.00791.x; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Smith RC, 2007, INSECT MOL BIOL, V16, P61, DOI 10.1111/j.1365-2583.2006.00701.x; Smith RC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002965; Smith RC, 2011, GENETICA, V139, P7, DOI 10.1007/s10709-010-9459-7; Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001; Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192; Zieler H, 2001, J EXP BIOL, V204, P4157	36	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76097	10.1371/journal.pone.0076097	http://dx.doi.org/10.1371/journal.pone.0076097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098427	gold, Green Submitted, Green Published			2022-12-27	WOS:000325427100041
J	Alexiou, K; Wilbring, M; Matschke, K; Dschietzig, T				Alexiou, Konstantin; Wilbring, Manuel; Matschke, Klaus; Dschietzig, Thomas			Relaxin Protects Rat Lungs from Ischemia-Reperfusion Injury via Inducible NO Synthase: Role of ERK-1/2, PI3K, and Forkhead Transcription Factor FKHRL1	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GLUCOCORTICOID-RECEPTOR; PREGNANCY HORMONE; TNF-ALPHA; DYSFUNCTION; ATTENUATION; INVOLVEMENT; INHIBITION; ANTAGONIST; EXPRESSION	Introduction: Early allograft dysfunction following lung transplantation is mainly an ischemia/reperfusion (IR) injury. We showed that relaxin-2 (relaxin) exerts a protective effect in lung IR, attributable to decreases in endothelin-1 (ET-1) production, leukocyte recruitment, and free radical generation. Here, we summarize our investigations into relaxin's signalling. Materials and Methods: Isolated rat lungs were perfused with vehicle or 5 nM relaxin (n = 6-10 each). Thereafter, experiments were conducted in the presence of relaxin plus vehicle, the protein kinase A inhibitors H-89 and KT-5720, the NO synthase (NOS) inhibitor L-NAME, the iNOS inhibitor 1400W, the nNOS inhibitor SMTC, the extracellular signal-regulated kinase-1/2 (ERK-1/2) inhibitor PD-98059, the phosphatidylinositol-3 kinase (PI3K) inhibitor wortmannin, the endothelin type-B (ETB) antagonist A-192621, or the glucocorticoid receptor (GR) antagonist RU-486. After 90 min ischemia and 90 min reperfusion we determined wet-to-dry (W/D) weight ratio, mean pulmonary arterial pressure (MPAP), vascular release of ET-1, neutrophil elastase (NE), myeloperoxidase (MPO), and malondialdehyde (MDA). Primary rat pulmonary vascular cells were similarly treated. Results: IR lungs displayed significantly elevated W/D ratios, MPAP, as well as ET-1, NE, MDA, and MPO. In the presence of relaxin, all of these parameters were markedly improved. This protective effect was completely abolished by L-NAME, 1400W, PD-98059, and wortmannin whereas neither PKA and nNOS inhibition nor ETB and GR antagonism were effective. Analysis of NOS gene expression and activity revealed that the relaxin-induced early and moderate iNOS stimulation is ERK1/2-dependent and counter-balanced by PI3K. Relaxin-PI3K-related phosphorylation of a forkhead transcription factor, FKHRL1, paralleled this regulation. In pulmonary endothelial and smooth muscle cells, FKHRL1 was essential to relaxin-PI3K signalling towards iNOS. Conclusion: In this short-time experimental setting, relaxin protects against IR-induced lung injury via early and moderate iNOS induction, dependent on balanced ERK-1/2 and PI3K-FKHRL1 stimulation. These findings render relaxin a candidate drug for lung preservation.	[Alexiou, Konstantin; Wilbring, Manuel; Matschke, Klaus] Univ Heart Ctr Dresden, Dept Cardiac Surg, Dresden, Germany; [Dschietzig, Thomas] Immundiagnostik AG, Bensheim, Germany; [Dschietzig, Thomas] Charite, Dept Cardiol & Angiol, D-13353 Berlin, Germany	Technische Universitat Dresden; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Alexiou, K (corresponding author), Univ Heart Ctr Dresden, Dept Cardiac Surg, Dresden, Germany.	k_alexiou@yahoo.de	Matschke, Klaus/ABD-8795-2020	Dschietzig, Thomas Bernd/0000-0003-1186-8713				Alexiou K, 2010, J HEART LUNG TRANSPL, V29, P454, DOI 10.1016/j.healun.2009.09.012; BAHRAMI S, 1995, J LAB CLIN MED, V125, P487; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BOURGEOIS S, 1984, EMBO J, V3, P751, DOI 10.1002/j.1460-2075.1984.tb01879.x; Brunner F, 2006, PHARMACOL THERAPEUT, V111, P508, DOI 10.1016/j.pharmthera.2005.11.001; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Dahan D, 2012, AM J PHYSIOL-LUNG C, V303, pL824, DOI 10.1152/ajplung.00244.2011; Dschietzig T, 2003, CIRC RES, V92, P32, DOI 10.1161/01.RES.0000051884.27117.7E; Dschietzig T, 2004, FASEB J, V18, P1536, DOI 10.1096/fj.03-1120fje; Dschietzig T, 2012, CARDIOVASC RES, V95, P97, DOI 10.1093/cvr/cvs149; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Failli P, 2001, FASEB J, V15, P252, DOI 10.1096/fj.01-0569fje; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Ichihara A, 1998, AM J PHYSIOL-RENAL, V274, pF516, DOI 10.1152/ajprenal.1998.274.3.F516; Jeyabalan A, 2003, CIRC RES, V93, P1249, DOI 10.1161/01.RES.0000104086.43830.6C; Kanno S, 2000, CIRCULATION, V101, P2742, DOI 10.1161/01.CIR.101.23.2742; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Masini E, 1997, ENDOCRINOLOGY, V138, P4713, DOI 10.1210/en.138.11.4713; Masini E, 2002, BRIT J PHARMACOL, V137, P337, DOI 10.1038/sj.bjp.0704879; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Okada S, 2008, MOL CELL BIOCHEM, V315, P169, DOI 10.1007/s11010-008-9804-7; Parviz M, 1999, ANN THORAC SURG, V67, P522, DOI 10.1016/S0003-4975(98)01141-2; Perna AM, 2005, FASEB J, V19, P1525, DOI 10.1096/fj.04-3664fje; Qian ZP, 2001, CIRCULATION, V104, P2369, DOI 10.1161/hc4401.098471; Sedoris Kara C., 2009, Archives of Physiology and Biochemistry, V115, P34, DOI 10.1080/13813450902785267; von Geldern TW, 1999, J MED CHEM, V42, P3668, DOI 10.1021/jm990170q; Whitson BA, 2007, J HEART LUNG TRANSPL, V26, P1004, DOI 10.1016/j.healun.2007.07.018; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196	32	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75592	10.1371/journal.pone.0075592	http://dx.doi.org/10.1371/journal.pone.0075592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098703	Green Published, gold, Green Submitted			2022-12-27	WOS:000325423500074
J	Arentz, M; Sorensen, B; Horne, DJ; Walson, JL				Arentz, Matthew; Sorensen, Bess; Horne, David J.; Walson, Judd L.			Systematic Review of the Performance of Rapid Rifampicin Resistance Testing for Drug-Resistant Tuberculosis	PLOS ONE			English	Review							MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANCE; DIAGNOSIS; METAANALYSIS; ACCURACY; QUALITY; ASSAY	Introduction: Rapid tests for rifampicin resistance may be useful for identifying isolates at high risk of drug resistance, including multidrug-resistant TB (MDR-TB). However, choice of diagnostic test and prevalence of rifampicin resistance may both impact a diagnostic strategy for identifying drug resistant-TB. We performed a systematic review to evaluate the performance of WHO-endorsed rapid tests for rifampicin resistance detection. Methods: We searched MEDLINE, Embase and the Cochrane Library through January 1, 2012. For each rapid test, we determined pooled sensitivity and specificity estimates using a hierarchical random effects model. Predictive values of the tests were determined at different prevalence rates of rifampicin resistance and MDR-TB. Results: We identified 60 publications involving six different tests (INNO-LiPA Rif. TB assay, Genotype MTBDR assay, Genotype MTBDRplus assay, Colorimetric Redox Indicator (CRI) assay, Nitrate Reductase Assay (NRA) and MODS tests): for all tests, negative predictive values were high when rifampicin resistance prevalence was <= 30%. However, positive predictive values were considerably reduced for the INNO-LiPA Rif. TB assay, the MTBDRplus assay and MODS when rifampicin resistance prevalence was < 5%. Limitations: In many studies, it was unclear whether patient selection or index test performance could have introduced bias. In addition, we were unable to evaluate critical concentration thresholds for the colorimetric tests. Discussion: Rapid tests for rifampicin resistance alone cannot accurately predict rifampicin resistance or MDR-TB in areas with a low prevalence of rifampicin resistance. However, in areas with a high prevalence of rifampicin resistance and MDR-TB, these tests may be a valuable component of an MDR-TB management strategy.	[Arentz, Matthew; Horne, David J.] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Sorensen, Bess] Univ Washington, Ctr AIDS Res, Seattle, WA 98195 USA; [Walson, Judd L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Walson, Judd L.] Univ Washington, Dept Med, Seattle, WA USA; [Walson, Judd L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Walson, Judd L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Walson, Judd L.] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute	Arentz, M (corresponding author), Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA.	marentz@u.washington.edu	Walson, Judd/R-7269-2019; Arentz, Matt/GVU-4315-2022; Walson, Judd/HGC-4359-2022	Walson, Judd/0000-0003-4836-720X; Arentz, Matthew/0000-0002-1107-7754	National Institutes of Health; World Health Organization	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Health Organization(World Health Organization)	This work was supported through funding from the National Institutes of Health and the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR 2011; ARENTZ M, 2011, ENCY GLOBAL STUDIES, P45237; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; BROZEK J, 2008, GRADEPRO 3 6 WINDOWS, P45237; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Chang Kwok-Chiu, 2009, Expert Opin Med Diagn, V3, P99, DOI 10.1517/17530050802665694; COLLABORATION TC, 2011, REV MANAG REVMAN, P45237; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Leung E, 2012, INT J TUBERC LUNG D, V16, P16, DOI 10.5588/ijtld.10.0065; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Macaskill P, 2010, COCHRANE HDB SYSTEMA, V1st; MACASKILL P, 2010, ANAL PRESENTING RESU; Martin A, 2008, J ANTIMICROB CHEMOTH, V62, P56, DOI 10.1093/jac/dkn139; Martin A, 2007, J ANTIMICROB CHEMOTH, V59, P175, DOI 10.1093/jac/dkl477; Minion J, 2010, LANCET INFECT DIS, V10, P688, DOI 10.1016/S1473-3099(10)70165-1; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Morgan M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-62; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Smith SE, 2012, INT J TUBERC LUNG D, V16, P203, DOI 10.5588/ijtld.11.0445; StataCorp, 2021, STATA STAT SOFTWARE; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Tatsioni A, 2005, ANN INTERN MED, V142, P1048, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00004; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2011, NONC CULT DRUG SUSC; World Health organization, 2008, POL GUID DRUG SUSC T	27	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76533	10.1371/journal.pone.0076533	http://dx.doi.org/10.1371/journal.pone.0076533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098523	Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600062
J	Emamgholipour, S; Eshaghi, SM; Hossein-nezhad, A; Mirzaei, K; Maghbooli, Z; Sahraian, MA				Emamgholipour, Solaleh; Eshaghi, Seyede Mahdieh; Hossein-nezhad, Arash; Mirzaei, Khadijeh; Maghbooli, Zhila; Sahraian, Mohammad Ali			Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; REGULATORY T-CELLS; INSULIN-RESISTANCE; BODY-COMPOSITION; ADIPOSE-TISSUE; IMMUNE-SYSTEM; LEPTIN; INFLAMMATION; RECEPTOR; ADIPONECTIN	Background: Adipocytokines may be involved in multiple sclerosis (MS) as well as other autoimmune and inflammatory-related diseases. This study aims to compare levels of resistin, visfatin and leptin in three subgroups of MS patients with healthy subjects and also to study their relationship with Foxp3 expression and levels of several pro-inflammatory mediators such as interleukine-1 beta(IL-1 beta), tumor necrosis factor-alpha (TNF-alpha) and human sensitive C-reactive protein (hs-CRP). Methods: A total of 391 subjects including 200 healthy controls and 191 MS patients were recruited for this case-control study. Circulating adipocytokines and inflammatory mediators were measured using immunoassay methods. Foxp3 gene expression in peripheral blood mononuclear cells (PBMC) was determined by quantitative real-time PCR. Fat tissue mass was evaluated by using dual energy X-ray absorptiometery (DEXA). Results: A significant difference was observed in levels of inflammatory mediators, adipocytokines, Foxp3 gene expression and adipose tissue mass between MS patients and healthy controls. All adipocytokines were positively correlated with levels of inflammatory mediators and negatively correlated with Foxp3 expression in MS patients. In controls, there were positive correlations between circulating leptin and resistin with TNF-alpha and IL-1 beta in subgroup analysis, the highest levels of TNF-alpha, IL-1 beta, hs-CRP, resistin and leptin were observed in primary progressive-MS (PP-MS) patients. Also, expression of Foxp3 and levels of visfatin in relapsing remitting-MS(RR-MS) patients were higher compared with the other subgroups. Conclusions: Our findings suggest the potential role of adipocytokines in pathogenesis and severity of MS. Notably, the relationship of adipocytokines levels with inflammatory cytokines as well as clinical features of MS could be considerable in translational medicine and biomarker studies.	[Emamgholipour, Solaleh] Univ Tehran Med Sci, Sch Med, Dept Clin Biochem, Tehran, Iran; [Eshaghi, Seyede Mahdieh; Hossein-nezhad, Arash] Boston Univ, Med Ctr, Dept Med, Sect Endocrinol Nutr & Diabet,Vitamin D Skin & Bo, Boston, MA USA; [Eshaghi, Seyede Mahdieh; Hossein-nezhad, Arash; Maghbooli, Zhila] Univ Tehran Med Sci, Tehran, Iran; [Mirzaei, Khadijeh] Univ Tehran Med Sci, Sina Hosp, Sch Publ Hlth, Tehran, Iran; [Mirzaei, Khadijeh] Univ Tehran Med Sci, Sina Hosp, Publ Hlth Res Inst, Tehran, Iran; [Sahraian, Mohammad Ali] Univ Tehran Med Sci, Sina Hosp, Sina MS Res Ctr, Dept Neurol, Tehran, Iran	Tehran University of Medical Sciences; Boston University; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Hossein-nezhad, A (corresponding author), Boston Univ, Med Ctr, Dept Med, Sect Endocrinol Nutr & Diabet,Vitamin D Skin & Bo, Boston, MA USA.	arash_hsi@yahoo.com	Shirvani, Arash/AAD-6246-2020; Emamgholipour, Solaleh/T-6035-2017; Mirzaei, Khadijeh/D-5408-2018; Shirvani, Arash H/A-2847-2010	Mirzaei, Khadijeh/0000-0003-0231-0478; Shirvani, Arash H/0000-0003-2847-4737; Emamgholipour, Solaleh/0000-0002-9949-5773; Maghbooli, Zhila/0000-0001-8858-6269; Sahraian, Mohammad Ali/0000-0002-3224-8807				Alatab S, 2011, MINERVA MED, V102, P461; Alatab S, 2011, J MOL NEUROSCI, V44, P6, DOI 10.1007/s12031-010-9486-y; Bennett JL, 2009, CLIN NEUROPHARMACOL, V32, P121, DOI 10.1097/WNF.0b013e3181880359; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; Bjerg L, 2012, J NEUROIMMUNOL, V249, P76, DOI 10.1016/j.jneuroim.2012.04.012; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2002, J IMMUNOL, V168, P875, DOI 10.4049/jimmunol.168.2.875; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Chatzantoni K, 2004, J AUTOIMMUN, V23, P169, DOI 10.1016/j.jaut.2004.05.007; Dahl TB, 2012, ANNU REV NUTR, V32, P229, DOI 10.1146/annurev-nutr-071811-150746; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Della Libera C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019460; Duran I, 2001, MULT SCLER, V7, P151, DOI 10.1177/135245850100700303; Fantuzzi G, 2009, BRAIN BEHAV IMMUN, V23, P405, DOI 10.1016/j.bbi.2008.10.007; Filkova M, 2009, CLIN IMMUNOL, V133, P157, DOI 10.1016/j.clim.2009.07.013; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Frisullo G, 2004, J CLIN IMMUNOL, V24, P287, DOI 10.1023/B:JOCI.0000025450.48267.a5; Fritzsching B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017988; Gove ME, 2009, J LEUKOCYTE BIOL, V85, P491, DOI 10.1189/jlb.0808508; Graber JJ, 2011, J NEUROL SCI, V305, P1, DOI 10.1016/j.jns.2011.03.026; GREGOIRE F, 1992, J CELL PHYSIOL, V151, P300, DOI 10.1002/jcp.1041510211; Gutierrez DA, 2009, CURR DIABETES REP, V9, P26, DOI 10.1007/s11892-009-0006-9; Hagman S, 2011, J NEUROIMMUNOL, V234, P141, DOI 10.1016/j.jneuroim.2011.02.009; Hietaharju A, 2010, EUR J NEUROL, V17, P332, DOI 10.1111/j.1468-1331.2009.02701.x; Hong J, 2009, INT IMMUNOL, V21, P1329, DOI 10.1093/intimm/dxp100; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Kasper LH, 2010, NEUROLOGY, V74, pS2, DOI 10.1212/WNL.0b013e3181c97c8f; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kraszula L, 2012, NEUROL NEUROCHIR POL, V46, P22, DOI 10.5114/ninp.2012.27211; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Lago R, 2008, CELL IMMUNOL, V252, P139, DOI 10.1016/j.cellimm.2007.09.004; Lambert CP, 2002, ARCH PHYS MED REHAB, V83, P1559, DOI 10.1053/apmr.2002.35663; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Lee CH, 2005, DIABETES, V54, P2525, DOI 10.2337/diabetes.54.9.2525; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; MacLaren R, 2008, ADV EXP MED BIOL, V632, P1, DOI 10.1007/978-0-387-78952-1_1; Mahler A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043675; Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Mikulkova Z, 2011, J NEUROL SCI, V300, P135, DOI 10.1016/j.jns.2010.08.053; Mirzaei K, 2011, EUR J INFLAMM, V9, P31, DOI 10.1177/1721727X1100900105; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Robinson WH, 2003, CURR OPIN IMMUNOL, V15, P660, DOI 10.1016/j.coi.2003.09.015; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sioka C, 2011, J CLIN DENSITOM, V14, P465, DOI 10.1016/j.jocd.2011.04.012; Stofkova A, 2010, Endocr Regul, V44, P25; Su KG, 2009, CURR NEUROL NEUROSCI, V9, P411, DOI 10.1007/s11910-009-0060-3; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; van Boxel-Dezaire AHH, 2001, J NEUROIMMUNOL, V120, P152, DOI 10.1016/S0165-5728(01)00398-8; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Venken K, 2010, TRENDS MOL MED, V16, P58, DOI 10.1016/j.molmed.2009.12.003; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028	58	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76555	10.1371/journal.pone.0076555	http://dx.doi.org/10.1371/journal.pone.0076555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098530	Green Submitted, Green Published, gold			2022-12-27	WOS:000325483600065
J	Fujimoto, K; Hayashi, A; Kamata, Y; Ogawa, A; Watanabe, T; Ichikawa, R; Iso, Y; Koba, S; Kobayashi, Y; Koyama, T; Shichiri, M				Fujimoto, Kazumi; Hayashi, Akinori; Kamata, Yuji; Ogawa, Akifumi; Watanabe, Takuya; Ichikawa, Raishi; Iso, Yoshitaka; Koba, Shinji; Kobayashi, Youichi; Koyama, Takatoshi; Shichiri, Masayoshi			Circulating Levels of Human salusin-beta,a Potent Hemodynamic and Atherogenesis Regulator	PLOS ONE			English	Article							IDENTIFIED BIOACTIVE PEPTIDES; ALPHA; BETA; SALUSINS; SERUM; ATHEROSCLEROSIS; RELEASE	Using bioinformatics analysis, we previously identified salusin-beta, an endogenous bioactive peptide with diverse physiological activities. Salusin-beta is abundantly expressed in the neuroendocrine system and in systemic endocrine cells/macrophages. Salusin-beta acutely regulates hemodynamics and chronically induces atherosclerosis, but its unique physicochemical characteristics to tightly adhere to all types of plastic and glassware have prevented elucidation of its precise pathophysiological role. To quantitate plasma total salusin-beta concentrations, we produced rabbit and chicken polyclonal antibodies against the C-and N-terminal end sequences, circumvented its sticky nature, and successfully established a sandwich enzyme-linked immunosorbent assay (ELISA). Salusin-beta was abundantly present in the plasma of healthy volunteers, ranging from 1.9 to 6.6 nmol/L. Reverse phase-high performance liquid chromatography analysis showed that a single immunoreactive salusin-beta peak coincided with synthetic authentic salusin-beta. Plasma salusin-beta concentrations were unaffected by postural changes and by potent vasopressin release stimuli, such as hypertonic saline infusion or smoking. However, salusin-beta concentrations showed significant circadian variation; concentrations were high during the daytime and reached the lowest concentrations in the early morning. Plasma salusin-beta levels in subjects with diabetes mellitus, coronary artery disease, and cerebrovascular disease showed distinctly higher levels than healthy controls. Patients with panhypopituitarism combined with complete central diabetes insipidus also showed significantly higher plasma salusin-beta levels. Therefore, the ELISA system developed in this study will be useful for evaluating circulating total salusin-beta levels and for confirming the presence of authentic salusin-beta in human plasma. The obtained results suggest a limited contribution of the neuroendocrine system to peripheral total salusin-beta concentrations and a role for plasma total salusin-beta concentrations as an indicator of systemic vascular diseases.	[Fujimoto, Kazumi; Koyama, Takatoshi] Tokyo Med & Dent Univ, Lab Mol Genet Hematol, Grad Sch Hlth Care Sci, Tokyo, Japan; [Fujimoto, Kazumi; Hayashi, Akinori; Kamata, Yuji; Ogawa, Akifumi; Ichikawa, Raishi; Shichiri, Masayoshi] Kitasato Univ, Sch Med, Dept Endocrinol Diabet & Metab, Kanagawa, Japan; [Watanabe, Takuya] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Tokyo, Japan; [Iso, Yoshitaka; Koba, Shinji; Kobayashi, Youichi] Showa Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 142, Japan	Tokyo Medical & Dental University (TMDU); Kitasato University; Tokyo University of Pharmacy & Life Sciences; Showa University	Shichiri, M (corresponding author), Kitasato Univ, Sch Med, Dept Endocrinol Diabet & Metab, Kanagawa, Japan.	shichiri@kitasato-u.ac.jp	Hayashi, Akinori/AAD-2469-2020; Koba, Shinji/GZK-2961-2022	Hayashi, Akinori/0000-0002-9946-1004; Shichiri, Masayoshi/0000-0002-5704-1378	Kitasato University Hospital Shogaku-Kifukin	Kitasato University Hospital Shogaku-Kifukin	The study was supported in part by Grant-in-Aid from Kitasato University Hospital Shogaku-Kifukin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Gardiner SM, 2007, NAT MED, V13, P661, DOI 10.1038/nm0607-661a; Izumiyama H, 2005, HYPERTENSION, V45, P419, DOI 10.1161/01.HYP.0000156496.15668.62; Kimoto S, 2010, REGUL PEPTIDES, V162, P129, DOI 10.1016/j.regpep.2010.03.009; Koya T, 2012, AM J PHYSIOL-HEART C, V303, pH96, DOI 10.1152/ajpheart.00009.2012; Nagashima M, 2010, ATHEROSCLEROSIS, V212, P70, DOI 10.1016/j.atherosclerosis.2010.04.027; Saito T, 2008, J NEUROENDOCRINOL, V20, P207, DOI 10.1111/j.1365-2826.2007.01632.x; Sato K, 2006, PEPTIDES, V27, P2561, DOI 10.1016/j.peptides.2006.06.005; Sato K, 2010, REGUL PEPTIDES, V162, P68, DOI 10.1016/j.regpep.2010.02.010; Sato K, 2009, REGUL PEPTIDES, V158, P63, DOI 10.1016/j.regpep.2009.07.017; Sato K, 2008, PEPTIDES, V29, P2203, DOI 10.1016/j.peptides.2008.08.015; Shichiri M, 2003, NAT MED, V9, P1166, DOI 10.1038/nm913; SHICHIRI M, 2008, Patent No. 2010071237; Shichiri M, 2007, NAT MED, V13, P661, DOI 10.1038/nm0607-661b; Suzuki N, 2007, HYPERTENS RES, V30, P1255, DOI 10.1291/hypres.30.1255; Suzuki N, 2011, PEPTIDES, V32, P805, DOI 10.1016/j.peptides.2010.12.012; Takenoya AF, 2005, NEUROSCI LETT, V385, P110, DOI 10.1016/j.neulet.2005.05.061; TI Y, 2011, J HUM HYPERTENS, P45237; Watanabe T, 2008, HYPERTENS RES, V31, P463, DOI 10.1291/hypres.31.463; Watanabe T, 2008, CIRCULATION, V117, P638, DOI 10.1161/CIRCULATIONAHA.107.712539; Watanabe T, 2012, SENSORS-BASEL, V12, P4974, DOI 10.3390/s120404974; Watanabe T, 2011, J AM SOC HYPERTENS, V5, P359, DOI 10.1016/j.jash.2011.06.003	21	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76714	10.1371/journal.pone.0076714	http://dx.doi.org/10.1371/journal.pone.0076714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098553	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600072
J	Koehler, BC; Scherr, AL; Lorenz, S; Urbanik, T; Kautz, N; Elssner, C; Welte, S; Bermejo, JL; Jager, D; Schulze-Bergkamen, H				Koehler, Bruno Christian; Scherr, Anna-Lena; Lorenz, Stephan; Urbanik, Toni; Kautz, Nicole; Elssner, Christin; Welte, Stefan; Bermejo, Justo Lorenzo; Jaeger, Dirk; Schulze-Bergkamen, Henning			Beyond Cell Death - Antiapoptotic Bcl-2 Proteins Regulate Migration and Invasion of Colorectal Cancer Cells In Vitro	PLOS ONE			English	Article							BREAST-CANCER; APOPTOSIS RESISTANCE; OBATOCLAX MESYLATE; METASTASIS; FAMILY; AUTOPHAGY; LIFE; XL; OVEREXPRESSION; PROGRESSION	Migration and invasion of malignant cells are prerequisites for cancer progression and metastasis. The Bcl-2 family of proteins consists of about 25 members and has been extensively studied in the context of apoptosis. Despite the fact that small molecules targeting Bcl-2 proteins have already entered clinical trials, very few studies investigated a role of antiapoptotic Bcl-2 proteins beside cell death in the context of metastasis. The aim of this study was to dissect a potential role of the antiapoptotic Bcl-2 proteins Mcl-1, Bcl-2 and Bcl-xL on migration and invasion of colorectal cancer cells independent of their cell death control function. We used migration and invasion assays as well as three dimensional cell cultures to analyze colorectal cancer cell lines (HT29 and SW480) after siRNA mediated knockdown or overexpression of Mcl-1, Bcl-2 or Bcl-xL. We observed neither spontaneous cell death induction nor impaired proliferation of cells lacking Mcl-1, Bcl-2 or Bcl-xL. In contrast, knockdown of Mcl-1 led to increased proliferation. Strikingly, we demonstrate a profound impairment of both, migration and invasion, of colorectal cancer cells after Mcl-1, Bcl-2 or Bcl-xL knockdown. This phenotype was completely revised in cells overexpressing Mcl-1, Bcl-2 or Bcl-xL. The most pronounced effect among the investigated proteins was observed for Bcl-2. The data presented indicate a pivotal role of Mcl-1, Bcl-2 and Bcl-xL for migration and invasion of colorectal cancer cells independent of their known antiapoptotic effects. Thus, our study illustrates novel antitumoral mechanisms of Bcl-2 protein targeting.	[Koehler, Bruno Christian; Scherr, Anna-Lena; Lorenz, Stephan; Urbanik, Toni; Kautz, Nicole; Elssner, Christin; Welte, Stefan; Jaeger, Dirk; Schulze-Bergkamen, Henning] Univ Heidelberg Hosp, Dept Med Oncol, Natl Ctr Tumor Dis, Heidelberg, Germany; [Bermejo, Justo Lorenzo] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Koehler, BC (corresponding author), Univ Heidelberg Hosp, Dept Med Oncol, Natl Ctr Tumor Dis, Heidelberg, Germany.	bruno.koehler@nct-heidelberg.de		Lorenzo Bermejo, Justo/0000-0002-6568-5333	Medical Faculty of the University of Heidelberg, Germany; German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG SCHU 1443/4-1]; Merck Serono GmbH (Darmstadt, Germany)	Medical Faculty of the University of Heidelberg, Germany; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Merck Serono GmbH (Darmstadt, Germany)	This study was supported by a Postdoctoral-Fellowship granted to BCK from the Medical Faculty of the University of Heidelberg, Germany (http://www.medizinische-fakultaet-hd.uni-heidelberg.de), and grants to HSB from the German Research Foundation (Deutsche Forschungsgemeinschaft, http://www.dfg.de/, DFG SCHU 1443/4-1) and from Merck Serono GmbH (Darmstadt, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2011, INT J ONCOL, V38, P71, DOI 10.3892/ijo_00000825; Alderton GK, 2013, NAT REV CANCER, V13, P3, DOI 10.1038/nrc3428; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Buglioni S, 1999, INT J CANCER, V84, P545, DOI 10.1002/(SICI)1097-0215(19991222)84:6<545::AID-IJC1>3.0.CO;2-2; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; DelBufalo D, 1997, FASEB J, V11, P947, DOI 10.1096/fasebj.11.12.9337147; DEVRIES JE, 1995, BRIT J CANCER, V71, P271, DOI 10.1038/bjc.1995.55; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez Y, 2002, INT J CANCER, V101, P317, DOI 10.1002/ijc.10628; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1; Goard CA, 2013, CORE EVID, V8, P15, DOI 10.2147/CE.S42568; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henderson-Jackson EB, 2010, INT J CLIN EXP PATHO, V3, P768; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Joudeh J, 2012, EXPERT OPIN INV DRUG, V21, P363, DOI 10.1517/13543784.2012.652302; Koehler BC, 2009, WORLD J GASTROENTERO, V15, P5924, DOI 10.3748/wjg.15.5924; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Krishna S, 2011, BIOCHEM J, V435, P545, DOI 10.1042/BJ20101996; Labi V, 2008, CELL DEATH DIFFER, V15, P977, DOI 10.1038/cdd.2008.37; Laulier C, 2012, MUTAT RES-REV MUTAT, V751, P247, DOI 10.1016/j.mrrev.2012.05.002; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038000; Low ICC, 2011, ANTIOXID REDOX SIGN, V15, P2975, DOI 10.1089/ars.2010.3851; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mitry E, 2002, BRIT J SURG, V89, P1557, DOI 10.1046/j.1365-2168.2002.02276.x; Ni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038802; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Schulze-Bergkamen H, 2008, WORLD J GASTROENTERO, V14, P3829, DOI 10.3748/wjg.14.3829; Schutte M, 2011, ASSAY DRUG DEV TECHN, V9, P475, DOI 10.1089/adt.2011.0371; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Tischner D, 2012, APOPTOSIS, V17, P1197, DOI 10.1007/s10495-012-0756-8; Um JH, 2004, J PHARMACOL EXP THER, V311, P1062, DOI 10.1124/jpet.104.070938; Wanebo HJ, 2012, CLIN EXP METASTAS, V29, P821, DOI 10.1007/s10585-012-9517-x; Wick W, 2001, J NEURO-ONCOL, V53, P177, DOI 10.1023/A:1012209518843; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yang JS, 2011, ACTA HISTOCHEM, V113, P810, DOI 10.1016/j.acthis.2011.01.002; Yang JS, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-117; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zinkel SS, 2008, METHOD ENZYMOL, V442, P231, DOI 10.1016/S0076-6879(08)01412-2	48	70	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76446	10.1371/journal.pone.0076446	http://dx.doi.org/10.1371/journal.pone.0076446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098503	Green Published, gold, Green Submitted			2022-12-27	WOS:000325483600053
J	Qian, ZH; Dominguez, SR; Holmes, KV				Qian, Zhaohui; Dominguez, Samuel R.; Holmes, Kathryn V.			Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation	PLOS ONE			English	Article							RECEPTOR-INDEPENDENT INFECTION; MURINE CORONAVIRUS; CATHEPSIN-L; FUNCTIONAL RECEPTOR; AMINOPEPTIDASE-N; INFLUENZA-VIRUS; PROTEIN; TMPRSS2; FUSION; MECHANISMS	Little is known about the biology of the emerging human group c betacoronavirus, Middle East Respiratory Syndrome coronavirus (MERS-CoV). Because coronavirus spike glycoproteins (S) mediate virus entry, affect viral host range, and elicit neutralizing antibodies, analyzing the functions of MERS-CoV S protein is a high research priority. MERS-CoV S on lentivirus pseudovirions mediated entry into a variety of cell types including embryo cells from New World Eptesicus fuscus bats. Surprisingly, a polyclonal antibody to the S protein of MHV, a group a murine betacoronavirus, cross-reacted in immunoblots with the S2 domain of group c MERS-CoV spike protein. MERS pseudovirions released from 293T cells contained only uncleaved S, and pseudovirus entry was blocked by lysosomotropic reagents NH4Cl and bafilomycin and inhibitors of cathepsin L. However, when MERS pseudovirions with uncleaved S protein were adsorbed at 4 degrees C to Vero E6 cells, brief trypsin treatment at neutral pH triggered virus entry at the plasma membrane and syncytia formation. When 293T cells producing MERS pseudotypes co-expressed serine proteases TMPRSS-2 or -4, large syncytia formed at neutral pH, and the pseudovirions produced were non-infectious and deficient in S protein. These experiments show that if S protein on MERS pseudovirions is uncleaved, then viruses enter by endocytosis in a cathepsin L-dependent manner, but if MERS-CoV S is cleaved, either during virus maturation by serine proteases or on pseudovirions by trypsin in extracellular fluids, then viruses enter at the plasma membrane at neutral pH and cause massive syncytia formation even in cells that express little or no MERS-CoV receptor. Thus, whether MERS-CoV enters cells within endosomes or at the plasma membrane depends upon the host cell type and tissue, and is determined by the location of host proteases that cleave the viral spike glycoprotein and activate membrane fusion.	[Qian, Zhaohui; Dominguez, Samuel R.; Holmes, Kathryn V.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA; [Qian, Zhaohui] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Qian, Zhaohui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Dominguez, Samuel R.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Colorado System; University of Colorado Anschutz Medical Campus	Holmes, KV (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA.	kathryn.holmes@ucdenver.edu	Qian, Zhaohui/AFR-9488-2022	Qian, Zhaohui/0000-0003-4116-4450	State of Colorado Bioscience Discovery Evaluation Grant Program [HB-07-1001]; NIH [K08 AI-073525]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI073525] Funding Source: NIH RePORTER	State of Colorado Bioscience Discovery Evaluation Grant Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the State of Colorado Bioscience Discovery Evaluation Grant Program (HB-07-1001) and NIH grant K08 AI-073525 to SRD. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; [Anonymous], 2013, MIDDL E RESP SYNDR C; Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Carrington CVF, 2008, EMERG INFECT DIS, V14, P1890, DOI 10.3201/eid1412.080642; Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123; Chan KH, 2013, J INFECT; Chan RW, 2013, J VIROL; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dominguez SR, 2007, EMERG INFECT DIS, V13, P1295, DOI 10.3201/eid1309.070491; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; FRANA MF, 1985, J VIROL, V56, P912, DOI 10.1128/JVI.56.3.912-920.1985; GALLAGHER TM, 1992, VIROLOGY, V191, P517, DOI 10.1016/0042-6822(92)90223-C; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Holmes KV, 2013, MBIO, V4, DOI 10.1128/mBio.00548-12; Howard MW, 2008, J VIROL, V82, P2883, DOI 10.1128/JVI.01805-07; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kawase M, 2009, J VIROL, V83, P712, DOI 10.1128/JVI.01933-08; Kindler E, 2013, MBIO, V4, DOI 10.1128/mBio.00611-12; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; LIFSON JD, 1986, NATURE, V323, P725, DOI 10.1038/323725a0; Lontok E, 2004, J VIROL, V78, P5913, DOI 10.1128/JVI.78.11.5913-5922.2004; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Miura TA, 2008, J VIROL, V82, P755, DOI 10.1128/JVI.01851-07; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Ontiveros E, 2003, J VIROL, V77, P10260, DOI 10.1128/JVI.77.19.10260-10269.2003; Osborne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019156; Peng GQ, 2012, J BIOL CHEM, V287, P41931, DOI 10.1074/jbc.M112.418210; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Qian ZH, 2004, J VIROL, V78, P5766, DOI 10.1128/JVI.78.11.5766-5772.2004; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rockx B, 2010, J INFECT DIS, V201, P946, DOI 10.1086/651022; Shirogane Y, 2008, J VIROL, V82, P8942, DOI 10.1128/JVI.00676-08; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; STURMAN LS, 1980, J VIROL, V33, P449, DOI 10.1128/JVI.33.1.449-462.1980; Tresnan DB, 1996, J VIROL, V70, P8669, DOI 10.1128/JVI.70.12.8669-8674.1996; Tripet B, 2007, J CHROMATOGR A, V1141, P212, DOI 10.1016/j.chroma.2006.12.024; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zelus BD, 2003, J VIROL, V77, P830, DOI 10.1128/JVI.77.2.830-840.2003	68	129	137	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76469	10.1371/journal.pone.0076469	http://dx.doi.org/10.1371/journal.pone.0076469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098509	gold, Green Published, Green Submitted			2022-12-27	WOS:000325483600057
J	Scorzeto, M; Giacomello, M; Toniolo, L; Canato, M; Blaauw, B; Paolini, C; Protasi, F; Reggiani, C; Stienen, GJM				Scorzeto, Michele; Giacomello, Marta; Toniolo, Luana; Canato, Marta; Blaauw, Bert; Paolini, Cecilia; Protasi, Feliciano; Reggiani, Carlo; Stienen, Ger J. M.			Mitochondrial Ca2+-Handling in Fast Skeletal Muscle Fibers from Wild Type and Calsequestrin-Null Mice	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; SLOW-TWITCH; ESSENTIAL COMPONENT; CALCIUM TRANSIENTS; CA2+ DYNAMICS; MOUSE; CONTRACTION; INDICATORS; ENERGETICS; MOVEMENTS	Mitochondrial calcium handling and its relation with calcium released from sarcoplasmic reticulum (SR) in muscle tissue are subject of lively debate. In this study we aimed to clarify how the SR determines mitochondrial calcium handling using dCASQ-null mice which lack both isoforms of the major Ca2+-binding protein inside SR, calsequestrin. Mitochondrial free Ca2+-concentration ([Ca2+](mito)) was determined by means of a genetically targeted ratiometric FRET-based probe. Electron microscopy revealed a highly significant increase in intermyofibrillar mitochondria (+ 55%) and augmented coupling (+ 12%) between Ca2+ release units of the SR and mitochondria in dCASQ-null vs. WT fibers. Significant differences in the baseline [Ca2+](mito) were observed between quiescent WT and dCASQ-null fibers, but not in the resting cytosolic Ca2+ concentration. The rise in [Ca2+] mito during electrical stimulation occurred in 20230 ms, while the decline during and after stimulation was governed by 4 rate constants of approximately 40, 1.6, 0.2 and 0.03 s(-1). Accordingly, frequency- dependent increase in [Ca2+] mito occurred during sustained contractions. In dCASQ-null fibers the increases in [Ca2+] mito were less pronounced than in WT fibers and even lower when extracellular calcium was removed. The amplitude and duration of [Ca2+] mito transients were increased by inhibition of mitochondrial Na+/Ca2+ exchanger (mNCX). These results provide direct evidence for fast Ca2+ accumulation inside the mitochondria, involvement of the mNCX in mitochondrial Ca2+-handling and a dependence of mitochondrial Ca2+-handling on intracellular (SR) and external Ca2+ stores in fast skeletal muscle fibers. dCASQ-null mice represent a model for malignant hyperthermia. The differences in structure and in mitochondrial function observed relative to WT may represent compensatory mechanisms for the disease-related reduction of calcium storage capacity of the SR and/or SR Ca2+- leakage.	[Scorzeto, Michele; Toniolo, Luana; Canato, Marta; Blaauw, Bert; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Scorzeto, Michele; Toniolo, Luana; Canato, Marta; Blaauw, Bert; Reggiani, Carlo] Univ Padua, IIM, Padua, Italy; [Giacomello, Marta; Blaauw, Bert] Venetian Inst Mol Med, Padua, Italy; [Paolini, Cecilia; Protasi, Feliciano] Univ G DAnnunzio, DNI, Chieti, Italy; [Paolini, Cecilia; Protasi, Feliciano] Univ G DAnnunzio, Ctr Res Ageing CeSI, Chieti, Italy; [Paolini, Cecilia; Protasi, Feliciano] Univ G DAnnunzio, IIM, Chieti, Italy; [Stienen, Ger J. M.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Physiol Lab, Amsterdam, Netherlands; [Stienen, Ger J. M.] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands	University of Padua; University of Padua; Veneto Institute Molecular Medicine; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam	Stienen, GJM (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Physiol Lab, Amsterdam, Netherlands.	g.stienen@vumc.nl	Paolini, Cecilia/AAI-4444-2021; Toniolo, Luana/B-9647-2014; GIACOMELLO, MARTA/HGB-1486-2022; Marta, Giacomello/B-6308-2013; blaauw, bert/A-7614-2014	Toniolo, Luana/0000-0001-7160-5638; blaauw, bert/0000-0002-3893-1463; Giacomello, Marta/0000-0002-0290-6602; Stienen, Ger/0000-0001-5829-0328; BLAAUW, BERT/0000-0002-4167-5106	Italian Telethon Foundation [GGP08153]; University G. d'Annunzio	Italian Telethon Foundation(Fondazione Telethon); University G. d'Annunzio	This study was supported by grant #GGP08153 from the Italian Telethon Foundation and by Research Funds from the University G. d'Annunzio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; BARCLAY CJ, 1993, J PHYSIOL-LONDON, V472, P61, DOI 10.1113/jphysiol.1993.sp019937; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Baylor SM, 2007, J GEN PHYSIOL, V130, P283, DOI 10.1085/jgp.200709827; Baylor SM, 2012, J GEN PHYSIOL, V139, P261, DOI 10.1085/jgp.201210773; BLINKS JR, 1978, J PHYSIOL-LONDON, V277, P291, DOI 10.1113/jphysiol.1978.sp012273; Bolanos P, 2008, PFLUG ARCH EUR J PHY, V455, P721, DOI 10.1007/s00424-007-0312-5; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Bruton JD, 2003, J PHYSIOL-LONDON, V552, P393, DOI 10.1113/jphysiol.org; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; Chikando AC, 2011, J MOL CELL CARDIOL, V51, P627, DOI 10.1016/j.yjmcc.2011.08.003; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Defranchi E, 2005, MICROSC RES TECHNIQ, V67, P27, DOI 10.1002/jemt.20177; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; DiFranco M, 2009, J VIS EXP, V32; Eisenberg B. R., 2010, COMPREHENSIVE PHYSL, P73; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; JUNG DW, 1995, J BIOL CHEM, V270, P672, DOI 10.1074/jbc.270.2.672; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; LOUD AV, 1965, LAB INVEST, V14, P996; MOBLEY BA, 1975, J GEN PHYSIOL, V66, P31, DOI 10.1085/jgp.66.1.31; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; O'Rourke B, 2009, J MOL CELL CARDIOL, V46, P767, DOI 10.1016/j.yjmcc.2008.12.011; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pan S, 2011, SCI CHINA LIFE SCI, V54, P763, DOI 10.1007/s11427-011-4203-9; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Paolini C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/634075; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rossi AE, 2011, AM J PHYSIOL-CELL PH, V301, pC1128, DOI 10.1152/ajpcell.00194.2011; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; Tang S, 2011, P NATL ACAD SCI USA, V108, P16265, DOI 10.1073/pnas.1103015108; Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, pC575, DOI 10.1152/ajpcell.00119.2011; Yi JX, 2011, J BIOL CHEM, V286, P32436, DOI 10.1074/jbc.M110.217711; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74919	10.1371/journal.pone.0074919	http://dx.doi.org/10.1371/journal.pone.0074919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098358	Green Submitted, gold, Green Published			2022-12-27	WOS:000325483600013
J	Li, M; Chen, SC; Zheng, HL; Chen, DH; Zhu, MH; Wang, W; Liu, F; Zhang, CY				Li, Meng; Chen, Shicai; Zheng, Hongliang; Chen, Donghui; Zhu, Minhui; Wang, Wei; Liu, Fei; Zhang, Caiyun			Reinnervation of Bilateral Posterior Cricoarytenoid Muscles Using the Left Phrenic Nerve in Patients with Bilateral Vocal Fold Paralysis	PLOS ONE			English	Article							LARYNGEAL REINNERVATION; INNERVATION; PEDICLE; BRANCH; GRAFT	Objective: To evaluate the feasibility, effectiveness, and safety of reinnervation of the bilateral posterior cricoarytenoid (PCA) muscles using the left phrenic nerve in patients with bilateral vocal fold paralysis. Methods: Forty-four patients with bilateral vocal fold paralysis who underwent reinnervation of the bilateral PCA muscles using the left phrenic nerve were enrolled in this study. Videostroboscopy, perceptual evaluation, acoustic analysis, maximum phonation time, pulmonary function testing, and laryngeal electromyography were performed preoperatively and postoperatively. Patients were followed-up for at least 1 year after surgery. Results: Videostroboscopy showed that within 1 year after reinnervation, abductive movement could be observed in the left vocal folds of 87% of patients and the right vocal folds of 72% of patients. Abductive excursion on the left side was significantly larger than that on the right side (P < 0.05); most of the vocal function parameters were improved postoperatively compared with the preoperative parameters, albeit without a significant difference (P > 0.05). No patients developed immediate dyspnea after surgery, and the pulmonary function parameters recovered to normal reference value levels within 1 year. Postoperative laryngeal electromyography confirmed successful reinnervation of the bilateral PCA muscles. Eighty-seven percent of patients in this series were decannulated and did not show obvious dyspnea after physical activity. Those who were decannulated after subsequent arytenoidectomy were not included in calculating the success rate of decannulation. Conclusions: Reinnervation of the bilateral PCA muscles using the left phrenic nerve can restore inspiratory vocal fold abduction to a physiologically satisfactory extent while preserving phonatory function at the preoperative level without evident morbidity.	[Li, Meng; Chen, Shicai; Zheng, Hongliang; Chen, Donghui; Zhu, Minhui; Wang, Wei; Liu, Fei; Zhang, Caiyun] Second Mil Med Univ, Dept Otolaryngol Head & Neck Surg, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University	Zheng, HL (corresponding author), Second Mil Med Univ, Dept Otolaryngol Head & Neck Surg, Changhai Hosp, Shanghai, Peoples R China.	zheng_hl2004@163.com		Li, Meng/0000-0001-8502-7621	National Natural Science Foundation of China [81100724, 81170899, 81070774]; Science and Technology Commission of Shanghai Municipality [10XD1405500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Grant No. 81100724, 81170899, 81070774 for science research from National Natural Science Foundation of China, and Grant No. 10XD1405500 from the Science and Technology Commission of Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDISSERA F, 1989, LARYNGOSCOPE, V99, P1286; Chen DH, 2011, LARYNGOSCOPE, V121, P1035, DOI 10.1002/lary.21739; Chen Shi-cai, 2004, Zhonghua Er Bi Yan Hou Ke Za Zhi, V39, P464; CRUMLEY RL, 1982, LARYNGOSCOPE, V92, P1, DOI 10.1288/00005537-198209001-00001; CRUMLEY RL, 1983, LARYNGOSCOPE, V93, P425; CRUMLEY RL, 1980, OTOLARYNG HEAD NECK, V88, P159, DOI 10.1177/019459988008800212; Crumley RL, 2000, ANN OTO RHINOL LARYN, V109, P365, DOI 10.1177/000348940010900405; CRUMLEY RL, 1984, ANN OTO RHINOL LARYN, V93, P351, DOI 10.1177/000348948409300414; DOYLE PJ, 1993, ANN OTO RHINOL LARYN, V102, P837, DOI 10.1177/000348949310201103; ELIES W, 1992, LARYNGO RHINO OTOL, V71, P35, DOI 10.1055/s-2007-997241; FACKLER CD, 1967, J APPL PHYSIOL, V23, P923, DOI 10.1152/jappl.1967.23.6.923; FATA JJ, 1987, ANN OTO RHINOL LARYN, V96, P479, DOI 10.1177/000348948709600501; GREEN DC, 1992, LARYNGOSCOPE, V102, P14; Kwak PE, 2010, LARYNGOSCOPE, V120, P463, DOI 10.1002/lary.20752; Lorenz RR, 2008, ANN OTO RHINOL LARYN, V117, P40, DOI 10.1177/000348940811700109; Luedemann W, 2002, J NEUROSURG, V96, P523, DOI 10.3171/jns.2002.96.3.0523; MANIGLIA AJ, 1989, ANN OTO RHINOL LARYN, V98, P907, DOI 10.1177/000348948909801113; Maranillo E, 2003, LARYNGOSCOPE, V113, P602, DOI 10.1097/00005537-200304000-00004; Marie JP, 2010, SURGERY OF LARYNX AND TRACHEA, P279, DOI 10.1007/978-3-540-79136-2_16; MARIE JP, 1989, ANN OTO RHINOL LARYN, V98, P530, DOI 10.1177/000348948909800707; Marina MB, 2011, CURR OPIN OTOLARYNGO, V19, P434, DOI 10.1097/MOO.0b013e32834c7d30; Misiolek M, 2007, EUR ARCH OTO-RHINO-L, V264, P895, DOI 10.1007/s00405-007-0288-y; Paniello RC, 2004, OTOLARYNG CLIN N AM, V37, P161, DOI 10.1016/S0030-6665(03)00164-6; Paniello RC, 2001, ANN OTO RHINOL LARYN, V110, P532, DOI 10.1177/000348940111000607; Banzatto MGP, 2010, INT J PEDIATR OTORHI, V74, P860, DOI 10.1016/j.ijporl.2010.04.012; Rosen CA, 2005, LARYNGOSCOPE, V115, P423, DOI 10.1097/01.mlg.0000157830.38627.85; SANDERS I, 1993, ARCH OTOLARYNGOL, V119, P934; Shiotani A, 2001, LARYNGOSCOPE, V111, P472, DOI 10.1097/00005537-200103000-00017; Toth A, 2005, OTOLARYNG HEAD NECK, V132, P701, DOI 10.1016/j.otohns.2005.01.045; TUCKER HM, 1989, ANN OTO RHINOL LARYN, V98, P674, DOI 10.1177/000348948909800903; TUCKER HM, 1970, ARCHIV OTOLARYNGOL, V92, P530; van Lith-Bijl JT, 1998, ARCH OTOLARYNGOL, V124, P393, DOI 10.1001/archotol.124.4.393; VanLithBijl JT, 1997, ARCH OTOLARYNGOL, V123, P406; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019128; WU H, 1990, J MED COLL PLA, V5, P95; Wu YZ, 2004, ARCH OTOLARYNGOL, V130, P1070, DOI 10.1001/archotol.130.9.1070; Xu WD, 2005, J NEUROSURG, V103, P464, DOI 10.3171/jns.2005.103.3.0464; Xu Wei, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P408; Zabrodsky M, 2012, ACTA OTORHINOLARYNGO, V32, P222; Zheng HL, 1998, OTOLARYNG HEAD NECK, V119, P540, DOI 10.1016/S0194-5998(98)70122-6; Zheng Hongliang, 2002, Zhonghua Er Bi Yan Hou Ke Za Zhi, V37, P210	41	17	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77233	10.1371/journal.pone.0077233	http://dx.doi.org/10.1371/journal.pone.0077233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098581	gold, Green Published, Green Submitted			2022-12-27	WOS:000325434500097
J	Ma, J; Li, XY; Xu, J; Zhang, Q; Liu, ZL; Jia, PP; Zhou, JM; Guo, F; You, XF; Yu, LY; Zhao, LX; Jiang, JD; Cen, S				Ma, Jing; Li, Xiaoyu; Xu, Jian; Zhang, Quan; Liu, Zhenlong; Jia, Pingping; Zhou, Jinming; Guo, Fei; You, Xuefu; Yu, Liyan; Zhao, Lixun; Jiang, Jiandong; Cen, Shan			The Roles of APOBEC3G Complexes in the Incorporation of APOBEC3G into HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; EDITING ENZYME APOBEC3G; VIF PROTEIN; RNA; GAG; ASSOCIATION; DEGRADATION; INFECTION; MEMBRANE; VIRIONS	Background: The incorporation of human APOBEC3G (hA3G) into HIV is required for exerting its antiviral activity, therefore the mechanism underlying hA3G virion encapsidation has been investigated extensively. hA3G was shown to form low-molecular-mass (LMM) and high-molecular-mass (HMM) complexes. The function of different forms of hA3G in its viral incorporation remains unclear. Methodology/Principal Findings: In this study, we investigated the subcellular distribution and lipid raft association of hA3G using subcellular fractionation, membrane floatation assay and pulse-chase radiolabeling experiments respectively, and studied the correlation between the ability of hA3G to form the different complex and its viral incorporation. Our work herein provides evidence that the majority of newly-synthesized hA3G interacts with membrane lipid raft domains to form Lipid raft-associated hA3G (RA hA3G), which serve as the precursor of mature HMM hA3G complex, while a minority of newly-synthesized hA3G remains in the cytoplasm as a soluble LMM form. The distribution of hA3G among the soluble LMM form, the RA LMM form and the mature forms of HMM is regulated by a mechanism involving the N-terminal part of the linker region and the C-terminus of hA3G. Mutagenesis studies reveal a direct correlation between the ability of hA3G to form the RA LMM complex and its viral incorporation. Conclusions/Significance: Together these data suggest that the Lipid raft-associated LMM A3G complex functions as the cellular source of viral hA3G.	[Ma, Jing; Li, Xiaoyu; Xu, Jian; Zhang, Quan; Liu, Zhenlong; Jia, Pingping; Zhou, Jinming; You, Xuefu; Yu, Liyan; Zhao, Lixun; Jiang, Jiandong; Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Guo, Fei] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Ma, Jing; Cen, Shan] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Ma, Jing; Cen, Shan] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; [Ma, Jing; Cen, Shan] McGill Univ, Montreal, PQ, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Lady Davis Institute; McGill University; McGill University; McGill University	Cen, S (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	shancen@imb.pumc.edu.cn	Liu, Zhenlong/AAE-7581-2021; yu, liyan/GYD-2950-2022	yu, liyan/0000-0002-8861-9806; Guo, Fei/0000-0003-3500-1006; Liu, Zhenlong/0000-0001-9149-7179	973 program [2012CB911102]; Nature Science Foundation of China [30973569]; National S&T Major Special Project on Major New Drug Innovation [2012ZX09102101-018]; Canadian Institutes for Health Research	973 program(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project on Major New Drug Innovation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by 973 program (2012CB911102) and Nature Science Foundation of China 30973569 (SC), The National S&T Major Special Project on Major New Drug Innovation 2012ZX09102101-018 (SC), and the Canadian Institutes for Health Research grant (SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Friew YN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-56; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Halwani R, 2003, J VIROL, V77, P3973, DOI 10.1128/JVI.77.7.3973-3984.2003; Huang Y, 2001, J VIROL, V75, P4947, DOI 10.1128/JVI.75.10.4947-4951.2001; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Khan MN, 2007, SURFACTANT SCI SER, V133, P1; Khorchid A, 2002, J VIROL, V76, P4131, DOI 10.1128/JVI.76.8.4131-4137.2002; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; YU J, 1973, Journal of Supramolecular Structure, V1, P233, DOI 10.1002/jss.400010308; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74892	10.1371/journal.pone.0074892	http://dx.doi.org/10.1371/journal.pone.0074892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098356	Green Submitted, Green Published, gold			2022-12-27	WOS:000325434500016
J	Smith, WD; Miller, JA; Heppell, SS				Smith, Wade D.; Miller, Jessica A.; Heppell, Selina S.			Elemental Markers in Elasmobranchs: Effects of Environmental History and Growth on Vertebral Chemistry	PLOS ONE			English	Article							ROCKFISH SEBASTES-MELANOPS; OTOLITH CHEMISTRY; ROUND STINGRAY; TRACE-METALS; PARTITION-COEFFICIENTS; POPULATION-STRUCTURE; SPATIAL VARIATION; UROBATIS-HALLERI; WATER CHEMISTRY; ESTUARINE FISH	Differences in the chemical composition of calcified skeletal structures (e. g. shells, otoliths) have proven useful for reconstructing the environmental history of many marine species. However, the extent to which ambient environmental conditions can be inferred from the elemental signatures within the vertebrae of elasmobranchs (sharks, skates, rays) has not been evaluated. To assess the relationship between water and vertebral elemental composition, we conducted two laboratory studies using round stingrays, Urobatis halleri, as a model species. First, we examined the effects of temperature (16 degrees, 18 degrees, 24 degrees C) on vertebral elemental incorporation (Li/Ca, Mg/Ca, Mn/Ca, Zn/Ca, Sr/Ca, Ba/Ca). Second, we tested the relationship between water and subsequent vertebral elemental composition by manipulating dissolved barium concentrations (1x, 3x, 6x). We also evaluated the influence of natural variation in growth rate on elemental incorporation for both experiments. Finally, we examined the accuracy of classifying individuals to known environmental histories (temperature and barium treatments) using vertebral elemental composition. Temperature had strong, negative effects on the uptake of magnesium (D-Mg) and barium (D-Ba) and positively influenced manganese (D-Mn) incorporation. Temperature-dependent responses were not observed for lithium and strontium. Vertebral Ba/Ca was positively correlated with ambient Ba/Ca. Partition coefficients (D-Ba) revealed increased discrimination of barium in response to increased dissolved barium concentrations. There were no significant relationships between elemental incorporation and somatic growth or vertebral precipitation rates for any elements except Zn. Relationships between somatic growth rate and D-Zn were, however, inconsistent and inconclusive. Variation in the vertebral elemental signatures of U. halleri reliably distinguished individual rays from each treatment based on temperature (85%) and Ba exposure (96%) history. These results support the assumption that vertebral elemental composition reflects the environmental conditions during deposition and validates the use of vertebral elemental signatures as natural markers in an elasmobranch. Vertebral elemental analysis is a promising tool for the study of elasmobranch population structure, movement, and habitat use.	[Smith, Wade D.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Miller, Jessica A.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Coastal Oregon Marine Expt Stn, Newport, OR 97365 USA; [Heppell, Selina S.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Smith, WD (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA.	wade.smith@oregonstate.edu		Miller, Jessica/0000-0002-6491-4085	National Science Foundation [OCE 0840860]; Mamie Markham Research Awards (HMSC-OSU); Thomas G. Scott Publication Fund	National Science Foundation(National Science Foundation (NSF)); Mamie Markham Research Awards (HMSC-OSU); Thomas G. Scott Publication Fund	Funding for this research was provided by a National Science Foundation Small Grant for Exploratory Research (OCE 0840860; http://www.nsf.gov/geo/oce/programs/biores.jsp) and Mamie Markham Research Awards (HMSC-OSU). Publication of this paper was supported, in part, by the Thomas G. Scott Publication Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOBA T, 1992, CALCIFIED TISSUE INT, V51, P143, DOI 10.1007/BF00298503; Ashhurst DE, 2004, MATRIX BIOL, V23, P15, DOI 10.1016/j.matbio.2004.02.001; Babel JS, 1967, BULLETIN, V137, P2; Balter V, 2004, GEOCHIM COSMOCHIM AC, V68, P423, DOI 10.1016/S0016-7037(03)00453-8; Balter V, 2010, GEOCHIM COSMOCHIM AC, V74, P3449, DOI 10.1016/j.gca.2010.03.015; Barnes TC, 2013, CAN J FISH AQUAT SCI, V70, P1159, DOI 10.1139/cjfas-2012-0442; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Cailliet G.M., 2004, BIOL SHARKS THEIR RE; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Chittaro PM, 2006, ESTUAR COAST SHELF S, V67, P673, DOI 10.1016/j.ecss.2005.12.014; Chowdhury MJ, 2012, FISH PHYSL SER B, V31B; CLEMENT JG, 1992, AUST J MAR FRESH RES, V43, P157; de Vries MC, 2005, GEOCHIM COSMOCHIM AC, V69, P4061, DOI 10.1016/j.gca.2005.03.052; Dean MN, 2006, ZOOLOGY, V109, P164, DOI 10.1016/j.zool.2006.03.002; Dean MN, 2009, J ANAT, V215, P227, DOI 10.1111/j.1469-7580.2009.01116.x; DELANEY ML, 1985, GEOCHIM COSMOCHIM AC, V49, P1327, DOI 10.1016/0016-7037(85)90284-4; DiMaria RA, 2010, ENVIRON BIOL FISH, V89, P453, DOI 10.1007/s10641-010-9665-2; Dorval E, 2007, CAN J FISH AQUAT SCI, V64, P411, DOI 10.1139/F07-015; Dove SG, 1996, J EXP MAR BIOL ECOL, V205, P15, DOI 10.1016/S0022-0981(96)02610-X; DOYLE J, 1968, COMP BIOCHEM PHYSIOL, V25, P201, DOI 10.1016/0010-406X(68)90927-4; Edmonds JS, 1996, SCI TOTAL ENVIRON, V192, P151, DOI 10.1016/S0048-9697(96)05311-9; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Elsdon TS, 2002, CAN J FISH AQUAT SCI, V59, P1796, DOI 10.1139/F02-154; Evans DH, 2004, BIOL SHARKS THEIR RE; FLEISHMAN DG, 1986, COMP BIOCHEM PHYS A, V84, P643, DOI 10.1016/0300-9629(86)90379-8; FOWLER AJ, 1995, CAN J FISH AQUAT SCI, V52, P1431, DOI 10.1139/f95-138; Friedrich LA, 2008, ENVIRON SCI TECHNOL, V42, P3514, DOI 10.1021/es072093r; Gaetani GA, 2006, GEOCHIM COSMOCHIM AC, V70, P4617, DOI 10.1016/j.gca.2006.07.008; Gelsleichter J, 1997, T AM FISH SOC, V126, P862, DOI 10.1577/1548-8659(1997)126<0862:UOCAAF>2.3.CO;2; Gillanders BM, 2002, CAN J FISH AQUAT SCI, V59, P669, DOI 10.1139/F02-040; Gosnell KJ, 2012, MAR CHEM, V132, P68, DOI 10.1016/j.marchem.2012.01.004; Hale LF, 2008, J FISH BIOL, V73, P510, DOI 10.1111/j.1095-8649.2008.01940.x; Hale LF, 2006, ENVIRON BIOL FISH, V77, P317, DOI 10.1007/s10641-006-9124-2; Hamer PA, 2007, J FISH BIOL, V71, P1035, DOI 10.1111/j.1095-8649.2007.01570.x; Hicks AS, 2010, J EXP MAR BIOL ECOL, V394, P86, DOI 10.1016/j.jembe.2010.07.018; Hobson KA, 2010, UNDERSTANDING MOVEME; HOFF GR, 1995, B MAR SCI, V56, P578; Hoisington G, 2005, MAR ENVIRON RES, V60, P437, DOI 10.1016/j.marenvres.2005.01.003; Hurst TP, 2010, FISH B-NOAA, V108, P382; KALISH JM, 1989, J EXP MAR BIOL ECOL, V132, P151, DOI 10.1016/0022-0981(89)90126-3; Kent AJR, 2006, AM MINERAL, V91, P1401, DOI 10.2138/am.2006.2030; Kerr LA, 2006, ENVIRON BIOL FISH, V77, P337, DOI 10.1007/s10641-006-9125-1; Lea DW, 2006, OCEANS MARINE GEOCHE, V6; Limburg KE, 2011, P NATL ACAD SCI USA, V108, pE177, DOI 10.1073/pnas.1100684108; Lloyd DC, 2008, MAR ECOL PROG SER, V353, P115, DOI 10.3354/meps07172; LOWENSTAM HA, 1954, J GEOL, V62, P284, DOI 10.1086/626163; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Madejczyk MS, 2009, COMP BIOCHEM PHYS C, V149, P566, DOI 10.1016/j.cbpc.2008.12.009; Marohn L, 2011, ANAL BIOANAL CHEM, V399, P2175, DOI 10.1007/s00216-010-4412-2; Marriott CS, 2004, EARTH PLANET SC LETT, V222, P615, DOI 10.1016/j.epsl.2004.02.031; Martin GB, 2005, MAR ECOL PROG SER, V293, P223; Martin GB, 2006, MAR ECOL PROG SER, V324, P229, DOI 10.3354/meps324229; Mathews T, 2009, SCI TOTAL ENVIRON, V407, P5156, DOI 10.1016/j.scitotenv.2009.06.003; MAYER I, 1986, CALCIFIED TISSUE INT, V38, P293, DOI 10.1007/BF02556609; Mayer I, 2003, EUR J INORG CHEM, P1445; McGarigal K., 2000, MULTIVARIATE STAT WI; McMahon KW, 2011, CAN J FISH AQUAT SCI, V68, P1330, DOI 10.1139/F2011-070; Miller JA, 2009, J FISH BIOL, V75, P39, DOI 10.1111/j.1095-8649.2009.02262.x; Miller JA, 2005, CAN J FISH AQUAT SCI, V62, P2189, DOI 10.1139/F05-133; Miller JA, 2004, CAN J FISH AQUAT SCI, V61, P1723, DOI 10.1139/F04-111; Miller MB, 2006, J EXP MAR BIOL ECOL, V329, P135, DOI 10.1016/j.jembe.2005.08.016; MILNER NJ, 1982, J FISH BIOL, V21, P325, DOI 10.1111/j.1095-8649.1982.tb02838.x; Milton DA, 2001, J EXP MAR BIOL ECOL, V264, P47, DOI 10.1016/S0022-0981(01)00301-X; MORSE JW, 1990, CHEM GEOL, V82, P265, DOI 10.1016/0009-2541(90)90085-L; MULLIGAN TJ, 1983, CAN J FISH AQUAT SCI, V40, P215, DOI 10.1139/f83-032; OKUMURA M, 1986, GEOCHIM COSMOCHIM AC, V50, P49, DOI 10.1016/0016-7037(86)90047-5; PENTREATH R J, 1973, Journal of Experimental Marine Biology and Ecology, V12, P327, DOI 10.1016/0022-0981(73)90062-2; Ranaldi MM, 2010, COMP BIOCHEM PHYS C, V152, P248, DOI 10.1016/j.cbpc.2010.04.012; Ridewood WG, 1921, PHILOS T R SOC LON B, V210, P311, DOI 10.1098/rstb.1921.0008; Rollion-Bard C, 2009, EARTH PLANET SC LETT, V286, P63, DOI 10.1016/j.epsl.2009.06.015; Rosenthal Y, 1997, GEOCHIM COSMOCHIM AC, V61, P3633, DOI 10.1016/S0016-7037(97)00181-6; Scheiner SM, 2001, DESIGN ANAL ECOLOGIC; SCHIFANO G, 1982, CHEM GEOL, V35, P321, DOI 10.1016/0009-2541(82)90009-2; SCHOENBE.HP, 1963, BIOCHIM BIOPHYS ACTA, V75, P96, DOI 10.1016/0006-3002(63)90583-3; Simkiss K, 1974, AGEING FISH; Simpfendorfer CA, 2000, FISH B-NOAA, V98, P811; Smith WD, 2007, MAR FRESHWATER RES, V58, P54, DOI 10.1071/MF06083; Sponaugle S, 2010, ENVIRON BIOL FISH, V89, P221, DOI 10.1007/s10641-010-9676-z; Stecher HA, 1996, GEOCHIM COSMOCHIM AC, V60, P3445, DOI 10.1016/0016-7037(96)00179-2; Strasser CA, 2008, J EXP MAR BIOL ECOL, V355, P153, DOI 10.1016/j.jembe.2007.12.022; Strasser CA, 2008, MAR ECOL PROG SER, V370, P155, DOI 10.3354/meps07658; Swearer SE, 2003, ESTUAR COAST SHELF S, V56, P1111, DOI 10.1016/S0272-7714(02)00317-7; Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043; THOMPSON THOMAS G., 1955, DEEP SEA RES, V3, P20; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Tillett BJ, 2011, MAR ECOL PROG SER, V434, P133, DOI 10.3354/meps09222; TITUS K, 1984, AM MIDL NAT, V111, P1, DOI 10.2307/2425535; Vallee BL, 1983, ZINC ENZYMES METAL I, V5; Veinott GI, 1999, T AM FISH SOC, V128, P352, DOI 10.1577/1548-8659(1999)128&lt;0352:AEOESI&gt;2.0.CO;2; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Walther BD, 2010, ENVIRON BIOL FISH, V89, P441, DOI 10.1007/s10641-010-9661-6; Watanabe T, 1997, AQUACULTURE, V151, P185, DOI 10.1016/S0044-8486(96)01503-7; Webb SD, 2012, MAR ECOL PROG SER, V453, P189, DOI 10.3354/meps09653; Welden BA, 1987, AGE GROWTH FISH; Wells BK, 2000, CAN J FISH AQUAT SCI, V57, P2122, DOI 10.1139/cjfas-57-10-2122; Wells BK, 2003, CAN J FISH AQUAT SCI, V60, P361, DOI 10.1139/F03-028; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; WILLIS JN, 1984, MAR BIOL, V80, P273, DOI 10.1007/BF00392822; Zacherl DC, 2003, GEOCHIM COSMOCHIM AC, V67, P4091, DOI 10.1016/S0016-7037(03)00384-3; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zumholz K, 2007, MAR BIOL, V151, P1321, DOI 10.1007/s00227-006-0564-1; Zwolsman JJG, 1997, GEOCHIM COSMOCHIM AC, V61, P1635, DOI 10.1016/S0016-7037(97)00029-X	106	37	38	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e62423	10.1371/journal.pone.0062423	http://dx.doi.org/10.1371/journal.pone.0062423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098320	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100001
J	Benhajali, H; Ezzaouia, M; Lunel, C; Charfi, F; Hausberger, M				Benhajali, Haifa; Ezzaouia, Mohammed; Lunel, Christophe; Charfi, Faouzia; Hausberger, Martine			Temporal Feeding Pattern May Influence Reproduction Efficiency, the Example of Breeding Mares	PLOS ONE			English	Article							STRESS-LIKE CONCENTRATIONS; LUTEINIZING-HORMONE; ESTROUS BEHAVIOR; TIME BUDGET; SECRETION; CORTISOL; LEPTIN; LH; TRANSPORTATION; INHIBITION	Discomfort in farm animals may be induced by inappropriate types or timing of food supplies. Thus, time restriction of meals and lack of roughage have been shown to be one source of emergence of oral stereotypies and abnormal behaviour in horses which have evolved to eat high-fibre diets in small amounts over long periods of time. This feeding pattern is often altered in domestic environment where horses are often fed low fibre meals that can be rapidly consumed. This study aimed at determining the effect of the temporal pattern of feeding on reproductive efficiency of breeding mares, One hundred Arab breeding mares were divided into two groups that differed only in the temporal pattern of roughage availability: only at night for the standard feeding pattern group (SFP mares), night and day for the "continuous feeding" group (CF mares). The total amount of roughage provided was the same as the CF mares received half of the hay during the day while in paddock (haynets). Mares were tested for oestrus detection by teasing with one stallion and were then examined clinically by rectal palpations and ultrasound before being mated naturally or inseminated by fresh or frozen semen. Multivariate logistic regression was used to analyse data. The treatment affected significantly the reproductive efficiency of the mares with fewer oestrus abnormalities (p = 0.0002) and more fertility (p = 0.024) in CF mares (conception rate = 81% versus 55% in SFP mares). Ensuring semi-continous feeding by providing roughage may be a way of fulfilling the basic physiological needs of the horses' digestive system, reducing stress and associated inhibitors of reproduction. To our knowledge, this study provides the first evidence of an impact of temporal feeding patterns on reproductive success in a Mammal. Temporal patterns of feeding may be a major and underestimated factor in breeding.	[Benhajali, Haifa; Lunel, Christophe; Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Benhajali, Haifa; Ezzaouia, Mohammed] Haras Natl Sidi Thabet, Sidi Thabet, Tunisia; [Charfi, Faouzia] Univ Tunis ElManar, Unite Biol Anim & Systemat Evolut, Tunis, Tunisia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Universite de Tunis-El-Manar	Hausberger, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	martine.hausberger@univ-rennes1.fr			Universite Rennes 1	Universite Rennes 1	Universite Rennes 1 (http://www.univ-rennes1.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2003, REPRODUCTION, P283; Amstalden M, 2003, BIOL REPROD, V69, P1539, DOI 10.1095/biolreprod.103.018119; BALDWIN DM, 1974, ENDOCRINOLOGY, V94, P1397, DOI 10.1210/endo-94-5-1397; Barb CR, 1999, J ANIM SCI, V77, P1249; BARB CR, 1982, J REPROD FERTIL, V64, P85, DOI 10.1530/jrf.0.0640085; BARNETT JL, 1991, ANIM REPROD SCI, V25, P265, DOI 10.1016/0378-4320(91)90021-Q; BAUCUS KL, 1990, J ANIM SCI, V68, P345; BAUCUS KL, 1990, J ANIM SCI, V68, P419; Benhajali H, 2009, ANIMAL, V3, P1308, DOI 10.1017/S1751731109004820; Benhajali H, 2007, HORSE BEHAV WELFARE; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Berger A, 1999, APPL ANIM BEHAV SCI, V64, P1, DOI 10.1016/S0168-1591(99)00026-X; Berghold P, 2007, ANIM REPROD SCI, V102, P276, DOI 10.1016/j.anireprosci.2006.11.009; Bhardwaj SK, 2004, REPROD NUTR DEV, V44, P29, DOI 10.1051/rnd:2004014; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; BOYD LE, 1988, APPL ANIM BEHAV SCI, V21, P5, DOI 10.1016/0168-1591(88)90098-6; Broom D. M., 1993, Equine Veterinary Education, V5, P151, DOI 10.1111/j.2042-3292.1993.tb01026.x; Buff PR, 2007, DOMEST ANIM ENDOCRIN, V33, P430, DOI 10.1016/j.domaniend.2006.08.007; Chebel RC, 2007, ANIM REPROD SCI, V101, P208, DOI 10.1016/j.anireprosci.2006.09.010; CHEN MD, 1992, NEUROENDOCRINOLOGY, V56, P666, DOI 10.1159/000126291; Chrousos George P., 1998, Annals of Internal Medicine, V129, P229; Daley CA, 1999, BIOL REPROD, V60, P158, DOI 10.1095/biolreprod60.1.158; Dobson H, 1999, J REPROD FERTIL, V116, P1, DOI 10.1530/jrf.0.1160001; Dobson H, 2000, ANIM REPROD SCI, V60, P743, DOI 10.1016/S0378-4320(00)00080-4; DUBEY AK, 1985, BIOL REPROD, V33, P423, DOI 10.1095/biolreprod33.2.423; EHNERT K, 1991, J ANIM SCI, V69, P2988, DOI 10.2527/1991.6972988x; Ferreira-Dias G, 2005, DOMEST ANIM ENDOCRIN, V29, P203, DOI 10.1016/j.domaniend.2005.02.006; Fitzgerald BP, 2000, BIOL REPROD, V63, P335, DOI 10.1095/biolreprod63.1.335; Gastal M. O., 2004, Animal Reproduction, V1, P115; Guillaume D, 2007, EQUIDEE, V59, P52; Harris P, 2005, VET J, V170, P10, DOI 10.1016/j.tvjl.2004.08.007; HARRIS PA, 1999, P BEVA SPEC M NUTR B, P45; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; HENNEKE DR, 1984, THERIOGENOLOGY, V21, P897, DOI 10.1016/0093-691X(84)90383-2; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Komesaroff PA, 1998, AM J PHYSIOL-ENDOC M, V275, pE671, DOI 10.1152/ajpendo.1998.275.4.E671; LEE AH, 1986, AM J VET RES, V47, P2000; Macfarlane MS, 2000, ANIM REPROD SCI, V63, P167, DOI 10.1016/S0378-4320(00)00179-2; Madhuranath B N, 2006, Indian J Exp Biol, V44, P28; Mann GE, 2001, VET J, V161, P301, DOI 10.1053/tvjl.2000.0522; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Merl S, 2000, J EQUINE VET SCI, V20, P586, DOI 10.1016/S0737-0806(00)70267-X; Murray MJ, 1996, EQUINE VET J, V28, P368, DOI 10.1111/j.2042-3306.1996.tb03107.x; Nambo Yasuo, 1996, Journal of Equine Science, V7, P1, DOI 10.1294/jes.7.1; Nicol CJ, 2002, VET REC, V151, P658, DOI 10.1136/vr.151.22.658; Phogat JB, 1999, J REPROD FERTIL, V116, P9, DOI 10.1530/jrf.0.1160009; Piccione G, 2013, BIOL RHYTHM RES, V44, P143, DOI 10.1080/09291016.2012.656245; RABIN DS, 1990, BIOL REPROD, V42, P74, DOI 10.1095/biolreprod42.1.74; SAKAKURA M, 1975, J CLIN ENDOCR METAB, V40, P774, DOI 10.1210/jcem-40-5-774; SMITH ER, 1971, NEUROENDOCRINOLOGY, V8, P94, DOI 10.1159/000121997; Soede NM, 1997, ANIM REPROD SCI, V46, P133, DOI 10.1016/S0378-4320(96)01609-0; STOEBEL DP, 1982, J DAIRY SCI, V65, P1016, DOI 10.3168/jds.S0022-0302(82)82303-5; Tischner M, 2006, ANIM REPROD SCI, V94, P234, DOI 10.1016/j.anireprosci.2006.04.043; TSUMA VT, 1995, J VET MED A, V42, P153, DOI 10.1111/j.1439-0442.1995.tb00367.x; Waring G.H., 2003, HORSE BEHAV, V2; WILLARD JG, 1977, J ANIM SCI, V45, P87, DOI 10.2527/jas1977.45187x; Wronska-Fortuna D, 1997, P 6 INT S MOL PHYS A, P417; ZIECIK AJ, 1995, ANIM REPROD SCI, V37, P337, DOI 10.1016/0378-4320(94)01336-K	58	14	14	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e73858	10.1371/journal.pone.0073858	http://dx.doi.org/10.1371/journal.pone.0073858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098636	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500007
J	Seo, JH; Yu, JH; Suh, H; Kim, MS; Cho, SR				Seo, Jung Hwa; Yu, Ji Hea; Suh, Hwal; Kim, Myung-Sun; Cho, Sung-Rae			Fibroblast Growth Factor-2 Induced by Enriched Environment Enhances Angiogenesis and Motor Function in Chronic Hypoxic-Ischemic Brain Injury	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; CELL-PROLIFERATION; STRUCTURAL-CHANGES; PHYSICAL-EXERCISE; FACTOR EXPRESSION; MESSENGER-RNA; ACTIVIN-A; RAT; RECOVERY; INCREASES	This study aimed to investigate the effects of enriched environment (EE) on promoting angiogenesis and neurobehavioral function in an animal model of chronic hypoxic-ischemic (HI) brain injury. HI brain damage was induced in seven day-old CD-1 (R) mice by unilateral carotid artery ligation and exposure to hypoxia (8% O2 for 90 min). At six weeks of age, the mice were randomly assigned to either EE or standard cages (SC) for two months. Rotarod, forelimb-use asymmetry, and grip strength tests were performed to evaluate neurobehavioral function. In order to identify angiogenic growth factors regulated by EE, an array-based multiplex ELISA assay was used to measure the expression in frontal cortex, striatum, and cerebellum. Among the growth factors, the expression of fibroblast growth factor-2 (FGF-2) was confirmed using western blotting. Platelet endothelial cell adhesion molecule-1 (PECAM-1) and alpha-smooth muscle actin (alpha-SMA) were also evaluated using immunohistochemistry. As a result, mice exposed to EE showed significant improvements in rotarod and ladder walking performances compared to SC controls. The level of FGF-2 was significantly higher in the frontal cortex of EE mice at 8 weeks after treatment in multiplex ELISA and western blot. On the other hand, FGF-2 in the striatum significantly increased at 2 weeks after exposure to EE earlier than in the frontal cortex. Expression of activin A was similarly upregulated as FGF-2 expression pattern. Particularly, all animals treated with FGF-2 neutralizing antibody abolished the beneficial effect of EE on motor performance relative to mice not given anti-FGF-2. Immunohistochemistry showed that densities of alpha-SMA(+) and PECAM-1(+) cells in frontal cortex, striatum, and hippocampus were significantly increased following EE, suggesting the histological findings exhibit a similar pattern to the upregulation of FGF-2 in the brain. In conclusion, EE enhances endogenous angiogenesis and neurobehavioral functions mediated by upregulation of FGF-2 in chronic hypoxic-ischemic brain injury.	[Seo, Jung Hwa; Yu, Ji Hea; Kim, Myung-Sun; Cho, Sung-Rae] Yonsei Univ, Coll Med, Dept & Res Inst Rehabil Med, Seoul, South Korea; [Seo, Jung Hwa; Suh, Hwal; Cho, Sung-Rae] Yonsei Univ, Grad Program Nano Sci & Technol, Seoul 120749, South Korea; [Yu, Ji Hea; Cho, Sung-Rae] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea; [Suh, Hwal] Yonsei Univ, Coll Med, Dept Med Engn, Seoul, South Korea; [Kim, Myung-Sun] Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Kim, Myung-Sun; Cho, Sung-Rae] Avison Biomed Res Ctr, Yonsei Stem Cell Ctr, Seoul, South Korea; [Cho, Sung-Rae] Yonsei Univ, Coll Med, Rehabil Inst Neuromuscular Dis, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Hanyang University; Yonsei University; Yonsei University Health System	Cho, SR (corresponding author), Yonsei Univ, Coll Med, Dept & Res Inst Rehabil Med, Seoul, South Korea.	srcho918@yuhs.ac		Cho, Sung-Rae/0000-0003-1429-2684	National Research Foundation [NRF-2010-0020408, 2010-0024334]; Ministry of Education, Science and Technology, Republic of Korea; Chyung Ki Lee Research Fund; Yonsei University College of Medicine [6-2013-0045]; Students' Association of the Graduate School of Yonsei University; Graduate School of Yonsei University	National Research Foundation; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Chyung Ki Lee Research Fund; Yonsei University College of Medicine(General Electric); Students' Association of the Graduate School of Yonsei University; Graduate School of Yonsei University	This study was supported by grants from the National Research Foundation (NRF-2010-0020408; 2010-0024334) funded by the Ministry of Education, Science and Technology, Republic of Korea, the 2011 Chyung Ki Lee Research Fund, the Yonsei University College of Medicine (6-2013-0045), and the Students' Association of the Graduate School of Yonsei University funded by the Graduate School of Yonsei University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Bengoetxea H, 2008, CEREB CORTEX, V18, P1630, DOI 10.1093/cercor/bhm190; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Brown M. D., 2003, Angiogenesis, V6, P1, DOI 10.1023/A:1025809808697; Buschmann I, 1999, NEWS PHYSIOL SCI, V14, P121; Carro E, 2000, J NEUROSCI, V20, P2926; Cho SH, 2003, J IMMUNOL, V170, P4045, DOI 10.4049/jimmunol.170.8.4045; Cohen AD, 2003, J NEUROCHEM, V85, P299, DOI 10.1046/j.1471-4159.2003.01657.x; Comeau WL, 2007, BEHAV BRAIN RES, V180, P18, DOI 10.1016/j.bbr.2007.02.026; Ding Y, 2004, NEUROSCIENCE, V123, P667, DOI 10.1016/j.neuroscience.2003.08.031; Ekstrand J, 2008, NEUROSCI LETT, V442, P203, DOI 10.1016/j.neulet.2008.06.085; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Franklin TB, 2006, BRAIN RES, V1095, P1, DOI 10.1016/j.brainres.2006.04.025; Frazzitta G, 2009, MOVEMENT DISORD, V24, P1139, DOI 10.1002/mds.22491; Gertz K, 2006, CIRC RES, V99, P1132, DOI 10.1161/01.RES.0000250175.14861.77; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Gomez-Pinilla F, 1998, NEUROSCIENCE, V85, P53, DOI 10.1016/S0306-4522(97)00576-9; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Im SH, 2010, NEUROSCIENCE, V169, P259, DOI 10.1016/j.neuroscience.2010.04.038; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kleim JA, 2002, BRAIN RES, V934, P1, DOI 10.1016/S0006-8993(02)02239-4; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li Q, 2002, EXP NEUROL, V177, P531, DOI 10.1006/exnr.2002.7994; Macko RF, 2005, STROKE, V36, P2206, DOI 10.1161/01.STR.0000181076.91805.89; Mizutani K, 2013, NEUROL SCI, V34, P861, DOI 10.1007/s10072-012-1137-3; Monfils MH, 2006, EUR J NEUROSCI, V24, P739, DOI 10.1111/j.1460-9568.2006.04939.x; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Skalak TC, 1998, MICROCIRCULATION-LON, V5, P91, DOI 10.1038/sj.mn.7300022; Soffie M, 1999, BEHAV BRAIN RES, V101, P37, DOI 10.1016/S0166-4328(98)00139-9; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Takakusaki K, 2003, NEUROSCIENCE, V119, P293, DOI 10.1016/S0306-4522(03)00095-2; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1; Wei L, 2001, STROKE, V32, P2179, DOI 10.1161/hs0901.094282; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Yager Jerome Y, 2004, Semin Pediatr Neurol, V11, P31, DOI 10.1016/j.spen.2004.01.006	48	37	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74405	10.1371/journal.pone.0074405	http://dx.doi.org/10.1371/journal.pone.0074405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098645	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500016
J	Eriksen, MB; Nielsen, MFB; Brusgaard, K; Tan, QH; Andersen, MS; Glintborg, D; Gaster, M				Eriksen, Mette B.; Nielsen, Michael F. B.; Brusgaard, Klaus; Tan, Qihua; Andersen, Marianne S.; Glintborg, Dorte; Gaster, Michael			Genetic Alterations within the DENND1A Gene in Patients with Polycystic Ovary Syndrome (PCOS)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CHROMOSOME 2P16.3; BODY HAIR; PROTEIN; WOMEN; HIRSUTISM; VARIANTS; DOMAIN; PREMENOPAUSAL	Polycystic ovary syndrome (PCOS), the most common endocrine disease among premenopausal women, is caused by both genes and environment. We and others previously reported association between single nucleotide polymorphisms (SNPs) in the DENND1A gene and PCOS. We therefore sequenced the DENND1A gene in white patients with PCOS to identify possible alterations that may be implicated in the PCOS pathogenesis. Patients were referred with PCOS and/or hirsutism between 1998 and 2011 (n = 261). PCOS was diagnosed according to the Rotterdam criteria (n = 165). Sequence analysis was performed in 10 patients with PCOS. Additional patients (n = 251) and healthy female controls (n = 248) were included for SNP genotyping. Patients underwent clinical examination including Ferriman-Gallwey score (FG-score), biochemical analyses and transvaginal ultrasound. Mutation analysis was carried out by bidirectional sequencing. SNP genotyping was tested by allelic discrimination in real-time PCR in the additional patients and controls. Sequencing of the DENND1A gene identified eight SNPs; seven were not known to be associated with any diseases. One missense SNP was detected (rs189947178, A/C), potentially altering the structural conformation of the DENND1A protein. SNP genotyping of rs189947178 showed significantly more carriers among patients with PCOS and moderate hirsutism compared to controls. However, due to small sample size and lack of multiple regression analysis supporting an association between rs189947178 and FG-score or PCOS diagnosis, this could be a false positive finding. In conclusion, sequence analysis of the DENND1A gene of patients with PCOS did not identify alterations that alone could be responsible for the PCOS pathogenesis, but a missense SNP (rs189947178) was identified in one patient and significantly more carriers of rs189947178 were found among patients with PCOS and moderate hirsutism vs. controls. Additional studies with independent cohort are needed to confirm this due to the small sample size of this study.	[Eriksen, Mette B.; Andersen, Marianne S.; Glintborg, Dorte; Gaster, Michael] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Eriksen, Mette B.; Nielsen, Michael F. B.; Gaster, Michael] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense, Denmark; [Eriksen, Mette B.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Brusgaard, Klaus; Tan, Qihua] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Tan, Qihua] Univ Southern Denmark, Dept Epidemiol & Biostat, Inst Publ Hlth, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Eriksen, MB (corresponding author), Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark.	mette.eriksen@ouh.rsyd.dk	Brusgaard, Klaus/AGE-8988-2022; Andersen, Marianne Skovsager/AAE-1751-2019; Tan, Qihua/F-1349-2015; Glintborg, Dorte/AAE-3676-2019; Tan, Qihua/AAG-2582-2019	Andersen, Marianne Skovsager/0000-0002-4603-9504; Tan, Qihua/0000-0003-3194-0030; Glintborg, Dorte/0000-0002-8338-8025; Tan, Qihua/0000-0003-3194-0030; Nielsen, Michael Friberg Bruun/0000-0003-3244-9438; Brusgaard, Klaus/0000-0002-2096-4988; Brandt Eriksen, Mette/0000-0001-6785-261X	Region of Southern Denmark [09/13388]; University of Southern Denmark; Augustinus Foundation; A.P. Moller Foundation for the Advancement of Medical Science; Odense University Hospital; Aase og Ejner Danielsens Foundation; Brothers Hartmann Foundation; Vilhelm Bangs Foundation; Familien Hede Nielsens Foundation	Region of Southern Denmark; University of Southern Denmark; Augustinus Foundation; A.P. Moller Foundation for the Advancement of Medical Science; Odense University Hospital; Aase og Ejner Danielsens Foundation; Brothers Hartmann Foundation; Vilhelm Bangs Foundation; Familien Hede Nielsens Foundation	Region of Southern Denmark (grant no. 09/13388), University of Southern Denmark, the Augustinus Foundation, the A.P. Moller Foundation for the Advancement of Medical Science, the free research funds of Odense University Hospital, Aase og Ejner Danielsens Foundation, the Brothers Hartmann Foundation, Vilhelm Bangs Foundation and Familien Hede Nielsens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Api M, 2009, ARCH GYNECOL OBSTET, V279, P473, DOI 10.1007/s00404-008-0747-8; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cook H, 2011, FERTIL STERIL, V96, P1266, DOI 10.1016/j.fertnstert.2011.08.022; Cui LL, 2013, HUM REPROD, V28, P538, DOI 10.1093/humrep/des424; DeUgarte CM, 2006, J CLIN ENDOCR METAB, V91, P1345, DOI 10.1210/jc.2004-2301; Diamanti-Kandarakis Evanthia, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000598; Eriksen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014469; Eriksen MB, 2012, EUR J OBSTET GYN R B, V163, P39, DOI 10.1016/j.ejogrb.2012.03.020; Eriksen MB, 2011, J CLIN ENDOCR METAB, V96, pE1298, DOI 10.1210/jc.2011-0278; Escobar-Morreale HF, 2012, HUM REPROD UPDATE, V18, P146, DOI 10.1093/humupd/dmr042; Ewens KG, 2011, FERTIL STERIL, V95, P2538, DOI 10.1016/j.fertnstert.2011.02.050; Ewens KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016390; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Glintborg D, 2005, J CLIN ENDOCR METAB, V90, P1347, DOI 10.1210/jc.2004-1214; Glintborg D, 2004, FERTIL STERIL, V82, P1570, DOI 10.1016/j.fertnstert.2004.06.040; Glintborg D, 2012, GYNECOL ENDOCRINOL, V28, P170, DOI 10.3109/09513590.2011.589926; Glintborg D, 2010, CLIN ENDOCRINOL, V73, P732, DOI 10.1111/j.1365-2265.2010.03873.x; Glintborg D, 2010, GYNECOL ENDOCRINOL, V26, P281, DOI 10.3109/09513590903247873; Goodarzi MO, 2012, J MED GENET, V49, P90, DOI 10.1136/jmedgenet-2011-100427; Jones MR, 2012, STEROIDS, V77, P317, DOI 10.1016/j.steroids.2011.12.005; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lerchbaum E, 2011, HORM METAB RES, V43, P743, DOI 10.1055/s-0031-1286279; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Moran C, 2010, GYNECOL OBSTET INVES, V69, P274, DOI 10.1159/000277640; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Ohdaira H, 2009, COMPUT BIOL CHEM, V33, P429, DOI 10.1016/j.compbiolchem.2009.09.003; Sagsoz N, 2004, YONSEI MED J, V45, P483; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Tellez R, 1995, REV MED CHILE, V123, P1349; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Welt CK, 2012, J CLIN ENDOCR METAB, V97, pE1342, DOI 10.1210/jc.2011-3478; Wu XD, 2011, P NATL ACAD SCI USA, V108, P18672, DOI 10.1073/pnas.1110415108; 2000, J CLIN ENDOCR METAB, V85, P2434, DOI DOI 10.1210/JC.85.7.2434.PUBMED:10902790; J CLIN ENDOCR METAB, V89, P2745, DOI DOI 10.1210/JC.2003-032046.PUBMED:15181052	45	28	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77186	10.1371/journal.pone.0077186	http://dx.doi.org/10.1371/journal.pone.0077186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086769	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900113
J	Sakharwade, SC; Sharma, PK; Mukhopadhaya, A				Sakharwade, Sanica C.; Sharma, Praveen K.; Mukhopadhaya, Arunika			Vibrio cholerae Porin OmpU Induces Pro-Inflammatory Responses, but Down-Regulates LPS-Mediated Effects in RAW 264.7, THP-1 and Human PBMCs	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; TNF-ALPHA; CYTOKINE PRODUCTION; EPITHELIAL-CELLS; NITRIC-OXIDE; EXPRESSION; RELEASE; VACCINE; RESISTANCE; TOLERANCE	Vibrio cholerae porin OmpU plays a crucial role in the survival of the organism in the human gut. Various observations suggest critical involvement of OmpU in V. cholerae pathogenesis. However, OmpU is poorly characterized in terms of its ability to evoke cellular responses, particularly in the context of host immune system. Therefore, towards characterizing V. cholerae OmpU for its host immunomodulatory functions, we have studied the ability of OmpU to elicit pro-inflammatory responses in a range of immune cells which include, mouse RAW 264.7 macrophages, human THP-1 monocytes and human PBMCs. We have observed that purified OmpU induces pro-inflammatory responses in terms of production of NO, TNF and IL-6. Interestingly, pre-treatment of the cells with OmpU suppresses the production of NO, TNF, IL-6 as well as IL-12 upon subsequent activation with LPS. Our results therefore suggest that V. cholerae OmpU may have a differential regulatory role in terms of host immunomodulatory function: it can induce pro-inflammatory responses in target host immune cells, whereas it can also exert suppressive effect on LPS-induced pro-inflammatory responses. In addition, our study indicates that purified OmpU may have the ability to skew the Th1 response towards the Th2 response, presumably via suppression of IL-12 production.	[Sakharwade, Sanica C.; Sharma, Praveen K.; Mukhopadhaya, Arunika] Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Mohali, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Mukhopadhaya, A (corresponding author), Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Mohali, Punjab, India.	arunika@iisermohali.ac.in		Mukhopadhaya, Arunika/0000-0003-2121-7885	Department of Biotechnology (DBT), India (DBT) [BT/PR1205/MED/29/318/2011]; IISER Mohali	Department of Biotechnology (DBT), India (DBT); IISER Mohali	This work was supported by a grant from the Department of Biotechnology (DBT), India (DBT Grant No. BT/PR1205/MED/29/318/2011) and funding from IISER Mohali. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARDINI ML, 1993, INFECT IMMUN, V61, P3625, DOI 10.1128/IAI.61.9.3625-3635.1993; Biancone L, 1997, EXP NEPHROL, V5, P330; Biswas T, 2000, FEMS IMMUNOL MED MIC, V29, P129; Burkart V, 2002, J IMMUNOL, V168, P1730, DOI 10.4049/jimmunol.168.4.1730; Cai SH, 2013, J FISH DIS, V36, P695, DOI 10.1111/jfd.12036; Chakrabarti Sr, 1996, J BACTERIOL, V178, P524, DOI 10.1128/jb.178.2.524-530.1996; Chan ED, 1999, J IMMUNOL, V162, P415; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Domingos MO, 2009, TOXICON, V53, P570, DOI 10.1016/j.toxicon.2008.12.017; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Duret G, 2006, J BIOL CHEM, V281, P19899, DOI 10.1074/jbc.M602426200; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; GALDIERO F, 1993, INFECT IMMUN, V61, P155, DOI 10.1128/IAI.61.1.155-161.1993; Galdiero M, 2003, FEMS MICROBIOL LETT, V226, P57, DOI 10.1016/S0378-1097(03)00562-7; Galdiero M, 2001, MICROBIOL-SGM, V147, P2697, DOI 10.1099/00221287-147-10-2697; Galdiero M, 2004, INFECT IMMUN, V72, P1204, DOI 10.1128/IAI.72.2.1204-1209.2004; Goel AK, 2010, WORLD J MICROB BIOT, V26, P281, DOI 10.1007/s11274-009-0171-7; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Gupta S, 1999, MOL CELL BIOCHEM, V194, P235, DOI 10.1023/A:1006971621653; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; Holm MM, 2004, INFECT IMMUN, V72, P1906, DOI 10.1128/IAI.72.4.1906-1913.2004; HOUSSIAU FA, 1989, J IMMUNOL, V143, P2520; Khan J, 2012, PROTEIN EXPRES PURIF, V85, P204, DOI 10.1016/j.pep.2012.08.005; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Latz E, 2004, J IMMUNOL, V172, P2431, DOI 10.4049/jimmunol.172.4.2431; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Mathur J, 2004, INFECT IMMUN, V72, P3577, DOI 10.1128/IAI.72.6.3577-3583.2004; Merrell DS, 2001, J BACTERIOL, V183, P2746, DOI 10.1128/JB.183.9.2746-2754.2001; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Nakasone N, 1998, INFECT IMMUN, V66, P4726, DOI 10.1128/IAI.66.10.4726-4728.1998; Negm RS, 1999, CAN J MICROBIOL, V45, P658, DOI 10.1139/cjm-45-8-658; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Provenzano D, 2001, J BACTERIOL, V183, P3652, DOI 10.1128/JB.183.12.3652-3662.2001; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rolhion N, 2007, MOL MICROBIOL, V63, P1684, DOI 10.1111/j.1365-2958.2007.05638.x; Sarkar M, 2012, FEBS J, V279, P1464, DOI 10.1111/j.1742-4658.2012.08539.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SETRAKIAN JC, 1994, ARCH SURG-CHICAGO, V129, P187; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; SPERANDIO V, 1995, INFECT IMMUN, V63, P4433, DOI 10.1128/IAI.63.11.4433-4438.1995; TABARAIE B, 1994, MICROBIOL IMMUNOL, V38, P553, DOI 10.1111/j.1348-0421.1994.tb01822.x; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Viana CFG, 2002, TOXICON, V40, P1487, DOI 10.1016/S0041-0101(02)00170-8; Wang Q, 2011, LETT APPL MICROBIOL, V53, P22, DOI 10.1111/j.1472-765X.2011.03062.x; Whitaker WB, 2012, INFECT IMMUN, V80, P1834, DOI 10.1128/IAI.06284-11; Wibbenmeyer JA, 2002, INFECT IMMUN, V70, P121, DOI 10.1128/IAI.70.1.121-126.2002; Xiong XP, 2010, MAR BIOTECHNOL, V12, P686, DOI 10.1007/s10126-009-9256-4	53	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76583	10.1371/journal.pone.0076583	http://dx.doi.org/10.1371/journal.pone.0076583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086753	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900106
J	Beck-Johnson, LM; Nelson, WA; Paaijmans, KP; Read, AF; Thomas, MB; Bjornstad, ON				Beck-Johnson, Lindsay M.; Nelson, William A.; Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.			The Effect of Temperature on Anopheles Mosquito Population Dynamics and the Potential for Malaria Transmission	PLOS ONE			English	Article							GAMBIAE GILES COMPLEX; CLIMATE-CHANGE; PLASMODIUM-FALCIPARUM; GENERATION SEPARATION; DEPENDENT DEVELOPMENT; IMMATURE STAGES; AQUATIC STAGES; BODY-SIZE; DIPTERA; MODEL	The parasites that cause malaria depend on Anopheles mosquitoes for transmission; because of this, mosquito population dynamics are a key determinant of malaria risk. Development and survival rates of both the Anopheles mosquitoes and the Plasmodium parasites that cause malaria depend on temperature, making this a potential driver of mosquito population dynamics and malaria transmission. We developed a temperature-dependent, stage-structured delayed differential equation model to better understand how climate determines risk. Including the full mosquito life cycle in the model reveals that the mosquito population abundance is more sensitive to temperature than previously thought because it is strongly influenced by the dynamics of the juvenile mosquito stages whose vital rates are also temperature-dependent. Additionally, the model predicts a peak in abundance of mosquitoes old enough to vector malaria at more accurate temperatures than previous models. Our results point to the importance of incorporating detailed vector biology into models for predicting the risk for vector borne diseases.	[Beck-Johnson, Lindsay M.; Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Beck-Johnson, Lindsay M.; Read, Andrew F.; Bjornstad, Ottar N.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Read, Andrew F.; Bjornstad, Ottar N.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Beck-Johnson, LM (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	lmb404@psu.edu	Paaijmans, Krijn/ABC-9928-2020; Peijnenburg, Katja TCA/F-7176-2016; de Voogd, Nicole/I-9280-2012; Nelson, William A/D-1405-2013	Peijnenburg, Katja TCA/0000-0001-7544-1079; de Voogd, Nicole/0000-0002-7985-5604; Erpenbeck, Dirk/0000-0003-2716-1085	United States Department of Agriculture National Research Initiative [2006-35302-17149]; National Science Foundation-EID program grant [EF-0914384]	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); National Science Foundation-EID program grant	This research was supported by United States Department of Agriculture National Research Initiative 2006-35302-17149 to ONB, www.usda.gov, and by National Science Foundation-EID program grant EF-0914384 to MBT and AFR, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677; ANIEDU I, 1993, INSECT SCI APPL, V14, P39, DOI 10.1017/S1742758400013370; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Bayoh MN, 2001, THESIS U DURHAM; Beaty B.J., 1996, BIOL DIS VECTORS; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; BRIGGS CJ, 1995, AM NAT, V145, P855, DOI 10.1086/285774; Centers for Disease Control and Prevention (CDC), 2012, MAL FACTS; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; Clements AN., 1992, BIOL MOSQUITOES DEV; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; de Roos AM, 2003, THEOR POPUL BIOL, V63, P1, DOI 10.1016/S0040-5809(02)00009-6; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Ellner S.P., 2006, DYNAMIC MODELS BIOL, DOI DOI 10.1139/F10-077; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Lardeux FJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-141; LYIMO EO, 1992, PARASITOLOGY, V104, P233, DOI 10.1017/S0031182000061667; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; McCauley E, 2008, NATURE, V455, P1240, DOI 10.1038/nature07220; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Mukiama TK, 1989, FIELD STUDIES LARVAL; Munga S, 2007, J MED ENTOMOL, V44, P758, DOI 10.1603/0022-2585(2007)44[758:SOISOA]2.0.CO;2; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; Mwangangi JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-114; NISBET RM, 1983, THEOR POPUL BIOL, V23, P114, DOI 10.1016/0040-5809(83)90008-4; Okogun Godwin Ray Anugboba, 2005, Journal of Vector Borne Diseases, V42, P45; Paaijmans KP, 2008, HYDROL PROCESS, V22, P4789, DOI 10.1002/hyp.7099; Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2009, ENV HLTH PERSPECT, V118; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; REISEN WK, 1975, MOSQ NEWS, V35, P473; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Ross R., 1910, PREVENTION MALARIA; SERVICE MW, 1977, J MED ENTOMOL, V13, P535, DOI 10.1093/jmedent/13.4-5.535; SERVICE MW, 1973, B ENTOMOL RES, V62, P359, DOI 10.1017/S0007485300003862; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Timmermann S. E., 1993, Bulletin of the Society for Vector Ecology, V18, P174; Yamanaka T, 2012, AM NAT, V179, P95, DOI 10.1086/663201; [No title captured]	60	181	183	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79276	10.1371/journal.pone.0079276	http://dx.doi.org/10.1371/journal.pone.0079276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24098416	gold, Green Published, Green Submitted			2022-12-27	WOS:000327143800053
J	Fredriksson, NJ; Hermansson, M; Wilen, BM				Fredriksson, Nils Johan; Hermansson, Malte; Wilen, Britt-Marie			The Choice of PCR Primers Has Great Impact on Assessments of Bacterial Community Diversity and Dynamics in a Wastewater Treatment Plant	PLOS ONE			English	Article							ESTIMATING PROKARYOTIC DIVERSITY; RNA GENE DATABASE; WEB-BASED TOOL; ACTIVATED-SLUDGE; MICROBIAL COMMUNITIES; TREATMENT SYSTEM; 16S; LIBRARIES; QUANTIFICATION; SPECIFICITY	Assessments of bacterial community diversity and dynamics are fundamental for the understanding of microbial ecology as well as biotechnological applications. We show that the choice of PCR primers has great impact on the results of analyses of diversity and dynamics using gene libraries and DNA fingerprinting. Two universal primer pairs targeting the 16S rRNA gene, 27F&1492R and 63F&M1387R, were compared and evaluated by analyzing the bacterial community in the activated sludge of a large-scale wastewater treatment plant. The two primer pairs targeted distinct parts of the bacterial community, none encompassing the other, both with similar richness. Had only one primer pair been used, very different conclusions had been drawn regarding dominant phylogenetic and putative functional groups. With 27F&1492R, Betaproteobacteria would have been determined to be the dominating taxa while 63F&M1387R would have described Alphaproteobacteria as the most common taxa. Microscopy and fluorescence in situ hybridization analysis showed that both Alphaproteobacteria and Betaproteobacteria were abundant in the activated sludge, confirming that the two primer pairs target two different fractions of the bacterial community. Furthermore, terminal restriction fragment polymorphism analyses of a series of four activated sludge samples showed that the two primer pairs would have resulted in different conclusions about community stability and the factors contributing to changes in community composition. In conclusion, different PCR primer pairs, although considered universal, target different ranges of bacteria and will thus show the diversity and dynamics of different fractions of the bacterial community in the analyzed sample. We also show that while a database search can serve as an indicator of how universal a primer pair is, an experimental assessment is necessary to evaluate the suitability for a specific environmental sample.	[Fredriksson, Nils Johan; Wilen, Britt-Marie] Chalmers Univ Technol, Dept Civil & Environm Engn, S-41296 Gothenburg, Sweden; [Hermansson, Malte] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Fredriksson, NJ (corresponding author), Chalmers Univ Technol, Dept Civil & Environm Engn, S-41296 Gothenburg, Sweden.	johan.fredriksson@chalmers.se	Fredriksson, Nils Johan/AAC-8083-2020; Wilen, Britt-Marie/B-5042-2016	Fredriksson, Nils Johan/0000-0002-5763-6777; Wilen, Britt-Marie/0000-0001-6155-7759; Steensland, Pia/0000-0003-4443-5017	FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning	FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This work was funded by a research grant from FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsubasi AT, 2009, ENVIRON SCI TECHNOL, V43, P2950, DOI 10.1021/es8026488; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; [Anonymous], 2003, PROGRAM SPADE SPECIE; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bramucci M, 2003, APPL MICROBIOL BIOT, V62, P594, DOI 10.1007/s00253-003-1372-x; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Curtis TP, 2006, WATER SCI TECHNOL, V54, P227, DOI 10.2166/wst.2006.391; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2006, TRENDS BIOTECHNOL, V24, P483, DOI 10.1016/j.tibtech.2006.09.002; Dedysh SN, 2004, MICROBIOL-SGM, V150, P1301, DOI 10.1099/mic.0.26585-0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Figuerola ELM, 2007, ENVIRON MICROBIOL, V9, P1780, DOI 10.1111/j.1462-2920.2007.01298.x; Fortuna AM, 2011, APPL MICROBIOL BIOT, V91, P1193, DOI 10.1007/s00253-011-3363-7; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hugenholtz P, 2002, GENOME BIOL, V3; Jin DC, 2011, J ENVIRON SCI-CHINA, V23, P1880, DOI 10.1016/S1001-0742(10)60621-3; Kemp PF, 2004, LIMNOL OCEANOGR-METH, V2, P114, DOI 10.4319/lom.2004.2.114; Khan ST, 2002, APPL ENVIRON MICROB, V68, P3206, DOI 10.1128/AEM.68.7.3206-3214.2002; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kong YH, 2007, MICROBIOL-SGM, V153, P4061, DOI 10.1099/mic.0.2007/007245-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Layton AC, 2000, APPL ENVIRON MICROB, V66, P1167, DOI 10.1128/AEM.66.3.1167-1174.2000; Legendre P., 2012, NUMERICAL ECOLOGY; Lowe BA, 2011, VET MICROBIOL, V147, P346, DOI 10.1016/j.vetmic.2010.06.025; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; McMahon KD, 2007, CURR OPIN BIOTECH, V18, P287, DOI 10.1016/j.copbio.2007.04.007; Mertens B, 2005, ENVIRON MICROBIOL, V7, P660, DOI 10.1111/j.1462-2920.2005.00735.x; Morales SE, 2009, APPL ENVIRON MICROB, V75, P2677, DOI 10.1128/AEM.02166-08; Nadarajah N, 2007, WATER RES, V41, P2563, DOI 10.1016/j.watres.2007.02.002; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Pholchan MK, 2010, WATER RES, V44, P1341, DOI 10.1016/j.watres.2009.11.005; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Saikaly PE, 2005, APPL ENVIRON MICROB, V71, P5814, DOI 10.1128/AEM.71.10.5814-5822.2005; Saikaly PE, 2004, MICROB ECOL, V48, P274, DOI 10.1007/s00248-003-1027-6; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URAKAMI T, 1995, INT J SYST BACTERIOL, V45, P528, DOI 10.1099/00207713-45-3-528; Valentin-Vargas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042524; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wartiainen I, 2006, INT J SYST EVOL MICR, V56, P541, DOI 10.1099/ijs.0.63912-0; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilen BM, 2010, WATER ENVIRON RES, V82, P155, DOI 10.2175/106143009X426004; Yang C, 2011, ENVIRON SCI TECHNOL, V45, P7408, DOI 10.1021/es2010545; Yuan ZG, 2002, WATER RES, V36, P482, DOI 10.1016/S0043-1354(01)00230-5; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	68	133	135	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76431	10.1371/journal.pone.0076431	http://dx.doi.org/10.1371/journal.pone.0076431			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	23977009	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100066
J	Gao, YR; Choe, AS; Stepniewska, I; Li, X; Avison, MJ; Anderson, AW				Gao, Yurui; Choe, Ann S.; Stepniewska, Iwona; Li, Xia; Avison, Malcolm J.; Anderson, Adam W.			Validation of DTI Tractography-Based Measures of Primary Motor Area Connectivity in the Squirrel Monkey Brain	PLOS ONE			English	Article							WHITE-MATTER; DIFFUSION; TRACKING; MRI; RESOLUTION; PATHWAYS; SEGMENTATION; ACCURACY; DORSAL; TRACTS	Diffusion tensor imaging (DTI) tractography provides noninvasive measures of structural cortico-cortical connectivity of the brain. However, the agreement between DTI-tractography-based measures and histological 'ground truth' has not been quantified. In this study, we reconstructed the 3D density distribution maps (DDM) of fibers labeled with an anatomical tracer, biotinylated dextran amine (BDA), as well as DTI tractography-derived streamlines connecting the primary motor (M1) cortex to other cortical regions in the squirrel monkey brain. We evaluated the agreement in M1-cortical connectivity between the fibers labeled in the brain tissue and DTI streamlines on a regional and voxel-by-voxel basis. We found that DTI tractography is capable of providing inter-regional connectivity comparable to the neuroanatomical connectivity, but is less reliable measuring voxel-to-voxel variations within regions.	[Gao, Yurui; Choe, Ann S.; Anderson, Adam W.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Gao, Yurui; Choe, Ann S.; Li, Xia; Avison, Malcolm J.; Anderson, Adam W.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Stepniewska, Iwona] Vanderbilt Univ, Dept Psychol, Nashville, TN 37235 USA; [Avison, Malcolm J.; Anderson, Adam W.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Avison, Malcolm J.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Avison, Malcolm J.] Vanderbilt Univ, Dept Neurol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Gao, YR (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	yurui.gao@vanderbilt.edu	AS, Choe/I-2637-2019; Gao, Yurui/W-4327-2017	AS, Choe/0000-0001-7352-1489; 	National Institutes of Health [R01-NS58639, R01-DA028303, 1S10 RR 17789]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, U24DK059637, P30DK058404, P60DK020593, U2CDK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institutes of Health grants R01-NS58639, R01-DA028303 and 1S10 RR 17789. Experiments were performed in part through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Cho KH, 2008, NEUROIMAGE, V42, P262, DOI 10.1016/j.neuroimage.2008.03.053; Choe AS, 2011, MAGN RESON IMAGING, V29, P683, DOI 10.1016/j.mri.2011.02.022; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; D'Arceuil HE, 2007, NEUROIMAGE, V35, P553, DOI 10.1016/j.neuroimage.2006.12.028; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Hubbard PL, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P353, DOI 10.1016/B978-0-12-374709-9.00016-X; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Lazar M, 2005, NEUROIMAGE, V24, P524, DOI 10.1016/j.neuroimage.2004.08.050; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Li CM, 2008, LECT NOTES COMPUT SC, V5242, P1083; Marchi V., 1885, RIV SPER FRENIATRIA, V11, P492; Morecraft RJ, 2009, CLASSIC CONT NEURAL, P274; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; NAUTA WJH, 1993, J NEUROSCI, V13, P1337; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Rohde GK, 2003, IEEE T MED IMAGING, V22, P1470, DOI 10.1109/TMI.2003.819299; Seehaus AK, 2013, CEREB CORTEX, V23, P442, DOI 10.1093/cercor/bhs036; Singer C., 1952, VESALIUS HUMAN BRAIN; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; STEPNIEWSKA I, 1993, J COMP NEUROL, V330, P238, DOI 10.1002/cne.903300207; TOGA AW, 1994, NEUROIMAGE, V1, P334, DOI 10.1006/nimg.1994.1018; Vercelli A, 2000, BRAIN RES B, V51; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1	50	80	80	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75065	10.1371/journal.pone.0075065	http://dx.doi.org/10.1371/journal.pone.0075065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24349360	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100015
J	Liu, YX; Wang, XJ; Liu, YX; Sun, DP; Ding, SJ; Zhang, BB; Du, ZH; Xue, FZ				Liu, Yunxia; Wang, Xianjun; Liu, Yanxun; Sun, Dapeng; Ding, Shujun; Zhang, Bingbing; Du, Zhaohui; Xue, Fuzhong			Detecting Spatial-Temporal Clusters of HFMD from 2007 to 2011 in Shandong Province, China	PLOS ONE			English	Article							MOUTH-DISEASE; FOOT; HAND; OUTBREAK; ONYCHOMADESIS; EPIDEMIOLOGY; INFECTIONS; CITY	Background: Hand, foot, and mouth disease (HFMD) has caused major public health concerns worldwide, and has become one of the leading causes of children death. China is the most serious epidemic area with a total of 3,419,149 reported cases just from 2008 to 2010, and its different geographic areas might have different spatial epidemiology characteristics at different spatial-temporal scale levels. We conducted spatial and spatial-temporal epidemiology analysis to HFMD at county level in Shandong Province, China. Methods: Based on the China National Disease Surveillance Reporting and Management System, the spatial-temporal database of HFMD from 2007 to 2011 was built. The global autocorrelation statistic (Moran's I) was first used to detect the spatial autocorrelation of HFMD cases in each year. Purely Spatial scan statistics combined with Space-time scan statistic were used to detect epidemic clusters. Results: The annual average incidence rate was 93.70 per 100,000 in Shandong Province. Most HFMD cases (93.94%) were aged within 0-5 years old with an average male-to-female sex ratio 1.71, and the incidence seasonal peak was between April and July. The dominant pathogen was EV71 (47.35%), and CoxA16 (26.59%). HFMD had positive spatial autocorrelation at medium spatial scale level (county level) with higher Moran's I from 0.31 to 0.62 (P<0.001). Seven spatial-temporal clusters were detected from 2007 to 2011 in the landscape of the whole Shandong, with EV71 or CoxA16 as the dominant pathogen for most hotspots areas. Conclusions: The spatial-temporal clusters of HFMD wandered around the whole Shandong Province during 2007 to 2011, with EV71 or CoxA16 as the dominant pathogen. These findings suggested that a real-time spatial-temporal surveillance system should be established for identifying high incidence region and conducting prevention to HFMD timely.	[Liu, Yunxia; Liu, Yanxun; Zhang, Bingbing; Du, Zhaohui; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China; [Wang, Xianjun; Sun, Dapeng; Ding, Shujun] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China	Shandong University	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Du, Zhaohui/AAK-6231-2021; Xue, Fuzhong/AAG-4808-2020; zhang, liwen/L-7005-2016; He, Huiguang/AAD-7643-2020	Du, Zhaohui/0000-0002-7125-8928; He, Huiguang/0000-0002-0684-1711; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81001292]; Shandong Province science and technology development plan [2009GG10002055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province science and technology development plan	This work was supported by No.81001292 of the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm), 2009GG10002055 of Shandong Province science and technology development plan in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Anselin L, 2004, GEODA0 95I RELEASE N; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Cao Li-Hua, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P227; Chang Zhao-rui, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P676; Chinese Center for Disease Control and Prevention(China CDC), 2010, NAT INC DEATH CAS NO; Chinese Ministry of Health, 2008, HAND FOOT MOUTH DIS; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Higgs BW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001284; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Liu Wen-dong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P813; Ma E, 2010, JPN J INFECT DIS, V63, P422; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Ni HX, 2012, J CLIN VIROL, V54, P342, DOI 10.1016/j.jcv.2012.04.021; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Puenpa J, 2011, ARCH VIROL, V156, P2007, DOI 10.1007/s00705-011-1098-5; Tang Xian-yan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P274; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Xiao Ge-xin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P808; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	36	38	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63447	10.1371/journal.pone.0063447	http://dx.doi.org/10.1371/journal.pone.0063447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	24098769	Green Published, gold, Green Submitted			2022-12-27	WOS:000319330200039
J	Li, SH; Zhang, XJ; Sun, Z; Li, FH; Xiang, JH				Li, Shihao; Zhang, Xiaojun; Sun, Zheng; Li, Fuhua; Xiang, Jianhai			Transcriptome Analysis on Chinese Shrimp Fenneropenaeus chinensis during WSSV Acute Infection	PLOS ONE			English	Article							SPOT-SYNDROME-VIRUS; BLACK TIGER SHRIMP; DIFFERENTIALLY EXPRESSED GENES; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; PROPHENOLOXIDASE-ACTIVATING SYSTEM; ANTILIPOPOLYSACCHARIDE FACTOR ALF; RNA INTERFERENCE PATHWAY; PENAEUS-MONODON; MOLECULAR-CLONING; ANTIMICROBIAL ACTIVITY	Previous studies have discovered a lot of immune-related genes responding to white spot syndrome virus (WSSV) infection in crustacean. However, little information is available in relation to underlying mechanisms of host responses during the WSSV acute infection stage in naturally infected shrimp. In this study, we employed next-generation sequencing and bioinformatic techniques to observe the transcriptome differences of the shrimp between latent infection stage and acute infection stage. A total of 64,188,426 Illumina reads, including 31,685,758 reads from the latent infection group and 32,502,668 reads from the acute infection group, were generated and assembled into 46,676 unigenes (mean length: 676 bp; range: 200-15,094 bp). Approximately 24,000 peptides were predicted and classified based on homology searches, gene ontology, clusters of orthologous groups of proteins, and biological pathway mapping. Among which, 805 differentially expressed genes were identified and categorized into 11 groups based on their possible function. Genes in the Toll and IMD pathways, the Ras-activated endocytosis process, the RNA interference pathway, anti-lipopolysaccharide factors and many other genes, were found to be activated in shrimp from latent infection stage to acute infection stage. The anti-bacterially proPO-activating cascade was firstly uncovered to be probably participated in antiviral process. These genes contain not only members playing function in host defense against WSSV, but also genes utilized by WSSV for its rapid proliferation. In addition, the transcriptome data provides detail information for identifying novel genes in absence of the genome database of shrimp.	[Li, Shihao; Zhang, Xiaojun; Sun, Zheng; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Li, FH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	fhli@ms.qdio.ac.cn; jhxiang@ms.qdio.ac.cn	zhang, jin/GXV-9154-2022; xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787; Sun, Zheng/0000-0002-8537-8576; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046	Major State Basic Research Development Program [2012CB114403]; National High Tech Research and Development Program [2012AA10A404, 2012AA092205]; National Natural Science Foundation Program [31072203]; China Agriculture Research System-47 [CARS-47]; Special Fund for Agro-scientific Research in the Public Interest [201103034]	Major State Basic Research Development Program(National Basic Research Program of China); National High Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation Program(National Natural Science Foundation of China (NSFC)); China Agriculture Research System-47; Special Fund for Agro-scientific Research in the Public Interest	This work was financially supported by the Major State Basic Research Development Program (2012CB114403), National High Tech Research and Development Program (2012AA10A404, 2012AA092205), National Natural Science Foundation Program (31072203), China Agriculture Research System-47 (CARS-47), and Special Fund for Agro-scientific Research in the Public Interest (201103034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Assavalapsakul W, 2009, DIS AQUAT ORGAN, V84, P167, DOI 10.3354/dao02044; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Beale KM, 2008, COMP BIOCHEM PHYS D, V3, P263, DOI 10.1016/j.cbd.2008.07.001; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Chen LL, 2000, DIS AQUAT ORGAN, V40, P157, DOI 10.3354/dao040157; Chen P, 2010, FISH SHELLFISH IMMUN, V28, P106, DOI 10.1016/j.fsi.2009.10.002; Chen WY, 2008, DEV COMP IMMUNOL, V32, P1142, DOI 10.1016/j.dci.2008.03.003; Chen YH, 2012, FISH SHELLFISH IMMUN, V32, P373, DOI 10.1016/j.fsi.2011.11.032; Codran A, 2006, J GEN VIROL, V87, P2583, DOI 10.1099/vir.0.81710-0; Dechklar M, 2008, BIOCHEM BIOPH RES CO, V367, P768, DOI 10.1016/j.bbrc.2008.01.031; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Flegel T.W., 2008, DIS ASIAN AQUACULTUR, V6, P355; Fujioka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016324; Gai YC, 2008, FISH SHELLFISH IMMUN, V24, P156, DOI 10.1016/j.fsi.2007.08.006; Gao HW, 2009, MOL BIOL REP, V36, P1159, DOI 10.1007/s11033-008-9292-6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han F, 2012, GENE, V495, P65, DOI 10.1016/j.gene.2011.11.048; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; HOESS A, 1993, EMBO J, V12, P3351, DOI 10.1002/j.1460-2075.1993.tb06008.x; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hossain MS, 2004, VIROLOGY, V325, P106, DOI 10.1016/j.virol.2004.05.005; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Huang XD, 2009, FISH SHELLFISH IMMUN, V27, P230, DOI 10.1016/j.fsi.2009.05.003; Imjongjirak C, 2007, MOL IMMUNOL, V44, P3195, DOI 10.1016/j.molimm.2007.01.028; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jimenez-Vega F, 2007, J SHELLFISH RES, V26, P1169, DOI 10.2983/0730-8000(2007)26[1169:IOLVAA]2.0.CO;2; Jiravanichpaisal P, 2006, FISH SHELLFISH IMMUN, V20, P718, DOI 10.1016/j.fsi.2005.09.002; Jiravanichpaisal P, 2004, FISH SHELLFISH IMMUN, V17, P265, DOI 10.1016/j.fsi.2004.03.010; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Khadijah S, 2003, J VIROL, V77, P10162, DOI 10.1128/JVI.77.18.10162-10167.2003; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Ko CF, 2007, DEV COMP IMMUNOL, V31, P12, DOI 10.1016/j.dci.2006.05.002; Krishnan P, 2009, DIS AQUAT ORGAN, V86, P263, DOI 10.3354/dao02126; Lai CY, 2005, FISH SHELLFISH IMMUN, V18, P417, DOI 10.1016/j.fsi.2004.10.004; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Li CH, 2008, DEV COMP IMMUNOL, V32, P784, DOI 10.1016/j.dci.2007.11.008; Li FH, 2010, DEV COMP IMMUNOL, V34, P874, DOI 10.1016/j.dci.2010.03.008; Li FH, 2009, DEV COMP IMMUNOL, V33, P1093, DOI 10.1016/j.dci.2009.06.001; Liu B, 2006, AQUACULTURE, V253, P163, DOI 10.1016/j.aquaculture.2005.08.022; Liu CH, 2006, FISH SHELLFISH IMMUN, V21, P60, DOI 10.1016/j.fsi.2005.10.004; Liu FS, 2005, MAR BIOTECHNOL, V7, P600, DOI 10.1007/s10126-005-5006-4; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Magbanua FO, 2000, DIS AQUAT ORGAN, V42, P77, DOI 10.3354/dao042077; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; Masuda T, 2012, FISH SHELLFISH IMMUN, V32, P61, DOI 10.1016/j.fsi.2011.10.020; Mekata T, 2011, MOL CELL PROBE, V25, P94, DOI 10.1016/j.mcp.2011.02.001; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naitza S, 2004, MOL IMMUNOL, V40, P887, DOI 10.1016/j.molimm.2003.10.008; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Prapavorarat A, 2010, J BIOL CHEM, V285, P21467, DOI 10.1074/jbc.M110.130526; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ren Q, 2009, FISH SHELLFISH IMMUN, V26, P787, DOI 10.1016/j.fsi.2009.03.004; Robalino J, 2005, J VIROL, V79, P13561, DOI 10.1128/JVI.79.21.13561-13571.2005; Roux MM, 2002, J VIROL, V76, P8978, DOI 10.1128/JVI.76.17.8978.2002; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Saksmerprome V, 2009, J VIROL METHODS, V162, P213, DOI 10.1016/j.jviromet.2009.08.010; Sarathi M, 2008, MAR BIOTECHNOL, V10, P198, DOI 10.1007/s10126-007-9052-y; Shekhar MS, 2009, MAR BIOTECHNOL, V11, P1, DOI 10.1007/s10126-008-9155-0; Shi XZ, 2009, FISH SHELLFISH IMMUN, V27, P610, DOI 10.1016/j.fsi.2009.07.005; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Sritunyalucksana K, 1999, DEV COMP IMMUNOL, V23, P179, DOI 10.1016/S0145-305X(99)00005-1; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Su JS, 2008, FISH SHELLFISH IMMUN, V24, P223, DOI 10.1016/j.fsi.2007.11.006; Sun C, 2011, MOL BIOL REP, V38, P5313, DOI 10.1007/s11033-011-0681-x; Sun YM, 2013, AQUACULTURE, V376, P124, DOI 10.1016/j.aquaculture.2012.11.014; Supungul P, 2004, DIS AQUAT ORGAN, V61, P123, DOI 10.3354/dao061123; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Swift ML, 1997, J CHEM INF COMP SCI, V37, P411, DOI 10.1021/ci960402j; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan LT, 2001, J FISH DIS, V24, P315, DOI 10.1046/j.1365-2761.2001.00286.x; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Thakur PC, 2002, DIS AQUAT ORGAN, V49, P235, DOI 10.3354/dao049235; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Tirasophon W, 2005, BIOCHEM BIOPH RES CO, V334, P102, DOI 10.1016/j.bbrc.2005.06.063; Tirasophon W, 2007, ANTIVIR RES, V74, P150, DOI 10.1016/j.antiviral.2006.11.002; Tsai MF, 1999, DIS AQUAT ORGAN, V38, P107, DOI 10.3354/dao038107; Unajak S, 2006, COMP BIOCHEM PHYS B, V145, P179, DOI 10.1016/j.cbpb.2006.07.002; Van Hamme E, 2008, J GEN VIROL, V89, P2147, DOI 10.1099/vir.0.2008/001602-0; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Wang DD, 2012, CHIN J OCEANOL LIMN, V30, P611, DOI 10.1007/s00343-012-1195-7; Wang LL, 2011, AFR J BIOTECHNOL, V10, P17678, DOI 10.5897/AJB11.2017; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Westenberg M, 2005, VIRUS RES, V114, P133, DOI 10.1016/j.virusres.2005.06.006; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Wu Y, 2007, AQUACULTURE, V271, P21, DOI 10.1016/j.aquaculture.2007.06.029; Xu JY, 2007, ANTIVIR RES, V73, P126, DOI 10.1016/j.antiviral.2006.08.007; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; You XX, 2010, AQUACULTURE, V305, P133, DOI 10.1016/j.aquaculture.2010.04.024; Zeng Y, 2009, FISH SHELLFISH IMMUN, V26, P646, DOI 10.1016/j.fsi.2008.11.005; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P945, DOI 10.1016/j.dci.2010.04.002; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhao PC, 2011, INSECT BIOCHEM MOLEC, V41, P645, DOI 10.1016/j.ibmb.2011.04.006; Zhao ZY, 2007, FISH SHELLFISH IMMUN, V22, P520, DOI 10.1016/j.fsi.2006.07.003; Zhu F, 2012, MAR BIOTECHNOL, V14, P63, DOI 10.1007/s10126-011-9387-2; Zong RR, 2008, FISH SHELLFISH IMMUN, V25, P258, DOI 10.1016/j.fsi.2008.05.006	119	131	138	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58627	10.1371/journal.pone.0058627	http://dx.doi.org/10.1371/journal.pone.0058627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	24098432	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100033
J	Liu, Y; Miao, W; Wang, JQ; Gao, PY; Yin, GH; Zhang, LP; Lv, CK; Ji, ZY; Yu, T; Sabel, BA; He, HG; Peng, Y				Liu, Yue; Miao, Wen; Wang, Jieqiong; Gao, Peiyi; Yin, Guangheng; Zhang, Liping; Lv, Chuankai; Ji, Zhiying; Yu, Tong; Sabel, B. A.; He, Huiguang; Peng, Yun			Structural Abnormalities in Early Tourette Syndrome Children: A Combined Voxel-Based Morphometry and Tract-Based Spatial Statistics Study	PLOS ONE			English	Article							TIC SEVERITY; FRONTAL-LOBE; BRAIN; VOLUMES; CONNECTIVITY; LOCALIZATION; INHIBITION; PREVALENCE; ATTENTION; SYSTEM	Tourette Syndrome (TS) is characterized with chronic motor and vocal tics beginning in childhood. Abnormality of both gray (GM) and white matter (WM) has been observed in cortico-striato-thalamo-cortical circuits and sensory-motor cortex of adult TS patient. It is not clear if these morphological changes are also present in TS children and if there are any microstructural changes of WM. To understand the developmental cause of such changes, we investigated volumetric changes of GM and WM using VBM and microstructural changes of WM using DTI, and correlated these changes with tic severity and duration. T1 images and Diffusion Tensor Images (DTI) from 21 TS children were compared with 20 age and gender matched health control children using a 1.5T Philips scanner. All of the 21 TS children met the DSM-IV-TR criteria. T1 images were analyzed using DARTEL-VBM in conjunction with statistical parametric mapping (SPM). Diffusion tensor imaging (DTI) analysis was performed using Tract-Based Spatial Statistics (TBSS). Brain volume changes were found in left superior temporal gyrus, left and right paracentral gyrus, right precuneous cortex, right pre- and post-central gyrus, left temporal occipital fusiform cortex, right frontal pole, and left lingual gyrus. Significant axial diffusivity (AD) and mean diffusivity (MD) increases were found in anterior thalamic radiation, right cingulum bundle projecting to the cingulate gurus and forceps minor. Decreases in white matter volume (WMV) in the right frontal pole were inversely related with tic severity (YGTSS), and increases in AD and MD were positively correlated with tic severity and duration, respectively. These changes in TS children can be interpreted as signs of neural plasticity in response to the experiential demand. Our findings may suggest that the morphological and microstructural measurements from structural MRI and DTI can potentially be used as a biomarker of the pathophysiologic pattern of early TS children.	[Liu, Yue; Yin, Guangheng; Lv, Chuankai; Yu, Tong; Peng, Yun] Capital Med Univ, Beijing Childrens Hosp, Dept Radiol, Beijing, Peoples R China; [Miao, Wen; Wang, Jieqiong; Sabel, B. A.; He, Huiguang] Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China; [Liu, Yue; Yin, Guangheng; Lv, Chuankai; Yu, Tong; Peng, Yun] Capital Med Univ, Beijing Key Lab Magnet Imaging Device & Tech, Beijing Childrens Hosp, Beijing, Peoples R China; [Gao, Peiyi] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China; [Zhang, Liping; Ji, Zhiying] Capital Med Univ, Dept Med, Beijing Childrens Hosp, Beijing, Peoples R China; [Sabel, B. A.] Univ Magdeburg, Fac Med, Inst Med Psychol, D-39106 Magdeburg, Germany	Capital Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Capital Medical University; Capital Medical University; Otto von Guericke University	He, HG (corresponding author), Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China.	huiguang.he@ia.ac.cn; ppengyun@yahoo.com	Du, Zhaohui/AAK-6231-2021; Xue, Fuzhong/AAG-4808-2020; zhang, liwen/L-7005-2016; He, Huiguang/AAD-7643-2020	Du, Zhaohui/0000-0002-7125-8928; He, Huiguang/0000-0002-0684-1711; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [61271151, 61228103, 31271161]; capital health research and development of special [2011-2009-03]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); capital health research and development of special; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China (61271151, 61228103, and 31271161) and the capital health research and development of special (2011-2009-03). SB was partly supported by Chinese Academy of Sciences Senior Visiting Professorships Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bloch MH, 2005, NEUROLOGY, V65, P1253, DOI 10.1212/01.wnl.0000180957.98702.69; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Boroojerdi B, 1999, BRIT J PSYCHIAT, V175, P375, DOI 10.1192/bjp.175.4.375; CDE MR, 2011, MULT SCLER INT, V2011, P4875; COMINGS DE, 1984, AM J HUM GENET, V36, P586; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Draganski B, 2010, BRAIN, V133, P3661, DOI 10.1093/brain/awq300; Fahim C, 2009, BRAIN TOPOGR, V22, P176, DOI 10.1007/s10548-009-0105-6; Fan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035889; Fredericksen KA, 2002, NEUROLOGY, V58, P85, DOI 10.1212/WNL.58.1.85; Gerard E, 2003, J PSYCHOSOM RES, V55, P13, DOI 10.1016/S0022-3999(02)00581-0; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hugdahl K, 1998, BEHAV BRAIN SCI, V21, P335, DOI 10.1017/S0140525X98301211; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; Knight T, 2012, PEDIATR NEUROL, V47, P77, DOI 10.1016/j.pediatrneurol.2012.05.002; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lucas A R, 1982, Adv Neurol, V35, P267; Makki MI, 2008, MOVEMENT DISORD, V23, P2349, DOI 10.1002/mds.22264; Marsh R, 2007, AM J PSYCHIAT, V164, P955, DOI 10.1176/appi.ajp.164.6.955; Mason A, 1998, DEV MED CHILD NEUROL, V40, P292; Miao W, 2013, AM J NEURORADIOL, V34, P1264, DOI 10.3174/ajnr.A3370; Muller-Vahl KR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-47; Neuner I, 2010, NEUROIMAGE, V51, P1184, DOI 10.1016/j.neuroimage.2010.02.049; Neuner Irene, 2009, Biol Psychiatry, V65, pe5, DOI 10.1016/j.biopsych.2008.09.030; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Petek E, 2001, AM J HUM GENET, V68, P848, DOI 10.1086/319523; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Plessen KJ, 2009, J PSYCHOSOM RES, V67, P559, DOI 10.1016/j.jpsychores.2009.07.005; Plessen KJ, 2004, AM J PSYCHIAT, V161, P2028, DOI 10.1176/appi.ajp.161.11.2028; Retz-Junginger P, 2003, NERVENARZT, V74, P987, DOI 10.1007/s00115-002-1447-4; Rueda MR, 2005, DEV NEUROPSYCHOL, V28, P573, DOI 10.1207/s15326942dn2802_2; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Schiffer B, 2007, J PSYCHIATR RES, V41, P753, DOI 10.1016/j.jpsychires.2006.06.003; Shprecher D, 2009, MOVEMENT DISORD, V24, P15, DOI 10.1002/mds.22378; Singer HS, 2005, LANCET NEUROL, V4, P149, DOI 10.1016/S1474-4422(05)01012-4; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Stern JS, 2005, POSTGRAD MED J, V81, P12, DOI 10.1136/pgmj.2004.023614; STOKES A, 1991, PEDIATRICS, V87, P936; Thomalla G, 2009, BRAIN, V132, P765, DOI 10.1093/brain/awn339; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011	50	38	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76105	10.1371/journal.pone.0076105	http://dx.doi.org/10.1371/journal.pone.0076105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098769	Green Submitted, Green Published, gold			2022-12-27	WOS:000325423500139
J	Becking, LE; Erpenbeck, D; Peijnenburg, KTCA; de Voogd, NJ				Becking, Leontine E.; Erpenbeck, Dirk; Peijnenburg, Katja T. C. A.; de Voogd, Nicole J.			Phylogeography of the Sponge Suberites diversicolor in Indonesia: Insights into the Evolution of Marine Lake Populations	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; HALOCARIDINA-RUBRA; LIFE-HISTORY; CORAL-REEFS; PORIFERA; BIODIVERSITY; DEMOSPONGIAE; SPECIATION; DYNAMICS; PATTERNS	The existence of multiple independently derived populations in landlocked marine lakes provides an opportunity for fundamental research into the role of isolation in population divergence and speciation in marine taxa. Marine lakes are landlocked water bodies that maintain a marine character through narrow submarine connections to the sea and could be regarded as the marine equivalents of terrestrial islands. The sponge Suberites diversicolor (Porifera: Demospongiae: Suberitidae) is typical of marine lake habitats in the Indo-Australian Archipelago. Four molecular markers (two mitochondrial and two nuclear) were employed to study genetic structure of populations within and between marine lakes in Indonesia and three coastal locations in Indonesia, Singapore and Australia. Within populations of S. diversicolor two strongly divergent lineages (A & B) (COI: p = 0.4% and ITS: p = 7.3%) were found, that may constitute cryptic species. Lineage A only occurred in Kakaban lake (East Kalimantan), while lineage B was present in all sampled populations. Within lineage B, we found low levels of genetic diversity in lakes, though there was spatial genetic population structuring. The Australian population is genetically differentiated from the Indonesian populations. Within Indonesia we did not record an East-West barrier, which has frequently been reported for other marine invertebrates. Kakaban lake is the largest and most isolated marine lake in Indonesia and contains the highest genetic diversity with genetic variants not observed elsewhere. Kakaban lake may be an area where multiple putative refugia populations have come into secondary contact, resulting in high levels of genetic diversity and a high number of endemic species.	[Becking, Leontine E.; Peijnenburg, Katja T. C. A.; de Voogd, Nicole J.] Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands; [Becking, Leontine E.] Inst Marine Resources & Ecosyst Studies IMARES, Maritime Dept, Den Helder, Netherlands; [Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Erpenbeck, Dirk] Univ Munich, GeoBio Ctr, Munich, Germany; [Peijnenburg, Katja T. C. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam IBED, Amsterdam, Netherlands	Naturalis Biodiversity Center; Wageningen University & Research; University of Munich; University of Munich; University of Amsterdam	Becking, LE (corresponding author), Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands.	lisa.becking@naturalis.nl	Paaijmans, Krijn/ABC-9928-2020; Peijnenburg, Katja TCA/F-7176-2016; de Voogd, Nicole/I-9280-2012; Nelson, William A/D-1405-2013	Peijnenburg, Katja TCA/0000-0001-7544-1079; de Voogd, Nicole/0000-0002-7985-5604; Erpenbeck, Dirk/0000-0003-2716-1085	Netherlands Organisation for Scientific Research (NWO) [817.01.008, 825.12.007]; NWO-VENI grant [863.08.024]; De Beukelaar- van der Hucht Stichting; World Wildlife Foundation Netherlands-INNO Fund; Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW); Conservation International Ecosystem Based Management program; David and Lucile Packard Foundation; Treub-Maatschappij Fund; Leiden University Fund (LUF)/Slingelands; Singapore Airlines; A.M. Buitendijk Fund; J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO-VENI grant; De Beukelaar- van der Hucht Stichting; World Wildlife Foundation Netherlands-INNO Fund; Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW); Conservation International Ecosystem Based Management program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Treub-Maatschappij Fund; Leiden University Fund (LUF)/Slingelands; Singapore Airlines; A.M. Buitendijk Fund; J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center)	L. Becking is supported by the Netherlands Organisation for Scientific Research (NWO) (ALW# 817.01.008; Rubicon# 825.12.007). K. Peijnenburg was supported by NWO-VENI grant #863.08.024. Fieldwork in Indonesia was made possible through additional financial support of De Beukelaar- van der Hucht Stichting, World Wildlife Foundation Netherlands-INNO Fund, the Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW), Conservation International Ecosystem Based Management program (funded by The David and Lucile Packard Foundation), the Treub-Maatschappij Fund, the Leiden University Fund (LUF)/Slingelands, Singapore Airlines, the A.M. Buitendijk Fund and the J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakis N, 2012, ZOOL J LINN SOC-LOND, V166, P225, DOI 10.1111/j.1096-3642.2012.00848.x; Arp G, 1996, RES REPORTS S, V2, P1; Azzini Francesca, 2007, V28, P157; Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Bauza-Ribot MM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-221; Becking L. E., 2009, Zoologische Mededelingen (Leiden), V83, P853; Becking LE, 2013, MAR ECOL PROG SER, V481, P105, DOI 10.3354/meps10155; Becking LE, 2011, HYDROBIOLOGIA, V677, P89, DOI 10.1007/s10750-011-0742-0; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Blanquer A, 2008, MAR ECOL PROG SER, V371, P109, DOI 10.3354/meps07679; Botello A, 2010, BIOL J LINN SOC, V99, P315, DOI 10.1111/j.1095-8312.2009.01355.x; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chen XY, 2009, ECOLOGY, V90, P39, DOI 10.1890/08-1520.1; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; Chombard Catherine, 1999, Memoirs of the Queensland Museum, V44, P100; Colin P. L., 2009, MARINE ENV PALAU, P416; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Craft JD, 2008, LIMNOL OCEANOGR, V53, P675, DOI 10.4319/lo.2008.53.2.0675; Crandall ED, 2008, MOL ECOL, V17, P5276, DOI 10.1111/j.1365-294X.2008.03995.x; Dawson M. N., 2009, ENCY ISLANDS, P603; Dawson MN, 2005, J MAR BIOL ASSOC UK, V85, P679, DOI 10.1017/S0025315405011604; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P9235, DOI 10.1073/pnas.0503635102; Dawson MN, 2006, JMBA GLOBAL MARINE E, V3, P26; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; DeBiasse MB, 2010, CORAL REEFS, V29, P47, DOI 10.1007/s00338-009-0554-0; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Erpenbeck D, 2005, J ZOOL SYST EVOL RES, V43, P93, DOI 10.1111/j.1439-0469.2005.00306.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GEYH MA, 1979, NATURE, V278, P441, DOI 10.1038/278441a0; Goto TV, 2011, ZOOL SCI, V28, P568, DOI 10.2108/zsj.28.568; Gotoh RO, 2009, GENES GENET SYST, V84, P287, DOI 10.1266/ggs.84.287; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hamner WM, 1998, PHYS GEOGR, V19, P175, DOI 10.1080/02723646.1998.10642647; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Hoeksema Bert W., 2007, V29, P117; Holthuis L.B., 1973, Zoologische Verh Leiden, VNo. 128, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kano Y, 2004, ZOOL SCR, V33, P423, DOI 10.1111/j.0300-3256.2004.00159.x; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lim SC, 2009, RAFFLES B ZOOL, P41; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; MAC ARTHUR ROBERT H., 1967; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Maldonado M, 1999, NATURE, V398, P476, DOI 10.1038/19007; Mariani S, 2005, J PLANKTON RES, V27, P249, DOI 10.1093/plankt/fbh173; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; McCormack GP, 2002, J NAT HIST, V36, P1009, DOI 10.1080/00222930110040394; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Morley R.J., 2000, ORIGIN EVOLUTION TRO, P378; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Nuryanto A, 2009, CORAL REEFS, V28, P607, DOI 10.1007/s00338-009-0483-y; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Perez-Porro AR, 2012, HYDROBIOLOGIA, V687, P315, DOI 10.1007/s10750-011-0919-6; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRONZATO R, 1994, B ZOOL, V61, P395, DOI 10.1080/11250009409355912; Rambaut A., 2007, TRACER V1 4; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Rua CPJ, 2011, J MAR BIOL ASSOC UK, V91, P1015, DOI 10.1017/S0025315410002122; Russ A, 2010, REV BIOL TROP, V58, P159; Santos SR, 2006, MOL ECOL, V15, P2699, DOI 10.1111/j.1365-294X.2006.02965.x; Santos SR, 2011, HYDROBIOLOGIA, V677, P53, DOI 10.1007/s10750-010-0588-x; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timm J, 2008, MOL ECOL, V17, P3999, DOI 10.1111/j.1365-294X.2008.03881.x; Tomascik T, 1997, ECOLOGY INDONESIA 2, P752; Tomascik Tomas, 1994, Tropical Biodiversity, V2, P385; Uriz MJ, 2012, ADV MAR BIOL, V61, P345, DOI 10.1016/B978-0-12-387787-1.00006-4; Vogler C, 2013, CORAL REEFS, V32, P515, DOI 10.1007/s00338-012-1003-z; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Whittaker RJ, 2008, ISLAND BIOGEOGRAPHY; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; Worheide G, 2002, MOL ECOL, V11, P1753, DOI 10.1046/j.1365-294X.2002.01570.x; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Wulff JL, 2006, BIOL BULL-US, V211, P83, DOI 10.2307/4134581; WULFF JL, 1995, CORAL REEFS, V14, P55, DOI 10.1007/BF00304073; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xavier JR, 2010, CONTRIB ZOOL, V79, P119, DOI 10.1163/18759866-07903004; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	94	181	183	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75996	10.1371/journal.pone.0075996	http://dx.doi.org/10.1371/journal.pone.0075996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098416	Green Published, gold, Green Submitted			2022-12-27	WOS:000325427100034
J	Okumura, N; Kay, EP; Nakahara, M; Hamuro, J; Kinoshita, S; Koizumi, N				Okumura, Naoki; Kay, EunDuck P.; Nakahara, Makiko; Hamuro, Junji; Kinoshita, Shigeru; Koizumi, Noriko			Inhibition of TGF-beta Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; ALLOGRAFT-REJECTION; AMNIOTIC MEMBRANE; ROCK INHIBITOR; AQUEOUS-HUMOR; RABBIT MODEL; TRANSPLANTATION; KERATOPLASTY; PRIMATE; VIVO	Corneal endothelial dysfunctions occurring in patients with Fuchs' endothelial corneal dystrophy, pseudoexfoliation syndrome, corneal endotheliitis, and surgically induced corneal endothelial damage cause blindness due to the loss of endothelial function that maintains corneal transparency. Transplantation of cultivated corneal endothelial cells (CECs) has been researched to repair endothelial dysfunction in animal models, though the in vitro expansion of human CECs (HCECs) is a pivotal practical issue. In this study we established an optimum condition for the cultivation of HCECs. When exposed to culture conditions, both primate and human CECs showed two distinct phenotypes: contact-inhibited polygonal monolayer and fibroblastic phenotypes. The use of SB431542, a selective inhibitor of the transforming growth factor-beta (TGF-beta) receptor, counteracted the fibroblastic phenotypes to the normal contact-inhibited monolayer, and these polygonal cells maintained endothelial physiological functions. Expression of ZO-1 and Na+/K+-ATPase maintained their subcellular localization at the plasma membrane. Furthermore, expression of type I collagen and fibronectin was greatly reduced. This present study may prove to be the substantial protocol to provide the efficient in vitro expansion of HCECs with an inhibitor to the TGF-beta receptor, and may ultimately provide clinicians with a new therapeutic modality in regenerative medicine for the treatment of corneal endothelial dysfunctions.	[Okumura, Naoki; Kay, EunDuck P.; Nakahara, Makiko; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Okumura, Naoki; Hamuro, Junji; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Doshisha University; Kyoto Prefectural University of Medicine	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan [LS117]; Grants-in-Aid for Scientific Research [23659818] Funding Source: KAKEN	Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported in part by the Highway Program for realization of regenerative medicine (Kinoshita and Okumura); http://www.mext.go.jp/english/; and the Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan (Koizumi: LS117); http://www.jsps.go.jp/english/e-jisedai/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PA, 1995, INVEST OPHTH VIS SCI, V36, P1115; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Chen KH, 1999, INVEST OPHTH VIS SCI, V40, P2513; Coster DJ, 2005, AM J OPHTHALMOL, V140, P1112, DOI 10.1016/j.ajo.2005.07.024; Darlington JK, 2006, OPHTHALMOLOGY, V113, P2171, DOI 10.1016/j.ophtha.2006.06.034; Engelmann K, 2004, EXP EYE RES, V78, P573, DOI 10.1016/S0014-4835(03)00209-4; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kawaguchi R, 2001, CORNEA, V20, P100, DOI 10.1097/00003226-200101000-00019; Khaireddin R, 2003, GRAEF ARCH CLIN EXP, V241, P1020, DOI 10.1007/s00417-003-0759-9; Kim TY, 2001, INVEST OPHTH VIS SCI, V42, P3142; Ko MK, 2001, EXP CELL RES, V264, P363, DOI 10.1006/excr.2000.5155; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Koizumi N, 2008, OPHTHALMOLOGY, V115, P292, DOI 10.1016/j.ophtha.2007.04.053; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Melles GRJ, 2000, OPHTHALMOLOGY, V107, P1850, DOI 10.1016/S0161-6420(00)00253-0; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3128, DOI 10.1167/iovs.05-0251; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Mimura T, 2003, EXP EYE RES, V76, P745, DOI 10.1016/S0014-4835(03)00057-5; Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012; Naumann GOH, 2000, OPHTHALMOLOGY, V107, P1111, DOI 10.1016/S0161-6420(00)00087-7; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; Patel SV, 2009, INVEST OPHTH VIS SCI, V50, P2123, DOI 10.1167/iovs.08-2653; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Simic P, 2007, EMBO REP, V8, P327, DOI 10.1038/sj.embor.7400943; Song JS, 2010, INVEST OPHTH VIS SCI, V51, P822, DOI 10.1167/iovs.09-4240; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	45	147	152	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e58000	10.1371/journal.pone.0058000	http://dx.doi.org/10.1371/journal.pone.0058000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451286	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500147
J	Luo, JL; Li, WF; Qiu, J; Wei, DT; Liu, YJ; Zhang, QL				Luo, Junlong; Li, Wenfu; Qiu, Jiang; Wei, Dongtao; Liu, Yijun; Zhang, Qinlin			Neural Basis of Scientific Innovation Induced by Heuristic Prototype	PLOS ONE			English	Article							DIVERGENT THINKING; CREATIVE-THINKING; INSIGHT; EEG; MEMORY; RECOGNITION; PERFORMANCE; LOCUS; FMRI	A number of major inventions in history have been based on bionic imitation. Heuristics, by applying biological systems to the creation of artificial devices and machines, might be one of the most critical processes in scientific innovation. In particular, prototype heuristics propositions that innovation may engage automatic activation of a prototype such as a biological system to form novel associations between a prototype's function and problem-solving. We speculated that the cortical dissociation between the automatic activation and forming novel associations in innovation is critical point to heuristic creativity. In the present study, novel and old scientific innovations (NSI and OSI) were selected as experimental materials in using learning-testing paradigm to explore the neural basis of scientific innovation induced by heuristic prototype. College students were required to resolve NSI problems (to which they did not know the answers) and OSI problems (to which they knew the answers). From two fMRI experiments, our results showed that the subjects could resolve NSI when provided with heuristic prototypes. In Experiment 1, it was found that the lingual gyrus (LG; BA18) might be related to prototype heuristics in college students resolving NSI after learning a relative prototype. In Experiment 2, the LG (BA18) and precuneus (BA31) were significantly activated for NSI compared to OSI when college students learned all prototypes one day before the test. In addition, the mean beta-values of these brain regions of NSI were all correlated with the behavior accuracy of NSI. As our hypothesis indicated, the findings suggested that the LG might be involved in forming novel associations using heuristic information, while the precuneus might be involved in the automatic activation of heuristic prototype during scientific innovation.	[Luo, Junlong; Li, Wenfu; Qiu, Jiang; Wei, Dongtao; Liu, Yijun; Zhang, Qinlin] Southwest Univ, Sch Psychol, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Luo, Junlong] Shanghai Normal Univ, Coll Educ, Shanghai, Peoples R China	Southwest University - China; Shanghai Normal University	Qiu, J (corresponding author), Southwest Univ, Sch Psychol, Key Lab Cognit & Personal, Chongqing, Peoples R China.	qiuj318@swu.edu.cn; qlzhang.swu@gmail.com	Luo, Jianfei/O-9548-2019; Luo, Jianfei/P-7219-2017	Luo, Jianfei/0000-0002-9570-4224; Luo, Jianfei/0000-0002-9570-4224	National Natural Science Foundation of China [31170983, 30970892, 31200768, 31070900, 31271087]; Program for New Century Excellent Talents in University by the Ministry of Education; Program for Talents in Colleges and Universities in Chongqing; Fundamental Research Funds for the Central Universities [SWU1209101]; Key Discipline Fund of National 211 Project [NSKD11007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Program for Talents in Colleges and Universities in Chongqing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This research was supported by the National Natural Science Foundation of China (31170983; 30970892; 31200768; 31070900; 31271087), the Program for New Century Excellent Talents in University (2011) by the Ministry of Education, the Program for Talents in Colleges and Universities in Chongqing, the Fundamental Research Funds for the Central Universities (SWU1209101) and the Key Discipline Fund of National 211 Project (NSKD11007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof M, 2004, ANN NEUROL, V56, P583, DOI 10.1002/ana.20246; BLAGROVE M, 1994, PERS INDIV DIFFER, V16, P981, DOI 10.1016/0191-8869(94)90242-9; Blagrove M, 2000, PERS INDIV DIFFER, V28, P41, DOI 10.1016/S0191-8869(99)00078-1; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carlsson I, 2000, NEUROPSYCHOLOGIA, V38, P873, DOI 10.1016/S0028-3932(99)00128-1; Dickinson MH, 1999, P NATL ACAD SCI USA, V96, P14208, DOI 10.1073/pnas.96.25.14208; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; DOMINO G, 1970, J CONSULT CLIN PSYCH, V35, P48, DOI 10.1037/h0029624; Fink A, 2006, EUR J NEUROSCI, V23, P2241, DOI 10.1111/j.1460-9568.2006.04751.x; Fink A, 2007, METHODS, V42, P68, DOI 10.1016/j.ymeth.2006.12.001; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Jausovec N, 2000, INT J PSYCHOPHYSIOL, V36, P73, DOI 10.1016/S0167-8760(99)00113-0; Jausovec N, 2000, BRAIN TOPOGR, V12, P229, DOI 10.1023/A:1023446024923; Jin SH, 2006, BRAIN COGNITION, V62, P191, DOI 10.1016/j.bandc.2006.05.001; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Molle M, 1999, PSYCHOPHYSIOLOGY, V36, P95, DOI 10.1017/S0048577299961619; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Nyberg L, 2000, J COGNITIVE NEUROSCI, V12, P163, DOI 10.1162/089892900561805; Qiu J, 2010, CORTEX, V46, P397, DOI 10.1016/j.cortex.2009.06.006; Razoumnikova OM, 2000, COGNITIVE BRAIN RES, V10, P11, DOI 10.1016/S0926-6410(00)00017-3; Rugg MD, 1998, NEUROIMAGE, V8, P262, DOI 10.1006/nimg.1998.0363; Stoppel CM, 2009, HUM BRAIN MAPP, V30, P3759, DOI 10.1002/hbm.20804; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian F, 2011, BEHAV BRAIN RES, V216, P626, DOI 10.1016/j.bbr.2010.09.005; Vogel S, 2000, CATS PAWS CATAPULTS	34	87	108	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e49231	10.1371/journal.pone.0049231	http://dx.doi.org/10.1371/journal.pone.0049231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	24098501	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400001
J	Luo, JF; Wang, Y; Tang, SS; Liang, JW; Lin, WT; Luo, LX				Luo, Jianfei; Wang, Yuan; Tang, Shuishui; Liang, Jianwen; Lin, Weitie; Luo, Lixin			Isolation and Identification of Algicidal Compound from Streptomyces and Algicidal Mechanism to Microcystis aeruginosa	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; TOXIC DINOFLAGELLATE; BIOLOGICAL-ACTIVITY; RED-TIDE; CYANOBACTERIA; BACTERIUM; SAPONIN; METABOLITES; BLOOMS; FUNGUS	The biological control of cyanobacterial harmful algal blooms (cyanoHABs) is important to promote human health, environmental protection, and economic growth. Active algicidal compounds and algicidal mechanisms should be identified and investigated to control cyanoHABs. In this study, the algicidal actinobacterium Streptomyces sp. L74 was isolated from the soil of a nearby pond which located in the center lake of Guanghzou Higher Education Mega Center. Results showed that the algicidal activities of cyanoHABs are mainly achieved via an indirect attack by producing algicidal compounds. All active algicidal compounds are hydrophilic substances that are heat and pH stable. In the present study, an active compound (B3) was isolated and purified by high-performance liquid chromatography and identified as a type of triterpenoid saponin (2-hydroxy-12-oleanene-3, 28-O-D- glucopyranosyl) with a molecular formula of C42H70O13 as determined by infrared spectrometry, electrospray ionization mass spectrometry, and nuclear magnetic resonance. Active algicidal compounds from Streptomyces sp. L74 were shown to disrupt the antioxidant systems of Microcystis aeruginosa cells.	[Luo, Jianfei; Wang, Yuan; Tang, Shuishui; Liang, Jianwen; Lin, Weitie; Luo, Lixin] S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Lin, WT (corresponding author), S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	weitie@21cn.com; btlxluo@scut.edu.cn	Luo, Jianfei/O-9548-2019; Luo, Jianfei/P-7219-2017	Luo, Jianfei/0000-0002-9570-4224; Luo, Jianfei/0000-0002-9570-4224	National Natural Science Foundation of China [21076090, 21276099]; Specialized Research Found for the Doctoral Program of Higher Education of China [20120172120045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Found for the Doctoral Program of Higher Education of China	This work was supported by the National Natural Science Foundation of China (21076090 and 21276099) and the Specialized Research Found for the Doctoral Program of Higher Education of China (20120172120045)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H E, 1983, METHOD ENZYMATIC ANA, P273, DOI DOI 10.1016/B978-0-12-091302-2.50032-3; Ahn CY, 2003, BIOTECHNOL LETT, V25, P1137, DOI 10.1023/A:1024508927361; Aliyu AB, 2011, J MED PLANTS RES, V5, P6709, DOI 10.5897/JMPR10.708; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Arabski M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/286216; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; CIVELLO PM, 1995, J AGR FOOD CHEM, V43, P2596, DOI 10.1021/jf00058a008; DAFT MJ, 1975, FRESHWATER BIOL, V5, P577, DOI 10.1111/j.1365-2427.1975.tb00157.x; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gause GF, 2004, HDB MICROBIOLOGICAL, P704; Hasegawa H, 1996, PLANTA MED, V62, P453, DOI 10.1055/s-2006-957938; Isaka M, 2011, J NAT PROD, V74, P300, DOI 10.1021/np100873t; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Nakamura N, 2003, J BIOSCI BIOENG, V95, P179, DOI 10.1263/jbb.95.179; Noike M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042090; Noike M, 2012, CHEMBIOCHEM, V13, P566, DOI 10.1002/cbic.201100725; Pelaez F, 2000, SYST APPL MICROBIOL, V23, P333, DOI 10.1016/S0723-2020(00)80062-4; Podolak Irma, 2007, Acta Pol Pharm, V64, P39; REDHEAD K, 1978, APPL ENVIRON MICROB, V35, P962, DOI 10.1128/AEM.35.5.962-969.1978; SAFFERMAN RS, 1963, SCIENCE, V140, P679, DOI 10.1126/science.140.3567.679; SAFFERMAN RS, 1962, APPL MICROBIOL, V10, P289, DOI 10.1128/AEM.10.4.289-292.1962; Sakata T, 2011, FISHERIES SCI, V77, P397, DOI 10.1007/s12562-011-0345-8; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; SHIGEMATSU N, 1992, J ANTIBIOT, V45, P704, DOI 10.7164/antibiotics.45.704; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Son JW, 2008, BIOTECHNOL LETT, V30, P713, DOI 10.1007/s10529-007-9590-4; Tan H, 2009, LETT APPL MICROBIOL, V49, P248, DOI 10.1111/j.1472-765X.2009.02649.x; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Volk RB, 2005, J APPL PHYCOL, V17, P339, DOI 10.1007/s10811-005-7292-7; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; WHYTE LG, 1985, J APPL BACTERIOL, V58, P195, DOI 10.1111/j.1365-2672.1985.tb01447.x; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Yamamoto Y, 1998, J APPL PHYCOL, V10, P391, DOI 10.1023/A:1008077414808; Yang JD, 2009, INT J MOL SCI, V10, P4157, DOI 10.3390/ijms10094157; Zhou LH, 2007, HARMFUL ALGAE, V6, P354, DOI 10.1016/j.hal.2006.10.002; Zuo WJ, 2011, PLANTA MED, V77, P1835, DOI 10.1055/s-0030-1271164	44	87	108	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76444	10.1371/journal.pone.0076444	http://dx.doi.org/10.1371/journal.pone.0076444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098501	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600052
J	Chen, YH; Li, M; Li, B; Wang, WF; Lin, AJ; Sheng, MJ				Chen, Yihui; Li, Min; Li, Bing; Wang, Weifang; Lin, Anjuan; Sheng, Minjie			Effect of Reactive Oxygen Species Generation in Rabbit Corneal Epithelial Cells on Inflammatory and Apoptotic Signaling Pathways in the Presence of High Osmotic Pressure	PLOS ONE			English	Article							NF-KAPPA-B; FAS-LIGAND; DRY EYE; HYPEROSMOTIC ACTIVATION; CD95 LIGAND; EXPRESSION; STRESS; SYSTEM; JNK; REJECTION	It is generally accepted that high osmotic pressure (HOP) of lacrimal fluid is the core mechanism causing ocular inflammation and injury. However, the association between HOP and the regulation of cell inflammatory response and apoptotic pathways remains unclear. In the present study, we used HOP to interfere with in vitro cultured rabbit corneal epithelial cells, and found that HOP increased the generation of reactive oxygen species (ROS) in rabbit corneal epithelial cells, and increased ROS in turn induced the activation of JNK inflammatory signaling pathway, which further promoted the expression of pro-inflammatory factor NF-kappa beta and induced the generation of inflammatory factor IL-1 beta and TNF-alpha. In addition, HOP-induced ROS in rabbit corneal epithelial cells regulated the CD95/CD95L-mediated cell apoptotic signaling pathway by activating JNK inflammatory signaling pathway. These findings may serve as new theoretical basis and a new way of thinking about the treatment of ocular diseases, especially dry eye.	[Chen, Yihui; Li, Min; Li, Bing; Wang, Weifang; Lin, Anjuan; Sheng, Minjie] Tongji Univ, Dept Ophthalmol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	Sheng, MJ (corresponding author), Tongji Univ, Dept Ophthalmol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	cyh80h@163.com	Woo, Patrick Chiu Yat/C-4449-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832; hu, yong fei/0000-0002-2158-6018	Natural Science Foundation of Shanghai [11ZR1427900]; Youth Research Project of Shanghai Municipal Health Bureau [2010Y164]; Young Talent Training Plan of Tongji University [2010KJ018]; Young Talent Training Plan of Shanghai Tenth PeopleShanghai Tenth People?? Hospital [11RQ108]; Shanghai Health Hospital Development Center Foundation Project [SHDC12007104]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Youth Research Project of Shanghai Municipal Health Bureau; Young Talent Training Plan of Tongji University; Young Talent Training Plan of Shanghai Tenth PeopleShanghai Tenth People?? Hospital; Shanghai Health Hospital Development Center Foundation Project	This work was supported by grants from the Natural Science Foundation of Shanghai (No. 11ZR1427900); the Youth Research Project of Shanghai Municipal Health Bureau(No. 2010Y164); the Young Talent Training Plan of Tongji University(No. 2010KJ018); the Young Talent Training Plan of Shanghai Tenth PeopleShanghai Tenth People?? Hospital (No. 11RQ108); Shanghai Health Hospital Development Center Foundation Project (SHDC12007104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Brignole F, 1998, EXP EYE RES, V67, P687, DOI 10.1006/exer.1998.0566; Bron AJ, 2009, OCUL SURF, V7, P78, DOI 10.1016/S1542-0124(12)70299-9; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Eisner V, 2006, FEBS LETT, V580, P4495, DOI 10.1016/j.febslet.2006.07.029; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; Guo J, 2005, ACTA PHARMACOL SIN, V26, P780, DOI 10.1111/j.1745-7254.2005.00140.x; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Li HL, 2005, INT J MOL MED, V16, P41; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Mohan RR, 1997, EXP EYE RES, V65, P575, DOI 10.1006/exer.1997.0371; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Perry Henry D, 2008, Am J Manag Care, V14, pS79; Pinkenburg O, 2004, J VIROL METHODS, V120, P119, DOI 10.1016/j.jviromet.2004.04.007; Png E, 2011, J CELL PHYSIOL, V226, P693, DOI 10.1002/jcp.22389; Rakhorst HA, 2006, INT J ORAL MAX SURG, V35, P935, DOI 10.1016/j.ijom.2006.06.011; Reinehr R, 2006, ACTA PHYSIOL, V187, P199, DOI 10.1111/j.1748-1716.2006.01541.x; Reinehr R, 2007, METHOD ENZYMOL, V428, P145, DOI 10.1016/S0076-6879(07)28008-5; Sagrista ML, 2002, FREE RADICAL RES, V36, P329, DOI 10.1080/10715760290019354; Shimizu H, 2012, LIFE SCI, V90, P525, DOI 10.1016/j.lfs.2012.01.013; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Tong JK, 2010, AM J RESP CELL MOL, V43, P342, DOI 10.1165/rcmb.2008-0454OC; Uchino Yuichi, 2012, Cornea, V31 Suppl 1, pS63, DOI 10.1097/ICO.0b013e31826a5de1; VAUX DL, 1995, NATURE, V377, P576, DOI 10.1038/377576a0; Wilson SE, 1996, INVEST OPHTH VIS SCI, V37, P1582; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Yamagami S, 1997, TRANSPLANTATION, V64, P1107, DOI 10.1097/00007890-199710270-00004; Zietz C, 2001, AM J PATHOL, V159, P963, DOI 10.1016/S0002-9440(10)61772-5	31	34	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72900	10.1371/journal.pone.0072900	http://dx.doi.org/10.1371/journal.pone.0072900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24098729	Green Submitted, Green Published, gold			2022-12-27	WOS:000323378000116
J	Suchankova, P; Steensland, P; Fredriksson, I; Engel, JA; Jerlhag, E				Suchankova, Petra; Steensland, Pia; Fredriksson, Ida; Engel, Jorgen A.; Jerlhag, Elisabet			Ghrelin Receptor (GHS-R1A) Antagonism Suppresses Both Alcohol Consumption and the Alcohol Deprivation Effect in Rats following Long-Term Voluntary Alcohol Consumption	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; STIMULATES LOCOMOTOR-ACTIVITY; CONDITIONED PLACE PREFERENCE; ACCUMBAL DOPAMINE-OVERFLOW; NUCLEUS-ACCUMBENS; ETHANOL INTAKE; SYSTEMIC GHRELIN; DRUG-ADDICTION; MESSENGER-RNA; REWARD	Alcohol dependence is a heterogeneous disorder where several signalling systems play important roles. Recent studies implicate that the gut-brain hormone ghrelin, an orexigenic peptide, is a potential mediator of alcohol related behaviours. Ghrelin increases whereas a ghrelin receptor (GHS-R1A) antagonist decreases alcohol consumption as well as operant self-administration of alcohol in rodents that have consumed alcohol for twelve weeks. In the present study we aimed at investigating the effect of acute and repeated treatment with the GHS-R1A antagonist JMV2959 on alcohol intake in a group of rats following voluntarily alcohol consumption for two, five and eight months. After approximately ten months of voluntary alcohol consumption the expression of the GHS-R1A gene (Ghsr) as well as the degree of methylation of a CpG island found in Ghsr was examined in reward related brain areas. In a separate group of rats, we examined the effect of the JMV2959 on alcohol relapse using the alcohol deprivation paradigm. Acute JMV2959 treatment was found to decrease alcohol intake and the effect was more pronounced after five, compared to two months of alcohol exposure. In addition, repeated JMV2959 treatment decreased alcohol intake without inducing tolerance or rebound increase in alcohol intake after the treatment. The GHS-R1A antagonist prevented the alcohol deprivation effect in rats. There was a significant down-regulation of the Ghsr expression in the ventral tegmental area (VTA) in high-compared to low-alcohol consuming rats after approximately ten months of voluntary alcohol consumption. Further analysis revealed a negative correlation between Ghsr expression in the VTA and alcohol intake. No differences in methylation degree were found between high-compared to low-alcohol consuming rats. These findings support previous studies showing that the ghrelin signalling system may constitute a potential target for development of novel treatment strategies for alcohol dependence.	[Suchankova, Petra; Engel, Jorgen A.; Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden; [Steensland, Pia; Fredriksson, Ida] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden	University of Gothenburg; Karolinska Institutet	Engel, JA (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden.	Jorgen.engel@pharm.gu.se	Fredriksson, Nils Johan/AAC-8083-2020; Wilen, Britt-Marie/B-5042-2016	Fredriksson, Nils Johan/0000-0002-5763-6777; Wilen, Britt-Marie/0000-0001-6155-7759; Steensland, Pia/0000-0003-4443-5017	Swedish Research Council [K2006-21X-04247-33-3, 2009-2782, K2010-80X-21496-01-6]; Swedish Brain Foundation; LUA/ALF from the Sahlgrenska University Hospital [148251]; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; foundation of Adlerbertska; foundation of Fredrik and Ingrid Thuring; foundation of Tore Nilsson; foundation of Langmanska; foundation of Torsten and Ragnar Soderberg; foundation of Wilhelm and Martina Lundgren; foundation of NovoNordisk; foundation of Knut and Alice Wallenberg; foundation of Magnus Bergvall; foundation of Aners; foundation of Jeansons; foundation of AkeWiberg; Swedish Society of Medicine; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; LUA/ALF from the Sahlgrenska University Hospital; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; foundation of Adlerbertska; foundation of Fredrik and Ingrid Thuring; foundation of Tore Nilsson; foundation of Langmanska; foundation of Torsten and Ragnar Soderberg; foundation of Wilhelm and Martina Lundgren; foundation of NovoNordisk; foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); foundation of Magnus Bergvall; foundation of Aners; foundation of Jeansons; foundation of AkeWiberg; Swedish Society of Medicine; Swedish Society for Medical Research	The research was supported by grants from the Swedish Research Council (grant no. K2006-21X-04247-33-3, 2009-2782 and K2010-80X-21496-01-6), The Swedish Brain Foundation, LUA/ALF (grant no. 148251) from the Sahlgrenska University Hospital, Alcohol Research Council of the Swedish Alcohol Retailing Monopoly and the foundations of Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Torsten and Ragnar Soderberg, Wilhelm and Martina Lundgren, NovoNordisk, Knut and Alice Wallenberg, Magnus Bergvall, Aners, Jeansons, AkeWiberg, the Swedish Society of Medicine, Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Addolorato G, 2006, ALCOHOL CLIN EXP RES, V30, p140A; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Blednov YA, 2004, ALCOHOL CLIN EXP RES, V28, P1683, DOI 10.1097/01.ALC.0000145790.60216.C8; Blomqvist O, 1997, EUR J PHARMACOL, V334, P149, DOI 10.1016/S0014-2999(97)01220-X; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Davis KW, 2007, REGUL PEPTIDES, V140, P148, DOI 10.1016/j.regpep.2006.12.003; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Egecioglu E, 2012, PSYCHONEUROENDOCRINO; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Ericson M, 2003, EUR J PHARMACOL, V467, P85, DOI 10.1016/S0014-2999(03)01564-4; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hansson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050409; Heyser CJ, 2003, NEUROPSYCHOPHARMACOL, V28, P1463, DOI 10.1038/sj.npp.1300175; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jerlhag E, 2008, EUR NEUROPSYCHOPHARM, V18, P508, DOI 10.1016/j.euroneuro.2008.02.006; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ALCOHOL ALCOHOLISM, V41, P486, DOI 10.1093/alcalc/agl049; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Jerlhag E, 2011, ALCOHOL, V45, P341, DOI 10.1016/j.alcohol.2010.10.002; Jerlhag E, 2011, ADDICT BIOL, V16, P82, DOI 10.1111/j.1369-1600.2010.00231.x; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koopmann A, 2012, PSYCHONEUROENDOCRINO, V37, P980, DOI 10.1016/j.psyneuen.2011.11.005; Kuzmin A, 2009, PSYCHOPHARMACOLOGY, V203, P99, DOI 10.1007/s00213-008-1375-5; Landgren S, 2008, ALCOHOL CLIN EXP RES, V32, P2054, DOI 10.1111/j.1530-0277.2008.00793.x; Landgren S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018170; Landgren S, 2011, BEHAV BRAIN RES, V221, P182, DOI 10.1016/j.bbr.2011.03.003; Landgren S, 2012, ADDICT BIOL, V17, P86, DOI 10.1111/j.1369-1600.2010.00280.x; Landgren S, 2010, ALCOHOL CLIN EXP RES, V34, P1519, DOI 10.1111/j.1530-0277.2010.01236.x; Larsson A, 2004, ALCOHOL, V34, P239, DOI 10.1016/j.alcohol.2004.10.002; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Leggio L, 2012, ADDICT BIOL, V17, P452, DOI 10.1111/j.1369-1600.2010.00308.x; Lewis MJ, 2004, ALCOHOL CLIN EXP RES, V28, P1822, DOI 10.1097/01.ALC.0000148099.12344.C8; Litten RZ, 2013, J ADDICT MED; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lof E, 2007, PSYCHOPHARMACOLOGY, V195, P333, DOI 10.1007/s00213-007-0899-4; McKee SA, 2009, BIOL PSYCHIAT, V66, P185, DOI 10.1016/j.biopsych.2009.01.029; Mitchell JM, 2012, PSYCHOPHARMACOLOGY, V223, P299, DOI 10.1007/s00213-012-2717-x; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Quarta D, 2009, NEUROCHEM INT, V54, P89, DOI 10.1016/j.neuint.2008.12.006; Rada P, 2004, ALCOHOL, V33, P91, DOI 10.1016/j.alcohol.2004.05.002; Salome N, 2009, J NEUROENDOCRINOL, V21, P777, DOI 10.1111/j.1365-2826.2009.01895.x; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Soderpalm B, 2009, PHARMACOPSYCHIATRY, V42, pS87, DOI 10.1055/s-0029-1220690; Soyka Michael, 2008, Curr Drug Abuse Rev, V1, P280; Spanagel R, 2000, ALCOHOL RES HEALTH, V24, P124; Spanagel R, 1997, TRENDS PHARMACOL SCI, V18, P54, DOI 10.1016/S0165-6147(97)89800-8; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Tessari M, 2007, ADDICT BIOL, V12, P22, DOI 10.1111/j.1369-1600.2007.00052.x; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wellman PJ, 2007, PHARMACOL BIOCHEM BE, V88, P89, DOI 10.1016/j.pbb.2007.07.008; Wellman PJ, 2011, REGUL PEPTIDES, V172, P77, DOI 10.1016/j.regpep.2011.08.014; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	71	133	135	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71284	10.1371/journal.pone.0071284	http://dx.doi.org/10.1371/journal.pone.0071284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977009	Green Published, gold, Green Submitted			2022-12-27	WOS:000324527300010
J	Jiang, FS; Li, WP; Huang, YF; Chen, YT; Jin, B; Chen, NP; Ding, ZS; Ding, XH				Jiang, Fusheng; Li, Weiping; Huang, Yanfen; Chen, Yitao; Jin, Bo; Chen, Nipi; Ding, Zhishan; Ding, Xinghong			Antioxidant, Antityrosinase and Antitumor Activity Comparison: The Potential Utilization of Fibrous Root Part of Bletilla striata (Thunb.) Reichb.f.	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; TYROSINASES; PREVENTION; EXTRACTS; SEQUENCE; ORCHIDS; AGENTS; PLANT	This study was carried out to evaluate the utilization probability of the fibrous root part (FRP) of Bletilla striata, which was usually discarded and harvesting pseudobulb part (PSP). The chemical composition, total phenolic content, DPPH radical scavenging activity, Ferric-reducing antioxidant power and tyrosinase inhibition activity were compared between FRP and PSP. Antioxidant and pro-oxidant effect as well as antitumor effect of the extract of FRP and PSP were analyzed by in vitro cell system as well. Thin layer chromatography and high performance liquid chromatography analysis indicated that the chemical compositions in the two parts were similar, but the content in FRP was much higher than PSP. Meanwhile, the FRP extracts showed higher phenolic content, stronger DPPH scavenging activity, Ferric-reducing antioxidant capacity and tyrosinase inhibition activity. Sub-fraction analysis revealed that the distribution characteristic of phenolic components and other active constituents in FRP and PSP were consistent, and mainly deposited in chloroform and acetoacetate fractions. Especially, the chloroform sub-fraction (sch) of FRP showed extraordinary DPPH scavenging activity and tyrosinase inhibition activity, with IC50 0.848 mg/L and 4.3 mg/L, respectively. Besides, tyrosinase inhibition activity was even stronger than the positive compound arbutin (31.8 mg/L). Moreover, In vitro cell system analysis confirmed that FRP extract exerts comparable activity with PSP, especially, the sub-fraction sch of FRP showed better antioxidant activity at low dosage and stronger per-oxidant activity at high dosage, and both sch of FRP and PSP can dose-dependent induce HepG2 cells apoptosis, which implied tumor therapeutic effect. Considering that an additional 0.3 kg FRP would be obtained when producing 1.0 kg PSP, our work demonstrated that FRP is very potential to be used together with PSP.	[Jiang, Fusheng; Huang, Yanfen; Chen, Yitao; Jin, Bo; Chen, Nipi; Ding, Zhishan] Zhejiang Chinese Med Univ, Inst Biotechnol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Weiping] Zhejiang Chinese Med Univ, Dept Med Chem, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Ding, Xinghong] Zhejiang Chinese Med Univ, Anal & Testing Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Ding, XH (corresponding author), Zhejiang Chinese Med Univ, Anal & Testing Ctr, Hangzhou, Zhejiang, Peoples R China.	xinghongding@163.com	黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022; Sinnaeve, Davy/F-2293-2013; Rokni-Zadeh, Hassan/B-8098-2008	Madder, Annemieke/0000-0003-0179-7608; Sinnaeve, Davy/0000-0003-2556-5895; Rokni-Zadeh, Hassan/0000-0001-5503-0344; Dai, Haibin/0000-0002-5768-2714; Martins, Jose/0000-0001-7350-2253; De Vleeschouwer, Matthias/0000-0001-6889-1928; Rozenski, Jef/0000-0001-9624-5536	Public Welfare Technology Research Projects of Zhejiang Province [2011C22047]; New-Shoot Talented Man Plan Project of Zhejiang Province [2010R4100581/4CE2011R4100191/4CE2012R410038]	Public Welfare Technology Research Projects of Zhejiang Province; New-Shoot Talented Man Plan Project of Zhejiang Province	This research was supported by the Public Welfare Technology Research Projects of Zhejiang Province (No. 2011C22047, http://www.zjkjt.gov.cn/) and New-Shoot Talented Man Plan Project of Zhejiang Province (No. 2010R4100581/4CE2011R4100191/4CE2012R410038, http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Canadanovic-Brunet JM, 2009, INT J FOOD SCI TECH, V44, P269, DOI 10.1111/j.1365-2621.2007.01680.x; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Ding ZS, 2008, MOLECULES, V13, P220, DOI 10.3390/molecules13020220; Duan XW, 2007, MOLECULES, V12, P759, DOI 10.3390/12040759; Gan RY, 2010, J MED PLANTS RES, V4, P2438; Kaji H, 2009, J CLIN PHARM THER, V34, P197, DOI 10.1111/j.1365-2710.2008.00993.x; Kong JM, 2003, ACTA PHARMACOL SIN, V24, P7; Lei TC, 1999, CHINESE TRADITIONAL, V30, P336; Liang QY, 2006, J GUANGXI MED U, V23, P36; Lin SQ, 1994, THESIS NATL CHENG KU; Luo Y, 2010, J BIOMED MATER RES A, V94A, P193, DOI 10.1002/jbm.a.32711; Maisuthisakul P, 2009, FOOD CHEM, V117, P332, DOI 10.1016/j.foodchem.2009.04.010; Mao XL, 2011, CENTRAL S PHARM, V9, P604; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Marxen K, 2007, SENSORS-BASEL, V7, P2080, DOI 10.3390/s7102080; Morita H, 2005, BIOORG MED CHEM LETT, V15, P1051, DOI 10.1016/j.bmcl.2004.12.026; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Gutierrez RMP, 2010, J MED PLANTS RES, V4, P592; PONNAZHAGAN S, 1994, J INVEST DERMATOL, V102, P744, DOI 10.1111/1523-1747.ep12376924; [黄海云 Rui Haiyun], 2003, [南京师大学报. 自然科学版, Journal of Nanjing Normal University. Natural Science], V26, P94; Shi J, 2009, THESIS HAINAN U HAIN; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Smit N, 2009, INT J MOL SCI, V10, P5326, DOI 10.3390/ijms10125326; Sun DF, 2006, CHINESE WILD PLANT R, V25, P34; Sun F, 2007, J DALIAN I LIGHT IND, V26, P97; TAKAGI S, 1983, PHYTOCHEMISTRY, V22, P1011, DOI 10.1016/0031-9422(83)85044-4; VanGelder CWG, 1997, PHYTOCHEMISTRY, V45, P1309, DOI 10.1016/S0031-9422(97)00186-6; VIDENSEK N, 1990, J NAT PROD, V53, P1609, DOI 10.1021/np50072a039; Wang CM, 2006, BIOTECHNOL LETT, V28, P539, DOI 10.1007/s10529-006-0011-x; Wazir D, 2011, J PLANT BIOCHEM BIOT, V20, P234, DOI 10.1007/s13562-011-0051-8; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038; Yang Y, 2009, ASIA PACIFIC TRADITI, V5, P23; Zhang HH, 2010, FREE RADICAL BIO MED, V49, P2010, DOI 10.1016/j.freeradbiomed.2010.09.031; Zhu JY, 2011, THESIS FUJIAN U TRAD	35	73	82	6	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58004	10.1371/journal.pone.0058004	http://dx.doi.org/10.1371/journal.pone.0058004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	24098758	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900220
J	Wang, W; Zhou, MW; Huang, WB; Zhang, XL				Wang, Wei; Zhou, Minwen; Huang, Wenbin; Zhang, Xiulan			Ex-PRESS Implantation Versus Trabeculectomy in Uncontrolled Glaucoma: A Meta-Analysis	PLOS ONE			English	Article							EX-PRESS(TM) MINI GLAUCOMA; FILTRATION DEVICE; SHUNT	Objective: To evaluate the efficacy and tolerability of Ex-PRESS implantation (Ex-Press) compared with trabeculectomy (Trab) in the treatment of patients with uncontrolled glaucoma. Methods: A comprehensive literature meta-analysis was performed according to the Cochrane Collaboration methodology to identify controlled clinical trials comparing Ex-Press with Trab. Efficacy estimates were measured by weight mean difference (WMD) for the percentage intraocular pressure (IOP) reduction from baseline to end-point, odds ratio (OR) for complete success, and qualified success rates. Tolerability estimates were measured by OR for adverse events. All outcomes were reported with a 95% confidence interval (CI). Data were synthesized by Stata 11.0 SE for Windows. Results: Eight controlled clinical trials meeting the predefined criteria were included in the meta-analysis. A total of 605 eyes from 559 patients with medically uncontrolled glaucoma were included. The weighted mean difference of the percentage IOP reduction from baseline was 2.33 (95% confidence interval: -22.59-7.24) when comparing Ex-Press with Trab. Ex-Press was associated with numerically greater, but nonsignificant, IOP lowering efficacy than Trab. The pooled odds ratio comparing Ex-Press with Trab were 0.93 (0.39, 2.23) for the complete success rate and 1.00 (0.39, 2.56) for the qualified success rate. Ex-Press was associated with a significantly lower frequency of hypotony and hyphema than Trab, with pooled ORs of 0.29 (0.13, 0.65) and 0.36 (0.13, 0.97), respectively. Conclusion: Ex-Press was associated with equivalent efficacy to Trab in lowering IOP. Comparable proportions of patients reached the IOP target with Ex-Press and Trab. Ex-Press was better tolerated than Trab.	[Wang, Wei; Zhou, Minwen; Huang, Wenbin; Zhang, Xiulan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn	Zhao, Zenghui/F-8061-2013	Zhao, Zenghui/0000-0002-6335-1655	National Natural Science Foundation of China [81170849]; Guangdong Provincial Natural Science Foundation [S2011020002401]; Fundamental Research Funds of State Key Laboratory of Ophthalmology [2011C02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds of State Key Laboratory of Ophthalmology	This work was supported in whole or in part by the National Natural Science Foundation of China (81170849), Guangdong Provincial Natural Science Foundation (S2011020002401), and the Fundamental Research Funds of State Key Laboratory of Ophthalmology (2011C02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz Hassan, 2011, Ophthalmic Surg Lasers Imaging, V42 Online, pe94, DOI 10.3928/15428877-20110922-01; Dahan E, 2005, J GLAUCOMA, V14, P98, DOI 10.1097/01.ijg.0000151688.34904.b7; Dahan E, 2012, EYE, V26, P703, DOI 10.1038/eye.2012.13; De Feo F, 2009, CAN J OPHTHALMOL, V44, P457, DOI 10.3129/i09-120; de Jong L, 2011, CLIN OPHTHALMOL, V5, P527, DOI 10.2147/OPTH.S18565; de Jong LAMS, 2009, ADV THER, V26, P336, DOI 10.1007/s12325-009-0017-6; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Francis BA, 2011, OPHTHALMOLOGY, V118, P1466, DOI 10.1016/j.ophtha.2011.03.028; Gallego-Pinazo R., 2009, Arch Soc Esp Oftalmol, V84, P293; Good TJ, 2011, AM J OPHTHALMOL, V151, P507, DOI 10.1016/j.ajo.2010.09.004; Hendrick AM, 2008, EXPERT REV MED DEVIC, V5, P673, DOI 10.1586/17434440.5.6.673; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Maris PJG, 2007, J GLAUCOMA, V16, P14, DOI 10.1097/01.ijg.0000243479.90403.cd; Marzette L, 2011, OPHTHAL SURG LAS IM, V42, P453, DOI 10.3928/15428877-20111017-03; Mosaed S, 2010, EXPERT REV MED DEVIC, V7, P661, DOI 10.1586/ERD.10.32; Nyska A, 2003, J GLAUCOMA, V12, P275, DOI 10.1097/00061198-200306000-00017; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rouse JM, 2012, DEV OPHTHALMOL, V50, P90, DOI 10.1159/000334780; Salim S, 2012, CURR OPIN OPHTHALMOL, V23, P89, DOI 10.1097/ICU.0b013e32834ff401; Seider MI, 2012, J GLAUCOMA, V21, P469, DOI 10.1097/IJG.0b013e3182182bfb; Sugiyama T, 2011, CLIN OPHTHALMOL, V5, P1063, DOI 10.2147/OPTH.S23129	21	93	100	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e63591	10.1371/journal.pone.0063591	http://dx.doi.org/10.1371/journal.pone.0063591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	24489511	Green Published, Green Submitted, gold			2022-12-27	WOS:000319799900008
